rTERT	rat telomerase	1.0
SPy	stratum pyramidale–cornu ammonis	1.0
EC50	concentration resulting in half the maximum response (determined from dose–response curve)	0.333333333333
EC50	half maximal effective concentration	0.333333333333
EC50	half-maximal agonist concentration	0.333333333333
ASLA	rterial spin labeling	0.5
ASLA	pplied science laboratories	0.5
mCad8	mouse cadherin-8	1.0
REM-	carbacholrapid eye movement sleep induced by carbachol	1.0
u-PA	urokinase plasminogen activator	1.0
EPEI	ethoxylated polyethyleneimine	1.0
LASP	1lim and sh3 protein 1	1.0
SPZ	subparaventricular zone	1.0
EIPSP-A	reversal potential of the gabaa receptor mediated inhibitory postsynaptic potential	1.0
MSSN	medium-sized spiny neuron	1.0
bHLH-Zip	basic helix-loop-helix-leucine zipper	1.0
LPDP	arkinson's disease patients with left initial motor signs	1.0
SPR	spironolactone	0.0833333333333
SPR	stimulus presentation rate	0.0833333333333
SPR	substance p receptor	0.75
SPR	surrogate peer-reared	0.0833333333333
SPS	ubstance p	0.125
SPS	isingle prolonged stress with isoflurane instead of ether	0.125
SPS	superior peri-insular sulcus	0.125
SPS	single prolonged stress	0.25
SPS	1 week after single-prolonged stress	0.125
SPS	single-prolonged stress	0.125
SPS	synaptic vesicle	0.125
SPT	the sucrose preference test	0.0833333333333
SPT	static posturographic test	0.0833333333333
SPT	serine-palmitoyl transferase	0.0833333333333
SPT	single particle tracking	0.166666666667
SPT	serine palmitoyltransferase	0.0833333333333
SPT	short photoperiod testosterone supplemented	0.0833333333333
SPT	sucrose preference test	0.416666666667
SPV	slow phase velocity of the nystagmus	0.142857142857
SPV	subparaventricular area	0.142857142857
SPV	slow phase velocity	0.571428571429
SPV	synaptosomal vesicle pellet	0.142857142857
SPW	in vitro sharp wave	0.25
SPW	sharp wave	0.25
SPW	ssharp waves	0.5
LLSRL	ong latency stretch reflex	1.0
SPI	spironolactone	0.333333333333
SPI	serine protease inhibitor	0.333333333333
SPI	septum-preference index	0.333333333333
SPL	superior parietal	0.0126582278481
SPL	superior parietal lobule	0.0126582278481
SPL	spiral ligament	0.0126582278481
SPL	rmssound pressure level root-mean-square	0.0126582278481
SPL	ssound pressure levels	0.0126582278481
SPL	sound-pressure level	0.0126582278481
SPL	sound pressure level. sound levels in db spl are expressed relative to a reference intensity i0 of 10-12 w/m2 (equivalent to 20 μpa)	0.0126582278481
SPL	sound pressure level	0.848101265823
SPL	saphenous nerve partial ligation	0.0126582278481
SPL	lateral spiriform nucleus	0.0253164556962
SPL	the superior parietal lobule	0.0126582278481
SPL	spatial learning	0.0126582278481
SPM	statistical parametrical mapping	0.0232558139535
SPM	statistical parametric map	0.116279069767
SPM	5statistical parametric mapping 5	0.0232558139535
SPM	standard progressive matrices	0.0232558139535
SPM	synaptosomal membrane	0.0232558139535
SPM	statistical parametric mapping	0.46511627907
SPM	2synaptic plasma membranes type ii	0.0232558139535
SPM	99statistical parametric mapping 99	0.0232558139535
SPM	8statistical parametric mapping	0.093023255814
SPM	synaptic plasma membrane	0.0232558139535
SPM	synaptosomal plasma membrane	0.0232558139535
SPM	2 and 5statistical parametric mappingversions 2 and 5	0.0232558139535
SPM	statistical parametric map(ping)	0.0232558139535
SPM	spermine	0.046511627907
SPM	5statistical parametric mapping	0.046511627907
SPN	ssympathetic preganglionic neurons	0.0666666666667
SPN	spiny projections neuron	0.0166666666667
SPN	superior parolivary nucleus	0.0166666666667
SPN	superior paraolivary nucleus	0.0833333333333
SPN	sympathetic preganglionic neurons	0.166666666667
SPN	sacral parasympathetic nucleus	0.266666666667
SPN	spiny projection neurons	0.0166666666667
SPN	spinal parasympathetic nucleus	0.0166666666667
SPN	sympathetic preganglionic neuron	0.283333333333
SPN	sympathetic preganglionic neurone	0.0333333333333
SPN	sympathetic preganglionic neurones	0.0166666666667
SPN	sympathetic ganglionic neuron	0.0166666666667
SPO	synaptoporin	0.166666666667
SPO	superior paraolivary nucleus	0.666666666667
SPO	superior paraolivary nu	0.166666666667
SPA	subparafascicular area	0.25
SPA	scintillation proximity assay	0.125
SPA	n6-p-sulfophenyladenosine	0.125
SPA	severe perinatal asphyxia	0.25
SPA	counts	0.125
SPA	spontaneous physical activity	0.125
SPB	suprapyramidal blade	0.142857142857
SPB	0.1 m sorenson's phosphate buffer	0.142857142857
SPB	sucrose phosphate buffer	0.142857142857
SPB	sorenson's phosphate buffer	0.142857142857
SPB	sorenson’s phosphate buffer	0.142857142857
SPB	supra-pyramidal bundle	0.142857142857
SPB	sodium phosphate buffer	0.142857142857
SPC	streptavidin–peroxidase conjugate	0.25
SPC	sspinocerebellar purkinje cells	0.25
SPC	sphingosylphosphorylcholine	0.5
SPD	spermidine	0.75
SPD	sec-butyl-propylacetamide	0.25
SPE	solid phase extraction	1.0
SPF	psubparafascicular thalamic nucleus	0.0909090909091
SPF	pvparvocellular subparafascicular thalamic nucleus	0.0909090909091
SPF	subparafascicular thalamic nucleus	0.363636363636
SPF	specified pathogen-free	0.0909090909091
SPF	subparafasicular thalamic nucleus	0.0909090909091
SPF	subparafascicular nucleus	0.272727272727
SPG	sucrose–potassium phosphate–glyoxylic acid	0.166666666667
SPG	sphenopalatine ganglion	0.166666666667
SPG	spastic paraplegia	0.5
SPG	2spastic paraplegia type 2	0.166666666667
rIGLE	rectal intraganglionic laminar ending	1.0
BKchannel	large-conductance ca2+-activated potassium channel	1.0
TYDC	tyrosine decarboxylase	1.0
TUNEL	terminal transferase dutp nick-end labeling	0.00664451827243
TUNEL	tdt-deoxyuridine triphosphate nick-end-labelling	0.00332225913621
TUNEL	in situ dna nick end labeling	0.00332225913621
TUNEL	terminal transferase dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-biotin nick end-labeling assay	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp–biotin nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated biotin-deoxyuridinetriphosphate nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotide transferase-mediated dutp-biotin nick end labeling	0.00332225913621
TUNEL	terminal transferase dutp-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp-biotin nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase nick end labeling	0.00332225913621
TUNEL	terminal uridine nucleotide end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated x-dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dntp nick end labeling	0.00332225913621
TUNEL	tdt-mediated dutp-biotin nick end-labeling	0.00332225913621
TUNEL	staining	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated uridine 5′-triphosphate-biotin nick end labeling	0.00332225913621
TUNEL	tdt-mediated uridine 5′-triphosphate–biotin nick end labeling	0.00332225913621
TUNEL	tdt-dutp nick-end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyltransferase (tdt)-mediated dutp-biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated nick end labeling	0.00332225913621
TUNEL	transferase-mediated digoxigenin-dutp nick end-labeling	0.00332225913621
TUNEL	terminal deoxyribonucleotide transferase (tdt)-mediated dutp nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-biotin nick-end labeling	0.0166112956811
TUNEL	terminal deoxynucleotidyl biotinylated dutp nick-end labeling	0.00332225913621
TUNEL	terminal desoxynucleotidyl transferase-mediated desoxyuridine trisphosphate-nick end labeling	0.00332225913621
TUNEL	terminal (tdt)-mediated dutp-biotin nick end labeling	0.00664451827243
TUNEL	terminal deoxyribonucleotidyl transferase-mediated deoxyuridyltriphosphate nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase biotinylated dutp nick end-labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase 3′-hydroxyl dna strand break labeling	0.00332225913621
TUNEL	terminal deoxytransferase-mediated deoxyuridine triphosphate nick end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated fluorescein-dutp nick-end labeling	0.00332225913621
TUNEL	deoxynucleotidyl transferase biotin-dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp nick-end	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp nick end labelling	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase–mediated dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt) to 3′-oh ends of dna	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated biotinylated dutp-nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase biotin-14-utp nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase dutp nick-end labeling	0.0132890365449
TUNEL	terminal deoxynucleotide transferase-mediated dutp nick end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp-fluorescein nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotityl transferase-mediated dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-biotin nick end labeling	0.0166112956811
TUNEL	tdt-mediated dutp-biotin nick end-labelling	0.00332225913621
TUNEL	terminal dutp nick end labeling	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase-mediated biotinylated utp nick end labeling	0.0166112956811
TUNEL	terminal deoxynucleotidyl transferase-mediated 2′-deoxyuridine 5′-triphosphate–biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated biotinylated utp nick end-labeling	0.00332225913621
TUNEL	terminal transferase dutp nick end-labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated uridine 5′-triphosphate-biotin nick end labeling	0.00996677740864
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp nick-end labeling	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase-mediated digoxygenin-11-dutp nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase tdt-mediated brdutp nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp–biotin nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated biotinylated utp nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-digoxigenin nick end labeling	0.00332225913621
TUNEL	terminal transferase (tdt)-mediated dutp nick-end labelling	0.00332225913621
TUNEL	terminal dudp nick-end labeling	0.00332225913621
TUNEL	terminal transferase-mediated deoxyuridine triphosphate–biotin nick end labeling	0.00332225913621
TUNEL	terminal transferase biotinylated-dutp nick end labeling	0.00332225913621
TUNEL	dutp-nick end labeling	0.00332225913621
TUNEL	transferase-mediated dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp-biotin nick end-labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp nick-end labeling	0.063122923588
TUNEL	terminal deoxynucleotidyl dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-biotin nick end labelling	0.00332225913621
TUNEL	ternimal deoxynucleotidyl transferase dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dna nick-end labeling	0.00996677740864
TUNEL	terminal deoxynucleotidyl transferase-mediated biotin-deoxyuracil triphosphate nick-end labelling	0.00332225913621
TUNEL	terminal udp-nick end labeling	0.00332225913621
TUNEL	transferase dutp nick end-labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyltransferase-mediated dutp nick end labeling	0.0166112956811
TUNEL	terminal deoxynucleotidyl transferase-mediated digoxigenin-dutp-biotin nick-end labeling	0.00332225913621
TUNEL	terminal dutp nick-end labeling	0.0299003322259
TUNEL	terminal deoxynucleotidyl transferase-mediated dna nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling	0.00664451827243
TUNEL	reaction	0.00332225913621
TUNEL	tdt-mediated dutp nick-end labeling	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp-nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling	0.00332225913621
TUNEL	terminal transferase-mediated dutp nick-end labeling	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase dutp nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate (dutp) nick-end-labeling assay	0.00332225913621
TUNEL	tdt-mediated deoxyuridine triphosphate-biotin nick end-labeling	0.00332225913621
TUNEL	terminal deoxytransferase-mediated deoxyunidine triphosphate end-labelling	0.00332225913621
TUNEL	terminal transferase mediated dutp nick-end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated uridine triphosphate nick end labeling	0.00332225913621
TUNEL	terminal transferase-mediated deoxyuridine triphosphate nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated utp nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt) mediated-dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate–biotin nick-end labeling	0.00332225913621
TUNEL	terminal deoxytransferase-mediated dutp–biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-digoxigenin nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase dutp-mediated nicked end labeling	0.00332225913621
TUNEL	terminal tdt-mediated dutp–biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp nick end-labelling	0.00664451827243
TUNEL	terminal-deoxynucleotidyl transferase dutp nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp-biotin nick end labeling	0.0199335548173
TUNEL	triphosphate-biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase biotin-dutp nick end labelling	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated uridine 5′-triphosphate-biotin nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated uridine 5′-triphosphate–biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling	0.00664451827243
TUNEL	terminal transferase (tdt)-mediated dutp-biotin nick end-labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-biotin nick end labeling assay	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase-mediated biotin dutp nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt) mediated dutp-biotin nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase mediated dutp nick end labeling	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase–mediated dutp end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase biotinylated utp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated deoxyuridine triphosphate (dvtp)-biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp nick end-labeling	0.0265780730897
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick-end labeling	0.00332225913621
TUNEL	terminal deoxytransferase (tdt)-mediated dutp-biotin nick end labelling	0.00332225913621
TUNEL	dutp-biotin nick end labeling assay	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp nick end labeling	0.00664451827243
TUNEL	terminal deoxynucleotidyl dutp transferase nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyltransferase-mediated dutp nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated uridine-5′-triphosphate–biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase biotin-dutp nick end-labeling	0.00332225913621
TUNEL	terminal uridylated nick-end labeling	0.00332225913621
TUNEL	in situ terminal-deoxy-transferase mediated dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase–mediated dntp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp nick end labeling	0.0498338870432
TUNEL	terminal deoxynucleotidyl-transferase-mediated dutp-biotin nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase–mediated dutp nick-end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyltransferase-mediated utp end labeling	0.00332225913621
TUNEL	terminal deoxynucleotide transferase dutp nick end-labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase dutp nick-end labelling	0.00332225913621
TUNEL	terminal dutp nick-end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated deoxyuridine triphosphate (dutp)-digoxigenin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-nick-end-labeling	0.00332225913621
TUNEL	terminal uridine deoxynucleotidyl transferase	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated biotin–dutp nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotide transferase-mediated dutp nick-end labeling	0.00996677740864
TUNEL	terminal tdt-mediated dutp-biotin nick end labeling	0.00332225913621
TUNEL	definition?	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated 2′-deoxyuridine 5′-triphosphate-biotin nick-end labeling	0.00332225913621
TUNEL	terminal dideoxynucleotidyl transferase-catalysed 2′-deoxyuridine-5′-triphosphate nick end-labelling	0.00332225913621
TUNEL	terminal deoxynucleotide transferase-mediated dutp-nick end-labelling	0.00332225913621
TUNEL	terminal deoxyribonucleotidyl transferase-mediated biotin-16–dutp nick end labelling	0.00332225913621
TUNEL	terminal transferase-mediated dutp–biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferees (tdt)-mediated dutp nick end labeling	0.00332225913621
TUNEL	terminal tdt-mediated dutp-biotin nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate–biotin nick end-labeling	0.00664451827243
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-fluorescein nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated deoxy uridine triphosphate nick end labeling	0.00332225913621
TUNEL	terminal udp nick end labeling	0.00332225913621
TUNEL	terminal deoxytransferase-mediated deoxyuridine triphosphate nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated datfp biotin nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase dutp nick end	0.00332225913621
TUNEL	terminal transferase biotinylated dutp nick end labelling	0.00332225913621
TUNEL	tdt-mediated dutp nick end-labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-biotin in situ nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase (tdt)-mediated dutp nick end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp biotin nick end labeling	0.00664451827243
TUNEL	tdt-mediated biotin-14-dutp nick-end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-deoxyuridine triphosphate nick end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp nick-ending labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated-dutp-biotin nick-end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated 2′-deoxy-uridine-5′-triphosphate nick end labeling	0.00332225913621
TUNEL	+tdt-mediated dutp nick end labeling-positive	0.00332225913621
TUNEL	terminal(tdt), mediated dutp-nick end labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated-dutp nick end labeling	0.00332225913621
TUNEL	tdt-mediated dutp nick end labelling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase-mediated dutp-biotin nick end-labeling	0.00332225913621
TUNEL	terminal deoxynucleotidyl transferase dutp nick end labeling	0.0764119601329
TUNEL	terminal deoxynucleotidyl transferase biotin-dutp nick end labeling	0.0332225913621
XPC	xeroderma pigmentosum protein c	1.0
XPA	xeroderma pigmentosum protein a	1.0
REMs	rapid eye movements	1.0
CHThigh-affinity	sodium-dependent choline transporter	1.0
fPP	frog pancreatic polypeptide	1.0
MCAOMCA	occlusion	1.0
qP	average of qj	1.0
CSNK	2a2alpha prime subunit of casein kinase ii	1.0
t-PDC	trans-2,4-pyrrolidinedicarboxylic acid	1.0
ASSN	association	1.0
mnVII	facial efferent	1.0
REMP	rem period	1.0
REMR	apid eye movement	1.0
REMS	rapid eye movement sleep	0.882352941176
REMS	d-srremsd plus sr141716a	0.0588235294118
REMS	rapid-eye-movement sleep	0.0588235294118
S-S	s.c. saline	1.0
S-R	stimulus–response	0.5
S-R	stimulus-response	0.5
CAMKII	calcium/calmodulin protein kinase ii	0.4
CAMKII	calcium/calmodulin-dependent protein kinase ii	0.2
CAMKII	calmodulin protein kinase ii	0.2
CAMKII	calcium/calmodulin dependent-protein kinase ii	0.2
PQQ	)	1.0
S-M	orsingle morphine exposure	1.0
S-L	s.c. ng-nitro-l-arginine methyl ester	1.0
IR-DIC	infrared–differential interference contrast	0.0625
IR-DIC	infrared-differential interference contrast	0.25
IR-DIC	infra-red differential interference contrast	0.0625
IR-DIC	infrared differential interference contrast	0.625
RARα	retinoic acid receptor α	1.0
RARβ	retinoid acid receptor β	1.0
JNK	–mapksc-jun-n-terminal kinase–mitogen-activated protein kinases	0.008
JNK	c-jun n-terminal kinases	0.048
JNK	c-jun nh2-terminal kinase-1	0.008
JNK	c-jun n-terminal protein kinase	0.04
JNK	c-jun n-terminal protein kinases	0.008
JNK	1c-jun n-terminal kinase	0.008
JNK	c-jun n-terminal kinase 1/2	0.008
JNK	c-jun nh2-terminal kinase	0.064
JNK	sc-jun amino-terminal kinases	0.008
JNK	sc-jun n-terminal kinases	0.016
JNK	c-jun n terminal kinase	0.008
JNK	3c-jun n-terminal kinase 3	0.032
JNK	c-jun nh2-terminal protein kinase or stress-activated protein kinase (sapk)	0.016
JNK	jun-n-terminal kinase	0.008
JNK	/sapkc-jun n-terminal protein kinase/stress-activated protein kinase	0.008
JNK	c-jun-n-terminal kinases	0.008
JNK	1/2c-jun-n-terminal kinase1/2	0.008
JNK	c-jun nh2-terminal kinase or stress-activated protein kinase (sapk)	0.008
JNK	c-jun-n-terminal kinases 1/2	0.008
JNK	c-jun n-terminal kinase	0.584
JNK	jun n-terminal kinase	0.024
JNK	c-jun-n-terminal kinase	0.04
JNK	cjun n-terminal kinase	0.008
JNK	jun kinase	0.008
JNK	c-jun n-terminal	0.008
JNK	c-jun amino terminal kinase1	0.008
ASST	attention-set-shifting task	1.0
GART-CRII	glycinamide ribonucleotide formyltransferase-cytokine receptor class ii	1.0
S-B	acs-baclofen	1.0
ASSR	auditory steady-state responses	1.0
NO-	7111-[2-[[(diphenylmethylene)imino]oxy]	0.75
NO-	synthase interneurons	0.25
BEI	brain efflux index	1.0
LPS-	4leistungsprüfungssystem 4	1.0
BEL	blood ethanol level	0.666666666667
BEL	4-bromoenol lactone	0.333333333333
BEM	boundary element model	1.0
6-PPH4	6-pyruvoyl-tetrahydropterin	1.0
BEC	blood ethanol contentration	0.0454545454545
BEC	sblood ethanol concentrations	0.136363636364
BEC	blood etoh concentration	0.0454545454545
BEC	blood ethanol concentration	0.545454545455
BEC	blood ethanol concentrations	0.0909090909091
BEC	bilateral entorhinal cortical lesions	0.0454545454545
BEC	sblood etoh concentrations	0.0454545454545
BEC	blood ethanol content	0.0454545454545
PAGDrost	periaqueductal gray, dorsal, rostral	1.0
BED	binge eating disorder	1.0
HL-	60 cells	0.5
HL-	60human promyelocytic leukemia hl 60 cell line	0.5
ENC	entorhinal cortex	0.5
ENC	engineered neural conduits	0.5
NADPHoxidase	nicotinamide adenine dinucleotide phosphate-oxidase	1.0
FrPaSS	frontoparietal somatosensory	1.0
CIAP	calf intestinal alkaline phosphatase	1.0
BER	β-endorphin-like immunoreactivity	0.0625
BER	base excision repair	0.9375
TREK-	1twik-1 related k+ channel	0.5
TREK-	1a two-pore domain (k(2)p) potassium channel	0.5
BET	brain extraction tool	0.5
BET	bromodomain and extraterminal	0.5
-DDA	2′5′-dideoxyadenosine	1.0
irCRHCRH	immunoreactivity	1.0
TMAOH	tetramethylammonium hydroxide	1.0
PCV	packed cell volume	1.0
GAP43	growth associated protein-43	0.5
GAP43	growth-associated protein 43	0.5
RFT	rise–fall time	0.333333333333
RFT	rod and frame test	0.666666666667
b-CT	subunit b of cholera toxin	1.0
GR-	113808[1-[2-methylsulphonylamino ethyl]-4-piperidinyl]	0.5
GR-	1254875-fluoro-2-methoxy-[1-[2-[(methylsulfonyl)amino]ethyl]	0.5
RFX	random effect model	1.0
DARTEL	diffeomorphic anatomical registration through exponentiated lie algebra	1.0
GRS	granular retrosplenial cortex	0.5
GRS	glutamate receptor subunit	0.5
GRP	30	0.0357142857143
GRP	gastrin releasing peptide	0.142857142857
GRP	gastrin-releasing peptide	0.428571428571
GRP	7878-kda glucose-regulated protein	0.0357142857143
GRP	glucose regulated protein	0.0357142857143
GRP	glucose-regulated protein	0.214285714286
GRP	78glucose-regulated proteins 78	0.0357142857143
GRP	glial-restricted precursor	0.0714285714286
GRX	glutathione reductase	1.0
GRF	ground reaction force	0.5
GRF	growth hormone releasing factor	0.5
GRG	lucocorticoid	0.5
GRG	lycyrrhiza	0.5
GRD	dorsal root ganglia	1.0
GRE	glucocorticoid receptor response element	0.0769230769231
GRE	glucocorticoid response element	0.461538461538
GRE	glucocorticoid responsive element	0.0769230769231
GRE	sglucocorticoid response elements	0.307692307692
GRE	3-lucbnip3 promoter with isolated putative gre3 site	0.0769230769231
GRB	2growth factor receptor bound protein 2	1.0
GRC	glucocorticoid receptor complex	1.0
VNTB	ventral nucleus of the trapezoidal body	0.142857142857
VNTB	ventral nucleus of the trapezoid body	0.857142857143
GRA	gravitational torque	1.0
GRN	granulin	0.666666666667
GRN	escreglucocorticoid receptor knock-out in the brain	0.333333333333
GRO	growth-related oncogene	0.333333333333
GRO	/kcgrowth-related oncogene (also called cxcl1)	0.333333333333
GRO	/kcgrowth-related oncogene	0.333333333333
GRL	granular cell layer	0.25
GRL	granule cell layer	0.75
GRM	5glutamate receptor metabotropic 5	0.5
GRM	3glutamate receptor 3	0.5
GRK	2g-protein-coupled receptor kinase 2	0.153846153846
GRK	g protein-coupled receptor kinase	0.153846153846
GRK	g-protein-coupled receptor kinase	0.230769230769
GRK	g-protein coupled receptor kinase	0.0769230769231
GRK	5g protein-coupled receptor kinase 5	0.0769230769231
GRK	sgpcr regulating kinases	0.0769230769231
GRK	2g protein-coupled receptor kinase 2	0.0769230769231
GRK	5g protein–coupled receptor kinase 5	0.0769230769231
GRK	1g protein-coupled receptor kinase 1 (rhodopsin kinase)	0.0769230769231
GRH	growth hormone-releasing hormone	1.0
sTNFRI	/fcrecombinant human stnf receptor i chimera protein	1.0
ENP	enriched no-porsolt	0.5
ENP	(porcine) expanded neural precursor	0.5
NON	ejacmales that mated but not to ejaculation within the 30-min test	1.0
TREKT	andem of p domains in a weak inwardly-rectifying potassium channel–related potassium channel	1.0
ES-SSS	electrical stimulation of the dura mater surrounding the superior sagittal sinus	1.0
LPSL	ipopolysaccharide	1.0
NOD	nucleotide binding oligomerization domain	0.333333333333
NOD	non-obese diabetic	0.333333333333
NOD	novel object discrimination	0.333333333333
SOD-1	cuzn superoxide dismutase	0.5
SOD-1	copper/zinc superoxide dismutase type 1	0.5
PPNd	pedunculopontine nucleus pars dissipata	1.0
SCNX	suprachiasmatic lesion group	1.0
LPSE	lithium–pilocarpine model of status epilepticus	1.0
PPNc	pedunculopontine nucleus pars compacta	1.0
NOC	nicotine+oral contraceptives	0.333333333333
NOC	nociceptin	0.666666666667
TJP	tight junction protein	0.5
TJP	stight junction proteins	0.5
ppTK	preprotachykinin	1.0
NOX	2nadph oxidase 2	0.2
NOX	3nicotinamide adenine dinucleotide phosphate-oxidase 3	0.2
NOX	3	0.2
NOX	normoxic control mice/normoxia	0.2
NOX	4	0.2
TJT	ight junction	1.0
HLH	helix-loop-helix	0.5
HLH	uang-lian-jie-du decoction	0.5
NOT	nucleus of the optic tract	0.888888888889
NOT	the novel object test	0.111111111111
fNIRS	functional near-infrared spectroscopy	1.0
IC-50	concentration to produce 50% depression	1.0
RITC	rhodamine-b-isothiocyanate	0.25
RITC	rhodamine isothiocyanate	0.75
NOR	nuclear orphan receptor	0.0833333333333
NOR	novel object recognition memory	0.0833333333333
NOR	novel-object recognition	0.0833333333333
NOR	noradrenaline	0.0833333333333
NOR	novel object reactivity	0.0833333333333
NOR	novel object recognition	0.583333333333
NOS	1apnitric oxide synthase 1	0.00299401197605
NOS	nitric oxide synthases	0.00299401197605
NOS	nitric synthase	0.00299401197605
NOS	neuronal isoform of the nitric oxide synthase	0.00299401197605
NOS	nitric oxide synthesis	0.00299401197605
NOS	redc-terminal electron-supplying nitric oxide synthase reductase module	0.00299401197605
NOS	sno synthases	0.00299401197605
NOS	neuronal nitric oxide synthase	0.00299401197605
NOS	reactive nitrogen species	0.00299401197605
NOS	nitric oxide synthetase	0.00299401197605
NOS	nitric oxide-synthesizing enzymes	0.00299401197605
NOS	2-/-inducible nitric oxide synthase 2 knockout	0.00299401197605
NOS	no synthase	0.0149700598802
NOS	nitric oxide synthase	0.937125748503
NOS	initric oxide synthase i	0.00299401197605
NOS	number of spikes in unit burst	0.00299401197605
NOS	2nitric oxide synthase 2	0.0059880239521
ICAM-I	intercellular adhesion molecule i	1.0
mAU	milli-absorbance unit	1.0
RFE	rod-and-frame effect	1.0
GAIPGα-	interacting protein	1.0
catechol-O-	methyltransferase	1.0
FJB	fluoro-jade b	0.833333333333
FJB	fluorojade b	0.166666666667
FJF	luoro-jade b	0.2
FJF	luoro-jade	0.8
ED-	1also known as cd68	0.333333333333
ED-	50effective dose	0.333333333333
ED-	1ectodysplasin 1	0.333333333333
DNCB2	4-dinitrochlorobenzene	1.0
mAC	hrmuscarinic acetylcholine receptors	0.027027027027
mAC	hrsmuscarinic acetylcholine receptors	0.108108108108
mAC	hrmuscarinic-acetylcholine receptor	0.027027027027
mAC	hrsmuscarinic cholinergic receptors	0.0540540540541
mAC	h receptors	0.027027027027
mAC	hrmuscarinic acetylcholine receptor	0.72972972973
mAC	hrmuscarinic ach receptor	0.027027027027
mAB	monoclonal antibody	0.666666666667
mAB	mouse monoclonal antibody	0.333333333333
PIGDP	ostural instability and gait disorder	1.0
ICARSI	nternational cooperative ataxia rating scale	1.0
L-AβH	l-aspartate-β-hydroxamate	1.0
SLIGRL-NH	2par-2 agonist	0.5
SLIGRL-NH	2ser–leu–ile–gly–arg–leu–amide	0.5
Thr4	gly7]-oxytocin	1.0
6-Methoxy-2	3-dihydro-[1,4]dioxino[2,3-b]	1.0
S-MCPG	(s)-α-methyl-4-carboxyphenylglycine	0.5
S-MCPG	(s)-α-methyl-3-carboxymethylphenylglycine	0.5
scRT-PCR	single-cell reverse transcriptase–polymerase chain reaction	0.25
scRT-PCR	single cell reverse transcription polymerase chain reaction	0.25
scRT-PCR	single-cell reverse transcriptase polymerase chain reaction	0.25
scRT-PCR	single cell reverse transcriptase polymerase chain reaction	0.25
MDCKIIM	adin-darby canine kidney cells strain ii	1.0
SLB-D	small ligand-binding domain	1.0
SNAREs	snap receptors	1.0
mAb	monoclonal antibody	1.0
RFM	reticular formation	1.0
PECAM	1platelet endothelial cell adhesion molecule-1	0.25
PECAM	platelet/endothelial cell adhesion molecule-1	0.25
PECAM	1platelet endothelial cell adhesion molecule	0.25
PECAM	platelet endothelial cell adhesion molecule	0.25
9S	10s,12r)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1h-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i]	0.5
9S	10r,12r)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1h-diindolo[1,2,3-fg:3′,2′,1′- kl]pyrrolo[3,4-i]	0.5
CFSE	carboxyfluorescein succinimidyl ester	1.0
ARTM	artemin	1.0
CAMKIIα	type ii calcium/calmodulin-dependent protein kinase	1.0
ARTN	artemin	1.0
MK-801dizocilpine	(5r,10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine	0.25
MK-801dizocilpine	(5r,10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate	0.75
ENa	na+ equilibrium potential	0.5
ENa	equilibrium potential of na+	0.5
βFNAβ-	funaltrexamine	1.0
MCAO-S	middle cerebral artery occlusion with only subcortical damage	1.0
DIVD	ays in vitro	1.0
DIVA	nucleus dorsalis intermedius ventralis anterior	1.0
PLV	phase-locked value	1.0
ODN-AS	oligodeoxynucleotide antisense	1.0
NaCNsodium	cyanide	1.0
TDCS	transcranial direct current stimulation	1.0
MCAO-C	middle cerebral artery occlusion with cortical and subcortical damage	1.0
AATα	1-antitrypsin	1.0
V-P	volume-percent	1.0
RLM	rhodamine latex microspheres	1.0
EDC	extensor digitorum communis	0.142857142857
EDC	ethanol-derived calories	0.142857142857
EDC	ethanol derived calories	0.285714285714
EDC	ethanol-derived total calories	0.142857142857
EDC	1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hcl	0.142857142857
EDC	endocrine disrupting chemical	0.142857142857
VR-1	vanilloid receptor type 1	1.0
RLN	recurrent laryngeal nerve	1.0
RLI	rostral linear nucleus	1.0
O12	orbital area 12	1.0
EDD	selectron-dense deposits	1.0
RLE	recent life events	1.0
RLF	rate-level function	1.0
Rp-8CPT-cAMPS	adenosine 3′,5′-cyclic monophosphorothiotate, 8-(4-chlorophenylthio)-rp isomer	1.0
EDL	extensor digitorum longus	0.814814814815
EDL	musculus extensor digitorum longus	0.037037037037
EDL	extensor digitorum longus muscle	0.111111111111
EDL	extensor digitorum longi	0.037037037037
LMW	low-molecular-weight	0.5
LMW	low molecular weight	0.25
LMW	low molecular weight form	0.25
EDR	extradimensional reversal	1.0
EDS	extradimensional set-shift	0.285714285714
EDS	extradimensional shift	0.285714285714
EDS	extra-dimensional shifts	0.142857142857
EDS	excessive daytime sleepiness	0.285714285714
nBMam	anteromedial subdivision of nucleus basalis of meynart	1.0
nBMal	anterolateral subdivision of nucleus basalis of meynart	1.0
LML	lacunosum moleculare layer	1.0
LMM	linear mixed model	1.0
SNCAα-	synuclein	0.666666666667
SNCAα-	synuclein mrna	0.333333333333
RLZ	44mg/kg riluzole	1.0
RLU	relative light unit	0.6
RLU	relative light units	0.4
LMA	locomotor activity	0.833333333333
LMA	locomotor activity test	0.166666666667
ICAM-1	intercellular adhesion molecule-1	0.8
ICAM-1	intercellular cell adhesion molecule-1	0.2
LMC	lateral motor column	0.666666666667
LMC	mmedial lmc	0.333333333333
LME	l-leucine methyl ester	1.0
RLS	rostro-lateral rhombencephalic respiratory site	0.142857142857
RLS	restless legs syndrome	0.857142857143
RLR	inger–locke solution	0.333333333333
RLR	rostrolateral rhombencephalon	0.666666666667
ADAMTS	a disintegrin and metalloproteinase with thrombospondin motifs	0.5
ADAMTS	a disintegrin and metalloprotease with thrombospondin motifs	0.5
DPV	differential pulse voltammetry	1.0
OUHSCT	he university of oklahoma health sciences center	1.0
DPT	days posttransfection	0.25
DPT	dynamic posturographic test	0.25
DPT	dorsal pontine tegmentum	0.25
DPT	days post-transplantation	0.25
DPS	days poststroke	0.5
DPS	zdays post-seizures	0.5
PKC1β	1β isoform of protein kinase c	1.0
DPQ	34-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2h)-isoquinolinone	1.0
La	lateral amygdaloid nucleus	0.666666666667
La	lateral amygdala	0.333333333333
PN1	post-natal day 1	1.0
Ll	lateral nucleus, lateral division	1.0
Lm	lateral nucleus, medial division	1.0
Rp-8-Br-cGMPS	(rp)-8-bromoguanosine-3′,5′-cyclic monophosphorothioate	0.5
Rp-8-Br-cGMPS	8-bromoguanosine,3′,5′-cyclic monophosphorothioate, rp-isomer	0.5
DPZ	donepezil	1.0
DPY	α,α′(2,2′)-dipyridyl	1.0
DPX	dtg, 1,3-di(2-tolyl)guanidine	0.0909090909091
DPX	dibutyl phthalate xylene	0.272727272727
DPX	distyrene plasticizer xylene	0.181818181818
DPX	dibutyl phathalate xylene	0.0909090909091
DPX	distrene plasticizer xylene	0.181818181818
DPX	dibutyl phthalate and xylene	0.0909090909091
DPX	distyrene plasticizer xylene mix	0.0909090909091
DPG	idorsal paragigantocellular nucleus	0.666666666667
DPG	idorsal paragigantocellular reticular nucleus	0.333333333333
DPF	days post fertilization	1.0
mFC	medial frontal cortex	1.0
DPD	paired whisker	0.5
DPD	i-n-butyle phthalate in xylene	0.5
DPC	diphenylamine-2-carboxylate	0.4
DPC	dense parietal cortex	0.2
DPC	dystrophin-associated protein complex	0.4
4-DAMP	: 11-dimethyl-4-diphenylacetoxypiperidinium iodide	0.0909090909091
4-DAMP	4-diphenylacetoxy-n-methyl-piperidine	0.0909090909091
4-DAMP	4-diphenylacetoxy-n-methylpiperidine	0.0909090909091
4-DAMP	4-diphenylacetoxy-n-(2-chloroethyl)-piperidine hydrochloride	0.0909090909091
4-DAMP	4-diphenylacetoxy-n-(2-chloroethyl)piperidine methiodide	0.0909090909091
4-DAMP	4-diphenylacetoxy-n-methylpiperidine methiodide	0.545454545455
DPA	delayed-paired associate task	0.2
DPA	docosapentaenoic acid (22:5 n-6)	0.2
DPA	differential pulse amperometry	0.4
DPA	22:5n-6	0.2
DOPAC	dihydroxyphenylacetic	0.00934579439252
DOPAC	3,4-dihydroxy-phenylacetic acid	0.00934579439252
DOPAC	3,4-dihydroxyphenylic acid	0.00934579439252
DOPAC	dihydrophenylacetic acid	0.00934579439252
DOPAC	3′4-dihydroxyphenylacetic acid	0.00934579439252
DOPAC	dihydroxy-phenyl acetic acid	0.00934579439252
DOPAC	dihydroxyphenyl acetic acid	0.0280373831776
DOPAC	dihydroxy-phenylacetic acid	0.00934579439252
DOPAC	3-4-dihydroxyphenylacetic acid	0.0280373831776
DOPAC	3:4-dihydroxyphenylacetic acid	0.00934579439252
DOPAC	3-4-dihydroxphenylacetic acid	0.00934579439252
DOPAC	3,4-dihydroxy-l-phenylacetic acid	0.00934579439252
DOPAC	3,4-dihydroxyphenylacetic acid	0.439252336449
DOPAC	dihydroxyphenylacetic acid	0.411214953271
DPN	diffuse peripheral neuropathy	0.0769230769231
DPN	diaryl-propionitrile	0.0769230769231
DPN	diarylpropionitril	0.0769230769231
DPN	dorsal penile nerve	0.0769230769231
DPN	diabetic peripheral polyneuropathy	0.0769230769231
DPN	days postnatum	0.0769230769231
DPN	diarylpropionitrile	0.538461538462
DPM	disintegration per minute	0.3
DPM	disintegrations per minute	0.7
DPL	days post-lesion	0.5
DPL	dentate polymorphic layer	0.5
MDC	monodansylcadaverine	0.666666666667
MDC	metalloproteinase-like, disintegrin-like, cysteine-rich	0.333333333333
DPI	diphenyleneiodonium chloride	0.181818181818
DPI	diphenylene iodonium	0.181818181818
DPI	diphenyleneiodonium	0.363636363636
DPI	diphenylenodium	0.0909090909091
DPI	depolarization-induced potentiation of inhibition	0.0909090909091
DPI	days post-insult	0.0909090909091
DPH	diphenhydramine	0.5
DPH	1,6-diphenyl-1,3,5-hexatriene	0.5
LF	low frequencies components in the power spectral analysis	0.0333333333333
LF	low frequency component of heart rate variability	0.0333333333333
LF	lateral fissure	0.0333333333333
LF	low frequency	0.266666666667
LF	2000lipofectamine 2000	0.0333333333333
LF	load force	0.0333333333333
LF	left frontal	0.0333333333333
LF	nucleus intermediolateralis, pars funicularis	0.0666666666667
LF	lateral-frontal	0.0333333333333
LF	low fat control	0.0333333333333
LF	low-fat diet	0.0333333333333
LF	lower-fit	0.0333333333333
LF	lateral funiculus	0.166666666667
LF	low frequency neurons	0.0333333333333
LF	later forgotten	0.0333333333333
LF	low-frequency component power	0.0333333333333
LF	low-frequency	0.0666666666667
LG	licking and grooming	0.047619047619
LG	low grooming rat	0.047619047619
LG	licking grooming	0.047619047619
LG	licking/grooming	0.190476190476
LG	thalamic lateral geniculate nucleus	0.047619047619
LG	lateral gastrocnemius	0.0952380952381
LG	lateral geniculate body	0.047619047619
LG	light grey	0.047619047619
LG	lateral geniculate area	0.047619047619
LG	linkage group	0.047619047619
LG	lateral gastrocnemius muscle	0.047619047619
LG	lateral geniculate	0.047619047619
LG	low grooming	0.047619047619
LG	lateral geniculate nucleus of the thalamus	0.047619047619
LG	lateral geniculate nucleus	0.142857142857
LD	lateral dorsal thalamus	0.00787401574803
LD	laterodorsal thalamic nucleus	0.0866141732283
LD	lateral dorsal nucleus of the thalamus	0.00787401574803
LD	late diestrus	0.00787401574803
LD	12:12 light–dark cycle	0.00787401574803
LD	12:1212-h light/dark	0.00787401574803
LD	light:dark schedule	0.00787401574803
LD	lateral dorsal nucleus	0.0236220472441
LD	light–dark	0.0708661417323
LD	12:1212-h light:12-h dark	0.00787401574803
LD	50dose that will kill 50% of mice injected within a four day period	0.00787401574803
LD	50lethal dose 50	0.00787401574803
LD	low-density	0.00787401574803
LD	latissimus dorsi	0.00787401574803
LD	light–dark condition	0.00787401574803
LD	12-h light:12-h dark	0.00787401574803
LD	long-day lighting	0.00787401574803
LD	12:1212-h light/dark cycle	0.0157480314961
LD	laterodorsal nucleus	0.0157480314961
LD	thallaterodorsal thalamus	0.00787401574803
LD	lexical decision	0.00787401574803
LD	lateral dorsal thalamic nucleus	0.00787401574803
LD	light:dark	0.0157480314961
LD	light–dark cycle	0.0314960629921
LD	low vesicular density	0.00787401574803
LD	light-dark condition	0.00787401574803
LD	ilatissimus dorsi	0.0157480314961
LD	laser doppler	0.0157480314961
LD	light: dark cycle	0.00787401574803
LD	light/dark box	0.00787401574803
LD	lateral dorsal nucleus of thalamus	0.00787401574803
LD	12:1212 h light: 12 h dark	0.00787401574803
LD	14-h light/10-h dark photocycle	0.00787401574803
LD	24-h light/dark cycle	0.00787401574803
LD	long days	0.00787401574803
LD	light:dark cycle	0.00787401574803
LD	light/lark	0.00787401574803
LD	light-dark (standard lighting cycle)	0.00787401574803
LD	long day length	0.00787401574803
LD	12-h light/dark cycle	0.00787401574803
LD	low dose	0.00787401574803
LD	(50)median lethal dose	0.00787401574803
LD	long day	0.0314960629921
LD	light/dark cycle	0.133858267717
LD	the light/dark (ld) box	0.00787401574803
LD	lateral dorsal nucleus thalamus	0.00787401574803
LD	light/dark	0.157480314961
LD	light dark	0.0157480314961
LD	low depression	0.00787401574803
LD	light deprivation	0.00787401574803
LD	linkage disequilibrium	0.0236220472441
LD	light-dark	0.00787401574803
LD	long-day conditions	0.00787401574803
LD	light–dark transition task	0.00787401574803
LD	long-lasting depression	0.0157480314961
LD	light–dark conditions	0.00787401574803
LD	lateral dorsal	0.00787401574803
LE	linear envelope	0.05
LE	2low dose 17β-estradiol-3-benzoate	0.05
LE	long–evans rat	0.05
LE	leu-enkephalin	0.05
LE	ntlateral entorhinal cortex	0.45
LE	labeling efficiency	0.1
LE	left ear	0.05
LE	large excitatory bouton type	0.05
LE	low estrogen	0.05
LE	persistently low exploratory activity	0.05
LE	lateral entorhinal	0.05
LB	lower blade	0.2
LB	low bigram string	0.2
LB	slewy bodies	0.6
LC	/msliquid chromatography–mass spectrometry	0.00287356321839
LC	linear classifier	0.00287356321839
LC	locus coerulus	0.00287356321839
LC	lit compartment.	0.00287356321839
LC	locus coeruleus	0.778735632184
LC	3microtubule-associated protein light chain 3	0.00287356321839
LC	lateral cortex of the inferior colliculus	0.00287356321839
LC	132	0.00287356321839
LC	–ms/msliquid chromatography–tandem mass spectrometry	0.00574712643678
LC	locus coereleus	0.00287356321839
LC	3microtubule-associated light chain protein-3	0.00287356321839
LC	late component	0.00287356321839
LC	3light chain 3	0.00862068965517
LC	locus ceruleus	0.0287356321839
LC	low-chirping	0.00287356321839
LC	clathrin light chain	0.00287356321839
LC	/ms/msliquid chromatography tandem mass spectrometry	0.00574712643678
LC	50lethal concentration of 50% cell death	0.00287356321839
LC	3	0.00574712643678
LC	nucleus locus coeruleus	0.00574712643678
LC	langerhans cell	0.00287356321839
LC	liquid chromatography–mass spectrometry	0.00287356321839
LC	locus coeruleus nucleus	0.00287356321839
LC	locus cœruleus	0.00287356321839
LC	low-calorie condition	0.00287356321839
LC	/msliquid chromatographic–mass spectrometric	0.00287356321839
LC	low density lipoprotein receptor-related protein light chain	0.00287356321839
LC	locous coeruleus	0.00287356321839
LC	linear combination	0.00287356321839
LC	/ms/mstandem mass spectroscopy	0.00287356321839
LC	light chain	0.00574712643678
LC	omlower center of mass	0.00287356321839
LC	acaudal lobe of cerebellum	0.00287356321839
LC	l-carnitine	0.00287356321839
LC	3microtubule-associated protein1 light chain 3	0.00574712643678
LC	large clip	0.00287356321839
LC	/ms/mshigh performance liquid chromatography–tandem mass spectrometry	0.00287356321839
LC	liquid chromatography	0.00862068965517
LC	3-ii1a/1b-light chain 3	0.00287356321839
LC	3light chain 3 of microtubule-associated protein 1a and b	0.00287356321839
LC	–msliquid chromatography–mass spectrometry	0.00574712643678
LC	3microtubule-associated protein 1a/1b light chain 3	0.00287356321839
LC	3microtubule-associated protein-1a/1b light chain 3	0.00287356321839
LC	/ms/msliquid chromatography/mass spectrometry	0.00574712643678
LC	/msliquid chromatography/mass spectrometry	0.0172413793103
LC	/sclocus coeruleus/subcoeruleus	0.00287356321839
LC	3:(map1lc3)microtubule-associated protein light chain 3	0.00287356321839
LC	–ms/msliquid chromatography–mass spectrometry	0.00287356321839
LC	3microtubule-associated protein 1 light chain 3	0.00862068965517
LC	–nelocus coeruleus–norepinephrine	0.00287356321839
BOC-CCK4	n-tert-butoxy-carbonyl-cholecystokinin tetrapeptide	1.0
LA	levator ani	0.0333333333333
LA	low-anxiety	0.0222222222222
LA	lateral nucleus of bla	0.0111111111111
LA	low-anxiety rats	0.0111111111111
LA	low-anxious	0.0111111111111
LA	light-adapted	0.0111111111111
LA	local anesthetics	0.0111111111111
LA	lateral nucleus of amygdala	0.0333333333333
LA	lateral amygdala	0.177777777778
LA	lateral amygdale	0.0111111111111
LA	rea l pallii	0.0111111111111
LA	lateral amygdalar nucleus	0.0222222222222
LA	lateroanterior hypothalamic nucleus	0.0444444444444
LA	high/low autotomy selection lines	0.0111111111111
LA	lateral hypothalamic area	0.0111111111111
LA	linoleic acid	0.0333333333333
LA	lower asymptote	0.0111111111111
LA	long-lasting afterhyperpolarization	0.0111111111111
LA	lateral nucleus of the amygdale	0.0222222222222
LA	lactic acid	0.0111111111111
LA	lateral nucleus of the amygdala	0.2
LA	lateral amygdaloid nucleus	0.0666666666667
LA	lateral amygdala nucleus	0.0111111111111
LA	low anxiety	0.0111111111111
LA	left atrium	0.0111111111111
LA	lipoic acid	0.0111111111111
LA	large aspiny	0.0222222222222
LA	nlow anxiety	0.0111111111111
LA	lateral nucleus	0.0333333333333
LA	light phase anesthesia	0.0111111111111
LA	levator ani muscle	0.0111111111111
LA	2kstudy of 2000 community volunteers in los angeles	0.0111111111111
LA	bulbocavernosus/levator ani muscle complex	0.0111111111111
LA	lactate	0.0111111111111
LA	slocal anesthetics	0.0111111111111
LA	locomotor activity	0.0222222222222
LA	lateral nucleus, amygdala	0.0111111111111
LN	light noise	0.0769230769231
LN	lateral nucleus of amygdala	0.0769230769231
LN	local interneuron	0.0769230769231
LN	lateral nucleus	0.0769230769231
LN	slocal interneurons	0.0769230769231
LN	natural logarithm	0.0769230769231
LN	lean male rats	0.0769230769231
LN	laminin	0.0769230769231
LN	dsdorsal lateral neurons	0.0769230769231
LN	lateral nerve	0.0769230769231
LN	modellinear–nonlinear cascade model	0.0769230769231
LN	lateral hypothalamic area	0.0769230769231
LN	late negativity	0.0769230769231
LO	lateral orbital cortex	0.533333333333
LO	low-intensity firing	0.0666666666667
LO	lipoxygenase	0.133333333333
LO	lateral orbitofrontal cortex	0.133333333333
LO	lateral occipital	0.0666666666667
LO	left occipital	0.0666666666667
LL	nucleus of lateral lemniscus	0.03125
LL	constant lighting conditions	0.03125
LL	nuclei of the lateral lemniscus	0.03125
LL	lower left quadrant	0.03125
LL	constant bright light	0.03125
LL	lower lip	0.03125
LL	light 24h	0.03125
LL	lateral lemniscus	0.21875
LL	large/late	0.03125
LL	prolonged constant light	0.03125
LL	light/light	0.03125
LL	lateral leminiscus	0.03125
LL	long latency	0.03125
LL	constant light	0.34375
LL	low-light open-field	0.03125
LL	bbrief constant light	0.03125
IκBI	kappa b	1.0
GBR-	129091-[2-[bis-(4-fluorophenyl)methoxy]ethyl]	0.142857142857
GBR-	129091-(2-(bis(4-fluorphenyl)-methoxy)-ethyl)-4-(3-phenyl-propyl)piperazine	0.142857142857
GBR-	12909a selective dopamine uptake inhibitor	0.142857142857
GBR-	12909	0.142857142857
GBR-	129091(2[bis(4-fluorophenyl)methoxy]ethyl[-4-3-phenylpropyl]	0.142857142857
GBR-	129091-(2-bis(4-fluorphenyl)-methoxy)-ethyl)-4-(3-phenyl-propyl) piperazine	0.142857142857
GBR-	12783	0.142857142857
LK	low k+	1.0
LH	blateral habenular nucleus	0.015306122449
LH	/pfalateral hypothalamus/perifornical area	0.00510204081633
LH	lutenizing hormone	0.00510204081633
LH	grouplearned helplessness group	0.00510204081633
LH	limited hold	0.00510204081633
LH	lateral horn of the spinal cord	0.00510204081633
LH	lateral habenula	0.0102040816327
LH	/peflateral hypothalamic perifornical area	0.00510204081633
LH	bthe lateral habenular nucleus	0.00510204081633
LH	bmmedial portion of the lateral habenula	0.00510204081633
LH	b/mhblateral/medial habenular nucleus	0.00510204081633
LH	yplateral hypothalamus	0.00510204081633
LH	cpfcaudal part of the perifornical lateral hypothalamic area	0.00510204081633
LH	lateral hypothalamic area	0.0867346938776
LH	orexinergic zone of the perifornical lateral hypothalamus	0.00510204081633
LH	left hemisphere	0.015306122449
LH	learned helplessness	0.0459183673469
LH	bmlateral habenula (medial portion)	0.00510204081633
LH	blateral habenular complex	0.0102040816327
LH	/pfalateral hypothalamic/perifornical area	0.00510204081633
LH	left hand	0.00510204081633
LH	blateral habenula	0.0765306122449
LH	ylateral hypothalamic	0.00510204081633
LH	lateral hypothalamus	0.352040816327
LH	luteinizing hormone	0.25
LH	lateral habenula nucleus	0.00510204081633
LH	ylateral hypothalamus	0.00510204081633
LH	blateral habenular nuc	0.00510204081633
LH	luteinising hormone	0.0102040816327
LH	lateral hypothalamic nucleus	0.0204081632653
LH	bmssuperior part of the medial division of the lateral part of the habenular complex	0.0102040816327
LI	labeling index	0.0392156862745
LI	-like immunoreactive	0.0196078431373
LI	like immunoreactive/immunoreactivity	0.0196078431373
LI	latent inhibition	0.176470588235
LI	low ethanol intake subgroup	0.00980392156863
LI	localization index	0.00980392156863
LI	-like imunnoreactivity	0.00980392156863
LI	alayer ia paleocortex	0.00980392156863
LI	like immunoreativity	0.00980392156863
LI	like immunoreactivity, like immunoreactive	0.00980392156863
LI	like immunoreactivity	0.421568627451
LI	like immunoreactive	0.0392156862745
LI	like immunoreactive, like immunoreactivity	0.00980392156863
LI	like-immunoreactivity	0.0588235294118
LI	long intromission	0.0196078431373
LI	low-immobility	0.00980392156863
LI	like immunoreactivity/immunoreactive	0.00980392156863
LI	labelling index	0.00980392156863
LI	-like immunoreactivity	0.0882352941176
LI	blayer ib	0.00980392156863
LI	liver	0.00980392156863
LV	lateral ventricule	0.02
LV	lateroventral end	0.02
LV	low-voltage	0.02
LV	pars lateralis	0.04
LV	elateral vestibular nucleus	0.06
LV	lentivirus	0.02
LV	lateral ventricles	0.08
LV	lentiviral vector	0.04
LV	lateral ventricle	0.56
LV	lentivirus vector	0.02
LV	pars lateralis of the ventral division of the medial geniculate body	0.04
LV	elateral vestibular nu	0.02
LV	length density of the nerve fibers	0.02
LV	left ventriculum	0.02
LV	pars lateralis of mgv	0.02
LW	lateral wing	0.25
LW	lateral wall	0.25
LW	long wavelength	0.25
LW	long withdrawal (40–45 days of cocaine withdrawal)	0.25
LT	non-pretreated post-lesion treated with estrogen	0.0333333333333
LT	leukotriene	0.133333333333
LT	low threshold	0.233333333333
LT	erlamina terminalis	0.0333333333333
LT	lamina terminalis	0.1
LT	low-threshold (neurons)	0.0666666666667
LT	low-threshold	0.0333333333333
LT	light transmittance	0.0333333333333
LT	lateral terminal nucleus of the accessory optic tract	0.0333333333333
LT	light-tone	0.0333333333333
LT	sleukotrienes	0.0333333333333
LT	long term	0.0666666666667
LT	coollow threshold cool responsive neuron	0.0333333333333
LT	long-term abuse	0.0666666666667
LT	light touch	0.0333333333333
LT	lateral temporal cortex	0.0333333333333
LU	low dose corticosterone, unstressed	0.5
LU	lung	0.5
LR	large axon terminal with round synaptic vesicles	0.0243902439024
LR	low responders	0.0731707317073
LR	large terminals in vpm	0.0243902439024
LR	intermediolateral region of the spinal cord segments	0.0243902439024
LR	left or right	0.0243902439024
LR	lateral rectus	0.0487804878049
LR	low-responder	0.0487804878049
LR	lateral recess of diencephalic ventricle	0.0243902439024
LR	lateral rectus muscle	0.0243902439024
LR	low responder to novelty	0.0243902439024
LR	lateral rhombencephalon	0.0243902439024
LR	learning rate ratio	0.0243902439024
LR	large axon terminal with round vesicles	0.0243902439024
LR	tlateral reticular nucleus	0.170731707317
LR	left and right	0.0243902439024
LR	low rearing	0.0243902439024
LR	low rapid eye movement sleep condition/group	0.0243902439024
LR	low responder rats	0.0243902439024
LR	11	0.0243902439024
LR	tennis-like racket	0.0243902439024
LR	large round synaptic vesicle ending	0.0243902439024
LR	later remembered	0.0243902439024
LR	low responder	0.0975609756098
LR	lateral reticular nucleus	0.0243902439024
LR	tlateral reticular nucleus of medulla	0.0243902439024
LR	low responders to novelty	0.0487804878049
LR	ratiolog2 ratio	0.0243902439024
LS	tlateral striatum	0.00840336134454
LS	long sleep	0.00840336134454
LS	low suppressors	0.00840336134454
LS	least squares	0.00840336134454
LS	laser speckle	0.00840336134454
LS	lateral septum	0.529411764706
LS	tlumbar spinothalamic	0.0336134453782
LS	lateral stimulation	0.00840336134454
LS	mvmedioventral part of the lateral septum	0.00840336134454
LS	lesion site	0.00840336134454
LS	lateral septal nucleus	0.100840336134
LS	tstriatum laterale (paleostriatum augmentatum)	0.00840336134454
LS	vventral portion of the lateral septal nucleus	0.00840336134454
LS	lumbosacral	0.0336134453782
LS	long shaft	0.00840336134454
LS	lateral suprasylvian area	0.00840336134454
LS	late-spiking	0.00840336134454
LS	nerve lesion with suture	0.00840336134454
LS	low salt	0.00840336134454
LS	/lsilateral septal nuclei/intermediate part	0.00840336134454
LS	latency time to seizure	0.00840336134454
LS	lateral shell of the central nucleus of the inferior colliculus	0.00840336134454
LS	2lysate supernatant 2	0.00840336134454
LS	long-shafted neurons	0.00840336134454
LS	low dose corticosterone, stressed	0.00840336134454
LS	vventral part of lateral septum	0.00840336134454
LS	vlateral septum ventral	0.00840336134454
LS	low sociability	0.00840336134454
LS	lumbo-sacral	0.00840336134454
LS	lateral sequence	0.00840336134454
LS	late stages	0.00840336134454
LS	light sleep	0.0168067226891
LS	vventral ls	0.00840336134454
LS	lunate sulcus	0.00840336134454
LS	lateral suprasylvian	0.0168067226891
LS	vventral part of lateral septal nucleus	0.00840336134454
LS	ddorsal lateral septum	0.00840336134454
LS	lateral segment	0.00840336134454
LP	2crude synaptic vesicle fraction	0.010752688172
LP	lateral posterior thalamic nucleus	0.0967741935484
LP	thalamic lateroposterior nucleus	0.010752688172
LP	1synaptosomal membrane fraction	0.010752688172
LP	lateral posterior nucleus	0.172043010753
LP	low ethanol preference subgroup	0.010752688172
LP	lateral posterior thalamic nuclei	0.010752688172
LP	low pressure	0.010752688172
LP	1lysis pellet 1=synaptosomal membrane fraction	0.010752688172
LP	long photoperiod	0.0430107526882
LP	mmedial part of the lateral posterior nucleus	0.010752688172
LP	lateral pyloric motorneuron	0.010752688172
LP	lipid peroxidation	0.0430107526882
LP	low predictability	0.010752688172
LP	lateral pallium	0.0322580645161
LP	long photoperiod ld14:10	0.010752688172
LP	lateroposterior thalamic nucleus	0.0215053763441
LP	levator palpebrae	0.010752688172
LP	levator palpebrae muscle	0.010752688172
LP	1/lp2lever press responses	0.010752688172
LP	accacclimatized to a long photoperiod	0.010752688172
LP	light pulse	0.0860215053763
LP	lateral posterior thalamus	0.010752688172
LP	lateral pyloric	0.0430107526882
LP	lrrostral division of the lateral posterior nucleus	0.010752688172
LP	luteal phase	0.010752688172
LP	light phase	0.010752688172
LP	2lysate pellet 2	0.010752688172
LP	olateral posterior	0.010752688172
LP	large pyramidal cell layer	0.010752688172
LP	low progesterone	0.010752688172
LP	long-lasting potentiation	0.010752688172
LP	blateral parabrachial area	0.0322580645161
LP	low pass	0.0215053763441
LP	lateral-posterior	0.010752688172
LP	low-pass	0.010752688172
LP	lateral posterior nucleus of the thalamus	0.010752688172
LP	lateral posterior nucleus thalamus	0.010752688172
LP	blateral parabrachial nucleus	0.010752688172
LP	lateral pyloric neuron	0.010752688172
LP	lever press	0.010752688172
LP	lateral posterior	0.0215053763441
LP	lateral posterior nucleus of thalamus	0.010752688172
LP	vventral part of lp	0.010752688172
LP	lumbar puncture	0.010752688172
LP	low protein	0.010752688172
LP	llateral–posterior nucleus	0.010752688172
LQ	laterality quotient	0.285714285714
LQ	lordosis quotient	0.571428571429
LQ	laterality quotients	0.142857142857
12-LO	12-lipoxygenase	1.0
CaBP	calcium binding protein	0.181818181818
CaBP	calbindin-d28k	0.363636363636
CaBP	calcium-binding proteins	0.0909090909091
CaBP	calbindin	0.0909090909091
CaBP	calbindin-dk28	0.0909090909091
CaBP	calbindin-dk28, ca2+ binding protein	0.0909090909091
CaBP	calbindin protein	0.0909090909091
DRDA	receptor	1.0
LZ	lateral zone	1.0
Mab	monoclonal antibody	1.0
GEPR-	9	1.0
LY	2940022-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one	0.0425531914894
LY	2940022-(4-morpholinyl)-8-phenyl-1(4h)-benzopyran-4-one hydrochloride	0.0425531914894
LY	lucifer yellow conjugated to dextran amine	0.0212765957447
LY	235959[(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid]	0.0212765957447
LY	ly3828843s,4ar,6s,8ar-6-[4-carboxy-phenyl] methyl-1,2,3,4,4a,5,6,7,8,8a-deca-hydroisoquinoline-3-carboxylic acid	0.0212765957447
LY	341495	0.0425531914894
LY	367385(s)-(+)-α-amino-4-carboxy-2-methylbenzeneacetic acid	0.0425531914894
LY	2940022-(4-morpholino)-8-phenyl-4h-1-benzopyran-4-one)	0.0212765957447
LY	2940022-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one hydrochloride	0.063829787234
LY	235959n-methyl-d-aspartic acid glutamatergic antagonist	0.0212765957447
LY	lucifer yellow–dextran amine	0.0212765957447
LY	lucifer yellow	0.404255319149
LY	2940022-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-1	0.0212765957447
LY	2940022-(4-morpholinyl)-8-phenyl-1(4h)-benzopyran-4-one	0.0212765957447
LY	367385(+)-2-methyl-4-carboxyphenylglycine	0.063829787234
LY	306740	0.0212765957447
LY	379268	0.0425531914894
LY	367385	0.0425531914894
LY	393053	0.0212765957447
CNTF	ciliary-derived neurotrophic factor	0.031746031746
CNTF	ciliary neurotrophic factor	0.952380952381
CNTF	(r), ciliary neurotrophic factor (receptor)	0.015873015873
PEPCK	phosphoenolpyruvate carboxykinase	1.0
PF-LHA	perifornical–lateral hypothalamic area	0.2
PF-LHA	perifornical-lateral hypothalamic area	0.8
NBAN	eurobasal-a	1.0
PNs	perineuronal nets	1.0
L-	type voltage-gated calcium channels	0.025
L-	826266[(2e)-n-[(5-bromo-2-methoxyphenyl)-sulfonyl]-3-[5-chloro-2-(2-naphthylmethyl) phenyl]	0.025
L-	15leibowitz's 15	0.025
L-	15 co2leibovitz-15 air co2	0.025
L-	isoaspartyl methyltransferase	0.025
L-	type ca2+ channel	0.1
L-	type-channels	0.025
L-	type calcium channel	0.25
L-	type ca2+-channels	0.025
L-	2-aal-2-aminoadipic acid	0.025
L-	baclofen	0.025
L-	type calcium channels	0.075
L-	buthionine sulfoximine	0.025
L-	type voltage sensitive ca2+ channels	0.025
L-	655;708	0.025
L-	type ca++ channel	0.025
L-	neuronslight neurons	0.025
L-	type voltage gated ca2+ channels	0.025
L-	amino acid decarboxylase	0.025
L-	701 (l-701324), 7-chloro-4-hydroxy-3-(3-phenoxy)phenylquinolin-2-[1h]-one	0.025
L-	14.5	0.025
L-	type voltage-gated ca2+ channel	0.025
L-	methylmalonic acid	0.025
L-	type calcium current	0.025
L-	menthol	0.025
L-	left	0.025
TBS-TGST	ris-buffered saline/0.1% triton x-100/5% goat serum	1.0
L6	sixth lumbar segment of the spinal cord	1.0
HEAT	hydrochloride2-{[β-(4-hydroxyphenyl)ethyl]aminome thyl}-1-tetralone hydrochloride	0.333333333333
HEAT	2-{[b-(4-hydroxyphenyl)ethyl]aminomethyl}-1-tetralone	0.666666666667
L5	lumbar segment 5	0.333333333333
L5	fifth lumbar	0.333333333333
L5	fifth lumbar segment	0.333333333333
L3	third lumbar segment	1.0
L1	l2,l3layer 1, layer 2, layer 3	0.333333333333
L1	cell recognition molecule l1, also known as nile	0.333333333333
L1	l1ngcam	0.333333333333
PNa	relative ca2+ permeability	1.0
3SR	4ars,6rs,8ars)-6-[2-(1h-tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid	1.0
B-CK	brain cytosolic isoform of ck	1.0
DEDTC	sodium diethyldithiocarbamate	0.333333333333
DEDTC	diethyldithiocarbamate	0.333333333333
DEDTC	sodium dietyldithiocarbamate	0.333333333333
RBDR	ho-binding domain of mouse rhotekin	1.0
GEPRs	genetically epilepsy-prone rats	1.0
S-4C3H-PG	(s)-4-carboxy-3-hydroxyphenylglycine	1.0
PNZ	perinuclear zone of the supraoptic nucleus	1.0
NRCCH	normalized range of the cross-correlation histogram	1.0
CeLc	central nucleus, lateral capsular division	0.5
CeLc	central amygdaloid nucleus, capsular subdivision	0.5
CFI	comparative fit index	1.0
DOPA3	4-dihydroxyphenylalanine	1.0
PNS	postnuclear supernatant	0.00952380952381
PNS	peripheral nervous system	0.914285714286
PNS	regeneration	0.00952380952381
PNS	perivascular nerve stimulation	0.00952380952381
PNS	prenatal stress	0.0380952380952
PNS	periarterial nerve stimulation	0.0190476190476
CFE	carbon fibre electrode	1.0
CFB	cerebral blood flow	1.0
CFC	ontrol+fluoxetine	0.0769230769231
CFC	contextual fear conditioning	0.692307692308
CFC	context fear conditioning	0.0769230769231
CFC	cued fear conditioning	0.0769230769231
CFC	3inflammatory proteins c3 complement	0.0769230769231
PNW	postnatal week	1.0
CFA	complete freund adjuvant	0.0188679245283
CFA	caudal forelimb area	0.0188679245283
CFA	complete freud's adjuvant	0.00943396226415
CFA	complete freund's adjuvant	0.471698113208
CFA	inflammation	0.00943396226415
CFA	complete freud’s adjuvant	0.00943396226415
CFA	complete freund’s adjuvant	0.462264150943
PNH	periventricular nodular heterotopia	1.0
EGF-R	epidermal growth factor-receptor	0.2
EGF-R	epidermal growth factor receptor	0.6
EGF-R	epidermal growth factor receptor(s)	0.2
PNO	pontine reticular nucleus oralis	1.0
PNN	speri-neuronal nets	0.0769230769231
PNN	perineuronal net	0.615384615385
PNN	prereneuronal net	0.0769230769231
PNN	sperineuronal nets	0.230769230769
PNA	peanut agglutinin	0.352941176471
PNA	phrenic nerve activity	0.235294117647
PNA	peanut lectin	0.0588235294118
PNA	peanut	0.0588235294118
PNA	phrenic nerve	0.0588235294118
PNA	pelvic nerve afferent	0.0588235294118
PNA	freqpna frequency	0.0588235294118
PNA	peanut agglutinin lectin	0.117647058824
CNPRCC	alifornia national primate research center	1.0
CFT	2-β-(4-carbomethoxy)-3-β-(4-fluorophenyl)tropane	1.0
PNB	periodic noise burst	1.0
CFR	climbing fiber response	1.0
PND	phrenic nerve discharge	0.0212765957447
PND	spostnatal days	0.0141843971631
PND	postnatal days	0.0212765957447
PND	postnatal day	0.86524822695
PND	post natal day	0.0141843971631
PND	post-natal days	0.00709219858156
PND	postnatal-day	0.00709219858156
PND	post-natal day	0.0425531914894
PND	postnatal day (age)	0.00709219858156
CFP	pecfp-c1	0.0833333333333
CFP	center of foot pressure	0.166666666667
CFP	centre of foot pressure	0.166666666667
CFP	cyan fluorescent protein	0.5
CFP	enhanced cyan fluorescent protein	0.0833333333333
SP-	1spastic paraplegia type-1	0.333333333333
SP-	sapdisulfide conjugate of substance p to saporin	0.333333333333
SP-	sapsubstance p–saporin	0.333333333333
AAAS	triple a syndrome	1.0
Ac-LEHD-pNA	ac-leu-glu-his-asp-paranitroaniline	1.0
KPSB	potassium phosphate saline buffer	1.0
dl-AP	5dl-2-amino-5-phosphonovaleric acid	0.5
dl-AP	3dl-amino-3-phosphonopropionic acid	0.125
dl-AP	3dl-2-amino-3-phosphonopropionic acid	0.125
dl-AP	5dl-2-amino-5-phosphonopentanoic acid	0.125
dl-AP	5(±)-2-amino-5-phosphonopentatonic acid	0.125
AP3	2-amino-3-phosphonopropionate	0.5
AP3	l-2-amino-3-phosphonopropionic acid	0.5
InsP3	inositol 1,4,5-trisphosphate	0.222222222222
InsP3	inositol 1,4,5-triphosphate	0.333333333333
InsP3	inositol-1,4,5-trisphosphate	0.333333333333
InsP3	1,3,4-inositoltrisphosphate	0.111111111111
AP1	activator protein-1	1.0
AP7	d-(-)-2-amino-7-phosphonoheptanoic acid	1.0
AP4	2-amino-4-phosphonobutyrate	0.333333333333
AP4	l-2-amino-4-phosphonobutyric acid	0.333333333333
AP4	2-amino-4-phosphonobutyric acid	0.333333333333
AP5	2-amino-5-phosphonovaleric acid	0.0555555555556
AP5	dl-2-amino-5-phosphonovalerate	0.0185185185185
AP5	dl-2-amino-5-phosphonopentanoic acid	0.0740740740741
AP5	2-amino-5-phosphonopentanoic acid	0.12962962963
AP5	d(-)-2-amino-5-phosphonopentanoate	0.0185185185185
AP5	d-l-5-aminophosphovalerate	0.0185185185185
AP5	d-2-amino-5-phosphonovalerate	0.037037037037
AP5	d(-)-2-aminophosphonopentanoic acid	0.037037037037
AP5	d,1-2-amino-5-phosponovalerate	0.0185185185185
AP5	(dl)-2-amino-5-phosphonopentanoate	0.0185185185185
AP5	d-2-amino-5-phosphonopentanoate	0.0555555555556
AP5	(±)-2-amino-5-phosphopentanoic acid	0.0185185185185
AP5	2-amino-5-phosphopentanoate	0.0185185185185
AP5	dl-2-amino-5-phosphopentanoic acid	0.0185185185185
AP5	d-2-amino-5-phosphonopentanoic acid	0.0185185185185
AP5	dl-2-amino-5-phosphonovaleric acid	0.0740740740741
AP5	d,l-amino-5phosphonopentanoic acid	0.0185185185185
AP5	(±)-2-amino-5-phosphonovaleric acid	0.0185185185185
AP5	2-amino-5-phosphonopentanoate	0.0740740740741
AP5	2-amino-5-phosphovalerate	0.0185185185185
AP5	d,l-2-amino-5-phosphonovaleric acid	0.0185185185185
AP5	d-(-)-2-amino-5-phosphonopentanoic acid	0.0185185185185
AP5	(±)-2-amino-5-phosphonopentanoic acid	0.0555555555556
AP5	d,l-2-amino-5-phosphonovalerate	0.037037037037
AP5	d(-)-2-amino-5-phosphonopentanoic acid	0.0925925925926
AP5	d(-)-2-amino-5-phosphonopentoic acid	0.0185185185185
p40B	orna disease virus nuclear protein 40	1.0
AAAD	aromatic l-amino acid decarboxylase	1.0
HiF	hippocampal formation	1.0
AP-	5d-2-amino-5-phosphopentanoic acid	0.0112359550562
AP-	5d(-)-2-amino-5-phosphononpentanoic acid	0.0112359550562
AP-	5d-2-amino-5-phosphonovalerate	0.0224719101124
AP-	5d-2-amino-5-phosphonopentanoic acid	0.0112359550562
AP-	7aminophosphoheptanoic acid	0.0112359550562
AP-	1activator protein 1	0.123595505618
AP-	5dl-2-amino-5-phosphovaleric acid	0.0112359550562
AP-	5dl-2-amino-5-phosphonovaleric acid	0.0898876404494
AP-	1activating protein-1	0.0674157303371
AP-	1	0.0674157303371
AP-	5	0.0224719101124
AP-	5d(-)-2-amino-5-phosphonopentanoic acid	0.0224719101124
AP-	1activator-protein 1	0.0224719101124
AP-	1 complexes	0.0112359550562
AP-	5dl-2-amino-5 phosphopentanoic acid	0.0112359550562
AP-	72-amino-7-phosphonoheptanoate	0.0112359550562
AP-	52-amino-5 phosphonopentanoate	0.0112359550562
AP-	1activator protein-1	0.191011235955
AP-	5(±)-2-amino-5-phosphonopentanoic acid	0.0224719101124
AP-	2αactivating protein-2α	0.0112359550562
AP-	4adaptor protein-4	0.0112359550562
AP-	5d-2amino-5phosphonovalerate	0.0112359550562
AP-	52-amino-5-phosphopentanoic acid	0.0224719101124
AP-	5d(-)2-amino-5-phosphonovaleric acid	0.0112359550562
AP-	5d-2-amino-5-phosphonovaleric acid	0.0112359550562
AP-	5aminophosphonopentanoic acid	0.0112359550562
AP-	72-amino-7-phosphonoheptanoic acid	0.0112359550562
AP-	5d-(-)-2-amino-5-phosphonopentanoic acid	0.0561797752809
AP-	5d-2-amino-5-phosphonopentanoate	0.0112359550562
AP-	5d-2-amine-5-phosphonopentanoic acid	0.0112359550562
AP-	52-amino-5-phosphonopentanoic acid	0.0337078651685
AP-	5dl-2-amino-5-phosphonopentanoic acid	0.0337078651685
M-CK	muscle cytosolic isoform of ck	1.0
oRG	outer radial glia	1.0
MOREPD	more affected idiopathic parkinson’s disease side	1.0
VLSM	voxel-based lesion symptom mapping	1.0
NNLA	n-nitro-l-arginine	1.0
CDSRT	conditional delayed stimulus-response association task	1.0
ras-MAPK	ras mitogen-activated protein kinase	1.0
rVLM	rostral ventrolateral medulla	0.75
rVLM	rostral part of the ventrolateral reticular nucleus of the medulla	0.25
dHPC	dorsal hippocampus	1.0
mmH	gmillimeters mercury	1.0
EAATN	a+-glutamate	1.0
HEI-OC	1house ear institute-organ of corti 1	1.0
MYRFM	yelin regulatory factor	1.0
pMPPI	4-ido-n-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]	1.0
MRX	prefix used for families with non-syndromic x-linked mental retardation	1.0
MRT	mean residence time	0.333333333333
MRT	memory retention test	0.333333333333
MRT	mean recovery time	0.333333333333
APs	action potentials	1.0
MAPKMAP	kinase	1.0
MRP	movement-related potential	0.1
MRP	multidrug resistance–associated protein	0.1
MRP	morphine	0.1
MRP	1multidrug resistance protein 1	0.1
MRP	multidrug resistance protein	0.1
MRP	multidrug resistance-associated protein	0.2
MRP	smultiple drug resistance-associated proteins	0.1
MRP	1multidrug resistance-associated protein 1	0.1
MRP	2multidrug resistance-associated protein 2	0.1
OBT-	taskown-body transformation task	1.0
IBMX	isobutylmethyl xanthine	0.025
IBMX	3-isobutyl-1-methyxanthine	0.025
IBMX	3-isobutyl-i-methylxanthine	0.025
IBMX	1-isobuthyl-1-methylxanthine	0.025
IBMX	isobutylmethylxanthine	0.15
IBMX	5-isobutyl-3-methylxanthine	0.025
IBMX	3-isobutyl-l-methylxanthine	0.025
IBMX	1-methyl-3-isobutylxanthine	0.025
IBMX	3-isobutyl-1-methylxantine	0.075
IBMX	3-isobutyl-1-methylxanthine	0.525
IBMX	3-isobutyl-1-methyl-xanthine	0.075
MRS	21792′-deoxy-n6-methyl adp diammonium salt	0.047619047619
MRS	2179n6-methyl-2′-deoxyadenosine 3′,5′-bisphosphate	0.047619047619
MRS	magnetic resonance spectroscopy	0.52380952381
MRS	21792′-deoxy-n6-methyladenosine 3′,5′-bisphosphate tetrasodium salt	0.0952380952381
MRS	21792′-deoxy-n6-methyladenosine 3′,5′-bisphosphate	0.047619047619
MRS	21792′-deoxy-n6-methyl adenosine 3′,5′-diphosphate diammonium salt	0.047619047619
MRS	2179n6-methyl-2′-deoxyadenosine-3′,5′-bisphosphate	0.142857142857
MRS	21792′-deoxy-n6-methyl adenosine 3′,5′-diphosphate	0.047619047619
MRL	mean response latency	1.0
MRM	multiple reaction mode	0.1
MRM	icroruby	0.1
MRM	magnetic resonance microscopy	0.2
MRM	re11-rad50	0.1
MRM	atrix reasoning	0.1
MRM	multiple reaction monitoring	0.2
MRM	multiple reactions monitoring	0.2
MRN	median raphe nucleus	0.821428571429
MRN	median raphe	0.0357142857143
MRN	mesencephalic reticular nucleus	0.0357142857143
MRN	medial raphe nuclei	0.0357142857143
MRN	midbrain reticular nucleus	0.0357142857143
MRN	medial raphe nucleus	0.0357142857143
MRI	magnetic resonance imaging/images	0.00515463917526
MRI	smagnetic resonance images	0.0103092783505
MRI	(functional) magnetic resonance imaging	0.00515463917526
MRI	magnetic resonance images	0.0309278350515
MRI	magnetic resonance image	0.020618556701
MRI	magnetic resonance imagining	0.00515463917526
MRI	magnetic resonance imaging	0.917525773196
MRI	projections	0.00515463917526
EGTA-AMEGTA	tetra(acetoxymethyl ester)	1.0
MRE	metal regulatory element	1.0
MRF	medullary reticular formation	0.352941176471
MRF	maximum rate of fall	0.0588235294118
MRF	mesencephalic reticular formation	0.411764705882
MRF	middle rhombencephalic reticular formation	0.0588235294118
MRF	midbrain reticular formation	0.117647058824
MRG	mean response to noise at optimal direction/mean response to gratings at optimal direction	1.0
MRC	mother-raised control	0.333333333333
MRC	medical research council	0.333333333333
MRC	mother reared control group	0.333333333333
BglII	??	1.0
TERT	telomerase reverse transcriptase	1.0
XK81	xenopus keratin 81	1.0
DDCD	opa decarboxylase	1.0
APR	acute phase response	1.0
APS	acute pain stress	0.25
APS	anterior peri-insular sulcus	0.25
APS	average pain sensitivity	0.25
APS	aminopropyl triethoxysilane	0.25
APP	amyloid β precursor protein	0.00523560209424
APP	transgenic mice overexpressing app and ps-1 mutant genes	0.00523560209424
APP	amyloid precursor protein	0.842931937173
APP	wtamyloid-precursor-protein	0.00523560209424
APP	acute-phase proteins	0.00523560209424
APP	mmature app	0.00523560209424
APP	amyloid-β precursor protein	0.0157068062827
APP	sweamyloid precursor protein swedish mutation (k651n/m652l)	0.00523560209424
APP	sweamyloid precursor protein with swedish mutation	0.00523560209424
APP	/ps1 transgenic mice	0.0104712041885
APP	tgapp transgenic	0.00523560209424
APP	/veapp vehicle	0.00523560209424
APP	swe micetransgenic mice carrying the swedish mutation of amyloid precursor protein	0.00523560209424
APP	sw/tauvlw mousedouble transgenic mouse expressing the above mentioned mutations in both app and tau genes	0.00523560209424
APP	amyloid β-protein precursor	0.00523560209424
APP	amyloid beta peptide precursor protein	0.00523560209424
APP	sαsecreted product of the α-cleavage of app	0.00523560209424
APP	swβ-amyloid precursor protein swedish mutation	0.00523560209424
APP	swe/ps1de9 mice	0.00523560209424
APP	alkaline phosphatase	0.00523560209424
APP	amyloid protein precursor	0.00523560209424
APP	β-amyloid precursor protein	0.0314136125654
APP	swe/ps1de9 transgenic animal model	0.00523560209424
APV	d(-)-2-amino-5-phosphonovaleric acid	0.0118343195266
APV	d-2-amino-5-phosphopentanoic acid	0.00591715976331
APV	2-amino-5-phosphonovaleric acid	0.0650887573964
APV	dl-2-amino-5-phosphonovalerate	0.0355029585799
APV	d(-)-2-amino-phosphonovaleric acid	0.00591715976331
APV	dl-2-amino-5-phosphonopentanoic acid	0.0591715976331
APV	2-amino-5-phosphonopentanoic acid	0.0355029585799
APV	d2-amino-5-phosphonovalerate	0.00591715976331
APV	2-amino-5-phosphono valeric acid	0.00591715976331
APV	d-2-amino-5-phosphonovalerate	0.0591715976331
APV	d-(-)2-amino-5-phosphonovaleric acid	0.00591715976331
APV	d,l-2amino-5-phosphonovaleric acid	0.00591715976331
APV	(2r)-amino-5-phosphonopentanoate	0.0118343195266
APV	l-2-amino-5-phosphonovaleric acid	0.00591715976331
APV	dl-2-amino-5-phosphono-valerate	0.00591715976331
APV	dl-2-amino-5-phosphovaleric acid	0.00591715976331
APV	2-amino-5-phosphovaleric acid	0.0177514792899
APV	2-amino-5-phosphono-valerate	0.00591715976331
APV	(ap-5)dl-2-amino-5-phosphonovaleric acid	0.00591715976331
APV	(2r)-amino-5-phosphonovaleric acid	0.0295857988166
APV	(r)-amino-5-phosphonovaleric acid	0.00591715976331
APV	4-aminophosphonovaleric acid	0.00591715976331
APV	(±)-2-amino-5-phosphonopentanoic acid	0.0177514792899
APV	d,l-2-amino-5-phosphonovalerate	0.0177514792899
APV	d-2-amino-5-phosphono-pentanoic acid	0.00591715976331
APV	dl-2-amino-5-phosphono-valeric acid	0.00591715976331
APV	d-2-amino-5-phosphonopentanoic acid	0.0355029585799
APV	(d)-2-amino-5-phosphonovaleric acid	0.00591715976331
APV	d(-)-2-amino-5-phosphono-pentanoic acid	0.00591715976331
APV	d-2-amino-5-phosphovaleric acid	0.00591715976331
APV	dl-ap5, dl-2-amino-5-phosphonovaleric acid	0.00591715976331
APV	dl-2-amino-5-phosphonovaleric acid	0.147928994083
APV	d(-)2-amino-5-phosphonovalerate	0.00591715976331
APV	d,l-amino-5-phosphono-valeric acid	0.00591715976331
APV	d(-)-2-amino-5-phosphonopetanoic acid	0.00591715976331
APV	d-2-amino-5-phosphono-valeric acid	0.00591715976331
APV	d-(–)-2-amino-5-phosphonovalerate	0.00591715976331
APV	d-(-)-2-amino-5-phosphonovaleric acid	0.0118343195266
APV	(±)-2-amino-5-phosphonovaleric acid	0.0118343195266
APV	d-amino-phosphonovalerate	0.0177514792899
APV	2-amino-phosphonovaleric acid	0.00591715976331
APV	2-amino-5-phosphovalerate	0.00591715976331
APV	d,l-2-amino-5-phosphonovaleric acid	0.0295857988166
APV	d(-)-2-amino-5-phosphonopentanotic acid	0.00591715976331
APV	d-(-)-2-amino-5-phosphonopentanoic acid	0.0118343195266
APV	dl-(-)-2-amino-5-phosphonovaleric acid	0.00591715976331
APV	dl-2-aminophosphopentanoic acid	0.00591715976331
APV	aminophosphonovaleric acid	0.0118343195266
APV	dl-2-amino-5-phosphopentanoic acid	0.0177514792899
APV	d(-)-2-amino-5-phosphopentanoic acid	0.00591715976331
APV	d-2-amino-5-phosphonovaleric acid	0.0532544378698
APV	d(-)-2-amino-5-phosphonopentanoic acid	0.0177514792899
APV	aminophosphonovalerate	0.0177514792899
APV	2-amino-5-phosphonovalerate	0.0650887573964
APV	dl-2-amino-5 phosphonovaleric acid	0.00591715976331
APV	d-amino-5-phosphonovalerate	0.00591715976331
APW	saction-potential-like waveforms	0.333333333333
APW	artificial pond water	0.333333333333
APW	action potential waveform	0.333333333333
APT	iodoaminopotentidine	0.0833333333333
APT	anterior pretectal nucleus	0.833333333333
APT	anterior pretectal nu	0.0833333333333
S-W	sleep–wakefulness	0.333333333333
S-W	sleep wakefulness	0.333333333333
S-W	sleep-wakefulness	0.333333333333
APH	area parahippocampalis	1.0
API	average pixel intensity	0.666666666667
API	triciribine	0.333333333333
APN	adiponectin	0.166666666667
APN	anterior pretectal nucleus	0.333333333333
APN	aminopeptidase n	0.5
APO	+asapomorphine plus auditory stimulation	0.111111111111
APO	+asapomorphine injection followed by auditory stimulation	0.222222222222
APO	apomorphine	0.555555555556
APO	apocynin	0.111111111111
VMMR	ventro-medial medullary reticular formation	1.0
APM	apomorphine	1.0
APB	aminopeptidase b	0.0909090909091
APB	r(+)-6-bromo-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzapine hydrobromide	0.0909090909091
APB	ammonium phosphate buffer	0.272727272727
APB	dl-2-amino-4-phosphonobutyric acid	0.0909090909091
APB	2-amino-4-phosphonobutyric acid	0.0909090909091
APB	abductor pollicis brevis	0.363636363636
APC	anti-adenomatous polyposis coli	0.0294117647059
APC	activated protein c	0.0294117647059
APC	adenomatous polyposis coli	0.352941176471
APC	adenomatous polyposis coli tumor suppressor gene	0.0294117647059
APC	antigen presenting cell	0.0882352941176
APC	adenomatous polyposis coli tumour suppressor protein	0.0294117647059
APC	antigen-presenting cell	0.0294117647059
APC	anterior parietal cortex	0.0294117647059
APC	anterior piriform cortex	0.176470588235
APC	allophycocyanin	0.0588235294118
APC	santigen-presenting cells	0.0294117647059
APC	adenomatous polyposis coli (clone cc1)	0.0294117647059
APC	adenomatus polyposis coli	0.0294117647059
APC	vrventral–rostral area of the apc	0.0294117647059
APC	adenomatous polyposis sporadic colorectal cancer	0.0294117647059
APA	anticipatory postural adjustment	0.25
APA	ntero-posterior	0.05
APA	ascending pharyngeal artery	0.1
APA	aminopeptidase a	0.05
APA	anticipatory postural adjustments	0.05
APA	f-1apoptotic protease activating factor 1	0.05
APA	santicipatory postural adjustments	0.4
APA	nterior-posterior	0.05
APF	anterior prefrontal cortex	0.25
APF	after puparium formation	0.25
APF	after pupa formation	0.25
APF	aminophenyl fluorescein	0.25
APD	santipsychotic drugs	0.222222222222
APD	action potential duration	0.444444444444
APD	50action potential duration measured as the time from the overshoot to 50% repolarization to resting potential	0.111111111111
APD	antipsychotic drug	0.222222222222
APE	/ref-1	0.166666666667
APE	2apurinic/apyrimidinic site endonuclease 2	0.166666666667
APE	1apurinic/apyrimidinic endonuclease-1	0.166666666667
APE	apurinic apyramidinic endonuclease	0.166666666667
APE	1ap endonuclease 1	0.166666666667
APE	1apurinic apyrimidinic endonuclease1	0.166666666667
rT	dtrecombinant termination deoxynucleotidyltransferase	0.111111111111
rT	dtterminal deoxynucleotidyl transferase recombinant enzyme	0.111111111111
rT	narostral nucleus taeniae of the amygdala	0.111111111111
rT	dtterminal deoxynucleotidyl transferase and recombinant enzyme	0.111111111111
rT	dtrecombinant terminal deoxynucleotidyl transferase	0.111111111111
rT	3reverse t3	0.111111111111
rT	halright thalamus	0.111111111111
rT	frcrat transferrin receptor	0.111111111111
rT	dtterminal deoxynucleotidyl transferase	0.111111111111
TNFRII	tumor necrosis factor receptor ii	1.0
α2C-OE-wt	control mice for mice overexpressing the α2c-adrenergic receptor	1.0
rP	50p50 ratio index of sensory gating	0.222222222222
rP	earson's correlation coefficient	0.222222222222
rP	olerostral pole	0.111111111111
rP	ol iidna-dependent rna-polymarese ii	0.111111111111
rP	ol iirna-polymerase ii	0.111111111111
rP	rostral pallium	0.111111111111
rP	earson’s correlation coefficient	0.111111111111
ADNP	activity dependent neuroprotective protein	0.333333333333
ADNP	activity-dependent neuroprotective protein	0.666666666667
rR	dgrostral dysgranular retrosplenial cortex	1.0
rS	triaright striatum	1.0
dsR	edred fluorescent protein from discosoma sp	1.0
LRTC	long-range temporal correlation	0.5
LRTC	long-range temporal correlations	0.5
DLPAG	dorso–lateral periaqueductal gray	0.0833333333333
DLPAG	dorsolateral periaqueductal gray	0.5
DLPAG	dorsolateral part of the periaqueductal gray	0.0833333333333
DLPAG	periaqueductal grey, dorsolateral nuclei	0.0833333333333
DLPAG	dorsolateral periaqueductal gray matter	0.0833333333333
DLPAG	or dldorsolateral periaqueductal gray matter	0.0833333333333
DLPAG	dorsolateral column of the periaqueductal gray	0.0833333333333
ADNF	activity-dependent neurotrophic factor	1.0
ADNA	aortic depressor nerve activity	1.0
p-PLCγ	1phosphorylated-plcγ1	1.0
rC	1rostral c1	0.333333333333
rC	lockproduct of the rat clock gene	0.333333333333
rC	ereright cerebellum	0.333333333333
BDLB	artha-duplac virus	1.0
rM	npnrostral part of the median preoptic nucleus	0.5
rM	1/s1right primary sensorimotor area	0.5
BDLA	bile duct ligation with hyperammonemia	1.0
smC	xsensorymotor cortex	1.0
5-HT5-hydroxytryptamine	serotonin	0.9375
5-HT5-hydroxytryptamine	or serotonin	0.0625
hTPH	2human tph2	1.0
K595N	mutation at codon 595 of amyloid precursor protein resulting in substitution of lysine by asparagine	1.0
DH1	4-dideoxy-1,4-imino-d-arabinitol hydrochloride	1.0
NF68	neurofilament 68	1.0
sAβAβ	25–35	1.0
mdD	mesodiencephalic dopaminergic	1.0
BRC	xbrain cortex	1.0
HCSSH	epes controlled salt solution	1.0
17α-M	et17α-methyltestosterone	1.0
TBARST	hiobarbituric acid reactive species	1.0
REML	restricted maximum likelihood	0.5
REML	restricted maximum likelihood estimation	0.5
AP-Luc	ap-1-dependent luciferase reporter construct	1.0
mdT	mediodorsal thalamus	1.0
WT-NPC	snpcs derived from wild-type mice	1.0
MVPO	medioventral periolivary nucleus	1.0
Gγ	2g protein gamma polypeptide 2	1.0
S-I	s.c. insulin	1.0
SAST	syntrophin-associated serine/threonine kinase	1.0
University	san bernardino	1.0
MVPA	multi-voxel pattern analysis	1.0
IGFBP-	5insulin-like growth factor binding protein-5	0.5
IGFBP-	2insulin-like growth factor binding protein-2	0.5
DPS-N	odays poststroke no whisker stimulation	1.0
vSUB	ventral subiculum	1.0
proSS	prosomatostatin	1.0
ChaT	choline acetyltransferase	1.0
Ref-1	apurinic/apyrimidinic endonuclease	1.0
MF-CA3	mossy fiber-ca3 pyramidal cell	1.0
PRE-INT	pre-intervention	1.0
Leu31	pro34]-pnpy, porcine [leu31,pro34]	1.0
LORETA	low-resolution brain electromagnetic tomography	0.357142857143
LORETA	low resolution electromagnetic tomography	0.0714285714286
LORETA	low-resolution electromagnetic tomography	0.285714285714
LORETA	low resolution brain electromagnetic tomography	0.214285714286
LORETA	low-resolution tomography	0.0714285714286
Rtm	reticular thalamic migration	1.0
MPAHE	maximum possible antihyperalgesic effect	1.0
rEPSP	recurrent excitatory postsynaptic potential	1.0
CD4-IgG	synthetic fusion protein (part of cd4 receptor fused to part of an immnuoglobulin)	1.0
TOADT	urned on after division	1.0
Chat	choline acetyltransferase	1.0
VOCCs	voltage operated calcium channels	1.0
8-OH-DPAT8-hydroxy-N	n-dipropyl-2-aminotetralin	1.0
GABABRGABA	b receptor	0.333333333333
GABABRGABA	receptor type b	0.333333333333
GABABRGABA	type b receptor	0.333333333333
PAR-1	protease-activated receptor-1	1.0
amygdalaCCK	cholecystokini	1.0
PLS-DA	partial least square-discriminant analysis	1.0
DHN	dorsal horn neuron	1.0
Gβγ	g protein β-γ subunit	1.0
D9-PROG2	2,4,6,6-17α,21,21,21-d9-prog	1.0
CeA	central amygdala	0.166666666667
CeA	central amygdaloid nucleus	0.166666666667
CeA	central nucleus of the amygdala	0.666666666667
SAHP	slow afterhyperpolarisation	1.0
CeN	central amygdaloid nucleus	0.5
CeN	central nucleus	0.5
CeM	central medial nucleus	0.285714285714
CeM	central nucleus, medial division	0.142857142857
CeM	central amygdaloid nucleus, medial subdivision	0.142857142857
CeM	central medial thalamic nucleus	0.142857142857
CeM	central amygdaloid nucleus, medial division	0.142857142857
CeM	nucleus centralis medialis	0.142857142857
CeL	lateral subdivision of the central nucleus of the amygdala	0.5
CeL	core and lateral central nucleus of the amygdala	0.5
NARTN	ational adult reading test	1.0
Ang1	angiopoietin-1	1.0
M1l	m1m and m2 are subdivisions of this)	1.0
a-PV	anti-parvalbumin	1.0
hLF	human lactoferrin	1.0
CRTN	a+/cl-/creatine transporter	1.0
mACSF	modified artificial cerebrospinal fluid	1.0
ADP-β-S	adenosine 5′-o-(2-thiodiphosphate)	1.0
CRTL	1cartilage-related aggrecan-binding link protein	1.0
PD-	980592′-amino-3′-methoxyflavone	0.5
PD-	de novode novo (drug naive) parkinson's disease patients	0.5
PLF	print length factor	1.0
brain-C	pr-nullbrain specific cpr-knockout	1.0
Sncasynuclein	alpha	1.0
LANR	low-affinity neurotrophin receptor	1.0
QHCl	quinine hydrochloride	1.0
SEB	staphylococcal enterotoxin b	1.0
MPAH	medial preoptic area of the hypothalamus	1.0
Stry	strychnine	1.0
eCB	sendocannabinoids	0.130434782609
eCB	endogenous cannabinoid	0.0434782608696
eCB	sendogenous cannabinoids	0.0434782608696
eCB	endocannabinoids	0.0434782608696
eCB	sendocannabinoid system	0.0434782608696
eCB	endocannabinoid	0.695652173913
DALCE	,	1.0
TJ-	54yokukansan	1.0
Bt2cAMP	dibutyryl camp	0.5
Bt2cAMP	dibutyryl cyclic amp	0.5
PLE	perseveration-like error	1.0
BTα-	bungarotoxin	1.0
LTLE	lesional temporal lobe epilepsy	1.0
sHFM	short humped frequency modulated	1.0
ICVC	intracerebroventricular cannulated	1.0
YAC	yeast artificial chromosomes	0.2
YAC	yeast artificial chromosome	0.6
YAC	72/yac128transgenic mouse model of huntington’s disease made using a yeast artificial chromosome containing the full length human gene and 72/128 cag repeats respectively	0.2
ECRF	extraclassical receptive field	1.0
cKONSE-C	re+ nrsfflox/flox mice	1.0
SOCE	store-operated ca2+ entry	1.0
SPAN	6-p-sulfophenyladenosine	1.0
CGP55845	3-n[1-(s)-(3,4-dichlorophenyl)ethyl]amino-2-(s)-hydroxypropyl-p-benzyl-phosphinic acid	1.0
TMCS	trimethylchlorosilane	1.0
mHNSC	mouse hippocampal neural stem cells	1.0
PFFSDA	average fano factor across all cells with a stable delay-activated response	1.0
dATP	[α33p]deoxy-atp	0.5
dATP	deoxyadenosine triphosphate	0.5
VWFA	visual word form area	1.0
mEJP	miniature excitatory junctional potential	1.0
SIBLING	males that were tested with a familiar female sibling that he had been housed with until 3 hours before testing	1.0
Pvc	caudal paraventricular nucleus	1.0
SOCS	3suppressor of cytokine signaling 3	0.307692307692
SOCS	2-tgsuppressor of cytokine signaling-2-transgenic	0.0769230769231
SOCS	3suppressor of cytokine signalling 3	0.0769230769231
SOCS	suppressor of cytokine signalling	0.0769230769231
SOCS	suppressors of cytokine signaling	0.153846153846
SOCS	suppressor of cytokine signaling	0.307692307692
VEGF-S	hortvascular endothelial growth factor promoter-luciferase plasmid which does not carry hypoxia response element	1.0
SPAR	spine-associated rap-gap	0.5
SPAR	spine-associated rap-specific gtpase-activating protein	0.5
NOP-	/-nop receptor knockout	1.0
hGAD	67human glutamate decarboxylase	1.0
c-nTS	solitary tract nucleus, commissural	1.0
zfDYN	azebrafish dynorphin a	1.0
DHEASDHEA	sulfate	1.0
IMC	nucleus isthmi, pars magnocellularis	1.0
FREF	reezing	1.0
NOC-	181-hydroxy-2-oxo-3.3-bis(3-aminoethyl)-1-triazene	0.5
NOC-	7[3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-n-methyl-1-propanamine]	0.5
2MB	22-methylbut-2-enal	1.0
DDSA	dodecenyl succinic anhydride	1.0
2ME	22-methoxyestradiol	1.0
GABA-	steroid	0.142857142857
GABA-	negativegamma-aminobutyric acid immunonegative	0.142857142857
GABA-	induced depolarization	0.142857142857
GABA-	inhibition	0.142857142857
GABA-	mediated inhibition	0.142857142857
GABA-	withdrawal syndrome	0.142857142857
GABA-	activated current	0.142857142857
nestin-GFP	green fluorescent protein driven by nestin promoter	1.0
GC-S	soluble guanylyl cyclase	1.0
IMD	intermediodorsal thalamic nucleus	0.375
IMD	intermittent movement disorder	0.125
IMD	intermediodorsal nucleus of thalamus	0.125
IMD	intermediate thalamic nucleus	0.125
IMD	intermediodorsal thalamus	0.25
sTBI	severe traumatic brain injury	1.0
CMS-S	er-rcms sertraline responders	1.0
NTDN-	terminal domain	1.0
r-IGT	rodent version of the iowa gambling task	1.0
algBST	anterolateral group of bst nuclei	1.0
Sos	member of a guanine nucleotide-releasing protein family that enhances the rate of gdp-gtp exchange on ras	1.0
DAdopamine	dopaminergic	1.0
RACE	5'rapid amplification of cdna ends	0.0333333333333
RACE	rapid amplification of cdna-ends	0.0333333333333
RACE	rapid amplification of cdna end	0.0333333333333
RACE	5′rapid amplification of cdna ends	0.0333333333333
RACE	rapid amplification of complementary dna ends	0.0333333333333
RACE	rapid amplification of cdna ends	0.8
RACE	3′ rapid amplification of the cdna ends	0.0333333333333
OTu	olfactory tubercle	1.0
RACK	receptor for activated c-kinase	0.25
RACK	pseudo-receptor octapeptide for activated pkcϵ	0.25
RACK	1receptor of activated protein kinase c 1	0.25
RACK	1protein receptor for activated c kinase 1	0.25
VCA	anteroventral cochlear nucleus	0.5
VCA	anterior ventral cochlear nucleus	0.5
VCC	voltage clamp current	0.5
VCC	voltage-gated calcium channels	0.5
TRYCAT	strp catabolized along the ido pathway	1.0
Nvehicle-treated	naloxone-challenged animals	1.0
PDS	paroxysmal depolarization shift	0.4375
PDS	paroxysmal depolarizing shift	0.5625
SBDP	sspectrin breakdown products	0.1
SBDP	spectrin breakdown product	0.8
SBDP	145aii-spectrin breakdown products of 145kda	0.1
VCM	vacuous chewing movement	0.166666666667
VCM	voltage-clamp mode	0.166666666667
VCM	svacuous chewing movements	0.166666666667
VCM	vacuous chewing movements	0.5
VCN	ventral collector nerve	0.03125
VCN	ventral cochlear nuclei	0.03125
VCN	ventral cochlear nucleus	0.9375
VCO	velocity-controlled oscillator	0.25
VCO	2rate of whole-body co2 production	0.75
VCP	/p97valosin containing protein	0.166666666667
VCP	vasolin-containing peptide	0.166666666667
VCP	posteroventral cochlear nucleus	0.166666666667
VCP	valosin-containing protein	0.333333333333
VCP	ventral cellular prominence	0.166666666667
TgC	transglutaminase type c, tissue transglutaminase	1.0
VCR	vincristine sulfate	0.142857142857
VCR	vestibulo-collic reflex	0.142857142857
VCR	vestibulo-cervical reflex	0.142857142857
VCR	vestibulocollic response	0.142857142857
VCR	vestibulocollic reflex	0.428571428571
VCS	vaginocervical stimulation	0.571428571429
VCS	vaginal–cervical stimulation	0.285714285714
VCS	stimulation of the vagina and cervix	0.142857142857
VCT	visual cue task	1.0
CLB	cell lysis buffer	1.0
THP3α	5α tetrahydroprogesterone	1.0
MDV	medial dorsal thalamus nucleus–ventral part	1.0
L-CT	/ctratio of latency of correct trials/number of correct trials	1.0
CLC	lateral capsular subdivision of the central amygdaloid nucleus	0.333333333333
CLC	centralis lateralis complex	0.333333333333
CLC	capsular subdivision of the central nucleus	0.333333333333
FAM-TAMRA	6-carboxyfluorescein-tetramethylrhodamine	1.0
ssOH	single strand	1.0
T-PBST	riton-x/phosphate buffered saline	1.0
P-MEK	phosphorylated form of mek	1.0
GABAR	sgabaa receptors	1.0
PDN	pyloric dilator nerve	0.5
PDN	primary dendritic number	0.5
TARC	thymus and activation-regulated chemokine	1.0
Pilo-SE	pilocarpine model of status epilepticus	1.0
N50	negative peak in the cortical response at 50 ms after stimulus	1.0
FACE	fluoroacetate	1.0
WKY	wistar–kyoto normotensive rat	0.0714285714286
WKY	rats	0.0714285714286
WKY	wistar kyoto rats	0.214285714286
WKY	ratswistar kyoto rats	0.0714285714286
WKY	normotensive wistar kyoto rat	0.0714285714286
WKY	/izmnormotensive wistar kyoto rats	0.0714285714286
WKY	wistar–kyoto	0.357142857143
WKY	/ncrlwistar kyoto rat	0.0714285714286
MEKERK	kinase	1.0
IMR	32 cells	1.0
GABAA	receptor structure	0.00892857142857
GABAA	receptor plasticity	0.00892857142857
GABAA	receptors gating	0.00892857142857
GABAA	receptor	0.4375
GABAA	gamma-aminobutyric acid a	0.00892857142857
GABAA	gababgabaergic receptor types a, and b	0.00892857142857
GABAA	gaba receptor subtype a	0.00892857142857
GABAA	receptora-type γ-aminobutyric acid receptor	0.00892857142857
GABAA	receptor subunits	0.0267857142857
GABAA	α1gabaa receptor α1 subunit	0.00892857142857
GABAA	receptors	0.276785714286
GABAA	gamma-aminobutyric acid a receptor	0.00892857142857
GABAA	receptor anchoring	0.00892857142857
GABAA	receptors brain mapping	0.00892857142857
GABAA	type a gaba receptor	0.00892857142857
GABAA	gamma-amino butyric acid-a	0.00892857142857
GABAA	receptor subtypes	0.00892857142857
GABAA	rgabaa-receptors	0.00892857142857
GABAA	receptor modulation	0.00892857142857
GABAA	modulation	0.00892857142857
GABAA	receptorgaba type a receptor	0.0267857142857
GABAA	receptor β3 subunit	0.00892857142857
GABAA	/b/c receptorgaba receptor type a/b/c	0.00892857142857
GABAA	type a gaba	0.0178571428571
GABAA	agonist	0.00892857142857
GABAA	receptor sub-units	0.00892857142857
GABAA	and gabab receptors	0.00892857142857
GABAA	β2/3	0.00892857142857
GABAA	gamma-aminobutyric acid-a	0.00892857142857
GABAB	1 and gabab2subunits of the gabab receptor	0.027027027027
GABAB	receptor knockout mice	0.027027027027
GABAB	r2gabab receptor r2 subunit	0.027027027027
GABAB	metabotropic gaba type b	0.027027027027
GABAB	receptors	0.459459459459
GABAB	rgabab-receptors	0.027027027027
GABAB	receptor	0.351351351351
GABAB	antagonist	0.027027027027
GABAB	gaba receptor subtype b	0.027027027027
GABAC	receptor	0.4
GABAC	receptors	0.6
FACS	fluorescent cell sorting	0.0454545454545
FACS	fluorescent activated cell sorting	0.0454545454545
FACS	fluorescence-activated cell scanning	0.0454545454545
FACS	fluorescence activated cell sorting	0.363636363636
FACS	fluorescence activated cell sorter	0.0454545454545
FACS	fluorescence-activated cell sorting	0.409090909091
FACS	fluorescence-activated cell sorter	0.0454545454545
L-NACN-L-	acetylcysteine	1.0
TARP	transmembrane ampar regulatory protein	0.111111111111
TARP	stransmembrane ampa receptor regulatory proteins	0.111111111111
TARP	transmembrane ampa receptor regulatory protein	0.555555555556
TARP	stransmembrane ampa receptor associated proteins	0.111111111111
TARP	transmembrane ampa receptor regulatory proteins	0.111111111111
VMPO	ventromedial preoptic nucleus	0.714285714286
VMPO	ventral medial preoptic nucleus	0.142857142857
VMPO	ventromedial preoptic area.	0.142857142857
SD-OFAS	prague–dawley-ofa	1.0
CLZ	clozapine	1.0
CXCRCXC	chemokine receptor	1.0
NOARG	nitroarginine	1.0
CDP-	cholinecytidine-5-diphosphocholine	0.5
CDP-	cholinecytidine-5′-diphosphocholine	0.5
SDF-1	stromal cell-derived factor 1	1.0
CLT	clotrimazole	0.333333333333
CLT	control group – non-exercised rats with saline injection	0.333333333333
CLT	centrolateral nucleus of the thalamus	0.333333333333
α-MSHα-	melanocyte stimulating hormone	0.333333333333
α-MSHα-	melanocyte-stimulating hormone	0.6
α-MSHα-	melanophore-stimulating hormone	0.0666666666667
LSD-test	fisher's least significant difference test	1.0
PDF	pigment dispersing factor	0.5
PDF	probability density function	0.5
M596L	mutation at codon 596 of amyloid precursor protein resulting in substitution of methionine by leucine	1.0
EGTAHTCaS	high-threshold calcium spike	1.0
SE-	neuronsneurons that demonstrated activity related to the specific elements of the operant task	1.0
TEACl	tetraethylammonium chloride	1.0
aENC	adipose-derived stem cell engineered fibroblast conduit	1.0
CLW	cochlear lateral wall	1.0
M-cell	mauthner cell	1.0
SSCANT-IV-V	layers iv and v of the anterior somatosensory cortex	1.0
TEACT	rolox equivalent antioxidant capacity	1.0
-α-MCPG	(±)-α-methyl-4-carboxyphenylglycine	1.0
CLP	contralateral paw	0.166666666667
CLP	contralateral hind paw	0.166666666667
CLP	cecal ligation and puncture	0.5
CLP	contralateral local pain	0.166666666667
TNBS	trinitrobenzenesulfonic acid	0.166666666667
TNBS	trinitrobenzene sulfonic acid	0.833333333333
HFS-Cx	high-frequency stimulation of contralateral cerebral cortex	1.0
dPC	the total number of dendritic profiles within a cluster	1.0
PDA	photodiode array	1.0
dPA	dysgranular parietal insular cortex	1.0
FWE	family wise error	0.1
FWE	family-wise error correction	0.05
FWE	family-wise (type-i) error rate	0.05
FWE	familywise error-rate	0.05
FWE	family-wise error rate	0.05
FWE	family-wise-error	0.05
FWE	family-wise error	0.65
BRDU	5-bromodeoxyuridine	1.0
mDYN	amammalian dynorphin a	1.0
CLS	confocal laser scanning	0.5
CLS	centrolateral segment	0.5
dPI	dysgranular posterior insular cortex	1.0
TRIPTAR	rna interacting protein	1.0
Rp-cAMP	rp isomer of cyclic amp	1.0
PIAL	pars intermedia of the anterior lobe	1.0
mBBB	mouse bbb locomotor score	1.0
CST	concept shifting test	0.0333333333333
CST	corticospinal tract	0.7
CST	cervical sympathetic trunk	0.0666666666667
CST	catestatin	0.0666666666667
CST	cortico-spinal tract	0.0666666666667
CST	corticospinal tract projecting through the posterior limb of the internal capsule	0.0333333333333
CST	scorticospinal tracts	0.0333333333333
DHPGS-3	5 dihydrophenylglicine	1.0
Put	putamen	1.0
CP-96	345, (2s,3s)-cis-(diphenylmethyl)-n-[(2-methoxyphenyl)-methyl-1-azabicyclo-[2.2.2]-octan-3-amine]	1.0
FAAHF	atty acid amide hydrolase	0.5
FAAHF	atty acid amide hydrolyase	0.5
KRPK	reb's ringer phosphate	0.6
KRPK	reb’s ringer phosphate	0.2
KRPK	rebs–ringer phosphate	0.2
Sar9-SP	[sar9, met(o2)11] substance p	1.0
CP-93	1293-(1,2,5,6-tetrahydropyrid-4-yl)pyrrollo[3,2-b]pyrid-5-one	1.0
CSPG	chondroitin-6-sulfate-containing proteoglycan	0.0212765957447
CSPG	chondroitin sulfate proteoglycan	0.531914893617
CSPG	chondroitin sulfate proteoglycans	0.0851063829787
CSPG	schondroitin sulphate proteoglycans	0.0212765957447
CSPG	schondroitin sulfate proteoglycans	0.31914893617
CSPG	chondroitin sulphate proteoglycan	0.0212765957447
R-PIA	r-phenylisopropyl adenosine	0.142857142857
R-PIA	r(-)n6-(2-phenylisopropyl)adenosine	0.142857142857
R-PIA	r-phenylisopropyladenosine	0.285714285714
R-PIA	(-)n6-phenylisopropyladenosine	0.142857142857
R-PIA	n6-(r-phenylisopropyl)-adenosine	0.142857142857
R-PIA	n6-r-phenylisopropyladenosine	0.142857142857
σR	1sigma receptor 1	0.5
σR	sigma receptor	0.5
R-LM	radiatum–lacunosum moleculare	1.0
CSPA	capsaicin-sensitive primary afferent	1.0
HIPPO	hippocampus	1.0
U-V	unchallenged vehicle	1.0
nDNA	nuclear dna	1.0
NFKB	nuclear factor kb	0.5
NFKB	1nuclear factor of kappa light polypeptide gene enhancer in b-cells 1	0.5
CSPs	cysteine string proteins	1.0
PSEN-1	presenilin-1	1.0
Rin	membrane input resistance	0.115384615385
Rin	intracellular resistance	0.0384615384615
Rin	apparent input resistance	0.0384615384615
Rin	cell input resistance	0.0384615384615
Rin	input resistance	0.730769230769
Rin	input membrane resistance	0.0384615384615
PLCP	hospholipase c	1.0
MUS-LO	low dose of muscimol	1.0
SENS	behavioral sensitization	0.5
SENS	group of animals that expressed sensitization on challenge day in experiment 2	0.5
CNQX6-Cyano-7-nitroquinoxaline-2	3-dione	0.5
CNQX6-Cyano-7-nitroquinoxaline-2	3-dione disodium	0.5
SLOSS	mith-lemli-optiz syndrome	1.0
DMA	dimethylacetal	0.25
DMA	nucleus dorsomedialis anterior	0.25
DMA	dorsomedial hypothalamic area	0.25
DMA	nucleus dorsomedialis anterior thalami	0.25
DMB	5,5′-dimethylbapta	1.0
DMC	dimethoxy curcumin	1.0
DMD	duchenne muscular dystrophy	1.0
DME	/f-12dulbecco’s modified eagle’s medium nutrient mixture f-12 ham	0.333333333333
DME	/highdulbecco's modified eagle's medium high glucose	0.666666666667
DMF	dimethylformamide	0.4
DMF	n,n-dimethylformamide	0.2
DMF	dimethylfumarate	0.2
DMF	4:5:1 mixture of dmem, earle's minimum essential medium and ham's f12 medium	0.2
PS-	1 or ps-2presenilin 1 or presenilin 2	0.2
PS-	paradoxical sleep without pgo waves and rems	0.2
PS-	1presenilin-1	0.6
DMH	dorsomedial nucleus of the hypothalamus	0.158536585366
DMH	dorsomedial nucleus	0.0243902439024
DMH	ddorsal region of the dmh	0.0121951219512
DMH	vventral part of the dorsomedial hypothalamic nucleus	0.0121951219512
DMH	hypothalamic dorsomedial nucleus	0.0121951219512
DMH	dorsomedial hypothalamic nucleus	0.365853658537
DMH	dorsomedial paraventricular nucleus	0.0121951219512
DMH	dorsomedial hypothalamic region	0.0121951219512
DMH	dorsal medial hypothalamus	0.0121951219512
DMH	dorsomedial hypothalamus	0.365853658537
DMH	dorsomedial hypothalamic area	0.0121951219512
DMI	desipramine	0.833333333333
DMI	desmethylimipramine	0.166666666667
DML	dentate molecular layer	1.0
RORα	retinoid-related orphan receptor alpha	1.0
DMN	dorsomedial nucleus of the hypothalamus	0.0322580645161
DMN	dorsomedial nucleus	0.290322580645
DMN	dorsomedial nuclei	0.0322580645161
DMN	deep mesencephalic nucleus	0.0322580645161
DMN	dorsal motor nucleus of the vagus	0.0322580645161
DMN	dorsal motor neuron	0.0322580645161
DMN	dorsomedial hypothalamic nucleus	0.0645161290323
DMN	default mode network	0.322580645161
DMN	default-mode network	0.0322580645161
DMN	digastric motoneuron	0.0322580645161
DMN	dorsal medullary nucleus	0.0322580645161
DMN	dorsal motor nucleus of the vagus nerve	0.0322580645161
DMN	dorsal motor nucleus	0.0322580645161
DMP	nucleus dorsomedialis posterior thalami	0.25
DMP	delayed matching-to-position	0.25
DMP	deep muscular plexus	0.25
DMP	delayed matching to position	0.25
JNK-	1	0.5
JNK-	interacting proteins	0.5
DMR	dynamic moving ripple	0.5
DMR	sdifferentially methylated regions	0.5
DMS	delayed match to sample	0.0909090909091
DMS	delayed-match-to-sample	0.0909090909091
DMS	10delayed matching-to-sample with a 10 min delay	0.0909090909091
DMS	delayed match-to-sample	0.0909090909091
DMS	vvisual delayed-matching-to-sample	0.0909090909091
DMS	delayed-matching-to-sample	0.0909090909091
DMS	delayed matching-to-sample	0.272727272727
DMS	dimethylsphingosine	0.0909090909091
DMS	dorsomedial striatum	0.0909090909091
DMT	1divalent metal transporter-1	0.222222222222
DMT	gdorsal medial tegmental area	0.111111111111
DMT	dorsomedial tegmental area	0.111111111111
DMT	dimethyltryptamine	0.111111111111
DMT	1divalent metal transporter 1	0.444444444444
I-RA	intact ra	1.0
DMV	dorsal motor nucleus of the vagus	0.724137931034
DMV	dorsal vagal nucleus	0.0344827586207
DMV	dorsal motor nucleus of the vagus nerve	0.0344827586207
DMV	dorsal vagal motor nucleus	0.0344827586207
DMV	dorsal motor nucleus of vagus	0.172413793103
biORN	bilaterally projecting orn	1.0
DMX	dorsal motor nucleus of the vagus	0.307692307692
DMX	dorsal motor nucleus of the vagus nerve	0.615384615385
DMX	dorsal motor vagal nucleus	0.0769230769231
DMZ	dorsomedial zone	1.0
PS1	presenilin 1	0.5
PS1	presenilin-1	0.5
192-SAP	192 igg-saporin	1.0
BSBS	bulbospinal barosensitive	1.0
NMDAR	antagonists	0.0185185185185
NMDAR	nmda-receptor	0.0185185185185
NMDAR	nmda receptors	0.0185185185185
NMDAR	snmda type glutamate receptors	0.0185185185185
NMDAR	nmda receptor/channel complex	0.0185185185185
NMDAR	1n-methyl d-aspartate glutamate receptor 1	0.0185185185185
NMDAR	1n-methyl-d-asparate receptor subunit 1	0.0185185185185
NMDAR	sn-methyl-d-aspartate receptors	0.222222222222
NMDAR	1n-methyl-d-aspartate receptor subunit 1	0.037037037037
NMDAR	1	0.0185185185185
NMDAR	n-methyl-d-aspartate glutamate receptor	0.0185185185185
NMDAR	2	0.0185185185185
NMDAR	n-methyl-d-aspartate receptor subunit	0.0185185185185
NMDAR	nmda receptor subunit	0.0185185185185
NMDAR	sn-methyl-d-aspartate subtype glutamate receptors	0.0185185185185
NMDAR	1n-methyl-d-aspartate receptor 1	0.0185185185185
NMDAR	n-methyl-d-aspartate receptor	0.166666666667
NMDAR	snmda receptors	0.037037037037
NMDAR	sn-methyl-d aspartate receptors	0.0555555555556
NMDAR	nmda-type glutamate receptor	0.0185185185185
NMDAR	fepspnmda receptor-mediated field excitatory postsynaptic potential	0.0185185185185
NMDAR	epscnmdar-mediated excitatory post-synaptic current	0.0185185185185
NMDAR	nmda receptor	0.12962962963
NMDAR	1n-methyl-d-aspartate receptor type 1	0.0185185185185
NMDAR	sn-methyl-d-aspartate subclass of glutamate receptors	0.0185185185185
K-BITK	aufman brief intelligence test	1.0
rt-PCR	real-time polymerase chain reaction	1.0
VNTR	svariable number of tandem repeats	0.166666666667
VNTR	variable number of tandem repeats	0.166666666667
VNTR	variable number tandem repeat	0.666666666667
SBBTS	uperblock blocking buffer containing 0.4% triton x-100	1.0
GST-P	1glutathione s-transferase p1	0.5
GST-P	iglutathione s-transferase pi	0.5
lPFC	lateral prefrontal cortex	1.0
TBST	tris buffer saline tween	0.00224719101124
TBST	x0.1% triton x-100 in tris-buffered saline	0.00224719101124
TBST	tbs containing 1% tween 20	0.00224719101124
TBST	rizma buffer saline	0.00224719101124
TBST	∗tris-buffered saline with 0.2% tween-20	0.00224719101124
TBST	tween-20	0.00224719101124
TBST	twice-buffered saline and tween-20	0.00224719101124
TBST	tris buffered saline with 0.1% tween 20	0.00224719101124
TBST	ris–hcl/sodium chloride buffer	0.00224719101124
TBST	tris-buffered saline containing 0.1% triton x-100	0.00224719101124
TBST	50 mm tris-buffered saline containing 0.5% tween-20	0.00449438202247
TBST	tris-buffered saline with triton-x-100	0.00224719101124
TBST	tris-buffered saline-tween 20	0.00224719101124
TBST	tris-buffered saline and tween 20	0.00224719101124
TBST	tris– buffered saline with 0.1% tween-20	0.00224719101124
TBST	tris buffered saline with tween-20	0.00224719101124
TBST	ris buffer saline	0.0157303370787
TBST	tris-buffered saline containing 0.05% tween-20	0.00224719101124
TBST	0.02 m tris buffer ph 7.5 containing 0.16 m sodium chloride and 0.05% tween 20	0.00224719101124
TBST	tris-buffered saline/tween 0.0005% v/v	0.00224719101124
TBST	tris–buffer containing nacl and triton x-100	0.00224719101124
TBST	tris-buffered saline with tween-20	0.00898876404494
TBST	tris-buffered saline plus tween 20	0.00224719101124
TBST	10 mm tris–hcl, ph 8.0, 150 mm nacl and 0.2% tween-20	0.00224719101124
TBST	0.5 m tris–hcl	0.00224719101124
TBST	tris-buffered saline and tween-20	0.00224719101124
TBST	ris–hcl buffered saline	0.00449438202247
TBST	tbs-tween 20	0.00224719101124
TBST	tris-buffered saline containing 0.1% tween-20	0.00674157303371
TBST	tris-buffered saline containing 0.5% tween 20	0.00224719101124
TBST	ris buffer solution	0.00449438202247
TBST	tris-buffered saline plus 0.1% triton x-100	0.00224719101124
TBST	tris-buffered saline containing 1% tween	0.00224719101124
TBST	wtris-buffered saline with 0.05% tween 20	0.00449438202247
TBST	ris-buffer saline	0.00674157303371
TBST	ris hcl-buffered saline	0.00224719101124
TBST	tris buffered saline and tween-20	0.00224719101124
TBST	ris–hcl buffer saline	0.00224719101124
TBST	tris-buffered saline plus tween	0.00224719101124
TBST	tris-buffered saline tween	0.00449438202247
TBST	tris–nacl with 0.5% triton x-100	0.00224719101124
TBST	tris-buffered saline with 0.05% tween	0.00224719101124
TBST	tris-buffered saline with 0.05% tween 20	0.00224719101124
TBST	tris buffer with triton x-100	0.00224719101124
TBST	tris buffered saline tween 20	0.00224719101124
TBST	tbs with triton x-100	0.00224719101124
TBST	rtris buffered saline plus 0.3% triton x-100	0.00224719101124
TBST	tris-buffered saline with tween	0.00674157303371
TBST	tris-buffered saline with tween 20	0.0179775280899
TBST	tris buffered saline-tween 20	0.00224719101124
TBST	ris-buffered solution	0.0134831460674
TBST	ris buffer	0.00224719101124
TBST	ris-buffered saline	0.649438202247
TBST	ris buffered saline	0.0179775280899
TBST	tris–buffered saline with tween 20	0.00224719101124
TBST	tris-buffered saline with triton	0.00449438202247
TBST	5% non-fat dry milk in 1× tbs with 0.05% tween-20	0.00224719101124
TBST	ris–saline buffer	0.00224719101124
TBST	tris–buffered saline-20% tween 20	0.00224719101124
TBST	rizma-buffered saline	0.00224719101124
TBST	risma-buffered saline	0.00224719101124
TBST	triton x-100	0.00224719101124
TBST	tris-buffered saline with 0.1% tween 20	0.00224719101124
TBST	rtris-buffered saline plus 0.3% triton x-100	0.00449438202247
TBST	5% nonfat dry milk in tris-buffered saline with 0.05% tween-20	0.00224719101124
TBST	0.3% tris-buffered saline/triton-x	0.00224719101124
TBST	1% normal goat serum and 0.5% triton x-100	0.00224719101124
TBST	tbs with tween 20	0.00449438202247
TBST	tris-buffered saline with triton x-100	0.00898876404494
TBST	tbs–tween 20	0.00224719101124
TBST	tris-buffered saline–tween	0.00224719101124
TBST	tris-buffered saline containing 0.5% tween-20	0.00224719101124
TBST	ris–hcl-buffered saline	0.0179775280899
TBST	ris-based saline	0.00224719101124
TBST	tris buffer saline supplemented with 0.3% triton x-100	0.00224719101124
TBST	tris–hcl buffer containing 0.5 m nacl and 0.05% tween20	0.00224719101124
TBST	ris–buffered saline	0.0224719101124
TBST	tris–buffered saline tween-20	0.00224719101124
TBST	/ttris-buffered saline and 0.1% tween-20	0.00224719101124
TBST	50mm tris-buffered saline containing 0.5% tween-20	0.00224719101124
TBST	tris-buffered saline plus 0.1% tween 20	0.00224719101124
TBST	ris-hcl buffered	0.00224719101124
TBST	tris-buffered saline containing triton x-100	0.00674157303371
TBST	tris-buffered saline tween-20	0.00674157303371
TBST	ris (0.05m)-buffered saline	0.00224719101124
TBST	rtbs containing 0.3% triton x-100	0.00449438202247
TBST	tris-buffered saline containing 0.05% tween 20	0.00449438202247
TBST	tbs with tween-20	0.00224719101124
TBST	10 mm tris–hcl (ph 7.5), 150 mm nacl and 0.1% tween-20	0.00224719101124
TBST	tris-buffered saline containing tween-20	0.00224719101124
TBSS	tract based spatial statistics	0.25
TBSS	tract-based spatial statistics	0.75
TBSH	tris-buffered saline with heparin	1.0
SABB	saline infusion in abb version	1.0
SABA	saline infusion in aba version	1.0
-rdgB	(mammalian) retinal degeneration b	1.0
NMDAN	methyl d-aspartate	1.0
EAUG	neuronexpiratory neuron with augmenting firing pattern	1.0
U-IL	unidirectional neurons, responsive with rotations directed towards the side ipsilateral to recording, in the left vestibular nucleus	1.0
NGF-BDNF	signaling	1.0
RIIβ	regulatory subunit ii beta	1.0
ZPLD	1	1.0
CTX-	sssomatosensory cortex	1.0
MVFM	aximal voluntary isometric force	1.0
XRE	xenobiotic-responsive element	1.0
cSCI	contusion sci	1.0
XRF	micro-x-ray fluorescence	1.0
elPBN	external lateral subnucleus of pbn	0.5
elPBN	external lateral parabrachial nucleus	0.5
DCSD-	cycloserine	1.0
XRX	rays	1.0
ICC-MY	myenteric interstitial cells of cajal at the level of the myenteric plexus	1.0
A5	a5 area	0.5
A5	a5 region	0.5
DPPIV	dipeptidyl peptidase iv	1.0
NMDA-	fepsp	0.25
NMDA-	receptor antagonist	0.5
NMDA-	/non-nmda-receptors	0.25
TPRV	1transient receptor potential vanilloid receptor-1	1.0
PSH	peristimulus histogram	0.428571428571
PSH	psychological stress-induced hyperthermia	0.142857142857
PSH	post-stimulus histogram	0.285714285714
PSH	peristimulus firing rate histogram	0.142857142857
PSI	sigjackknife significance of psi	0.142857142857
PSI	protein synthesis inhibition	0.142857142857
PSI	sprotein synthesis inhibitors	0.142857142857
PSI	phosphacan short isoform	0.285714285714
PSI	post-seizure induction	0.142857142857
PSI	protein synthesis inhibitor	0.142857142857
PSN	parasympathetic sacral nucleus	0.2
PSN	propriospinal neuron	0.2
PSN	persistent spontaneous nociception	0.6
CNMbasal	low insulin containing medium	1.0
PSL	/sphoto-stimulated luminescence/surface unit	0.142857142857
PSL	photo stimulus luminescence	0.142857142857
PSL	lamina pallio-subpallialis	0.142857142857
PSL	partial sciatic nerve ligation	0.285714285714
PSL	photostimulated luminescence	0.285714285714
PERC	perirhinal–entorhinal cortex	1.0
PSB	pallial–subpallial border	0.166666666667
PSB	presubiculum	0.166666666667
PSB	percentage of spikes within bursts	0.166666666667
PSB	post-stimulation baseline	0.166666666667
PSB	pontamine sky blue	0.333333333333
PSC	postsynaptic currents	0.025641025641
PSC	post-synaptic current	0.0769230769231
PSC	presymptomatic gene carriers	0.025641025641
PSC	peristimulus cross-correlation	0.025641025641
PSC	post synaptic current	0.025641025641
PSC	pontine urine storage center	0.025641025641
PSC	spostsynaptic currents	0.128205128205
PSC	postsynaptic current	0.589743589744
PSC	pontine storage center	0.025641025641
PSC	sperisynaptic schwann cells	0.025641025641
PSC	spost-synaptic currents	0.025641025641
PSA	population-spike amplitude	0.0169491525424
PSA	population spike amplitude	0.254237288136
PSA	power spectrum analysis	0.0677966101695
PSA	polysialylated neural cell adhesion molecule	0.0169491525424
PSA	ncampolysialylated synapse-variant of the neural cell adhesion molecule	0.0169491525424
PSA	polysiatylated	0.0169491525424
PSA	primary somatosensory area	0.0169491525424
PSA	period specific average	0.0169491525424
PSA	primary sensory areas	0.0169491525424
PSA	polysialic acid	0.508474576271
PSA	polysialylated	0.0169491525424
PSA	puromycin-sensitive aminopeptidase	0.0169491525424
PSA	α-2,8-linked polysialic acid	0.0169491525424
PSF	pre-spike “foot”	0.25
PSF	point spread function	0.5
PSF	post-stimulation freezing	0.25
vDMTS	taskvisual delayed-match-to-sample task	1.0
PSD	post-synaptic density protein	0.0108108108108
PSD	postsynpatic densities	0.00540540540541
PSD	partial sleep deprivation	0.00540540540541
PSD	presynaptic dendrite	0.00540540540541
PSD	spower spectral densities	0.0108108108108
PSD	95post-synaptic density-95	0.00540540540541
PSD	95postsynaptic density protein 95 kd	0.00540540540541
PSD	power spectral densities	0.0162162162162
PSD	post-stroke dementia	0.0108108108108
PSD	)	0.00540540540541
PSD	95postsynaptic density 95 protein	0.00540540540541
PSD	95post-synaptic density protein 95	0.0108108108108
PSD	95postsynaptic density 95	0.027027027027
PSD	spostsynaptic densities	0.0378378378378
PSD	postsynaptic density	0.551351351351
PSD	post-stimulus discharges	0.00540540540541
PSD	spost-synaptic densities	0.00540540540541
PSD	95postsynaptic density-95	0.0108108108108
PSD	postsynaptic membrane density	0.00540540540541
PSD	postsynaptic densities	0.0162162162162
PSD	95postsynaptic density protein 95	0.0216216216216
PSD	95	0.00540540540541
PSD	95post-synaptic density	0.00540540540541
PSD	phosphorylation site domain	0.00540540540541
PSD	power spectra density	0.00540540540541
PSD	post synaptic density	0.00540540540541
PSD	post-source decay	0.00540540540541
PSD	95postsynaptic density-95 protein	0.00540540540541
PSD	post-synaptic density	0.102702702703
PSD	power spectral density	0.0594594594595
PSD	postsynaptic density protein	0.0162162162162
PSD	dorsal psalterium	0.00540540540541
PSE	pseudoephedrine	0.5
PSE	point of subjective equality	0.5
PSZ	periventricular subependymal zone	1.0
PSR	population spike amplitude ratio	0.25
PSR	pitch-shift reflex	0.25
PSR	proximal stratum radium	0.25
PSR	polysynaptic reflex	0.25
PSS	physiological saline solution	0.15
PSS	predator scent stimulation	0.05
PSS	physiological standard solution	0.05
PSS	physiological salt solution	0.55
PSS	psychosocial stress	0.05
PSS	postsynaptic specialization	0.05
PSS	phosphoserine synthase	0.05
PSS	'sphotosensitive seizures	0.05
PSP	persephin	0.0416666666667
PSP	progressive supranuclear palsy	0.0625
PSP	field postsynaptic potential	0.0208333333333
PSP	spontaneous postsynaptic potential	0.0416666666667
PSP	post-synaptic potential	0.0416666666667
PSP	postsynaptic potential	0.625
PSP	spostsynaptic potentials	0.0625
PSP	postsynaptic potentials	0.0416666666667
PSP	population synaptic potential	0.0208333333333
PSP	pseudopregnancy	0.0208333333333
PSP	polysaccharide peptide	0.0208333333333
CGVL	ventrolateral divisions of the central gray	1.0
PSW	pre-synapse web	0.142857142857
PSW	positive slow wave	0.142857142857
PSW	polyspike-spike wave	0.142857142857
PSW	polyspike wave	0.142857142857
PSW	polyspike–wave	0.142857142857
PSW	polyspike-wave	0.285714285714
PST	peristimulus time histogram	0.2
PST	peri-stimulus time	0.2
PST	peri-stimulus-time	0.4
PST	post-stimulus histogram	0.2
GABA	ρ subunits	0.00373134328358
GABA	γ-[14c]	0.00373134328358
GABA	antagonists	0.00373134328358
GABA	gamma aminobutyric acid	0.0559701492537
GABA	(b) receptor	0.00373134328358
GABA	+gaba-immunoreactive	0.00373134328358
GABA	neuron	0.00373134328358
GABA	ergic	0.0522388059701
GABA	neurons	0.00746268656716
GABA	receptor	0.0261194029851
GABA	ergic interneuronal excitation	0.00373134328358
GABA	γ-aminobutyric acid	0.0410447761194
GABA	agonists	0.00373134328358
GABA	autoreceptor	0.00373134328358
GABA	and glutamate transporters	0.00373134328358
GABA	transporter (vgat)	0.00373134328358
GABA	gamma amino butyric acid	0.0373134328358
GABA	ergic synapses	0.00373134328358
GABA	transport	0.00746268656716
GABA	synthesizing neurons	0.00373134328358
GABA	aminobutyric acid	0.00373134328358
GABA	ergic inhibition	0.0223880597015
GABA	zinesr 95531 hydrobromide	0.00373134328358
GABA	γ-amino-butyric acid	0.00746268656716
GABA	ratio	0.00373134328358
GABA	gamma-amino-butiric acid	0.00373134328358
GABA	(a)gamma-aminobutyric acid receptor a	0.00373134328358
GABA	ergic phenotype	0.00373134328358
GABA	y-aminobutyric acid	0.00373134328358
GABA	ergicγ-aminobutyric acid-ergic	0.00373134328358
GABA	receptors	0.044776119403
GABA	ergic system	0.0186567164179
GABA	immunogold cytochemistry	0.00373134328358
GABA	gamma-amino butyric acid	0.0223880597015
GABA	gamma-aminobutyric acid	0.171641791045
GABA	neuroprotection	0.00373134328358
GABA	interneurons	0.00746268656716
GABA	γ-aminobutiric acid	0.00373134328358
GABA	gamma-aminobutyric acid polyclonal	0.00373134328358
GABA	ergic dysfunction	0.00373134328358
GABA	γ-amino-n-butyric acid	0.00373134328358
GABA	immunohistochemistry	0.00373134328358
GABA	ergic synapse	0.00746268656716
GABA	ergic neurons	0.0708955223881
GABA	gamma-aminobutyric acid and gabaergic	0.00373134328358
GABA	ergic and glutamatergic neuronal fates	0.00373134328358
GABA	responses	0.00373134328358
GABA	pharmacology	0.00373134328358
GABA	ergic projections	0.00373134328358
GABA	+gamma-aminobutyric acid immunopositive	0.00373134328358
GABA	withdrawal	0.00373134328358
GABA	ρ1 subunit	0.00373134328358
GABA	ergic transmission	0.00746268656716
GABA	egic feed-forward inhibition	0.00373134328358
GABA	ergic receptors	0.00746268656716
GABA	ergic innervation	0.00373134328358
GABA	ergic interneuron	0.0298507462687
GABA	inhibition	0.00373134328358
GABA	signaling	0.00746268656716
GABA	ergic deficit	0.00373134328358
GABA	gamma (γ)-aminobutyric acid	0.00373134328358
GABA	transporter	0.0373134328358
GABA	ergic neuron	0.00746268656716
GABA	ergic cells	0.00746268656716
GABA	γ-amino butyric acid	0.00746268656716
GABA	uptake	0.00373134328358
GABA	agonist	0.00373134328358
GABA	ergic projection	0.0111940298507
GABA	ergic interneurons	0.0261194029851
GABA	gamma amino-butyric acid	0.00746268656716
GABA	ergic modulation	0.00746268656716
GABA	ergic nonprincipal neurons	0.00373134328358
GABA	ergic interneurones	0.00373134328358
GABA	ergicutilizes gaba as the main neurotransmitter	0.00373134328358
GABA	hippocampal interneuron	0.00373134328358
GABA	transmission	0.00373134328358
GABA	gamma-amino-butyric acid	0.0111940298507
GABA	microinjection	0.00746268656716
GABA	release	0.0223880597015
GABA	ergic agonist	0.00373134328358
GABA	ergictransmitting or secreting γ-aminobutyic acid	0.00373134328358
GABA	atype a gamma-aminobutyric acid	0.00373134328358
GABA	re-uptake	0.00373134328358
sIL-	6rsoluble form of the il-6 receptor	1.0
BCM	curvebienenstock cooper munroe curve	0.5
BCM	bienenstock, cooper and munro	0.5
apoER	2apolipoprotein e receptor type 2	1.0
HNE	hydroxynonenal	0.142857142857
HNE	4-hydroxyl-2-nonenal	0.047619047619
HNE	4-hydroxy-2-nonenal	0.285714285714
HNE	4-hydroxynonenal	0.428571428571
HNE	4-hydroxy-2-neonenal	0.047619047619
HNE	4-hydroxy nonenal	0.047619047619
BCI	brain-derived neurotrophic factor cell index	1.0
HNG	[gly14]-humanin	1.0
IPTT-	200implantable programmable temperature transponder	1.0
BCF	brain-derived neurotrophic factor+ciliary neurotrophic factor+forskolin	1.0
BCG	bacillus calmette-guérin	0.25
BCG	bacille calmette–guerin	0.25
BCG	bacillus calmetteguérin	0.25
BCG	bacillus calmette–guérin	0.25
BCA	bicinchoninic acid	0.866666666667
BCA	bicinchoninic acid protein assay	0.0666666666667
BCA	bicinchoninic acid assay	0.0333333333333
BCA	assaybicinchoninic acid assay	0.0333333333333
BCB	blood–csf barrier	1.0
BCC	behavioural control column	1.0
HNS	hypothalamic–neurohypophysial system	0.142857142857
HNS	hypothalamo-neurohypophysial system	0.714285714286
HNS	hypothalamo–neurohypophysial system	0.142857142857
HNR	harmonics-to-noise ratio	1.0
A7	noradrenergic cell group in the lateral tegmentum	1.0
BCT	cerebellar basket cell terminal	0.5
BCT	rbox control of trained	0.5
GSDB	goat serum dilution buffer	1.0
BCV	biological variation	1.0
NM-	salsolinol	1.0
BCP	bone cancer pain	1.0
GS-PBS	goat serum dissolved in pbs	1.0
CICR	calcium induced calcium release	0.166666666667
CICR	calcium induced ca2+ release	0.0555555555556
CICR	ca2+-induced ca2+ release	0.222222222222
CICR	calcium-induced calcium release	0.555555555556
mCAMK	mouse α-calcium/calmodulin-dependent protein kinase ii promoter	1.0
REAK	rapid electrical amygdala kindling	1.0
papaNONOate	3-(2-hydroxy-2-nitroso-1-propylhydrazino)-1-propanamine	1.0
GHBR	gamma-hydroxybutyrate receptor	1.0
VHQ	vertigo handicap questionnaire	1.0
GHBP	growth hormone binding protein	1.0
SR-	955316-imino-3-(4-methoxyphenyl)-1(6h)-pyridazinebutanoic acid hydrobromide	1.0
Mch	acetyl-β-methylcholine	1.0
l-NMMANG-	monomethyl-l-arginine acetate salt	0.125
l-NMMANG-	monomethyl-l-arginine monoacetate	0.125
l-NMMANG-	monomethyl-l-arginine	0.375
l-NMMANG-	monomethyl-l-arginine acetate	0.25
l-NMMANG-	methy-l-arginine acetate salt	0.125
MaxiKBK	voltage-dependent and ca2+-activated k+	1.0
A6	noradrenergic cell group in the locus coeruleus	1.0
E-BSA	17β-estradiol conjugated to bovine serum albumin	1.0
GD3s-KOα2	8-sialyltransferase knockout	1.0
TRNv	visual segment of the thalamic reticular nucleus	0.5
TRNv	visual trn	0.5
SDIA	stromal cell-derived inducing activity	1.0
SRB	sulfate-reducing bacteria	1.0
SRC	synchrotron radiation centre	0.2
SRC	strength-response curve	0.2
SRC	standardized regression coefficients	0.2
SRC	steroid receptor coactivator	0.4
PBNα-	phenyl-n-tert-butyl-nitrone	0.666666666667
PBNα-	phenyl-n-tert-butyl nitrone	0.333333333333
EIPA	ethylisopropylamiloride	0.666666666667
EIPA	5-(n-ethyl-n-isopropyl)amiloride	0.333333333333
SRF	stimulus response function	0.25
SRF	stimulus–response function	0.0833333333333
SRF	surround receptive field	0.0833333333333
SRF	stimulus-response function	0.166666666667
SRF	serum response factor	0.25
SRF	subretrofacial nucleus	0.0833333333333
SRF	spatial receptive field	0.0833333333333
SRD	5a5α-reductase	0.333333333333
SRD	subnucleus reticularis dorsalis	0.333333333333
SRD	short recurrent discharge	0.333333333333
SRE	serum response element	0.909090909091
SRE	serum responsive element	0.0909090909091
CnMd	centromedian nucleus	1.0
PRKO	progestin receptor knockout	1.0
Calleja	major island	1.0
SRI	sserotonin reuptake inhibitors	0.333333333333
SRI	serotonin reuptake inhibitor	0.666666666667
SRO	strata radiatum and oriens dendrites	1.0
SRM	spatial reference memory	1.0
T-PERT	issue protein extraction reagent	1.0
SRS	systematic random sampling	0.05
SRS	erum replacement	0.05
SRS	salt-resistant rat given high salt diet	0.05
SRS	sspontaneous recurrent seizures	0.05
SRS	spontaneous recurrent seizure	0.15
SRS	startle response system	0.05
SRS	spontaneous recurrent seizures	0.4
SRS	systematically and randomly sampled	0.05
SRS	stress responsive subordinates	0.05
SRS	sleep regulatory substances	0.05
SRS	uppression ratio	0.05
SRT	saccadic reaction time	0.166666666667
SRT	skilled reaching task	0.166666666667
SRT	spinoreticular tract	0.166666666667
SRT	speech reception threshold	0.166666666667
SRT	social recognition test	0.333333333333
SRY	sex-determining region	1.0
NRISH	nonradioactive in situ hybridization	1.0
CE-LIFD	capillary electrophoresis with laser-induced fluorescence detection	1.0
dEMG	digastric electromyogram	1.0
TDI	threshold discrimination identification	0.333333333333
TDI	tolerable daily intake	0.333333333333
TDI	scorethreshold discrimination identification score	0.333333333333
NMU	neuromedin u	1.0
NMR	nuclear magnetic resonance imaging	0.0625
NMR	proton nuclear magnetic resonance	0.0625
NMR	nuclear magnetic resonance	0.875
NMS	neonatal maternal separation	0.285714285714
NMS	non-maternal separated	0.142857142857
NMS	al	0.142857142857
NMS	normal mouse serum	0.142857142857
NMS	n-methylscopolamine	0.142857142857
NMS	non-motoric symptoms	0.142857142857
TDM	theta detection method	0.333333333333
TDM	total distance moved	0.666666666667
TDL	total dendritic length	1.0
MYE	myelinated	1.0
RNBP	renin-binding protein	1.0
SRi	superficial radial nerve (ipsilateral with respect to the recording site)	1.0
HAHFD	shigh amplitude and high frequency discharges	0.5
HAHFD	shigh amplitude high frequency discharges	0.5
TDD	translation-dependent decay	1.0
lWM	lateral white matter	1.0
NMG	n-methyl- d-glucamine	0.2
NMG	n-methyl-glucamine	0.4
NMG	n-methyl-d-glucamine	0.4
NMD	nonsense-mediated decay	0.4
NMD	neuronal migration disorder	0.4
NMD	nonsense-mediated mrna decay	0.2
NME	normetanephrine	1.0
NMB	neuromedin b-preferring	0.333333333333
NMB	neuromedin-b peptide	0.333333333333
NMB	neuromedin b	0.333333333333
NMC	nucleus magnocellularis	1.0
SRt	nucleus subrotundus	1.0
NMA	nadic(r),methyl anhydride	0.333333333333
NMA	n-methyl-d,l-aspartate	0.333333333333
NMA	n-methyl-d,l-aspartic acid	0.333333333333
NMO	neuromyelitis optica	1.0
TDP	1tyrosyl-dna phosphodiesterase 1	0.333333333333
TDP	1tyrosyl-dna phosphodiesterase	0.333333333333
TDP	1tyrosyl dna phosphodiesterase 1	0.333333333333
NMJ	neuromuscular junction	0.9
NMJ	sneuromuscular junctions	0.1
mITC	medial intercalated amygdala neurons	1.0
TDU	tongue display unit	1.0
TDT	terminal deoxynucleotidyl transferase	1.0
FHM	familial hemiplegic migraine	0.666666666667
FHM	1familial hemiplegic migraine type-1	0.333333333333
LOC	lateral olivocochlear system	0.05
LOC	lateral olivocochlear efferent	0.05
LOC	lateral olivocochlear	0.25
LOC	lateral occipital complex	0.4
LOC	lateral olivocochlear (system)	0.05
LOC	lateral occipital cortex	0.05
LOC	/lotvlateral occipital cortex	0.05
LOC	loss of consciousness	0.1
TGF-βT	ransforming growth factor-β	1.0
LOF	loss-of-function	1.0
LOD	logarithm of the odds	0.222222222222
LOD	local optical density	0.111111111111
LOD	logarithm of the odds to the base 10	0.111111111111
LOD	lower limit of detection	0.111111111111
LOD	limit of detection	0.444444444444
MFA	meclofenamic acid	1.0
IFOF	inferior fronto-occipital fasciculus	1.0
FHF	awn-hooded	1.0
FHA	functional hypothalamic amenorrhea	1.0
I-κB	inhibitor-kappa b	0.25
I-κB	inhibitors of κb	0.25
I-κB	inhibitor-kappab	0.25
I-κB	nuclear factor kappa b inhibitory protein	0.25
FHC	ferritin heavy-chain	1.0
EB4	eb for 4h	1.0
LOS	losartan	0.5
LOS	lateral occipital sulcus	0.5
LOP	lateral occipital parietal	1.0
LOQ	lower limit of quantification	0.25
LOQ	limit of quantification	0.75
GluR1i	glutamate receptor subunit 1 flip	1.0
LOT	nucleus lateral olfactory tract	0.0294117647059
LOT	nucleus of the lateral olfactory tract	0.117647058824
LOT	lateral olfactory tract	0.823529411765
LOT	lateral occipito-temporal cortex	0.0294117647059
LOX	lipoxygenase	0.75
LOX	lipoxygenase(s)	0.25
HLP	hirulog-like peptide	1.0
LEMS	lambert–eaton myasthenic syndrome	1.0
EGTA-AM	egta-tetra(acetoxymethyl ester)	1.0
gCAN	ca2+-activated non-selective cationic conductance	1.0
A10dc	a10 dorsal caudal subpopulation of mesencephalic dopamine cells	1.0
riFS	repeated inescapable forced swim paradigm	1.0
ERGE	ther-a-go-go related gene	1.0
WAY-100635	n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-n-2-pyridinyl-cyclohexanecarboxamide maleate	0.25
WAY-100635	n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]	0.5
WAY-100635	n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)n-2-pyridinylcyclohexane carboxamide	0.25
PGS-GT	10% normal goat serum in phosphate-buffered saline containing triton x-100 and 1% w/v gelatin	1.0
non-RISH	non-radioactive in situ hybridization	1.0
VRFTV	irtual radial fitts' task	1.0
57-DHT	5,7-dihydroxytryptamine	1.0
semE	semaphorin e	1.0
CNPS	2′,3′-cyclic nucleotide 3′-phosphodiesterase	1.0
BFCN	basal forebrain cholinergic neuron	0.428571428571
BFCN	basal forebrain cholinergic neurons	0.428571428571
BFCN	basal forebrain cholinergic nuclei	0.142857142857
PIGD	postural instability and gait disability score of the updrs	1.0
AANAT	arylalkylamine n-acetyltransferase	0.5
AANAT	arylalkylamine-n-acetyltransferase	0.5
KW-6002	(e)-1,3-diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1h-purine-2,6-dione	1.0
NCS-1	neuronal calcium sensor-1	1.0
VEGF-W	tvascular endothelial growth factor promoter-luciferase plasmids carrying wild-type hypoxia response element	1.0
TCSA	total cross-sectional area	1.0
H3R	h3 receptor	1.0
RITG	right inferior temporal gyrus	1.0
lBST	/mbstlateral/medial part of the bed nucleus of the striae terminalis	1.0
SKF383931-phenyl-7	8-dihydroxy-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride	1.0
EBs	eye blinks	1.0
TIMG	toxin-induced myasthenia gravis	1.0
BFCS	basal forebrain cholinergic system	0.833333333333
BFCS	basal forebrain cortical cholinergic system	0.166666666667
TAGLN	3transgelin 3	1.0
ITPR21	4,5-trisphosphate receptor, type 2	1.0
EBE	vans blue dye	0.0666666666667
EBE	mbryoid body	0.0666666666667
EBE	vans blue	0.8
EBE	van’s blue	0.0666666666667
EBF	endoneurial blood flow	1.0
receptor-B	(npr-b)	1.0
Cyclopurine-deoxynucleoside8	5′-cyclopurine-2′-deoxynucleoside	1.0
EBA	endothelial barrier antigen	0.666666666667
EBA	extrastriate body area	0.333333333333
TGF-β1	transforming growth factor-β1	1.0
EBC	eyeblink conditioning	0.5
EBC	eye-blink conditioning	0.5
NOP	nociceptin/orphanin fq	0.111111111111
NOP	non-operated	0.111111111111
NOP	rnociceptin/orphanin fq opioid peptide receptor	0.111111111111
NOP	1nociceptin/orphanin fq peptide	0.111111111111
NOP	/orl1nociceptin/orphanin fq peptide receptor	0.111111111111
NOP	nociceptin/orphanin fq peptide	0.222222222222
NOP	rnociceptin/orphanin fq receptors(also known as orl-1), a member of the opioid family of g protein coupled receptors	0.111111111111
NOP	+/+nop receptor wild-type	0.111111111111
VGLUT-	2vesicular glutamate transporter 2	0.5
VGLUT-	2vesicular glutamate transporter-2	0.5
PDK-	13-phosphoinositide-dependent protein-kinase-1	0.5
PDK-	1phosphoinositide-dependent kinase i	0.5
EBI	electrode–brain interface	0.666666666667
EBI	early brain injury	0.333333333333
dsp4N-	(2-chloroethyl)-n-ethyl-bromo-benzylamine	1.0
JNKC-J	un amino-terminal kinase	1.0
EBP	50ezrin binding protein 50	1.0
HLA	human leukocyte antigen	1.0
EBR	eye-blink rates	1.0
EBS	extracellular bath solution	1.0
RJM	rhythmical jaw movement	1.0
Lin11	isl-1, mec3)	1.0
CP-99994	{(2s,3s)-3-(2-methoxybenzyl)amino-2-phenylpiperidine dihydyrochloride}	1.0
THAP	1	1.0
PECT	phosphoethanolamine cytidylyltransferase	1.0
BMPR	bone morphogenetic protein receptor	1.0
HREHIF	response element	1.0
VBB	vertical band of broca	1.0
DRP	dorsal root potential	0.857142857143
DRP	dihydropyirimidinase-related protein	0.142857142857
DRS	drug reaction scale	1.0
DRR	sdorsal root reflexes	0.1
DRR	dorsal l2–l5 rhizotomy	0.1
DRR	dorsal root reflex	0.6
DRR	dye recovery rate	0.1
DRR	dorsal root rhizotomy	0.1
RAPHE	raphe nuclei	1.0
DRT	dopamine replacement therapy	0.333333333333
DRT	delayed-response task	0.333333333333
DRT	delayed response task	0.333333333333
α7nAChR	α7 nicotinic acetylcholine receptor	1.0
DRV	ventral drn	0.25
DRV	ventral subnucleus of the dorsal raphe	0.25
DRV	dorsal raphe ventrolateral	0.25
DRV	dorsal raphe nucleus ventral part	0.25
DRI	interfascicular dorsal raphe nucleus	0.333333333333
DRI	dorsal raphe interfascicular	0.333333333333
DRI	interfascicular subnucleus of the dorsal raphe	0.333333333333
CONC	control group with control plasmid	1.0
DRM	detergent-resistant membrane	1.0
DRL	dorsal raphe lateral	0.2
DRL	differential reinforcement of low rates of responding	0.2
DRL	lateral division of dorsal raphe	0.2
DRL	dextran-tetramethylrhodamine-lysine	0.2
DRL	driven right leg	0.2
DRN	dorsal raphe nuclei	0.0531914893617
DRN	and drdorsal raphé nucleus	0.0106382978723
DRN	dorsal raphé nucleus	0.031914893617
DRN	dorsal raphe	0.0212765957447
DRN	dorsal raphe nucleus	0.851063829787
DRN	vmventromedial dorsal raphe nucleus subdivision	0.031914893617
rH-EPO	recombinant human erythropoietin	1.0
DRC	caudal dorsal raphe nucleus	0.25
DRC	dorsal raphe nucleus	0.25
DRC	dorsal raphe caudal	0.25
DRC	caudal subnucleus of the dorsal raphe	0.25
DRB	5,6-dichloro-1-β-d-ribofuranosylbenzimidazole	0.666666666667
DRB	6-dichloro-1-β-d-ribofuranosyl benzimidazole	0.333333333333
DRE	delayed response enhancement	0.666666666667
DRE	drug refractory epilepsy	0.333333333333
DRD	2	0.0434782608696
DRD	dorsal raphe dorsal	0.0434782608696
DRD	2dopamine receptor d2	0.130434782609
DRD	4dad4 receptor	0.0434782608696
DRD	4dopamine d4 receptor gene	0.0434782608696
DRD	2dopamine receptor type 2	0.0434782608696
DRD	elayed response	0.0434782608696
DRD	4dopamine receptor d4	0.0869565217391
DRD	dorsal subnucleus of the dorsal raphe	0.0434782608696
DRD	5dopamine receptor d5	0.0434782608696
DRD	dorsal drn	0.0434782608696
DRD	2dopamine d2 receptor gene	0.0434782608696
DRD	4dopamine d4 receptor	0.0434782608696
DRD	2da receptor 2	0.0434782608696
DRD	dorsal subdivision of the dorsal raphé nucleus	0.0434782608696
DRD	2dopamine receptor d2 gene	0.0434782608696
DRD	4da d4 receptor	0.0434782608696
DRD	damage recognition domain	0.0434782608696
DRD	dorsal raphe nucleus dorsal part	0.0434782608696
DRD	2gene encoding for the dad2 receptor	0.0434782608696
DRG	dorsal rot ganglion	0.00162074554295
DRG	dorsal root ganglion	0.67585089141
DRG	dorsal root ganglion/ganglia	0.00486223662885
DRG	)	0.00162074554295
DRG	dorsal root ganglia	0.290113452188
DRG	dorsal respiratory group	0.0032414910859
DRG	s	0.00162074554295
DRG	1developmentally regulated gtp-binding protein 1	0.00162074554295
DRG	dorsal root ganglion (ganglia)	0.0032414910859
DRG	sdorsal root ganglia	0.00486223662885
DRG	(cervical) dorsal root ganglion	0.00162074554295
DRG	dorsal root ganglia/ganglion	0.0032414910859
DRG	dorsal horn ganglion	0.00162074554295
DRG	neurons	0.00162074554295
DRG	dorsal root gangalion	0.00162074554295
DRG	) cell	0.00162074554295
THAL	thalidomide	1.0
cocaine-HC	lcocaine hydrochloride	0.5
cocaine-HC	lcocaine-hydrochloride	0.5
PACAP-	38the form of pituitary adenylyl cyclase-activating polypeptide with 38 amino acids	0.333333333333
PACAP-	receptor	0.333333333333
PACAP-	/-pituitary adenylate-cyclase activating polypeptide deficient	0.333333333333
NaGP	sodium β-glycerophosphate	1.0
aPVN	anterior paraventricular nucleus	1.0
DRt	dorsal reticular nucleus	1.0
zVAD-fmk	benzyloxycarbonyl-val-ala-asp-(o-methyl) fluoromethyl ketone	0.333333333333
zVAD-fmk	n-benzyloxycarbonyl-val-ala-asp-fluoromethylketone	0.666666666667
DRv	ventromedial region of b7 cell group (dorsal raphe)	1.0
hSSC	human spinal stem cell	1.0
IBPN	irregular burst pattern neuron	1.0
DRl	lateral wings of b7 cell group (dorsal raphe)	1.0
8-Br-cGMP	8-bromo-cyclic gmp	0.375
8-Br-cGMP	8-bromo-guanosine-3′5′-cyclicmonophosphate	0.125
8-Br-cGMP	8-bromoguanidine-3′,5′-cyclophosphate	0.125
8-Br-cGMP	8-bromo-cyclic guanylyl monophosphate	0.125
8-Br-cGMP	8-bromo-guanosine 3′,5′-cyclic monophosphate	0.125
8-Br-cGMP	8-bromoguanosine-3′,5′-cyclic monophosphate	0.125
WAVE-	1 proteinwasp-family protein member 1	1.0
RHUb1	anti-ubiquitin monoclonal antibody	1.0
aPVT	anterior thalamic midline paraventricular nucleus	1.0
suPAR	soluble urokinase-type plasminogen activator receptor	1.0
VMNdm	c, dorsomedial and central vmn	1.0
PASPER	arnt single minded protein	1.0
lncRNA	long non-coding rna	0.333333333333
lncRNA	slong non-coding rnas	0.333333333333
lncRNA	slong noncoding rnas	0.333333333333
SLIGRLS	er-leu-ile-gly-arg-leu-nh2	1.0
PDCl-trans-pyrrolidine-2	4-dicarboxylic acid	0.5
PDCl-trans-pyrrolidine-2	4-dicarboxylate	0.5
AKTA	kt serine-threonine kinase	1.0
VNX	vomeronasal organ-removed	0.5
VNX	vomeronasal organ removal	0.5
ELA	early life adversity	1.0
HEOG	horizontal electrooculography	0.333333333333
HEOG	horizontal electrooculogram	0.666666666667
t-PA	tissue-plasminogen activator	0.142857142857
t-PA	tissue-type plasminogen activator	0.142857142857
t-PA	tissue plasminogen activator	0.714285714286
Ncad	n-cadherin	1.0
L-LL	ook-locker	1.0
phospho-ERK	phosphorylated extracellular-signal regulated kinase	1.0
FRIL	freeze-fracture replica immunogold labeling	0.875
FRIL	freezer-fracture replica immunogold labeling	0.125
KISS	kisspeptin	1.0
ABHA	lkb homolog	1.0
IFAI	ncomplete freund’s adjuvant	1.0
5-HT3A-L	long form of the 5-ht3 receptor, a subunit	1.0
hTRPV	1human trpv1	1.0
PACAPn	n-amino acid form of pacap	1.0
PaVH	paraventricular hypothalamic nucleus	1.0
SPO-	taskspontaneous task	1.0
DR3	death receptor 3 for trail	1.0
CXC	chemokine of the c-x-c motif	1.0
hVAChT	human vesicular acetylcholine transporter	1.0
CXI	–iiilaminae i–iii of cerebral cortex	1.0
BMP-	2bone morphogenetic protein-2	0.5
BMP-	7bone morphogenetic protein-7	0.5
CXM	cycloheximide	1.0
HACU	high affinity choline uptake	0.142857142857
HACU	high-affinity choline uptake	0.857142857143
2VO	bilateral occlusion of the common carotid arteries (two-vessel occlusion)	0.111111111111
2VO	2-vessel occlusion	0.111111111111
2VO	/htbilateral carotid artery occlusion and hypovolemic hypotension	0.222222222222
2VO	two-vein occlusion	0.111111111111
2VO	two vessel occlusion	0.111111111111
2VO	/htbilateral carotid artery (two-vessel) occlusion and hypovolemic hypotension	0.111111111111
2VO	two-vessel occlusion	0.222222222222
SpVN	spinal vestibular nucleus	1.0
LAamygdala	lateral nucleus	1.0
GABAA-α	1ralpha-1 subunit of gabaa-receptor	0.5
GABAA-α	1alpha 1 subunit of the gabaa receptor	0.5
SNAPS-nitroso-N-acetyl-d	l-penicillamine	1.0
BNPI	brain-specific na+-dependent inorganic phosphate co-transporter	1.0
AKG	α-ketoglutarate	1.0
aEPSC	asynchronous epsc	1.0
MLF	medial longitudinal fasciculus	0.533333333333
MLF	medial longitudinal fascicle	0.333333333333
MLF	medial longitudonal fasciculus	0.0666666666667
MLF	nnucleus of the medial longitudinal fascicle	0.0666666666667
METH	methamphetamine	0.942857142857
METH	(+)-methamphetamine hydrochloride	0.0285714285714
METH	(+)methamphetamine	0.0285714285714
rhIL-1ra	recombinant human interleukin-1 receptor antagonist	1.0
S-3C-4HPG	s-3-carboxy-4-hydroxyphenylglycine	1.0
commNTS	commissural nucleus of the solitary tract	1.0
AKTP	rotein kinase b (pkb)	1.0
CRPC-	reactive protein	1.0
DAGO	(d-ala2-n-me-phe,gly-ol)enkephalin	0.333333333333
DAGO	[d-ala2,n-methyl-phe4,glycol5][tyrosol3,5]	0.333333333333
DAGO	d-ala(2), n-me-phe(4), gly-ol(5) enkephalin	0.333333333333
DAGK	diacylglycerol kinase	1.0
anti-C	amkiipolyclonal antibodies specific to ca2+/calmodulin-dependent protein kinase ii	1.0
P5β	3βiso-pregnanolone	1.0
TTCC	fragment of tetanus toxin	1.0
GOD	gradual osmolarity decrease	0.333333333333
GOD	glucose oxidase	0.666666666667
mSERT	mouse serotonin transporter	1.0
ω-CTx-GVIA	ω-conotoxin gvia	0.333333333333
ω-CTx-GVIA	ω-conotoxin-gvia	0.666666666667
NPCA	nipecotic acid	1.0
GOF	goodness of fit	0.857142857143
GOF	goodness-of-fit	0.142857142857
TTC2	3,5 triphenyltetrazolium chloride	0.0181818181818
TTC2	3, 5-triphenyltetrazolium chloride	0.0363636363636
TTC2	3,5-triphenyl-tetrazolium chloride	0.0181818181818
TTC2	3,5-triphenyltetrazolium-chloride	0.0181818181818
TTC2	3,5,-triphenyl tetrazolium chloride	0.0181818181818
TTC2	3,7-triphenyltetrazolium chloride	0.0181818181818
TTC2	3,5-triphenyltetrazolium chloride monohydrate	0.0181818181818
TTC2	3,5,-triphenyltetrazolium chloride	0.0363636363636
TTC2	3,5-triphenol tetrazolium chloride	0.0363636363636
TTC2	3,5-triphenyltetrazoliumchloride	0.0181818181818
TTC2	3,5-triphenyltetrazolium	0.0363636363636
TTC2	3,5-triphenyl-2h-tetrazolium chloride	0.0181818181818
TTC2	3,5-triphenyltetrazolium chloride	0.690909090909
TTC2	3,5-tripenyltetrazolium chloride	0.0181818181818
Di-I	1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	1.0
CAPP	ceramide-activated protein phosphatase	1.0
NPCN	iemann-pick disease type c	0.4
NPCN	iemann–pick type c	0.2
NPCN	iemann pick disease type c	0.2
NPCN	iemann-pick type c1	0.2
NPCM	neural precursor cell medium	1.0
CAPS	capsaicin	0.25
CAPS	cyclic amp phosphorylation site	0.25
CAPS	clinician administered ptsd scale	0.25
CAPS	chronic plus acute prolonged stress	0.25
EIMI	ethanol-induced motor incoordination	1.0
OW	soscillations and waves	1.0
PMCA-ATP	aseplasma membrane ca2+-atpase	1.0
CRH-R2	crh receptor type 2	1.0
DAG1	2-diacylglycerol	1.0
CRH-R1	type 1 crh receptor	0.333333333333
CRH-R1	crh-r2, corticotropin-releasing hormone receptor type 1, type 2	0.333333333333
CRH-R1	crh receptor type 1	0.333333333333
CAPE	)	0.2
CAPE	caffeic acid phenethyl ester	0.6
CAPE	caffeic-acid phenethyl-ester	0.2
CAPC	yclic alternating pattern	1.0
CaEDTA	ethylenediaminetetraacetic acid saturated with equimolar ca2+	1.0
MPG	major pelvic ganglion	0.7
MPG	l-glutamic acid monopotassium salt	0.1
MPG	major pelvic ganglia	0.1
MPG	major pelvic ganglions	0.1
MPE	maximal possible effect	0.111111111111
MPE	percent maximal possible antinociceptive effect	0.0277777777778
MPE	maximal possible antinociceptive effect	0.0277777777778
MPE	maximum possible effect	0.25
MPE	the per cent maximum possible effect	0.0277777777778
MPE	percent maximum possible effect	0.138888888889
MPE	percentages of maximum possible effects	0.0277777777778
MPE	maximum possible antinociceptive effect	0.0277777777778
MPE	percent maximal possible effect	0.111111111111
MPE	percentage of maximum possible effect	0.0277777777778
MPE	percent of maximum possible effect	0.0555555555556
MPE	per cent maximum possible effect	0.0277777777778
MPE	percent of maximal effect	0.0277777777778
MPE	maximum possible effects	0.0277777777778
MPE	maximum percent effect	0.0833333333333
MPB	medial parabrachial nucleus	0.777777777778
MPB	medial subnucleus of the parabrachial nucleus	0.111111111111
MPB	millonings phosphate buffer	0.111111111111
MPC	mean peak counts	0.142857142857
MPC	mouse pheochromocytoma	0.142857142857
MPC	medial prefrontal cortex	0.285714285714
MPC	medial premotor cortex	0.285714285714
MPC	multi protein complexes	0.142857142857
pPKC	phosphorylated protein kinase	1.0
MPA	3-mercaptopropionic acid	0.04
MPA	mercaptopropionic acid	0.04
MPA	medial preoptic area	0.56
MPA	metaphosphoric acid	0.04
MPA	medroxyprogesterone	0.04
MPA	medroxyprogesterone acetate	0.2
MPA	medial preoptic area of the hypothalamus	0.04
MPA	maximal possible analgesia	0.04
MPN	magmagnocellular medial preoptic nucleus	0.0571428571429
MPN	medial pretectal nucleus	0.0285714285714
MPN	(medial/mag), medial preoptic nucleus (medial subdivision/magnocellular subdivision)	0.0285714285714
MPN	medial preoptic nucleus	0.742857142857
MPN	medial preoptic nuclei	0.0285714285714
MPN	median preoptic nucleus	0.0285714285714
MPN	ccentral portion of the medial preoptic nucleus	0.0285714285714
MPN	medial pontine nucleus	0.0285714285714
MPN	magmagnocellular subdivision of the medial preoptic nucleus	0.0285714285714
MPO	medial preoptic region	0.0140845070423
MPO	medial preoptic area	0.450704225352
MPO	membrane potential oscillation	0.0140845070423
MPO	medial preoptic nucleus	0.183098591549
MPO	medial preoptic nuclei	0.0140845070423
MPO	myeloperoxidase	0.267605633803
MPO	median preoptic nucleus	0.0281690140845
MPO	medical preoptic area	0.0140845070423
MPO	smembrane potential oscillations	0.0140845070423
MPL	1-methyl-2-pyrrolidinone	1.0
PSSM	position-specific scoring matrix	1.0
AVP	eanteroventral periventricular nucleus	0.0230769230769
AVP	arginine-vasopressin	0.0923076923077
AVP	arginin-vasopressin	0.0307692307692
AVP	ventrolateral region of the anteroventral preoptic area	0.00769230769231
AVP	[arg8]-vasopressin	0.00769230769231
AVP	arginine–vasopressin	0.0307692307692
AVP	vasopressin	0.146153846154
AVP	arginine 8-vasopressin	0.00769230769231
AVP	)	0.00769230769231
AVP	arginine vasopressin	0.592307692308
AVP	arginin–vasopressin	0.00769230769231
AVP	8-arginine vasopressin	0.00769230769231
AVP	(4–9), fragment 8-arginine-vasopressin(4–9)	0.00769230769231
AVP	anteroventral preoptic nucleus	0.00769230769231
AVP	arginine8-vasopressin	0.00769230769231
AVP	vanteroventral periventricular nucleus	0.0153846153846
VEGFR-	2pvascular endothelial growth factor receptor-2 phosphate	0.333333333333
VEGFR-	2vascular endothelial growth factor receptor-2	0.333333333333
VEGFR-	2vascular endothelial growth factor receptor 2	0.333333333333
MPH	methylphenidate	1.0
MPI	maximal percentage of inhibition	0.333333333333
MPI	maximum possible inhibition	0.333333333333
MPI	multidimensional pain inventory	0.333333333333
ZMZM	241385	1.0
AVM	arteriovenous malformation	0.5
AVM	mapanatomical variability magnitude map	0.25
AVM	arteriovenous malformations	0.25
MPT	mitochondrial permeability transition pores	0.0555555555556
MPT	medial pretectal area	0.0555555555556
MPT	medial pretectal nucleus	0.0555555555556
MPT	mitochondrial permeability transition	0.666666666667
MPT	)	0.0555555555556
MPT	mitochondrial permeability transition pore	0.0555555555556
MPT	membrane permeability transition pore	0.0555555555556
PSIP	post-stimulus inhibitory period	1.0
MPS	iiiamucopolysaccharidosis iiia	0.5
MPS	mid prenatal stress group	0.5
MPP	+1-methyl-4-phenyl pyridinium ion	0.0277777777778
MPP	+1-methyl-4-phenyl-tetrahydropyridinium ion	0.0138888888889
MPP	+1-methyl-4-phenylpyridinium ion	0.152777777778
MPP	methyl phenyl pyridinium	0.0138888888889
MPP	13-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1h-pyrazole dihydrochloride	0.0138888888889
MPP	+1-methyl-4-phenylpyrindium	0.0138888888889
MPP	+, 1-methyl-4-phenyl-pyridinum ion	0.0138888888889
MPP	+	0.0277777777778
MPP	methyl-piperidino-pyrazole (highly selective erα antagonist)	0.0138888888889
MPP	+1-methyl-4-phenyl pyridinium ions	0.0138888888889
MPP	+, n-methyl-4-phenyl-dihydropyridinium	0.0138888888889
MPP	+1 methyl-4-phenylpyridinium	0.0138888888889
MPP	+1-methyl-4-phenylpyridinium	0.236111111111
MPP	+, 1-methyl-4-phenylpyridinium	0.138888888889
MPP	+, 1-methyl-4-phenylpyridium	0.0138888888889
MPP	+1-methyl-4-phenyl-pyridine ion	0.0138888888889
MPP	+, n-methyl-4-phenylpiridinium ion	0.0138888888889
MPP	+1-methyl-4-phenyl pyridnium	0.0138888888889
MPP	+1-methyl-4-phenylpyridimium	0.0138888888889
MPP	medial perforant path	0.0972222222222
MPP	+,	0.0138888888889
MPP	medial perforant pathway	0.0277777777778
MPP	+, 1-methyl-4-phenylpyridinium ion	0.0694444444444
MPP	methyl-piperidino-pyrazole	0.0138888888889
PSIS	posterior superior iliac spine	1.0
CRF-BP	corticotropin releasing factor binding protein	0.666666666667
CRF-BP	crf-binding protein	0.333333333333
AMPase	5′-adenylic acid deaminase	1.0
RQI	recombinant quantitative trait locus introgression	1.0
AVA	δ-amino-n-valeric acid	1.0
COX-II	cytochrome oxidase-ii	0.333333333333
COX-II	cytochrome c oxidase ii	0.333333333333
COX-II	cyclooxygenase 2	0.333333333333
C57	c57bl/6j	0.2
C57	c57bl/6j mouse strain	0.2
C57	c57bl/6 mice	0.2
C57	c57bl/6jico	0.2
C57	c57bl/6	0.2
WHO	world health organization	1.0
ADHX	alcohol dehydrogenase class iii	1.0
KATP-	channeladenosine-5′-triphosphate-sensitive k+ channel	1.0
totODOD	of the total staining	1.0
DOXY	doxycycline	1.0
WAY-	100 635	0.125
WAY-	100635n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-n-2-pyridylcyclohexane carboxamide maleate salt	0.125
WAY-	100635(n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-n-2-pyridylcyclohexane carboxamide maleate salt	0.125
WAY-	100635n-[2-[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]	0.125
WAY-	100635(n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl)-n-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride	0.125
WAY-	100635(n-2-[4-(2-methoxyphenyl-1-piperazinyl] ethyl]	0.125
WAY-	100635n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]	0.25
ADHD	attention -deficit/hyperactivity disorder	0.0204081632653
ADHD	attention deficit-hyperactivity disorder	0.0408163265306
ADHD	attention deficit hyperactivity disorder	0.551020408163
ADHD	attention deficit/hyperactivity disorder	0.0816326530612
ADHD	attentional deficit hyperactivity disorder	0.0204081632653
ADHD	attention-deficit hyperactivity disorder	0.102040816327
ADHD	attention-deficit/hyperactivity disorder	0.142857142857
ADHD	attention deficit and hyperactivity disorder	0.0204081632653
ADHD	attention deficit and hyperactivity disorders	0.0204081632653
THPtetrahydroprogesterone	allopregnanolone	1.0
PROP	propranolol	1.0
ER-α-IR	estrogen receptor-α-immunoreactive neurons	1.0
TIP39	tubero-infundibular peptide of 39 residues	1.0
FEN-	1flap endonuclease 1	1.0
eWAT	epididymal white adipose tissue	1.0
dMM	dorsomedial medulla	1.0
mPVN	magnocellular paraventricular nucleus	0.166666666667
mPVN	magnocellular subset of paraventricular nucleus	0.166666666667
mPVN	magnocellular part of paraventricular nucleus of the hypothalamus	0.166666666667
mPVN	magnocellular part of the paraventricular hypothalamic nucleus	0.166666666667
mPVN	medial parvocellular division of the paraventricular nucleus	0.166666666667
mPVN	middle paraventricular nucleus	0.166666666667
CA1-3	fields ca1-3 of ammon's horn	1.0
nPGi	nucleus paragigantocellularis	1.0
ANG-	2angiopoietin-2	1.0
COMT-mbcatechol-O-methyltransferase	membrane-bound isoform	1.0
ISIH	interspike interval histogram	0.692307692308
ISIH	interspike-interval histogram	0.0769230769231
ISIH	isi histogram	0.0769230769231
ISIH	sinterspike interval histograms	0.0769230769231
ISIH	inter-spike interval histogram	0.0769230769231
CSMN	corticospinal motor neurons	0.5
CSMN	scorticospinal motor neurons	0.5
mHBSS	modified hanks' balanced salt solution	1.0
CITZ	capsular infralimbic target zone	1.0
PI3-kinase	phosphatidylinositol 3-kinase	0.666666666667
PI3-kinase	phosphoinositol-3-phosphate-kinase	0.333333333333
h-DMEM	high-glucose dulbecco’s modified eagle medium	0.666666666667
h-DMEM	high-glucose dulbecco's modified eagle medium	0.333333333333
HCH-	acsf	1.0
EDRF	endothelium-derived releasing factor	1.0
PSSP	erceived stress scale	1.0
NRN	eutral red	1.0
9R	10s,12s)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1h-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i]	1.0
RPTPβ	receptor protein tyrosine phosphatase β	0.25
RPTPβ	/ζ	0.25
RPTPβ	receptor-type protein-tyrosine phosphatase β	0.25
RPTPβ	receptor protein tyrosine phosphatase beta	0.25
NORT	novel object recognition task	1.0
PMBSFI	ipsilateral pmbsf	1.0
WAYW	ay200070	1.0
PNDC	spn decomposition catalysts	1.0
RBDRNA-	binding domain	1.0
HOE-140	d-arginyl-[hyp3,thi5,d-tic7,oic8]-bradykinin	1.0
PDCl-trans-pyrrolidine	2–4,dicarboxylate	1.0
NRB	random bred control	1.0
AVPA	rginine-vasopressin	1.0
PTIP	hoton technology instruments	1.0
DEM	diethyl maleate	1.0
α-ARα-	adrenergic receptor	1.0
P-P	urkinje	1.0
CgA	chromogranin a	1.0
KGDHα-	ketoglutarate dehydrogenase	1.0
CgB	chromogranin b	1.0
P-E	pulse-echo	1.0
sV	spinal trigeminal nucleus	1.0
AAV-	2adeno-associated virus	0.333333333333
AAV-	laczadeno-associated viral vector containing lacz gene	0.333333333333
AAV-	2adeno-associated viral vectors of serotype 2	0.333333333333
CgS	cingulate sulcus	1.0
DMEMD	ulbecco’s modified essential medium	0.0036231884058
DMEMD	ulbecco's modification of eagle's medium	0.0036231884058
DMEMD	ulbecco's modified eagle's medium	0.260869565217
DMEMD	ulbelcco's modified eagle's medium	0.0036231884058
DMEMD	ulbeco’s modified eagle medium	0.0036231884058
DMEMD	ulbecco’s modified minimum essential medium	0.0036231884058
DMEMD	ulbecco’s modified eagle’s medium	0.278985507246
DMEMD	ulbecco’s-modified eagle medium	0.00724637681159
DMEMD	ulbecco’s modified eagle medium	0.166666666667
DMEMD	ulbecco's modified eagle medium	0.141304347826
DMEMD	ubelcco’s modified eagle medium	0.0036231884058
DMEMD	ulbecco's minimum essential medium	0.0108695652174
DMEMD	ulbecco modified eagle's medium	0.0036231884058
DMEMD	ulbecco’s minimum essential medium	0.00724637681159
DMEMD	ulbecco modified eagle medium	0.0108695652174
DMEMD	ulbecco's modified eagle culture medium	0.0036231884058
DMEMD	ulbecco’s-modified eagle’s medium	0.0253623188406
DMEMD	ulbecco's minimal essential media	0.0036231884058
DMEMD	ulvecco’s modified eagle’s medium	0.0036231884058
DMEMD	ulbecco’s minimum eagle medium	0.0036231884058
DMEMD	ulbecco’s minimal essential medium	0.0144927536232
DMEMD	ulbecco's modified eagle media	0.0036231884058
DMEMD	ulbecco's minimal essential medium	0.0108695652174
DMEMD	elbeco’s minimum essential medium	0.0036231884058
DMEMD	elbecco’s modified eagle’s medium	0.0036231884058
DMEMD	ulbecco's modified minimal essential medium	0.0036231884058
DMEMD	ulbecco's modified eagles medium	0.00724637681159
DMEMD	ulbecco’s-modified essential medium	0.0036231884058
GTP-γ-	[35s]guanosine 5′-(γ-[35s]	1.0
ONL-INL	outer- and inner nuclear layer	1.0
FLUTF	luted paranodal main region	1.0
CSDF	chronic social defeat stress	1.0
aMT6s	6-sulfatoxymelatonin	1.0
4-HPRN-	(4-hydroxyphenyl) retinamide	1.0
VLMTV	erbaler lern-und merkfähigkeitstest	1.0
dB-cAMPN6	2′-o-dybutyryladenosine 3′,5′-cyclic monophosphate sodium salt	1.0
hNS	human neural stem cells	1.0
hNT	human neuroteratocarcinoma neuron	0.5
hNT	human post-mitotic neurons	0.5
PKCε	protein kinase c epsilon	0.571428571429
PKCε	protein kinase cε	0.285714285714
PKCε	protein kinase c-epsilon	0.142857142857
PKCζ	/pkmζprotein-kinase c zeta or protein-kinase m zeta	1.0
PKCα	protein kinase c α	0.0909090909091
PKCα	protein kinase cα	0.272727272727
PKCα	protein kinase c alpha	0.272727272727
PKCα	protein kinase c α-subunit	0.181818181818
PKCα	protein kinase c-α	0.0909090909091
PKCα	protein kinase c-alpha	0.0909090909091
PKCγ	protein kinase c-gamma	0.0769230769231
PKCγ	gamma isoform of protein kinase c	0.0769230769231
PKCγ	protein kinase c γ isoform	0.0769230769231
PKCγ	protein kinase cγ	0.384615384615
PKCγ	protein kinase c gamma	0.153846153846
PKCγ	the γ isoform of protein kinase c	0.0769230769231
PKCγ	protein kinase c gamma isoform	0.0769230769231
PKCγ	protein kinase cγ subunit	0.0769230769231
GAD67-IR	67,000 mol. wt glutamate decarboxylase-immunoreactive	1.0
rVAChT	rat vesicular transporter for acetylcholine	1.0
CaMK2	calcium/calmodulin-dependent protein kinase 2	1.0
XTT2	3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2h-tetrazolium hydroxide	0.5
XTT2	3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2h-tetrazolium-5-carboxanilide	0.5
PAE	prenatal ethanol exposure	1.0
7Cl-k	7-chlorokynurenic acid	1.0
NAP-22	neuronal tissue-enriched acidic protein having a molecular mass of 22,000	1.0
LIMKLIM-	kinase	1.0
CDNB1-chloro-2	4-dinitrobenzene	1.0
ATRXα-	thalassemia mental retardation x-linked	1.0
BTXα-	bungarotoxin	0.75
BTXα-	[125i]-bungarotoxin	0.25
CRYC	ryptochrome	1.0
A2AR	adenosine a2a receptor	1.0
SPGR	spoiled gradient recall	1.0
AMVRT	avian myeloblastosis virus reverse transcriptase	1.0
4E-	bp1eukaryotic initiation factor 4e binding protein 1	1.0
VAAF	ventral anterior auditory field	1.0
SOAE	spontaneous otoacoustic emission	1.0
d-Ala2	mephe4, gly-ol5]enkephalin	0.0285714285714
d-Ala2	nme-phe4,gly-ol5]-enkephalin	0.0285714285714
d-Ala2	n-me-phe4, gly-ol5]-enkephalin	0.0285714285714
d-Ala2	d-leu5] enkephalin	0.0857142857143
d-Ala2	n-mephe4,gly5-ol]enkephalin	0.0285714285714
d-Ala2	mephe4,gly-ol5] enkephalin	0.0285714285714
d-Ala2	methyl-phe4, glyol5]enkephalin	0.0285714285714
d-Ala2	d-leu5]-enkephalin	0.0571428571429
d-Ala2	n-me-phe4,gly5-ol]enkephalin	0.0285714285714
d-Ala2	n-me-phe4, gly5-ol]enkephalin	0.0285714285714
d-Ala2	n-me-phe4,gly-ol5]-enkephalin	0.0285714285714
d-Ala2	glu4]-deltorphin	0.0571428571429
d-Ala2	n-mephe4, gly-ol]-enkephalin	0.0571428571429
d-Ala2	n-me-phe4, gly5-ol]-enkephalin	0.114285714286
d-Ala2	nmephe4,gly5-ol]	0.0285714285714
d-Ala2	nme-phe4, gly-ol5]-enkephalin	0.0571428571429
d-Ala2	nmephe4, gly(ol)5]enkephalin	0.0285714285714
d-Ala2	n-me-phe4, glycinol5)-enkephalin	0.0285714285714
d-Ala2	n-mephe4,gly-ol5]enkephalin	0.0571428571429
d-Ala2	n-mephe4,gly-ol5]-enkephalin	0.0285714285714
d-Ala2	n-mephe4, gly5-ol] enkephalin	0.0285714285714
d-Ala2	n-me-phe4,gly-ol5]	0.0285714285714
d-Ala2	n-mephe4, gly-ol5]-enkephalin	0.0285714285714
d-Ala2	n-me-phe4,gly5-ol]-enkephalin	0.0285714285714
d-Ala2	n-me-phe4, gly5] enkephalin-ol	0.0285714285714
DNIC	diffuse noxious inhibitory control	0.5
DNIC	diffuse noxious inhibition control	0.1
DNIC	diffuse noxious inhibitory controls	0.4
YGL	animals yoked to good learners	1.0
pVNLc	caudal part of the posterior vomeronasal nerve layer	1.0
TFBSTF	binding sites	1.0
Cg1	cg2, cg3, cingulate cortex areas 1, 2 and 3	0.5
Cg1	cingulate cortex area 1	0.5
TMAH	tetramethylammonium hydroxide	1.0
Cg2	cingulate cortex layer 2	1.0
SPGN	sympathetic postganglionic neuron	0.333333333333
SPGN	sympathetic preganglionic neuron	0.666666666667
pVNLr	rostral part of the posterior vomeronasal nerve layer	1.0
HA-DAHA-	tagged drebrin a	1.0
GST-NPKGST-	tagged n-terminal parkin fragment	1.0
SCNs	song-control nuclei	1.0
AVHN	anterior ventromedial hypothalamic nucleus	1.0
DNF	brain-derived neurotrophic factor	1.0
RSCIM	rabbit spinal cord ischemia model	1.0
MFW	mean frequency of withdrawal	1.0
SCH-23390	r-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5,-tetrahydro-1h-3-benzazepine hydrochloride	0.142857142857
SCH-23390	7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine	0.142857142857
SCH-23390	([3h](r+)7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride	0.142857142857
SCH-23390	(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride	0.142857142857
SCH-23390	r-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride	0.142857142857
SCH-23390	r(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride	0.142857142857
SCH-23390	r(+)-1-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine hcl	0.142857142857
SRSR	141716	0.666666666667
SRSR	141716a	0.333333333333
SRSS	ocial responsiveness scale	1.0
KETO	ketogenic	1.0
pDYN	prodynorphin	0.5
pDYN	pro-dynorphin	0.5
VA-	mismatched condition	1.0
IntA	anterior interpositus nucleus	1.0
TH-IRTH-	immunoreactivity	1.0
SNL-NH	rats that do not respond with hyperalgesia after spinal nerve ligation	1.0
CARTp	cocaine- and amphetamine-regulated transcript protein	1.0
NNLAN-	nitro-l-arginine	1.0
P-PKCθ	phospho-protein kinase c theta	1.0
RPER	atings of perceived exertion	1.0
ARTNA	rtemin	1.0
Hu-Bcl-2	human bcl-2	1.0
sMTF	synchrony modulation transfer function	1.0
Rdl	resistance to dieldrin gene	1.0
PUFA	polyunsaturated fatty acid/s	0.05
PUFA	spolyunsaturated fatty acids	0.2
PUFA	polyunsaturated fatty acid	0.55
PUFA	polyunsaturated fatty acids	0.2
TBARS	thiobarbituric acid-reactive substance	0.142857142857
TBARS	thiobarbituric acid-reactive substances	0.107142857143
TBARS	thiobarbituric acid reactive substances	0.464285714286
TBARS	thiobarbituric acid reactive species	0.142857142857
TBARS	thiobarbituric acid-reactive products	0.0357142857143
TBARS	thiobarbituric acid reactive substance	0.0357142857143
TBARS	thiobarbituric-acid reacting substances	0.0357142857143
TBARS	2-thiobarbituric acid reactive species	0.0357142857143
EDB	extensor digitorum brevis	1.0
VAH	ventilatory acclimatization to hypoxia	1.0
VAN	vestibular afferent neurons	1.0
VAL	ventral anterior-lateral complex thalamus	0.2
VAL	ventral anterior-lateral	0.2
VAL	ventral anterior-lateral nucleus of thalamus	0.2
VAL	video anticipatory looking	0.2
VAL	valine	0.2
BSI-B4	bandeiraea simplicifolia isolectin b4	1.0
VAB	vanilla sugar-sustained appetitive behavior	1.0
VAC	htvesicular ach transporter	0.0408163265306
VAC	ht-irvacht-immunoreactive	0.0204081632653
VAC	htvesicular transporter of acetylcholine	0.0204081632653
VAC	htvesicular acetylcholine transporter protein	0.0204081632653
VAC	ht	0.0204081632653
VAC	ht-irvacht immunoreactivity	0.0204081632653
VAC	htvesicular acetylcholine transporter	0.795918367347
VAC	ht)	0.0204081632653
VAC	htvesicular acetylcholine transporter-like immunoreactivity	0.0204081632653
VAC	htanti-vesicular acetylcholine transporter	0.0204081632653
N-ACSF	normal artificial cerebrospinal fluid	1.0
VAF	ventral amygdalofugal pathway	0.166666666667
VAF	variation accounted for	0.166666666667
VAF	variance accounted for	0.166666666667
VAF	ventral auditory field cortex	0.166666666667
VAF	ventral auditory field	0.333333333333
eNFT	extracellular (ghost) neurofibrillary tangle	1.0
VAD	vitamin a deprivation/deficient/deficiency	0.142857142857
VAD	vocalization afterdischarge	0.428571428571
VAD	vitamin a deficiency	0.428571428571
VAE	verrucae areae entorhinalis	1.0
EF-1α	elongation factor 1α	1.0
EDA	electrodermal activity	1.0
VAR	vector autoregressive	1.0
VAS	vasectomised	0.05
VAS	monoarticular vasti	0.05
VAS	visual analog scale	0.5
VAS	vasopressin	0.05
VAS	visual analogue scale	0.3
VAS	visual analog scores	0.05
L-AP	4l(+)-2-amino-4-phosphonobutyric acid	0.666666666667
L-AP	4	0.333333333333
NaN	na channel α-subunit	1.0
VAV	eterans affairs	1.0
VAT	vesicular acetylcholine transporter	0.5
VAT	visceral adipose tissue	0.5
EDG	endothelial differentiation gene	1.0
TSH40p	antiserum against th peptide phosphorylated at ser40	1.0
TAPS	transient amplifying cells	1.0
MCIP	1myocyte-enriched calcineurin interacting protein 1	1.0
trkB-IgG	synthetic fusion protein (part of trkb receptor fused to part of an immnuoglobulin)	1.0
TMRET	etra-methyl rhodamine methyl ester	1.0
SBFI	sodium-binding benzofuran isophthalate	1.0
AD-tau	soluble non-hyperphosphorylated tau isolated from ad brain	1.0
VMRT	visuomotor reaction time	1.0
VMRV	isceromotor response	1.0
irSST	somatostatin immunoreactivity	1.0
EPI-MS	/mselectrospray ion mass spectrometry	1.0
28GW	28 gestational weeks	1.0
PSTD	posttraumatic stress disorder	1.0
MIQ-RM	ovement imagery questionnaire-revised	0.5
MIQ-RM	ovement imagery questionnaire	0.5
U-MUS	1.5untrained group that received 1.5 μg/g of muscimol	1.0
PSTH	peristimulus time histogram	0.314606741573
PSTH	peristimulus spike time histogram	0.0112359550562
PSTH	peri-stimulus time interval histogram	0.0449438202247
PSTH	post stimulus time histogram	0.0337078651685
PSTH	peri-stimulus time histogram	0.14606741573
PSTH	speristimulus time interval histograms	0.0112359550562
PSTH	speri-stimulus time histograms	0.0449438202247
PSTH	peristimulus histogram	0.0224719101124
PSTH	poststimulus time histogram	0.0112359550562
PSTH	peri-stimulus time histograms	0.0337078651685
PSTH	spost-stimulus time histograms	0.0224719101124
PSTH	post-stimulus timed histogram	0.0112359550562
PSTH	post-stimulus time histogram	0.168539325843
PSTH	peristimulus-time histogram	0.0449438202247
PSTH	peristimulus time histograms	0.0786516853933
PSTN	parasubthalamic nucleus	1.0
CNQX6-cyano-7-nitoquinoxaline-2	3-dione	1.0
LMS	long maternal separation	1.0
HSC70	constitutive analogue of hsp70	0.5
HSC70	heat shock cognate protein 70	0.5
IBS-D	diarrhea-predominant ibs	1.0
M-	current	0.444444444444
M-	typematrix-type thalamocortical	0.111111111111
M-	mauthner	0.111111111111
M-	cellmauthner cell	0.222222222222
M-	maxmaximal m-wave	0.111111111111
LMT	left middle temporal gyrus	1.0
R-I	var-isovaline	1.0
GALTG	galanin transgenic	1.0
7-NI	7-nitro indazole	0.030303030303
7-NI	7-nitroindasole	0.030303030303
7-NI	7-nitro-indazole	0.030303030303
7-NI	7-nitroindazole	0.909090909091
M5	muscarinic receptor subtypes	1.0
M4	transmembrane regions 1–4	1.0
GPI-1046	[3-(3-pyridyl)-1-propyl-(2s)-1-(3,3-dimethyl-1,2,-dioxopentyl)-2-pyrrolidinecarboxylate]	1.0
M1	m2, m3muscarinic cholinergic receptor types 1, 2 and 3	0.333333333333
M1	primary motor cortex	0.666666666667
RLC	rostral subcoeruleus	0.333333333333
RLC	rate-level curve	0.333333333333
RLC	rate level curve	0.333333333333
M2	type 2 muscarinic receptor	0.333333333333
M2	secondary motor cortex	0.333333333333
M2	m3, m4, second, third and fourth transmembrane domains, respectively	0.333333333333
NRTP	nucleus reticularis tegmenti pontis	1.0
ANQX6-azido-7-nitro-1	4-dihydroquinoxaline-2,3-dione	1.0
LDG	lower blade of dentate gyrus	1.0
VLPOA	ventrolateral poa	1.0
nonREM	non-rapid eye movement	0.333333333333
nonREM	sleep	0.666666666667
UVR	ultraviolet irradiation	1.0
PCLP	urkinje cell layer of the cerebellar cortex	0.0909090909091
PCLP	urkinje cell layer	0.909090909091
DNM	dilator naris muscles	0.333333333333
DNM	3dynamin 3	0.333333333333
DNM	delayed non-matching to sample/position task	0.333333333333
SGRM	sselective glucocorticoid receptor modulators	1.0
BPSD	behavioral and psychological symptoms of dementia	1.0
UVN	unilateral vestibular neurectomy/neurectomized	0.5
UVN	unilateral vestibular neurectomy	0.5
dRN	dorsal raphe nucleus	1.0
LITG	left inferior temporal gyrus	1.0
AF-DX	11611-[[2-[(diethylamino)methyl]-1-piperidinyl]	0.5
AF-DX	116{11-[[2-[(diethylamino) methyl]-1-piperidinyl]	0.5
UVD	unilateral vestibular deafferentation	0.75
UVD	unilateral vestibular damage	0.25
UVG	unilateral vestibular ganglionectomy	1.0
Me	medial amygdaloid nucleus	0.8
Me	median nerve	0.2
rel-1S	2s,5r)-5-((1,1′-biphenyl-4-yl)methoxy)-2-(4-morpholinyl)-3-oxocyclopentyl)-4-heptenoic acid calcium salt	1.0
Mg	magnocellular nucleus	1.0
Mf	mirror focus	0.5
Mf	morphine-treated	0.5
DIOA	dihydroindenyl-oxy-alkanoic acid	1.0
GxH	hydrophilic globular che polymer made of x subunits	1.0
UPC	upright pyramidal cells	1.0
KN-	93n-[2-[[[3-(4-chlorophenyl)-2-propenyl]methylamino]	0.2
KN-	93	0.2
KN-	62	0.2
KN-	932-[n-(2-hydroxyethyl)-n-(4-methoxybenzenesulfonyl)]amino-n-(4-chlorocinnamyl)-n-methylbenzylamine phosphate	0.2
KN-	932-[n-(2-hydroxyethyl)]-n-(4-methoxybenzenesulfonyl)]	0.2
TAKTGF-β-	activated kinase-1	1.0
CGP-	55845a	1.0
WDIA	weight drop impact acceleration	1.0
PDIA	3protein disulfide isomerase a3	0.5
PDIA	1protein disulfide isomerase precursor	0.5
WINWIN	55212-2	0.5
WINWIN	55–212–2	0.5
ME	hypothalamic median eminence	0.0153846153846
ME	microsphere embolism	0.0307692307692
ME	medial entorhinal field	0.0153846153846
ME	malic enzyme	0.0153846153846
ME	movement execution	0.0153846153846
ME	motor execution	0.0153846153846
ME	mesencephalon	0.0153846153846
ME	mosaic end	0.0153846153846
ME	medium excitatory bouton type	0.0153846153846
ME	ntmedial entorhinal cortex	0.0153846153846
ME	/idmegalencephaly and intellectual disability	0.0153846153846
ME	2late metestrous	0.0153846153846
ME	medial eminence	0.0153846153846
ME	20.4 igg-saporin	0.0153846153846
ME	xmuscle extract	0.0153846153846
ME	methoxamine	0.0153846153846
ME	motor error	0.0153846153846
ME	(ext/in)median eminence (external part/internal part)	0.0153846153846
ME	met-enkephalin	0.0153846153846
ME	prenatal morphine-treated animals with emotional stress exposure	0.0153846153846
ME	nkmethionine enkephalin neurons	0.0153846153846
ME	mandibular epithelium	0.0153846153846
ME	medial entorhinal	0.0153846153846
ME	mounting efficiency	0.0153846153846
ME	methionine-enkephalin	0.0307692307692
ME	median eminence	0.538461538462
ME	medial amygdaloid nucleus	0.0153846153846
ME	muscularis externae	0.0153846153846
ME	7murine modified scrapie	0.0153846153846
MD	mediodorsal nucleus of the thalamus	0.0431034482759
MD	mean density	0.00862068965517
MD	myeloid differentiation protein	0.0172413793103
MD	2myeloid differentiation protein 2	0.00862068965517
MD	2myeloid differentiation factor 2	0.00862068965517
MD	modulation depth	0.00862068965517
MD	mediodorsal nucleus	0.112068965517
MD	microdialysis	0.00862068965517
MD	mediodorsal thalamus	0.0689655172414
MD	mean diffusion	0.00862068965517
MD	medial dorsal nucleus	0.0172413793103
MD	movement duration	0.0344827586207
MD	mediodorsal nucleus of thalamus	0.0172413793103
MD	medio-dorsal thalamus	0.00862068965517
MD	vcventral caudal portion of the medial dorsal nucleus	0.0172413793103
MD	medialis deltoid	0.00862068965517
MD	mcmagnocellular portion of mediodorsal thalamic nucleus	0.00862068965517
MD	mixed dementia	0.00862068965517
MD	major depressive disorder	0.00862068965517
MD	mediodorsal thalamic nucleus	0.137931034483
MD	thalmediodorsal thalamus	0.00862068965517
MD	ddorsal medullary reticular nucleus	0.00862068965517
MD	marginal decrease	0.00862068965517
MD	maximal axonal distance	0.00862068965517
MD	musicians’ dystonia	0.00862068965517
MD	molecular dynamic	0.00862068965517
MD	maternal deprivation	0.0172413793103
MD	mediodorsal end	0.00862068965517
MD	medial dorsal nucleus of the thalamus	0.00862068965517
MD	mediodorsal thalamic	0.00862068965517
MD	maximal distance	0.00862068965517
MD	molecular dynamics	0.0172413793103
MD	medial dorsal thalamic nucleus	0.00862068965517
MD	monocular deprivation	0.0948275862069
MD	mean diffusivity	0.0775862068966
MD	medial dorsal thalamic nuclei	0.00862068965517
MD	mediodorsal	0.051724137931
MD	major depression	0.051724137931
MD	medial-dorsal thalamus	0.00862068965517
MD	medial dorsal thalamus	0.00862068965517
MD	movement in dark condition	0.00862068965517
MG	medial geniculate body	0.105263157895
MG	mechanical grinding	0.0131578947368
MG	ventral division of the medial geniculate nucleus	0.0131578947368
MG	mandibular ganglia	0.0131578947368
MG	132	0.0131578947368
MG	microglia	0.0131578947368
MG	methylglyoxal	0.0131578947368
MG	132n-[(phenylmethoxy)carbonyl]-l-leucyl-n-[(1s)-1-formyl-3-methylbutyl]	0.0131578947368
MG	lur	0.0131578947368
MG	medial geniculate complex	0.0131578947368
MG	medial gray	0.0263157894737
MG	medial geniculate thalamic nucleus	0.0131578947368
MG	medialis gastrocnemius	0.0131578947368
MG	second monkey	0.0131578947368
MG	lur5metabotropic glutamate receptor	0.0131578947368
MG	vventral division of medial geniculate body	0.0131578947368
MG	mmedial division of medial geniculate thalamic nucleus	0.0131578947368
MG	mmedial division of the medial geniculate body	0.0131578947368
MG	vventral part of the medial geniculate nucleus	0.0131578947368
MG	132carbobenzoxyl-leucinyl-leucinyl-leucinal	0.0131578947368
MG	medial geniculate body (of the thalamus)	0.0131578947368
MG	+microgyria present	0.0263157894737
MG	medial geniculate nu	0.0131578947368
MG	vventral nucleus of the medial geniculate body	0.0263157894737
MG	medial gastrocnemius muscle	0.0394736842105
MG	cmmicroglia conditioned medium	0.0131578947368
MG	vventral division of the medial geniculate nucleus	0.0394736842105
MG	vmedial geniculate nucleus	0.0131578947368
MG	medial gray matter	0.0131578947368
MG	lur5	0.0131578947368
MG	medial geniculate nuclei	0.0131578947368
MG	medial geniculate nucleus	0.157894736842
MG	medial gastrocnemius	0.197368421053
MG	myasthenia gravis	0.0131578947368
MG	vvedial division of the medial geniculate body	0.0131578947368
MG	medial geniculate	0.0263157894737
MF	middle-frequency	0.025641025641
MF	mean frequency	0.025641025641
MF	modulation frequency	0.0769230769231
MF	mossy fibre	0.128205128205
MF	mossy fiber	0.333333333333
MF	microfilament	0.025641025641
MF	magnetic field	0.025641025641
MF	middle frequency	0.025641025641
MF	smossy fibers	0.025641025641
MF	medial frontal	0.025641025641
MF	moderate frequency	0.025641025641
MF	median frequency	0.025641025641
MF	multiple firing	0.025641025641
MF	muscle fiber	0.025641025641
MF	myelinated fibers	0.025641025641
MF	first monkey	0.025641025641
MF	mount frequency	0.025641025641
MF	mossy fibers	0.0512820512821
MF	median power frequency of emg signal	0.025641025641
MF	mossy fiber/fibers	0.025641025641
MA	martial artists	0.025
MA	mount attempt	0.1
MA	methamphetamine	0.275
MA	percent of the maximal amplitude	0.025
MA	monoarthritis	0.05
MA	magnocellular preoptic nucleus	0.025
MA	manual acupuncture	0.025
MA	medial/anterior divisions)	0.025
MA	myelinated axons	0.025
MA	mesenteric artery	0.025
MA	medial amygdala	0.175
MA	(s)microarousal(s)	0.025
MA	malonic acid	0.025
MA	(+)-methamphetamine	0.025
MA	bmonoclonal antibody	0.025
MA	mount attempts	0.025
MA	mental arithmetic	0.025
MA	+mns-2hmonoarthritic animals perfused 2 h after 4 min of noxious mechanical stimulation of the skin of the arthritic joint	0.025
MA	%maximum angular amplitude expressed in percentages of imposed situation	0.025
MA	medial amygdaloid nucleus	0.025
MC	4rmelanocortin-4 receptor	0.0444444444444
MC	omotor cortex	0.0222222222222
MC	mast cell	0.0222222222222
MC	4-rmelanocortin-4 receptors	0.0222222222222
MC	motor cue	0.0222222222222
MC	192	0.0666666666667
MC	4-rmelanocortin-4 receptor	0.0222222222222
MC	hacetyl-β-methylcholine	0.0444444444444
MC	3melanocortin receptor 3	0.0222222222222
MC	methylcellulose	0.0222222222222
MC	mossy cell	0.0222222222222
MC	maximum current	0.0222222222222
MC	medium clip	0.0222222222222
MC	hacetyl β-methylcholine	0.0222222222222
MC	xmotor cortex	0.0222222222222
MC	4rmelanocortin receptors type 4	0.0222222222222
MC	marginal cell	0.0222222222222
MC	mast cells	0.0222222222222
MC	4rmelanocortin 4 receptor	0.0222222222222
MC	melanocortin	0.0222222222222
MC	smitral cells	0.0222222222222
MC	smorphine-treated cats	0.0222222222222
MC	minocycline	0.0222222222222
MC	prenatal morphine-treated animals with control treatment	0.0222222222222
MC	müller cells	0.0222222222222
MC	hacetyl-beta-methylcholine	0.0222222222222
MC	ellmonte carlo simulator of cellular microphysiology	0.0222222222222
MC	mitral cells	0.0444444444444
MC	1rmelanocortin 1 receptor	0.0222222222222
MC	macrophage cluster	0.0222222222222
MC	motor cortex	0.177777777778
MC	mildly compressed group	0.0222222222222
MC	4rmelanocortin receptor 4	0.0222222222222
MB	midbrain	0.05
MB	mammillary bodies	0.05
MB	milk buffer	0.05
MB	midbrain tegmentum	0.05
MB	mammillary body	0.05
MB	mushroom bodies	0.05
MB	mushroom body	0.15
MB	microbead	0.1
MB	mitochondrial buffer	0.1
MB	mamillary body	0.05
MB	methylene blue	0.1
MB	mid brain	0.05
MB	smushroom bodies	0.05
MB	maleate buffer	0.1
MM	1methionine/methionine at codón 129 of prnp	0.0588235294118
MM	mamillaris medialis	0.0588235294118
MM	mirror movement	0.0588235294118
MM	mammillary nucleus	0.0588235294118
MM	medial mesopallium	0.0588235294118
MM	medial mammillary nucleus	0.176470588235
MM	mismatch	0.235294117647
MM	authner	0.0588235294118
MM	–gbsamolecular mechanics–generalized born and surface area	0.0588235294118
MM	mmedial part of medial mammillary nucleus	0.0588235294118
MM	multimodal cortex	0.0588235294118
MM	masetter muscle	0.0588235294118
ML	medial–lateral	0.102040816327
ML	mantle layer	0.00680272108844
ML	medio–lateral	0.00680272108844
ML	lateral mammillary nucleus	0.00680272108844
ML	mount latency	0.0136054421769
ML	myelin lamellae	0.00680272108844
ML	mid to lateral	0.00680272108844
ML	molecular layer of the cerebellum	0.0136054421769
ML	maximum likelihood	0.0136054421769
ML	medial lateral	0.0272108843537
ML	mitochondrial/lysosomal-enriched faction	0.00680272108844
ML	midline	0.0136054421769
ML	latency to the first mount	0.00680272108844
ML	medio-laterality	0.00680272108844
ML	mitral cell layer	0.00680272108844
ML	medio-lateral	0.047619047619
ML	mitral layer	0.00680272108844
ML	molecular layer of the cerebellar cortex	0.00680272108844
ML	molecular layer	0.251700680272
ML	molecular layers	0.00680272108844
ML	medio-lateral stereotactic coordinate	0.00680272108844
ML	medial-lateral	0.0204081632653
ML	mediolateral	0.265306122449
ML	middle layer	0.00680272108844
ML	medial lemniscus	0.0884353741497
ML	medial mammillary nucleus, pars lateralis	0.00680272108844
ML	movement in light condition	0.00680272108844
ML	molecular layer of cerebellum	0.00680272108844
ML	stratum moleculare	0.0204081632653
ML	medial–lateral direction of body sway	0.00680272108844
MO	(p/s)motor area (primary/secondary)	0.0238095238095
MO	middle occipital area	0.0238095238095
MO	medial orbital cortex	0.166666666667
MO	medulla oblongata	0.142857142857
MO	morpholino oligonucleotide	0.0238095238095
MO	month	0.0238095238095
MO	mustard oil (allyl isothiocyanate)	0.047619047619
MO	mounts without intromissions	0.0238095238095
MO	mustard oil	0.238095238095
MO	movement onset	0.0238095238095
MO	smorpholino oligonucleotides	0.0238095238095
MO	somatomotor cortex	0.0238095238095
MO	/vomedial/ventral orbital cortex	0.0238095238095
MO	movement observation experiment	0.0238095238095
MO	mineral oil	0.0238095238095
MO	morpholino	0.047619047619
MO	prelimbic and medial orbital areas of the prefrontal cortex	0.0238095238095
MO	medial orbitofrontal cortex	0.047619047619
MO	medulla	0.0238095238095
MN	motor neuron	0.0714285714286
MN	moderately negative	0.0357142857143
MN	motoneurons	0.0357142857143
MN	medial nucleus of the octavolateral area	0.107142857143
MN	myelinated nerve	0.0357142857143
MN	mental nerve	0.0357142857143
MN	smotoneurons	0.0714285714286
MN	9d cells	0.0357142857143
MN	motoneuron	0.285714285714
MN	metanephrine	0.0357142857143
MN	mammillary nuclei	0.0357142857143
MN	smotor neurons	0.0714285714286
MN	motor neurons	0.0357142857143
MN	median nerve	0.0714285714286
MN	motor neuron nmda	0.0357142857143
MI	modulation index	0.166666666667
MI	mutual information	0.0277777777778
MI	magnetic response recorded in the hemisphere ipsilateral to nerve stimulation	0.0277777777778
MI	primary motor cortex	0.25
MI	marginal increase	0.0277777777778
MI	monotonicity index	0.0555555555556
MI	magnetic quantum number describing the three resonance lines of nitroxide spin labels: mi=+1 is the low-field line	0.0277777777778
MI	motor imagery	0.166666666667
MI	monocularity index	0.0277777777778
MI	modification index	0.0277777777778
MI	maternal inflammation	0.0277777777778
MI	myocardial infarction	0.0833333333333
MI	intact male quail	0.0277777777778
MI	mechanically insensitive	0.0555555555556
MH	bmedial habenula	0.321428571429
MH	medial habenula	0.107142857143
MH	medial portion of the hypothalamus	0.0357142857143
MH	bmedial habenular nucleus	0.214285714286
MH	bthe medial habenular nucleus	0.0357142857143
MH	medial habenula nucleus	0.0357142857143
MH	bmedial habenular complex	0.107142857143
MH	malignant hyperthermia	0.0357142857143
MH	bmedial habenula nucleus	0.0357142857143
MH	maternal hyperthyroid rats	0.0357142857143
MH	bmedial habenular nu	0.0357142857143
MK	801dizocilpine maleate	0.105263157895
MK	801dizolcipine	0.0526315789474
MK	571(e)-3-[[[3-[2-(7-chloro-2-quinolinyl) ethenyl]phenyl]	0.0526315789474
MK	midkine	0.0526315789474
MK	801dizocilpine	0.368421052632
MK	mice treated with mk-801	0.0526315789474
MK	(+)801dizocilpine maleate	0.0526315789474
MK	801 binding	0.0526315789474
MK	801	0.157894736842
MK	2monkey 2	0.0526315789474
MU	multi-unit	0.666666666667
MU	multiunit	0.333333333333
MT	1membrane-type	0.00925925925926
MT	/v5middle temporal area of primates	0.00925925925926
MT	3mamba toxin 3	0.00925925925926
MT	movement time	0.12962962963
MT	mitral/tufted	0.0185185185185
MT	1-mmpmembrane type 1-mmp	0.00925925925926
MT	myoclonic twitch	0.00925925925926
MT	umedial tuberal	0.00925925925926
MT	mamillothalamic	0.00925925925926
MT	1-mmpmembrane type-1 matrix metalloproteinase	0.00925925925926
MT	middle temporal area	0.0648148148148
MT	minimum threshold	0.037037037037
MT	modus tollens	0.00925925925926
MT	umedial tubercle nucleus	0.00925925925926
MT	microtubule	0.0185185185185
MT	metallothioneins	0.00925925925926
MT	3metallo-thionein 3	0.00925925925926
MT	2	0.0185185185185
MT	2melatonin receptor 1b	0.00925925925926
MT	2r-komelatonin receptor 2 knock-out mouse	0.00925925925926
MT	multi-task model	0.00925925925926
MT	minimal threshold	0.0277777777778
MT	memory test	0.00925925925926
MT	cellmitral/tufted cell	0.00925925925926
MT	mesotocin	0.00925925925926
MT	medial temporal	0.00925925925926
MT	/v5	0.0185185185185
MT	smechanical thresholds	0.00925925925926
MT	medial terminalis	0.00925925925926
MT	midbrain tegmentum	0.00925925925926
MT	medial temporal area	0.0277777777778
MT	medial thalamus	0.00925925925926
MT	marimastat	0.00925925925926
MT	medial terminal nucleus	0.00925925925926
MT	2melatonin receptor type 2	0.0185185185185
MT	myelin thickness	0.00925925925926
MT	metallothionein	0.0833333333333
MT	middle temporal visual cortex	0.00925925925926
MT	middle temporal	0.037037037037
MT	microtubule-filled, electron-dense dendrites	0.00925925925926
MT	mamillothalamic tract	0.00925925925926
MT	middle temporal visual area	0.0277777777778
MT	mammillothalamic tract	0.0185185185185
MT	medial terminal nucleus of the accessory tract	0.00925925925926
MT	magnetization transfer	0.00925925925926
MT	mitochondria	0.00925925925926
MT	micturition threshold	0.00925925925926
MT	1-mmpmembrane-type 1 matrix metalloproteinase	0.00925925925926
MT	umedial tuberal nucleus	0.0185185185185
MT	medial terminal nucleus of the accessory optic tract	0.0277777777778
MT	medial terminal nucleus of accessory optic tract	0.00925925925926
MT	greenmitotracker green	0.00925925925926
MT	mutant type	0.00925925925926
MT	motor threshold	0.0648148148148
MW	mid wavelength cone opsin	0.0454545454545
MW	mid wavelength	0.0454545454545
MW	microwave	0.0454545454545
MW	molecular weight	0.863636363636
MV	micturition volume	0.0555555555556
MV	emedial vestibular nu	0.0555555555556
MV	amyosin va	0.111111111111
MV	medioventral nucleus	0.0555555555556
MV	movement variability	0.0555555555556
MV	epcparvicellular part of the medial vestibular nucleus	0.111111111111
MV	emedial vestibular nucleus	0.388888888889
MV	cmid vc	0.0555555555556
MV	medioventral nucleus of the thalamus	0.0555555555556
MV	medial visual area	0.0555555555556
MP	elderly subjects with mild presbycusis	0.0294117647059
MP	modus ponens	0.0294117647059
MP	methamphetamine	0.0294117647059
MP	methylprednisolone	0.147058823529
MP	metacarpophalangeal	0.0588235294118
MP	membrane potential	0.411764705882
MP	methylphenidate	0.0294117647059
MP	mononuclear phagocyte	0.0294117647059
MP	menstrual phase	0.0294117647059
MP	maximum bladder contraction pressure	0.0294117647059
MP	mobile phone	0.0294117647059
MP	myenteric plexus	0.0294117647059
MP	medial pallium	0.0588235294118
MP	medium of perfusion	0.0294117647059
MP	membrane-inserted protein fraction	0.0294117647059
MS	/dbmedial septal diagonal band complex	0.00408163265306
MS	/vdbmedial septum/vertical diagonal band	0.00408163265306
MS	conditionmovement plus somatosensory stimulation condition	0.00408163265306
MS	/dbmedial septum/vertical limb of the diagonal band of broca	0.00408163265306
MS	15repeated brief postnatal maternal separation	0.00408163265306
MS	3out layer of the ms	0.00408163265306
MS	mesencephalon superventricle	0.00408163265306
MS	/vdbmedial septum vertical limb of the diagonal band	0.00408163265306
MS	222tricaine methanesulfonate	0.00408163265306
MS	/ndbmedial septal area/nucleus of the diagonal band of broca	0.00408163265306
MS	maternal separation	0.0489795918367
MS	medium spiny	0.0122448979592
MS	180180 min of maternal separation from postnatal days 2–14	0.00408163265306
MS	mass spectrometry	0.069387755102
MS	222aminobenzoic acid ethylmethylester	0.00408163265306
MS	medial septum nucleus	0.00408163265306
MS	lfslow-frequency stimulation of the medial septum	0.00408163265306
MS	main shaft	0.00408163265306
MS	/strms with 1 h of restraint stress	0.00408163265306
MS	muscle stimulation	0.00408163265306
MS	multi-slice	0.00408163265306
MS	222ethyl 3-aminobenzoate methanesulfonate salt	0.00408163265306
MS	medium spiny neurons	0.00408163265306
MS	medial septal nucleus	0.069387755102
MS	medial septal area	0.0163265306122
MS	360wms360 water intake group	0.00408163265306
MS	180maternal separation	0.00408163265306
MS	missense	0.00816326530612
MS	gas chromatography/mass spectrometry	0.00408163265306
MS	–dbmedial septum–diagonal band	0.00408163265306
MS	multiple sclerosis	0.273469387755
MS	media stock	0.00408163265306
MS	/vdbmedial septal/vertical limb of the diagonal band of broca	0.00408163265306
MS	/dbmedial septum diagonal band area	0.00408163265306
MS	masseter muscle	0.00408163265306
MS	mem–eagle's medium with 15.8mm nahco3 and	0.00408163265306
MS	methanesulfonate	0.00408163265306
MS	maternally separated	0.00408163265306
MS	/mstandem mass spectrometry	0.0122448979592
MS	2–15maternal separation between the 2nd and the 15th postnatal days	0.00408163265306
MS	/dbmedial septum/diagonal band	0.00816326530612
MS	ntandem ms	0.00408163265306
MS	/dbmedial septum diagonal band complex	0.00408163265306
MS	medial septal	0.0122448979592
MS	2tandem mass spectrometry	0.00408163265306
MS	/vdbmedial septum/vertical limb of the diagonal band	0.00408163265306
MS	manual stimulation	0.00816326530612
MS	morphine sulfate	0.00816326530612
MS	missense oligonucleotide	0.00408163265306
MS	360360 min of maternal separation during postnatal days 1–21	0.00408163265306
MS	medium stock	0.00408163265306
MS	methansulfonate	0.00408163265306
MS	222tricaine methane sulfonate	0.00408163265306
MS	180maternal separation 180 min	0.00408163265306
MS	motion sickness	0.00408163265306
MS	medial septum	0.224489795918
MS	3hexperimental group of maternal separation 3h (pnd2–pnd14)	0.00408163265306
MS	medial stimulation	0.00408163265306
MS	tstriatum mediale (lobus parolfactorius)	0.00408163265306
MS	/vdbmedial septum/vertical limb of the diagonal band of broca	0.00816326530612
MS	gas chromatography–(electron impact) mass spectrometry	0.00408163265306
MS	/dbthe medial septal nucleus and the nucleus of the diagonal band of broca	0.00408163265306
MS	/dbbmedial septum/vertical limb of the diagonal band of broca	0.00408163265306
MS	mass spectrometer	0.00408163265306
MS	/dbbmedial septum/diagonal band of broca	0.00408163265306
MS	tmedial striatum	0.0122448979592
MR	median raphé nucleus	0.00657894736842
MR	emammillary recess 3v	0.00657894736842
MR	mineralocorticoid receptor	0.467105263158
MR	mineralocorticoid receptors	0.0657894736842
MR	multireceptive (neurons)	0.00657894736842
MR	medial rectus	0.0131578947368
MR	smineralocorticoid receptors	0.00657894736842
MR	medium round synaptic vesicle ending	0.00657894736842
MR	median raphe	0.0460526315789
MR	b8 cell group (median raphe)	0.00657894736842
MR	mother reared	0.00657894736842
MR	modulation rate	0.00657894736842
MR	magnetic resonance	0.164473684211
MR	mineralocorticoid (type i) receptor	0.00657894736842
MR	multireceptive	0.0197368421053
MR	medial rectus muscle	0.0131578947368
MR	metabolic rate	0.00657894736842
MR	muscarinic acetylcholine receptor	0.00657894736842
MR	nmr, nuclear magnetic resonance	0.00657894736842
MR	median raphe nucleus	0.0263157894737
MR	mineralocorticoid	0.0197368421053
MR	modified redox ratio	0.00657894736842
MR	mineralcorticoid receptor	0.00657894736842
MR	intermediomedial region of the spinal cord segments	0.00657894736842
MR	medullary raphé	0.00657894736842
MR	morphometry	0.00657894736842
MR	mental retardation	0.00657894736842
MR	mineralocortioid receptor	0.00657894736842
MR	monopodal romberg	0.00657894736842
MR	muscarinic receptor	0.0131578947368
MR	mother-reared	0.00657894736842
MR	myelination ratio	0.00657894736842
MR	minaralocorticoid receptor	0.00657894736842
P-cell	purkinje cell	1.0
MX	matrix zone	1.0
mtSOD	1mutant superoxide dismutase 1	1.0
MZ	multi-modal somatosensory cortex	0.0416666666667
MZ	marginal zone	0.625
MZ	multisensory zone	0.0416666666667
MZ	monozygotic	0.291666666667
sPLA	2secretory phospholipase a2	0.75
sPLA	2secreted pla2	0.25
DOI	[(±)-1-(4-iodo-2;5-dimethoxyphenyl)-2-aminopropane]	0.0714285714286
DOI	(±)-1-4-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane	0.0714285714286
DOI	2.5-dimetoxi-4-iodoamphetamine hydrobromide	0.0714285714286
DOI	4-iodo-(2,5-dimethoxy)-phenylisopropylamine	0.0714285714286
DOI	1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane	0.0714285714286
DOI	(±)-1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane	0.0714285714286
DOI	1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane	0.142857142857
DOI	(±)-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane	0.0714285714286
DOI	r(-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride	0.0714285714286
DOI	(±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride	0.0714285714286
DOI	[125i]	0.0714285714286
DOI	(±)-2,5-dimethoxy-4-iodoamphetamine hydrobromide	0.0714285714286
DOI	(±)1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane	0.0714285714286
DON	donepezil hydrochloride	0.5
DON	6-diazo-5-oxo-l-norleucine	0.5
vDBB	vertical limb of the diagonal band of broca	1.0
YM-09151-2	emonapride	1.0
2-APB	2-aminoethoxydiphenylborate	0.142857142857
2-APB	2-aminoethoxydiphenylborate (non-competitive insp3 receptor antagonist)	0.047619047619
2-APB	2-aminoethyl diphenyl borate	0.047619047619
2-APB	2-aminophenoxyethane-borate	0.047619047619
2-APB	2-aminoethyl diphenylborinate	0.142857142857
2-APB	2-aminethoxydiphenyl borane	0.047619047619
2-APB	2-aminoethoxydiphenylborane	0.0952380952381
2-APB	2-aminoethoxydiphenyl borate	0.428571428571
α-AR	alpha-adrenergic receptor	1.0
DOC	2	0.142857142857
DOC	deoxycorticosterone	0.857142857143
D-AP-	5d(-)-2-amino-5-phosphonopentanoic acid	0.5
D-AP-	5α-2-amino-5-phosphonovaleric acid	0.5
IAPSI	nternational affective picture set	0.166666666667
IAPSI	nternational affective picture system	0.833333333333
DOF	sdegrees of freedom	0.25
DOF	degrees-of-freedom	0.25
DOF	degree of freedom	0.25
DOF	degrees of freedom	0.25
NBR	negative bold response	1.0
α-BgTX	α-bungarotoxin	1.0
DOE	differential outcomes effect	1.0
D-AP5	d(-)-2-amino-5-phosphonopentanoic acid	0.5
D-AP5	???	0.0833333333333
D-AP5	aminophosphonopentanoic acid	0.0833333333333
D-AP5	d-2-amino-5-phosphonopentanoic acid	0.25
D-AP5	d-(-)-2-amino-5-phosphonopentanoic acid	0.0833333333333
2-APV	d(-)-2-amino-5-phosphonovaleric acid	0.5
2-APV	l-2-amino-5-phosphonovalerate	0.5
sPLW	scrambled point-light walker	1.0
T-PBS	triton/pbs	0.333333333333
T-PBS	0.3% triton/phosphate-buffered saline	0.333333333333
T-PBS	0.01% tween 20 pbs	0.333333333333
DOR	delta-opioid receptor	0.153846153846
DOR	δ opioid receptor	0.115384615385
DOR	delta (δ) opioid receptor	0.0384615384615
DOR	kor and mordelta-, kappa- and mu-opioid receptors	0.0384615384615
DOR	delta opioid receptor	0.5
DOR	δ-type opioid receptor	0.0384615384615
DOR	δ opioid receptors	0.0384615384615
DOR	δ-opioid receptor	0.0769230769231
DOS	depth of selectivity	1.0
DOP	delta opioid peptide	0.5
DOP	delta-opioid receptors	0.166666666667
DOP	delta opioid receptor	0.333333333333
NRN-	methyl-d-aspartate receptor subunit	0.5
NRN-	methyl-d-aspartate receptor	0.5
Lc	heterozygous lurcher mutant mice	1.0
CTFR	cystic fibrosis transmembrane conductance regulator	1.0
CPT-I	carnitine-palmitoyl-transferase-i	1.0
DPP	ivdipeptidyl peptidase iv	0.5
DPP	6dipeptidyl aminopeptidase-like protein	0.5
MSOP	(rs)-α-methylserine-o-phosphate	1.0
α-BgTx	α-bungarotoxin	1.0
β-NADHβ-	nicotinamide adenine dinucleotide	1.0
PHAL	phaseolus vulgaris leucoagglutinin	1.0
S-α-M4CPG	s-α-methyl-4-carboxyphenylglycine	1.0
HSV	herpes simplex virus type 1	0.230769230769
HSV	herpes simplex virus	0.692307692308
HSV	herpes simplex virus-1	0.0769230769231
AJM	ankle joint mobilization	1.0
BSA-C	acetylated bsa	0.25
BSA-C	acetylated bovine serum albumin	0.25
BSA-C	bovine serum albumin-c	0.25
BSA-C	acetylated and linearized bovine serum albumin	0.25
LVEEG	low-voltage electroencephalography	1.0
LG-ABNlicking	grooming, and arched-back nursing	1.0
NZRN	ormal zebrafish ringer’s	1.0
GluR	ampa receptor subunit	0.0192307692308
GluR	n-methyl-d-aspartate–glutamate receptor	0.0192307692308
GluR	ampa-type glutamate receptor subunit	0.0192307692308
GluR	glutamate receptor	0.557692307692
GluR	glutamate receptor subunit	0.326923076923
GluR	n-methyl-d-aspartate glutamate receptor	0.0192307692308
GluR	glutamate receptor (subunits numbered 1–4)	0.0192307692308
GluR	ampa receptor subunit 1	0.0192307692308
LDLR	low-density lipoprotein receptor	0.4
LDLR	low density lipoprotein	0.2
LDLR	low density lipoprotein receptor	0.4
BIIE0246	(s)-n2-[[1-[2-[4(r,s)-5,11-dihydro-6(6h)-oxodibenz-[b,e]azepin-11-yl]	1.0
ABAM	antibiotic/antimycotic	0.333333333333
ABAM	antibiotic-antimycotic	0.666666666667
q-PCR	quantitative polymerase chain reaction	0.5
q-PCR	qualitative polymerase chain reaction	0.5
KLHL	1kelch like protein 1	1.0
PRL-RPRL-	receptor	1.0
mAMPH	methamphetamine	1.0
sPL-	sersubplasmalemmal smooth endoplasmic reticulum	1.0
PRL-R	prolactin receptor	0.666666666667
PRL-R	koprl-r null-mutant	0.333333333333
pF-HHSiD	(±)-p-fluoro-hexahydro-sila-difenidol hydrochloride	1.0
2-AP5	2-amino-5-phosphonopentanoate	0.142857142857
2-AP5	d,l-2-amino-5-phosphonovaleric acid	0.142857142857
2-AP5	d,l-2-amino-5-phosphonovalerate	0.571428571429
2-AP5	dl-2-amino-5-phosphonopentanoic acid	0.142857142857
D-APV	d(-)-2-amino-5-phosphonovaleric acid	0.0588235294118
D-APV	2-amino-5-phosphonovaleric acid	0.0588235294118
D-APV	d-2-amino-4-phosphovaletic acid	0.0588235294118
D-APV	dl-2-amino-5-phosphonopentanoic acid	0.0588235294118
D-APV	d-2-amino-5-phosphonopentanoic acid	0.0588235294118
D-APV	d-amino-5-phosphonovaleric acid	0.0588235294118
D-APV	,	0.0588235294118
D-APV	d-2-amino-5-phosphonovalerate	0.176470588235
D-APV	antagonist for nmda type receptors	0.0588235294118
D-APV	d-2-amino-5-phosphonovaleric acid	0.0588235294118
D-APV	d(-)-2-amino-5-phosphonopentanoic acid	0.176470588235
D-APV	(-)-2-amino-5-phosphonopentanoic acid	0.0588235294118
D-APV	d-2-amino-5-phosphovalerate	0.0588235294118
9-OH-RISP	9-oh-risperidone	1.0
PUT	putrescine	0.6
PUT	putmanen	0.2
PUT	putamen	0.2
contra-D	hemisphere contralateral to the dystonic arm	1.0
PACPX	1, 3-dipropyl-8-(2-amino-4-chlorophenyl)-xanthine	1.0
2-VO	two-vein occlusion	0.166666666667
2-VO	2-vessel occlusion	0.166666666667
2-VO	two-vessel occlusion	0.5
2-VO	two-vessel occlusion model of forebrain ischemia	0.166666666667
DPB	density of presynaptic boutons	1.0
RIPC	rapid ischemic preconditioning	0.5
RIPC	rerat insulin 2 promoter cre recombinase transgene	0.5
BAT	brown adipose tissue	1.0
BAR	domain	1.0
BAS	astrocytic cell line	0.25
BAS	basic promoter	0.25
BAS	bioanalytical system	0.25
BAS	behavioral activity scores	0.25
BAP	back-propagating action potential	0.25
BAP	5-(biotinamido-)pentylamine	0.25
BAP	brightness area product	0.25
BAP	sbackpropagating action potentials	0.25
phospho-G	lur1phosphorylated glutamate receptor subunit 1	1.0
phospho-C	amkii	1.0
EPSCs	excitatory postsynaptic currents	1.0
BAX	bcl-2-associated protein x	1.0
RIPL	right inferior parietal lobe	1.0
BAF	bok-asp-fmk	0.5
BAF	boc-aspartyl(ome)-fluoromethylketone	0.5
DPO	dorsal periolivary nucleus	0.5
DPO	days post-operative	0.25
DPO	postoperative day	0.25
BAD	proteinbcl2-associated agonist of cell death protein	0.666666666667
BAD	bcl-2-associated death promoter homology	0.333333333333
PASATP	aced auditory serial-addition task	1.0
BAB	rodmann's area	0.135135135135
BAB	rodman’s area	0.027027027027
BAB	rodmann’s area	0.162162162162
BAB	rodmann area	0.594594594595
BAB	rodman area	0.0810810810811
BAC	bacterial artificial chromosome	0.540540540541
BAC	artificial chromosome	0.027027027027
BAC	sblood alcohol concentrations	0.027027027027
BAC	transgenic	0.027027027027
BAC	sbacterial artificial chromosomes	0.027027027027
BAC	bed nucleus of the anterior commissure	0.027027027027
BAC	bed nucleus of anterior commissure	0.027027027027
BAC	blood alcohol concentration	0.27027027027
BAC	blood alcohol content	0.027027027027
SKF-	81297	0.125
SKF-	82958	0.625
SKF-	38393	0.25
BAL	sblood-alcohol levels	0.125
BAL	blood alcohol level	0.5
BAL	sblood alcohol levels	0.375
BAM	22bam8-22)	0.2
BAM	bovine adrenal medulla	0.2
BAM	22bovine adrenal medulla 22	0.2
BAM	8-22bovine adrenal medulla peptide 8-22	0.2
BAM	8–22bovine adrenal medullary peptide 8–22	0.2
PEEP	positive end-expiratory pressure	0.5
PEEP	positive endexpiratory pressure	0.5
JM	joint mobilization	1.0
IRS-1	insulin receptor substrate 1	0.333333333333
IRS-1	insulin receptor substrate-1	0.666666666667
β-CCMβ-	carboline-3-carboxylate	1.0
TTXT	etrodotoxin	1.0
AcbSH	nucleus accumbens shell	1.0
pCO	2partial pressure carbon dioxide	0.333333333333
pCO	2partial pressure of carbon dioxide	0.333333333333
pCO	2carbon dioxide partial pressure	0.333333333333
C-cell	neuron with receptive field of the complex type	0.5
C-cell	cell with complex receptive field	0.5
TTXS	ttx-sensitive na+ current	1.0
FeTPPS5	10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron (iii) chloride	1.0
AAVA	deno-associated viral	1.0
STD	state-dependent memory	0.142857142857
STD	short-term diet	0.142857142857
STD	short-term depression	0.714285714286
ADNX	transection of the ipsilateral aortic depressor nerve	1.0
HODE	shydroxyoctadecadienoic acids	1.0
STG	superior temporal gyri	0.037037037037
STG	synaptotagmin	0.037037037037
STG	superior temporal gyrus	0.703703703704
STG	stomatogastric ganglion	0.222222222222
STA	spike-triggered averaging	0.166666666667
STA	spike-triggered average	0.5
STA	superficial temporal artery	0.333333333333
STB	stigmoid body	1.0
STC	striatal-thalamo-cortical	0.0909090909091
STC	sensory trigeminal complex	0.181818181818
STC	stanniocalcin	0.0909090909091
STC	spatial tuning curve	0.0909090909091
STC	saline-treated cats	0.0909090909091
STC	2stanniocalcin 2	0.0909090909091
STC	striato-thalamo-cortical	0.181818181818
STC	spatiotemporal convergence	0.181818181818
STL	step-through latency	0.666666666667
STL	step through latency	0.333333333333
TTX-	stetrodotoxin-sensitive	0.25
TTX-	sensitive na+ current	0.25
TTX-	resistant na+ current	0.25
TTX-	stetrodotoxin sensitive	0.25
STN	signal-to-noise ratio	0.00694444444444
STN	subthalamic nuclues	0.00694444444444
STN	subthalamic nucleus	0.909722222222
STN	subtalamic nucleus	0.00694444444444
STN	spinal trigeminal nucleus	0.0208333333333
STN	sub-thalamic nucleus	0.0208333333333
STN	nucleus of the tractus solitarius	0.00694444444444
STN	stomatogastric nerve	0.0138888888889
STN	subthalamic nuclei	0.00694444444444
STO	subthreshold membrane oscillation	1.0
STH	subthalamic nucleus	1.0
STI	1stress-inducible protein	0.5
STI	1stress inducible protein 1	0.5
STK	serine/threonine kinase	0.333333333333
STK	25serine/threonine kinase 25	0.333333333333
STK	serine threonine kinases	0.333333333333
STT	somatostatin	0.0714285714286
STT	spinothalamic tract	0.785714285714
STT	spino-thalamic tract	0.0714285714286
STT	spinal trigeminal tract	0.0714285714286
sH	spssmall heat shock proteins	1.0
STP	superior temporal polysensory area	0.0512820512821
STP	asuperior temporal polysensory area	0.025641025641
STP	short-term potentiation	0.769230769231
STP	short-term plasticity	0.025641025641
STP	short-term synaptic plasticity	0.025641025641
STP	superior temporal plane	0.025641025641
STP	aanterior superior temporal polysensory area	0.025641025641
STP	simultaneous temporal processing	0.025641025641
STP	short-term probe trial	0.025641025641
STR	striatum	0.611111111111
STR	ventral striatum	0.0555555555556
STR	chronic stress	0.0555555555556
STR	short tandem repeats	0.0555555555556
STR	strychnine	0.0555555555556
STR	the ipsilateral striatum	0.0555555555556
STR	dorsal striatum	0.111111111111
STS	sit-to-stand	0.166666666667
STS	staurosporine	0.208333333333
STS	superior temporal sulcus	0.583333333333
STS	steroid-sulfatase	0.0416666666667
AcYVAD-cmk	acetyl-tyr-val-ala-asp-chloromethylketone	1.0
STX	syntaxin	0.5
STX	or st8siaiisialyltransferase-x	0.25
STX	saxitoxin	0.25
iR-VC	ipsilateral rostral vestibulocerebellar group	1.0
STZ	streptozotocin (n-[methlynitrosocarbamoyl]-d-glucosamine)	0.0192307692308
STZ	streptozotocine	0.0192307692308
STZ	streptozotocin	0.961538461538
GnRH	gonadotrophin-releasing hormone	0.133333333333
GnRH	gonadotropin releasing hormone	0.133333333333
GnRH	gonadotropin hormone releasing hormone	0.0666666666667
GnRH	gonadotropin-releasing hormone	0.666666666667
TFM	transfer function magnitude	0.5
TFM	terpene free material	0.5
TFL	tensor fascia latae	0.0625
TFL	tensor fasciae latae	0.125
TFL	tail-flick latency	0.4375
TFL	tail flick latencies	0.0625
TFL	tail flick latency	0.3125
FGF-5	fibroblast growth factor-5	1.0
FGF-4	fibroblast growth factor-4	1.0
TFI	transient forebrain ischemia	0.5
TFI	transillumination fluorescence imaging	0.5
FGF-2	fibroblast growth factor type-2	0.0714285714286
FGF-2	fibroblast growth factor-2	0.428571428571
FGF-2	basic fibroblast growth factor-2	0.0714285714286
FGF-2	basic fibroblast growth factor	0.428571428571
nnAC	hrsneuronal nicotinic acetylcholine receptors	1.0
TFD	time–frequency distribution	1.0
Fos-IR	c-fos-immunoreactivity	0.25
Fos-IR	fos-immunoreactive	0.5
Fos-IR	fos immunoreactive, immunoreactivity	0.25
NCS	neuronal calcium sensor protein	0.0555555555556
NCS	neuronal calcium sensors	0.0555555555556
NCS	normal (physiological) saline	0.0555555555556
NCS	normal crayfish saline	0.111111111111
NCS	newborn calf serum	0.0555555555556
NCS	nerve conduction study	0.0555555555556
NCS	normal crayfish solution	0.111111111111
NCS	neuronal calcium-sensor protein	0.0555555555556
NCS	neuronal calcium sensor	0.333333333333
NCS	normal calf serum	0.0555555555556
NCS	norcoclaurine synthase	0.0555555555556
TFA	trans fatty acid	0.0588235294118
TFA	trifluoroacetic acid	0.882352941176
TFA	trans fatty acids	0.0588235294118
NCV	nerve conduction velocity	1.0
TFB	2mmitochondrial transcription factors b2	0.5
TFB	time to the first burst	0.5
NCI	neurogenic cutaneous inflammation	0.5
NCI	negative chemical ionization	0.5
NCL	neostriatum caudolaterale	0.2
NCL	nidopallium caudolaterale	0.4
NCL	neuronal ceroid lipofuscinosis	0.4
NCM	caudal medial nidopallium	0.2
NCM	caudo-medial neostriatum	0.2
NCM	neurons culture medium	0.2
NCM	neuron-conditioned medium	0.4
TβRI	transforming growth factor-β receptor i	1.0
cpt-cAMP	8-(4-chlorophenylthio)-cyclic-amp	1.0
TFT	tail-flick test	1.0
NCC	neural crest cell	1.0
LPOA	lateral preoptic area	1.0
NCE	non-contact erection	0.2
NCE	noncontact erection	0.4
NCE	sodium/calcium exchange	0.2
NCE	non-contact penile erection	0.2
NCF	neutrophil cytosolic factor	1.0
BW284c51	1,5-bis(4-allyldimethylammoniumphenyl)-pentan-3-one dibromide	0.5
BW284c51	1:5-bis(4-allydimethylammoniumphenyl)-pentan-3-one-dibromide	0.5
LID	liver igf-1 deficient	0.0714285714286
LID	l-dopa-induced dyskinesias	0.142857142857
LID	levodopa-induced dyskinesias	0.0714285714286
LID	sl-dopa-induced dyskinesias	0.0714285714286
LID	local inflammation of the drg	0.0714285714286
LID	levodopa-induced dyskinesia	0.142857142857
LID	l-dopa-induced dyskinesia	0.357142857143
LID	localized inflammation of the dorsal root ganglia	0.0714285714286
NEN	orth-east	1.0
LIF	(r), leukemia inhibitory factor (receptor)	0.0208333333333
LIF	leukemia inhibitory factor	0.895833333333
LIF	leukaemia inhibitory factor	0.0625
LIF	leukemia inhibiting factor	0.0208333333333
LM	stratum lacunosum-moleculare	0.0434782608696
LM	lateral mammillary nucleus	0.0434782608696
LM	littermates	0.0217391304348
LM	lateral magnocellular	0.0217391304348
LM	light microsscopy	0.0217391304348
LM	light microscopic	0.0217391304348
LM	lacunosus-molecularis	0.0217391304348
LM	light membrane	0.0434782608696
LM	olacunosum moleculare layer	0.0217391304348
LM	light microscope or microscopy	0.0217391304348
LM	/radstratum lacunosum-moleculare/radiatum	0.0217391304348
LM	olstratum lacunosum moleculare	0.0434782608696
LM	lateromedial part of v2l (see below)	0.0217391304348
LM	lacunosum-moleculare	0.0217391304348
LM	luminance cue	0.0217391304348
LM	nucleus lentiformis mesencephali	0.0434782608696
LM	light microscope	0.0434782608696
LM	slinear motifs	0.0217391304348
LM	lentiformis mesencephali	0.0217391304348
LM	light microscopy	0.391304347826
LM	lateromedial part of the visual extrastriate cortex	0.0217391304348
LM	lateral mammillary	0.0217391304348
LM	laryngeal motoneuron	0.0217391304348
torA	torsina	1.0
LIA	large-amplitude irregular activity	1.0
ACB	nucleus accumbens	1.0
mMU	male mouse urine	1.0
MAO-B	monoamine oxidase-b	0.181818181818
MAO-B	monoamine oxidase b	0.727272727273
MAO-B	monoamine oxidase type b	0.0909090909091
MAO-A	monoamine oxidase-a	0.166666666667
MAO-A	monoamine oxidase type a	0.333333333333
MAO-A	monoamine oxidase a	0.333333333333
MAO-A	monoamine-oxidase a	0.166666666667
FNZ	flunitrazepam	1.0
KA-	1kainate receptor subunit 1	1.0
cyclo-dA8	5′-cyclo-2′-deoxyadenosine	1.0
TPPII	tripeptidyl peptidase ii	1.0
LIP	vventral subdivision of lip	0.111111111111
LIP	lateral intraparietal	0.333333333333
LIP	lateral intraparietal area	0.333333333333
LIP	lateral intra-parietal cortex	0.111111111111
LIP	lateral intraparietal sulcus	0.111111111111
FNB	follicular (neural) network b	1.0
LIR	-like immunoreactive	0.333333333333
LIR	like-immunoreactive	0.666666666667
LIS	1	0.333333333333
LIS	1lissencephaly	0.333333333333
LIS	lisinopril	0.333333333333
SPGNs	sympathetic postganglionic neurons	1.0
t-HODE	total hydroxyoctadecadienoic acid	1.0
ApoE	apolipoprotein e (gene and protein)	0.0666666666667
ApoE	apolipoprotein e	0.933333333333
NEH	non-excitotoxic hypoxia	1.0
SarMetSP	[sar9,met(o2)11]-substance p	1.0
NS1026	7,8,9-tetrahydro-5-nitro-1 h-benz[g]indole-2,3-dione-3-oxime	1.0
DR-LW	lateral wings of dorsal raphe	1.0
ACD	age-related cognitive decline	0.25
ACD	asymmetric cell division	0.25
ACD	actinomycin d	0.25
ACD	abductor caudae dorsalis muscle	0.25
BLpc	parvicellular part of bl nucleus	1.0
GABARA	6gaba (a) receptor (α6 subunit)	1.0
IAUCUCI	nternational animal care and use committee	1.0
NEG	negative staining response	1.0
DLHd	l-homocysteic acid	1.0
IKCa	ca2+-dependent k+ current	1.0
KAc	potassium acetate	1.0
anti-AD	drugs	1.0
RIPAR	adio immunoprecipitation assay	1.0
NK1-R	neurokinin 1 receptor	1.0
L-TRY	l-tryptophan	1.0
NEC	non-epileptic control	0.333333333333
NEC	neuroepithelial cells	0.333333333333
NEC	sneuroepithelial cells	0.333333333333
ZnEDTA	ethylenediaminetetraacetic acid saturated with equimolar zn2+	1.0
BASE	baseline	1.0
BASB	ioanalytical systems	0.666666666667
BASB	ehavioral activation system	0.333333333333
MFSM	iller fisher syndrome	1.0
ODN-MM	oligodeoxynucleotide mismatch	1.0
NEA	sn-acylethanolamines	1.0
SCHSCH-	23390	1.0
RHY	rhythmic pattern	1.0
IDOindoleamine-2	3-dioxygenase	1.0
FAST	selected mouse line sensitive to ethanol stimulation	0.5
FAST	epileptogenic prone	0.5
PLC-γ1	phospholipase c-γ1	1.0
KAE	kaempferol	1.0
KAK	ainic acid	0.5
KAK	ainate	0.5
LI-	like immunoreactivity	0.75
LI-	like immunoreactive	0.25
RHS	right hand side	0.5
RHS	right-hand side	0.5
Trolox	((+/-)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)	1.0
RHT	retino-hypothalamic	0.0416666666667
RHT	retinohypothalamic tract	0.875
RHT	retino-hypothalamic tract	0.0416666666667
RHT	roll head tilt	0.0416666666667
RHI	rubber hand illusion	1.0
KAR	skainate-type glutamate receptors	0.0909090909091
KAR	skainate receptors	0.0909090909091
KAR	kainate receptor	0.727272727273
KAR	kainate-type glutamate receptor	0.0909090909091
LX	slipoxins	0.5
LX	slipoxin	0.5
WISW	istar	0.666666666667
WISW	eizmann institute of science	0.333333333333
KAT	kynurenine aminotransferase	1.0
cGDPR	cyclic gdp-ribose	1.0
RHC	right hindlimb contact	1.0
KAX	ketaset, acepromazine and xylazine	1.0
RHG	01rho gtp-ase activating protein 1	1.0
RHF	right hemifield	1.0
ABET	arecaidine but-2-ynyl ester tosylate	1.0
ACU	1-adamantyl-3-cyclohexylurea	1.0
cytC	cytochrome c	1.0
CLIO	cross-linked iron oxide	1.0
PEAP	place escape/avoidance paradigm	1.0
HFA	shuman fetal astrocytes	0.5
HFA	high-functioning autism	0.5
3R6R	3 or 6 days of rehydration following 9 days of dehydration	1.0
P2Y	metabotropic purinoceptor	1.0
P2X	purine 2x (receptor)	1.0
LTS-	interneurons	1.0
NEU	norepinephrine uptake transporter	0.333333333333
NEU	neutral	0.666666666667
5TG	5-thioglucose	1.0
CAMKIIC	a2+/calmodulin-dependent protein kinase ii	1.0
ANGPT-	1angiopoietin 1	1.0
SCI-IDSSCI	induced immune depression syndrome	1.0
HFE	flurothyl	0.5
HFE	high-fat emulsion	0.5
iSP	immunoreactive substance p	0.5
iSP	ipsilateral silent period	0.5
hERG	human ether-à-go-go related gene potassium channel	1.0
dl-AP-	5dl-2-amino-5-phosphonopentanoic acid	1.0
OX2	orexin type 2	1.0
OX-	42complement receptor type 3	0.25
OX-	6antibody against the mhc ii receptor	0.125
OX-	42	0.5
OX-	6	0.125
iSO	inner stratum oriens	1.0
DMNV	the dorsal motor nucleus of the vagus nerve	0.222222222222
DMNV	dorsal motor nucleus of the vagus	0.555555555556
DMNV	dorsal motor nucleus of the vagus nerve	0.111111111111
DMNV	dorsal motor nucleus of vagus	0.111111111111
tDCS	)	0.0769230769231
tDCS	confabulations	0.0769230769231
tDCS	transcranial direct current stimulation	0.769230769231
tDCS	time reproductionsuprasecond intervalsposterior parietal cortextemporal accuracytemporal variability	0.0769230769231
CNP3	ser-phe-phe-thr-thr-val-asn-gly-asn-his-tyr-pro-arg-ile-nh2	1.0
CNP2	asp-tyr-pro-arg-leu-nh2	1.0
WEAVER	word-form encoding by activation and verification	1.0
DMNX	dorsal motor nucleus of the vagus	0.714285714286
DMNX	dorsal motor nucleus of the vagus nerve	0.285714285714
E-LD	excitatory-long duration response	1.0
CNP4	gly-val-phe-thr-gln-gly-ala-his-gly-ser-tyr-pro-arg-val-nh2	1.0
GABA-TGABA-	aminotransferase	1.0
CNTL	controls	1.0
OXY	oxytocin	1.0
mPRF	medial pontine reticular formation	1.0
OXT	oxytocin	1.0
TBNTT	ris buffer (5 nm) containing 0.01% triton x-100 and 0.3% nacl	1.0
LTSA	long-term saccade adaptation	1.0
OXR	orexin receptor	0.333333333333
OXR	2orexin receptor 2	0.333333333333
OXR	1orexin receptor type 1	0.333333333333
OXO	oxotremorine	1.0
dl-APV	dl-2-amino-5-phosphonovalerate	0.111111111111
dl-APV	dl-2-amino-5-phosphonopentanoic acid	0.222222222222
dl-APV	dl-2-amino-5-phosphonoovaleric acid	0.111111111111
dl-APV	dl-2-amino-5-phosphonovaleric acid	0.333333333333
dl-APV	(±)-2-amino-5-phosphonopentanoic acid	0.111111111111
dl-APV	(±)-d,l-2-amino-5-phosphonopentanoic acid	0.111111111111
ICMS	intracortical microstimulation	1.0
TH-ir	th-immunoreactive	0.25
TH-ir	tyrosine hydroxylase-immunoreactive	0.25
TH-ir	tyrosine hydroxylase immunoreactive	0.5
OXA	orexin a	1.0
OXB	orexin b	1.0
Ammon	sector 1	1.0
2qVK	analogue. it is a modification of analogue 2j with addition of a chlorine at the meta position of the added benzene ring	1.0
-MOP	(ser375)a phosphoselective antibody directed against a single phosphorylated residue within mu opioid peptide receptor	1.0
VSAL	valine-serine-alanine-leucine	1.0
CZP	capsazepine	1.0
ACd	dorsal anterior cingulate cortex	0.5
ACd	anterior cingulate cortex	0.5
600H	z	1.0
L4	lumbar segment 4	0.333333333333
L4	fourth lumbar segment	0.333333333333
L4	fourth lumbar	0.333333333333
hdc-ACSF	high divalent cation artificial cerebrospinal fluid	1.0
RESSR	esidual estimated sum of squares	1.0
iSAT	inter-spontaneous activity transient	1.0
-MOE	2′-o-(methyl) ethyl	1.0
PEA-	15phosphoprotein enriched in astrocytes of 15 kda	0.75
PEA-	15	0.25
dATPαS	2′-deoxy 5′-o-(1-thio) atp	1.0
GTP-N	a+guanosine 5'-triphosphate sodium	1.0
ICMs	innervated continuously contracting human muscle fibres	1.0
DBL-KO	double-knockout	1.0
DC	diabetics rats receiving normal regimen	0.02
DC	dorsocaudal	0.02
DC	dorsal-cap	0.02
DC	dendritic cell	0.02
DC	dorsocentral	0.02
DC	drug-treated non-stressed control	0.02
DC	data recorder	0.02
DC	sdorsal columns	0.02
DC	monodansyl-cadaverine	0.02
DC	sdendritic cells	0.02
DC	potential	0.02
DC	dark compartment	0.02
DC	direct current	0.3
DC	ydendrite cytoplasm	0.02
DC	mean firing rate minus the spontaneous discharge	0.02
DC	xdoublecortin	0.04
DC	dorsal cortex of the inferior colliculus	0.04
DC	shift	0.02
DC	dorsal cap	0.02
DC	dorsal column	0.16
DC	dorsal cochlear nu	0.02
DC	dorsal cochlear nucleus	0.06
DC	dispersion coefficient	0.02
DC	dendritic cells	0.04
CZD	chlordiazepoxide	1.0
CZE	capillary zone electrophoresis	1.0
ATF	3activation transcription factor 3	0.0285714285714
ATF	3activating transcript factor 3	0.0285714285714
ATF	3activating transcriptional factor 3	0.0285714285714
ATF	6activating transcription factor-6	0.0285714285714
ATF	3-iractivating transcription factor 3–like immunoreactivity	0.0285714285714
ATF	4activating transcription factor 4	0.114285714286
ATF	sactivating transcription factors	0.0285714285714
ATF	3	0.0285714285714
ATF	6activating transcription factor 6	0.114285714286
ATF	activating transcription factors	0.0285714285714
ATF	3activating transcription factor 3	0.257142857143
ATF	activating transcription factor	0.228571428571
ATF	2activating transcription factor 2	0.0571428571429
GYKI	1-(4-aminophenyl)-4-methyl-7,8-methylene-dioxy-5h-2,3-benzodiazepine	1.0
ATD	acute tryptophan depletion	0.333333333333
ATD	amino terminal domain	0.166666666667
ATD	aromatase inhibitor	0.166666666667
ATD	1,4,6-androstatriene-3,17-dione	0.333333333333
l-trans-PDCl-trans-pyrollidine-2	4-dicarboxylic acid	1.0
GKAP	guanylate-kinase-associated protein	0.5
GKAP	guanylate kinase-associated protein	0.5
ATA	aurintricarboxylic acid	0.333333333333
ATA	atm absolute	0.0833333333333
ATA	absolute atmosphere	0.0833333333333
ATA	ng type	0.0833333333333
ATA	atmosphere absolute	0.166666666667
ATA	atmospheres absolute	0.166666666667
ATA	auritricarboxylic acid	0.0833333333333
ATN	anterior thalamic lesion	0.142857142857
ATN	anterior thalamic nuclei	0.857142857143
ATL	anterior temporal lobe	0.333333333333
ATL	aspirin-triggered lipoxin a4	0.333333333333
ATL	aspirin-triggered-15-epi-lipoxin a4	0.333333333333
ATM	ataxia–telangiectasia mutated	0.333333333333
ATM	average atmospheric pressure	0.333333333333
ATM	ataxia telangiectasia mutated	0.333333333333
SOCS-3	suppressor of cytokine signaling-3	1.0
ATI	atipamezole	1.0
EMF	electric and magnetic field	0.166666666667
EMF	electromagnetic field	0.5
EMF	selectromagnetic fields	0.166666666667
EMF	electromagnetic fields	0.166666666667
ATR	atropine	0.5
ATR	angiotensin ii receptor	0.5
ATS	amphetamine-type psychostimulants	0.5
ATS	amphetamine-type stimulants	0.5
ATP	bioluminescence	0.0333333333333
ATP	p2x receptors	0.0166666666667
ATP	adenosine-5′-triphosphate	0.0333333333333
ATP	αβ-methylene atp	0.0166666666667
ATP	]obulk concentration of atp resulting from atp release	0.0166666666667
ATP	receptor	0.05
ATP	aseadenosine triphosphatase	0.0166666666667
ATP	]oextracellular atp	0.0166666666667
ATP	and p2 receptors	0.0166666666667
ATP	asena+–k+-atpase	0.0166666666667
ATP	depletion	0.0166666666667
ATP	production	0.0166666666667
ATP	adenosine 5′-triphosphate	0.183333333333
ATP	adenosintriphosphate	0.0166666666667
ATP	metabolism	0.0166666666667
ATP	6v1bv-type proton atpase subunit b	0.0166666666667
ATP	]iintracellular atp concentration	0.0166666666667
ATP	adenosine triphosphate	0.333333333333
ATP	ase	0.0333333333333
ATP	adenosine tri-phosphate	0.0166666666667
ATP	adenosine-5’-triphosphate	0.0166666666667
ATP	level	0.0166666666667
ATP	synthase	0.0166666666667
ATP	release	0.0333333333333
ATP	adenosine 5′ triphosphate	0.0166666666667
CPT-II	carnitine-palmitoyl-transferase-ii	1.0
SCI-GBP	spinal cord injured animal receiving gabapentin	1.0
sAβ	42β- and γ-cleaved soluble aβ42	1.0
GluTs	glumate transporters	1.0
ATX	autotaxin	0.5
ATX	autaxin	0.5
SPIRO	spironolactone	1.0
DAEE	trans-2-decenoic acid ethyl ester	1.0
PETCO	2partial pressure of end-tidal carbon dioxide	0.5
PETCO	2end-tidal carbon dioxide partial pressures	0.5
IBA	1ionized calcium-binding adaptor molecule	0.166666666667
IBA	ionized calcium binding adaptor molecule 1	0.166666666667
IBA	1ionized calcium bindingadaptor molecule-1	0.166666666667
IBA	1ionized calcium binding adaptor molecule 1	0.166666666667
IBA	1ionized calcium-binding adapter molecule 1	0.166666666667
IBA	1ionised calcium binding adaptor molecule-1	0.166666666667
ATh	anterior thalamus	1.0
EMM	endogenous morphine metabolites	1.0
HYPO	hypothalamus	1.0
GABAA-PSCGABAA	receptor-mediated postsynaptic current	1.0
HYPH	hypophysis	1.0
IBA-	1ionized calcium binding adaptor molecule 1	0.25
IBA-	1ionized calcium binding adapter molecule 1	0.5
IBA-	1ionized calcium-binding adapter molecule-1	0.25
VLWM	ventrolateral white matter	1.0
SYN-IR	synaptophysin-immunoreactive	1.0
NT-IR	neurotensin immunoreactive	1.0
PNX	phoenixin-14 amide	1.0
NPAA	sn-pro-ala	1.0
PETH	peri-event-time histogram	0.125
PETH	peri-event time histogram	0.625
PETH	speri-event time histograms	0.125
PETH	peri-event time histograms	0.125
CARP	12carrageenan-inject at postnatal day 12	1.0
BKS	.db/db mice	1.0
IBAT	interscapular brown adipose tissue	1.0
NPAF	neuropeptide af	1.0
LNAA	large neutral amino acid	0.666666666667
LNAA	slarge neutral amino acids	0.333333333333
CFM	contextual fear memory	0.333333333333
CFM	conventional fluorescence microscope	0.333333333333
CFM	carbon-fibre microelectrode	0.333333333333
LRPLDL	r-related protein	0.5
LRPLDL	receptor-related protein	0.5
GFXGF-	109203x	1.0
CARM	1co-activator associated arginine methyltransferase 1	1.0
CARB	carbachol	1.0
NPAS	2	0.333333333333
NPAS	2neuronal pas domain protein 2	0.666666666667
NPAR	(-)-propylnorapomorphine	1.0
CARD	caspase-activating recruitment domain	0.333333333333
CARD	caspase-activating and recruitment domain	0.333333333333
CARD	catalysed reporter deposition	0.333333333333
cvISI	coefficient of variation interspike interval	1.0
PBS-CMF	phosphate-buffered saline, calcium and magnesium free	1.0
PGF2α	prostaglandin f2α	1.0
AT-	2angiotensin ii type 2 receptor	0.333333333333
AT-	1bangiotensin ii receptor subtype 1b	0.333333333333
AT-	1aangiotensin ii receptor subtype 1a	0.333333333333
KRBG	krebs'–ringer–bicarbonate supplemented with glucose	1.0
L-GABA	ergic neuronslarge gabaergic neurons	1.0
4-methyl-1H-1	2,3-triazol-1-yl)methyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate	1.0
FSSF	unctional source separation	1.0
p90RSK	p90 ribosomal s6 kinase	1.0
AT2	angiotensin type-2 receptor	0.5
AT2	angiotensin receptor subtype 2	0.5
A-V-cAVauditory	visual and congruent audiovisual stimuli	1.0
AT1	angiotensin ii type 1 receptor	0.333333333333
AT1	angiotensin ii type 1 receptors	0.333333333333
AT1	angiotensintype-1 receptor	0.333333333333
AHNp	posterior part of the ahn	1.0
8-OHDPAT	8-hydroxy dipropylaminotetralin	0.166666666667
8-OHDPAT	8-hydroxy-2-(di-n-propylamino)-tetralin	0.166666666667
8-OHDPAT	8-hydroxy-2-(di-n-propyl-amino)	0.166666666667
8-OHDPAT	8-hydroxy-2-(di-n-proplamino) tetralin hydrochloride	0.166666666667
8-OHDPAT	8-hydroxydipropylaminotetralin hydrobromide	0.166666666667
8-OHDPAT	8-hydroxy-2-(di-n-propylamino)-tetralin hydrobromide	0.166666666667
CFD	cumulative frequency distribution	1.0
CTDC-	terminal tail domain	0.333333333333
CTDC-	terminal domain	0.666666666667
ARTMA	rtimin	1.0
R-B	acr-baclofen	1.0
l-NAMEN-N	itro-l-arginine methyl ester hydrochloride	1.0
PPDyn	preprodynorphin	1.0
EcR	ecdysone receptor	1.0
PNV	parasympathetic nucleus of the vagus nerve	1.0
R-L	rostral–lateral	1.0
NF-IL	6nuclear factor il6	1.0
HBSS-	2hanks' balanced salt solution without ca2+ and mg2+	1.0
NCCN	a+-cl- cotransporter	1.0
CESD	center for epidemiologic studies depression scale	1.0
RetGC	retinal gc	1.0
TN-R	tenascin-r	1.0
NCCE	non-capacitative ca2+ entry	1.0
NANC	nonadrenergic noncholinergic	0.166666666667
NANC	non-adrenergic non-cholinergic	0.5
NANC	non-adrenergic, non-cholinergic	0.166666666667
NANC	relaxation	0.166666666667
Ecl	chloride equilibrium potential	1.0
BDHC	benzidine dihydrochloride	1.0
EMX	1drosophila homeobox gene empty spiracles (ems) mouse homolog	1.0
SJR	striatal jaw region	1.0
MAPK-K	mitogen-activated protein kinase-kinase	1.0
DBC-PD	evelopmental behavior checklist – parent version	1.0
TN-C	tenascin-c	1.0
hrBDNF	human recombinant bdnf	1.0
rmANOVA	repeated measures anovas	0.2
rmANOVA	repeated measures analysis of variance	0.6
rmANOVA	repeated measures of analysis of variance	0.2
PGRMC	1progesterone receptor membrane component 1	1.0
CGP-56	999a3-([1-(r)-(3-carboxyphenyl)ethylamino]2-(s)-hydroxy-propyl)-cyclohexyl-methyl-phosphinic acid (lithium salt)	1.0
UCP-	1uncoupling protein-1	1.0
TCDT	ranscranial doppler	1.0
A1-2	noradrenergic cell groups	1.0
NEEP	21neuronal enriched endosomal protein of 21 kda	1.0
Carboxy-PTIO	2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide	1.0
LEW-HYR	congenital hydrocephalic rats	1.0
p-WOX	1tyrosine 33-phosphorylated wox1	1.0
ZM241385	4-(2-[7-amino-2-(2-furyl)[1,2,4]-triazolo-[2,3-a]	0.333333333333
ZM241385	4-(2-[7-amino-2-{2-furyl}{1,2,4}triazolo{2,3-a} {1,3,5}triazin-5-yl-amino]ethyl)phenol	0.333333333333
ZM241385	4-(2-[7-amino-2-[2-furyl][1,2,4]	0.333333333333
86R	b+ efflux	1.0
R-715	aclys[d-βnal7,ile8]des-arg9-bradykinin	1.0
PDPD	158780 generic erbb receptors inhibitor	0.5
PDPD	149163	0.5
EDTA	ethylene diaminetetra-acetic acid	0.00074794315632
EDTA	ethylene diamino tetra acetic acid	0.00074794315632
EDTA	ethylene-diaminetetra-acetate	0.00149588631264
EDTA	ethylenediaminetetracetic acid	0.00224382946896
EDTA	ethylenediaminetetraacetic acide	0.00074794315632
EDTA	ethylenediaminetetraacetic	0.00074794315632
EDTA	ethylenediaminotetra-acetate	0.00149588631264
EDTA	ethylenediamine-tetraacetate	0.00074794315632
EDTA	ethylenediamine-tetra acetic acid	0.00074794315632
EDTA	ethylenediamine tetra acetic acid	0.00299177262528
EDTA	ethylenediaminetetra-acetic acid disodium salt	0.00074794315632
EDTA	ethylenediaminetetraacidic acid	0.00074794315632
EDTA	sodium ethylenediamine tetraacetate	0.00074794315632
EDTA	ethylenediaminetraacetic acid	0.00074794315632
EDTA	ethylenediamine-tetraacetate)	0.00074794315632
EDTA	ethylediaminetetra-acetate	0.00074794315632
EDTA	ethylene-diamine tetraacetic acid	0.00074794315632
EDTA	ethylene glycol-bis(2-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00074794315632
EDTA	ethylenediaminetetraacehic acid	0.00074794315632
EDTA	ethylenediaminetetraacetic acid	0.332834704562
EDTA	ethylene diaminotetraacetic acid	0.00074794315632
EDTA	ethylenediamine tetra-acedic acid	0.00074794315632
EDTA	ethylenediazminetetra acetic acid	0.00074794315632
EDTA	diaminoethanetetra acetic acid disodium salt	0.00074794315632
EDTA	ethylenediamine tetraacetic acid disodium	0.00149588631264
EDTA	ethylenediamine tetra-acetic acid	0.00299177262528
EDTA	ethylene glycol tetraacetic acid	0.00074794315632
EDTA	ethylenediamine tetraacetic acid	0.0321615557218
EDTA	ethylenediaminotetraacetic acid	0.00149588631264
EDTA	ethylenediaminetetraacetic acid disodium salt dihydrate	0.00074794315632
EDTA	ethylenediaminetetraacetic acid diacylglycerol	0.00074794315632
EDTA	diethylene-dinitrilo-tetraacetic acid	0.00074794315632
EDTA	ethylenediamine-tetraacetic acid	0.00448765893792
EDTA	ethylenediaminetetraacetate	0.0172026925954
EDTA	ethylendiaminetetraacetic acid	0.00299177262528
EDTA	ethylene-diamine-tetraacetate	0.00074794315632
EDTA	ethylene-diaminetetra- acetate	0.00074794315632
EDTA	ethylenediaminetetra acetate	0.00074794315632
EDTA	ethylenediamine tetra acetate	0.00074794315632
EDTA	ethylenediaminetetra-acetic acid	0.00673148840688
EDTA	ethylenediaminetetra acetic acid	0.00074794315632
EDTA	ethylenediamminetetraacetate	0.00299177262528
EDTA	edetic acid	0.00149588631264
EDTA	ethylene diamine tetraacetate	0.00149588631264
EDTA	ethylene diaminetetra-acetate	0.0037397157816
EDTA	ethylene diamine tetra acetate	0.00074794315632
EDTA	disodium ethylenediaminetetra-acetate. 2h2o	0.00074794315632
EDTA	ph 7.4	0.00074794315632
EDTA	ethylendiaminetetraacetate	0.00074794315632
EDTA	ethylene diamine tetraacetic acid	0.0142109199701
EDTA	ethylene diamine tetra acetic acid	0.00224382946896
EDTA	edtaethylenediaminetetraacetic acid	0.00074794315632
EDTA	na2disodium ethylenediaminetetraacetic acid	0.00074794315632
EDTA	ethylenediamine tetraacetate	0.0037397157816
EDTA	disodium ethylenediaminetetra-acetate	0.00074794315632
EDTA	ethylenediaminetetra-acetate	0.507853403141
EDTA	ethylenediamine tetra-acetate	0.00598354525056
EDTA	ethylene-diaminetetraacetate	0.00149588631264
EDTA	ethylene-diamine-tetraacetic acid	0.00448765893792
EDTA	ethylenediaminetetra acetic acid disodium salt	0.00074794315632
EDTA	ethylendiaminetetraacetic-acid	0.00074794315632
EDTA	ethylene diaminetetraacetic acid	0.00149588631264
EDTA	(ethylenedinitrilo)tetraacetic acid	0.00074794315632
EDTA	ethyelenediaminetetra-acetate	0.00074794315632
EDTA	ethylene diamine tetra-acetic acid	0.0037397157816
EDTA	ethylene-diaminetetra-acetic acid	0.00074794315632
EDTA	ethylendiaminetetra-acetate	0.00448765893792
PBT-X	phosphate buffer with triton-x 10	0.333333333333
PBT-X	phosphate buffer with triton x-100	0.666666666667
LMNF	large myelinated nerve fibers	1.0
NK2R	neurokinin-2 receptor	1.0
PTKS	rc-family protein tyrosine kinase	1.0
OPIDN	organophosphorus-induced delayed neuropathy	1.0
LDE	low-dose ethanol	0.5
LDE	light-dark emergence test	0.5
VTMN	ventral tuberomammillary nucleus	1.0
KG-buffer	potassium glutamate buffer	1.0
AICDAβPP	intracellular c-terminal domain fragment	1.0
tPDC	l-trans-pyrrolidine-2,4-dicarboxylic acid	1.0
SCNXSCN-	lesioned animals	1.0
CFS	cerebrospinal fluid	0.166666666667
CFS	chronic fatigue syndrome	0.5
CFS	classical fast spiking	0.166666666667
CFS	cytofluorimetric scanning	0.166666666667
Rpa	raphe pallidus	1.0
IVIG	intravenous immunoglobulin	0.666666666667
IVIG	i.v. immunoglobulin	0.333333333333
PNG	peripheral nerve graft	0.166666666667
PNG	ase fpeptide: n-glycosidase f	0.166666666667
PNG	ase-fpeptide n-glycosidase-f	0.166666666667
PNG	ase fpeptide:n-glycosidase f	0.166666666667
PNG	ase fpeptide-n-glycosidase f	0.166666666667
PNG	ase fpeptide n-glycanase f	0.166666666667
DTDS2	2′-dithienyl diselenide	1.0
TASKTWIK-	related acid sensing k+	0.166666666667
TASKTWIK-	related acid-sensitive potassium channel	0.166666666667
TASKTWIK-	related acid-sensitive k+ channels	0.333333333333
TASKTWIK-	related acid-sensitive k+ channel	0.333333333333
PaS	parasubiculum	1.0
POMA	paraneoplastic opsoclonus-myoclonus ataxia	1.0
CGI-	94comparative gene identification-94	1.0
PDPK	proline-directed ser/thr protein kinases	0.333333333333
PDPK	proline-directed protein kinase	0.666666666667
FKBP12	fk506 binding protein mol. wt 12,000	0.5
FKBP12	fk506-binding protein, 12kda	0.5
NTFN-	terminal fragment	1.0
CREBCA	constitutively active form of creb	1.0
riMLF	rostral interstitial nucleus of medial longitudinal fasciculus	1.0
n-BNI	norbinaltorphimine	0.5
n-BNI	nor-binaltorphimine	0.5
SBFIN	a+-binding benzofuran isophthalate	1.0
MGpd	posterodorsal medial geniculate nucleus	1.0
PB-GPB	0.1 m containing 0.2% gelatin	1.0
AgaIVA	ω-agatoxin iva	1.0
APMA	p-aminophenylmercuric acetate	1.0
PBST-R	phosphate-buffered saline containing triton x-100 and normal rabbit serum	1.0
uNOS	universal nitric oxide synthase	1.0
DNA-PK	csdna-protein kinase catalytic subunit	1.0
bAP	sbackpropagating action potentials	1.0
OFOF	1	1.0
17α-Eα-	estradiol	1.0
vMWM	virtual version of the morris water maze	1.0
PDD	phorbol-12,13-didecanoate	0.5
PDD	pervasive developmental disorder	0.5
488H	trans(±)-3,4-dichloro-n-methtyl-n-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide	1.0
MARCKS	myristoylated alanine-rich protein kinase c	0.0769230769231
MARCKS	myrisoylated alanine-rich c kinase substrate	0.0769230769231
MARCKS	myristolated alanine-rich c-kinase substrate	0.0769230769231
MARCKS	myristoylated alanine-rich c-kinase substrate	0.230769230769
MARCKS	myristoylated alanine-rich c kinase substrate	0.538461538462
FPRL	1formyl-peptid-receptor-like 1	1.0
SRIF-LI	somatostatin-like immunoreactivity	1.0
PETP	ositron emission tomography	1.0
U-69	593(+)-(5α,7α,8β)-n-methyl-n-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]	1.0
esMEP	seffector-specific motor evoked potentials scores	1.0
PC12-TrkB	pc12 cell-derived line	1.0
GABAARGABA	a receptor	0.1
GABAARGABA	receptor type a	0.3
GABAARGABA	type a receptor	0.5
GABAARGABA	receptor of type a	0.1
XII	hypoglossal motor neurons	0.0333333333333
XII	cranial nerve xii (hypoglossal nerve)	0.0333333333333
XII	nthe hypoglossal nerve roots	0.0333333333333
XII	tracheosyringeal part	0.0333333333333
XII	hypoglossal nerve	0.0333333333333
XII	hypoglossal nucleus	0.466666666667
XII	hypoglossal	0.233333333333
XII	hypoglossus	0.0333333333333
XII	pharyngeal	0.0333333333333
XII	hypoglossal motor nucleus	0.0666666666667
U-cell	unidentified cell	1.0
3-NP	3-nitro propionic acid	0.0416666666667
3-NP	3-nitropropionate	0.0416666666667
3-NP	3-nitroproprionic acid	0.125
3-NP	3-nitropropionic acid	0.791666666667
AG-879	3,5-di-tert-butyl-4-hydroxybenzyl-isodenecyanthioacetamide	1.0
WTC	57bl6 wild type/background mouse strain	1.0
MEF	mouse embryonic fibroblast	0.384615384615
MEF	2myocyte enhancer transcription factor 2	0.0769230769231
MEF	embryonic fibroblasts	0.0769230769231
MEF	smovement evoked fields	0.0769230769231
MEF	2myocyte enhancer factor 2	0.230769230769
MEF	mouse embryonic fibroblasts	0.0769230769231
MEF	mouse embryo fibroblast cells	0.0769230769231
KCNMB	1	0.5
KCNMB	2	0.5
GDT	gap detection task	0.5
GDT	gap detection threshold	0.5
Cy3	cyanine dye 3	0.0769230769231
Cy3	carboxymethylindocyanine	0.153846153846
Cy3	indocarbocyanin	0.230769230769
Cy3	indocarbocyanine	0.153846153846
Cy3	carboxyl-indocyanine	0.0769230769231
Cy3	cyanine 3	0.153846153846
Cy3	cyanine 3.18	0.153846153846
Cy2	carbocyanin	0.5
Cy2	cyanine 2.18	0.25
Cy2	cyanine 2	0.25
MEC	medial division of the ec	0.0769230769231
MEC	mecamylamine	0.384615384615
MEC	medial entorhinal cortex	0.538461538462
Cy5	cyanine 5.18	0.375
Cy5	indodicarbocyanine 5	0.125
Cy5	cyanine-5.18	0.25
Cy5	cyanine 5	0.125
Cy5	cyanine dye 5	0.125
PRt	perireticular nucleus	1.0
LSDL	east significance difference	1.0
SPES	single pulse electrical stimulation	0.5
SPES	olid phase extraction	0.5
CGIC	pg islands	1.0
5-HIAA	5-hydroxy-indoleacetic acid	0.00763358778626
5-HIAA	5-hydroxyindoleatic acid	0.0152671755725
5-HIAA	5-hyroxyindole acetic acid	0.00763358778626
5-HIAA	5-hydroxyindoleacetic acid	0.671755725191
5-HIAA	5-hydroxyindolacetic acid	0.106870229008
5-HIAA	5-hydroxyindole-3-acetic acid	0.0534351145038
5-HIAA	5 hydroxyindoleacetic acid	0.00763358778626
5-HIAA	5-hydroxyindole-acetic acid	0.00763358778626
5-HIAA	5-hydroxy indolacetic acid	0.00763358778626
5-HIAA	5-hydroxy indole acetic acid	0.00763358778626
5-HIAA	5-hydroxyundoleactic acid	0.00763358778626
5-HIAA	5-hydroxyinolacetic acid	0.00763358778626
5-HIAA	5-hydroxyindole acetic acid	0.0916030534351
GDX	gonadectomy/gonadectomized	0.0555555555556
GDX	+tgonadectomized rats that received testosterone replacement treatment	0.0555555555556
GDX	castrated	0.0555555555556
GDX	+ttestosterone-treated castrated male	0.0555555555556
GDX	gonadectomized	0.555555555556
GDX	gonadectomy	0.222222222222
VSMCs	vascular smooth muscle cells	1.0
nAChR	nicotinic acetylcholine receptor	0.857142857143
nAChR	nicotinic acetylcholine	0.0357142857143
nAChR	nicotinic–acetylcholine receptor	0.0357142857143
nAChR	nicotinic cholinergic receptor	0.0357142857143
nAChR	nicotinic aceylcholine receptor	0.0357142857143
F-CSA	fiber cross-sectional area	1.0
-hydroperoxyeicosa-5Z	8z, 10e, 14z-tetraenoic acid	1.0
3-NY	3-nitrotyrosine	1.0
2-Me-S-ATP	2-methyl-thio-atp	1.0
TH-IMF	tyrosine hydroxylase-immunofluorescent	1.0
CEm	central nucleus, medial division	1.0
AAAH	aromatic amino acid hydroxylase	1.0
calcein-AM	calcein-acetoxymethyl ester	1.0
ACHs	auto-correlation histograms	1.0
IPACL	lateral division of the interstitial nucleus of the posterior limb of the anterior commissure	0.333333333333
IPACL	interstitial nucleus of the posterior limb of the anterior commissure lateral division	0.333333333333
IPACL	interstitial nucleus of the posterior limb of the anterior commissure	0.333333333333
DAXX	fas death domain-associated protein	1.0
TUNELTDT-	mediated dutp-biotin nick end-labeling technique	1.0
fNR	1floxed n-methyl-d-aspartate receptor i subunit	1.0
POMe	nucleus preopticus medianus	1.0
lCBF	local cerebral blood flow	1.0
Restructuring-strength	‘learning index’ of rf restructuring	1.0
NEAT	non-exercise activity thermogenesis	1.0
NLSN-	lauroylsarcosine	0.666666666667
NLSN-	laoroylsarcosine	0.333333333333
N-acetyltransferase	camp, cyclic amp	1.0
EBAE	vans-blue albumin	0.5
EBAE	vans blue albumin	0.5
sTNF	soluble tumor necrosis factor-alpha	1.0
BDAAAH-D	biopterin-dependent aromatic amino acid hydroxylase domain	1.0
NFOG-Q	new fog questionnaire	1.0
vlPFC	ventrolateral prefrontal cortex	0.333333333333
vlPFC	ventral lateral prefrontal cortex	0.333333333333
vlPFC	ventrolateral pfc	0.333333333333
OGBO	regon green bapta am	1.0
VGL	ventral glial limitans	1.0
MAP1A	microtubule-associated protein 1a	1.0
MAP1B	microtubule-associated protein 1b	1.0
GDF	5growth/differentiation factor five	0.333333333333
GDF	growth differentiating factors	0.333333333333
GDF	growth/differentiation factor	0.333333333333
fFGS	female flank gland secretion	1.0
Ndc	neostriatum dorsocaudale	1.0
PRG	putative rhythm generating	1.0
VGB	vigabatrin	1.0
VGC	vestibular ganglion cell	1.0
VGX	vagotomized	0.5
VGX	vagotomy	0.5
t-MCAO	transient mcao	1.0
VGT	vesicular gaba transporter	1.0
VGV	an gehuchten	1.0
DNEB	dorsal norepinephrine bundle	1.0
SuVN	superior vestibular nucleus	1.0
OGB-	1oregon green bapta-1	0.2
OGB-	1oregon green 488 bapta-1	0.8
ONPG	ortho-nitrophenyl-beta-d-galactopyranoside	1.0
HBMEC	human brain microvascular endothelial cell line	0.5
HBMEC	shuman brain microvascular endothelial cells	0.5
db-cAMP	n6,2′-o-dibutyryladenosine-3′5′-cyclic monophosphate, sodium salt	0.5
db-cAMP	dibutyryl adenosine 3′,5′-cyclic monophosphate	0.5
PMLS	posterior medial lateral suprasylvian area	0.0714285714286
PMLS	posteromedial suprasylvian sulcus	0.142857142857
PMLS	posterior medial lateral suprasylvian sulcas	0.0714285714286
PMLS	areapostero-medial lateral suprasylvian area	0.0714285714286
PMLS	posteromedial lateral suprasylvian	0.142857142857
PMLS	posteromedial lateral suprasylvian area	0.214285714286
PMLS	posteromedial lateral suprasylvian cortex	0.214285714286
PMLS	postero–medial lateral suprasylvian	0.0714285714286
LY354740	(+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid	0.333333333333
LY354740	(1s,2s,5r,6s)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid	0.333333333333
LY354740	(+)-1s,2s,5r,6s-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid	0.333333333333
CIDSCNS	injury-induced immunodepression	0.5
CIDSCNS	injury-induced immunodepression syndrome	0.5
PSVP	renatal stress+vehicle	1.0
PDGF-BB	platelet-derived growth factor-bb	0.333333333333
PDGF-BB	platelet-derived growth factor	0.666666666667
TβOA	threo-beta-benzyl-oxy-aspartate	1.0
MPEP	6-methyl-2-(phenylethynyl)pyridine	0.0789473684211
MPEP	2-methyl-6-(phenylethynyl)pyridine	0.184210526316
MPEP	2-methyl-6-(phenylethynyl) pyridine hydrochloride	0.0263157894737
MPEP	2-methyl-6-phenylethynyl-pyridine	0.0526315789474
MPEP	6-methyl-2-(phenylethynyl)-pyridine	0.105263157895
MPEP	2-methyl-6-(phenylethynyl)pyridine hydrochloride	0.289473684211
MPEP	2-methyl-6-(phenyl-ethynyl)pyridine	0.0263157894737
MPEP	6-methyl-2-(phenylethynyl) pyridine hydrochloride	0.0263157894737
MPEP	6-methyl-2-(phenylethyl)pyridine	0.0263157894737
MPEP	2-methyl-6-(phenylethynyl)-pyridine	0.0789473684211
MPEP	methyl-phenyl-ethynylpyridine	0.0263157894737
MPEP	2-methyl-6-(phenylethylnyl)-pyridine	0.0263157894737
MPEP	methyl-6-(phenylethynyl)pyridine	0.0263157894737
MPEP	6-methyl-2-(phenyl-ethynyl)pyridine	0.0263157894737
DR-VRP	ventral root potential evoked by dorsal root stimulation	0.5
DR-VRP	dorsal root–ventral root potential	0.5
MON	monocular	1.0
OGG17	8-dihydro-8-oxoguanine dna glycosylase	1.0
p-Aktphospho-Akt	p–gsk-3β, phospho–gsk-3β	1.0
CCKL	cholecystokinin large	1.0
FSC	fetal spinal cord	0.25
FSC	forward scattering	0.25
FSC	forward scatter	0.5
MUS-HI	high dose of muscimol	1.0
FSH	follicular stimulating hormone	0.166666666667
FSH	follicle stimulating hormone	0.5
FSH	follicle-stimulating hormone	0.333333333333
FSI	fast-spiking interneuron	0.4
FSI	fast-spiking interneurons	0.2
FSI	firing-induced suppression of inhibition	0.2
FSI	freezer storage interval	0.2
UMNF	unmyelinated nerve fibers	1.0
FSK	forskolin	1.0
FSL	first spike latency	0.6
FSL	flinders sensitive line	0.2
FSL	rats	0.2
DCFH	2′,7′-dichlorodihydrofluorescein	0.2
DCFH	2′,7′-dichlorofluorescein	0.2
DCFH	2-da2', 7'-dichlorodihydrofluorescein diacetate	0.2
DCFH	dichlorofluorescein	0.2
DCFH	nonfluorescent di-chlorofluorescein	0.2
NPFF-R	2neuropeptide ff receptor 2	1.0
FSR	free-standing rears	0.6
FSR	feasible stability region	0.4
FSS	forced swimming stress	0.666666666667
FSS	1hand primary sensory cortex functional source	0.333333333333
FST	force swim test	0.0138888888889
FST	force swimming test	0.0138888888889
FST	forced-swim test	0.0416666666667
FST	forced swim test	0.597222222222
FST	fundus of the superior temporal sulcus	0.0138888888889
FST	fundus of superior temporal sulcus	0.0277777777778
FST	fasted group	0.0277777777778
FST	forced swim tests	0.0138888888889
FST	the forced swim test	0.0138888888889
FST	forced swimming test	0.236111111111
nAchR	nicotinic acetylcholine receptor	1.0
NHS-Nanogold	n-hydroxy-succinimido-nanogold	1.0
NCC1	na-cl cotransporter 1	1.0
NOR-AN	[nphe1]nociceptin(1–13)nh2	1.0
tcASW	tissue culture artificial salt water	0.666666666667
tcASW	tissue culture artificial seawater	0.333333333333
DMSOD	imethyl sulfoxide	0.666666666667
DMSOD	imethylsulfoxide	0.333333333333
SGPT	serum glutamate pyruvate transaminase	1.0
AX-CPTAX	version of continuous performance task	1.0
SNLL	5/l6 spinal nerve ligation	1.0
GDNFR1	gdnf receptor alpha precursor	1.0
T2WI	t2-weighted image	1.0
MTII	melanotan ii	1.0
RELN	reelin	1.0
GAT-1	gaba transporter 1	1.0
GSK-3	glycogen synthase kinase-3	1.0
MT-PTP	mitochondrial permeability transition pore	1.0
GM-CSFG	ranulocyte-macrophage colony-stimulating factor	0.333333333333
GM-CSFG	ranulocyte–macrophage colony-stimulating factor	0.666666666667
EASEE	xpression analysis systematic explorer	1.0
PbTx-3	brevetoxin-3	1.0
GTP-CH	guanosine triphosphate cyclohydrolase	1.0
158N	murine oligodendrocytes	1.0
WESTW	omen’s estrogen for stroke	1.0
LIR-	like immunoreactivity	1.0
ZTZ	eitgeber time	1.0
Lvm	ventromedial subdivision of the lateral amygdalar nucleus	0.666666666667
Lvm	ventromedial subdivision of the lateral nucleus	0.333333333333
Lvl	ventrolateral subdivision of the lateral nucleus	1.0
C-INSL	7c-peptide of human preproinsulin-like peptide 7	1.0
CCKA	cholecystokinin type a receptor	0.5
CCKA	receptors	0.5
GF109203X	2-[1-(3-dimethylaminopropyl)indol-3-yl]-3-(indol-3-yl)maleimide	0.5
GF109203X	2[1-(3-dimethylaminopropyl)-1h-indol-3-yl]-maleimide	0.5
MOVD	iscrete movements	1.0
RUN	voluntary running activity	0.5
RUN	running	0.5
LUHMES	cellslund university human nesencephalon cells	1.0
EAAT	sexcitatory amino-acid transporters	0.015873015873
EAAT	2excitatory amino acid transporter 2	0.047619047619
EAAT	excitatory amino acid transporters	0.0793650793651
EAAT	3excitatory amino acid transporter 3	0.015873015873
EAAT	excitatory amino acid transporter or glutamate transporter	0.015873015873
EAAT	2excitatory amino acid transporter-2	0.015873015873
EAAT	sexcitatory aminoacid transporters	0.015873015873
EAAT	glutamate transporter	0.015873015873
EAAT	excitatory amino-acid transporter	0.047619047619
EAAT	excitatory amino acid transporter (=glutamate transporter)	0.031746031746
EAAT	excitatory amino acid transporter	0.444444444444
EAAT	3	0.047619047619
EAAT	2	0.031746031746
EAAT	sexcitatory amino acid transporters	0.0793650793651
EAAT	2excitatory amino acid transporter 2 (protein name)	0.015873015873
EAAT	excitatory amino acids transporter	0.015873015873
EAAT	1excitatory amino acid transporter 1	0.015873015873
EAAT	1excitatory amino acid transporter	0.015873015873
EAAT	1/glastexcitatory amino acid transporter 1	0.015873015873
EAAT	3glutamate transporter type 3	0.015873015873
ALIC	anterior limb of the internal capsule	1.0
VEGF-B	vascular endothelial growth factor b	1.0
GSNOS-	nitrosoglutathione	1.0
β-MEβ-	mercaptoethanol	1.0
DPFC	dorsolateral prefrontal cortex	1.0
INSFp	interstitial nucleus of the superior fasciculus, posterior fibres	1.0
FBSF	etal bovine serum	1.0
DCF2	7-dichlorofluorescein	1.0
DiI1NM-PP1	1-amino-1-tert-butyl-3-(1’-napthylmethyl)pyrazolo[3,4-d]pyramindine	1.0
anti-NGF	antiserum against nerve growth factor	0.5
anti-NGF	treatment	0.5
HCRT-	irhcrt immunoreactive	1.0
DIO	diet-induced obese or diet-induced obesity	0.166666666667
DIO	diet-induced obese	0.5
DIO	diet-induced obesity	0.333333333333
DII	scale	0.5
DII	iodothyronine deiodinase type ii	0.5
DID	drinking in the dark	0.666666666667
DID	drinking-in-the-dark	0.333333333333
DIE	dorsal intermediate entorhinal field	1.0
DIF	differential responses	0.333333333333
DIF	differential interference contrast	0.333333333333
DIF	double immunofluorescent	0.333333333333
DIG	digoxigenin-11-utp	0.010101010101
DIG	anterior digastric muscle	0.020202020202
DIG	digoxygenin	0.0606060606061
DIG	digoxigenin	0.909090909091
INSL	3insulin-like peptide 3	0.666666666667
INSL	7insulin-like peptide 7	0.333333333333
DIA	differential in-gel analysis	1.0
DIB	days in block	1.0
DIC	days in culture	0.102040816327
DIC	dynein intermediate chain	0.0204081632653
DIC	dorsal cortex of the inferior colliculus	0.0204081632653
DIC	odifferential interference contrast	0.0204081632653
DIC	differential interference contrast	0.632653061224
DIC	differential-interference contrast	0.0204081632653
DIC	difference interference contrast	0.0204081632653
DIC	diffrential interference contrast	0.0204081632653
DIC	differential interference-contrast optics	0.0204081632653
DIC	differential interference	0.0204081632653
DIC	differential interference-contrast	0.102040816327
4-NQO	4-nitroquinoline-1-oxide	1.0
HBMHEPES	buffer medium	1.0
dmCP	medio dorsal caudate-putamen	1.0
RECR	igid eyes closed condition	1.0
LC-MS	/msliquid chromatography/tandem mass spectrometry	0.1
LC-MS	/msliquid chromatography-tandem mass spectrometry	0.2
LC-MS	/ms	0.1
LC-MS	liquid chromatography–tandem mass spectrometric	0.1
LC-MS	liquid chromatography–mass spectrometry	0.1
LC-MS	/msliquid chromatography tandem mass spectrometry	0.2
LC-MS	liquid chromatography mass spectrometer	0.1
LC-MS	/msliquid chromatography with tandem mass spectrometry	0.1
DIV	77 days in vitro	0.00380228136882
DIV	3day 3 in vitro	0.00380228136882
DIV	day in vitro	0.0988593155894
DIV	days in vivo	0.00380228136882
DIV	day(s) in vitro	0.0494296577947
DIV	days in vitro culture	0.00380228136882
DIV	on day in vitro	0.00380228136882
DIV	day/days in vitro	0.00760456273764
DIV	days in vitro	0.825095057034
S-4C-3HPG	s-4-carboxy-3-hydroxyphenylglycine	1.0
DIP	drebrin-immunopositive	0.2
DIP	distal–interphalangeal	0.2
DIP	nucleus dorsointermedius posterior thalami	0.2
DIP	distal-interphalangeal	0.2
DIP	dorsal intraparietal	0.2
STNBS	toned b protein	1.0
DIR	double inversion recovery	0.5
DIR	dopamine inhibition reversal	0.5
DNPHD	initrophenylhidrazine	1.0
nNOS-	/-neuronal nitric oxide synthase deficient	0.5
nNOS-	/-neuronal nitric oxide synthase gene deletion	0.5
MRSM	agnetic resonance spectroscopy	1.0
tTS	tetracyline-controlled transcriptional suppressor	1.0
rGC	rostral gustatory cortex	0.5
rGC	rostral part of the gustatory cortex	0.5
tACPD1-Aminocyclopentane-trans-1	3-dicarboxylic acid	1.0
rGH	rat growth hormone	1.0
AGI	anogenital investigation	0.5
AGI	ano-genital investigation	0.5
PCNA	proliferating cell nuclear antigen	0.924528301887
PCNA	proliferating-cells-nuclear-antigen	0.0188679245283
PCNA	proliferating cellular nuclear antigen	0.0188679245283
PCNA	proliferating control nuclear antigen	0.0188679245283
PCNA	proliferating-cell nuclear antigen	0.0188679245283
UTC	untouched control	1.0
IRZ	intermediate reticular zone	1.0
GABAARα1	α1 subunit of the gabaa receptor	1.0
VPDV	isual pattern discrimination	1.0
OEAN-	oleoylethanolamide	1.0
IRP	ipsilateral referred pain	0.25
IRP	immediately releasing pool	0.25
IRP	1iron regulatory protein 1	0.5
pre-AH	i/tonepretraining ahi lesion/auditory fear conditioning	1.0
IRS	p53insulin receptor tyrosine kinase substrate p53	0.166666666667
IRS	insulin receptor substrate	0.666666666667
IRS	1insulin receptor substrate 1	0.166666666667
IRT	interresponse time	0.25
IRT	intermediate reticular nucleus	0.5
IRT	intermediate reticular formation	0.25
mtDNA	mitochondrial deoxyribonucleotidyl nucleic acid	0.0555555555556
mtDNA	mitochondrial dna	0.888888888889
mtDNA	mitochondrial deoxyribonucleic acid	0.0555555555556
UTR	untranslated region	0.857142857143
UTR	untranslated regions	0.0285714285714
UTR	5′ untranslated region	0.0285714285714
UTR	s3′-untranslated regions	0.0285714285714
UTR	suntranslated regions	0.0285714285714
UTR	3′ untranslated region	0.0285714285714
IRI	interpersonal reactivity index	0.2
IRI	ischemia reperfusion injury	0.2
IRI	inter-response interval	0.2
IRI	mmunoreactive	0.2
IRI	ischemia–reperfusion injury	0.2
UTP	uridine 5′-triphosphate	0.378378378378
UTP	uridine-triphosphate	0.027027027027
UTP	uridine triphosphate	0.432432432432
UTP	uridine s-triphosphate	0.027027027027
UTP	uridine 5′ triphosphate	0.0540540540541
UTP	uracil triphosphate	0.0540540540541
UTP	uridine-5′-triphosphate	0.027027027027
IRK	inward rectifying k+ channel	1.0
MRR	maximum rate of rise	1.0
IRA	ideomotor response activation	1.0
IRC	immunoreactive cells	0.5
IRC	sictal respiratory changes	0.5
IRE	/irpiron-responsive element/iron-regulatory protein	0.0625
IRE	iron-responsive element	0.125
IRE	inositol requiring	0.0625
IRE	/irpiron-responsive element/iron regulatory protein	0.0625
IRE	1ainositol-requiring protein 1α	0.0625
IRE	1inhibitor resistant esterase 1	0.0625
IRE	insulin responsive element	0.125
IRE	1inositol-requiring enzyme 1	0.1875
IRE	1-pphosphorylated inositol-requiring 1	0.0625
IRE	iron regulatory element	0.0625
IRE	1inositol requiring enzyme 1	0.0625
IRE	iron response element	0.0625
IRF	inferior reticular formation	0.25
IRF	7interferon regulatory factor 7	0.25
IRF	inhibitory receptive field	0.5
HDL-	chigh density lipoprotein cholesterol	1.0
PWT	spaw withdrawal thresholds	0.0606060606061
PWT	paw withdrawal threshold	0.787878787879
PWT	paw-withdrawal threshold	0.0909090909091
PWT	paw withdrawal thresholds	0.030303030303
PWT	paw withdrawal mechanical threshold	0.030303030303
PWR	paw withdrawal responses	0.5
PWR	paw withdrawal response	0.5
ELP-C	extra lever-presses in completed trials	1.0
RZR	retinoic acid receptor-related orphan receptor	1.0
DNPH2	4-dinitrophenylhydrazone	0.0555555555556
DNPH2	4-dinitropenylhydrazine	0.0555555555556
DNPH2	4-dinitrophenyl hydrazine	0.0555555555556
DNPH2	4-dinitrophenylhydrazine	0.833333333333
WY	14643	1.0
IRt	intermediate reticular zone	0.5
IRt	intermediate subdivision of reticular formation	0.5
nTMS	navigated transcranial magnetic stimulation	1.0
PWF	paw withdrawal frequency	1.0
PWD	paw-withdrawal duration	0.166666666667
PWD	paw withdrawal duration	0.833333333333
PWB	sprosodic word boundaries	1.0
TGF-α	transforming growth factor-α	0.857142857143
TGF-α	tumor growth factor-α	0.142857142857
TGF-β	transforming growth factor beta	0.1
TGF-β	1transforming growth factor-beta1	0.02
TGF-β	transforming growth factor β	0.1
TGF-β	transforming growth factor-beta	0.14
TGF-β	transforming growth factor-beta1	0.02
TGF-β	tumor growth factors beta	0.02
TGF-β	tumor growth factor-β	0.02
TGF-β	transforming growth factor-β	0.36
TGF-β	1transforming growth factor beta 1	0.04
TGF-β	1transforming-growth factor-β1	0.02
TGF-β	1transforming growth factor beta-1	0.02
TGF-β	transforming growth factor	0.02
TGF-β	1transforming growth factor-β1	0.12
CP-154526	butyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7h-pyrrolo[2,3-d] pyrimidin-4-yl]	1.0
PBNN-	tert-butyl-α-phenylnitrone	1.0
PWM	periventricular white matter	0.5
PWM	periependymal white matter	0.5
rMDD	remitted major depressive disorder	1.0
NAB	normal anxiety-related behavior	0.25
NAB	non-α/β cell	0.25
NAB	not alpha/beta (cell)	0.25
NAB	not alpha/beta (cells)	0.25
NAC	nucleus accumbens	0.75
NAC	nucleus accumbens core	0.05
NAC	sshell of the nucleus accumbens	0.0166666666667
NAC	nucleus accumbens septi	0.0166666666667
NAC	snucleus accumbens shell	0.0166666666667
NAC	onucleus accumbens core	0.0166666666667
NAC	1	0.0333333333333
NAC	non-β-amyloid component	0.0166666666667
NAC	n-acetyl cysteine	0.0166666666667
NAC	n-acetyl-cysteine	0.0166666666667
NAC	non-aβ component of ad amyloid	0.0166666666667
NAC	no acid-evoked current	0.0166666666667
NAC	1 mm n-acetyl-l-cysteine	0.0166666666667
HBO	hyperbaric oxygenation	0.125
HBO	hyperbaric oxygen	0.375
HBO	hyperbaric oxygen or hyperbaric oxygenation	0.125
HBO	2hyperbaric oxygen	0.375
NAA	n-acetylaspartate	0.625
NAA	n-acetyl-l-aspartate	0.125
NAA	neurofilament-associated antigen	0.125
NAA	neurofilament associated antigen	0.125
rmIL-	2recombinant mouse interleukin-2	1.0
Sevoflurane2	2,2-trifluoro-1-[trifluoromethyl]ethyl fluoromethyl ether	1.0
NAD	nicotinamide adenine dinucleotide	0.333333333333
NAD	(h), (reduced) nicotinamide adenine dinucleotide	0.0277777777778
NAD	+nicotinamide adenine dinucleotide	0.305555555556
NAD	(p)hnicotinamide adenine dinucleotide phosphate	0.0277777777778
NAD	+, oxidized nicotinamide-adenosine dinucleotide	0.0277777777778
NAD	+	0.0277777777778
NAD	(p)hnicotinamide adenine dinucleotide phosphate-oxidase	0.0277777777778
NAD	β-nicotinamide adenine dinucleotide	0.0277777777778
NAD	(h) means nad and nadh together	0.0277777777778
NAD	+, nicotinamide adenine dinucleotide	0.0555555555556
NAD	(a)number of axodendritic synaptic profiles in a unit area	0.0277777777778
NAD	(p)hnicotinamide adenine dinucleotide phosphate oxidase	0.0277777777778
NAD	+oxidized nicotinamide adenine dinucleotide	0.0277777777778
NAD	(a)number of axodendritic synapses per unit area of neuropil	0.0277777777778
ILG	intermediolateral grey matter	1.0
BOP	blast overpressure	1.0
HBD	hyaluronan binding domain	1.0
BOS	base of support	0.25
BOS	bird's own song	0.25
BOS	base-of-support	0.5
NAN	vehicle injection of 50% dmso	0.25
NAN	egative affect	0.25
NAN	naïve as neonates	0.25
NAN	eutravidin biotin binding protein	0.25
NAO	nonyl acridine orange	1.0
HBC	2-hydropropyl-β-cyclodextrin	0.166666666667
HBC	2-hydroxypropyl-beta-cyclodextrin	0.166666666667
HBC	2-hydroxypropyl-β-cyclodextrin	0.666666666667
NAM	nicotinamide	1.0
NAS	nucleus accumbens	0.235294117647
NAS	1-naphthyl acetyl-spermine	0.0588235294118
NAS	hnucleus accumbens shell	0.0588235294118
NAS	nucleus accumbens septi	0.352941176471
NAS	number of axosomatic synapses per unit length of somal profile	0.0588235294118
NAS	nucleus accumbens shell	0.176470588235
NAS	neuroactive steroid	0.0588235294118
NAP	noraminophenazone	1.0
ILE	isoleucine	1.0
APPAβ	(β-amyloid) precursor protein	0.333333333333
APPAβ	precursor protein	0.666666666667
NAT	n-acetyltransferase	0.222222222222
NAT	n-acetyl tryptophan	0.111111111111
NAT	snatural antisense transcripts	0.222222222222
NAT	nutrient amino acid transporter	0.111111111111
NAT	noradrenaline transporter	0.333333333333
NSFT	the novelty-suppressed feeding test	0.5
NSFT	novelty-suppressed feeding test	0.5
DTPA	diethylenetriaminepentaacetic acid	1.0
NE-LX	noradrenergically lesioned	1.0
SEMS	tandard error of mean	1.0
peri-LCα	peri-locus coeruleus α	0.5
peri-LCα	peri-locus coeruleus alpha	0.5
HBS	hepes-buffered saline	1.0
TRNs	somatic trn	1.0
NAc	nucleus accumbens	0.93023255814
NAc	nucleus accumbens core	0.046511627907
NAc	nucleus ambiguus, compact formation	0.0232558139535
SV-	40simian virus-40	1.0
CEl	central nucleus, lateral division	1.0
NAe	nucleus ambiguus, external formation	1.0
PPT1	3,5-tris (4-hydroxyphenyl)-4-propyl-1h-pyrazole	1.0
d-AP-	5d-(-)-2-amino-5-phosphonopentanoic acid	1.0
SGGLs	sulfoglucuronyl glycolipids	1.0
PPT4	4',4''-(4-propyl-[1h]-pyrazole-1,3,5-triyl)trisphenol	0.111111111111
PPT4	4′,4″-(4-propyl-(1h)-pyrazole-1,3,5-triyl) trisphenol	0.111111111111
PPT4	4,4,-(4-propil-[1h-pyrazole-1,3,5-triyl)tris-phenol	0.111111111111
PPT4	4′,4″-(4-propyl-[1h]-pyrazole-1,3,5-triyl)trisphenol	0.222222222222
PPT4	4′,4″-(4-propyl-[1h]-pyrazole-1,3,5-triyl)trisphenol (propyl-pyrazole-triol)	0.111111111111
PPT4	4′,4″-[4-propyl-(1h)-pyrazole-1,3,5-triyl]trisphenol	0.111111111111
PPT4	4′,4′-(4-propyl-[1h]-pyrazole-1,3,5-triyl)tris-phenol	0.111111111111
PPT4	4′,4″-(4-propyl-[1h]-pyrazole-1,3,5-triyl) trisphenol	0.111111111111
aL	acute light	1.0
NAs	nucleus accumbens shell	0.666666666667
NAs	nucleus ambiguus, semicompact formation	0.333333333333
d-AP5	d(-)-2-amino-5-phosphonovaleric acid	0.111111111111
d-AP5	d(-)-2-amino-5-phosphonopentanoic	0.111111111111
d-AP5	2-amino-5-phosphonopentanoate	0.111111111111
d-AP5	d-2-amino-5-phosphonopentanoic acid	0.111111111111
d-AP5	d-2-amino-5-phoshonovaleric acid	0.111111111111
d-AP5	d-2-amino-5-phosphonopentanoate	0.111111111111
d-AP5	d-aminophosphopentanoic acid	0.111111111111
d-AP5	d(-)-2-amino-5-phosphonopentanoic acid	0.111111111111
d-AP5	d(-)-amino-5-phosphonopentanoic acid	0.111111111111
vDB	medial septum/vertical limb of the diagonal band of broca	0.25
vDB	medial septum/vertical limb of the diagonal band	0.5
vDB	vertical limb of diagonal band	0.25
vDG	ventral dentate gyrus	0.5
vDG	dentate gyrus, ventral part	0.5
EM-1	endomorphin-1	1.0
dHIP	dorsal hippocampus	1.0
SV2	synaptic vesicle protein 2	1.0
Annotation	visualization, and integrated discovery	0.333333333333
Annotation	visualization and integrated discovery	0.666666666667
HPTLC	high performance thin layer chromatography	0.5
HPTLC	high-performance thin layer chromatography	0.5
6OHDA	6-hydroxydopamine	1.0
SVN	superior vestibular nucleus	1.0
SVM	support vector machine	0.666666666667
SVM	support vector machines	0.333333333333
NEIL	1endonuclease viii-like dna glycosylase	1.0
CDKN-	1acyclin-dependent kinase inhibitor 1a	1.0
SVH	subjective visual horizontal	1.0
LOWESS	locally weighted scatterplot smoothing	0.5
LOWESS	locally weighted regression and smoothing	0.5
SVF	stromal vascular fraction	1.0
SVG	simian virus 40 glial	1.0
SVD	singular value decomposition	1.0
SVC	small volume correction	0.4
SVC	subthreshold voltage-dependent cation	0.2
SVC	small-volume correction	0.4
SAFA	saturated fatty acids	1.0
lDS	lateral dorsal striatum	1.0
d-APV	d(-)-2-amino-5-phosphonovaleric acid	0.115384615385
d-APV	d-2-amino-5-phosphopentanoic acid	0.0384615384615
d-APV	d-amino-phosphonovalerate	0.0384615384615
d-APV	d(-)-2-amino-5-phosphono-pentanoic acid	0.0384615384615
d-APV	d-(-)-2-amino-5-phosphonovalerate	0.0384615384615
d-APV	d-(-)-2-amino-5-phosphonopentanoic acid	0.0769230769231
d-APV	d-2-amino-5-phosphonovalerate	0.153846153846
d-APV	d(-)-2-amino-5-phosphopentanoic acid	0.0384615384615
d-APV	d-2-amino-5-phosphonovaleric acid	0.269230769231
d-APV	d-(+)-2-amino-5-phosphonopentanoic acid	0.0384615384615
d-APV	2-d-l-aminophosphonovaleric acid	0.0384615384615
d-APV	d(-)-2-amino-5-phosphonopentanoic acid	0.0384615384615
d-APV	d-(-)-2-amino-5-phosphonovaleric acid	0.0384615384615
d-APV	d-2-amino-5-phosphovalerate	0.0384615384615
ALFFA	mplitude of low-frequency fluctuations	1.0
SVZ	subventricular zone of the lateral ventricle	0.00985221674877
SVZ	)	0.00492610837438
SVZ	subventricular zone	0.935960591133
SVZ	(a), subventricular zone (anterior)	0.00492610837438
SVZ	subventricular zones	0.00492610837438
SVZ	forebrain subventricular zone	0.00492610837438
SVZ	subventricularzone	0.00492610837438
SVZ	aanterior subventricular zone	0.00985221674877
SVZ	sub-ventricular zone	0.0197044334975
bFGFR	basic fibroblast growth factor receptor	1.0
MGMT	methylguanin-dna methyltransferase	1.0
SVV	subjective visual vertical	1.0
PPTA	preprotachykinin-a	0.166666666667
PPTA	preprotachykinin a	0.833333333333
PPTB	preprotachykinin b	1.0
ILI	interlick interval	0.25
ILI	nterleukin	0.5
ILI	psilateral	0.25
nNCBT	selectroneutral na+-coupled hco3- transporters	1.0
TENS	transcutaneous electrical nerve stimulation	0.75
TENS	transcutaneous electric nerve stimulation	0.25
SVP	seminal vesicle pressure	1.0
IDR-fastfast	delayed rectifier type potassium current	1.0
SNR1	sense phosphodiester oligodeoxynucleotide specific for nmdar1	1.0
fALFF	fractional amplitude of low-frequency fluctuation	0.333333333333
fALFF	fractional alff	0.666666666667
LDDMM	large deformation diffeomorphic metric mapping	1.0
hd-EEG	high-density electroencephalography	1.0
PEN	avdqdlgpevppenvlgallrv	1.0
6-Bromo-1	3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta[c]quinolin-8-yl]	0.5
6-Bromo-1	3-benzodioxol-5-yl)-3a,4,5,9b-3h-cyclopenta[c]quinoline	0.5
GXT	graded exercise test	1.0
THS19p	antiserum against th peptide phosphorylated at ser19	1.0
CPRNADPH-	cytochrome p450 reductase	1.0
l-AP-4	amino-4-phosphonobutyric acid	1.0
5αR-	25α-reductase type-2	1.0
LPIG	left posterior insular gyrus	1.0
PPTg	pedunculopontine tegmental nucleus	1.0
SOREMP	ssleep-onset rem sleep periods	0.5
SOREMP	sleep onset rem sleep	0.5
FLX	far lateral complex	0.285714285714
FLX	fluoxetine	0.714285714286
ddY	control mother strain	1.0
ILP	ipsilateral local pain	0.5
ILP	sinsulin-like peptides	0.5
MWUM	ann-whitney u	1.0
BAPTA-AM	bis-(o-aminophenoxy)-n,n,n′,n′-tetraacetic acid	0.0714285714286
BAPTA-AM	1,2 bis-(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid acetoxymethyl ester	0.0714285714286
BAPTA-AM	(2-aminophenoxi)ethane-n-n-n',n'-tetraacetic acid tetrakis(acetoxymethyl) ester	0.0714285714286
BAPTA-AM	membrane-permeable methyl ester derivative of bapta	0.0714285714286
BAPTA-AM	1,2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetra-acetic acid acetoxymethyl ester	0.214285714286
BAPTA-AM	1,2-bis(o-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid tetra(acetoxymethyl)ester	0.0714285714286
BAPTA-AM	1,2-bis-(o-aminophenoxy)ethane-n,n,n′,n′-tetra-acetic acid tetra(acetoxymethyl)-ester	0.0714285714286
BAPTA-AM	bis-(-o-aminophenoxy)-ethane-n,n,n,n,-tetraacetic acid acetoxymethyl	0.0714285714286
BAPTA-AM	1,2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetracetic acid–acetoxymethyl ester	0.0714285714286
BAPTA-AM	1,2-bis-(2-aminophenoxy)ethane-tetra-acetic acid acetoxymethyl ester	0.0714285714286
BAPTA-AM	1,2-bis-(2-aminophenoxy)ethane-n,n,n′,n′-tetra-acetate acetoxymethyl ester	0.0714285714286
BAPTA-AM	1,2-bis(o-aminophenoxy)-ethane-n,n,n′,n′-tetraacetic acid tetrakis(acetoxymethyl ester)	0.0714285714286
FLS	forelimb somatosensory	1.0
FLASH	fast low-angle shot	1.0
FLU	flutamide	0.2
FLU	flutamide (4′nitro-3′-trifluoromethylsobutyranilide)	0.2
FLU	flumazenil	0.2
FLU	fluphenazine decanoate	0.2
FLU	fluoxetine	0.2
FLT	flight	0.75
FLT	spaceflight	0.25
rIL-2	recombinant hil-2	1.0
FLI	fos-like immunoreactivity	0.6
FLI	neuronfos-like immunoreactive neuron	0.1
FLI	c-fos-like immunoreactivity	0.1
FLI	c-fos-like immunoreactive or c-fos-like immunoreactivity	0.1
FLI	fos-like inmmunoreactivity	0.1
PED	periodic epileptiform discharge	0.5
PED	post-exercise depression	0.5
PDGF	platelet-derived growth factor ββ	0.0322580645161
PDGF	platelet derived growth factor-aa	0.0322580645161
PDGF	arplatelet derived growth factor alpha-receptor	0.0322580645161
PDGF	platelet derived growth factor	0.0322580645161
PDGF	platelet-derived growth factor	0.870967741935
FLM	fluorescent latex microspheres	0.5
FLM	forelimb motor	0.5
CLTC	(hc)clathrin heavy chain	1.0
i-NOS	inducible nitric oxide synthase	1.0
FLA	forelimb activity	0.5
FLA	flip angle	0.5
αBTX	alpha-bungarotoxin	1.0
GTP-γ	sguanosine 5′-o-(3-thiotriphosphate) tetralithium salt	1.0
ZIrm	zona incerta, rostromedial part	1.0
FLF	ield l	1.0
NK1R-LI	neurokinin-1 receptor-like immunoreactivity	1.0
ENK-	posdopamine d2 receptors	1.0
COL	9a1 cochlea	1.0
seqREMS	sequential rapid eye movement sleep	1.0
ST-EST	stressed estradiol animal group	1.0
Vcpc	ventralis caudalis parvocellularis	1.0
Ce-AMY	central amygdala	1.0
HBHAH	anks' balanced salt solution	1.0
αBTx	[125i]	1.0
DRP-	2dihydropyrimidinase-related protein-2	0.5
DRP-	2dihydropyrimidinase-like protein 2	0.5
GAL-LI	galanin-like immunoreactivity	1.0
mAChR-IR	muscarinic acetylcholine receptor-immunoreactive	1.0
DIPY	dipyridamole	1.0
d-AA	d-arginine	1.0
KCa	calcium activated potassium channel	0.333333333333
KCa	ca2+-activated k+ channels	0.333333333333
KCa	large-conductance, ca2+-activated potassium currents	0.333333333333
MALDI-IMS	matrix assisted laser desorption/ionization-imaging mass spectrometry	1.0
KCl	potassium chloride	1.0
JIP	c-jun n-terminal kinase interacting protein	1.0
acH	4acetylated histone 4	1.0
mBDNF	mature brain-derived neurotrophic factor	0.333333333333
mBDNF	mature bdnf	0.666666666667
NMDG	+n-methyl-d-glucamine	0.153846153846
NMDG	n-methyl-d-glucamine	0.461538461538
NMDG	n-methyl d-glucamine	0.0769230769231
NMDG	+, n-methyl-d-glucamine	0.307692307692
C-γ	1	1.0
d-AP	5d-amino-5-phosphonovanolenic acid	0.030303030303
d-AP	5d-(-)-2-amino phosphonopentanoic acid	0.030303030303
d-AP	5d-2-amino-5-phosphonopropanoate	0.030303030303
d-AP	5d(-)-2-amino-5-phospho-pentanoic acid	0.030303030303
d-AP	5	0.030303030303
d-AP	5d-(-)-2-amino-5-phosphonovaleric acid	0.030303030303
d-AP	5d-(-) 2-amino-5-phosphopentanoic acid	0.030303030303
d-AP	5d (-)-2-amino-5-phosphonovaleric acid	0.030303030303
d-AP	5d-(-)-2-amino-5-phosphonopentanoic acid	0.333333333333
d-AP	5d-(-)-2-amino-5-phosphonopentanoate	0.030303030303
d-AP	5d(-)-2-amino-5-phosphonopentanoic acid	0.0606060606061
d-AP	5d-2-amino-5-phosphonopentanoic acid	0.0606060606061
d-AP	7d(-)-2-amino-7-phosphono-heptanoic acid	0.0606060606061
d-AP	5d-2-amino-5-phosphonovaleric acid	0.0909090909091
d-AP	5d(-)-2-amino-5-phosphonovaleric acid	0.030303030303
d-AP	5d-2-amino-5-phosphonopentanoate	0.0606060606061
d-AP	5d-2-amino-5-phosphono-pentanoate	0.030303030303
NMDA	n-methyl- d-aspartate	0.00227272727273
NMDA	n-methyl-dl-aspartate	0.00113636363636
NMDA	receptor subunit	0.00113636363636
NMDA	and non-nmda receptors	0.00113636363636
NMDA	non-n-methyl d-aspartate	0.00113636363636
NMDA	n-methyl d-aspartate	0.00227272727273
NMDA	receptor	0.0829545454545
NMDA	n-methyl-d-aspartate	0.795454545455
NMDA	subtypes	0.00113636363636
NMDA	receptor activity	0.00113636363636
NMDA	receptor subunit 1	0.00113636363636
NMDA	n-methyl-d-asparatate	0.00113636363636
NMDA	receptor antagonist	0.00454545454545
NMDA	acide n-méthyl-d-aspartique	0.00113636363636
NMDA	rnmda receptors	0.00113636363636
NMDA	receptorn-methyl-d-aspartic acid receptor	0.00227272727273
NMDA	receptor subunits	0.00227272727273
NMDA	rn-methyl-d-aspartic acid receptor	0.00113636363636
NMDA	receptors	0.0420454545455
NMDA	receptor-independent ltp	0.00113636363636
NMDA	receptorsn-methyl-d-aspartate receptors	0.00113636363636
NMDA	n-methyl- d-asparatate	0.00113636363636
NMDA	rn-methyl-d-aspartate receptor	0.00568181818182
NMDA	n-methyl-d-aspartic acid	0.0227272727273
NMDA	glutamate n-methyl-d-aspartate	0.00113636363636
NMDA	rnmda-receptors	0.00113636363636
NMDA	lesion	0.00113636363636
NMDA	rn-methyl-d-aspartate receptors	0.00340909090909
NMDA	glutamatergic n-methyl-d-aspartic acid receptor	0.00113636363636
NMDA	neurofibrillary tangle	0.00113636363636
NMDA	neurotoxicity	0.00113636363636
NMDA	receptor phosphorylation	0.00113636363636
NMDA	antagonist	0.00113636363636
NMDA	receptor subunit composition	0.00113636363636
NMDA	glutamate receptor	0.00113636363636
NMDA	2b	0.00113636363636
NMDA	and ampa receptors	0.00113636363636
NMDA	receptorn-methyl-d-aspartate-type glutamate receptor	0.00113636363636
NMDA	n-methyl-d-asparate	0.00227272727273
NMDA	receptor antagonists	0.00113636363636
BFGF	basic fibroblast growth factor	1.0
hAβ	human amyloid β-peptide	1.0
PSA-NCAM-IR	polysialylated neural cell adhesion molecule immunoreactivity	1.0
MSHα-	melanocyte stimulating hormone	1.0
BFGN	basal forebrain gabaergic neuron	1.0
PI3-K	phosphatidylinositol 3-kinase	0.333333333333
PI3-K	phosphatidylinositol 3′-kinase	0.666666666667
mPFCX	medial prefrontal cortex	1.0
βT-IIIβ-	tubulin iii	1.0
KCA	potassium channel activator	1.0
KCC	2k+/cl- co-transporter	0.037037037037
KCC	2k+-cl- cotransporter	0.148148148148
KCC	2k+-cl--cotransporter	0.037037037037
KCC	potassium–chloride cotransporter	0.037037037037
KCC	2cation chloride cotransporter 2	0.037037037037
KCC	2potassium chloride co-transporter 2	0.0740740740741
KCC	2k+–cl- cotransporter	0.037037037037
KCC	2	0.0740740740741
KCC	2k+–cl- co-transporter 2	0.037037037037
KCC	2k+-cl- co-transporter	0.037037037037
KCC	2potassium-chloride co-transporter 2	0.037037037037
KCC	potassium chloride co-transporter	0.037037037037
KCC	1k+–cl- cotransporter 1	0.037037037037
KCC	2k-cl cotransporter 2	0.037037037037
KCC	2potassium chloride cotransporter-2	0.037037037037
KCC	2k+/cl- co-transporter 2	0.037037037037
KCC	2potassium/chloride co-transporter	0.037037037037
KCC	2k+–cl--cotransporter 2	0.037037037037
KCC	2potassium-chloride cotransporter 2	0.037037037037
KCC	potassium/chloride cotransporter	0.037037037037
KCC	2k+, cl--cotransporter 2	0.037037037037
KCC	2potassium–chloride cotransporter type 2	0.037037037037
Th12	12th thoracic vertebra	1.0
I-86	alternatively spliced embryonic gad67 mrna containing the 86 bp-long exon 7/b	1.0
KCO	potassium channel opener	1.0
KCN	potassium cyanide	0.857142857143
KCN	cyanide potassium	0.142857142857
MnTMPyP	mn(iii)-tetrakis-(1-methyl-4-pyridyl)-porphyrin pentachloride	1.0
PKAcα	protein kinase a α catalytic subunit	1.0
NIOMN	ofer institute of occupational medicine	1.0
eYFP	enhanced yellow fluorescent protein	1.0
QNTSQ	uebec newborn twin study	1.0
STZ-	ratsstreptozotocine-treated diabetic rats	1.0
CWMC	incinnati water maze	1.0
coifC	oiflet	1.0
Erev	reversal potential	1.0
RWD	acreward acquisition	1.0
CXCR	chemokine (c-x-c motif) receptor	0.111111111111
CXCR	2chemokine (c-x-c motif) receptor 2	0.111111111111
CXCR	7chemokine receptor type 7	0.111111111111
CXCR	4chemokine receptor 4	0.222222222222
CXCR	4cxc chemokine receptor 4	0.222222222222
CXCR	4	0.111111111111
CXCR	4alpha chemokine receptor 4	0.111111111111
KF17837	(e)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methyl-3,7-dihydro-1h-purine-2,6-dione	1.0
Na	areal density	0.5
Na	sodium	0.5
PERKRNA-	dependent protein kinase-like endoplasmic reticulum eukaryotic initiation factor 2α kinase	0.333333333333
PERKRNA-	dependent protein kinase-like endoplasmic reticulum-resident kinase	0.333333333333
PERKRNA-	dependent protein kinase-like endoplasmic reticulum kinase	0.333333333333
Nd	neostriatum dorsale	1.0
Nx	negative waves with peak latency of x ms	1.0
S-SKF	s(-)-skf-38393	1.0
FFR	frequency-following response	1.0
TpH	tryptophan hydroxylase	1.0
CXCL	chemokine (c-x-c motif) ligand	0.25
CXCL	12(c-x-c motif) ligand 12	0.25
CXCL	8cxc ligand 8	0.25
CXCL	12chemokine(c-x-c motif) ligand 12	0.25
Nt	n-terminus	1.0
GRGDSPG	ly-arg-gly-asp-ser-phe	1.0
Nv	numerical density (number per unit volume)	1.0
DARPPDA	and camp-regulated protein of 32 kda	1.0
NH	usnormal human serum	0.0526315789474
NH	non-handled control group	0.0526315789474
NH	4clammonium chloride	0.0526315789474
NH	normal-hearing	0.0526315789474
NH	normal hearing	0.0526315789474
NH	normal hamsters	0.0526315789474
NH	4acammonium acetate	0.0526315789474
NH	non-handling	0.0526315789474
NH	4cl	0.0526315789474
NH	2dad5′-amino-5′-deoxyadenosine	0.0526315789474
NH	normal housing	0.0526315789474
NH	neurohypophysis	0.157894736842
NH	/strnh with 1 h of restraint stress	0.0526315789474
NH	non-handled	0.105263157895
NH	nonhandled	0.0526315789474
NH	norharman (unsubstituted bc)	0.0526315789474
NI	dnucleus incertus dissipata	0.0666666666667
NI	nucleus isthmi	0.133333333333
NI	nucleus interpositus	0.0666666666667
NI	rnear infrared light	0.0666666666667
NI	naturally infected	0.0666666666667
NI	neural integrator	0.0666666666667
NI	intermediate nidopallium	0.0666666666667
NI	fnucleus interface	0.0666666666667
NI	neurogenic inflammation	0.0666666666667
NI	fthe nucleus interfacialis	0.0666666666667
NI	nucleus incertus	0.0666666666667
NI	nearness index	0.0666666666667
NI	fnucleus interfacialis	0.0666666666667
NI	fnucleus interface of the nidopallium	0.0666666666667
NK	1r+nk1 receptor (substance p receptor) expressing	0.0103092783505
NK	(s), neurokinin(s)	0.0103092783505
NK	1-r-irneurokinin-1 receptor immunoreactivity	0.0103092783505
NK	1 antagonists	0.0103092783505
NK	1neurokinin	0.0103092783505
NK	3nk3 subtype tachykinin receptor	0.0103092783505
NK	1-rneurokinin-1 receptor	0.0103092783505
NK	1 tachykinin receptor antagonist	0.0103092783505
NK	3neurokinin 3	0.0412371134021
NK	3neurokinin 3 receptor	0.020618556701
NK	1rneurokinin 1 receptor	0.123711340206
NK	1rneurokinin-1 receptor	0.0412371134021
NK	1rneurokinin1 receptors	0.0103092783505
NK	newman–keuls	0.0103092783505
NK	1 receptorneurokinin 1 receptor	0.020618556701
NK	1neurokinin-1	0.0515463917526
NK	neurokinin receptor	0.0103092783505
NK	3-rneurokinin 3 receptor	0.0103092783505
NK	natural killer	0.0618556701031
NK	1 receptor	0.020618556701
NK	1-/-mice knockout for nk1	0.0103092783505
NK	3rneurokinin 3 receptor	0.020618556701
NK	1neurokinin 1	0.113402061856
NK	3rneurokinin-3 receptor	0.0103092783505
NK	1neurokinin 1 receptor	0.0412371134021
NK	1 antagonist	0.0103092783505
NK	3rsneurokinin-3 receptors	0.0103092783505
NK	1neurokinin-1 receptor	0.0103092783505
NK	neurokinin	0.247422680412
NK	neuromedin k	0.020618556701
NL	nucleus lateralis	0.0909090909091
NL	nucleus limitans	0.0454545454545
NL	new location	0.0454545454545
NL	nucleus laminaris	0.454545454545
NL	n. laminaris	0.0454545454545
NL	neuroleptic	0.0454545454545
NL	2neuroligin 2	0.0454545454545
NL	no light	0.0454545454545
NL	neutral losses	0.0454545454545
NL	4neuroligin 4	0.0454545454545
NL	neuroligin	0.0909090909091
NM	number of movements	0.0333333333333
NM	normal myelination	0.0666666666667
NM	nicotine+meth	0.0333333333333
NM	neuromelanin	0.0333333333333
NM	n. magnocellularis	0.0333333333333
NM	nutrient medium	0.0333333333333
NM	cochlear nucleus magnocellularis	0.0333333333333
NM	nitrogen mustard	0.0333333333333
NM	groupnormal control group	0.0333333333333
NM	nictitating membrane	0.0666666666667
NM	normetanephrine	0.0333333333333
NM	(r)saln-methyl-(r)-salsolinol	0.0333333333333
NM	nucleus magnocellularis	0.5
NM	normal male	0.0333333333333
NN	naive controls (rats)	0.25
NN	acl	0.25
NN	nervi nervorum	0.25
NN	lan-nitro-l-arginine	0.25
NO	nitrogen monoxide	0.00214592274678
NO	*, nitric oxide	0.00214592274678
NO	⋅, nitric oxide	0.00214592274678
NO	xnitric oxide metabolite	0.00214592274678
NO	•nitric oxide	0.00214592274678
NO	noduli	0.00214592274678
NO	xnitrite/nitrate	0.00429184549356
NO	no odor	0.00214592274678
NO	nitrite oxide	0.00214592274678
NO	spermine/no adduct	0.00214592274678
NO	nitric oxide (no)	0.00214592274678
NO	xtotal nitric oxide products (sum of nitrite+nitrate)	0.00214592274678
NO	3-(2-hydroxy-2-nitroso-1-propylhydrazino)-1-propanamine	0.00214592274678
NO	1-propanamine,3-(2-hydroxy-2-nitroso-1-propylhydrazino) nonoate	0.00214592274678
NO	·nitric oxide	0.00214592274678
NO	nitric oxide	0.952789699571
NO	xnitrate plus nitrite	0.00214592274678
NO	sensor	0.00214592274678
NO	treatmentnormal control	0.00214592274678
NO	snitric oxide synthase	0.00214592274678
NO	2-nitrite	0.00429184549356
NIHN	ational institutes of health	0.891891891892
NIHN	ational institute of health	0.108108108108
NB	neurobasal culture medium	0.0322580645161
NB	nitrobenzene	0.0322580645161
NB	normal bath	0.0322580645161
NB	stmstimulation of the cholinergic nucleus basalis	0.0322580645161
NB	nucleus basalis of meynert	0.0645161290323
NB	neurobasal medium supplemented with 35mm glucose, 0.5mm glutamine, 27.5mm nacl, 2.5μg/ml fungizone, 50μg/ml gentamicin, and n2 supplement; final osmolality 305–310mosm/l	0.0322580645161
NB	neurobasal medium	0.0967741935484
NB	neurobiotin	0.0645161290323
NB	negative-binomial	0.0322580645161
NB	2aneuroblastoma neuro2a	0.0322580645161
NB	nucleus basalis	0.225806451613
NB	nucleus basalis magnocellularis	0.0967741935484
NB	no break	0.0322580645161
NB	neural basal medium	0.0322580645161
NB	neuroblast	0.0322580645161
NB	neurobasal	0.0967741935484
NB	network burst	0.0322580645161
NC	number of cells labelled in the io	0.0285714285714
NC	neutral cue	0.0285714285714
NC	non-copulating	0.0285714285714
NC	adn-cadherin	0.0285714285714
NC	nitrocellulose	0.0571428571429
NC	ornuclear receptor corepressor	0.0285714285714
NC	nasal cavity	0.0285714285714
NC	nitrocellulose beads	0.0285714285714
NC	nitrocellulose filter	0.0285714285714
NC	negative control	0.0571428571429
NC	pnucleus of the posterior commissure	0.0285714285714
NC	nucleus circularis	0.0571428571429
NC	ref, noise of ucrref	0.0285714285714
NC	normal control	0.285714285714
NC	anucleus caudatus	0.0285714285714
NC	number of micturition contractions	0.0285714285714
NC	normal cages used in the animal house	0.0285714285714
NC	caudate nuclei	0.0285714285714
NC	caudal neostriatum	0.0285714285714
NC	caudal nidopallium	0.0285714285714
NC	novel context	0.0285714285714
NC	ornuclear receptor co-repressor	0.0285714285714
NC	snormal controls	0.0285714285714
ND	numerical density	0.117647058824
ND	6nadh dehydrogenase subunit 6	0.0588235294118
ND	snumerical densities	0.0588235294118
ND	non-demented	0.0588235294118
ND	not detectable	0.0588235294118
ND	no-drug control group	0.0588235294118
ND	non-diabetic	0.0588235294118
ND	nucleus dorsalis	0.0588235294118
ND	7/23 cell	0.0588235294118
ND	normal diet	0.0588235294118
ND	nose down	0.0588235294118
ND	negative difference	0.0588235294118
ND	null direction	0.0588235294118
ND	nose-down	0.176470588235
NE	nuclear envelope	0.0176211453744
NE	northeast	0.0264317180617
NE	noradrenergic neurons	0.00440528634361
NE	non-epileptic	0.00440528634361
NE	non-epileptic rats	0.00440528634361
NE	noradrenaline	0.0132158590308
NE	norephinephrine	0.00440528634361
NE	cells with no change in excitability	0.00440528634361
NE	no effect	0.0176211453744
NE	neuroepithelium	0.00881057268722
NE	norepinephrine/noradrenaline	0.00881057268722
NE	norepinephrine	0.84140969163
NE	neonatal encephalopathy	0.00440528634361
NE	noreprinephrine	0.00440528634361
NE	1neuropeptide e1	0.00440528634361
NE	noradrenergic	0.0176211453744
NE	noradrenergic/norepinephrine	0.00440528634361
NE	ltdnorepinephrine induced ltd	0.00440528634361
NE	northeast quadrant	0.00440528634361
NF	normalization factor	0.00869565217391
NF	neurofilament(s)	0.00869565217391
NF	68neurofilament 68	0.0173913043478
NF	1neurofibromin 1	0.00869565217391
NF	neurofilament	0.4
NF	kappa-b	0.00869565217391
NF	2neurofibromatosis type 2	0.0173913043478
NF	160neurofilament 160	0.00869565217391
NF	200200 kda neurofilament h	0.00869565217391
NF	nerve filament	0.00869565217391
NF	nucleus fastigius	0.00869565217391
NF	+neurofilament-immunopositive	0.00869565217391
NF	nerve fiber	0.00869565217391
NF	kappa bnuclear factor ‘kappa-light-chain-enhancer’ of activated b-cells	0.00869565217391
NF	1anuclear factor 1 a	0.00869565217391
NF	200neurofilament 200 kda	0.0347826086957
NF	kbnuclear factor kappa beta	0.0173913043478
NF	200kneurofilament 200k	0.00869565217391
NF	1neurofibromatosis type 1	0.0173913043478
NF	h/mneurofilament heavy and medium chain	0.00869565217391
NF	neurofilaments	0.0260869565217
NF	/bd/o–nf/bd/onf/bd/o continuing on nf/bd/o after delivery	0.00869565217391
NF	200heavy neurofilament (∼200kda)	0.00869565217391
NF	70neurofilament 70	0.00869565217391
NF	1neurofibromin gene (human)	0.00869565217391
NF	hneurofilament h	0.00869565217391
NF	1neurofibromatosis-1	0.00869565217391
NF	200neurofilament 200	0.113043478261
NF	(t)neurofibrillary (tangles)	0.00869565217391
NF	normally fed	0.00869565217391
NF	nerve fiber layer of the retina	0.00869565217391
NF	neurofilament 200	0.00869565217391
NF	(t), neurofibrillary (tangles)	0.00869565217391
NF	sneurofilaments	0.00869565217391
NF	200neurofilament 200 kd	0.0347826086957
NF	sneurotrophic factors	0.0173913043478
NF	200200 kd neurofilament h	0.00869565217391
NF	nuclear factor	0.0260869565217
NF	nucleoplasmic fraction	0.00869565217391
NF	kbnuclear factor kappa b	0.00869565217391
NF	200high molecular weight neurofilament marker	0.00869565217391
NF	pan neurofilament	0.00869565217391
NF	mneurofilament heavy polypeptide	0.00869565217391
NG	2proteoglycan neuron-glia 2 protein	0.0222222222222
NG	108-15 cell	0.0222222222222
NG	108-15neuroblastoma×glioma cell line	0.0222222222222
NG	nucleus gracilis	0.0222222222222
NG	nodose ganglia	0.0888888888889
NG	2ng2 proteoglycan	0.0222222222222
NG	2neuron/glia 2 chondroitin sulphate proteoglycan	0.0222222222222
NG	108-15 cells	0.0222222222222
NG	neck-grab	0.0666666666667
NG	108-15	0.0666666666667
NG	2	0.2
NG	2chondroitin sulfate proteoglycan	0.0666666666667
NG	2 proteoglycan	0.0222222222222
NG	2chondroitin sulfate proteoglycan neuron-glia antigen 2	0.0222222222222
NG	2a transmembrane chondroitin sulfate proteoglycan expressed on several types of immature progenitor cells	0.0222222222222
NG	2 glia	0.0222222222222
NG	2chondroitin sulfate protein	0.0222222222222
NG	nodose ganglion	0.111111111111
NG	neck grab	0.0444444444444
NG	normal glucose	0.0444444444444
NG	negative geotaxis test	0.0222222222222
NG	2ng2 chondroitin sulfate proteoglycan	0.0222222222222
NX	non-exercise group	0.5
NX	dorsal vagal motor nucleus	0.5
NY	nuclear yellow	1.0
NZ	nodular zone	1.0
PN-	1protease nexin-1	1.0
RPMI-	1640roswell park memorial institute-1640	1.0
ES-FCSES-	qualified fetal calf serum	1.0
NP	ontcnucleus reticularis pontis caudalis	0.0238095238095
NP	neuron profile	0.142857142857
NP	3third whisker pad-evoked beta wave	0.0238095238095
NP	non-pacemaker	0.0238095238095
NP	neural progenitor	0.0238095238095
NP	nucleus prepositus	0.0238095238095
NP	sneuron profiles	0.0238095238095
NP	nonpyramidal cells	0.0238095238095
NP	neuritic plaques	0.047619047619
NP	nitroprusside	0.0238095238095
NP	ochannel open probability	0.0238095238095
NP	neuritic plaque	0.047619047619
NP	nonperforated (synapses)	0.0238095238095
NP	no pre-exposure	0.0238095238095
NP	1neuronal pentraxin 1	0.0238095238095
NP	40 ppinonidet-np40 protease and phosphatase inhibitor	0.0238095238095
NP	non-phosphorylated	0.0238095238095
NP	–nfnon-phosphorylated neurofilaments	0.0238095238095
NP	neurogenic pain	0.0238095238095
NP	40nonidet-p-40 substitute	0.0238095238095
NP	non-p zones	0.0238095238095
NP	40nonyl phenoxylpolyethoxylethanol	0.0238095238095
NP	alcohol-nonpreferring	0.0238095238095
NP	ratsalcohol non-preferring np rats	0.0238095238095
NP	opatch open probability	0.0238095238095
NP	nucleus pulposus	0.0238095238095
NP	oopen state probability	0.0238095238095
NP	ratalcohol non-preferring rat	0.0238095238095
NP	nose poke	0.0238095238095
NP	sodium nitroprusside	0.0238095238095
NP	neuronal pentraxin	0.0238095238095
NP	non-preferring (rats)	0.0238095238095
NP	natriuretic peptide	0.0238095238095
NP	no pups	0.0238095238095
NP	sneural progenitors	0.0238095238095
NR	2bnmda receptor subtype 2b	0.0113636363636
NR	2bn-methyl-d-aspartate receptor nr2b subunit	0.0113636363636
NR	1n-methyl-d-aspartate-receptor subunit 1	0.0113636363636
NR	2bn-methyl-d-aspartate receptor subtype 2b	0.0113636363636
NR	neural response	0.0113636363636
NR	1d1	0.0113636363636
NR	1nmda receptor r1 subunit	0.0113636363636
NR	nmda receptor subunits	0.0113636363636
NR	2a/bn-methyl-d-aspartate receptor 2a/b	0.0113636363636
NR	2b subunitmouse ε2 subunit	0.0113636363636
NR	2anmda receptor subunit 2a	0.0227272727273
NR	2b subunit	0.0340909090909
NR	non-rebound	0.0113636363636
NR	1n-methyl-d-aspartate receptor 1 subunit	0.0113636363636
NR	1neuregulin 1	0.0113636363636
NR	4a2	0.0113636363636
NR	non-responsive	0.0113636363636
NR	no response	0.0113636363636
NR	nucleus reuniens	0.0113636363636
NR	1n-methyl-d-aspartate receptor i subunit	0.0113636363636
NR	2a and nr2b subunits	0.0113636363636
NR	non-denaturing	0.0113636363636
NR	1nmdar1	0.0113636363636
NR	2a/2bnmdar2a/2b	0.0113636363636
NR	1subunit 1 of the nmda receptor	0.0113636363636
NR	1nmda receptor subunit 1	0.0454545454545
NR	2bn-methyl-d-aspartic acid receptor 2b subunit	0.0113636363636
NR	nmda receptor subunit	0.0227272727273
NR	2a-nmdarnr2a-containing n-methyl-d-aspartate receptor	0.0113636363636
NR	nmda receptor subunit(s)	0.0113636363636
NR	1n-methyl-d-aspartate receptor 1	0.0454545454545
NR	n-methyl-d-aspartate receptor	0.0113636363636
NR	1n-methyl-d-aspartic acid-type 1	0.0113636363636
NR	2nmda receptor subunit 2	0.0113636363636
NR	1/nr2xnmda receptor containing nr2 subunit	0.0113636363636
NR	nursery reared	0.0113636363636
NR	1n-methyl-d-aspartate subunit r1	0.0113636363636
NR	neural retina	0.0113636363636
NR	2b antagonist	0.0113636363636
NR	2bnmda receptor 2b subunit	0.0113636363636
NR	1nmda receptor nr1 subunit	0.0113636363636
NR	1nmda-nr1 subunit	0.0113636363636
NR	2n-methyl-d-aspartate receptor type 2 subunit	0.0113636363636
NR	1nmdar1 subunit of the nmda receptor	0.0113636363636
NR	2bn-methyl-d-aspartate receptor subunit 2b	0.0454545454545
NR	normal rat	0.0113636363636
NR	normal romberg	0.0113636363636
NR	2d	0.0113636363636
NR	2b transgenic mice	0.0113636363636
NR	2bn-methyl-d-aspartate receptor subunit type 2b	0.0113636363636
NR	1	0.0113636363636
NR	2bnmda receptor subunit 2b	0.0568181818182
NR	2a	0.0227272727273
NR	2b	0.102272727273
NR	nmda receptor	0.0340909090909
NR	2a/b	0.0113636363636
NR	glutamatergic-n-methyl-d-aspartate receptor	0.0113636363636
NR	2b subunit of the nmda receptor	0.0113636363636
NR	1n-methyl-d-aspartate receptor 1 subtype	0.0113636363636
NR	non-respiratory graft activity	0.0113636363636
NS	no separation	0.0114942528736
NS	non-direction selective	0.0114942528736
NS	not significant	0.103448275862
NS	non-suckled	0.0114942528736
NS	nicotine+saline	0.0114942528736
NS	neostriatum	0.0114942528736
NS	non-associated stimulus	0.0114942528736
NS	/pc	0.0114942528736
NS	non-stress	0.0114942528736
NS	non stress	0.0114942528736
NS	398	0.0114942528736
NS	+noisei.p. injection normal saline	0.0114942528736
NS	non-selective	0.0114942528736
NS	no sag potential	0.0114942528736
NS	non-rewarded stimulus	0.0229885057471
NS	normal sera	0.0114942528736
NS	normal saline solution	0.0114942528736
NS	normal serum	0.0574712643678
NS	neural stem	0.0114942528736
NS	danigrostriatal dopamine	0.0114942528736
NS	vmventral mesencephalon neurospheres derived at e14.5	0.0114942528736
NS	nociceptive specific	0.114942528736
NS	normal saline	0.114942528736
NS	nociceptive-specific	0.114942528736
NS	no shock	0.0229885057471
NS	non separated	0.0114942528736
NS	neuroscore	0.0114942528736
NS	non-significant	0.0229885057471
NS	no stress	0.0344827586207
NS	non-separated controls	0.0114942528736
NS	+tno shock+test	0.0114942528736
NS	nonsignificant	0.0114942528736
NS	neutral stimulus	0.0114942528736
NS	number of scans	0.0114942528736
NS	nociceptive specific neurons	0.0114942528736
NS	neurospheres	0.0114942528736
NS	nervous system	0.0114942528736
NS	/pcsneural stem/progenitor cells	0.0114942528736
NS	non-stressed	0.0114942528736
NS	1619	0.0114942528736
NS	non significant	0.0229885057471
NS	non-surgery	0.0114942528736
NT	neural tube	0.00675675675676
NT	neurotrophin 3	0.00675675675676
NT	neurofibrillary tangles	0.00675675675676
NT	nasal-to-temporal	0.00675675675676
NT	(8–13), 8–13 fragment of neurotensin	0.0135135135135
NT	no touch	0.00675675675676
NT	n-terminal fragment of ps-1	0.00675675675676
NT	no tetanic stimulation	0.00675675675676
NT	non-transgenic	0.0405405405405
NT	neurotrace	0.00675675675676
NT	2ntera-2cld/1	0.00675675675676
NT	4neurotrophin-4	0.00675675675676
NT	2-n cells	0.00675675675676
NT	2neurotensin receptor 2	0.00675675675676
NT	nervus terminalis	0.00675675675676
NT	4	0.00675675675676
NT	neurotransmitter	0.00675675675676
NT	2ntera-2	0.00675675675676
NT	5eecto-5′-nucleotidase	0.00675675675676
NT	no treatment	0.0135135135135
NT	4neurotrophin 4	0.00675675675676
NT	2-n neurons	0.00675675675676
NT	neurotensin	0.216216216216
NT	3-nitrotyrosine	0.0135135135135
NT	n-terminally directed	0.00675675675676
NT	3neurotrophic factor 3	0.0135135135135
NT	neurotrophin	0.297297297297
NT	nontransgenic	0.0202702702703
NT	era2	0.00675675675676
NT	newly trained	0.00675675675676
NT	4-/-nt4 null mutant	0.00675675675676
NT	3neurotrophin-3	0.0608108108108
NT	caudal hypothalamus	0.00675675675676
NT	sneuropil threads	0.00675675675676
NT	4/5neurotrophin-4/5	0.00675675675676
NT	gnon-transgenic	0.00675675675676
NT	/nneurotensin/neuromedin	0.00675675675676
NT	4/5	0.00675675675676
NT	sneurotrophins	0.0135135135135
NT	non-targeting	0.00675675675676
NT	nasal to temporal	0.00675675675676
NT	non-tested	0.00675675675676
NT	neurotrophins	0.00675675675676
NT	3neurotrophin 3	0.0337837837838
NT	nitrotyrosine	0.0337837837838
NT	2 neuron	0.00675675675676
NU	nose-up	0.5
NU	nose up	0.333333333333
NU	normalized units	0.166666666667
NV	numerical density	0.25
NV	environmental sounds	0.125
NV	naive	0.25
NV	snprtrigeminal main sensory nucleus	0.125
NV	neuron density within a given brain region	0.125
NV	synapse density	0.125
NW	northwest	1.0
CNRQ	scalibrated normalized relative quantities	1.0
BEHAB	brain-enriched hyaluronan binding	1.0
NRSS	normal rabbit serum solution	1.0
N-	type voltage-gated calcium channels	0.00892857142857
N-	methyl-salsolinol	0.00892857142857
N-	nitro-l-arginine methyl ester	0.00892857142857
N-	methyl-d-aspartic acid (nmda)	0.00892857142857
N-	ethyl-2-bromobenzylamine (dsp-4)	0.00892857142857
N-	2-mpgn-2-mercaptopropionyl glycine	0.0178571428571
N-	ethylmaleimide-sensitive factor	0.00892857142857
N-	acetylaspartate (naa)	0.00892857142857
N-	acetyl-aspartyl-glutamate	0.00892857142857
N-	terminalamino terminal	0.00892857142857
N-	myc	0.00892857142857
N-	methyl-d-aspartate receptors	0.0357142857143
N-	glycanasparagine-linked oligosaccharide	0.00892857142857
N-	linked glycosylation	0.00892857142857
N-	terminusamino-terminus	0.00892857142857
N-	arachidonoylethanolamine	0.00892857142857
N-	methyl-d-aspartate receptor complex	0.00892857142857
N-	glycosylation	0.00892857142857
N-	acetyl-l-aspartate (naa)	0.00892857142857
N-	bestnacl-best	0.00892857142857
N-	myc downstream-regulated gene 2	0.00892857142857
N-	2-hydroxyethylpiperazine-n′-2-ethanesulphonic acid	0.00892857142857
N-	cadherin	0.0357142857143
N-	type	0.0357142857143
N-	acetylgalactosamine	0.00892857142857
N-	acetylaspartate	0.0178571428571
N-	methyl-d-aspartate receptor subunits	0.00892857142857
N-	(4-hydroxyphenyl) retinamide	0.00892857142857
N-	acetylcysteine	0.0178571428571
N-	methyl scopolamine	0.00892857142857
N-	methyl-d-aspartate	0.303571428571
N-	acetyl cysteine	0.00892857142857
N-	methyl-d-aspartate (nmda) receptor	0.00892857142857
N-	acetyl-o-methyldopamine	0.00892857142857
N-	acetyl-l-aspartate	0.00892857142857
N-	methyl-d-aspartic acid	0.0357142857143
N-	2-hydroxyethylpiperazine-n-2-ethanesulphonic acid	0.00892857142857
N-	methyl-d-aspartate receptor	0.151785714286
N-	methyl- d-aspartate	0.00892857142857
N-	methyl-n-nitrosourea	0.00892857142857
N-	acetyltransferase	0.0178571428571
N-	methyltransferase	0.00892857142857
N-	stearoyltyrosine	0.00892857142857
N-	acetylaspartylglutamate	0.0178571428571
N-	methyl d-aspartate receptor 1	0.00892857142857
N-	type ca2+ channel	0.00892857142857
PONSP	eripheral optogenetic neural stimulation	1.0
M-CSF	macrophage colony-stimulating factor	1.0
CIRCBF	1-interacting co-repressor	1.0
N0	number of response failures	1.0
β-CNA	β-chlornaltrexamine	1.0
nST	nucleus of the stria terminalis	1.0
SVDA	synaptic vesicular dopamine	1.0
ICON	neuroninspiratory neuron with continuous firing pattern	1.0
FRMC	fetal rat myocardial cell	1.0
VPMPC	parvicellular part of the ventroposterior medial thalamic nucleus	1.0
IPAC	interstitial nucleus of the anterior commissure	0.0714285714286
IPAC	interstitial nucleus of posterior limb of anterior commissure	0.142857142857
IPAC	interstitial nucleus of the posterior limb of the anterior commissure	0.785714285714
TRAILTNF-	related apoptosis-inducing ligand	1.0
IPAN	sintrinsic primary afferent neurons	0.1
IPAN	intrinsic primary afferent neuron	0.9
IPAI	ngenuity pathways analyses	0.125
IPAI	ngenuity pathways analysis	0.25
IPAI	ngenuity pathway analysis	0.625
cSRT	contralateral hemisphere of srt	1.0
-ATPase	sodium–potassium adenosine triphosphatase	0.5
-ATPase	sodium and potassium ion-transport adenosinetriphosphatase (ec 3.6.1.3)	0.5
OZR	obese zucker rat	1.0
ST-EPSC	ssolitary tract-evoked excitatory postsynaptic currents	1.0
CHAPSpolyethyleneimine	3-[(3-cholamidopropyl) dimethylammonio]-1 propanesulphonate	1.0
ω-CgTX-GVIA	ω-conotoxin-gvia	1.0
AEECA	nimal experimentation ethics committee	1.0
AZN	azulenyl nitrone	1.0
-4C3HPG	(s)-4-carboxy-3-hydroxyphenilglycine	1.0
AZA	acetazolamide	1.0
AZD	6244	0.5
AZD	0328	0.5
CAT-	315	1.0
BNSTal	anterolateral part of the bnst	1.0
BNSTam	anteromedial part of the bnst	1.0
3α-D	iol3α-androstanediol	1.0
MHPG	4-hydroxy 3-methoxy phenylglycol	0.0526315789474
MHPG	4-hydroxy-3-methoxyphenylglycol	0.0526315789474
MHPG	3-methoxy-4-hydroexyphenylglycol	0.0526315789474
MHPG	3-methoxy-4-hydroxyphenylethyleneglycol	0.105263157895
MHPG	3-methoxy-4-hydroxyphenylethylene glycol	0.105263157895
MHPG	3-methoxy4-hydroxyphenylglycol	0.0526315789474
MHPG	3-methoxy-4-hydroxy-phenylglycol	0.0526315789474
MHPG	4-hydroxy-3- methoxyphenylglycol	0.0526315789474
MHPG	3-methoxy-4-hydroxyphenylglycol	0.368421052632
MHPG	3-methoxy-4-hydorxyphenethyleneglycol	0.0526315789474
MHPG	3-methoxy-4-hydroxy-phenethyleneglycol	0.0526315789474
ZDFZ	ucker diabetic fatty	1.0
NnAChR	neuronal nicotinic acetylcholine receptor	1.0
2RT	half relaxation time	1.0
LPTGDS	prostaglandin d2 synthase	1.0
SCYA	2small inducible cytokine a2	1.0
PBem	external medial parabrachial subnucleus	1.0
aC	ganterior cingulate cortex	1.0
GDEE	glutamic-acid diethyl ester	0.333333333333
GDEE	l-glutamic acid diethyl ester	0.333333333333
GDEE	glutamate diethyl ester	0.333333333333
MEPC	sminiature end-plate currents	0.6
MEPC	miniature endplate current	0.2
MEPC	miniature postsynaptic current	0.2
ppTRH	prepro-trh	0.5
ppTRH	preprotrh	0.5
aI	anterior insula	0.5
aI	nsanterior insular cortex	0.5
MEPO	median preoptic nucleus	1.0
T-SAL	trained group treated with saline	1.0
8-Methyl-9H-1	3-dioxolo[4,5-h][2,3]	1.0
MEPH	mephedrone	1.0
aN	a+iintracellular na+ activity	1.0
aP	alkaline phosphatase	1.0
Watson	1986)	1.0
aR	bs)-a-(4-hydroxyphenyl)-b-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate	0.5
aR	2after the second recovery period	0.5
rVRG	rostral division of the ventral respiratory group	0.2
rVRG	rostral ventral respiratory group	0.8
MEPP	miniature end-plate potential	0.266666666667
MEPP	sminiature endplate potentials	0.0666666666667
MEPP	miniature endplate potential	0.666666666667
BNTX	(e)-7-benzylidenenaltrexone	0.333333333333
BNTX	,	0.333333333333
BNTX	7-benzylidenenaltrexone maleate	0.333333333333
RMSSD	root-mean-square of the sum of successive rr interval differences	1.0
TMLC	transforming growth factor-β-responsive mink lung epithelial cell	1.0
3IL	third intracellular loop	1.0
ETHYL	ethyl isobutyrate	1.0
AHPT	train afterhyperpolarization	1.0
OBx	olfactory bulbectomy	1.0
DSCAMD	own syndrome cell adhesion molecule	1.0
111I	n-troponolateindium-111-troponolate	1.0
UDP-	glucoseuridine 5′-diphosphoglucose	1.0
HUCBC	s)	0.333333333333
HUCBC	human umbilical cord blood cells	0.666666666667
tricineN-	[tris(hydroxymethyl)methyl]glycine	1.0
FKBP	38fk506 binding protein 38	0.0769230769231
FKBP	1212-kda immunophilin fk506-binding protein	0.0769230769231
FKBP	fk506-binding protein	0.0769230769231
FKBP	12fk506 binding protein	0.0769230769231
FKBP	sfk506 binding proteins	0.0769230769231
FKBP	12fk506 binding protein 12 kda	0.0769230769231
FKBP	52	0.0769230769231
FKBP	5	0.0769230769231
FKBP	5fk506 binding protein 5	0.0769230769231
FKBP	4fk506-binding protein 4	0.0769230769231
FKBP	12fk506 binding protein 12	0.0769230769231
FKBP	fk506 binding protein	0.153846153846
NDV	newcastle disease virus	1.0
vcCP	uventrocaudal caudate-putamen	1.0
tatCN	21	1.0
AHPA	fterhyperpolarization	1.0
STZ-HGSTZ-injected	hyperglycemic	1.0
AHPN	6-[3-adamantyl-4-hydroxyphenyl]-2-napthalene carboxylic acid	1.0
RT-QPCR	reverse transcription-quantitative pcr	1.0
3H-	5-httritiated serotonin	0.5
3H-	flunitrazepam	0.5
CORM-	2carbon monoxide-releasing molecule tricarbonyldichlororuthenium (ii) dimer	1.0
SerT	serotonin transporter	1.0
CATC	atalase	1.0
NOSNO	synthases	0.2
NOSNO	synthase	0.8
Aβ43	amyloid 1–43	1.0
PSMA	prostate specific membrane antigen	0.5
PSMA	sproteasome alpha subunits	0.5
TIRFM	total internal reflection fluorescence microscopy	1.0
PSMD	proteasome activity	1.0
t-CREB	total-cyclic amp response element binding protein	1.0
ETCO	2end-tidal co2	1.0
EF-T	umtmitochondrial tu translation elongation factor	1.0
PCxPDpaleocortex	posterior part, dorsal division	1.0
pLV-BDNF	lentiviral plasmid encoding bdnf	1.0
5-OH-C	5-hydroxycytosine	1.0
WAY100635	n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]	1.0
IWAT	inguinal white adipose tissue	1.0
MDl	mediodorsal lateral thalamic nucleus	0.5
MDl	lateral md	0.5
PAC1	periamygdaloid cortex 1	1.0
MEApd	posterodorsal part of the mea	1.0
DSBR	double strand break repair	0.5
DSBR	double-strand break repair	0.5
tS	tudent's t	1.0
tO	trans-2-octenal	1.0
MPPG	(rs)-α-methyl-4-phosphonophenylglycine	1.0
tH	trans-2-heptenal	1.0
PAC-	1high affinity pituitary adenylate cyclase activating polypeptide receptor	1.0
CI95	95% confidence interval	1.0
tB	octertbutyl carbamate	0.333333333333
tB	idtruncated bid	0.666666666667
tC	amkiitotal camkii	0.5
tC	pre-bötzinger complex	0.5
tA	mpamplitude of response to ttone	1.0
mnX	vagal efferent	1.0
p130C	asp130 crk-associated substrate	1.0
bHLH-	transcription factor	1.0
NCAM	psapolysialylated variant of neural cell adhesion molecule	0.0142857142857
NCAM	psa	0.0142857142857
NCAM	neural cell adhesion molecule	0.9
NCAM	-/-neural cell adhesion molecule	0.0142857142857
NCAM	neural cell adhesion molecules	0.0142857142857
NCAM	neuronal cell adhesion molecule	0.0428571428571
scE	spatial context encoded	1.0
scF	vsingle chain antibody fragments	1.0
mnV	trigeminal efferent	1.0
BDVB	orna disease virus	1.0
NLE	norleucine	0.5
NLE	snegative life events	0.5
scR	spatial context retrieved	1.0
Sp5O	subnucleus oralis of the trigeminal complex	0.333333333333
Sp5O	oral part of the spinal trigeminal nucleus	0.333333333333
Sp5O	spinal trigeminal nucleus, pars oralis	0.333333333333
gK-C	aca2+-activated voltage-dependent k+ conductance	1.0
PACs	sulcal division of the periamygdaloid cortex	0.333333333333
PACs	periamygdaloid cortex, sulcal portion	0.333333333333
PACs	sulcal division of the pac	0.333333333333
AL-BTXA	lexa-fluo-488-conjugated α-bungarotoxin	1.0
BTCP	[3h]	0.5
BTCP	3h-n-[1-92-benzo(b)thiophenylcyclohexyl]-piperidine	0.5
Sp5C	spinal trigeminal nucleus	0.25
Sp5C	subnucleus caudalis of the trigeminal complex	0.25
Sp5C	caudal part of the spinal trigeminal nucleus	0.25
Sp5C	spinal trigeminal subnucleus caudalis	0.25
cGKI	cyclic guanosine-3′,5′-monophosphate-dependent protein kinase type i	0.5
cGKI	cyclic gmp-dependent protein kinase	0.5
CO2	carbon dioxide	1.0
NRPc	nucleus reticularis pontis caudalis	1.0
CPF	(dd), n-carbomethoxycarbonyl-d-prolyl-d-phenylalanine	0.5
CPF	chlorpyrifos	0.5
GABARA-IR	gabaa receptor immunoreactivity	1.0
sE	ngsoluble endoglin	1.0
PACm	medial division of the pac	0.666666666667
PACm	medial division of the periamygdaloid cortex	0.333333333333
NAP-	22	1.0
PACo	periamygdaloid cortex, oral portion	1.0
HEPESU-	(2-hydroxyethyl) piperaxine-1-ethane sulfonic acid	1.0
endothelinB	receptor	1.0
endothelinA	receptor	1.0
NTSap	nts at the level of the area postrema	1.0
A3AR	adenosine a3 receptor	1.0
CNQX6-cyano-7-nitoroquinoxaline-2	3-dione	1.0
SGCT	subependymal giant cell tumor	1.0
bfSPR	bullfrog substance p receptor	1.0
APP-KPI	app-kunitz-type protease inhibitor domain	1.0
scoresBasso	beattie, and bresnahan locomotive rating scale	1.0
PTEN	phosphatase and tensin homolog deleted in chromosome ten	0.0666666666667
PTEN	phosphatase and tensing homolog deleted on chromosome 10	0.0666666666667
PTEN	phosphatase and tensin homolog deleted on chromosome 10	0.266666666667
PTEN	3-phosphoinositide 3-phosphatase	0.0666666666667
PTEN	phosphatase and tensin homolog on chromosome ten	0.0666666666667
PTEN	phosphatase and tensin homolog	0.266666666667
PTEN	phosphatase and tensing homologue deleted on chromosome 10	0.0666666666667
PTEN	inhibitor	0.0666666666667
PTEN	phosphatase and tensin homolog deleted from chromosome 10	0.0666666666667
PLTP	phospholipid transfer protein	1.0
PACC	perigenual anterior cingulate cortex	1.0
NSCC	nonselective cation conductance	0.333333333333
NSCC	a2+-permeable nonselective cation	0.333333333333
NSCC	snonselective cation channels	0.333333333333
GSK-β	glycogen synthase kinase-β	1.0
4AP	4-amino-pyridine	0.0526315789474
4AP	4-aminopyridine	0.947368421053
DRVL	dorsal raphe nucleus ventrolateral part	1.0
TMEM	100	1.0
α-SYN	alpha-synuclein	1.0
LC-HG	cell type with light cytoplasm and granules with halo	1.0
pmRF	pontomedullary reticular formation	1.0
TMEV	infection	0.5
TMEV	theiler’s murine encephalomyelitis virus	0.5
-IH-imidazole	dihcl	1.0
h5-HT	3arshuman 5-ht3a receptors	1.0
UFG	underfed group	1.0
α-FMHα-	fluoromethylhistidine	1.0
DLF	dorsal lateral funiculus	0.0625
DLF	dorsolateral funiculus of the spinal cord	0.0625
DLF	dorsolateral funiculus	0.75
DLF	dorsal lateral furniculus	0.0625
DLF	dorsalateral funiculus	0.0625
APOD	apolipoprotein d	1.0
APOE	apolipoprotein e	0.357142857143
APOE	4apolipoprotein e allele ε4	0.0714285714286
APOE	designation for human apolipoprotein e gene	0.142857142857
APOE	4apolipoprotein e4	0.0714285714286
APOE	koapolipoprotein e-deficient	0.0714285714286
APOE	human gene for apoe	0.0714285714286
APOE	gene encoding apolipoprotein e	0.0714285714286
APOE	apolipoprotein e gene	0.0714285714286
APOE	geneapolipoprotein e gene	0.0714285714286
APOB	apolipoprotein b	1.0
APOA	anterior preoptic area	1.0
MCMCM	arkov chain monte carlo	1.0
β-L-ODAP	β-n-oxalyl-l-α,β-diaminopropionic acid	1.0
EABR	electrically evoked auditory brain stem response	1.0
GABA-IRGABA-	immunoreactive	1.0
α-B	gtα-bungarotoxin	0.5
α-B	crystallin	0.166666666667
α-B	utxα-bungarotoxin.	0.166666666667
α-B	gtxα-bungarotoxin	0.166666666667
α-C	amkiialpha-calcium–calmodulin kinase ii	0.5
α-C	txmiiα-conotoxin mii	0.5
α-E	217 α-estradiol	1.0
iNTS	intermediate nts	0.5
iNTS	intermediate nucleus of the solitary tract	0.5
FKBPFK	506 binding protein	0.666666666667
FKBPFK	506 binding proteins	0.333333333333
α-M	e-5-htα-methyl-5-ht	0.25
α-M	e-5htα-methylserotonin maleate salt	0.25
α-M	edaα-methyldopamine	0.25
α-M	e-5-htα-me-5-hydroxytryptamine maleate	0.25
WRS	restraint stress combined with water immersion	1.0
SHAM	sham-operation	0.125
SHAM	sham surgery	0.25
SHAM	group of rats with sham-operations	0.0625
SHAM	sham-operated	0.1875
SHAM	surgery control procedure	0.0625
SHAM	sham adrenalectomized	0.0625
SHAM	sham-treated group	0.0625
SHAM	sham-operated control	0.0625
SHAM	sham surgery group	0.0625
SHAM	sham lesion	0.0625
LCMRglc	local cerebral metabolic rate of glucose utilization	1.0
PVNH	periventricular nodular heterotopia	1.0
SR141716A	n-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide	0.4
SR141716A	n-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazolecarboxamide hcl	0.2
SR141716A	n-piperidino-5-(4-clorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide	0.2
SR141716A	[n-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1h-pyrazole-3-carboxamide hydrochloride]	0.2
RCPCGRP	receptor component protein	1.0
HO-1	heme oxygenase-1	1.0
HO-2	heme oxygenase type 2	1.0
DLN	dorsolateral nucleus	0.5
DLN	dorsal lateral nucleus of the spinal cord	0.5
UFP	ultrafine particles	1.0
WPPSI-RW	echsler preschool and primary scale of intelligence-revised	1.0
Av3V	anteroventral tip of the third ventricle	1.0
LCMRglu	local cerebral glucose utilization	1.0
SAMSNH	2-his-met-arg-ser-ala-met-ser-gly-leu-his-leu-val-lys-arg-arg-cooh	1.0
5-CSRT	five-choice serial reaction time task	0.2
5-CSRT	five-choice serial reaction time (task)	0.2
5-CSRT	5-choice serial reaction time	0.2
5-CSRT	five choice serial reaction time	0.4
HU-2101	1-dimethylheptyl-11-hydroxytetrahydrocannabinol	1.0
D-DT	d-dopachrome tautomerase	1.0
piRNA	piwi interacting rna	0.5
piRNA	piwi-interacting rna	0.5
L-T33	5,3′-triiodo-l-thyronine	1.0
PMRF	pontomedullary reticular formation	0.666666666667
PMRF	pontomedullary medial reticular formation	0.333333333333
PFK	phosphofructokinase	1.0
RpcAMPS	rp-adenosine 3,5-cyclic monophosphothioate triethylamine	1.0
ELP-U	extra lever-presses in uncompleted trials	1.0
19F	csi19f chemical shift imaging	1.0
dSWD	smean total duration of swds	1.0
SP-S	apsubstance p conjugated to saporin	1.0
8-bromo-cAMP	8-bromoadenosine-3′,5′-cyclophosphate sodium	0.5
8-bromo-cAMP	8′-bromoadenosine 3′,5′-cyclic monophosphate	0.5
GENESISG	eneral neural simulation system	1.0
VEST	vestibular stimulation	1.0
aVCS	artificial vaginocervical stimulation	1.0
alBST	lateral region of the anterior bed nucleus of the stria terminalis	0.5
alBST	anterolateral subnucleus of the bst	0.5
PBSGT	phosphate-buffered saline containing 0.1% triton x-100 and 3% normal goat serum	0.333333333333
PBSGT	phosphate-buffered saline containing 1% normal goat serum and 0.3% triton x-100	0.666666666667
7-OH-DPAT	r(+)-7-hydroxy-dipropylaminotetralin [2-(n,n-di-2,3(n)-propylamino)-7-hydroxy-1,2,3,4-tetrahydronaphthalene]	0.111111111111
7-OH-DPAT	7-hydroxy-2-(di-n-propylamino)tetralin	0.333333333333
7-OH-DPAT	(±)-7-hydroxy-n,n-di-n-propyl-2-aminotetralin	0.111111111111
7-OH-DPAT	7-hydroxy-dipropylaminotetralin	0.111111111111
7-OH-DPAT	[3h]	0.111111111111
7-OH-DPAT	r-(+)-7-hydroxy-dipropylaminotetralin (2-(n,n-di[2,3(n)-3h]propylamino)-7-hydroxy-1,2,3,4-tetrahydronaphthalene)	0.111111111111
7-OH-DPAT	2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene	0.111111111111
BCNU	1-3-bis-chloroethyl-nitrosurea	1.0
U-69593	(+)-(5α7α,7β)-n-methyl-n-[7-(1-pyrrolidinyl)-1-oxaspiro[4,5]dec-8-yl]	0.5
U-69593	5α,7α,8β-(-)-n-methyl-n-[7-(1-pyrrolidinyl)-1-oscaspiro(4,5)dec-8-yl]phenyl-benzeneacetamide	0.5
BPGO	biological process	1.0
FADDF	as associated death domain	0.111111111111
FADDF	as-associated protein with the death domain	0.111111111111
FADDF	as-associated death domain	0.333333333333
FADDF	as-associated protein with death domain	0.444444444444
2MeS-ATP	2-methylthioatp	1.0
LFT-V	light finger touch only during vibration	1.0
2N	2bdfirst 2months of life of normal vision followed by 2months of binocular deprivation	1.0
CCKS	cholecystokinin small	1.0
fLP	fast long-lasting potentiation	1.0
PBBS	phosphate bicarbonate buffer saline	0.5
PBBS	peripheral benzodiazepine binding site	0.5
post-RP	post-reperfusion	1.0
IT-5	huntingtin gene	1.0
BNST-	ovoval nucleus of the bed nucleus of stria terminalis	1.0
CCKB	receptors	1.0
iTBS	intermittent theta burst stimulation	0.5
iTBS	intermittent tbs	0.5
VE-	cadherin	1.0
CNTFRα	ciliary neurotrophic factor receptor alpha	0.2
CNTFRα	cntf receptor-α	0.2
CNTFRα	ciliary neurotrophic factor receptor α	0.6
MWRTM	ann–whitney rank test	1.0
WT-GSK-	3βwild-type glycogen synthase kinase-3β	1.0
VEV	oluntary exercise	1.0
MSLT	multiple sleep latency test	1.0
IT-G	entintra-tympanic gentamicin	1.0
VES	vitamin e succinate	1.0
VEP	svisually evoked potentials	0.1
VEP	svisual evoked potentials	0.1
VEP	(s), visual evoked potential(s)	0.1
VEP	visual evoked potentials	0.2
VEP	visual-evoked potential	0.2
VEP	visual evoked potential	0.3
MCH-IRMCH-	immunoreactive	1.0
TPEN	n,n,n′,n′-tetrakis(2-pyridyl-methyl)ethylenediamine	0.25
TPEN	tetrakis(2-pyridylmethyl)ethylenediamine	0.25
TPEN	n,n,n′,n′-tetrakis(2-pyridalmethyl)ethylenediamine	0.25
TPEN	tetrakis-(2-pyridylmethyl) ethylenediamine	0.25
ESZ	eszopiclone	1.0
PFL	paraflocculus	1.0
MdD	dorsal medullary reticular field	0.333333333333
MdD	dorsal medullary reticular formation	0.333333333333
MdD	dorsal subdivision of reticular formation	0.333333333333
VEF	'svisual evoked magnetic fields	1.0
LDB	light-dark box	0.5
LDB	light–dark box	0.5
I-state	inhibited state	1.0
NTSVL	ventrolateral subnucleus of solitary tract nucleus	0.666666666667
NTSVL	ventrolateral subnucleus of the solitary tract nucleus	0.333333333333
CCK-	8cholecystokinin 8	0.0833333333333
CCK-	8cholecystokinin-8	0.166666666667
CCK-	8cell counting kit-8	0.25
CCK-	4cholecystokinin-4	0.0833333333333
CCK-	4cholecystokinin-tetrapeptide	0.166666666667
CCK-	8cholecystokinin octapeptide	0.166666666667
CCK-	8scholecystokinin-8 sulfate	0.0833333333333
IT-S	alineintra-tympanic saline	1.0
VEN	von economo neuron	0.333333333333
VEN	ventral endopiriform nucleus	0.333333333333
VEN	svon economo neurons	0.333333333333
VEL	keystroke velocity	1.0
PCPP	oisson cluster-process	1.0
MdV	ventral medullary reticular nucleus	0.333333333333
MdV	ventral subdivision of reticular formation	0.333333333333
MdV	ventral medullary reticular formation	0.333333333333
VEH	/vehvehicle/vehicle	0.0204081632653
VEH	2vehicle 2	0.0204081632653
VEH	vehicle control group	0.0204081632653
VEH	infusion vehicle of 0.1% dmso in saline	0.0204081632653
VEH	vehicle.	0.0204081632653
VEH	vehicle	0.755102040816
VEH	vehicle (saline only)-injected group	0.0204081632653
VEH	vehicle group	0.0408163265306
VEH	vehicle treatment	0.0204081632653
VEH	+asvehicle injection followed by auditory stimulation	0.0408163265306
VEH	+asvehicle and auditory stimulation	0.0204081632653
GNB	3guanine nucleotide-binding protein β3	0.5
GNB	1guanine nucleotide-binding protein beta subunit 1	0.5
MPGF	major proglucagon fragment	1.0
MMEP	multi-microelectrode plate	1.0
GNC	guanylyl cyclase	1.0
VPNP	vasopressin neurophysin	1.0
FTP	future time perspective	1.0
NF-κB	nuclear factor-kappab	0.0263157894737
NF-κB	nuclear factor kappa beta	0.00877192982456
NF-κB	transcription factor nuclear factor-kappa b	0.00877192982456
NF-κB	nuclear factor-κb	0.263157894737
NF-κB	nuclear transcription factor κb	0.00877192982456
NF-κB	transcription factor nuclear factor-kappab	0.00877192982456
NF-κB	nuclear factor-kb	0.00877192982456
NF-κB	nuclear factor kappab	0.0175438596491
NF-κB	nuclear factor kappa-b	0.00877192982456
NF-κB	nuclear factor kappa b	0.219298245614
NF-κB	nuclear factor-κ b	0.00877192982456
NF-κB	nuclear factor-kappa b	0.157894736842
NF-κB	nuclear factor “kappa-light-chain-enhancer” of activated b-cells	0.00877192982456
NF-κB	osmoregulation	0.00877192982456
NF-κB	nuclear transcription factor-κb	0.0175438596491
NF-κB	signaling	0.00877192982456
NF-κB	nuclear factor kappa-light-chain-enhancer of activated b cells	0.0526315789474
NF-κB	nuclear transcription factor κappab	0.00877192982456
NF-κB	nuclear factor of kappa light polypeptide gene enhancer in b-cells	0.00877192982456
NF-κB	nuclear factor κb	0.140350877193
BIRC-	3baculovirus inhibitor-of-apoptosis repeat containing-3	1.0
VEn	ventral endopiriform nucleus	1.0
8-CPT8-cyclopentyl-1	3-dimethylxanthine	1.0
EFHC	1ef-hand c1 protein	1.0
nISI	normalized isi	1.0
STED	stimulated emission depletion	0.5
STED	stimulated emission depletion microscope	0.5
L-655	708	1.0
alpha2C-	adrenergic receptor	0.5
alpha2C-	antagonist	0.5
IMBI	nstitute of molecular biology	1.0
-5Z	8z,11z,14z-eic osatetraenamide	1.0
Hpc	hippocampal	1.0
STEP	striatally-enriched phosphatase	0.2
STEP	striatal-enriched protein tyrosine phosphatase	0.6
STEP	striatal enriched tyrosine phosphatase	0.2
MTBSTFAN-	methyl-n-(tert-butyldimethylsilyl)trifluoroacetamide	1.0
LIo	lic, intermediate nucleus of the lateral group, pars oralis, pars caudalis	1.0
STET	strong tetanus	1.0
TTX-R-IN	attx-resistance na+ currents	1.0
FWHM	full-width half-maximum	0.0454545454545
FWHM	full-width-half-maximum	0.0909090909091
FWHM	full width half maximum	0.0909090909091
FWHM	full-width at half-maximum	0.136363636364
FWHM	full width at half maximum	0.590909090909
FWHM	full-width at half maximum	0.0454545454545
trkB-R	tyrosine kinase b receptor	1.0
CLOZ	clozapine	1.0
IRBP	imidazoline receptor binding protein	1.0
sema3A	semaphorin 3a	1.0
LARC	liver and activation-regulated chemokine	1.0
sGLFP	spontaneous glomerular layer field potential	1.0
6TG	6-thioguanine	1.0
mIPSCs	miniature inhibitory postsynaptic currents	1.0
tSC	terminal schwann cell	1.0
LRAPA	liposomal rapamycin	1.0
pNTS	precomissural nucleus tractus solitarius	1.0
PDGFPDGFR-β	platelet-derived growth factor, receptor beta	1.0
SSH	suppressive subtractive hybridization	0.5
SSH	suppression subtractive hybridization	0.5
RAIC	rostral agranular insular cortex	1.0
NSI	normalized signal intensities	0.5
NSI	ggnormal sheep serum igg	0.5
RSd	nucleus reticularis superior, pars dorsalis	1.0
VDMS	variable delayed matching-to-sample	1.0
ENUN-	ethyl-n-nitrosourea	0.5
ENUN-	ethyl-n-nitrosurea	0.5
TS-EPSC	sts-evoked epscs	1.0
CGP35348	3-aminopropyl (diethoxymethyl) phosphinic acid	0.166666666667
CGP35348	(3-aminopropyl)(diethoxymethyl)phosphinic acid	0.166666666667
CGP35348	3-aminopropyldiethoxymethylphosphinic acid	0.166666666667
CGP35348	p-(3-aminopropyl)-p-diethoxymethyl-phosphonic acid	0.166666666667
CGP35348	p-(3-aminopropyl)-p-diethoxymethyl-phosphinic acid	0.166666666667
CGP35348	p-(3-aminopropyl)-p-diethoxymethylphosphinic acid	0.166666666667
ωAga-IVA	ω-agatoxin-iva	1.0
MHCs	myosin heavy chains	1.0
RSv	nucleus reticularis superior, pars ventralis	1.0
S-RA	sham-operated groups	1.0
RT-97	neurofilament h	1.0
CNQX6-cyano-7-nitroquinoxaline-2	3-dion	0.005
CNQX6-cyano-7-nitroquinoxaline-2	3-(1h,4h)-dione	0.005
CNQX6-cyano-7-nitroquinoxaline-2	3dione	0.005
CNQX6-cyano-7-nitroquinoxaline-2	3-dione	0.89
CNQX6-cyano-7-nitroquinoxaline-2	3-dione disodium	0.06
CNQX6-cyano-7-nitroquinoxaline-2	3-dione disodium salt	0.035
CCK-LICCK-	like immunoreactivity	1.0
C-HTM	high-threshold mechanoreceptors	1.0
PFS	pyrogen-free saline	0.75
PFS	parallel fiber stimulation	0.25
RSN	rubrospinal neuron	0.333333333333
RSN	sresting state networks	0.666666666667
PLIP	hase lag index	1.0
RSI	repetitive strain injury	1.0
RSK	2isoform two of the 90 kda ribosomal s6 kinase	0.166666666667
RSK	2p90 ribosomal s6 kinase isozyme	0.166666666667
RSK	90-kda ribosomal s6 kinase	0.166666666667
RSK	ribosomal protein s6 kinase	0.166666666667
RSK	ribosomal s6 kinase	0.333333333333
RSD	rapid-eye-movement sleep deprivation	0.166666666667
RSD	rapid eye movement sleep deprivation	0.166666666667
RSD	dysgranular retrosplenial cortex	0.166666666667
RSD	right side down	0.166666666667
RSD	relative standard deviation	0.166666666667
RSD	rapid sustained discharge	0.166666666667
MCSP	melanoma chondroitin sulfate proteoglycan	1.0
RSG	retrosplenial area, granular	0.111111111111
RSG	retrosplenial granular cortex	0.555555555556
RSG	bretrosplenial granular b cortex	0.111111111111
RSG	granular retrosplenial cortex	0.222222222222
IGABAGABA-	activated current	1.0
RSA	retrosplenial cortex	0.0588235294118
RSA	respiratory sinus arrhythmia	0.0588235294118
RSA	rhythmical slow activity	0.0588235294118
RSA	agranular retrosplenial cortex	0.117647058824
RSA	rhythmic slow activity	0.294117647059
RSA	retrosplenial area, agranular	0.0588235294118
RSA	rat serum albumin	0.117647058824
RSA	retrosplenial agranular cortex	0.235294117647
BDHIB	uss-durkee hostility inventory	1.0
RSC	96rat schwann cell line	0.111111111111
RSC	retrosplenial cortex	0.777777777778
RSC	bretrosplenial cortex	0.111111111111
PLIC	posterior limb of the internal capsule	1.0
WAYWAY	100135	1.0
oxyH	boxygenated hemoglobin	1.0
RST	rubrospinal tract	0.75
RST	rank sum test	0.25
RSV	regulated secretory vesicle	0.142857142857
RSV	rous sarcoma virus	0.714285714286
RSV	retinal slip velocity	0.142857142857
mTBI	minimal traumatic brain injury	0.333333333333
mTBI	mild traumatic brain injury	0.666666666667
RSQ	response style questionnaire	1.0
RSR	ett syndrome	0.5
RSR	andom sampling	0.5
RSS	root sum square	1.0
-O-sulfo-α-d-glucopyranoside	sodium salt	1.0
SMARTS	pontaneous motor activity recording and tracking	1.0
DKS	domain knowledge scores	1.0
TMPDN	n,n′,n′-tetramethyl-p-phenylenediamine	1.0
NEL	neuron-specific enolase	1.0
IP-	10inducible protein-10	0.2
IP-	dep.immuno-depleted	0.2
IP-	ischemic preconditioned non-enriched	0.2
IP-	10γ-interferon inducible protein 10	0.2
IP-	3inositol trisphosphate-3	0.2
IP3	1,4,5-triphosphate	0.0188679245283
IP3	inositol-1,4,5-triphosphate	0.11320754717
IP3	inositol (1,4,5)-triphosphate	0.0188679245283
IP3	inositol-(1,4,5)-trisphosphate	0.0188679245283
IP3	inositol-(1, 4, 5)-triphosphate	0.0188679245283
IP3	inositol triphosphate	0.169811320755
IP3	1,4,5-inositol-trisphosphate	0.0188679245283
IP3	1,4,5-inositol triphosphate	0.0188679245283
IP3	inositol 1,4,5-trisphosphate	0.339622641509
IP3	inositol 1,4,5,-triphosphate	0.0188679245283
IP3	inositol trisphosphate	0.0377358490566
IP3	inositol 1,4,5-triphosphate	0.0943396226415
IP3	phosphoinositol trisphosphate	0.0188679245283
IP3	inositol-1,4,5-trisphosphate	0.0943396226415
Ro5-4864	4′-chlorodiazepam	1.0
DKO	micedouble-knockout mice	0.142857142857
DKO	double knockout	0.714285714286
DKO	double knock out	0.142857142857
9-DiI1	1′-dioleyl-3,3,3′,3′-tetramethulindocarbocyanine methanesulfonate	1.0
mAIP	myristoylated autocamtide-2-related inhibitory peptide	1.0
pEGFP	plasmid encoding enhanced green fluorescent protein	0.333333333333
pEGFP	plasmid encoding egfp	0.333333333333
pEGFP	enhanced green fluorescent protein	0.333333333333
HEPESHCO-	(3-)-free n-2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	1.0
CBPCREB-	binding protein	1.0
L-NAME	nω-nitro-l-arginine-methyl ester	0.04
L-NAME	nω-nitro-l-arginine methyl ester	0.04
L-NAME	n-nitro-l-arginine methyl ester	0.12
L-NAME	nω-nitro-l-arginine	0.04
L-NAME	l-arginine methyl ester	0.04
L-NAME	ng-nitro-l-arginine methylester	0.04
L-NAME	ng-nitro-l-arginine methyl ester	0.28
L-NAME	nω-nitro-l-arginine methyl ester hcl	0.04
L-NAME	l-nitroarginine methyl ester	0.08
L-NAME	ng-nitro-l-arginine	0.04
L-NAME	l-arg(no2)-ome·hcl	0.04
L-NAME	nω-nitro-l-arginine methylester	0.04
L-NAME	n′-nitro-l-arginine methyl ester	0.04
L-NAME	nw-nitro-l-arginine methyl ester	0.04
L-NAME	l-n(g)-nitroarginine methyl ester	0.04
L-NAME	l-n-arginine-methyl ester	0.04
rER	rough endoplasmic reteicula	0.125
rER	rough endoplasmic reticulum	0.75
rER	cisterns of rough endoplasmic reticulum	0.125
OASIS	old astrocyte specifically induced substance	1.0
EM-MP	external muscle–myenteric plexus	1.0
CP-M	lateral and medial caudate–putamen	1.0
POvl	ventral lamella of the principal olive	1.0
cMDD	current major depressive disorder	1.0
α-MT	α-methyl-p-tyrosine	1.0
IADP	adp current	1.0
PRCP	cg repressive complex	1.0
LDPT	long descending propriospinal tract	1.0
URE	unrestrained eater	1.0
RH-D	tetramethylrhodamine-conjugated dextran	1.0
LDPS	animals that received flash stimulation without preceding dark rearing	1.0
CNPC-	type natriuretic peptide	1.0
ddC	2′,3′-dideoxycytidine	1.0
CCX	cingulate cortex	1.0
LIPL	left inferior parietal lobe	1.0
p75NtR	low-affinity nerve growth factor receptor	1.0
MSN-D	1d1r-containing medium spiny neurons	1.0
NSP	neural stem/progenitor cell	0.4
NSP	nucleus subputaminalis	0.2
NSP	nigrostriatal pathway	0.2
NSP	neural stem/progenitor cells	0.2
pSTG	posterior superior temporal gyrus	0.5
pSTG	posterior stg	0.5
pre-CS	altered context prior to presentation of conditioned stimulus	1.0
GSH-	reduced glutathione	1.0
TANKTRAF	family member-associated activator of nf-kappa b	1.0
HFLH	enle fiber layer	1.0
IPB	infra-pyramidal bundle	0.25
IPB	infrapyramidal blade	0.25
IPB	intonational phrase boundary	0.25
IPB	sintonational phrase boundaries	0.25
PYY	peptide tyrosine tyrosine	0.0714285714286
PYY	peptide tyrosine–tyrosine	0.0714285714286
PYY	peptide yy	0.785714285714
PYY	polypeptide yy	0.0714285714286
TANOVA	topographic analysis of variance	1.0
IPA	ingenuity pathway analysis	0.6
IPA	anterior part of the intraparietal sulcus	0.2
IPA	indole-3-propionic acid	0.2
IPF	interpeduncular fossa	1.0
IPG	immobilized ph gradients	0.1
IPG	inferior frontal gyrus	0.1
IPG	immobilized ph-gradient	0.1
IPG	immobilized ph gradient	0.5
IPG	immobilized ph gradient buffer	0.1
IPG	internal pulse generator	0.1
IPD	idiopathic parkinson’s disease	0.666666666667
IPD	idiopathic parkinson's disease	0.333333333333
IPE	initial precipitating event	1.0
endo-G	endonuclease-g	1.0
EDMPP	equilibrium potential for dimethylphenylpiperazinium action	1.0
PYR	pyramidal cell	1.0
IPI	inter-pulse interval	0.173913043478
IPI	inter-peak interval	0.0434782608696
IPI	intraparenchymal injection	0.0434782608696
IPI	interpeduncular nucleus intermediate subnucleus	0.0434782608696
IPI	interpulse interval	0.565217391304
IPI	intermediate subnucleus of the i.p.	0.0434782608696
IPI	sinter-pulse intervals	0.0434782608696
IPI	sinterpulse intervals	0.0434782608696
IPN	interpeduncular nucleus	1.0
GABAARGABAA	receptor	0.916666666667
GABAARGABAA	receptors	0.0833333333333
IPL	the inferior parietal lobule	0.01
IPL	inferior parietal lobe	0.02
IPL	interpeduncular nucleus lateral subnucleus	0.01
IPL	inner plexiform layer	0.72
IPL	lateral interpeduncular nucleus	0.01
IPL	internal plexiform layer of the olfactory bulb	0.01
IPL	inner plexiform layers	0.01
IPL	inner plexiform layer of the retina	0.01
IPL	internal plexiform layer	0.06
IPL	intermediate lobe plus posterior lobe	0.01
IPL	inferior parietal lobule	0.12
IPL	intraplantar	0.01
IPR	rostral subnucleus of the i.p.	0.25
IPR	interpeduncular nucleus rostral subnucleus	0.5
IPR	voltage-gated proton current	0.25
IPS	intraparietal sulcus	0.8
IPS	ipsilateral to tilt	0.05
IPS	inferior peri-insular sulcus	0.05
IPS	intraparietal sulci	0.05
IPS	nucleus interstitio-pretecto-subpretectalis	0.05
IPP	image pro plus	1.0
vMPFC	ventral portion of the mpfc	0.333333333333
vMPFC	ventral medial prefrontal cortex	0.666666666667
GPI-	1046	0.666666666667
GPI-	anchor	0.333333333333
COX-IV	cytochrome c oxidase-iv	1.0
NGD	+nicotinamide-guanine dinucleotide	1.0
NGE	neuropeptide glycine-glutamic acid	0.5
NGE	neuropeptide ge	0.5
NGF	neuronal growth factor	0.00367647058824
NGF	neural growth factor	0.00367647058824
NGF	)	0.00183823529412
NGF	receptor	0.00183823529412
NGF	nerve growth factor	0.987132352941
NGF	nerve growth factor brain derived	0.00183823529412
STPBS	5% normal horse serum and 0.3% triton x-100 in pbs	1.0
db-cAMPN6	2′-o-dibutyryl cyclic amp	1.0
HDR	hemodynamic response	1.0
NGB	2904	1.0
NGC	pαnucleus reticularis gigantocellularis pars α	0.2
NGC	neurogliaform cell	0.2
NGC	nucleus reticularis gigantocellularis	0.4
NGC	nucleus gigantocellularis	0.2
NSDA	nigrostriatal dopaminergic pathway	0.1
NSDA	nigrostriatal dopamine	0.1
NSDA	nigrostriatal dopaminergic	0.8
NGM	normal growth medium	0.666666666667
NGM	nematode growth medium	0.333333333333
NGN	ewport green	1.0
MG-	microgyria absent	1.0
HDE	high-dose-ethanol	1.0
apoEKO	apolipoprotein e knockout	1.0
HDC	histidine decarboxylase	0.875
HDC	histamine decarboxylase	0.125
HDB	horizontal limb of the diagonal band	0.063829787234
HDB	nu horizontal limb diagonal band	0.0212765957447
HDB	mmedial part of the horizontal limb of the diagonal band of broca	0.0212765957447
HDB	the horizontal limb of the diagonal band	0.0212765957447
HDB	horizontal limb of the diagonal band of broca	0.276595744681
HDB	horizontal nucleus of the diagonal band of broca	0.0212765957447
HDB	horizontal limb nuclei of the diagonal band of broca	0.0212765957447
HDB	horizontal diagonal band of broca	0.127659574468
HDB	horizontal part of the diagonal band	0.0212765957447
HDB	horizontal diagonal band	0.063829787234
HDB	horizontal limb diagonal band	0.0212765957447
HDB	horizontal limb of diagonal band nucleus	0.0212765957447
HDB	horizontal diagonal band nucleus	0.0212765957447
HDB	nucleus of the horizontal limb of the diagonal band of broca	0.0425531914894
HDB	nucleus of the horizontal limb of the diagonal band	0.148936170213
HDB	horizontal limb of diagonal band	0.0851063829787
HDA	hypothalamic defence area	0.666666666667
HDA	hypothalamic defense area	0.333333333333
NGS	5% normal goat serum	0.00251889168766
NGS	10% normal goat serum	0.00251889168766
NGS	/tx3% normal goat serum plus 0.1% triton x-100	0.00251889168766
NGS	next-generation sequencing	0.00251889168766
NGS	normal goat seruml	0.00251889168766
NGS	normal goat serum	0.982367758186
NGS	55% normal goat serum	0.00251889168766
NGS	next generation sequencing	0.00251889168766
HDN	human diabetic neuropathy	1.0
HDM	shistone lysine demethylases	0.25
HDM	hard diet mice	0.25
HDM	shistone demethylases	0.5
HDL	high-density lipoprotein	0.625
HDL	haloperidol	0.125
HDL	high density lipoprotein	0.25
CIIC	ognitive impairment index	1.0
HDI	shistone deacetylase inhibitors	1.0
HDH	igh dexterity	0.0144927536232
HDH	untington's disease	0.507246376812
HDH	untington's disease gene	0.0144927536232
HDH	untington disease	0.0289855072464
HDH	untington’s disease	0.420289855072
HDH	yperpallium densocellulare	0.0144927536232
BMC	sbone marrow cells	0.2
BMC	bicuculline methchloride	0.2
BMC	bicuculline methochloride	0.6
SH2	src homology 2	0.5
SH2	src homology 2 domain	0.5
BMA	basomedial nucleus of the amygdala	0.111111111111
BMA	basomedial amygdala	0.333333333333
BMA	anterior part of basomedial amygdaloid nucleus	0.111111111111
BMA	aanterior accessory basal nucleus	0.111111111111
BMA	anterior part of the basomedial amygdala	0.111111111111
BMA	anterior basomedial nucleus	0.111111111111
BMA	basomedial nucleus of amygdala	0.111111111111
BMF	best modulation frequency	1.0
GABAARγ-	aminobutyric acid receptor type a	0.25
GABAARγ-	aminobutyric acid type a receptor	0.5
GABAARγ-	aminobutyric acida receptor	0.25
BMD	bone mineral density	0.5
BMD	becker muscular dystrophy	0.5
BME	basal eagle medium	0.0769230769231
BME	basal modified eagle's medium	0.0769230769231
BME	beta-mercaptoethanol	0.0769230769231
BME	basal medium essential	0.0769230769231
BME	basal eagle's medium	0.0769230769231
BME	basal medium eagle’s solution	0.0769230769231
BME	basal eagle's medium with earle's salts	0.153846153846
BME	basal medium eagle	0.230769230769
BME	basal medium of eagle	0.0769230769231
BME	basal eagle’s medium	0.0769230769231
BMI	brain machine interfaces	0.015873015873
BMI	bicuculline methiodine	0.015873015873
BMI	brain-machine interface	0.015873015873
BMI	bicuculline	0.015873015873
BMI	15-vdsinjected with 15.4×10-3 μg/g of bicuculline and confronted with the visual danger stimulus during the last minute	0.015873015873
BMI	bicuculline methoiodide	0.015873015873
BMI	(-)-bicuculline methiodide	0.031746031746
BMI	bicuculline methoidide	0.015873015873
BMI	bicuculline methiodide	0.666666666667
BMI	body mass index	0.190476190476
non-CCK-	dependent	1.0
BMS	brief maternal separation	0.333333333333
BMS	basso mouse scale	0.333333333333
BMS	bimanual motor skill	0.333333333333
BMP	4bone morphogenetic protein 4	0.121951219512
BMP	posterior basomedial amygdala nucleus	0.0243902439024
BMP	bone morphogenic protein	0.0487804878049
BMP	5bone morphogenetic protein-5	0.0243902439024
BMP	7bone morphogenetic protein 7	0.0243902439024
BMP	sbone morphogenetic proteins	0.0243902439024
BMP	basomedial posterior amygdala	0.0243902439024
BMP	2/4bone morphogenetic proteins 2 and 4	0.0243902439024
BMP	bone morphogenetic protein	0.487804878049
BMP	4bone morphogenic protein 4	0.0243902439024
BMP	4	0.0243902439024
BMP	bone morphogenetic proteins	0.0487804878049
BMP	basomedial nucleus of the amygdala (posterior)	0.0243902439024
BMP	basomedial amygdaloid nucleus (posterior)	0.0243902439024
BMP	7bone morphogenetic protein-7	0.0243902439024
BMP	6bone morphogenetic protein-6	0.0243902439024
Dp71	dystrophin protein of 71,000 mol. wt, or g-dystrophin	1.0
mEPSC	miniature excitatory postsynaptic current	0.47191011236
mEPSC	miniature excitatory post-synaptic current	0.0561797752809
mEPSC	sminiature excitatory postsynaptic currents (“minis”)	0.0112359550562
mEPSC	miniature excitatory postsynaptic currents	0.0224719101124
mEPSC	sminiature evoked excitatory postsynaptic currents	0.0112359550562
mEPSC	spontaneous miniature excitatory post-synaptic current	0.0112359550562
mEPSC	miniature excitatory postsynaptic/autaptic current	0.0112359550562
mEPSC	sminiature excitatory post-synaptic currents	0.0337078651685
mEPSC	sminiature excitatory post-synaptic current	0.0112359550562
mEPSC	miniature excitatory post-synaptic currents	0.0112359550562
mEPSC	miniature spontaneous excitatory post-synaptic current	0.0112359550562
mEPSC	sminiature excitatory postsynaptic currents	0.202247191011
mEPSC	sminiature epscs	0.0561797752809
mEPSC	spontaneous miniature excitatory postsynaptic current	0.0224719101124
mEPSC	miniature epsc	0.0561797752809
BMT	bone marrow transplantation	1.0
DMCM	methyl-6,7-dimethoxy-4-ethyl-β-carboline	1.0
PRDX	2peroxiredoxin 2	1.0
BMY	vehicle injection of distilled water	1.0
2hD	2 h periods of sleep deprivation during the sleep deprivation protocol	1.0
SHP	sh2 domain-containing protein tyrosine phosphatase	0.5
SHP	2phosphotyrosine phosphatase	0.5
RMR	recalculated mr	0.5
RMR	epeated measures	0.5
SHR	spontaneously-hypertensive rats	0.0571428571429
SHR	spontaneous hypertensive rat	0.0285714285714
SHR	spontaneous hypertensive rodent	0.0285714285714
SHR	/ncrlspontaneously hypertensive rat	0.0285714285714
SHR	s	0.0285714285714
SHR	spontaneously hypertensive rats	0.228571428571
SHR	stroke-prone shr	0.0285714285714
SHR	spontaneously hypertensive rat	0.514285714286
SHR	spontaneously hypertensive rat(s)	0.0285714285714
SHR	sspontaneously hypertensive rats	0.0285714285714
DPPC	dipalmitoylphosphatidylcholine	0.333333333333
DPPC	1-palmitoyl-2-palmitoyl-diacyl-sn-glycero-3-phosphatidylcholine	0.333333333333
DPPC	dipalmitoyl phosphatidylcholine	0.333333333333
SHT	spinohypothalamic tract	1.0
ACFS	artificial cerebrospinal fluid	1.0
SHV	subjective haptic vertical	1.0
ECF	extracellular fluid	0.578947368421
ECF	extracellular solution	0.105263157895
ECF	enhanced chemifluorescence	0.210526315789
ECF	eyes closed on foam	0.105263157895
RNR-D	reward/no-reward differential	1.0
SHY	septohypothalamic nucleus	1.0
MEKMAP	kinase kinase	0.333333333333
MEKMAP	kinase/erk kinase kinase	0.333333333333
MEKMAP	erk kinase	0.333333333333
ECE	riochrome cyanine staining	0.142857142857
ECE	picatechin	0.142857142857
ECE	endothelin converting enzyme	0.142857142857
ECE	endothelin-converting enzyme	0.571428571429
TBS-TT	ris-buffered saline-tween 20	0.0161290322581
TBS-TT	ris-buffered saline and tween 20	0.0161290322581
TBS-TT	ris-buffered saline+tween 20	0.0161290322581
TBS-TT	ris-buffered saline containing tween-20	0.0161290322581
TBS-TT	ris-buffered saline with 0.1% tween-20	0.0161290322581
TBS-TT	ween in tris-buffered saline	0.0161290322581
TBS-TT	ris-buffered saline–tween-20	0.0161290322581
TBS-TT	ris-buffered saline/0.1% tween-20	0.0322580645161
TBS-TT	ris-buffered saline containing tween 20	0.0161290322581
TBS-TT	riton x-100	0.0161290322581
TBS-TT	ris-buffered saline with 0.2% triton x-100	0.0161290322581
TBS-TT	ris-buffered saline–tween 20	0.0161290322581
TBS-TT	ris-buffered saline with added triton x-100	0.0161290322581
TBS-TT	ris–buffered saline–tween	0.0161290322581
TBS-TT	ris-buffered saline plus tween-20	0.0161290322581
TBS-TT	ris-buffered saline – tween 20	0.0161290322581
TBS-TT	ris-base saline–tween	0.0161290322581
TBS-TT	ris-buffered saline containing 0.05% (v/v) tween 20	0.0161290322581
TBS-TT	ris-buffered saline and 0.1% tween 20	0.0161290322581
TBS-TT	ris-buffered saline with 0.05% tween-20	0.0483870967742
TBS-TT	ris-buffered saline solution with 0.1% tween-20	0.0161290322581
TBS-TT	ris–hcl (ph 7.4) containing 150 mmol/l nacl and 0.05% tween 20	0.0161290322581
TBS-TT	ris-buffered saline containing 0.1% tween-20	0.0322580645161
TBS-TT	ris-buffered saline-tween-20	0.0161290322581
TBS-TT	ris-buffered saline with tween 20	0.0483870967742
TBS-TT	ris-buffered saline containing 0.01% triton x-100	0.0322580645161
TBS-TT	ris-buffered saline/tween 20	0.0161290322581
TBS-TT	ris-buffered saline containing 1% triton x-100	0.0161290322581
TBS-TT	ris-buffered saline with 0.2% tween-20	0.0161290322581
TBS-TT	ris-buffered saline tween-20	0.0161290322581
TBS-TT	ris-buffered saline 1×, 0.05% tween	0.0161290322581
TBS-TT	ris-buffered saline containing 0.05% tween 20	0.0161290322581
TBS-TT	ris-buffered saline solution with tween-20	0.0161290322581
TBS-TT	ris-buffered saline/tween	0.0161290322581
TBS-TT	ris-buffered saline with 0.3% triton x-100	0.0322580645161
TBS-TT	ris-buffered saline containing 0.1% tween	0.0161290322581
TBS-TT	ris-buffered saline containing 0.1% tween 20	0.0322580645161
TBS-TT	ris-buffered solution–triton	0.0161290322581
TBS-TT	ris-buffered saline with triton x-100	0.0645161290323
TBS-TT	ris-buffered saline containing 0.05% tween-20	0.0161290322581
TBS-TT	ris-buffered saline–tween	0.0161290322581
TBS-TT	ris-buffered saline with tween	0.0161290322581
TBS-TT	ris-buffered saline with tween-20	0.0483870967742
TBS-TT	ween 20 in tris-buffered saline	0.0161290322581
TBS-TT	ris-buffered saline containing tween	0.0161290322581
TBS-TT	ris-buffered saline with 0.1% triton x-100	0.0161290322581
TBS-TT	ris-buffered saline with 0.1% tween 20	0.0161290322581
TBS-TT	ris buffer containing 1% triton x-100	0.0161290322581
BMPRII	bone morphogenetic protein receptor ii	0.5
BMPRII	bone morphogenetic protein receptor type ii	0.5
intgE	integral value of the excitatory conductance change	1.0
DHPC	dorsal hippocampus	1.0
MCCG	2s,1′s,2′s-2-methyl-2-(carboxycyclopropyl)glycine	0.25
MCCG	α-methyl-(2s,3s,4s)-α-(carboxycyclopropyl)-glycine	0.25
MCCG	(2s,3s,4s)-2-methyl-2-(carboxycyclopropyl)glycine	0.5
DHPG	dihydroxyphenyl glycol	0.037037037037
DHPG	(r,s)-3,5-dihydroxyphenylglycine	0.185185185185
DHPG	s-3,5-dihydroxyphenylglycine	0.037037037037
DHPG	(s)-3,5-dihydoxyphenylglycine	0.037037037037
DHPG	dihydroxyphenylaglycine	0.037037037037
DHPG	3,5-dihydroxyphenylglycine	0.185185185185
DHPG	(s)-3,5-dihydroxyphenylglycine	0.148148148148
DHPG	(rs)-3,5-dihydroxyphenylglycine	0.0740740740741
DHPG	dihydroxyphenylglycol	0.0740740740741
DHPG	(rs)-3,5-dihydroxyphenyl-glycine	0.037037037037
DHPG	dihydroxyphenylglycine	0.148148148148
p70S	6k70kda ribosomal protein s6 kinase	0.1
p70S	6k70-kda ribosomal s6 kinase	0.1
p70S	6kp70s6 kinase	0.1
p70S	6k70 kda ribosomal s6 kinase	0.1
p70S	6kp70s6kinase	0.2
p70S	6kp70 ribosomal protein s6 kinase	0.1
p70S	6kp70 s6 kinase	0.1
p70S	6kp70 ribosomal s6 protein kinase	0.1
p70S	6kribosomal protein s6 kinase	0.1
POST	recordings made after the initial injection	0.2
POST	postsubiculum	0.2
POST	the seven onsets following the transients	0.2
POST	post-treatment sample	0.2
POST	after-stimulus air exposure	0.2
DNMTDNA	methyltransferase	0.6
DNMTDNA	methyltransferases	0.2
DNMTDNA	methyl-transferase	0.1
DNMTDNA	methyl transferase enzymes	0.1
SHM	sham-operated control	1.0
intgI	integral value of the inhibitory conductance change	1.0
LNX	left olfactory nerve transection	1.0
MGC	4607	0.25
MGC	metacerebral giant cell	0.5
MGC	medial geniculate complex	0.25
MGB	medial geniculate body	0.782608695652
MGB	minor groove binder	0.0434782608696
MGB	medical geniculate body	0.0434782608696
MGB	the medial geniculate body	0.0434782608696
MGB	medial geniculate body of the thalamus	0.0434782608696
MGB	vventral division of the medial geniculate body	0.0434782608696
MGA	medial giant axon	1.0
TBZ	tetrabenazine	1.0
MGG	may–grunwald/giemsa stain	1.0
CTXω-	conotoxin	0.5
CTXω-	conotoxin gvia	0.5
MGE	medial ganglionic eminence	0.894736842105
MGE	medial ganglionic eminences	0.105263157895
IH	immunohistochemistry	0.105263157895
IH	immunohistology	0.0526315789474
IH	hyperpolarisation-activated cation current	0.0526315789474
IH	interval histogram	0.0526315789474
IH	inward cationic conductance	0.0526315789474
IH	hyperpolarization-activated depolarizing current	0.0526315789474
IH	chimmunohistochemistry	0.0526315789474
IH	idling hypothesis	0.0526315789474
IH	yincerto-hypothalamic area	0.0526315789474
IH	intermittent hypoxia	0.473684210526
NG-	2neuroglial protein 2	0.166666666667
NG-	108 cells	0.166666666667
NG-	monomethyl-l-arginine	0.166666666667
NG-	2chondroitin sulfate proteoglycan	0.166666666667
NG-	nitro-l-arginine methyl ester	0.333333333333
TBS	theta-burst synaptic stimulation	0.00230414746544
TBS	continuous theta burst stimulation	0.00230414746544
TBS	+ttris-buffered saline containing 0.05% tween-20	0.00230414746544
TBS	tris–buffered solution	0.00230414746544
TBS	0.1-m tris-buffered saline	0.00230414746544
TBS	trisbuffered saline	0.00230414746544
TBS	tris buffered saline	0.0460829493088
TBS	tris/chloride-buffered saline	0.00230414746544
TBS	theta burst stimulation	0.0506912442396
TBS	θ-burst stimulation	0.00230414746544
TBS	–tweentris-buffered saline containing 0.1% tween 20	0.00230414746544
TBS	tris-buffered saline	0.714285714286
TBS	+ttbs with 1% triton x-100	0.00230414746544
TBS	trisma-buffered saline	0.00230414746544
TBS	0.05m tris–hcl-buffered saline	0.00230414746544
TBS	tissue-buffering solution	0.00460829493088
TBS	0.1 m tris-buffered saline (ph 7.40)	0.00230414746544
TBS	+50 mm tris-buffered saline containing 4% horse serum and 0.2% triton x-100	0.00230414746544
TBS	/ttris-buffered saline containing 0.1% tween-20	0.00460829493088
TBS	tris-buffer-saline	0.00230414746544
TBS	100mm tris-hcl ph 7.41.5m nacl	0.00230414746544
TBS	ph 7.5, containing 0.05% tween 20	0.00230414746544
TBS	tissue buffering solution	0.00230414746544
TBS	20 mm tris-buffered saline	0.00230414746544
TBS	tris buffer with saline	0.00230414746544
TBS	+ttriton diluted in tris-buffered saline	0.00230414746544
TBS	20 mm tris–hcl (ph 7.4)/150 mm nacl	0.00230414746544
TBS	+, tris-buffered saline with triton x-100	0.00230414746544
TBS	tris-buffer saline	0.00921658986175
TBS	theta-burst stimulation	0.036866359447
TBS	tris-buffered salaine	0.00230414746544
TBS	triphosphate-buffered saline	0.00230414746544
TBS	tris buffer saline	0.00691244239631
TBS	tris-buffered saline with 0.1% triton x-100	0.00230414746544
TBS	+ttris-buffered saline containing 0.05% tween 20	0.00460829493088
TBS	–ttris-buffered saline with triton x-100	0.00230414746544
TBS	/ttris-buffered saline with 0.5% tween	0.00230414746544
TBS	theta-bust stimulation	0.00230414746544
TBS	+ttris-buffered saline+tween-20	0.00230414746544
TBS	—tweentris-buffered saline in tween 20	0.00230414746544
TBS	theta-burst tms	0.00230414746544
TBS	tris–hcl-buffered saline	0.0138248847926
TBS	+tris-buffered saline	0.00230414746544
TBS	/ttris-buffered saline containing 0.1% tween 20	0.00230414746544
TBS	ttris-buffered saline with 0.05% tween-20	0.00230414746544
TBS	+tris-buffered saline containing 0.5% triton x-100	0.00230414746544
TBS	tris–buffered saline	0.0253456221198
TBR	2t-brain gene-2	0.333333333333
TBR	time to burst-suppression recovery	0.333333333333
TBR	– theta–beta ratio	0.333333333333
MGN	medial geniculate nucleus of the thalamus	0.0416666666667
MGN	medial geniculate nucleus	0.958333333333
MGM	medial part of the geniculate nucleus	0.1
MGM	ethyl green	0.1
MGM	medial division of the medial geniculate body	0.5
MGM	alachite green	0.1
MGM	medial division of the medial geniculate nucleus	0.2
MGL	monoacyl glycerol lipase	0.166666666667
MGL	monoacylglycerol lipase	0.5
MGL	monoglyceride lipase	0.166666666667
MGL	monoacylglyceride lipase	0.166666666667
TBI	)	0.00980392156863
TBI	trauma brain injury	0.00980392156863
TBI	traumatic brain injury	0.980392156863
TBH	tris-buffered horse serum	0.5
TBH	tyramine β-hydroxylase	0.5
MGP	medical geniculate nucleus, posterior post	0.111111111111
MGP	medial globus pallidus	0.777777777778
MGP	medial globus pallidus (entopeduncular nu)	0.111111111111
TBM	tensor-based morphometry	1.0
DL-AP5	dl-2-amino-5-phosphonovaleric acid	0.428571428571
DL-AP5	dl-2-amino-5-phosphonopentanoic acid	0.428571428571
DL-AP5	(±)-2-amino-5-phosphonopentatonic acid	0.142857142857
TBO	time spent in the open arm	0.5
TBO	time to burst-suppression origin	0.5
EthD-1	ethidium homodimer	1.0
TBA	thiobarbituric-acid	0.0769230769231
TBA	tetrabutylammonium	0.0769230769231
TBA	thiobarbituric acid	0.846153846154
TBC	1d7tbc1 domain family member 7	1.0
TBE	tribromoethernol	0.333333333333
TBE	tris–boric acid–edta	0.333333333333
TBE	time spent in the closed arm	0.333333333333
KOR1	kappa opioid receptor	0.5
KOR1	cloned κ-opioid receptor	0.5
TBF	stail beat frequencies	0.5
TBF	theta burst firing	0.5
RETEST	retested	1.0
PDAR	akinetic/rigidity predominant parkinson's disease	1.0
Fra	fos-related antigen	1.0
FOCS	fibre optic chemical sensor	1.0
LUT	lower urinary tract	1.0
MVEP	multi-focal vep	1.0
LFLBlow-firing	low-bursting	1.0
FBDP	fodrin breakdown product	1.0
BoNTs	botulinum neurotoxins	1.0
DBH-I	immunoreactivity to dopamine beta hydroxylase	1.0
OCTN	novel organic cation transporter	1.0
OCTO	ptimum cutting temperature	1.0
LUC	stratum lucidum	0.25
LUC	luciferase	0.75
LEWL	ewis	1.0
ADSC	adipose tissue-derived stem cells	0.5
ADSC	adipose-derived stem cells	0.5
MAASM	indful attention awareness scale	1.0
TUJβIII-	tubulin	1.0
S-ESBAS-	ethylsulfonylbenzoylalanine	1.0
MWWM	ann–whitney–wilcoxon	1.0
ALOaxial	forelimb, orolingual	1.0
AMD31001	1'-[1,4-phenylenebis-(methylene)]-bis-(1,4,8,11-tetraazacyclotetradecane) octahydrochloride dehydrate	1.0
P-tau	soluble abnormally hyperphosphorylated tau isolated from ad brain	1.0
LTP-IE	long-term potentiation of intrinsic excitability	1.0
oxy-E	oxyethidium	1.0
PDAc	phorbol 12,13-diacetate	1.0
RMA	robust multi-array average expression measure	0.2
RMA	robust microarray analysis	0.2
RMA	robust multi-array average	0.4
RMA	rostral motor area	0.2
MBEAM	ontreal battery of evaluation of amusia	1.0
SSTKO	somatostatin knockout	1.0
H-HH	odgkin-huxley	0.5
H-HH	amburger-hamilton	0.5
DWT	discrete wavelet transforms	1.0
NFAT	c4	0.25
NFAT	nuclear factor of activated t cell	0.25
NFAT	nuclear factor of activated t cells	0.5
TSBT	ris saline buffer	1.0
rt-RT-PCR	reverse transcription followed by real-time polymerase chain reaction	1.0
LDSV	large dense-cored vesicle	1.0
pGC	particulate guanylate cyclase	0.5
pGC	particulate guanylyl cyclase	0.5
MUNE	motor unit number estimation	1.0
SCFSKP	cullin, f-box	1.0
ECP	exo/endo cycling vesicle pool	1.0
TCIT	emperament and character inventory	1.0
3-MGT	3-methylglutaconic acid	1.0
GIRKG-	protein-coupled inwardly rectifying potassium (channels)	0.0666666666667
GIRKG-	protein-coupled inwardly rectifying k+	0.133333333333
GIRKG-	protein sensitive inwardly rectifying potassium channel	0.0666666666667
GIRKG-	protein-activated inwardly rectifying potassium channels	0.0666666666667
GIRKG-	protein coupled inward rectifying potassium	0.0666666666667
GIRKG-	protein-coupled inwardly rectifying potassium channels	0.133333333333
GIRKG-	protein coupled inward rectifier potassium channel	0.0666666666667
GIRKG-	protein-coupled inwardly rectifying potassium	0.133333333333
GIRKG-	protein-coupled inward-rectifying potassium channel	0.0666666666667
GIRKG-	protein activated potassium channel	0.0666666666667
GIRKG-	protein coupled inwardly-rectifying potassium currents	0.0666666666667
GIRKG-	protein-coupled inward rectifier k+	0.0666666666667
Fr2	frontal cortex	0.333333333333
Fr2	frontal area 2	0.333333333333
Fr2	frontal cortex area 2	0.333333333333
Fr1	fr2, fr3motor cortical areas	0.25
Fr1	primary motor cortex	0.5
Fr1	motor cortex	0.25
N-AGN-	arachidonylglycine	1.0
GAP-43	growth-associated protein of 43kda	0.0204081632653
GAP-43	growth-associated protein 43	0.163265306122
GAP-43	growth-associated phosphoprotein 43	0.0204081632653
GAP-43	growth-associated protein of 43,000 mol. wt	0.0408163265306
GAP-43	growth-associated protein-43-kd	0.0204081632653
GAP-43	growth-associated protein of apparent molecular weight 43,000	0.0204081632653
GAP-43	growth-associated protein, mol. wt 43 000	0.0204081632653
GAP-43	growth associated protein-43	0.0612244897959
GAP-43	growth-associated phosphoprotein	0.0204081632653
GAP-43	neuromodulin	0.0204081632653
GAP-43	growth-associated protein-43	0.469387755102
GAP-43	growth-associated protein	0.0816326530612
GAP-43	43-kda growth-associated protein	0.0204081632653
GAP-43	growth-associated peptide-43	0.0204081632653
SDS-FRLSDS-	digested freeze-fracture replica labeling	1.0
3T	three times the threshold	1.0
TCID	tissue culture infectious dose	1.0
LNG	liquid nitrogen grinding	1.0
XPNPEP	1x-prolyl aminopeptidase p1xpnpep1	1.0
1-BnTIQ1-benzyl-1	2,3,4-tetrahydroisoquinoline	1.0
ACCM	astrocyte conditioned medium	1.0
NFS	non-fast-spiking	1.0
LNA	lateral amygdaloid nucleus	0.25
LNA	δ-linolenic acid	0.25
LNA	lateral nucleus of amygdala	0.25
LNA	lateral nucleus of amygdale	0.25
BCIP5-bromo-4-chloro-3-indoyl-phosphate	4-toluidine salt	1.0
TBSTTX-	100 in tbs	1.0
STX-	3syntaxin 3	1.0
LNC	later negative component	0.25
LNC	late negative component	0.75
Ip	pump current	0.333333333333
Ip	peak amplitude of postsynaptic currents	0.333333333333
Ip	na+/k+ pump current	0.333333333333
KET	ketanserin	1.0
VPLpc	ventral posterolateral nucleus thalamus, parvicellular part	0.5
VPLpc	ventroposterolateral parvicellular thalamic nucleus	0.5
3rdV	3rd ventricle	1.0
PD98059	2,2′-amino 3′-methoxy-phenyl-(oxanaphthalen-4-one)	0.25
PD98059	2-(2-amino-3-methoxyphenyl)-4h-1-benzopyran-4-one	0.25
PD98059	2′-amino-3′-methoxyflavone	0.25
PD98059	[2-(2′-amino-3′-methoxyphenyl)-oxanaphthalen-4-one]	0.25
AcbC	core of the nucleus accumbens	0.333333333333
AcbC	nucleus accumbens core	0.333333333333
AcbC	core region of the accumbens nucleus	0.333333333333
D-PBSD	ulbecco’s phosphate-buffered saline	1.0
OT-	iroxytocin immunoreactive	1.0
ECE-	1endothelin-converting enzyme	0.333333333333
ECE-	1endothelin-converting enzyme 1	0.333333333333
ECE-	2endothelin-converting enzyme-2	0.333333333333
NPVFVPNLPQRF-NH	2	1.0
3C	b3rd cerebellar lobule	1.0
-MK-	801	1.0
3B	r-7ni3-bromo 7-nitroindazole	0.5
3B	r7ni3-bromo-7-nitroindazole	0.5
ABIA	pplied biosystems inc.	0.5
ABIA	pplied biosystems	0.5
C-Pcaudate-putamen	striatum	1.0
NORTN	ovel object recognition task	1.0
NoCRD	no colorectal distension	1.0
CARB-I	carbachol inhibited	1.0
VVAV	icia villosa agglutinin	0.75
VVAV	icia villosa lectin	0.25
dfEPSP	dendritic field excitatory postsynaptic potential	1.0
SR-A-	deficient mice	1.0
CARB-E	carbachol excited	1.0
DRSTD	elayed recognition span task	1.0
SATB	special at-rich sequence binding	0.5
SATB	1special at-rich dna-binding protein 1	0.5
t-JNK	total jnk	1.0
αCAMKII	α-calmodulin-dependent kinase ii	1.0
DMRD	uncan’s new multiple range	1.0
WGTAW	isconsin general testing apparatus	1.0
TCC2	3,5-triphenyltetrazolium chloride	1.0
βAPPβ-	amyloid precursor protein	1.0
CVISI	coefficient of variation	0.5
CVISI	cmaverage coefficient of variation of the interspike intervals for cell c across all trials with memoranda m	0.5
DALBKD	es-arg8-leu9-bk	1.0
rTMS	repetitive transcranial magnetic stimulation	0.84
rTMS	repetitive tms	0.12
rTMS	repeated transcranial magnetic stimulation	0.04
dAAO	d-amino acid oxidase	1.0
AEMS	anterior extramural migratory stream	1.0
PCom	nucleus of the posterior commissure	1.0
dICN	dorsal intercalated nucleus	1.0
TβR-II	type ii transforming growth factor-beta receptor	1.0
Isk	voltage-gated potassium channel subtype	1.0
PAINT	promoter analysis and interaction network generation tool	1.0
ICAM	intercellular adhesion molecule	0.714285714286
ICAM	intracellular adhesion molecule	0.142857142857
ICAM	1intercellular adhesion molecule 1	0.142857142857
ICAI	cariin	0.333333333333
ICAI	ndependent component analysis	0.666666666667
L-365	260, 3r(+)-n-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl)-n′-(3-methyl-phenyl)urea	0.5
L-365	260	0.5
ICAD	inhibitor of cad	0.333333333333
ICAD	inhibitor of caspase-activated dnase	0.666666666667
DRGN	dorsal root ganglion neuron	1.0
OXO-MN	n,n,-trimethyl-4-(2-oxo-1-pyrrolidinyl)-2-butyn-1-ammonium iodide, oxotremorine methiodide	1.0
DRGs	dorsal root ganglia	1.0
P65	positive peak in the cortical response at 65 ms after stimulus	1.0
LGIC	ligand-gated ion channel	0.666666666667
LGIC	ligand-gated ionic channel	0.333333333333
OTA	oxytocin antagonist	0.583333333333
OTA	oxytocin receptor antagonist	0.166666666667
OTA	d(ch2)5[tyr(me)2,thr4,orn8,tyr-nh29]-vasotocin	0.0833333333333
OTA	ochratoxin a	0.0833333333333
OTA	d-(ch2)5[tyr(me)2,thr4, orn8,tyr-nh29]vasotocin	0.0833333333333
OTC	organotypic culture	0.4
OTC	ornithine transcarbamylase	0.4
OTC	organotypic slice cultures	0.2
pMFG	peak magnetic field gradient	1.0
Mes-V	mesencephalic trigeminal nucleus	1.0
D-FEN	dexfenfluramine	1.0
IBP	isoquinoline-binding protein	1.0
TEST	testing	0.5
TEST	post-conditioning	0.5
N-7-nitrobenz-2-oxa-1	3-diazol-4-yl) amino] caproyl}	1.0
OTR	oxytocin receptors	0.0909090909091
OTR	oxytocin receptor	0.636363636364
OTR	sot receptors	0.0909090909091
OTR	open-to-total ratio	0.0909090909091
OTR	open–total ratio	0.0909090909091
OTS	occipitotemporal sulcus	1.0
TESP	succinyl phosphonate triethyl ester	1.0
GSA-I-B4	griffonia simplicifolia b4-isolectin	1.0
HTMT	histaminetrifluoromethyl toluidide	1.0
IGFI	insulin-like growth factor-i	1.0
NALPNA	cht leucine-rich-repeat protein	1.0
rfMRI	resting state functional magnetic resonance imaging	1.0
hUCB	human umbilical cord blood	1.0
l-NAMEN-	omega-nitro-l-arginine methyl ester	0.25
l-NAMEN-	nitro-l-arginine methyl ester hydrochloride	0.25
l-NAMEN-	nitro-l-arginine methyl ester	0.5
DY-	9760e3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]	1.0
CRABP	cellular retinoic acid-binding protein	0.5
CRABP	cellular retinoic acid binding protein	0.5
NRPC	nucleus reticularis pontis caudalis	1.0
MDCKM	adin-darby canine kidney cells	0.4
MDCKM	adin-darby canine kidney	0.4
MDCKM	adin–darby canine kidney	0.2
pAOBc	caudal region of the posterior accessory olfactory bulb	1.0
HU210	(-)-11-hydroxy-δ8-tetrahydrocannabinol-dimethyl-heptyl	1.0
IMLI	ntermediolateral column	1.0
AEBSF	[4-(2-aminoethyl)-benzenesulphonylfluoride, hcl]	0.1
AEBSF	4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride	0.3
AEBSF	4-(2-aminoethyl)-benzenesulfonylfluoride hydrochloride	0.1
AEBSF	4-(2-aminoethyl) benzenesulphonyl fluoride	0.1
AEBSF	4-(2-aminoethyl)benzenesulphonylfluoride	0.1
AEBSF	4-(2-aminoethyl)-benzene sulfonyl fluoride–hcl	0.1
AEBSF	4-(2-aminoethyl)-benezensulfanyl fluoxide	0.1
AEBSF	4-(2-aminoethyl)benzene-sulfonyl fluoride hydrochloride	0.1
HAEC	human amniotic epithelial cell(s)	1.0
LTXα-	latrotoxin	1.0
EPW	electrical stimulation-induced paw withdrawal	1.0
DAAO	d-amino acid oxidase	1.0
GLRA1null	null allele of the glra1 gene	1.0
SCWP	standard cage whisker-paired	1.0
hSYN	mouse anti-synaptophysin	1.0
VEGFRVEGF	transmembrane tyrosine kinase receptors	1.0
DCTN	5dynactin 5	1.0
GLYX-	13	1.0
d-M	etd-methionine	1.0
GDIR	ab gdp dissociation inhibitor	1.0
TLAT	latency to peak of the n30 auditory potential evoked by the second (test) click	0.5
TLAT	test latency	0.5
IPSPB	late inhibitory postsynaptic potentials	0.5
IPSPB	ipsp mediated by gabab receptors	0.5
IPSPA	early inhibitory postsynaptic potentials	0.333333333333
IPSPA	ipsp mediated by gabaa receptors	0.333333333333
IPSPA	inhibitory postsynaptic potential mediated by gabaa receptors	0.333333333333
SOCC	store-operated ca2+ channel	0.5
SOCC	store-operated calcium current	0.5
NBQX6	7-dinitroquinoxaline-2,3-dione	1.0
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxo-benso[f]quinoxaline-7-sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxobenzo[f]quinoxaline-7-sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-6nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxibenzo[f]quinoxaline-7-sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo{f}quinoxaline-7-sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-4-nitro-2,3-dixo-benzo(f) quinoxaline-7-sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide	0.388888888889
NBQX1	2, 3, 4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxobenzo(f)quinoxaline-7sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxo[f]quinoxaline-7-sulfonamide disodium	0.0555555555556
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxobenzo-[f]-quinoxaline-7-sulfonamide	0.0555555555556
NBQX1	2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide disodium salt hydrate	0.0555555555556
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzoquinoxaline-7-sulfonamide	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulphonamide	0.0181818181818
NBQX2	3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f] quinoxaline-2,3-dione	0.0181818181818
NBQX2	3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)-quinoxaline	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7 -sulfonamide	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo(f)quinoxaline-7-sulfonamide	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline -7-sulfonamide	0.0181818181818
NBQX2	3-dihydroxy-6-nitro-7-sulfamoyl-benzo-quinoxaline	0.0181818181818
NBQX2	3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]-quinoxaline	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetraqhydrobenzo(f)quinoxaline-7-sulfonamide disodium salt	0.0545454545455
NBQX2	3-dioxo-6-nitro-1,2,3,4,-tetrahydrobenzo(f)quinoxaline-7-sulfonamide	0.0181818181818
NBQX2	3,-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulphonamide	0.0181818181818
NBQX2	3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione	0.127272727273
NBQX2	3,-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide	0.0363636363636
NBQX2	3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinixaline	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulphonamide disodium	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo [f] quinoxaline-7-sulfoamide disodium	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4,-tetrahydrobenzo[f]quinoxaline-7-sulfonamide	0.0363636363636
NBQX2	3-dihydroxy-6-nitro-7-sulfamoylbenzoquinoxaline	0.0181818181818
NBQX2	3-dihydroxy-6-nitro-7-sulfonyl-benzo[f]quinoxaline	0.0181818181818
NBQX2	3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione	0.0181818181818
NBQX2	3-dihydro-6-nitro-7-sulfamoyl-benzo(f) quinoxaline	0.0181818181818
NBQX2	3,-dioxo-6-nitro-1,2,3,4,-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide	0.327272727273
NBQX2	3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f) quinoxaline	0.0181818181818
NBQX2	3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline	0.0181818181818
NBQX2	3-dioxo-6-nitro-1,2,3,4-tetra-hydrobenzo[f]quinoxaline-7-sulfonamide	0.0181818181818
MS222	tricaine methanesulfonate	0.333333333333
MS222	3-aminobenzoic acid ethyl ester, methanesulfonate salt	0.333333333333
MS222	ethyl m-aminobenzoate	0.333333333333
HIOP	transient increase of the intraocular pressure	1.0
d-P	en5]-enkephalin; rvmrostral ventromedial medulla	1.0
H2DCF-DA	dichlorodihydrofluorescein diacetate	1.0
IPSPs	inhibitory post synaptic potentials	0.111111111111
IPSPs	inhibitory postsynaptic potentials	0.888888888889
l-NAMENG	nitro-l-arginine methyl ester hydrochloride	0.5
l-NAMENG	-nitro-l-arginine methyl ester	0.5
PARV	parvalbumin	1.0
CPDX1	3-dipropyl-8-phenylxanthine, an a1 receptor antagonist	1.0
LY215490	(3sr,4ars,6rs,8ars)-6-[2-(1h-tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid	1.0
DAOA	d-amino-acid oxidase activator	1.0
rh5HTTLPR	rhesus serotonin transporter-linked polymorphic region	1.0
U91356A	((r)-5-(propylamino)-5,6-dihydro-4h-imidazo[4,5,1-ij]-quinolin-2(1h)-one hydrochloride)	1.0
BFNAβ-	funaltrexamine	1.0
d-T	rpd-tryptophan	1.0
NONMYE	unmyelinated	1.0
2P-	domain k+ channels	1.0
LTBP-1	latent tgf-β-binding protein-1	1.0
Vodm	dorsomedial nucleus of vo	1.0
CTAPD-P	he-cys-trp-arg-thr-pen-thr-nh2	1.0
beta-FNA	beta-funaltrexamine	1.0
MCH-	1 receptor	0.5
MCH-	1rmch receptor1	0.5
Fos	sexual behavior, associative learning, odor, nucleus accumbens, hypothalmus	1.0
lSN	lateral substantia nigra	1.0
aLHA	anterior portion of the lateral hypothalamic area	0.5
aLHA	anterior lateral hypothalamic area	0.5
EPI	paired pulse index of field excitatory postsynaptic potential	0.0243902439024
EPI	echo planar imaging	0.268292682927
EPI	echo echoplanar imaging	0.0243902439024
EPI	echoplanar imaging	0.0243902439024
EPI	epinephrine	0.0487804878049
EPI	echoplanar images	0.0731707317073
EPI	echo-planar imaging	0.292682926829
EPI	echo planar images	0.0243902439024
EPI	echoplanar image	0.0243902439024
EPI	epsp paired-pulse facilitation index	0.0243902439024
EPI	echo-planar-imaging	0.0731707317073
EPI	echo planar image	0.0243902439024
EPI	sechoplanar images	0.0243902439024
EPI	executive dysfunction index	0.0243902439024
EPI	paired-pulse index of field excitatory postsynaptic potential	0.0243902439024
GTP-	binding protein	0.666666666667
GTP-	binding proteins	0.333333333333
JPSH	joint peristimulus histogram	1.0
5-NO2BAPTA	1,2-bis(2-amino-5-nitrophenoxy)ethane-n,n,n′,n′-tetra-acetate	1.0
Mes5	mesencephalic trigeminal tract nucleus	1.0
PI-PLC	phosphatidylinositol-specific phospholipase c	0.5
PI-PLC	phosphatidylinositol specific phospholipase c	0.25
PI-PLC	phosphatidylinositol–phospholipase	0.25
BAMEC	bovine adrenal medulla endothelial cell	1.0
NR-2C	nmda receptor 2c subunit	1.0
TβRIITGFβ	type ii receptor	1.0
ZO-	1zonulla occludin-1	0.0833333333333
ZO-	1zonula-occludens-1	0.0833333333333
ZO-	2zonula occludens-2	0.0833333333333
ZO-	1zonula occludens 1	0.0833333333333
ZO-	1zonula occludens-1	0.666666666667
SREBP	sterol regulatory element binding protein	1.0
KPBS-T	potassium containing phosphate-buffered saline solution with 0.1% triton x-100	0.333333333333
KPBS-T	potassium phosphate-buffered saline/0.25% triton x	0.333333333333
KPBS-T	potassium phosphate-buffered saline+0.25% triton x-100	0.333333333333
LRAPATAC	liposomal rapamycin/tacrolimus	1.0
spNTS	nucleus tractus solitarius (sub-postremal)	0.5
spNTS	subpostremal nucleus tractus solitarius	0.5
dKO	double knockout	1.0
EMSA	electrophoresis mobility shift assay	0.0625
EMSA	electrophoretic mobility shift analysis	0.03125
EMSA	electrophoretic mobility shift assays	0.03125
EMSA	electrophoretic mobility-shift analysis	0.03125
EMSA	electrophoretic mobility shift assay	0.75
EMSA	electro-mobility shift assay	0.03125
EMSA	electromobility shift assay	0.03125
EMSA	electrophoretic-mobility-shift-assay	0.03125
D-NNA	ng-nitro-l-arginine	1.0
MDTN	mediodorsal thalamic nuclei	1.0
EMSE	lectron microscopy sciences	1.0
l-CSS	l-cysteinsulphinate	1.0
ZOL	zolpidem	1.0
Rtp	primordium of reticular thalamic nucleus	1.0
GiDA	gigantocellular depressor area	1.0
ZOZ	onula occludens	1.0
p-DAB	1phosphorylated dab1	1.0
deoxyH	bdeoxygenated hemoglobin	1.0
wtERK	2-gfpexpressing erk2 coupled to green fluorescent protein	1.0
MCHL	monaural conductive hearing loss	1.0
rGMV	regional gray matter volume	0.5
rGMV	regional gm volume	0.5
z-FA-	fmkn-benzyloxycarbonyl-phe-ala-fluoromethyl ketone	1.0
LL-GABA	length of gaba synapses per unit length	1.0
rAChE	recombinant ache	1.0
TLCK	n-tosyl-l-lysyl chloromethylketone	0.666666666667
TLCK	na-p-tosyl-l-lysine chloromethylketone	0.333333333333
GTPG	uanosine-5'-triphosphate	1.0
GSHPx	seleno-glutathione peroxidase-i	1.0
MALDI-TOF-MS	matrix-assisted laser desorption ionization-time of flight-mass spectrometry	0.333333333333
MALDI-TOF-MS	/msmatrix-assisted laser desorption ionization-time of flight-tandem mass spectrometry	0.666666666667
InsP3inositol-1	4,5-triphosphate	0.5
InsP3inositol-1	4,5-trisphosphate	0.5
HPOA	preoptic area/hypothalamus region	0.5
HPOA	preoptic/hypothalamic block	0.5
NOC-183	3-bis(aminoethyl)-1-hydroxy-1-oxo-1-triazene (a no donor)	0.333333333333
NOC-183	3-bis(aminoethyl)-1-hydroxy-1-oxo-1-triazene (or deta nonoate, a no donor)	0.333333333333
NOC-183	3-bis(aminoethyl)-1-hydroxy-1-oxo-1-triazene	0.333333333333
BBBEC	shuman bbb endothelial cell line hcmec/d3	1.0
NAMPT	nicotinamide phosphoribosyltransferase	1.0
PBS-MC	phosphate buffered saline with mg2+ and ca2+	1.0
ECEL	1endothelin converting enzyme like-1	1.0
TUNELT	dt uptake nick-end labelling	0.0277777777778
TUNELT	erminal deoxynucleotidyl transferase-mediated dutp-digoxigenin nick-end labeling	0.0277777777778
TUNELT	erminal deoxynucleotidyl transferase-mediated dutp nick-end labeling	0.0277777777778
TUNELT	dt-mediated dutp-biotin nick end labeling	0.0555555555556
TUNELT	erminal utp nick end labeling	0.0277777777778
TUNELT	dt-mediated dutp-x nick end labeling	0.0277777777778
TUNELT	erminal deoxynucleotidyl transferase dutp nick end labeling	0.0277777777778
TUNELT	dt-mediated dutp nick-end labeling	0.305555555556
TUNELT	erminal deoxynucleotidyl-transferase-mediated dutp nick-end labeling	0.0277777777778
TUNELT	dt-mediated dutp-biotin nick-end labeling	0.0277777777778
TUNELT	erminal deoxynucleotidyl transferase-mediated dutp nick-end-labeling	0.0277777777778
TUNELT	dt-mediated dutp nick end labeling	0.25
TUNELT	dt-mediated dutp-digoxigenin nick end labeling	0.0277777777778
TUNELT	dt-mediated dutp nick end-labeling	0.0555555555556
TUNELT	erminal deoxynucleotidyl transferase–mediated 2′-deoxyuridine-5-triphosphate (dutp) nick-end labeling	0.0277777777778
TUNELT	erminal deoxynucleotidyl transferase-mediated digoxigenin-dutp-biotin nick-end labeling	0.0277777777778
LPBS	lateral parabrachial nucleus superior	1.0
GABABR1	gabab receptor subunit r1	1.0
LINGO	1leucine-rich repeat and immunoglobulin domain-containing-1	1.0
OPTN	optineurin	1.0
APAA	nticipatory postural adjustment	1.0
LCHBSS	low-calcium hanks' balanced salt solution	1.0
hDB	ventral and horizontal positions of the diagonal band	0.5
hDB	horizontal limb of diagonal band	0.5
moB	uchemouse butyrylcholinesterase	1.0
ω-AgaIVA	ω-agatoxin iva	1.0
trans-PDC	l-trans-pyrrolidine-2,4-dicarboxylic acid	1.0
PDR	preferred direction response	1.0
pBST	principal nucleus of the bed nucleus of the stria terminalis	1.0
NMDG-ACSFN-	methyl-d- glucamine-artificial cerebro-spinal fluid	1.0
INCON-MATCH	incongruent/gender-match	1.0
εPKC	epsilon protein kinase c	1.0
SDGRG	serine–aspartate–glycine–arginine–glycine	1.0
NTR	neurotensin receptor	0.2
NTR	p75 neurotrophin receptor	0.2
NTR	neurotrophin receptor	0.6
PELP1proline-	glutamic acid- and leucine-rich protein-1	1.0
IRβ	insulin receptor β subunit	1.0
αBGTα-	bungarotoxin	1.0
rp49RNA	binding protein 49	1.0
1DR	one-direction rewarded	1.0
LY-294	002	1.0
L-NNA	rgng-nitro-l-arginine	0.166666666667
L-NNA	ng-nitro-l-arginine	0.666666666667
L-NNA	nω-nitro-l-arginine	0.166666666667
SELEX	systematic evolution of ligands by exponential enrichment	1.0
DAF-FM	4-amino-5-methylamino-2′,7′ diaminofluorescein-fm	0.333333333333
DAF-FM	diaminofluorescein-fm	0.333333333333
DAF-FM	4-amino-5-methylamino-2′,7′-difluorofluorescein	0.333333333333
Hipp	hippocampal activity	1.0
CMS-VCMS	vehicle	1.0
VVD	volume occupied by densely packed vesicles within terminal	1.0
VDRCV	ienna drosophila rnai center	1.0
NINCDS	–adrdanational institute of neurological and communicative disorders and stroke–alzheimer’s disease and related disorders association	1.0
PMPA	phosphonomethyl-pentanedioic acid	1.0
MUFA	monounsaturated fatty acids	0.5
MUFA	monounsaturated fatty acid	0.5
BKBB	amford kowal and bench	1.0
NBIC	nucleus of the brachium of the inferior colliculus	1.0
WSC	water-soluble carbodiimide	1.0
BCTCN-	(4-tertiary butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2h)-carbox-amide	0.5
BCTCN-	(4-t-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2h)-carboxamide	0.5
NOCD	naturally occurring cell death	1.0
WSI	weighted shift index	1.0
NOCI	nociceptor or nociceptive	1.0
PBSMT	pbs with instant skimmed milk and triton x-100	1.0
L-DOPAL-3	4-dihydroxyphenylalanine	1.0
NOCM	novel context mismatch	1.0
Hyp3	thi5, d-tic7, oic8]-bk	0.5
Hyp3	thi5,d-tic7,oic8]-bk	0.5
WSN	warm-sensitive neuron	0.666666666667
WSN	warm sensitive neuron	0.333333333333
HYP	hypothalamus	1.0
GBR-12909	1-[2-[bis(4-fluorophenyl)methoxy]ethyl]	0.666666666667
GBR-12909	1-[2-bis(4-flurophenyl)methoxy]-ethyl-4-(3-phenylpropyl)piperazine dihydrochloride	0.333333333333
MKP-	1	0.111111111111
MKP-	1map kinase phosphatase-1	0.111111111111
MKP-	1mapk-phosphatase 1	0.111111111111
MKP-	1mapk phosphatase-1	0.222222222222
MKP-	1mitogen-activated protein kinase phosphatase-1	0.444444444444
WSW	illiams syndrome	0.6
WSW	erner syndrome	0.4
ANSA	1-amino-2-naphthol-4-sulphonic acid	1.0
E-DEC	decrementing expiratory	1.0
cis-ACDA	1-aminocyclobutane-cis-1,3-dicarboxylic acid	1.0
MVeMC	medial vestibular nucleus, magnocellular part	1.0
SNARES	ouble nsf attachment receptor	1.0
mNOS	mitochondrial nitric oxide synthase	1.0
8-brcAMP	8-bromo-adenosine-3′:5′-cyclic monophosphate sodium	1.0
dMRI	diffusion-weighted mri	1.0
motV	trigeminal motor nucleus	1.0
KYNA	kynurenate	0.0769230769231
KYNA	kynurenic acid	0.923076923077
LHPA	limbic-hypothalamic-pituitary-adrenal	0.2
LHPA	limbic–hypothalamic–pituitary–adrenal	0.4
LHPA	limbic–hypothalamo–pituitary–adrenal	0.2
LHPA	limbic hpa	0.2
NVHL	neonatal ventral hippocampus lesion	0.5
NVHL	neonatal ventral hippocampal lesions	0.5
DOPδ	opioid peptide	1.0
fMRI	)	0.00414937759336
fMRI	functional magnetic resonance tomography	0.00414937759336
fMRI	functional mri	0.0248962655602
fMRI	functional magnetic resonance imaging	0.96265560166
fMRI	functional magnetic resonance	0.00414937759336
WM-VLF	white matter ventrolateral funiculus	1.0
TuJ1	neuron-specific β-tubulin	1.0
IVLM	intermediate ventrolateral medulla	1.0
VKQ	visual-kinetic quotient	1.0
LNGF-r	low affinity receptor for nerve growth factor	1.0
VKV	itamin k	1.0
VGSC	voltage-gated sodium channels	0.166666666667
VGSC	svoltage-gated sodium channels	0.166666666667
VGSC	voltage-gated sodium channel	0.666666666667
IDYID	yoked	1.0
4hrR	10 min ischemia and 4 h reperfusion	1.0
NVH-	lesioned rats	1.0
TPGS	tocopheryl polyethylene glycol succinate	1.0
d-Tyr1	(nme)phe3]npff	1.0
BCL-	2b-cell lymphoma 2	1.0
pBRS	physiological bath recording solution	1.0
MPAM	edroxyprogesterone acetate	1.0
MPAO	medial preoptic area	1.0
Sol	nucleus of the solitary tract	0.5
Sol	soleus	0.5
MPAG	medial periaqueductal gray matter	1.0
mICN	medial intercalated nucleus	1.0
IOPr	principal nucleus of the inferior olivary nucleus	1.0
3MSM	odified mini-mental state examination	1.0
VLPFC	ventrolateral prefrontal cortex	0.888888888889
VLPFC	ventral lateral prefrontal cortex	0.0555555555556
VLPFC	ventro-lateral aspects of prefrontal cortex	0.0555555555556
M-35	galanin (1–12)-pro-bradykinin (2–9)	1.0
SDVN	sub-diaphragmatic vagus nerve	1.0
SSEA-	1stage specific embryonic antigen	1.0
α-Me-5-HT	α-methyl-5-hydroxytryptamine	1.0
FWL	foot withdrawal latency	1.0
CLMC	lomeleon	1.0
O-	2aoligodendrocyte-type 2 astrocyte	0.333333333333
O-	negative natural odor	0.333333333333
O-	11846-azidohex-2-enyl-delta8-tetrahydrocannabinol	0.333333333333
POU	4f3	1.0
proDYN	prodynorphin	1.0
CBACBA	/caj mouse	1.0
NMDARNMDA	receptor	0.923076923077
NMDARNMDA	receptors	0.0769230769231
OBCAM	opioid-binding cell adhesion molecule	0.666666666667
OBCAM	opioid binding cell adhesion molecule	0.333333333333
vGABA	tvesicular gaba transporter	1.0
TBHP	tert-butyl-hydroperoxide	1.0
NTR-	2neurotensin receptor-2	1.0
OVX-Eovariectomized	estrogen replaced	1.0
CB-HRP	cholera toxin b-chain conjugated horseradish peroxidase	1.0
DPBS	dulbecco’s ‘a’ phosphate-buffered saline	0.333333333333
DPBS	dulbecco's phosphate-buffered saline	0.333333333333
DPBS	dulbecco’s phosphate-buffered saline	0.333333333333
EEDQ	n-ethoxycarbonyl-2-ethoxy-1,2-dihydroxyquinoline	0.5
EEDQ	n-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline	0.5
DTOPV	diphenylamino-s-triazine-bridged p-phenylene vinylene	1.0
HMNs	hypoglossal motoneurons	1.0
mdx3C	v mice	1.0
MDm	medial md	1.0
MTMT	(methylthio)methanethiol	1.0
PRHP	erirhinal cortex	1.0
SMV	superior medullary velum	1.0
DMPFC	dorsal medial prefrontal cortex	0.25
DMPFC	dorsomedial prefrontal cortex	0.75
SNARESNAP	receptor	1.0
SCN-	thiocyanate	1.0
SpVe	spinal vestibular nucleus	1.0
sMRI	structural t1-weighted mri	1.0
CCII	controlled cortical impact injury	1.0
SKF383931-phenyl-2	3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol, d1 agonist	0.5
SKF383931-phenyl-2	3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol	0.5
Ob	obese	1.0
t-PDCL-trans-pyrrolidine-2	4-dicarboxylic acid	1.0
POF	premature ovarian failure	0.5
POF	parieto-occipital fissure	0.5
DIID	ogiel type ii neuron	0.5
DIID	ickman impulsivity inventory	0.5
Os	oligosyndactyly	1.0
nNOS	neural nitric synthase	0.00473933649289
nNOS	neuronal from of nitric oxide synthase (nos i)	0.00473933649289
nNOS	nitric oxide synthase, neuronal isoform	0.00473933649289
nNOS	neuronal nitric oxide synathase	0.00473933649289
nNOS	neuronal form of nitric oxide synthase	0.00473933649289
nNOS	neuronal-type nitric oxide synthase	0.00473933649289
nNOS	neuronal nitric oxide syntethase	0.00473933649289
nNOS	neural isoform of nitric oxide synthase	0.00473933649289
nNOS	nos-i, neuronal nitric oxide synthase	0.00473933649289
nNOS	neuronal nitric oxide synthetase	0.00473933649289
nNOS	neuronal isoform of nitric oxide synthase	0.0142180094787
nNOS	neuronal type nitric oxide synthase	0.00473933649289
nNOS	neuronal isoform of nitric oxide synthase (type i)	0.00473933649289
nNOS	(nos-1), neuronal nitric oxide synthase	0.00473933649289
nNOS	nitric oxide synthase neuronal isoform	0.00473933649289
nNOS	neuronal nitric oxide synthase 1	0.00473933649289
nNOS	brain or neuronal nitric oxide synthase	0.00473933649289
nNOS	neuronal nos	0.0568720379147
nNOS	nitric oxide synthase	0.0142180094787
nNOS	neuronal nitric oxide synthase (nos1)	0.00473933649289
nNOS	neuronal nitric oxide synthase (type i)	0.00473933649289
nNOS	neuronal nitric oxide	0.00947867298578
nNOS	neuronal (type 1) nitric oxide synthase	0.00473933649289
nNOS	neuronal nitric oxide synthase	0.78672985782
nNOS	: neuronal nitric oxide synthase	0.00473933649289
nNOS	neuronal no synthase	0.00947867298578
nNOS	neuronal no-synthase	0.00473933649289
nNOS	neuronal isoform of the nitric oxide synthase	0.00473933649289
nNOS	neuronal isoform of nos	0.00473933649289
OO	orbicularis oculi muscle	0.166666666667
OO	orbicularis oculi	0.5
OO	corbicularis oculi	0.166666666667
OO	emgorbicularis oculi electromyography	0.166666666667
ON	olfactory sensory neuron	0.0243902439024
ON	osteonectin	0.0243902439024
ON	on levodopa medication	0.0243902439024
ON	olfactory neuroepithelium	0.0487804878049
ON	optic nerve	0.243902439024
ON	/rtovernight at room temperature	0.0243902439024
ON	cells	0.0487804878049
ON	olfactory nerve layer	0.0243902439024
ON	overnight	0.0487804878049
ON	antisense oligoneucleotide	0.0243902439024
ON	visual pathway	0.0243902439024
ON	2optic nerve half nearer to the optic chiasm	0.0243902439024
ON	olfactory nerve	0.365853658537
ON	olfactory neuron	0.0243902439024
ON	–glolfactory nerve–glomerular layer	0.0243902439024
OM	voculomotor complex	0.0588235294118
OM	pposterior octavomotor nucleus (ventral nucleus of the ola)	0.0588235294118
OM	outer membrane	0.0588235294118
OM	olfactory mucosa(e)	0.0588235294118
OM	gpoligodendrocyte myelin glycoprotein	0.176470588235
OM	oxymetazoline	0.0588235294118
OM	olfactory mucosa	0.117647058824
OM	tractus occipitomesencephalicus	0.0588235294118
OM	coculomotor complex	0.0588235294118
OM	oncomodulin	0.0588235294118
OM	gpoligodendrocyte-myelin glycoprotein	0.235294117647
OL	soligodendrocytes	0.125
OL	cellsoligodendroglial cell line	0.03125
OL	overlap value	0.03125
OL	olfactory sensory neuron layer	0.03125
OL	outer layer	0.03125
OL	overlap	0.03125
OL	optic layer	0.0625
OL	oligodendrocyte	0.5625
OL	olfactory lobe	0.03125
OL	optic lobe	0.0625
RQR	ayleigh quotient	0.25
RQR	omberg's quotient	0.25
RQR	omberg quotient	0.5
ωMVIIC	omega-conopeptide mviic	0.5
ωMVIIC	ω-conotoxin mviic	0.5
OI	olfactory imagery	0.166666666667
OI	optimum intensity	0.166666666667
OI	internal oblique	0.166666666667
OI	obliquus internus abdominis	0.333333333333
OI	orientation index	0.166666666667
OH	tris–[hydroxyethylamino]methane	0.166666666667
OH	hydroxyl radical	0.833333333333
OG	otic ganglion	0.5
OG	otic ganglia	0.5
OF	open field	0.75
OF	open field test	0.0416666666667
OF	orbitofrontal	0.0416666666667
OF	open-field exposed	0.0416666666667
OF	object fixation	0.0416666666667
OF	orbitofrontal cortex	0.0416666666667
OF	ocular following	0.0416666666667
OE	overexpressing	0.0322580645161
OE	otic epithelium	0.0645161290323
OE	over-expressed	0.0322580645161
OE	overexpression	0.0322580645161
OE	obliquus externus abdominis	0.0645161290323
OE	xolfactory epithelium lesions	0.0322580645161
OE	over-expressing	0.0322580645161
OE	alpha2c-adrenoceptor overexpressing	0.0645161290323
OE	olfactory epithelium	0.645161290323
OD	(relative) optical density	0.00564971751412
OD	ocular dominance	0.0282485875706
OD	optic density	0.0169491525424
OD	ratiorelative optical density	0.00564971751412
OD	olfactory dysfunction	0.00564971751412
OD	oxygen deprivation	0.00564971751412
OD	relative optical density	0.00564971751412
OD	optical densities	0.0169491525424
OD	optical density	0.887005649718
OD	outer diameter	0.0225988700565
OC	orbital cortex	0.0322580645161
OC	border orientation contrast	0.0322580645161
OC	antibodyoncogene/calbiochem 5-ht2ar antibody	0.0322580645161
OC	octopus cell region	0.0322580645161
OC	oral contraceptives	0.0645161290323
OC	1boccipital primary binocular visual area	0.0322580645161
OC	+all olivocochlear pathways intact	0.0322580645161
OC	outer contour	0.0322580645161
OC	optical tract	0.0322580645161
OC	olfactory cortex	0.0322580645161
OC	2-mmoccipital cortex area 2 mediomedial part	0.0322580645161
OC	orientation contrast	0.0322580645161
OC	occipital cortex	0.0645161290323
OC	2mmoccipital cortex	0.0322580645161
OC	primary visual area	0.0322580645161
OC	optic chiasm	0.0967741935484
OC	lhypochlorite	0.0322580645161
OC	oral contraceptive	0.0322580645161
OC	organ of corti	0.225806451613
OC	onset-chopper	0.0322580645161
OC	olivocochlear	0.0322580645161
OB	olfactory bulb	0.898550724638
OB	orientation bias	0.0434782608696
OB	olfactory brain	0.00724637681159
OB	solfactory bulbs	0.00724637681159
OB	main olfactory bulbs	0.00724637681159
OB	olfactory bulbs	0.0144927536232
OB	olfactory bulbectomy	0.00724637681159
OB	main olfactory bulb	0.0144927536232
OA	nucleus olfactorius anterior	0.05
OA	overlapping area	0.05
OA	octopamine	0.1
OA	open arms	0.05
OA	open arm	0.1
OA	occipital artery	0.1
OA	octopamine hydrochloride	0.05
OA	okadaic acid	0.5
CYN	caulerpenyne	1.0
NTT	4	1.0
TBHA	threo-β-hydroxyaspartic acid	0.333333333333
TBHA	threo-β-hydroxy-aspartate	0.333333333333
TBHA	dl-threo-β-hydroxy-aspartic acid	0.333333333333
OZ	5z-7-oxozeaenol	1.0
OX	optic chiasma	0.0416666666667
OX	orexin	0.125
OX	2orexin-2 receptor subtype	0.0416666666667
OX	2rorexin-2 receptor	0.0416666666667
OX	42/cd11bsingle-pass type-1α chain 1136 aa glycoprotein(microglia/macrophage-specific marker	0.0416666666667
OX	1rorexin-1 receptor	0.0833333333333
OX	1rorexin receptor 1	0.0416666666667
OX	42	0.0416666666667
OX	2orexin type 2 receptor	0.0416666666667
OX	2	0.0416666666667
OX	optic chiasm	0.0833333333333
OX	oxytocin	0.0416666666667
OX	2rorexin 2 receptor	0.208333333333
OX	1rorexin receptor1	0.0416666666667
OX	1rorexin 1 receptor	0.0416666666667
OX	2rorexin receptor 2	0.0416666666667
cABR	auditory brainstem responses to complex sounds	1.0
OV	pars ovoidea of the ventral division of the medial geniculate body	0.25
OV	nucleus ovoidalis	0.125
OV	pars ovoidea	0.25
OV	olfactory ventricle	0.25
OV	pars ovoidea of mgv	0.125
OT	nucleus of the optic tract	0.0120481927711
OT	uolfactory tubercle	0.0240963855422
OT	tectum opticum	0.0120481927711
OT	oxytocinergic	0.0120481927711
OT	optic tectum	0.132530120482
OT	operated triceps	0.0120481927711
OT	occipitotemporal area	0.0120481927711
OT	occipitotemporal	0.0120481927711
OT	orientation tuning	0.0361445783133
OT	overtrained	0.0120481927711
OT	oxytocin	0.469879518072
OT	optic tract	0.120481927711
OT	onset time	0.0120481927711
OT	olfactory tubercle	0.120481927711
OS	optic stalk	0.0909090909091
OS	outer segment	0.363636363636
OS	orientation-selective	0.0909090909091
OS	outer segments	0.181818181818
OS	oxidative stress	0.181818181818
OS	oblique shaft	0.0909090909091
OR	opioid receptor	0.108108108108
OR	solfactory receptors	0.0540540540541
OR	operating room	0.027027027027
OR	mu opioid receptor	0.027027027027
OR	μ-opioid receptor	0.027027027027
OR	outer retina	0.027027027027
OR	optic radiations	0.027027027027
OR	ioocyte ringer's solution	0.027027027027
OR	oriens	0.027027027027
OR	ioocyte ringer solution	0.027027027027
OR	odds ratio	0.0540540540541
OR	ioocyte ringer’s solution	0.027027027027
OR	mu-opioid receptor	0.027027027027
OR	odorant receptor protein	0.027027027027
OR	obesity resistant	0.027027027027
OR	odorant receptor	0.0540540540541
OR	odds ratios	0.027027027027
OR	μ opioid receptor	0.0540540540541
OR	object recognition	0.108108108108
OR	obesity-resistant	0.027027027027
OR	olfactory receptor	0.108108108108
OR	outward rectifying potassium current	0.027027027027
OR	sopioid receptors	0.027027027027
OR	delta opioid receptor	0.027027027027
OP	4-1cytochrome c oxidase or complex iv subunit 1	0.0416666666667
OP	object placement	0.0416666666667
OP	osteogenic protein	0.0416666666667
OP	optic nerve layer	0.0416666666667
OP	open field	0.0416666666667
OP	soscillatory potentials	0.0416666666667
OP	obesity-prone	0.0416666666667
OP	obesity prone	0.0416666666667
OP	sorganophosphates	0.0416666666667
OP	opponens pollicis	0.166666666667
OP	organophosphorus	0.0416666666667
OP	organophosphate	0.125
OP	olivary pretectal nucleus	0.0416666666667
OP	oligodendrocyte precursor	0.0416666666667
OP	occipitoparietal area	0.0416666666667
OP	oligodendrocyte progenitor	0.0833333333333
OP	other perforated (synapses)	0.0416666666667
OP	roorbital proisocortex (dysgranular cortex)	0.0416666666667
DEX	dexamphetamine	0.04
DEX	dextrorphan tartrate	0.04
DEX	dexamethasone	0.92
DHSDN	asei hypersensitivity site	1.0
DR-DRW	delayed-response delayed-reward go/nogo	1.0
DR-DRP	dorsal root potential evoked by dorsal root stimulation	1.0
INOS	inducible nitric oxide synthetase	1.0
DEP	maternally deprived	0.5
DEP	maternal deprivation	0.5
CMLN-ε-	carboxymethyllysine–bovine serum albumin	1.0
DER	denial of expected reward	0.333333333333
DER	denied expected reward	0.666666666667
DES	diethylstilbestrol	1.0
DET	differential emotions theory	1.0
NP-C	niemann–pick disease type c	0.5
NP-C	niemann–pick disease, type c	0.5
SIN-1A	3-morpholino-n-nitroso-aminoacetonitrile	1.0
GRGDTP	glycine–arginine–glycine–aspartate–thrionine–proline	1.0
FH	factor h	0.333333333333
FH	complement factor h	0.333333333333
FH	fasudil hydrochloride	0.333333333333
Ainf	inflected dorsal root ganglion a-neuron	1.0
7-Cl-KYN	7-chlorokynurenic acid	1.0
ILBD	incidental lewy body disease	1.0
DEN	denervation alone or in combination with hyperthyroidism	0.25
DEN	dorsal endopiriform nucleus	0.5
DEN	dendrite	0.25
SMF	static magnetic field	1.0
VCD	valnoctamide	1.0
AFNIA	nalysis of functional neuroimages	0.833333333333
AFNIA	nalysis of functional neuorimages	0.166666666667
DED	death effector domain	1.0
JDP	2jun dimerization protein 2	1.0
DEF	defecation	1.0
DEG	/enacdegenerin/epithelial sodium channel	0.142857142857
DEG	degenerins	0.142857142857
DEG	sdifferentially expressed genes	0.428571428571
DEG	differentially expressed genes	0.285714285714
SMD	standardized mean difference	1.0
FKN	fractalkine	1.0
OB-Rb	functional form of rat leptin receptor	1.0
SMC	somatosensory cortex	0.166666666667
SMC	sensorimotor cortex	0.222222222222
SMC	ssmooth muscle cells	0.0555555555556
SMC	supramolecular complex	0.0555555555556
SMC	primary sensorimotor cortex	0.0555555555556
SMC	xsensorimotor cortex	0.111111111111
SMC	smooth muscle cell	0.166666666667
SMC	sensory motor cortex	0.0555555555556
SMC	smooth muscle cells	0.0555555555556
SMC	sphingomyelinase-ceramide	0.0555555555556
NNDAN	n-dimethyl acetamide	1.0
rCP	rostral caudate putamen	1.0
SCH23390	[r]-3-methyl-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine	0.2
SCH23390	r(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride	0.2
SCH23390	r(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepin hydrochloride	0.2
SCH23390	r(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine	0.2
SCH23390	(r)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine, 125941-87-9	0.2
FM	frequency modulation	0.05
FM	formalin	0.05
FM	1–43n-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl)-pyridinium dibromide	0.025
FM	1-43n-(3-(triethylammonium) propyl)-4-(4-dibutilaminostyryl pyridinium dibromide)	0.025
FM	nforward model noise	0.025
FM	4-64(n-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl)pyridinium dibromide	0.025
FM	4-64n-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl) pyridinium dibromide	0.025
FM	frequency-modulated	0.075
FM	1-43(n-(3-triethyammoniumpropyl)-4-(4-(dibutylamino)styryl)pyridinium dibromide	0.025
FM	1–43n-(3-triethylammoniumpropyl)-4-(4-dibutylamino styryl)pyridinium dibromide	0.025
FM	1-43	0.15
FM	4-64n-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl)pyridinium dibromide	0.025
FM	1-43n-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl)pyridinium dibromide	0.025
FM	fear matirx	0.025
FM	frequency modulated tone	0.025
FM	1-43n-(3-triethylammoniumpropyl)-4-(4-dibutylamino) styryl) pyridium bromide	0.025
FM	1-43triethylammonium(propyl)-4-(2-(4-dibutylamino-phenyl)vinyl)pyridinium	0.025
FM	fluorescent microscopy	0.025
FM	1-43 fluorometry	0.025
FM	1-43fei mao styryl dye 1-43	0.025
FM	1–43	0.025
FM	freely moving task	0.025
FM	1–43(n-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl)pyridinium dibromide	0.025
FM	frequency modulated	0.15
FM	1-43n-(3-triethylammonium propyl)-4-(4-dibutylamino)styryl)pyridinium	0.025
FM	1-43 staining	0.025
CAZ	cytomatrix at the active zone	1.0
rCM	glcregional cerebral glucose metabolism	1.0
AT2R	angiotensin ii subtype 2 receptor	1.0
MPTPN-methyl-4-phenyl-1	2,3,6-tetrahydropyridine	1.0
SMA	spiral modiolar artery	0.0144927536232
SMA	sympatho–medullo–adrenal	0.0144927536232
SMA	supplemental motor area	0.0144927536232
SMA	sstartle response maximal amplitudes	0.0144927536232
SMA	psupplementary motor area proper	0.0144927536232
SMA	the supplementary motor area	0.0144927536232
SMA	spinal muscular atrophy	0.0869565217391
SMA	spontaneous motor activity	0.0289855072464
SMA	supplementary motor area	0.753623188406
SMA	supplementary motor cortex	0.0289855072464
SMA	smooth muscle actin	0.0144927536232
DEn	dorsal endopiriform nucleus	1.0
cADP-r	cyclic adenosine diphosphate-ribose	1.0
Vmax	maximal rate of rise of action potential	0.5
Vmax	maximal velocity (uptake)	0.5
FS-S	alfootshock+saline	1.0
UPO	unstable periodic orbit	1.0
UPM	universal primer mix	1.0
PCBP	poly(c)-binding protein	1.0
NHDC	neonatal-hemidecorticated cats	1.0
HETE	hydroxyeicosatetraenoic acid	1.0
UPD	untrained + pd	1.0
mMGC	medial division of the medial geniculate complex	1.0
MDH	medullary dorsal horn	0.777777777778
MDH	malate dehydrogenase	0.222222222222
leu-ENK	leucine enkephalin	1.0
SNHL	sensorineural hearing loss	0.909090909091
SNHL	ssensorineural hearing losses	0.0909090909091
VITI	variable intertrial interval	1.0
DABCO1	4-diazabicyclo [2,2,2] octane	0.2
DABCO1	4-diazabicyclo octane in glycerine	0.2
DABCO1	4–diazabicyclo[2.2.2]octane	0.2
DABCO1	4-diazabicyclo[2.2.2]octane	0.4
JPYJ	apanese yen	1.0
VITB	vagal nerve-innervated taste bud	1.0
L-NMA	ng-methyl-l-arginine	0.5
L-NMA	nitrous oxide synthase inhibitor	0.5
UPR	unfolded protein response.	0.0555555555556
UPR	unfolded protein response	0.888888888889
UPR	unfolded-protein response	0.0555555555556
UPS	ubiquitin–proteasome system	0.4
UPS	ubiquitin proteasome system	0.25
UPS	ubiquitin-proteasome system	0.3
UPS	ubiquitin proteasomal system	0.05
UPP	ubiquitin–proteasome system	0.333333333333
UPP	ubiquitin–proteasome pathway	0.333333333333
UPP	ubiquitin proteosomal pathway	0.333333333333
IVD	intraventricular distance	1.0
IVF	in vitro fertilization	1.0
AZT-VXAZT-	injected voluntary exercise	1.0
IVA	ω-agatoxin iv	0.25
IVA	ω-agatoxin iva	0.75
IVC	individually ventilated cages	0.25
IVC	inferior vena cava	0.5
IVC	individually ventilated cage	0.25
IVM	ivermectin	1.0
IVN	inferior vestibular nucleus	0.857142857143
IVN	inferior (spinal) vestibular nucleus	0.142857142857
MDM	smonocyte-derived macrophages	0.166666666667
MDM	enière's disease	0.166666666667
MDM	maximum dipole moment	0.166666666667
MDM	monocyte-derived macrophage	0.166666666667
MDM	orphine/dnazyme	0.166666666667
MDM	2mouse double minute	0.166666666667
IVH	intraventricular hemorrhage	1.0
IVK	in vitro kindling	1.0
IVT	in vitro translation	0.5
IVT	intravitreal	0.5
IVP	intravesical pressure	1.0
miRISC	mirna-induced silencing complex	1.0
CEBPCCAAT	/enhancer binding proteins	1.0
Osc	oscillations	1.0
WHBP	working heart–brainstem preparation	1.0
ACC	acceleration	0.0111111111111
ACC	nucleus accumbens	0.0666666666667
ACC	the anterior cingulate gyrus	0.0111111111111
ACC	acetyl-coa carboxylase	0.0111111111111
ACC	autologous cancer cell	0.0111111111111
ACC	anterior cingulated cortex	0.0222222222222
ACC	acetylcoa carboxylase	0.0111111111111
ACC	anterior cingulate cortex	0.822222222222
ACC	agenesis of the corpus callosum	0.0111111111111
ACC	accumbens nucleus	0.0111111111111
ACC	shellshell of the nucleus accumbens	0.0111111111111
NEO	neostigmine	0.25
NEO	neomycin phosphotransferase	0.5
NEO	neomycin gene	0.25
ACA	(d/v)anterior cingulate area (dorsal part/ventral part)	0.0714285714286
ACA	anterior cerebral arteries	0.0714285714286
ACA	/oaanterior cerebral artery/olfactory artery	0.0714285714286
ACA	anterior cingulate area	0.214285714286
ACA	anterior cerebral artery	0.285714285714
ACA	acetoacetate	0.0714285714286
ACA	asphyxial cardiac arrest	0.214285714286
NEM	n-ethylmaleimaide	0.111111111111
NEM	non-eye movement	0.111111111111
NEM	n-ethyl-maleimide	0.111111111111
NEM	n-ethylmaleimide	0.666666666667
ACG	anterior cingulate gyrus	0.333333333333
ACG	anterior cingulate cortex	0.333333333333
ACG	absolute change in gain	0.333333333333
ACF	autocorrelation function	0.4
ACF	artificial cerebrospinal fluid	0.6
ACE	angiotensin-convertion enzyme	0.125
ACE	angiotensin i-converting enzyme	0.125
ACE	2angiotensin converting enzyme 2	0.125
ACE	angiotensin-converting enzyme	0.25
ACE	central amygdala	0.125
ACE	acetophenone	0.125
ACE	angiotensin converting enzyme	0.125
LCGU	local cerebral glucose utilization	1.0
NEF	neuroendocrine factor	1.0
TNTTBS	/0.05% tween-20	1.0
HFS	high-fat refined sugar diet	0.00740740740741
HFS	high fat stress	0.00740740740741
HFS	high-frequency conditioning stimulus	0.00740740740741
HFS	high-frequency stimulation	0.585185185185
HFS	high frequency stimulus	0.0148148148148
HFS	high-frequency stimulus	0.00740740740741
HFS	high-fat sucrose	0.00740740740741
HFS	high frequency stimulation	0.362962962963
ACH	acetylcholine	0.333333333333
ACH	autocorrelation histogram	0.666666666667
ACN	acetonitrile	1.0
ACM	astrocytes culture medium	0.1
ACM	astrocyte-conditioned medium	0.9
ACL	aphasia test	1.0
ACS	acyl-coa synthetase	0.2
ACS	amino cupric silver stain	0.4
ACS	anterior calcarine sulcus	0.2
ACS	air-puff-predictive conditioned stimulus	0.2
ME7	scrapie strain inoculum.	1.0
ACP	nucleus accumbens	1.0
HFM	shuman fetal microglia	1.0
RAVLTR	ey auditory verbal learning test	1.0
NEX	number of excitations	1.0
ACT	activity control task	0.333333333333
ACT	actin	0.333333333333
ACT	constitutively active	0.333333333333
KOPR	kappa opioid receptor	1.0
KOPS	1 knock-out	1.0
NET	(slc6a2)norepinephrine transporter	0.0277777777778
NET	sum of all the torques acting at a joint	0.0277777777778
NET	norepinephrine transporter	0.888888888889
NET	noradrenaline transporter	0.0555555555556
HFB	heptafluorobutyric acid anhydrid	1.0
NER	nuclear extraction reagent	0.0833333333333
NER	noda epileptic rat	0.0833333333333
NER	non-envelope responsive	0.0833333333333
NER	nucleotide excision repair	0.75
HFD	high-fat diet	0.666666666667
HFD	high fat-refined carbohydrate diet	0.0666666666667
HFD	high fat diet	0.266666666667
NEP	neutral endopeptidase	0.272727272727
NEP	neuroepithelium	0.0909090909091
NEP	neprilysin	0.363636363636
NEP	2neprilysin 2	0.0909090909091
NEP	neuroepithelial cell	0.0909090909091
NEP	non-enriched porsolt	0.0909090909091
Sham	sham-operated	1.0
EA-1	episodic ataxia type 1	1.0
GPI-AP	sglycosylphosphatidylinositol-anchored proteins	1.0
apoMK	mice treated with apomorphine and mk-801 (0.1 mg/kg)	1.0
dlPFC	dorsolateral prefrontal cortex	1.0
TIRF	total internal reflection fluorescence	1.0
ACe	central amygdala nucleus	0.333333333333
ACe	amygdaloid central nucleus	0.333333333333
ACe	central nucleus of the amygdala	0.333333333333
BKC	a2+- and voltage-activated large conductance k+ channel	0.0833333333333
BKC	alarge conductance ca2+-activated k+ channel	0.0833333333333
BKC	alarge-conductance calcium-activated potassium channel	0.0833333333333
BKC	alarge conductance ca2+-activated k+ channels	0.0833333333333
BKC	alarge-conductance ca2+-activated k+	0.0833333333333
BKC	a channellarge conductance calcium-activated potassium channel	0.0833333333333
BKC	alarge conductance ca2+-activated potassium channel	0.0833333333333
BKC	a2+-activated k+ current bk type	0.0833333333333
BKC	a“big” ca2+-dependent k+-conductance	0.0833333333333
BKC	alarge conductance calcium-activated potassium channel	0.0833333333333
BKC	a channelslarge-conductance ca2+-activated k+ channels	0.0833333333333
BKC	alarge-conductance ca2+-activated k+ channels	0.0833333333333
BOO	bladder outlet obstruction	1.0
PHGPx	phospholipid hydroperoxide glutathione peroxidase	1.0
ACh	acethylcholine	0.00636942675159
ACh	acetylcholine	0.993630573248
ACo	auditory cortex	0.333333333333
ACo	anterior cortical amygdaloid nucleus	0.333333333333
ACo	anterior cortical nucleus of the amygdala	0.333333333333
zfPDYN	zebrafish prodynorphin	1.0
PHALP	haseolus vulgaris leucoagglutinin	1.0
p-αC	amkiiphosphorylated αcamkii	1.0
DHR-	123dihydrorhodamine 123	0.5
DHR-	123dihydrorhodamine-123	0.5
PGFs	f prostaglandins	1.0
TIRT	oll/interleukin-1 receptor	0.333333333333
TIRT	oll/il-1 receptor homology domain	0.333333333333
TIRT	oll-interleukin 1 receptor	0.333333333333
THIP2	5,6,7-retrahydroisoxazolo(5,4-c)pyridine-3-ol hydrochloride	1.0
ACx	auditory cortex	1.0
THIP4	5,6,7-tetrahydroisoxazolo-[5,4-c]pyridine-3-ol	0.333333333333
THIP4	5,6,7-tetrahydroisoxazolo-(5,4,-c)pyridim-3-ol	0.333333333333
THIP4	5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-3-ol	0.333333333333
aMpT	α-methyl-p-tyrosine	1.0
POMT	1/pomt2protein o-mannosyltransferase 1 and 2	1.0
ANOVAR	analysis of variance for repeated measurements	1.0
SBT	sexual behavior test	1.0
metabolismATP-	asesl-acetylcarnitine	1.0
DR-CV	caudal ventral pole of dorsal raphe	1.0
MTHFR	methylenetetrahydrofolate reductase	1.0
BK-	channelbig-conductance ca2+-activated k+ channel	1.0
βA	β-amyloid	0.5
βA	amyloid β peptide	0.5
TEA-	sensitive k+ current	1.0
βG	alβ-galactosidase	1.0
βE	217β-estradiol	0.666666666667
βE	217β-estradiol or estrogen	0.333333333333
uM	t-ckubiquitous mitochondrial isoform of creatine kinase	0.333333333333
uM	tckubiquitous mitochondrial creatine kinase	0.333333333333
uM	i-ckubiquitous mitochondrial creatine kinase	0.333333333333
PASAT	paced auditory serial addition test	1.0
POMG	nt1protein o-mannose udp-n-acetylglucosaminyl transferase 1	1.0
DTNB	5,5′-dithio-bis(2-nitrobenzoic acid)	0.1
DTNB	5′,5-dithiobis(2-nitrobenzoic acid)	0.1
DTNB	dithiobisnitrobenzoate	0.1
DTNB	dithiobis-(2-nitrobenzoic acid)	0.1
DTNB	di-thio nitro benzene	0.1
DTNB	5,5′-dithiobis-2-nitrobenzoic acid	0.2
DTNB	5,5′-dithiobis(2-nitrobenzoic acid)	0.1
DTNB	5-5′-dithio-bis-2-nitrobenzoic acid	0.1
DTNB	dithionitrobenzoic acid	0.1
TEMPOL4-hydroxy-2	2,6,6-tetramethylpiperidine-n-oxyl	0.333333333333
TEMPOL4-hydroxy-2	2,6,6-four methys piperidine	0.333333333333
TEMPOL4-hydroxy-2	2,6,6-tetramethylpiperidine 1-oxyl	0.333333333333
POMC	pro-opiomelanocorticotrophin	0.0140845070423
POMC	pro-opiomelanocortin	0.380281690141
POMC	prooppiomelanocortin	0.0140845070423
POMC	proopiomelanocortin	0.591549295775
ACHE	acetylcholinesterase	1.0
SJA	6017n-(4-fluorophenylsulfonyl)-l-valyl-l-leucinal	1.0
uEPSC	unitary excitatory postsynaptic current	1.0
MSEQ	motor sequence learning task	1.0
GDP	guanosine diphosphate	0.291666666667
GDP	giant depolarizing potential	0.125
GDP	guanosine 5′-diphosphate sodium salt	0.0416666666667
GDP	s	0.0416666666667
GDP	guanosine 5′-diphosphate	0.166666666667
GDP	guanosine-5′-diphosphate	0.333333333333
MED	multi-electrode dish	0.5
MED	multiple epiphyseal dysplasia	0.25
MED	median nerve	0.25
MEG	magnetoencephalography	0.797101449275
MEG	magnitoencephalogram	0.0144927536232
MEG	)	0.0289855072464
MEG	magnetaencephalogram	0.0144927536232
MEG	magnetoencephalogram	0.0579710144928
MEG	magnetoencephalography or magnetoencephalogram	0.0144927536232
MEG	magneto-encephalography	0.0144927536232
MEG	/eegmagneto- and electro-encephalography	0.0144927536232
MEG	magnetoencephalographic	0.0289855072464
MEG	magnetoencephalography/magnetoencephalographic	0.0144927536232
NE-	ergicnorepinephrinergic	1.0
MEA	micro-electrode array	0.0789473684211
MEA	medial entorhinal area	0.0526315789474
MEA	medial nucleus, amygdala	0.0263157894737
MEA	smicroelectrode arrays	0.0263157894737
MEA	multi-electrode array	0.105263157895
MEA	medial nucleus of the amygdala	0.0263157894737
MEA	microelectrode array	0.105263157895
MEA	pdposterodorsal division of the medial nucleus of the amygdala	0.0263157894737
MEA	medial amygdala	0.131578947368
MEA	pdposterodorsal medial amygdala	0.0526315789474
MEA	medial amygdalar nucleus	0.0263157894737
MEA	midbrain extrapyramidal area	0.0263157894737
MEA	medial amygdale	0.0263157894737
MEA	mesencephalic extrapyramidal area	0.0263157894737
MEA	multielectrode array	0.105263157895
MEA	multielectrode array recordings	0.0263157894737
MEA	(ad/pd/pv)medial nucleus amygdala (anterodorsal/posterodorsal/posteroventral)	0.0263157894737
MEA	medial entorhinal cortex	0.0526315789474
MEA	medial division of the extended amygdala	0.0263157894737
MEA	medial amygdaloid nucleus	0.0263157894737
GFRGDNF	family receptor	1.0
3-NT	nitrotyrosine	0.111111111111
3-NT	3-nitrotyrosine	0.888888888889
MEB	)	1.0
MEM	modified eagle’s medium	0.018018018018
MEM	modified eagle's medium	0.036036036036
MEM	10mem with 10% horse serum	0.00900900900901
MEM	minimal essential media	0.036036036036
MEM	eagle’s minimal essential medium	0.018018018018
MEM	10/10mem with 10% horse serum and 10% fetal bovine serum	0.00900900900901
MEM	memantine	0.00900900900901
MEM	minimum essential media	0.027027027027
MEM	et5-enkephalin	0.00900900900901
MEM	minimum essential medium	0.459459459459
MEM	minimum essential medium with earle's salts	0.00900900900901
MEM	eagle’s minimal essential medium (earle’s salts)	0.00900900900901
MEM	minimum essential medium eagle	0.00900900900901
MEM	minimal essential medium	0.333333333333
MEM	eagle's minimum essential medium	0.00900900900901
MEL	melatonin	0.75
MEL	murine erythroleukaemia	0.25
MEN	multiple endocrine neoplasia	0.5
MEN	2multiple endocrine neoplasia type 2	0.25
MEN	1multiple endocrine neoplasia type 1	0.25
εC3	n4-ethenocytosine	1.0
MEK	mitogen-activated protein kinase kinase	0.269230769231
MEK	map kinase kinase	0.0192307692308
MEK	1/2mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2	0.0192307692308
MEK	mitogen-activated protein kinase/extracellular signal-regulated kinase kinase	0.0384615384615
MEK	mitogen-activated extracellular-regulated kinase	0.0192307692308
MEK	1/2mapk/erk kinase1/2	0.0192307692308
MEK	mitogen-activated erk-activating kinase	0.0192307692308
MEK	mitogen extracellular regulating kinase	0.0192307692308
MEK	mitogen-activated kinase	0.0192307692308
MEK	erk kinase	0.0192307692308
MEK	mitogen-activated protein kinase/extracellular signal-related protein kinase kinase	0.0192307692308
MEK	1	0.0192307692308
MEK	mitogen-activated protein kinase/extracellular signal-regulated kinase	0.0192307692308
MEK	mitogen-activated protein kinase kinases	0.0192307692308
MEK	mitogen-activated/extracellular signal-regulated kinase kinase	0.0192307692308
MEK	dual-specificity (threonine/tyrosine) mapk kinase/erk kinase (mitogen activated protein kinase kinase, map kinase kinase, mapkk)	0.0192307692308
MEK	mitogen activated kinase kinase	0.0192307692308
MEK	–erk	0.0192307692308
MEK	1/2mitogen-activated protein kinase kinase 1/2	0.0384615384615
MEK	1mitogen extracellular kinase 1	0.0192307692308
MEK	mitogen-activated protein kinase kinase (erk kinase)	0.0192307692308
MEK	extracellular signal-regulated protein (erk) kinase	0.0192307692308
MEK	extracellular signal-regulated protein kinases	0.0192307692308
MEK	mitogen-activated protein kinase/extracellular signal-regulated kinase activating kinase	0.0192307692308
MEK	mitogenically extraregulated kinase	0.0192307692308
MEK	mitogen-activated protein kinase	0.0961538461538
MEK	mitogen-activated protein kinase/extracellular signal regulated kinase kinase	0.0192307692308
MEK	mitogen-activated protein/erk kinase	0.0192307692308
MEK	mitogen and extracellular-signal related kinase kinase	0.0192307692308
MEK	mitogen activated protein kinase kinase	0.0192307692308
MEK	/mapkmitogen-activated protein kinase	0.0192307692308
MEK	1/2mitogen-activated protein/extracellular signal-regulated kinase kinase	0.0192307692308
MEK	inhibitor	0.0192307692308
AVP-IR	sarginine vasopressin immunoreactive neurons	1.0
MET	methionine	0.142857142857
MET	mesenchymal–epithelial transition	0.142857142857
MET	metyrapone	0.285714285714
MET	methiothepin	0.142857142857
MET	cycling rats perfused on metestrus	0.142857142857
MET	mechanotransduction	0.142857142857
MEP	magnetosensory evoked potential	0.0222222222222
MEP	smotor-evoked potentials	0.111111111111
MEP	motor evoked potentials	0.0888888888889
MEP	motor-evoked potentials	0.133333333333
MEP	motor-evoked potential	0.266666666667
MEP	smotor end plates	0.0444444444444
MEP	motor evoked potential	0.222222222222
MEP	smotor evoked potentials	0.111111111111
MES	morpholino-ethane sulfate	0.0625
MES	2-ethanesulfonic acid	0.0625
MES	2-(n-morpholino)ethanesulfonic acid	0.1875
MES	methansulfonate	0.0625
MES	methanesulfonate	0.0625
MES	2-(n-morpholino)ethanesulfonic acid hydrate	0.0625
MES	2-morpho-linoethane sulfonic acid	0.0625
MES	morpholinoethanesulfonic acid	0.0625
MES	23.5 cells	0.0625
MES	mesencephalon	0.0625
MES	maximal electroshock seizure	0.0625
MES	2-[n-morpholino]ethanesulfonic acid	0.125
MES	rat mesencephalic neuronal cell line	0.0625
MER	microelectrode recording	0.5
MER	micro-electrophysiological recordings	0.5
GDH	glutamate dehydrogenase	0.75
GDH	l-glutamate dehydrogenase	0.125
GDH	glutamate dehydrogenase (ec 1.4.1.3)	0.125
hApoE	human apolipoprotein e	1.0
4-CPGRS-	4-carboxyphenylglycine	1.0
FETF	isher exact test	1.0
BS-1	bandeiraea simplicifolia lectin	1.0
3α-HSD	3α-hydroxysteroid dehydrogenase	0.8
3α-HSD	3α-hydroxysteroid oxidoreductase	0.2
HSD-	111-beta-hydroxysteroid dehydrogenase	0.5
HSD-	111-hydroxysteroid dehydrogenase	0.5
GAT-3	gaba transporter 3	1.0
cDFM	checked downward frequency modulated	1.0
GHBγ-	hydroxybutyric acid	0.25
GHBγ-	hydroxybutyrate	0.75
ISOisoproterenol	β-adrenoceptor agonist	1.0
3PGA	d(-3)-phosphoglyceric acid	1.0
LWL	iu-wei-di-huang decoction	1.0
S-TRAIL	secretable form of tumor necrosis factor-related apoptosis-inducing ligand	1.0
Z-VAD-FMK	benzyloxycarbonyl-val-ala-asp(ome)-fluoromethylketone	0.333333333333
Z-VAD-FMK	benzyl-oxycarbonyl-val-ala-asp-fluoromethylketone	0.333333333333
Z-VAD-FMK	z-val-ala-asp(ome)-fluoromethyl ketone	0.333333333333
LWC	locked wheel control	1.0
CLPB	caudolateral parabrachial region	1.0
PDCD	10	0.5
PDCD	4programmed cell death protein 4	0.5
CFDA5	6-carboxyfluoroscein diacetate	1.0
AR-JP	autosomal recessive juvenile parkinson’s disease	1.0
AIRP	anti-idiotypic imidazoline receptor protein	1.0
SP-LI	substance p-like immunostaining	0.5
SP-LI	substance p-like immunoreactivity	0.5
CEDC	ambridge electronic design	1.0
GGTI	geranylgeranyl transferase inhibitor	1.0
LLOQ	lower limit of quantitation	1.0
DR-CD	caudal dorsal pole of dorsal raphe	1.0
PWMT	paw withdrawal mechanical threshold	1.0
3HADH	3-hydroxyacyl coa dehydrogenase	1.0
LPOF	lateral posterior orbitofrontal cortex	1.0
POLβ	polymerase β	1.0
sar9-SP	[sar9,met(o2)11]substance p	1.0
TTF-1	thyroid transcription factor-1	1.0
pPYY	porcine peptide yy	1.0
ELF-EF	sextremely low-frequency electric fields	1.0
Msx1homeobox	msh-like 1	1.0
VMPJ	ventral mesopontine junction	1.0
ADNFLE	autosomal dominant nocturnal frontal lobe epilepsy	1.0
AVP-	irarginine vasopressin immunoreactive	0.333333333333
AVP-	irvasopressin-immunoreactive	0.333333333333
AVP-	irarginine-vasopressin immunoreactive	0.333333333333
WKS	wernicke–korsakoff syndrome	1.0
AMPA-	binding protein	1.0
GEFG	uanine nucleotide exchange factor	1.0
HSDH	onestly significant difference	1.0
NFOGQ	new freezing of gait questionnaire	1.0
NFκBI-C	nuclear factor kappa b inhibitor scrambled control	1.0
cPKC	conventional pkc	0.2
cPKC	conventional protein kinase c	0.3
cPKC	conventional- or classic-type protein kinase c	0.2
cPKC	classic protein kinase c	0.1
cPKC	“conventional” or “classical” protein kinase c	0.1
cPKC	classic pkc	0.1
HSDD	hypoactive sexual desire disorder	1.0
KGA	potassium channel activated by a g-protein from the atrium	1.0
PBel	external lateral parabrachial subnucleus	0.5
PBel	external lateral subnucleus of the parabrachial nucleus	0.5
EZH	2enhancer of zeste homolog 2	1.0
GEFS	+generalized epilepsy with febrile seizures plus	1.0
PBF	/stposterior biceps femoris/semitendinosus	0.5
PBF	phosphate-buffered formalin	0.5
KGF	keratinocyte growth factor	1.0
Mia-CK	ubiquitous isoform of mi-ckm	1.0
BLAST	basic local alignment search tool	1.0
vPCC	ventral portion of the posterior cingulate cortex	1.0
HSDT	ukey-kramer honest significant difference	0.5
HSDT	ukey’s honest significant difference	0.5
cMAP	compound motor action potential	1.0
CPK	creatine phosphokinase	1.0
CPL	cytoplasmic loop	1.0
CPM	counts per minute	1.0
CPN	caudate–putamen nucleus	0.333333333333
CPN	caudate-putamen nucleus	0.166666666667
CPN	callosal projection neurons	0.166666666667
CPN	scallosal projection neurons	0.166666666667
CPN	callosal projection neuron	0.166666666667
CPO	chlorpyrifos oxon	1.0
CPA	6-cyclopentyl adenosine	0.0208333333333
CPA	don6-cyclopentyladenosine	0.0208333333333
CPA	n6-cyclopentyladenosine	0.145833333333
CPA	2-chloro-n6-cyclopentyladenosine	0.0208333333333
CPA	commissural pretectal area	0.0416666666667
CPA	constant potential amperometry	0.0208333333333
CPA	cyclopiazonic acid	0.375
CPA	conditioned place aversion paradigm	0.0208333333333
CPA	conditioned place aversion	0.1875
CPA	conditioned place avoidance	0.0625
CPA	caudal pressor area	0.0625
CPA	caudal pressor area of the caudal medulla	0.0208333333333
CPC	onstructional praxis	0.5
CPC	central piriform cortex	0.5
CPD	cyclobutane pyrimidine dimer	0.5
CPD	carboxypeptidase d	0.5
CPE	cytoplasmic polyadenylation element	0.2
CPE	carboxypeptidase-e	0.4
CPE	carboxypeptidase e	0.4
GABHSG	roup a beta-hemolytic streptococcus	1.0
CPG	central-pattern-generator	0.0243902439024
CPG	(s)-4-carboxyphenylglycine	0.0243902439024
CPG	locomotor central pattern generator	0.0243902439024
CPG	central pattern generators	0.0487804878049
CPG	candidate plasticity-related gene	0.0243902439024
CPG	scentral pattern generators	0.146341463415
CPG	central pattern generator	0.682926829268
CPG	central pattern generating circuit	0.0243902439024
CPX	carboxypeptidase x	0.5
CPX	8-cyclopentyl-1,3-dipropylxanthine	0.5
CPZ	cuprizone	0.0909090909091
CPZ	carboxypeptidase z	0.0909090909091
CPZ	chlorpromazine	0.272727272727
CPZ	capsazepine	0.545454545455
LYLY341495	(2s)-2-amino-2-[(1s,2s)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid, a group ii antagonist	1.0
CPP	3-(2-carboxypiperazin-4-yl) propyl-1-phosphonic acid	0.00671140939597
CPP	3-(r)-2-carboxypiperazin-4-propyl-1-phosphonic acid	0.0134228187919
CPP	3(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	[±]-3-(2-carboxypiperazin-4yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	3-(2-carboxypiperazine-4-yl) propyl-1-phosphonic acid	0.00671140939597
CPP	3-[(±)-2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	(±)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	0.0134228187919
CPP	((r)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	32caspase-3	0.00671140939597
CPP	3-(2-carboxypiperzin-4-yl)-propyl-1-phosphonic acid	0.0134228187919
CPP	3-((±)-2 carboxy-piperazin-4-yl)propyl-1-phosphonic acid	0.00671140939597
CPP	3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	0.0201342281879
CPP	3,3-(2-carboxypiperazin-4-yl)-propylphosphonate	0.00671140939597
CPP	chronic pelvic pain	0.00671140939597
CPP	(±)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.0402684563758
CPP	conditioning place preference	0.00671140939597
CPP	crossed phrenic phenomenon	0.00671140939597
CPP	3-3(2-carboxypiperazin-4-yl) propyl-1-phosphate	0.00671140939597
CPP	3-((rs)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.0134228187919
CPP	3-(2-carboxypiperazin-4-yl)-propyl-propyl-l-phosphonic-phosphonic acid	0.00671140939597
CPP	(±)-3-(2-carboxypiperazine-4-yl) propyl-1-phosphonic acid	0.00671140939597
CPP	3-rs-2-carboxypiperazin-4-yl-propyl-1-phosphonic acid	0.00671140939597
CPP	[3h]	0.00671140939597
CPP	3-[(r)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid	0.00671140939597
CPP	3-((±)-2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	32-(carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	conditioned place-preference	0.00671140939597
CPP	(±)-3(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	0.00671140939597
CPP	3-((r)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.0134228187919
CPP	±-3-[2-carboxypiperazin-4-yl]propanephosphonic acid	0.00671140939597
CPP	(±)3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate	0.00671140939597
CPP	(dl-3/(r)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	[±]-3-[2-carboxypiperazin-4-yl]	0.0134228187919
CPP	(rs)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.0134228187919
CPP	(3-phosphonopropyl)-piperazine-2-carboxylic acid	0.00671140939597
CPP	3-(r-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	3-((r)2-carboxypiperazine-4-yl)-propyl-1-phosphoric acid	0.00671140939597
CPP	3-(2-carboxypiperzin-4-yl)-propyl-1-phosponic acid	0.00671140939597
CPP	conditional place preference	0.00671140939597
CPP	3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	conditioned place preference	0.51677852349
CPP	(r)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	0.0134228187919
CPP	3-[(±)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid	0.00671140939597
CPP	3-(r)-2-(carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.00671140939597
CPP	conditioned place preference paradigm	0.0201342281879
CPP	prepiriform cortex	0.00671140939597
CPP	cerebral perfusion pressure	0.0335570469799
CPP	4-(3-phosphonopropyl)-2-piperazine-carboxylic acid	0.00671140939597
CPP	conditioned place-preference paradigm	0.00671140939597
CPP	(3-[(r)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid)	0.00671140939597
CPP	3-[(r)-2-carboxypiperazin-4-yl]-prop-2-enyl-1-phosphonic acid	0.00671140939597
CPP	conditioned placed preference	0.00671140939597
CPR	chlorpheniramine	0.25
CPR	cardiopulmonary resuscitation	0.5
CPR	cytochrome p450 reductase	0.25
CPS	composite pain score	0.0833333333333
CPS	cold pressor stress	0.166666666667
CPS	capsaicin	0.0833333333333
CPS	closure-positivity shift	0.0833333333333
CPS	cryoprotectant	0.0833333333333
CPS	closure positive shift	0.166666666667
CPS	central pain syndrome	0.166666666667
CPS	cerebral protein synthesis	0.166666666667
CPT	8-cyclopentyl-theophylline	0.0416666666667
CPT	cold pressor test	0.0416666666667
CPT	camptothecin	0.125
CPT	8-cyclopentyltheophilline	0.0416666666667
CPT	cyproheptadine hydrochloride	0.0416666666667
CPT	cyclopentyl-1,3-dimethylxanthine	0.0833333333333
CPT	8-cyclo-pentyl-theophylline	0.0416666666667
CPT	ome8-(4-chlorophenylthio)-2′-o-methyladenosine-3′5′-cyclic monophosphate	0.0416666666667
CPT	8-cyclopentyl-1-3-dimethylxanthine	0.0416666666667
CPT	cyclopentyltheophylline	0.0416666666667
CPT	8-cyclopentyltheophylline	0.25
CPT	8-cyclopentyl-1,3-dimethylxanthine	0.0833333333333
CPT	continuous performance task	0.0416666666667
CPT	current perception threshold	0.0416666666667
CPT	8-cyclopentyl-1,3-dimethylxantine	0.0416666666667
CPU	caudate putamen	0.666666666667
CPU	caudate–putamen	0.333333333333
CPV	chronic variable physical stress	0.5
CPV	converted pixel value	0.5
Gpi	internal part of the gp	1.0
RBWG	reduced body weight gain	1.0
ABOD	absolute optical density	1.0
DMPX	3,7-dimethyl-1-propargyl-xanthine	0.333333333333
DMPX	3,7-dimethyl-1-propargylxanthine	0.666666666667
mtV	tract of the mesencephalic trigeminal nucleus	1.0
UCLAU	niversity of california at los angeles	1.0
DMPP	1,1-dimethyl-4-phenyl-piperazinium iodide	0.1
DMPP	1,1-dimethl-4-phenylpiperazinium	0.1
DMPP	dimethylphenylpiperazinium	0.5
DMPP	1,1-dimethyl-4-phenylpiperzinium	0.1
DMPP	1,1-dimethyl-4-phenylpiperazinium iodide	0.1
DMPP	1,1-dimethyl-4-phenylpiperazinium iodine	0.1
GABABGABA	receptor subtype b	0.5
GABABGABA	receptor b subtype	0.5
PP-1α	protein phosphatase 1α	1.0
DMPO	dorsal-medial paraolivary nucleus	0.25
DMPO	dorsal medial periolivary nucleus	0.25
DMPO	5,5-dimethyl-1-pyrroline-n-oxide	0.25
DMPO	5′,5′-dimethyl-1-pyroline n-oxide	0.25
Cli	caudal linear raphe nucleus	1.0
DMPK	myotonic dystrophy protein kinase	1.0
Me-AMY	medial amygdala	1.0
PEAQX	[[[(1s)-1-(4-bromophenyl)ethyl]amino]	1.0
CPu	caudate putamen	0.0384615384615
CPu	caudate putamen nucleus	0.0384615384615
CPu	caudate–putamen	0.769230769231
CPu	caudate–putamen nucleus	0.0384615384615
CPu	caudate-putamen	0.0384615384615
CPu	caudate–putamen (striatum)	0.0384615384615
CPu	caudate–putamen complex	0.0384615384615
mMMSE	modified mini-mental status examination	1.0
NILT	near-infrared light therapy	1.0
CDCH	caudodorsal cell hormone	1.0
DREZ	dorsal root entry zone	1.0
apCAM	aplysia cell adhesion molecule	1.0
DT-RMI	diffusion tensor magnetic resonance imaging	1.0
5-HT5-hydroxy-tryptamine	serotonin	1.0
OVx	ovariectomy	1.0
αMPTα-	methyl-p-tyrosine	1.0
intra-CA	1intra-dorsal hippocampal	1.0
γ-GCSγ-	glutamylcysteine synthetase	1.0
P-CFGPBS	containing 0.07% cold fish gelatin	1.0
GFRα1	glial cell line-derived neurotrophic factor receptor α1	0.5
GFRα1	gdnf family receptor α1	0.5
DREM	direct transition to rem	1.0
DREAM	downstream regulatory element antagonist modulator	1.0
EVAE	arth-vertical axis	1.0
ICCD	intensified ccd	1.0
CnF	cuneiform nucleus	1.0
ICCL	inner cortical cell layer	1.0
OVX	ovariectomy or ovariectomized	0.0430107526882
OVX	ovariectomy/ovariectomized	0.0537634408602
OVX	ovariectomy, ovariectomized	0.0215053763441
OVX	ovariectomy(ovariectomized)	0.010752688172
OVX	oophorectomized	0.010752688172
OVX	+e2ovariectomized estrogen-primed	0.010752688172
OVX	+eestradiol-treated ovariectomized	0.0322580645161
OVX	ovariectomized	0.677419354839
OVX	+eovariectomy plus 17-β-estradiol implant	0.010752688172
OVX	bilateral ovariectomy	0.010752688172
OVX	ovariectomy	0.118279569892
ICCI	mmunocytochemistry	1.0
TRAAK	tandem of p domains in a weak inwardly-rectifying k+ channel–related arachidonic acid-stimulated k+ channel	0.5
TRAAK	twik-related arachidonic acid-stimulated k+ channel	0.5
LTBABC	hybrid between the abc domains of synapsin and the b subunit of the heat-labile toxin of e. coli	1.0
OVA	ovalbumin	1.0
OVE	26transgenic type 1 diabetic	1.0
d-PDMP	d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propranol	1.0
EVAc	ethylene vinyl acetate copolymer	1.0
LMTK-	thymidine kinase negative mouse l-cells	1.0
αβmATP	α,β-methylene-atp	1.0
HVCRARA-	projecting hvc neurons	1.0
A-H	4/h3acetylated histone h4/h3	1.0
8-cpt-cAMP	8-chlorophenylthio-cyclic-amp	1.0
FGF-	2fibroblast growth factor -2	0.0555555555556
FGF-	2basic fibroblast growth factor-2	0.0277777777778
FGF-	1fibroblast growth factor 1	0.0277777777778
FGF-	2 binding sites	0.0277777777778
FGF-	2fibroblast growth factor	0.0833333333333
FGF-	2fibroblast growth factors-2	0.0277777777778
FGF-	2basic fibroblast growth factor 2	0.0277777777778
FGF-	2basic fibroblast growth factor	0.0555555555556
FGF-	2	0.25
FGF-	1fibroblast growth factor-1	0.0277777777778
FGF-	2fibroblast growth factor-2	0.305555555556
FGF-	2fibroblast growth factor 2	0.0833333333333
IRLSI	nternational rls study group rating scale	1.0
APDs	antipsychotic drugs	1.0
CHL1	close homologue of l1	1.0
KDELCOOH-	terminal lys-asp-glu-leu	1.0
LIF-R	leukemia inhibitory factor receptor	1.0
PB-T	phosphate buffer with 0.3% triton x-100	0.333333333333
PB-T	phosphate buffer with triton x-100	0.666666666667
sALS	sporadic amyotrophic lateral sclerosis	0.5
sALS	sporadic form of als	0.5
AVPO	anteroventral preoptic region	1.0
SKFSKF	10047	1.0
dmPAG	dorsomedial periaqueductal gray	0.5
dmPAG	dorsomedial periaqueductal gray column	0.25
dmPAG	dorsomedial column of the periaqueductal gray matter	0.25
AVPN	sairway vagal preganglionic neurons	1.0
8-OH-DPATR	(±)8-hydroxydipropylaminotetralin hydrobromide	1.0
RPTPζ	receptor-type protein-tyrosine phosphataseζ	0.5
RPTPζ	receptor protein tyrosine phosphatase ζ	0.5
l-GLU	l-glutamate	0.5
l-GLU	glutamate	0.5
UDTR	up-down transformed-rule	1.0
NHSD	no history of sexual dysfunction	1.0
LFB-PAS	luxol fast blue-periodic acid-schiff	0.5
LFB-PAS	luxol-fast blue-pas	0.5
A-C	u-agamino-cupric-silver	1.0
TPBPB	containing 0.10% triton x100	1.0
vSPVZ	ventral sub-paraventricular zone	1.0
AIAR	androgen-inducible aldehyde reductase	1.0
VGNC	voltage-gated na-channels	1.0
iUL	ipsilateral upper lip	1.0
oC	organ of corti	1.0
BMP-2	bone morphogenetic protein-2	1.0
DMSCN	dorsomedial suprachiasmatic nucleus	1.0
AC-LEHD-AMCN-	acetyl-leu-glu-his-asp-7-amino-4-methylcoumarin	1.0
UK-14	304, 5-bromo-n-(4,5-dihydro-1h-imidazol-2-yl)-6-quinoxalinamine	0.333333333333
UK-14	3045-bromo-6-(2-imidazolin-2-ylamino)-quinoxaline tartrate	0.333333333333
UK-14	314	0.333333333333
RT-PCR	reverse transcription-mediated polymerase chain reaction	0.00215517241379
RT-PCR	real time reverse transcription polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcriptional polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcription-pcr	0.00646551724138
RT-PCR	real-time reverse transcription polymerase chain reaction	0.00215517241379
RT-PCR	everse transcription polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcriptase-polymer chain reaction	0.00215517241379
RT-PCR	real-time reverse-transcribed polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcription pcr	0.00646551724138
RT-PCR	reverse transcription-polymerase chain reaction	0.217672413793
RT-PCR	reverse transcriptase-pcr	0.00215517241379
RT-PCR	reverse transcription coupled with polymerase chain reaction	0.00215517241379
RT-PCR	reverse-transcription-coupled polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcription-polymelase chain reaction	0.00215517241379
RT-PCR	reverse-transcription pcr	0.00215517241379
RT-PCR	reverse transcription followed by polymerase chain reaction	0.00215517241379
RT-PCR	real-time quantitative reverse transcription polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcriptase pcr	0.0193965517241
RT-PCR	reverse-transcriptase–polymerase chain reaction	0.00215517241379
RT-PCR	real time reverse transcriptase polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcriptase polymerase chain reaction	0.0840517241379
RT-PCR	reverse transcriptase polymer chain reaction	0.00215517241379
RT-PCR	real-time-polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcriptase-polymerase chain reaction	0.0969827586207
RT-PCR	reverse-transcription–polymerase chain reaction	0.010775862069
RT-PCR	reverse transcript polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcriptase–polymerase chain reaction	0.0862068965517
RT-PCR	reverse-transcription polymerase chain reaction	0.0344827586207
RT-PCR	reverse-transcriptase polymerase chain reaction	0.0215517241379
RT-PCR	reverse transcription–polymerase chain reaction	0.159482758621
RT-PCR	real-time polymerase chain reactions	0.00215517241379
RT-PCR	real time/reverse transcriptase polymerase chain reaction	0.00215517241379
RT-PCR	real-time polymerase chain reaction	0.0323275862069
RT-PCR	reverse transcription and polymerase chain reaction	0.00431034482759
RT-PCR	real-time pcr	0.00215517241379
RT-PCR	reverse transcription polymerase chain reaction	0.135775862069
RT-PCR	real time-polymerase chain reactions	0.00215517241379
RT-PCR	real time-polymerase chain reaction	0.010775862069
RT-PCR	reverse transcript-polymerase chain reaction	0.00215517241379
RT-PCR	reverse transcription coupled with the polymerase chain reaction	0.00215517241379
RT-PCR	real-time–polymerase chain reaction	0.00215517241379
RT-PCR	real time polymerase chain reaction	0.0150862068966
RT-PCR	retro-transcription polymerase chain reaction	0.00215517241379
pMAPK-	irphosphorylated mitogen activated protein kinase – immunoreactive	1.0
SBSB	203580	0.333333333333
SBSB	224289	0.333333333333
SBSB	230580	0.333333333333
ω-Cg-GVIA	ω-conotoxin-gvia	1.0
-5-methyl-1H-1	2,3-triazol-4-yl]-2,3-dihydro-1h-isoindol-1-one	1.0
FL-D	fluorescein-conjugated dextran	1.0
FLAMEFMRIB	's local analysis of mixed effects	1.0
SS-14	somatostatin-14	1.0
β-A	myloid	0.5
β-A	drβ-adrenergic receptor	0.5
β-G	albeta-galactosidase	0.166666666667
β-G	alβ-galactosidase	0.833333333333
GVIAω-	conotoxin gvia	0.666666666667
GVIAω-	conotoxin-gvia	0.333333333333
β-E	ndorphin	1.0
CT-ISI	cue–target interstimulus interval	1.0
sAEP	slow auditory evoked potential	1.0
DHBA3	4-dihydroxybenzylamine	0.666666666667
DHBA3	4-dihydroxybenzalamine	0.333333333333
pPSD	perforated post-synaptic density	1.0
GABRG	2	1.0
TeNt	tetanus toxin	1.0
GABRA	1gaba-a receptor subunit alpha-1	1.0
AICAR	5′-aminoimidazole-4-carboxamide riboside	0.333333333333
AICAR	5-aminoimidazole-4-carboxamide-riboside	0.333333333333
AICAR	5-aminoimidazole-4-carboxamide-1-b-d-ribofuranoside	0.333333333333
HC-3	hemicholinium-3	1.0
CDC-	42cell division cycle protein-42	1.0
RAAS	renin-angiotensin-aldosterone system	0.5
RAAS	renin–angiotensin–aldosterone system	0.5
Hc	hippocampus	1.0
cVRG	caudal division of the ventral respiratory group	0.5
cVRG	caudal ventral respiratory group	0.5
CYP450	cytochrome p450	1.0
TRP	transient receptor potential channel	0.0363636363636
TRP	transient–receptor–potential	0.0181818181818
TRP	+protein–carbohydrate mixture containing tryptophan	0.0363636363636
TRP	channeltransient receptor potential channel	0.0363636363636
TRP	transient receptor potential cation channel	0.0181818181818
TRP	transient receptor potential	0.709090909091
TRP	l-tryptophan	0.0181818181818
TRP	tryptophan	0.0909090909091
TRP	ion channel	0.0181818181818
TRP	channels	0.0181818181818
Bmax	maximum number of binding sites	0.285714285714
Bmax	maximum binding capacity	0.142857142857
Bmax	maximal number of sites	0.142857142857
Bmax	maximum density of binding sites	0.142857142857
Bmax	total concentration of receptor	0.142857142857
Bmax	receptor density	0.142857142857
wLFS	weak low-frequency stimulation	1.0
CMCC-	mechanocold unit	1.0
TRR	epetition time	1.0
AMLS	anteromedial lateral suprasylvian cortex	0.333333333333
AMLS	alls, pmls, plls, anteromedial, anterolateral, posteromedial and posterolateral suprasylvian sulcus	0.333333333333
AMLS	anteromedial suprasylvian sulcus	0.333333333333
trk-C	receptor tyrosine kinase-c	1.0
RAD	radiatum	0.5
RAD	stratum radiatum	0.5
FGF2	fibroblast growth factor-2	0.25
FGF2	basic fibroblast growth factor	0.75
nSec1	neuronal sec1	1.0
β-ENDβ-	endorphin	1.0
r-PIA	(-)-n6-(r-phenylisopropyl)adenosine	1.0
nACh	nicotinic acetylcholine	1.0
anti-N	ogo-66 receptor antibody	1.0
SCREBP-	1csterol regulatory element binding protein 1c	1.0
CGRP-LI	cgrp-like immunoreactivity	1.0
L-5-HTP	l-5-hydroxytryptophan	1.0
NS-EST	non-stressed estradiol animal group	1.0
NGFI	nerve growth factor-induced	1.0
COLDAIR	cold assisted intronic noncoding rna	1.0
Clc	central nucleus, latocellular part	1.0
APLPAPP-	like protein	1.0
D-APVD-	2-amino-5-phosphonovaleric acid	0.666666666667
D-APVD-	aminophosphonovalerate	0.333333333333
NR1NR2	nr3, nr2a, nr2b or nr2d, n-methyl-d-aspartate receptor subunit type 1, 2, 3, 2a, 2b or 2c	0.5
NR1NR2	subunits of the n-methyl-d-aspartate receptor	0.5
2-methylthio-ATP	2-methylthioadenosine triphosphate tetrasodium salt	1.0
CSEC	rocus sativus l. extract	1.0
CDCA	common disease/common allele	1.0
CDCC	enters for disease control and prevention	1.0
PLPE	1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphatidylethanolamine	1.0
4-CINα-	cyano-4-hydroxycinnamic acid	0.5
4-CINα-	cyano-4-hydroxycinnamate	0.5
PARG	poly(adp-ribose) glycohydrolase	1.0
VLDL-R	very low density lipoprotein receptor	1.0
apoGADGAD	in apoenzyme form	1.0
PAGD	periaqueductal gray, dorsal	1.0
PAGE	sodium docecyl sulfate–polyacrylamide gel electrophoresis	0.00520833333333
PAGE	sodium dodecyl sulphate polyacrylamide gel electrophoresis	0.00520833333333
PAGE	sodium dodecyl sulphate–polyacrlyamide gel electrophoresis	0.0104166666667
PAGE	polyacrylamide minigel electrophoresis	0.00520833333333
PAGE	sds–polyacrylamide gel electrophoresis	0.0208333333333
PAGE	polyacrylamide-gel electrophoresis	0.00520833333333
PAGE	sodium dodecyl sulfate–polyacrylamide gel electrophoresis	0.171875
PAGE	sodium dodecyl sulphate–polyacrylamide gel electrophoresis	0.1875
PAGE	polyacrylamide gel electrophoresis	0.442708333333
PAGE	sodium dodecylsulphate–polyacrylamide gel electrophoresis	0.046875
PAGE	sodium dodecylsulfate-polyacrylamide gel electrophoresis	0.0104166666667
PAGE	sodium dodecylsulfate–polyacrylamide gel electrophoresis	0.0572916666667
PAGE	polyacrylamide gel	0.0208333333333
PAGE	polycrylamide gel electrophoresis	0.00520833333333
PAGE	sodium dodecylsulphate–polyacrylamide gel electrophoresis semithin	0.00520833333333
pCPA	4-chloro-l-phenylalanine	0.166666666667
pCPA	p-chlorophenylalanine	0.666666666667
pCPA	p-chlorophenylalanine methyl ester	0.166666666667
GFRα-	1	0.5
GFRα-	1gdnf-family receptor α-1	0.5
CAB	1	1.0
mEPC	miniature endplate current	0.666666666667
mEPC	miniature end-plate currents	0.333333333333
BCAB	icinchoninic acid	1.0
HPAA	hypothalamo–pituitary–adrenal axis	1.0
mEPI	multi-band epi	1.0
C-δ	1	1.0
Rolipram	[4-(3′-cyclopentyloxy-4′-methoxyphenyl)-2-pyrrolidone]	1.0
NGFR	nerve growth factor receptor	0.5
NGFR	ngf receptor	0.5
mEPP	miniature end-plate potential	0.333333333333
mEPP	sminiature end-plate potentials	0.166666666667
mEPP	miniature endplate potential	0.5
IASPI	nternational association for the study of pain	1.0
CMTMR	oschloromethyl tetramethylrosamine	0.5
CMTMR	5-{[(4-chloromethyl)benzoyl]amino}tetramethylrhodamine	0.5
DNQX	6,7-dinitroquinoxaline-2,3(1h,4h)-dione	0.0810810810811
DNQX	6,7-dinitroquinoxaline	0.027027027027
DNQX	5,6-dinitroquinoxaline-2,3-dione	0.027027027027
DNQX	6,7-dinityo-quinoxaline-2,3-dione	0.027027027027
DNQX	6,7-dinitroquinoxaline-2,3-dione	0.783783783784
DNQX	dinitroquinoxaline	0.0540540540541
BCAA	branched chain amino acids	1.0
USAU	nited states of america	1.0
HMC	hypaxial motor column	0.5
HMC	hoffman modulation contrast	0.5
APCI	atmospheric pressure chemical ionization	1.0
IMEANFR	instantaneous mean frequency	1.0
OPRM	1mu opioid receptor	1.0
CGS21680	2-[p-(-2-carboxyethyl)-phenylethylamino]-5′-n-ethylcarboxamidoadenosine	0.25
CGS21680	2-p-(2-carboxyethyl)phenethylamino-5′-n-ethylcarboxamidoadenosine hydrochloride	0.25
CGS21680	2-[4-(carboxyethyl)phenylethylamino]-5′-n-ethylcarboxamidoadenosine	0.25
CGS21680	2-p-(2-carboxyethyl)phenethylamino-5′-n-ethylcarboxamidoadenosine	0.25
APCA	denomatous polyposis coli	1.0
β3AR	β3-adrenergic receptor	1.0
5-HT2	serotonin	1.0
sGmax	specific maximal conductance	1.0
iSPN	indirect pathway spn	1.0
dE	elbow velocity	1.0
NGFr	nerve growth factor receptor	0.666666666667
NGFr	p75 low-affinity neurotrophin receptor	0.333333333333
SM-PBS	non-fat skimmed dry milk in pbs	1.0
18F-	fluoro-2-deoxy-glucose positron emission tomography	1.0
HTR	1ahuman 5-hydroxytryptamine (serotonin) receptor 1a	0.333333333333
HTR	head-twitch response	0.666666666667
mGluR	metabotropic glur	0.0121951219512
mGluR	metabotrophic glutamate receptor subunit	0.0121951219512
mGluR	metabotropic glutamate receptors	0.0243902439024
mGluR	metabotrophic glutamate receptor	0.0121951219512
mGluR	metabolic glutamate receptor	0.0121951219512
mGluR	metabotropic glutamate receptor	0.914634146341
mGluR	metabotropic glutamate receptor subtype	0.0121951219512
XOS	cross-orientation suppression	1.0
hβE	human β-endorphin	1.0
BAXB	cl-2-associated x protein	0.5
BAXB	cl-2–associated x protein	0.5
nBMp	posterior subdivision of nucleus basalis	1.0
alloP	allopregnanolone	1.0
nBMi	intermediate subdivision of nucleus basalis of meynart	1.0
mGlu5	metabotropic glutamate receptor type 5	1.0
GABAAR-α	6	1.0
SCRAM	scrambled	1.0
nBMa	anterior subdivision of nucleus basalis of meynart (consisting of nbmam and nbmal)	1.0
XOM	cross-orientation masking	1.0
PEG-CAT	polyethylene glycol–conjugated catalase	1.0
MDS-UPDRSM	ovement disorder society-sponsored unified parkinson’s disease rating scale	0.5
MDS-UPDRSM	ovement disorder society unified parkinson’s disease rating scale	0.5
PAP-I	pancreatitis-associated protein-i	1.0
RasGRP	ras guanyl nucleotide-releasing protein	1.0
HPA-	axishypothalamus–pituitary–adrenal axis	0.0769230769231
HPA-	axishypothalamo-pituitary-adrenal axis	0.0769230769231
HPA-	axishypothalamic-pituitary-adrenal axis	0.0769230769231
HPA-	axishypothalamic–pituitary–adrenal axis	0.230769230769
HPA-	axishypothalamic–pituitary-adrenal axis	0.0769230769231
HPA-	axishypothalamo–pituitary–adrenal axis	0.0769230769231
HPA-	axis	0.384615384615
LLC-PK1	eli lilly and company canine kidney	1.0
W-7	n-(6-aminohexyl)-5-chloro-1-naphtalenesulfonamide	1.0
ACX	auditory cortex	1.0
MTEAS	mock teas	1.0
BUGT	human bilirubin-uridine 5′-diphosphate-glucuronosyl-transferase	1.0
DTX-ID	endrotoxin-i	1.0
PARC	pulmonary activation-regulated chemokine	1.0
dLVN	dorsocaudal portion of the lvn	1.0
RSV-LTRR	ous sarcoma virus long terminal repeat	1.0
S-ON	stimulus-on	1.0
PVth	paraventricular thalamic nucleus	0.5
PVth	thalamic paraventricular nucleus	0.5
CPT8-cyclopentyl-1	3-dimethylxanthine (8-cyclopentyl-theophylline)	0.5
CPT8-cyclopentyl-1	3-dimethylxanthine (an adenosine a1 receptor antagonist)	0.5
CRAC	channelca2+ release-activated ca2+ channel	1.0
192SAP	192 igg-saporin	1.0
CRAO	central retinal artery occlusion	1.0
γ-GCL-C	gamma-glutamylcysteine ligase-c	1.0
UTHSCSA	university of texas health science center at san antonio	1.0
QUIN2	3-pyridinedicarboxylic acid	1.0
DYRK	1adual-specificity tyrosine phosphorylation-regulated kinase 1a	0.5
DYRK	1adual-specificity tyrosine-(y)-phosphorylation-regulated kinase 1a	0.5
SNRI5-HT	and norepinephrine reuptake inhibitor	1.0
αMMTα-	methyl-m-tyrosine	1.0
IGTI	owa gambling task	1.0
DRGII	homeobox gene	1.0
IGTT	intraperitoneal glucose tolerance test	1.0
DOMA3	4-dihydroxymandelic acid	1.0
IGTP	interferon-γ-induced gtpase	1.0
GFXGF	109203x	1.0
PPNdm	pedunculopontine nucleus pars dissipata medialis	1.0
TPLSM	two photon laser scanning confocal microscopy	1.0
chGRP-R	chicken gastrin releasing peptide receptor	1.0
CIII	mitochondrial complex iii	1.0
polyPSC	polysynaptic postsynaptic current	1.0
hrbFGF	human recombinant basic fibroblast growth factor	1.0
PPNdv	pedunculopontine nucleus pars dissipata ventralis	1.0
vmT	ventromedial thalamus	1.0
PPNdr	pedunculopontine nucleus pars dissipata rostralis	1.0
pLTF	phrenic long-term facilitation	1.0
M-MLV	moloney murine leukemia virus	1.0
fMLF	formyl-methionyl-leucyl-proline	1.0
GSEAGSE	analysis	1.0
DPYSL	2dihydropyrimidinase-related protein 2	1.0
LRPLDL-	related receptor protein	1.0
ERRβ	estrogen-related receptor β	1.0
DBADBA	/2j	1.0
VIC	arvoltage-induced ca2+ release	1.0
VIA	ventrointermediate area	1.0
cSI	contralateral primary somatosensory cortex	1.0
Sal	saline-treated	1.0
PHCCCN-	phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide	1.0
VIH	vitellogenesis-inhibiting hormone	0.5
VIH	vehicle-injected hypoxia-ischemia rats	0.5
VII	mfacial motor nucleus	0.0833333333333
VII	central facial motor nucleus	0.0833333333333
VII	nfacial nucleus	0.0833333333333
VII	facial nucleus	0.333333333333
VII	facial	0.0833333333333
VII	facial nerve	0.0833333333333
VII	mofacial nucleus	0.166666666667
VII	facial motor nucleus	0.0833333333333
cSC	caudal solitary complex	1.0
VIM	ventral intermediate nucleus	0.5
VIM	vimentin	0.5
VIS	pprimary visual area	0.5
VIS	visual stimuli only	0.5
VIP	vasoactive intestinal polypeptide	0.532894736842
VIP	vasoactive intestinal peptide	0.421052631579
VIP	ventral intraparietal	0.0131578947368
VIP	ventral intraparietal area	0.00657894736842
VIP	vasoactive intestinal	0.00657894736842
VIP	vector vip substrate kit	0.00657894736842
VIP	variable importance in the projection	0.00657894736842
VIP	vasoactive intestinal polypeptide.	0.00657894736842
VIQ	verbal intelligence quotient	1.0
VIV	vivarium	0.666666666667
VIV	vivarium ground control	0.333333333333
MAL-6	2,2,6,6-tetramethyl-4-maleimidopiperidine-1-oxyl	1.0
ZNPC	zone of non-proliferating cells	1.0
ssEM	serial section electron microscopy	1.0
CPTCDP-choline-1	2 diacylglycerol phosphocholine transferase	1.0
HPβCD	2-hydroxypropyl-β-cyclodextrin	1.0
TYR	tyrosine	1.0
lAHP	late after-hyperpolarising potential	1.0
STAT	1αsignal transducer and activator of transcription 1α	0.0232558139535
STAT	signal transducers and activators of transcription	0.139534883721
STAT	signal transducer and activation of transcription	0.0232558139535
STAT	3signal transducers and activators of transcription 3	0.0232558139535
STAT	3signal transducer and activator of transcription-3	0.0697674418605
STAT	signal-transducer and activator of transcription	0.0232558139535
STAT	3	0.0697674418605
STAT	5	0.046511627907
STAT	3signal transducer and activator of transcription 3	0.348837209302
STAT	signal transducer and activator of transcription	0.209302325581
STAT	3signal transducers and transcription activators 3	0.0232558139535
PDXK	pyridoxal kinase	1.0
FJ-BF	luoro-jade b	1.0
ABA	activity-based animal model of anorexia nervosa	0.2
ABA	activity-based anorexia	0.4
ABA	pplied biosystems	0.4
ALG2	apoptosis-linked gene 2	1.0
α-KGAα-	ketoglutaric acid	1.0
NLAR	non-linear autoregressive	1.0
AAAATP	ases associated with diverse cellular activities	1.0
ALG-	2apoptosis-linked gene-2	1.0
PDXP	pyridoxal phosphate phosphatase	1.0
tVTA	tail of the ventral tegmental area	0.5
tVTA	tail of ventral tegmental area	0.5
pGSK-	3phosphorylated gsk-3	1.0
VCMs	vacuous chewing movements	1.0
STAI	state trait anxiety inventory	1.0
mIκB-α	mutant i κb-α	1.0
NAcINT	intermediate zone of the nucleus accumbens shell	1.0
SMI31	highly phosphorylated neurofilament 160–200,000 mol. wt	1.0
hyperalgesianociceptorG-	protein-coupled receptorg-protein-coupled receptor kinase 2chronic pain	1.0
ILA	infralimbic area	0.5
ILA	infralimbic cortical area	0.5
ADDA	dderall xr®	1.0
HIAA	5-hydroxyindolacetic acid	0.5
HIAA	hydroxyindoleacetic acid	0.5
hASC	shuman adipose-derived stem cells	1.0
7β-OHCH	7β-hydroxycholesterol	1.0
RCA-	1ricinus communis agglutinin-1	1.0
ABI	auditory brainstem implant	1.0
tOD	threshold optical density	1.0
CCGO	cellular component	1.0
BICL	bilateral internal carotid ligation	1.0
BLMH	bleomycin hydrolase	1.0
PCxPVpaleocortex	posterior part, ventral division	1.0
ABL	lateral/basolateral nuclear complex of the amygdala	0.166666666667
ABL	basolateral amygdala	0.666666666667
ABL	basolateral amygdala nucleus	0.166666666667
cMRI	conventional mri	1.0
BICB	ayesian information criterion	1.0
AFNI	analysis of functional neuroimages	1.0
HGS	hibernating ground squirrel	1.0
β-GPβ-	glycerophosphate	1.0
DIGD	igoxigenin	1.0
DIGE	difference gel electrophoresis	1.0
caudalMF	caudal middle frontal gyrus	1.0
PARK	parkin	1.0
cADP	rcyclic adp-ribose	1.0
HGN	hypogastric nerves	0.333333333333
HGN	hypogastric nerve	0.666666666667
HR-MAS	high-resolution magic angle spinning	1.0
RIII	reflex	1.0
SXVthreonine	serine, any amino acid, and valine	1.0
ALLNN-	acetyl-leu-leu-norleucinal	1.0
VIIRVL	juxtafacial ventrolateral medulla	1.0
SMI32	non-phosphorylated neurofilament 160–200,000 mol. wt	1.0
cADD	cumulative afterdischarge duration	1.0
NR1NR2A	nr2b, nmdar subunits	1.0
FPMOV	beginning of the fixation point movement	1.0
ICANC	a2+-activated non-specific cation current	0.25
ICANC	a2+-activated non-selective cation current	0.25
ICANC	a2+-activated nonspecific cationic current	0.25
ICANC	a2+-activated non-specific cationic current	0.25
SGCE	epsilon-sarcoglycan gene	1.0
NTPD	ase2	0.111111111111
NTPD	aseecto-nucleoside triphosphate diphosphohydrolase	0.222222222222
NTPD	asesnucleoside triphosphate diphosphohydrolases	0.111111111111
NTPD	aseectonucleoside triphosphate diphosphohydrolase	0.111111111111
NTPD	asenucleoside triphosphate diphosphohydrolase	0.444444444444
HGK	hpk/gck-like kinase	1.0
SDS-PAGES	odium dodecyl sulfate polyacrylamide gel electrophoresis	1.0
IT-	typeintratelencephalic-type	1.0
ptiO	2brain tissue oxygen	1.0
INMT	indole-n-methyl transferase	1.0
EDSS	expanded disability status scale	1.0
UEA	utah electrode array	1.0
Rasd1RAS	dexamethasone-induced 1	1.0
SIBR	synthetic inhibitory bic-derived rna	1.0
TRITC	tetramethyl rhodamine iso-thiocyanate	0.047619047619
TRITC	tetramethylrhodamine isothiocyanate	0.428571428571
TRITC	tetramethylrhodamine isothiocyanate.	0.0119047619048
TRITC	tetramethyl rhodamine isothyocyanate	0.0119047619048
TRITC	tetra methyl rhodamine iso thio cyanate	0.0119047619048
TRITC	tetramethylrhodamine	0.0238095238095
TRITC	tetramethylrhodamine-isothiocyanate conjugated	0.0119047619048
TRITC	tetramethylrhodamine isothiocynate	0.0119047619048
TRITC	tretramethyl rhodamine isothiocyanate	0.0119047619048
TRITC	tetramethylrhodamine isothiocyanate isomer r	0.0119047619048
TRITC	rhodamine isothiocyanate	0.0119047619048
TRITC	tetramethyl rhodamine isothiocyanate	0.297619047619
TRITC	tetramethylrodamine isothiocyanate	0.0119047619048
TRITC	tetrarhodamine isothiocyanate	0.0238095238095
TRITC	tetramethyl rhodamine	0.0238095238095
TRITC	tetramethyl rhodamine isothiocynate	0.0119047619048
TRITC	tetramethyl-rhodamine isothiocyanate	0.0357142857143
JBD	c-jun n-terminal kinase binding domain of c-jun n-terminal kinase-interacting protein-1	0.5
JBD	c-jun n-terminal kinase–binding domain	0.5
SIa	substantia innominata pars anterior	1.0
β-FNA	β-funaltrexamine	1.0
βFGF	fibroblast growth factor	1.0
sPDC	squared partial directed coherence	1.0
INMI	isolated neck movement index	1.0
ADMHAδ-	mechanoheat unit	1.0
TASK-	3	1.0
DGC	dentate granule cell layer	0.0416666666667
DGC	sdentate granule cells acutely isolated from 7–14-day-old rats	0.0416666666667
DGC	dentate granule cells	0.0416666666667
DGC	deep granule cells	0.0416666666667
DGC	dentate gyrus granule cell	0.0416666666667
DGC	dentate granule cell	0.166666666667
DGC	dystrophin-associated glycoprotein complex	0.0833333333333
DGC	dorsal grey commissure	0.0416666666667
DGC	dystrophin glycoprotein complex	0.0416666666667
DGC	dorsal gray commissural	0.0416666666667
DGC	dorsal gray commissure	0.416666666667
ARL671566-N	n-diehyl-β-γ-dibromomethylene-d-atp	0.333333333333
ARL671566-N	n-diethyl-d-β,γ-dibromomethylene atp	0.333333333333
ARL671566-N	n-diethyl-d-β,γ-dibromomethyleneatp	0.333333333333
DFB3	3′-difluorobenzaldazine	1.0
SNJ-	1945	1.0
DGG	distal glossopharyngeal ganglia	0.5
DGG	γ-d-glutamylglyine	0.5
DGD	entate gyrus	1.0
ODI	ocular dominance index	1.0
LCFA	long chain fatty acids	1.0
DGN	dentate granule neuron	0.5
DGN	sdentate granule neurons	0.5
SPSY	spermine synthase	1.0
DGL	dentate granule cell layer	1.0
DGM	dorsal gray matter	1.0
DGR	abbreviation for peptide sequence sdgrg	1.0
Vcoll	the size of the collateral ipsp	1.0
PABPC	5poly(a) binding protein cytoplasmic 5	1.0
CDKICDK	inhibitor	1.0
PQBP	1polyglutamine tract-binding protein-1	1.0
MTHF-DH	methylenetetrahydrofolate dehydrogenase	1.0
ENVAE	cole nationale vétérinaire d’alfort	1.0
d-NAMENG-	nitro-d-arginine-methyl ester	1.0
UN-	neuronsbehaviorally unidentified neurons	1.0
mABH	mouse alkb homologue	1.0
UNP	unpaired	1.0
l-NBP	l-3-n-butylphthalide	1.0
MTOC	microtubule-organizing center	1.0
NDOM	nondominant	1.0
nHL	horizontal limb of the diagonal band nuclei	1.0
HERA	hemispheric encoding retrieval asymmetry model	1.0
HERG	human ether-a-go-go-related gene	0.25
HERG	human eag-related gene	0.25
HERG	ether a go-go k+ channels	0.25
HERG	human ether-a-go-go related gene	0.25
nHH	ill coefficient	0.8
nHH	ill coefficients	0.2
G272V	p301l and r406w, found in ftdp-17	1.0
BAG	1bcl-2-associated athanogene-1	0.5
BAG	5bcl2-associated athanogene 5	0.5
NWN	orth-west	1.0
UNC	5aunc5 homologue a	0.166666666667
UNC	5huncoordinated gene 5h	0.166666666667
UNC	5	0.166666666667
UNC	5h2uncoordinated gene 5h2	0.166666666667
UNC	uncoordinated	0.166666666667
UNC	5c	0.166666666667
PC12	pheochromocytoma	0.5
PC12	rat pheochromocytoma cell line	0.333333333333
PC12	cell line from rat pheochromocytoma	0.166666666667
UNG	uracil glycosylase	0.8
UNG	uracil-dna n-glycosylase	0.1
UNG	2uracil-dna glycosylase 2 (nuclear)	0.1
PUFAs	polyunsaturated fatty acids	1.0
UNI	unilateral lesion group	1.0
PCDH	protocadherin	0.333333333333
PCDH	15protocadherin-15	0.333333333333
PCDH	sprotocadherins	0.333333333333
IDIBELLI	nstitute for biomedical investigation of bellvitge	1.0
HERV	human endogenous retrovirus	1.0
PVDF	polyvinylidine fluoride	0.00892857142857
PVDF	polyvinyliden fluoride	0.00892857142857
PVDF	polyvinylidene difluoride membrane	0.0178571428571
PVDF	polyvinyldifluoridine	0.00892857142857
PVDF	polyvinyl difluoride	0.00892857142857
PVDF	poly(vinylidene difluoride)	0.0178571428571
PVDF	polyvinyldene difluoride	0.00892857142857
PVDF	,	0.00892857142857
PVDF	polyvinylidene difluoride membranes	0.00892857142857
PVDF	polyvinylidene difluoride	0.553571428571
PVDF	polyvinylidenedifluoride	0.0178571428571
PVDF	polyvinyldiene fluoride	0.00892857142857
PVDF	polyvinylidene fluoride	0.303571428571
PVDF	polyvinyldifluoride	0.0178571428571
ITO	interstitial nucleus of the optic tract	1.0
ITM	intermediate-term memory	0.4
ITM	intermediate memory	0.6
OMG	[3h]-o-methylglucose	1.0
NmEGF	n-myristoylated egf receptor fragment (651–658)	1.0
ITI	inter-trial-interval	0.0240963855422
ITI	inter-train interval	0.0240963855422
ITI	inter-tap interval	0.0120481927711
ITI	intertrial interval	0.409638554217
ITI	intertribal interval	0.0120481927711
ITI	inter-transient interval	0.0120481927711
ITI	inter-tap-interval	0.0120481927711
ITI	intertrial intervals	0.0120481927711
ITI	sinter-trial interval	0.0120481927711
ITI	inter-tap intervals	0.0120481927711
ITI	inter-trial intervals	0.0120481927711
ITI	inter-trial interval	0.44578313253
ITF	inducible transcription factor	0.916666666667
ITF	sinducible transcriptional factors	0.0833333333333
ITG	intra temporal gyrus	0.333333333333
ITG	inferior temporal gyrus	0.666666666667
ITD	sinteraural time differences	0.1
ITD	’sinteraural time differences	0.1
ITD	inter-aural timing difference	0.1
ITD	interaural temporal difference	0.1
ITD	interaural time difference	0.6
ITC	intertrial crossing	0.125
ITC	intercalated	0.25
ITC	intercalated amygdaloid cells	0.125
ITC	intercalated cell masses of the amygdala	0.125
ITC	inter-trial phase coherence	0.125
ITC	intercalated cell mass	0.125
ITC	inter-trial coherence	0.125
fMEPC	sminiature end-plate currents’ frequency	1.0
OML	outer one-third of the molecular layer	0.0714285714286
OML	outer mantle layer	0.0714285714286
OML	outer molecular layer	0.714285714286
OML	outer molecular layer (of the dentate gyrus)	0.0714285714286
OML	outer molecular layer of the dentate gyrus	0.0714285714286
OMS	olfactomimetic stimulation	1.0
OMP	olfactory marker protein	1.0
NIAAAN	ational institute on alcohol abuse and alcoholism	1.0
REOR	igid eyes open condition	1.0
ITT	insulin tolerance test	1.0
ITR	intertrial response	0.25
ITR	inverted terminal repeat	0.25
ITR	transient outward rectifying potassium conductance	0.25
ITR	sinverted terminal repeats	0.25
ITP	incomplete triceps paralysis	1.0
LDTg	lateral dorsal tegmental nucleus	0.1
LDTg	laterodorsal tegmental field	0.1
LDTg	laterodorsal tegmental nucleus	0.8
AAE	augmented acoustic environment	0.5
AAE	adolescent alcohol exposure	0.5
AAD	asymmetric axodendritic synapses	1.0
ERKR	as/extracellular signal regulated kinase	1.0
AAF	anterior auditory field	0.909090909091
AAF	auditory field	0.0909090909091
AAA	dl-alpha-aminoadipic acid	0.0909090909091
AAA	anterior amygdalar area	0.0909090909091
AAA	abdominal aortic aneurysm	0.0909090909091
AAA	+atpases associated with a variety of cellular activities	0.181818181818
AAA	anterior amygdaloid nuclei	0.0909090909091
AAA	anterior amygdaloid area	0.272727272727
AAA	anterior amygdaloid nucleus	0.0909090909091
AAA	triple alanine	0.0909090909091
MERFM	et-enkephalin-arg6-phe7	1.0
ELK	ets oncogene proteins	1.0
AAL	automated anatomical labeling	1.0
TMR-D	tetramethylrhodamine dextran	1.0
LCAT	lecithin:cholesterol acyl transferase	1.0
IFLMR	interface between stratum lacunosum-moleculare and stratum radiatum	1.0
PS2	presenilin-2	0.5
PS2	presenilin 2	0.5
AAV	adeno-associated virus	0.681818181818
AAV	adeno-associated viral	0.181818181818
AAV	adeno-associated viruses	0.0454545454545
AAV	9adeno-associated virus serotype 9	0.0454545454545
AAV	ventral part of the anterior amygdaloid area	0.0454545454545
NAcCORE	nucleus accumbens core	1.0
LCAM	liver cell adhesion molecule	1.0
AAS	anabolic-androgenic steroids	0.0909090909091
AAS	anabolic—androgenic steroids	0.0909090909091
AAS	anabolic androgenic steroid	0.181818181818
AAS	asymmetric axospinous synapses	0.0909090909091
AAS	anabolic androgenic steroids	0.363636363636
AAS	anabolic–androgenic steroids	0.0909090909091
AAS	androgenic-anabolic steroids	0.0909090909091
LCAO	left coronary artery occlusion	1.0
ra-CNTF	ppolyclonal rabbit-anti-rat ciliary neurotrophic factor	0.5
ra-CNTF	ppolyclonal rabbit–anti-rat ciliary neurotrophic factor	0.5
LPGI	lateral paragigantocellular reticular nucleus	0.5
LPGI	lateral paragigantocellular nucleus	0.5
ERKO	estrogen receptor knock out	1.0
BIN	binocular	1.0
POMC-EGFPPOMC-	enhanced green fluorescent protein	1.0
BIM	bisindolylmaleimide	0.333333333333
BIM	bicuculline methobromide	0.0833333333333
BIM	bisindolylmaleimide i hydrochloride	0.0833333333333
BIM	bisindolylmaleimide i	0.333333333333
BIM	ibisindoleylmaleimide i (pkc inhibitor)	0.0833333333333
BIM	bisindolylmaleimide ii	0.0833333333333
TEMED	n,n,n′,n′-tetramethylethylenediamine	1.0
BIG	1	1.0
BID	β interaction domain	1.0
4α-PDD	4α-phorbol 12,13-didecanoate	1.0
BIC	nucleus brachium inferior colliculus	0.0285714285714
BIC	the brachium of the inferior colliculus	0.0285714285714
BIC	brachium of the ic	0.0571428571429
BIC	bicuculline	0.457142857143
BIC	bicuculline methochloride	0.0285714285714
BIC	1(s), (9) (-) bicuculline methochloride	0.0285714285714
BIC	nucleus of the brachium of the inferior colliculus	0.0571428571429
BIC	brachium of the inferior colliculus	0.0857142857143
BIC	bicuculline methiodide	0.228571428571
TRDA	tetramethylrhodamine dextran amine	0.5
TRDA	texas red-conjugated dextran amine	0.5
SCNT	sciatic nerve transection	0.666666666667
SCNT	somatic cell nuclear transfer	0.333333333333
rDLPFC	right dorsolateral prefrontal cortical areas	1.0
IFN-γ-R	interferon-γ receptor	1.0
CIMT	constraint-induced movement therapy	1.0
αSNAPN-	ethylmaleimide sensitive fusion protein attachment protein alpha	1.0
TIPP	[ψ], h-tyr-ticψ[ch2-nh]	0.5
TIPP	ψh-tyr-tic[ch2nh]-phe-phe-oh	0.5
BIT	brain ischemic tolerance	1.0
LPGi	lateral paragigantocellularis	0.2
LPGi	lateral paragigantocellularis nucleus	0.2
LPGi	lateral paragigantocellular nucleus	0.6
BIS	bisindolylmaleimide	0.25
BIS	vbisindolylmaleimide v	0.25
BIS	ibisindolylmaleimide i	0.25
BIS	behavioral inhibition system	0.25
OVX-Povariectomized	progesterone replaced	1.0
MENTHOMLN	64 n-terminal domain homolog	1.0
rAF	relative arithmetic fluorescence ratio	1.0
β-DG	beta dystroglycan	1.0
rAC	rostral anterior cingulate cortex	1.0
RLX	3relaxin-3	1.0
Ac-YVAD-cmk	acetyl-tyrosinyl-valyl-alanyl-aspartyl-chloro-methylketone	1.0
MGST	3microsomal glutathione s-transferase 3	1.0
SLR	simple linear regression	0.2
SLR	signal log2 ratio	0.2
SLR	subthalamic locomotor region	0.4
SLR	short-latency response	0.2
SLM	stratum lacunosum-moleculare	0.714285714286
SLM	stratum lacunosum moleculare	0.238095238095
SLM	stratum lacunosum-moleculare dendrites	0.047619047619
SLN	superior laryngeal nerve	1.0
SLO	scanning laser ophthalmoscopy	0.5
SLO	streptolysin o	0.5
SLH	sporadically lurking hap1-immunoreactive	1.0
ELD	excitatory long-duration	1.0
MCx	primary motor cortex	0.5
MCx	pericruciate motor cortex	0.5
SLD	sublaterodorsal nucleus	0.5
SLD	sublaterodorsal tegmental nucleus	0.5
SLE	seizure-like event	0.428571428571
SLE	spongiform leukoencephalopathy	0.142857142857
SLE	sseizure-like events	0.142857142857
SLE	systemic lupus erythematosus	0.285714285714
SLF	/af tptemporoparietal portion of superior longitudinal fasciculus/arcuate fasciculus	0.142857142857
SLF	superior longitudinal fasciculus	0.571428571429
SLF	spiral ligament fibrocyte	0.285714285714
TBS-XT	ris-buffered saline with 0.25% triton-x® 100	1.0
SLA	spontaneous locomotor activity	1.0
NMDA-AN-	methyl-d-aspartate receptor antagonists	1.0
XRCC	1x-ray cross-complementary factor 1	0.25
XRCC	1x-ray cross-complementing protein 1	0.25
XRCC	1x-ray cross-complementing 1	0.25
XRCC	2x-ray repair cross-complementing protein 2	0.25
MCN	magnocellular neuron	0.333333333333
MCN	medial cerebellar nuclei	0.666666666667
MCM	artinotti cell	0.142857142857
MCM	2mini-chromosome maintenance protein 2	0.142857142857
MCM	microglial-conditioned medium	0.142857142857
MCM	2minichromosome maintenance protein 2	0.142857142857
MCM	microglia-conditioned medium	0.142857142857
MCM	methylmalonyl-coa mutase	0.142857142857
MCM	meningeal cell-conditioned medium	0.142857142857
MCL	molecular cell layer	0.0357142857143
MCL	mitral cell layers	0.0357142857143
MCL	mitral cell layer of the olfactory bulb	0.0357142857143
MCL	mitral cell layer of olfactory bulb	0.0357142857143
MCL	mitral cell layer	0.857142857143
Naloxone	(5α)-4,5-epoxy-3,14-dihydro-17-(2-propenyl) morphinan-6-one	1.0
MCJ	myoclonic jerk	1.0
MCI	mild cognitive impairment	0.894736842105
MCI	stablemild cognitive impairment subjects remaining stable	0.0526315789474
MCI	mild cognitive impairments	0.0526315789474
NHEJ	non-homologous end joining	0.5
NHEJ	non-homologous end-joining	0.25
NHEJ	nonhomologous end joining	0.25
GFR	growth factor reduced	0.142857142857
GFR	3high affinity receptor for artemin	0.142857142857
GFR	αglycosylphosphatidylinositol-anchored gdnf receptor-a	0.142857142857
GFR	glomerular filtration rate	0.142857142857
GFR	gdnf family receptor	0.142857142857
GFR	alpha-1gdnf family receptor a1pha 1	0.142857142857
GFR	glial cell line-derived neurotrophic factor receptor	0.142857142857
SLu	stratum lucidum	1.0
GFP	expression vector containing green fluorescence protein	0.00396825396825
GFP	enhanced green fluorescent protein	0.00793650793651
GFP	green florescence protein	0.00396825396825
GFP	green florescent protein	0.00793650793651
GFP	(enhanced) green fluorescent protein	0.00396825396825
GFP	green fluorescent protein	0.912698412698
GFP	green fluorescence protein	0.0198412698413
GFP	global field power	0.0198412698413
GFP	green-fluorescent protein	0.0198412698413
MCD	mean current density	0.0833333333333
MCD	malformation of cortical development	0.166666666667
MCD	minimum covariance determinant	0.0833333333333
MCD	methyl-β-cyclodextrin	0.25
MCD	malformations of cortical development	0.416666666667
MCC	middle cingulate cortex	1.0
RCSM	rhythmic cloacal sphincter movement	1.0
MCA	mid-cerebral artery	0.00724637681159
MCA	omiddle cerebral artery occlusion	0.18115942029
MCA	occlusion	0.00724637681159
MCA	middle cerebral artery	0.775362318841
MCA	:omiddle cerebral artery occlusion	0.00724637681159
MCA	oocclusion of the middle cerebral artery	0.00724637681159
MCA	o	0.00724637681159
MCA	mecamylamine	0.00724637681159
BACE-	1β-secretase-1	1.0
BDAbiotinylated	3000 molecular weight dextran, lysine fixable	1.0
hAADC	human aadc	1.0
RCSR	oyal college of surgeons	0.75
RCSR	egulator of calmodulin signaling	0.25
3-HK	3-hydroxykynurenine	1.0
TGFα	transforming growth factor-alpha	0.0714285714286
TGFα	transforming growth factor α	0.5
TGFα	tumor growth factor-α	0.0714285714286
TGFα	transforming growth factor-α	0.0714285714286
TGFα	transforming growth factor alpha	0.214285714286
TGFα	transforming growth factor	0.0714285714286
TGFβ	transforming growth factor beta	0.2
TGFβ	transforming growth factor β	0.25
TGFβ	1transforming growth factor-β1	0.1
TGFβ	1transforming growth factor β1	0.1
TGFβ	s	0.05
TGFβ	signaling	0.05
TGFβ	transforming growth factor-β	0.2
TGFβ	transforming growth factor	0.05
GFM	glucose-free medium	1.0
MCV	motor nerve conduction velocity	0.5
MCV	mean cell volume	0.5
MCT	monocarboxylate lactate transporter	0.0625
MCT	medium-chain triglyceride	0.0625
MCT	smonocarboxylate transporters	0.125
MCT	4monocarboxylate transporter 4	0.0625
MCT	h+-monocarboxylate cotransporter	0.0625
MCT	2monocarboxylate transporter 2	0.0625
MCT	2monocarboxylate transporter-2	0.0625
MCT	monocarboxylate transporter	0.5
MCS	mercaptosuccinate	0.666666666667
MCS	multiple cloning site	0.333333333333
MCR	melanocortin receptor	1.0
MCP	magnocellular preoptic area	0.0588235294118
MCP	3-mercaptopropionate zog, z-oxoglutanate	0.0588235294118
MCP	monocyte chemoattractant protein	0.235294117647
MCP	medial collateral projection	0.117647058824
MCP	metacarpophalangeal	0.117647058824
MCP	midcommissural point	0.0588235294118
MCP	middle cerebellar peduncle	0.0588235294118
MCP	1monocyte chemoattractant protein-1	0.0588235294118
MCP	macrophage chemoattractant protein	0.117647058824
MCP	multicatalytic proteasome	0.0588235294118
MCP	magnocellular preoptic nucleus	0.0588235294118
aF	2after the second fatiguing period	1.0
EXB	+exarats that exercised 3 times per week during four weeks before and four weeks after the induction of the pd	1.0
psAHP	post-stimulus afterhyperpolarization	1.0
NP-OT-IR	neurophysin–oxytocin-immunoreactive	1.0
EXA	rats that exercised 3 times per week during four weeks after the induction of the pd	1.0
LQT	long qt	1.0
EXO	exophthalmus	1.0
SFIS	ciatic functional index	1.0
CPBS	conventional profile-based sampling	1.0
EXT	extinction test	0.25
EXT	extinction	0.25
EXT	tooth-extraction	0.25
EXT	operant extinction	0.25
CTOP	d-phe-cys-tyr-d-trp-orn-thr-pen-thr-nh2	0.333333333333
CTOP	d-phe-cys-tyr-dtrp-orn-thr-pen-thr-nh2	0.0666666666667
CTOP	cys2,tyr3,orn5,pen7-amide	0.0666666666667
CTOP	d-phe-cys-tyr-d-trp-orn-thr-pen-thr-nh2; dmso, dimethylsulfoxide	0.0666666666667
CTOP	d-phe-cys-tyr-d-trp-orn-thr-nh2	0.0666666666667
CTOP	d-phe-cys-tyr-d-trp-orn-thr-phe-thr-nh2	0.133333333333
CTOP	definition?	0.0666666666667
CTOP	d-phe-cys-thr-d-trp-orn-thr-pen-thr-nh2	0.0666666666667
CTOP	d-phe-cys-tyr-d-trp-orn-thr-pen-thr amide	0.133333333333
PERKPRKR-	like endoplasmic reticulum kinase	1.0
CPBG	1-(m-chlorophenyl) biguanide	0.333333333333
CPBG	1-(m-chlorphenyl)-biguanide	0.333333333333
CPBG	1-(m-chlorophenyl)-biguanide	0.333333333333
cCBF	cortico-cerebral blood flow	1.0
DLPT	dorsolateral pontine tegmentum	1.0
NCXN	a+/ca2+ exchanger	0.285714285714
NCXN	a+/ca2+ exchangers	0.285714285714
NCXN	a+-ca2+ exchanger	0.142857142857
NCXN	a+–ca2+ exchanger	0.142857142857
NCXN	a+–ca2+ exchangers	0.142857142857
H-8	n-[2-(methylamino)-ethyl]-5-isoquinolinesulfonamide dihydrochloride	1.0
H-9	n-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulphonamide	1.0
CPP-1	cyclo(-7-aminoheptanoyl-phe-d-try-lys-o-benzyl-thr) acetate	1.0
MDMA	methylenedioxymethamphetamine, “ecstasy”	0.0769230769231
MDMA	3,4-methylenedioxymethamphetamine, “ecstasy”	0.0769230769231
MDMA	(±)3,4-methylenedioxymethamphetamine	0.0769230769231
MDMA	3,4-methylenedioxymethamphetamine	0.230769230769
MDMA	3-4-methylenedioxymethamphetmine	0.0769230769231
MDMA	methylenedioxymethamphetamine	0.384615384615
MDMA	(±)-3,4-methylenedioxymethamphetamine	0.0769230769231
RORE	retinoic acid receptor-related orphan receptor response element	1.0
H-7	1-(5-isoquinolinylsulfonyl)-2-methylpiperazine	0.25
H-7	1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine	0.25
H-7	1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride	0.5
DLPF	dorsolateral prefrontal	0.5
DLPF	dorsolateral prefrontal cortex	0.5
PRVC	sphase response-variance curves	1.0
CCI-I	onchronic constriction injury of the infraorbital nerve	1.0
ELT	escape latency time	1.0
DLPC	dilinoleoylphosphatidylcholine	0.5
DLPC	dorsolateral prefrontal cortex	0.5
DLPO	dorsolateral periolivary nucleus	1.0
β-ala-NKA	[β-ala8]neurokinin a4–10	1.0
αBTXα-	bungarotoxin	1.0
U-BMI	15untrained group receiving 15.4×10-3 μg/g of bicuculline	1.0
NK1R	neurokinin-1 receptor	1.0
aNGF	antiserum against ngf	1.0
OCDO	bsessive compulsive disorder	1.0
H-V	horizontal/vertical	0.5
H-V	synthetic fibronectin peptide v	0.5
mito-EYFP	mitochondrial eyfp targeting construct	1.0
TNF-	p75rtumor necrosis factor receptor p75	0.125
TNF-	alpha	0.25
TNF-	a	0.125
TNF-	alphatumor necrosis factor-alpha	0.25
TNF-	alphatumor necrosis factor alpha	0.25
pKC	protein kinase c	1.0
L-732	138n-acetyl-1-tryptophan 3,5-bis (trifuluorometyl) benzyl ester	1.0
ABICA	kaike's bayesian information criterion	1.0
H-I	hypoxia-ischemia	0.5
H-I	hypoxia–ischemia	0.5
H-E	hematoxylin–eosin	0.5
H-E	hematoxylin and eosin	0.5
mLRP	mini–low density lipoprotein receptor-related protein receptor	1.0
pKI	negative logarithm to base 10 of the equilibrium inhibition constant	1.0
H-A	gghigh-aggression	1.0
InsP3Rinositol-1	4,5-trisphosphate receptor	1.0
SDH-B	bilateral subdural haematoma	1.0
trans-PDCtrans-pyrrolidine-2	4-dicarboxylate	1.0
EDAC	1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride	0.5
EDAC	1-ethyl-3-(3-dimethylaminopropyl)carbodiimide	0.5
KIR	inward rectifying potassium channel	0.25
KIR	inward rectifier k+ current	0.25
KIR	inwardly-rectifying k+ current	0.25
KIR	inwardly rectifying potassium current	0.25
QTOF	quadrupole time-of-flight	1.0
KIV	knock-in promoter iv	1.0
l-NNANω-	nitro-l-arginine	1.0
KII	calcium/calmodulin-dependent protein kinase ii	1.0
NINCDS-ADRDA	national institute of neurological, communicative diseases and stroke–alzheimer’s disease and related diseases association	1.0
TBSA	total body surface area	1.0
l-NMMA	l-ng-monomethylarginine	0.2
l-NMMA	ng-monomethyl-l-arginine	0.2
l-NMMA	ngmonomethyl-l-arginine	0.2
l-NMMA	ng-monomethyl-l-arginine acetate	0.4
PBcl	central lateral parabrachial subnucleus	0.5
PBcl	central lateral subnucleus of the parabrachial nucleus	0.5
RLV	right lateral ventricle	1.0
CP55940	(-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol	1.0
iCA	3intermediate ca3	1.0
lS	trialeft striatum	1.0
Pr	primer	0.5
Pr	prepositus nucleus	0.5
CRS	+lithchronic restraint stress+chronic lithium treatment	0.0833333333333
CRS	chronic restraint stress	0.916666666667
CRP	contralateral referred pain	1.0
NORPs	nitric oxide-responsive phosphoproteins	1.0
Pv	paraventricular nucleus	0.666666666667
Pv	paraventricular thalamic nucleus	0.333333333333
CRT	cathode ray tube	0.444444444444
CRT	combined raven’s test	0.111111111111
CRT	creatine transporter	0.222222222222
CRT	calretinin	0.222222222222
dPSP	depolarizing postsynaptic potential	1.0
Pz	pirenzipine	1.0
Px	positive waves with peak latency of x ms	1.0
CRY	cryptochrome	0.666666666667
CRY	1cryptochrome gene 1	0.333333333333
HVA-C	ahigh voltage activated ca	1.0
LEGE	large-epp generating ending	1.0
CRB	cerebellum	1.0
Pc	purkinje cell	1.0
Pa	paraventricular nucleus of the hypothalamus	0.5
Pa	paraventricular hypothalamic nucleus	0.5
Pf	parafascicular thalamic nucleus	0.153846153846
Pf	parafascicular nucleus of the thalamus	0.153846153846
Pf	nucleus parafascicularis	0.0769230769231
Pf	primary focus	0.0769230769231
Pf	parafascicular nucleus	0.461538461538
Pf	fractional ca2+ current	0.0769230769231
Pg	perigeniculate nucleus	1.0
CRD	central respiratory drive	0.0526315789474
CRD	colorectal distension	0.631578947368
CRD	cysteine-rich domain	0.105263157895
CRD	colorectal distention	0.210526315789
CRE	camp-responsive elements	0.0185185185185
CRE	cyclic amp binding protein response element	0.0185185185185
CRE	cyclic amp responsive element	0.0185185185185
CRE	cyclic amp response element	0.314814814815
CRE	camp response element	0.314814814815
CRE	camp response-element	0.0185185185185
CRE	camp responsive element	0.0185185185185
CRE	camp-response element	0.0185185185185
CRE	camp response elements	0.0185185185185
CRE	cyclic-amp response element	0.111111111111
CRE	camp-responsive element	0.0925925925926
CRE	cyclic amp-response element	0.037037037037
CRH	corticotropin releasing factor	0.0136054421769
CRH	corticotrophin releasing hormone	0.0408163265306
CRH	corticotropin-releasing-hormone	0.00680272108844
CRH	r2corticotropin releasing hormone receptor 2	0.00680272108844
CRH	corticotropin releasing hormone	0.142857142857
CRH	corticotropin-releasing hormone	0.639455782313
CRH	corticotrophin-releasing hormone	0.149659863946
Pi	inorganic phosphate	1.0
CRN	cochlear root neuron	0.333333333333
CRN	cranial relay neuron	0.333333333333
CRN	cue-related negativity	0.333333333333
Po	posterior thalamic nucleus	0.0909090909091
Po	posterior group of the thalamus	0.0909090909091
Po	posterior nucleus	0.0909090909091
Po	posterior thalamic nuclear group	0.272727272727
Po	posterior nucleus of thalamus	0.0909090909091
Po	glycoprotein po	0.0909090909091
Po	single-channel opening probability	0.0909090909091
Po	open probability of channel	0.0909090909091
Po	probability of channel opening	0.0909090909091
CRL	crown-to-rump-length	0.25
CRL	crown to rump length	0.25
CRL	crown-rump length	0.5
XIAPX	chromosome-linked inhibitor of apoptosis	1.0
PR	progestin receptor	0.0632911392405
PR	sprogestin receptors	0.0126582278481
PR	progressive ratio	0.215189873418
PR	prerubral field	0.0379746835443
PR	hcperirhinal cortex	0.0126582278481
PR	progestin receptors	0.0126582278481
PR	progesterone receptor	0.227848101266
PR	pinch responsive	0.0126582278481
PR	erirubral field	0.0126582278481
PR	progestin hormone-receptor	0.0126582278481
PR	progesterone receptors	0.0253164556962
PR	hperirhinal	0.0126582278481
PR	sprogesterone receptors	0.0126582278481
PR	prenatal	0.0126582278481
PR	progesterone nuclear receptors	0.0126582278481
PR	pressure	0.0126582278481
PR	parietorostral area	0.0126582278481
PR	pontine reticular nucleus	0.0126582278481
PR	3proteinase-3	0.0126582278481
PR	preference ratios	0.0126582278481
PR	pattern recognition	0.0126582278481
PR	photoreceptor	0.0253164556962
PR	hperirhinal cortex	0.151898734177
PR	postural response	0.0253164556962
PR	profile condition of hi test	0.0126582278481
PR	place response	0.0126582278481
PS	phase-shuffled randomization	0.00512820512821
PS	promoter silencer	0.00512820512821
PS	phosphatidyl serine	0.00512820512821
PS	spresenilin proteins	0.00512820512821
PS	paradoxical sleep	0.128205128205
PS	population spike	0.312820512821
PS	ipectoralis superior	0.0102564102564
PS	1de9exon-9-deleted ps1	0.00512820512821
PS	1presenlin-1	0.00512820512821
PS	2presenilin 2	0.0102564102564
PS	phosphate buffer	0.00512820512821
PS	population spike(s)	0.00512820512821
PS	2wtwild type ps2	0.00512820512821
PS	phase synchrony	0.00512820512821
PS	1mutmice overexpressing mutated (m146l) human presenilin-1	0.00512820512821
PS	er129phospho-serine-129	0.00512820512821
PS	presenilins	0.00512820512821
PS	phosphatidylserine	0.0512820512821
PS	phosphoserine	0.00512820512821
PS	paternal stress	0.00512820512821
PS	prenatally stressed	0.00512820512821
PS	1 ps2 genes	0.00512820512821
PS	2presenilin-2	0.00512820512821
PS	posterior suprasylvian area	0.00512820512821
PS	+, paradoxical sleep with pgo waves and rems	0.00512820512821
PS	presenilin	0.0564102564103
PS	1-ntfpresenelin n-terminal fragment	0.00512820512821
PS	post-stimulation	0.00512820512821
PS	psychological stress	0.00512820512821
PS	ttransition period from slow-wave sleep to ps	0.00512820512821
PS	areaposterior suprasylvian area	0.00512820512821
PS	physiological saline	0.0102564102564
PS	parastrial nucleus	0.00512820512821
PS	spopulation spikes	0.00512820512821
PS	1presenilin1	0.0102564102564
PS	prenatal stress	0.025641025641
PS	probabilistically predictive stimulus	0.00512820512821
PS	prestimulus	0.00512820512821
PS	6phospho-s6 ribosomal protein	0.00512820512821
PS	1presenilin 1	0.0923076923077
PS	phosphorothioate	0.00512820512821
PS	2population spike after the second pulse of a pair of pulses	0.00512820512821
PS	principal sulcus	0.0102564102564
PS	power spectrum	0.0102564102564
PS	protamine sulfate	0.00512820512821
PS	pregnenolone sulfate	0.0153846153846
PS	population spike amplitude	0.00512820512821
PS	permeability coefficient-surface area product	0.00512820512821
PS	ttransient period from slow-wave sleep to ps	0.00512820512821
PS	propriospinal	0.00512820512821
PS	perineal stimulation	0.00512820512821
PS	presenilin (1 and 2)	0.00512820512821
PS	penicillin–streptomycin	0.00512820512821
PS	1presenilin-1	0.0307692307692
PS	1de9presenilin-1 protein with deletion of exon 9	0.00512820512821
PS	population spikes	0.0153846153846
PP	hfshigh-frequency stimulation of the perforant path	0.00806451612903
PP	paw preference	0.00806451612903
PP	yparapyramidal region	0.00806451612903
PP	preferred initial posture	0.00806451612903
PP	1cprotein phosphatase 1 catalytic subunit	0.00806451612903
PP	rism	0.00806451612903
PP	perforant path	0.0967741935484
PP	perforant bath	0.00806451612903
PP	paired-pulse	0.0161290322581
PP	paleostriatum primitivum	0.0161290322581
PP	paired pulse	0.0403225806452
PP	2bca2+/calmondulin-dependent protein phosphatase	0.00806451612903
PP	prepubertal	0.00806451612903
PP	posterior parietal	0.00806451612903
PP	cposterior parietal cortex	0.00806451612903
PP	1	0.0161290322581
PP	vventral part of the periventricular pretectal nucleus	0.00806451612903
PP	2bprotein phosphatase 2b	0.0322580645161
PP	peak-to-peak	0.00806451612903
PP	postpartum	0.0241935483871
PP	1protein phosphatase type 1	0.00806451612903
PP	posterior pituitary	0.00806451612903
PP	pyrophosphate	0.00806451612903
PP	irposterior piriform cortex	0.00806451612903
PP	phosphoinositol phosphatase	0.00806451612903
PP	pancreatic polypeptide	0.0806451612903
PP	protein phosphatase	0.0645161290323
PP	ddorsal periventricular pretectal nucleus	0.00806451612903
PP	per protocol	0.00806451612903
PP	peripeduncular nucleus	0.0403225806452
PP	parapyramidal group	0.0161290322581
PP	perforant pathway	0.0322580645161
PP	1protein phosphatase-1	0.00806451612903
PP	1protein-phosphatase-1	0.00806451612903
PP	perfusion pressure	0.0161290322581
PP	urkinje cell layer	0.00806451612903
PP	2aprotein phosphatase 2a	0.112903225806
PP	prepulse	0.00806451612903
PP	picric acid–sodium phosphate	0.00806451612903
PP	peripeduncular area	0.0241935483871
PP	iinorganic pyrophosphate	0.00806451612903
PP	2aprotein phosphatase-2a	0.0161290322581
PP	itposterior lobe of the pituitary	0.00806451612903
PP	1protein phosphatase 1	0.0887096774194
PP	speyer's patches	0.00806451612903
PP	picric acid-sodium phosphate	0.00806451612903
PP	aparvocellular part of the preoptic region	0.00806451612903
PP	ulnperipulvinar nucleus	0.00806451612903
PP	pulsatile arterial blood pressure	0.0161290322581
PQ	performance quotient	0.333333333333
PQ	paraquat	0.666666666667
PV	paraventricular	0.00540540540541
PV	paraventricular hypothalamic nucleus	0.0108108108108
PV	+parvalbumin-positive neurons	0.00540540540541
PV	paraventricular nucleus of thalamus	0.00540540540541
PV	periventricular	0.0108108108108
PV	aperiventricular anterior hypothalamus	0.00540540540541
PV	parvalbumine	0.00540540540541
PV	3parvalbumin	0.00540540540541
PV	peak velocity	0.0108108108108
PV	parvalbumin	0.745945945946
PV	popreoptic periventricular nucleus	0.00540540540541
PV	+parvalbumin positive neuron	0.00540540540541
PV	peak of velocity	0.0108108108108
PV	pperiventricular hypothalamic area	0.00540540540541
PV	principal sensory trigeminal nucleus	0.00540540540541
PV	(±)parvalbumin immunopositive/immunonegative)	0.00540540540541
PV	parvabumin	0.00540540540541
PV	+parvalbumin-positive	0.0108108108108
PV	calcium binding protein parvalbumin	0.00540540540541
PV	passive vision	0.00540540540541
PV	position-vestibular	0.00540540540541
PV	paraventricular nucleus	0.0216216216216
PV	paraventricular nucleus of the thalamus	0.0162162162162
PV	posterior paraventricular nucleus of the thalamus	0.00540540540541
PV	hypothalamic paraventricular nucleus	0.00540540540541
PV	paraventricular thalamic nuclei	0.00540540540541
PV	parietoventral area	0.00540540540541
PV	parvalbumin (calcium binding protein)	0.00540540540541
PV	paraventricular thalamic nucleus	0.0432432432432
PV	pixel value	0.00540540540541
PV	posteroventral	0.00540540540541
PW	principal whisker	0.0714285714286
PW	pseudoword	0.0714285714286
PW	3-4postnatal weeks 3–4	0.0714285714286
PW	from parturition to weaning	0.0714285714286
PW	pulse wave	0.0714285714286
PW	pseudowords	0.0714285714286
PW	stimulation pulse width	0.0714285714286
PW	passive wake	0.0714285714286
PW	pond water	0.0714285714286
PW	paw withdrawal	0.357142857143
PT	rpar triangularis	0.0192307692308
PT	probe trials	0.0192307692308
PT	prothrombin time	0.0192307692308
PT	pars tuberalis	0.0384615384615
PT	paratenial thalamic nucleus	0.0769230769231
PT	planum temporale	0.0576923076923
PT	pretectum	0.0192307692308
PT	pseudotrained	0.0192307692308
PT	photothrombosis	0.0384615384615
PT	putamen and thalamus	0.0192307692308
PT	hprethalamus (ventral thalamus)	0.0192307692308
PT	paratenial nucleus of thalamus	0.0192307692308
PT	plateau termination	0.0192307692308
PT	pyramidal tract neuron	0.0192307692308
PT	paratenial	0.0192307692308
PT	parataenial nucleus	0.0192307692308
PT	passive touch	0.0192307692308
PT	gpedunculopontine tegmental nucleus	0.0192307692308
PT	phosphotyrosine	0.0192307692308
PT	pretectal nucleus	0.0192307692308
PT	pallium of the telencephalon	0.0192307692308
PT	paratenial nucleus	0.0192307692308
PT	posterior tibial	0.0192307692308
PT	txpertussis toxin	0.0192307692308
PT	phosphothreonine	0.0192307692308
PT	hprethalamus	0.0384615384615
PT	spalatine tonsils	0.0192307692308
PT	xpertussis toxin	0.0192307692308
PT	pretense	0.0192307692308
PT	pertussis toxin	0.0192307692308
PT	pressure threshold	0.0384615384615
PT	/mepars tuberalis/median eminence	0.0192307692308
PT	pre-training test	0.0384615384615
PT	piracetam-treated	0.0192307692308
PT	nucleus pretectalis	0.0384615384615
PT	pyramidal tract	0.0769230769231
PT	posterior tuberculum	0.0192307692308
PT	w0.1% tween 20 in pbs	0.0192307692308
PU	perceptual upright	0.166666666667
PU	perfusion units	0.333333333333
PU	post urethane injection	0.166666666667
PU	perfusion unit	0.166666666667
PU	putamen	0.166666666667
PZ	proliferative zone	0.25
PZ	posterior zone	0.75
PX	1hemichannel pannexin-1	1.0
PY	pyramidal	0.1
PY	pyloric	0.1
PY	pyruvate	0.1
PY	pyloric motorneuron	0.1
PY	phosphotyrosine	0.2
PY	pyramidal tract	0.1
PY	pyloric neuron	0.1
PY	cortical pyramidal cell	0.1
PY	pyloric constrictor	0.1
IPDv	inferior precentral dimple-ventral	1.0
PB	wawaist area of parabrachial nucleus	0.000970873786408
PB	containing 0.9% nacl, 0.3% triton x-100, and 0.1% sodium azide	0.000970873786408
PB	100 mm phosphate buffer	0.000970873786408
PB	phosphate-buffered saline	0.000970873786408
PB	sprimed-bursts	0.000970873786408
PB	posterior biceps	0.000970873786408
PB	pentobarbital	0.000970873786408
PB	elexternal lateral subnucleus of the parabrachial nucleus	0.000970873786408
PB	phosphate buffer (0.1m, ph 7.4)	0.000970873786408
PB	phosphate-buffered solution	0.00194174757282
PB	primary branch	0.000970873786408
PB	phosphate-buffer	0.00291262135922
PB	pauser-buildup	0.000970873786408
PB	0.1 m phosphate buffer, ph 7.2	0.000970873786408
PB	phosphate buffer (0.10 m; ph 7.4)	0.000970873786408
PB	phosphate buffer	0.91359223301
PB	protocerebral bridge	0.000970873786408
PB	phosphate-buffered sucrose	0.000970873786408
PB	(±)-pentobarbitone	0.000970873786408
PB	parabrachial area	0.000970873786408
PB	0.1 m phosphate buffer	0.000970873786408
PB	rparabrachial nucleus	0.000970873786408
PB	parabrachial	0.000970873786408
PB	sprimed bursts	0.000970873786408
PB	vlventral lateral parabrachial subnucleus	0.000970873786408
PB	potassium buffer	0.000970873786408
PB	sodium phosphate buffer	0.0203883495146
PB	primary somatosensory area	0.000970873786408
PB	0.1m sodium phosphate buffer	0.00291262135922
PB	phosphate buffer 0.1m	0.000970873786408
PB	pinch and brush	0.000970873786408
PB	0.1m sodium phosphate buffer at ph 7.4	0.000970873786408
PB	parabrachial nucleus	0.00970873786408
PB	0.1m phosphate buffer	0.00291262135922
PB	freqpb frequency	0.000970873786408
PB	elexternal lateral subnucleus of parabrachial nucleus	0.000970873786408
PB	eexternal lateral parabrachial nucleus	0.000970873786408
PB	sodium phosphate	0.000970873786408
PB	0.01m phosphate buffer	0.000970873786408
PB	peripheral blood	0.000970873786408
PB	0.1-m phosphate buffer	0.000970873786408
PB	0.1m sodium phosphate buffer (ph 7.4)	0.000970873786408
PB	vtaparabrachial ventral tegmental area	0.000970873786408
PB	phosphate buffer (0.1 m, ph 7.4)	0.000970873786408
PB	parabrachial nuclei	0.000970873786408
PB	posterior brain	0.000970873786408
PB	phosphate buffer containing 0.1% triton x-100	0.000970873786408
PB	1dpbs containing 1% bsa	0.000970873786408
PB	phosphate buffered	0.00194174757282
PB	phosphate buffered saline	0.000970873786408
PB	0.10 m phosphate buffer	0.000970873786408
PB	phospate buffer	0.000970873786408
PB	permeabilization buffer	0.000970873786408
PC	omnucleus of the posterior commisure	0.00531914893617
PC	12rat pheochromocytoma cell line	0.0106382978723
PC	/rscposterior cingulate/retrosplenial cortex	0.00531914893617
PC	purkinje cell	0.0585106382979
PC	1first principal component	0.00531914893617
PC	12rat adrenal pheochromocytoma	0.00531914893617
PC	prefrontal cortex	0.00531914893617
PC	12 cellscell line derived from a pheochromocytoma of the rat adrenal medulla	0.00531914893617
PC	protein carbonyl groups	0.00531914893617
PC	protein c	0.00531914893617
PC	12rat pheochromocytoma cells	0.0106382978723
PC	oouter layer of the parietal cortex	0.00531914893617
PC	precursor-protein convertase	0.00531914893617
PC	passive control group	0.00531914893617
PC	r-mg-cplxphosphocreatine–mg-complex acetate	0.00531914893617
PC	12 pheochromocytoma cells	0.00531914893617
PC	paracentral thalamic nucleus	0.0212765957447
PC	protein carbonyl	0.0106382978723
PC	12 cell	0.0106382978723
PC	12pheochromocytoma-12	0.0106382978723
PC	12 cellrat pheochromocytoma cell	0.00531914893617
PC	perirhinal cortex	0.0106382978723
PC	posterior cortex	0.00531914893617
PC	procerebrum	0.00531914893617
PC	anterior commissure–posterior commissure	0.00531914893617
PC	pair-housed condition	0.00531914893617
PC	pars compacta	0.00531914893617
PC	paracentral thalamic	0.00531914893617
PC	piriform cortex	0.117021276596
PC	parietal cortex	0.0106382978723
PC	xpiriform cortex	0.00531914893617
PC	prohormone convertase	0.0106382978723
PC	person cartoons	0.00531914893617
PC	peak count	0.00531914893617
PC	post-conceptional	0.00531914893617
PC	2proprotein convertase 2	0.00531914893617
PC	12 cellsrat pheochromocytoma cells	0.0212765957447
PC	12pheochromocytoma cells	0.0159574468085
PC	(s)purkinje cell(s)	0.00531914893617
PC	partition cells	0.00531914893617
PC	spyramidal cells	0.00531914893617
PC	personal computer	0.0212765957447
PC	prohormone convertases	0.00531914893617
PC	posterior commissure	0.031914893617
PC	cerebellar purkinje cells	0.00531914893617
PC	rphosphocreatine	0.0744680851064
PC	spurkinje cells	0.0212765957447
PC	principal component	0.0212765957447
PC	onposterior cortical nucleus of the amygdala	0.00531914893617
PC	paracentral	0.00531914893617
PC	rephosphocreatine	0.00531914893617
PC	passive control	0.00531914893617
PC	12pheochromocytoma 12	0.0159574468085
PC	paracentral nucleus of thalamus	0.00531914893617
PC	parvocellular subnucleus of the nts	0.00531914893617
PC	phosphatidylcholine	0.0478723404255
PC	12	0.0425531914894
PC	pacinian corpuscle-like (receptors)	0.00531914893617
PC	paracentral nucleus	0.00531914893617
PC	proprotein convertase	0.0106382978723
PC	12 cells	0.0904255319149
PC	pyramidal cell	0.0106382978723
PC	sprincipal components	0.0106382978723
PC	pyruvate carboxylase	0.00531914893617
PC	principal components	0.00531914893617
PC	2prohormone convertase 2	0.0106382978723
PC	uprecuneus	0.00531914893617
PC	12pheochromocytoma cell line	0.0159574468085
PC	polymorphic cell	0.00531914893617
PC	prenatally compromised	0.00531914893617
PC	12pheochromocytoma	0.0212765957447
PC	ogd preconditioning	0.00531914893617
PA	9090 days survival time after cochlear ablation	0.0232558139535
PA	paraventricular hypothalamic nucleus	0.0232558139535
PA	pallidum	0.0232558139535
PA	aauditory paired-association learning	0.0232558139535
PA	perinatal asphyxia	0.046511627907
PA	proportional area=stained area/reference area	0.0232558139535
PA	positive affect	0.0232558139535
PA	1b3platelet-activating factor acetylhydrolase ib subunit gamma	0.0232558139535
PA	paleostriatum augmentatum	0.0232558139535
PA	pathological aging	0.0232558139535
PA	parvalbumin	0.0232558139535
PA	1parietal 1 (cortex)	0.0232558139535
PA	phentolamine	0.0232558139535
PA	posterior amygdalar nucleus	0.0232558139535
PA	passive avoidance	0.116279069767
PA	task passive avoidance step through task	0.0232558139535
PA	passive aviodance	0.0232558139535
PA	posterior hypothalamic nucleus	0.0232558139535
PA	proportional area of cell immunoreactivity	0.0232558139535
PA	post atropine injection	0.0232558139535
PA	arterial blood pressure	0.0232558139535
PA	taskpassive avoidance step-through task	0.0232558139535
PA	plasminogen activator	0.0232558139535
PA	phosphatidic acid	0.093023255814
PA	preferred angle between figure's lines	0.0232558139535
PA	paraformaldehyde	0.093023255814
PA	parietal insular cortex	0.0232558139535
PA	protein aggregate	0.046511627907
PA	physical activity	0.0232558139535
PA	splasminogen activators	0.0232558139535
PA	posterior nucleus of the amygdala	0.0232558139535
PF	pair fed	0.0119047619048
PF	parallel fibre	0.047619047619
PF	lparaflocculus	0.0119047619048
PF	projected field	0.0119047619048
PF	cprefrontal cortex	0.0119047619048
PF	perifornical region	0.0119047619048
PF	posterior funiculus	0.0238095238095
PF	parafasicular	0.0119047619048
PF	pair-fed control group	0.0119047619048
PF	paraformaldehyde in phosphate-buffered saline	0.0119047619048
PF	parallel fiber	0.261904761905
PF	/lhperifornical/lateral hypothalamic	0.0119047619048
PF	sparallel fibers	0.0238095238095
PF	/lhperifornical/lateral hypothalamus	0.0119047619048
PF	/lhperifornical-lateral hypothalamic area	0.0119047619048
PF	parafascicular	0.0119047619048
PF	posterior fusiform	0.0119047619048
PF	parafascicular nucleus thalamus	0.0119047619048
PF	perfusion fluid	0.0119047619048
PF	pattern forming	0.0119047619048
PF	nucleus parafascicularis thalami	0.0119047619048
PF	parallel fibers	0.0119047619048
PF	perifacial region	0.0119047619048
PF	parafascicular nucleus	0.0357142857143
PF	paraformaldehyde	0.22619047619
PF	–lhaperifornical–lateral hypothalamic area	0.0119047619048
PF	parafascicular thalamic nucleus	0.0952380952381
PF	pair-fed	0.0238095238095
PF	prefrontal cortex	0.0119047619048
PF	parafascicular thalamic	0.0119047619048
DMVN	dorsal motor vagal nucleus	1.0
PD	pyloric dilator motorneuron	0.00591715976331
PD	980592-amino-3-methoxyflavone	0.00591715976331
PD	posterodorsal	0.00591715976331
PD	preferred direction	0.0118343195266
PD	proximal dendrite	0.00591715976331
PD	980592′-amino-3′-methoxyflavone	0.0177514792899
PD	proline-rich synapse-associated protein-1	0.00591715976331
PD	pulse duration	0.00591715976331
PD	panic disorder	0.0177514792899
PD	parkinson's disease	0.183431952663
PD	postnatal days	0.00591715976331
PD	onparkinson's disease patients on medication	0.00591715976331
PD	pyloric dilator	0.0118343195266
PD	128907	0.00591715976331
PD	protein deficiency	0.00591715976331
PD	posthatch day	0.00591715976331
PD	piloric dilator	0.00591715976331
PD	980592-(2′-amino-3′-methoxyphenyl)-oxanaphthalen-4-one	0.00591715976331
PD	30postnatal day 30	0.00591715976331
PD	980592-(2-amino-3-methoxyphenyl)-4h-1-benzopyran-4-one	0.0177514792899
PD	posterodorsal area	0.0118343195266
PD	98059	0.0118343195266
PD	pyloric dilator neuron	0.00591715976331
PD	persistent depression	0.00591715976331
PD	posterior deltoid	0.0177514792899
PD	parkinson’s disease	0.183431952663
PD	postpartum day	0.00591715976331
PD	pd98059 [2-2′amino-3′-methoxy-phenyl(-oxanaphthalen-4-one)]	0.00591715976331
PD	prion diseases	0.00591715976331
PD	098059	0.00591715976331
PD	spostnatal days	0.0118343195266
PD	post-discharge	0.00591715976331
PD	proton-density	0.00591715976331
PD	postnatal day	0.331360946746
PD	980592′ -amino-3′ -methoxyflavone	0.00591715976331
PD	partial denervation	0.00591715976331
PD	posterodorsal auditory area	0.0118343195266
PD	proton density	0.00591715976331
PD	1postnatal day 1	0.0118343195266
PE	preexposed condition	0.0151515151515
PE	phenylephrine	0.19696969697
PE	peak equivalent	0.0151515151515
PE	perseveration error	0.030303030303
PE	pre-exposed group	0.0151515151515
PE	preexposed	0.0454545454545
PE	nkpreproenkephalin	0.0151515151515
PE	parameter estimate	0.0151515151515
PE	phenylephrine hydrochloride	0.030303030303
PE	pre-exposed subgroup	0.0151515151515
PE	phosphatidylethanolamine	0.106060606061
PE	pressure ejection	0.0151515151515
PE	pre-exposed	0.151515151515
PE	hypothalamic periventricular nucleus	0.0151515151515
PE	prethalamic eminentia	0.0151515151515
PE	phorbole ester	0.0151515151515
PE	polyethylene	0.0606060606061
PE	phycoerythrin	0.121212121212
PE	2i[125i]-(e)-n-(3-iodoprop-2-enyl)-2β-carboxymethyl-3β-(4′-methylphenyl)-nortropane	0.0151515151515
PE	perseverative error	0.0151515151515
PE	plasma extravasation	0.0454545454545
PE	pigment epithelium	0.0151515151515
PE	phosphatidyl ethanolamine	0.0151515151515
PK	proteinase k	0.0714285714286
PK	2prokineticin 2	0.0714285714286
PK	protein kinase	0.214285714286
PK	iprotein kinase inhibitor	0.0714285714286
PK	2prokineticin2	0.0714285714286
PK	/pnaratio of potassium and sodium permeability	0.0714285714286
PK	pharmacokinetic	0.142857142857
PK	sprotein kinases	0.0714285714286
PK	pyruvate kinase	0.0714285714286
PK	pharmacokinetics	0.0714285714286
PK	parkinsonian	0.0714285714286
PH	pleckstrin homology	0.0377358490566
PH	3phosphohistone h3	0.0566037735849
PH	posterior hypothalamus	0.358490566038
PH	phenobarbital	0.0188679245283
PH	prepositus hypoglossi nuclei	0.0188679245283
PH	posterior nucleus	0.0188679245283
PH	prepositus hypoglossus	0.0188679245283
PH	peak height	0.0188679245283
PH	3phospho-histone h3	0.0188679245283
PH	post-hatching	0.0188679245283
PH	posterior hypothalamic nucleus	0.132075471698
PH	profound hypothermia	0.0188679245283
PH	3phosphohistone 3	0.0188679245283
PH	3phospho histone 3	0.0188679245283
PH	prepositus hypoglossi	0.0188679245283
PH	posterior hypothalamic area	0.0943396226415
PH	potential of hydrogen	0.0188679245283
PH	3phosphor-histone 3	0.0188679245283
PH	prepositus hipoglossi	0.0188679245283
PH	processing hypothesis	0.0188679245283
PH	precision histogram	0.0188679245283
PH	8phenylalanine hydroxylase subtype-8	0.0188679245283
PI	propodium iodine	0.003300330033
PI	phosphoinositol	0.00660066006601
PI	pulse interval	0.003300330033
PI	3kphosphoinositide-3 kinase	0.013201320132
PI	3kphosphatidyl inositol 3-kinase	0.00660066006601
PI	3kphosphoinositide 3-kinases	0.003300330033
PI	3k/aktphosphoinositide 3-kinase/protein kinase b	0.003300330033
PI	3kphosphatidylinositol 3 kinase	0.003300330033
PI	3kphosphatidylinositol 3-kinases	0.003300330033
PI	3kphosphatidylinositol-3 kinase	0.03300330033
PI	3-kinasephosphoinositide 3-kinase	0.00660066006601
PI	3-kinase	0.003300330033
PI	3-kphosphoinositide 3-kinase	0.00660066006601
PI	3kphosphotidylinositol-3-kinase	0.003300330033
PI	3kphosphoinositide 3-knase	0.003300330033
PI	3 kinasephosphatidylinositol 3 kinase	0.003300330033
PI	3kphosphatidylinositide 3-kinase	0.003300330033
PI	pinch	0.003300330033
PI	3k/akt	0.003300330033
PI	poly-phosphoinositide	0.003300330033
PI	3 kphosphatidylinositol-3 kinase	0.003300330033
PI	posterior insula	0.003300330033
PI	3-kinasephophatidylinositol 3-kinase	0.003300330033
PI	plantar incision	0.003300330033
PI	3-kinasephosphatidylinositol-3 kinase	0.003300330033
PI	3kphosphoinositide 3 kinase	0.003300330033
PI	3-kinase–aktphosphatidylinositol 3′-kinase/akt	0.003300330033
PI	3-kphosphatidylino 3-kinase	0.003300330033
PI	3k	0.00660066006601
PI	3k-pkbphosphatidylinosotol kinase-protein kinase b	0.003300330033
PI	proactive interference from previously relevant material	0.003300330033
PI	3kinasephosphotidylinositol-3-kinases	0.003300330033
PI	protease inhibitor cocktail i	0.003300330033
PI	3k)	0.003300330033
PI	3kphosphatidylinositol-3-kinase	0.03300330033
PI	3phosphoinositide-3-kinase	0.003300330033
PI	3kphosphoinositide 3-kinase	0.0528052805281
PI	3 kinasephosphatidylinositol 3-kinase	0.003300330033
PI	3phosphatidylinositol-3 kinase	0.003300330033
PI	3phosphatidylinositol 3	0.003300330033
PI	pixel intensity	0.003300330033
PI	phosphatidyl inositol	0.003300330033
PI	4kphosphatidylinositol 4-hydroxy kinase	0.003300330033
PI	3k)/pkcphosphoinositide 3-kinase	0.003300330033
PI	3kphosphoinositide-3-kinase	0.013201320132
PI	3-kphosphoinositide-3 kinase	0.003300330033
PI	3k/aktphosphoinositol-3-kinase/protein kinase b	0.003300330033
PI	3kphosphatidylinositol 3-kinase	0.108910891089
PI	3phosphoinositide 3	0.003300330033
PI	post-injection	0.003300330033
PI	(3)kphosphatidylinositol 3-kinase	0.003300330033
PI	proactive interference	0.003300330033
PI	3k/akt-1phosphoinositide 3 kinase/protein kinase b	0.003300330033
PI	protease inhibitor	0.003300330033
PI	3kphoshatidylinositol-3-kinase	0.003300330033
PI	propidium iodide	0.333333333333
PI	3-aktphosphatidylinositol-3-kinase-akt	0.003300330033
PI	3-kpi3-kinase	0.003300330033
PI	3-kinasephosphatidylinositol 3-kinase	0.00660066006601
PI	preference index	0.003300330033
PI	3-kphosphatidylinositiol 3-kinase	0.003300330033
PI	3k–aktphosphatidylinositol 3-kinase	0.003300330033
PI	peak-interval	0.003300330033
PI	phosphatidylinositol	0.029702970297
PI	3phosphatidylinositol 3-kinase	0.00990099009901
PI	propidiun iodide	0.003300330033
PI	3-kphosphatidylinositol-3 kinase	0.003300330033
PI	phosphoinositide	0.026402640264
PI	previously institutionalized	0.003300330033
PI	3kphosphatidilinositol-3kinase	0.003300330033
PI	propridium iodide	0.003300330033
PI	proliferation index	0.003300330033
PI	3kphosphatidylinositol kinase	0.003300330033
PI	3-kphosphoinositide-3-kinase	0.003300330033
PI	3-kphosphoinositol 3-kinase	0.003300330033
PI	3kphosphoinositol-3-kinase	0.003300330033
PI	pars intermedia	0.003300330033
PI	3kphosphatidylinositol 3′-kinase	0.00660066006601
PI	3kphosphatidylinositol 3-kinase-akt	0.003300330033
PI	isoelectric point	0.003300330033
PI	3-kphosphatidylinositol-3-kinase	0.00990099009901
PI	3kphosphatidylinositol-3-oh kinase	0.00990099009901
PI	polyphosphoinositide	0.003300330033
PI	3kphophatidylinositol-3 kinase	0.003300330033
PI	3phosphatidylinositol-3	0.003300330033
PI	3kγ	0.003300330033
PI	plasma insulin	0.003300330033
PI	3-kphosphatidyl inositol 3 kinase	0.00660066006601
PI	3-kphosphoinositide 3-kinases	0.003300330033
PI	3 kinase γ	0.003300330033
PI	pre-injection	0.003300330033
PI	preimmune	0.003300330033
PI	3kphosphoinositol 3-kinase	0.003300330033
PI	3phosphoinositide 3 kinase	0.003300330033
PI	3-kphosphatidylinositol 3-kinase	0.029702970297
PN	postnatally	0.0106382978723
PN	sperineuronal nets	0.0531914893617
PN	pyridine nucleotide	0.0106382978723
PN	postnatal	0.0744680851064
PN	pelvic nerve	0.0106382978723
PN	phrenicus nerve	0.0106382978723
PN	peroxynitrite	0.0212765957447
PN	principal neuron	0.0106382978723
PN	projection neuron	0.0212765957447
PN	paranigral nuclei	0.0106382978723
PN	pontine nuclei	0.063829787234
PN	peripheral nerve	0.0957446808511
PN	pyridoxine	0.0106382978723
PN	primary neuronal	0.0106382978723
PN	primary-like with a notch	0.0106382978723
PN	nucleus paranigralis	0.0106382978723
PN	polymorphonuclear	0.0106382978723
PN	sprojection neurons	0.0106382978723
PN	paranigral nucleus	0.0425531914894
PN	pontine nucleus	0.0106382978723
PN	fphrenic burst frequency	0.0106382978723
PN	postnatal day	0.329787234043
PN	postnatal day(s)	0.0106382978723
PN	post natal day	0.0106382978723
PN	posterior neostriatum	0.0106382978723
PN	preoptic nucleus	0.0106382978723
PN	caudal preoptic nucleus	0.0106382978723
PN	post-natal day	0.0212765957447
PN	perineuronal net	0.063829787234
PN	vtaparanigral ventral tegmental area	0.0106382978723
PO	/ahpreoptic anterior hypothalamus	0.04
PO	thalamic posterior complex	0.02
PO	preoptic area	0.06
PO	propylene oxide	0.02
PO	posterior nucleus of thalamus	0.02
PO	single-channel open probability	0.02
PO	posterior nuclear complex	0.02
PO	minminimum open probability	0.02
PO	/ahpreoptic area/anterior hypothalamus	0.02
PO	preoptic nuclei	0.02
PO	perturbation only	0.02
PO	phosphodiester	0.02
PO	preoptic region	0.02
PO	post-operative	0.02
PO	mposteromedial nucleus of the thalamus	0.02
PO	posterior nucleus	0.02
PO	posterior nuclear group of the thalamus	0.02
PO	2partial pressure of oxygen	0.08
PO	posterior thalamic nucleus	0.04
PO	parieto-occipital area	0.02
PO	posteromedial complex	0.02
PO	predator odor	0.02
PO	/ahpreoptic zone of the anterior hypothalamus	0.02
PO	posterior complex thalamus	0.02
PO	pparietal operculum	0.02
PO	principal olive	0.1
PO	/ahpreoptic/anterior hypothalamus	0.02
PO	+animals exposed to the predator odour	0.02
PO	2partial pressure of o2	0.02
PO	mmedial (rostral) portion of the posterior thalamic complex	0.02
PO	mmedial posterior complex of the thalamus	0.02
PO	/ah)	0.02
PO	parietal operculum	0.02
PO	mpostero-medial nucleus of the thalamus	0.02
PO	preoptic nucleus	0.06
PO	preferred orientation	0.02
PO	posterior oral	0.02
PL	plexiform layer	0.0105263157895
PL	prelimbic cortex	0.336842105263
PL	pars lateralis	0.0105263157895
PL	nprimarylike-with-notch	0.0105263157895
PL	post-lesion	0.0210526315789
PL	prelimbic area	0.0842105263158
PL	proprioceptive loss	0.0105263157895
PL	phospholipid	0.0105263157895
PL	peoneus longus	0.0105263157895
PL	paralemniscal area	0.0105263157895
PL	from parturition throughout life	0.0105263157895
PL	polymorphic cell layer–dentate gyrus	0.0105263157895
PL	pyramidal layer	0.0105263157895
PL	paw length	0.0210526315789
PL	phospholipids	0.0105263157895
PL	prelimbic	0.0947368421053
PL	phantom limb	0.0105263157895
PL	prelimbic cortex (area 32)	0.0105263157895
PL	peroneus longus	0.0105263157895
PL	iposterior limitans thalamic nucleus	0.0210526315789
PL	poor learner	0.0105263157895
PL	/moprelimbic and medial orbital areas of the prefrontal cortex	0.0105263157895
PL	iposterior limitans	0.0105263157895
PL	/ilprelimbic/infralimbic cortex	0.0105263157895
PL	prelimbic prefrontal cortex	0.0105263157895
PL	medial prefrontal cortex prelimbic area	0.0105263157895
PL	perceptual learning	0.0105263157895
PL	/ilprelimbic/infralimbic	0.0210526315789
PL	cortexprelimbic cortex	0.0105263157895
PL	poly-lysine	0.0105263157895
PL	pfcprelimbic medial prefrontal cortex	0.0105263157895
PL	posterior limitans	0.0105263157895
PL	placebo monkeys	0.0105263157895
PL	pyridoxal	0.0105263157895
PL	pituitary posterior lobe	0.0105263157895
PL	rphase-locked response	0.0105263157895
PL	primary-like	0.0105263157895
PL	paralaminar nucleus	0.0526315789474
PL	placebo	0.0105263157895
PL	paralemniscal nucleus	0.0105263157895
PL	control (placebo-treated)	0.0105263157895
PM	premamillary area	0.025641025641
PM	pattern motion	0.025641025641
PM	npacemaker nucleus	0.025641025641
PM	+kapathological medium plus kainate	0.025641025641
PM	ppars parvocellularis	0.025641025641
PM	nucleus paramedianus	0.025641025641
PM	nparamedian reticular nucleus	0.025641025641
PM	pathological medium	0.0769230769231
PM	ddorsal premotor cortex	0.153846153846
PM	pyridoxamine	0.025641025641
PM	plasma membrane	0.0512820512821
PM	particulate matter	0.025641025641
PM	ddorsal premotor area	0.025641025641
PM	postmortem	0.025641025641
PM	+kapathological medium+kainate	0.025641025641
PM	procedural memory	0.025641025641
PM	nrparamedian raphe	0.025641025641
PM	v-rrostral part of ventral premotor cortex	0.025641025641
PM	posterior mesencephalon	0.025641025641
PM	gmagnocellular preoptic nucleus	0.025641025641
PM	pointing movement experiment	0.025641025641
PM	vventral premammillary nucleus	0.025641025641
PM	nrparamedian raphe nuc	0.025641025641
PM	premotor cortex	0.025641025641
PM	psoas major	0.025641025641
PM	ddorsal premammillary nucleus	0.025641025641
PM	perfect match	0.0512820512821
PM	poor memory	0.025641025641
PM	premotor area	0.025641025641
PM	polymorphic cell layer	0.025641025641
P2	synaptosomal fraction	0.5
P2	purinergic receptor	0.5
Z-VAD	(ome)-fmkbenzyloxycarbonyl-val-ala-asp(o-methyl)-fluoromethylketone	1.0
MPRAGE	magnetization prepared reduced angle gradient echo sequence	0.2
MPRAGE	magnetization-prepared rapid-acquisition gradient echo	0.2
MPRAGE	magnetization-prepared rapid-acquired gradient echo sequence	0.2
MPRAGE	magnetization-prepared rapid acquisition with gradient echo	0.2
MPRAGE	magnetization prepared rapid acquisition gradient echo	0.2
P1	the first negative and positive electric response	1.0
P7	p8, postnatal day 7, 8	1.0
IIdelayed	family pictures ii	1.0
cNA	the compact formation of the nucleus ambiguus	0.5
cNA	the compact formation of the nucleus ambiguous	0.5
C3Hx	cervical level 3 hemisection	1.0
ELr	entorhinal cortex, lateral rostral subfield	1.0
SCsup	superficial layers of the superior colliculus	1.0
T-BMI	15trained group that received bicuculline doses of 15.4×10-3 μg/g	1.0
AB-OSN	solfactory sensory neurons that are responsive to both acetophenone and benzaldehyde	1.0
RISCRNA-	induced silencing complex	1.0
OPT	o-phthalaldehyde	0.2
OPT	olivary pretectal nucleus	0.4
OPT	optokinetic test	0.2
OPT	open field test	0.2
CR3	complement receptor 3	0.714285714286
CR3	type 3 complement receptor	0.142857142857
CR3	complement receptor 3 (cd11b)	0.142857142857
CR0	conditioned response (after costimulation), control region	1.0
IPDL	dorsal lateral subnucleus of the i.p.	1.0
RMTG	rostromedial tegmental nucleus	1.0
TBS-	plustris-buffered saline supplemented with 0.1% triton x-100 and 3% donkey serum	0.5
TBS-	ttris-buffered saline + tween	0.5
ICES	electrically stimulated ic	1.0
ICER	inducible camp early repressor	0.5
ICER	inducible camp response early repressor	0.166666666667
ICER	inducible cyclic-amp early repressor	0.333333333333
SPRM	selective progestin receptor modulator	1.0
INSERMI	nstitut national de la santé et de la recherche médicale	1.0
OPA	ortho-phthaldialdehyde	0.0434782608696
OPA	solno-phthaldialdehyde reaction solution	0.0434782608696
OPA	orto-phtalaldehyde	0.0434782608696
OPA	o-phthalaldehyde/t-butylthiol	0.0434782608696
OPA	o-phthaldehyde	0.0434782608696
OPA	o-phthalaldehyde	0.260869565217
OPA	ortho-phthalaldehyde	0.0434782608696
OPA	orthophthaldialdehyde	0.0434782608696
OPA	orthophosphoric acid	0.0434782608696
OPA	o-pthaldialdehyde	0.0869565217391
OPA	o-phthadialdehyde	0.0434782608696
OPA	o-phthaldialdehyde	0.217391304348
OPA	o-phthalidialdehyde	0.0434782608696
OPC	soligodendrocyte progenitor cells	0.272727272727
OPC	oligodendrocyte precursor proliferation	0.0227272727273
OPC	oligodendrocyte precursor cells	0.0909090909091
OPC	oligodendrocyte progenitor cell	0.136363636364
OPC	oligodendrocyte progenitor cells	0.0681818181818
OPC	outer pillar cell	0.0227272727273
OPC	soligodendrocyte precursor cells	0.159090909091
OPC	oligodendrocyte precursor glial cell	0.0227272727273
OPC	orbitofrontal cortex	0.0227272727273
OPC	oligodendrocyte precursor cell	0.181818181818
OPL	outer plexiform layer	0.951612903226
OPL	oligodendrocyte precursor	0.0161290322581
OPL	outer plexiform layer of the retina	0.0161290322581
OPL	ordinal linguistic personification	0.0161290322581
ECAR	extracellular acidification rate	1.0
OPN	4-/-melanopsin-less	0.0666666666667
OPN	4xxenopus opn4	0.0666666666667
OPN	omnipause neurons	0.0666666666667
OPN	osteopontin	0.2
OPN	olivary pretectal nuclei	0.0666666666667
OPN	olivary pretectal nucleus	0.333333333333
OPN	omnipause neuron	0.2
PsynPmGluR	and pex, glutamate concentrations at synapse, mglur and extracellular space	1.0
CR-	calretinin-negative	1.0
WGA-HRP	wheatgerm agglutinin–horseradish peroxidase complex	0.04
WGA-HRP	wheat germ agglutinin–horseradish peroxidase	0.16
WGA-HRP	wheat germ agglutinin and horseradish peroxidase complex	0.04
WGA-HRP	wheatgerm agglutinin–horseradish peroxidase	0.04
WGA-HRP	wheatgerm agglutinin horseradish peroxidase	0.04
WGA-HRP	lectin-conjugated peroxidase	0.04
WGA-HRP	wheat-germ agglutinin conjugated to horseradish peroxidase	0.12
WGA-HRP	wheatgerm-agglutinin horseradish peroxidise	0.04
WGA-HRP	wheat germ agglutinin–conjugated horseradish peroxidase	0.08
WGA-HRP	wheatgerm agglutinin conjugated to horseradish peroxidase	0.04
WGA-HRP	wheat germ agglutinin-conjugated horseradish peroxidase	0.08
WGA-HRP	horseradish peroxidase conjugated to wheat germ agglutinin	0.08
WGA-HRP	wheat germ agglutinin conjugated to horseradish peroxidase	0.16
WGA-HRP	wheat germ agglutinin-horseradish peroxidase	0.04
MCH-ir	mch immunoreactivity	1.0
NPY-	sapneuropeptide y-sap	0.2
NPY-	sapdisulfide conjugate of neuropeptide y and saporin	0.2
NPY-	irnpy immunoreactivity	0.4
NPY-	irneuropeptide y immunoreactive	0.2
MAE	motion aftereffect	1.0
VMAT	2vesicular monoamine transport 2	0.0232558139535
VMAT	2vesicular monoamine transporter 2	0.325581395349
VMAT	2vesicular monoamine transporter-2	0.0232558139535
VMAT	1vesicular monoamine transporter	0.0232558139535
VMAT	vesicular monoamine transporters	0.0232558139535
VMAT	vesicular monoamine transporter	0.255813953488
VMAT	vesicular transporter for monoamines	0.0232558139535
VMAT	2neuronal vesicular monoamine transporter	0.046511627907
VMAT	2vesicle monoamine transporter type 2	0.0232558139535
VMAT	2	0.0232558139535
VMAT	2vesicular monoamine transporter type 2	0.093023255814
VMAT	2vesicle monoamine transporter-2	0.0232558139535
VMAT	2vesicular monoamine transporter	0.093023255814
ABCATP-	binding cassette	0.875
ABCATP-	binding cassette protein	0.125
NCTRN	ational center for toxicological research	1.0
DNMSD	elayed non-match to sample	1.0
UFP-	512h-dmt-tic-nh-ch(ch2–cooh)-bid	0.333333333333
UFP-	101[nphe(1), arg(14), lys(15)]n/ofq-nh(2)	0.333333333333
UFP-	101	0.333333333333
CREBCRE-	binding protein	1.0
SM-MAP1B	slow-migrating microtubule-associated protein 1b	1.0
PTH2	parathyroid hormone-2	1.0
cH	cis-4-heptenal	1.0
ANDI	available neuronal density index	1.0
dMCA	distal middle cerebral artery	1.0
cM	centimorgan	0.666666666667
cM	maxconcomitant mmax	0.333333333333
cL	chronic light	1.0
bufferSalt	tris, edta, np40	1.0
DAMS	drosophila activity monitor system	1.0
DAMP	sdanger-associated molecular patterns	0.5
DAMP	4-deoxy acetyl methyl piperidine mustard	0.5
cG	nrhchicken gonadotrophin-releasing hormone	1.0
cF	os-ircfos-immunoreactive	0.333333333333
cF	os	0.666666666667
MC4-R	melanocortin receptor-4	1.0
mPICA	medial posterior inferior cerebellar artery branch	1.0
rtPCR	real-time quantitative polymerase chain reaction	0.5
rtPCR	real-time pcr	0.5
HPRT-	hypoxanthine-guanine phosphoribosyltransferase deficient	1.0
cR	af-1	0.5
cR	dgcaudal dysgranular retrosplenial cortex	0.5
cP	olecaudal pole of the telencephalon	1.0
GSH-P	xglutathione	0.2
GSH-P	xgsh peroxidase	0.2
GSH-P	xglutathione peroxidase	0.6
nAchRs	nicotinic acetylcholine receptors	1.0
GTA	gated threshold adaptation and gated anti-hebbian learning	1.0
cT	nacaudal nucleus taeniae of the amygdala	1.0
Oc2L	occipital cortex, area 2, lateral part	0.5
Oc2L	lateral occipital area 2	0.5
Oc2M	occipital cortex, area 2, medial part	1.0
LC-PCRL	ight cycler polymerase chain reaction	1.0
Te2D	temporal area 2, dorsal part	1.0
CD68	tgfβ1	1.0
N-KN	ewman-keuls	1.0
WSRW	ithdrawal seizure-resistant	1.0
zVAD-	fmkbenzyl-oxycarbonyl-val-ala-asp-fluoromethylketone	0.333333333333
zVAD-	fmk	0.333333333333
zVAD-	fmkn-benzyloxycarbonyl-ala-asp-fluoromethyl ketone	0.333333333333
EEWP	enriched environment whisker-paired	1.0
ARNDA	lcohol-related neurological disorders	1.0
V2L	secondary visual cortex	1.0
E-face	the cytoplasmic leaflet of the plasma membrane, respectively	1.0
D1R	dopamine d1 receptor	0.25
D1R	d1 dopaminergic receptor	0.25
D1R	d1 dopamine receptor	0.5
CAPSC	linician-administered ptsd scale	0.333333333333
CAPSC	hinese affective picture system	0.666666666667
SIDS	sudden infant death syndrome	1.0
NPYN	europeptide y	1.0
PSCH	suprachiasmatic preoptic nucleus	1.0
PSCI	post-stroke cognitive impairment	1.0
GSE	gene set enrichment	1.0
FMR	focus of maximal response	0.25
FMR	1fragile x mental retardation gene	0.25
FMR	1fragile x mental retardation 1	0.25
FMR	1/fmr1fragile x mental retardation 1 gene	0.25
ABHD6α	β-hydrolase domain 6	1.0
SPSC	spontaneous post-synaptic current	1.0
DNMS-	120delayed non-match to sample test at a 2 min delay	1.0
DAB-HRP	diaminobenzidine–horseradish peroxidase	1.0
PTCH	patched receptor	1.0
TVOR	translational vestibulo-ocular reflex	0.5
TVOR	translational vestibulo-ocular reflexe	0.5
NGST	normal goat serum in pbs with triton x-100	0.25
NGST	normal goat serum plus 0.3% triton x-100 in 0.1m phosphate-buffered saline	0.25
NGST	normal goat serum in 0.01 m pbs with 0.3% triton-x 100	0.25
NGST	normal goat serum in pbs with 0.3% triton x-100	0.25
PTCC	peak-to-trough correlation coefficient	1.0
PSG	postsygmoid gyrus	0.333333333333
PSG	spolysomnograms	0.333333333333
PSG	polysomnography	0.333333333333
MCAOM	iddle cerebral artery occlusion	1.0
VRAC	volume-regulated anion channel	1.0
StreptABComplex	streptavidin–biotin-complex	1.0
WASO	wake after sleep onset	1.0
shRNA-	scrscrambled oligonucleotide sequence	1.0
cVLM	caudal part of the ventrolateral reticular nucleus of the medulla	0.333333333333
cVLM	caudal ventrolateral medulla	0.666666666667
rBMF	rate best modulation frequency	1.0
RASGRP	1ras guanyl releasing protein 1	1.0
TPH-IR	tryptophan hydroxylase-immunoreactive	1.0
vD	dot mean velocity	1.0
vF	von frey	0.5
vF	hvon frey hairs	0.5
vG	lut2vesicular glutamate transporter 2	0.307692307692
vG	lut2	0.0769230769231
vG	lutvesicular glutamate transporter	0.307692307692
vG	lut1vesicular glutamate transporter 1	0.230769230769
vG	lut2type 2 vesicular glutamate transporter	0.0769230769231
vH	iventral hippocampus	1.0
vM	npoventral median preoptic nucleus	0.333333333333
vM	1vibrissal motor cortex	0.333333333333
vM	eaventral medial amygdale	0.333333333333
vP	noventral pontine nucleus oralis	0.5
vP	utventral putamen	0.5
DLPMC	dorsolateral premotor cortex	1.0
vR	eventral reuniens nucleus	1.0
RANOVA	random analysis of variance	1.0
vT	elventral telencephalon	1.0
KDEL	receptor	1.0
LPV	lower pulmonary vein	1.0
NaCh-R	tetrodotoxin-resistant sodium channel	1.0
Bot-C1	botulinum toxin c-1	1.0
cGMP	guanosine 3′,5′-cyclic monophosphate	0.123287671233
cGMP	cyclic guanosine monophosphate	0.41095890411
cGMP	cyclic guanylyl monophosphate	0.013698630137
cGMP	cyclic guanosine 3′5′-cyclic monophosphate	0.013698630137
cGMP	cyclic guanosine-5′-monophosphate	0.013698630137
cGMP	guanosine-3′,5′-cyclic monophosphate	0.027397260274
cGMP	cyclic guanosine 3′,5′monophosphate	0.013698630137
cGMP	3′,5′-cyclic guanosine monophosphate	0.041095890411
cGMP	cyclic guanosine 3′,5′-cyclic monophosphate	0.013698630137
cGMP	cyclic 3′-5′-guanosine monophosphate	0.013698630137
cGMP	cyclic gmp	0.0821917808219
cGMP	release in vivo	0.013698630137
cGMP	cyclic guanosine-3′,5′-monophosphate	0.013698630137
cGMP	cyclic guanosine 3′-5′-monophosphate	0.013698630137
cGMP	cyclic guanylylmonophosphate	0.013698630137
cGMP	cyclic 3′,5′-guanosine monophosphate	0.013698630137
cGMP	cyclic guanine monophosphate	0.013698630137
cGMP	cyclicgmp	0.013698630137
cGMP	cyclic guanosine 3′,5′-monophosphate	0.109589041096
cGMP	guanilate cyclase	0.013698630137
cGMP	cyclic guanosine mono-phosphate	0.013698630137
ZTTAN-	benzyloxycarbonyl-thioprolyl-thioprolinal-dimethylacetal	1.0
LPT	lever press task	0.166666666667
LPT	lateral pontine tegmentum	0.5
LPT	long-term potentiation	0.166666666667
LPT	lateropontine tegmentum	0.166666666667
DCXD	oublecortin	1.0
RFRPRF-	amide related peptide	1.0
HbCO	carboxyhemoglobin	1.0
polyQ	polyglutamine	0.857142857143
polyQ	polyglutamine chain	0.142857142857
PHA-L	leucoagglutinin of the phaseolus vulgaris	0.030303030303
PHA-L	phaseolus vulgaris leuco-agglutinin	0.030303030303
PHA-L	phaseolus vulgaris leucoagglutinin	0.666666666667
PHA-L	phaseolus vulgaris-leucoagglutinin	0.242424242424
PHA-L	phaseolus vulgaris lectin	0.030303030303
3NT	3-nitrotyrosine	1.0
ωGVIA	ω-conotoxin gvia	1.0
DPPX	dipeptidyl aminopeptidase x	1.0
3NP	3-nitropropionate	0.111111111111
3NP	3-nitropropionic acid	0.888888888889
EARLY-LTP	protein synthesis-independent ltp (	1.0
GMAP	galanin message-associated peptide	1.0
gAUC	glucose area under the curve	1.0
JLO	judgment of line orientation	1.0
ADMCAδ-	mechanocold unit	1.0
TRag	thrombin receptor agonist	1.0
LMPC	laser microdissection and pressure catapulting	1.0
DMCMmethyl-6	7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate	1.0
CSCE	crude spinal cord extract	1.0
EtBr	ethidium bromide	1.0
MCDP	mast cell degranulating peptide	1.0
IETF	immediate-early transcription factor	1.0
GTG	gold thioglucose	1.0
LMFG	left middle frontal gyrus	1.0
OL-	pcol-protocadherin	1.0
ACST	auditory-cued sensorimotor task	1.0
JLJ	ackson laboratories	1.0
Fam2	first and second recording sessions in the familiar arena	1.0
DDMD	rift diffusion model	1.0
BBNB	road band noise	1.0
P-MKK	3/6phosphorylated mkk3/6	1.0
NP-SH	non-protein thiol	1.0
aOBSC	adult olfactory bulb stem cells	1.0
FORKO	follitropin receptor knockout	1.0
LPH	lactase-phlorizin hydrolase	1.0
siNS	non-silencing sirna	1.0
HNC	)	1.0
DEAE	diethylaminoethyl	1.0
nBOR	nucleus of the basal optic root	1.0
mIPS	middle segment of the intraparietal sulcus	1.0
GFRα	growth factor receptor alpha	0.0714285714286
GFRα	1glial cell line-derived neurotrophic factor family receptor α1	0.0714285714286
GFRα	glial cell line-derived neurotrophic factor family receptor-α	0.0714285714286
GFRα	1	0.0714285714286
GFRα	2	0.0714285714286
GFRα	glial cell line-derived neurotrophic factor receptor α	0.0714285714286
GFRα	glial cell line-derived neurotrophic factor family receptor alpha	0.0714285714286
GFRα	gdnf family receptor α	0.142857142857
GFRα	2receptor for neurturin	0.142857142857
GFRα	glial cell line-derived neurotrophic factor family α receptor	0.0714285714286
GFRα	gdnf family α receptor	0.0714285714286
GFRα	2glial cell line-derived neurotrophic factor family receptor-alpha 2	0.0714285714286
15855A	(±)-trans-1,3,4,4a,5,10b-hexahydro-4-propyl-2h-[1]benzopyrano[3,4-b]	1.0
mcPVH	midcaudal portion of the pvh	1.0
CSPGs	chondroitin sulphate proteoglycans	0.5
CSPGs	chondroitin sulfate proteoglycans	0.5
APES	3-aminopropyltriethoxylane	1.0
NICDN	otch internal cellular domain	0.166666666667
NICDN	otch intracellular domain	0.833333333333
GCPII	/iiihuman glutamate carboxypeptidase ii/iii	1.0
E-LTP	early-long-term potentiation	0.181818181818
E-LTP	early phase long-term potential	0.0909090909091
E-LTP	early ltp	0.0909090909091
E-LTP	early long-term potentiation	0.363636363636
E-LTP	early-phase long-term potentiation	0.0909090909091
E-LTP	early phase of long-term potentiation	0.181818181818
αβmeATPalpha	beta-methylene adenosine triphosphate	1.0
CeMPV	medial portion of the central nucleus of the amygdala	1.0
iSRT	ipsilateral hemisphere of srt	1.0
CPCA	5′-(n-cyclopropyl)-carboxamidoadenosine	0.666666666667
CPCA	constrained principal component analysis	0.333333333333
APEC	2-[(2-aminoethylamino)carbonylethylphenylethylamino]-5′-n-ethylcarboxamidoadenosine	0.333333333333
APEC	2-[(2-aminoethylamino)-carbonylethylphenylethyl amino]-5′-n-ethylcarboxamidoadenosine	0.333333333333
APEC	2-[(2-aminoethylamino)carbonylethylphenylethylamino]-5′-n-ethyl carboxamide adenosine	0.333333333333
lesL	ong evans shaker rat	1.0
fAHPfast	early component of afterhyperpolarization	1.0
rsFC	resting state functional connectivity	0.5
rsFC	resting-state functional connectivity	0.5
HNK	1human natural killer cell antigen 1	1.0
OPPO	scillatory firing neuron projecting to peripheral nerves	1.0
E-LTD	early long-term depression	1.0
DAmax	peak extracellular concentration of da	1.0
192-I	gg saporin192 immunoglobulin g saporin	1.0
BOLD	blood oxygen level-dependent	0.133333333333
BOLD	blood-oxygenation level dependent	0.0190476190476
BOLD	blood oxygenation level-dependent	0.133333333333
BOLD	blood oxygenation level-dependent contrast	0.00952380952381
BOLD	blood oxygenation-level dependent	0.00952380952381
BOLD	blood oxygenation level dependent imaging	0.00952380952381
BOLD	blood oxygen-level dependent	0.0285714285714
BOLD	blood-oxygenation-level-dependent	0.0571428571429
BOLD	blood-oxygen level dependent	0.0190476190476
BOLD	blood oxygenation level–dependent	0.00952380952381
BOLD	blood oxygenation level dependent	0.104761904762
BOLD	blood-oxygen-level-dependent	0.0952380952381
BOLD	blood oxygen level dependant	0.00952380952381
BOLD	blood-oxygenated level dependent	0.0190476190476
BOLD	blood oxygen level dependent	0.266666666667
BOLD	blood-oxygen-level dependent	0.0190476190476
BOLD	blood oxygen-level-dependent	0.00952380952381
BOLD	blood oxygen-dependent level	0.00952380952381
BOLD	blood oxygen level dependence	0.00952380952381
BOLD	blood oxygen level–dependent	0.0190476190476
BOLD	fmriblood oxygenation level-dependent functional magnetic resonance imaging	0.00952380952381
SSSE	self-sustaining status epilepticus	1.0
Pbr	parabrachial nuclear complex	1.0
ITAM	immunoreceptor tyrosine-based activation motif	0.333333333333
ITAM	immunoreceptor tyrosine-based activatory motif	0.333333333333
ITAM	simmunoreceptor tyrosine-based activation motifs	0.333333333333
SSSS	ensation seeking scale	1.0
M-TMD	myofascial temporomandibular disorders	1.0
NNGHN-	isobutyl-n-(4-methoxyphenylsulfonyl)-glycyl hydroxamic acid	0.5
NNGHN-	isobutyl-n-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid	0.5
VIF	variance inflation factor	1.0
XAC	8-{4-[(2-aminoethyl) amino]carbonylmethyl-oxyphenyl}xanthine	0.25
XAC	8-{4-[(2-aminoethyl)amino]carbonylmethyl-oxyphenyl}xanthine	0.75
MS-DBB	medial septum–diagonal band of broca	0.5
MS-DBB	medial septum-diagonal band of broca	0.5
ISCH	ischemic surgery	0.5
ISCH	ischemia	0.5
CDP-C	holinecytidine 5′ diphosphocholine	1.0
XAG	glutamate transporters	1.0
NGD-	4715	1.0
CN-	cyanide	1.0
p-NF	phosphorylated neurofilament	1.0
ASON	antisense oligonucleotide	1.0
pAb	polyclonal antibody	1.0
p-NA	p-nitroaniline	1.0
KIBRA	kidney and brain expressed protein	0.666666666667
KIBRA	kidney/brain	0.333333333333
CRCC	linical research center	1.0
mGlu	metabotropic glutamate receptor	0.2
mGlu	metabotropic glutamate	0.8
TMBPT	cells specific to myelin basic protein	1.0
SN-VTA	substantia nigra-ventral tegmental area	0.666666666667
SN-VTA	substantia nigra–ventral tegmental area	0.333333333333
M100907	r-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine-methanol	0.5
M100907	r-(+)-α-(2,3-dimethoxyphenyl)-1-[4-fluorophenyl-ethyl)]-4-piperidinemethanol	0.5
Quis	quisqualate	1.0
ICJ	ileocaecal junction	1.0
CNQX6-cynao-7-nitroquinoxaline-2	3-dione	1.0
EFBD	excess folic acid and vitamin b12 deficient	1.0
CNT	corneal nerve terminal	0.5
CNT	carbon nanotube	0.5
ilPFC	infralimbic prefrontal cortex	1.0
ω-CT	x-gviaω-conotoxin-gvia	0.333333333333
ω-CT	x mviicω-conotoxin mviic	0.333333333333
ω-CT	xω-conotoxin gvia	0.333333333333
t-S	yn itotal-synapsin i	1.0
sSWD	mean single swds duration	1.0
PBSPB	saline solution	0.5
PBSPB	saline	0.5
ICN	sintrinsic connectivity networks	0.125
ICN	intrinsic connectivity network	0.125
ICN	intercollicular nucleus	0.125
ICN	inferior cardiac nerve	0.125
ICN	intracellular notch receptor domain	0.125
ICN	intercalated nucleus	0.125
ICN	intrinsic cardiac neuron	0.125
ICN	interposed cerebellar nuclei	0.125
BCW	black-cheeked waxbill	1.0
ICM	dumodulated ic	0.142857142857
ICM	intercalated cell masses	0.142857142857
ICM	intra-cisterna magna	0.142857142857
ICM	sintercalated cell masses	0.285714285714
ICM	intercalated cell masses of amygdala	0.142857142857
ICM	pericapsular clusters of intercalated cell masses	0.142857142857
BCH	2-amino-2-norbornate-carboxylic acid	0.5
BCH	2-aminobicyclo-[2.2.1]-heptane-2-carboxylic acid	0.5
α-SYNα-	synuclein	1.0
LNNA	l-nω-nitro arginine	1.0
INMDAN-	methyl-d-aspartate current	1.0
dl-STR	dorsolateral striatum	1.0
ISSXX-	linked infantile spasms	1.0
BCS	body of the calcarine sulcus	0.333333333333
BCS	bathocuproine disulfonate	0.333333333333
BCS	brachium colliculi superioris	0.333333333333
DpMe	deep mesencephalon	0.5
DpMe	deep mesencephalic nucleus	0.5
8PT	8-phenyltheophylline	1.0
BSSB	erg balance scale	1.0
GCLγ-	glutamyl cysteine ligase	1.0
H1	type-1 histamine	1.0
KOI	knee only ipsilateral	1.0
PBSG	gelatin in pbs	0.5
PBSG	phosphate buffered saline containing bsa and gelatin	0.5
MnR	median raphe nucleus	1.0
MMAN	medial magnocellular nucleus of the anterior nidopallium	1.0
FA	fast adapting	0.0149253731343
FA	2hfatty acid 2-hydroxylase	0.0149253731343
FA	ifield area	0.0149253731343
FA	formic acid	0.0298507462687
FA	filp angle	0.0149253731343
FA	fluoroacetate	0.0149253731343
FA	field area	0.044776119403
FA	focal adhesion	0.0149253731343
FA	fear acquisition	0.0149253731343
FA	tractus fronto-arcopallialis	0.0149253731343
FA	factor analysis	0.044776119403
FA	fatty acids	0.0298507462687
FA	fractional anisotropic	0.0149253731343
FA	fluorocitric acid	0.0149253731343
FA	fast adaptation	0.0149253731343
FA	formaldehyde	0.044776119403
FA	fluctuating asymmetry	0.0149253731343
FA	flip angle	0.089552238806
FA	forced activity	0.0149253731343
FA	/pbsformaldehyde in phosphate-buffered saline	0.0149253731343
FA	fatty acid	0.0746268656716
FA	cfluoroacetate	0.0149253731343
FA	fractional anisotropy	0.388059701493
FA	fetal age	0.0149253731343
FA	ferulic acid	0.0149253731343
8-BrcAMP	8-bromo camp	1.0
TPCA	2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide	1.0
TRAAKTWIK	related arachidonic acid-stimulated k+ channel	1.0
P-CaMKII	phosphorylated form of camkii at thr 286	1.0
CEPC	dc42 effector protein	1.0
ScV	subnucleus caudalis of the spinal trigeminal nucleus	1.0
mCHT	mouse cht	1.0
d-AMPH	d-amphetamine	1.0
EADP	equilibrium potential of the adp	1.0
VOE	variance of the error	0.5
VOE	ventriculo-olfactory extension	0.5
VOG	video-oculography	1.0
CPP3	3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate	1.0
rAAV-	controlraav encoding gfp	1.0
VOC	volatile organic compound	0.666666666667
VOC	vestibuloocular collic	0.333333333333
VOI	volume-of-interest	0.0833333333333
VOI	volume of interest	0.833333333333
VOI	svolumes of interest	0.0833333333333
CK2	casein kinase 2	0.5
CK2	casein kinase-2	0.5
VOV	entral orbital cortex	1.0
t-C	amkiitotal-camkii	1.0
DETAN-	1 [3-(trimethoxysilyl) propyl] diethylenetriamine	1.0
VOR	vestibulo-ocular reflex	0.633333333333
VOR	vestibule-ocular reflex	0.0333333333333
VOR	vestibuloocular response	0.0333333333333
VOR	vestibuloocular reflex	0.233333333333
VOR	vestibular ocular reflex	0.0666666666667
MS-VLDBB	medial septum-vertical limb of diagonal band of broca	0.5
MS-VLDBB	medial septal-vertical limb of diagonal band of broca	0.5
8oxoG	8-oxoguanine	1.0
G-V	curvevoltage-dependent activation curve	1.0
5α-THDOC5α-pregnane-3α	21-diol-20-1	1.0
ALAA	lpha-linoleic acid	1.0
ga-CNTF	ppolyclonal goat–anti-ciliary neurotrophic factor	0.5
ga-CNTF	ppolyclonal goat-anti-ciliary neurotrophic factor	0.5
ANLS	astrocyte neuron lactate shuttle	0.333333333333
ANLS	astrocyte–neuron lactate shuttle	0.333333333333
ANLS	astrocyte-to-neuron lactate shuttle	0.333333333333
CLIP	crosslinking-ip	1.0
V-O	vestibular-only	1.0
FOSB	delta fosb	1.0
STOP	stable tubule only polypeptide	1.0
DPND	iarylpropionitrile	1.0
rBNB	rectangular broadband noise burst	1.0
AMP-PNP	5′-adenylylamidodiphosphate	1.0
V-M	variance-mean	1.0
NLGN	sneuroligins	0.5
NLGN	neuroligin	0.5
pre-SMA	pre-supplementary motor area	0.714285714286
pre-SMA	pre-supplementary-motor area	0.142857142857
pre-SMA	presupplementary motor area	0.142857142857
STAR	steroidogenic acute regulatory protein	1.0
SNOS-	nitrosothiols	1.0
KCC1	2, k-cl cotransporter 1, 2	1.0
dMRF	dorsal mesencephalic reticular formation	1.0
4C-3H-PG	(r)-4-carboxy-3-hydroxyphenyl-glycine	1.0
3meC	3-methylcytosine	1.0
OLCM	oligodendrocyte conditioned medium	1.0
sRPTPζ	shorter receptor form of receptor-type protein tyrosine phosphatase ζ	1.0
ESME	xperience sampling method	1.0
SCOPA-COG	scale for outcomes in parkinson's disease cognition	1.0
NT-3	neurotrophin-3	0.868852459016
NT-3	neurtrophin-3	0.016393442623
NT-3	neurotrophic factor 3	0.0327868852459
NT-3	neurotrophin 3	0.0819672131148
hrIL-	1βhuman recombinant interleukin-1β	1.0
NT-4	neurotrophin-4/5	0.125
NT-4	neurotrophin 4/5	0.125
NT-4	neurotrophin-4	0.75
SYAP	1synapse-associated protein 1	1.0
pAD	primary afterdischarge	1.0
GRAPPA	generalized auto-calibrating partially parallel acquisitions	1.0
RPMI-1640	roswell park memorial institute media 1640	1.0
pPC	posterior piriform cortex	0.666666666667
pPC	posterior pc	0.333333333333
pPB	pontine parabrachial nucleus	1.0
sRPTPβ	shorter receptor form of receptor-type protein-tyrosine phosphatase β	1.0
Gro-α	melanocyte growth-stimulating activity	1.0
PVh	paraventricular nucleus	1.0
4-AP	4-amino pyridine	0.00740740740741
4-AP	4-amino-pyridine	0.00740740740741
4-AP	4-aminopyridin	0.00740740740741
4-AP	4-aminoprydine	0.00740740740741
4-AP	4-aminopyridine	0.955555555556
4-AP	4-aminopiridyne	0.00740740740741
4-AP	sensitive k+ current	0.00740740740741
Br-cGMP	8-bromo-cyclic gmp	1.0
Hsp27	heat shock protein of 27kda	0.5
Hsp27	heat shock protein 27kda	0.5
HMGAH	igh mobility group a	1.0
pPV	posterior periventricle	1.0
4-HPP	4-hydroxyphenylpyruvate	1.0
GHSR	ghrelin/growth hormone secretagogue receptor	0.125
GHSR	growth hormone secretagogue 1 receptor	0.125
GHSR	growth hormone secretagogue receptor	0.25
GHSR	growth hormone secretagogue receptor (ghrelin receptor)	0.125
GHSR	ghelin/growth hormone secretagogue receptor	0.125
GHSR	ghrelin receptor	0.25
dTMR	dextran tetramethyl rhodamine	1.0
RPaG	right parietal ganglion	1.0
RAWM	radial water maze	0.166666666667
RAWM	radial arm water maze	0.833333333333
FF	foot faults	0.05
FF	fimbria/fornix	0.05
FF	frequency of firing	0.05
FF	cmaverage fano factor for cell c across all trials with memoranda m	0.05
FF	/bbfoot faults per beam breaks	0.05
FF	frequency facilitation	0.05
FF	force field perturbation	0.05
FF	soma form factor	0.05
FF	ratio statistic	0.05
FF	forel field	0.05
FF	fimbria–fornix	0.2
FF	fimbria-fornix	0.2
FF	fundamental frequency	0.05
FF	false-font string	0.05
SCH233903-methyl-1-phenyl-2	3,4,5-tetrahydro-7-chloro-8-hydroxy-(1h)-3-benzazepine	1.0
FOS-	irfos immunoreactivity	1.0
mAbs	monoclonal antibodies	1.0
KNRK	kristen murine sarcoma virus transformed rat kidney epithelial cell line	1.0
C6	glioma c6bu-1 cells	1.0
LHIPP	left hippocampus	1.0
PFI	prolonged focal ischemia	1.0
C5	anti-neuroglycan c monoclonal antibody	1.0
DPN2	3-bis(4-hydroxyphenyl)-propionitrile	0.625
DPN2	3-bis(4-hydroxyphenyl)propionitrile	0.125
DPN2	3-bis(4-hydroxyphenyl)-propionitrile (highly potent erβ agonist)	0.125
DPN2	3-bis(4-hydroxyphenyl)-propionitrile (diarylpropionitrile)	0.125
PBS-XCD	pbs-x containing λ-carrageenan and donkey serum	1.0
CIC	hemotactic index	0.0625
CIC	central inferior colliculus	0.0625
CIC	central nucleus	0.0625
CIC	central nucleus of inferior colliculus	0.125
CIC	central nucleus of the ic	0.125
CIC	cortex of inferior colliculus	0.0625
CIC	central nucleus of the inferior colliculus	0.5
CIB	calcium imaging buffer	1.0
CIA	collagen-induced arthritis	1.0
DAg	dark agouti	1.0
BMAa	basomedial nucleus, amygdala, anterior part	1.0
CIE	chronic intermittent ethanol	1.0
CID	collision-induced dissociation	1.0
SR95531	2-(3-carboxypropyl)-3-amino-6-methoxyphenyl-pyridazinium bromide	1.0
iNOSI	nducible nitric oxide synthase	1.0
CIH	chronic intermittent hypoxia	1.0
CIO	contralateral inferior olive	1.0
DPCPX1	3-dipropyl-8-cyclopentylxanthine	0.857142857143
DPCPX1	3-dipropyl-8-cyclopentyl xanthine	0.142857142857
vLGN	ventrolateral geniculate nucleus	0.0909090909091
vLGN	ventral part of the lateral geniculate body	0.0909090909091
vLGN	ventral lateral geniculate nucleus	0.818181818182
CIS	clinically isolated syndrome	0.166666666667
CIS	chronic immobilization stress	0.5
CIS	current injection stimulus	0.166666666667
CIS	central insular sulcus	0.166666666667
CIR	cardiac-type inwardly rectifying k+ channel	0.5
CIR	cardiac inward rectifier	0.5
CIP	congenital insensitivity to pain	0.25
CIP	cyclin-dependent kinase 5 inhibitor peptide	0.25
CIP	caudal intraparietal	0.25
CIP	/kipcyclin/kinase inhibitor proteins	0.25
CuZnSOD	copper–zinc superoxide dismutase	1.0
dlpSCN	dorsolateral peri–suprachiasmatic nucleus	1.0
CIT	citalopram	0.333333333333
CIT	citrulline	0.666666666667
CO	control	0.0263157894737
CO	control mice	0.0131578947368
CO	chiasma opticum	0.0131578947368
CO	cytochrome oxidase staining	0.0131578947368
CO	2carbon dioxide	0.0657894736842
CO	choline oxidase	0.0131578947368
CO	cornea only	0.0131578947368
CO	disomic control	0.0131578947368
CO	common outcome	0.0131578947368
CO	control rats recieving normal regimen	0.0131578947368
CO	control treatment group	0.0131578947368
CO	2	0.0131578947368
CO	2carbondioxide	0.0131578947368
CO	xcytochrome c oxidase	0.0131578947368
CO	coconut oil	0.0131578947368
CO	2 laser	0.0263157894737
CO	carbon monoxide	0.197368421053
CO	cardiac output	0.0131578947368
CO	cytochrome c oxidase	0.0263157894737
CO	control odor	0.0131578947368
CO	cytochrome oxidase-c	0.0131578947368
CO	coupled oscillators	0.0131578947368
CO	cytochrome oxidase	0.434210526316
NRXN	neurexin	1.0
BBSB	ardet–biedl syndrome	1.0
TrkB	tyrosine kinase b	0.5
TrkB	neurotrophin receptor tyrosine kinase b	0.25
TrkB	protein-tyrosine kinase b	0.25
M6P	mannose-6-phosphate	1.0
PVLV	primary value and learned value	1.0
DAF	dorsal auditory field	0.5
DAF	delayed auditory feedback	0.5
DAG	1,2-diacylglycerol	0.0178571428571
DAG	diacyl glycerol	0.0178571428571
DAG	diacylglycerole	0.0178571428571
DAG	donkey anti-goat	0.0357142857143
DAG	diacilglicerol	0.0178571428571
DAG	diacylglycerol	0.875
DAG	phosphatidylserine/diacylglycerol	0.0178571428571
PNU-	282987n-[(3r)-1-azabicyclo[2.2.2]oct-3-yl]	1.0
Li-SG	limitans-suprageniculate nucleus	1.0
DAB	3,3′-diaminobenzidine tetrahydrochloride	0.061919504644
DAB	3′,3-diaminobenzidine-tetrachloride	0.0015479876161
DAB	3′,3′-diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	dab and hydrogen peroxide intensified by ammonium nickel sulfate	0.0015479876161
DAB	3′3′-diaminobenzidine	0.0046439628483
DAB	diaminobenzidine tetrahydrochloride	0.0572755417957
DAB	diaminobenzidine hcl	0.0015479876161
DAB	3,3′-diaminobenzidine-tetrahydrochloride	0.0030959752322
DAB	3′,3-diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	3′,3′ diaminobenzidine	0.0015479876161
DAB	diaminobenzine	0.0015479876161
DAB	3–3′diamino benzidine	0.0015479876161
DAB	3–3′ diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	diamino benzidine-4hcl	0.0015479876161
DAB	diaminobenzidine tetrachloride	0.0030959752322
DAB	diaminobenzedine	0.0015479876161
DAB	3,3’-diaminobenzidine	0.0030959752322
DAB	nickel-enhanced diaminobenzidine	0.0015479876161
DAB	diaminobenzidine-tetrahydrochloride	0.0015479876161
DAB	3′,3′-diaminobenzidinetetrahydrochloride	0.0015479876161
DAB	3.3′-diaminobenzidine	0.0030959752322
DAB	3,3′-diaminobenzidine–4hcl	0.0061919504644
DAB	3′,3′-diaminobenzidine	0.0077399380805
DAB	diaminobenzadine tetrahydrochloride	0.0015479876161
DAB	diamino benzidine	0.0030959752322
DAB	3′3 diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	3′-diaminobenzidine	0.0046439628483
DAB	3,3′-diaminobenzidine hydrochloride	0.0015479876161
DAB	diamino-benzidine	0.0015479876161
DAB	3,3′-diaminobenzidine tetra-hydrochloride	0.0015479876161
DAB	diaminobenzedrine	0.0015479876161
DAB	3-3′-diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	diaminobenzidine tetrahydrocholoride	0.0015479876161
DAB	3–3′ diaminobenzidine-hci	0.0015479876161
DAB	3,3’-diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	3′,3-diaminobenzidine	0.0030959752322
DAB	3′3-diaminobenzidine	0.0046439628483
DAB	diaminobenizidine	0.0015479876161
DAB	3,3′,diaminobenzidine	0.0015479876161
DAB	diaminbenzidine	0.0015479876161
DAB	3′-3-diamino-benzidine	0.0015479876161
DAB	3′3′-diaminobenzidine-tetrahydrochloride	0.0015479876161
DAB	diaminobenzidine tetrahydrochroride	0.0015479876161
DAB	3,3′-diaminobenzidine tetrachloride	0.0061919504644
DAB	diaminobenzidine tetrahydro-chloride	0.0015479876161
DAB	1disabled 1	0.0015479876161
DAB	diaminobenzidine	0.493808049536
DAB	3,3′-diaminobenzidine	0.238390092879
DAB	days after birth	0.0030959752322
DAB	/ninickel-enhanced diaminobenzidine	0.0015479876161
DAB	diaminobenzidene tetrahydrochloride	0.0030959752322
DAB	3,3-diaminobenzidine	0.0015479876161
DAB	diaminobenzidine hydrochloride	0.0046439628483
DAB	3-3′-diaminobenzidine	0.0077399380805
DAB	3,3 ́-diaminobenzidine	0.0015479876161
DAB	(3,3′-diaminobenzidine)	0.0015479876161
DAB	3,3′ diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	3,3′diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	diaminobenzidene	0.0046439628483
DAB	3-3-diaminobenzidine tetrahydrochloride	0.0015479876161
DAB	3′3 diaminobenzidine	0.0015479876161
DAB	1disabled-1	0.0015479876161
DAB	3,3′-diaminobenzidine substrate	0.0015479876161
DAB	3,3′-diaminebenzidine	0.0015479876161
DAB	3,3′-diaminobenzidine-4hcl	0.0015479876161
DAB	3,3-diaminobenzidene	0.0015479876161
DAB	3, 3′-diaminobenzidine	0.0015479876161
DAB	3′-3′ diaminobenzidine tetrahydrochloride	0.0015479876161
BMAL	1brain and muscle arnt-like 1	1.0
DAN	differential screening-selected gene aberrative in neuroblastoma	0.25
DAN	dabetic autonomic neuropathy	0.25
DAN	2,3-diaminonaphthalene	0.25
DAN	dantrolene	0.25
DAO	dorsal accessory olive	0.875
DAO	d-amino acid oxidase	0.125
DAI	diffuse axonal injury	1.0
THPO	4,5,6,7-tetrahydroisoxazolo[4,5-c]-pyridin-3-ol hydrobromide	1.0
DAT	dopamine transporters	0.0188679245283
DAT	dopamine membrane transporter	0.0125786163522
DAT	dopamine n acetyltransferase	0.0062893081761
DAT	1gene coding for the dopamine transporter	0.0062893081761
DAT	1dopamine transporter	0.0125786163522
DAT	dopamine reuptake transporter	0.0062893081761
DAT	dopamine plasma membrane transporter	0.0062893081761
DAT	dopamine transporter	0.924528301887
DAT	dementia of the alzheimer's type	0.0062893081761
DAU	dopamine uptake transporter	1.0
GPCR	g protein-coupled receptor	0.121212121212
GPCR	sg protein–coupled receptors	0.030303030303
GPCR	(g protein)-coupled receptor	0.030303030303
GPCR	sg-protein coupled receptors	0.0909090909091
GPCR	sg-protein–coupled receptors	0.030303030303
GPCR	sg-protein-coupled receptors/7-transmembrane domain metabotropic receptors	0.030303030303
GPCR	s	0.0606060606061
GPCR	sg-protein-coupled receptors	0.272727272727
GPCR	142g-protein-coupled receptor-142	0.030303030303
GPCR	g protein-coupled receptors	0.030303030303
GPCR	sg protein-coupled receptors	0.151515151515
GPCR	g-protein-coupled receptor	0.121212121212
ICx	external nucleus of the inferior colliculus	0.5
ICx	external nucleus of the ic	0.5
DAP	depolarising after-potential	0.05
DAP	diastolic arterial pressure	0.05
DAP	depolarizing afterpotential	0.35
DAP	sdystrophin associated proteins	0.05
DAP	12dnax activating protein 12	0.05
DAP	sdepolarization prior to aps	0.05
DAP	distal blood pressure	0.05
DAP	dystrophin-associated protein complex	0.05
DAP	dystrophin-associated protein	0.15
DAP	sdystrophin-associated proteins	0.1
DAP	12dnax-activating protein of 12 kda (dap12), also called killer cell activating receptor-associated protein (karap) and tyro protein tyrosine kinase binding protein (tyrobp)	0.05
SBRs	signal to background ratios	1.0
DAR	transcription domains-associated repair (formerly differentiation-associated repair)	0.125
DAR	dopamine receptor	0.5
DAR	donkey anti-rabbit γ-globulin	0.125
DAR	donkey anti-rabbit	0.25
vGlut1	vesicular glutamate transporter type 1	1.0
INDA	induced activity	1.0
MAC-	1membrane-activated complex-1	0.25
MAC-	1microglia associated cytokine-1	0.25
MAC-	1macrophage antigen complex-1	0.5
ADAR2	dsrna-specific adenosine deaminase 1	1.0
ADAR1	dsrna-specific adenosine deaminase, dsrad or drada	1.0
U50488H	trans-(±)-3,4-dichloro-n-methyl-n-(2-[1-pyrrolidinyl]cyclohexyl)-benzeneacetamide methanesulfonate salt	0.5
U50488H	trans-(-)-3,4-dichloro-n-methyl-n-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide hydrochloride	0.5
EYM	experimental young males	1.0
HIOMT	hydroxyindole-o-methyltranferase	0.25
HIOMT	hydroxyindole-o-methyltransferase	0.75
OPAll	orbital periallocortex (agranular cortex)	1.0
VPLo	oral part of the ventroposterolateral nucleus	1.0
KHC	kinesin heavy chain	1.0
DA-	ergicdopaminergic	1.0
nNC	snon-neuronal cells	1.0
2-DE	two dimensional gel electrophoresis	0.1
2-DE	two-dimensional polyacrylamide gel electrophoresis	0.1
2-DE	2-dimensional gel electrophoresis	0.1
2-DE	two-dimensional gel electrophoresis	0.3
2-DE	two-dimensional electrophoresis	0.3
2-DE	2-dimensional electrophoresis	0.1
DA4	5-diaminofluorescein diacetate	1.0
PK-A	protein kinase-a	1.0
LCHAD	long-chain 3-hydroxyacyl-coa dehydrogenase	1.0
MACB	muscimol infusion in acb version	1.0
vlPAG-II	ncomplete ventrolateral periaqueductal gray area lesion	1.0
mPAP	mouse peroxidase–antiperoxidase complex	1.0
GAPDHG	lyceraldehyde 3-phosphate dehydrogenase	0.333333333333
GAPDHG	lyceraldehyde-3-phosphate dehydrogenase	0.666666666667
FJ	fluoro-jade	1.0
RCM	rhodamine-coated microspheres	1.0
IJP	inhibitory junction potential	1.0
SRR	social recognition ratio	1.0
RANTESR	egulated upon activation normal t-cell expressed and secreted	1.0
β-aminoethylether-N	n,n′,n′-tetraacetic acid tetrasodium salt	1.0
NKCC	1na+-k+-2cl- co-transporter isoform 1	0.0416666666667
NKCC	1na+–k+-2cl- co-transporter 1	0.0416666666667
NKCC	1na2+/k+/cl- co-transporter 1	0.0416666666667
NKCC	sodium/potassium/chloride cotransporter	0.0416666666667
NKCC	1sodium–potassium–chloride cotransporter type 1	0.0416666666667
NKCC	1na+–k+–2cl- cotransporter	0.0416666666667
NKCC	1sodium–potassium–chloride cotransporter isoform-1	0.0416666666667
NKCC	1na+-k+-cl- co-transporter	0.0416666666667
NKCC	1na+-k+-cl- cotransporter type1	0.0416666666667
NKCC	1	0.125
NKCC	sodium potassium chloride co-transporter	0.0416666666667
NKCC	1sodium-potassium-chloride co-transporter 1	0.0416666666667
NKCC	1na+-k+-2cl- cotransporter	0.0833333333333
NKCC	na+–k+–2cl- cotransporter	0.0416666666667
NKCC	1na+-k+-2cl--cotransporter	0.0416666666667
NKCC	1sodium potassium chloride co-transporter	0.0416666666667
NKCC	1na-k-2cl cotransporter 1	0.0416666666667
NKCC	1na+/k+/cl- cotransporter 1	0.0416666666667
NKCC	1na+/k+/cl- co-transporter	0.0416666666667
NKCC	1na+-k+-cl--cotransporter 1	0.0416666666667
NKCC	1na+–k+–cl--cotransporter 1	0.0416666666667
OOM	orbicularis oculi muscle (eyelid muscle)	1.0
INK4	inhibitors of cyclin-dependent kinase 4	1.0
CY	3indocarbocyanin	0.142857142857
CY	3cyanine dye 3	0.142857142857
CY	cyanamide	0.142857142857
CY	3cyanine 3	0.285714285714
CY	cytosolic fraction	0.142857142857
CY	cyaninine dye	0.142857142857
CI-	1041	1.0
DβHDA	beta-hydroxylase	1.0
2-OH-E	+2-hydroxyethidium	1.0
CoMA	corticomedial amygdala	1.0
CCOOH	terminus	1.0
VPLV	entral posterolateral	1.0
SBFSEM	serial block face sem	1.0
AGO	argonaute	1.0
AGM	anterior gracilis muscle	1.0
AGL	average gray level	1.0
HIV-	1hiv type 1	0.0769230769231
HIV-	1 tat	0.0769230769231
HIV-	1human immunodeficiency virus	0.0769230769231
HIV-	1 proteins	0.0769230769231
HIV-	1human immunodeficiency virus type 1	0.0769230769231
HIV-	1human immunodeficiency virus 1	0.0769230769231
HIV-	1	0.153846153846
HIV-	1human immunodeficiency virus-type 1	0.0769230769231
HIV-	1 gp120 coat protein	0.0769230769231
HIV-	1human immunodeficiency virus-1	0.230769230769
AGG	aggrecan	1.0
AGE	advanced glycation end product	0.153846153846
AGE	agarose gel electrophoresis	0.0769230769231
AGE	aged garlic extract	0.0769230769231
AGE	advanced glycation end-product	0.307692307692
AGE	advanced glycation endproducts	0.0769230769231
AGE	advanced glycation endproduct	0.0769230769231
AGE	sadvanced glycation end products	0.153846153846
AGE	sadvanced glycation end-products	0.0769230769231
PTPMEG	protein-tyrosine phosphatase megakaryoblastic	1.0
AGC	asynchronous ground control	1.0
AGB	agmatine	1.0
D-FISH	double-fluorescent in situ hybridization	1.0
LPAG	or ltlateral periaqueductal gray matter	0.0833333333333
LPAG	lateral column of the periaqueductal gray	0.0833333333333
LPAG	lateral periaqueductal gray	0.666666666667
LPAG	periaqueductal grey, lateral nuclei	0.0833333333333
LPAG	lateral pag	0.0833333333333
atDCS	anodal tdcs	1.0
-MCPG	(rs)-α-methyl-4-carboxyphenylglycine	0.333333333333
-MCPG	(s)-α-methyl-4-carboxyphenylglycine	0.333333333333
-MCPG	(-)-amino-4-carboxy-methyl-phenylacetic acid	0.333333333333
AGV	sabsolute gray values	0.5
AGV	anterior gastric vagal branch	0.5
AGU	albino swiss/anatomy glasgow university	1.0
AGT	antenatal glucocorticoid treatment	0.5
AGT	angiotensinogen	0.5
AGS	activator of g-protein signaling	0.25
AGS	activator of g protein signaling	0.25
AGS	audiogenic seizure	0.5
SCLC	small-cell lung carcinoma	1.0
HDMEM	hepes-buffered dulbecco’s modified eagle’s medium	1.0
p-F-HHSiD	parafluorohexahydrosiladifenidol	1.0
BWT	beam walking test	1.0
Giα1	g-protein inhibiting α 1	1.0
PSD-95	synapse-associated protein of mol. wt 90,000/psd protein of mol. wt 95,000	1.0
Ac-DEVD-CHO	n-acetyl-asp-glu-val-asp-cho (aldehyde)	1.0
HLV	hemispheric lesion volume	1.0
MEGM	agnetoencephalography	1.0
cPAGdl	caudal periaqueductal gray, dorsolateral sector	1.0
PRNP	reening	0.5
PRNP	human prion protein gene	0.5
1BnTIQ1-benzyl-1	2,3,4-tetrahydroisoquinoline	1.0
DAMGOd-Ala2	n,me-phe4,gly-ol5-enkephalin	0.333333333333
DAMGOd-Ala2	n-mephe4, gly5-ol-enkephalin	0.222222222222
DAMGOd-Ala2	n-me-phe-gly5(ol)-enkephalin	0.111111111111
DAMGOd-Ala2	n-me-phe4, gly5-ol-enkephalin acetate salt	0.111111111111
DAMGOd-Ala2	n-me-phe4, gly-ol5-enkephalin	0.222222222222
BWB	black and white box	0.5
BWB	a-wei-di-huang decoction	0.5
BWC	brain water content	1.0
b-cAMP	8-bromoadenosine 3′,5′-cyclic monophosphate	1.0
BWG	body weight gain	1.0
-O	pioid receptor-1	1.0
HAChT	high affinity choline transporter	1.0
MSAP	mean systemic arterial pressure	1.0
mGLUR	metabotropic glutamate receptor	1.0
SNc	substantia nigra, pars compacta	0.0576923076923
SNc	substantia nigra compacta	0.0192307692308
SNc	substantia nigra pars compacta	0.884615384615
SNc	pars compacta of substantia nigra	0.0192307692308
SNc	pars compacta of the substantia nigra	0.0192307692308
SRc	superficial radial nerve (contralateral with respect to the recording site)	1.0
p-CREB	phosphor-creb	0.0714285714286
p-CREB	phosphorylated creb	0.214285714286
p-CREB	phosphorylated camp-responsive element binding protein	0.0714285714286
p-CREB	phospho–cyclic amp response element binding protein	0.0714285714286
p-CREB	phosphorylated cyclic amp response element binding protein	0.142857142857
p-CREB	phosphorylated cyclic amp response element-binding protein	0.0714285714286
p-CREB	phosphorylated camp response element binding protein	0.142857142857
p-CREB	phospho-creb	0.0714285714286
p-CREB	phospho-cyclic amp response element-binding protein	0.0714285714286
p-CREB	phospho-camp response element-binding protein	0.0714285714286
SNl	substantia nigra, pars lateralis	1.0
rOD	relative optical density	1.0
DARPP-32	dopamine and adenosine 3′:5′-monophosphate-regulated phosphoprotein	0.047619047619
DARPP-32	dopamine- and cyclic adenosine 3′,5′-monophosphate-regulated phosphoprotein	0.047619047619
DARPP-32	dopamine and cyclic adenosine 3‘5‘-monophosphate-regulated phosphoprotein	0.047619047619
DARPP-32	dopamine- and camp-regulated phosphoprotein-32	0.047619047619
DARPP-32	dopamine- and camp-regulated phosphoprotein of 32 kda	0.047619047619
DARPP-32	dopamine- and adenosine 3′,5′-monophosphate-regulated phosphoprotein of 32 000 mol. wt	0.047619047619
DARPP-32	dopamine and camp-regulated phosphoprotein	0.047619047619
DARPP-32	dopamine- and cyclic amp-regulated phosphoprotein with a molecular weight of 32,000	0.0952380952381
DARPP-32	dopamine- and cyclic-amp-regulated phosphoprotein of mol. wt 32,000	0.047619047619
DARPP-32	32 000 mol. wt dopamine- and camp-regulated phosphoprotein	0.047619047619
DARPP-32	dopamine–cyclic amp-regulated phosphoprotein 32	0.047619047619
DARPP-32	dopamine- and cyclic amp-regulated phosphoprotein of mol. wt 32,000	0.047619047619
DARPP-32	dopamine and cyclic amp-regulated phosphoprotein, apparent molecular weight 32 000	0.047619047619
DARPP-32	dopamine- and camp-regulated 32,000 mol. wt protein	0.047619047619
DARPP-32	adenosine 3′5-monophosphate regulated phosphoprotein of mr 32 kda	0.047619047619
DARPP-32	dopamine and cyclic amp-regulated phosphoprotein of mol. wt 32,000	0.047619047619
DARPP-32	32,000mol. wt dopamine- and camp-regulated phosphoprotein	0.0952380952381
DARPP-32	dopamine and adenosine 3′:5′-monophosphate-regulated phosphoprotein-32,000	0.047619047619
DARPP-32	dopamine and cyclic amp-regulated phosphoprotein, 32 000 mol. wt	0.047619047619
B-HRP	horseradish peroxidase-conjugated choleratoxin subunit b	0.333333333333
B-HRP	choleragenoid horseradish peroxidase	0.333333333333
B-HRP	cholera toxin subunit b conjugated to horseradish peroxidase	0.333333333333
SCL-	90rsymptom checklist 90r	1.0
MAa	anterior ma	1.0
FN	fastigial nucleus	0.181818181818
FN	facial nucleus	0.181818181818
FN	feature negative	0.0909090909091
FN	femoral nerves	0.0909090909091
FN	fibronectin	0.181818181818
FN	false negative	0.0909090909091
FN	400	0.0909090909091
FN	nucleus fastigii	0.0909090909091
MAb	monoclonal antibody	1.0
SNr	pars reticulata of substantia nigra	0.0188679245283
SNr	substantia nigra reticulata	0.0188679245283
SNr	substantia nigra pars reticulata	0.849056603774
SNr	pars reticulata of the substantia nigra	0.0188679245283
SNr	substantia nigra, pars reticulata	0.0566037735849
SNr	substantia nigra pars reticularis	0.0377358490566
lLN	vslarge ventral lateral neurons	1.0
dLG	dorsal lateral geniculate body	0.5
dLG	dorsal lateral geniculate nucleus	0.5
TBOA	dl-threo-β-benzyloxyaspartate	0.25
TBOA	dl-threo-β-benzyloxyaspartic acid	0.375
TBOA	threo-β-benzyloxyaspartic acid	0.0625
TBOA	threo-β-benzoylaspartic acid	0.0625
TBOA	dl-threo-beta-benzyloxyaspartate	0.1875
TBOA	dl-threo-b-benzoyloxyaspartate	0.0625
LPMR	lateral posterior nucleus	1.0
MAP	2microtubule-associated protein type ii	0.00282485875706
MAP	mean arterial blood pressure	0.045197740113
MAP	(k), mitogen-activated protein (kinase)	0.00282485875706
MAP	1microtubule-associated protein 1	0.00564971751412
MAP	2microtubule-associated protein 2	0.206214689266
MAP	maximum probability maps	0.00282485875706
MAP	kinase-phosphatase-3	0.00282485875706
MAP	mitogen activating protein	0.00282485875706
MAP	4	0.00282485875706
MAP	6microtubule associated protein 6	0.00282485875706
MAP	1microtubule associated protein 1	0.00282485875706
MAP	mitogen activated protein kinase	0.00282485875706
MAP	2membrane-associated protein-2	0.00282485875706
MAP	kinasemitogen activated protein kinase	0.00564971751412
MAP	mitogen activated protein	0.00847457627119
MAP	kinase	0.045197740113
MAP	2microtubule-associated protein	0.0254237288136
MAP	2microtubule associated protein-2	0.0112994350282
MAP	kinases	0.0112994350282
MAP	mitogen activated	0.00282485875706
MAP	2microtubule associated protein	0.00564971751412
MAP	2microtubule-associated protein2	0.00282485875706
MAP	mitogen-activated protein kinase	0.00282485875706
MAP	mean arterial pressure	0.265536723164
MAP	/erkmitogen-activated protein kinase/extracellular regulated kinase	0.00282485875706
MAP	2+microtubule-associated protein 2–positive	0.00282485875706
MAP	kinasemitogen-activated protein kinase	0.0169491525424
MAP	2microtubule associated protein 2	0.0367231638418
MAP	motor assessment panel	0.00282485875706
MAP	2anti-microtubule-associated protein 2	0.00282485875706
MAP	changes in mean arterial pressure	0.00282485875706
MAP	kinasemitogen-activate protein kinase	0.00282485875706
MAP	multiple antigen peptide	0.00282485875706
MAP	microtubule associated protein	0.00847457627119
MAP	mitogen-activated protein	0.104519774011
MAP	2microtubule-associated protein-2	0.0282485875706
MAP	2microtubule-associated protein type 2	0.00282485875706
MAP	2microtubule-assocated protein	0.00282485875706
MAP	maximum a posteriori	0.00282485875706
MAP	multiple antigenic peptide	0.00282485875706
MAP	1bmicrotubule-associated protein 1b	0.00564971751412
MAP	3kmitogen-activated protein kinase kinase kinase	0.00282485875706
MAP	microtubule associated protein 2	0.00282485875706
MAP	kinase phosphatase	0.00282485875706
MAP	microtubule-associated protein	0.0847457627119
MAP	mean arterial pressures	0.00282485875706
SND	sympathetic nerve discharge	0.5
SND	striatonigral degeneration	0.5
MAR	matrix attachment region	0.5
MAR	multivariate autoregressive modeling	0.5
SNB	spinal nucleus of the bulbocavernosus	0.7
SNB	spinal nucleus of bulbocavernosus	0.1
SNB	spinal nucleus of the pelvic bulbocavernosus muscle	0.1
SNB	spinal nucleus of the bulbospongiosus	0.1
SNC	compact part of substantia nigra	0.0322580645161
SNC	substantia nigra pars compacta	0.806451612903
SNC	substantia nigra compact part	0.0322580645161
SNC	sciatic nerve crush	0.0322580645161
SNC	substantia nigra compacta	0.0967741935484
SNA	sympathetic nerve activity	0.8
SNA	gsong system nuclear ag (antigen)	0.0666666666667
SNA	splanchnic sympathetic nerve activity	0.0666666666667
SNA	spontaneous neuronal activity	0.0666666666667
e-LTP	excitatory ltp	1.0
SNL	sciatic nerve ligation	0.0178571428571
SNL	spinal nerve lesion	0.0357142857143
SNL	ligation of spinal nerves	0.0178571428571
SNL	spinal nerve ligated	0.0357142857143
SNL	l5/l6 spinal nerve ligation	0.0178571428571
SNL	substantia nigra-pars lateralis	0.0178571428571
SNL	substantia nigra pars lateralis	0.0714285714286
SNL	substantia nigra lateralis	0.0178571428571
SNL	spinal nerve ligation	0.767857142857
MAZ	multipolar cell accumulation zone	0.5
MAZ	myc-associated zinc finger	0.5
CBPCREB	binding protein	1.0
SNK	student–newman–keuls	0.6
SNK	student newman–keuls multiple comparisons test	0.2
SNK	teststudent-newman-keul's test	0.2
HIVE	hiv encephalopathy	1.0
SNI	spared sciatic nerve injury	0.0909090909091
SNI	sural nerve injury	0.0454545454545
SNI	spared nerve injury	0.863636363636
SNV	stearyl-norleucine17 vasoactive intestinal peptide	1.0
CuZn-SOD	copper–zinc superoxide dismutase	1.0
MAC	mouse anti-chicken γ-globulin	0.0909090909091
MAC	minimum alveolar anesthetic concentration that prevents purposeful movement to supramaximal noxious stimulation in 50% subjects	0.0909090909091
MAC	minimum alveolar anesthetic concentration	0.0909090909091
MAC	minimum alveolar concentration	0.272727272727
MAC	minimal alveolar concentration of anesthesia gas	0.0909090909091
MAC	membrane attack complex	0.181818181818
MAC	minimal alveolar concentration	0.0909090909091
MAC	macrophage	0.0909090909091
MAB	(±)-7-[125i]	0.333333333333
MAB	malic acid buffer	0.333333333333
MAB	mouse anti-myelin/oligodendrocyte specific protein monoclonal antibody	0.333333333333
SNR	substantia nigra reticulata	0.0294117647059
SNR	substantia nigra pars reticulata	0.514705882353
SNR	ssignal-to-noises	0.0147058823529
SNR	substantia nigra	0.0294117647059
SNR	substantia nigra pars reticulate	0.0147058823529
SNR	signal-to-noise	0.0147058823529
SNR	substantia nigra reticular part	0.0294117647059
SNR	signal-to-noise ratio	0.264705882353
SNR	reticular part of substantia nigra	0.0147058823529
SNR	substantia nigra-pars reticulata	0.0147058823529
SNR	signal to noise ratio	0.0588235294118
SNS	sympathetic nervous system	0.615384615385
SNS	striato-nigro-striatal	0.0769230769231
SNS	sticks-and-stones	0.0769230769231
SNS	sensory neuron-specific	0.0769230769231
SNS	tetrodotoxin-resistant sensory-neuron-specific sodium channel	0.0769230769231
SNS	sensory neuron specific sodium channel	0.0769230769231
SNP	sshort neural precursors	0.0108695652174
SNP	ssingle nucleotide polymorphism	0.0108695652174
SNP	single nucleotide polymorphisms	0.0108695652174
SNP	sodium nitroprusside	0.5
SNP	ssingle nucleotide polymorphisms	0.0760869565217
SNP	rsubstantia nigra pars reticulata	0.0108695652174
SNP	csubstantia nigra pars compacta	0.0217391304348
SNP	single nucleotide polymorphism	0.271739130435
SNP	single-nucleotide polymorphism	0.0326086956522
SNP	single-nucleotide polymoprphism	0.0108695652174
SNP	subepidermal nerve plexus	0.0108695652174
SNP	sodium peroxynitrite	0.0108695652174
SNP	ssingle-nucleotide polymorphisms	0.0217391304348
Cb	cerebellum	1.0
MAI	myelin-associated inhibitor	1.0
MAK	mass action kinetics	0.5
MAK	methylamylketone	0.5
APLPβ-	amyloid precursor protein	1.0
MAM	methylazomethanol acetate	0.0555555555556
MAM	6-monoacetylmorphine	0.111111111111
MAM	methylazoxylmethanol	0.0555555555556
MAM	mitochondrion-associated endoplasmic reticulum membrane	0.0555555555556
MAM	methylazoxymethanol acetate	0.444444444444
MAM	metylazoxy methanol acetate	0.0555555555556
MAM	methylazoxymethanol	0.222222222222
HIP-CA	3ca3-region of the hippocampus	1.0
MAO	bmonoamine oxidase type b	0.0217391304348
MAO	monoamine oxidase inhibitor	0.0217391304348
MAO	medial accessory olive	0.0869565217391
MAO	monoamino oxidase	0.0217391304348
MAO	a/bmonoamine oxidase a/b	0.0217391304348
MAO	medial accessory io	0.0217391304348
MAO	monoaminooxidase	0.0217391304348
MAO	monoamine oxidase	0.782608695652
RTMD	right middle temporal gyrus	1.0
Ap2A	diadenosine diphosphate	1.0
AATase	aspartate aminotransferase (ec 2.6.1.1)	1.0
GDX-Egonadectomised	estradiol replaced	1.0
TDG	thymidine dna glycosylase	1.0
EVC	extrastriate visual cortex	1.0
EVE	extracellular volume expansion	1.0
EVF	extracellular volume fraction	1.0
WAHG	wheat-germ agglutinin apo-horseradish peroxidase conjugated to colloidal gold	0.5
WAHG	wheat-germ apo-horseradish peroxidase gold-conjugate	0.5
LSv	ventral lateral septum	1.0
MGST3	microsomal glutathione s-transferase type 3	1.0
YNPRCY	erkes national primate research center	1.0
αβ-meATP	α,β-methylene atp	1.0
eOBSC	embryonic olfactory bulb stem cells	1.0
hnRNP	heterogeneous nuclear ribonucleoprotein	0.833333333333
hnRNP	heterogeneous ribonucleoprotein	0.166666666667
apoMK1	mice treated with apomorphine and mk-801 (1.0 mg/kg)	1.0
LSF	isher statistic	0.5
LSF	lateral suprasylvian field	0.5
LSG	lumbar sympathetic ganglion	1.0
LSD	least squares differences	0.012987012987
LSD	lateral septum, dorsal	0.012987012987
LSD	1lysine specific demethylase 1	0.012987012987
LSD	lateral septum, dorsal portion	0.012987012987
LSD	least significant difference test	0.025974025974
LSD	least significant differences	0.012987012987
LSD	least significance difference	0.0649350649351
LSD	,	0.012987012987
LSD	least-significant difference	0.012987012987
LSD	least-significant-difference	0.038961038961
LSD	least squares difference	0.012987012987
LSD	least square difference	0.038961038961
LSD	lysergic acid diethylamide	0.0519480519481
LSD	lysosomal storage disease	0.012987012987
LSD	least significant difference	0.636363636364
LSD	1lysine-specific demethylase 1	0.012987012987
LSD	fisher’s least significant difference	0.012987012987
LSE	lumbosacral enlargement	1.0
LSC	laser speckle contrast	0.333333333333
LSC	lumbar sympathetic chain	0.666666666667
GGPP	geranylgeranylpyrophosphate	1.0
LSA	lateral septal area	0.5
LSA	lenticulostriate arteries	0.5
LSN	lateral spinal nucleus	0.6
LSN	long-shaft neurons	0.0666666666667
LSN	lumbar splanchnic nerve	0.0666666666667
LSN	lateral septal nucleus	0.266666666667
LSO	lateral superior olive	0.842105263158
LSO	organum septi lateralis	0.0263157894737
LSO	lateral superior olivary nucleus	0.0789473684211
LSO	lateral superior olivary complex	0.0263157894737
LSO	mso, lateral and medial superior olive	0.0263157894737
LSM	laser-scanning microscope	0.25
LSM	least squared means	0.25
LSM	laser scanning microscopy	0.5
LSI	lateral septum, intermediate portion	0.333333333333
LSI	lateral septal nucleus, intermediate part	0.333333333333
LSI	intermediate aspect of the lateral septum	0.333333333333
LSV	ventral lateral septal nucleus	0.142857142857
LSV	ventral lateral septum	0.142857142857
LSV	ventrolateral septum	0.142857142857
LSV	lateral septum ventrale	0.142857142857
LSV	lateral septal nucleus, ventral part	0.142857142857
LSV	lateral septum, ventral portion	0.142857142857
LSV	lateral septum, ventral	0.142857142857
LSW	late slow wave	1.0
LST	lumbar sympathetic trunk	1.0
SFKS	rc-family tyrosine kinase	0.333333333333
SFKS	rc family kinase	0.666666666667
LSP	low speed pellet	1.0
mSG	middle of suprasylvian gyrus	1.0
LPMC	lateral premotor cortex	1.0
MKPMAPK	phosphatase	1.0
DNA-damage-inducible	beta	1.0
LLLT	low-level light therapy	1.0
d-Ala2-MePhe4	gly-ol5]enkephalin	1.0
o-AP	orthodromic action potential	1.0
γH	2axphosphorylated (ser 139) histon h2a.x	1.0
pME	paired microelectrode	1.0
pMF	phrenic motor facilitation	1.0
FKBP-	52fk506-binding protein 52	1.0
LHRH	luteinizing hormone-releasing hormone	0.588235294118
LHRH	gonadotropin-releasing hormone	0.0588235294118
LHRH	leutenizing hormone releasing hormone	0.0588235294118
LHRH	luteinizing hormone–releasing hormone	0.117647058824
LHRH	luteinizing hormone releasing hormone	0.176470588235
DDB	digoxigenin detection buffer	1.0
vLS	ventral lateral septum	0.666666666667
vLS	ventral parts of the lateral septal nucleus	0.333333333333
AMFR	amplitude modulation following response	0.5
AMFR	samplitude modulation following responses	0.5
HEPESN-	2-hydroxyethylpiperazine-n′-2-ethane sulfonic acid	0.034188034188
HEPESN-	2-hydroxyethylpiperazine-n′2-ethanesulfonic acid	0.00854700854701
HEPESN-	2-hydroxyetyl piperazine-n′-2-ethanesulfonic acid	0.00854700854701
HEPESN-	[2-hydroxyethyl]piperazine-n′-[2-etanesulfonic acid]	0.00854700854701
HEPESN-	(2-hydroxyethyl)-piperazine-n-2-ethanesulfonic acid	0.017094017094
HEPESN-	2-hydoxyethylpiperazine-n′-2-ethanesulfonic acid	0.00854700854701
HEPESN-	hydroxyethylpiperazine-n′-2-ethanesulfonate	0.017094017094
HEPESN-	2-hydroxyethylpiperazine-n'-2-ethanesulphonic acid	0.00854700854701
HEPESN-	2-hydoxyethylpiperazine-n′-2-ethanesulphonic acid	0.00854700854701
HEPESN-	2-hydroxylethylpiperazine-n′-2-ethanesulfonic acid	0.00854700854701
HEPESN-	2-hydroxyethylpiper-azine-n′-2-ethanesulfonic acid	0.00854700854701
HEPESN-	[2-hydroxyethyl]piperazine-n′-[2-ethanesulphonic acid]	0.00854700854701
HEPESN-	2-hydroxytryptamine	0.00854700854701
HEPESN-	hydroxyethylpiperazine-n-2-ethanesulfonate	0.00854700854701
HEPESN-	(2-hydroxethyl)piperazine-n′-(2-ethanesulfonic acid)	0.00854700854701
HEPESN-	(2-hydroxyethyl)piperazine-n′-2-ethanesulfonic acid	0.0512820512821
HEPESN-	[2-hydroxyethyl]-piperazine-n′-[2-ethanesulfonic acid]	0.017094017094
HEPESN-	2-hydroxyethylpiperazine-n-2-ethanesulfonic acid	0.025641025641
HEPESN-	hydroxyethylpiperazine-n′-2-ethanesulphonic acid	0.00854700854701
HEPESN-	2-hydroxyethylpiperazine-n′-2-ethanesulphonic acid	0.0598290598291
HEPESN-	2-hydroxyethlpiperazine-n′-2-ethanesulphonic acid	0.017094017094
HEPESN-	hydroxyethylpiperazine-n-ethane sulfonic acid	0.00854700854701
HEPESN-	2-hydroxyethylpiperazine ethane sulfonic acid	0.017094017094
HEPESN-	(2-hydroxyethyl)piperazine-n′-(2-ethanesulphonic acid)	0.017094017094
HEPESN-	(2-hydroxymethyl)piperazine-n′-(2-ethanesulfonic acid)	0.00854700854701
HEPESN-	(2-hydroxyethyl) piperazine-n′-(2-ethanesulfonic acid)	0.025641025641
HEPESN-	(2-hydroxyethyl)piperazine-n'-(2-ethanesulfonic acid)	0.00854700854701
HEPESN-	(2-hydroxyethyl) piperazine-n′-(2-ethane)-sulfonic acid	0.00854700854701
HEPESN-	2-hydroxy-ethylpiperazine-n′-2-ethanesulfonic acid	0.00854700854701
HEPESN-	(2-hydroxyethyl) piperazine-n′-(2-ethanesulphonic acid)	0.00854700854701
HEPESN-	(2-hydroxyethyl)piperazine-n′-(2-ethanesulforic acid)	0.00854700854701
HEPESN-	[2-hydroxyethyl] piperazine-n′-[2-ethanesulfonic acid]	0.025641025641
HEPESN-	(2-hydroxyethyl) piperazine-n-(2-ethanesulfonic) acid	0.00854700854701
HEPESN-	[2-hydroxyethyl]piperazine-n′-[ethanesulfonic acid]	0.00854700854701
HEPESN-	2-hydroxyethylpiperazine-n′ 2-ethanesulfonic acid	0.00854700854701
HEPESN-	[2-hydroxyethyl)piperazine-n′-(2-ethane-sulfonic) acid	0.00854700854701
HEPESN-	2-hydroxyethylpiperazine-n’-2-ethasneslufonic acid	0.00854700854701
HEPESN-	[2-hydroxyethyl]piperazine-n′-[2ethanesulfonic acid]	0.00854700854701
HEPESN-	[2-hydroxyethyl]piperazine-n′-[2-ethanesulfonic acid]	0.042735042735
HEPESN-	(2-hydroxyethyl)-piperazine-n-s-ethanesulfonic acid	0.00854700854701
HEPESN-	2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.25641025641
HEPESN-	[2-hydroxyethl] piperazine-n′[2-ethanosulfonic acid]	0.00854700854701
HEPESN-	[2-hydroxyethyl]piperazine-n′-[2-ethane-sulfonic acid]	0.00854700854701
HEPESN-	(2-hydroxyetyl)piperazine-n′-(2-ethanesulphonic acid)	0.00854700854701
HEPESN-	2-hydroxyethylpiperazine-n′n′-2-ethanesulfonic acid	0.00854700854701
HEPESN-	(2-hydeoxyethyl)piperazine-n′-(2-ethanesulfonic acid)	0.017094017094
HEPESN-	(2-hydroxyethyl)piperazine-n′-(2-ethanesulfonic acid)	0.0940170940171
GDX-TPgonadectomised	testosterone propionate replaced	1.0
BAEP	brainstem auditory evoked potential	0.75
BAEP	sbrainstem auditory evoked potentials	0.25
αSMA	alpha smooth muscle actin	1.0
BAER	brainstem auditory evoked response	0.666666666667
BAER	brainstem auditory-evoked response	0.333333333333
NMLF	nucleus of median longitudinal fascicle	1.0
EGR-1	early growth response gene-1	0.5
EGR-1	egr gene-1	0.5
NMLA	n-methyl-l-aspartic acid	0.5
NMLA	n-methyl-l-arginine	0.5
EDCM	. extensor digitorum communis	1.0
QHC	lquinine hcl	0.2
QHC	lquinine hydrochloride dehydrate	0.2
QHC	lquinine hydrochloride	0.6
Cu	znsodcopper/zinc superoxide dismutase	0.2
Cu	zn-superoxide dismutase	0.2
Cu	zn-sod, copper, zinc-superoxide dismutase	0.2
Cu	cuneate nucleus	0.2
Cu	zn-sod, cu, zn-superoxide dismutase	0.2
TRPCTRP	canonical subfamily	1.0
BAEC	bovine aortic endothelial cells	0.5
BAEC	bovine aortic endothelial cell	0.5
vlOFC	ventrolateral orbital frontal cortex	1.0
LBBA	low basal brain activity	1.0
LOB	lobeline	1.0
TMRE	tetramethylrhodamine ethyl ester	1.0
NMDAN-methyl-d	l-aspartate	1.0
CTP	complete triceps paralysis	0.2
CTP	cytosine triphosphate	0.2
CTP	cytidine-5′-triphosphate	0.2
CTP	cytosine 5′-triphosphate	0.2
CTP	cytidine triphosphate	0.2
CTR	control	0.588235294118
CTR	untreated control	0.0588235294118
CTR	calcitonin receptor	0.0588235294118
CTR	control mouse	0.0588235294118
CTR	loccenter locomotion	0.0588235294118
CTR	saline/d609-injected gerbils	0.0588235294118
CTR	control group	0.117647058824
CTS	cardiotonic steroids	0.5
CTS	compound threshold shift	0.5
NRG-	1neuregulin-1	1.0
TMRM	tetramethylrhodamine	0.333333333333
TMRM	tetramethyl-rhodamine methyl ester	0.333333333333
TMRM	tetramethylrhodaminemethylester	0.333333333333
dACC	dorsal anterior cingulate cortex	0.666666666667
dACC	dorsal anterior cingulate	0.166666666667
dACC	dorsal anterior cingulated	0.166666666667
CTX	ceftriaxone	0.047619047619
CTX	ω-conotoxin mviic	0.047619047619
CTX	[125i]	0.047619047619
CTX	upprimary somatosensory cortex layers i–iii	0.047619047619
CTX	charybdotoxin	0.190476190476
CTX	retrosplenial cortex	0.047619047619
CTX	cortex	0.333333333333
CTX	cholera toxin	0.142857142857
CTX	cerebrotendinous xanthomatosis	0.047619047619
CTX	contextual	0.047619047619
VAPB	vesicle-associated membrane protein-associated protein-b	0.5
VAPB	vamp-associated protein b/c	0.5
CTZ	cyclothiazide	1.0
CTD	carboxy terminal domain	1.0
CTF	central tegmental	0.111111111111
CTF	constitutive transcription factor	0.111111111111
CTF	central tegmental field	0.444444444444
CTF	central tegmented field	0.111111111111
CTF	c-terminal fragment	0.222222222222
CTG	cervicothoracic ganglia	1.0
CTA	corticothalamic axons	0.0344827586207
CTA	central tegmental area	0.0344827586207
CTA	conditioned taste aversion	0.793103448276
CTA	conditioned-taste aversion	0.0344827586207
CTA	conditioned taste avoidance	0.0344827586207
CTA	corticoamygdaloid transition area	0.0344827586207
CTA	conditioned taste-aversion	0.0344827586207
CTB	cholera toxin b-subunit	0.0434782608696
CTB	cholera toxin-b	0.0144927536232
CTB	555ctb-alexa fluor 555	0.0144927536232
CTB	choleratoxin subunit b	0.0144927536232
CTB	cholera b toxin subunit	0.0144927536232
CTB	cholera toxin subunit β	0.0144927536232
CTB	cholera toxin b	0.173913043478
CTB	cholera toxin-β	0.0144927536232
CTB	choleragenoid tracer	0.0144927536232
CTB	choleratoxin b subunit	0.0144927536232
CTB	choleragenoid toxin subunit b	0.0144927536232
CTB	cyanotriphenylborate	0.0144927536232
CTB	cholera toxin b subunit	0.391304347826
CTB	cholera toxin β-subunit	0.0289855072464
CTB	cholera toxin β subunit	0.0144927536232
CTB	cholera toxin subunit b	0.144927536232
CTB	cholera toxin-b subunit	0.0144927536232
CTB	irctb immunoreactive	0.0144927536232
CTB	cholera toxin subunit beta	0.0144927536232
CTB	cholera toxin b-chain	0.0144927536232
CTC	cerebello-thalamo-cortical	1.0
CTL	control	0.6
CTL	cytotoxic t lymphocyte	0.1
CTL	comet tail length	0.1
CTL	controls	0.1
CTL	control group	0.1
AchE	acetylcholinesterase	1.0
TGF-ββ-	transforming growth factor	1.0
CTI	condition-test interval	1.0
5-LOX	5-lipoxygenase	1.0
PSA-NCAMα-2	8-linked sialic acid neural cell adhesion molecule	1.0
OT-IR	oxytocin-immunoreactive	1.0
ABSS	artificial balanced salt solution	1.0
CSQ	calsequestrin	1.0
TM-PAP	transmembrane prostatic acid phosphatase	1.0
CTx	conotoxin	1.0
ZVAD-FMK	fluoromethylketone	1.0
HzkHz	hertz, kilohertz	1.0
LDIPSC	long-duration induced postsynaptic current	1.0
RIIH	recurrent insulin-induced hypoglycemia	0.5
RIIH	recurring insulin-induced hypoglycemia	0.5
p-PKCζ	phosphorylated-protein kinase cζ	1.0
CTb	cholera toxin b-subunit	0.0588235294118
CTb	cholera toxin-b	0.0588235294118
CTb	cholera toxin b subunit	0.470588235294
CTb	cholera toxin β-subunit	0.0588235294118
CTb	cholera toxin β subunit	0.0588235294118
CTb	cholera toxin subunit b	0.235294117647
CTb	cholera toxin β	0.0588235294118
20-HE	20-hydroxyecdysone	1.0
MOBP	myelin-associated oligodendrocytic basic protein	0.5
MOBP	myelin-associated oligodedrocytic basic protein	0.5
BTNRHB	oys town national research hospital	1.0
mOP	mouse osteopontin	1.0
AP5d	l-amino-5-phosphonopentanoic acid	0.5
AP5d	l-2-amino-5-phosphonopentanoic acid	0.5
ORs	μ-opioid receptors	1.0
8-CPT	8-cyclopentyl-1,3-dipropylxanthine	0.5
8-CPT	8-cyclopentyltheophylline	0.5
S-AP	4(s)-2-amino-4-phosphonobutanoic acid	1.0
CRPS-I	complex regional pain syndrome type i	1.0
ABS-	201	1.0
lacZ	beta-galactosidase	1.0
APO-UNSUS	apomorphine-unsusceptible	1.0
CT1	cardiotrophin 1	1.0
ORX	orchidectomized	0.222222222222
ORX	orexin	0.222222222222
ORX	+e2orchidectomized estrogen-primed	0.111111111111
ORX	orchidectomy, orchidectomized	0.111111111111
ORX	sorexins	0.111111111111
ORX	2 rorexin-2 receptor	0.111111111111
ORX	orexin/hypocretin	0.111111111111
ORT	object recognition test	1.0
IA-AVPN	sinspiratory-activated airway vagal preganglionic neurons	1.0
pSSC	primary somatosensory cortex	1.0
NBFP	network burst falling phase	1.0
RAMP	4ribosome-associated membrane protein 4	0.111111111111
RAMP	receptor activity modifying protein	0.111111111111
RAMP	1receptor activity modifying protein 1	0.111111111111
RAMP	shaped time-function (for a passive paw movement)	0.111111111111
RAMP	1receptor activity-modifying protein 1	0.222222222222
RAMP	receptor activity-modifying protein	0.333333333333
ORN	olfactory receptor neuron	0.709677419355
ORN	solfactory receptor neuron	0.0322580645161
ORN	olfactory receptor neurons	0.0967741935484
ORN	solfactory receptor neurons	0.161290322581
ORO	regon-r	1.0
ORL	1opioid receptor-like 1	0.333333333333
ORL	1opioid receptor-like receptor-1	0.0666666666667
ORL	1opioid receptor like 1	0.0666666666667
ORL	opioid receptor-like	0.133333333333
ORL	1 receptor	0.2
ORL	1opioid receptor-like	0.0666666666667
ORL	1opioid-receptor-like	0.0666666666667
ORL	1nociceptin/orphanin fq receptor	0.0666666666667
FMPP	familial male precocious puberty	1.0
IPII	nternational protein index	1.0
ORI	stratum oriens	1.0
ORF	open reading frames	0.0416666666667
ORF	open reading frame	0.916666666667
ORF	(partial) open reading frame	0.0416666666667
CT-	1cardiotropin-1	0.142857142857
CT-	1rαcardiotrophin-1 receptor-α	0.142857142857
CT-	bcholera toxin	0.142857142857
CT-	1cardiotrophin-1	0.571428571429
PTPS	6-pyruvoyl-tetrahydropterin synthase	1.0
ORB	orbital cortex	1.0
ORC	orchiectomized	1.0
ORA	over-representation analysis	1.0
nCMR	glcnormalized regional glucose metabolic rate	1.0
WRAM	water-escape motivated radial arm maze	0.5
WRAM	water escape radial arm maze	0.5
DG-GCL	dentate gyrus-granule cell layer	1.0
PSEN	2presenilin 2	0.5
PSEN	1presenilin1	0.5
SDZSDZ-205	557	1.0
vBNST	ventral bed nucleus of the stria terminalis	1.0
NGS-TBS-T	normal goat serum in tris-buffered saline with triton x-100	0.5
NGS-TBS-T	tris-buffered saline, containing 5% normal goat serum and 0.3% triton x-100	0.5
TCP-BP	tcp-binding protein	1.0
mVII	facial nuclei	1.0
BayK	s-(-)-bayk8644	1.0
MOR-P	2a phosphoselective antibody directed against phosphorylated thr370 and ser375 within mu opioid peptide receptor	1.0
CPT-cGMP	8-(4-chlorophenylthio) guanosine-3′,5′-cyclic monophosphate	1.0
DMT1	divalent metal transporter 1	1.0
G-CSF	granulocyte colony stimulating factor	0.0909090909091
G-CSF	granulocyte colony-stimulating factor	0.636363636364
G-CSF	granulocyte-colony stimulating factor	0.272727272727
ISKSK-	mediated current	1.0
mOD	mean optical density	1.0
COXIVC	oxidase subunit iv	1.0
9AC	9-anthracene carboxylic acid	1.0
rIOM	rostral medial accessory olive	1.0
FRS	fractional release in response to stimulation	1.0
UP	utricular potential	0.333333333333
UP	un-explicitly paired training	0.333333333333
UP	–down state	0.333333333333
NO-LTP	nitric oxide-dependent long-term potentiation	1.0
GOTMG	ene ontology tree machine	1.0
Tpk	time from onset of da release to maximum	1.0
NKAPNF-κB	activating protein	1.0
EGCL	external granule cell layer	1.0
RNIRNA	integrity numbers	1.0
DMTP	delayed matching to place	1.0
DMTS	delayed matching-to-sample	0.4
DMTS	delayed matching to sample	0.4
DMTS	delayed matching to position	0.2
DMTU	1,3-dimethyl-2-thiourea	1.0
iIC	ipsilateral inferior colliculus	1.0
GMF-KOGMF-	knockout	1.0
rPAG	rostral periaqueductal gray matter	0.5
rPAG	rostral periaqueductal gray	0.5
bHLH	basic helix-loop-helix	0.391304347826
bHLH	basic-helix-loop-helix	0.0434782608696
bHLH	basic helix–loop–helix	0.434782608696
bHLH	basic helix–loop–helix transcription factors	0.0434782608696
bHLH	basic helix–loop–helix transcription factor	0.0434782608696
bHLH	basic-helix–loop–helix	0.0434782608696
LNL	ewy neurites	0.5
LNL	ewy neurite	0.5
NMDARN-M	ethyl-d-aspartic acid receptor	1.0
ALaged	large litter size	1.0
NPNFP	non-phosphorylated neurofilament protein	1.0
CALP	calsenilin-like protein	1.0
dMCAO	distal middle cerebral artery occlusion	1.0
CALR	calretinin	1.0
cPLA2	85,000 mol. wt cytosolic phospholipase a2	1.0
GABAA-RGABAA-	receptor	1.0
EMGRMS	electromyography root mean square	1.0
cHP	caudal hippocampus	1.0
CALI	chromophore-assisted laser inactivation	1.0
CALM	clathrin assembly lymphoid myeloid leukemia protein	1.0
MALDI	matrix-assisted laser desorption/ionization	0.666666666667
MALDI	tofmatrix-assisted laser desorption ionization time of flight	0.166666666667
MALDI	matrix-assisted laser desorption ionization	0.166666666667
iP	inbred alcohol-preferring	1.0
OLSAO	ldenburg sentence test	1.0
CHPG	(rs)-2-chloro-5-hydroxyphenyl-glycine	0.166666666667
CHPG	(rs)-2-chloro-5-hydroxyphenylglycine	0.666666666667
CHPG	(r,s)-2-chloro-5-hydroxyphenylglycine	0.166666666667
CHPC	ryptomys hottenttotus pretoriae	1.0
UHPLC	/ms/ms2ultrahigh performance liquid chromatography/tandem mass spectrometry	1.0
AGMA	frican green monkey	1.0
CIRS-GC	umulative illness rating scale geriatric	1.0
NFDM	nonfat dry milk	0.25
NFDM	nonfat dried milk	0.5
NFDM	non-fat dried milk	0.25
BuTCh	butyrylthiocholine iodide	1.0
KO-	miceknockout mice	1.0
NOLANω-	nitro-[l]-arginine	1.0
NQO-	1nad(p)h:quinone oxidoreductase-1	0.5
NQO-	1nad(p)h/quinone oxidoreductase-1	0.5
BIFP	bicuculline-induced field potential	1.0
PCNAP	roliferating cell nuclear antigen	1.0
P2Y6	pyrimidinergic receptor p2y6	1.0
pcDNA-A	pcdna-i/amp vector containing the dopamine transporter cdna in the antisense orientation	1.0
Ac-YVAD-AMC	acetyl-tyr-val-ala-asp-amino-4-methylcoumarin	1.0
IOVL	ventrolateral protrusion of the inferior olivary nucleus	1.0
m-3M3FBS2	4,6-trimethyl-n-(m-3-trifluoromethylphenyl) benzenesulfonamide	1.0
11β-HSD	211β-hydroxysteroid dehydrogenase type 2	1.0
α2AR	alpha2-adrenergic receptor and α2a, α2b and α2c receptor subtypes	1.0
AcSh	nucleus accumbens shell	1.0
FABF	rontal assessment battery	1.0
DCF-H	2′,7′-dichlorofluorescein diacetate	1.0
rsfMRI	“resting state” fmri	0.333333333333
rsfMRI	resting-state functional magnetic resonance imaging	0.333333333333
rsfMRI	resting state fmri	0.333333333333
ZIV	ventral zona incerta	0.5
ZIV	zona incerta, ventral part	0.5
NPM	nucleophosmin	1.0
ZIR	rostral zona incerta	1.0
ZIP	zinc-regulated transporter (zrt1) and iron regulated-like proteins	1.0
NPL	number of paw liftings	0.5
NPL	rnon–phase-locked response	0.5
-OR	mu-opioid receptor	0.666666666667
-OR	sμ-opioid receptors	0.333333333333
IP-10	interferon-γ inducible protein-10	1.0
DOPSdl-threo-3	4-dihydroxyphenylserine	1.0
ZID	dorsal zona incerta	0.333333333333
ZID	/zivzona incerta dorsal/ventral part	0.333333333333
ZID	zona incerta, dorsal part	0.333333333333
NPN	neuropilin	1.0
MAL	myelin and lymphocyte-associated protein	0.5
MAL	myelin and lymphocyte protein	0.5
DHEAS	dehydroepiandrosterone sulfate	0.769230769231
DHEAS	dehydroepiandrostedione sulfate	0.0769230769231
DHEAS	dehydroepiandrosterone sulphate	0.0769230769231
DHEAS	dehydroepiandrosterone 3-sulfate	0.0769230769231
ZIM	medial zona incerta	1.0
ZII	(±)zebrin ii immunopositive/immunonegative	1.0
ZIv	ventral zona incerta	1.0
PBST-A	0.1% sodium azide in triton x-100	0.333333333333
PBST-A	zphosphate-buffered saline containing 0.1% triton x-100 and 0.1% sodium azide	0.333333333333
PBST-A	zphosphate buffer containing 0.9% nacl and 0.3% triton x-100 and 0.1% sodium azide	0.333333333333
ADPRADP-	ribose	1.0
ZIr	rostral zona incerta	1.0
AHD	aldehyde dehydrogenase	1.0
fSFM	fixed sinusoidal frequency modulated	1.0
MCFS	macrophage colony-stimulating factor	1.0
CSAC	ockayne syndrome group a gene (csa) or protein (csa)	1.0
DYN-B	dynorphin b	1.0
MENT	mentalizing network	1.0
MUC	multi-unit cluster	1.0
DYN-A	dynorphin a	1.0
EJPS	excitatory junctional potentials	1.0
DHEAs	dehydroepiandrosterone sulphate	1.0
pptA	preprotachykinin a	1.0
MCFA	smedium-chain fatty acids	0.5
MCFA	medium-chain fatty acid	0.5
TRESKTWIK-	related spinal cord k+ channel	1.0
Csl	central nucleus, superior lateral part	1.0
WHIMSW	omen's health initiative memory study	0.5
WHIMSW	omen’s health initiative memory study	0.5
tERK	total extracellular signal-regulated kinase	0.666666666667
tERK	total extracellular signal-regulated kinases 1/2	0.333333333333
NGBN	euroglobin	1.0
SCOP	scopolamine	1.0
DHAD	ocosahexaenoic acid	1.0
AHN	adult hippocampal neurogenesis	0.5
AHN	anterior hypothalamic nucleus	0.5
RINRNA	integrity number	1.0
APDb	action potential duration at the base	0.5
APDb	action potential duration at base	0.5
pCPT-	cgmp8-(4-chlorophenylthio)-guanosine 3′,5′-cyclic monophosphate	1.0
YSE	young epileptic group	1.0
5-HT2A	serotonin-2a receptor	1.0
TMML	tinnitus minimal masking level	1.0
CHAPS	3-[(3-chloroamino-dopropyl)-dimethylamine]-1-propanesulfonate	0.030303030303
CHAPS	3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate	0.030303030303
CHAPS	3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate hydrate	0.030303030303
CHAPS	3-[3- (bile amide propyl) two a 3-aminopropanesulfonic acid hydrate	0.030303030303
CHAPS	3-[(3-cholamidopropyl)-dimethylammonio]-1-propane-sulfonate	0.030303030303
CHAPS	3-[(3-cholamidopropyl)dimethylammonio]-1 propane sulfonate	0.030303030303
CHAPS	3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate	0.212121212121
CHAPS	3-[(3-chomalidopropyl)dimethylammonio]-1-propanesulfonate	0.030303030303
CHAPS	3-[-(3-chloramidopropyl)dimethylammonio]-1-propanesulfonic acid	0.0606060606061
CHAPS	3-[(3-cholamidopropyl)dim-ethylammonio]-1-propanesulfonate	0.030303030303
CHAPS	(3-[(3-cholamidopropyl)dimethylammonio]1-propane-sulfonate	0.030303030303
CHAPS	3-[(3-cholanidopropyl)dimethylammonio]-1-propanesulfonate	0.030303030303
CHAPS	3-[(3-cholamidopropyl)dimethyl-ammonio]-1-propanesulphonate	0.030303030303
CHAPS	3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulphonate	0.030303030303
CHAPS	3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate	0.030303030303
CHAPS	3-[(3-cholamidopropyl) dimethylammonio]-1-propane sulfonic acid	0.030303030303
CHAPS	3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid	0.030303030303
CHAPS	3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulphonic acid	0.030303030303
CHAPS	3-[(3-cholamido-propyl)-dimethyl-ammonio]-1-propanesulfonate	0.0606060606061
CHAPS	3-((3-cholamidopropyl) dimethylammonio)-1-propanesulphonate	0.030303030303
CHAPS	3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonate	0.0606060606061
CHAPS	3-[(3-cholamidopropyl)dimethylammonium]-propane-1-sulfonic acid	0.030303030303
CHAPS	3-[(3-cholamido-propyl)-dimethylammonio]-1-propanesulfonate	0.030303030303
CHAPS	3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulphonate	0.030303030303
CRE-	regulated gene expression	1.0
nSM	aseneutral sphingomyelinase	1.0
ectoATP	ase	1.0
mPMAT	mouse plasma membrane monoamine transporter	1.0
AHM	ammonium hepta molybdate	1.0
TH-I	immunoreactivity to tyrosine hydroxylase enzyme	1.0
LSNd	dorsolateral septal nucleus	1.0
RA-GHGH	treated ra	1.0
STIM-ON	stimulators switched on	1.0
P2X2R	p2x2 receptor	1.0
CsA	cyclosporin a	0.875
CsA	cyclosporine a	0.125
BDS-II	blood-depressing substance	1.0
MUM	“match-and-utilization” model	1.0
hMT	+human motion complex	0.5
hMT	1human mutant torsina	0.5
MRAsmodified	rapidly adapting mechanoreceptor	1.0
HACPT	2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole	1.0
AHV	angular head velocity	1.0
FPINV	inversion of fixation point movement	1.0
PP-2A	protein phosphatase 2a	1.0
TACETNF-α	converting enzyme	1.0
SUBS	subretinal space	1.0
dAC	dorsal anterior cingulate	1.0
RRXR	hodamine red x	1.0
VSV-G-LV	lentivirus pseudotyped with vesicular stomatitis virus glycoprotein	1.0
dAI	dysgranular anterior insular cortex	1.0
AM-SPN	adrenal medullary-sympathetic preganglionic neuron	1.0
RITSCRNA-	induced transcriptional silencing complex	1.0
erbB	family	1.0
l-DOPA-	induced dyskinesia	1.0
dAP	3,4-diaminopyridine	1.0
LUR	latency of ur	1.0
ISEN	intrinsic subependymal neurons	1.0
TNST	ris non-saline buffer	0.4
TNST	ris non-saline	0.2
TNST	ris-buffered non-saline	0.2
TNST	rizma non-saline	0.2
p75LNTR	low-affinity neurotrophin receptor	0.5
p75LNTR	p75 low-affinity neurotrophin receptor	0.5
BDNF-SC	sschwann cells over-expressing brain-derived neurotrophic factor	1.0
XCD	pbs containing triton x-100, λ-carrageenan and donkey serum	1.0
OVLT	organum vasculosum of the lamina terminals	0.0277777777778
OVLT	vascular organ of the lamina terminalis	0.152777777778
OVLT	organum vasculosum of the lamina terminalis	0.569444444444
OVLT	organum vasculosum laminae terminalis	0.125
OVLT	organun vasculosum of lamina terminalis	0.0138888888889
OVLT	organum vasculosum lamina terminalis	0.0972222222222
OVLT	organ vasculosum of the lamina terminalis	0.0138888888889
I-I	intranasal insulin	1.0
DABdiaminobenzidine	fgfr, fibroblast growth factor receptor	0.5
DABdiaminobenzidine	3,3′-diaminobenzidine tetra-hydrochloride	0.5
I-L	intranasal ng-nitro-l-arginine methyl ester	1.0
I-O	input–output	1.0
I-S	intranasal saline	1.0
VISTMS	visual stimulus followed after 187 ms by a transcranial magnetic stimulation pulse	1.0
CREM	camp-responsive element modulator	0.111111111111
CREM	cyclic-amp responsive element modulator	0.222222222222
CREM	camp response element modulator	0.222222222222
CREM	camp responsive element modulator	0.222222222222
CREM	cyclic amp response element modulator	0.222222222222
pVIII	nposterior branch of the vestibular nerve	1.0
I-V	current-voltage	1.0
tMCAO	transient occlusion of the middle cerebral artery	0.0625
tMCAO	transient middle cerebral artery occlusion	0.875
tMCAO	transitory middle cerebral artery occlusion	0.0625
CREB	camp response element-binding	0.0107142857143
CREB	camp-reponse element-binding protein	0.00357142857143
CREB	cyclic adenosine monophosphate response element binding protein	0.00357142857143
CREB	c-amp responsive element binding protein	0.00357142857143
CREB	camp responsive element-binding protein	0.00357142857143
CREB	cyclic amp response-element binding protein	0.00714285714286
CREB	calcium/camp response element binding protein	0.00357142857143
CREB	camp-response element-binding protein transcription factor	0.00357142857143
CREB	cyclic amp response element binding	0.00357142857143
CREB	cyclic amp response element binding protein	0.132142857143
CREB	cyclic-amp responsive element-binding protein	0.00357142857143
CREB	camp-response element binding protein	0.0428571428571
CREB	c-amp response element binding protein	0.00714285714286
CREB	cyclic amp-responsive element-binding	0.00357142857143
CREB	cyclic amp-responsive element binding factor	0.00357142857143
CREB	cyclic-amp regulatory element binding protein	0.00357142857143
CREB	calcium and camp response element binding protein	0.00357142857143
CREB	camp-responsive element binding protein	0.025
CREB	camp/ca response element binding protein	0.00357142857143
CREB	camp/ca2+ response element binding protein	0.00357142857143
CREB	cyclic amp responsive element-binding protein	0.00357142857143
CREB	camp/ca2+ response element-binding protein	0.00357142857143
CREB	camp-responsive element-binding protein	0.0178571428571
CREB	camp-response-element binding protein.	0.00357142857143
CREB	3′,5′-cyclic amp response element-binding protein	0.00357142857143
CREB	cyclic amp-response element binding protein	0.00357142857143
CREB	cyclic adenosine monophosphate (camp) response element-binding protein	0.00357142857143
CREB	camp response element-binding protein	0.15
CREB	camp-response-element-binding protein	0.00357142857143
CREB	3′–5′-cyclic amp response element-binding	0.00357142857143
CREB	cyclic-amp response element binding protein	0.0428571428571
CREB	cyclic amp-responsive element binding protein	0.0142857142857
CREB	camp response element binding	0.0214285714286
CREB	camp-response element bonding protein	0.00357142857143
CREB	cyclic amp-response-element-binding protein	0.00714285714286
CREB	cyclic adenosine monophosphate response element-binding protein	0.00357142857143
CREB	cyclic amp response element-binding protein	0.0678571428571
CREB	camp response binding protein	0.00357142857143
CREB	camp responsive element binding protein	0.025
CREB	camp-response element-binding protein	0.0285714285714
CREB	cyclic amp-responsive element-binding protein	0.00357142857143
CREB	camp responsive element binding	0.00357142857143
CREB	3′,5′-cyclic amp-response element binding protein	0.00357142857143
CREB	cyclic-amp response element binding- protein	0.00357142857143
CREB	cyclic amp response element-binding	0.0107142857143
CREB	camp response-element binding protein	0.0107142857143
CREB	cyclic-amp-response element binding protein	0.00357142857143
CREB	3′-5′-cyclic amp response element-binding	0.00357142857143
CREB	cyclic amp responsive element	0.00357142857143
CREB	camp response-element-binding protein	0.00714285714286
CREB	cyclic amp response element (cre) binding protein	0.00357142857143
CREB	cyclic amp-response element binding	0.0142857142857
CREB	camp responsive element-binding factor	0.00357142857143
CREB	camp-dependent response element binding protein	0.00357142857143
CREB	cyclic-amp response element-binding protein	0.0107142857143
CREB	cyclic-amp-responsive-element-binding protein	0.00357142857143
CREB	cre binding protein	0.00714285714286
CREB	cyclic amp-response element-binding protein	0.0107142857143
CREB	3′-5′-cyclic amp response element binding protein	0.00357142857143
CREB	camp response element binding protein	0.175
CREB	cyclic amp responsive element binding protein	0.0178571428571
CREB	camp-responsing element binding protein	0.00357142857143
CREC	a2+/camp response element	1.0
SR-NPSR	14 1716a	1.0
VU	0240551	1.0
GFAP-	irglial fibrillary acidic protein-immunoreactivity	0.5
GFAP-	irglial fibrillary acidic protein immunoreactivity	0.5
PAFP	araformaldehyde	0.5
PAFP	latelet-activating factor	0.5
SD-L	social defeat-long	1.0
I-XF	irst to 10th cerebellar lobes	1.0
AIDA	aminoindan dicarboxylic acid	0.0909090909091
AIDA	(r,s)-1-aminoindan-1,5-dicarboxylic acid	0.181818181818
AIDA	1-aminoindan-1,5-dicarboxylate	0.0909090909091
AIDA	1-aminoindan-1,5-dicarboxylic acid	0.0909090909091
AIDA	(r,s)-1-aminoindan-1,5-dicarboxylic acid/upf 523	0.0909090909091
AIDA	(rs)-1-aminoindan-1,5-dicarboxylic acid	0.363636363636
AIDA	(rs)-1-aminoindian-1,5-dicarboxylic acid	0.0909090909091
QCFIlong	quasi constant frequency	1.0
MAP2a	b, microtubule-associated protein-2a,b	1.0
BMGβ	2 microglobulin	1.0
cdACC	caudal–dorsal anterior cingulate cortex	1.0
AIDS	dementia complex	0.0714285714286
AIDS	acquired immune deficiency syndrome	0.142857142857
AIDS	acquired immunodeficiency syndrome	0.785714285714
AIDP	acute inflammatory demyelinating polyradiculoneuropathy	0.5
AIDP	acute inflammatory demyelinating polyneuropathy	0.5
BCFA	sbranched chain fatty acids	1.0
control-C	copulator of control group	1.0
AVOR	artificial vestibulo-ocular reflex	0.5
AVOR	angular vestibulo-ocular reflex	0.5
TBSTRIS	buffered saline	1.0
5α-DH-DOC	5α-dehydro-deoxycorticosterone	1.0
SCVAR	ssympathetic cutaneous vasomotor alerting responses	0.666666666667
SCVAR	sympathetic cutaneous vasomotor alerting response	0.333333333333
GUK	guanylate kinase-like	1.0
ALCAR	acetyl-l-carnitine	1.0
WAIS-RW	echsler intelligence scale revised	0.25
WAIS-RW	echsler adult intelligence scale–revised	0.25
WAIS-RW	echsler adult intelligence scale revised	0.5
ELISA	enzyme-linked immunosorbent assay system	0.00354609929078
ELISA	enzyme-linked-immunosorbent serologic assay	0.00354609929078
ELISA	enzyme-linked immunosorbent assays	0.0106382978723
ELISA	enzyme-linked immunoassay	0.00709219858156
ELISA	enzyme-linked immunosorbent asssay	0.00354609929078
ELISA	enzyme-linked immunosolvent assay	0.00354609929078
ELISA	enzyme-linked immunosorbant assay	0.0177304964539
ELISA	enzyme-linked immunoabsorbent assay	0.0141843971631
ELISA	enzyme-linked immunosorbent assay	0.879432624113
ELISA	enzyme linked immunosorbent assay	0.0177304964539
ELISA	enzyme-linked immunoadsorbent assay	0.0106382978723
ELISA	sandwich enzyme-linked immunosorbent assay	0.00354609929078
ELISA	enzyme immunoassay system assay	0.00354609929078
ELISA	enzyme-linked immumnosorbent assay	0.00354609929078
ELISA	enzyme-linked immuno-sorbent assay	0.00709219858156
ELISA	enzyme-linked immuosorbent assay	0.00354609929078
ELISA	enzyme-linked-immunosorbent-assay	0.00354609929078
ELISA	enzyme-linked immuno sorbent assay	0.00354609929078
NO2-	nitrite	1.0
ppORX	preproorexin	1.0
VMl	ventromedial thalamic nucleus, lateral part	1.0
VMh	ventromedial nucleus of the hypothalamus	1.0
mtNOS	mitochondrial nitric oxide synthase	1.0
VMe	ventral mesencephalon explant	1.0
VMb	basal ventral medial nucleus	1.0
rhEPO	recombinant human erythropoietin	1.0
TOST	two one-sided tests	1.0
DHKA	dihydrokainate	1.0
BETB	rain extraction tool	1.0
55845A	[3-[[1-(s)-(3,4-dichlorophenyl)ethyl]amino]	0.666666666667
55845A	3-n-[1-(s)-(3,4-dichlorophenyl)ethyl]amino-2-(s)-hydroxypropyl-p-benzyl-phosphinic acid	0.333333333333
βARK	β-adrenergic receptor kinase	1.0
5mC	5-methyl cytosine	0.333333333333
5mC	5-methylcytosine	0.666666666667
mKRB	modified krebs–ringer bicarbonate medium	1.0
GABABR1b	gabab receptor r1 isoform b	1.0
sEPSC	spontaneous excitatory postsynaptic currents	0.0289855072464
sEPSC	sspontaneous excitatory postsynaptic currents	0.246376811594
sEPSC	sspontaneous excitatory post synaptic currents	0.0144927536232
sEPSC	spontaneous excitatory post-synaptic current	0.0579710144928
sEPSC	sspontaneous epscs	0.0289855072464
sEPSC	spontaneous excitatory postsynaptic current	0.463768115942
sEPSC	spontaneous epsc	0.0869565217391
sEPSC	sspontaneous excitatory post-synaptic currents	0.0144927536232
sEPSC	spontaneous excitatory synaptic currents	0.0144927536232
sEPSC	oscspontaneous oscillating excitatory postsynaptic current	0.0144927536232
sEPSC	spontaneous excitatory post-synaptic currents	0.0289855072464
TBS-TXT	riton-x in tbs	0.5
TBS-TXT	ris-buffered saline with the addition of 0.3% triton x-100	0.5
TGF-β2	transforming growth factor-beta 2	1.0
VMN	ventromedial hypothalamic nucleus	0.121212121212
VMN	vlventrolateral division of the ventromedial nucleus	0.030303030303
VMN	vlventrolateral portion of the ventromedial nucleus of the hypothalamus	0.030303030303
VMN	ventromedial nucleus of the hypothalamus	0.272727272727
VMN	vlventrolateral aspect of the ventromedial nucleus	0.030303030303
VMN	vlventrolateral division of the hypothalamic ventromedial nucleus	0.030303030303
VMN	nucleus ventromedialis hypothalami	0.0606060606061
VMN	vlventrolateral part of the ventromedial nucleus of the hypothalamus	0.030303030303
VMN	ventromedial nucleus	0.30303030303
VMN	ventromedial	0.030303030303
VMN	ventral medial nucleus of the hypothalamus	0.030303030303
VMN	ventral motor nucleus of the trigeminal nerve	0.030303030303
PCCG-IV	(2s,1′s,2′s,3′r)-2-(2′-carboxy-3′-phenylcyclopropyl)glycine	1.0
VMM	ventromedial medulla	1.0
Ser	serine	1.0
VMH	ventromedial hypothalamic nucleus	0.28
VMH	vlventrolateral ventromedial nucleus	0.01
VMH	ventromedial hypothalamic (nucleus)	0.01
VMH	hypothalamic ventromedial nucleus	0.01
VMH	hypothalamus ventromedial	0.01
VMH	ventromedial nucleus of the hypothalamus	0.19
VMH	ventromedial hypothalamic nuclei	0.01
VMH	vlventrolateral subdivision of the ventromedial nucleus of the hypothalamus	0.01
VMH	vlventrolateral region of the ventromedial hypothalamus	0.01
VMH	ventromedial paraventricular nucleus	0.01
VMH	vlventrolateral subdivision of the vmh	0.01
VMH	ventromedial hypothalamus	0.34
VMH	ventromedial nucleus	0.08
VMH	ventromedial hypothalamic area	0.01
VMH	ventromedial hypothalamic	0.01
VMF	ventromedial funiculus	1.0
MPOS	medial parieto-occipital sulcus	1.0
GFAPG	lial fibrilary acidic protein	0.125
GFAPG	lial fibrillary acidic protein	0.75
GFAPG	lial-fibrillary acidic protein	0.125
RESTRE	1-silencing transcription factor	1.0
VMB	ventral midbrain	1.0
VMA	3-methoxy-4-hydroxy-mandelic acid	1.0
TUJ	1β-tubulin iii	0.4
TUJ	1βiii-tubulin	0.2
TUJ	1anti-βiii tubulin antibody	0.2
TUJ	1beta iii tubulin antibody	0.2
CREB-P	phosphorylated cyclic amp response element binding protein	1.0
MPON	medial preoptic nucleus	1.0
PPAR	peroxisome proliferator-activator receptor	0.0666666666667
PPAR	peroxisome proliferator–activated receptor	0.0666666666667
PPAR	speroxisome proliferator-activated receptors	0.0666666666667
PPAR	delta	0.0666666666667
PPAR	peroxisome proliferator-activated receptor	0.533333333333
PPAR	peroxisome proliferators-activated receptor	0.133333333333
PPAR	proliferator-activated receptor	0.0666666666667
MPOL	medial preoptic nucleus, lateral part	1.0
PPAP	r(-)-n-(3-propyl-1-propyl)-1-phenyl-2-aminopropane hydrochloride	1.0
TUB	microtubules	1.0
MPOA	medial preoptic area of the hypothalamus	0.0483870967742
MPOA	/ahmedial preoptic area/anterior hypothalamus	0.0322580645161
MPOA	medial pre-optic area	0.0161290322581
MPOA	medial preoptic area	0.903225806452
VMR	visceromotor response	0.571428571429
VMR	visceromotor reflex	0.142857142857
VMR	vasomotor reactivity	0.142857142857
VMR	viscero-motor response	0.142857142857
VMS	ventral medullary surface	0.5
VMS	ventromedial striatum	0.5
VMP	vocal motor pathway	0.5
VMP	oposterior part of the ventral medial thalamic nucleus	0.5
BL-AM	basolateral amygdala	1.0
EcoG	cortical eeg	1.0
oPRL	ovine prolactin	1.0
PGOmt	muscle tone with eeg activation and pgo waves	1.0
STMS	tone t-maze	1.0
NMPN-	methylprotoporphyrin ix	1.0
E15	embryonic day 15	1.0
UNR	unrestrained	1.0
AGRP	agouti-related protein	0.714285714286
AGRP	agouti-related protein (83-132) amide	0.142857142857
AGRP	agouti gene-related peptide	0.142857142857
CMS	caudoventral migratory stream	0.0588235294118
CMS	chronic mild stresses	0.0588235294118
CMS	common mode sense	0.0588235294118
CMS	centromedial segment	0.0588235294118
CMS	cortical midline structure	0.0588235294118
CMS	chronic mild stress	0.705882352941
STMN	3stathmin-like3	0.5
STMN	stathmin	0.5
mtPSD	multitaper-derived power spectral density	1.0
Cdk	cyclin-dependent kinase	1.0
Q-	bestquinine-best	0.333333333333
Q-	type ca2+ channel	0.333333333333
Q-	factorquality factor	0.333333333333
sSC	superior colliculus, superficial layers	0.2
sSC	superficial superior colliculus	0.2
sSC	superficial layer of the superior colliculus	0.2
sSC	superficial layers of the superior colliculus	0.2
sSC	superficial (visual) layers of the rodent superior colliculus	0.2
PDTC	pyrrolidine dithiocarbamate	0.636363636364
PDTC	pyrrolidine dithiocarbamate ammonium salt	0.0909090909091
PDTC	pyrrolidinedithiocarbamate	0.0909090909091
PDTC	ammonium pyrrolidinedithiocarbamate	0.0909090909091
PDTC	ammonium pyrrolidedithiocarbamate	0.0909090909091
S-SCH	s(-)-sch-23388	1.0
HRSDH	amilton rating scale for depression	1.0
DCONT	control brainstem site dorsal to substantia nigra pars reticulata	1.0
PWTL	paw withdrawal thermal latency	1.0
OLAN	olanzapine	1.0
LAMP	limbic system-associated membrane protein	0.714285714286
LAMP	limbic-associated membrane protein	0.142857142857
LAMP	2lysosomal-associated membrane protein 2	0.142857142857
KBRKB-R	7943	1.0
c-R	el	0.333333333333
c-R	et	0.333333333333
c-R	etret tyrosine kinase	0.333333333333
STC-AP	stanniocalcin-alkaline phosphatase fusion protein	1.0
RSERIES	series resistance	1.0
LPTB	long phosphotyrosine-binding domain	1.0
PWTP	aw withdrawal threshold	1.0
5-NS	5-doxylstearic acid	1.0
TNF-α	tumor necrosis factor-alpha	0.0828402366864
TNF-α	tumour necrosis factor-alpha	0.00591715976331
TNF-α	tumour necrosis factor-α	0.0414201183432
TNF-α	tumor necrosisfactor-α	0.00591715976331
TNF-α	tissue necrosis factor-α	0.00591715976331
TNF-α	tumour necrosis factor alpha	0.0118343195266
TNF-α	tumor-necrosis factor-α	0.0177514792899
TNF-α	tumor necrosis factor alpha	0.100591715976
TNF-α	tumor necrosis factor-α	0.609467455621
TNF-α	tumor necrosis factor α	0.10650887574
TNF-α	tumor necrosis factor	0.0118343195266
FPSCO	fear-potentiated startle control	1.0
GPERG-	protein-activated oestrogen receptor	1.0
CCCP	carbonyl cyanide m-chlorophenyl hydrazone	0.0769230769231
CCCP	carbonyl cyanide 3-chlorophenylhydrazone	0.0769230769231
CCCP	carbonyl cyanide m-chlorophenylhydrasone	0.0769230769231
CCCP	carbonyl cyanide m-chlorophenylhydrazone	0.692307692308
CCCP	carbonyl cyanide chlorophenyl hydrazone	0.0769230769231
pDMS	posterior subregion of the dorsomedial striatum	1.0
TRHRTRH-	receptors	1.0
-DII	type ii iodothyronine 5′-deiodinase	1.0
S-PRL	prolactin variant from suckled rats	1.0
FSFIF	emale sexual function index	1.0
PDGFRα	platelet-derived growth factor receptor alpha	0.333333333333
PDGFRα	platelet derived growth factor receptor alpha	0.333333333333
PDGFRα	platelet-derived growth factor receptor-α	0.333333333333
FOM	omega-3-supplemented rats from strains selectively bred to be seizure-prone	1.0
L-15	leibowitz culture medium	1.0
DAF-24	5-diaminofluorescein	1.0
SL-M	stratum lacunosum-moleculare	1.0
QQ	sensitized quinpirole (drug)	1.0
DPH1	6-diphenyl-1,3,5-hexatriene	1.0
QS	quiet sleep	0.666666666667
QS	sensitized quinpirole (no drug)	0.111111111111
QS	quiet stance	0.111111111111
QS	4quiet sleep 4	0.111111111111
DICC	days in co-culture	1.0
QW	quiet wake	0.0952380952381
QW	quiet waking	0.714285714286
QW	quiet wakefulness	0.190476190476
VSDI	voltage-sensitive dye imaging	1.0
QX	314lidocaine n-ethyl bromide	1.0
QA	quite awake	0.05
QA	quinolinic acid	0.9
QA	quisqualate	0.05
QC	quality control	0.75
QC	quantal content	0.25
DICS	dynamic imaging of coherent sources	1.0
QD	quantum dot	1.0
rhesmRNA	encoding rhes	1.0
INRAI	nstitut national de la recherche agronomique	1.0
pCB-PzDA	sodium 4-(p-chlorobenzoyl)-cis-piperazine-2,3-dicarboxylate	1.0
tSNP	stag-snps	1.0
USPIO	ultrasmall superparamagnetic iron oxide	1.0
PAP	pancreatitis-associated protein	0.0277777777778
PAP	peroxidase–antiperoxidase	0.458333333333
PAP	pulsatile arterial pressure	0.152777777778
PAP	peroxidase–anti-peroxidase complex	0.0138888888889
PAP	peroxidase antiperoxidase	0.0138888888889
PAP	peroxidase–anti-peroxidase	0.0833333333333
PAP	peroxidase-antiperoxidase	0.0555555555556
PAP	peroxidase anti-peroxidase method	0.0138888888889
PAP	7peripheral benzodiazepine receptor-associated protein7	0.0138888888889
PAP	peroxidase anti-peroxidase	0.111111111111
PAP	phasic arterial pressure	0.0138888888889
PAP	prostatic acid phosphatase	0.0277777777778
PAP	ositive affect	0.0138888888889
PAQ	physical ability questionnaire	1.0
PAR	protease-activated receptor	0.269230769231
PAR	sproteinase-activated receptors	0.0384615384615
PAR	poly adp-ribose	0.0384615384615
PAR	partitioning defective	0.0384615384615
PAR	poly(adp-ribosyl)ated proteins	0.0384615384615
PAR	proteinase-activated receptor	0.0384615384615
PAR	parietal cortex	0.0384615384615
PAR	poly(adp-ribose) polymers	0.115384615385
PAR	parasubiculum	0.0384615384615
PAR	population spike amplitude ratio	0.0384615384615
PAR	poly(adp-ribose) or adp-ribose polymer	0.0384615384615
PAR	2proteinase-activated receptor-2	0.0384615384615
PAR	passive avoidance response	0.0384615384615
PAR	poly(adp-ribose)	0.115384615385
PAR	proteinase-activated receptors	0.0384615384615
PAR	sprotease-activated receptors	0.0384615384615
PAS	prepare and select	0.0833333333333
PAS	paired associative stimulation	0.25
PAS	peripheral anionic site	0.166666666667
PAS	periodic acid–schiff	0.0833333333333
PAS	periodic acid-schiff	0.0833333333333
PAS	periodic acid schiff	0.25
PAS	percentage of area of staining	0.0833333333333
PAT	preventive antibacterial treatment	0.125
PAT	passive avoidance test	0.125
PAT	transitory activation phase	0.125
PAT	palmitoyl acyl-transferase	0.125
PAT	peptide analog of thymulin	0.375
PAT	sprimary afferent terminals	0.125
CKC	corticokinematic coherence	1.0
DRX	dorsal rhizotomy	1.0
KATP	channelatp-sensitive potassium channel comprised by inwardly rectifying k+ channel and sulfonylurea receptor	0.111111111111
KATP	channelsatp-sensitive potassium channels	0.111111111111
KATP	channels	0.111111111111
KATP	channelatp-sensitive potassium channel	0.222222222222
KATP	channel	0.333333333333
KATP	atp-sensitive k+ channel	0.111111111111
ASCT	1	1.0
PAZ	presynaptic active zone	1.0
PdBu	phorbol-12,13-dibutyrate	1.0
CONR	control group with sirack1 plasmid	1.0
PAA	piriform-amygdalar area	1.0
PAC	1-rpacap-specific receptor	0.047619047619
PAC	primary auditory cortex	0.0952380952381
PAC	1-rpituitary adenylate cyclase-activating polypeptide-specific receptor	0.047619047619
PAC	1-rpituitary adenylate cyclase activating polypeptide receptor	0.047619047619
PAC	1pituitary adenylate cyclase-activating polypeptide selective receptor	0.047619047619
PAC	parietal association cortex	0.047619047619
PAC	(s), periamygdaloid cortex (sulcal division)	0.047619047619
PAC	1-rpituitary adenylate cyclase–activating polypeptide–specific receptor	0.047619047619
PAC	periamygdaloid cortex	0.238095238095
PAC	1-rpituitary adenylyl cyclase-activating polypeptide receptor 1	0.0952380952381
PAC	i–iii periamygdaloid cortexsubdivisions i–iii	0.047619047619
PAC	1-rpacap receptor	0.047619047619
PAC	1pacap selective receptor	0.047619047619
PAC	phosphatase of activated cells	0.047619047619
PAC	paracentral nucleus	0.047619047619
PAD	primary afferent depolarization	0.916666666667
PAD	peptidylarginine deiminase	0.0833333333333
MSCBM	mesenchymal stem cell basal medium	1.0
PAF	platelet-activating factor, 1-o-alkyl-2-acetyl-sn-glycero-3-phosphocholine	0.0833333333333
PAF	primary afferent fiber	0.0833333333333
PAF	1-o-alkyl-2-acetyl-sn-glycero-3-phosphocholine	0.0833333333333
PAF	paraformaldehyde in 0.1m phosphate buffer	0.0833333333333
PAF	platelet-activating factor	0.0833333333333
PAF	posterior auditory field	0.166666666667
PAF	picric acid–paraformaldehyde fixative	0.0833333333333
PAF	paraformaldehyde	0.333333333333
PAG	periaqueductal grey	0.0681818181818
PAG	periaqueductal gray region	0.00378787878788
PAG	periaqueductal gray	0.704545454545
PAG	phosphate activated glutaminase	0.00757575757576
PAG	periaqueductal gray matter	0.117424242424
PAG	lateral periaqueductal gray	0.00378787878788
PAG	periaqueductal gray area	0.0151515151515
PAG	peri aqueductal grey	0.00378787878788
PAG	periaquaductal gray	0.00378787878788
PAG	vlventrolateral zone of pag	0.00757575757576
PAG	dmdorsomedial column of the periaqueductal gray matter	0.00378787878788
PAG	peri-aqueductal gray	0.00378787878788
PAG	vlventrolateral periaqueductal gray	0.00378787878788
PAG	peri-aqueductal grey	0.00378787878788
PAG	midbrain periaqueductal gray	0.00378787878788
PAG	–rvmperiaqueductal gray–rostral ventromedial medulla system	0.00378787878788
PAG	perioquductal gray	0.00378787878788
PAG	dldorsolateral part of the periaqueductal gray	0.00378787878788
PAG	phosphate-activated glutaminase	0.0265151515152
PAG	periaqueductal grey matter	0.00757575757576
PAH	primary afferent hyperpolarization	0.333333333333
PAH	phenylalanine hydroxylase	0.333333333333
PAH	p-aminohippurate	0.333333333333
CONT	control	0.375
CONT	standard control	0.125
CONT	contralateral to tilt	0.125
CONT	contralateral	0.125
CONT	anaesthetic control	0.125
CONT	control handling	0.125
PAK	1p21-activated kinase-1	0.125
PAK	p-21-activated kinase	0.125
PAK	p21-activated kinase	0.5
PAK	p21-activated kinase (pak1-3) family of serine/threonine kinases	0.125
PAK	3p21 activated kinase type 3	0.125
nACSF	normal artificial cerebrospinal fluid	1.0
PAM	peptidylglycine α-amidating monooxygenase	0.333333333333
PAM	positive allosteric modulator	0.333333333333
PAM	partial allosteric modulator	0.333333333333
PAN	anti-neurofilament antibody	0.2
PAN	/pvcpolyacrylonitrile:polyvinylchloride	0.2
PAN	sphasically active neurons	0.2
PAN	polyacrylonitrile	0.2
PAN	periodic activity neuron	0.2
PAO	polyamine oxidase	0.142857142857
PAO	phenylarsine oxide	0.857142857143
DCN	dorsal commissural nucleus	0.043956043956
DCN	dorsal cutaneous nerve	0.010989010989
DCN	dorsal column nuclei (cuneate and gracilis)	0.010989010989
DCN	deep-cerebellar nuclei	0.010989010989
DCN	dorsal collector nerve	0.021978021978
DCN	deep cerebellar nuclei	0.263736263736
DCN	dorsal cochlear nucleus	0.505494505495
DCN	dorsal column nuclei	0.10989010989
DCN	dorsal column nucleus	0.021978021978
46V	ventral 46	1.0
DCM	dorsal commissure	0.222222222222
DCM	dynamic causal modeling	0.444444444444
DCM	dichloromethane	0.333333333333
LFBL	uxor fast blue	0.0833333333333
LFBL	uxol fast blue	0.833333333333
LFBL	uxul fast blue	0.0833333333333
INIC	internal nucleus of the inferior colliculus	1.0
DCI	delayed cell injury	0.333333333333
DCI	decarboxylase inhibitor	0.333333333333
DCI	delayed cerebral ischemia	0.333333333333
DCF	2′,7′-dichlorodihydrofluorescein diacetate	0.04
DCF	dichlorofluorescein	0.16
DCF	dichlorodihydrofluorescein	0.08
DCF	r-deoxycoformycin	0.04
DCF	dichlorofluorescin	0.08
DCF	2′, 7′-dichlorohydrofluorescein diacetate	0.04
DCF	fluorescent 2′,7′-dichlorofluorescein	0.04
DCF	2′-deoxycoformycin	0.04
DCF	2′,7′-dichlorohydrofluorescein diacetate	0.04
DCF	2′,7′-dichlorofluorescin	0.04
DCF	dicholorfluorescein	0.04
DCF	dihydrochlorofluorescein diacetate	0.04
DCF	6-carboxy-2′,7′-dichlorohydrofluorescein diacetate	0.04
DCF	2′,7′-dichlorofluorescein	0.2
DCF	2′-7′-dichlorofluorescein	0.04
DCF	2,7-dichlorofluorescin diacetate	0.04
UNL	ulnar nerve	1.0
PERI	perirhinal cortex	1.0
DCC	discontinuous current clamp	0.1875
DCC	deleted in colorectal carcinoma	0.0625
DCC	dynamic current clamp	0.0625
DCC	deleted in colorectal cancer	0.625
DCC	dextran-coated charcoal	0.0625
PERM	permethrin	1.0
non-R	neuronnon-respiratory neuron	1.0
p70-S	6kp70-s6kinase	1.0
PVP40-TTBS	polyvinylpyrrolidone-40-ttbs	1.0
DCX	doublecortin	0.94495412844
DCX	+doublecortin-positive	0.00917431192661
DCX	+irdoublecortin immunoreactivity	0.00917431192661
DCX	+dcx-labeled	0.00917431192661
DCX	double cortin	0.00917431192661
DCX	+doublecortin immunopositive	0.00917431192661
DCX	irdoublecortin-immunoreactive	0.00917431192661
DCV	sdense core vesicles	0.166666666667
DCV	dense core vesicle	0.333333333333
DCV	number of dense core vesicles within a terminal	0.0833333333333
DCV	dense core secretory vesicles	0.0833333333333
DCV	dense-core vesicle	0.0833333333333
DCV	dense-cored vesicle	0.166666666667
DCV	dense core vesicles	0.0833333333333
DAQ	dopamine quinone	1.0
DCT	dorsal commissure tract	1.0
CREBC	a2+/camp-response element-binding protein	1.0
DCS	d-cycloserine	0.857142857143
DCS	(transcranial) direct current stimulation	0.142857142857
DCP	1decapping protein 1	0.333333333333
DCP	dense cortical plate	0.333333333333
DCP	direct current potential	0.333333333333
L-AVPN	slaryngeal-projecting avpns	1.0
PVHm	periventricular nucleus of hypothalamus, magnocellular part	1.0
M40	(1-12)-pro3-(ala-leu)2-ala amide	1.0
AEAN-	arachidonoylethanolamide	0.111111111111
AEAN-	arachidonylethanolamine	0.444444444444
AEAN-	arachidonylethanolamine anandamide	0.111111111111
AEAN-	arachidonoylethanolamide (anandamide)	0.111111111111
AEAN-	arachidonoylethanolamide/anandamide	0.111111111111
AEAN-	arachidonylethanolamide (anandamide)	0.111111111111
FLIPFLICE	inhibitor protein	1.0
MAAM	aackia amurensis agglutinin	1.0
CREB-	1	0.25
CREB-	mediated gene expression	0.25
CREB-	1camp response element-binding protein-1	0.25
CREB-	sirnasmall interfering rna against cyclic amp response element-binding protein	0.25
NRF-	1nuclear respiratory factor-1	0.4
NRF-	1nuclear respiratory factor 1	0.4
NRF-	2nuclear respiratory factor 2	0.2
PNKC	paroxysmal non-kinesigenic dyskinesia	1.0
qEEG	– quantitative electroencephalogram	1.0
mMAN	medial part of the magnocellular nucleus of the anterior neostriatum	1.0
ACSMA	merican college of sports medicine	1.0
PVHp	periventricular nucleus of hypothalamus, parvocellular part	1.0
nLM	nucleus lentiformis mesencephali	1.0
MAAB	muscimol infusion in aab version	1.0
AP-AHP	action potential afterhyperpolarization	1.0
dO	orientation velocity	1.0
DIC-IR	differential interference contrast optics with infrared	0.5
DIC-IR	infrared differential interference contrast optic	0.5
dM	eadorsal medial amygdale	0.5
dM	npodorsal median preoptic nucleus	0.5
dH	2odistilled water	0.5
dH	idorsal hippocampus	0.25
dH	2odistilled h2o	0.25
dI	dorsal interneuron	0.5
dI	/iratio of the change in light intensity measured during an action potential to the resting light intensity	0.5
CK-	19cytokeratin-19	1.0
IHP	inhomogeneous poisson process	0.5
IHP	initial head position (in space)	0.5
IHQ	immunohistochemistry	1.0
dB	spldecibels sound-pressure-level	0.0714285714286
dB	decibels	0.142857142857
dB	pespldecibel peak equivalent sound pressure level	0.0714285714286
dB	/octdecibel per octave	0.142857142857
dB	spldecibel re sound pressure level	0.0714285714286
dB	campdibutyryl cyclic amp	0.0714285714286
dB	decibel	0.285714285714
dB	spldecibel sound pressure level	0.142857142857
dC	opcenter of pressure velocity	1.0
DRRs	dorsal root reflexes	1.0
TANKTNF	receptor-associated factor family member-associated nfκb activator	1.0
IHH	intermittent hypercapnic-hypoxia	0.5
IHH	nicotine and intermittent hypercapnic-hypoxia	0.5
ωCgTx-GVIA	ω-conotoxin-gvia	1.0
dV	ramus descendens nervi trigemini	0.25
dV	descending root of the trigeminal nerve	0.5
dV	trigeminal descending tract	0.25
IHC	immunohistochemistry	0.622222222222
IHC	immunohistochemistry/immunohistochemical	0.00740740740741
IHC	sinner hcs	0.00740740740741
IHC	inner hair cells	0.0666666666667
IHC	inner hair cell(s)	0.00740740740741
IHC	immunohistochemical or immunohistochemistry	0.00740740740741
IHC	sinner hair cells	0.037037037037
IHC	inner hair cell	0.207407407407
IHC	ohinter-hemispheric coherence indices	0.00740740740741
IHC	immunohistochemical	0.0296296296296
IHA	intercalated hyperstriatum accessorium	1.0
OIS	optical imaging spectroscopy	0.5
OIS	optical imaging of intrinsic signal	0.5
dS	ubdorsal subiculum	1.0
dP	dorsal progenitor domains	0.125
dP	50p50 difference score index of sensory gating	0.25
dP	a5dorsal paratrigeminal region	0.375
dP	a5dorsal paratrigeminal nucleus	0.25
CChcarbachol	the cholinergic agonist	1.0
GBF	ganglion blood flow	1.0
AEP	sauditory-evoked potentials	0.111111111111
AEP	auditory evoked potential	0.333333333333
AEP	anterior entopenduncular area	0.0555555555556
AEP	auditory-evoked potential	0.277777777778
AEP	acoustically evoked potential	0.0555555555556
AEP	saverage evoked potentials	0.0555555555556
AEP	auditory evoked potentials	0.0555555555556
AEP	sauditory evoked potentials	0.0555555555556
AES	anterior ectosylvian sulcus	0.75
AES	anterior ectosylvian nucleus	0.25
AFDX-	11611-[2-[(diethylamino)methyl]-1piperidinyl]	1.0
RHC-80267	1,6-bis(cyclohexyloximinocarbonylamino)hexane	1.0
GBC	globular/bushy cell	0.125
GBC	globular bushy cell	0.5
GBC	globose basal cell	0.25
GBC	sglobular bushy cells	0.125
AEV	anterior ectosylvian visual area	1.0
GBN	sgaze-related burst neurons	1.0
GBL	γ-butyrolactone	0.5
GBL	gamma-butyrolactone	0.5
GBM	glioblastoma multiforme	0.857142857143
GBM	glioblastoma	0.142857142857
GAPDH	glyceraldehydes-3-phosphate dehydrogenase	0.0228758169935
GAPDH	glyceraldehyde 3 phosphate dehydrogenase	0.00326797385621
GAPDH	glyceraldehyde phosphatase dehydrogenase	0.00653594771242
GAPDH	glyceraldehyde-phosphate dehydrogenase	0.00326797385621
GAPDH	glyceraldehyde-3-phoshpate dehydrogenase	0.00326797385621
GAPDH	glyceraldahyde-3-phosphate-dehydrogenase	0.00326797385621
GAPDH	glyceraldehyd-3-phosphate dehydrogenase	0.00326797385621
GAPDH	glyceraldehyde-3-phosphate-dehydrogenase	0.016339869281
GAPDH	glyceraldehyde phosphate dehydrogenase	0.0196078431373
GAPDH	glyceraldehyde phosphate 3-dehydrogenase	0.00326797385621
GAPDH	glucose-6-phosphate dehydrogenase	0.00326797385621
GAPDH	glyceraldehyde 3-phosphate	0.00326797385621
GAPDH	glyceraldehyde-3-phosphate	0.00653594771242
GAPDH	glyceraldehyde 3-phophate dehydrogenase	0.00653594771242
GAPDH	glyceraldehydes-3 phosphate dehydrogenase	0.00326797385621
GAPDH	glyceraldehyde-3 phosphate dehydrogenase	0.00653594771242
GAPDH	glyceraldehyde3-phosphate dehydrogenase	0.00326797385621
GAPDH	glyceraldehyde-3-phosphate dehydrogenase (ec 1.2.1.12)	0.00326797385621
GAPDH	glyceraldehyde-3-phosphate dehydrogenase	0.584967320261
GAPDH	glyceraldyehyde-3-phosphate dehydrogenase	0.0130718954248
GAPDH	glyceraldehyde-3- phosphate dehydrogenase	0.00326797385621
GAPDH	glyceraldehydes 3-phosphate dehydrogenase	0.016339869281
GAPDH	glyceraldehyde 3-phosphate dehydrogenase	0.251633986928
GAPDH	glycerol-alpha-phosphate dehydrogenase	0.00326797385621
GAPDH	glycerealdehyde 3-phosphate dehydrogenease	0.00326797385621
GAPDH	glyceradehyde-3-phosphate-dehydrogenase	0.00326797385621
LPCV	left pre-caval vein	1.0
AEA	arachidonoyl ethanolamide (anandamide)	0.0294117647059
AEA	arachidonylethanolamine	0.0294117647059
AEA	arachidonoylethanolamide or anandamide	0.0294117647059
AEA	arachidonoylethanolamide (anandamide)	0.0294117647059
AEA	endocannabinoid/endovanniloid anandamide	0.0294117647059
AEA	anadamide	0.0294117647059
AEA	anandamide	0.764705882353
AEA	arachidonoyl ethanolamine	0.0294117647059
AEA	arachidonyl ethanolamide	0.0294117647059
AEC	adenylate energy charge	0.111111111111
AEC	3-amino-9-ethyl carbazole	0.111111111111
AEC	aggregation enhanced culture	0.111111111111
AEC	alkaline-evoked current	0.111111111111
AEC	3-amino-9-ethyl-carbazole	0.111111111111
AEC	3-amino-9-ethylcarbazole	0.333333333333
AEC	aminoethyl carbazole	0.111111111111
ECA	external carotid artery	1.0
GBR	sgabaa/benzodiazepine receptors	0.25
GBR	129091-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride	0.25
GBR	12909: 1-(2-[bis(4-fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride	0.25
GBR	12909	0.25
AED	anti-epileptic drug	0.192307692308
AED	antiepileptic drug	0.423076923077
AED	santiepileptic drugs	0.153846153846
AED	santi-epileptic drugs	0.0769230769231
AED	antiepileptic drugs	0.115384615385
AED	santi-epilepsy drugs	0.0384615384615
GBP	glutamate-binding protein	0.25
GBP	gabapentin	0.75
AEF	auditory evoked magnetic field	0.75
AEF	anterior ectosylvian field	0.25
AEI	allelic expression imbalance	1.0
o-ATPATP-	2′,3′-dialdehyde	1.0
II-AVPN	sinspiratory-inhibited airway vagal preganglionic neurons	1.0
CVTC	cerebellar vermis thalamic cortical	0.5
CVTC	cerebellar vermis-thalamo-cortical	0.5
AEL	after egg laying	0.6
AEL	after egg-laying	0.4
GBX	gaboxadol or thip (a gaba agonist)	1.0
VFOR	visual frame of reference	1.0
IFCDM	insulin-free chemically defined medium	1.0
mBNST	medial bed nucleus of the stria terminalis	1.0
OTOTO	osmium-thiocarbohydrazide	0.5
OTOTO	osmium tetroxide/thiocarbohydrazide	0.5
PNGaseF	peptide-n-gycosidase f	1.0
PDIα	phosphodiesterase iα	1.0
PRLR	prolactin receptor	1.0
GDPB	global density of presynaptic boutons	1.0
PKCεPKC	epsilon	1.0
Cdks	cyclin-dependent kinases	1.0
BUN	blood urea nitrogen	1.0
OD650nm	optical density measured at 650 nm	1.0
BUL	bilateral ureter ligature	1.0
WGA-HRP-	goldwheat germ agglutinin-conjugated horseradish peroxidase-colloidal gold complex	1.0
GSAG	riffonia simplicifolia isolectin b4	1.0
HETAB	hexadecyltrimethylammonium bromide	1.0
LCMR	glc(s)local cerebral metabolic rate(s) for glucose	1.0
LCMS	/msliquid chromatography/tandem mass spectrometry	0.5
LCMS	liquid chromatography–mass spectrometry	0.5
TBS-Ths	tris-buffered saline plus 3.0% normal horse serum/0.2% triton x-100	1.0
rMT	rest motor threshold	0.222222222222
rMT	resting motor threshold	0.777777777778
CCRcytokines	chemokines, and chemokine receptors	1.0
MOp	primary motor area	1.0
MSCT	miniature synaptic ca2+ transient	1.0
DβH	dopamine β hydroxylase	0.047619047619
DβH	dopamine-beta-hydroxylase	0.047619047619
DβH	anti-dopamine β hydroxylase	0.047619047619
DβH	dopamine beta hydroxylase	0.0952380952381
DβH	dopamine-β-hydroxylase	0.619047619048
DβH	dopamine β-hydroxylase	0.142857142857
gp140TrkA	high-affinity nerve growth factor receptor	1.0
pSTAT3	tyr705 phosphorylated stat3	1.0
SAMS-	adenosyl methionine	0.333333333333
SAMS-	adenosyl-l-methionine	0.333333333333
SAMS-	adenosylmethionine	0.333333333333
100330A	n-(4,4-diphenyl-3-butenyl)guvacine	1.0
AE1	anti-ache antibody	0.5
AE1	anion exchanger 1	0.5
SAPO	192 igg–saporin lesion	0.5
SAPO	192 igg-saporin lesions	0.5
SAPK	stress-activated protein kinase	0.777777777778
SAPK	c-jun n-terminal kinase stress-activated protein kinase	0.111111111111
SAPK	stress-activated protein kinase/c-jun n-terminal kinase	0.111111111111
MOS	main olfactory system	0.666666666667
MOS	major olfactory system	0.166666666667
MOS	mirror-oriented selection	0.166666666667
MOR	morphine hydrochloride	0.00980392156863
MOR	morphine	0.0294117647059
MOR	1dmorphine receptor-1d isoform	0.00980392156863
MOR	mu (μ) opioid receptor	0.00980392156863
MOR	μ-opiate receptor	0.0196078431373
MOR	mu opiate receptor	0.00980392156863
MOR	sμ-opioid receptors	0.00980392156863
MOR	m opioid receptor	0.00980392156863
MOR	μ-type opioid receptor	0.00980392156863
MOR	smu opioid receptors	0.0196078431373
MOR	mu-opioid receptor	0.0980392156863
MOR	mu opioid receptor	0.205882352941
MOR	μ opioid receptors	0.00980392156863
MOR	μ-opioid receptor	0.401960784314
MOR	1μ-opioid receptor 1	0.00980392156863
MOR	morphine treatment group	0.00980392156863
MOR	1μ-opioid receptor protein	0.00980392156863
MOR	1imor1-like immunoreactivity	0.00980392156863
MOR	μ opioid receptor	0.0980392156863
MOR	1cloned mu-opioid receptor	0.00980392156863
MOP	μ-opioid	0.0769230769231
MOP	rmu-opioid receptor	0.0769230769231
MOP	mu-opioid peptide	0.0769230769231
MOP	)	0.0769230769231
MOP	μ opioid	0.153846153846
MOP	μ opioid peptide	0.0769230769231
MOP	mu opioid receptor	0.153846153846
MOP	mu opioid	0.0769230769231
MOP	mu-opioid receptors	0.0769230769231
MOP	mu opioid peptide	0.153846153846
6S-BH4	6s-tetrahydrobiopterin	1.0
NECA	5′-n-ethylcarboxamido-adenosine	0.1
NECA	n-ethylcarboxamidoadenosine	0.2
NECA	5′-n-ethyl-carboxamidoadenosine	0.1
NECA	5′-(n-ethylcarboxamido)adenosine	0.1
NECA	5′-n-ethylcarboxamidoadenosine	0.2
NECA	5′-(n-ethylcarboxamido)-adenosine	0.1
NECA	5′-n-ethylcarboxamide adenosine	0.1
NECA	5′-(n-ethylcarboxamido) adenosine	0.1
MOI	multiplicity of infectivity	0.0833333333333
MOI	multiplicities of infection	0.0833333333333
MOI	multiplicity of infection	0.833333333333
LPC-	2late positive component-2	1.0
Cdk5	cyclin-dependent kinase 5	1.0
MOM	mouse on mouse	0.5
MOM	orphine/odn	0.5
MOL	molecular layer of the dentate gyrus	1.0
MOC	medial olivocochlear system	0.166666666667
MOC	medial olivocochlear	0.833333333333
MOB	main olfactory systems	0.0181818181818
MOB	main olfactory bulb	0.963636363636
MOB	the main olfactory bulb	0.0181818181818
MOA	monoamine oxidase	1.0
BZGABAA	associated benzodiazepine binding sites	1.0
MOG	myelin/oligodendrocyte glycoprotein	0.047619047619
MOG	35–55myelin oligodendrocyte glycoprotein peptide 35–55	0.047619047619
MOG	middle occipital gyrus	0.047619047619
MOG	myelin-oligodendrocyte glycoprotein	0.0952380952381
MOG	myelin oligodendrocyte glycoprotein	0.761904761905
MOE	main olfactory epithelium	1.0
MOD	modafinil	0.5
MOD	mean optical density	0.5
ETR	entry to repeat	1.0
ETS	electron transport system	1.0
Ap4A	diadenosine teraphosphate	0.5
Ap4A	diadenosine tetraphosphate	0.5
CNQX6-cyano-7-nitroquinoxiline-2	3-dione	1.0
ETU	elementary temporal-unit	1.0
ALLOallopregnanolone	3α-hydroxy-5α-pregnan-20-one	1.0
ETX	ethosuximide	1.0
KMK	unming	1.0
ETB	endothelin type b receptor	0.2
ETB	receptor	0.2
ETB	receptorendothelin b receptor	0.2
ETB	endothelin receptor-b	0.2
ETB	endothelin b receptor	0.2
ETC	errors-to-criterion	0.0555555555556
ETC	external tufted cell	0.111111111111
ETC	electron transport chain	0.777777777778
ETC	sexternal tufted cells	0.0555555555556
hNSE	mouse anti-neuron-specific enolase	1.0
KMT	lysine methyl-transferase	1.0
ETF	electron-transferring flavoprotein	0.5
ETF	ear tip fibroblast	0.5
Board	is, internal standard	1.0
ETE	estimated tissue equivalents	1.0
CMMC	scolonic-migrating motor complexes	1.0
ETH	ethosuximide	1.0
ETI	eticlopride	1.0
ETM	elevated t maze	1.0
hTERT	human telomerase	1.0
mPGES-	1	0.25
mPGES-	2membrane-associated prostaglandin e synthase-2	0.25
mPGES-	1microsomal prostaglandin e synthase-1	0.5
CPFE	context preexposure facilitation effect	0.5
CPFE	context pre-exposure facilitation effect	0.25
CPFE	context pre-exposure facilitation effect paradigm	0.25
pO2	partial pressure of oxygen	1.0
GRP-R	gastrin releasing peptide receptor	0.666666666667
GRP-R	exgastrin-releasing peptide receptor–egfp transfected and expressing	0.333333333333
sstSRIF	receptor subtype	1.0
SSRI	sseizure-suppressing effect of selective 5-ht reuptake inhibitors	0.0121951219512
SSRI	serotonin reuptake inhibitor	0.0365853658537
SSRI	selective serotonin reuptake inhibitor	0.487804878049
SSRI	selective 5-ht reuptake inhibitors	0.0121951219512
SSRI	serotonin selective reuptake inhibitor	0.0121951219512
SSRI	’sselective serotonin reuptake inhibitors	0.0121951219512
SSRI	sserotonin selective reuptake inhibitors	0.0121951219512
SSRI	5-ht selective reuptake inhibitors	0.0121951219512
SSRI	selective 5-ht reuptake inhibitor	0.0975609756098
SSRI	5-ht selective reuptake inhibitor	0.0121951219512
SSRI	sserotonin selective reuptake blockers	0.0121951219512
SSRI	selective serotonin re-uptake inhibitor	0.0365853658537
SSRI	sselective serotonin reuptake inhibitors	0.170731707317
SSRI	serotonin-selective re-uptake inhibitor	0.0121951219512
SSRI	selective serotonin reuptake inhibitors	0.0487804878049
SSRI	exposure	0.0121951219512
mBMSC	mouse bone marrow stromal cell	1.0
BLAamygdala	basolateral nucleus	1.0
hnRNP-K	heterogeneous nuclear ribonucleoprotein k	1.0
TCAs	thalamocortical axons	1.0
hROS	highly-reactive oxygen species	1.0
AAI	adult attachment interview	1.0
THAd	l-threo-beta-hydroxyaspartate	1.0
DHAA	dehydroascorbic acid	1.0
IVGTT	intravenous glucose tolerance test	1.0
NADPH	reduced nicotinamide adenine dinucleotide phosphate	0.25
NADPH	nicotinic adenine dinucleotide phosphate	0.00625
NADPH	dnicotinamide adenine dinucleotide phosphate-diaphorase	0.00625
NADPH	oxidasenicotinamide adenine dinucleotide phosphate oxidase	0.00625
NADPH	β-nicotinamide adenine dinucleotide phosphate (reduced form)	0.00625
NADPH	nicotinamide adenine dinucleotide phosphate hydrogen	0.00625
NADPH	beta-nicotinamide adenine dicnucleotide phosphate sodium salt	0.00625
NADPH	nicotinamide adenine dinucleotide phosphate reduced form	0.00625
NADPH	reduced forms of nicotinamide adenine dinucleotide phosphate	0.00625
NADPH	dnadph diaphorase	0.0125
NADPH	nicotinamide adenosine dinucleotide phosphate	0.00625
NADPH	+, reduced nicotinamide adenine dinucleotide phosphate-diaphorase	0.00625
NADPH	β-nicotinamide adenine dinucleotide phosphate	0.00625
NADPH	dreduced nicotinamide adenine dinucleotide phosphate diaphorase	0.00625
NADPH	nicotinamide adenine dinucleotide phosphate-oxidase	0.03125
NADPH	nicotinamide adenine dinucleotide phosphate	0.3875
NADPH	reduced nicotinamide adenine dinucleotide phosohate	0.00625
NADPH	reduced β-nicotinamide adenine dinucleotide phosphate	0.00625
NADPH	reduced nicotinamide dinucleotide phosphate	0.00625
NADPH	oxidasenicotinamide adenine dinucleotide phosphate-oxidase	0.00625
NADPH	nicotinamide-adenine dinucleotide phosphate	0.00625
NADPH	diaphorase	0.025
NADPH	nicotinamide adenine dinucleotide phosphate diaphorase	0.00625
NADPH	nicotiamide adenine dinucleotide phosphate	0.00625
NADPH	nicotinamide adenine dinucleotide phosphate hydride	0.00625
NADPH	oxidase	0.08125
NADPH	nicotinamide adenine dinucleotide phosphate (reduced)	0.00625
NADPH	d	0.00625
NADPH	nicotine adenine dinucleotide phosphate	0.00625
NADPH	nicotinamide adenine dinucleotide phosphate (reduced form)	0.01875
NADPH	nicotinamide adenine dinucleotide phosphate, reduced form	0.0125
NADPH	reduced form of nicotinamide adenine dinucleotide phosphate	0.025
NADPH	reduced nicotinamide adenine dinucleotide	0.00625
NADPH	reduced nicotinamide adenosine dinucleotide phosphate	0.00625
gDNA	genomic dna	0.5
gDNA	genomic deoxyribonucleic acid	0.5
nanoLC-MS	/msnanoscale liquid-chromatography tandem mass spectrometry	1.0
c-REM	carbachol-induced rapid eye movement	1.0
4HNE	hydroxynonenal	0.5
4HNE	4-hydroxy-2(e)-nonenal	0.5
LAα-	lipoic acid	1.0
TCAP	teneurin c-terminal-associated peptide	1.0
TDST	ongue drive system	1.0
E-AUG	augmenting expiratory	1.0
QNP	quinpirole	1.0
EPQE	ysenck personality questionnaire	1.0
6hRF	restricted feeding: 6 h daily meal	1.0
YSyoung	small litter size	1.0
EDEC	neuronexpiratory neuron with decrementing firing pattern	1.0
FLICE	caspase 8/fadd-like il-1 beta-converting enzyme	1.0
DRd	dorsomedial region of b7 cell group (dorsal raphe)	1.0
Fas-L	fas ligand	1.0
QNB	3-quinuclidinylbenzilate	0.166666666667
QNB	quinuclidinylbenzilate	0.166666666667
QNB	quinuclidinyl benzilate	0.666666666667
LCAL	eber congenital amaurosis	1.0
BLOTTO	phosphate-buffered saline containing 4% dried non-fat milk	0.5
BLOTTO	4% dried non-fat milk in phosphate-buffered saline	0.5
ET-	1endothelin 1	0.0909090909091
ET-	1endothelin-1	0.863636363636
ET-	3endothelin-3	0.0454545454545
FUMH	fumarate hydratase	1.0
sPSP	spontaneous postsynaptic potential	1.0
TMPD	tetramethylphenylenediamine	1.0
αE2	17-α-estradiol	0.5
αE2	17α-estradiol	0.5
iFBP	ipsilateral furry buccal pad	1.0
CVR	cell volume regulation	0.333333333333
CVR	cerebrovascular resistance	0.666666666667
CVS	chronic variable stress	0.666666666667
CVS	caloric vestibular stimulation	0.166666666667
CVS	chronic variable stressors	0.166666666667
CVN	scardiac vagal neurons	0.333333333333
CVN	cardiac vagal neurons	0.166666666667
CVN	scardioinhibitory vagal neurons	0.166666666667
CVN	cardiac vagal neuron	0.333333333333
CVO	circumventricular organ	0.5
CVO	circumventricular organs	0.125
CVO	circumoventricular organ	0.0625
CVO	scircumventricular organs	0.3125
4VO	four-vessel occlusion	1.0
CVM	caudal ventral medulla	0.5
CVM	chronic variable mild	0.5
Rp-cAMPS	rp-adenosine 3′,5′-cyclic monophosphothioate triethylamine	0.25
Rp-cAMPS	rp-adenosine-3′,5′-cyclic monophosphorothioate	0.5
Rp-cAMPS	adenosine 3′,5′-cyclic monophosphothioate	0.25
FMR1	human fragile x mental retardation 1 gene	0.5
FMR1	fmr1fragile x mental retardation 1 gene or transcript	0.5
SPVZ	subparaventricular zone	1.0
CVD	cerebrovascular disease	0.25
CVD	control vaginal delivery	0.5
CVD	cardiovascular disease	0.25
CVE	cerebral vascular endothelial	1.0
CVC	cutaneous vasoconstrictor (neuron)	0.142857142857
CVC	ontrol+vehicle	0.142857142857
CVC	resyl violet	0.714285714286
SVZDL	dorsolateral subventricular zone	1.0
VLLPBN	ventrolateral lpbn	1.0
PGFF-	prostaglandin	1.0
RGS-	19regulator of g protein signalling 19	1.0
ChE	cholinesterase	1.0
SpVO	spinal trigeminal nucleus, pars oralis	1.0
bS	lobovine slo channel	1.0
RGS4	regulator of g protein signaling 4	1.0
RGS7	r7regulator of g protein signaling 7	1.0
CXIV	–vilaminae iv–vi of cerebral cortex	1.0
EHAE	arth-horizontal axis	1.0
ICV-STZ	intracerebroventricular-streptozotocin	1.0
NDRG	2n-myc downstream-regulated gene 2	1.0
lSON	lateral division of the supraoptic nucleus	1.0
AMPPNP	5′-adenylyl-β,γ-imidodiphosphate	1.0
ISZI	n situ zymography	1.0
PBST-Az	pbst with 0.1% sodium azide	1.0
FJCF	luro jade-c	0.333333333333
FJCF	luoro-jade c	0.333333333333
FJCF	luorojade c	0.333333333333
CaMII	calmodulin gene ii	1.0
RGSR	egulator of g protein signaling	1.0
AMAXA	brand name of the nucleofector device and associated reagents	1.0
FMRI	functional magnetic resonance imaging	0.75
FMRI	functional magnetic resonance imagin	0.25
ABD-F	7-fluoro-4-sulfamoyl-2,1,3-benzoxadiazole	1.0
KIAA	1199	0.5
KIAA	2022	0.5
FMRF	amideh-phenylalanine-methionine-arginine-phenylalanine-nh2	1.0
ARDS	acute respiratory distress syndrome	1.0
CV-	2inverse square of the coefficient of variation	0.5
CV-	2squared coefficient of variation	0.5
FMRP	fragile x mental retardation protein 1	0.0526315789474
FMRP	fragile x mental retardation protein	0.736842105263
FMRP	human fragile x mental retardation 1 protein	0.0526315789474
FMRP	+fmrp positive	0.0526315789474
FMRP	fmrpfragile x mental retardation protein	0.0526315789474
FMRP	fmr1 protein	0.0526315789474
MAP1B-P	phosphorylated isoform of map1b-p defined by the monoclonal antibody 1b-p	1.0
TTPV	time to peak velocity	1.0
TMP2	4,6-trimethylphenol	1.0
AFRRA-	fiber-mediated reflex responses	1.0
t-A	kttotal akt	1.0
VLBW	very low birth weight	1.0
BARTB	alloon analog risk task	1.0
vHIPP	ventral hippocampus	1.0
DERM-SAP	dermorphin-saporin	1.0
ADNF-	9	1.0
SST-LI	somatostatin-like immunoreactivity	1.0
WDR	wide dynamic neuron	0.025641025641
WDR	wide-dynamic range neurons	0.025641025641
WDR	neurone	0.025641025641
WDR	wide dynamic range	0.564102564103
WDR	neuron	0.025641025641
WDR	wide-dynamic-range	0.102564102564
WDR	wide-dynamic range	0.128205128205
WDR	neurons	0.025641025641
WDR	wide dynamic range cells	0.0512820512821
WDR	wide dynamic range (neurons)	0.025641025641
WDS	wet-dog-shakes	0.5
WDS	wet-dog shakes	0.5
Aβ40	amyloid β1–40	1.0
CANP	calcium-activated neutral protease	1.0
WDW	estern diet	0.4
WDW	allerian degeneration	0.6
SIHT	stress-induced hyperthermia test	1.0
TFLZn	n-(6-methoxy-8-quinoyly)-p-carboxybenzoylsulphonamide	1.0
s-PF	subparafascicular nucleus	1.0
FPFIX	static fixation	1.0
Ad-GFP	adenoviruses expressing green fluorescent protein	1.0
PDGFα-R	platelet-derived growth factor α receptor	1.0
dMGC	dorsal division of the medial geniculate complex	1.0
-N-methylbenzylamine	phosphate	1.0
MIR	morphine-induced group with sirack1 plasmid	1.0
EKG	electrocardiography	0.166666666667
EKG	electrocardiograph	0.166666666667
EKG	electrocardiogram	0.666666666667
RES	restrained/restraint	0.5
RES	reserpine	0.5
phenylethanolamine-N-	methyltransferase	1.0
PBS-GPBS	containing 5% normal goat serum	1.0
KOPκ	opioid peptide	1.0
Trk	neurotrophic factor receptor, tyrosine kinase	0.0833333333333
Trk	tyrosine protein kinase receptor	0.0833333333333
Trk	troponyosin receptor kinase	0.0833333333333
Trk	receptor tyrosine kinase	0.0833333333333
Trk	tyrosine receptor kinase	0.0833333333333
Trk	tyrosine kinase	0.333333333333
Trk	neurotrophin tyrosine kinase receptor	0.0833333333333
Trk	tyrosine kinase receptor	0.166666666667
GLSG	uanglingsan	1.0
EKC	/dendokinin c and endokinin d	0.5
EKC	ethylketocyclazocine	0.5
5HT	1a autoreceptor	0.0526315789474
5HT	5-hydroxytryptamine, serotonin	0.0263157894737
5HT	1a and 5ht2aserotonin receptors	0.0263157894737
5HT	5hydroxytryptamine (serotonin)	0.0263157894737
5HT	3aionotropic serotonin receptor	0.0263157894737
5HT	3rserotonin 3 receptor	0.0263157894737
5HT	serotonin/serotonergic	0.0263157894737
5HT	serotonin	0.421052631579
5HT	1aserotonin 1a (receptor)	0.0263157894737
5HT	2c receptors	0.0263157894737
5HT	5-hydroxy tryptophan	0.0263157894737
5HT	2a receptor	0.0263157894737
5HT	2c	0.0263157894737
5HT	5-hydroxytryptamine	0.184210526316
5HT	1a-receptors	0.0263157894737
5HT	1a	0.0263157894737
NIBS	non-invasive brain stimulation	1.0
bpV	(pic)dipotassium bisperoxo (pyridine-2-carboxyl) oxovanadate	1.0
Trp	w) and aspartic acid (asp, d) amino acids	1.0
S4	sleep stages 1–4	1.0
BSTIA	intraamygdaloid bed nucleus of the stria terminalis	1.0
IKKIκB	kinase	1.0
BiBN-99	5,11-dihydro-chloro-11-((4-(3-((2,2-dimethyl-1-oxo-pentyl)ethylamino)propyl)-1-piperidinyl)acetyl)-6h-pyridol(2,3-b) (1,4) benzodiazepin-6-one	1.0
TrK	tyrosine kinase receptor	0.5
TrK	tyrosine kinase	0.5
BIR	birefringence	0.25
BIR	baculovirus inhibitory repeat	0.25
BIR	baculoviral inhibitor repeat	0.25
BIR	baculoviral inhibitor of apoptosis repeat	0.25
TrC	trigeminal nuclear complex	1.0
NIH-ID	neuronal intranuclear hyaline inclusion disease	1.0
NOx-	total no metabolite (nitrite plus nitrate)	1.0
CO-I	cytochrome c oxidase subunit i	1.0
araC	cytosine-d-arabinofuranoside	1.0
DNase	deoxyribonuclease	1.0
BIP	binding immunoglobulin protein	0.5
BIP	bursting activity-inducing peptide	0.5
D-FITC	fluorescein isothiocyanate-conjugated dextran	1.0
AFB	animal-free blocker	1.0
CARS-MC	linician-administered rating scale for mania factor 1	1.0
mtPAGFP	mitochondria-targeted photoactivatable green fluorescent protein	1.0
L-NNAN-	omega-nitro-l-arginin	1.0
3-HPG	(s)-3-hydroxyphenylglycine	1.0
DDAH	1n(g),n(g)-dimethylarginine dimethylaminohydrolase 1	1.0
Hediger	1992)	1.0
ELME	ukaryotic linear motifs	1.0
CGS-12066A	7-trifluoromethyl-4(4-methyl-1-piperazinyl)-pyrrolo[1,2-a]quinoxaline	1.0
HCSS	hepes-buffered control salt solution	1.0
RYGBR	oux-en-y gastric bypass	1.0
PLMD	periodic leg movement disorder	1.0
REC	recording	0.166666666667
REC	recovery	0.5
REC	retinal explant cultures	0.166666666667
REC	rectus femoris	0.166666666667
JMJD	5jumonji domain containing 5	1.0
RDRR	ey's 15 delayed recall	1.0
FHVS	female hamster vaginal secretions	1.0
β-Gal	β-galactosidase	1.0
a-CNTF	mmonoclonal mouse–anti-rat ciliary neurotrophic factor	0.5
a-CNTF	mmonoclonal mouse-anti-rat ciliary neurotrophic factor	0.5
3α5α-THP	3α,5α-tetrahydroprogesterone	1.0
MSGR	motion sickness growth rate	1.0
IP3Rsinositol-1	4, 5-triphosphate receptors	0.5
IP3Rsinositol-1	4,5-trisphosphate receptors	0.5
TRANSIENT	the five onsets immediately following the pulse	1.0
RTI-121	3β-(4-iodophenyl)tropane-2β-carboxylic acid isopropyl ester	0.6
RTI-121	3β-[4-(trimethylstannyl)phenyl]-tropan-2β-carboxylic acid isopropyl ester	0.4
GACSF	glycerol-based artificial cerebrospinal fluid	1.0
ATE	atenolol	0.5
ATE	acute exercise training	0.5
I-VS	imagery and visuo-spatial working memory task	1.0
SRBC	sheep red blood cell	1.0
New2	first and second recording session in a new arena	1.0
FCS	fetal calf serum	0.929824561404
FCS	fetal calcium serum	0.00877192982456
FCS	foetal calf serum	0.0438596491228
FCS	fluorescence correlation spectroscopy	0.00877192982456
FCS	fetal bovine serum	0.00877192982456
NAcVERT	vertex of the nucleus accumbens shell	1.0
OLETFO	tsuka long-evans tokushima fatty	0.333333333333
OLETFO	tsuka long evans tokushima fatty	0.666666666667
UBD	urinary bladder distension	1.0
KA-SE	kainic acid status epilepticus	0.5
KA-SE	kainic acid-induced status epilepticus	0.5
AROU	arousal phase of hibernators	1.0
maxMEP	100% maximum stimulator output when active motor threshold exceeded 50%	1.0
t-BHP	tert-butylhydroperoxide	1.0
LFC	longitudinal fissure of cerebrum	0.333333333333
LFC	left forelimb contact	0.333333333333
LFC	low fat control	0.333333333333
PAI-	1plasminogen activator inhibitor 1	0.142857142857
PAI-	2plasminogen activator inhibitor 2	0.142857142857
PAI-	1plasminogen activator inhibitor type 1	0.285714285714
PAI-	1plasminogen activator inhibitor	0.142857142857
PAI-	1plasminogen activator inhibitor-1	0.285714285714
NLOT	nucleus of the lateral olfactory tract	1.0
COC-M	cocaine-methiodide	1.0
PRODH	proline dehydrogenase	1.0
IMLF	interstitial nucleus of the medial longitudinal fasciculus	1.0
uniORN	unilaterally projecting orn	1.0
dPM	dorsal premotor cortex	1.0
ILN	interlayer neuron	1.0
dihydro-ceramideD-erythro-dihydro-sphingosine	n-acetyl-	1.0
CRECCab45	reticulocalbin, erc-55, calumenin	1.0
17βE	17β-estradiol	1.0
SLI	sschmidt-lanterman incisures	0.5
SLI	specific language impairment	0.5
F3N-BDNF	brain-derived neurotrophic factor-secreting cells	1.0
ESTE	xpressed sequence tag	0.333333333333
ESTE	astern standard time	0.666666666667
F3A-NTN	neurturin-secreting cells	1.0
GAMT	guanidinoacetate methyl transferase	0.333333333333
GAMT	s-adenosyl-l-methionine:n-guanidinoacetate methyltransferase	0.333333333333
GAMT	guanidinoacetate-methyltransferase	0.333333333333
SOSS	ystematic screening of handwriting difficulties	1.0
PFLH	perifornical lateral hypothalamus	1.0
CRGO	%relative go-performance (change of shuttle-box compartment)	1.0
MLVM	oloney murine leukaemia virus	1.0
cAV	congruent audiovisual stimuli	1.0
CMF-BSS	ca2+/mg2+-free bss	1.0
ESTR	17β-estradiol	1.0
sPSD	segmented post-synaptic density	1.0
factor-IL	6	1.0
LIM-	type homeobox genes	0.5
LIM-	homeodomain	0.5
SOSI	orientation selectivity index of surround effect	1.0
sPSC	sspontaneous postsynaptic currents	0.444444444444
sPSC	sspontaneous pscs	0.111111111111
sPSC	spontaneous postsynaptic current	0.333333333333
sPSC	spontaneous psc	0.111111111111
27-OH	chol27-hydroxycholesterol	1.0
YVAD-CMK	n-acetyl-tyr-val-ala-asp-chloromethylketone	1.0
LFT	light finger touch	1.0
PCREB	phosphorylated camp response element binding protein	1.0
cPRC	scumulative phase response curves	1.0
SNAPS-nitroso-d	l-penicillamine	1.0
SMLA	super-active mouse leptin antagonist	1.0
R-ODR	rotatory oculomotor delayed-response	1.0
CORIII	cortex layer iii	1.0
SLC	sschmidt–lanterman clefts	0.0666666666667
SLC	6asolute carrier 6a	0.0666666666667
SLC	10solute carrier family 10	0.133333333333
SLC	4 family	0.0666666666667
SLC	22a2	0.0666666666667
SLC	1a3solute carrier family1 or member 3 (gene name)	0.0666666666667
SLC	solute carrier	0.2
SLC	18a1	0.0666666666667
SLC	6a8solute carrier family 6	0.0666666666667
SLC	4solute carrier 4	0.133333333333
SLC	6solute carrier 6	0.0666666666667
HYPOX	hypophysectomized	1.0
DRMrDRMm	and drmc, rostral, middle, or caudal drm	1.0
dCN	deep cerebellar nuclei	1.0
LICI	long-interval intracortical inhibition	0.5
LICI	long-latency cortical inhibition	0.5
PbAc	lead acetate	1.0
d-JNKI	1d-retro-inverso form of c-jun n-terminal kinase-inhibitor	1.0
cSNc	central substantia nigra, pars compacta	1.0
SULT	sulfotransferase	1.0
ISGS	inferior sagittal sulcus	1.0
SULP	sulpiride	1.0
dCA	3dorsal field 3 of ammon’s horn	1.0
mtH	tthuntingtin mutant protein	1.0
NHEN	a–h exchanger	0.25
NHEN	aples high excitability	0.25
NHEN	a+/h+ exchanger	0.25
NHEN	a/h exchange	0.25
pSCN	peri–suprachiasmatic nucleus	1.0
miRNA	mirmicrorna	0.0625
miRNA	microrna	0.3125
miRNA	micrornas	0.125
miRNA	smicrornas	0.5
WST-1	4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2h-5-tetrazolio]-1,3-benzene disulfonate	1.0
CeLcn	central nucleus, lateral central division	0.5
CeLcn	central amygdaloid nucleus, lateral subdivision	0.5
CLAT	latency to peak of the n30 auditory potential evoked by the first (conditioning) click	0.5
CLAT	conditioning latency	0.5
mtD	sred2mitochondria-targeted red fluorescent protein	1.0
NHEK	snormal human epidermal keratinocytes	1.0
MCH	+neurons immunoreactive for melanin concentrating hormone	0.0212765957447
MCH	melanin-concentrating hormone	0.68085106383
MCH	4-methylcyclohexanol	0.0212765957447
MCH	melanin concentrating hormone	0.255319148936
MCH	mean cell hemoglobin	0.0212765957447
SPW-R	sharp wave–ripple	0.4
SPW-R	sharp wave-ripple complex	0.2
SPW-R	sharp-wave-ripple complexes	0.2
SPW-R	ssharp wave-ripple complexes	0.2
ROMK	1potassium inwardly rectifying channel	1.0
-UTR	3′untranslated region	0.166666666667
-UTR	3′-untranslated region	0.833333333333
cSNP	coding single nucleotide polymorphism (snp in protein-coding region)	1.0
CLAP	clathrin-ap2 binding	1.0
DSHBD	evelopmental studies hybridoma bank	1.0
GFS	static level of grip force	0.5
GFS	gyrus frontalis superior	0.5
S-3HPG	s-3-hydroxyphenylglycine	1.0
τAR	anomalous rectification time constant	1.0
VS1	1st visual stimulus	1.0
VS2	2nd visual stimulus	1.0
TWF	1twinfilin 1	1.0
TWK	potassium channels with two “p” (pore-forming) domains per subunit	1.0
FNIRTFMRIB	's non-linear image registration tool	0.5
FNIRTFMRIB	's non-linear registration tool	0.5
MCB	monochlorobimane	0.75
MCB	multiple comparison with the best	0.25
TWR	tuning width ratio	1.0
APAAP	alkaline phosphatase-anti-alkaline phosphatase	1.0
TWT	triple wild type	1.0
NIPP-	1nuclear inhibitor of protein phosphatase 1	1.0
EYFP	yellow fluorescent protein	0.125
EYFP	enhanced yellow fluorescent protein	0.75
EYFP	enhanced green fluorescent protein	0.125
CP-101	606	0.5
CP-101	606(1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol	0.5
stPVNPVN	electric stimulation	1.0
AMMA	advanced measures of music audiation	1.0
SMCI	stable mild cognitive impairment	1.0
TREK-1	twik-1 related k+ channel	1.0
QS-H	quiet sleep with high-voltage eeg	1.0
SP-ir	substance p-immunoreactivity	1.0
QS-M	quiet sleep with moderate-voltage eeg	1.0
DMhp	dorsomedial nucleus	1.0
GFI	increments of grip force	1.0
GCOSG	enechip operating software	0.5
GCOSG	ene chip operating software	0.5
Dp	dorsal portion of medial vestibular nuclei	1.0
STDEV	standard deviation	1.0
BSTB	lock-suppression-test	1.0
D-AAO	d-amino acid oxidase	1.0
ANLSH	astrocyte-neuron lactate shuttle hypothesis	1.0
MEK-1	map kinase kinase	1.0
OIFO	peration iraqi freedom	1.0
ω-CgTX	ω-conotoxin gvia	1.0
CP-AMPA	receptor	1.0
IATI	mplicit association test	1.0
GFL	glial cell line-derived neurotrophic factor family ligands	0.333333333333
GFL	sgdnf family ligands	0.333333333333
GFL	glial cell line–derived neurotrophic factor family of ligands	0.333333333333
cone-ON-BC	cone-dominant on type bc	1.0
MCX	+tcastrated male quail treated with exogenous testosterone	1.0
3-ATA	3-amino thioacridone	1.0
Lgals3lectin	galactose binding, soluble 3	1.0
CRMP-	2collapsin response mediator protein-2	0.25
CRMP-	2collapsing response mediator protein 2	0.25
CRMP-	2	0.25
CRMP-	2collapsin response mediator protein 2	0.25
DHED	ihydroethidium	1.0
DHEA	docosahexaenoyl ethanolamine/synaptamide	0.0357142857143
DHEA	dehydroepiandosterone	0.0357142857143
DHEA	dehydroepiandrosterone	0.892857142857
DHEA	(s)both dhea and dheas	0.0357142857143
ATF-	1activating transcription factor 1	0.0588235294118
ATF-	1activating transcription factor-1	0.0588235294118
ATF-	2activating transcription factor-2	0.0588235294118
ATF-	1activation transcription factor-1	0.0588235294118
ATF-	3activating transcription factor-3	0.117647058824
ATF-	3activating transcription factor 3	0.235294117647
ATF-	2activating transcription factor 2	0.294117647059
ATF-	4activating transcription factor-4	0.117647058824
VSR	vestibulospinal reflex	0.75
VSR	vestibulo-spinal reflex	0.25
VSS	very stress sensitive	0.5
VSS	vertigo symptom scale	0.5
VST	vestibulospinal tract	0.666666666667
VST	ventral striatum	0.333333333333
VSV	vesicular stomatitis virus	1.0
R-CPP	3-([r]-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.333333333333
R-CPP	3-[(r)-carboxypiperazin-4-yl]-propyl-phosphonic acid	0.333333333333
R-CPP	3-((r)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate	0.333333333333
LVNd	lateral vestibular nucleus, dorsal part	1.0
VNAB	ventral noradrenergic bundle	0.5
VNAB	ventral noradrenergic ascending bundle	0.5
ELISAE	nzyme-linked immunosorbent assay	0.6
ELISAE	nzyme linked immunosorbent assay	0.4
TPOH	tryptophan hydroxylase	1.0
HIPP	ventral hippocampus	0.0714285714286
HIPP	hilar perforant path-associated	0.142857142857
HIPP	dorsal hippocampus	0.0714285714286
HIPP	hippocampus proper	0.0714285714286
HIPP	hilar perforant path	0.0714285714286
HIPP	hilar perforant path-associated cell	0.0714285714286
HIPP	hippocampus	0.428571428571
HIPP	hippocampal formation	0.0714285714286
PCCA	/pccαpropionyl-coa carboxylase alpha-subunit	1.0
DAGL	diacylglycerol lipase	1.0
VSC	ventral subcoeruleus	0.25
VSC	4.1ventral spinal cord cells clone 4.1	0.25
VSC	visuospatial cueing	0.25
VSC	4.1 motoneurons	0.25
VSD	voltage-sensitive dye imaging	0.0909090909091
VSD	voltage sensitive dye	0.181818181818
VSD	voltage-sensitive dye	0.545454545455
VSD	(i)voltage-sensitive dye (imaging)	0.0909090909091
VSD	variable stimulus duration	0.0909090909091
OSMRβ	oncostatin m receptor β	1.0
hPRL	human prolactin	1.0
VSG	ventral swallowing group	1.0
IMFI	ntrinsic mode functions	1.0
LVNv	lateral vestibular nucleus, ventral part	1.0
VSL	+shventral subicular–lesioned rats reared in standard housing condition	1.0
JMP	jumping	1.0
VSN	vomeronasal sensory neuron	1.0
cPGES	cytosolic prostaglandin-e synthase	1.0
EOB	external oblique	1.0
2-MeS-ATP	2-methylthio adenosine 5′-triphosphate	0.5
2-MeS-ATP	2-methylthio-atp	0.5
EOG	electroocculogram	0.0111111111111
EOG	electrooculogram	0.588888888889
EOG	electro-oculographic	0.0111111111111
EOG	electro-oculogram	0.233333333333
EOG	selectrooculograms	0.0222222222222
EOG	selectro-oculograms	0.0111111111111
EOG	electro-olfactogram	0.0333333333333
EOG	electro-oculography	0.0222222222222
EOG	electrooculograms	0.0111111111111
EOG	electrooculogram or -graphy or -graphic	0.0111111111111
EOG	electrooculographic	0.0111111111111
EOG	electrooculographic, electrooculogram	0.0111111111111
EOG	electrooculography	0.0111111111111
EOG	electroculographic activity	0.0111111111111
EOF	eyes open on foam	1.0
EOE	nd organ group	1.0
EOD	every other day	0.125
EOD	electric organ discharge	0.875
HCNP	hippocampal cholinergic neurostimulating peptide	1.0
pVHLH	ippel–lindau tumor-suppressor protein	1.0
IMHV	intermediate, medial part of the hyperstriatum ventrale	0.0625
IMHV	intermediate medial neostriatum ventrale	0.0625
IMHV	intermediate medial hyperstriatum ventrale	0.4375
IMHV	intermediate hyperstriatum ventrale	0.125
IMHV	intermediate and medial part of the hyperstriatum ventrale	0.3125
dODN	degenerated oligonucleotide	0.2
dODN	degenerated antisense oligonucleotide	0.2
dODN	degenerate oligodeoxynucleotide	0.4
dODN	degenerate oligonucleotide	0.2
EOM	extraocular muscles	0.25
EOM	sextraocular muscles	0.5
EOM	extraocular muscle(s)	0.25
GrDG	granule cell layer of dentate gyrus	1.0
iEMG	integrated emg	1.0
EOP	endogenous opioid peptide	0.5
EOP	endogenous opioid peptides	0.5
HCNA	94	1.0
Mib-CK	sarcomeric isoform of mi-ckm	1.0
PDVF	polyvinylidene difluoride	1.0
CBQCA	3-(4-carboxybenzoyl)-2-quinoline carboxaldehyde	1.0
FFPE	formalin-fixed paraffin embedded	1.0
BGB	ergmann glia	1.0
RNAPRNA	polymerase	1.0
sPSCs	spontaneous postsynaptic currents	1.0
FAIRE	formaldehyde-assisted isolation of regulatory elements	1.0
IE-LTD	long-lasting depression of intrinsic excitability	1.0
OCAM	olfactory cell adhesion molecule	1.0
BLAp	basolateral nucleus, amygdala, posterior part	1.0
β-PMAβ-	phorbol 12-myristate 13-acetate	1.0
SPIO	superparamagnetic iron oxide	1.0
ROIR	egion of intertest	1.0
irC-INSL	7c-peptide of human preproinsulin-like peptide 7 immunoreactivity	1.0
DPBSD	ulbecco's modified phosphate buffered saline	0.111111111111
DPBSD	ulbecco’s pbs solution	0.111111111111
DPBSD	ulbecco's phosphate buffered saline	0.111111111111
DPBSD	ulbecco's phosphate-buffered saline	0.333333333333
DPBSD	ulbecco’s phosphate-buffered saline	0.222222222222
DPBSD	ulbecco's phosphate buffer saline	0.111111111111
RONNR	egional order neural network	1.0
VNn	vestibular nuclei neurons	0.5
VNn	vestibular nucleus neuron	0.5
3α5β-THP	3α,5β-tetrahydroprogesterone	1.0
SDF-	1stromal cell-derived factor-1	0.0833333333333
SDF-	1stromal cell-derived factor	0.0833333333333
SDF-	1αstromal cell derived factor one alpha	0.0833333333333
SDF-	1stromal cell derived factor-1	0.0833333333333
SDF-	1stromal cell-derived factor 1	0.166666666667
SDF-	1αstromal cell–derived factor-1α	0.0833333333333
SDF-	1αstromal cell-derived factor-1α	0.25
SDF-	1αstromal cell-derived factor 1α	0.166666666667
THDOC3α	5α-tetrahydrodeoxycorticosterone	0.5
THDOC3α	21-dihydroxy-5α-pregnan-20-one	0.5
GON	glaucomatous optic neuropathy	1.0
BESA	brain electrical source analysis	0.333333333333
BESA	brain electric source analysis	0.666666666667
APGWamide	the neuropeptide ala-pro-gly-trp-nh2	1.0
P5α	3βiso-allopregnanolone	1.0
pTH	phosphorylated tyrosine hydroxylase	1.0
PIP3phosphatidylinositol-3	4,5-triphosphate	0.666666666667
PIP3phosphatidylinositol-3	4,5-trisphosphate	0.333333333333
NAN-190	1-(2-methoxy-phenyl)-4-[(2-phthalimido)butyl]piperazine	0.5
NAN-190	1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine	0.5
CCAS	cerebellar cognitive affective syndrome	1.0
anti-PY	phosphotyrosine antiserum	1.0
HCN-	irhcn-immunoreactivities	1.0
PTW	pbs with 0.1% tween 20	1.0
TRPL	transient receptor potential-like	1.0
SDS-PAGESDS-	polyacrylamide gel	0.2
SDS-PAGESDS-	polyacrylamide gel electrophoresis	0.8
CCAO	common carotid artery occlusion	1.0
preCG	precentral gyrus	1.0
C-PMN	c-fibre polymodal nociceptor afferents	1.0
HEPESN	′-2-hydroxyethylpiperazine-n′-2 ethanesulphonic acid	1.0
DSGL	dentate supragranular layer	1.0
CYWHSC	hildren youth and women’s health service	1.0
LBDL	ewy body diseases	0.5
LBDL	ewy body disease	0.5
PTR	potentiated transmitter release	1.0
RASR	enin angiotensin system	0.5
RASR	enin–angiotensin system	0.5
NMUR	2neuromedin u receptor 2	1.0
2-P	domain k+ channels	1.0
hDLG	human homologue of the drosophila discs large tumour suppressor protein	1.0
PregS	pregnenolone sulfate	1.0
K-SK	olmogorov–smirnov test	0.0769230769231
K-SK	olmogorov-smirnov	0.923076923077
MVP100	major vault protein 100	1.0
CMM	caudal medial mesopallium	0.125
CMM	caudal midline medulla	0.5
CMM	caudomedial mesopallium	0.25
CMM	central medial medulla	0.125
CML	corticomuscular latency	0.5
CML	intermediolateral column	0.5
SPWBS	sharp wave-like burst stimulation	1.0
EXP	sexually-experienced	1.0
HVAC	high-voltage-activated calcium current	1.0
CMH	c-unit responding to mechanical and heat stimulation	0.25
CMH	mechano- and heat-responsive c-unit	0.25
CMH	c-mechano-heat	0.25
CMH	mechano-heat-sensitive c-fiber	0.25
CMG	cystometrogram	0.5
CMG	scystometrograms	0.25
CMG	cystometry	0.25
CMF	calcium-magnesium-free medium	0.2
CMF	ca2+/mg2+-free hanks' balanced salt solution	0.2
CMF	ca2+-mg2+ free hanks' balanced salt solution	0.2
CMF	calcium–magnesium free	0.2
CMF	calcium/magnesium free ringer’s solution	0.2
CME	clathrin-mediated endocytosis	0.4
CME	corticomotor excitability	0.4
CME	11medium conditioned by nse11	0.2
CMD	scongenital muscular dystrophies	1.0
CMC	carboxymethylcellulose	0.4
CMC	entre median nucleus	0.1
CMC	carboxymethyl cellulose sodium salt	0.1
CMC	carboxymethyl cellulose	0.1
CMC	mechano-cold-sensitive c-fiber	0.1
CMC	mechano-cold-receptive c-fibre	0.1
CMC	carboxy methyl cellulose	0.1
PCW	pneumococcal cell walls	0.5
PCW	pneumococcal cell wall	0.5
CMA	corticomedial amygdala	0.125
CMA	chaperone-mediated autophagy	0.25
CMA	cingulate motor area	0.25
CMA	sconditioned response maximal amplitudes	0.125
CMA	central motor areas	0.125
CMA	chaperon-mediated autophagy	0.125
IN-	1	1.0
ACThCh	acetylthiocholine iodide	1.0
PCN	primary cortical neuron	0.333333333333
PCN	postoptic commissure nucleus	0.166666666667
PCN	paracentral nucleus thalamus	0.166666666667
PCN	sprecerebellar neurons	0.166666666667
PCN	primary cortical neurons	0.166666666667
CMZ	calmidazolium	0.25
CMZ	clomethiazole	0.5
CMZ	circumferential marginal zone	0.25
PCL	purkinje cell layer	0.0833333333333
PCL	cerebellar purkinje cell layer	0.0833333333333
PCL	polycaprolactone	0.166666666667
PCL	pyramidal cell layer	0.583333333333
PCL	pyramidal cell layer or stratum pyramidale	0.0833333333333
PCM	progenitor cell culture medium	1.0
PCB	polychlorinated biphenyl	0.5
PCB	spolychlorinated biphenyls	0.25
PCB	principal cell body	0.25
CMV	cytomegalo virus	0.0333333333333
CMV	cytomegalovirus	0.866666666667
CMV	human cytomegalovirus	0.0333333333333
CMV	mpcytomegalovirus minimal promoter	0.0333333333333
CMV	cytomegaly virus	0.0333333333333
PCA	para-chloroamphetamine	0.0147058823529
PCA	parachloroamphetamine	0.0441176470588
PCA	principal-component analysis	0.0294117647059
PCA	portacaval anastomosis (shunt)	0.0147058823529
PCA	principal components analysis	0.0441176470588
PCA	p-chloroamphetamine	0.176470588235
PCA	perchloric acid	0.132352941176
PCA	principal component analysis	0.455882352941
PCA	posterior cricoarytenoid muscle	0.0441176470588
PCA	posterior cerebral artery	0.0147058823529
PCA	posterior cricoarytenoid	0.0294117647059
2-DG	[14c]2-deoxyglucose	0.0769230769231
2-DG	2-deoxy-d-glucose	0.153846153846
2-DG	2-deoxycglucose	0.0384615384615
2-DG	2-14c deoxyglucose	0.0384615384615
2-DG	2-deoxyglucose	0.653846153846
2-DG	14c-2-deoxyglucose	0.0384615384615
CMR	glcregional glucose metabolic rate	0.25
CMR	cardiosomatic motor reflex	0.25
CMR	glccerebral metabolic rate of glucose	0.25
CMR	glc global cerebral metabolic rate for glucose; dgdeoxyglucose	0.25
PCD	primary ciliary dyskinesia	0.0555555555556
PCD	programmed cell death	0.944444444444
CMP	centre median and parafascicular complex	0.25
CMP	critical maturational period of decreased brain vulnerability to injury	0.25
CMP	compound membrane potential	0.5
CMm	mammillary nucleus	1.0
RVEST	vestibular ratio	1.0
PCr	phosphorylcreatine	0.2
PCr	phosphocreatine	0.8
PCs	ratio of permeabilities to ca2+ and cs+	1.0
BMEC	brain microvessel endothelial cell	1.0
SCG-10	superior cervical ganglia-10	1.0
ONPRCO	regon national primate research center	1.0
DETAPAC	diethylene-triamine penta-acetic acid	1.0
HCHWA-D	hereditary cerebral hemorrhage with amyloidosis—duchtype	1.0
Basso	beattie, bresnahan locomotor rating scale	1.0
C-TAF	1common form of the taf1 gene	1.0
SO	supraoptic nucleus of the hypothalamus	0.0106382978723
SO	sham-operated	0.0106382978723
SO	spontaneous oscillation	0.0106382978723
SO	superior olive	0.0851063829787
SO	sodium orthovanadate	0.0106382978723
SO	superior olivary nucleus	0.0106382978723
SO	sham operation, sham-operated	0.0106382978723
SO	superior olivary complex	0.031914893617
SO	substituted objects	0.0106382978723
SO	superior oblique muscle	0.0106382978723
SO	stratum oriens of ca1	0.0106382978723
SO	somatostatin	0.0106382978723
SO	stratum opticum of superior colliculus	0.0106382978723
SO	stratum oriens	0.308510638298
SO	stratum opticum	0.202127659574
SO	sham-operation	0.0106382978723
SO	sham operated	0.0212765957447
SO	sham operation	0.0106382978723
SO	substituted object in object recognition task	0.0106382978723
SO	stratum opticum (optic layer of superior colliculus)	0.0106382978723
SO	sesame oil	0.0106382978723
SO	slow-twitch oxidative	0.0106382978723
SO	soybean oil	0.0106382978723
SO	supraoptic nucleus	0.148936170213
SO	or sonsupraoptic nucleus	0.0106382978723
PEPS	pericentral spikes	1.0
PEPT	oligopeptide transporter	1.0
DSGC	direction selective ganglion cell	0.5
DSGC	directional selective ganglion cell	0.5
PVNp	parvocellular pvn	0.5
PVNp	hypothalamic paraventricular nucleus, parvocellular	0.5
Q15704-pregnen-11β	21-diol-3,20-dione 21-sulfate sodium salt	1.0
WGAapoHRP	wheat germ agglutinin apo horseradish peroxidase	1.0
ARPP-	19camp regulated phosphoprotein 19	1.0
PEP-	19	0.666666666667
PEP-	19purkinje cells expressed peptide	0.333333333333
OUO	rnstein-uhlenbeck	1.0
dADSC	differentiated adsc	1.0
SNPR	substantia nigra pars reticulata	1.0
RE-	1repressor element-1	1.0
tEE	total energy expenditure	1.0
VLPAG	or vlventrolateral periaqueductal gray matter	0.047619047619
VLPAG	ventrolateral pag	0.047619047619
VLPAG	ventrolateral column of the periaqueductal gray	0.047619047619
VLPAG	ventrolateral part of the periaqueductal gray	0.047619047619
VLPAG	ventrolateral periaqueductal gray	0.809523809524
QUI	quinpirole	1.0
bZIP	basic region/leucine zipper motif	0.333333333333
bZIP	basic leucine zipper	0.333333333333
bZIP	basic domain leucine zipper	0.333333333333
PrPSc	disease-associated, proteinase resistant prion protein	1.0
mRNA	dendritic transport	0.00847457627119
mRNA	amplification	0.0169491525424
mRNA	granules	0.0169491525424
mRNA	localization	0.0169491525424
mRNA	hippocampal cholinergic neurostimulating peptide precursor protein messenger rna	0.00847457627119
mRNA	cb1 expression	0.00847457627119
mRNA	messenger ribonuclein acid	0.00847457627119
mRNA	messenger rna	0.525423728814
mRNA	messenger ribose nucleic acid	0.00847457627119
mRNA	+mrna positive	0.00847457627119
mRNA	s	0.0254237288136
mRNA	levels	0.00847457627119
mRNA	+mrna-positive	0.00847457627119
mRNA	messenger ribonuclear acid	0.00847457627119
mRNA	transcription	0.00847457627119
mRNA	distribution	0.00847457627119
mRNA	expression	0.0762711864407
mRNA	messenger ribonucleic acid	0.220338983051
mRNA	transport	0.00847457627119
MAGL	monoacylglycerol lipase	0.857142857143
MAGL	monoacylglyceride lipase	0.142857142857
SNPC	substantia nigra pars compacta	0.5
SNPC	pars compacta of substantia nigra	0.5
HPG-	axishypothalamus-pituitary-gonadal axis	1.0
VPl	lateral part of the ventral pallidum	0.333333333333
VPl	ventroposterior lateral nucleus	0.333333333333
VPl	ventral posterior lateral nucleus	0.333333333333
MK-801	(5r,10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine hydrogen	0.00740740740741
MK-801	(5r,10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen maleate	0.00740740740741
MK-801	(5r,10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine	0.0222222222222
MK-801	(+)-5-methyl-10,11-dihydroxy-5-dibenzo(a,d)cycloheptene-5,10-imine	0.00740740740741
MK-801	(5r,10s)-(+)-5-methyl-10,11-dihydro-5-h-dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen maleate	0.00740740740741
MK-801	(-)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate	0.00740740740741
MK-801	dizocipline maleate	0.00740740740741
MK-801	dizocilpine	0.0592592592593
MK-801	dizocilpine moleate	0.00740740740741
MK-801	dizocilpine maleate	0.8
MK-801	(+)-5-methyl-10,11-dihydro-5h-dibenzo-[a,d]-cyclohepten-5,10-imine hydrogen maleate	0.00740740740741
MK-801	(+)-mk-801 hydrogen maleate	0.00740740740741
MK-801	(5r,10s)-(+)-methyl-10,11-dihydro-5h-dibenzo[a,d]-cyclohepten-5-10-imine hydrogen maleate	0.00740740740741
MK-801	(+)-10,11-dihydro-5-methyl-5h-dibenzo[a,b]cycloheptene-5,10-imine	0.00740740740741
MK-801	dizocilpine hydrogen maleate	0.0148148148148
MK-801	(+)-5-methyl-10,11-dihydro-5h-dibenzo(a,d)cyclohept-5,10-imine maleate	0.00740740740741
MK-801	(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine, dizocilpine	0.00740740740741
MK-801	[(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten,5,10-imine maleate	0.00740740740741
INa	fast na+ current	0.125
INa	ttx-r na current	0.125
INa	transient sodium current	0.125
INa	sslowly inactivating na+ current	0.125
INa	ppersistent voltage-gated na+ currents	0.125
INa	sodium current	0.375
miR-	132	0.166666666667
miR-	922	0.166666666667
miR-	124	0.166666666667
miR-	7-1	0.166666666667
miR-	negmirna mimic-negative control	0.333333333333
ω-CTX	ω-conotoxin	1.0
OKR	optokinetic response	0.25
OKR	optokinetic reflex	0.75
PVNT	paraventricular thalamic nucleus	1.0
CGP-55845A	3-n[1-(s)-(3,4-dichlorophenyl)ethyl]amino-2-(s)-hydroxypropyl-p-benzyl-phosphinic acid	1.0
INT	interaction torque	0.111111111111
INT	intact	0.222222222222
INT	inhibitory interneuron	0.111111111111
INT	p-iodonitrotetrazolium	0.111111111111
INT	interpositus cerebellar nuclei	0.111111111111
INT	abducens internuclear neuron	0.111111111111
INT	inter-segmental interaction torque	0.111111111111
INT	intrinsic lingual muscles	0.111111111111
SNPr	substantia nigra pars reticulata	1.0
PC1	pc2, pcsfirst and second principal components	1.0
INP	nucleus intrapeduncularis	1.0
INS	/delinsertion/deletion	0.333333333333
INS	insular	0.333333333333
INS	insulin	0.333333333333
INL	inner granular layer	0.0126582278481
INL	inner nuclear layer	0.962025316456
INL	inner nuclear layer of the retina	0.0253164556962
CERAD	consortium to establish a registry of ad	0.333333333333
CERAD	the consortium to establish a registry for alzheimer’s disease	0.333333333333
CERAD	consortium to establish a registry for alzheimer's disease	0.333333333333
SGLT	sodium-dependent glucose transporter	0.333333333333
SGLT	1sodium-dependent glucose cotransporter	0.333333333333
SGLT	sodium-glucose transporter	0.333333333333
UHU	ncaria hook	1.0
INH	isonicotinic acid hydrazide	1.0
ASE-	20aged epileptic group with the onset of epilepsy at 20 months of age	1.0
VNN	vestibular nucleus neuron	1.0
IND	indomethacin group	0.5
IND	inter-neuronal distance	0.5
INF	interferon	0.333333333333
INF	intranuclear foci	0.333333333333
INF	infundibular nucleus	0.333333333333
P-face	the protoplasmic leaflet of the plasma membrane	1.0
OKN	optokinetic nystagmus	1.0
GLI	gray-level-index	0.25
GLI	grey level index	0.25
GLI	gray level index	0.5
CVF	crude vesicle fraction	0.5
CVF	cobra venom factor	0.5
dbB	diagonal band of broca	1.0
GLL	glomerular layer	1.0
GLM	generalized linear model	0.129032258065
GLM	glomerular layer	0.0322580645161
GLM	general linear modeling	0.0322580645161
GLM	general lineal model	0.0322580645161
GLM	general linear model	0.741935483871
GLM	generalised linear model	0.0322580645161
GLN	glutamine	1.0
IBI	interburst interval	0.5
IBI	inter-burst interval	0.4
IBI	inter-burst intervals	0.1
CUSUM	cumulative sum histogram	0.5
CUSUM	cumulative sum	0.5
AKR	1caldo-keto reductase 1c	1.0
Ac-DEVD-AFC	n-acetyl-asp-glu-val-asp-7-amino-4-trifluoromethyl coumarin	1.0
ORIS	optical recording of intrinsic signals	1.0
GLE	glia limitans externa	1.0
AKT	protein kinase b (pkb)	0.125
AKT	akt proto-oncogene protein/protein kinase b	0.125
AKT	serine/threonine protein kinase akt or protein kinase b	0.125
AKT	1serine–threonine-specific protein kinase akt-pkb	0.125
AKT	protein kinase b	0.375
AKT	serine/threonine protein kinase b	0.125
FIN	finasteride	1.0
GLY	glycine	0.833333333333
GLY	glycinergic	0.166666666667
nC5aR	neuronal c5ar	1.0
ALBSF	anterolateral medial barrel subfield	1.0
GLP	glucagon-like peptide	0.25
GLP	good laboratory practice	0.25
GLP	galloping	0.25
GLP	globus pallidus	0.25
GLS	glutaminase	0.5
GLS	generalized limbic seizures	0.5
GLT	1glutamate type 1 transporter	0.0555555555556
GLT	1glutamate transporter type 1	0.0555555555556
GLT	1glutamate transporter-1	0.0555555555556
GLT	1	0.111111111111
GLT	glutamate transporter 1	0.0555555555556
GLT	1 variant	0.0555555555556
GLT	1glutamate transporter 1	0.333333333333
GLT	glutamate transporter	0.222222222222
GLT	1glutamate transporter #2 (pines et al., 1992)	0.0555555555556
GLU	gluteus maximus	0.0416666666667
GLU	l-glutamate	0.0416666666667
GLU	glutamatergic	0.0416666666667
GLU	glutamate	0.833333333333
GLU	glutamate and glutamatergic	0.0416666666667
CHARMED	composite hindered and restricted model of diffusion	1.0
SB-	242084	0.0833333333333
SB-	269970((2r)-1-[(3-hydroxyphenyl)sulfonyl]-2-(2-(4-methyl-1-piperidinyl)ethyl)pyrrolidine	0.0833333333333
SB-	334867-a	0.0833333333333
SB-	431542activin-like kinase 5 inhibitor	0.0833333333333
SB-	269970(r)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol hydrochloride	0.0833333333333
SB-	269970(r)-3-(2-(2-(4-methylpiperidin-1-yl) ethyl) pyrrolidine-1-sulfonyl) phenol hydrochloride	0.0833333333333
SB-	3ct4-phenoxyphenylsulfonyl)methylthiirane	0.0833333333333
SB-	243213	0.0833333333333
SB-	2585854-iodo-n-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]benzene-sulfonamide hydrochloride	0.0833333333333
SB-	418024	0.0833333333333
SB-	334867	0.166666666667
NS16191	3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2h-benzimidazol-2-one	1.0
MPBA	medial parabrachial area	1.0
SCHS	chwann cell hyperplasia	1.0
opioid-R	opioid receptor	1.0
BST	bed nuclei stria terminalis	0.0128205128205
BST	bed nuclei of stria terminalis	0.0128205128205
BST	bed nucleus of stria terminalis	0.0897435897436
BST	ventral bed nuclei of the stria terminalis	0.0128205128205
BST	basal forebrain in the nucleus of the stria terminalis	0.0128205128205
BST	ovoval subdivision of the bed nucleus of the stria terminalis	0.0128205128205
BST	fufusiform subnucleus of bed nucleus of the stria terminalis	0.0128205128205
BST	bed nucleus of the striae terminalis	0.0128205128205
BST	bursting cell	0.0128205128205
BST	bed nucleus of striatum terminal	0.0128205128205
BST	bed nucleus of the stria terminalis (a.k.a. bnst)	0.0128205128205
BST	bed nuclei of the stria terminalis	0.0384615384615
BST	pprincipal nucleus of the bed nuclei of the stria terminalis	0.0128205128205
BST	alanterolateral bed nucleus of the stria terminalis	0.025641025641
BST	vventral subdivision of the bed nucleus of the stria terminalis	0.0128205128205
BST	vventral bed nucleus of the stria terminalis	0.0128205128205
BST	bed nucleus stria terminalis	0.0128205128205
BST	avanteroventral bed nucleus of the stria terminalis	0.0128205128205
BST	bed nucleus of the stria terminalis	0.615384615385
BST	ssupracapsular bed nucleus of the stria terminalis	0.0128205128205
BST	vlventrolateral part of the bed nucleus of the stria terminalis	0.0128205128205
BST	mmedial bed nucleus of the stria terminalis	0.0128205128205
MECA	mecamylamine	0.5
MECA	32mouse pan-endothelial cell antigen	0.5
BSP	bromosulfophthalein	1.0
BSR	brain stimulation reward	0.428571428571
BSR	burst suppression ratio	0.571428571429
BSS	basic salt solution	0.0416666666667
BSS	blind source separation	0.0416666666667
BSS	balanced salt solution	0.708333333333
BSS	20glucose balanced salt solution	0.0416666666667
BSS	basal salt solution	0.166666666667
BSL	1bandeiraea simplicifolia lectin 1	0.5
BSL	baseline events	0.5
BSM	biotin switch method	0.333333333333
BSM	buffer saturation model	0.333333333333
BSM	bulbospongiosus muscles	0.333333333333
RIFG	right inferior frontal gyrus	1.0
BSO	buthionine sulfoximine	0.357142857143
BSO	l-buthionine-[s,r]-sulfoximine	0.214285714286
BSO	buthionine sulfoxamine	0.0714285714286
BSO	buthionine sulphoximine	0.0714285714286
BSO	l-buthionine sulfoximine	0.285714285714
PREPLPREP-	like	1.0
anandamideN-	arachidonoyl ethanolamine	0.5
anandamideN-	arachidonyl ethanolamide	0.5
BSD	brainstem-diencephalon	1.0
VNS	vagal nerve stimulation	0.142857142857
VNS	vagus nerve stimulation	0.571428571429
VNS	vomeronasal system	0.285714285714
BSF	2bottenstein and sato’s culture medium	1.0
MECP	2human methyl cpg binding-protein 2 gene	0.111111111111
MECP	2methyl-cpg-binding protein-2	0.111111111111
MECP	2methyl-cpg-binding protein 2	0.111111111111
MECP	2methyl-cpg binding protein 2	0.111111111111
MECP	2methyl-cpg-binding protein 2 (human gene)	0.111111111111
MECP	2	0.222222222222
MECP	2/mecp2methyl-cpg binding protein 2	0.111111111111
MECP	2methyl cpg binding protein 2	0.111111111111
BSA	bovine serum albumin	0.982651796778
BSA	bovine-serum albumin	0.00123915737299
BSA	phosphate-buffered saline containing bovine serum albumin	0.00123915737299
BSA	bovine serum	0.00123915737299
BSA	bovine serum albumine	0.00495662949195
BSA	bovin serum albumin	0.00123915737299
BSA	bovine serum albumen	0.00247831474597
BSA	bovine serine albumin	0.00123915737299
BSA	1% bovine serum albumin	0.00123915737299
BSA	bovine albumin serum	0.00123915737299
BSA	corticosterone conjugated to a bovine serum albumin molecule	0.00123915737299
BSC	bumetanide-sensitive na+–k+–2cl- cotransporter	1.0
DCSP	digital chemospectrophotography	1.0
MPF	mean power of frequency	0.5
MPF	maximum voluntary pulling force	0.5
PGm	medial subdivision of the preglomerular nucleus	1.0
sCJD	sporadic creutzfeldt–jakob disease	0.5
sCJD	sporadic creutzfeldt-jakob’s disease	0.5
VNP	vomeronasal pocket	1.0
POLRMT	mitochondrial rna polymerase	1.0
BS3	bis(sulfosuccinimidyl)suberate	1.0
SB203580	[4-(3-iodophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1h-imidazole]	0.5
SB203580	4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1h-imidazole	0.5
caM	ekconstitutive-active mek1	1.0
β-ADRβ-	adrenoceptors	1.0
CAT	anti-catalase	0.0434782608696
CAT	catalase	0.565217391304
CAT	chloramphenicol acetyltransferase	0.260869565217
CAT	construct	0.0434782608696
CAT	chloramphenicol acetyl transferase	0.0434782608696
CAT	nucleus of central acoustic tract	0.0434782608696
B-HB	enjamini-hochberg	0.5
B-HB	enjamini-hochberg's	0.5
PFT-αP	ifithrin-alpha	1.0
SBR	synchronized-burst rate	1.0
α-BGT	α-bungarotoxin	1.0
SBP	systolic blood pressure	0.8
SBP	spectrin breakdown product	0.1
SBP	systolic arterial blood pressure	0.1
QUIS	quisqualic acid	1.0
CNPDC	hina natural products database	1.0
T43	5,3′,5′-tetraiodothyronine	1.0
MMT	methadone maintenance treatment	1.0
SARA	scale for the assessment and rating of ataxia	1.0
MMP	metalloproteinase	0.0588235294118
MMP	smetalloproteinases	0.00980392156863
MMP	matrix metalloproteinases	0.0588235294118
MMP	smatrix metalloproteinases	0.0980392156863
MMP	smatrix metalloproteases	0.00980392156863
MMP	matrix metallopeptidase	0.0294117647059
MMP	matrix-metalloproteinase	0.00980392156863
MMP	matrix metalloprotease	0.00980392156863
MMP	matrix metalloprotienase	0.00980392156863
MMP	multichannel matching pursuit	0.00980392156863
MMP	9matrix metallo proteinases 9	0.00980392156863
MMP	9matrix metallopeptidase 9	0.00980392156863
MMP	9matrix metalloproteinase-9	0.0196078431373
MMP	mitochondrial membrane potential	0.127450980392
MMP	matrix metalloproteinase	0.480392156863
MMP	mitochondrial transmembrane potential	0.00980392156863
MMP	9matrix metalloproteinase 9	0.0294117647059
MMP	machine-mounted probe	0.00980392156863
MMS	methyl methanesulfonate	0.5
MMS	mini-mental status	0.5
MMR	mismatch repair	1.0
ACPD	1-aminocyclopentane-1,3-dicarboxylate	0.0769230769231
ACPD	1s,3r-aminocyclopentane-1,3-dicarboxylate	0.0384615384615
ACPD	(1s,3r)-1-amino-1,3-cyclopentane dicarboxylate	0.0384615384615
ACPD	(1s,3r)-1-aminocyclopentane-1,3-dicarboxylic acid	0.153846153846
ACPD	(1s,3r)-1-amino-cyclopentane-1,3-dicarboxylic acid	0.0384615384615
ACPD	1-aminocyclopentane-trans-1,3-dicarboxylic acid	0.0384615384615
ACPD	1s,3r-amino cyclopentane 2,3-dicarboxylic acid	0.0384615384615
ACPD	trans-1s,3r-1-amino-1,3-cyclopentanedicarboxylic acid	0.0384615384615
ACPD	(1s,3r)-1-aminocyclopentane-1,3-dicarboxylate	0.0384615384615
ACPD	(±)-1-aminocylopentane-trans-1,3-dicarboxylic acid	0.0384615384615
ACPD	1-aminocyclopentane-1,3-dicarboxylic acid	0.0384615384615
ACPD	1-amino-1,3-cyclopentane dicarboxylate	0.0384615384615
ACPD	trans-(1s,3r)-1-aminocyclopentane-1,3-dicarboxylic acid	0.0384615384615
ACPD	1s,3r-aminocyclopentane dicarboxylic acid	0.0384615384615
ACPD	trans-(±)-1-amino-1,3-cyclopentanedicarboxylic acid	0.0384615384615
ACPD	trans-1-amino-cyclopentyl-1,3-dicarboxylate	0.115384615385
ACPD	d,l-1-amino-1,3-cyclopentane-dicarboxylic acid	0.0384615384615
ACPD	1s,3r-1-aminocyclopentane-trans-1,3-dicarboxylic acid	0.0384615384615
ACPD	(±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid	0.0384615384615
ACPD	1s,3r-aminocyclopentane-2,3-dicarboxylic acid	0.0384615384615
MML	middle molecular layer	0.555555555556
MML	middle molecular layer of the dentate gyrus	0.111111111111
MML	medial molecular layer	0.111111111111
MML	middle of the molecular layer (of dentate gyrus)	0.222222222222
MMN	medial mammillary nucleus	0.0714285714286
MMN	mismatch negativity	0.714285714286
MMN	medial mamillary nucleus	0.142857142857
MMN	masseter motoneuron	0.0714285714286
MMI	methimazole	0.4
MMI	methylmercaptoimidazole	0.6
ZONAB	zonula occludens-1-associated nucleic acid-binding protein	1.0
OXTR	oxytocin receptor	1.0
CAO	coronary artery occlusion	1.0
SBH	subcortical band heterotopia	1.0
QUIN	quinolinic acid	0.764705882353
QUIN	quinolinate	0.176470588235
QUIN	quinpirole	0.0588235294118
MMA	methylmalonate	0.166666666667
MMA	monoclonal igm antibody	0.166666666667
MMA	middle meningeal artery	0.166666666667
MMA	methylmalonic acid	0.5
ACPI	advanced configuration and power interface	1.0
MMC	median motor column	0.333333333333
MMC	mucosal mast cell	0.333333333333
MMC	mitomycin c	0.333333333333
BFNIS	benign familial neonatal-infantile seizures	1.0
ERT	2second part of eye reaction time	0.125
ERT	estrogen replacement therapy	0.75
ERT	estrogen replacement treatment	0.125
BBMG	bovine brain mixed gangliosides	1.0
KOK	nockout	1.0
PCMS	p-chloromercuriphenylsulfonate	0.333333333333
PCMS	p-chloromercuriphenyl sulfonic acid	0.333333333333
PCMS	p-chloromercuriphenylsulphonate	0.333333333333
ERP	sevent related potentials	0.017094017094
ERP	evoked response potential	0.00854700854701
ERP	event-related brain potential	0.042735042735
ERP	event-related brain potentials	0.00854700854701
ERP	evoked related potential	0.00854700854701
ERP	event related potential	0.042735042735
ERP	sevent-related potentials	0.128205128205
ERP	s	0.00854700854701
ERP	event-related potentials	0.0854700854701
ERP	sevent-related brain potentials	0.00854700854701
ERP	sevoked response potentials	0.00854700854701
ERP	sevent-related cortical potentials	0.00854700854701
ERP	event-related potential	0.623931623932
GABA-T	gaba-transaminase	1.0
ERS	event-related synchronization	1.0
EGABAGABA-	evoked current reversal potential	1.0
CHIPC	terminus hsp70 interacting protein	1.0
KOC	knee only contralateral	1.0
ERX	estrogen receptor x	1.0
UABU	niversity of alabama at birmingham	1.0
RM-ANOVA	repeated-measure analysis of variance	0.0714285714286
RM-ANOVA	repeated measures analysis of variance	0.714285714286
RM-ANOVA	analysis of variance with repeated measures	0.0714285714286
RM-ANOVA	repeated measures of analysis of variance	0.0714285714286
RM-ANOVA	repeated measures one-way analysis of variance	0.0714285714286
ERD	)	0.0909090909091
ERD	event related desynchronization	0.0909090909091
ERD	event-related desynchronization	0.727272727273
ERD	/ersevent-related desynchronization/synchronization	0.0909090909091
ERE	oestrogen response element	0.0526315789474
ERE	estrogen responsive element e-3-ol estratriene-3-ol	0.0526315789474
ERE	sestrogen responsive elements	0.0526315789474
ERE	estradiol responsive element	0.0526315789474
ERE	estrogen responsive element	0.0526315789474
ERE	estrogen response elements	0.105263157895
ERE	estrogen response element	0.631578947368
ERF	sevent-related magnetic fields	0.166666666667
ERF	event-related magnetic fields	0.166666666667
ERF	sevent-related fields	0.166666666667
ERF	event-related field	0.166666666667
ERF	excitatory receptive field	0.333333333333
ERG	electroretinogram/electroretinography	0.047619047619
ERG	electroretinogram	0.714285714286
ERG	electroretinography	0.0952380952381
ERG	ether-a-go-go-related gene	0.047619047619
ERG	ether-a-go-go related gene	0.047619047619
ERG	k+ channels	0.047619047619
PTX-B	pertussis toxin b-oligomer	1.0
l-NAMENω-	nitro-l-arginine-methylester	0.0526315789474
l-NAMENω-	nitro-l-arginine-methyl-ester	0.0526315789474
l-NAMENω-	nitro-l-arginine methyl ester hydrochloride	0.157894736842
l-NAMENω-	nitro-l-arginine methyl ester	0.684210526316
l-NAMENω-	nitro-l-arginine-methyl ester	0.0526315789474
GTCS	generalized tonic-clonic seizure	0.333333333333
GTCS	generalized tonic–clonic seizure	0.666666666667
ERM	ezrin radixin moesin	0.25
ERM	ezrin-radixin-moesin	0.25
ERM	ezrin–radixin–moesin	0.5
ERN	error-related negativity	0.833333333333
ERN	(ne)error related negativity	0.166666666667
KOR	kappa (κ) opioid receptor	0.0625
KOR	κ-opioid receptor	0.0625
KOR	kappa-opioid receptor	0.125
KOR	kappa opioid receptor	0.75
Ad-RSVβgal	recombinant adenovirus encoding the e. coli β-galactosidase	1.0
NRPv	nucleus reticularis parvocellularis	0.5
NRPv	nucleus reticularis parivocellularis	0.5
cDNA	scomplementary dna	0.0102040816327
cDNA	complimentary dna	0.0510204081633
cDNA	copy dna	0.030612244898
cDNA	complementary dna	0.744897959184
cDNA	complementary deoxyribonucleic acid	0.0816326530612
cDNA	microarray	0.0204081632653
cDNA	subtraction	0.0102040816327
cDNA	arrays	0.0102040816327
cDNA	array	0.030612244898
cDNA	complimentary deoxy nucleic acid	0.0102040816327
ERK	extracellular related kinase	0.00298507462687
ERK	extracellular-regulated kinase	0.0328358208955
ERK	1/2extracellular signal regulated kinases 1 and 2	0.00298507462687
ERK	extracellular signal-related protein kinase	0.00597014925373
ERK	1/2event-related kinase 1/2	0.00597014925373
ERK	extracellular signal regulated-kinase	0.00298507462687
ERK	1/2extracellular signal-regulated kinase 1 and 2	0.0089552238806
ERK	sextracellular regulated protein kinases	0.00298507462687
ERK	1/2extracellular signal-regulated protein kinase 1 and 2	0.00298507462687
ERK	extracellularly regulated kinase	0.00298507462687
ERK	1 and erk2extracellular signal-regulated kinases	0.00298507462687
ERK	extracellular-signal-regulated kinases	0.00298507462687
ERK	sextracellular signal-regulated kinases	0.00597014925373
ERK	1/2extracellular-regulated kinases 1/2	0.00298507462687
ERK	extracellular-signal regulated kinase	0.0179104477612
ERK	1 and erk 2extracellular signal-regulated protein kinases 1 and 2	0.00298507462687
ERK	extracellular signal-regulated kinases	0.0388059701493
ERK	1/2extracellular signal-regulated kinase 1/2	0.0298507462687
ERK	extracellular signal regulate	0.00298507462687
ERK	extracellular signal related kinase	0.00597014925373
ERK	extracellular signal-related kinase 1/2	0.00298507462687
ERK	1/2extracellular-signal-regulated kinase 1/2	0.00597014925373
ERK	extracellular signal-regulated protein kinase	0.044776119403
ERK	extracellular regulated protein kinasesl	0.00298507462687
ERK	extracellular-signal-regulated kinase	0.0149253731343
ERK	1/2extracellular-regulated kinase 1/2	0.00597014925373
ERK	extracellular-related kinase	0.0089552238806
ERK	1/2extracellular signal-regulated kinase	0.0089552238806
ERK	extracellular-signal related kinase	0.00597014925373
ERK	extracellular signal-regulated kinase	0.468656716418
ERK	extracellular signal-regulated kinases 1 and 2	0.00298507462687
ERK	1/2extracellular signal-regulated protein kinase	0.00298507462687
ERK	1/2extracellular signal-regulated protein kinases 1 and 2	0.00298507462687
ERK	extracellular-regulating kinase	0.00298507462687
ERK	extracellular signal regulated kinase	0.0298507462687
ERK	/mapkextracellular signal-related kinase/mitogen-activated protein kinase	0.00298507462687
ERK	1/2	0.0089552238806
ERK	1/2extracellular signal-regulated kinases	0.00597014925373
ERK	1/2extracellular signal-regulated kinase ½	0.00298507462687
ERK	1/2extracellular-regulated kinase 1 and 2	0.00298507462687
ERK	signaling pathway	0.00298507462687
ERK	1/2extracellular signal-regulated protein kinases	0.00298507462687
ERK	extracellular signal-related kinase	0.0238805970149
ERK	extracellular signal relay serine/threonine kinase (mitogen activated protein kinase, map kinase, mapk)	0.00298507462687
ERK	extracellular signal-responsive kinase	0.00298507462687
ERK	1/2extracellular signal-regulated kinase-1 and -2	0.00597014925373
ERK	signaling	0.00298507462687
ERK	1/2extracellular related kinase	0.00597014925373
ERK	1/2extracellular signal-regulated kinase1/2	0.00298507462687
ERK	sextracellular signal-regulated protein kinases	0.00597014925373
ERK	extracellular signal-regulated protein kinases	0.00298507462687
ERK	1/2extracellular signal regulated kinase 1/2	0.00298507462687
ERK	/mapkextracellular signal-regulated kinase/mitogen-activated protein kinase	0.00597014925373
ERK	extra-cellular regulated kinase	0.00298507462687
ERK	extracellular receptor kinase	0.00298507462687
ERK	1/2extracellular regulated mitogen-activated protein kinases	0.00298507462687
ERK	1/2extracellular signal-regulated kinases ½	0.00298507462687
ERK	extracellular regulated kinase	0.0268656716418
ERK	1/2extracellular-signal-regulated-kinase 1/2	0.00298507462687
ERK	s 1 and 2extracellular signal-related kinases 42/44	0.00298507462687
ERK	extracellular regulated protein kinase	0.00298507462687
ERK	phosphorylation	0.00298507462687
ERK	/mapkextracellular-signal-related/mitogen-activated protein kinase	0.00298507462687
ERK	1/2extracellular signal-regulated protein kinase1/2	0.00298507462687
ERK	2	0.00298507462687
ERK	1/2extracellular signal-regulated kinases 1 and 2	0.0149253731343
ERK	extracellular regulated protein kinases	0.00298507462687
ERK	signal-regulated kinase	0.00298507462687
ERK	1/2extracellular signal-related kinase	0.00298507462687
ERK	extracelular-regulated kinase	0.00298507462687
ERK	extracellular signal-regulated protein	0.00298507462687
ERK	extracellular-regulated kinases	0.00597014925373
ERK	1/2extracellular-signal-regulated kinase	0.00298507462687
ERK	extra cellular regulated kinase	0.00298507462687
ERK	extracellular regulated map kinase	0.00298507462687
ERK	2p42 erk	0.00298507462687
MPV	17lmitochondrial membrane protein-like	1.0
VAMS	visual analog mood scale	1.0
CPDM	dorsomedial subregion of the caudate-putamen	1.0
CPDL	dorsolateral subregion of the caudate-putamen	1.0
ERs	estrogen receptors	1.0
IBT	simpulsive behavioural tendencies	1.0
MeCP2	mecp2, mecp2methyl-cpg-binding protein 2	1.0
DLARD	ivision of laboratory animal resources	1.0
spV	spinal trigeminal tract	1.0
CAF	conditional accuracy function	0.166666666667
CAF	caffeine	0.166666666667
CAF	conditional auditory feedback	0.166666666667
CAF	control aged females	0.166666666667
CAF	calcineurin autoinhibitory fragment	0.166666666667
CAF	newborns exposed to caffeine	0.166666666667
MDCK	madin–darby canine kidney	1.0
LLGL	1lethal(2) giant larvae protein homolog 1	1.0
FBNF	1fischer 344×brown norway f1	0.142857142857
FBNF	ischer 344/brown norway f1 hybrid	0.142857142857
FBNF	ischer brown norway	0.571428571429
FBNF	1fisher 344×brown norway hybrids	0.142857142857
DSST	digit symbol substitution test	1.0
RU38486	definition?	1.0
HEDTA	trisodium n-(hydroxyethyl)-ethylenediaminetriacetate	1.0
mWDR	mechano-receptive wide dynamic range	1.0
AVI	amyloid-β vulnerability index	1.0
rVAF	rostral half of the ventral amygdalofugal pathway	1.0
VLDL	very low-density lipoprotein	0.666666666667
VLDL	very-low-density lipoprotein	0.333333333333
PGG	proximal glossopharyngeal ganglia	1.0
Munc18a	murine unc18a	1.0
SNCA	gene coding for α-synuclein	0.5
SNCA	alpha-synuclein	0.5
VLDB	vertical limb of the diagonal band	1.0
PGD	2	0.142857142857
PGD	2prostaglandin d2	0.857142857143
NF-κBN	uclear factor-κb	0.5
NF-κBN	uclear factor κ b	0.5
SNL-H	rats responding to sensory testing with hyperalgesia after spinal nerve ligation	1.0
URmean	ur as average across the whole psth (during costimulation)	1.0
vPM	ventral premotor cortex	0.5
vPM	ventral premammillary nucleus	0.5
DYX	1c1	1.0
TATI	tumor-associated trypsin inhibitor	1.0
MPOAvl	ventrolateral part of the mpoa	1.0
KDELL	ys-asp-glu-leu	1.0
CD11bCD11b	complement receptor 3/cluster of differentiation 11b protein	1.0
DPCPX	1,3-dipropyl-8-cyclopentylxanthine	0.25
DPCPX	8-cyclopentyl-dipropylxanthine	0.05
DPCPX	8-cyclopentyl-1,3-dipropylxanthine	0.6
DPCPX	8-cyclopentyl dipropyixanthine	0.05
DPCPX	cyclopentyl-dipropyl-xanthine	0.05
dL	length velocity	1.0
EGABAGABAA	current equilibrium potential	1.0
KDELRKDEL	receptor	1.0
AOAA	aminooxyacetic acid	0.428571428571
AOAA	aminooxyacetate	0.142857142857
AOAA	amino-oxyacetic acid	0.428571428571
EPSE	sextrapyramidal side effects	0.5
EPSE	voked potential sampler	0.5
EPSC	excitatory post synaptic current	0.00374531835206
EPSC	excitatory post-synaptic current	0.0561797752809
EPSC	/pexcitatory postsynaptic current/potential	0.00374531835206
EPSC	/epspexcitatory post-synaptic current/potential	0.00749063670412
EPSC	(p)excitatory postsynaptic current (potential)	0.00374531835206
EPSC	sexcitory postsynaptic currents	0.00374531835206
EPSC	excitatory post-synaptic currents	0.00374531835206
EPSC	sexcitatory post-synaptic currents	0.0149812734082
EPSC	s	0.00374531835206
EPSC	excitatory postsynaptic/autaptic current	0.00374531835206
EPSC	sexcitatory postsynaptic currents	0.142322097378
EPSC	evoked excitatory postsynaptic current	0.00749063670412
EPSC	excitatory postsynaptic currents	0.0337078651685
EPSC	nmda receptor-mediated component of epsc	0.00374531835206
EPSC	glutamatergic excitatory postsynaptic current	0.00374531835206
EPSC	(evoked) excitatory postsynaptic current	0.00374531835206
EPSC	excitatory postsynaptic current	0.700374531835
SQRT	square-root	1.0
QLQ	uadratus lumborum	1.0
PGN	pregnanolone	0.0769230769231
PGN	peptidoglycan	0.0769230769231
PGN	perigeniculate nucleus	0.615384615385
PGN	pontine gray nucleus	0.153846153846
PGN	principal ganglionic neurons	0.0769230769231
GlyRα1	glycine receptor α1 subunit	1.0
CS-AC	ockayne syndrome complementation group a cell line or patient	1.0
PGO	ponto-geniculo-occipital wave	0.0740740740741
PGO	pontogeniculooccipital wave	0.037037037037
PGO	pontine-geniculate-occipital	0.037037037037
PGO	ponto-geniculo-occipital	0.777777777778
PGO	pontine-geniculo-occipital	0.037037037037
PGO	wavesponto-geniculo-occipital waves	0.037037037037
ER-	stress	0.666666666667
ER-	associated degradation	0.333333333333
Oxy-Hb	oxyhemoglobin	1.0
EPSP	excitatory postsynaptic potential	0.830588235294
EPSP	excitatory postynaptic potential	0.00235294117647
EPSP	2the slope of the population excitatory postsynaptic potential after the second pulse of a pair of pulses	0.00235294117647
EPSP	excitatory post-synaptic potentials	0.00705882352941
EPSP	/cexcitatory postsynaptic potential/current	0.00235294117647
EPSP	field excitatory postsynaptic potential	0.00235294117647
EPSP	s	0.00235294117647
EPSP	excitatory synaptic potential	0.00235294117647
EPSP	sexcitatory post-synaptic potentials	0.0141176470588
EPSP	extracellular postsynaptic potential	0.00235294117647
EPSP	sslope of the excitatory postsynaptic potential	0.00235294117647
EPSP	excitatory postsynaptic potentials	0.0164705882353
EPSP	/cexcitatory post-synaptic potential/current	0.00235294117647
EPSP	sexcitatory postsynaptic potentials	0.0517647058824
EPSP	excitatory post-synaptic potential	0.0588235294118
Rt	reticular nucleus	0.125
Rt	reticular thalamus	0.125
Rt	nucleus rotundus	0.125
Rt	reticular thalamic nucleus	0.625
ORX-A	orexin a	1.0
DNDA	ergic neurons	1.0
ONDE	originally non-deprived eye	1.0
Rs	series resistance	0.333333333333
Rs	resistance of the activated subsynaptic membrane	0.333333333333
Rs	stabilized achr	0.333333333333
SPTA	striato-pallial transition area	1.0
PGJ	2	1.0
SPTB	short phosphotyrosine-binding domain	1.0
Cho	choline	1.0
Rd	dendritic resistance between synapses	0.333333333333
Rd	membrane resistance at depolarized membrane potentials	0.333333333333
Rd	rhodamine-conjugated α-bungarotoxin	0.333333333333
Re	reuniens thalamic nucleus	0.428571428571
Re	reuniens	0.142857142857
Re	reuniens nucleus	0.142857142857
Re	nucleus reuniens	0.142857142857
Re	extracellular resistance	0.142857142857
Rg	synaptic cleft (gap) resistance	1.0
Ra	specific axial resistivity	1.0
8-MM-IBMX	8-methoxymethyl-ibmx	1.0
qRT	pcrquantitative real-time polymerase chain reactions	0.5
qRT	–pcrquantitative reverse transcriptase polymerase chain reaction	0.5
Rm	membrane input resistance	0.142857142857
Rm	membrane resistance	0.142857142857
Rm	specific membrane resistance	0.142857142857
Rm	input resistance	0.285714285714
Rm	membrane resistivity	0.142857142857
Rm	specific membrane resistivity	0.142857142857
Rn	input resistance	1.0
MVIICω-	conotoxin mviic	1.0
G-protein	guanine nucleotide binding protein	0.4
G-protein	guanine nucleotide-binding protein	0.2
G-protein	gtp-binding protein	0.4
Ri	apparent input resistance	1.0
RT	reticular thalamus	0.00167785234899
RT	reverse transcriptase/transcription	0.00167785234899
RT	reversal training	0.00335570469799
RT	nucleus reticularis thalami	0.00335570469799
RT	reaction time	0.0989932885906
RT	97200 kd neurofilament heavy antibody	0.00167785234899
RT	–pcrreverse-transcription polymerase chain reaction	0.00167785234899
RT	reverse transcribed	0.00335570469799
RT	reverse-transcriptase	0.00167785234899
RT	–pcrreverse transcription–polymerase chain reaction	0.00335570469799
RT	reverse transcriptase	0.0687919463087
RT	–pcrreverse transcriptase polymerase chain reaction	0.00167785234899
RT	pcrreverse transcriptase polymerase chain reaction	0.00167785234899
RT	qpcrreal time quantitative polymerase chain reaction	0.00167785234899
RT	retrotranscription	0.00167785234899
RT	–pcrreal time polymerase chain reaction	0.00167785234899
RT	)	0.00167785234899
RT	reverse-transcribed	0.00167785234899
RT	–bold relationship	0.00167785234899
RT	reaction times	0.00167785234899
RT	response time	0.0167785234899
RT	qpcrreal-time quantitative pcr	0.00167785234899
RT	rise time	0.00167785234899
RT	pcrreal-time polymerase chain reaction	0.00167785234899
RT	reticular nucleus thalamus	0.00167785234899
RT	nreticular thalamic nucleus	0.00167785234899
RT	sresponse times	0.00838926174497
RT	sreaction times	0.00838926174497
RT	hreticular thalamic nucleus	0.00167785234899
RT	reaction-time	0.00167785234899
RT	rt-pcrreverse transcription real-time polymerase chain reaction	0.00167785234899
RT	real-time	0.00167785234899
RT	reverse transcribed/reverse transcription	0.00167785234899
RT	–pcr	0.00503355704698
RT	97	0.00167785234899
RT	restricted treat	0.00167785234899
RT	reverse transcriptase, reverse transcribed	0.00167785234899
RT	relative threshold	0.00167785234899
RT	/pcrreverse transcription/polymerase chain reaction	0.00167785234899
RT	reverse transcription	0.159395973154
RT	–pcrreverse transcriptase–polymerase chain reaction	0.00503355704698
RT	rhythmic theme	0.00167785234899
RT	room temperature	0.557046979866
RT	_pcrreverse transcriptase-polymerase chain reaction	0.00167785234899
RT	97phosphorylated neurofilament	0.00167785234899
RT	reticular nucleus of thalamus	0.00167785234899
RT	reticular nucleus of the thalamus	0.00167785234899
RT	reticular thalamic nucleus	0.00167785234899
RU	486mifepristone	0.0769230769231
RU	38486	0.153846153846
RU	49	0.0769230769231
RU	resonance unit	0.0769230769231
RU	4055517-beta-hydroxy-11-beta-/4-/[methyl]-[1-methylethyl]	0.0769230769231
RU	38486mifepristone	0.153846153846
RU	486	0.384615384615
RV	crostral vc	0.0769230769231
RV	residual variance	0.538461538462
RV	rhombencephalic ventricle	0.0769230769231
RV	right ventriculum	0.0769230769231
RV	retroviral vector	0.153846153846
RV	residual volume	0.0769230769231
RW	reward period	0.111111111111
RW	red wine (ethanol-added)	0.111111111111
RW	real word	0.111111111111
RW	running wheel	0.333333333333
RW	restful waking	0.111111111111
RW	running-wheel	0.111111111111
RW	rewarming	0.111111111111
RP	arostral paraventricular area	0.0192307692308
RP	ed1right pedal dorsal 1	0.0576923076923
RP	58prp58 promoter fragment	0.0192307692308
RP	raphe pallidus	0.0192307692308
RP	membrane resting potential	0.0192307692308
RP	arostral raphe pallidus area	0.0192307692308
RP	readiness potential	0.0192307692308
RP	reserve pool	0.0576923076923
RP	araphe nucleus	0.0192307692308
RP	nucleus raphé pallidus	0.0192307692308
RP	reverse primer	0.0192307692308
RP	araphe pallidus nucleus	0.0769230769231
RP	retinitis pigmentosa	0.192307692308
RP	onucleus reticularis pontis oralis	0.0192307692308
RP	a/robraphe pallidus/raphe obscurus	0.0192307692308
RP	resting potential	0.0192307692308
RP	anucleus raphe pallidus	0.0384615384615
RP	rostral auditory parabelt of hackett et al. (1998)	0.0192307692308
RP	rostral pole division of the medial geniculate body	0.0192307692308
RP	releasable pools	0.0192307692308
RP	reverse phase	0.0192307692308
RP	refractory period	0.0192307692308
RP	ed1right pedal dorsal one	0.0192307692308
RP	resting pressure	0.0192307692308
RP	araphe pallidus	0.192307692308
RP	recurrence pattern	0.0192307692308
dCPU	dorsal caudate putamen	1.0
RR	recovery rate	0.047619047619
RR	random ratio	0.047619047619
RR	response requirement	0.047619047619
RR	heart beat-to-beat interval	0.047619047619
RR	recruiting rhythm	0.047619047619
RR	relapsing–remitting	0.047619047619
RR	righting reflex	0.0952380952381
RR	repeated restraint	0.047619047619
RR	rate of respiration	0.047619047619
RR	ruthenium red	0.0952380952381
RR	relative ratio	0.0952380952381
RR	repeatedly restrained	0.047619047619
RR	retrorubral nucleus	0.142857142857
RR	recognition ratio	0.142857142857
RS	series resistance	0.0441176470588
RS	receptor subunit	0.0147058823529
RS	retrosplenial	0.0147058823529
RS	random-shock control group	0.0147058823529
RS	rare stimulus	0.0147058823529
RS	rotational score	0.0147058823529
RS	recovery sleep	0.0882352941176
RS	renin substrate	0.0147058823529
RS	regular-spiking (cortical neuron)	0.0147058823529
RS	)-cppgα-cyclopropyl-4-phosphonophenylglycine	0.0147058823529
RS	79948	0.0147058823529
RS	+wirestraint combined with water immersion stress	0.0147058823529
RS	round small	0.0147058823529
RS	regular spiking	0.0882352941176
RS	)-ppg(rs)-4-phosphonophenylglycine	0.0147058823529
RS	reticulospinal	0.0588235294118
RS	reverse-sutured	0.0147058823529
RS	v-bventral retrosplenial cortex dorsal part	0.0147058823529
RS	retrosplenial cortex	0.0735294117647
RS	acute restraint stress	0.0147058823529
RS	regular spiking (pyramidal cell)	0.0147058823529
RS	regular-spiking, accommodating (cells)	0.0147058823529
RS	restraint stress	0.0588235294118
RS	regular-spiking	0.102941176471
RS	rhombencephalic superventricle	0.0147058823529
RS	ggranular retrosplenial cortex	0.0147058823529
RS	random start randomization	0.0147058823529
RS	reactive species	0.0588235294118
RS	response strength	0.0147058823529
RS	cingulate and retrosplenial cortex	0.0147058823529
RS	regular spiking cell	0.0147058823529
RS	repetitive stimulation	0.0294117647059
RS	repetition suppression	0.0441176470588
RS	reticulospinal neurons	0.0147058823529
DEVD-CHO	ac-asp-glu-val-asp-aldehyde	0.2
DEVD-CHO	n-acetyl-asp-glu-val-asp-cho	0.2
DEVD-CHO	n-acetyl-asp-glu-val-asp-aldehyde	0.4
DEVD-CHO	n-acetyl-asp-glu-val-asp-cho (aldehyde)	0.2
1MeTIQ1-methyl-1	2,3,4-tetrahydroisoquinoline	1.0
c-AMP	cyclic amp	1.0
RX	821002	1.0
PGT	phosphate gelatin triton x-100	0.5
PGT	prostaglandin transporter	0.5
RZ	regeneration zone	0.5
RZ	receptive zone	0.5
RD	/shamregular diet plus sham	0.0588235294118
RD	rebound depolarisation	0.0588235294118
RD	23buv excision repair protein rad23 homolog b	0.0588235294118
RD	radial diffusion	0.0588235294118
RD	regular diet	0.235294117647
RD	/sedregular diet/sedentary	0.0588235294118
RD	radial diffusivity	0.176470588235
RD	relative density	0.117647058824
RD	subset of r cells with delay in spike onset	0.0588235294118
RD	raphe dorsalis	0.0588235294118
RD	red	0.0588235294118
RE	1/nrserepressor element 1/neuron-restrictive silencer element	0.0333333333333
RE	remaining error	0.0333333333333
RE	nucleus reuniens of thalamus	0.0666666666667
RE	rest	0.0333333333333
RE	1repressor element-1 binding site	0.0333333333333
RE	right ear	0.0333333333333
RE	retinal error	0.0333333333333
RE	restrained eater	0.0333333333333
RE	thalamic reticular cells	0.0333333333333
RE	reticular	0.0333333333333
RE	reality	0.0333333333333
RE	nucleus reuniens	0.1
RE	reproductive experience	0.0333333333333
RE	reticular thalamic	0.0333333333333
RE	rostral extension	0.0333333333333
RE	thalamic reticular	0.0666666666667
RE	reference error	0.0333333333333
RE	room effect	0.0333333333333
RE	regenerative electrode	0.0333333333333
RE	thalamic reticular nucleus	0.1
RE	thalamic reticular (neuron)	0.0333333333333
RE	reuniens nucleus	0.0666666666667
RE	input resistance	0.0333333333333
RF	amide peptide	0.00862068965517
RF	right frontal	0.00862068965517
RF	restricted feeding	0.0603448275862
RF	2h2h refed after a 48h fasted	0.00862068965517
RF	reference-front	0.00862068965517
RF	amide-like peptides	0.00862068965517
RF	reissner's fiber	0.00862068965517
RF	receptive fields	0.0172413793103
RF	rectus femoris	0.0603448275862
RF	sreceptive fields	0.00862068965517
RF	9selective neuropeptide ff receptor 2 antagonist	0.00862068965517
RF	photorefractory	0.00862068965517
RF	food-restricted group	0.00862068965517
RF	radiofrequency	0.0172413793103
RF	rhinal fissure	0.00862068965517
RF	rapid firing	0.00862068965517
RF	irectus femoris of the quadriceps	0.0172413793103
RF	respiratory frequency	0.00862068965517
RF	receptive field	0.465517241379
RF	amide-related peptide	0.00862068965517
RF	multi-unit receptive field	0.00862068965517
RF	reticular formation	0.137931034483
RF	mechanoreceptive field	0.0344827586207
RF	smechanoreceptive fields	0.00862068965517
RF	amide	0.00862068965517
RF	radio frequency	0.0172413793103
RF	peripheral receptive field	0.00862068965517
RF	midlinemidline of reaching frequency	0.00862068965517
RF	response frequencies	0.00862068965517
RG	random plasma glucose	0.166666666667
RG	radial glial cell	0.166666666667
RG	radial glia	0.5
RG	rhythm generating	0.166666666667
KOdisrupted-gene	or “knockout” mouse	1.0
RA	respiratory amplitude	0.0114942528736
RA	all-trans-retinoic acid	0.0229885057471
RA	all-trans retinoic acid	0.0114942528736
RA	receptor antagonist	0.0114942528736
RA	reference area	0.0229885057471
RA	integrated rectified average	0.0114942528736
RA	retinoic acid	0.402298850575
RA	nucleus robustus arcopallialis	0.0114942528736
RA	nucleus robustus archistriatalis	0.0229885057471
RA	/psretrobulbar area/pallial septum	0.0114942528736
RA	irectus abdominis	0.0229885057471
RA	rectus abdominis	0.0344827586207
RA	retinoic acid (all-trans)	0.0114942528736
RA	right atrium	0.0114942528736
RA	drecombinant adenoviral vector	0.0344827586207
RA	rheumatoid arthritis	0.0229885057471
RA	room air	0.0804597701149
RA	robust nucleus of the arcopallium	0.126436781609
RA	relative anisotropy	0.0114942528736
RA	retroauricular subdivision of the facial nucleus	0.0114942528736
RA	reproductively active	0.0114942528736
RA	ruptured aneurysm	0.0114942528736
RA	nucleus retroambiguus	0.0114942528736
RA	rapidly adapting	0.0344827586207
RA	rapidly adapting (receptors)	0.0114942528736
RA	retonic acid	0.0114942528736
RB	2reactive blue 2	0.333333333333
RB	percent reversible binding	0.0833333333333
RB	101h3n-ch(ch2-ch2-s-ch3)-ch2-s-s-ch2-ch(ch2ϕ)-conh-ch(ch2ϕ)-cooch2ϕ	0.0833333333333
RB	cellsretinoblastoma cells	0.0833333333333
RB	rhodamine beads	0.166666666667
RB	red beads	0.25
RC	srenshaw cells	0.0714285714286
RC	retrochiasmatic nucleus	0.0714285714286
RC	rostral central subnucleus of the nucleus of the solitary tract	0.0714285714286
RC	restriction cages: special cages used to restrict the free movement of the animals	0.0714285714286
RC	recombinant “congenic”	0.0714285714286
RC	regenerated cellulose	0.0714285714286
RC	hretrochiasmatic area	0.214285714286
RC	recoverin	0.0714285714286
RC	adr-cadherin	0.0714285714286
RC	root cell	0.0714285714286
RC	retrochiasmatic area	0.0714285714286
RC	respiratory control	0.0714285714286
RL	irostral linear nucleus	0.272727272727
RL	irostral linear raphe nucleus	0.0909090909091
RL	reinforcement learning	0.0909090909091
RL	rhombic lip	0.0909090909091
RL	rostral lateral subnucleus of the nucleus of the solitary tract	0.0909090909091
RL	round large	0.0909090909091
RL	rostral linear nucleus raphe	0.0909090909091
RL	lung resistance	0.0909090909091
RL	irostral linear nucleus of raphe	0.0909090909091
RM	graphe magnus nucleus	0.12962962963
RM	reference memory	0.0555555555556
RM	graphe magnus	0.0925925925926
RM	repeated measures	0.277777777778
RM	anovarepeated measures analysis of variances	0.0185185185185
RM	repeated measurement	0.0185185185185
RM	retromamillary nucleus	0.0185185185185
RM	repeated-measures	0.0185185185185
RM	anovarepeated-measures analysis of variance	0.0185185185185
RM	remyelination	0.037037037037
RM	nucleus raphe magnus	0.0185185185185
RM	raphe magnus	0.0185185185185
RM	retromammillary nucleus	0.0185185185185
RM	repeated measure	0.037037037037
RM	eight-arm radial maze	0.0185185185185
RM	anovarepeated measures analysis of variance	0.0925925925926
RM	gnucleus raphe magnus	0.037037037037
RM	input resistance	0.0185185185185
RM	nucleus raphé magnus	0.0185185185185
RM	anovaanova of repeated measures	0.0185185185185
RM	retromamillary area	0.0185185185185
RN	rectal nerves	0.0208333333333
RN	input resistance	0.0833333333333
RN	aseribonuclease	0.1875
RN	raphe nucleus of the pons	0.0208333333333
RN	reticular nucleus	0.0208333333333
RN	membrane input resistance	0.0208333333333
RN	range normalization scores	0.0208333333333
RN	reversal-negativity	0.0208333333333
RN	spared cortex in the damaged hemisphere	0.0208333333333
RN	resistance measured with 40 ms current pulse	0.0208333333333
RN	raphe nuclei	0.125
RN	aseribonuclease a	0.0208333333333
RN	neuronal input resistance	0.0208333333333
RN	apparent input resistance	0.0208333333333
RN	ase protection assay	0.125
RN	red nucleus	0.1875
RN	raphe nucleus	0.0416666666667
RN	input membrane resistance	0.0208333333333
RO	braphe obscurus	0.25
RO	xsreactive oxygen species	0.0625
RO	braphe obscurus nucleus	0.125
RO	right occipital	0.0625
RO	bnucleus raphe obscurus	0.1875
RO	reverse osmosis	0.0625
RO	60-0175(s)-2-(chloro-5-fluoro-indol-1-yl)-1-methylethylamine 1:1 c4h4o4	0.0625
RO	bnucleus raphé obscurus	0.0625
RO	receptor occupancy	0.0625
RO	raphe obscurus	0.0625
RH	right hemisphere	0.214285714286
RH	8repeated-handling day 8	0.0714285714286
RH	rhomboid nucleus	0.0714285714286
RH	795	0.0714285714286
RH	2ring h2	0.0714285714286
RH	proportion of receptors in the high-affinity state	0.0714285714286
RH	right hand	0.0714285714286
RH	123rhodamine 123	0.142857142857
RH	random hexamer	0.0714285714286
RH	raphe-hippocampal	0.0714285714286
RH	rhomboid nucleus of thalamus	0.0714285714286
RI	retroinsular cortex	0.047619047619
RI	recovery index	0.0952380952381
RI	rostral interstitial nucleus of medial longitudinal fasciculus	0.047619047619
RI	rostral interstitial nucleus of mlf	0.0952380952381
RI	reproductively inactive	0.047619047619
RI	recognition index	0.0952380952381
RI	retention index	0.047619047619
RI	recombinant inbred	0.142857142857
RI	rhythmicity index	0.0952380952381
RI	regularity index	0.047619047619
RI	rectification index	0.190476190476
RI	resettable integrator	0.047619047619
catFISH	cellular compartment analysis of temporal activity by fluorescence in situ hybridization	1.0
NAAG	n-acetyl-aspartyl-glutamate	0.142857142857
NAAG	n-acetylaspartylglutamate	0.714285714286
NAAG	n-acetyl-asp-glu	0.142857142857
ω-GsTx	ω-grammotoxin sia	1.0
CAm	median part of the central nucleus of the amygdala	1.0
R2	nmda receptor proteins r1 and r2	1.0
EMDE	mpirical mode decomposition	1.0
KRBSK	rebs-ringer bicarbonate buffer solution	0.5
KRBSK	rebs–ringer bicarbonate buffer solution	0.5
CAl	lateral part of the central nucleus of the amygdala	1.0
XSCP	decussation of the superior cerebellar peduncle	1.0
5-CSRTT	5-choice serial reaction time task	0.5
5-CSRTT	5-choice serial rt task	0.25
5-CSRTT	five-choice serial reaction time task	0.25
Ch2	cholinergic cells of the vertical limb of the diagonal band	1.0
SH-CM	shoulder-centre of mass	1.0
Ch4	cholinergic neurons of the horizontal limb of the diagonal band/cholinergic neurons of the nucleus basalis	0.2
Ch4	cholinergic nucleus basalis	0.2
Ch4	cholinergic neurons of the nucleus basalis of meynert	0.4
Ch4	cholinergic cells of the nucleus basalis of meynert	0.2
VMPFC	ventral medial prefrontal cortex	0.142857142857
VMPFC	ventromedial prefrontal cortex	0.857142857143
Ch6	cholinergic ldt	1.0
RIPRNA	immunoprecipitation	1.0
R-	type calcium channel	0.166666666667
R-	right	0.166666666667
R-	type ca2+ channel	0.333333333333
R-	mycrapsyn-myc	0.166666666667
R-	isovaline	0.166666666667
TSTQ	time spent in target quadrant	1.0
eNA	the external formation of the nucleus ambiguus	1.0
DR-RD	rostral dorsal pole of dorsal raphe	1.0
383931-Phenyl-2	3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol	1.0
SUV	ssmall unilamellar vesicles	0.333333333333
SUV	standard uptake value	0.333333333333
SUV	standardized uptake value	0.333333333333
MIN	midline nuclei	0.5
MIN	medial interlaminar nucleus	0.5
PGZ	periventicular gray zone of optic tectum	1.0
FMMUF	ourth military medical university	1.0
GPXGSH	peroxidase	1.0
F-L	ugarofusiform lugaro cell	1.0
ACAT	acyl-coenzyme a: cholesterol acyltransferase	1.0
LTAC	liposomal tacrolimus	1.0
VPpc	ventral posterior nucleus thalamus, parvicellular part	0.5
VPpc	ventroposterior parvicellular nucleus of the thalamus	0.5
DR-RV	rostral ventral pole of dorsal raphe	1.0
LGCM	latent growth curve model	1.0
noT	non-runner mice after cci	1.0
SUS	sustentacular	1.0
VDNGRVTA	da neuron glutamatergic response	1.0
ARJP	autosomal recessive juvenile form of parkinsonism	1.0
MS-SE	multislice-spin echo	1.0
CEOAE	click-evoked otoacoustic emission	1.0
CHTC	cerebellar hemisphere thalamic cortical	0.5
CHTC	cerebellar hemisphere-thalamo-cortical	0.5
WFN	wide-field neuron	1.0
zfPENK	zebrafish proenkephalin	1.0
FLIP-LFADD-	like interleukin-1β-converting enzyme-inhibitory protein	1.0
NS-	398n-[2-(cyclohexyloxy)-4-nitrophenyl] -methanesulfonamide	0.5
NS-	398n-[2-cyclohexyloxy-4-nitrophenyl] methanesulphonamide	0.5
WFA	wisteria floribunda lectin	0.142857142857
WFA	wistaria floribunda agglutinin	0.142857142857
WFA	wisteria floribunda agglutinin	0.714285714286
rrGH	recombinant rat growth hormone	1.0
IBSC	integrated brain slice chamber	1.0
VTApn	paranigral ventral tegmental area	1.0
V46	ventral area 46	1.0
9THC	δ9-tetrahydrocannabinol	0.5
9THC	δ9tetrahydrocannabinol	0.5
WRME	working-reference memory error	1.0
OVX-EPovariectomized	estrogen and progesterone replaced	1.0
WFV	wide-field vertical	1.0
SDN-POA	sexually dimorphic nucleus of the preoptic area	0.666666666667
SDN-POA	sexually dimorphic area of the preoptic area	0.333333333333
o-ATP	atp-2′,3′-dialdehyde	1.0
eN	phrenhanced natronomonas pharaonis halorhodopsin	1.0
aVTA	anterior ventral tegmental area	0.666666666667
aVTA	anterior vta	0.333333333333
WCW	ilson-cowan	1.0
DEA	nonoatediethylamine nonoate	0.333333333333
DEA	diethylamine	0.333333333333
DEA	/nodiethylamine nitric oxide adduct	0.333333333333
DNQX6-7-dinitroquinoxaline-2	3-dione	1.0
DISC-	1disrupted in schizophrenia-1	1.0
G-CSFG	ranulocyte colony-stimulating factor	1.0
U69593	(5α,7α,8β)-(+)-n-methyl-n-(7-[1-pyrrolidinyl]1-oxoaspiro[4,5]	1.0
KIM	kinase interacting motif	0.5
KIM	kidney injury molecule	0.5
mt-P	ericammitochondrial-targeted ratiometric pericam	1.0
nMLF	nucleus of the medial longitudinal fasciculus	1.0
CHST	cycle peristimulus time histogram	1.0
α-DTXα-	dendrotoxin	1.0
AIDSA	cquired immune deficiency syndrome	1.0
hMTIIA	human metallothionein iia	1.0
X-P04	5-bromo-4-chloro-3-indoyl phosphate	1.0
SHRP	stress hypo-responsive period	0.125
SHRP	stress hyporesponsive period	0.75
SHRP	stress-hyporesponsive-period	0.125
aPFC	anterior prefrontal cortex	1.0
NK-3R	neurokinin-3 receptor	1.0
lacZE	scherichia coli lacz gene	1.0
NPSR	neuropeptide s receptor	1.0
MGad	anterodorsal medial geniculate nucleus	1.0
cLH	caudal part of the lateral hypothalamic area	1.0
L-VF	lateral and ventral funiculi	1.0
iMG	ipsilateral medial geniculate body	1.0
non-N-	methyl-d-aspartate receptor	1.0
GADγ-	amino decarboxylase	1.0
MMTS	methyl methanethiosulfonate	1.0
MMTV	mouse mammary tumor viruses	1.0
CPPα-	3-(2-carboxy-piperazin-4-yl)-propyl-1-phosphonic acid	1.0
CHT1	high-affinity choline transporter 1	1.0
iMS	intramedial septum	1.0
V4T	area v4 transient	1.0
LaDL	dorsolateral portion of the lateral amygdaloid nucleus	0.5
LaDL	dorsolateral portion of the lateral nucleus of the amygdala	0.5
NAPE-PLDN-	acyl-phosphatidylethanolamine-specific phospholipase d	0.25
NAPE-PLDN-	acylphosphatidylethanolamine-specific phospholipase d	0.25
NAPE-PLDN-	acyl phosphotidylethanolamine phospholipase d	0.25
NAPE-PLDN-	acylphosphatidylethanolamine-hydrolyzing phospholipase d	0.25
NPSH	nonprotein sulfhydryl	1.0
NDA2	3-naphtalen-dicarboxaldehyde	1.0
hepesN-	2-hydroxyethylpiperazine-n′-2-ethane sulfonic acid	1.0
NF200	neurofilament 200	0.8
NF200	200,000 mol. wt neurofilament subunit	0.2
CDKN	1ccyclin-dependent kinase inhibitor 1c	1.0
FEPSP	field excitatory postsynaptic potentials	1.0
Dnase	deoxyribonuclease	1.0
AFMA	tomic force microscopy	1.0
ORXE	orchidectomized male treated with estrogen	1.0
DBcAMP	dibutyryl cyclic-amp	0.5
DBcAMP	dibutyryl cyclic amp	0.5
OATP2	organic anion transporter polypeptide 2	1.0
hrCNE	high resolution clear native electrophoresis	1.0
KB-R	79432-[2-[4-(4-nitrobenyloxy) phenyl] ethyl]	0.333333333333
KB-R	79432-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]	0.666666666667
NArPE	n-arachidonoylphosphatidylethanolamine	1.0
MID	monetary incentive delay	1.0
PRN	medial portion of pontine reticular nucleus	0.333333333333
PRN	propranolol	0.333333333333
PRN	perireticular thalamic nucleus	0.333333333333
Dn	day n (i.e. the number of days between the two lesions)	1.0
Pt	paratenial nucleus	0.5
Pt	paratenial thalamic nucleus	0.5
DEA-NONO	atediethylamine nonoate	0.5
DEA-NONO	atedyethylamine nonoate	0.5
Pu	putamen	1.0
NBI	nasal bias index	1.0
CII	cognitive impairment index	0.5
CII	bovine type ii collagen	0.5
NBH	naloxone benzoylhydrazone	0.333333333333
NBH	brain homogenate prepared from normal brains	0.333333333333
NBH	normal brain homogenate	0.333333333333
Ad-Ang1	adenoviruses expressing angiopoietin-1	1.0
HNRNPAB	heterogeneous nuclear ribonucleoprotein a/b	1.0
1BD	2bd, 4bd, 6bdfirst 2, 4 and 6months of life of binocular deprivation, respectively	1.0
t-ACPDtrans-aminocyclopentane-1	3-dicarboxylic acid	1.0
YVAD-pNA	n-acetyl-tyr-val-ala-asp-p-nitroanilide	1.0
ONBL	outer neuroblastic layer	1.0
LHEE	grouplearned helplessness-enriched environment group	1.0
VGCCs	voltage-gated calcium channels	1.0
gNap	persistent sodium conductance	1.0
CRH-BP	corticotropin-releasing hormone binding protein	1.0
CMS-R	escms resilience	1.0
cVitERE	chicken vitellogenin estrogen response element	1.0
Ch5	cholinergic ppt	1.0
CMS-E	sc-rcms escitalopram responders	1.0
EGCG	(-)-epigallocatechin-3-gallate	1.0
NONSYN	nonsynaptic	1.0
WILD	wild-type group of mice	1.0
DIFP	diisopropyl fluorophosphate	1.0
TMR-SP	tetramethylrhodamine-conjugated substance p	1.0
NDEL	1	1.0
hAPPSw	indhuman amyloid precursor protein carrying familial ad-linked swedish and indiana mutations	1.0
DCFH-DA2	7-dichlorofluorescin diacetate	0.5
DCFH-DA2	7-dichlorofluorescein diacetate	0.5
p-NFκB	phosphorylated nfκb	1.0
CRC	ajal–retzius	0.25
CRC	ajal-retzius	0.25
CRC	ongo red	0.25
CRC	harles river	0.25
CVPN	scardiac vagal preganglionic neurons	1.0
OGZ	outer granule zone	1.0
ZEN	zinc-enriched	0.75
ZEN	zinc enriched	0.25
CDK-	2cyclin-dependent kinase 2	1.0
IRS-	1insulin receptor substrate-1	1.0
cfASWC	a2+-free artificial salt water	0.5
cfASWC	a2+-free artificial seawater	0.5
FMRPF	ragile x mental retardation protein	0.666666666667
FMRPF	ragile x protein	0.333333333333
TEV	tobacco etch virus protease	1.0
SHS	rc homology	0.25
SHS	rc-homology	0.25
SHS	rc homology region	0.25
SHS	septo-hippocampal system	0.25
CRF	contrast response function	0.00467289719626
CRF	2corticotropin-releasing factor receptor type-2	0.00467289719626
CRF	corticotropin release factor	0.00467289719626
CRF	center receptive field	0.00467289719626
CRF	2corticotropin-releasing factor type-2 receptors	0.00467289719626
CRF	r-1corticotropin-releasing-factor receptor 1	0.00467289719626
CRF	cortical recruitment function	0.00467289719626
CRF	scontrast response functions	0.00467289719626
CRF	continuous reinforcement schedule	0.00467289719626
CRF	2corticotropin-releasing factor 2 receptor	0.00467289719626
CRF	corticotrophin releasing factor	0.0514018691589
CRF	classical receptive field	0.0514018691589
CRF	corticotropin-releasing factor	0.5
CRF	1 receptorcorticotropin-releasing factor receptor 1	0.00467289719626
CRF	corticotropin-releasing factor, ioa, subnucleus a of the medial nucleus of inferior olivary nucleus	0.00467289719626
CRF	2 receptorcorticotropin-releasing factor type 2 receptor	0.00467289719626
CRF	continuous reinforcement	0.00934579439252
CRF	2 receptorcrf type 2 receptor	0.00467289719626
CRF	2corticotropin-releasing factor receptor type 2	0.00467289719626
CRF	2corticotropin-releasing factor receptor 2	0.00467289719626
CRF	1 or crf2corticotropin releasing hormone receptors 1 or 2	0.00467289719626
CRF	corticotropin-releasing hormone	0.00467289719626
CRF	continuous schedule of reinforcement	0.00467289719626
CRF	classic receptive field	0.00467289719626
CRF	corticotropin releasing factor	0.182242990654
CRF	corticotropic-releasing factor	0.00467289719626
CRF	corticotrophin-releasing factor	0.0607476635514
CRF	cerebrospinal fluid	0.00467289719626
CRF	corticotrophin release factor	0.00467289719626
CRF	corticotropin-releasing-factor	0.00467289719626
CRF	2corticotrophin-releasing factor receptor subtype 2	0.00467289719626
CRF	r-2corticotropin-releasing-factor receptor 2	0.00467289719626
CRF	corticotrophin-releasing	0.00467289719626
CRF	1corticotrophin-releasing factor type 1	0.00467289719626
CRF	1rcorticotropin-releasing factor type 1 receptor	0.00467289719626
CRF	mrna	0.00467289719626
CRF	2type 2 corticotropin-releasing factor receptor	0.00467289719626
ORXT	orchidectomized male treated with testosterone	1.0
p-PKC	phosphorylated-conventional protein kinase c	0.5
p-PKC	phosphorylated protein kinase c	0.5
p-PKB	/aktphospho-pkb/akt	1.0
p-PKA	phosphorylated-protein kinase a	1.0
CRG	central rhythm generator	0.5
CRG	cervical root ganglion	0.5
125I-LVA	125i-linear vasopressin-1a antagonist	1.0
QRT-PCR	quantitative real-time reverse transcriptase-pcr	0.166666666667
QRT-PCR	quantitative real-time pcr	0.166666666667
QRT-PCR	quantitative real-time rt-pcr	0.166666666667
QRT-PCR	quantitative real time polymerase chain reaction	0.166666666667
QRT-PCR	relative quantitative multiplex real-time reverse transcriptase polymerase chain reaction	0.166666666667
QRT-PCR	quantitative real-time polymerase chain reaction	0.166666666667
PANAS-X	positive and negative affect schedule– expanded form	1.0
ET-1	endothelin-1	0.75
ET-1	endothelin 1	0.25
CIN	commissural interneuron	0.5
CIN	car-independent navigation	0.5
FTIRF	ourier transform infrared microspectroscopy	1.0
Pe	periventricular nucleus	0.333333333333
Pe	periventricular area of hypothalamus	0.333333333333
Pe	periventricular hypothalamic nucleus	0.333333333333
CRIB	cdc 42/rac interactive binding	1.0
PMBSFc	contralateral pmbsf	1.0
COX-I	cyclooxygenase 1	1.0
YM2981986-Amino-N-cyclohexyl-N	3-dimethylthiazolo[3,2-a]benzimi dazole-2-carboxamide hydrochloride	1.0
BERKO	knockout mice missing estrogen receptor beta	1.0
Calb	calbindin d-28k	1.0
gamma-H	2ax	1.0
XLIF	leukemia inhibitory factor	1.0
cPPT	central polypurine tract	1.0
LIDL-DOPA-	induced dyskinesia	1.0
PrRP	prolactin releasing peptide	1.0
Pn	pontine nuclei	0.25
Pn	postnatal day n	0.25
Pn	pacemaker nucleus	0.25
Pn	pontine nucleus	0.25
RPVC	right parietovisceral connection	1.0
PBS-XPBS	containing 0.2% triton x-100	1.0
cMMP-	3catalytic mmp-3	1.0
Pl	plantaris	0.5
Pl	pulvinar	0.5
URTI	upper respiratory tract infection	1.0
CalB	calbindin-d28k	1.0
CRM	clockwise rotary motion	0.5
CRM	coordinate response measure corpus	0.5
GAERS	genetic absence epileptic rats from strasbourg	0.1
GAERS	genetic absence epilepsy rat from strasbourg	0.3
GAERS	genetic absence epilepsy rats from strasbourg	0.5
GAERS	genetic absence epilepsy rat of strasbourg	0.1
UDG	uracil-dna glycosylase	0.25
UDG	uracil dna glycosylase	0.5
UDG	upper blade of dentate gyrus	0.25
HBSS	hanks’ balanced salt solution	0.178571428571
HBSS	hank’s buffered salt solution	0.0178571428571
HBSS	hepes-buffered saline solution	0.0178571428571
HBSS	4-(2-hydroxyethyl)-1-piperazineethansulfonic acid	0.0178571428571
HBSS	hank’s buffered saline solution	0.0178571428571
HBSS	hepes-buffered salt solution	0.0535714285714
HBSS	hanks balanced salt solution	0.0714285714286
HBSS	hank's balanced salt solution	0.267857142857
HBSS	hank’s balanced salt solution	0.125
HBSS	hanks' balanced salt solution	0.214285714286
HBSS	hank's buffered salt solution	0.0178571428571
15NPI	15 non-paced intromissions	1.0
HDIPS	exploratory head dip	1.0
POCE1H-observed	13c-edited	1.0
P77PMC	pei 1977 peking medical college rats	1.0
MPAE	maximal possible analgesic effect	1.0
PDE-	5phosphodiesterase type 5 inhibitor	1.0
NDEP	non-deprived control	1.0
GLASTG	lu–asp transporter	0.333333333333
GLASTG	lu-asp transporter	0.666666666667
HBSH	anks’ buffered saline	0.333333333333
HBSH	epes-buffered solution	0.333333333333
HBSH	epes-buffered saline	0.333333333333
SR59230A	3-(2-ethylphenoxy)-1-[(1s)-1,2,3,4-tetrahydronapth-1-ylamino]-2s-2-propranolol oxalate	1.0
rEMG	full-wave rectified electromyogram	1.0
ω-Aga-IVA	ω-agatoxin-iva	0.857142857143
ω-Aga-IVA	ω-agatoxin iva	0.142857142857
RRTF	srepetition rate transfer functions	0.5
RRTF	repetition rate transfer function	0.5
COX-1	cyclo-oxygenase-1	1.0
COX-2	inducible cyclooxygenase	0.166666666667
COX-2	cyclooxygenase-2	0.5
COX-2	cyclo-oxygenase-2	0.333333333333
OfM	orofacial motor cortex	1.0
shCTRL	small hairpin control (non-silencing) rna	1.0
QPCR	quantitative polymerase chain reaction	0.714285714286
QPCR	quantitative real-time polymerase chain reaction	0.142857142857
QPCR	quantitative pcr	0.142857142857
Ucn	urocortin	1.0
OGB	5-noregon green bapta 5-n	1.0
NMTIQ	n-methyl-1,2,3,4-tetrahydroisoquinoline	1.0
hnCRH	heteronuclear crh	1.0
MII	secondary motor cortex	1.0
NMDAN-	methyl-d-asparatate	0.000981354268891
NMDAN-	methyl d-aspartic acid	0.000981354268891
NMDAN-	methy-d-aspartate	0.000981354268891
NMDAN-	methyl-d-aspartate receptors	0.000981354268891
NMDAN-	methyl d-aspartate	0.00883218842002
NMDAN-	methyld-aspartate	0.000981354268891
NMDAN-	methyl-d-aspartic acid (nmda) glutamatergic receptors	0.000981354268891
NMDAN-	methyl-d-aspartate-receptor	0.000981354268891
NMDAN-	methyl-d-aspartate (glutamate receptor agonist)	0.000981354268891
NMDAN-	methyl-d–aspartate	0.000981354268891
NMDAN-	methyl-d-aspartate(nmda) subtype of the glutamate receptor	0.000981354268891
NMDAN-	methyl-daspartate	0.000981354268891
NMDAN-	methyle-d-asparatate	0.000981354268891
NMDAN-	methyl-d-aspartate	0.799803729146
NMDAN-	methyl-d-asparte	0.000981354268891
NMDAN-	methyl d-aspartate receptor	0.000981354268891
NMDAN-	methyl-d-aspartatic acid	0.000981354268891
NMDAN-	metil d-aspartato	0.000981354268891
NMDAN-	methyl-d-aspartic acid	0.15897939156
NMDAN-	methyl-d-asparic acid	0.00196270853778
NMDAN-	methyl-d-aspartate receptor	0.00588812561335
NMDAN-	methyl-d-aspartate acid	0.00196270853778
NMDAN-	methyl-dl-aspartate	0.000981354268891
NMDAN-	methyl-d-aspartate glutamate	0.00196270853778
NMDAN-	methyl-d-asparate	0.00294406280667
NMDAN-	methyl-d-aspartate glutamate receptor	0.000981354268891
DNS	donkey normal serum	1.0
intgT	integral value of the total conductance change	1.0
PGPP	rotein gene product	1.0
RM-ANOVAR	epeated measures analysis of variance	1.0
TQT	target quadrant	1.0
BODIPY	boron-dipyrromethene	1.0
ω-CTX-GVIA	ω-conotoxin-gvia	1.0
FGFRs	fibroblast growth factor receptors	1.0
OMAG	optical microangiography	1.0
HSC	70constitutively active heat shock protein 70 kda	0.0909090909091
HSC	70heat shock cognate protein 70	0.0909090909091
HSC	hematopoietic stem cell	0.0909090909091
HSC	)70	0.0909090909091
HSC	hippocampal slice cultures	0.0909090909091
HSC	hematopoetic stem cell	0.0909090909091
HSC	heat shock cognate protein	0.0909090909091
HSC	shuman schwann cells	0.0909090909091
HSC	/hsp70citosolic/nuclear forms of hsp70	0.0909090909091
HSC	71heat-shock cognate 71 kda protein	0.0909090909091
HSC	shematopoietic stem cells	0.0909090909091
HSA	human serum albumin	1.0
HSF	1heat shock factor 1	0.5
HSF	heat shock factor	0.166666666667
HSF	1heat shock transcription factor 1	0.166666666667
HSF	heat shock transcription factor	0.166666666667
HSD	honest significant differences	0.0344827586207
HSD	hypoxic spreading depression	0.0344827586207
HSD	honestly significantly different	0.0344827586207
HSD	17b17β-hydroxysteroid dehydrogenase	0.0344827586207
HSD	histogram of spectral densities	0.103448275862
HSD	211-β-hydroxysteroid dehydrogenase type 2	0.0689655172414
HSD	highest significant difference	0.0344827586207
HSD	honestly significant difference	0.413793103448
HSD	honest significant difference	0.0689655172414
HSD	honest significance difference	0.0344827586207
HSD	hypoxia-induced spreading depression	0.0689655172414
HSD	2hydroxysteroid dehydrogenase type 2	0.0344827586207
HSD	high-sodium diet	0.0344827586207
HSE	horizontal system equatorial	0.5
HSE	heat shock element	0.5
FVBF	riend virus b type	1.0
mrIL-1β	murine recombinant interleukin-1β	1.0
HSI	hippocampal sympathetic ingrowth	1.0
HSN	spontaneous nystagmus	1.0
HSR	highly stress resilient	0.5
HSR	highly stress-resilient	0.5
mDAT	mouse dopamine transporter	0.5
mDAT	mouse high-affinity dopamine transporter protein	0.5
HSP	27heat shock protein 27	0.0416666666667
HSP	heat shock proteins	0.0416666666667
HSP	70heat-shock protein 70	0.0138888888889
HSP	sheat shock proteins	0.0833333333333
HSP	27	0.0138888888889
HSP	7070 kda inducible heat shock protein	0.0138888888889
HSP	27heat shock protein 27 kda	0.0138888888889
HSP	heat shock protein	0.458333333333
HSP	s)	0.0138888888889
HSP	7070 kda heat shock protein	0.0138888888889
HSP	25	0.0138888888889
HSP	47heat shock protein 47	0.0138888888889
HSP	heat shock/stress protein	0.0138888888889
HSP	70/72	0.0138888888889
HSP	hereditary spastic paraplegia	0.0277777777778
HSP	70heat shock protein 70	0.0555555555556
HSP	70	0.0138888888889
HSP	heat-shock protein	0.0277777777778
HSP	90	0.0138888888889
HSP	70sheat shock proteins 70 kda	0.0138888888889
HSP	70heat shock proteins 70	0.0138888888889
HSP	2727 kda heat shock protein	0.0138888888889
HSP	60heat shock protein-60	0.0138888888889
HSP	90heat shock protein 90	0.0416666666667
BN-P	ageblue-native page	1.0
VEGF	vascular endothelial growth factors	0.00900900900901
VEGF	vascular-endothelial growth factor	0.00900900900901
VEGF	vascular endothelial growth factor	0.954954954955
VEGF	vascular endothelial cell growth factor	0.00900900900901
VEGF	vascular endothelial growth factor a	0.018018018018
HST	heat stimulation	1.0
Nvl	nucleus of the vertical limb of the diagonal band of broca	1.0
MIC	minimum inhibitory concentration	0.333333333333
MIC	morphine-induced group with control plasmid	0.333333333333
MIC	micturition	0.333333333333
PG	pheromone gland	0.0119047619048
PG	iparagigantocellular nucleus	0.0119047619048
PG	iparagigantocellularis	0.0119047619048
PG	periglomerular	0.119047619048
PG	sproteoglycans	0.047619047619
PG	inucleus paragigantocellularis	0.0238095238095
PG	prostaglandin (as in pge2)	0.0119047619048
PG	speriglomerular interneurons	0.0119047619048
PG	prostaglandins	0.0119047619048
PG	periglomerular cell	0.0238095238095
PG	pentagastrin	0.0119047619048
PG	cellperiglomerular cell	0.0238095238095
PG	paragigantocellularis	0.0119047619048
PG	speriglomerular cells	0.0119047619048
PG	pregeniculate nucleus	0.0238095238095
PG	prostaglandin	0.285714285714
PG	proteoglycan	0.0238095238095
PG	pregabalin	0.0119047619048
PG	perineuronal glial cell	0.0119047619048
PG	periglomerular cells	0.0238095238095
PG	sprostaglandins	0.0952380952381
PG	pontine gray	0.0119047619048
PG	pontine grey	0.0119047619048
PG	petrosal ganglia	0.0119047619048
PG	propylene glycol	0.0119047619048
PG	petrosal ganglion	0.0238095238095
PG	pelvic ganglion	0.0119047619048
PG	pelvic paracervical ganglion	0.0119047619048
PG	the precentral gyrus	0.0119047619048
PG	pathological gambling	0.0119047619048
PG	pelvic paracervical parasympathetic ganglia	0.0238095238095
PG	01037	0.0119047619048
PG	peptidoglycan	0.0119047619048
PG	preglomerular nucleus	0.0119047619048
FGFR-	1fibroblast growth factor receptor type 1	0.333333333333
FGFR-	1fibroblast growth factor receptor 1	0.666666666667
CCK-4	cholecystokinin tetrapeptide	1.0
FL-WGABODIPY-FL	–wheat germ agglutinin	1.0
RKCR	inger-krebs containing choline chloride	1.0
CCK-8	cck-octapeptide	0.2
CCK-8	cholecystokinin octapeptide	0.6
CCK-8	sulphated cholecystokinin-8	0.2
CTSD	cathepsin d	1.0
SHMS	ham-operated	1.0
RhoGAP	rho gtpase-activating protein	1.0
IL-2	interleukin-2	1.0
3H-ACh	tritiated acetylcholine	1.0
PTIO	2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-l-oxyl-3-oxide potassium	0.5
PTIO	2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide	0.5
IL-3	interleukin 3	1.0
EZHE	nhancer of zeste homolog	1.0
RPMC	srat peritoneal mast cells	1.0
SYB	synaptobrevin	0.5
SYB	2synaptobrevin2	0.5
NMDARN-methyl	d-aspartate receptor	1.0
MNUN-	methyl-n-nitrosourea	1.0
GERLG	olgi’s apparatus-endoplasmic reticulum-lysosomes	1.0
18F-FDG	2-[18f]fluoro-2-deoxy-d-glucose	0.5
18F-FDG	18f-fluorodeoxyglucose	0.5
SYN	synaptophysin	0.692307692308
SYN	synapsin	0.230769230769
SYN	synaptic	0.0769230769231
SYM	symptomatic	1.0
NINL	iinovel image novel location delayed	1.0
SYS	modelsystemic rotenone model	1.0
SYP	synaptophysin	1.0
SYT	synaptotagmin	1.0
CIV	mitochondrial complex iv	1.0
trans-ACPD	1-aminocyclopentane-trans-1,3-dicarboxylic acid	0.142857142857
trans-ACPD	trans-1-aminocyclopentane-1,3-dicarboxylic acid	0.142857142857
trans-ACPD	(±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid	0.571428571429
trans-ACPD	(1s,3r)-1-aminocyclopentane-1,3-dicarboxylic acid	0.142857142857
CMXR	oschloromethyl-x-rosamine	1.0
EMG	electromyogram, electromyographic	0.00306748466258
EMG	electromyographic, electromyogram	0.00306748466258
EMG	electromyogram or -graphy or -graphic	0.00306748466258
EMG	electromyographic signals	0.00306748466258
EMG	electromyography/electromyograph	0.00306748466258
EMG	electromyographic/electromyogram	0.00613496932515
EMG	electromyograph	0.021472392638
EMG	electromyogramm	0.00613496932515
EMG	electromyograms	0.00306748466258
EMG	electromyographic	0.141104294479
EMG	electromyography/electromyograph/electromyogram	0.00306748466258
EMG	electromyography	0.196319018405
EMG	electromyogram	0.539877300613
EMG	electromyography/electromyographic	0.00920245398773
EMG	electromyography/electromyographically/electromyographic	0.00306748466258
EMG	electromyographic/electromyography	0.00306748466258
EMG	electromiogram	0.00306748466258
EMG	activityelectromyographic activity	0.00306748466258
EMG	electromygram	0.00306748466258
EMG	electromyogram/electromyographic	0.0122699386503
EMG	electromyographic activity	0.0153374233129
EMG	– electromyogram	0.00306748466258
EMG	selectromyograms	0.00306748466258
EMG	electromyogram, electromyography	0.00306748466258
EMG	activity	0.00306748466258
EMG	elecromyography	0.00306748466258
RGS	rp-8-bromoguanosine 3′,5′-cyclic monophosphothioate	0.0588235294118
RGS	regulator of g-protein signaling	0.352941176471
RGS	regulator of g protein signaling	0.176470588235
RGS	regulators of g protein signaling (rgs) proteins	0.0588235294118
RGS	regulators of g-protein signaling	0.117647058824
RGS	6g-protein signaling 6	0.0588235294118
RGS	4regulator of g-protein signaling 4	0.176470588235
EMA	electromyogram	0.333333333333
EMA	ethidium monoazide	0.333333333333
EMA	ethidium monoazide bromide	0.333333333333
Rhod	lissamine–rhodamine	1.0
RGV	relative gray value	1.0
3H-QNB	3h-quinuclidinyl benzilate	1.0
MDL100	907	1.0
EMO	emotional	1.0
EMI	entorhinal cortex, medial intermediate subfield	1.0
WTCCCW	ellcome trust case control consortium	1.0
RGB	red, green, blue	1.0
RGC	radial glial cell	0.012987012987
RGC	retinal ganglion cell layer	0.012987012987
RGC	retinal ganglion cell	0.753246753247
RGC	sretinal ganglion cells	0.12987012987
RGC	sradial glial cells	0.012987012987
RGC	retinal ganglionic cell	0.012987012987
RGC	retinal ganglion cells	0.0649350649351
RGD	arginine-glycine-aspartate peptide	0.111111111111
RGD	arginine-glycine-aspartate	0.111111111111
RGD	arginine–glycine–aspartate	0.222222222222
RGD	regular diet	0.111111111111
RGD	arg-gly-asp	0.333333333333
RGD	abbreviation for peptide sequence grgds	0.111111111111
RGE	restricted gas exchange	1.0
EMS	ethanol-monitor-saline	1.0
EMR	enhanced mechanical reactivity	1.0
H89	n-[2-((p-bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide, hcl	0.5
H89	h89 dihydrochloride	0.5
BXSB	mouse	1.0
KRBK	rebs-ringer bicarbonate solution	0.1
KRBK	rebs–ringer bicarbonate buffer	0.1
KRBK	rebs–ringer bicarbonate	0.1
KRBK	rebs-ringer bicarbonate buffer	0.2
KRBK	reb-ringer buffered saline solution	0.1
KRBK	rebs–ringer bicarbonate/glucose buffer	0.1
KRBK	rebs-ringer bicarbonate	0.2
KRBK	rebs bicarbonate dissection buffer	0.1
KS-TK	olmogorov-smirnov test	1.0
LDA	linear discriminant analysis	1.0
STIM	stimulation	0.5
STIM	stimulus delivery	0.5
FRDAF	riedreich ataxia	0.75
FRDAF	riedreich's ataxia	0.25
LDF	laser doppler flow	0.227272727273
LDF	laser doppler-flowmeter	0.0454545454545
LDF	laser-doppler flowmetry	0.181818181818
LDF	laser doppler flowmeter	0.0454545454545
LDF	laser doppler flowmetry	0.409090909091
LDF	laser-doppler flow	0.0909090909091
HMDS	hexamethyldisilazan	1.0
NNSnon-segmented	negative-strand	1.0
SMRT	silencing mediator of retinoid and thyroid receptor	1.0
LDH	lumbar dorsal horn	0.00699300699301
LDH	lactate dehydrogenase release to lactate dehydrogenase	0.00699300699301
LDH	lactate dehydrogenase assay	0.00699300699301
LDH	anti-lactate dehydrogenase polyclonal antibody	0.00699300699301
LDH	lactate dehydrogenase	0.951048951049
LDH	lactose dehydrogenase	0.013986013986
LDH	lactate dehydrogenase (e.c. 1.1.1.27)	0.00699300699301
TEA-OH	tetraethylammonium hydroxide	1.0
LDN	long spike duration neuron	1.0
MEGAM	olecular evolutionary genetic analysis	1.0
LDL	rlow density lipoprotein receptor	0.0909090909091
LDL	amina dissecans	0.0454545454545
LDL	ow dexterity	0.0454545454545
LDL	receptor	0.0454545454545
LDL	low-density lipoproteins	0.0909090909091
LDL	low density lipoprotein	0.181818181818
LDL	receptor-related protein	0.0454545454545
LDL	low-density lipoprotein	0.454545454545
LDS	lithium dodecyl sulfate	0.5
LDS	lithium-dodecyl sulfate	0.25
LDS	large-deflection stock	0.25
m-BSA	methylated bovine serum albumin	1.0
MSNA	muscle sympathetic nerve activity	1.0
LDV	large dense-core vesicle	1.0
LDT	latero-dorsal tegmental nucleus	0.0246913580247
LDT	lateral dorsal tegmentum	0.0123456790123
LDT	laterodorsal tegmental	0.0740740740741
LDT	laterodorsal tegmental nucleus	0.407407407407
LDT	laterodorsal pontine tegmentum	0.0123456790123
LDT	dorsolateral tegmental nucleus	0.0123456790123
LDT	pedunculopontine and laterodorsal tegmental nuclei	0.0123456790123
LDT	/pptlatero-dorsal and pedunculo-pontine tegmentum	0.0123456790123
LDT	/pptthe lateral dorsal tegmentum/pedunculopontine	0.0123456790123
LDT	/pptlatero dorsal tegmentum/pedunculo pontine tegmentum	0.0123456790123
LDT	laterodorsal tegmental nuclei	0.0123456790123
LDT	glateral dorsal tegmental nucleus	0.037037037037
LDT	laterodorsal tegmentum	0.111111111111
LDT	laterodorsal tegmental area	0.0123456790123
LDT	glaterodorsal tegmentum	0.0123456790123
LDT	/pptlaterodorsal and pedunculopontine tegmental nuclei	0.0123456790123
LDT	glaterodorsal tegmental nucleus	0.197530864198
LDT	glaterodorsal tegmental area	0.0123456790123
NMADN-	methyl-d-aspartate	1.0
GHK	goldman–hodgkin–katz	0.5
GHK	goldmann–hodgkin–katz	0.5
STIR	short tau inversion recovery	1.0
SMST	sensorimotor striatum	1.0
PWPT	paw withdrawal pressure threshold	1.0
APCs	antigen-presenting cells	1.0
5-HT-LI	5-ht-like immunoreactive	1.0
5-HTserotonin	5-hydroxytryptamine	0.75
5-HTserotonin	5-hydroxy-tryptamine	0.25
PBvl	ventral lateral parabrachial subnucleus	1.0
IL-2R	interleukin-2 receptor	1.0
tACPDtrans-1-amino-cyclopentane-1	3-dicarboxylic acid	1.0
VEH-VXDMSO-	injected voluntary exercise	1.0
CLC-	4	1.0
HLSD	honestly least square difference	1.0
TFO	triple-helix-forming oligodeoxynucleotide	1.0
pVI	principal abducens motor nucleus	1.0
3-K	phosphatidylinositol 3-kinase	1.0
QDECQuery	design, estimate, contrast	1.0
xesC	xestospongin c	1.0
KAS	rats with fully kindled audiogenic seizures	1.0
EM-	2endomorphin-2	0.333333333333
EM-	1endomorphin-1	0.666666666667
IT50	time of 50% of maximal increase	1.0
d-OGB-	1dextran-conjugated oregon green 488 bapta-1	1.0
CBFV	cerebral blood flow velocity	1.0
GESC	ganglionic eminence stem cells	1.0
sTPS	strong θ-patterned stimulation	1.0
EM1	endomorphin-1	1.0
EM2	endomorphin-2	1.0
ILF	inferior longitudinal fasciculus	1.0
COP	copulation testing sample	0.111111111111
COP	center of foot pressure	0.111111111111
COP	center of pressure	0.333333333333
COP	centre of pressure	0.444444444444
ILD	interaural level difference	0.5
ILD	’sinteraural level differences	0.25
ILD	inter-aural level difference	0.25
COR	chick olfactory receptor	0.5
COR	cortisol	0.5
ILB	4isolectin b4	1.0
ILC	intensely-labeled cell	0.166666666667
ILC	xinfralimbic cortex	0.166666666667
ILC	infralimbic cortex	0.666666666667
PLSDP	rotected least significant difference	0.666666666667
PLSDP	rotected last significant difference	0.333333333333
COV	coefficient of variation	1.0
PET	positron emission computed tomography	0.0162601626016
PET	)	0.0162601626016
PET	positron emission tomography	0.943089430894
PET	positron-emission tomography	0.0162601626016
PET	[18f]fluorodeoxyglucose–positron emission tomography	0.00813008130081
COX	cyclooxygenase inhibitor	0.0121951219512
COX	cytochrome c oxidase	0.0731707317073
COX	2cyclooxygenase-2	0.0121951219512
COX	cyclooxygenase	0.707317073171
COX	1cytochrome oxidase subunit 1	0.0121951219512
COX	ivcytochrome c oxidase subunit iv	0.0121951219512
COX	: cyclooxygenase	0.0121951219512
COX	cytochrome oxidase	0.0243902439024
COX	c oxidase	0.0121951219512
COX	icytochrome c oxidase i	0.0121951219512
COX	ivsubunit iv of the cytochrome c oxidase	0.0121951219512
COX	2cyclooxygenase 2	0.0487804878049
COX	cyclo-oxygenase	0.0365853658537
COX	ivcytochrome oxidase subunit iv	0.0121951219512
ILL	intermediate nucleus of the lateral lemniscus	1.0
ILM	inspiratory laryngeal motoneuron	0.166666666667
ILM	inner limiting membrane	0.833333333333
PEP	polysynaptic evoked potential	0.25
PEP	19peptide 19	0.5
PEP	prolyl endopeptidase	0.25
ILK	integrin-linked kinase	1.0
PER	perirhinal cortex	0.148148148148
PER	2period2 protein	0.0740740740741
PER	proboscis extension reflex	0.037037037037
PER	1-irper1 immunohistochemistry	0.037037037037
PER	1period 1	0.037037037037
PER	2protein of clock gene per2	0.037037037037
PER	period	0.0740740740741
PER	1period gene 1	0.037037037037
PER	1protein per1	0.037037037037
PER	1	0.037037037037
PER	proboscis extension response	0.0740740740741
PER	2	0.037037037037
PER	2period2	0.111111111111
PER	2period 2	0.111111111111
PER	2clock protein period2	0.037037037037
PER	peroneus longus	0.037037037037
PER	2clock protein per2	0.037037037037
PES	post-error slowing	0.333333333333
PES	palmitoylethanolamide	0.333333333333
PES	peri-electrode space	0.333333333333
COA	a,pcortical nucleus of amygdala, anterior, posterior division	1.0
COC	crossed olivocochlear pathways	0.125
COC	cocaine	0.5
COC	cyanide-induced outward current	0.125
COC	cocktail	0.125
COC	ytochrome oxidase	0.125
PEH	perievent histogram	0.4
PEH	phenylethylidenehydrazine	0.2
PEH	peri-event histogram	0.4
PEI	post-ejaculatory interval	0.1
PEI	postejaculatory interval following the first ejaculation	0.1
PEI	polyethyleneimine	0.4
PEI	polyethylenimine	0.2
PEI	post ejaculatory interval	0.1
PEI	postejaculatory interval	0.1
COG	center of gravity	1.0
COI	subunit i of cytochrome oxidase	0.5
COI	cytochrome oxidase i	0.5
COH	bcarboxyhemoglobin	0.666666666667
COH	coherence	0.333333333333
PEF	perifornical area	0.25
PEF	parietal eye fields	0.25
PEF	parietal eye field	0.25
PEF	perifornical nucleus	0.25
PEG	polyethylene glycol	0.823529411765
PEG	pegylated	0.0588235294118
PEG	post-embedding colloidal gold labeling	0.0588235294118
PEG	polyethylene glicol	0.0588235294118
COM	center of mass	0.307692307692
COM	commissural neurons of the superficial layers of the sc	0.0769230769231
COM	centre of mass	0.461538461538
COM	center-of-mass	0.153846153846
PEA	phosphorylethanolamine	0.0909090909091
PEA	palmitoylethanolamide	0.0909090909091
PEA	palmitoyl ethanolamine	0.0909090909091
PEA	phosphoethanolamine	0.0909090909091
PEA	phenyl ethyl alcohol	0.545454545455
PEA	palmitoylethanolamine	0.0909090909091
D-NAME	d-nitroarginine methyl ester	0.2
D-NAME	n′-nitro-d-arginine methyl ester	0.2
D-NAME	ng-nitro-d-arginine methyl ester	0.2
D-NAME	nω-nitro-d-arginine-methyl ester	0.2
D-NAME	ng-nitro-d-arginine methyl ester)	0.2
CON	control	0.333333333333
CON	home-cage control	0.0416666666667
CON	no-shock control group	0.0416666666667
CON	control monkey	0.0416666666667
CON	control rats	0.0416666666667
CON	controls	0.0416666666667
CON	neurologically intact control subjects	0.0416666666667
CON	congruent	0.0416666666667
CON	control mice	0.0416666666667
CON	control (mice)	0.0416666666667
CON	combined control group	0.0416666666667
CON	control diet	0.0416666666667
CON	grouped control (handled-only control group and saline-treated control group)	0.0416666666667
CON	control group	0.166666666667
COp	posterior cortical nucleus	1.0
post-AH	i/tonepost-training ahi lesion/auditory fear conditioning	1.0
rCBV	relative cerebral blood volume	0.5
rCBV	percent change in relative cbv	0.5
AC-PC	anterior commissure-posterior commissure	1.0
FILMFMRIB	's improved linear model	1.0
COx	cytochrome oxidase	1.0
LWM	low weight molecules	1.0
BAPTA-AMO	o′-bis(2-aminophenyl) ethyleneglycol-n, n, n′, n′-tetraacetic acid, tetraacetoxymethyl ester	1.0
DSP-4	n-(-2-chloroethyl)-n-ethyl-2-bromobenzylamine	0.111111111111
DSP-4	β-halobenzylamine-n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine	0.111111111111
DSP-4	n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine	0.666666666667
DSP-4	n-(2-chloroethyl)-n-2-bromobenzylamine hydrochloride	0.111111111111
COa	anterior cortical nucleus	1.0
AOT	accessory olfactory tract	0.5
AOT	nucleus of the accessory olfactory tract	0.5
rCBF	regional cbf	0.0243902439024
rCBF	regional cerebral blood flow	0.926829268293
rCBF	relative cerebral blood flow	0.0243902439024
rCBF	regional cortical blood flow	0.0243902439024
ILp	intermediolateral cell column	1.0
AP-5d	l-2-amino-5-phosphonopentanoic acid	0.666666666667
AP-5d	l-2-amino-5-phosphonovaleric acid	0.333333333333
P-	phospho-	0.0344827586207
P-	body	0.0344827586207
P-	faceprotoplasmic leaflet	0.0344827586207
P-	selectin	0.0344827586207
P-	wavepontine-wave	0.0344827586207
P-	faceprotoplasmic fracture face	0.0344827586207
P-	cellspurkinje cells	0.0344827586207
P-	c-junphospho-c-jun	0.0689655172414
P-	gp(s)p-glycoprotein(s)	0.0344827586207
P-	gppermeability-glycoprotein	0.0344827586207
P-	gpp-glycoprotein	0.241379310345
P-	tauphosphorylated tau	0.0344827586207
P-	taskpassive reward task	0.0344827586207
P-	20passage-20	0.0344827586207
P-	#postnatal day #	0.0344827586207
P-	correlation	0.0344827586207
P-	faceprotoplasmic face	0.0344827586207
P-	eif2α	0.0344827586207
P-	saporin	0.0344827586207
P-	p38phosphorylated p38	0.103448275862
PENK	proenkephalin	1.0
FLUT	flutamide	1.0
VPPC	ventral posterior thalamic nucleus, parvicellular part	0.5
VPPC	parvicellular part of the ventral posterior thalamic nucleus	0.5
NSD-1015	3-hydroxybenzylhydrazine	1.0
tGS	total glutathione	1.0
ERK1	2extracellular signal-regulated kinase 1,2	1.0
NPFR1npfr1	neuropeptide f receptor-1	1.0
NIST	bed nucleus of the stria terminalis	1.0
DAB-Ni	diaminobenzidine-nickel	0.5
DAB-Ni	nickel-enhanced 3,3′-diaminobenzidine	0.5
NEPHGE	non-equilibrium ph gradient gel electrophoresis	0.5
NEPHGE	non-equilibrium ph gradient electrophoresis	0.5
RMag	response magnitude	1.0
BAPTA-AM1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid tetrakis(acetoxymethyl ester)	0.0909090909091
BAPTA-AM1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid tetrakis(acetoxy-methyl) ester	0.0909090909091
BAPTA-AM1	2-bis(2-aminophenoxy)ethane-n,n,n',n''-tetraacetic acid tetrakis(acetoxymethyl ester)	0.0909090909091
BAPTA-AM1	2-bis(2-aminophenoxy)ethance-n,n,n′,n′-tetraacetic acid, tetraacetoxymethyl ester	0.0909090909091
BAPTA-AM1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid tetrakis (acetoxymethyl ester)	0.272727272727
BAPTA-AM1	2-bis(o-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid	0.0909090909091
BAPTA-AM1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid tetracetoxy methyl ester	0.0909090909091
BAPTA-AM1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid, cell permeable	0.0909090909091
BAPTA-AM1	2-bis-(2-aminophenoxy)-ethane-n,n,n′,n′-tetraacetic acid tetra(acetoxy-methyl)	0.0909090909091
PNOC	pronociceptin	0.666666666667
PNOC	pronociceptin/orphanin fq	0.333333333333
COC-	only crossed olivocochlear pathways cut (leaving uncrossed olivocochlear pathways intact)	1.0
mPOA	medial preoptic area	1.0
R-M	rostral–medial	1.0
192IgG	carbocyanine 3-conjugated immunoglobulin 192	1.0
NDGA	nordihydroguaiaretic acid	1.0
DRVC	visual cortex of dark-reared animal	1.0
SNRI	5-ht/norepinephrine reuptake inhibitors	0.166666666667
SNRI	serotonin-norepinephrine reuptake inhibitor	0.166666666667
SNRI	serotonin and norepinephrine reuptake inhibitor	0.166666666667
SNRI	selective norepinephrine reuptake inhibitor	0.166666666667
SNRI	5-ht and ne reuptake inhibitor	0.166666666667
SNRI	selective noradrenalin reuptake inhibitor	0.166666666667
fEPSPs	field excitatory post-synaptic potentials	0.5
fEPSPs	field excitatory postsynaptic potentials	0.5
LPCSE	lithium-pilocarpine-induced status epilepticus	1.0
IL-	1βinterleukin-1β	0.258928571429
IL-	3interleukin-3	0.00446428571429
IL-	2interleukin-2	0.0178571428571
IL-	11rinterleukin-11 receptor	0.00446428571429
IL-	6interlukin-6	0.00446428571429
IL-	6abanti-interleukin-6 antibody	0.00446428571429
IL-	1ri/fcrecombinant human interleukin-1β receptor i chimera protein	0.00446428571429
IL-	1interleukin-1	0.0401785714286
IL-	1β/6/10interleukin-1β/6/10	0.00446428571429
IL-	33interleukin-33	0.00446428571429
IL-	18interleukin-18	0.00446428571429
IL-	6interleukin- 6	0.00446428571429
IL-	6rinterleukin-6 receptor	0.00446428571429
IL-	23interleukin-23	0.00446428571429
IL-	1rinterleukin-1 receptor	0.00892857142857
IL-	10interleukin-10	0.0491071428571
IL-	1β	0.0178571428571
IL-	6asinterleukin-6 antiserum	0.00446428571429
IL-	18rαil-18 receptor α	0.00446428571429
IL-	1βinterleukin 1-β	0.00446428571429
IL-	1	0.00446428571429
IL-	3	0.00446428571429
IL-	1ril-1 receptor	0.00446428571429
IL-	6	0.00892857142857
IL-	7rinterleukin-7 receptor	0.00446428571429
IL-	1rinterleukin-1 beta receptor	0.00446428571429
IL-	1r1interleukin-1 receptor type i	0.00446428571429
IL-	28rαinterleukin-28 receptor α subunit	0.00446428571429
IL-	17interleukin 17	0.00446428571429
IL-	6interleukin-6	0.21875
IL-	6interleukin 6	0.0133928571429
IL-	6(r), interleukin 6 (receptor)	0.00446428571429
IL-	1βinterleukin-1 beta	0.0178571428571
IL-	1βinterleukin 1β	0.0446428571429
IL-	2interleukin 2	0.00446428571429
IL-	6ril-6 receptor	0.00446428571429
IL-	12interleukin-12	0.00446428571429
IL-	17a	0.00446428571429
IL-	1βinterleukin-1beta	0.03125
IL-	10	0.00446428571429
IL-	1rainterleukin-1 receptor antagonist	0.0535714285714
IL-	18rinterleukin-18 receptor	0.00446428571429
IL-	1ri-irtype i il-1 receptor immunoreactivity	0.00446428571429
IL-	31interleukin 31	0.00446428571429
IL-	1riinterleukin-1 receptor type i	0.00446428571429
IL-	31rainterleukin-31 receptor a	0.00446428571429
IL-	18 kointerleukin-18 knockout	0.00446428571429
IL-	1βinterleukin 1 beta	0.00892857142857
IL-	1rail-1 receptor antagonist	0.0178571428571
IL-	4interleukin-4	0.00446428571429
IL-	1interleukin 1	0.00892857142857
IL-	1βinterleukin 1 β	0.00446428571429
IL-	4rαil-4 receptor α chain	0.00446428571429
IL-	2rαinterleukin-2 receptor α subunit	0.00446428571429
IL-	1βinterleukin 1-beta	0.00892857142857
IL-	1interleukin-1β	0.00446428571429
B-FABP	brain-fatty acid binding protein	1.0
CN-A	calcineurin a subunit	1.0
2-YFP	16:wldscrossbred line of thy1.2-yfp16 and wlds mice	1.0
PE-	50polyethylene-50	1.0
WDB	wash dilution buffer	1.0
IL3	interleukin-3	1.0
OEC	/onfnon-pure oec culture containing both oecs and onfs	0.2
OEC	olfactory ensheathing cell	0.2
OEC	solfactory ensheathing cells	0.6
OEA	oleoylethanolamine	0.5
OEA	oleoylethanolamide	0.5
DPARSF	data-processing assistant for resting-state	1.0
OEF	oxygen extraction fraction	1.0
GNS	goat normal serum	1.0
LGMD	limb girdle muscular dystrophy	0.5
LGMD	limb-girdle muscular dystrophy	0.5
GNX	ganaxolone	0.5
GNX	neonatally gonadectomized males	0.5
P-C	amkiiphosphorylated calcium-dependent calmodulin kinase ii	1.0
MKK	mitogen activated kinase kinase	0.0714285714286
MKK	mitogen-activated protein kinase kinase	0.214285714286
MKK	4/7mitogen activated protein kinase kinase 4/7	0.0714285714286
MKK	map kinase kinase	0.142857142857
MKK	7mitogen-activated protein kinase kinase 7	0.142857142857
MKK	4map kinase kinase 4	0.0714285714286
MKK	7map kinase kinase 7	0.0714285714286
MKK	mapk kinase	0.0714285714286
MKK	4mitogen-activated protein kinase kinase 4	0.142857142857
AIP	myristoyl autocamtide-2-related inhibitory peptide	0.166666666667
AIP	acute intermittent porphyria	0.166666666667
AIP	anterior intraparietal	0.166666666667
AIP	anterior intraparietal area	0.166666666667
AIP	autocamtide-2-related inhibitory peptide	0.166666666667
AIP	agranular insular cortex posterior	0.166666666667
AIS	acute immobilization stress	0.0666666666667
AIS	artificial intracellular solution	0.0666666666667
AIS	axon initial segment	0.666666666667
AIS	acute ischemic stroke	0.0666666666667
AIS	androgen insensitivity syndrome	0.0666666666667
AIS	axon initial segments	0.0666666666667
AIR	automated image registration	0.666666666667
AIR	odorless air	0.333333333333
AIM	sabnormal involuntary movements	0.857142857143
AIM	abnormal involuntary movement	0.142857142857
AIL	advanced intercross line	1.0
SHE	saline-home cage-ethanol	1.0
AII	secondary auditory cortex	0.1
AII	angiotensim ii	0.1
AII	secondary auditory area	0.2
AII	tannexin ii tetramer	0.1
AII	angiotensin ii	0.2
AII	vventral part of secondary auditory cortex	0.1
AII	secondary auditory field	0.1
AII	secondary auditory cortical area	0.1
AIH	acute intermittent hypoxia	1.0
MKP	mitogen-activated kinase phosphatase	0.166666666667
MKP	mitogen-activated protein kinase phosphatase	0.333333333333
MKP	2mapk phosphatase 2	0.166666666667
MKP	map kinase phosphatase	0.166666666667
MKP	mitogen-activated protein kinase phosphatases	0.166666666667
AIE	adolescent intermittent ethanol	1.0
AID	α1 interaction domain	0.2
AID	autoinhibitory domain	0.4
AID	dorsal agranular insular cortex	0.2
AID	dorsal part of the agranular insular cortex	0.2
met-ENK	methionine-enkephalin	0.5
met-ENK	met-enkephalin	0.5
AIF	1allograft inflammatory factor 1	0.03125
AIF	1allograft inflammatory factor	0.03125
AIF	apoptosis-inducing factor	0.65625
AIF	apoptosis inducing factor	0.28125
AIA	antigen-induced arthritis	0.333333333333
AIA	amino-imidazo-azaarene	0.333333333333
AIA	granular insular cortex	0.333333333333
P-N	positive–negative	1.0
AIC	anterior intercalated cell mass	0.25
AIC	acetylcholine-induced contractions	0.25
AIC	anterior insular cortex	0.5
AIB	α-aminoisobutyric acid	1.0
TGENT	ranslational genomics institute	1.0
MION	monocrystalline iron oxide nonoparticles	1.0
NSN	acl solution	1.0
NSO	non-substituted objects	0.5
NSO	non-substituted object in object recognition task	0.5
NSA	non-stressed in adolescence	1.0
NSB	non-synaptic bouton	0.25
NSB	non-specific binding	0.5
NSB	nonspecific binding	0.25
NSC	neural stem cell	0.258064516129
NSC	non-smoking controls	0.0161290322581
NSC	neurosecretory cells	0.0161290322581
NSC	multipotent neural stem cell	0.0161290322581
NSC	34 cells	0.0161290322581
NSC	sfetal neural stem cells	0.0161290322581
NSC	neural stem/progenitor cell	0.0322580645161
NSC	neural stem cells	0.161290322581
NSC	sneural stem cells	0.451612903226
NSC	s/tcpuntransduced neural stem/progenitor cells as floating neurospheres on tissue culture plastic	0.0161290322581
NSD	normal-sodium diet	0.5
NSD	1015m-hydroxybenzylhydrazine	0.5
NSE	neuronal specific enolase	0.0246913580247
NSE	neutron specific enolase	0.0123456790123
NSE	neuron specific enolase	0.283950617284
NSE	neurone-specific enolase	0.0123456790123
NSE	11striatal neurospheres derived at e11	0.0123456790123
NSE	neuron specific-enolase	0.0123456790123
NSE	neuron-specific endolase	0.0123456790123
NSE	neuron-specific enolase	0.62962962963
NSF	n-ethylmaleimide-sensitive fusion protein	0.272727272727
NSF	n-ethyl maleimide-sensitive fusion protein	0.0909090909091
NSF	n-ethyl-maleimide-sensitive factor	0.0909090909091
NSF	novelty-suppressed feeding	0.0909090909091
NSF	n-ethylmaleimide-sensitive factor	0.363636363636
NSF	novelty suppressed feeding	0.0909090909091
NSG	neurosecretory granule	1.0
MAGICM	edulloblastoma advanced genomics international consortium	1.0
LCIC	lateral cortex of the inferior colliculus	0.666666666667
LCIC	lateral cortex of inferior colliculus	0.333333333333
MEAD	multi-electrode array device	1.0
NSPC	neural stem/progenitor cell	0.25
NSPC	sneural stem/progenitor cells	0.75
dynamin-DN	dynamin dominant-negative inhibitory peptide	1.0
HBSHEPES-	buffered saline	0.857142857143
HBSHEPES-	buffered solution	0.142857142857
NSR	negative slope resistance	1.0
NSS	neurological stroke scale	0.0416666666667
NSS	normal sheep serum	0.333333333333
NSS	neurologic severity score	0.0416666666667
NSS	neurological severity score	0.333333333333
NSS	normal swine serum	0.25
NST	nocistatin	0.0526315789474
NST	neuronostatin	0.105263157895
NST	nucleus of the solitary tract	0.736842105263
NST	neuron-specific tubulin	0.0526315789474
NST	neuron specific tubulin	0.0526315789474
NSU	no strategies users	1.0
GEP	granulin/epithelin precursor	1.0
DMCC	dorsomedial cell column	1.0
H-current	hyperpolarization-activated cationic current	1.0
IP-G	entintra-peritoneal gentamicin	1.0
IdU	5-iodo-2′-deoxyuridine	1.0
VOLT	vascular organ of the lamina terminalis	1.0
rIL	recombinant il-33	1.0
RMTR	esting motor threshold	1.0
EAM	experimental aged males	1.0
HPGDS	hematopoietic prostaglandin d synthase	1.0
ccC	orpus callosum	1.0
SDT	stop delay time	0.333333333333
SDT	signal detection theory	0.666666666667
HFHS	high-fat high-sugar	1.0
SDP	slow-developing potentiation	1.0
SDR	2stromal cell-derived receptor 2	0.333333333333
SDR	spatial delayed-response	0.333333333333
SDR	slow depolarizing response	0.333333333333
SDS	prague–dawley	0.061433447099
SDS	small-deflection stock	0.00170648464164
SDS	sodium dodecylsulfate detergent	0.00511945392491
SDS	sodium dodecylsulfate. the abbreviations used were based on the guidance of the chemoarchitectonic atlas of the rat forebrain and the chemoarchitectonic atlas of the rat brainstem (paxinos et al., 1999a,b) and the rat brain in stereotaxic coordinates (paxinos and watson, 1998)	0.00170648464164
SDS	sodium dodecyl sulfate	0.578498293515
SDS	sodium dodecyl sulfate–polyacrylamide gel electrophoresis	0.00170648464164
SDS	sodium dodecylsulfate	0.080204778157
SDS	–pagesodium dodecyl sulfate-polyacrylamide gel electrophoresis	0.00170648464164
SDS	–pagesodium dodecyl sulfate–polyacrylamide gel electrophoresis	0.042662116041
SDS	sodium-dodecyl-sulfate	0.00341296928328
SDS	prague-dawley	0.00511945392491
SDS	–pagesodium dodecyl sulfate polyacrylamide gel electrophoresis	0.0204778156997
SDS	1sodium dodecyl sulphate	0.00170648464164
SDS	–pagesodium dodecyl sulfate-polyacrilamide	0.00170648464164
SDS	sodium lauryl sulphate	0.00170648464164
SDS	–pagedodecyl sulphate polyacrylamide gel electrophoresis	0.00170648464164
SDS	sodium dodceyl sulfate	0.00170648464164
SDS	sodium monododecyl sulfate	0.00170648464164
SDS	self-rating depression scale	0.00341296928328
SDS	sodium docedyl sulfate	0.00170648464164
SDS	–pagesodium dodecylsulfate–polyacrylamide gel electrophoresis	0.00170648464164
SDS	sodium dodecyl sulphate	0.141638225256
SDS	sodium dodecyl sulfate–polyacrylamide	0.00170648464164
SDS	prague dawley	0.00853242320819
SDS	prague–dawley rats	0.00170648464164
SDS	sodium dodecylsulphate	0.0255972696246
DS-CT	difference score of correct trials	1.0
MK-	801diclozipine	0.0153846153846
MK-	801dizocilpine maleate	0.0923076923077
MK-	801(+)-mk 801 maleate	0.0153846153846
MK-	801dizocilpine	0.276923076923
MK-	801hydrogen maleate (m107)	0.0153846153846
MK-	801dizocilpine hydrogen maleate	0.0307692307692
MK-	801mk-801 hydrogen maleate	0.0153846153846
MK-	801 binding	0.0153846153846
MK-	801(+)-mk-801 maleate	0.0307692307692
MK-	801	0.492307692308
NPLN	ormal print length	1.0
17OH-P	17-hydroxyprogesterone	1.0
SDE	symbolic distance effect	1.0
SDF	stromal derived factor	0.111111111111
SDF	stromal cell-derived factor	0.111111111111
SDF	1stromal-derived factor 1	0.111111111111
SDF	spike density function	0.444444444444
SDF	1stromal cell-derived factor 1	0.222222222222
JARIDJ	umonji and arid containing protein	1.0
SDA	sexually dimorphic complex	0.333333333333
SDA	sexually dimorphic area	0.666666666667
SDB	sleep-disordered breathing	0.333333333333
SDB	sleep disordered breathing	0.666666666667
SDC	sodium deoxycholate	0.5
SDC	second depolarizing component	0.5
SDL	step-down latency	1.0
SDM	soft-diet mice	1.0
SDN	sexually dimorphic nucleus of preoptic area	0.142857142857
SDN	salivary duct nerve	0.142857142857
SDN	short spike duration neuron	0.142857142857
SDN	signal-dependent noise	0.285714285714
SDN	sexually dimorphic nucleus	0.285714285714
SDH	succinate dehydrogenase	0.545454545455
SDH	subdural haematoma groups	0.030303030303
SDH	subdural haematoma	0.030303030303
SDH	superficial dorsal horn	0.272727272727
SDH	succinic dehydrogenase	0.0606060606061
SDH	spinal dorsal horn	0.0606060606061
SDI	single daily injection	1.0
DCG-IV	(2s,1′r,2′r,3′r)-(2′,3′-dicarboxycyclopropyl)glycine	0.0909090909091
DCG-IV	(2s,1′r,2′r,3′r)-2-(2,3-dicarboxycyclopropyl)glycine	0.0909090909091
DCG-IV	(2s,2′r,3′r)-2-(2′3′-dicarboxycyclopropyl)glycine	0.0909090909091
DCG-IV	(2s,2′r,3′r)-2-(2′,3′-dicarboxycyclopropyl)glycine	0.0909090909091
DCG-IV	(2s,1′r,2′r,3′r)-2-(2′,3′-dicarboxycyclopropyl)glycine	0.0909090909091
DCG-IV	(2s,1″r,2″r,3″r)-2-(2,3-dicarboxycyclopropyl)glycine	0.0909090909091
DCG-IV	(2s,1′r,2′r,3′r)-2-(2,3-dicarboxycyclopropyl) glycine	0.0909090909091
DCG-IV	(2s,1′r,2′r,3′r)-2-(2′,3′-dicarboxycyclopropyl) glycine	0.0909090909091
DCG-IV	(2s,2′r,3′r)-2-(2′,3′-dicarboxycyclopropyl) glycine	0.0909090909091
DCG-IV	(2s,1′r,3r′)-2(2,3-dicarboxycyclopropyl)glycine	0.0909090909091
DCG-IV	(2s,1′r,2′r,3′r)-2-(2′,3′-dicarboxycyclopropyl)-glycine	0.0909090909091
d-A	spd-aspartate	0.5
d-A	mphd-amphetamine	0.25
d-A	la2]deltorphin ii	0.25
MYRIPM	yosin viia-rab interacting protein	1.0
BACE	1β-amyloid cleavage enzyme 1	0.0769230769231
BACE	1beta-site app cleaving enzyme 1	0.0769230769231
BACE	1β-site app cleaving enzyme	0.0769230769231
BACE	1β-site amyloid precursor protein-cleaving enzyme	0.0769230769231
BACE	1β-site amyloid precursor protein–cleaving enzyme	0.0769230769231
BACE	1β-site amyloid precursor protein-cleaving enzyme-1	0.0769230769231
BACE	1β-site app-cleaving enzyme 1	0.307692307692
BACE	β-site app-cleaving enzyme	0.0769230769231
BACE	1β-site amyloid precursor protein cleaving enzyme	0.0769230769231
BACE	1β-site app cleaving enzyme 1	0.0769230769231
BACB	acterial artificial chromosomes	1.0
d-H	2odistilled water	1.0
PARN	poly(a) ribonuclease	1.0
GTAH	gated threshold adaptation, gated anti-hebbian and gated hebbian learning	1.0
EPR	electron paramagnetic resonance	1.0
EPS	extrapyramidal motor side effects	0.285714285714
EPS	extrapyramidal side effect	0.142857142857
EPS	extrapyramidal side effects	0.571428571429
EPP	endplate potential	0.714285714286
EPP	sendplate potentials	0.0714285714286
EPP	send plate potentials	0.0714285714286
EPP	evoked endplate potential	0.0714285714286
EPP	end-plate potential	0.0714285714286
αBTXα	bungarotoxin	1.0
EPN	entopeduncular nucleus	0.857142857143
EPN	endopiriform nucleus	0.0714285714286
EPN	eicosapentaneuropeptide	0.0714285714286
EPO	erythropoietin	1.0
EPL	external plexiform layer	0.886363636364
EPL	ependymal layer	0.0227272727273
EPL	external plexiform layer of the olfactory bulb	0.0227272727273
EPL	external plexiform layer of olfactory bulb	0.0227272727273
EPL	experimental print length	0.0227272727273
EPL	external plexiforme layer	0.0227272727273
EPM	elevated plus maze test	0.0379746835443
EPM	elevated plus-maze	0.177215189873
EPM	1progressive myoclonus epilepsy type 1	0.0126582278481
EPM	elevated-plus maze	0.0253164556962
EPM	elevated-plus-maze	0.0126582278481
EPM	elevated plus maze	0.683544303797
EPM	the elevated plus maze test	0.0126582278481
EPM	elevated plus maze task	0.0126582278481
EPM	elevated plus-maze test	0.0253164556962
PARS	parallel analysis of rna structure	0.5
PARS	poly (adp-ribose) synthase	0.5
pAOBr	rostral region of the posterior accessory olfactory bulb	1.0
TLRT	oll like receptor	0.0666666666667
TLRT	oll-like receptor	0.933333333333
PARP	poly(adp-ribose)polymerase	0.0512820512821
PARP	poly(adp-ribose)-polymerase-1	0.025641025641
PARP	poly-adp ribose polymerase	0.0512820512821
PARP	poly-adp-ribose-polymerase	0.025641025641
PARP	poly adp-ribose polymerase	0.025641025641
PARP	poly-adp-ribose polymerase	0.102564102564
PARP	1 activation	0.025641025641
PARP	inhibition	0.025641025641
PARP	poly (adp-ribose) polymerase	0.25641025641
PARP	activity	0.025641025641
PARP	1poly (adp-ribose) polymerase-1	0.025641025641
PARP	1poly-adp ribose polymerase	0.025641025641
PARP	poly adpribose-polymerase	0.025641025641
PARP	poly(adp-ribose) polymerase	0.282051282051
PARP	spoly(adp-ribose) polymerases	0.025641025641
46349B	trans,4-[3z-3(2-dimethylaminoethyl)oxyimino-3-(2-fluorophenyl)propen-1-yl]phenol hemifumarate	1.0
TIMP-	1	1.0
EPB	epibatidine	1.0
EPC	send-plate currents	0.3
EPC	sendothelial progenitor cells	0.3
EPC	estrogen preconditioning	0.1
EPC	endplate current	0.2
EPC	evoked postsynaptic current	0.1
EPA	searly postural adjustments	0.111111111111
EPA	eicosapentaenoic acids	0.111111111111
EPA	eicosapentaenoic acid	0.777777777778
DSMT	he diagnostic and statistical manual of mental disorders	1.0
PDGFRAP	latelet-derived growth factor receptor 1a	1.0
DNQX6	7-dinitroquinoxaline-2,3-dione disodium	0.015625
DNQX6	7-dinitroquinoxaline-dione	0.015625
DNQX6	7-dinitroquinoxaline-2,3(1h, 4h)-dione	0.03125
DNQX6	7-dinitroquinoxaline-2,3(1h,4h)-dione	0.125
DNQX6	7-dinitroquinoxaline-2, 3-dione	0.015625
DNQX6	7-dinitroquinoxaline-2,3-dione disodium salt	0.03125
DNQX6	7-dinitoquinoxaline-2,3-dione	0.015625
DNQX6	7–dinitroquinoxaline -2,3-dione	0.015625
DNQX6	7-dinitroquinolixaline-2,3 dione	0.015625
DNQX6	7-dinitroquinoxaline	0.015625
DNQX6	7-dinitroquinoxaline-2,3-done	0.015625
DNQX6	7-dinitroquinoxaline-2,3-dione	0.65625
DNQX6	7-dinitroquinoxaline-2,3,(1h,4h)-dione	0.015625
DNQX6	7-dinitroquinoxalline-2,3-dione	0.015625
GDX-TP	gonadectomized, testosterone proprionate implanted	1.0
hNP	shuman neural progenitors	1.0
12-LOX	12-lipoxygenase	1.0
TNP-ATP2	3-o-2,4,6-trinitrophenyl-atp	1.0
aceK	potassium acesulfame	1.0
EPs	evoked potentials	1.0
DSMD	iagnostic and statistical manual	0.5
DSMD	iagnostic and statistical manual for mental disorders	0.5
MWCO	molecular weight cutoff	1.0
Rmag	magnitude of excitatory responses	1.0
SBP-1	sulfoglucuronyl carbohydrate binding protein-1	1.0
GTPγs	guanosine 5′-o-(3-thiotriphosphate) tetralithium salt	1.0
LYL	ucifer yellow conjugated to dextran amine	0.0555555555556
LYL	ucifer yellow	0.888888888889
LYL	ucifer yellow ch ammonium salt	0.0555555555556
TFC	tone fear conditioning	0.5
TFC	trace fear conditioning	0.5
cDLOP	cyclo1-8[d-leu5]octapeptide	1.0
amOT	anteromedial olfactory tubercle	1.0
GSEA	gene set enrichment analysis	1.0
NAAN-	acetyl aspartate	0.176470588235
NAAN-	acetyl aspartic acid	0.0588235294118
NAAN-	acetylaspartate concentration	0.0588235294118
NAAN-	acetylaspartate	0.647058823529
NAAN-	acetyl-l-aspartate	0.0588235294118
rVCN	rostral ventral cochlear nucleus	1.0
TX-100	triton x-100	1.0
NMJs	neuromuscular junctions	1.0
Rad	stratum radiatum	1.0
CTFC-	terminal fragment	0.5
CTFC-	terminal fragment of app	0.5
NF-m	neurofilament m	1.0
pY-NR	2bnr2b phosphorylated in tyrosine	1.0
LY-	538576-methyl-1-(1-methylethyl)-ergoline-8-carboxylic acid (8β)-2-hydroxy-1-methylpropyl ester (z)-2-butenedioate	0.5
LY-	2940022-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one hydrochloride	0.5
cTGN	corneal trigeminal ganglion neuron	1.0
K-entropy	kolmogorov entropy	1.0
TMETris-HCL	magnesium chloride and edta buffer	1.0
EPMT	elevated plus-maze test	1.0
OBBTO	dyssey blocking buffer with 0.2% tween-20	1.0
BNSTpm	posteromedial part of the bnst	1.0
BNSTpl	posterolateral part of the bnst	1.0
PAR-	1protease-activated receptor 1	0.166666666667
PAR-	4nuclear protein prostate apoptosis response	0.333333333333
PAR-	2	0.166666666667
PAR-	4nuclear protein prostate apoptosis response 4	0.166666666667
PAR-	2protease-activated receptor 2	0.166666666667
NF-T	neurofilament-triplet	1.0
EPMZ	elevated plus maze	0.5
EPMZ	elevated plus-maze	0.5
TLR-	4toll-like receptor-4	1.0
mU	cn 2urocortin 2 (mouse)	1.0
EPME	levated plus maze	1.0
NF-M	medium molecular weight subunit of nf	0.125
NF-M	neurofilament middle (subunit)	0.125
NF-M	neurofilament medium	0.25
NF-M	medium molecular mass neurofilament	0.125
NF-M	middle-molecular-weight neurofilament	0.125
NF-M	medium neurofilament subunit	0.25
NF-L	-m, -h, neurofilament of low, medium and high molecular weight, respectively	0.0714285714286
NF-L	neurofilament triplet l protein	0.0714285714286
NF-L	neurofilament light	0.142857142857
NF-L	light-molecular-weight neurofilament	0.0714285714286
NF-L	neurofilament-l	0.142857142857
NF-L	light neurofilament subunit	0.142857142857
NF-L	low molecular weight subunit of nf	0.0714285714286
NF-L	neurofilament light (subunit)	0.0714285714286
NF-L	low-molecular-weight neurofilament protein	0.0714285714286
NF-L	nf-m, nf-h, low, middle and high subunits of neurofilaments, respectively	0.0714285714286
NF-L	neurofilament light chain	0.0714285714286
EPMA	electron probe x-ray microanalysis	1.0
TLR4	toll-like receptor 4	1.0
NF-H	high molecular weight subunit of nf	0.05
NF-H	heavy neurofilament	0.05
NF-H	high-molecular-weight neurofilament subunit	0.05
NF-H	neurofilament high (subunit)	0.05
NF-H	neurofilament 200 (heavy chain)	0.05
NF-H	heavy neurofilament subunit	0.1
NF-H	heavy neurofilament protein	0.05
NF-H	neurofilament heavy chain	0.05
NF-H	neurofilament-h	0.2
NF-H	heavy-molecular-weight neurofilament	0.05
NF-H	neurofilament heavy-chain	0.05
NF-H	neurofilament heavy	0.1
NF-H	neurofilament h	0.1
NF-H	heavy chain neurofilament	0.05
NaSal	sodium salicylate	1.0
ECIC	external cortex inferior colliculus	0.0588235294118
ECIC	external inferior colliculus	0.117647058824
ECIC	external cortex of the inferior colliculus	0.588235294118
ECIC	external cortex of inferior colliculus	0.117647058824
ECIC	external cortex of the ic	0.117647058824
GWAS	genome wide association studies	0.166666666667
GWAS	genome-wide association studies	0.833333333333
JRSJ	ankovic rating scale	1.0
TMTT	rail making test	1.0
VUBV	rije universiteit brussel	1.0
iCGRP	calcitonin gene-release peptide like immunoreactivity	0.111111111111
iCGRP	immunoreactive calcitonin gene-related peptide	0.777777777778
iCGRP	immunoreactive cgrp	0.111111111111
cha-CNTF	ppolyclonal chicken-anti-ciliary neurotrophic factor	1.0
anti-DBH-	sapanti-dopamine-β-hydroxylase-saporin	1.0
PVhyp	hypothalamic paraventricular nucleus	1.0
EPQ-RE	ysenck’s personality inventory	1.0
SVZS	ubventricular zone	1.0
CTAPH-D-P	he-cys-tyr-d-trp-arg-thr-pen-thr-nh2	1.0
TMTF	temporal modulation transfer function	1.0
AF64A	ethylcholine mustard aziridinium ion	0.5
AF64A	ethylcholine mustard azirinium ion	0.166666666667
AF64A	ethylcholine aziridinium	0.333333333333
trans-ACPDtrans-1-aminocyclopentane-trans-1	3-dicarboxylic acid	1.0
SVZa	anterior subventricular zone	1.0
ACTH	corticotropin	0.010582010582
ACTH	adrenocorticotropin hormone	0.126984126984
ACTH	adreno-corticotrophic hormone	0.00529100529101
ACTH	adrenal corticotropin hormone	0.010582010582
ACTH	adrenocortiocotrophic hormone	0.00529100529101
ACTH	adrenocorticotropic releasing hormone	0.00529100529101
ACTH	adreno corticotropic hormone	0.00529100529101
ACTH	adenocorticotrophic hormone	0.00529100529101
ACTH	adrenocorticotrophic hormone	0.153439153439
ACTH	adrenocorticotropin	0.0740740740741
ACTH	adrenocorticotropin releasing hormone	0.00529100529101
ACTH	adrenocorticotropin-releasing hormone	0.015873015873
ACTH	adrenocorticotropic-hormone	0.015873015873
ACTH	adrenocorticotrophin	0.021164021164
ACTH	adrenocorticotrophin hormone	0.010582010582
ACTH	adrenal corticotrophic hormone	0.00529100529101
ACTH	corticotrophin	0.00529100529101
ACTH	adrenocorticotropic hormone	0.513227513228
ACTH	adrenocorticotrope hormone	0.00529100529101
ssDNA	single-stranded dna	1.0
NF4494	4′,4″,4‴-[carbonylbis[imino-5,1,3-benzenetriyl bis(carbonyl-imino)]]tetrakis(benzene-1,3-disulfonic acid)	1.0
KAkainate	kainic acid	1.0
SFO	subfornical organ	1.0
nIV	trochlear nucleus	1.0
CABAD	calcium bound and determined program	1.0
wsAZN	water-soluble derivative of azn	1.0
NAC-	snucleus accumbens shell	1.0
GABAB-	mediated inhibition	1.0
Ras	guanine nucleotide-binding/exchanging protooncogene product	1.0
SCHSCH-23390	r(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride	1.0
NACC	nucleus accumbens	0.75
NACC	nucleus accumbens core	0.25
DLWM	dorsolateral white matter	1.0
BDGB	artha-dupgreen virus	1.0
TFEB	transcription factor eb	1.0
WKYW	istar kyoto	0.0952380952381
WKYW	istar kyoto rat	0.0952380952381
WKYW	istar-kyoto rats	0.047619047619
WKYW	istar–kyoto	0.142857142857
WKYW	istar-kyoto rat	0.047619047619
WKYW	istar–kyoto rat	0.047619047619
WKYW	istar kyoto rats	0.190476190476
WKYW	istar–kyoto rats	0.047619047619
WKYW	istar-kyoto	0.285714285714
BMP-4	bone morphogenetic protein 4	1.0
GABABR	2gabab receptor-2	0.333333333333
GABABR	sgabab receptors	0.333333333333
GABABR	2gaba b receptor 2	0.333333333333
NACS	nucleus accumbens shell	1.0
NACP	non-a-beta-component precursor	1.0
TFEQ	three-factor eating questionnaire	1.0
AMPAR	amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor	0.08
AMPAR	ampa-type glutamate receptor	0.04
AMPAR	s-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.04
AMPAR	sampa subtype of glutamate receptors	0.04
AMPAR	sα-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors	0.04
AMPAR	a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor	0.04
AMPAR	sα-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors	0.04
AMPAR	trafficking	0.08
AMPAR	sα-amino-hydroxy-5-methyl-4-isoxazolepropionic acid type glutamate receptors	0.04
AMPAR	ampa receptor	0.08
AMPAR	sα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors	0.16
AMPAR	sampa receptors	0.24
AMPAR	alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor	0.08
GPDH	glyceraldehyde 3-phosphate dehydrogenase	1.0
TMT2	5-dihydro-2,4,5-trimethylthiazoline	0.75
TMT2	5-dihydro-2, 4, 5-trimethylthiazole	0.25
VMpo	ventromedial thalamic nucleus, posterior part	1.0
OLG	soligodendrocytes	0.5
OLG	olfactory loss group	0.5
LTCP	low-threshold ca2+ potential	0.8
LTCP	low-threshold calcium potential	0.2
IEG-TF	immediate early gene transcription factor	1.0
cC	3caspase 3	0.5
cC	hatcholine acetyltransferase of the common type	0.5
WCST	wisconsin card sorting test	0.5
WCST	wisconsin card sort test	0.5
VREST	resting membrane potential	1.0
PAGvl	ventrolateral pag	1.0
OEPC	oleyloxyethylphosphorylcholine	1.0
FM-USV	frequency-modulated ultrasonic vocalization	1.0
AS6012451	3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]	1.0
RasGEF	ras-guanine nucleotide exchange factor	0.5
RasGEF	ras guanyl nucleotide exchange factor	0.5
tdT	omatomutated form of red fluorescent protein from discosoma sp	1.0
HPLC-ESI-MS	high performance liquid chromatography-electrospray ionization-mass spectrometry	1.0
XLAGX-	linked lissencephaly with ambiguous genitalia	1.0
catD	cathepsin d	1.0
catE	cathepsin e	1.0
NR1NR2a	nr2b, subunits of the n-methyl-d-aspartate glutamate receptor	1.0
eEPSC	sevoked excitatory postsynaptic currents	0.173913043478
eEPSC	glutamatergic excitatory postsynaptic current	0.0434782608696
eEPSC	evoked epsc	0.0434782608696
eEPSC	excitatory (glutamatergic) postsynaptic current	0.0434782608696
eEPSC	action potential-dependent epsc	0.0434782608696
eEPSC	evoked excitatory postsynaptic current	0.521739130435
eEPSC	sevoked excitatory postsynaptic current	0.0434782608696
eEPSC	sevoked excitory postsynaptic currents	0.0434782608696
eEPSC	sevoked epscs	0.0434782608696
SDCBP	syntenin-1	1.0
βIII	tubulin	1.0
NADPH-	dnicotine adenine dinucleotide phosphate-diaphorase	0.0277777777778
NADPH-	cytochrome p450 reductase	0.0277777777778
NADPH-	diaphorase	0.305555555556
NADPH-	dnicotinamide adenine dinucleotide phosphate-diaphorase	0.0833333333333
NADPH-	diaphorase histochemistry	0.0277777777778
NADPH-	dnicotinamide adenine dinucleotide phosphate-diaphorase histochemical activity	0.0277777777778
NADPH-	dnicotinamide adenine dinucleotide phosphate diaphorase	0.166666666667
NADPH-	dnadph-diaphorase	0.0555555555556
NADPH-	dreduced nicotinamide adenine dinucleotide phosphate-diaphorase	0.0277777777778
NADPH-	dnicotinamide adenine dinucleotide phosphate –diaphorase	0.0277777777778
NADPH-	d histochemistry	0.0277777777778
NADPH-	dependent diaphorase	0.0277777777778
NADPH-	dnadph diaphorase	0.0833333333333
NADPH-	dnicotinamide adenine dinucleotide phosphate	0.0277777777778
NADPH-	oxidase	0.0277777777778
NADPH-	dβ nicotinamide adenine dinucleotide phosphate diaphorase	0.0277777777778
FAHA	6-(fluoroacetamido)-1-hexanoicanilide	1.0
SPSSS	tatistical package of social science	0.5
SPSSS	tatistical package for the social sciences	0.5
ThT	thioflavin-t	1.0
totMGV	mean gray value of total staining	1.0
dlMRF	mesencephalic reticular formation dorsolateral to the red nucleus	1.0
FMCD	focal malformations of cortical development	1.0
eEPSP	sevoked excitatory postsynaptic potentials	0.5
eEPSP	evoked excitatory postsynaptic potential	0.5
SHP-	2	1.0
OLP	soligodendrocyte precursor cells	0.333333333333
OLP	soligodendrocyte progenitor cells	0.333333333333
OLP	oligodendrocyte progenitor	0.333333333333
PIPK	5phosphatidylinositol-4-phosphate-5-kinase	1.0
2DE	two-dimensional electrophoresis	0.666666666667
2DE	two-dimensional gel electrophoresis	0.333333333333
2DG	[14c]2-deoxyglucose	0.1
2DG	2-deoxy [14c]	0.1
2DG	3h-2-deoxyglucose	0.1
2DG	2-[14c] deoxy-d-glucose	0.2
2DG	2-deoxyglucose	0.4
2DG	2-deoxy-d-glucose	0.1
contra-PTV	contralateral postero-temporal visual cortex	1.0
LTPAPLTP	induced with action potentials	1.0
hSC	shuman schwann cells	1.0
hSA	human serum albumin	1.0
NK-1R	neurokinin-1 receptor	1.0
BAPTA1	2-bis (o-aminophenoxy) ethane-n, n, n', n'-tetraacetic acid	0.0277777777778
BAPTA1	2-bis (o-aminophenoxy) ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid	0.277777777778
BAPTA1	2-bis(o-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid)	0.0277777777778
BAPTA1	2-bis(o-aminophenoxy) ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA1	2-bis(o-aminophenoxy)ethane-n,n,n’,n’-tetraacetic acid	0.0277777777778
BAPTA1	2-bis(2-aminophenoxy)ethane n,n,n′,n′-tetra-acetic acid	0.0277777777778
BAPTA1	2-bis(2-aminophenoxy)ethane-n,n,n-tetraacetic acid	0.0277777777778
BAPTA1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic-acid	0.0277777777778
BAPTA1	2-bis(2-aminophenoxy) ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA1	2-bis(2-amino-phenoxy)ethane-n,n,n′,n′-tetraacetic acid tetrapotassium salt	0.0277777777778
BAPTA1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetra acetic acid tetrakis	0.0277777777778
BAPTA1	2-bis (2-aminophenoxy) ethane-n,n,n,ntetraacetic acid	0.0277777777778
BAPTA1	2-bis(o-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid	0.166666666667
BAPTA1	2-bis(2-aminophenoxy)-ethane-n,n,n′,n′-tetraacetic acid	0.0555555555556
BAPTA1	2,-bis(2-aminophenoxy)ethane-n,n,n′,n′′-tetraacetic acid	0.0277777777778
BAPTA1	2-bis(o-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid	0.0277777777778
BAPTA1	2 bis-(2-aminophenoxy)ethane-n,n,n′,n′,-tetraacetic acid	0.0277777777778
BAPTA1	2-bis [2-aminophenoxy] ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA1	2-bis (2-aminophenoxy) ethane-n,n,n′n′-tetraacetic acid	0.0277777777778
BAPTA1	2-bis (2-aminophenoxy) ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
tADAtrans-azetidine-2	4-dicarboxylic acid	1.0
NIFE	nifedipine	1.0
MALDI-T	ofmatrix assisted laser desorption ionization-time of flight	0.5
MALDI-T	of/tofmatrix assisted laser desorption ionization time-of-flight/time-of-flight	0.5
IKK	iκb kinase	0.25
IKK	inhibitor of kappab kinase	0.25
IKK	inhibitory subunit of nuclear factor-κ b kinase	0.25
IKK	+ current	0.25
TRAP-14	thrombin receptor agonist peptide	1.0
NF-κβ	nuclear factor kappa beta	0.333333333333
NF-κβ	nuclear factor-κβ	0.666666666667
AMT4H-1	3-thiazin-2-amine, 5,6-dihydro-6-methyl-hydrochloride	1.0
EHMT	2euchromatic histone-lysine n-methyltransferase 2	1.0
α-GDH	glycerol-3-phosphate-dehydrogenase	1.0
NADPHd	reduced nicotinamide adenine dinucleotide phosphate diaphorase	0.2
NADPHd	nicotinamide adenine dinucleotide phosphate-diaphorase	0.2
NADPHd	nadph-diaphorase	0.4
NADPHd	nicotinamide adenine dinucleotide phosphate diaphorase	0.2
NK-1r	neurokinin-1 receptor	1.0
L-TIN	low-slope temperature-insensitive neuron	1.0
RFRP-	3rf-amide-related peptide-3	1.0
gERP	gustatory event-related potentials	1.0
TCEP	tris(carboxyethyl)phosphine hydrochloride	0.333333333333
TCEP	tris(carboxyethyl)phosphine	0.333333333333
TCEP	tris(2-carboxyethyl)phosphine	0.333333333333
DNGRD	elta/notch-1 like epidermal growth factor	1.0
cNB	central narrow bandwidth	1.0
MDA-L	ysmalondialdehyde-lysine	1.0
FPLSDF	isher's protected least significant difference	1.0
AGm	medial agranular area of frontal cortex	1.0
HSPC	hematopoietic stem/progenitor cells	1.0
fRFM	fixed rippled frequency modulated	1.0
GLP-1	glucagon-like peptide-1 (7–36)-amide	1.0
GLP-2	glucagon-like peptide-2	1.0
MRS1220	9-chloro-2-(2-furyl)-5-[(phenylacetyl)amino][1,2,4]	1.0
D-Ala2	nme-phe4,gly-ol5]enkephalin	0.0833333333333
D-Ala2	n-me-phe4gly5-ol]-enkephalin	0.0833333333333
D-Ala2	glu4]-deltorphin	0.0833333333333
D-Ala2	n-me-phe4,gly-ol5)-enkephalin	0.0833333333333
D-Ala2	n-me-phe4, gly5-ol]-enkephalin	0.25
D-Ala2	n-me4,gly5-ol]-enkephalin	0.0833333333333
D-Ala2	n-me-phe4,gly5-ol]-enkephalin	0.0833333333333
D-Ala2	glu4]deltorphin	0.0833333333333
D-Ala2	n-mephe4, gly-ol]-enkephalin	0.166666666667
ELAV	embryonic lethal abnormal vision	1.0
CDIC	a2+-dependent inactivation	1.0
PAMP	spathogen-associated molecular patterns	0.4
PAMP	pathogen-associated molecular pattern	0.2
PAMP	pathogen associated molecular pattern	0.2
PAMP	proadrenomedullin n-terminal 20 peptide	0.2
TAC1tachykinin	precursor 1	1.0
SEEG	stereo-electroencephalographic	1.0
d2H	2odouble-distilled water	1.0
NFBD	normal folic acid and vitamin b12 deficient	1.0
RNAase	ribonuclease	1.0
3-D	synaptic ultrastructure	0.142857142857
3-D	three-dimensional	0.857142857143
SCGx	superior cervical ganglionectomy	1.0
TBS-TTBS-T	ween 20	0.5
TBS-TTBS-T	ween-20	0.5
RSNA	renal sympathetic activity	0.111111111111
RSNA	renal sympathetic nerve activity	0.888888888889
Lac	lactate	1.0
α2C-KO-wt	control mice for mice lacking the α2c-adrenergic receptor	1.0
WNIN	/obwistar of national institute of nutrition obese	1.0
IdoA	iduronic acid	1.0
RSNP	regular-spiking non-pyramidal	1.0
Lat	lateral nucleus	0.5
Lat	dorsolateral/lateral	0.5
DNA-	binding factor	1.0
RFLP	restriction fragment length polymorphism	1.0
PBSM	phosphate-buffered saline containing metabisulphite	1.0
PBSB	phosphate buffer saline containing 0.1% bovine serum albumin	1.0
PBSA	phosphate-buffered saline supplemented with 0.5% albumin	0.5
PBSA	phosphate-buffered saline containing 1% bovine serum albumin	0.5
FIRF	inite impulse response	1.0
8-OH	dg8-hydroxydeoxyguanosine	0.266666666667
8-OH	dg8-hydroxy-2-deoxyguanosine	0.133333333333
8-OH	dg8-hydroxy-2′deoxyguanosine	0.0666666666667
8-OH	dg8-hydroxyguanine	0.0666666666667
8-OH	dg8-hydroxy deoxyguanosine	0.0666666666667
8-OH	dg8-hydroxy-2′-deoxyguanosine	0.4
PBSF	pbs with photoflo	1.0
PBSD	ulbecco's phosphate-buffered saline	0.333333333333
PBSD	ulbecco’s phosphate-saline	0.333333333333
PBSD	ulbecco's phosphate buffer saline	0.333333333333
R-lobe	rhabdomeral lobe	1.0
15I	15 intromission female group	0.5
15I	15 intromissions	0.5
PMLD	spelizaeus-merzbacher-like diseases	1.0
BrI	brdu labeling index	1.0
GUS-ββ-	glucuronidase	1.0
PBSP	hosphate buffer saline	0.0588235294118
PBSP	hosphate-buffered saline	0.705882352941
PBSP	hosphate-buffered solution	0.0588235294118
PBSP	hosphate buffered saline	0.176470588235
Cg3	cingulate cortex area 3	1.0
PBST	phosphate-buffered saline containing 0.3% triton x-100	0.0928571428571
PBST	phosphate buffer with 0.1% tween 20	0.0214285714286
PBST	phosphate-buffered saline with 0.05% tween 20	0.0142857142857
PBST	phosphate-buffered saline/0.5% triton x-100	0.00714285714286
PBST	pbs with 0.3% triton x-100	0.00714285714286
PBST	phosphate-buffered saline+tween	0.0142857142857
PBST	phosphate-buffered saline with tween-20	0.00714285714286
PBST	0.05 m phosphate-buffered saline containing 0.1% or 0.3% (as indicated) triton x-100	0.00714285714286
PBST	0.05 m phosphate-buffered saline containing triton x-100	0.00714285714286
PBST	pbs containing 0.03% triton x-100	0.00714285714286
PBST	0.2% (v/v) triton x-100 in pbs	0.00714285714286
PBST	0.3% triton x-100 in 0.05m phosphate-buffered saline	0.0142857142857
PBST	phosphate-buffered saline containing 1% triton	0.0142857142857
PBST	phosphate-buffered saline (ph 7.4) with 0.3% triton x-100	0.00714285714286
PBST	0.1 m phosphate-buffered saline containing 0.2% triton x-100	0.00714285714286
PBST	phosphate buffered saline containing 0.1% tween	0.00714285714286
PBST	phosphate-buffered saline containing 0.01% (w/v) sodium azide and 0.2% (v/v) tween 20	0.00714285714286
PBST	pbs with triton x-100	0.0142857142857
PBST	phosphate-buffered saline containing 0.3% tween-20	0.00714285714286
PBST	phosphate-buffered saline with 0.1% tween-20	0.0142857142857
PBST	pbs containing triton x-100	0.00714285714286
PBST	phosphate-buffer saline with 0.3% triton x-100	0.00714285714286
PBST	phosphate-buffered saline with 0.1% triton x-100	0.00714285714286
PBST	phosphate buffer saline with 0.5% of triton x-100	0.00714285714286
PBST	0.1 m phosphate buffer saline containing 0.2% triton x-100	0.00714285714286
PBST	phosphate buffered saline containing 0.5% triton x-100	0.00714285714286
PBST	0.1m pbs containing 0.03% triton x-100	0.00714285714286
PBST	0.01 m pbs containing 0.1% triton x-100	0.00714285714286
PBST	pbs and 0.03% triton x-100	0.00714285714286
PBST	phosphate buffer saline containing 0.2% triton x-100	0.00714285714286
PBST	phosphate buffer containing 0.9% nacl and 0.3% triton x-100	0.0142857142857
PBST	phosphate-buffered saline with 0.2% triton x-100	0.00714285714286
PBST	phosphate-buffered saline with tween 20	0.00714285714286
PBST	0.1 m phosphate-buffered saline containing 0.3% triton x-100	0.0142857142857
PBST	phosphate buffer containing 0.9% nacl supplemented with 0.3% triton x-100	0.00714285714286
PBST	0.1m phosphate-buffered saline containing 0.3% triton x-100	0.00714285714286
PBST	phosphate-buffered saline containing 0.4% triton x-100	0.00714285714286
PBST	0.1% triton x-100 in phosphate buffered saline	0.00714285714286
PBST	phosphate-buffered saline containing 0.5% triton x-100	0.00714285714286
PBST	phosphate-buffered saline containing 0.1% triton x-100	0.0142857142857
PBST	x0.1% triton x-100 in pbs	0.00714285714286
PBST	0.1m phosphate-buffered saline containing 0.2% triton x-100	0.00714285714286
PBST	0.1 m phosphate-buffered saline containing 0.2% triton x-100	0.00714285714286
PBST	phosphate-buffered saline with 0.5% triton x-100	0.00714285714286
PBST	phosphate-buffered saline+0.1% tween 20	0.0142857142857
PBST	5% dry milk in phosphate-buffered saline/0.1% (v/v) tween 20	0.00714285714286
PBST	0.2% triton x-100 in phosphate-buffered saline	0.00714285714286
PBST	phosphate-buffered saline–tween	0.00714285714286
PBST	phosphate-buffered saline triton x-100	0.00714285714286
PBST	5% nonfat dry milk in pbs with 0.05% tween-20	0.00714285714286
PBST	phosphate-buffered saline containing 0.05% tween	0.0142857142857
PBST	phosphate-buffered saline containing triton x-100	0.0214285714286
PBST	phosphate-buffered saline with 0.1% tween 20	0.00714285714286
PBST	phosphate-buffered saline containing 0.8% triton x-100	0.00714285714286
PBST	phosphate-buffered saline containing 0.5% triton-x	0.00714285714286
PBST	phosphate-buffered saline containing 0.1% tween	0.00714285714286
PBST	phosphate-buffered saline containing 0.1% tween 20	0.0142857142857
PBST	phosphate buffer saline containing 0.3% trition x-100	0.00714285714286
PBST	wphosphate buffered saline with tween 20	0.00714285714286
PBST	10% normal swine serum diluted in a phosphate buffer saline solution containing 0.3% triton x-100	0.00714285714286
PBST	x0.1% triton x-100 in phosphate-buffered saline	0.00714285714286
PBST	0.1 m saline phosphate buffer containing 0.3% triton x-100	0.00714285714286
PBST	triton x-100	0.00714285714286
PBST	phosphate buffer saline with 0.3% triton x-100	0.00714285714286
PBST	phosphate-buffered saline containing triton	0.00714285714286
PBST	0.3% triton x-100	0.00714285714286
PBST	phosphate-buffered saline triton	0.00714285714286
PBST	phosphate-buffered saline containing triton-x	0.0142857142857
PBST	phosphate-buffered saline with 0.2% tween-20	0.00714285714286
PBST	pbs containing 0.3% triton x-100	0.0428571428571
PBST	phosphate-buffered saline with 0.3% triton x-100	0.0285714285714
PBST	pbs with 0.1% tween 20	0.0142857142857
PBST	phosphate buffered-saline (pbs) containing 0.25% triton x-100	0.00714285714286
PBST	phosphate-buffered saline with triton x	0.00714285714286
PBST	pbs with tween 20	0.00714285714286
PBST	pbs plus triton x-100	0.00714285714286
PBST	phosphate buffered saline containing tween-20	0.00714285714286
PBST	phosphate buffer solution with 0.2% triton x-100	0.00714285714286
PBST	phosphate-buffered saline with triton x-100	0.0428571428571
PBST	0.1% triton x-100 in phosphate-buffered saline	0.00714285714286
PBST	0.3% triton x-100 in pbs	0.0142857142857
PBST	phosphate-buffered saline with triton-x 100	0.00714285714286
PBST	pbs containing 0.1% tween 20	0.00714285714286
PBST	phosphate-buffered saline with 0.05% tween-20	0.00714285714286
PBST	wpbs containing 0.1% tween 20	0.00714285714286
PBST	phosphate-buffered saline containing tween 20	0.00714285714286
PBST	pbs–1% tween 20	0.00714285714286
PBST	0.3% triton x-100 in phosphate-buffered saline	0.00714285714286
PBST	phosphate-buffered saline with triton	0.00714285714286
PBST	pbs supplemented with 0.1% tween 20	0.00714285714286
PBST	0.1% triton x in pbs	0.00714285714286
PBST	0.05% v/v tween in phosphate buffer saline	0.00714285714286
PBST	phosphate-buffered saline+triton x-100	0.00714285714286
PBST	phosphate-buffered saline containing 0.01% tween-20	0.00714285714286
PBST	xphosphate-buffered saline with triton x-100	0.00714285714286
PBST	phosphate-buffered saline/tween 20	0.00714285714286
F12CS	hams f12 culture medium containing fetal calf serum, penicillin and streptomycin	1.0
U69	593, ([+]-[5α,7α,8β]	0.5
U69	593(5a,7a,8b)-(-)-n-methyl-n-(7-(1-pyrrolidinyl)1-oxaspiro (4,5) dec-8-yl) benzeneacetamide	0.5
60S	large ribosomal subunit	1.0
VSSC	voltage-sensitive sodium channel	0.333333333333
VSSC	voltage sensitive sodium channels	0.333333333333
VSSC	svoltage-sensitive sodium channels	0.333333333333
RU486	mifepristone	1.0
VTVBS	virtual time to virtual boundary of stability	1.0
lNAC1	the long isoform of nac1	1.0
gIX	glossopharyngeal ganglia	1.0
L-KYN	sl-kynurenine sulfate	1.0
5-MeODMT	5-methoxy-n,n-dimethyltryptamine	1.0
SOAS	timulus onset asynchrony	1.0
-ACA	ϵ-aminocaproic acid	1.0
DPQ3	4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2h)-isoquinolinone	1.0
A1254	aroclor 1254	1.0
-IR	-immunoreactive	0.142857142857
-IR	-immunoreactivity	0.142857142857
-IR	immunoreactivity, immunoreactive	0.0714285714286
-IR	immunoreactivity	0.214285714286
-IR	immunoreactive	0.214285714286
-IR	-immunoreactivity, -immunoreactive	0.0714285714286
-IR	-like immunoreactivity	0.0714285714286
-IR	-immunoreactive or -immunoreactivity	0.0714285714286
PBSt	posterior biceps-semitendinosus	1.0
-A	b-antibody	1.0
-C	ca1(dg) neurones from control rats	1.0
KBHK	rebs–bicarbonate–hepes buffer	1.0
FMRIBF	unctional magnetic resonance imaging of the brain	0.5
FMRIBF	unctional mri of the brain software library	0.5
-N	n, n', n'-tetraacetic acid	0.00862068965517
-N	n,n',n'-tetra-acetic acid	0.00862068965517
-N	n,n′, n′-tetraacetic acid	0.0172413793103
-N	n,n′,n′-tetraacetic acid	0.620689655172
-N	n, n, n′-tetraacetic acid	0.00862068965517
-N	n,n′,n′-tetra-acetate	0.0172413793103
-N	n,n,n-tetraacetic acid	0.0258620689655
-N	n,n′,n′tetraacetate	0.00862068965517
-N	n,n′,n′-tetraaccetic acid	0.00862068965517
-N	n,n′,n-tetraacetic acid	0.00862068965517
-N	n,n′,n′-tetraacetic acid, tetrasodium salt	0.00862068965517
-N	n,′,n′-tetraacetic acid	0.00862068965517
-N	n,n',n'-tetraacetic acid	0.00862068965517
-N	n′-tetraacetic acid	0.0344827586207
-N	n,n′n′-tetraacetic acid	0.0344827586207
-N	n,n′,n′-tetraacetic-acid	0.0172413793103
-N	n, n′, n′-tetraacetic acid	0.00862068965517
-N	n,n′,n′ tetraacetic acid	0.0172413793103
-N	n,n′,n[prime-tetraacetic acid	0.00862068965517
-N	n,n′,n′-tetra acetic acid	0.0431034482759
-N	n,n,n tetraacetic acid	0.00862068965517
-N	n,n′,n′ tetraacetate	0.00862068965517
-N	urr1-null heterozygous	0.00862068965517
-N	n,n′,n′-tetraacetic acid; hepes, hco(3-)-free n-2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.00862068965517
-N	n,n′,n′-tetra-acetic acid	0.0431034482759
-I	protein kinase c ϵ inhibitor	1.0
PMDP	elizaeus-merzbacher disorder	0.333333333333
PMDP	elizaeus-merzbacher disease	0.666666666667
CPCCOet	7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester	1.0
LSTG	left superior temporal gyrus	1.0
hAβPP	human β-amyloid precursor protein	1.0
dVDAVP	[deamino-cys1, d-3-(pyridyl)-ala2,arg8]-vasopressin	1.0
PMDD	premenstrual dysphoric disorder	1.0
PPHS	platelet-poor horse serum	1.0
Nω-	nitro-l-arginine	1.0
BRS-	3bombesin-like peptide receptor subtype 3	0.333333333333
BRS-	3bombesin receptor subtype-3	0.666666666667
SSADH	succinate semialdehyde dehydrogenase	1.0
RPTP	receptor-type protein tyrosine phosphatase ζ	0.142857142857
RPTP	receptor protein tyrosine phosphatase	0.571428571429
RPTP	receptor-type protein tyrosine phosphatase	0.285714285714
PBS-TX-NGSPBS-TX	containing normal goat serum 10%	1.0
2-ME	2-mercaptoethanol	1.0
p-NF-H	neurofilament of high molecular weight	1.0
mTERF	smitochondrial termination factors	1.0
mZ	nrmetabotropic zinc receptor	1.0
GABARGABAA	receptor	0.75
GABARGABAA	receptors	0.25
myr-PKI	14–22myristoylated cyclic amp-dependent protein kinase inhibitor peptide	1.0
rRSP	rostral retrosplenial cortex	1.0
cPVH	caudal portion of the pvh	1.0
RPTK	sreceptor protein tyrosine kinases	1.0
RPTPσ	receptor protein tyrosine phosphatase σ	0.5
RPTPσ	receptor protein tyrosine phosphatase sigma	0.5
EPSPslow	slow excitatory postsynaptic potential	1.0
BPDP	arkinson's disease patients with bilateral initial motor signs	1.0
TβRITGFβ	type i receptor	1.0
RET-	2rectal thermoprobe	1.0
EBVE	pstein-barr virus	1.0
ALPFC	anterolateral pfc	1.0
PCSA	physiological cross-sectional area	1.0
SDS-FRL	sodium dodecylsulfate detergent-washed freeze-fracture replica labeling	1.0
APPα-	amyloid precursor protein	1.0
Smorphine-treated	saline-challenged animals	1.0
XIAPX-	linked inhibitory apoptosis protein	0.166666666667
XIAPX-	chromosome-linked inhibitor of apoptosis protein	0.166666666667
XIAPX-	linked inhibitor of apoptosis protein	0.333333333333
XIAPX-	chromosome linked inhibitor of apoptosis protein	0.166666666667
XIAPX-	chromosome-linked inhibitors of apoptosis	0.166666666667
NPYF	(d-tyr)l(me-phe)qpqrf-amide	1.0
2-PAM	pralidoxime	1.0
MAPs	microtubule-associated proteins	1.0
SDS-PAGESDS	–polyacrylamide resolving gel	0.333333333333
SDS-PAGESDS	–polyacrylamide gel electrophoresis	0.333333333333
SDS-PAGESDS	polyacrylamide gel electrophoresis	0.333333333333
plPFC	prelimbic prefrontal cortex	1.0
MITC	midline and intralaminar thalamic complex	1.0
TSN	trigeminal sensory nucleus	0.6
TSN	temporal semantic network	0.2
TSN	trigeminal sensory nuclei	0.2
TSO	trained + sham-operated	1.0
c-M	npomidline/central median preoptic nucleus	1.0
TSM	tractus septopallio-mesencephalicus	0.5
TSM	tractus septomesencephalicus	0.5
c-J	unjun oncogene	0.0416666666667
c-J	un n-terminal kinase 3 (jnk3)	0.0416666666667
c-J	un nh2-terminal kinase	0.0416666666667
c-J	un n terminal kinase	0.0416666666667
c-J	un	0.583333333333
c-J	un n-terminal protein kinase	0.0416666666667
c-J	un phosphorylation	0.0416666666667
c-J	un n-terminal kinase	0.166666666667
TSH	thyroid stimulating hormone	0.2
TSH	thyroid-stimulating hormone	0.6
TSH	thyrotropin	0.2
c-H	2dcfda5-(and-6-)carboxy-2′,7′-dichlorodihydrofluorescein diacetate	1.0
TSF	thickness sub fraction	1.0
c-F	os-immunoreactivity	0.02
c-F	osprotein product of c-fos gene	0.01
c-F	os-lic-fos-like immunoreactive	0.01
c-F	os protein	0.04
c-F	os-irc-fos-immunoreactive	0.02
c-F	os expression	0.01
c-F	os immunohistochemistry	0.03
c-F	os-lirc-fos-like-immunoreactivity	0.01
c-F	osfbj osteosarcoma oncogene	0.01
c-F	os induction	0.01
c-F	os+c-fos positive	0.02
c-F	os/nadph-d co-localization	0.01
c-F	os immunoreactivity	0.04
c-F	os imomunohistochemistry	0.01
c-F	os-irc-fos immunoreactive/c-fos immunoreactivity	0.01
c-F	os-immunohistochemistry	0.01
c-F	os	0.71
c-F	os immunochemistry	0.01
c-F	os-irc-fos-like-immunoreactive	0.01
TSD	total sleep deprivation	1.0
TSE	stransmissible spongiform encephalopathies	0.333333333333
TSE	tranmissible spongiform encephalopathy	0.111111111111
TSE	transmissible spongiform encephalopathy	0.222222222222
TSE	transmissible spongiform encephalopathies	0.111111111111
TSE	temporal spectral evolution	0.222222222222
GUO	guanosine	1.0
TSC	tuberous sclerosis complex	0.7
TSC	time spent in cataplexy	0.1
TSC	taste sensory cell	0.1
TSC	1/2tuberous sclerosis complex1/2	0.1
Gβγβγ	subunit of gi/o-protein	1.0
TSA	kittyramide signal-amplification kit	0.0169491525424
TSA	trichloroacetic acid	0.0169491525424
TSA	tyramide signal amplification.	0.0169491525424
TSA	trichostatin a	0.271186440678
TSA	tyramide signal amplification	0.661016949153
TSA	tyramide signal-amplification	0.0169491525424
Robo	roundabout	1.0
HZac	heterozygous cre-activated mice	1.0
Mash-1	mouse achaete-scute homolog-1	1.0
HBDDE2	2′, 3, 3′, 4, 4′-hexahydroxy-1, 1′ biphenyl-6,6′-dimethanol dimethyl ether	1.0
TPMPA1	2,5,6-tetrahydropyridine-4-ylmethylphosphinic.	0.5
TPMPA1	2,5,6-tetrahydropyridin-4-yl)-methylphosphinic acid	0.5
snIX	glossopharyngeal afferent	1.0
TST	ris–buffered saline	0.0208333333333
TST	ris-buffered saline	0.208333333333
TST	ris–saline	0.0833333333333
TST	tail suspension test serotonine	0.0208333333333
TST	ris saline	0.0416666666667
TST	ris-saline	0.0208333333333
TST	tail-suspension test	0.0208333333333
TST	hioflavin s	0.0208333333333
TST	s65dn	0.0208333333333
TST	urner syndrome	0.0208333333333
TST	ourette syndrome	0.0416666666667
TST	s65dn mouse	0.0208333333333
TST	tail suspension test	0.375
TST	total sleep time	0.0833333333333
TSR	thrombospondin type 1 repeat	0.5
TSR	total spike rate (this is a function whose values describe the global behaviour of the neural responses)	0.5
TSS	transcription start site	0.714285714286
TSS	total symmetric synapses	0.142857142857
TSS	transcription start sites	0.142857142857
TSP	3-(trimethylsilyl)-2,2,3,3-tetradeuteropropionate	0.142857142857
TSP	3-trimethyl silyl propionic acid	0.142857142857
TSP	trimethylsilyl propionate	0.142857142857
TSP	thrombospondin	0.428571428571
TSP	total-signal-power	0.142857142857
TSQ	n-(6-methoxy-8-quinolyl)-para-toluenesulfonamide	0.166666666667
TSQ	n-(6-methoxy-8-quinolyl)-p-toluensulphonamide	0.166666666667
TSQ	n-6-metoxy-p-toluenesulfonamide quinoline	0.166666666667
TSQ	6-methoxy-8-toluene sulphonamide quinoline	0.166666666667
TSQ	6-methoxy 8-para toluene sulfonamide quinoline	0.333333333333
Y25130	n-(1-azabicyclo[2.2.2.]oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4,dihydro-2h-1,4-benzoxazine-8-carboxamide	1.0
SBDPα-	spectrin breakdown product	1.0
SAM-RS	significance analysis of microarrays using rank scores	1.0
β-CDβ-	cyclodextrin	1.0
PGRN	progranulin	1.0
L-ENK	leucine enkephalin	1.0
GEO	gene expression omnibus	1.0
NIMHANSN	ational institute of mental health and neurosciences	1.0
TIFF	tagged image file format	1.0
PACAP	pituitary adenylate cyclase activating peptide	0.0377358490566
PACAP	pituitary adenylate cyclase-activating polypeptide-38	0.0188679245283
PACAP	pituitary andenylyl cyclase activating polypeptide	0.0188679245283
PACAP	6-38high affinity pituitary adenylate cyclase activating polypeptide receptor antagonist	0.0377358490566
PACAP	pituitary adenylyl cyclase activating peptide	0.0377358490566
PACAP	pituitary adenylate cyclase activating polypeptide 1	0.0188679245283
PACAP	+/+wildtype	0.0188679245283
PACAP	pituitary adenylate cyclase-activating peptide	0.11320754717
PACAP	pituitary adenylate cyclase–activating polypeptide	0.0188679245283
PACAP	pituitary adenylate cyclase-activating polypeptide	0.396226415094
PACAP	pituitary adenylate cyclase activating polypeptide	0.169811320755
PACAP	pituitary adenylyl cyclase-activating peptide	0.0188679245283
PACAP	pituitary adenylyl cyclase activating polypeptide	0.0188679245283
PACAP	pituitary adenylyl cyclase-activating polypeptide	0.0566037735849
PACAP	1-rpituitary adenylate cyclase-activating polypeptide receptor	0.0188679245283
8-PST	8-(p-sulfophenyl)theophylline	0.5
8-PST	8-(p-sulphophenyltheophylline)	0.5
OX-R	1orexin type 1	1.0
TAN-	67	1.0
3-APS	3-aminopropanesulphonic acid	1.0
OX-B	orexin-b	1.0
OX-A	orexin a	0.5
OX-A	orexin-a	0.5
lPMA	left premotor area	1.0
Ara-c	cytosine β-d-arabinofuranoside	1.0
Y5	npy(y5) receptor	1.0
iNFT	intracellular neurofibrillary tangle	1.0
rRP	a-ctbcholera toxin b-subunit derived from the rostral raphe pallidus nucleus	0.333333333333
rRP	arostral raphe pallidus	0.666666666667
IODM	inferior olive (dorsomedial cell group)	0.5
IODM	dorsomedial cell group of the inferior olivary nucleus	0.5
25kDa	component of the snare complex	1.0
TS-	eepscts-evoked excitatory postsynaptic current	1.0
PrPc	prion protein	0.25
PrPc	normal, cellular prion protein	0.25
PrPc	cellular prion protein	0.5
DC-LG	cell type with dense cytoplasm and large granules	1.0
DMH-CT	bcholera toxin b-subunit derived from the dorsomedial hypothalamus	1.0
VWT	visual water task	1.0
tRNA	transfer rna	0.666666666667
tRNA	transfer ribonucleic acid	0.333333333333
VWV	an der waerden	1.0
VWM	ventral white matter	0.5
VWM	vanishing white matter	0.25
VWM	visual working memory	0.25
miRNAM	icrorna	1.0
DHAP	dihydroxyacetone phosphate	1.0
Ara-C	cytosine arabinoside	1.0
TS2	temporal auditory association area	1.0
ABpc	accessory basal nucleus, parvicellular division	1.0
TS1	anterior temporal auditory association area	1.0
LY393053	(±)-2-amino-2-(3-cis and trans-carboxycyclobutyl-3-(9-thioxanthyl)propionic acid)	1.0
DCVs	dense-cored vesicles	1.0
RER	enyi entropy	0.0384615384615
RER	receipt of expected reward	0.0384615384615
RER	rough endoplasmic reticulum	0.615384615385
RER	respiratory exchange ratio	0.230769230769
RER	receiving expected reward	0.0769230769231
S2	deep slow-wave sleep	0.333333333333
S2	electrical stimulation applied during the 13th fraction	0.166666666667
S2	slow wave sleep stage 2	0.166666666667
S2	secondary somatosensory cortex	0.166666666667
S2	deep slow wave sleep	0.166666666667
S1	electrical stimulation applied during the third fraction	0.0833333333333
S1	first sacral segment of the spinal cord	0.0833333333333
S1	light slow-wave sleep	0.166666666667
S1	primary somatosensory cortex	0.5
S1	slow wave sleep stage 1	0.0833333333333
S1	light slow wave sleep	0.0833333333333
PPW	pentosephosphate pathway	1.0
REV	reversal	1.0
S6	steps 1–6	1.0
RET	relative electron transmission	0.0909090909091
RET	c-ret proto-oncogene protein	0.0909090909091
RET	low affinity tyrosine kinase receptor for gdnf family members	0.0909090909091
RET	tyrosine kinase ‘rearranged after transfection’	0.0909090909091
RET	receptor tyrosine kinase	0.0909090909091
RET	tyrosine kinase	0.0909090909091
RET	receptor re-arranged during transfections	0.0909090909091
RET	isoforms	0.0909090909091
RET	reversal exploring test	0.0909090909091
RET	rearranged during transfection	0.0909090909091
RET	retention	0.0909090909091
PTHrP	parathyroid hormone related peptide	0.5
PTHrP	parathyroid hormone-related peptide	0.5
S-	2stimulus-2	0.107142857143
S-	1-psphingosine-1-phosphate	0.0357142857143
S-	14danimals perfused 14 days after intraarticular injection of saline and not further stimulated	0.0357142857143
S-	nitrosothiols	0.107142857143
S-	neuronslow type neuron	0.0357142857143
S-	fepspslope of field excitatory post-synaptic potential	0.0357142857143
S-	100b	0.0357142857143
S-	methyl-l-thiocitrulline	0.0357142857143
S-	oligossense oligodeoxynucleotides	0.0714285714286
S-	allyl-l-cysteine	0.0357142857143
S-	nonreinforced stimulus	0.0357142857143
S-	nitrosylation	0.142857142857
S-	bestsucrose-best	0.0357142857143
S-	100	0.142857142857
S-	unrewarded stimulus	0.0357142857143
S-	stimulus associated with punishment	0.0357142857143
S-	aspirin	0.0357142857143
REM	rapid eye movement	0.712918660287
REM	rapid eye movement (sleep)	0.00478468899522
REM	sleeprapid-eye-movement sleep	0.00956937799043
REM	rapid-eye-movement	0.0717703349282
REM	rapid eye movements	0.0191387559809
REM	sleep	0.0382775119617
REM	sleeprapid eye movement sleep	0.0334928229665
REM	rapid-eye-movement sleep	0.0143540669856
REM	rapid eye movement sleep	0.0478468899522
REM	rapid eye-movement	0.0143540669856
REM	or rrapid eye movement	0.00478468899522
REM	rapid-eye movement	0.0287081339713
AMPTα-	methyl-dl-tyrosine methyl ester hydrochloride	0.333333333333
AMPTα-	methyl-p-tyrosine	0.666666666667
CRNOGO	%relative nogo-performance (no change of shuttle-box compartment)	1.0
REA	key-reaction force torque	0.5
REA	radioenzymatic assay	0.5
REG	region	1.0
RED	recurrent epileptiform discharge	1.0
REE	resting energy expenditure	1.0
sIS	spontaneous interictal spike	1.0
LFD	low-frequency depression	1.0
FCR	flexor carpi radialis	1.0
LFF	low-frequency fluctuations	0.333333333333
LFF	low-frequency fatigue	0.666666666667
LFA	left–right alternation	1.0
FCU	musculus flexor carpi ulnaris	1.0
FCV	fast cyclic voltammetry	0.625
FCV	fast-scan cyclic voltammetry	0.375
LFB	luxol fast blue	1.0
FCX	+tcastrated female quail treated with exogenous testosterone	0.333333333333
FCX	frontal cortex	0.666666666667
LFO	low-frequency oscillatory	1.0
LFN	late frontal negativity	1.0
RSQR	elationship scales questionnaire	1.0
IMLC	intermediolateral cell column	1.0
AUAP	abridged universal amplification primer	1.0
FG-7142	n-methyl-β-carboline-3-carboxamide	1.0
FCA	freund's complete adjuvant	0.5
FCA	functional cerebral asymmetry	0.25
FCA	sfunctional cerebral asymmetries	0.25
HMBA	hexamethylene-bisacetamide	1.0
FCC	federal communications commission	1.0
FCD	focal cortical dysplasia	0.714285714286
FCD	focal cortical dysplasias	0.142857142857
FCD	fos-cells density	0.142857142857
LFP	+pclateral fluid percussion combined with pilocarpine	0.0140845070423
LFP	local field potentials	0.12676056338
LFP	lateral fluid-percussion	0.0140845070423
LFP	slocal field potentials	0.0985915492958
LFP	lateral fluid percussion	0.0281690140845
LFP	local field potential	0.69014084507
LFP	local-field potential	0.0281690140845
LFS	low fat stress	0.0138888888889
LFS	latency to the first spike	0.0138888888889
LFS	low frequency stimulation	0.361111111111
LFS	ltdlow frequency stimulation induced ltd	0.0138888888889
LFS	low-frequency stimulation	0.583333333333
LFS	low-frequency afferent stimulation	0.0138888888889
LFR	low firing rate	0.5
LFR	latency to the first reach	0.5
FCI	focal cerebral ischemia	1.0
GABAγ	3gaba-a receptor subunit gamma 3	1.0
FCM	fibroblast-conditioned medium	0.333333333333
FCM	facial cancer model	0.333333333333
FCM	fluorescein-coated microspheres	0.333333333333
FCN	forebrain cholinergic neuron	0.5
FCN	ferrocyanide ions	0.5
Sx	syntaxin chimera	1.0
G-CSFR	granulocyte-colony stimulating factor receptor	0.25
G-CSFR	granulocyte-colony stimulating factor-receptor	0.25
G-CSFR	granulocyte colony-stimulating factor receptor	0.5
NTR-2	neurotensin receptor, type-2	1.0
ADNIA	lzheimer’s disease neuroimaging initiative	1.0
NTR-1	neurotensin receptor, type-1	1.0
MP-RAGE	magnetization-prepared rapid-acquisition gradient echo	1.0
St	stria terminalis	1.0
OGDR	oxygen-glucose deprivation reperfusion	0.5
OGDR	oxygen and glucose deprivation/reperfusion	0.5
Sh	simple end-stopped	1.0
cADPR	cyclic adp-ribose	0.5
cADPR	cyclic adp ribose	0.5
Sn	standard deviation of the noise	1.0
Sm	submedius thalamic nucleus	0.333333333333
Sm	nucleus submedius	0.666666666667
E-WNE	dinger-westphal nucleus	1.0
GABAβ	3gaba-a receptor subunit beta 3	1.0
Bcl-2	b cell lymphoma 2	1.0
Sg	suprageniculate nucleus	1.0
MIP-1	macrophage inflammatory protein-1	1.0
TPBSTRIS	phosphate buffer solution	1.0
SZ	stratum zonale	0.44
SZ	subventricular zone	0.04
SZ	s-offschizophrenic subjects off medication at least 4 weeks	0.04
SZ	schizophrenic	0.04
SZ	stratum zonale (zonal layer of superior colliculus)	0.04
SZ	schizophrenia	0.32
SZ	stratum zonale of superior colliculus	0.04
SZ	subependymal zone	0.04
SX	somatosensory cortex	1.0
SS	sound stress	0.0169491525424
SS	simple spike	0.0677966101695
SS	somatosensory	0.0169491525424
SS	slice-selective	0.0169491525424
SS	short-shafted neurons	0.0169491525424
SS	saline with saline challenge	0.0169491525424
SS	strong stimulus	0.0169491525424
SS	sham skin	0.0169491525424
SS	serial subtraction	0.0169491525424
SS	single spike	0.0169491525424
SS	salicylate	0.0169491525424
SS	spherical synaptic bodies	0.0169491525424
SS	seizure severity	0.0169491525424
SS	somatostatin	0.152542372881
SS	single-stranded	0.0169491525424
SS	stress sensitive	0.0169491525424
SS	homozygous short allele carrier	0.0169491525424
SS	swim stress	0.0338983050847
SS	strategy score	0.0169491525424
SS	cortex—somatosensory area	0.0169491525424
SS	sham adrenalectomy, stressed	0.0169491525424
SS	saline+saline	0.0169491525424
SS	set-shifting phase	0.0169491525424
SS	spontaneous sleep	0.0169491525424
SS	sodium salicylate	0.0508474576271
SS	saline controls	0.0169491525424
SS	prenatally stressed mice treated with ssri during postnatal days 1–21	0.0169491525424
SS	stop success	0.0169491525424
SS	somatosensory cortex	0.0508474576271
SS	subarachnoid space	0.0169491525424
SS	simple spikes	0.0169491525424
SS	suprasylvian sulcus	0.0169491525424
SS	slow-spiking	0.0169491525424
SS	saline solution	0.0169491525424
SS	short shaft	0.0169491525424
SS	self-stimulation	0.0508474576271
SS	intracranial self-stimulation	0.0169491525424
SS	ssupplemental somatosensory area	0.0169491525424
SS	small/soon or small/sure	0.0169491525424
SS	short sleep	0.0169491525424
SS	stress-sensitive	0.0169491525424
SR	stratum radiatum	0.28431372549
SR	–spstratum pyramidale together with radiatum	0.00980392156863
SR	955316-imino-3-(4-methoxyphenyl)-1(6h)-pyridazinebutanoic acid hbr	0.0196078431373
SR	mr, nr, strong, moderate and non-rhythmically firing cells of ath	0.00980392156863
SR	sstartle responses	0.00980392156863
SR	49682non-peptide antagonist of the high affinity neurotensin receptor	0.00980392156863
SR	synaptic ribbon	0.0196078431373
SR	141716cb1 receptor antagonist	0.00980392156863
SR	144190	0.00980392156863
SR	sharpened romberg	0.00980392156863
SR	142948a	0.0294117647059
SR	small axon terminal with round vesicles	0.00980392156863
SR	sensory rating	0.00980392156863
SR	reversal of simple discrimination	0.00980392156863
SR	small round synaptic vesicle ending	0.00980392156863
SR	141716	0.0294117647059
SR	955316-imino-3-(4-methoxyphenyl)-1(6h)-pyridazinebutanoic acid	0.0294117647059
SR	skate ringer	0.00980392156863
SR	101sulforhodamine 101	0.0196078431373
SR	spontaneous (discharge) rate	0.0196078431373
SR	141716a[n-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1h-pyrazole-3-carboxyamide]	0.00980392156863
SR	spike rate	0.00980392156863
SR	small terminals in vpm	0.00980392156863
SR	141716a	0.0490196078431
SR	spontaneous discharge rate	0.00980392156863
SR	serine racemase	0.00980392156863
SR	tnucleus subrotundus	0.00980392156863
SR	startle response	0.00980392156863
SR	95531	0.00980392156863
SR	sleep recovery	0.00980392156863
SR	48692	0.0294117647059
SR	sarcoplasmic reticulum	0.00980392156863
SR	signal recovery	0.00980392156863
SR	spontaneous rate	0.0294117647059
SR	small axon terminal with round synaptic vesicles	0.00980392156863
SR	sleep restriction	0.0294117647059
SR	suppression ratio	0.0294117647059
SR	140333	0.0196078431373
SR	955312-(3-carboxypropyl)-3-amino-6-methoxyphenyl-pyridazinium bromide	0.00980392156863
SR	superior rectus muscle	0.0196078431373
SR	strongly relearning	0.00980392156863
SR	955316-imino-3-(4-methoxyphenyl)-1(6h)-pyridazinebutanoic acid hydrobromide	0.0196078431373
SR	142801	0.00980392156863
SR	sepiapterin reductase	0.00980392156863
SR	shortening reaction	0.00980392156863
SR	sscavenger receptors	0.00980392156863
SR	sursway-referenced visual surround motion	0.00980392156863
SR	stratum radiatum of ca1	0.00980392156863
SR	scavenger receptor	0.00980392156863
SQ	225369-tetrahydro-2-furanyl)-9h-purin-6-amine	0.2
SQ	acute quinpirole	0.2
SQ	225369-(tetrahydro-2-furanyl)-9h-purin-6-amine	0.4
SQ	square control figure	0.2
SP	/stimspikes per stimulus	0.00303951367781
SP	21dshort photoperiod during 21 days	0.00303951367781
SP	sucrose preference	0.00303951367781
SP	nsubplate neuron(s)	0.00303951367781
SP	fsubstance p frontier	0.00303951367781
SP	short photoperiod	0.00911854103343
SP	substance-p	0.00303951367781
SP	senile plaque	0.0151975683891
SP	schizophrenia	0.00303951367781
SP	medium and small pyramidal cell layer	0.00303951367781
SP	ssenile plaques	0.0121580547112
SP	short photoperiod ld10:14	0.00303951367781
SP	sway path	0.00303951367781
SP	nucleus subpretectalis	0.00607902735562
SP	substance p	0.741641337386
SP	600125	0.00607902735562
SP	stratum pyramidale	0.0577507598784
SP	starting point	0.00607902735562
SP	signal peptide	0.00303951367781
SP	strata pyramidale	0.00303951367781
SP	succinyl phosphonate	0.00303951367781
SP	serine–proline	0.00303951367781
SP	smooth pursuit	0.00303951367781
SP	cellsuperficial pyramidal cell	0.00303951367781
SP	stump pain	0.00303951367781
SP	secondary prosencephalon	0.00303951367781
SP	silent period	0.00607902735562
SP	starting position	0.00303951367781
SP	asubparaventricular zone of the hypothalamus	0.00303951367781
SP	subplate	0.0212765957447
SP	superficial peroneal	0.00911854103343
SP	sharp potential	0.00607902735562
SP	600125signal pharmaceuticals library compound number 600125	0.00303951367781
SP	/dlshort photoperiods by delaying light onset	0.00303951367781
SP	short-lasting potentiation	0.00303951367781
SP	spleen	0.00303951367781
SP	5spinal trigeminal tract	0.00303951367781
SP	1	0.00303951367781
SP	schizophrenia patients	0.00303951367781
SP	socially partnered	0.00303951367781
SP	senile plaques	0.0121580547112
SP	solution point	0.00303951367781
SP	side population	0.00303951367781
SW	spike–wave	0.08
SW	short withdrawal (1 day of cocaine withdrawal)	0.04
SW	spike-wave	0.16
SW	spontaneous withdrawal	0.04
SW	spike and wave	0.04
SW	spike width	0.04
SW	spike-and-wave	0.04
SW	swim only	0.04
SW	short wavelength	0.04
SW	slow wave	0.24
SW	southwest	0.24
SV	2synaptic vesicle protein 2	0.125
SV	subventricular	0.0208333333333
SV	2synaptic vesicle glycoprotein 2	0.0208333333333
SV	2synaptic vesicle protein	0.0208333333333
SV	surface area per unit volume	0.0208333333333
SV	40 vectors	0.0208333333333
SV	2bsynaptic vesicle glycoprotein 2b	0.0208333333333
SV	40 ltag	0.0208333333333
SV	40mpsimian virus 40 minimal promoter	0.0208333333333
SV	subjective vertical	0.0208333333333
SV	serotonergic vulnerability	0.0208333333333
SV	2	0.0416666666667
SV	esuperior vestibular nucleus	0.0208333333333
SV	40simian virus 40	0.0208333333333
SV	simvastatin	0.0416666666667
SV	40 large tagsimian virus 40 large t antigen	0.0208333333333
SV	synaptic vesicle	0.145833333333
SV	ssmall vesicles	0.0208333333333
SV	espinal vestibular nucleus	0.0208333333333
SV	2asynaptic vesicle protein 2a	0.0208333333333
SV	2asynaptic vesicle protein 2 a	0.0208333333333
SV	synaptic vesicle protein	0.0208333333333
SV	stria vascularis	0.0833333333333
SV	2a synaptic vesicle protein	0.0208333333333
SV	ssynaptic vesicles	0.0208333333333
SV	synaptic vesicles	0.125
SV	sham group of animals treated with vehicle	0.0208333333333
SU	side-up	0.181818181818
SU	54023-[3-(2-carboxyethyl)-4-methylpyrrol-2-methylidenyl]-2-indolinone	0.0909090909091
SU	syntrophin unique	0.0909090909091
SU	54023-[(3-(2-carboxyethyl)-4-methylpyrrol-2-yl)methylene]-2-indolinone	0.0909090909091
SU	sham adrenalectomy, unstressed	0.0909090909091
SU	suicide victims	0.0909090909091
SU	steer urine	0.0909090909091
SU	single unit	0.181818181818
SU	strategies users	0.0909090909091
ST	solitarius (solitary) tract	0.0169491525424
ST	strong training	0.0169491525424
ST	hsubthalamic nucleus	0.135593220339
ST	standard housing	0.0169491525424
ST	sub-threshold time	0.0169491525424
ST	restraint stress without chewing	0.0169491525424
ST	stria terminalis	0.0508474576271
ST	stare condition of the hi test	0.0169491525424
ST	rstria terminalis	0.0169491525424
ST	dorsal striatum	0.0338983050847
ST	semitendinosus	0.0508474576271
ST	simple theme	0.0169491525424
ST	1000spinally transected+treadmill training for 1000 steps/session	0.0169491525424
ST	stabilization time	0.0169491525424
ST	sulfatide	0.0169491525424
ST	2	0.0338983050847
ST	ssign-trackers	0.0169491525424
ST	short term	0.0338983050847
ST	solitary tract	0.0677966101695
ST	single-transduced	0.0169491525424
ST	8sialv or pst-1 (pst)polysialyltransferase-1	0.0169491525424
ST	sulfotransferase	0.0169491525424
ST	striatum area	0.0169491525424
ST	modelstereotactic infusion of rotenone model	0.0169491525424
ST	swimming training	0.0169491525424
ST	supratemporal auditory cortices	0.0169491525424
ST	stearoylcarnitine chloride	0.0169491525424
ST	complete spinal cord transection	0.0169491525424
ST	striatum	0.118644067797
ST	semimembranosus	0.0169491525424
ST	simultaneously bilateral stimulation	0.0169491525424
ST	sedentary/tpa-stop	0.0169491525424
ST	satellite cells	0.0169491525424
ST	short-term abuse	0.0338983050847
ST	strong training protocol	0.0169491525424
SK	small conductance ca2+ activated k+ channel	0.04
SK	small-conductance k+	0.04
SK	channelsmall-conductance ca2+-activated voltage-independent k+ channel	0.04
SK	small-conductance calcium-activated k+ channel	0.04
SK	small conductance	0.04
SK	small conductance calcium-activated potassium	0.08
SK	3small conductance ca2+-activated k+ channel protein 3	0.04
SK	small conductance ca2+-activated k+ channel	0.04
SK	small-conductance ca2+-dependent k+	0.04
SK	small conductance ca2+-activated k+ channels	0.04
SK	channels	0.08
SK	small conductance ca2+-dependent k+ channel	0.04
SK	3	0.04
SK	small-conductance ca2+-activated k+ channels	0.04
SK	small conductance k+ current	0.04
SK	2small-conductance ca2+-activated potassium channel	0.04
SK	small-conductance kca channels	0.04
SK	“small conductance” or “mini-k” type of ca2+-dependent k+ channel	0.04
SK	small conductance calcium-activated potassium channel	0.12
SK	small-conductance apamin-sensitive ca2+-dependent k+	0.04
SK	skull surface	0.04
TEAS	transcutaneous electric acupoint stimulation	1.0
SI	semantic interference	0.00704225352113
SI	nucleus basalis magnocellularis/substantia innominata	0.00704225352113
SI	severity index	0.00704225352113
SI	suppression index	0.00704225352113
SI	stimulus intensity	0.00704225352113
SI	single	0.00704225352113
SI	primary somatosensory (cortex)	0.00704225352113
SI	signal intensity	0.0211267605634
SI	sham-intubated	0.00704225352113
SI	ntintermediate subnucleus of the nucleus of the solitary tract complex	0.00704225352113
SI	testsocial interaction test	0.00704225352113
SI	first somatic sensory area	0.00704225352113
SI	synchronization index	0.00704225352113
SI	substantia innominate	0.00704225352113
SI	selectivity index	0.0281690140845
SI	primary somatosensory cortex	0.232394366197
SI	sleep interruption	0.00704225352113
SI	substantia innominata	0.302816901408
SI	primary somatic sensory cortex	0.00704225352113
SI	scaled inclusivity	0.00704225352113
SI	stepping index	0.00704225352113
SI	sham intubated	0.00704225352113
SI	square index	0.00704225352113
SI	substantia innominata (basal ganglia of meynert)	0.00704225352113
SI	selectivity index value	0.00704225352113
SI	first somatic sensory cortex	0.0211267605634
SI	sulcation index	0.0140845070423
SI	sleep inertia	0.00704225352113
SI	surprise index	0.00704225352113
SI	stroke index	0.0140845070423
SI	swimming induction	0.00704225352113
SI	sympathoinhibitory	0.00704225352113
SI	stimulus-specific indices	0.00704225352113
SI	similarity index	0.00704225352113
SI	socially isolated	0.0140845070423
SI	nucleus basalis of meynert/substantia innominata	0.0140845070423
SI	somatosensory cortex	0.0140845070423
SI	shift index	0.00704225352113
SI	summed ion intensity	0.00704225352113
SI	stimulation index	0.00704225352113
SI	still-image cricket	0.00704225352113
SI	primary somatosensory area	0.0140845070423
SI	primary somatosensory	0.0211267605634
SI	/miprimary sensorimotor	0.00704225352113
SI	social interaction	0.0633802816901
SH	sulfhydryl	0.0434782608696
SH	sham-operated groups	0.0434782608696
SH	social housing	0.0434782608696
SH	sham-operated control	0.0434782608696
SH	spinal cord hemisection at c2	0.0434782608696
SH	3glb2sh3 domain growth factor receptor bound 2-like endophilin b2	0.0434782608696
SH	3src-homology 3	0.0434782608696
SH	sham operation	0.0434782608696
SH	standard-housed	0.0434782608696
SH	sham control	0.0869565217391
SH	iseptohippocampal nucleus	0.217391304348
SH	socially housed	0.0434782608696
SH	sustained hypoxia	0.0434782608696
SH	2src homologue 2 domain	0.0434782608696
SH	spike height	0.0434782608696
SH	septohippocampal	0.0434782608696
SH	8single-handling day 8	0.0434782608696
SH	3src homology 3	0.0434782608696
WIN55212-2	r(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]	1.0
SN	prsubstantia nigra pars reticularis	0.00230414746544
SN	rpars reticulata of substantia nigra	0.00460829493088
SN	spontaneous nystagmus	0.00921658986175
SN	c dasubstantial nigra dopamine	0.00230414746544
SN	saline no lever available	0.00230414746544
SN	signal to noise	0.00230414746544
SN	short n-terminal	0.00230414746544
SN	single	0.00230414746544
SN	subjective night	0.00230414746544
SN	salivary gland neurone	0.00230414746544
SN	lsubstantia nigra pars lateralis	0.00230414746544
SN	synaptoneurosome	0.00230414746544
SN	rsubstantia nigra	0.00230414746544
SN	/vtasubstantia nigra and ventral tegmental area taken together	0.00230414746544
SN	sciatic nerves	0.00230414746544
SN	signal-to-noise ratio	0.00230414746544
SN	/vtasubstantia nigra/ventral tegmental area	0.00230414746544
SN	pcsn pars compacta	0.00460829493088
SN	substancia nigra pars compacta	0.00230414746544
SN	subtantia nigra	0.00230414746544
SN	signal-to-noise	0.00691244239631
SN	csubstantia nigra pars compacta	0.135944700461
SN	rsubstatia nigra reticulata	0.00230414746544
SN	r-oflsubstantia nigra pars reticulata oro-facio-lingual	0.00230414746544
SN	pcsubstantia nigra	0.00230414746544
SN	pcsubstantia nigra pars compacta	0.101382488479
SN	a9substantia nigra	0.00230414746544
SN	solitary nucleus	0.00230414746544
SN	spinal nerve	0.00230414746544
SN	rsubstantia nigra pars reticulata	0.158986175115
SN	csubstantia nigra-pars compacta	0.00230414746544
SN	‘cz’, sn ‘critical zone’	0.00230414746544
SN	rsubstantia nigra pars reticulate	0.0138248847926
SN	csubstantia nigra	0.00230414746544
SN	rreticular part of substantia nigra	0.00230414746544
SN	rprsubstantia nigra pars reticulata	0.00230414746544
SN	xsnx-482	0.00230414746544
SN	56 cells	0.00691244239631
SN	prsubstantia nigra pars reticulata	0.0299539170507
SN	substantia nigra	0.405529953917
SN	prsubstantia nigra pars reticulate	0.00460829493088
SN	secretoneurin	0.00230414746544
SN	rsn reticulata	0.00230414746544
SN	rsubstantia nigra pars reticularis	0.00460829493088
SN	rsubstantia nigra reticulate	0.00460829493088
SN	rsn pars reticulata	0.00230414746544
SN	rsubstantia nigra reticulata	0.0138248847926
SN	csubstantia nigra compacta	0.00921658986175
SN	sciatic nerve	0.00691244239631
SN	substantia nigra lesion	0.00230414746544
SN	substantia nigra pars compacta	0.00230414746544
SM	stria medullaris of the thalamus	0.030303030303
SM	sphingomyelin	0.121212121212
SM	stria medullaris	0.030303030303
SM	submedius	0.030303030303
SM	dstria medullaris	0.030303030303
SM	medial septum	0.030303030303
SM	suspension medium	0.030303030303
SM	submedial thalamic nucleus	0.030303030303
SM	semitendinosus	0.030303030303
SM	superficial mammillary nucleus	0.030303030303
SM	sensory-motor cortex/stratum moleculare–dentate gyrus, cornu ammonis	0.030303030303
SM	smooth muscle	0.030303030303
SM	1sensorimotor primary hand cortical areas	0.030303030303
SM	striated muscle	0.030303030303
SM	softmax network	0.030303030303
SM	nucleus of stria medullaris	0.030303030303
SM	segmented motion	0.030303030303
SM	border of somatosensory and motor cortex	0.030303030303
SM	1primary sensorimotor cortex	0.030303030303
SM	supraminimal stimulation	0.030303030303
SM	semimembranosus	0.030303030303
SM	synaptic membrane	0.030303030303
SM	scala media	0.030303030303
SM	standard medium	0.0606060606061
SM	saline+meth	0.030303030303
SM	stratum moleculare	0.030303030303
SM	submucosa	0.030303030303
SM	asesphingomyelinase	0.030303030303
SM	scrambled motion	0.030303030303
SL	synchronization likelihood	0.0571428571429
SL	standard-reared lesioned group	0.0285714285714
SL	spiral ligament	0.0571428571429
SL	heterozygous short allele carrier	0.0285714285714
SL	the same location exposure twice	0.0285714285714
SL	nervesuperior laryngeal nerve	0.0285714285714
SL	327α-[amino[(4-aminophenyl)thio]methylene]	0.0285714285714
SL	stratum lemnisci	0.0285714285714
SL	ustratum lucidum	0.0285714285714
SL	/srstratum lucidum/stratum radiatum	0.0285714285714
SL	nucleus septalis lateralis	0.0857142857143
SL	–mstratum lacunosum together with moleculare	0.0285714285714
SL	saline lever available	0.0285714285714
SL	lateral septal nucleus	0.0571428571429
SL	sphingolipid	0.0285714285714
SL	327	0.0285714285714
SL	short latency	0.0285714285714
SL	single-labeled	0.0285714285714
SL	stratum lucidum	0.285714285714
SL	single-lesioned animals with a unilateral infarct	0.0285714285714
SL	somatolactin	0.0285714285714
SC	sighted control	0.00502512562814
SC	stem cell group	0.00502512562814
SC	suprachiasmatic nucleus	0.0150753768844
SC	spike count	0.00502512562814
SC	synaptic cleft	0.00502512562814
SC	schwann cell	0.0100502512563
SC	stellate cell	0.00502512562814
SC	ventral horn of c1 segment of spinal cord	0.00502512562814
SC	hsuprachiasmatic nucleus	0.0251256281407
SC	prenatal saline-treated animals with control treatment	0.00502512562814
SC	satellite glial cell	0.00502512562814
SC	spinal cord	0.0653266331658
SC	superior colliculus	0.562814070352
SC	ssaline-treated cats	0.00502512562814
SC	schäffer collateral	0.00502512562814
SC	schaffer collateral	0.00502512562814
SC	spectral counts	0.00502512562814
SC	superior colliculi	0.00502512562814
SC	sschwann cells	0.0100502512563
SC	saline	0.00502512562814
SC	sedentary control	0.00502512562814
SC	skin conductance	0.00502512562814
SC	standard condition	0.00502512562814
SC	spatial cue	0.00502512562814
SC	stressed and chewing	0.00502512562814
SC	spherical cell	0.00502512562814
SC	sham control	0.00502512562814
SC	vsubceruleus ventrale	0.00502512562814
SC	superior collicular	0.00502512562814
SC	smoking control	0.00502512562814
SC	subcutaneous	0.0201005025126
SC	sucrose consumption	0.00502512562814
SC	standard cage	0.00502512562814
SC	locus subcoeruleus	0.00502512562814
SC	complex spelling and counting	0.00502512562814
SC	stem cells	0.00502512562814
SC	standard conditions	0.00502512562814
SC	supporting cell	0.00502512562814
SC	sleep control	0.00502512562814
SC	control rats from strains selectively bred to be seizure-resistant	0.00502512562814
SC	ssustentacular cells	0.00502512562814
SC	hthiocholine	0.00502512562814
SC	subcoeruleus	0.0100502512563
SC	saline with cocaine challenge	0.00502512562814
SC	suckle control	0.00502512562814
SC	sedentary/control	0.00502512562814
SC	subcutaneously	0.00502512562814
SC	somatosensory cortex	0.0100502512563
SC	single cream	0.00502512562814
SC	small clip	0.00502512562814
SC	surgical control	0.00502512562814
SC	sschaffer collaterals	0.00502512562814
SC	scotophase condition	0.00502512562814
SC	scene cartoons	0.00502512562814
SC	schwann cells	0.00502512562814
SC	shaker control	0.00502512562814
SC	schaeffer collateral	0.00502512562814
SC	serum-containing	0.00502512562814
SC	supragranular callosal neurons	0.00502512562814
SC	sstem cells	0.00502512562814
SC	ssupporting cells	0.00502512562814
SC	standard reared control group	0.00502512562814
SC	osensory cortex	0.00502512562814
SB	2035804-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1h-imidazole	0.037037037037
SB	sodium butyrate	0.148148148148
SB	2432135-methyl-1-({2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl}carbamoyl)-6-trifluoromethylindoline	0.037037037037
SB	synchronization boundary	0.037037037037
SB	secondary branch/sub-branch	0.037037037037
SB	staining buffer	0.037037037037
SB	specific binding	0.037037037037
SB	203580[4-(4-fluorophenyl)-2-(4-methylsul-finylphenyl)-5-(4-pyridyl)1 h-imidazole]	0.037037037037
SB	spontaneous burst	0.037037037037
SB	side bias	0.037037037037
SB	269970sb269970 hydrochloride	0.037037037037
SB	number of spikes	0.037037037037
SB	2035804-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1h-imidazole	0.0740740740741
SB	p38 inhibitorsb203580	0.037037037037
SB	start beep	0.037037037037
SB	ssyllable boundaries	0.037037037037
SB	small boutons	0.037037037037
SB	269.970	0.037037037037
SB	269970(2r)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl	0.037037037037
SB	222200	0.037037037037
SB	203580	0.0740740740741
SB	sodium phenylbutyrate	0.037037037037
SA	superoxide anions	0.027027027027
SA	splice acceptor	0.027027027027
SA	salicylic acid	0.027027027027
SA	spike amplitude	0.027027027027
SA	streptavidin	0.027027027027
SA	spike arrest	0.027027027027
SA	self-administration	0.216216216216
SA	sialic acid	0.027027027027
SA	short axon	0.0540540540541
SA	sodium arsanylate	0.027027027027
SA	sinoatrial	0.0540540540541
SA	short-axon	0.027027027027
SA	stressed in adolescence	0.027027027027
SA	spontaneous activity	0.0540540540541
SA	sleep apnea	0.0540540540541
SA	slowly adapting	0.027027027027
SA	slowly adapting (receptors)	0.027027027027
SA	sample area	0.027027027027
SA	sway area	0.027027027027
SA	short-axon cell	0.027027027027
SA	slowly adapting neuron	0.027027027027
SA	slowly accommodating	0.027027027027
SA	spine apparatus	0.0540540540541
SA	saline alternate environment	0.027027027027
SA	spontaneously active	0.027027027027
microPET	small-animal positron emission tomography	0.333333333333
microPET	high-resolution positron emission tomography	0.333333333333
microPET	small animal positron emission tomography	0.333333333333
SG	suprasylvian gyrus	0.0133333333333
SG	sinus gland	0.0133333333333
SG	vector slate grey	0.0133333333333
SG	sstress granules	0.0133333333333
SG	supragenicular area	0.0133333333333
SG	slate gray	0.0133333333333
SG	stellate ganglion	0.0266666666667
SG	substantia gelatinosa	0.333333333333
SG	spiral ganglion	0.08
SG	spiral ganglion cells	0.0133333333333
SG	suprageniculate thalamic nucleus	0.04
SG	supragranular	0.0133333333333
SG	suprageniculate nucleus	0.146666666667
SG	stress granule	0.08
SG	spinal ganglia	0.0133333333333
SG	stratum granulosum	0.0133333333333
SG	starting gains	0.0133333333333
SG	supragranular layer	0.0133333333333
SG	self-grooming	0.0133333333333
SG	sspinal ganglia	0.0133333333333
SG	substantia gelatinosa.	0.0133333333333
SG	spiral ganglia	0.0133333333333
SG	subesophageal ganglion	0.0133333333333
SG	suprageniculate nucleus of the thalamus	0.0133333333333
SG	ssegmental ganglia	0.0133333333333
SG	stellate ganglia	0.0133333333333
SG	slate grey	0.0133333333333
SG	stratum granulosum–dentate gyrus	0.0133333333333
SF	9spodoptera frugiperda	0.0322580645161
SF	soluble fraction	0.0322580645161
SF	stress fiber	0.0322580645161
SF	hepatocyte growth factor/scatter factor	0.0322580645161
SF	spatial filter	0.0322580645161
SF	isepto-fimbrial septum	0.0322580645161
SF	nsensory feedback noise	0.0322580645161
SF	iseptofimbrial nucleus	0.0967741935484
SF	space-fixed	0.0322580645161
SF	sleep fragmentation	0.0645161290323
SF	minimally supplemented serum free medium	0.0322580645161
SF	saturated fat	0.0322580645161
SF	septofimbrial nucleus	0.0645161290323
SF	scheduled feeding	0.0322580645161
SF	serum-free	0.0322580645161
SF	spontaneous firing	0.0322580645161
SF	/hgfscatter factor/hepatocyte growth factor	0.0322580645161
SF	spatial frequency	0.258064516129
SF	shape factor	0.0322580645161
SF	synaptophysin	0.0322580645161
SE	sleep efficiency (ratio of total sleep time/total recording time)	0.0078125
SE	status epilepticus	0.609375
SE	standard environments	0.0078125
SE	septal progenitor domain	0.0078125
SE	standard error	0.1015625
SE	single electrode shuffling	0.0078125
SE	social environment	0.0078125
SE	sample entropy	0.0078125
SE	standard environment	0.046875
SE	superficial layer of entorhinal cortex	0.0078125
SE	spectral edge	0.0078125
SE	sympathoexcitatory	0.0078125
SE	septic encephalopathy	0.015625
SE	southeast	0.0390625
SE	standard error of the mean	0.03125
SE	standard errors	0.0078125
SE	small excitatory bouton type	0.0078125
SE	subependymal layer	0.0078125
SE	stop error	0.0078125
SE	sensory epithelium	0.0078125
SE	standard error of mean	0.0234375
SE	prenatal saline-treated animals with emotional stress exposure	0.0078125
SE	spin echo	0.0078125
SE	spin-echo	0.0078125
SD	splice donor	0.00448430493274
SD	stimulus duration	0.0179372197309
SD	sleep deprivation	0.103139013453
SD	/galactose-leu-uragalactose based synthetic dropout with no leucine and uracil	0.00448430493274
SD	short days	0.00448430493274
SD	symbol detection	0.00448430493274
SD	discriminative stimulus	0.00448430493274
SD	sstandard deviations	0.00448430493274
SD	somatodendritic	0.00448430493274
SD	social defeat	0.0134529147982
SD	standard deviation of the mean	0.00448430493274
SD	seizure duration	0.00448430493274
SD	simple discrimination	0.0313901345291
SD	sleep duration	0.00448430493274
SD	short-day conditions	0.00448430493274
SD	subjective day	0.00448430493274
SD	spreading depolarization	0.0134529147982
SD	sprague–dawley	0.0403587443946
SD	somal diameter	0.00448430493274
SD	sham group of animals treated with drug	0.00448430493274
SD	sleep deprivation or prolonged waking	0.00448430493274
SD	side-down	0.00448430493274
SD	short-day lighting	0.00448430493274
SD	standard deviations	0.0224215246637
SD	slow deflection	0.00448430493274
SD	short day length	0.00448430493274
SD	+rsleep deprivation plus recovery	0.00448430493274
SD	spreading depression	0.0762331838565
SD	sprague–dawley rat	0.00896860986547
SD	soma-dendritic	0.00448430493274
SD	short day	0.0179372197309
SD	standard deviation	0.560538116592
IBH	baseline holding current	1.0
NRPm	nucleus reticularis paramedianus	1.0
mitAAT	mitochondrial aspartate aminotransferase	1.0
IBK	large-conductance calcium-activated current	1.0
IBM	isolated brain microvessels	1.0
IBO	ibotenic acid-lesioned group	0.0909090909091
IBO	ibotenate	0.0909090909091
IBO	ibotenic acid	0.818181818182
CAS	contralateral acoustic stimulation	0.333333333333
CAS	central auditory system	0.666666666667
CAR	coxsackie and adenovirus receptor	0.5
CAR	carrageenan	0.5
PGl	lateral subdivision of the preglomerular nucleus	1.0
CAP	scompound action potentials	0.0307692307692
CAP	capsaicin	0.153846153846
CAP	angiotensin-converting enzyme inhibitor captopril	0.0153846153846
CAP	capsazepine	0.0153846153846
CAP	compound action potential	0.584615384615
CAP	compound action potentials	0.0307692307692
CAP	cytoplasmic isoform of acid phosphatase	0.0153846153846
CAP	captopril	0.153846153846
IBD	inflammatory bowel disease	0.777777777778
IBD	/nrcinstitute for biodiagnostics/national research council of canada	0.111111111111
IBD	identical by descent	0.111111111111
CAV	3caveolin-3	1.0
CAU	caudate	1.0
PGi	paragigantocellularis nucleus	0.4
PGi	nucleus paragigantocellularis	0.6
IBX	iberiotoxin	1.0
1meA	1-methyladenine	1.0
IBZ	ischemic boundary zone	0.571428571429
IBZ	ischemic border area	0.285714285714
IBZ	ischemic border zone	0.142857142857
CAH	congenital adrenal hyperplasia	1.0
MK8015-methyl-10	11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine	1.0
CAN	scolospinal afferent neurons	0.25
CAN	central autonomic nucleus	0.25
CAN	ca2+-activated non-selective cation (channel or current)	0.25
CAN	calcium-activated non-specific cationic	0.25
CAM	cell adhesion molecule	0.588235294118
CAM	scell adhesion molecules	0.235294117647
CAM	kinase iicalmodulin kinase ii	0.0588235294118
CAM	control aged males	0.0588235294118
CAM	dl-camphor	0.0588235294118
VAMP	synaptobrevin	0.047619047619
VAMP	vesicular associated membrane protein	0.047619047619
VAMP	vesicle-associated membrane protein	0.619047619048
VAMP	vesicle associated membrane protein	0.0952380952381
VAMP	2vesicle-associated membrane protein 2	0.142857142857
VAMP	2vesicle-associated membrane snap25 protein 2	0.047619047619
LHC	left hindlimb contact	1.0
CAA	conditioned active avoidance	0.0666666666667
CAA	cerebral amyloid angiopathy	0.6
CAA	mmon’s horm	0.0666666666667
CAA	mmon’s horn	0.133333333333
CAA	chloroacetaldehyde	0.0666666666667
CAA	mmon's horn	0.0666666666667
IBS	irritable bowel syndrome	0.916666666667
IBS	inflammatory bowel syndrome	0.0833333333333
CAG	cytosine-adenine-guanine trinucleotide	0.142857142857
CAG	repeats	0.142857142857
CAG	hybrid cmv/chicken β-actin promoter	0.142857142857
CAG	modified chicken β-actin promoter with a cytomegalovirus immediate early enhancer	0.142857142857
CAG	cytosine adenine guanine	0.285714285714
CAG	cytosine, adenine, guanine triplet repeat	0.142857142857
IBU	ibuprofen	1.0
CAE	childhood absence epilepsy	1.0
CAD	caspase-activated dnase	0.6
CAD	coronary artery disease	0.2
CAD	collisionally activated dissociation	0.2
EIH	eye in head	1.0
MRSA	methicillin-resistant staphylococcus aureus	1.0
iPLA	2calcium-independent phospholipase a2	0.4
iPLA	2vicalcium-independent phospholipase a2 group vi	0.2
iPLA	2ca2+-independent phospholipase a2	0.4
PGE	1prostaglandin e1	0.0277777777778
PGE	2prostaglandin e2	0.833333333333
PGE	2prostaglandin	0.0138888888889
PGE	paw grip endurance	0.0138888888889
PGE	2prostaglandin 2	0.0138888888889
PGE	2prostaglandin-e2	0.0138888888889
PGE	2	0.0555555555556
PGE	prostaglandin e	0.0277777777778
PGB	pregabalin	1.0
PGC	primary gustatory cortex	0.166666666667
PGC	1α	0.166666666667
PGC	periglomerular cells	0.166666666667
PGC	1peroxisome-proliferator-activated receptor-γ co-activator-1	0.166666666667
PGC	preganglionic column	0.166666666667
PGC	periglomerular cell	0.166666666667
DYT	1	0.285714285714
DYT	1 dystoniatorsion dystonia type 1	0.142857142857
DYT	1 dystonia	0.142857142857
DYT	3 dystonia	0.142857142857
DYT	6	0.285714285714
IBa	barium current	0.666666666667
IBa	txr, toxin resistant-type barium current	0.166666666667
IBa	voltage-dependent ba2+ currents	0.166666666667
PGL	plasma glucose level	1.0
PGM	1 mm mgcl2 in pbs	1.0
ASIC	1	0.03125
ASIC	acid sensing ion channel	0.21875
ASIC	acid-sensing ion channel	0.28125
ASIC	1aacid-sensing ion channels 1a	0.03125
ASIC	2acid-sensing ion channel 2	0.03125
ASIC	3acid-sensing ion channel 3	0.03125
ASIC	3acid sensing ion channel 3	0.03125
ASIC	acid-sensitive ion channel	0.03125
ASIC	1bacid-sensing ion channel 1b	0.03125
ASIC	3-/-acid-sensing ion channel 3 knockout	0.03125
ASIC	acid-sensing ion channels	0.03125
ASIC	sacid-sensing ion channels	0.15625
ASIC	2acid sensitive ion channel 2	0.03125
ASIC	1aacid-sensing ion channels	0.03125
PGK	phosphoglycerate kinase promoter	0.125
PGK	phosphoglycerate kinase	0.5
PGK	phosphoglycerate kinase i promoter	0.125
PGK	phosphoglycerate kinase 1	0.125
PGK	1phosphoglycerate kinase-1	0.125
PGH	2prostaglandin h2	1.0
PGI	2prostaglandin i2	0.4
PGI	2prostacyclin	0.6
PGV	preliminary designation of a posterolateral thalamic region in tenrec	1.0
PGW	persian gulf war	1.0
DYN	dynorphin a-(1–17)	0.0625
DYN	prodynorphin	0.0625
DYN	dynorphinergic	0.0625
DYN	dynorphins	0.0625
DYN	dynorphin	0.75
PGS	prostaglandins	1.0
PGP	protein gene product	0.2
PGP	9.5protein gene peptide 9.5	0.0333333333333
PGP	protein gene product 9.5	0.1
PGP	9.5protein gene-product 9.5	0.0333333333333
PGP	9.5protein gene product 9.5	0.6
PGP	9.5	0.0333333333333
sCD	146	1.0
DYD	iamidino yellow dihydrochloride	0.1
DYD	iamidino yellow	0.8
DYD	iamino yellow	0.1
2hRF	restricted feeding: 2 h daily meal	1.0
ASIS	anterior superior iliac spine	0.666666666667
ASIS	anterior superior iliac spines	0.333333333333
NUDR	/deaf-1nuclear-deformed epidermal auto regulatory factor-1	0.5
NUDR	nuclear deformed epidermal autoregulatory factor	0.5
KFNK	ölliker-fuse nucleus	0.5
KFNK	ölliker–fuse nucleus	0.5
SOA	stimulus onset asynchrony	0.666666666667
SOA	stimulus-mask onset asynchrony	0.0833333333333
SOA	supraoculomotor	0.0833333333333
SOA	sstimulus onset asynchronies	0.166666666667
PBSTSS	phosphate-buffered saline with triton-x 100 and sheep serum	1.0
LHL	uteinizing hormone	0.5
LHL	left hindlimb	0.5
DCHF-DA	2′, 7′-dichlorofluorescein diacetate	0.5
DCHF-DA	2′,7′-dichlorofluorescein diacetate	0.5
D-A	la2]deltorphin ii	1.0
N-Arg	ng-nitro-l-arginine	1.0
WFAW	isteria floribunda agglutinin	0.818181818182
WFAW	isteria floribunda lectin	0.0909090909091
WFAW	isteria floribunda aggulutinin	0.0909090909091
SOC	spinooccipital motor column	0.04
SOC	store-operated channel	0.04
SOC	store-operated ca2+	0.04
SOC	store-operated channels	0.04
SOC	channelsstore-operated calcium channels	0.04
SOC	superior olivary complex	0.72
SOC	self-organized criticality	0.08
5D9D	either 5 or 9 days of dehydration, respectively	1.0
TSMT	ranscranial magnetic stimulation	1.0
NOxnitrate	nitrite and s-nitroso compounds	1.0
MBH	medial basal hypothalamus	0.3125
MBH	medial hypothalamus	0.0625
MBH	mediobasal hypothalamus	0.625
E-NCAM	embryonic form of neural cell adhesion molecule	1.0
HSP-	27heat shock protein 27	0.333333333333
HSP-	7272-kda heat-shock protein	0.333333333333
HSP-	70heat shock protein-70	0.333333333333
TBSθ-	burst stimulation	1.0
nsOD	nonspecific staining od	1.0
UDS	urinary drug screen	1.0
UDP	uridine 5′-diphosphate	0.333333333333
UDP	uridine diphosphate	0.333333333333
UDP	unusual distal process	0.166666666667
UDP	uridine 5′-disphosphate	0.166666666667
fT	femtotesla	1.0
IB-	4isolectin	1.0
NBQX	6-nitro-7-sulphamoylbenzo[f]quinoxalin-2,3-dione	0.0192307692308
NBQX	1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide disodium	0.0192307692308
NBQX	6-nitro-7-sulfamoylbenzo(f)quinoxaline-2-3-dione disodium	0.0192307692308
NBQX	6-nitro-7-sulphamoylbenzo[f]quinoxalone-2,3-dione disodium	0.0769230769231
NBQX	6-nitro-7-sulphamoylbenzo[f]quinoxaline	0.0192307692308
NBQX	6-nitro-7-sulphamoylbenzo(f)-quinoxaline-2,3-dione	0.0192307692308
NBQX	2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)-quinoxaline	0.0192307692308
NBQX	2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline	0.0961538461538
NBQX	6-nitro-7-sulphamoylbenzo[f]quinoxaline-2,3-dione	0.0384615384615
NBQX	1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide	0.0576923076923
NBQX	6-nitro-7-sulphomoylbenzo[f]quinoxaline-2,3-dione	0.0192307692308
NBQX	2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxalone	0.0192307692308
NBQX	1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benz[f]quinoxaline-7-sulphonamide	0.0192307692308
NBQX	2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulphonamide	0.0192307692308
NBQX	2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulphonamide disodium	0.0192307692308
NBQX	2,3-dihydro-6-nitro-7-sulfamoyl-benzo(f)-quinoxaline	0.0192307692308
NBQX	6-nitro-7-sulphamoylbenzo[f]quinoxaline-2,3-dione disodium	0.0192307692308
NBQX	6-nitro-7-sulphamoylbenzo(f)quinoxaline-2-3-dione	0.0384615384615
NBQX	6-nitro-7-sulphamoylbenzo[f]quinoxaline-2,3 dione	0.0192307692308
NBQX	6-nitro-7-sulphamoylbenz[f]quinoxaline-2,3-dione	0.0192307692308
NBQX	2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)quinoxalone	0.0192307692308
NBQX	1,2,3,4-tetrahydro-6-nitro-2,3,-dioxo-benzo[f]quinoxaline-7-sulfonamide	0.0192307692308
NBQX	3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline	0.0192307692308
NBQX	2,3-dihydro-6-cyano-7-sulphamoyl-benzo(f)quinozaline	0.0192307692308
NBQX	2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)quinoxaline	0.0192307692308
NBQX	2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]quinoxaline	0.0192307692308
NBQX	6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione	0.115384615385
NBQX	non-n-methyl-d-aspartic acid glutamatergic antagonist glutamatergic antagonist	0.0192307692308
NBQX	1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulphonamide	0.0384615384615
NBQX	6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione	0.0384615384615
NBQX	6-nitro-7-sulphanoylbenzo[f]quinoxaline-2,3-dione	0.0192307692308
NBQX	dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide	0.0192307692308
NBQX	2,3-dioxo-6-nitro-1,2,3,4 tetrahydrobenzo[f]quinoxaline-7-sulphonamide disodium	0.0192307692308
NBQX	6-nitro-7-sulfanobenzo(f)quinoxaline-2-3-dione disodium	0.0192307692308
CA3	field 3 of cornu ammonis (ammon's horn) of the hippocampus	0.166666666667
CA3	field ca3 of ammon’s horn	0.166666666667
CA3	ammon's horn, areas 1 and 3	0.166666666667
CA3	fields ca1–ca3 of the hippocampus	0.166666666667
CA3	cornu ammonis, subfields 1, 2 and 3	0.166666666667
CA3	field ca3 of the hippocampus	0.166666666667
CA2	ca1/ca2 fields of the hippocampus	0.333333333333
CA2	field 2 of cornu ammonis (ammon's horn) of the hippocampus	0.333333333333
CA2	field ca2 of the hippocampus	0.333333333333
CA1	ca2, ca3, ca4areas of ammon’s horn	0.047619047619
CA1	2,3 or 4, cornu ammonis subfield 1,2,3 or 4, respectively	0.047619047619
CA1	ca2, ca3, hippocampal subfields	0.047619047619
CA1	ca2, ca3, ca1, ca2 and ca3 regions of ammon's horn	0.047619047619
CA1	ca3, cornu ammonis zone 1, 3	0.047619047619
CA1	field 1 of cornu ammonis (ammon's horn) of the hippocampus	0.047619047619
CA1	ca3, ca4, cornu ammonis regions 1,3,4 of hippocampus	0.047619047619
CA1	ca2, ca3ammon’s horn 1, 2, 3	0.047619047619
CA1	ca3hippocampal ca1, ca3 regions	0.047619047619
CA1	ca3hippocampal cornu ammonis	0.047619047619
CA1	field 1 of the cornu ammonis of the hippocampus	0.047619047619
CA1	ca2, ca3, ca4, hippocampal subfields	0.047619047619
CA1	field ca1 of ammon’s horn	0.0952380952381
CA1	cornu ammonis area 1	0.0952380952381
CA1	cornus ammon's field 1 of the hippocampus	0.047619047619
CA1	ca3, ca3a, ca3b, ca3careas of ammon’s horn	0.047619047619
CA1	cornu ammonis 1	0.047619047619
CA1	field ca1 of the hippocampus	0.047619047619
CA1	ca3cornu ammonis regions of the hippocampus	0.047619047619
SKF812796-chloro-7	8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine	1.0
T-SH	total thiol	1.0
OGP	octyl b-d-glucopyranoside	1.0
CA4	hippocampal subfields	0.333333333333
CA4	ammon's horn (hippocampus) subfields	0.333333333333
CA4	field ca4 of the hippocampus	0.333333333333
IIP-MF	intra/infra pyramidal mossy fibres	1.0
fA	bp75fusogenic abp75 immunoporter	1.0
fC	xfrontal cortex	1.0
OGI	oculogyral illusion	1.0
nFR	nonfreezers	0.333333333333
nFR	snonfreezers	0.333333333333
nFR	normalized fractional release	0.333333333333
fF	tfast fourier transform	1.0
OGD	oxygen–glucose-deprivation	0.0103092783505
OGD	oxygen glucose deprivation	0.0927835051546
OGD	oxygen-glucose deprivation	0.319587628866
OGD	oxygen–glucose deprivation	0.20618556701
OGD	oxygen and glucose deprivation	0.237113402062
OGD	)	0.020618556701
OGD	oxygen/glucose deprivation	0.0824742268041
OGD	oxygen- and glucose-deprivation	0.0103092783505
OGD	combined oxygen–glucose deprivation	0.0103092783505
OGD	/roxygen-glucose deprivation/reperfusion	0.0103092783505
OGG	1	0.333333333333
OGG	1oxoguanine dna glycosylase	0.333333333333
OGG	18-oxoguanine dna glycosylase	0.333333333333
UDI	use-dependent inactivation	1.0
IB4	bandeiraea simplicifolia isolectin b4	0.0714285714286
IB4	isolectin b4 from banderia simplicifolia	0.0714285714286
IB4	isolectin i-b4 from bandaireae simplicifolia	0.0714285714286
IB4	griffonia simplicifolia b4-isolectin	0.0714285714286
IB4	isolectin from griffonia simplicifolia	0.0714285714286
IB4	bandeiraea simplicifolia agglutinin isolectin b4	0.0714285714286
IB4	isolectin b4	0.5
IB4	bandairaea simplicifolia isolectin b4	0.0714285714286
MBF	mesenteric blood flow	1.0
fO	familiar object	1.0
GHT	geniculohypothalamic tract	1.0
4-HPAA	4-hydroxyphenylacetaldehyde	1.0
NFκBN	uclear factor kappa b	1.0
IL-8	interleukin-8	1.0
SFVS	emliki-forest virus	0.5
SFVS	emliki forest virus	0.5
GHR	genetic high risk	0.125
GHR	ghrelin	0.125
GHR	growth hormone receptor	0.625
GHR	ghrelin receptor	0.125
GHS	growth hormone secretagogue	1.0
MIA	maternal immune activation	0.5
MIA	5-(n-methyl-n-isobutyl)-amiloride	0.5
GAS	gastrocnemius	1.0
IL-6	interleukin-6	1.0
DCFDA	carboxy-2′, 7′-dichlorodihydrofluorescein diacetate	0.25
DCFDA	5-(and 6)-carboxyl-2′,7′-dichlorodihydro fluorescein diacetate	0.25
DCFDA	dichlorofluorescein diacetate	0.5
IL-1	interleukin-1	0.909090909091
IL-1	interleukin-1β	0.0909090909091
MIG	monokine induced by gamma interferon	1.0
MIF	macrophage migration inhibitory factor	0.333333333333
MIF	multiply-innervated muscle fibre	0.166666666667
MIF	mean instantaneous frequency	0.166666666667
MIF	multiply-innervated muscle fiber	0.166666666667
MIF	mifepriston	0.166666666667
SF-	36short form questionnaires	0.333333333333
SF-	1steroidogenic factor-1	0.666666666667
RCIR	espiration change index	1.0
GHB	gamma-hydroxybutyrate	0.571428571429
GHB	gamma hydroxybutyric acid	0.142857142857
GHB	gamma-hydroxybutyric acid	0.142857142857
GHB	γ-hydroxybutyrate	0.142857142857
Trans-ACPD	(+/-)-1-aminocyclopentane-trans-1,3,-dicarboxylic acid	1.0
MIQ	movement imagery questionnaire	1.0
MIP	monocyte inducible protein	0.125
MIP	molluscan insulin-like peptide	0.125
MIP	macrophage inflammatory protein	0.5
MIP	3amacrophage inflammatory protein 3a	0.125
MIP	maximum intensity projection	0.125
GAP	43growth-associated protein 43	0.272727272727
GAP	growth-associated protein 43	0.030303030303
GAP	glyceraldehyde-3-phosphate	0.030303030303
GAP	43growth-associated protein of 43 kd	0.030303030303
GAP	glyceraldehyde 3-phosphate dehydrogenase	0.030303030303
GAP	43growth-associated protein 43 kda	0.0606060606061
GAP	guanosine triphosphatase activating protein	0.030303030303
GAP	growth-associated phosphoprotein	0.030303030303
GAP	43growth associated protein-43	0.030303030303
GAP	43growth associated protein 43	0.0909090909091
GAP	growth-associated protein	0.30303030303
GAP	sgtpase-activating proteins	0.030303030303
GAP	43growth associated protein-43-kda	0.030303030303
MIT	minimum inertia tensor	0.5
MIT	methylisothiazolinone	0.5
SNAPS-	nitroso-n-acetyl-dl-penicillamine	0.166666666667
SNAPS-	nitroso-n-acetylpenicillamine	0.5
SNAPS-	nitroso-n-acetyl-penicillamine	0.333333333333
AR-C66096	2-(propylthio)adenosine-5′-o-(β,γ-difluoromethylene)triphosphate	1.0
DGCR	6digeorge syndrome critical region 6	0.5
DGCR	8digeorge syndrome critical region gene 8	0.5
8-Hydroxy-N	n-dipropyl-2-aminotetralin	1.0
AOD	average optical density	0.666666666667
AOD	anterior olfactory nucleus (dorsal)	0.333333333333
CRA	compound remote associates	0.5
CRA	cluster randomization analysis	0.5
AOB	accessory olfactory bulb	1.0
AOA	2ataxia oculomotor apraxia 2	0.2
AOA	anterior olfactory area	0.2
AOA	amino-oxyacetate	0.4
AOA	aminooxyacetate	0.2
R-state	resting state	1.0
AON	accessory olivary nuclei	0.0526315789474
AON	anterior olfactory nuclei	0.0526315789474
AON	anterior olfactory nucleus	0.842105263158
AON	aortic nerve	0.0526315789474
AOM	anterior olfactory nucleus (medial)	0.5
AOM	azoxymethane	0.5
WSCPW	illiams syndrome cognitive profile	1.0
cOPN	4xchicken opn4x	1.0
GAM	goat anti-mouse	0.5
GAM	goat–anti-mouse igg	0.5
AOI	area of interest	0.8
AOI	areas of interest	0.2
DPAT8-Hydroxy-N	n-dipropyl-2-aminotetralin	1.0
SCDH	spinal cord dorsal horn	1.0
SOR	spatial object recognition	0.333333333333
SOR	retrochiasmatic supraoptic nucleus	0.333333333333
SOR	sustained outward rectification	0.333333333333
AOS	accessory olfactory system	0.5
AOS	accessory optic system	0.5
Wa-1	waved-1 mutant strain	1.0
AOP	anterior olfactory nucleus – posterior part	0.5
AOP	anterior olfactory nucleus, posterior part	0.5
ERAI	endoplasmic reticulum stress-activated indicator	1.0
sCR	1slexlewis x glycosylation of the scr1 molecule	1.0
NQN	12-benzamido-1 4-naphthoquinone	1.0
NQO	1nadph:quinone oxidoreductase	1.0
AOX	4aldehyde oxidase 4	0.5
AOX	acyl-coa oxidase	0.5
CBF1	c-promoter binding factor	1.0
TACTV	total activity	1.0
DMAG	17-dimethylaminoethylamino-17-desmethoxygeldanamycin	1.0
OT-Np	oxytocin-related neurophysin	1.0
SFv	tissue shrinkage factor	1.0
SOV	sodium-orthovanadate	1.0
BG	basal ganglia (putamen and globus pallidus)	0.047619047619
BG	basal ganglia	0.857142857143
BG	background	0.047619047619
BG	biglycan	0.047619047619
SSMUS	hanghai second medical university	1.0
5α-R	5α-reductase	0.6
5α-R	steroid 5α-reductase	0.2
5α-R	25α-reductase type-2	0.2
SubCa	subcoeruleus pars alpha	1.0
KOGRN-	deficient	1.0
AP-7	2-amino-7-phosphoroseptanoic acid	0.5
AP-7	2-amino-7-phosphonoheptanoic acid	0.5
PLST	protected least significance test	0.5
PLST	posterior lateral superior temporal gyrus	0.5
LHa	lateral anterior hypothalamus	0.5
LHa	lateral hypothalamus	0.5
ceA	central nucleus of the amygdala	1.0
NPY-IR	neuropeptide y immunoreactive	0.5
NPY-IR	neuropeptide y-like immunoreactivity	0.5
SFV	semliki forest virus	1.0
SFR	spontaneous firing rate	0.8
SFR	spontaneous firing rates	0.2
SFS	ylvian fissure	1.0
SFP	sf plane	0.5
SFP	spontaneous field potential	0.5
GAB	ergic neurons	0.5
GAB	gabapentin	0.5
SFN	sulforaphane	1.0
DiOC63	3″-dihexyloxacarbocyanine iodide	1.0
SFL	shape-from-luminance	1.0
SFM	shape-from-motion	0.153846153846
SFM	serum-free medium	0.384615384615
SFM	sequential finger tapping movements	0.0769230769231
SFM	serum-free defined medium	0.0769230769231
SFM	sequential finger movement	0.0769230769231
SFM	serum free medium	0.230769230769
SFK	ssrc family kinases	0.4
SFK	ssrc family protein kinases	0.2
SFK	ssrc family tyrosine kinases	0.2
SFK	src-family kinase	0.2
ACTN	2α-actinin-2	0.5
ACTN	4alpha actinin 4	0.5
SFI	sciatic function index	0.4
SFI	sciatic functional index	0.6
POAH	preoptic-anterior hypothalamus	0.2
POAH	preoptic/anterior region of the hypothalamus	0.2
POAH	preoptic anterior hypothalamus	0.2
POAH	preoptic/anterior hypothalamic area	0.2
POAH	preoptic/anterior hypothalamus	0.2
SFG	the superior frontal gyrus	0.166666666667
SFG	superior frontal gyrus	0.833333333333
MBS	modified barth's solution	0.111111111111
MBS	m-maleido-benzoyl-n-hydroxysuccinimide	0.111111111111
MBS	m-maleimidobenzoyl-n-hydroxysuccinimide ester	0.111111111111
MBS	modified barth’s solution	0.111111111111
MBS	m-maleimidobenzoic acid n-hydroxysuccinimide ester	0.111111111111
MBS	mouse brain standard	0.222222222222
MBS	maximum backward shift	0.222222222222
SFB	spikes fired in bursts	1.0
SFC	sleep fragmentation control	0.666666666667
SFC	signed fold-change	0.333333333333
IL-B	4isolectin b4	1.0
SFA	saturated fatty acid	0.111111111111
SFA	spike frequency adaptation	0.777777777778
SFA	*, pattern of occurrence of spindle frequency activity	0.111111111111
KSP	lysine–serine–proline	1.0
ASL	arterial spin labeling	0.666666666667
ASL	argininosuccinate lyase	0.333333333333
Enk	leucine-enkephalin	1.0
PAPC	1-palmitoyl-2-arachidonoyl-diacyl-sn-glycero-3-phosphatidylcholine	1.0
HSPG	heparan sulfate proteoglycan	0.3
HSPG	heparan sulfate proteoglycans	0.1
HSPG	sheparan sulfate proteoglycans	0.2
HSPG	heparan sulphate proteoglycan	0.3
HSPG	sheparin/heparan sulfate proteoglycans	0.1
2PLSM	two-photon laser scanning microscopy	1.0
Ent	entorhinal cortex	1.0
HSPA	5heat shock protein a5	0.5
HSPA	2heat shock-related 70 kda protein 2	0.5
KSK	olmogorov–smirnov	0.5
KSK	olmogorov-smirnoff	0.25
KSK	olmogorov-smirnov	0.25
Tad	time to anoxic depolarization	1.0
GSK-	3glycogen synthase kinase 3	0.025
GSK-	3βglycogen synthesis kinase 3β	0.025
GSK-	3αglycogen synthase kinase	0.025
GSK-	3βglycogen synthase kinase 3 beta	0.025
GSK-	3βglycogen synthase kinase-3 beta	0.025
GSK-	3βglycogen synthase kinase 3β	0.075
GSK-	3glycogen synthase kinase-3	0.175
GSK-	3	0.025
GSK-	3β	0.1
GSK-	3βglycogen synthase kinase-3β	0.475
GSK-	3glycogen-synthase-kinase-3	0.025
ICS-205930	3-tropanylindole-3-carboxylate hydrochloride	1.0
PNMT	phenylethanolamine n-methyltransferase	0.4375
PNMT	phenylethanolamine-n-methyltransferase	0.28125
PNMT	phenylethanolamine n-methyl transferase	0.09375
PNMT	phenylethanolamine-n-methyl transferase	0.03125
PNMT	adrenaline synthesizing enzyme	0.03125
PNMT	phenyletanolamine-n-methyltransferase	0.03125
PNMT	phenyl-n-methyl transferase	0.09375
stRM	grmg stimulation	1.0
X-EDL	cross-reinnervated edl	1.0
ADAR	2adenosine deaminase dependent on rna 2	0.5
ADAR	2 mrna expression	0.5
m2AC	hr	1.0
fEPSP	sfield-excitatory-post-synaptic potentials	0.0049504950495
fEPSP	sfield excitatory postsynaptic potentials	0.128712871287
fEPSP	focal excitatory postsynaptic potential	0.0049504950495
fEPSP	field epsp	0.029702970297
fEPSP	sfield excitatory post-synaptic potentials	0.019801980198
fEPSP	field extracellular post-synaptic potential	0.0049504950495
fEPSP	field-excitatory postsynaptic field potentials	0.0049504950495
fEPSP	field recording of excitatory post-synaptic potential	0.0049504950495
fEPSP	field excitatory synaptic potential	0.0049504950495
fEPSP	sfield epsps	0.0049504950495
fEPSP	excitatory postsynaptic potential	0.00990099009901
fEPSP	field excitatory postsynaptic potentials	0.039603960396
fEPSP	field excitatory post synaptic potential	0.0247524752475
fEPSP	field excitatory post-synaptic potential	0.0792079207921
fEPSP	field excitatory postsynaptic potential	0.574257425743
fEPSP	sfield excitatory synaptic potentials	0.0049504950495
fEPSP	field excitatory post synaptic potentials	0.0049504950495
fEPSP	excitatory postsynaptic field potential	0.0049504950495
fEPSP	fast excitatory synaptic potential	0.0049504950495
fEPSP	field excitatory postsynaptic potentiation	0.0049504950495
fEPSP	fast excitatory postsynaptic potential	0.0049504950495
fEPSP	sexcitatory post-synaptic potentials	0.0049504950495
fEPSP	sfield excitatory post synaptic potentials	0.0049504950495
fEPSP	focal excitatory postsynaptic potentials	0.0049504950495
fEPSP	field excitatory post-synaptic potentials	0.0148514851485
MNI-G	lu4-methoxy-7-nitroindolinyl-caged l-glutamate	1.0
ADAM	10	0.1
ADAM	a disintegrin and metalloproteinase	0.1
ADAM	a disintegrin and metalloprotease	0.5
ADAM	disintegrin/metalloprotease	0.1
ADAM	10a disintegrin and metallopeptidase domain 10	0.1
ADAM	sa disintegrin and metalloproteases	0.1
3alpha-HSD	3alpha-hydroxysteroid dehydrogenase	1.0
Ptprc	protein-tyrosine phosphatase receptor type c	1.0
ADAC	adenosine amine congener	1.0
GSK3	glycogen synthase kinase 3	1.0
SR-A	class a scavenger receptor	1.0
MEM10	minimal essential medium containing 10 mm glucose	1.0
BSβ-	sitosterol	1.0
IMN	intermesenteric nerve	1.0
COSC	scortical organotypic slice cultures	1.0
microRNA-	134 (mir-134)	1.0
QX-314	n-ethyl-lidocaine br	0.111111111111
QX-314	n-(2,6-dimethylphenylcarbamoylmethyl) triethylammonium bromide	0.111111111111
QX-314	lidocaine	0.111111111111
QX-314	lidocaine n-ethyl bromide	0.555555555556
QX-314	n-(2,6-dimethyl-phenylcarbamoylmethyl)-triethylammonium bromide	0.111111111111
NOISE	alonenoise control	1.0
CP-AMPAR	calcium-permeable ampa receptor	0.333333333333
CP-AMPAR	calcium permeable ampa receptors	0.333333333333
CP-AMPAR	scalcium permeable ampa-type glutamate receptors	0.333333333333
DR-MD	mid dorsal pole of dorsal raphe	1.0
NACN-A	cetylcysteine	1.0
WT-D	wild type-denervated	1.0
TIFT	riton x-100 insoluble fraction	1.0
irreC	irregular chiasm c	1.0
EPOR	erythropoietin receptor	1.0
DMTHA	dorsal medial thalamus	1.0
QTP	quetiapine	1.0
RTWAT	retroperitoneal wat	1.0
PMO	sphosphorodiamidate morpholino oligonucleotides	1.0
FMRIB	functional mri of the brain	0.5
FMRIB	functional magnetic resonance imaging of the brain (oxford)	0.5
polyI	:cpoly-inosinic/cytidylic acid	1.0
KPBSK	rebs phosphate buffer saline	1.0
WT-n	cypd-ko (n) and cypd-ko-nwild-type mice and mice lacking cypd at n months of age	1.0
OKAN	optokinetic afternystagmus	1.0
DMRTD	uncan’s multiple range test	1.0
IET	etomidate-activated current	1.0
KS-	testkolmogorow–smirnow-test	1.0
recP	rprecombinant prion protein	1.0
USEPAU	nited states environmental protection agency	1.0
CNBD	cyclic nucleotide-binding domain	1.0
GPCRGTP-	binding protein-coupled receptor	1.0
AP-1	activating protein	0.03125
AP-1	activated protein-1	0.03125
AP-1	activation protein-1	0.03125
AP-1	activator protein-1 transcription factor	0.03125
AP-1	activator protein-1	0.78125
AP-1	activator protein complex 1	0.03125
AP-1	activator protein 1	0.03125
AP-1	activating protein-1	0.03125
SREBP-	1	0.5
SREBP-	2sterol regulatory element binding proteins-2	0.5
AP-3	2-amino-3-phosphonopropionate	0.5
AP-3	3-aminophosphonovaleric acid	0.5
AP-4	(±)-2-amino-4-phosphonobutyric acid	1.0
AP-5	(±)2-amino,5-phosphonopentanoic acid	0.0344827586207
AP-5	dl-(-)-2-amino-5-methyl-4-isoxazolepropionic acid	0.0344827586207
AP-5	2-amino-5-phosphonovaleric acid	0.0344827586207
AP-5	2-amino-5-phosphonopentanoate	0.0689655172414
AP-5	dl-2-amino-5-phosphonopentanoic acid	0.0689655172414
AP-5	2-amino-5-phosphonopentanoic acid	0.172413793103
AP-5	d(–)-2-amino-5-phosphonopentanoic acid	0.0344827586207
AP-5	dl-2-amino-5-phosphonovaleric acid	0.137931034483
AP-5	(±)-2-amino-5-phosphonopentanoic acid	0.172413793103
AP-5	d-2-amino-5-phosphonovalerate	0.0344827586207
AP-5	d-2-amino-5-phosphonovaleric acid	0.0689655172414
AP-5	d,l-2-amino-5-phosphonopentanoic acid	0.103448275862
AP-5	d(-)-2-amino-5-phosphonopentanoic acid	0.0344827586207
IDEC	neuroninspiratory neuron with decrementing firing pattern	1.0
BACEβ-	secretase	0.166666666667
BACEβ-	amyloid precursor protein cleaving enzyme	0.166666666667
BACEβ-	site β-amyloid precursor protein cleaving enzyme	0.166666666667
BACEβ-	site app cleaving enzyme	0.166666666667
BACEβ-	site amyloid precursor protein cleavage enzyme	0.166666666667
BACEβ-	secretase enzyme	0.166666666667
SPHK	sphingosine kinase	1.0
APC-CC	1adenomatus polyposis coli (clone cc1)	0.25
APC-CC	1adenomatous polysis coli (clone cc1)	0.25
APC-CC	1adenomatous polyposis coli (clone cc1)	0.25
APC-CC	1adenomatous polyposis coli gene clone cc1	0.25
nAChRs	nicotinic acetylcholine receptors	0.666666666667
nAChRs	neuronal nicotinic ach receptors	0.333333333333
YHT	yaw head tilt	1.0
gAD	globular adiponectin	1.0
mcIO	or mcmedial column of the inferior olive	0.333333333333
mcIO	medial column of the inferior olive	0.666666666667
QTG	quantitative trait gene	1.0
GOLGA	5golgin subfamily a member 5	1.0
mEX	moderate exercise group	1.0
FBPd-fructose-1	6-bisphosphate	1.0
ERβ	estrogen receptor beta	0.538461538462
ERβ	estrogen receptor-β	0.115384615385
ERβ	estrogen receptor β	0.346153846154
TSP-	1thrombospondin-1	1.0
NAEN	acylethanolamine	1.0
rmANCOVA	repeated measures analysis of covariance	1.0
IκBKIκB	kinase	1.0
AX-DRG	axotomized dorsal root ganglion	1.0
Tris-base	tris-hydroxymethylaminomethane	0.333333333333
Tris-base	tris(hydroxymethyl)aminomethane	0.666666666667
N-VGCCN-	type voltage-gated calcium channel	1.0
JMV-	431boc-arg-arg-pro-tyrψ (ch2nh)ile-leu-oh	1.0
dChAT	drosophila chat	1.0
TSPO	mitochondrial translocator protein	0.1
TSPO	translocator protein-18 kda	0.1
TSPO	18-kda translocator protein	0.1
TSPO	translocator protein 18 kda	0.2
TSPO	18kda translocator protein	0.1
TSPO	translocator protein of 18 kda	0.1
TSPO	translocator protein 18kda	0.1
TSPO	translocator protein	0.1
TSPO	translocator protein 18-kda	0.1
ISPC	inhibitory postsynaptic currents	1.0
mKATP	mitochondrial atp-sensitive k+ channels	1.0
RBPRNA-	binding protein	1.0
PYK2	proline-rich tyrosine kinase 2	0.5
PYK2	protein tyrosine kinase 2	0.5
ARNT	arylhydrocarbon receptor translocator	1.0
VSMC	vascular smooth muscle cell	0.5
VSMC	svascular smooth muscle cells	0.5
ERα	alpha form of the estrogen receptor	0.0294117647059
ERα	nuclear estrogen receptor alpha	0.0294117647059
ERα	estrogen receptor alpha	0.529411764706
ERα	estrogen receptor α	0.294117647059
ERα	estrogen receptor-α	0.0882352941176
ERα	/βestrogen receptor α/β	0.0294117647059
ARND	alcohol related neurodevelopmental disorder	1.0
cNG	cyclic nucleotide-gated	1.0
RFc	caudal reticular formation	1.0
WBW	estern blotting	0.181818181818
WBW	estern immunoblotting	0.0909090909091
WBW	estern blot	0.727272727273
GNTI	5′-guanidinonaltrindole	1.0
WBS	white–black box shuttle	0.5
WBS	whole blood 5-ht	0.5
PPRE	peroxisome proliferator-activated receptor response element	0.5
PPRE	peroxisome proliferator response element	0.5
MMPI	matrix metalloproteinase inhibitor	1.0
LOV	ligature of the ophthalmic vessels	1.0
VTC	ventrotemporal crescent	1.0
ROCKR	ho-assoicated protein kinase	0.1
ROCKR	ho kinase	0.6
ROCKR	hoa kinase	0.1
ROCKR	ho-associated protein kinase	0.1
ROCKR	hoa/rho-associated kinase	0.1
abLIM	actin-binding lim domain protein	1.0
5-A	za5-aza-2′deoxycytidine	1.0
WBC	whole-brain correction	1.0
5-C	5-cytosine	1.0
5-B	rdu5-bromodeoxiuridine	1.0
5-L	ipoxygenase	1.0
SINE	short interspersed nuclear element	1.0
5-I	tub5-iodotubericidin	1.0
WBH	peritoneal lavage–whole body hyperthermia	1.0
TLV	total lesion volume	1.0
FDOPA	[18f]-6-fluoro-dopa	0.5
FDOPA	[18f]fluorodopa	0.5
GFP-TTC	green fluorescent protein-labeled non-toxic c-fragment of tetanus toxin	0.5
GFP-TTC	fusion protein of the green fluorescent protein and the c fragment of tetanus toxin	0.5
G3PDH	glyceraldehyde-3-phosphate dehydrogenase	0.833333333333
G3PDH	glyceraldehyde 3-phosphate dehydrogenase	0.166666666667
-LIR	-like immunoreactivity	1.0
MHSNM	eihuasannong	1.0
MB-COMT	membrane-bound isoform of comt	1.0
ChCoT	choline cotransporter	1.0
PBS-B	sodium phosphate-buffered saline with blocking reagent	1.0
BW619C89	4-amino-2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)pyrimidine	1.0
Pen2	5]-enkephalin	1.0
ETSE	26 transformation-specific sequence	1.0
TRAPPC	5trafficking protein particle complex 5	1.0
Thr	threonine	1.0
GLRA	1glycine receptor subunit alpha-1	1.0
-LI-	like immunoreactivity	0.833333333333
-LI-	like-immunoreactivity	0.166666666667
TFCE	threshold-free clustered enhancement	0.5
TFCE	threshold-free cluster enhancement	0.5
BAPTA	1,2-bis (2-aminophenoxy)ethane-n,n,n′,n′-tetra-acetic acid tetrakis (acetoxymethyl) ester	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxy)ethane-n,n,n’,n’-tetraacetic acid	0.0555555555556
BAPTA	1,2-bis(2-aminophenoyx)ethane-n′,n′,n′,n′-tetra-acetate	0.0277777777778
BAPTA	1,2-bis-(α-aminophenoxyl)ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA	bis-(aminophenoxy)ethanetetra-acetate	0.0277777777778
BAPTA	bis(2-aminophenoxy)ethane-n,n,n′,n′-tetra-acetate	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxy)ethane n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetate	0.0555555555556
BAPTA	definition?	0.0277777777778
BAPTA	1,2-bis-(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid	0.0555555555556
BAPTA	o,o′-bis(2-aminophenyl)ethyleneglycol-n,n,n′,n′-tetra-acetate	0.0555555555556
BAPTA	1,2-bis(o-aminophenoxy)-ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA	1,2-bis-(o-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetra-acetic acid	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxylethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA	1,2-bis-(2-aminophenoxy)ethane-tetra-acetate	0.0277777777778
BAPTA	ethylenedioxybis(o-phenylenenitrilo) tetraacetic acid	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetracetic acid	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxyl)ethane-n,n,n′,n′-tetra-acetate	0.0277777777778
BAPTA	bis-(o-aminophenoxy)-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA	1,2-bis(o-aminophenoxy)ethane-n,n-n′,n′-tetraacetic acid	0.0277777777778
BAPTA	1,2-bis-(2-aminophenoxy)-ethane-n,n,n′,n′-tetraacetic acid	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid	0.0555555555556
BAPTA	bis-(o-aminophenoxy)-n,n,n′,n′-tetra-acetic acid	0.0277777777778
BAPTA	1,2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetra-acetate	0.111111111111
BAPTA	1,2-bis-(2-aminophenoxy)ethane-n,n,n′,n′-tetra-acetate	0.0833333333333
HNK-1	3′ sulfated glucuronic acid	1.0
SHAM-H	sham-hippocampal lesion	1.0
dmnX	dorsal motor nucleus of the vagus	1.0
FICO2	fraction of inspired carbon dioxide	1.0
BIBO3304	(r)-n-{[4-(aminocarbonylaminomethyl)-phenyl]methyl}-n2-(diphenylacetyl)-argininamide-trifluoroacetate	1.0
TLC	thin-layer chromatography	0.545454545455
TLC	thin layer chromatography	0.272727272727
TLC	tectal longitudinal column	0.181818181818
BLTLTB	4 receptor	1.0
MMP-	2 knockout	0.0454545454545
MMP-	2matrix metalloprotease-2	0.0454545454545
MMP-	3matrix metalloproteinase 3	0.0454545454545
MMP-	2matrix metalloproteinase-2	0.0454545454545
MMP-	9matrix metalloproteinase 9 (gelatinase b)	0.0454545454545
MMP-	2/9 double knockout	0.0454545454545
MMP-	3	0.0454545454545
MMP-	9matrix metallopeptidase-9	0.0454545454545
MMP-	9+mmp-9-positive	0.0454545454545
MMP-	9matrix metalloproteinase-9	0.227272727273
MMP-	9	0.272727272727
MMP-	9matrix metalloproteinase 9	0.0909090909091
C-IN	scommissural interneurons	1.0
AVR	antagonist vibratory response	1.0
PV-IR	parvalbumin immunoreactive	0.5
PV-IR	parvalbumin-immunoreactive	0.5
vS	ubventral subiculum	1.0
AcTCh	acetylthiocholine iodide	1.0
iMGB	vinferior part of the ventral division of the medial geniculate body	1.0
SIN-	13-morpholino-synonimine	0.1
SIN-	1s-morpholinosydnonimine	0.1
SIN-	1	0.1
SIN-	13-morpholinosydnonimine	0.5
SIN-	13-(4-morpholinyl)-sydonone imine hydrochloride	0.1
SIN-	13-(4-morpholinyl)sydnonimine hydrochloride	0.1
dRP	5′-deoxyribose phosphate	1.0
t-ACPD1-aminocyclopentane-trans-1	3-dicarboxylic acid	1.0
iAV	temporally incongruent audiovisual stimuli	1.0
VAMP-	1vesicle associated membrane protein-1	0.166666666667
VAMP-	2vesicle-associated membrane protein-2	0.166666666667
VAMP-	2vesicle-associated membrane protein 2	0.166666666667
VAMP-	1vesicle-associated membrane protein-1	0.5
oCRF	ovian corticotropin-releasing factor	0.333333333333
oCRF	ovine corticotropin releasing factor	0.333333333333
oCRF	ovine crf	0.333333333333
TLF	thoracolumbar fascia	1.0
DPSP	depolarizing postsynaptic potential	0.8
DPSP	sdepolarizing postsynaptic potentials	0.2
PMSFP	henylmethylsulfonyl fluoride	1.0
MPTA	mesopontine tegmental anesthesia area	1.0
tNFT	total number of neurofibrillary tangles	1.0
pGFAP	polyclonal gfap	1.0
UCRref	mean, ucrref as average across the whole psth (before costimulation)	1.0
RUNXR	unt-related transcription factor	1.0
NFLM	nucleus of the medial longitudinal fascicle	1.0
AA-NAT	arylalkylamine n-acetyltransferase	1.0
SEGE	small-epp generating ending	1.0
SEGA	subependymal giant-cell astrocytomas	1.0
mOFC	medial orbital frontal cortex	0.5
mOFC	medial orbitofrontal cortex	0.5
dcCP	udorsocaudal caudate-putamen	1.0
4Br-A23187	4-bromo-a23187 (4-bromo-calcimycin)	1.0
GADPH	glyceraldehyde-3-phosphate dehydrogenase	0.714285714286
GADPH	glyceraldehyde 3-phosphate dehydrogenase	0.142857142857
GADPH	glyceraldehyde-3 phosphate dehydrogenase	0.142857142857
BLI	bioluminescence imaging	1.0
MK-8015S	10r-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine maleate	1.0
UCHL-	1ubiquitin-c-terminal hydrolase 1	1.0
LESCO	light-enhanced startle control	1.0
DiD1	1′-dioctodecyl-3,3,3′,3′-tetramethylindodi, 4-chlorobenzenesulfonate salt	1.0
L-PGDS	lipocalin-type prostaglandin d synthases	0.5
L-PGDS	lipocalin prostaglandin d synthase	0.5
N20	negative peak in the cortical response at 20 ms after stimulus	1.0
SNX	482	0.5
SNX	14sorting nexin 14	0.5
PECAM-	1platelet endothelial cell adhesion molecule-1	1.0
CCK-8S	cholecystokinin-8-sulfate	0.5
CCK-8S	sulfated cholecystokinin octapeptide	0.5
Bpc	parvicellular basal nucleus	0.333333333333
Bpc	basal nucleus, parvicellular division	0.333333333333
Bpc	basal amygdala, parvicellular region	0.333333333333
SA-HRP	streptavidin conjugated to horseradish peroxidase	1.0
FITC	fluorescein	0.0403022670025
FITC	fluorescein 5′-isothiocyanate	0.00251889168766
FITC	fluorescein thiocyanate	0.00503778337531
FITC	fluorescein isocyanate	0.00251889168766
FITC	fluorescein iso-thio cyanate	0.00251889168766
FITC	fluoresceine isothiocyanate	0.00503778337531
FITC	fluoroscein-isothiocyanate	0.00251889168766
FITC	fluorescein isothyocynate	0.00251889168766
FITC	fluorescein isothiocyannate	0.00251889168766
FITC	fluorescein-isothyocyanate	0.00251889168766
FITC	fluorescein isothyocyanate	0.00251889168766
FITC	fluorescein isothiocynate	0.00503778337531
FITC	fluorescein-5-isothiocyanate	0.00251889168766
FITC	fluorescein-isothiocyanate	0.00755667506297
FITC	fluorescein isthiocyanate	0.00251889168766
FITC	–albuminbovine desiccate albumin–fluorescein isothiocyanate	0.00251889168766
FITC	fluorescein isothiocyanate conjugated	0.00251889168766
FITC	fluorescien isothiocyanate	0.00755667506297
FITC	fluorescein iso-thio-cyanate	0.00251889168766
FITC	fluorescein isothiocyanate-inulin	0.00251889168766
FITC	fluoresceinisothiocyanate	0.00251889168766
FITC	fluorescein isothiocyanate	0.879093198992
FITC	fluoroisothiocyanate	0.00503778337531
FITC	fluorescein isothiocyanate hydrochloride	0.00251889168766
FITC	fluorescence microscopy	0.00251889168766
FITC	fluoroscein isothiocyanate	0.00251889168766
FITB	facial nerve-innervated taste bud	1.0
N2A	neuro 2a cells	1.0
nNCT	number of neuroeffector calcium transients per stimulus per cell	1.0
oxM	35 m oxidized	1.0
SAP-97	synapse-associated protein 97	1.0
ME-LM	me-like material	1.0
GrL	granular layer	1.0
GTPδS	guanosin 5′-(trihydrogen diphosphate)	1.0
tPA-	/-tpa knockout mice	1.0
vW	fvon willebrand factor	1.0
PLD2	phospholipase d2	1.0
N2a	neuro-2a	1.0
BQ	123	1.0
ANC	ascending neural contractions	0.5
ANC	available neuronal count	0.5
3αA-diol5α-androstan-3α	17β-diol	1.0
3xT	g-adtriple transgenic ad	0.5
3xT	g-ad mice	0.5
gKL	low-voltage-activated potassium conductance	1.0
NF-PTN	afion®-modified platinum	1.0
CPα	1c	1.0
ZAP	zaprinast	0.5
ZAP	impedance amplitude profile	0.5
CRMP	2collapsin response mediator protein	0.25
CRMP	collapsin response mediator protein	0.5
CRMP	scollapsin response mediator proteins	0.25
GAPGTP	ase activating proteins	0.25
GAPGTP	ase activating protein	0.5
GAPGTP	ase-activating protein	0.25
p-MAPKII	phosphorylated mitogen-activated protein kinase ii	1.0
PPE-B	preproenkephalin-b, prodynorphin	1.0
SSI-	3stuttering severity instrument-iii	1.0
PPE-A	preproenkephalin-a	1.0
Myris-100	myristyldimethylbenzylammonium chloride	1.0
sLORETA	standardized low-resolution brain electromagnetic tomography	0.5
sLORETA	standardized low resolution brain electromagnetic tomography	0.333333333333
sLORETA	standardized low resolution electromagnetic tomography	0.166666666667
mSON	medial supraoptic nucleus	0.666666666667
mSON	medial division of the supraoptic nucleus	0.333333333333
GOSG	lasgow outcome scale	0.5
GOSG	lasgow coma scale	0.5
mSOD	1sod1-mutant	0.5
mSOD	mutant superoxide dismutase	0.5
PMBA	phenylbenzene-ω-phosphono-α-amino acid	1.0
H2	histamine receptor subtypes 1 and 2	1.0
L-SC	lateral part of the superior colliculus	1.0
VSCCs	voltage-sensitive ca2+ channels	0.5
VSCCs	voltage-sensitive calcium channels	0.5
Para	parasubiculum	1.0
hGDNF	human gdnf	1.0
CHOPCCAAT	/enhancer-binding protein homologous protein	1.0
CM-H	2dcfda5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate	0.25
CM-H	2dcfda5-(and -6) chloromethy-2′, 7-dichlorodihydrofluorescein diacetate acetyl ester	0.25
CM-H	2dcfda5-(and-6-)-chloromethyl-2′,7′-dichlorodi-hydrofluorescein diacetate acetyl ester	0.25
CM-H	2dcfda5-(and -6) chloromethyl-2′,7-dichlorodihydrofluorescein diacetate acetyl ester	0.25
DIS	diagnostic interview schedule	1.0
DSV	decussatio supraoptica dorsalis	0.5
DSV	decussatio supraopticus ventralis	0.5
NSFA	non-stationary fluctuation analysis	1.0
BV-	2 cells	1.0
Pla	anterior pulvinar nucleus	1.0
8-oxo-dG7	8-dihydro-8-oxoguanine	1.0
Plm	medial pulvinar nucleus	1.0
Pll	lateral pulvinar nucleus	1.0
TUDCA	tauroursodeoxycholic acid	1.0
HAWIE-R	revised hamburg wechsler intelligence exam	1.0
EPO-R	erythropoietin receptor	1.0
rhGCPII	/iiirecombinant human glutamate carboxypeptidase ii/iii	1.0
11HSD	2	1.0
α-CGRP	and β-cgrp	1.0
α-MDα-	methyldopa	1.0
LIMK	2	0.333333333333
LIMK	(lin-11/isl-1/mec-3)-domain-containing protein kinase	0.333333333333
LIMK	1lim kinase-1	0.333333333333
PMDproliferation	migration and differentiation	1.0
GC-MS	gas chromatography–mass spectrometry	1.0
PVDFP	olyvinylidene difluoride	1.0
Coca	cocaine-sensitized	1.0
PPSS	preprosomatostatin	1.0
LIMA	1lim domain and actin-binding 1	1.0
S63	s73, serine residues at position 63 or 73	1.0
SSIA	swim stress-induced analgesia	1.0
7SC	7s snare complex	1.0
miRDB	microrna database	1.0
UCBC	umbilical cord blood cell	1.0
α-MSH	α-melanin stimulating hormone	0.0769230769231
α-MSH	alpha-melanocyte stimulating hormone	0.384615384615
α-MSH	α-melanophore-stimulating hormone	0.0769230769231
α-MSH	alpha melanocyte stimulating hormone	0.0769230769231
α-MSH	α-melanocyte-stimulating hormone	0.153846153846
α-MSH	alpha-melanocyte-stimulating hormone	0.230769230769
GLMG	eneral linear model	1.0
SSII	secondary somatosensory cortex	1.0
PBS-H	pbs with 10% horse serum	1.0
MEFS	mouse embryonic fibroblasts	1.0
PCUN	precuneus	1.0
peri-LC	pericoerulear	1.0
Par2	parietal cortex 2	0.333333333333
Par2	parietal area 2	0.333333333333
Par2	secondary somatosensory cortex	0.333333333333
Par1	parietal cortex, area 1	0.142857142857
Par1	parietal cortex 1	0.142857142857
Par1	primary somatosensory cortex	0.428571428571
Par1	area 1 of the parietal cortex	0.142857142857
Par1	parietal area 1	0.142857142857
LDCV	large dense-cored vesicle	0.157894736842
LDCV	large dense core vesicle	0.0526315789474
LDCV	large dense-core vesicles	0.0526315789474
LDCV	large dense core vesicles	0.157894736842
LDCV	large dense-core vesicle	0.315789473684
LDCV	slarge dense core vesicles	0.210526315789
LDCV	large-dense core vesicle	0.0526315789474
TMP	thiamine monophosphatase	0.5
TMP	thiamine 5′-monophosphate	0.5
TMR	tetramethylrhodamine-labeled dextran	0.0909090909091
TMR	tetramethylrhodamine dextran	0.0909090909091
TMR	tetramethylrhodamine	0.272727272727
TMR	tetramethyl rhodamine dextran-amine	0.0909090909091
TMR	transmembrane receptors	0.0909090909091
TMR	transmembrane region	0.0909090909091
TMR	dextran–tetramethylrhodamine–lysine	0.0909090909091
TMR	target-masker-ratio	0.0909090909091
TMR	tetramethyl rhodamine	0.0909090909091
TMS	)	0.015873015873
TMS	trans-cranial magnetic stimulation	0.015873015873
TMS	transcranial magnetic stimulation	0.920634920635
TMS	transmembrane segment	0.015873015873
TMS	temporal migratory stream	0.015873015873
TMS	(repetitive) transcranial magnetic stimulation	0.015873015873
TMT	trail making test	0.142857142857
TMT	trimethyltin	0.571428571429
TMT	trimethylthiazoline	0.214285714286
TMT	ransmembrane	0.0714285714286
5-LO	5-lipoxygenase	1.0
GWB	sgw bodies	1.0
PPNpc	tegmental pedunculopontine nucleus pars compacta	1.0
p42IP	4	1.0
TMZ	temozolomide	1.0
VUM	mx1ventral unpaired median neuron 1 of the maxillary neuromere	1.0
PPNpd	tegmental pedunculopontine nucleus pars dissipata	1.0
TMA	+tetramethyl ammonium	0.0666666666667
TMA	tetramethylammonium	0.533333333333
TMA	tetramethylammonium chloride	0.0666666666667
TMA	+, tetramethylammonium-chloride	0.0666666666667
TMA	+, tetramethylammonium	0.133333333333
TMA	tetramethylammoniumchloride	0.0666666666667
TMA	–dphtrimethylamine–diphenylhexatriene	0.0666666666667
TMB	3,3′,5,5′-tetramethyl benzidine dihydrochloride	0.03125
TMB	3,3-5,5-tetramethylbenzidine	0.03125
TMB	straumatic microbleedings	0.03125
TMB	–co2+, tetramethylbenzidine with cobalt intensification	0.03125
TMB	tetramethylbenzidine	0.6875
TMB	3,3′,5,5′-tetramethylbenzidine	0.03125
TMB	3,3′,5,5′-tetramethylbenzidine dihydrochloride	0.03125
TMB	tetramethylbenzidine dihydrochloride	0.03125
TMB	tetramethyl benzidine	0.0625
TMB	2,3′,5,5′-tetramethylbenzidine	0.03125
TMC	transmembrane channel-like protein	0.5
TMC	total mean charge	0.5
TMD	transmembrane domain	0.0833333333333
TMD	transmembrane spanning domain	0.0833333333333
TMD	temporomandibular disorders	0.333333333333
TMD	temporomandibular disorder	0.25
TMD	temporomandibular joint disorder	0.166666666667
TMD	transmembrane domain.	0.0833333333333
TME	tris(hydroxymethyl)-aminomethane (tris) hcl, 3 mm mgcl2, 2mm egta	1.0
GWS	gaba-withdrawal syndrome	1.0
vWFV	on willebrand factor	1.0
LPVC	left parietovisceral connection	1.0
BNST-OV	oval nucleus of bed nucleus of stria terminalis	0.25
BNST-OV	oval nucleus of the bed nucleus of the stria terminalis	0.5
BNST-OV	bed nucleus of the stria terminalis	0.25
ATLD	ataxia-telangiectasia-like disorder	0.333333333333
ATLD	ataxia telangiectasia-like disorder	0.333333333333
ATLD	ataxia–telangiectasia-like disorder	0.333333333333
VNOX	vomeronasal organ removal	1.0
TMN	vventral division of tuberomammillary nucleus	0.125
TMN	tuberomammillary nuclei	0.125
TMN	tuberomamillary nucleus	0.125
TMN	tuberomammillary nucleus	0.5
TMN	tuberomammilary nucleus	0.125
HWL	hind-paw withdrawal latency	0.25
HWL	hindpaw withdrawal latency	0.75
WBP	whole-body pointing	1.0
TRPV-	1transient receptor potential for vanilloids-1	1.0
KOAM	conditional knockout	1.0
NSIN	ew serum i	1.0
NJN	eighbour-joining	1.0
TMd	tuberomammillary nucleus, dorsal part	1.0
EcoRI	??	1.0
MCPGα-	methyl-4-carboxyphenylglycine	1.0
CAC	ornu ammonis (ammon's horn)	0.125
CAC	calphostin c	0.125
CAC	ornus ammonis	0.125
CAC	ornu ammonis	0.375
CAC	carbamylcholine chloride	0.125
CAC	ornet d’ammon	0.125
HWT	head withdrawal threshold	0.5
HWT	hind-paw withdrawal threshold	0.5
DSA	digital subtraction angiography	0.333333333333
DSA	dense sinusoid axon terminal	0.333333333333
DSA	delayed spatial alternation	0.333333333333
NADPH-diaphorase	β-nicotinamide adenine dinucleotide phosphate-diaphorase	1.0
TALK	tandem of p domains in a weak inwardly-rectifying k+ channel–related alkaline ph activated k+ channel	1.0
CHAN6-cyclohexyladenosine	a1 receptor agonist	1.0
nPIST	postsynaptic density-95/discs large/zona occludins-1 domain protein interacting specifically with tc10	0.5
nPIST	neuronal isoform of protein-interacting specifically with tc10	0.5
MGBv	ventral partition of the medial geniculate body	1.0
Safm	saline injected 10 min before 5% formalin injection group of rats	1.0
ETNO	evoked transient network oscillation	1.0
LVHF	low-voltage high-frequency	1.0
rPH	rat prolyl 4-hydroxylase	1.0
lPOA	lateral preoptic area	1.0
5-HOID	5-hydroxyindole	1.0
Nacc	nucleus accumbens	1.0
FDLM	. flexor digitorum superficialis	1.0
PLMI	periodic leg movement index	1.0
PPIX	protoporphyrin ix	1.0
HILIC-MS	hydrophilic interaction liquid chromatography/mass spectrometry	1.0
DMOG	dimethyloxallyl glycine	0.25
DMOG	dimethyloxylalyglycine	0.25
DMOG	dimethyloxalylglycine	0.25
DMOG	dimethyloxaloylglycine	0.25
GCPSG	raded chronic pain scale	1.0
ELPSPs	electrotonic postsynaptic potentials	1.0
GABAA-RGABA	receptor type-a	1.0
PPIL	2peptidylprolyl isomerase (cyclophilin)-like 2	1.0
ABvm	accessory basal nucleus, ventromedial division	1.0
DHCR	243-beta-hydroxysterol delta-24-reductase	0.5
DHCR	77-dehydrocholesterol reductase	0.5
TM-	conditiontarget-mask condition	0.5
TM-	4tropomyosin-4	0.5
PPIA	peptidylprolil isomerase a	0.333333333333
PPIA	peptidyl-prolyl cis-trans isomerase a	0.666666666667
c-IAP	2cellular inhibitor-of-apoptosis protein 2	1.0
PSIA	peripheral stimulation-induced analgesia	1.0
EIS	eye in space	1.0
NFκB	nuclear factor-κb	0.105263157895
NFκB	nuclear factor kappab	0.0526315789474
NFκB	nuclear factor-κ b	0.0526315789474
NFκB	nuclear factor kappa b	0.421052631579
NFκB	nuclear factor kappa-light-chain-enhancer of activated b cells	0.105263157895
NFκB	aactivated nuclear factor kappab	0.0526315789474
NFκB	nuclear factor κ b	0.0526315789474
NFκB	nuclear factor κ binding protein	0.0526315789474
NFκB	nuclear factor κb	0.105263157895
EIU	endotoxin-induced uveitis	1.0
RCZ	rostral cingulate zone	1.0
RCT	srandomized controlled trials	1.0
msFC	medial part of left superior frontal gyrus	1.0
RCP	recycling pool	0.333333333333
RCP	receptor component protein	0.666666666667
RCR	respiratory control ratio	1.0
RWM	radial arm water maze	0.333333333333
RWM	round window membrane	0.666666666667
EIA	enzyme immunometric assay	0.0666666666667
EIA	enzyme-immunoassay	0.0333333333333
EIA	enzyme immunoassay	0.833333333333
EIA	enzyme immune-assay	0.0333333333333
EIA	enzyme immunoassay analysis	0.0333333333333
S-ACH	autocorrelation histogram following the subtraction of the shift predictor	1.0
EIC	external cortex of the inferior colliculus	0.5
EIC	electrically-induced contractions	0.5
RCH	residual calcium hypothesis	0.5
RCH	retrochiasmatic nucleus	0.5
RCI	respiratory control index	0.666666666667
RCI	respiratory control indices	0.333333333333
EIF	electrically-induced muscle fatigue	1.0
RCD	right cerebellar damage	1.0
AACOCF3	arachidonyl trifluoromethyl ketone	1.0
RLLFTA	rg-leu-leu-phe-thr-nh2	1.0
ω-CgTx	ω-conotoxin	0.2
ω-CgTx	ω-conotoxin gvia	0.8
RCA	retrochiasmatic area	1.0
EIN	excitatory network interneurons	0.5
EIN	excitatory interneuron	0.5
BRORIN	brain-specific chordin-like	1.0
TEA-CL	tetraethylammonium chloride	1.0
FAS	fully androgenized sterile females	0.0666666666667
FAS	fetal alcohol syndrome	0.8
FAS	fas receptor (aka apo[apoptosis]-1, cd95)	0.0666666666667
FAS	foetal alcohol syndrome	0.0666666666667
uSTS	upper bank of anterior superior temporal sulcus	1.0
FAV	audiovisual facilitation index	1.0
F8Famide	or morphine-modulating peptide)	1.0
FAT	frontal aslant tract	1.0
FAK	focal adhesion kinases	0.0833333333333
FAK	focal adhesion kinase	0.833333333333
FAK	py861fak phosphorylation at tyrosine 861	0.0833333333333
IMRF	intermediate reticular formation	1.0
SMON	subacute myelo-optio-neuropathy	0.333333333333
SMON	subacute myelo-optico-neuropathy	0.333333333333
SMON	subacute myelo-optic neuropathy	0.333333333333
FAO	fast adapting stretch receptor organ	1.0
FAM	6-carboxyfluorescein	0.75
FAM	full allosteric modulator	0.25
2-D3-D	2-, 3-dimensional	1.0
FAA	food-anticipatory activity	0.222222222222
FAA	food anticipatory activity	0.666666666667
FAA	food-related anticipatory activity	0.111111111111
FAF	ukomys anselli	0.333333333333
FAF	frequency-altered feedback	0.333333333333
FAF	erulic acid	0.333333333333
LEDL	ight-emitting diode	1.0
FAD	fadrozole	0.030303030303
FAD	familial early onset alzheimer's disease	0.030303030303
FAD	familial alzheimer's disease	0.272727272727
FAD	familial form of alzheimer’s disease	0.030303030303
FAD	familial alzheimer’s disease	0.242424242424
FAD	familial ad	0.151515151515
FAD	early-onset familial ad	0.030303030303
FAD	flavin–adenosine–dinucleotide	0.030303030303
FAD	flavin adenine nucleotide	0.030303030303
FAD	familiar form of ad	0.030303030303
FAD	oxidized flavin adenine dinucleotide	0.030303030303
FAD	flavin adenine dinucleotide	0.0606060606061
FAD	(h), (reduced) flavin adenine dinucleotide	0.030303030303
FAE	fetal alcohol exposure	0.6
FAE	formic acid extraction	0.2
FAE	fetal alcohol effects	0.2
AMPA-G	lur1ampa receptor 1	1.0
NMTP	non-matching-to-place	1.0
RVLM	rostral ventral lateral medulla	0.0204081632653
RVLM	rostral ventrolateral medulla oblongata	0.0204081632653
RVLM	rostral ventrolateral medullary pressor area	0.030612244898
RVLM	rostral ventrolateral medulla	0.857142857143
RVLM	rostroventrolateral medulla	0.0612244897959
RVLM	pressor area of the rostral medulla	0.0102040816327
ALLOP	allopregnanolone	0.5
ALLOP	allopregnanolone (3α-hydroxy-5α-pregnan-20-one)	0.5
7D	7 days	1.0
UCR	unconditioned response	0.25
UCR	2upstream conserved region 2	0.25
UCR	upstream conserved region	0.25
UCR	unconditioned rf center response (after costimulation)	0.25
PINK	1pten induced kinase 1	0.142857142857
PINK	1phosphate and tensin homolog [pten] induced putative kinase 1	0.142857142857
PINK	1pten-induced putative kinase 1	0.571428571429
PINK	1pten-induced kinase 1	0.142857142857
C-PCP	chronic pcp treatment	1.0
KGEP	solution containing potassium glutamate, egta and pipes	1.0
LY303870	(r)-1-[n-(2-methoxybenzyl)acetylamino]-3-(1h-indol-3-yl)-2-[n-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino]	1.0
D2	dba/2j	0.142857142857
D2	dopamine receptor type 2	0.142857142857
D2	minor axis of the soma	0.142857142857
D2	dopamine receptor 2	0.142857142857
D2	dopamine d2 receptor	0.142857142857
D2	d3, or d4 receptor)	0.142857142857
D2	type 2 deiodinase	0.142857142857
NBA	number of brief awakenings	1.0
IRAKIL-	1 receptor-associated kinase	1.0
RC-	3095	1.0
pFRG	para-facial respiratory group	0.142857142857
pFRG	parafacial respiratory group	0.857142857143
RTI-S	53β-(4-iodophenyl)tropan-2β-carboxylic acid methyl ester	1.0
7N	facial nerve	0.333333333333
7N	facial nuclei	0.0833333333333
7N	facial nucleus	0.5
7N	facial nu	0.0833333333333
mDMEMD	ulbecco's modified eagle medium	1.0
MCP-1	monocyte chemotactic protein 1	0.166666666667
MCP-1	monocyte chemoattractant protein-1	0.5
MCP-1	monocyte chemoattractant protein 1	0.166666666667
MCP-1	monocyte chemoattractant protein	0.166666666667
RGBred	green, blue video segmentation	0.333333333333
RGBred	green, blue	0.333333333333
RGBred	green and blue color model	0.333333333333
OAG	1-oleoyl-2-acetyl-sn-glycerol	0.666666666667
OAG	1-oleoyl-2-acetylglycerol	0.333333333333
SWIM	swimming	1.0
OAE	otoacoustic emissions	0.166666666667
OAE	percentage of open-arms entries	0.166666666667
OAE	open-arms entries	0.166666666667
OAE	otoacoustic emission	0.5
OAB	overactive bladder	1.0
OAA	oxaloacetate	1.0
CCT	central conduction time	0.25
CCT	chronic corticosterone treatment	0.25
CCT	cation-cl cotransporter	0.25
CCT	cytidine triphosphate:phosphocholine cytidylyltransferase	0.25
CCW	counter-clockwise	0.0769230769231
CCW	counterclockwise	0.769230769231
CCW	counter clockwise	0.153846153846
NBSN	ijmegen breakage syndrome	1.0
CCP	3cleaved caspase 3	1.0
CCS	childhood or adolescence cancer survivors	1.0
CCR	1	0.1
CCR	2cc chemokine receptor 2	0.1
CCR	5chemokine receptor 5	0.1
CCR	chemokine receptor	0.1
CCR	2chemokine receptor 2	0.2
CCR	7c-c chemokine receptor type 7	0.1
CCR	chemokine (c-c motif) receptor	0.1
CCR	2chemokine (c–c motif) receptor 2	0.1
CCR	2chemokine (c-c motif) receptor 2	0.1
CCM	central cerebellar mass	0.0909090909091
CCM	cloacal contact movement	0.181818181818
CCM	control conditioned medium	0.0909090909091
CCM	cerebral cavernous malformation	0.0909090909091
CCM	cloacal contact movements	0.272727272727
CCM	complete culture medium	0.181818181818
CCM	current-clamp mode	0.0909090909091
CCL	22cc-chemokine ligand 22	0.1
CCL	2cc chemokine ligand 2	0.1
CCL	2chemokine (c-c motif) ligand 2	0.2
CCL	2chemokine (c–c motif) ligand 2	0.2
CCL	chemokine (c-c motif) ligand	0.1
CCL	2	0.1
CCL	5	0.1
CCL	2chemokine (cc motif) ligand 2	0.1
OAT	percentage of open-arms time	0.666666666667
OAT	organic anion transporter	0.333333333333
CCI	chronic constrictive injury	0.0114942528736
CCI	controlled cortical impact injury	0.0114942528736
CCI	chronic constriction injury of the sciatic nerve	0.0344827586207
CCI	cortical contusion injury	0.0344827586207
CCI	chronic constriction injury model	0.0114942528736
CCI	chronic construction inquiry	0.0114942528736
CCI	chronic sciatic nerve constriction injury	0.0114942528736
CCI	chronic constriction injury (of sciatic nerve)	0.0114942528736
CCI	closed cortical impact	0.0114942528736
CCI	controlled cortical impact	0.126436781609
CCI	chronic constriction injury	0.712643678161
CCI	chronic constriction nerve injury	0.0114942528736
CCH	cross-correlation histograms	0.111111111111
CCH	crosscorrelation histogram	0.111111111111
CCH	carbachol	0.111111111111
CCH	cross-correlation histogram	0.666666666667
CCK	cholecystokinin-8	0.0078125
CCK	cholecystokinin octapeptide	0.0078125
CCK	receptor	0.0078125
CCK	cholecystokinin	0.96875
CCK	2rcholecystokinin b/2 receptor	0.0078125
OAP	orthogonal arrays of particle	0.1
OAP	sorthogonal arrays of proteins	0.1
OAP	orthogonal array of particles	0.2
OAP	orthogonal arrays of particles	0.2
OAP	sorthogonal arrays of particles	0.3
OAP	orthogonally arranged particle	0.1
CCE	capacitive ca2+ entry	0.25
CCE	capacitative calcium entry	0.5
CCE	crossmodal congruency effects	0.25
CCD	charged coupled device	0.0322580645161
CCD	charge couple device	0.0322580645161
CCD	charge-coupled device camera	0.0322580645161
CCD	cooled charge device	0.0322580645161
CCD	charge coupled device	0.161290322581
CCD	charge-coupled device	0.483870967742
CCD	charge-coupled-device	0.0645161290323
CCD	charged-coupled device	0.0322580645161
CCD	charge-device-based	0.0322580645161
CCD	cortical current density	0.0322580645161
CCD	cytochalasin d	0.0322580645161
CCD	charge coupled-device	0.0322580645161
CCG	clock-controlled gene	0.333333333333
CCG	cross-correlogram	0.333333333333
CCG	sclock-controlled genes	0.166666666667
CCG	cranial cervical ganglia	0.166666666667
CCF	correlation coefficient function	0.375
CCF	cross correlation function	0.125
CCF	cross-correlation function	0.5
CCA	scommon carotid arteries	0.0612244897959
CCA	common carotid arteries	0.0612244897959
CCA	common carotid artery	0.877551020408
CCC	concordance correlation coefficient	0.333333333333
CCC	cation–chloride cotransporters	0.333333333333
CCC	cross-correlation coefficient	0.333333333333
PF-EPSC	parallel fiber-evoked excitatory postsynaptic current	1.0
NINLN	ovel image novel location	1.0
PIK	3c3class iii phosphoinositide 3-kinase	1.0
PIL	posterior intralaminar nucleus	0.333333333333
PIL	posterior intralaminar thalamic nucleus	0.666666666667
Ras-ERK2	ras-extracellular signal-activated kinase 2	1.0
PIN	protein inhibitor of nnos	0.125
PIN	posterior intralaminar nucleus	0.25
PIN	posterior intralaminar thalamic nucleus	0.375
PIN	pinacolone	0.125
PIN	pathologically interconnected neurons	0.125
Grid2	glutamate receptor ionotropic delta 2	1.0
PIA	pontine inhibitory area	0.5
PIA	phenylisopropyladenosine	0.25
PIA	pregnancy-induced analgesia	0.25
PIC	picrotoxin	0.230769230769
PIC	protease inhibitor cocktail	0.230769230769
PIC	persistent inward current	0.307692307692
PIC	phosphatase inhibitor cocktail	0.0769230769231
PIC	posterior insular cortex	0.0769230769231
PIC	paracapsular intercalated islands	0.0769230769231
PID	peri-infarcts depolarizations	0.111111111111
PID	peri-infarct depolarization	0.222222222222
PID	post-implantation day	0.111111111111
PID	peripherally-propagating injury discharge	0.111111111111
PID	postinjury day	0.111111111111
PID	post-ictal depression	0.111111111111
PID	post-injection day	0.111111111111
PID	post-injury day	0.111111111111
FLIP	flice (caspase 8) inhibitory protein	1.0
PIF	propidium iodide fluorescence	1.0
FLIR	fos-like immunoreactivity	1.0
FLIM	fluorescence lifetime imaging microscopy	1.0
7T	esla	1.0
FLII	flightless 1 homolog	1.0
CCh	carbachol	1.0
CORT-nursed	offspring nursed by mothers drinking the corticosterone solution	0.5
CORT-nursed	corticosterone-nursed	0.5
PIP	sphosphorylated phosphoinositides	0.0714285714286
PIP	posterior interpositus and aip, anterior interpositus)	0.0714285714286
PIP	proximal–interphalangeal	0.0714285714286
PIP	proximal-interphalangeal	0.0714285714286
PIP	2phosphatidylinositol-4′5′-bisphosphate	0.0714285714286
PIP	ropidium iodide	0.571428571429
PIP	5k2aphosphatidyl inositol 4-phosphate 5-kinase type ii α	0.0714285714286
glyco-D	atglycosylated active form of dat	1.0
PIR	post-inhibitory rebound	0.0833333333333
PIR	piriform cortex	0.583333333333
PIR	postinhibitory rebound	0.0833333333333
PIR	piriform area	0.166666666667
PIR	systempassive infrared system	0.0833333333333
vCJD	variant creutzfeldt-jakob disease	0.666666666667
vCJD	variant creutzfeldt-jacob disease	0.333333333333
PIT	2,2′-pyridylisatogen	0.2
PIT	pavlovian-to-instrumental transfer	0.2
PIT	posterior intralaminar thalamic complex	0.2
PIT	paw-immersion test	0.2
PIT	pituitary	0.2
CKIIα	α-subunit of calcium/calmodulin-dependent protein kinase ii	1.0
AVN	atrioventricular node	1.0
F-DIMF	rontal disinhibition model	1.0
mFB	medial forebrain bundle	1.0
DOA	delayed object alternation	1.0
ASK1	apoptosis signal-regulating kinase 1	1.0
PI-	3kphosphatidylinositol-3-kinase	0.0714285714286
PI-	3kphosphatidyl inositol 3 kinase	0.0714285714286
PI-	3kphosphatidylinositol 3-kinase	0.142857142857
PI-	3kphosphoinositide 3-kinase	0.142857142857
PI-	3 kinasephosphoinositide-3 kinase	0.0714285714286
PI-	3kphosphoinositol-3 kinase	0.0714285714286
PI-	3kphosphatidylinositol-3 kinase	0.0714285714286
PI-	3kphosphoinositide-3 kinase	0.0714285714286
PI-	3k/akt signaling pathway	0.0714285714286
PI-	3 kinase	0.0714285714286
PI-	3kphosphoinositide-3-kinase	0.0714285714286
PI-	3k/aktpi3-kinase-akt	0.0714285714286
CMF-HBSS	ca2+/mg2+-free hank's balanced salt solution	1.0
MC3-R	melanocortin receptor-3	1.0
Aββ-	amyloid	0.622950819672
Aββ-	amyloid protein	0.0819672131148
Aββ-	pleated amyloid peptide	0.016393442623
Aββ-	amyloid peptide	0.262295081967
Aββ-	amyloid peptides	0.016393442623
UBx	unilateral olfactory bulbectomy	1.0
CA1CA3	cornu ammonis 1, 3	0.333333333333
CA1CA3	ammon's horn	0.333333333333
CA1CA3	subfields of cornu ammonis according to lorente de no	0.333333333333
CA1CA2	ca3, cornu ammonis 1, 2, 3	0.333333333333
CA1CA2	ca3, ca4, subfields of cornu ammonis according to lorente de no (1934)	0.333333333333
CA1CA2	ca3, ca4, hippocampal subfields	0.333333333333
UK14	304, 5-bromo-n-(4,5-dihydro-1h-imidazol-2-yl)-6-quinoxalinamine	1.0
mFR	mean firing rate	1.0
DATDA	transporter	1.0
8OHG	8 hydroxyguanosine	0.5
8OHG	8-hydroxyguanosine	0.5
PenN	penile nerves	1.0
HAPLN	hyaluronan and proteoglycan link protein	1.0
vmCP	ventro-medial caudate-putamen	1.0
tCA	3temporal ca3	1.0
HEK-293	human embryonic kidney-293 cells	1.0
SGFS	stratum griseum et fibrosum superficiale	1.0
ac-LDL	1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine bound to acetylated low-density lipoprotein	1.0
nDB	nucleus of diagonal band	0.5
nDB	medial septum/nucleus of diagonal band	0.5
CC1	2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]	0.5
CC1	adenomatous polyposis coli gene	0.5
DOX	doxycycline	1.0
CC-	chemokine	0.5
CC-	chemokine ligand 3	0.5
CDEX	2-hydroxypropyl-β-cyclodextrin	1.0
AFPα-	fetoprotein	1.0
UBA	52	1.0
UBB	ubiquitin-b	1.0
UBC	unipolar brush cell	0.866666666667
UBC	sunipolar brush cells	0.133333333333
ATLUM	automatic tape-collecting lathe ultramicrotome	1.0
CFTR	cystic fibrosis transmembrane regulator	0.166666666667
CFTR	cystic fibrosis transmembrane conductance regulator	0.833333333333
TEA-C	ltetraethylammonium-cl	0.142857142857
TEA-C	ltetraethylammonium chloride	0.714285714286
TEA-C	ltetraethyl ammonium chloride	0.142857142857
MWS	molecular weight standard	1.0
M-THA	medial part of the tuberal hypothalamic area	1.0
MWT	10-meter walk test	0.5
MWT	molecular weight	0.5
t-DARPP	truncated darpp-32	1.0
AMe	medial nucleus of the amygdala	0.5
AMe	median amygdala nucleus	0.5
β-APPβ-	amyloid precursor protein	1.0
MWF	myelin water fraction	1.0
AMs	aneurally cultured non-contracting human muscle cells	1.0
GJB	2connexin26 gene	1.0
GJC	gap junctional communication	1.0
MWM	morris water maze	0.769230769231
MWM	morris type water maze	0.0769230769231
MWM	4morris water maze protocol with four trials per day and a 3–5 min inter-trial interval	0.0769230769231
MWM	ann–whitney u-test	0.0769230769231
AMI	amitriptyline	0.2
AMI	aged moderately impaired	0.2
AMI	auditory midbrain implant	0.2
AMI	acute myocardia infarction	0.2
AMI	aged with moderate cognitive impairments	0.2
AMH	iitype-ii aδ mechano-heat	0.333333333333
AMH	aδ-mechano-heat	0.333333333333
AMH	a-delta fibre mechanoheat afferent	0.333333333333
CVLT	californian verbal learning test	1.0
NWP	no whisker pairing	1.0
AMO	antisense morpholino oligonucleotide	1.0
AMN	082	0.25
AMN	accessory magnocellular hypothalamic nuclei	0.25
AMN	adrenomyeloneuropathy	0.25
AMN	atropine methyl nitrate	0.25
AMA	cetomethoxy	1.0
AMC	adrenomedullary chromaffin cell	0.047619047619
AMC	amoeboid microglial cells	0.380952380952
AMC	ameboid microglial cells	0.047619047619
AMC	aminomethylcoumarinamide	0.047619047619
AMC	7-amino-4-methyl coumarin	0.0952380952381
AMC	amido-4-methylcoumarin	0.047619047619
AMC	7-amido-4-methylcoumarin	0.047619047619
AMC	aminomethylcoumarin	0.047619047619
AMC	7-amino-4-methylcoumarine	0.047619047619
AMC	7-amino-4-methylcoumarin	0.190476190476
AMB	ambiguous	0.333333333333
AMB	ambiguus nucleus	0.333333333333
AMB	nucleus ambiguus	0.333333333333
NSTT	nucleus of the spinal trigeminal tract	1.0
AMG	/ecca3 and entorhinal amygdala cortex	0.0625
AMG	amygdaloid nucleus	0.0625
AMG	autometallography	0.25
AMG	amygdala	0.625
AMY	ventromedial amygdala	0.0666666666667
AMY	amygdala nucleus	0.0666666666667
AMY	amygdala	0.8
AMY	amygdaloid complex	0.0666666666667
AMX	amygdala lesion	1.0
TRESK	tandem of p domains in a weak inwardly-rectifying k+ channel–related spinal cord k+ channel	1.0
L-NAMENω-	nitro-l-arginine methyl ester	1.0
AMP	adenosine mono-phosphate	0.0625
AMP	responsive element binding protein	0.0625
AMP	response element-binding protein	0.0625
AMP	adenosine monophosphate	0.125
AMP	kinase	0.0625
AMP	amplitude of emg signal	0.0625
AMP	cyclic adenosine monophosphate	0.0625
AMP	d-amphetamine	0.0625
AMP	adenosine 5′-monophosphate	0.0625
AMP	amphetamine	0.125
AMP	response element binding protein	0.25
CVLM	caudal aspect of the ventrolateral medulla	0.0212765957447
CVLM	caudal ventrolateral medulla	0.914893617021
CVLM	depressor area of the caudal medulla	0.0212765957447
CVLM	caudal ventrolateral medullary depressor area	0.0425531914894
AMT	a-delta fibre mechanothermal afferent	0.2
AMT	anandamide membrane transporter	0.4
AMT	active motor threshold	0.4
T2W	t2-weighted	1.0
AMV	anterior medullary velum	0.5
AMV	avian myoblastosis virus	0.5
ACTBβ-	actin	1.0
5α-DHP	5α-dihydroprogesterone	0.6
5α-DHP	5α-hydroxysteroid reductase	0.2
5α-DHP	5α-dehydro-progesterone	0.2
5α-DHT	5α-dihydrotestosterone (androstanolone)	1.0
astrocytesSHRSP	l-serine	1.0
PS-C	copulator of prenatally stressed group	1.0
G-GG	reenhouse-geisser	1.0
dFMR	1drosophila fragile x mental retardation protein 1	1.0
CaMK	ca2+/calmodulin-dependent protein kinase	0.4
CaMK	ca2+/calmodulin-dependent kinase	0.2
CaMK	calcium-calmodulin-dependent protein kinase	0.2
CaMK	cam-dependent kinase	0.2
I-RTX	iodo-resiniferatoxin	0.5
I-RTX	5-iodoresiniferatoxin	0.5
CaMI	calmodulin gene i	1.0
LGd	dorsal lateral geniculate nucleus	1.0
hCGRP	8-37truncated human calcitonin gene-related peptide	1.0
Rinput	input resistance	1.0
CBCL-APCBCL	attention problems	1.0
EJC	exon-junction complex	0.5
EJC	excitatory junctional current	0.5
TBSTTRIS	buffer salin -tween 20	1.0
OOPC	oleyloxyethyl phosphorylcholine	1.0
SHHSS	leep heart health study	1.0
NADHP-	dnicotinamide adenine dinucleotide phosphate-diaphorase	1.0
OXNP	oxytocin neurophysin	1.0
OERP	olfactory event-related potential	0.5
OERP	olfactory event-related potentials	0.5
KCNQ	channels	0.5
KCNQ	4	0.5
DSM-IV	diagnostic and statistical manual	1.0
2-YFPH	:wldscrossbred line of thy1.2-yfph and wlds mice	1.0
F344	fischer 344	0.2
F344	f1 brown norway×fisher 344 rats	0.2
F344	brown norway×fischer 344	0.2
F344	fischer 344 rats	0.4
KCNJ	10	1.0
KCNK	15potassium channel subfamily k member 15	1.0
POCD	postoperative cognitive dysfunction	1.0
T-TBSTBS-	buffered saline containing 5% tween-20	1.0
NPHH	umulin neutral protamine hagedorn	1.0
KCNC	2	1.0
LMWA	low molecular weight antioxidant	1.0
EPSCAMPA	receptor-mediated excitatory postsynaptic current	1.0
LMWH	low molecular weight heparin	0.5
LMWH	low-molecular-weight heparin	0.5
RTSR	ubinstein–taybi syndrome	1.0
KUT	kami-untan-to	1.0
LY306740	(r)-1-[n-(2-methoxybenzyl)acetylamino]-3-(1h-indol-3-yl)-2-[n-(2-(4-cyclohexylpiperazin-1-yl)acetyl)amino]	1.0
LDL-	rlow density lipoprotein receptor	0.5
LDL-	clow density lipoprotein cholesterol	0.5
CGS12066B	7-trifluoromethyl-4(4-methyl-1-piperazinyl)-pyrrolo[1,2-a]quinoxaline	1.0
adipoQ	receptor 7 or 8	1.0
UEAU	lex europaeus agglutinin	1.0
BAOT	bed nucleus accessory olfactory tract	0.333333333333
BAOT	bed nucleus of the accessory olfactory tract	0.666666666667
DOM	dominant	0.5
DOM	domoic acid	0.5
GYG	glycine–tyrosine–glycine	1.0
MDL-	28170z-val-phe-cho	1.0
TRP-	protein–carbohydrate mixture lacking tryptophan	1.0
RBC	the rancho bernardo cohort	0.125
RBC	red blood cell	0.5
RBC	retinal bipolar cell	0.125
RBC	rod bipolar cells	0.125
RBC	radiolabeled red blood cell	0.125
KTBT	tris–hcl/nacl/kcl/triton x-100	1.0
GTP-γ-SG	uanosine-5′-[γ-thio] triphosphate	1.0
-D3R	dopamine d3 receptor	1.0
0-M	g2+zero-magnesium	1.0
DSID	ata sciences international	1.0
PSDF	peri-stimulus density function	1.0
BIBP-	3226(r)-n2-(diphenylacetyl)-n-[(4-hydroxyphenyl)methyl]-argininamide	1.0
MEME	minimal essential medium eagle	0.25
MEME	agle's minimal essential medium	0.25
MEME	agle’s minimum essential medium	0.25
MEME	agle′s minimum essential medium	0.25
AADC	aromatic amino acid decarboxylase	0.103448275862
AADC	aromatic 1-amino-acid decarboxylase	0.0344827586207
AADC	aromatic–amino acid decarboxylase	0.0344827586207
AADC	aromatic l-amino acid dopa decarboxylase	0.0344827586207
AADC	aromatic l-amino acid decarboxylase	0.48275862069
AADC	aromatic acid decarboxylase	0.0344827586207
AADC	l-aromatic-amino acid-decarboxylase	0.0344827586207
AADC	aromatic aminoacid decarboxylase	0.0344827586207
AADC	aromatic l-amino-acid decarboxylase	0.0344827586207
AADC	l-amino acid decarboxylase	0.0344827586207
AADC	amino acid decarboxylase	0.0344827586207
AADC	l-aromatic amino acid decarboxylase	0.103448275862
ATCHI	acetylthiocholine iodide	1.0
vmARC	ventromedial arcuate nucleus	1.0
SCBF	spinal cord blood flow	1.0
TRPM	transient receptor potential channels of the melastatin family	0.0625
TRPM	8transient receptor potential channel subfamily m member 8	0.0625
TRPM	8transient receptor potential m8	0.0625
TRPM	8transient receptor potential channel m8	0.0625
TRPM	2 channel antagonists	0.0625
TRPM	5trp channel superfamily member 5	0.0625
TRPM	transient receptor potential (melastatin family)	0.0625
TRPM	8	0.25
TRPM	8transient receptor potential melastatin 8	0.1875
TRPM	8transient receptor potential melastatin 8 channel	0.0625
TRPM	2melastatin-like transient receptor potential 2	0.0625
MEMM	inimum essential medium	0.4
MEMM	inimum essential medium eagle	0.1
MEMM	inimal essential medium	0.5
TRPC	transient receptor potential (canonical family)	0.0769230769231
TRPC	6	0.0769230769231
TRPC	6transient receptor potential channel 6	0.0769230769231
TRPC	2transient receptor potential channel type 2	0.153846153846
TRPC	1	0.0769230769231
TRPC	canonical type trp	0.0769230769231
TRPC	1transient receptor potential channel 1	0.0769230769231
TRPC	short or classical transient receptor potential	0.0769230769231
TRPC	transient receptor potential channels	0.0769230769231
TRPC	stransient receptor potential channels	0.0769230769231
TRPC	channelstransient receptor potential cation channels	0.0769230769231
TRPC	channel	0.0769230769231
TRPA	1transient receptor potential a1	0.208333333333
TRPA	1trp ankyrin 1	0.0833333333333
TRPA	1transient receptor potential ankyrin 1 channel	0.0416666666667
TRPA	1transient receptor potential ankyrin 1	0.125
TRPA	1	0.208333333333
TRPA	1transient receptor potential channel a1	0.0833333333333
TRPA	1transient receptor potential ankyrin-1	0.0416666666667
TRPA	1transient receptor potential ankyrin type 1	0.0416666666667
TRPA	1transient receptor potential ankyrin type 1 receptor	0.0416666666667
TRPA	1transient receptor potential a1 channel	0.0416666666667
TRPA	1ankyrin-repeat transient receptor potential 1	0.0416666666667
TRPA	transient receptor potential ankyrin	0.0416666666667
TIDA	tuberoinfundibular dopamine	0.142857142857
TIDA	tuberoinfundibular dopaminergic	0.571428571429
TIDA	tuberoinfundibular dopaminergic neurons	0.285714285714
MEMS	minimal essential medium containing 10% fetal bovine serum	1.0
A-PS	amplitude of the population spike	0.5
A-PS	amplitude of the ps	0.5
TRPV	1transient receptor potential vanilloid one	0.00699300699301
TRPV	1vanilloid receptor subtype 1	0.00699300699301
TRPV	3transient receptor potential vanilloid 3	0.00699300699301
TRPV	vanilloid family of transient receptor potential channels	0.00699300699301
TRPV	4transient receptor potential vanilloid 4	0.00699300699301
TRPV	1transient receptor potential vanilloid-1	0.027972027972
TRPV	1transient receptor potential vanilloid receptor	0.013986013986
TRPV	1transient receptor potential vanilloid receptor 1 channel protein	0.00699300699301
TRPV	1transient receptor potential channel type 1	0.00699300699301
TRPV	1transient receptor potential cation channel subfamily v member 1	0.027972027972
TRPV	1transient potential vanilloid receptor 1	0.00699300699301
TRPV	1vanilloid receptor	0.00699300699301
TRPV	1transient receptor potential vanilloid receptor-1	0.020979020979
TRPV	1transient receptor potential vanilloid 1 channel	0.00699300699301
TRPV	1transient receptor potential vanilloid type 1 channel	0.020979020979
TRPV	1transient receptor potential vallinoid-1	0.00699300699301
TRPV	1transient receptor potential v1 (vanilloid receptor)	0.00699300699301
TRPV	1	0.034965034965
TRPV	1transient receptor potential vanilloid type 1	0.132867132867
TRPV	1transient receptor potential vanilloid type 1 receptor	0.020979020979
TRPV	transient receptor potential vanilloid	0.034965034965
TRPV	2transient receptor potential vanilloid family ion channel 2	0.00699300699301
TRPV	1vanilloid receptor 1	0.00699300699301
TRPV	1transient potential receptor vanilloid 1	0.00699300699301
TRPV	4	0.00699300699301
TRPV	1transient receptor potential vanilloid receptor 1	0.020979020979
TRPV	1transient receptor potential cation channel superfamily v-1	0.00699300699301
TRPV	1transient receptor potential vanilloid subunit one channel	0.00699300699301
TRPV	1transient receptor potential vanilloid subfamily 1	0.020979020979
TRPV	1capsaicin receptor	0.00699300699301
TRPV	1capsaicin receptor 1	0.00699300699301
TRPV	1transient receptor vanilloid 1	0.00699300699301
TRPV	1 receptors	0.00699300699301
TRPV	1transient receptor potential vanilloid subfamily member 1	0.00699300699301
TRPV	1transient receptor potential receptor v1	0.00699300699301
TRPV	1trp vanilloid 1	0.00699300699301
TRPV	4transient receptor potential vanilloid-4 channel	0.00699300699301
TRPV	1trpv1 subtype of transient receptor potential	0.00699300699301
TRPV	2	0.00699300699301
TRPV	1-/-transient receptor potential vanilloid type 1 knockout mice	0.00699300699301
TRPV	1transient receptor potential vanilloid receptor 1 (formerly vr1)	0.00699300699301
TRPV	1transient receptor potential channel vanilloid 1	0.00699300699301
TRPV	1transient receptor potential vanilloid	0.00699300699301
TRPV	4transient receptor potential channel 4 of the vanilloid subfamily	0.00699300699301
TRPV	1transient receptor potential–vanilloid type-1	0.00699300699301
TRPV	1vanilloid type 1 transient receptor potential receptor	0.00699300699301
TRPV	1transient receptor potential v1	0.0629370629371
TRPV	1transient receptor potential vanilloid receptor type 1	0.020979020979
TRPV	1(-/-)capsaicin receptor deficient	0.00699300699301
TRPV	1transient potential receptor vanilloid type 1	0.00699300699301
TRPV	1transient receptor potential channel v1	0.00699300699301
TRPV	1transient receptor potential cation channel vanilloid type 1	0.00699300699301
TRPV	1transient receptor potential v1 channel	0.00699300699301
TRPV	transient receptor potential vanilloid-related	0.013986013986
TRPV	1transient receptor potential vanilloid 1	0.230769230769
TRPV	4trp vanilloid 4	0.00699300699301
TRPV	1transient receptor potential vanilloid receptor one	0.00699300699301
TAMTyro3	axl, and mer	1.0
MPM-	2	1.0
mc-PAF	1-o-hexadecyl-2-o-(methylcarbamyl)-sn-glycero-3-phosphocoline	1.0
AVT	arginine vasotocin	0.3
AVT	anteroventricular thalamic nucleus	0.1
AVT	[arg8]-vasotocin	0.1
AVT	anteroventral thalamus	0.1
AVT	area ventralis of tsai	0.1
AVT	anteroventral thalamic nucleus	0.1
AVT	area ventralis of tsai or ventral tegmental area	0.1
AVT	vasotocin	0.1
ccDSCT	dorsal spinocerebellar tract neurons located in clarke’s column	1.0
des-G	ly9-[arg8]-vasopressin	1.0
T-TBST	ween 20 in tris-buffered saline	0.25
T-TBST	ris-buffered saline plus 0.05% tween-20	0.25
T-TBST	ris-buffered saline containing 0.1% tween-20	0.25
T-TBST	riton-x/tris-buffered saline	0.25
LY382884	3s,4ar,6s,8ar-6-(4-carboxyphenyl)methyl-1,2,3,4,4a,5,6,7,8,8a-deca-hydroisoquinoline-3-carboxylic acid	1.0
AAAlko	alcohol	1.0
FTI-	277	1.0
OBXA	blation of the olfactory bulbs	1.0
LFA-1	lymphocyte function-associated antigen-1	1.0
EPIE	pinephrine	0.5
EPIE	cho-planar imaging	0.5
HFPH	uynh-feldt probabilities	1.0
VLVp	nucleus ventralis lemnisci lateralis, pars posterior	1.0
IPSP	(miniature-)inhibitory postsynaptic potential	0.00510204081633
IPSP	inhibitory post-synaptic potential	0.0663265306122
IPSP	inhibitory post synaptic potential	0.00510204081633
IPSP	sinhibitory postsynaptic responses	0.00510204081633
IPSP	sinhibitory post-synaptic potentials	0.0204081632653
IPSP	/cinhibitory post-synaptic potential/current	0.00510204081633
IPSP	inhibitory postsynaptic potential	0.795918367347
IPSP	inhibitory postsynaptic potential?	0.00510204081633
IPSP	/ipscinhibitory postsynaptic potential/current	0.00510204081633
IPSP	sinhibitory postsynaptic potentials	0.0765306122449
IPSP	inhibitory post-synaptic potentials	0.0102040816327
OTKO	oxytocin knockout	1.0
aPKCζ	atypical protein kinase c-zeta	1.0
Unop	unoperated	1.0
Tx	triton x-100	0.333333333333
Tx	pbs containing triton x-100	0.333333333333
Tx	pbs–triton x-100	0.333333333333
MLCK	myosin light chain kinase	1.0
Tr	trembler mouse	1.0
Ts	duration of s-phase	1.0
HPRT	hypoxanthine phosphoribosyl transferase	0.0740740740741
HPRT	hypoxanthine–phosphoribosyl–transferase	0.037037037037
HPRT	hypoxanthine-guanine phosphoribosyltransferase	0.111111111111
HPRT	1hypoxanthine phosphoribosyltransferase 1	0.148148148148
HPRT	hypoxanthine guanine phosphorybosyl transferase	0.037037037037
HPRT	hypoxanthine-guanine phosphoribosyl transferase	0.037037037037
HPRT	hypoxanthine phosphorybosyl transferase	0.037037037037
HPRT	hypoxanthine phosphoribosyltransferase	0.222222222222
HPRT	1hypoxanthine phosphoribosyl-transferase 1	0.037037037037
HPRT	hypoxanthine-phosphoribosyl-transferase	0.037037037037
HPRT	hypoxanthine–guanine phosphoribosyl transferase	0.037037037037
HPRT	hypoxanthine guanine phosphoribosyl transferase	0.185185185185
HAMDH	amilton depression rating scale	1.0
Cnf	cuneiformis nucleus	1.0
IPSC	sinhibitory postsynaptic currents	0.173184357542
IPSC	inhibitory post-synaptic current	0.0614525139665
IPSC	’sinhibitory postsynaptic currents	0.00558659217877
IPSC	inhibitory postsynaptic currents	0.0223463687151
IPSC	inhibitory postsynaptic current	0.670391061453
IPSC	(evoked) inhibitory postsynaptic current	0.00558659217877
IPSC	sinhibitory post-synaptic currents	0.0223463687151
IPSC	s	0.0111731843575
IPSC	/pinhibitory postsynaptic current/potential	0.00558659217877
IPSC	inhibitory postsynaptic potential	0.0111731843575
IPSC	(miniature-)inhibitory postsynaptic current	0.00558659217877
IPSC	inhibitory post synaptic current	0.00558659217877
CRPS	complex regional pain syndrome	1.0
LGD	dorsal lateral geniculate nucleus	1.0
Th	t-helper	1.0
SPNL	spinal nerve ligation	1.0
Tf	transferrin	1.0
Tg	transgenic	1.0
IPSI	ipsilateral paw	0.111111111111
IPSI	the ipsilateral svz	0.111111111111
IPSI	inhibitory synaptic potential	0.111111111111
IPSI	ipsilateral hind paw	0.111111111111
IPSI	ipsilateral	0.444444444444
IPSI	ipsilateral movement	0.111111111111
PREGS	pregnenolone sulfate	1.0
Tc	total cell cycle time	0.5
Tc	core temperature	0.5
hIAPP	human islet amyloid polypeptide	1.0
CPEO	chronic progressive external ophthalmoplegia	1.0
TX	texture cue	0.0434782608696
TX	triton x-100	0.478260869565
TX	pbs with 0.1% triton x-100	0.0434782608696
TX	+t3hypothyroid rats injected with t3	0.0869565217391
TX	triton-x	0.0434782608696
TX	phosphate-buffered saline containing triton x-100	0.0434782608696
TX	100triton x-100	0.130434782609
TX	phosphate-buffered saline–triton x-100	0.0434782608696
TX	100tris-buffered saline+10% normal horse serum (nhs)+0.35% triton x	0.0434782608696
TX	phosphate-buffered saline containing triton x	0.0434782608696
SH-SY	5y	0.333333333333
SH-SY	5y cell	0.333333333333
SH-SY	5y cells	0.333333333333
SPNs	sympathetic preganglionic neurons	1.0
TW	tail-withdrawal	0.25
TW	time window	0.5
TW	tween-20	0.25
TT	tris buffer containing 1% triton x-100	0.0588235294118
TT	xtetrodotoxin	0.117647058824
TT	tractus tectothalamicus	0.0588235294118
TT	thioflavine t	0.0588235294118
TT	ailsurface temperature of the tail	0.0588235294118
TT	esla	0.117647058824
TT	tetanus toxin	0.0588235294118
TT	ailtail surface temperature	0.0588235294118
TT	2f/hchr21tt2f mouse es cell lines containing a single human chromosome 21	0.0588235294118
TT	tenia tecta	0.0588235294118
TT	3retention test session 3	0.0588235294118
TT	tactile threshold	0.0588235294118
TT	terminal tree	0.0588235294118
TT	taenia tecta	0.117647058824
TU	tuberal nucleus	0.333333333333
TU	transducing units	0.333333333333
TU	olfactory tubercle	0.333333333333
A-	fibre	0.05
A-	type potassium current	0.1
A-	type k+ channels	0.05
A-	fibers	0.05
A-	4256191-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea	0.05
A-	kinase	0.05
A-	current	0.3
A-	fibre sprouting	0.05
A-	fiber demyelination	0.05
A-	fibres	0.05
A-	803467	0.05
A-	type	0.05
A-	fiber blockade	0.05
A-	like current	0.05
TS	tactile stimulation	0.0263157894737
TS	torus semicircularis	0.0526315789474
TS	number of minutes elapsed from the start of surgery	0.0263157894737
TS	tris saline	0.0263157894737
TS	trizma saline buffer	0.0263157894737
TS	trophoblast stem	0.0263157894737
TS	thioflavine s	0.0263157894737
TS	test stimulation	0.0263157894737
TS	test stimulus	0.105263157895
TS	tandem stance	0.0263157894737
TS	solitary tract	0.0263157894737
TS	tail suspension test	0.0263157894737
TS	tractus solitarius	0.157894736842
TS	tetanic stimulation	0.0789473684211
TS	total synaptic density	0.0263157894737
TS	triangular septum	0.0263157894737
TS	transcutaneous electrical stimulation	0.0263157894737
TS	triangular septal nucleus	0.0526315789474
TS	tilted frame strobe vision	0.0263157894737
TS	nucleus triangularis	0.0263157894737
TS	telencephalic superventricle	0.0263157894737
TS	toe spread	0.0526315789474
TS	tris–buffered saline	0.0263157894737
TS	tractus solitarii	0.0263157894737
TS	tris-saline	0.0263157894737
TP	tenodesis prehension	0.0277777777778
TP	testosterone propionate	0.277777777778
TP	tube protrusion	0.0277777777778
TP	pperiventricular nucleus of the posterior tuberculum	0.0277777777778
TP	mild tail-pinch	0.0277777777778
TP	temporal posterior area	0.0277777777778
TP	posterior tubercle	0.0277777777778
TP	total particulate	0.0277777777778
TP	test potential	0.111111111111
TP	temporo-parietal	0.0277777777778
TP	pperiventricular nucleus of the posterior tubercle	0.0277777777778
TP	gonadectomized and immediately implanted with testosterone propionate	0.0277777777778
TP	%total performance	0.0277777777778
TP	tracheal pressure	0.0555555555556
TP	14-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl] phenyl 4-methoxybenzoate hydrochloride	0.0277777777778
TP	thermal polypnea	0.0277777777778
TP	terminal phase	0.0277777777778
TP	temporal poles	0.0277777777778
TP	threshold pressure	0.0277777777778
TP	tract potential	0.0277777777778
TP	testosterone-propionate	0.0277777777778
TP	pperiventricular nucleus of posterior tuberculum	0.0277777777778
TP	time to the peak of action potential	0.0277777777778
TQ	target quadrants	0.25
TQ	target quadrant	0.5
TQ	tinnitus questionnaire	0.25
A1	noradrenergic cell group in the ventrolateral medulla	0.2
A1	primary auditory cortex	0.4
A1	a1 noradrenergic cells	0.2
A1	a2aadenosinergic receptor types 1 and 2a	0.2
TO	tectum opticum	0.25
TO	time spent on open quadrants	0.125
TO	optic tectum	0.125
TO	time out	0.125
TO	time-out	0.125
TO	temporo-occipital incisure	0.125
TO	tuberculum olfactorium	0.125
TL	torus longitudinalis	0.25
TL	thoracolumbar	0.5
TL	r	0.125
TL	tail-flick latency	0.125
TM	tension/mucosal (receptors)	0.0227272727273
TM	transmembrane domain	0.227272727273
TM	mixing time	0.0227272727273
TM	transmembrane region	0.0227272727273
TM	transmembrane	0.295454545455
TM	tuberomammillary nucleus	0.159090909091
TM	cc-terminal transmembrane	0.0227272727273
TM	total membranes	0.0227272727273
TM	nucleus tuberomammillaris	0.0227272727273
TM	receptortension/mucosal receptor	0.0227272727273
TM	tuberomamillary nucleus	0.0454545454545
TM	tunicamycin	0.0227272727273
TM	tuberomammillary	0.0681818181818
TM	tuberomamillary nuclei	0.0227272727273
TJ	stight junctions	0.25
TJ	tight junctions	0.25
TJ	tight junction	0.5
TK	thymidine kinase	0.285714285714
TK	ω-agatoxin tk	0.142857142857
TK	thymidine kinase cassette	0.142857142857
TK	omega agatoxin tk	0.142857142857
TK	/gfp)fusa fusion protein between tk and gfp	0.142857142857
TK	tachykinin	0.142857142857
TH	sthyroid hormones	0.00129198966408
TH	tyrosine hydroyxlase	0.00129198966408
TH	+tyrosine hydroxylase positive	0.00129198966408
TH	+th-immunopositive	0.00129198966408
TH	threshold	0.00258397932817
TH	+tyrosine hydroxylase–positive	0.00129198966408
TH	thermal hyperalgesia	0.00129198966408
TH	thalamus and hypothalamus	0.00129198966408
TH	tyrosine hydroxylase	0.93669250646
TH	+tyrosine hydroxylase immunopositive	0.00129198966408
TH	tyrosine hydrolase	0.00129198966408
TH	+tyrosine-hydroxylase positive	0.00129198966408
TH	+tyrosine hydroxylase–immunopositive	0.00258397932817
TH	thyroid hormones	0.00258397932817
TH	thyroid hormone	0.00516795865633
TH	thalamus	0.00387596899225
TH	irtyrosine hydroxylase immunoreactive	0.00258397932817
TH	+, tyrosine hydroxylase-positive	0.00129198966408
TH	triple helix	0.00129198966408
TH	wtnormal human α-synuclein in tyrosine-hydroxylase-containing neurons	0.00129198966408
TH	tyrosin hydroxylase	0.00129198966408
TH	(s)thyroid hormone(s)	0.00129198966408
TH	+tyrosine hydroxylase-positive	0.00129198966408
TH	tyrosine-hydroxylase	0.00387596899225
TH	(+)tyrosine hydroxylase-positive	0.00129198966408
TH	+th-expressing	0.00258397932817
TH	tyrosinhydroxylase	0.00129198966408
TH	thyrosine hydroxylase	0.00129198966408
TH	tyrosine hyroxylase	0.00129198966408
TH	tyrosine hydroxylase.	0.00129198966408
TH	tyrosine hydoxylase	0.00129198966408
TH	tyrosine hydroxilase	0.00387596899225
TH	mrna	0.00129198966408
TH	tyrosine hydroxylase enzyme	0.00129198966408
TH	–irtyrosine hydroxylase–immunoreactivity	0.00129198966408
TH	total homogenate	0.00129198966408
TI	inspiratory time	0.2
TI	time of inversion	0.1
TI	scapsurface temperature of interscapular back area	0.1
TI	time period following the preparatory inversion	0.1
TI	inversion time	0.1
TI	transitive inference	0.2
TI	duration of inspiratory burst	0.1
TI	transformation index	0.1
TF	transcription factor	0.194444444444
TF	transferrin	0.0277777777778
TF	tissue factor	0.0277777777778
TF	theaflavin	0.0277777777778
TF	stranscription factors	0.0277777777778
TF	tail flick	0.222222222222
TF	transfer function	0.0555555555556
TF	time-frequency	0.0833333333333
TF	total number of flinches	0.0277777777778
TF	temporal frequency	0.0833333333333
TF	trophic factor	0.0277777777778
TF	transcription factors	0.0277777777778
TF	tail-flick	0.111111111111
TF	thymic factor	0.0277777777778
TF	time–frequency	0.0277777777778
TG	total triglyceride	0.0142857142857
TG	2tissue transglutaminase-2	0.0142857142857
TG	thapsigargin	0.0428571428571
TG	transgenic	0.0428571428571
TG	triglyceride	0.0285714285714
TG	trigeminal ganglia	0.228571428571
TG	transglutaminase	0.0142857142857
TG	transgenic mice	0.0142857142857
TG	striglycerides	0.0142857142857
TG	1gat1 overexpressing mice	0.0142857142857
TG	trigeminal	0.0142857142857
TG	triglycerides	0.0285714285714
TG	trigeminal ganglion	0.528571428571
TD	temporal dorsal area	0.0526315789474
TD	thiamine deficient	0.0526315789474
TD	total distance	0.0526315789474
TD	typically developing	0.0526315789474
TD	temporal difference	0.210526315789
TD	temporal-difference	0.0526315789474
TD	7day 7 after thiamine deficiency	0.0526315789474
TD	tardive dyskinesia	0.315789473684
TD	thiamine deficiency	0.105263157895
TD	typically-developing	0.0526315789474
TE	inferior temporal cortex	0.0131578947368
TE	expiratory time	0.0131578947368
TE	tissue equivalent	0.0131578947368
TE	tissue equivalents	0.0131578947368
TE	echo-time	0.0263157894737
TE	excitation time	0.0131578947368
TE	temporal error	0.0131578947368
TE	effeffective echo time	0.0263157894737
TE	tris/edta	0.0131578947368
TE	duration of expiratory period	0.0131578947368
TE	echo spacing	0.0131578947368
TE	1area te1 of seltzer and pandya (1978)	0.0131578947368
TE	echo time	0.486842105263
TE	trypsin-edta	0.0131578947368
TE	time to echo	0.0131578947368
TE	anterior temporal visual association area	0.0131578947368
TE	temporal association area	0.0131578947368
TE	tris ethylenediaminetetra-acetic acid	0.0131578947368
TE	number of minutes elapsed from the end of surgery	0.0131578947368
TE	3temporal cortex area 3	0.0131578947368
TE	thalamic eminence	0.0131578947368
TE	tris-edta buffer	0.0131578947368
TE	stransposable elements	0.0131578947368
TE	temporal cortex	0.0657894736842
TE	tris-edta	0.0394736842105
TE	time of echo	0.0263157894737
TE	time-echo	0.0263157894737
TE	time-to-echo	0.0131578947368
TE	/trecho time/repetition time	0.0131578947368
TE	thorny excrescences	0.0131578947368
TB	odydeep body temperature	0.0222222222222
TB	tris buffer	0.422222222222
TB	acksurface temperature of lumbosacral back area	0.0222222222222
TB	triceps brachii	0.155555555556
TB	tris–hcl buffer	0.0222222222222
TB	itriceps brachii	0.0444444444444
TB	tris buffer containing mgcl2, sucrose and bovine serum albumin	0.0222222222222
TB	true blue	0.133333333333
TB	0.1 m tris buffer at ph=8.0	0.0222222222222
TB	trapezoid body	0.0444444444444
TB	tris buffer (0.25m, ph 7.4)	0.0222222222222
TB	total binding	0.0222222222222
TB	body temperature	0.0222222222222
TB	percent total binding	0.0222222222222
TC	test to conditioning	0.0175438596491
TC	tilted frame continuous vision	0.0175438596491
TC	trials to learning criterion	0.0175438596491
TC	tonic convulsion	0.0175438596491
TC	total cholesterol	0.0701754385965
TC	colonic temperature	0.0175438596491
TC	thalamocortical (neuron)	0.0175438596491
TC	thermal coefficient	0.0175438596491
TC	training context	0.0175438596491
TC	time control	0.0350877192982
TC	testing chamber	0.0175438596491
TC	thalamocortical axons	0.0175438596491
TC	rtotal creatine	0.0175438596491
TC	trained control	0.0175438596491
TC	time-constant	0.0175438596491
TC	tangential cell	0.0350877192982
TC	thalamocortical cells	0.0175438596491
TC	treadmill control	0.0175438596491
TC	2ntandem c2 domain nuclear protein	0.0175438596491
TC	total plasma cholesterol	0.0175438596491
TC	50median toxic concentration	0.0175438596491
TC	temporal cortex	0.0350877192982
TC	thalamocortical	0.508771929825
DAMGOT	yr-d-ala-gly-n-me-phe-gly-ol enkephalin	0.25
DAMGOT	yr-d-ala-gly-n-methyl-phe-gly-ol	0.5
DAMGOT	yr-d-ala-gly-nme-phe-gly-ol	0.25
TA	acquisition time	0.0212765957447
TA	translation arrest	0.0425531914894
TA	tasktactile discrimination with auditory clues	0.0212765957447
TA	tuberal area	0.0212765957447
TA	triton sodium azide	0.0212765957447
TA	testing arena	0.0212765957447
TA	typical absence	0.0212765957447
TA	terminal arborization	0.0212765957447
TA	thyroarytenoid muscle	0.063829787234
TA	tonic activity	0.0212765957447
TA	tibialis anterior	0.68085106383
TA	itibialis anterior	0.0425531914894
AA	ascorbic acid	0.159420289855
AA	anterior	0.0144927536232
AA	amino acids	0.0289855072464
AA	adjuvant arthritis	0.0144927536232
AA	amyl acetate	0.0144927536232
AA	antinociceptive activity	0.0144927536232
AA	radioactive amino acids	0.0144927536232
AA	arcopallium anterius (archistriatum anterior)	0.0144927536232
AA	arcopallium anterior	0.0144927536232
AA	2pascorbic acid-2-phosphate	0.0144927536232
AA	ambulatory activity test	0.0144927536232
AA	anterior amygdala	0.0144927536232
AA	anticipatory activity	0.0144927536232
AA	amino acid	0.0289855072464
AA	amygdala	0.0144927536232
AA	l-ascorbic acid	0.0144927536232
AA	anterior amygdaloid area	0.0289855072464
AA	dl-α-aminoadipic acid	0.0144927536232
AA	isoamyl acetate	0.0144927536232
AA	arachidonic acid	0.521739130435
AA	tritiated amino acids	0.0144927536232
AC	hr development	0.00217391304348
AC	h-lxcholinergically lesioned	0.00217391304348
AC	ganterior cingulate cortex	0.0108695652174
AC	alternating current	0.0130434782609
AC	autocorrelation	0.00217391304348
AC	axonal coat	0.00434782608696
AC	axon-cap	0.00217391304348
AC	h-non-cholinergic	0.00217391304348
AC	hr(s), nicotinic acetylcholine receptor(s)	0.00217391304348
AC	astrocyte	0.00217391304348
AC	animal cap	0.00217391304348
AC	heacetyl cholinesterase	0.00434782608696
AC	hrnicotinic acetylcholine receptor	0.00869565217391
AC	ganterior cingulate	0.00217391304348
AC	hbpacetylcholine binding protein	0.00217391304348
AC	iiiadenylyl cyclase type iii	0.00434782608696
AC	hebrain acetylcholinesterase	0.00217391304348
AC	he-ttailed ache	0.00217391304348
AC	hesacetylcholinesterases	0.00217391304348
AC	oanterior cortical nucleus	0.00217391304348
AC	heacetylcholinesterase (ec 3.1.1.7)	0.00217391304348
AC	h release in vivo	0.00217391304348
AC	adenylyl cyclase	0.0826086956522
AC	–pcanterior comissure–posterior commissure	0.00217391304348
AC	he inhibitors	0.00217391304348
AC	vventral anterior cingulate cortex	0.00434782608696
AC	h in vivo release	0.00217391304348
AC	anterior cingulate	0.0108695652174
AC	anterior cingulate area	0.00217391304348
AC	h transporter	0.00217391304348
AC	he-ssynaptic acetylcholinesterase	0.00217391304348
AC	active control group	0.00217391304348
AC	oanterior cortical amygdala	0.00652173913043
AC	adenylate cyclase	0.0304347826087
AC	hrcholinergic receptor	0.00217391304348
AC	3activated caspase-3	0.00652173913043
AC	ddorsal anterior cingulate cortex	0.00434782608696
AC	hrsacetylcholine receptors	0.00217391304348
AC	ppanterior commissure pars posterior	0.00217391304348
AC	hacetylcholine.	0.00217391304348
AC	anterior commissure	0.0304347826087
AC	ranterior commissure pars rostralis	0.00217391304348
AC	h response	0.00217391304348
AC	h)	0.00217391304348
AC	auditory cortex	0.0391304347826
AC	activation	0.00217391304348
AC	amacrine cell	0.00869565217391
AC	active control protocol	0.00217391304348
AC	autocorrelation function	0.00217391304348
AC	xauditory cortex	0.00869565217391
AC	hcholinergic	0.00217391304348
AC	hacetylcholine	0.35
AC	–pcanterior and posterior commissure	0.00217391304348
AC	saxonal coats	0.00217391304348
AC	xthalamorecipient auditory cortex	0.00217391304348
AC	aged control group	0.00217391304348
AC	adenyl cyclase	0.00434782608696
AC	3activated caspase 3	0.00217391304348
AC	danterior cingulate cortex	0.00434782608696
AC	hracetylcholine receptor	0.05
AC	anterior cingulate area 1	0.00217391304348
AC	affirmation of the consequence	0.00217391304348
AC	oanterior cortical amygdaloid nucleus	0.00652173913043
AC	amygdaloid complex	0.00217391304348
AC	area centralis	0.00217391304348
AC	amplitude of modulation (first harmonic)	0.00217391304348
AC	heacetylcholine esterase	0.0173913043478
AC	hacetylcholinechloride	0.00217391304348
AC	yastrocyte cytoplasm	0.00217391304348
AC	1adenylate cyclase 1	0.00217391304348
AC	heacetylcholinesterase	0.154347826087
AC	h release	0.00434782608696
AC	he-ssynaptic ache	0.00217391304348
AC	ddorsal anterior cingulate	0.00434782608696
AC	anterior cingulate cortex	0.0130434782609
AC	ddorsal anterior cingulate cortex (area 24b)	0.00217391304348
AC	oanterior cortical nucleus of the amygdala	0.00434782608696
AC	heiacetylcholinesterase inhibitor	0.00217391304348
AB	mbasomedial nucleus of the amygdala	0.047619047619
AB	3-aminobenzamide	0.047619047619
AB	anterobasal nucleus	0.047619047619
AB	anterior biceps	0.047619047619
AB	santibodies	0.047619047619
AB	accessory basal nucleus	0.0952380952381
AB	able-bodied	0.047619047619
AB	anterior burster neuron	0.047619047619
AB	acute buspirone	0.047619047619
AB	alamar blue	0.047619047619
AB	attentional blink	0.047619047619
AB	anterior burster	0.0952380952381
AB	complexavidin–biotin peroxidase complex	0.047619047619
AB	complexavidin–biotin complex	0.047619047619
AB	2n-insab2n-induced neurons	0.047619047619
AB	anterior burster interneuron	0.0952380952381
AB	antibody	0.0952380952381
AE	absolute error	0.0769230769231
AE	active exploration	0.0769230769231
AE	anion exchanger	0.153846153846
AE	sanion exchangers	0.0769230769231
AE	all electrodes shuffling	0.0769230769231
AE	annulus erector	0.0769230769231
AE	acquired epilepsy	0.230769230769
AE	3anion exchanger 3	0.0769230769231
AE	3anion exchanger isoform 3	0.0769230769231
AE	alcohol exposed	0.0769230769231
AD	axial diffusivity	0.0084388185654
AD	afterdischarge	0.147679324895
AD	adult stage	0.0042194092827
AD	50analgesic dose for 50%	0.0042194092827
AD	tissue	0.0042194092827
AD	analog-to-digital	0.0042194092827
AD	alzheimer’s disease	0.270042194093
AD	anterodorsal nucleus	0.0253164556962
AD	safterdischarges	0.0084388185654
AD	anterior dorsal thalamus	0.0042194092827
AD	anterior deltoid	0.0168776371308
AD	axonal diameter	0.0084388185654
AD	distilled water	0.0042194092827
AD	axial diffusion	0.0042194092827
AD	anterior dorsal nucleus	0.0042194092827
AD	arcopallium dorsale	0.0042194092827
AD	alzheimer's disease	0.337552742616
AD	anoxic depolarization	0.0126582278481
AD	anterior dorsal thalamic nucleus	0.0042194092827
AD	antidepressant medication	0.0042194092827
AD	anterior digastric	0.0042194092827
AD	acceleration duration	0.0084388185654
AD	antral distension	0.0042194092827
AD	anogenital distance	0.0042194092827
AD	santidepressants	0.0042194092827
AD	after-discharge	0.0042194092827
AD	anterodorsal thalamus	0.0042194092827
AD	adult	0.0042194092827
AD	alzheimers disease	0.0042194092827
AD	anterodorsal thalamic nucleus	0.0253164556962
AD	dorsal acropallium	0.0042194092827
AD	anterodorsal nucleus, thalamus	0.0042194092827
AD	after discharge	0.0042194092827
AD	antidepressant	0.0042194092827
AD	adenosine	0.0253164556962
AD	model	0.0042194092827
AD	am, and av, anterior dorsal, anterior medial, and anterior ventral nuclei of the anterior thalamus	0.0042194092827
AG	llateral agranular (frontal) cortex	0.0625
AG	mmedial agranular (frontal) cortex	0.0625
AG	1first agonist	0.0625
AG	825erbb2 receptor inhibitor	0.0625
AG	angular gyrus	0.125
AG	allylglycine	0.0625
AG	aminoguanidine	0.5
AG	mmedial agranular cortex	0.0625
AF	64a	0.15
AF	arcuate fasciculus	0.15
AF	64a)	0.05
AF	type iiafferent type ii fibers	0.05
AF	anterior funiculus	0.05
AF	ratiorelative arithmetic fluorescence	0.05
AF	anterior auditory field	0.05
AF	abundance factor	0.05
AF	arithmetic fluorescence	0.05
AF	594-btxalexa fluor 594–conjugated α-bungarotoxin	0.05
AF	transcription activation function	0.05
AF	average firing frequency	0.05
AF	acid fuchsin staining	0.05
AF	amyelinated fibers	0.05
AF	647alexafluor 647	0.1
AI	aged cognitively impaired	0.0263157894737
AI	aged, impaired animals	0.0131578947368
AI	aged memory-impaired	0.0131578947368
AI	attenuation index	0.0131578947368
AI	activation index	0.0131578947368
AI	(d/p/v)agranular insular area (dorsal part/posterior part/ventral part)	0.0131578947368
AI	aromatase inhibitors	0.0131578947368
AI	primary auditory cortex	0.276315789474
AI	antinociception index	0.0131578947368
AI	anchoring index	0.0394736842105
AI	primary auditory area	0.0263157894737
AI	pinsular cortex	0.0131578947368
AI	age-impaired	0.0131578947368
AI	aged cognitively-impaired	0.0131578947368
AI	agranular insular cortex	0.289473684211
AI	ntanterior interposed nucleus	0.0131578947368
AI	amiloride insensitive	0.0131578947368
AI	acute immobilization	0.0131578947368
AI	d,p,vagranular insular cortex, dorsal, posterior and ventral divisions	0.0131578947368
AI	ddorsal agranular insular cortex	0.0131578947368
AI	varchistriatum pars ventralis	0.0131578947368
AI	apoptotic index	0.0263157894737
AI	primary auditory field	0.0263157894737
AI	asymmetry index	0.0131578947368
AI	arcopallium intermedium	0.0394736842105
AI	anxiety index	0.0131578947368
AI	agranular division of the insular cortex	0.0131578947368
HB-EGF	heparin-binding egf-like growth factor	0.166666666667
HB-EGF	heparin-binding epidermal growth factor-like growth factor	0.5
HB-EGF	heparin-binding epidermal growth factor	0.333333333333
T4	l-thyroxine	0.142857142857
T4	thyroxine	0.857142857143
AM	fura-2 acetoxymethyl ester	0.0344827586207
AM	anteromedian nucleus	0.0114942528736
AM	acetoxymethyl	0.0459770114943
AM	acetomethoxyl	0.0114942528736
AM	fura-2-acetoxymethyl ester	0.0114942528736
AM	acetoxy methyl	0.0114942528736
AM	amplitude modulations	0.0114942528736
AM	fura-2 acetoxymethylester	0.0229885057471
AM	anteromedial nucleus	0.0459770114943
AM	251	0.0229885057471
AM	astrocytic medium	0.0114942528736
AM	1-[2-(5-carboxyoxazol-2-yl)-6-aminobenzo-furan-5-oxy]-2-(2′-amino-5′-methyl-phenoxy)-ethane-n,n,n′,n′-tetracetic acid, penta-acetoxymethyl ester	0.0114942528736
AM	membrane permeable form	0.0114942528736
AM	amastatin	0.0114942528736
AM	adrenal medullary	0.0114942528736
AM	1,2-bis(2-aminophenoxy)ethane-n,n,n,n-tetraacetic acid acetoxymethyl ester	0.0114942528736
AM	amplitude modulated	0.0114942528736
AM	anteromedial	0.0114942528736
AM	anteromedial nucleus of thalamus	0.0114942528736
AM	actual movement	0.0114942528736
AM	amplitude modulation	0.0804597701149
AM	amplitude modulation or amplitude modulated	0.0114942528736
AM	adrenal medulla	0.0344827586207
AM	anteromedial nucleus, thalamus	0.0114942528736
AM	acute morphine	0.0114942528736
AM	anterior medial thalamic nucleus	0.0229885057471
AM	fura-2 acetoxmethylester	0.0114942528736
AM	630	0.0114942528736
AM	fura-2 acetoxy methyl ester	0.0114942528736
AM	fluo3/acetoxymethyl ester	0.0114942528736
AM	251cb1 receptor antagonist	0.0114942528736
AM	anteromedial nucleus of the thalamus	0.0114942528736
AM	anteromedial thalamic nucleus	0.0804597701149
AM	404n-arachidonoylphenolamine	0.0114942528736
AM	arcopallium mediale	0.0114942528736
AM	astrocyte membrane	0.0114942528736
AM	medial arcopallium	0.0114942528736
AM	1-43	0.0114942528736
AM	amygdala	0.0114942528736
AM	1,2-bis-aminophenoxyethanetetra-acetic acid acetoxymethyl ester	0.0114942528736
AM	tetrakis(acetoxymethyl)	0.0114942528736
AM	adrenomedullin	0.0574712643678
AM	anterior medial nucleus	0.0114942528736
AM	1,2-bis(-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid/tetraacetoxymethyl ester	0.0114942528736
AM	acetoxymethylester	0.0344827586207
AM	acetoxymethyl ester	0.126436781609
T3	[3,5,3′]l-triiodothyronine	0.125
T3	3,3′,5-triiodothyronine	0.25
T3	triiodothyronine	0.375
T3	3,5,3′-l-triiodothyronine	0.125
T3	3,5,5′-triiodothyronine	0.125
AO	acridine orange	0.333333333333
AO	anterior olfactory nucleus	0.111111111111
AO	antisense oligonucleotide	0.222222222222
AO	anterior olfactory cortex	0.111111111111
AO	adult albino oxford rat	0.111111111111
AO	antioxidants	0.111111111111
AN	auditory nerve	0.157894736842
AN	anticipatory period for no-outcome	0.0526315789474
AN	acoustic noise	0.0526315789474
AN	auditory neuropathy	0.105263157895
AN	anorexia nervosa	0.263157894737
AN	arcuate nucleus	0.0526315789474
AN	aortic nerve	0.157894736842
AN	2/ng2neural/glial antigen 2	0.0526315789474
AN	sauditory neurons	0.0526315789474
AN	anterior neuropore	0.0526315789474
AQ	aqueduct	0.5
AQ	cerebral aqueduct	0.25
AQ	aquaduct of sylvius	0.25
AP	2activator protein-2	0.00180505415162
AP	5d-2-amino-5-phosphonovalerate	0.00902527075812
AP	itanterior lobe of the pituitary	0.00180505415162
AP	action potential	0.227436823105
AP	ap-fused m-semah	0.00180505415162
AP	apurinic/apyrimidinic	0.00180505415162
AP	5d-2-amino-5-phosphonopentanoic acid	0.00180505415162
AP	auditory pathway above ic	0.00180505415162
AP	acid phosphatase	0.00180505415162
AP	5d-2-amino-5-phosphonepentanoate	0.00180505415162
AP	allopregnanolone	0.00361010830325
AP	apurimidinic	0.00180505415162
AP	action potentials	0.0108303249097
AP	5amino-5-phosphonopentanoic acid	0.00361010830325
AP	4	0.00180505415162
AP	adaptor protein	0.00180505415162
AP	anterior precuneus	0.00180505415162
AP	anterior to posterior location	0.00180505415162
AP	anterior posterior	0.0108303249097
AP	antero–posterior	0.00361010830325
AP	anterior–posterior from bregma	0.00180505415162
AP	5d-(-)-2-amino-5-phosphonoeptanoic acid	0.00180505415162
AP	5(±)-2-amino-5-phosphopentanoic acid	0.00180505415162
AP	adenopituitary	0.00180505415162
AP	5(2r)-amino-5-phosphonovaleric acid	0.00902527075812
AP	5d-2-amino-5-phosphonovaleric acid	0.00180505415162
AP	5aminophosphonopentanoic acid	0.00180505415162
AP	apyrimidinic	0.00180505415162
AP	anterior–posterior co-ordinate	0.00180505415162
AP	alkaline phosphate	0.00180505415162
AP	5amino-5-phosphonopentanoate	0.00180505415162
AP	5l-(+)-2-amino-5-phosphonopentanoic acid	0.00180505415162
AP	affinity purification	0.00361010830325
AP	2m1ap-2 complex subunit mu-1	0.00180505415162
AP	5dl-2-amino-5-phosphonovalerate	0.00361010830325
AP	2activation protein 2	0.00180505415162
AP	5±-2-amino-5-phosphonopentanoic acid	0.00361010830325
AP	5amino-phosphonopentanoic acid	0.00180505415162
AP	amyloid plaques	0.00180505415162
AP	iramygdalo-piriform transition area	0.00180505415162
AP	anterior relative to bregma	0.00180505415162
AP	abasic	0.00180505415162
AP	5dl-2-amino-5-phosphonovaleric acid	0.00902527075812
AP	2adaptor protein 2	0.00180505415162
AP	adaptor/assembly protein	0.00180505415162
AP	5d(-)-aminophosphonopentanoic acid	0.00180505415162
AP	anterior to bregma	0.00180505415162
AP	anterior–posterior direction of body sway	0.00180505415162
AP	antero-posterior	0.0198555956679
AP	52-amino-5-phosphopentanoic acid	0.00180505415162
AP	saction potentials	0.0108303249097
AP	anteroposterior plane	0.00180505415162
AP	5d(–)-2-amino-5-phosphonophenylglycine	0.00180505415162
AP	(s)action potential(s)	0.00180505415162
AP	5dl-2-amino-5-phosphonopentanoic acid	0.014440433213
AP	anterio-posterior	0.00180505415162
AP	siteapurinic or apyrimidinic site	0.00180505415162
AP	anterior to the interaural line	0.00541516245487
AP	anterior–posterior	0.0649819494585
AP	area postrema	0.129963898917
AP	spike amplitude	0.00180505415162
AP	air puff	0.00180505415162
AP	anterior-posterior	0.014440433213
AP	membrane-associated protein fraction	0.00180505415162
AP	artificial perilymph	0.00361010830325
AP	iramygdalopiriform transition area	0.00541516245487
AP	2adapter protein 2	0.00180505415162
AP	5d(-)-2-amino-5-phosphonopentanoic acid	0.0126353790614
AP	anteroposterior coordinate	0.00180505415162
AP	arterial blood pressure	0.0072202166065
AP	alkaline-phosphatase	0.00361010830325
AP	5d(-)-2-amino-5-phosphonopentanoicvaleric acid	0.00180505415162
AP	posterior	0.00180505415162
AP	anteroposterior	0.086642599278
AP	anterioposterior	0.0306859205776
AP	anterior/posterior	0.00180505415162
AP	5(dl)-amino-5-phosphonovaleric acid	0.00180505415162
AP	alkaline phosphatase	0.0613718411552
AP	52-amino-5-phosphonopentanoate	0.00180505415162
AP	anterior pagoda	0.00361010830325
AP	anticipatory period for punishment	0.00180505415162
AP	50μ2 subunit of adaptor protein complex 2	0.00180505415162
AP	5d-2-amino-5-phosphono-pentanoic acid	0.00180505415162
AP	assembly protein	0.00180505415162
AP	52-amino-5-phosphonopentanoic acid	0.014440433213
AP	5d-2-amino-5-phosphopentanoate	0.00180505415162
AP	antero-posteriority	0.00180505415162
AP	anterior–posterior co-ordinate (relative to bregma)	0.00180505415162
AP	alkaline phosphatise	0.00361010830325
AP	5d-(–)-2-amino-5-phosphonopentanoic acid	0.00180505415162
AP	amyloid plaque	0.00180505415162
AP	52-amino-5-phosphonopropionic acid	0.00180505415162
AP	arterial pressure	0.0324909747292
AP	acute pancreatitis	0.00180505415162
AP	1	0.00180505415162
AP	activating peptide	0.00180505415162
AP	5	0.00180505415162
AP	5(±)-2-amino-5-phosphonopentanoic acid	0.00541516245487
AP	5aminophosphovaneric acid	0.00180505415162
AP	adapter primer	0.00180505415162
AP	antero-posterior direction	0.00180505415162
AP	5(α)-2-amino-5-phosphonopentanoic acid	0.00180505415162
AP	activator protein	0.00902527075812
AP	anterior to posterior	0.00180505415162
AP	antero-posterior stereotactic coordinate	0.00180505415162
AP	52-amino-5-phosphonovaleric acid	0.00902527075812
AP	5d-(-)-2-amino-5-phosphonopentanoic acid	0.0108303249097
AP	iramygdalopiriform transitional area	0.00180505415162
AP	7d(-)-2-amino-7-phosphonoheptanoic acid	0.00180505415162
AP	human placental alkaline phosphatase transgene	0.00180505415162
AP	hosalkaline phosphatase	0.00180505415162
AP	5dl-2-amino-5-phosphonopentameric acid	0.00180505415162
AP	tanterior pretectal nucleus	0.00180505415162
AP	anterior pituitary	0.00180505415162
AS	axoplasmic signal	0.0222222222222
AS	albino swiss (rats)	0.0222222222222
AS	antisense	0.177777777778
AS	auditory stimulation	0.0666666666667
AS	antisense oligonucleotide	0.0222222222222
AS	acute saline	0.0222222222222
AS	antiserum	0.0222222222222
AS	amiloride sensitive	0.0222222222222
AS	tramygdalo-striatal transition area	0.0222222222222
AS	active sleep	0.155555555556
AS	arcuate sulcus	0.0222222222222
AS	adapting stimulus	0.0222222222222
AS	appetite suppression	0.0222222222222
AS	acoustic startle	0.0222222222222
AS	–cachaete–scute complex	0.0222222222222
AS	acutely stressed	0.0222222222222
AS	neurotrophin-3 antiserum	0.0222222222222
AS	anxiety sensitivity	0.0222222222222
AS	audiogenic susceptible naı̈ve rats	0.0222222222222
AS	tramygdalostriatal transition area	0.0666666666667
AS	acute stress	0.0222222222222
AS	wistar audiogenic seizures	0.0222222222222
AS	2acrylodan-cplartlsvag-lpgkk	0.0222222222222
AS	albino swiss	0.0222222222222
AS	90ninety days after surgery	0.0222222222222
AS	asymmetry index	0.0222222222222
AS	odnantisense oligodeoxynucleotide	0.0222222222222
AS	antisense oligo cdna probe	0.0222222222222
AR	aldose reductase	0.039603960396
AR	androgen receptor	0.445544554455
AR	adaptation ratio	0.00990099009901
AR	antigen retrieval	0.00990099009901
AR	adenosine receptor	0.039603960396
AR	agonist ratio	0.00990099009901
AR	sadrenoreceptors	0.00990099009901
AR	mmedial subdivision of arrn	0.00990099009901
AR	adrenergic receptors	0.029702970297
AR	adrenergic receptor or adrenoceptor	0.00990099009901
AR	nuclear androgen receptor	0.00990099009901
AR	anticipatory period for reward	0.00990099009901
AR	axonal reflex	0.00990099009901
AR	adjacent right quadrant	0.00990099009901
AR	adrenergic	0.00990099009901
AR	adrenergic receptor	0.0693069306931
AR	androgen receptors	0.019801980198
AR	sandrogen receptors	0.019801980198
AR	arcuate nucleus of hypothalamus	0.00990099009901
AR	adrenoreceptor	0.00990099009901
AR	arousals	0.00990099009901
AR	acute restraint	0.00990099009901
AR	anomalous rectification	0.00990099009901
AR	adrenoceptor	0.138613861386
AR	adrenoreceptors	0.039603960396
AU	absorbance unit	0.0555555555556
AU	aged cognitively-unimpaired	0.0555555555556
AU	aged unimpaired	0.0555555555556
AU	arbitrary unit	0.0555555555556
AU	aged, unimpaired animals	0.0555555555556
AU	age-unimpaired	0.0555555555556
AU	aged memory-unimpaired	0.0555555555556
AU	arbitrary densitometric units	0.0555555555556
AU	arthrobacter ureafaciens	0.0555555555556
AU	arbitrary units	0.277777777778
AU	aged cognitively unimpaired	0.166666666667
AU	13antiserum directed against kv subfamily member 1.3 ion channel	0.0555555555556
AT	2-r	0.0227272727273
AT	1 and at2 subtype receptors	0.0227272727273
AT	area tempestas	0.0227272727273
AT	adoptive transfer	0.0227272727273
AT	1 receptor	0.0454545454545
AT	ataxia-telangiectasia	0.0227272727273
AT	2 receptorangiotensin type 2 receptor	0.0227272727273
AT	1angiotensin type 1	0.0227272727273
AT	ganterior tegmental nucleus	0.0454545454545
AT	average transmittance	0.0227272727273
AT	8abnormally hyperphosphorylated tau protein	0.0227272727273
AT	axonal transport	0.0227272727273
AT	1bangiotensin ii subtype 1b receptor	0.0227272727273
AT	1 and at2 receptor subtypes	0.0227272727273
AT	1	0.0227272727273
AT	2ang ii type 2 receptor	0.0227272727273
AT	uaarcuate tuberal area	0.0227272727273
AT	2angiotensin ii receptor subtype 2	0.0454545454545
AT	2angiotensin ii receptor type 2	0.0227272727273
AT	2angiotensin type 2 receptor	0.0227272727273
AT	ataxia telangiectasia	0.0227272727273
AT	1 receptors	0.0454545454545
AT	active touch	0.0227272727273
AT	array tomography	0.0227272727273
AT	2angiotensin ii type 2	0.0454545454545
AT	1ang ii type 1	0.0227272727273
AT	8abnormally phosphorylated tau	0.0227272727273
AT	100	0.0227272727273
AT	aerobically trained	0.0227272727273
AT	1rangiotensin type 1 receptor	0.0454545454545
AT	afferent tetanus	0.0227272727273
AT	avoidance test	0.0227272727273
AT	4angiotensin 4 receptor	0.0227272727273
AT	axon terminal	0.0454545454545
AT	tauhuman misfolded truncated tau protein	0.0227272727273
AT	2rangiotensin ii type 2 receptor	0.0227272727273
AT	1angiotensin ii receptor type 1	0.0227272727273
AW	active wakefulness	0.0967741935484
AW	analysis window	0.0645161290323
AW	anterior whiskers representation	0.0322580645161
AW	active waking	0.41935483871
AW	wakefulness	0.0645161290323
AW	active wake	0.129032258065
AW	alert waking	0.0322580645161
AW	awake	0.0322580645161
AW	active or attentive waking	0.0322580645161
AW	alert wakefulness	0.0322580645161
AW	active awake	0.0322580645161
AW	awake state	0.0322580645161
AV	3vanterior part of the third ventricle	0.0196078431373
AV	anterior ventral thalamus	0.0196078431373
AV	3vanteroventral third ventricle region	0.0392156862745
AV	anterior ventral nucleus	0.0196078431373
AV	maudio-visual dynamic movie	0.0196078431373
AV	anteroventral auditory field	0.0196078431373
AV	active vision	0.0196078431373
AV	3vanteroventral third ventricle	0.0588235294118
AV	audio–visual	0.0196078431373
AV	anteroventral area	0.0196078431373
AV	anteroventral nucleus of the thalamus	0.0196078431373
AV	annexin v	0.0196078431373
AV	anteroventral thalamic	0.0196078431373
AV	anteroventral nucleus	0.137254901961
AV	autophagy vacuoles	0.0196078431373
AV	anteroventral thalamic nucleus	0.21568627451
AV	3vanteroventral portion of the third cerebral ventricle	0.0196078431373
AV	avoidance	0.0196078431373
AV	anteroventral nucleus of thalamus	0.0196078431373
AV	vventral part of the anteroventral nucleus	0.0196078431373
AV	abdominal vagus	0.0196078431373
AV	audiovisual	0.0588235294118
AV	anteroventral nucleus, thalamus	0.0196078431373
AV	3vanteroventral third ventricular region	0.0196078431373
AV	audio-visual condition	0.0196078431373
AV	anterior ventral thalamic nucleus	0.0196078431373
AV	sautophagic vacuoles	0.0196078431373
AV	atrioventricular	0.0392156862745
AV	afferent volley	0.0196078431373
AY	amygdala	1.0
NAGO	+nago-positive	1.0
PbTx	ptychodiscus brevis toxin	1.0
AZ	apposition zone	0.153846153846
AZ	anterior zone	0.230769230769
AZ	active zone	0.384615384615
AZ	synaptic active zones	0.0769230769231
AZ	number of separate active zones within a terminal	0.0769230769231
AZ	active zone (of synapse)	0.0769230769231
ACIII	adenylate cyclase type 3	1.0
RAP-KO	rap knockout	1.0
Ab	antibody	1.0
Ad	adenovirus	1.0
sucrose-ACSFACSF	with 5 mm kcl and 215 mm sucrose instead of nacl	1.0
rhE	porecombinant human epo	1.0
LABORASL	aboratory animal behavior observation registration and analysis system	1.0
PK11195	1-(2-chlorophenyl)-n-methyl-n-(1-methyl-propyl)-3-isoquinoline carboxamide	0.5
PK11195	1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamide	0.5
Aq	aqueduct	1.0
Ar	area of the region to be measured	1.0
RRMS	relapsing-remitting ms	0.5
RRMS	relapsing-remitting form of ms	0.5
DPNdiarylpropionitrile	2,3-bis(4-hydroxyphenyl)-propionitrile	1.0
Az	choline mustard aziridinium	1.0
8-Br-cAMP	8-bromoadenosine 3′,5′-cyclic monophosphate	0.333333333333
8-Br-cAMP	8-bromo-cyclic amp	0.166666666667
8-Br-cAMP	8-bromo-adenosine-3′5′-cyclicmonophosphate	0.166666666667
8-Br-cAMP	8-bromo-cyclic-amp	0.333333333333
cBF	caudal basal forebrain	1.0
FALS	sporadic and familial	0.0666666666667
FALS	familial amyotrophic lateral sclerosi	0.0666666666667
FALS	familial amyotrophic lateral sclerosis	0.6
FALS	familial form of als	0.0666666666667
FALS	familial als	0.133333333333
FALS	familial	0.0666666666667
PDHC	pyruvate dehydrogenase complex	1.0
FAF-BSA	fatty acid-free bovine serum albumin	1.0
ARNTA	ryl hydrocarbon receptor nuclear translocator	1.0
c-DCF	carboxy-2′,7′-dichlorofluorescein diacetate	1.0
NTNHnon-toxin	non-hemagglutinin	1.0
α2A-KO	mice lacking the α2a-ar	1.0
CAFF	caffeine	1.0
MMNM	ismatch negativity	1.0
TCGAP-WT	wild-type tcgap	1.0
WLG	word list generation	1.0
HIVEHIV-	1 encephalitis	1.0
STEPST	riatal-enriched protein tyrosine phosphatase	1.0
5-HT-LIR	serotonin-like immunoreactiv(e)(ity)	1.0
ERαKO	estrogen receptor-alpha knockout	0.5
ERαKO	erα knock-out mouse	0.5
hSSTR	shuman somatostatin receptors	1.0
uracil-DNA	glycosylase	1.0
MAPEG	superfamilymembrane-associated proteins involved in eicosanoid and gluthathione metabolism	1.0
PUR	very intense purple (vip) reaction product	0.333333333333
PUR	pelvic-urethral reflex	0.333333333333
PUR	reaction product produced by vector vip (very intense purple) substrate kit	0.333333333333
Sp5	spinal trigeminal nucleus	0.5
Sp5	nucleus of the spinal tract of the trigeminal nerve	0.5
gX	vagal ganglia	1.0
HPLCH	igh-performance liquid chromatography	1.0
gF	fluid intelligence	1.0
FAβ	1-42fluoroscein conjugated aβ1-42	1.0
GLP-	1raglucagon-like peptide-1 receptor agonist	0.0769230769231
GLP-	1rglucagon-like peptide 1 receptor	0.0769230769231
GLP-	1glucagon-like peptide 1	0.307692307692
GLP-	1rglp-1 receptors	0.0769230769231
GLP-	2	0.0769230769231
GLP-	1rglp-1 receptor	0.0769230769231
GLP-	1glucagon-like peptide-1	0.307692307692
gN	amaximal sodium conductance	1.0
LMN	lower motoneuron	0.5
LMN	lateral mammillary nucleus	0.5
aVNL	anterior vomeronasal nerve layer	1.0
gK	potassium conductance	0.5
gK	(ca), ca2+-dependent k+ conductance	0.5
hLIF	human leukemia inhibitory factor	1.0
8OH	dg8-hydroxy-deoxyguanosine	0.5
8OH	dg8-hidroxy-2'-deoxyguanosine	0.5
gH	+voltage-gated proton conductance	1.0
TUC-	4toad/ulip/crmp family protein 4	1.0
cellsN	urr1gpx-1dopaminergiclentivirusesbeta-boswellic acid	1.0
mAChR	muscarinic cholinergic receptor	0.0909090909091
mAChR	muscarinic acetylcholine receptor	0.727272727273
mAChR	muscarinic cholinergic receptors	0.0909090909091
mAChR	muscarinic acetylcholine receptors	0.0909090909091
FKBP-12	fk-506-binding protein 12	0.333333333333
FKBP-12	12,000 mol. wt fk506 binding protein	0.333333333333
FKBP-12	fk506 binding protein 12	0.333333333333
RPeD1	neuron right pedal dorsal 1	1.0
SpV	spinal trigeminal nucleus	0.5
SpV	spinal trigeminal tract	0.5
SpI	spinal subnucleus interpolaris of the trigeminal nerve	1.0
PN-COC	prenatal cocaine	1.0
SpL	lateral spiriform nucleus	0.5
SpL	nucleus spiriformis lateralis	0.5
SpM	nucleus spiriformis medialis	1.0
Aββ	amyloid	1.0
hWT	human wild-type	1.0
8-isoPGF2α	8-isoprostaglandin f2α	1.0
DUSP	dual-specificity phosphatase	1.0
EEDQN-ethoxycarbonyl-2-ethoxy-1	2-dihydroquinoline	1.0
SNAP25	synaptosomal associated protein of 25 kda	1.0
PKC-δPKC-	delta	1.0
PBSAT	phosphate-buffered saline supplemented with 0.5% albumin supplemented with 0.5% triton x-100	1.0
cPFC	contralateral prefrontal cortex	1.0
DXMdexamethasone	sodium phosphate	1.0
GABAAδ	receptorsgabaa receptors containing the δ subunit	1.0
GRα-IR	glucocorticoid receptor α immunoreactivity	1.0
GABAAα	1gaba receptor type a α1 subunit	1.0
GABAAγ	receptorsgabaa receptors containing the γ subunit	0.5
GABAAγ	2	0.5
FFMQF	ive-facet mindfulness questionnaire	1.0
JO	jaw-opening	0.5
JO	sjaw-opening subdivision of the vmo	0.5
ARFADP-	ribosylation factor	1.0
SAMPaccelerated-prone	short-lived	1.0
t-BOOH	tert-butyl hydroperoxide	1.0
UPGMA	unweighted paired-group method with arithmetic mean	1.0
O-2	superoxide anion	1.0
X-gal	5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside	0.666666666667
X-gal	5-bromo-4-chloro-3-indolyl-β-d-galactosidase	0.166666666667
X-gal	5-bromo-4-chloro-3-indolyl-b-d-galactopyranoside	0.166666666667
JZLJZL	184	1.0
t-ACPDaminocyclopentane-1S	3r-dicarboxylic acid	1.0
SEAP	secreted alkaline phosphatase	1.0
EDSSE	xpanded disability status scale	1.0
TFSθ	frequency stimulation	1.0
LRRC	8leucine-rich repeat-containing 8	1.0
CIHRC	anadian institutes of health research	1.0
PCLε-	caprolactone	1.0
ATF-3	activating transcription factor 3	1.0
ATF-2	fusion protein substrate for p38 mapk	0.25
ATF-2	activating transcription factor-2	0.75
LRRK	2leucine-rich repeat kinase 2	0.888888888889
LRRK	2leucine rich repeat kinase 2	0.111111111111
GAL-R	galanin receptor	1.0
MAGuK	membrane-associated guanylate kinase homolog	1.0
GTP-γ-S	tetralithium guanosine 5′-[γ-thio]triphosphate	0.333333333333
GTP-γ-S	guanosine-5′-[γ-thio] triphosphate	0.333333333333
GTP-γ-S	guanosine-5′-[γ-thio]triphosphate	0.333333333333
Rli	rostral linear raphe nucleus	1.0
avgCCF	averaged cross-correlation function	1.0
ELEL	/suz	1.0
hABH	human alkb homologue	1.0
JC	sjaw-closing subdivision of the vmo	0.5
JC	jaw-closing	0.5
zR	aldhzebra finch retinaldehyde-specific aldehyde dehydrogenase	1.0
N-CAM	neural cell adhesion molecule	0.727272727273
N-CAM	neuronal cell adhesion molecule	0.272727272727
S-COMT	soluble isoform of comt	1.0
Glyrb	murine gene of the glycine receptor β-subunit	1.0
Popen	open probability	1.0
WGA-gold	wga-conjugated 10-nm colloidal gold	1.0
acetyl-C	oaacetyl-coenzyme a	1.0
aEPSP	artificial epsp	1.0
FIVE	fiv encephalopathy	1.0
DHPLC	denaturing high-performance liquid chromatography	1.0
LHCM	lipopolysaccharide and hypoxia stimulated conditioned medium	1.0
fAD	familial alzheimer’s disease	1.0
sVII	superficial facial motor	1.0
GPCRG	protein-coupled receptors	0.0416666666667
GPCRG	protein-coupled receptor	0.583333333333
GPCRG	i protein–coupled receptor	0.0416666666667
GPCRG	protein–coupled receptor	0.208333333333
GPCRG	protein coupled receptor	0.0833333333333
GPCRG	protein–coupled receptors	0.0416666666667
b-NOS	neuronal nitric oxide synthase	1.0
PSDP	ower spectral density	1.0
PUMA	p53-upregulated modulator of apoptosis	1.0
VSWM	visuo-spatial working memory	1.0
MEQ6-metoxy-N-ethyl-1	2-dihydroquinoline	1.0
XLMRX-	linked mental retardation	1.0
cy3-SP	cyanine 3.18-labeled substance p	1.0
3-HANA	3-hydroxyanthranilate	1.0
CF-EPSC	climbing fiber–mediated excitatory postsynaptic current	1.0
LY303070	(-)1-(4-aminophenyl)-3-methyl-carbonyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5h-2,3-benzodiazepine	1.0
τI	nactinactivation time constant	1.0
2DG14C	2-deoxyglucose	1.0
V1aR	vasopressin v1a receptor	1.0
τO	open time constant	1.0
3NPA	3-nitropropionic acid	1.0
τC	closed time constant	1.0
DL-TBOA	dl-threo-βbenzoyloxyaspartate	1.0
FRA-	2fos-related antigen-2	1.0
DA-MEL	dopamine-melatonin	1.0
P-FIT	parieto-frontal integration theory	1.0
GABAγ-	aminobutyric acid	0.838709677419
GABAγ-	aminobutynic acid	0.0161290322581
GABAγ-	amino-glutamic acid	0.0161290322581
GABAγ-	aminobutylic acid	0.0322580645161
GABAγ-	amino butyric acid	0.0967741935484
post-H	post-hypoxia	1.0
APP670	671 and the human tau gene on a homozygous mouse tau knockout background	1.0
5FOA	5-fluoroorotic acid	1.0
LSPW	large-amplitude in vitro sharp wave	1.0
RIPA	radio immunoprecipitation assay	0.111111111111
RIPA	bufferradioimmunoprecipitation assay buffer	0.037037037037
RIPA	radioimmunoprecipitation	0.111111111111
RIPA	radioimmunoprecipitation assay	0.407407407407
RIPA	radioimmuno precipitation assay	0.0740740740741
RIPA	50mm tris–hcl ph 8.0, 150mm sodium chloride, 0.1% sds, 1% nonidet p-40, 0.5% sodium deoxycholate buffer	0.037037037037
RIPA	radio-immunoprecipitation assay	0.185185185185
RIPA	radial immunoprecipitation assay	0.037037037037
XIAP	x-linked inhibitor of apoptosis	1.0
SPFp	parvocellular part of the subparafascicular nucleus of the thalamus	0.5
SPFp	parvicellular part of the subparafascicular thalamic nucleus	0.5
ZRFTZ	relative finishing time	1.0
PnO	nucleus reticularis pontis oralis	0.166666666667
PnO	pontine reticular nucleus, oral part	0.166666666667
PnO	nucleus pontis oralis	0.166666666667
PnO	pontine reticular nucleus, oral	0.166666666667
PnO	oral pontine reticular nucleus	0.333333333333
AUDA	12-(3-adamantan-1-yl-ureido)-dodecanoic acid	1.0
PnC	nucleus reticularis pontis caudalis	0.285714285714
PnC	pontine reticular nucleus, caudal	0.142857142857
PnC	caudal pontine reticular nucleus	0.428571428571
PnC	pontine reticular nucleus, caudal part	0.142857142857
FGF-R	1fibroblast growth factor receptor-1	1.0
ASPD	antisocial personality disorder	1.0
PFTG	pontine gigantocellular tegmental field	1.0
INap	persistent sodium current	1.0
dSAT	difficult version of the spatial alternation task	0.5
dSAT	distractor version of sat	0.5
LCAD	long-chain acyl coa dehydrogenase	1.0
BBBB	asso beattie and bresnahan	0.0909090909091
BBBB	asso-beattie-bresnahan	0.272727272727
BBBB	asso beattie bresnahan	0.181818181818
BBBB	asso beattie bresnahan locomotor rating scale	0.0909090909091
BBBB	asso–beattie–bresnahan	0.181818181818
BBBB	lood–brain barrier	0.181818181818
DPOAE	distortion product otoacoustic emission	0.5
DPOAE	sdistortion product otoacoustic emissions	0.142857142857
DPOAE	distortion product oto-acoustic emission	0.0714285714286
DPOAE	sdistortion products of otoacoustic emissions	0.0714285714286
DPOAE	distortion product otoacoustic emissions	0.214285714286
KVIQK	inesthetic and visual imagery questionnaire	1.0
pri-N	primarylike-with-notch	1.0
GAR-HRP	horseradish peroxidase-linked goat anti-rat antibody)	1.0
REHL	respiratory evaporative heat loss	1.0
SNO-C	yss-nitrosocysteine	1.0
WAISW	echsler adult intelligence scale revised	1.0
5-FU	5′-fluorouridine	0.5
5-FU	5-fluorouracil	0.5
KAA-	type k+ channel	1.0
PFT-	μpifithrin-mu	1.0
AVD	apoptotic volume decrease	1.0
DARRP-	32dopamine and cyclic amp-regulated phosphoprotein	1.0
GWASG	enome wide association studies	1.0
ER-α	estradiol receptor alpha	0.142857142857
ER-α	estrogen receptor alpha	0.428571428571
ER-α	irestrogen receptor-alpha immunoreactive	0.142857142857
ER-α	estrogen receptor-α	0.285714285714
ceramideD-erythro-sphingosine	n-acetyl-	1.0
ER-β	estrogen receptor-beta	0.285714285714
ER-β	estrogen receptor beta	0.285714285714
ER-β	estrogen-receptor beta	0.142857142857
ER-β	estrogen receptor-β	0.142857142857
ER-β	estradiol receptor beta	0.142857142857
BAY	36-7620	1.0
CVLTC	alifornia verbal learning test	1.0
tcMMEP	stranscranial magnetic motor evoked potentials	1.0
RAPMR	aven’s advanced progressive matrix	0.5
RAPMR	aven’s advanced progressive matrices	0.5
HANDHIV-	associated neurocognitive disorder	0.5
HANDHIV-	1 associated neurocognitive disorders	0.5
MPTP-HCl1-methyl-4-phenyl-1	2,3,6-tetrahydropyridine hydrochloride	1.0
AcbSh	shell of the nucleus accumbens	1.0
MARK	4microtubule affinity-regulating kinase 4	1.0
cSFO	ventromedial core part of the subfornical organ	1.0
ACASA	symptomatic carotid atherosclerosis study	1.0
VIII	octaval nerve	0.25
VIII	vestibulocochlear nerve	0.25
VIII	vestibular nerve	0.25
VIII	nvestibular nerve	0.25
ppDYN	preprodynorphin	1.0
GDN-1	glia-derived nexin 1	1.0
PACAP-LIPACAP-	like immunoreative	1.0
SSGS	superior sagittal sulcus	1.0
VISC	visceral cortex	1.0
CERADC	onsortium to establish a registry for alzheimer's disease	0.5
CERADC	onsortium to establish a registry for alzheimer’s disease	0.5
MLKL	mixed lineage kinase domain-like protein	1.0
OFC	orbital cortex	0.0144927536232
OFC	orbtiofrontal cortex	0.0144927536232
OFC	orbital frontal cortex	0.101449275362
OFC	orbitofrontal cortices	0.0144927536232
OFC	orbito–frontal cortex	0.0144927536232
OFC	orbital prefrontal cortex	0.0144927536232
OFC	orbitofrontal cortex	0.811594202899
OFC	orbitofrontal cortex/cortical	0.0144927536232
TOR	target of rapamycin	0.666666666667
TOR	turn-over rate	0.333333333333
TOS	transverse occipital sulcus	1.0
TOP	5′ oligopyrimidic tract	1.0
TOT	loctotal locomotion	0.5
TOT	total	0.5
IAN	inferior alveolar nerve	1.0
MPQM	cgill pain questionnaire	1.0
TOL	olfactory tubercle	1.0
TOM	tractus occipitomesencephalicus	0.333333333333
TOM	theory of mind	0.666666666667
TOC	/vehtocinoic acid/vehicle	0.5
TOC	transient outward current	0.5
IFN-γI	nterferon-γ	0.5
IFN-γI	nterferon-gamma	0.5
TOF	time-of-flight	0.666666666667
TOF	time of flight	0.333333333333
NHE	1na+/h+ exchange enzyme type 1	0.142857142857
NHE	na+/h+ exchanger	0.142857142857
NHE	sodium–hydrogen exchanger	0.285714285714
NHE	inhibitors	0.142857142857
NHE	sodium/hydrogen exchange	0.142857142857
NHE	na+/h+ exchanger subtype	0.142857142857
phospho-T	rkaphosphorylated tyrosine kinase a	0.5
phospho-T	rkaphosphorylated trka	0.5
NHA	normal human astrocytes	1.0
DTNBP	1dysbindin-1	1.0
HIV	human immunodeficiency virus	0.95
HIV	)	0.05
LRP	low-density lipoprotein-receptor-related protein	0.0322580645161
LRP	4low-density lipoprotein receptor-related protein 4	0.0322580645161
LRP	low density lipoprotein-related protein	0.0322580645161
LRP	low density lipoprotein receptor protein	0.0322580645161
LRP	1lipoprotein receptor-related protein 1	0.0322580645161
LRP	ldl-receptor-related protein	0.0645161290323
LRP	lung resistance-related protein	0.0322580645161
LRP	lipoprotein receptor-related protein	0.0645161290323
LRP	lipoprotein receptor related protein	0.0322580645161
LRP	1	0.0322580645161
LRP	lung resistance proteins	0.0322580645161
LRP	low density lipoprotein receptor-related protein	0.129032258065
LRP	low-density lipoprotein receptor related protein	0.0322580645161
LRP	1low density lipoprotein receptor-related protein 1	0.0645161290323
LRP	low-density lipoprotein receptor-related protein	0.225806451613
LRP	lateralized readiness potential	0.0645161290323
LRP	lateralized readiness potentials	0.0322580645161
LRP	lung-resistance protein	0.0322580645161
B-50	neuromodulin (or gap-43)	1.0
C-GBP	control animal receiving gabapentin	1.0
PMCAO	permanent middle cerebral artery occlusion	1.0
PEBP	phosphatidylethanolamine binding protein	0.5
PEBP	phosphatidylethanolamine-binding protein	0.5
HIC	handling-induced convulsion	0.75
HIC	handling-induced convulsions	0.25
NHP	nonhuman primate	0.6
NHP	non-human primate	0.2
NHP	2l1high mobility group-like nuclear protein 2 homologue 1	0.2
NHS	sulfo-n-hydroxysuccinimide	0.00925925925926
NHS	n-hydroxysuccinimidyl	0.00925925925926
NHS	normal serum serum	0.00925925925926
NHS	normal horse serum	0.962962962963
NHS	sulfo-n-hydroxy-succinimide	0.00925925925926
IAD	interanterodorsal thalamic nucleus	0.5
IAD	adenosine-induced current	0.5
DPCPX8-cyclopentyl-1	3-dipropylxanthine (a1r antagonist)	0.0333333333333
DPCPX8-cyclopentyl-1	3-dipropylxanthine	0.966666666667
HII	histogram of interspike intervals	1.0
TSBTT	ris-buffered saline with 0.1% triton-x 100	0.5
TSBTT	ris saline buffer with 0.5% triton x-100	0.5
HIL	hilus	1.0
Intra-B	mean interval separating two consecutive ponto-geniculo-occipital waves in a burst	1.0
TmRhd	tetramethylrhodamine	1.0
galanin-IR	galanin-immunoreactive	1.0
I-IC	interictal	1.0
NH-	bestnacl and hcl-best	1.0
ABADAβ-	binding alcohol dehydrogenase	1.0
CHO-K	1/a5chinese hamster ovary cells expressing nicotinic acetylcholine receptor	1.0
NH2	[phe1ψ(ch2-nh)gly2]	1.0
IAB	simpulsive-aggressive behaviours	1.0
HI-	2hemorrhagic infarction type 2	1.0
DIPPC	dorsal inferior ppc	1.0
FFEM	freeze fracture electron microscopy	0.333333333333
FFEM	freeze-fracture electron microscopy	0.333333333333
FFEM	freeze-fracture electron micrograph	0.333333333333
CISAN	cardiac ischemic-sensitive afferent neurons	1.0
MSPG	(±)-α-methyl-(4-sulfonophenyl)glycine	0.666666666667
MSPG	(rs)-α-methyl-4-sulfonophenylglycine	0.333333333333
SR142801	((s)-(n)-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl)-4-phenylpiperidin-4-yl)n-methylacetamide)	1.0
MK-8015-methyl-10	11-dihydro-5h-dibenzo[a,d]-cyclohepten-5,10-imine hydrogen maleate	0.333333333333
MK-8015-methyl-10	11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine	0.333333333333
MK-8015-methyl-10	11-dihydro5h-dibenzo[a,d]cyclohepten-5,10-imine	0.333333333333
AlloP	allopregnanolone	1.0
FDRF	alse discovery rate	1.0
OHSC	organotypic hippocampal slice culture	0.5
OHSC	organotypic hippocampal slice cultures	0.5
SAMS	ynthetic aperture magnetometry	1.0
SAMR	accelerated senescence-resistant mice	0.1
SAMR	senescence-resistant mice	0.1
SAMR	1senescence-accelerated mouse resistant/1	0.1
SAMR	senescence-accelerated mice resistant	0.1
SAMR	1accelerated senescence-resistant mouse prone-1	0.1
SAMR	senescence-accelerated-resistant mice	0.2
SAMR	1senescence-accelerated resistant mouse prone-1	0.1
SAMR	1senescence-accelerated mice/resistance 1	0.1
SAMR	1sam resitant/1	0.1
SAMP	accelerated senescence-prone mice	0.0769230769231
SAMP	senescence-accelerated-prone mice	0.230769230769
SAMP	senescence-accelerated mice prone	0.0769230769231
SAMP	8senescence-accelerated mouse/prone 8	0.0769230769231
SAMP	senescence-accelerated mouse prone	0.0769230769231
SAMP	senescence-prone strains	0.0769230769231
SAMP	8senescence accelerated mouse prone/8	0.0769230769231
SAMP	8senescence-accelerated mouse prone-8	0.0769230769231
SAMP	8senescence-accelerated mouse prone/8	0.0769230769231
SAMP	8	0.153846153846
REM-ON	rapid eye movement on	1.0
STh	subthalamic nucleus	0.666666666667
STh	suprathalamic nucleus	0.333333333333
YPRX	tyr-pro-arg-x	1.0
NaHCO3	sodium bicarbonate	1.0
M-AIRM	authner-initiated abrupt increase in rate	1.0
EOAE	evoked otoacoustic emission	1.0
ET-A	endothelin receptor a	1.0
Z-DEVD-FMX	benzyloxy-carbonyl-asp-glu-val-asp-fluoromethylketone	1.0
MALP-	2macrophage-activating lipopeptide-2	1.0
EGR	early growth response	0.4
EGR	early growth response gene	0.4
EGR	1early growth response 1	0.2
SRA	stretch reflex activity	1.0
dBNST	dorsal bed nucleus of the stria terminalis	0.857142857143
dBNST	dorsal bed nucleus stria terminalis	0.142857142857
EGO	early gamma oscillation	1.0
EGL	egg-laying defective	0.0416666666667
EGL	external germinal layer	0.25
EGL	external granular layer	0.333333333333
EGL	external granule layer	0.0416666666667
EGL	binner external germinal layer	0.0416666666667
EGL	external granule layer of the cerebellum	0.0416666666667
EGL	external granule cell layer	0.25
EGC	ectopic granule cell	0.25
EGC	epigallocatechin	0.25
EGC	senteric glial cells	0.25
EGC	(-)-epigallocatechin	0.25
EGF	epithelial growth factor	0.0265486725664
EGF	epidermal growth factor	0.964601769912
EGF	embryonic growth factor	0.00884955752212
NADH-TR	nicotinamide adenine dinucleotide–tetrazolium reductase	1.0
8-OH-2-DG	8-hydroxy-2′-deoxyguanosine	1.0
LBP	laminin-binding protein	0.25
LBP	lipopolysaccharide binding protein	0.5
LBP	low back pain	0.25
LBS	long burst stimulation	0.5
LBS	linear biological structure	0.5
LBR	lamin b receptor	1.0
RAB	rabbit affinity purified anti-bdnf antibody	0.2
RAB	rectus abdominis	0.2
RAB	rabbit polyclonal antibody	0.2
RAB	rabbit anti-bdnf antibody	0.2
RAB	3gap1rab3 gtpase activating protein subunit 1	0.2
RAC	regional activation curve	0.333333333333
RAC	right anterior semicircular canal	0.333333333333
RAC	[11c]-raclopride	0.333333333333
RAN	randomly sequenced oligodeoxynucleotide	1.0
RAL	raloxifene	1.0
RAM	radial arm maze	0.833333333333
RAM	redox active metals	0.0555555555556
RAM	radial-arm maze	0.111111111111
SMIT	sodium/myoinositol transporter	0.333333333333
SMIT	sodium-dependent myo-inositol transporter	0.666666666667
FGL	)	0.5
FGL	peptide	0.5
p1R	tp1 reticular formation	1.0
RAR	etinoic acid	0.0526315789474
RAR	retinoic acid receptors	0.0526315789474
RAR	sretinoic acid receptors	0.0526315789474
RAR	rapidly adapting receptor	0.105263157895
RAR	retinoic acid receptor	0.684210526316
RAR	ectus abdominis	0.0526315789474
RAS	right anterior superior region	0.0555555555556
RAS	renin–angiotensin system	0.444444444444
RAS	renin-angiotensin systems	0.0555555555556
RAS	proto-oncogene protein p21	0.0555555555556
RAS	renin–ang system	0.0555555555556
RAS	renin-angiotensin system	0.277777777778
RAS	reticular activating system	0.0555555555556
RAP	receptor-associated protein	0.545454545455
RAP	rapamycin	0.272727272727
RAP	right atrial pressure	0.181818181818
LBF	long burst frequency (mean number of bursts containing five or more ponto-geniculo-occipital waves/min)	1.0
FGD	fluorogold	1.0
ChTX	charybdotoxin	1.0
FGF	2fibroblast growth factor-2 (basic fibroblast growth factor)	0.00684931506849
FGF	fibroblast growth factor	0.36301369863
FGF	22fibroblast growth factor 22	0.00684931506849
FGF	2fibroblast growth factor	0.027397260274
FGF	2basic fibroblast growth factor	0.027397260274
FGF	2	0.00684931506849
FGF	luorogold	0.301369863014
FGF	sfibroblast growth factors	0.013698630137
FGF	8fibroblast growth factors	0.00684931506849
FGF	8fibroblast growth factor 8	0.00684931506849
FGF	2fibroblast growth factor-2	0.041095890411
FGF	fibroblast growth factors	0.00684931506849
FGF	2fibroblast growth factor 2	0.0547945205479
FGF	luoro-gold	0.130136986301
FGG	frequency generalization gradients	1.0
dl-TBOA	dl-threo-b-benzyloxyaspartic acid	0.25
dl-TBOA	dl-threo-β-benzyloxyaspartate	0.375
dl-TBOA	dl-threo-beta-benzyloxyaspartate	0.125
dl-TBOA	dl-threo-beta-benzyloxyaspartic acid	0.125
dl-TBOA	dl-threo-b-benzyloxyaspartate	0.125
FGA	first generation antipsychotic	1.0
NTBS	nickel tris-buffered saline	1.0
BFC	basal forebrain complex	0.166666666667
BFC	basal forebrain cholinergic projection neurons	0.166666666667
BFC	bilateral forelimb clonus	0.166666666667
BFC	basal forebrain cholinergic	0.5
BFB	basal forebrain	0.714285714286
BFB	iceps femoris	0.285714285714
BFA	brefeldin a	0.666666666667
BFA	bafliomycin a1	0.333333333333
GSRG	alvanic skin response	1.0
TTXR	ttx-resistant na+ current	1.0
IB-MECAN	6-(3-iodobenzyl)-5′-n-methyl carboxoamidoadenosine	1.0
PFCP	refrontal cortex	1.0
βAβ-	amyloid	1.0
T-AAHC	topographic—atomize and agglomerate hierarchical clustering	1.0
d-myo-IP3	d-myo-inositol-1,4,5-trisphosphate	1.0
BFS	brief frequency stimulation	1.0
FG-	7142n-methyl-β-carboline-3-carboxamide	0.25
FG-	7142n-methyl-beta-carboline-3-carboxamide	0.25
FG-	7142	0.25
FG-	7142beta carboline-3-carboxylic acid methyl amide	0.25
1-EBIO	1-ethyl-2-benzimidazolinone	1.0
SMI-	312pan-axonal neurofilament marker	0.166666666667
SMI-	32non-phosphorylated neurofilament	0.166666666667
SMI-	32	0.166666666667
SMI-	32nonphosphorylated neurofilament protein	0.166666666667
SMI-	32sternberger monoclonal-incorporated antibody 32	0.166666666667
SMI-	32nonphosphorylated neurofilaments	0.166666666667
BFT	brain-friendly trio	1.0
L-SS	prenatally stressed mice treated with ssri during postnatal weeks 6–8	1.0
D-Pen2	5]enkephalin	0.5
D-Pen2	5]-enkephalin	0.5
Vθ	voltage threshold	1.0
Lgals1lectin	galactose binding, soluble 1	1.0
V3A	visual area 3a	1.0
PUPS	males that were tested with 2–3 day old conspecific pups	1.0
KOIL-	10 knockout mice	1.0
PKIPKA	inhibitor (pkai5–24)	0.5
PKIPKA	inhibitor fragment 14–22 myristoylated trifluoracetate salt	0.5
TCTP	translationally-controlled tumor protein	1.0
2-ACT	two-alternative choice task	1.0
ARHGEF	6rac/cdc42 guanine nucleotide exchange factor (gef) 6	1.0
EG-	1early growth response-1	1.0
PFCX	prefrontal cortex	1.0
iso-PPADS	pyridoxal-phosphate-6-azophenyl-2′,5′-disulphonic acid	1.0
AMPARα-	amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor	0.125
AMPARα-	amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor	0.0625
AMPARα-	amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor	0.5
AMPARα-	amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor	0.125
AMPARα-	amino-3-hydroxi-5-methylisoxazole-4-propionic acid receptors	0.0625
AMPARα-	amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid receptor	0.0625
AMPARα-	amino-3-hydroxi-5-methylisoxazole-4-propionic acid receptor	0.0625
PILO	pilocarpine	1.0
IFT	total intromission frequency	1.0
VDCCs	voltage-dependent ca2+ currents	0.5
VDCCs	voltage-dependent calcium channels	0.5
l-AA	l-arginine	1.0
OCM	oculomotor nucleus	1.0
LIVBP	leucine/isoleucine/valine-binding protein	1.0
IFS	inferior frontal sulcus	1.0
OCC	occipital cortex	0.5
OCC	cortex-hippocampal organotypic slice cultures	0.5
OCB	olivary cochlear bundle	0.333333333333
OCB	soligoclonal bands	0.333333333333
OCB	open channel blockers	0.333333333333
OCD	obsessive-compulsive disorder	0.357142857143
OCD	obsessive–compulsive disorder	0.357142857143
OCD	obsessive compulsive disorder	0.285714285714
COND	condition	1.0
PHF	taupaired helical filament tau	0.0384615384615
PHF	paired helical filament	0.307692307692
PHF	1paired helical filaments	0.0384615384615
PHF	spaired helical filaments	0.0769230769231
PHF	passive high frequency	0.0384615384615
PHF	paired helical filaments	0.5
uPAR	urokinase–type plasminogen activator receptor	0.5
uPAR	urokinase-type plasminogen activator receptor	0.5
IFG	inferior frontal gyrus	0.958333333333
IFG	isometric force generation	0.0416666666667
IFA	incomplete freund's adjuvant	1.0
TEFT	hyrotroph embryonic factor	1.0
IFL	infralimbic cortex	1.0
OCP	outward current pulse	1.0
IFN	interferon	0.791666666667
IFN	interferon gamma	0.0416666666667
IFN	type 1 interferon	0.0416666666667
IFN	interfascicular subnucleus of the ventral tegmental area	0.0416666666667
IFN	interferon-γ	0.0416666666667
IFN	sinterferons	0.0416666666667
c-Ara	cytosine-1-β-d-arabinofuranoside	1.0
GABAγ-A	minobutyric acid	1.0
OCT	optimal cutting temperature medium	0.0384615384615
OCT	optimum cutting temperature	0.115384615385
OCT	optimal cutting temperature	0.346153846154
OCT	optimum cutting temperature (compound)	0.0384615384615
OCT	optimum cutting temperature compound	0.0384615384615
OCT	organic cation transporter	0.230769230769
OCT	octreotide	0.0769230769231
OCT	optical coherence tomography	0.0384615384615
OCT	2	0.0384615384615
OCT	???	0.0384615384615
IFJ	inferior frontal junction	1.0
ANG-II	angiotensin ii	1.0
PKR	ipkr inhibitor	0.333333333333
PKR	double-stranded rna-activated protein kinase	0.333333333333
PKR	double-stranded rna-dependent protein kinase	0.333333333333
CEF	ceftriaxone	0.666666666667
CEF	chick embryonic fibroblast	0.333333333333
CEE	conjugated equine estrogen	0.333333333333
CEE	creatine ethyl ester	0.166666666667
CEE	groupcontrol-enriched environment group	0.166666666667
CEE	conjugated equine estrogens	0.333333333333
CED	chronic energy deficiency	0.25
CED	convection-enhanced delivery	0.25
CED	c. elegans death gene	0.25
CED	cambridge electronic design	0.25
CEC	oefficient of error	1.0
CEB	cell extraction buffer	1.0
CEA	mmedial central amygdaloid nucleus	0.0294117647059
CEA	childhood emotional abuse	0.0294117647059
CEA	central nucleus of the amygdale	0.0294117647059
CEA	central division of the extended amygdala	0.0294117647059
CEA	central amygdala	0.205882352941
CEA	central amygdaloid nucleus	0.0294117647059
CEA	central nucleus of amygdala	0.0294117647059
CEA	central amygdalar nucleus	0.0294117647059
CEA	centromedial amygdala	0.0294117647059
CEA	central nucleus of the amygdala	0.529411764706
CEA	(l/c)central amygdala (lateral/capsular)	0.0294117647059
ASMT	acetylserotonin methyltransferase	1.0
sDBS	(simulated) deep brain stimulation	1.0
3β-HSD	3β-hydroxysteroid dehydrogenase/δ5-δ4-isomerase	0.428571428571
3β-HSD	3β-hydroxysteroiddehydrogenase-isomerase	0.142857142857
3β-HSD	3β-hydroxysteroid dehydrogenase	0.428571428571
cIPS	caudal segment of the intraparietal sulcus	1.0
SAPAP	synapse-associated protein 90/postsynaptic density protein-95-associated protein	1.0
11-KT	11-ketotestosterone	1.0
PKB	serine-threonine kinase akt/protein kinase b	0.0833333333333
PKB	protein kinase b	0.75
PKB	/aktprotein kinase b	0.0833333333333
PKB	/aktprotein kinase b/akt	0.0833333333333
PKC	ϵ, protein kinase c ϵ	0.00255754475703
PKC	γprotein kinase c γ	0.00255754475703
PKC	(conventional) protein kinase c	0.00255754475703
PKC	ϵiprotein kinase c epsilon inhibitor	0.00255754475703
PKC	amiica2+/calmodulin-dependent protein kinase ii	0.00255754475703
PKC	protein kinase c	0.946291560102
PKC	protein kinase c-dependent	0.00255754475703
PKC	alphaprotein kinase c alpha	0.00255754475703
PKC	phosphokinase c	0.00255754475703
PKC	calcium/phospholid-dependent protein kinase	0.00255754475703
PKC	protein-kinase c	0.00255754475703
PKC	protein kinase	0.00255754475703
PKC	apl iiaplysia californica pkc isoform two	0.00255754475703
PKC	ϵ-odnpkcϵ-selective antisense oligodeoxynucleotide	0.00255754475703
PKC	protein-kinase-c	0.00255754475703
PKC	ϵ, protein kinase c (ϵ isoform)	0.00255754475703
PKC	protein kinase-c	0.00255754475703
PKC	ca2+/phospholipid-dependent protein kinase	0.00255754475703
PKC	calcium and phospholipid-dependent protein kinase	0.00255754475703
PKC	phospholipid-dependent protein kinase	0.00255754475703
PKC	ca2+-dependent protein kinase	0.00255754475703
PKC	phosophokinase c	0.00255754475703
PKA	camp dependent protein kinase	0.00704225352113
PKA	camp-dependent-protein-kinase-a	0.00352112676056
PKA	protein kinase	0.00704225352113
PKA	camp-dependent protein kinase a	0.0140845070423
PKA	camp-dependent protein kinase	0.0950704225352
PKA	cyclic amp-dependent protein kinase a	0.00704225352113
PKA	catprotein kinase a catalytic subunit	0.00352112676056
PKA	camp binding to protein kinase a	0.00352112676056
PKA	protein kinase-a	0.00704225352113
PKA	protein kinase a (camp-dependent protein kinase)	0.00352112676056
PKA	protein kinase a (cyclic-amp-dependent protein kinase)	0.00352112676056
PKA	cyclic-amp-dependent protein kinase	0.0105633802817
PKA	cyclic amp-dependent protein kinase	0.0457746478873
PKA	protein kinase a	0.771126760563
PKA	camp-dependent kinase	0.00704225352113
PKA	camp-protein kinase a	0.00352112676056
PKA	phospho-(ser/thr) protein kinase a substrates	0.00352112676056
PKA	ccatalytic subunit of protein kinase a	0.00352112676056
CES	cauda equina syndrome	1.0
CER	cerebellum	0.357142857143
CER	c2-ceramide	0.0714285714286
CER	cytoplasmic extraction reagent	0.0714285714286
CER	conditioned emotional response	0.5
PKD	2l1polycystic kidney disease 2-like 1	0.5
PKD	protein kinase d	0.5
STM	short-term memory	0.95
STM	saline/tris–hcl/mgcl2 buffer	0.05
NRTK	non-receptor protein tyrosine kinase	1.0
RECA	rat endothelial cell-specific antibody	0.166666666667
RECA	rat endothelial cell antigen	0.833333333333
BODIPY-FL	4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid	1.0
NRTN	neurturin	1.0
PKM	protein kinase m zeta	0.25
PKM	zetaprotein kinase m zeta	0.25
PKM	protein kinase m	0.5
LFHBlow-firing	high-bursting	1.0
MAOr	rostral region of the medial accessory olive	1.0
sP	substance p	1.0
CTX-B	cholera toxin subunit b	1.0
NEON	o end organ group	1.0
mDA	midbrain dopaminergic	1.0
IMM-H	004	1.0
HAThead	arms and trunk	1.0
LTCCL-	type calcium channels	1.0
PHR	phrenic nerve (activity)	1.0
mDR	3–5medial dorsal raphe levels 3 through 5	1.0
BgTx	bungarotoxin	1.0
sT	ie2fcsoluble extracellular domain of tunica intima endothelial kinase 2 and fc fusion protein	1.0
gKC	acalcium-activated potassium conductance	1.0
FLIFOS-	like immunoreactivity	1.0
LY-278584	1-methyl-n-(8-methyl-8-azabicyclo[3.2.3]-oct-3-yl)-1h-indazole-3-carboxamide maleate salt	1.0
OC-	all olivocochlear pathways cut	1.0
CONG	congruent	1.0
BN-R	bombesin-like peptide receptor	1.0
MAOB	monoamine oxidase b	0.666666666667
MAOB	monoamine oxidase type b	0.333333333333
MAOA	monoamine oxidase type a	0.285714285714
MAOA	monoamine oxidase a	0.714285714286
ATPγS	adenosine 5′-o-(3-thiophosphate)	0.333333333333
ATPγS	adenosine 5′-(3-thiotriphosphate)	0.333333333333
ATPγS	adenosine 5′-o-(2-thiotriphosphate)	0.333333333333
PNAC	perineuronal astrocyte	1.0
PPRF	paramedian pontine reticular formation	1.0
MAOI	monoamine oxidase inhibitor	1.0
PHT	phenytoin	0.5
PHT	pitch head tilt	0.5
5-OH-α-M	eda1-(3′,4′,5′-trihydroxyphenyl)-2-aminopropane	1.0
PIE	prolonged increased excitability	1.0
mRFP	monomeric red fluorescent protein	1.0
MUT	mutated	1.0
GLUT-	1glucose transporter-1	0.333333333333
GLUT-	1glucose transporter 1	0.333333333333
GLUT-	4glucose transporter 4	0.166666666667
GLUT-	1glucose transporter	0.166666666667
PEITC	phenylethyl isothiocyanate	1.0
MUP	major urinary protein	0.75
MUP	mouse urinary protein	0.25
MUS	muscular torque	0.2
MUS	muscimol	0.8
VMAT2	vesicular monoamine transporter type 2	0.333333333333
VMAT2	vesicular monoamine transporter 2	0.666666666667
BMEβ-	mercaptoethanol	1.0
CHAN	6-cyclohexyladenosine	0.8
CHAN	6-cyclohexaladenosine	0.2
HIBD	hypoxic–ischemic brain damage	0.5
HIBD	hypoxic–ischemic brain injury	0.5
MUA	multi-unit activity	0.285714285714
MUA	multiple unit activities	0.0714285714286
MUA	multiple unit activity	0.142857142857
MUA	multi-unit activities	0.0714285714286
MUA	multiunit activity	0.357142857143
MUA	multiple-unit activity	0.0714285714286
GRAV	gravitational torque	1.0
CHAT	choline acetyltransferase	1.0
SIUS	outhern illinois university	1.0
SAOA	sporadic adult onset ataxia	1.0
STZ-D	streptozotocin-induced diabetes	1.0
GLUT1	glucose transporter 1	1.0
ASS	argininosuccinate synthetase	1.0
ASR	acoustic startle reaction	0.0384615384615
ASR	acoustic startle response	0.692307692308
ASR	acoustic startle reflex	0.230769230769
ASR	acoustic startle responses	0.0384615384615
PBS-A	phosphate-buffered saline containing 0.2% bovine serum albumin	0.5
PBS-A	0.2% bovine serum albumin in phosphate-buffered saline	0.5
ASP	aspartate	0.6
ASP	putative antisense promoter	0.2
ASP	amnesic shellfish poisoning	0.2
ASW	artificial sea water	0.4
ASW	artificial seawater	0.6
ASV	antisauvagine-30	1.0
ASU	arbitrary startle unit	1.0
AST	associative striatum	0.25
AST	anterior part of the dorsal striatum	0.25
AST	asymmetric sampling in time	0.25
AST	aspartate transaminase	0.25
sG	nrhsalmon gonadotropin releasing hormone	0.5
sG	maxspecific maximal conductance	0.5
TIEM	trapezoidal imposed eye movement	1.0
l-T	rpl-tryptophan	1.0
PBS-M	pbs with 0.25% triton x-100 and non-fat dry milk	1.0
sF	ltsoluble fms-like tyrosine kinase-1	1.0
ASC	apoptosis-associated speck-like protein containing a caspase-activating recruitment domain	0.125
ASC	sadipose-derived stem cells	0.125
ASC	adipose-derived stem cells	0.125
ASC	adipose-derived stem cell	0.125
ASC	hiacetylthiocholine iodide	0.125
ASC	antidepressant sensitive cataleptics	0.125
ASC	conditioned medium	0.125
ASC	adipose-derived mesenchymal stem cells	0.125
ASB	appetitive sexual behavior	1.0
ASA	sperger syndrome	0.333333333333
ASA	acetylsalicylic acid	0.333333333333
ASA	ngelman syndrome	0.333333333333
ORAC	oxygen radical absorbance capacity	1.0
ASF	antisense oligodeoxynucleotide to c-fos	1.0
2-D	electrophoresis	0.166666666667
2-D	two-dimensional	0.666666666667
2-D	2-dimension	0.166666666667
ASD	autism spectrum disorder	0.5
ASD	adjusted synaptic density	0.0714285714286
ASD	autism spectrum disorders	0.357142857143
ASD	autism disorders	0.0714285714286
ASK	1apoptosis signal-regulating kinase	0.142857142857
ASK	1apoptosis signal-regulated kinase 1	0.285714285714
ASK	1apoptosis signal-regulating kinase 1	0.571428571429
GAMTS-	adenosyl-l-methionine:n-guanidinoacetate methyltransferase	1.0
ASI	anxiety sensitivity index	0.333333333333
ASI	aged severely impaired	0.333333333333
ASI	adolescent social isolation	0.333333333333
PBS-X	phosphate-buffered saline containing 0.3% triton x-100	0.2
PBS-X	2 ml triton x-100 dissolved in 1 l pbs	0.1
PBS-X	phosphate-buffered saline with triton-x	0.1
PBS-X	pbs plus 0.1% triton-x	0.1
PBS-X	pbs containing triton x-100	0.1
PBS-X	phosphate-buffered saline (0.05 m) including 0.1% triton-x-100	0.1
PBS-X	phosphate-buffered saline with 0.3% triton x-100	0.1
PBS-X	phosphate-buffered saline containing triton-x 100	0.1
PBS-X	phosphate-buffered saline containing triton x	0.1
ASO	antisense oligonucleotide	0.25
ASO	antisense oligonucleotides	0.5
ASO	adult thy-1 mice	0.25
SWS2	deep slow-wave sleep	1.0
SWS1	light slow-wave sleep	1.0
2-M	esamp2-methylthio-amp triethylammonium salt	0.111111111111
2-M	e-5-ht2-methyl-5-hydroxytryptamine	0.111111111111
2-M	esatp2-(methylthio)atp tetrasodium salt hydrate	0.111111111111
2-M	esatp2-methylthio atp	0.111111111111
2-M	esadp2-methylthioadenosine-5′-o-diphosphate	0.111111111111
2-M	esamp2-methylthioadenosine-5′-monophosphate	0.111111111111
2-M	esatp2-(methylthio)atp	0.111111111111
2-M	esadp2-methylthio-adp	0.111111111111
2-M	esatp2-methylthioadenosine triphosphate	0.111111111111
NCX	noncovalent complexes	0.5
NCX	na+/ca2+ exchanger	0.5
BMMC	bone marrow mononuclear cell	1.0
2-AFC	two-alternative forced choice	1.0
DUM	dorsal unpaired median	1.0
IAL	inter-aural line	0.5
IAL	interaural level	0.5
FIAU	1-(2-deoxy-2 fluoro-b-d-arabinofuranosyl)-5 iodouracil	1.0
LAMP-	1lysosomal-associated membrane protein-1	0.5
LAMP-	2lysosomal-associated membrane protein 2	0.5
NT-6	neurotrophin-6	1.0
REMSD	rapid eye movement sleep deprivation	0.75
REMSD	rapid eye movement sleep–deprived	0.25
THDA	tuberohypophysial dopaminergic neurons	1.0
GSHG	lutathione	1.0
DMED	ulbecco’s modified eagle	0.5
DMED	ulbecco’s modified basal eagle’s medium	0.5
TFN	tonic firing neuron	1.0
DMEB	dulbecco's modified eagle's medium supplemented with bovine serum albumin	1.0
ICP-AES	inductively coupled plasma atomic emission spectroscopy	1.0
REMSP	rapid eye movement sleep deprivation	1.0
3aS	6as)-6a-naphthalen-2-ylmethyl-5-methyliden-hexahydro-cyclopental[c]furan-1-on	1.0
d-Ala	n-me-phe, gly-ol]-enkephalin	0.333333333333
d-Ala	n-me-phe, gly-ol]-enkephalin acetate	0.333333333333
d-Ala	nme-phe, gly-ol]-enkephalin	0.333333333333
DMEM	dulbecco’s minimal essential medium	0.013986013986
DMEM	/f-12dulbecco's modified eagle's medium:nutrient mixture f-12 ham	0.00699300699301
DMEM	dulbecco’s modified eagle’s medium	0.230769230769
DMEM	/f12dulbecco’s modified eagle medium f12	0.00699300699301
DMEM	/serumdulbecco's modified eagle medium supplemented with serum	0.00699300699301
DMEM	dulbecco's modified eagle's medium	0.433566433566
DMEM	/f12dulbecco’s modified eagle’s medium/f12	0.00699300699301
DMEM	dulbecco’s modified eagle medium	0.027972027972
DMEM	/f12dulbecco's modified eagles medium/hams f12(1:1)	0.00699300699301
DMEM	/ham f12dulbecco's modified eagle medium/hamf12 based medium	0.00699300699301
DMEM	dulbecco's modified essential medium	0.027972027972
DMEM	/f12dulbecco's modified eagle's medium/ham's nutrient mixture (f12)	0.00699300699301
DMEM	modified dulbecco's eagle's medium	0.00699300699301
DMEM	/f12dulbecco’s modified eagle’s medium/ham’s f-12	0.00699300699301
DMEM	dulbecco's modified eagle medium	0.0839160839161
DMEM	:hams-f12dulbecco's modified eagle's medium and ham's nutrient mixtures f-12	0.00699300699301
DMEM	+f12dulbecco’s modified eagle’s medium plus f12	0.00699300699301
DMEM	dulbecco modified eagle medium	0.00699300699301
DMEM	/f12hamdulbecco’s modified eagle’s medium nutrient mixture f-12 ham	0.00699300699301
DMEM	+supplemented dulbecco's modified eagle's medium	0.00699300699301
DMEM	dulbecco's modified eagles medium	0.013986013986
DMEM	/f12dulbecco's modified eagle's medium/nutrient mixture f-12 ham's	0.00699300699301
DMEM	/bsadmem stock with 2% bovine serum albumin	0.00699300699301
DMEM	dulbecco's minimum essential medium	0.020979020979
DMEM	/f-12dulbecco's modified eagle's medium and nutrient mixture f-12	0.00699300699301
DMEM	/f12dulbecco's modified eagle's medium/f12	0.00699300699301
DMEM	dulbecco's modified eagles' medium	0.00699300699301
DMEM	/f12dulbecco's modified eagles's medium and hams f12	0.00699300699301
DMEM	/f12dulbecco’s modified eagle’s medium/ham’s nutrient mixture f12	0.00699300699301
PSM	′n-terminally truncated intracellular form of prostate specific membrane antigen	1.0
AS-	oligosantisense oligodeoxynucleotides	1.0
Edg	endothelial differentiation gene	1.0
fRPTPβ	full-length form of receptor-type protein-tyrosine phosphatase β	1.0
FGF-1	acidic fibroblast growth factor	1.0
BODIPY-FL-	conantokin-g	1.0
ESRE	lectron spin resonance	1.0
MK801	dizocilpine maleate	0.454545454545
MK801	(+)-5-methyl-10,11-dihydro-5h-dibenzocyclohepten-5,10-imine	0.181818181818
MK801	(+)-mk801 maleate	0.0909090909091
MK801	(5r, 105)-(+)-5-methyl-10,11-dihydro-sh-dibenzo[a,b]-cyclohepten-5,10-imine	0.0909090909091
MK801	dizocilpine	0.181818181818
NPFF	2rneuropeptide ff2 receptor	0.0769230769231
NPFF	neuropeptide ff	0.692307692308
NPFF	neuropeptide phe-leu-phe-gln-pro-gln-arg-phe-nh2	0.0769230769231
NPFF	2rneuropeptide ff 2 receptor	0.0769230769231
NPFF	2neuropeptide ff receptor 2	0.0769230769231
TFG	transfer function gains	1.0
rsS	pearman's rank correlation coefficient	1.0
TI-R	srapidly discharging tonic type i neurons discharging specifically in association with cortical activation during both waking and paradoxical sleep	1.0
Information	usa	1.0
CBALB	/cj	1.0
LGI1leucine-rich	glioma-inactivated 1	1.0
EBNA-	1epstein-barr nuclear antigen 1	1.0
HSTS	head stabilization on the trunk strategy	1.0
NCT	mmature nicastrin	0.333333333333
NCT	neuroeffector calcium transient	0.666666666667
pIII	uperioculomotor urocortin-containing neurons	0.5
pIII	uperioculomotor urocortin-containing population of neuron	0.5
GTPγ	–s binding	1.0
nRPC	nucleus reticularis pontis caudalis	1.0
NEI	neuropeptide glutamic acid-isoleucine	1.0
IVAω-	agatoxin iva	0.5
IVAω-	agatoxin-iva	0.5
BAIB	eck anxiety inventory	1.0
PTLp	parietal region	1.0
SCHSCH	23390	1.0
vSPZ	ventral subparaventricular zone	1.0
mFGS	male flank gland secretion	1.0
SLFS	strong low-frequency stimulation	1.0
zfPOMC	zebrafish proopiomelanocortin	1.0
Amy	amygdala	1.0
PKCγP	rotein kinase c gamma	1.0
L-HCA	l-homocysteic acid	1.0
hNK-3R	human neurokinin-3 receptor	1.0
eRNA	senhancer rnas	1.0
MEK1	mitogen-activated protein kinase kinase 1	1.0
STIM-OFF	stimulators switched off	1.0
A-VS	actual mirror-reading and visuo-spatial attention deviation	1.0
MEKK	1	0.5
MEKK	mek kinase	0.5
YM-2981986-Amino-N-cyclohexyl-N	3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide hydrochloride	1.0
PMCC	product-moment correlation coefficient	1.0
NFκBNF	kappa-b	1.0
TIBC	total iron binding capacity	1.0
AC-V	adenylate cyclase type v	1.0
PRRN	posterior rhombencephalic reticular nuclei	0.166666666667
PRRN	posterior rhombencephalic reticular nucleus	0.833333333333
pACC	perigenual anterior cingulate cortex	0.5
pACC	perigenual cingulate	0.5
PKCγ-	irprotein kinase cγ immunoreactivity	1.0
IE-LTP	long-lasting potentiation of intrinsic excitability	1.0
γ-GCS	hcatalytic (heavy) subunit of γ-glutamyl cysteine synthetase	1.0
ERCC	excision repair cross-complementing	0.5
ERCC	1excision-repair cross-complementing protein 1	0.5
hOGG	1human 8-oxoguanine glycosylase	1.0
rT33	3′,5′-l-triiodothyronine (reverse t3)	1.0
IEM-	14601-trimethylammonio-5-(1-adamantane-methylammoniopentane) dibromide	1.0
gPA	granular parietal insular cortex	1.0
TFP	trifluoperazine	1.0
I-B4-HRP	horseradish peroxidase conjugated griffonia simplicifolia b4-isolectin	1.0
snX	vagal afferent	1.0
ERβKO	estrogen receptor-beta knockout	1.0
Te3V	temporal area 3, ventral part	1.0
TFR	time–frequency representation	0.5
TFR	2transferrin receptor 2	0.5
Te3R	temporal area 3, rostral part	1.0
IDAP	membrane current mediating dap	1.0
ICSS	intracranial electrical self-stimulation	0.0625
ICSS	intracranial self-stimulation	0.875
ICSS	intracranial self stimulation	0.0625
MUSC	muscimol	1.0
IICR	ip3-induced ca2+ release	0.333333333333
IICR	inositol-1,4,5-trisphosphate-induced calcium release	0.666666666667
MLEC	mink lung epithelial cell	1.0
FiO2	fraction of inspired oxygen	1.0
sBP	systolic blood pressure	1.0
irPNX	phoenixin immunoreactivity	1.0
MAP2-P	map2 phosphorylated at the site recognised by antibody 305	1.0
LIG	1 or lig3ligase 1/3	1.0
DNLL	dorsal nucleus of lateral lemniscus	0.166666666667
DNLL	dorsal nucleus of the lateral lemniscus	0.833333333333
pIκB	phosphorylated iκb	1.0
NICDNOTCH	intracellular domain	1.0
AKAPA-	kinase anchoring protein	1.0
NGFI-B	nerve-growth factor inducible-b gene	0.166666666667
NGFI-B	nerve growth factor-inducible b	0.333333333333
NGFI-B	nerve growth factor inducible gene-b	0.166666666667
NGFI-B	nerve growth factor inducible b gene	0.166666666667
NGFI-B	nerve growth factor inducible-b	0.166666666667
NGFI-A	nerve growth factor-induced gene a	0.3
NGFI-A	nerve growth factor induced gene-a	0.1
NGFI-A	nerve growth factor inducible-a gene	0.1
NGFI-A	nerve growth factor-inducible protein a	0.1
NGFI-A	nerve growth factor inducible gene-a	0.1
NGFI-A	ngf induced gene	0.1
NGFI-A	nerve growth factor inducible clone a	0.1
NGFI-A	/bnerve growth factor induced-gene a/b	0.1
EBHDethyl-3	4 dihydroxybenzoate	1.0
DEPC	diethyl pyrocarbonate	0.483870967742
DEPC	diethol pyrocarbonate	0.0161290322581
DEPC	diechypyrocarbonate	0.0161290322581
DEPC	diethylpyrocarbonate	0.467741935484
DEPC	,	0.0161290322581
ActR	activin receptor	1.0
LIC	lung inflation cycle	1.0
LASCL	aboratory animal science center	1.0
12M	hypoglossal nucleus	1.0
12N	hypoglossal nucleus	1.0
SPLN	greater splanchnic nerve	1.0
LIL	ike immunoreactivity	1.0
SPLS	ound pressure level	1.0
IRES-	hapinternal ribosomal entry site–human placental alkaline phosphatase	1.0
E-6-BSA1	3,5(10)-estratrien-3,16a,17b-triol-6-one-6-carboxymethyloxine:bsa	1.0
LIM	domain	0.166666666667
LIM	kinaselim domain containing protein kinase	0.166666666667
LIM	dl-limonene	0.166666666667
LIM	muscle lim domain protein	0.166666666667
LIM	protein	0.166666666667
LIM	infra/prelimbic cortex	0.166666666667
LIN	7clin-7 homolog c	0.333333333333
LIN	28	0.333333333333
LIN	linolenic acid	0.333333333333
PKAP	rotein kinase a	1.0
GABAGABA	ergic neurons	1.0
CM-P	fcentromedian–parafascicular complex	1.0
NAIP	neuronal apoptosis-inhibitory protein	0.333333333333
NAIP	neuronal apoptosis inhibitory protein	0.333333333333
NAIP	neuronal apoptotic inhibitory protein	0.333333333333
ADMA	asymmetric dimethylarginine	0.666666666667
ADMA	bductor digiti minimi	0.333333333333
LII	–iiilayers ii–iii	1.0
shC	trlcontrol shrna	1.0
NOXNADPH	oxidase	0.833333333333
NOXNADPH	oxidase holoenzyme	0.166666666667
CeLpc	central nucleus, lateral paracapsular division	1.0
PIQ	performance intelligence quotient	1.0
NHMRCN	ational health and medical research council	1.0
eFP	evoked field potential	1.0
APPswe	swedish mutation of app	1.0
SYNC	synchrony	1.0
HCO	3-bicarbonate	1.0
Pli	inferior pulvinar nucleus	1.0
WKSW	ernike's encephalopathy and korsakoff's psychosis	0.2
WKSW	ernicke–korsakoff syndrome	0.2
WKSW	ernicke-korsakoff syndrome	0.4
WKSW	ernicke-korsakoff's syndrome	0.2
FNC	human fetal neuroepithelial cells	1.0
Protein	x-linked 2	1.0
LSBL	aemmli sample buffer	1.0
PF-SC	parallel fibre–stellate cell	1.0
IFNγR	1interferon-γ receptor type 1	1.0
1-NA-	spermine1-naphthylacetyl spermine	1.0
TEF	thyroid embryonic factor	1.0
CNQX6-cyano-7-nitroquinoxalline-2	3-dione	1.0
LP-P	ullateral posterior–pulvinar complex	1.0
cDM	caudal dorsomedial dorsal raphe nucleus	1.0
PIphosphatidylinositol-4	5-bisphosphate	1.0
cDI	caudal di	1.0
Cash-1	chicken achaete-scute homolog-1	1.0
VFV	on frey	1.0
QUICK	the quantitative insulin sensitivity check index	1.0
TdR	thymidine	1.0
TdT	terminal deoxytransferase	0.0322580645161
TdT	terminal deoxynucleotidyltransferase	0.0322580645161
TdT	terminal deoxyribonucleotidyl transferase	0.0645161290323
TdT	terminal transferase	0.0322580645161
TdT	terminal deoxynucleotidyl transferase	0.838709677419
CCKBR	cholecystokinin b receptor	1.0
PIS	postcentral insular sulcus	0.5
PIS	prolonged immobilization stress	0.5
NOND	naturally occurring neuronal death	1.0
IH-GHGH	treated ih	1.0
STO-	609sto-609 acetate	1.0
WNK	with no lysine	1.0
MANOVA	multivariate anova	0.0851063829787
MANOVA	multivariate one-way analysis of variance	0.0212765957447
MANOVA	smultivariate analysis of variance	0.0212765957447
MANOVA	analysis of variance for repeated measurements	0.0212765957447
MANOVA	smultivariate anova	0.0212765957447
MANOVA	multivariate analysis of variance	0.723404255319
MANOVA	multiple analysis of variance	0.106382978723
NS-MSC	neurosphere-like aggregates from mscs	1.0
FSAF	orce sensitive applications	1.0
WNT	wingless and integration-1	1.0
PGES	prostaglandin e synthase	1.0
KEPIK	inase c-enhanced pp1 inhibitor	1.0
CPGC	entral pattern generator	1.0
OFF-	cells	0.666666666667
OFF-	center cell	0.333333333333
8aR	12as,13as)-5,8,8a,9,10,11,12,12a,13,13adechydro-3-methoxy-12-(ethylsulfonyl)-6h-isoquino[2.1g][1,6]	1.0
d-Pen	2d-pen5]-enkephalin	1.0
CE-T	1wicontrast-enhanced t1-weighted imaging	1.0
ecNOS	endothelial nos	1.0
APTD	dorsal anteriopretectal thalamic nucleus	1.0
PGE-	2prostaglandin-e 2	1.0
WS	wire suspension test	0.333333333333
WS	weak stimulus	0.333333333333
WS	warm-sensitive	0.333333333333
l-DOPAl-3	4-dihydroxyphenylalanine	1.0
MKKK	mapk kinase kinase	1.0
BSTSc	central division of bsts	1.0
PGE1	prostaglandin e1	1.0
PGE2	prostaglandin of e2 type	0.0625
PGE2	prostagland e2	0.0625
PGE2	prostaglandin e2	0.875
APTT	activated partial thromboplastin time	1.0
DORA-	12dual orexin receptor antagonist	1.0
NETNE	transporter	1.0
NGF-LI	nerve growth factor-like immunoreactivity	1.0
D-AP-5	d-2-amino-5-phosphonovaleric acid	1.0
iEX	intense exercise group	1.0
MP-RAGEM	agnetization-prepared rapid gradient echo	1.0
APVDL-	2-amino-5-phosphonovaleric acid	0.166666666667
APVDL-	2-amino-5-phosphonpentanoic acid	0.166666666667
APVDL-	2-amino-5-phosphonopentanoic acid	0.666666666667
UICU	niversity of illinois at chicago	1.0
vAChT	vesicular acetylcholine transporter	1.0
LDSF	lateral dorsal thalamic nucleus superficial part	1.0
VNSV	agus nerve stimulation	1.0
L-NA	n-nitro-l-arginine	0.5
L-NA	l-ng-nitro-arginine	0.5
-EPB	[3h]	1.0
MePD	posterodorsal portion of the medial amygdala	0.25
MePD	medial amygdaloid nucleus, posterodorsal part	0.5
MePD	posterodorsal medial amygdaloid nucleus	0.25
LL-non-GABA	length of non-gaba synapses per unit length	1.0
VDDC	voltage-dependent calcium channel	1.0
MEPSP	miniature excitatory postsynaptic potential	1.0
dbBKS	.cg-m+/+leprdb/j mice	1.0
MePV	medial amygdala nucleus, posteroventral part	0.2
MePV	medial amygdaloid nucleus, posteroventral part	0.4
MePV	posteroventral portion of the medial amygdala	0.2
MePV	posteroventral medial amygdala	0.2
CCR2	monocyte chemoattractant protein-1 receptor	1.0
DOPSl-threo-3	4-dihydroxyphenylserine	1.0
CDSN	corneodesmosin	1.0
5-PDYN	prodynorphin	1.0
CDSG	candidate dyslexia susceptibility gene	1.0
EPPGE	2 receptor	1.0
LoC	locus coeruleus	1.0
ALXLXA	4 receptor	1.0
MVNv	medial vestibular nucleus, ventral part	1.0
KPI-	2kinase/phosphatase/inhibitor-2	1.0
CFLIR	c-fos like immunoreactivity	1.0
DCIC	dorsal inferior colliculus	0.142857142857
DCIC	dorsal cortex of inferior colliculus	0.0714285714286
DCIC	dorsal cortex of the inferior colliculus	0.571428571429
DCIC	dorsal cortex inferior colliculus	0.0714285714286
DCIC	dorsal cortex of the ic	0.142857142857
FSH-R	follicle stimulating hormone receptor	1.0
MHP	36 cell line	1.0
MVNd	medial vestibular nucleus, dorsal part	1.0
HVOR	horizontal vestibulo-ocular reflex	1.0
MVNn	medial vestibular nucleus neurons	0.5
MVNn	medial vestibular nucleus neuron	0.5
KPIK	unitz-type protease inhibitor	0.5
KPIK	unitz protease inhibitor	0.5
9-THC	delta-9-tetrahydrocannabinol	0.0909090909091
9-THC	δ-9-tetrahydrocannabinol	0.0909090909091
9-THC	delta9 tetrahydrocannabinol	0.0909090909091
9-THC	δ9-tetrahydrocannabinol	0.727272727273
SCdm	deep medial superior colliculus	1.0
ANF	atrial natriuretic factor	0.5
ANF	auditory nerve fiber	0.5
γ-GT	γ-glutamyl transpeptidase	0.333333333333
γ-GT	l-γ-glutamyl transpeptidase	0.333333333333
γ-GT	γ-glutamyltransferase	0.333333333333
TREKTWIK-	1-related potassium channel	0.333333333333
TREKTWIK-	related k+ channel	0.666666666667
α-MCPG	(±) α-methyl-4-carboxyphenylglycine	1.0
HERV-W	human endogenous retrovirus w family	1.0
nSWD	smean number of swds	1.0
HFSH	igh frequency stimulation	1.0
PAC3	periamygdaloid cortex 3	1.0
SuVe	superior vestibular nucleus	1.0
RURU	38486	1.0
PVWM	peri-ventricular white matter	1.0
vlPOA	ventrolateral preoptic area	1.0
VDD-	8eight-channel vapor delivery device	1.0
CCRM	counterclockwise rotary motion	1.0
rDAO	rostral part of the dorsal accessory olive	1.0
-O-MOE	2′-o-(2-methoxyethyl)	1.0
CCRS	cytochrome c reductase rotenone-sensitive	1.0
CCRT	total cytochrome c reductase	1.0
GAVSTA	glycine-alanine-valine-serine-threonine-alanine peptide	1.0
-SH	sulfhydryl	1.0
-SE	ca1(dg) neurones from status epilepticus rats	1.0
IFN-ARIFN-	alpha receptor	1.0
Trp-OH	tryptophan hydroxylase	1.0
LRP-	1low-density lipoprotein receptor-related protein-1	1.0
TCMT	raditional chinese medicine	1.0
GAGs	glycosaminoglycans	1.0
NADAN-	arachidonoyl-dopamine	1.0
ANH	atrial natriuretic hormone	1.0
5-CTH	yp5-ct-evoked membrane hyperpolarization	1.0
PPn	prepacemaker nucleus	1.0
OCO	necut	1.0
MAP-	taumicrotubule-associated protein-tau	0.0204081632653
MAP-	kinasemitogen activated protein kinase	0.0612244897959
MAP-	2anti-microtubule-associated protein-2 antibody	0.0204081632653
MAP-	2microtubule-associated protein-2	0.367346938776
MAP-	2microtubule-associated protein 2	0.163265306122
MAP-	kinasemitogen-activated protein kinase	0.0204081632653
MAP-	taumicrotubule-associated protein tau	0.0204081632653
MAP-	kinase	0.0204081632653
MAP-	2microtubal associated protein-2	0.0204081632653
MAP-	2	0.0612244897959
MAP-	2microtubule associated protein-2	0.102040816327
MAP-	1bmicrotubule-associated protein 1b	0.0204081632653
MAP-	2microtubule associated protein 2	0.0816326530612
MAP-	2microtubule associated protein	0.0204081632653
MAP2	microtubule-associated protein 2	0.636363636364
MAP2	microtubule associated protein-2	0.030303030303
MAP2	microtubule-associated protein	0.0909090909091
MAP2	microtubule-associated protein-2	0.212121212121
MAP2	microtubule-associated phosphoprotein	0.030303030303
3-HSOR	3-hydroxysteroid oxidoreductase enzymes	1.0
BMpc	parvicellular part of bm nucleus	1.0
sACSF	sucrose artificial cerebrospinal fluid	0.333333333333
sACSF	sucrose containing artificial cerebrospinal fluid	0.333333333333
sACSF	sucrose-containing artificial cerebrospinal fluid	0.333333333333
MAP4	s-2-amino-2-methyl-4-phosphonobutanoate	0.333333333333
MAP4	(s)-amino-2-methyl-4-phosphonobutanoic acid	0.333333333333
MAP4	(s)-2-amino-2-methyl-4-phosphonobutanoic acid/α-methyl-ap4	0.333333333333
LIMK-	1lim domain kinase-1	1.0
NIDAN	ational institute on drug abuse	0.714285714286
NIDAN	ational institute of drug abuse	0.285714285714
FGL-BSAFGL	–bovine serum albumin conjugate	1.0
BDNFB	rain-derived neurotrophic factor	1.0
SACS-	allyl cysteine	0.333333333333
SACS-	allyl-l-cysteine	0.666666666667
iPLA2	insensitive high molecular weight pla2	1.0
PPC	posterior parietal cortex	0.875
PPC	posterior piriform cortex	0.0833333333333
PPC	pharmacological preconditioning	0.0416666666667
PPB	phonological phrase boundary	0.25
PPB	sphonological phrase boundaries	0.25
PPB	paraformaldehyde/sodium phosphate buffer	0.25
PPB	4% paraformaldehyde in pb, ph 7.4	0.25
PPA	preproenkephalin a	0.25
PPA	parahippocampal place area	0.25
PPA	peak-phase activity	0.25
PPA	sodium pyrophosphate	0.25
ASRA	coustic startle response	1.0
PPG	preproglucagon	0.285714285714
PPG	pterygopalatine ganglia	0.142857142857
PPG	dl-propargylglycine	0.428571428571
PPG	propylene glycol	0.142857142857
PPF	putative pattern forming	0.00925925925926
PPF	paired-pulse facilitation.	0.00925925925926
PPF	paired-pulse facilitation	0.777777777778
PPF	prepulse facilitation	0.00925925925926
PPF	pair-pulse facilitation	0.00925925925926
PPF	/dpaired-pulse facilitation/depression	0.00925925925926
PPF	peak power frequency	0.00925925925926
PPF	paired pulse facilitation	0.12037037037
PPF	pulse facilitation	0.00925925925926
PPF	propentofylline	0.037037037037
PPE	plasma protein extravasation	0.0526315789474
PPE	preproenkephalin	0.921052631579
PPE	paired pulse excitation	0.0263157894737
PPD	paired pulse depression	0.146341463415
PPD	preprodynorphin	0.390243902439
PPD	postpartum day	0.0243902439024
PPD	proximal pars distalis	0.0243902439024
PPD	paraphenylenediamine	0.0243902439024
PPD	paired-pulse depression	0.390243902439
Glra1spd	spasmodic allele of the glra1 gene	1.0
PPI	peak probability index	0.00900900900901
PPI	prepulse inhibition of acoustic startle	0.036036036036
PPI	psychophysiological interaction	0.036036036036
PPI	paired pulse inhibition	0.00900900900901
PPI	prepulse inhibition of startle reflex	0.00900900900901
PPI	prepulse inhibition of startle	0.00900900900901
PPI	pre-pulse inhibition	0.0810810810811
PPI	protease and phosphatase inhibitor	0.00900900900901
PPI	paired-pulse population spike index	0.00900900900901
PPI	asepeptidyl-prolyl isomerase	0.00900900900901
PPI	prepulse inhibition	0.675675675676
PPI	prepulse-induced inhibition of acoustic startle response	0.00900900900901
PPI	prepulse inhibition.	0.00900900900901
PPI	paired pulse population spike index	0.00900900900901
PPI	asepeptidyl-prolyl cis/transisomerase	0.00900900900901
PPI	pre-pulse inhibition of acoustic startle reaction	0.00900900900901
PPI	phosphatase inhibitor	0.00900900900901
PPI	paired-pulse inhibition	0.0540540540541
CV-ISI	coefficient of variation of the interspike intervals	1.0
PPN	preganglionic parasympathetic neuron	0.0576923076923
PPN	posterior pole of the nidopallium	0.0192307692308
PPN	pulse propagation network	0.0192307692308
PPN	‘cz’, ppn ‘critical zone’	0.0192307692308
PPN	pedunculopontine nucleus	0.423076923077
PPN	peripeduncular nucleus	0.0384615384615
PPN	tegmental pedunculopontine nucleus	0.0576923076923
PPN	sparasympathetic preganglionic neurons	0.0384615384615
PPN	pedunculopontine tegmental nucleus	0.25
PPN	penduculopontine nucleus	0.0192307692308
PPN	pedunculopontine nuclei	0.0192307692308
PPN	posterior pretectal nucleus	0.0384615384615
PPM	posterior probability maps	1.0
PPL	posterior parietal lobe	1.0
PPS	preputial separation	0.25
PPS	paired-pulse stimulation	0.5
PPS	perforant path stimulation	0.25
PPR	parapyramidal region	0.0147058823529
PPR	paired–pulse ratio	0.0147058823529
PPR	paired-pulse reaction	0.0147058823529
PPR	pair-pulse ratio	0.0147058823529
PPR	paired-pulse response ratio	0.0147058823529
PPR	spaired pulse ratios	0.0147058823529
PPR	rapid perforated patch recording	0.0147058823529
PPR	paired-pulse ratio	0.632352941176
PPR	postpyramidal nucleus of the raphe	0.0147058823529
PPR	paired pulse ratio	0.220588235294
PPR	paired-pulse response	0.0294117647059
PPP	proximal process potential	0.555555555556
PPP	prepropacap	0.111111111111
PPP	platelet-poor plasma	0.222222222222
PPP	pentose phosphate pathway	0.111111111111
GalNAc	n-acetylgalactosamine	1.0
PPV	positive predictive value	0.5
PPV	posterior periventricle	0.5
PPT	propyl pyrazole triol	0.00826446280992
PPT	paw-pressure test	0.00826446280992
PPT	mdiffuse medial part of the ppt	0.00826446280992
PPT	pedunculopontine nucleus	0.0247933884298
PPT	laterodorsal/pedunclopontine tegmental nuclei	0.00826446280992
PPT	gpedunculopontine tegnenatal nucleus	0.00826446280992
PPT	β-preprotachykinin	0.00826446280992
PPT	mesopontine laterodorsal and pedunculopontine tegmental nuclei	0.00826446280992
PPT	pediculopontine tegmentum	0.00826446280992
PPT	gpedunculopontine tegmentum	0.0165289256198
PPT	posterior pretectal nucleus	0.0247933884298
PPT	preprotachykinin	0.206611570248
PPT	pedunculo-pontine tegmental nucleus	0.0165289256198
PPT	gpedunculopontine tegmental nucleus	0.157024793388
PPT	propyl-pyrazole triol	0.0165289256198
PPT	gpedunculoponting tegmental nucleus	0.00826446280992
PPT	pedunculopontine tegmentum	0.0826446280992
PPT	apreprotachykinin a	0.00826446280992
PPT	gpedunculopontine nucleus	0.00826446280992
PPT	gpedunculopontine nuclei	0.00826446280992
PPT	pedunculopontine tegmental nucleus	0.223140495868
PPT	tegmental pedunculopontine nucleus	0.00826446280992
PPT	paw pressure threshold	0.00826446280992
PPT	propyl-pyrazole-triol	0.00826446280992
PPT	propylpyrazoletriol	0.0247933884298
PPT	peduncolopontine	0.00826446280992
PPT	pressure pain threshold	0.0165289256198
PPT	g	0.00826446280992
PPT	rat preprotachykinin	0.00826446280992
PPT	pedunculopontine tegmental	0.0413223140496
PPY	parapyramidal region	1.0
PMNT	phenylethanolamine n-methyltransferase	0.5
PMNT	phenylethanolamine-n-methyltransferase	0.5
CTβ	cholera toxin β subunit	1.0
DAD	opamine	0.375
DAD	diode array	0.125
DAD	diode array detection	0.125
DAD	2rdopamine d2 receptor	0.125
DAD	4dopamine receptor d4	0.125
DAD	elayed alternation	0.125
CGS-	216804-[2-[[6-amino-9-(n-ethyl-β-d-ribofuranuronamidosyl)-9h-purin-2-yl]amino]	0.333333333333
CGS-	216802-p-(2-carboxyethyl)phenethylamino-5′-n-ethylcarboxamidoadenosine hydrochloride	0.333333333333
CGS-	19755cis-4-[phosphomethyl]-2-piperidinecarboxylic acid	0.333333333333
NVA	non-viable cell with abnormal nucleus	1.0
NUDEL	nuclear distribution protein nude-like 1	1.0
T-UDCA	taurine-conjugated ursodeoxycholic acid	1.0
PETG	2-phenylethyl-β-d-thiogalactopyranoside	1.0
PP-	2aprotein phosphatase-2a	0.111111111111
PP-	1protein phosphatase 1	0.222222222222
PP-	1protein phosphatase-1	0.333333333333
PP-	2bprotein phosphatase 2b	0.222222222222
PP-	2bprotein phosphatase-2b	0.111111111111
mvPNA	minute volume pna	1.0
PP1	protein phosphatase 1	1.0
NSAIDs	non-steroidal anti-inflammatory drugs	1.0
MTPG	(rs)-α-methyl-4-tetrazolylphenylglycine	1.0
CRH-R	corticotropin-releasing hormone receptor	0.285714285714
CRH-R	1corticotropin-releasing hormone receptor type 1	0.142857142857
CRH-R	1corticotropin-releasing hormone receptor 1	0.285714285714
CRH-R	1corticotrophin releasing hormone type 1 receptor	0.142857142857
CRH-R	2corticotropin releasing hormone receptor 2	0.142857142857
TBOAd	l-threo-β-benzyloxyaspartate	1.0
BPND	binding potential (ratio at equilibrium of specifically bound radioligand to that of nondisplaceable radioligand in tissue)	0.333333333333
BPND	binding potential	0.666666666667
SSEP	steady-state evoked potential	0.5
SSEP	ssomatosensory evoked potentials	0.5
PCIS	precentral insular sulcus	1.0
FNZF	lunitrazepam	1.0
MAPK	mitogen-activated protein kinase or map kinase	0.00328947368421
MAPK	p38 kinase of 38 kda	0.00328947368421
MAPK	/erk or mekmitogen-activated protein kinase/extracellular signal-regulated kinase kinase	0.00328947368421
MAPK	smitogen-activated protein kinase	0.00328947368421
MAPK	p44/42 mitogen-activated protein kinase	0.00328947368421
MAPK	mitogen-activated protein kinase/extracellular regulated kinase	0.00328947368421
MAPK	mitogen activated protein kinase	0.0559210526316
MAPK	mitogen-activated kinase	0.00328947368421
MAPK	p38 map kinase	0.00657894736842
MAPK	/erk1/2mitogen-activated protein kinase/extracellular signal-regulated kinase1/2	0.00328947368421
MAPK	phospho-p38-mitogen activated protein kinase	0.00328947368421
MAPK	mitogen-activating protein kinase	0.00328947368421
MAPK	p38mitogen-activated protein kinase p38	0.00328947368421
MAPK	mitogen activated proteins kinase	0.00328947368421
MAPK	smitogen activated protein kinases	0.00328947368421
MAPK	smitogen-activated protein kinases	0.0296052631579
MAPK	/erkmitogen-activated protein kinase/extracellular regulated kinase	0.00328947368421
MAPK	mitogen-activated protein kinases	0.0493421052632
MAPK	/erkmitogen-activated protein kinase/extracellular signal regulated kinase	0.00328947368421
MAPK	p42/p44-mitogen activated protein kinase	0.00328947368421
MAPK	smitogen activated group of protein kinases	0.00328947368421
MAPK	mitogen-activated protein kinase	0.756578947368
MAPK	/erkmitogen-activated protein/extracellular signal-regulated kinase	0.00328947368421
MAPK	map kinase	0.00328947368421
MAPK	mitogen-activated protein	0.00328947368421
MAPK	microtubule-associated protein kinase	0.00328947368421
MAPK	/erkmitogen-activated protein kinase/extracellular signal regulated protein kinase	0.00328947368421
MAPK	mitogen-associated protein kinase	0.00657894736842
MAPK	mitogen activating protein kinase	0.00657894736842
MAPK	mitogen activated kinases	0.00328947368421
MAPK	p38 mitogen-activated protein kinase	0.0131578947368
MW-RSTM	ann–whitney rank sum test	1.0
APL	allosteric potentiating ligand	0.5
APL	artificial perilymph	0.5
MAPM	ean arterial pressure	1.0
11βHSD	111beta-hydroxysteroid dehydrogenase 1	1.0
DAL	days after lesion	1.0
ωCmTx-MVIIC	ω-conotoxin-mviic	1.0
NSAIDS	nonsteroidal anti-inflammatory drags	1.0
httH	untingtin protein	1.0
BBCEC	sbovine brain capillary endothelial cells	1.0
UCNU	rocortin	1.0
BD	brainstem–diencephalon	0.0526315789474
BD	biotin dextran	0.0526315789474
BD	binocular deprivation	0.0526315789474
BD	burst duration	0.157894736842
BD	antibodybd pharmingen 5-ht2ar antibody	0.0526315789474
BD	bipolar disorder	0.263157894737
BD	best duration	0.0526315789474
BD	2distant target	0.0526315789474
BD	biotin–dextran	0.0526315789474
BD	brainstem/diencephalon	0.0526315789474
BD	brain damaged	0.0526315789474
BD	brainstem-diencephalon	0.0526315789474
BD	basal dendrites	0.0526315789474
GSP	gene-specific primer	0.333333333333
GSP	gene specific primer	0.666666666667
dNTP	sdeoxynucleotides	0.142857142857
dNTP	deoxynucleoside-triphosphate	0.0714285714286
dNTP	deoxynucleosidetriphosphate	0.0714285714286
dNTP	deoxyribonucleotide triphosphate	0.0714285714286
dNTP	sdeoxyribonucleoside triphosphates	0.0714285714286
dNTP	sdeoxynucleotide triphosphates	0.0714285714286
dNTP	deoxynucleotriphosphate	0.0714285714286
dNTP	deoxynucleotide triphosphate	0.0714285714286
dNTP	sdeoxynucleoside triphosphates	0.0714285714286
dNTP	deoxyribonucleotide triphosphates	0.142857142857
dNTP	deoxyribonucleoside triphosphate	0.142857142857
GSR	galvanic skin response	1.0
BA	basilar artery	0.04
BA	basolateral nucleus of bla	0.04
BA	butyric acid	0.08
BA	sbrodmann areas	0.08
BA	40brodmann’s area 40	0.04
BA	rats administered with bacoside a	0.04
BA	basal nucleus of the basolateral complex	0.04
BA	branched axon	0.04
BA	basal amygdala	0.12
BA	brodmann’s area	0.04
BA	37brodmann’s area 37	0.04
BA	basal amygdaloid nucleus	0.04
BA	basal nucleus of the amygdala	0.12
BA	brodmanns area	0.04
BA	brodmann area	0.12
BA	benzaldehyde	0.04
BA	4brodman area 4	0.04
BB	regma	0.115384615385
BB	(blocking buffer) 5% non fat dry milk in phosphate-buffered saline containing 0.05% tween 20	0.0384615384615
BB	–ckbrain-type isoform of cytosolic creatine kinase	0.0384615384615
BB	ibiceps brachii	0.0769230769231
BB	11012s-allyl-n1-hidroxy-3r-isobutyl-n4-(1s-methylcarbamoyl-2-phenylethyl)-succinamide	0.0384615384615
BB	binding buffer	0.0384615384615
BB	blocking buffer	0.307692307692
BB	basilen blue	0.0384615384615
BB	beam-break sensor	0.0384615384615
BB	biceps brachii	0.153846153846
BB	band of baillarger	0.0384615384615
BB	beam breaks	0.0384615384615
BB	4bombesin receptor 4	0.0384615384615
BC	sbushy cells	0.0645161290323
BC	bladder capacity	0.0645161290323
BC	brachium conjunctivum	0.161290322581
BC	sballoon cells	0.0322580645161
BC	bicuculline	0.0322580645161
BC	hebutyrylcholinesterase	0.0322580645161
BC	bushy cells	0.0322580645161
BC	balloon cell	0.0322580645161
BC	betweenness centrality	0.0322580645161
BC	basal condition	0.0322580645161
BC	+β-carbolinium ion	0.0322580645161
BC	bipolar cell	0.161290322581
BC	basal cell	0.0645161290323
BC	bulbocavernosus	0.0645161290323
BC	basket cell	0.0967741935484
BC	bulbocavernosus muscle	0.0322580645161
BC	on-type bipolar cell	0.0322580645161
BL	basolateral	0.0222222222222
BL	basolateral amygdaloid complex	0.0222222222222
BL	cued with the box plus the light	0.0222222222222
BL	baseline day	0.0222222222222
BL	basal lamina	0.0444444444444
BL	basolateral nucleus	0.0444444444444
BL	baseline	0.177777777778
BL	pposterior subdivision of the basolateral nucleus	0.0666666666667
BL	aanterior subdivision of the basolateral amygdalar nucleus	0.0222222222222
BL	implicit baseline	0.0222222222222
BL	basolateral amygdaloid nucleus	0.133333333333
BL	basal nucleus	0.0222222222222
BL	pposterior subdivision of the basolateral amygdalar nucleus	0.0666666666667
BL	basolateral complex of the amygdala	0.0222222222222
BL	bilateral sympathectomy	0.0222222222222
BL	basolateral amygdaloid nuclei	0.0222222222222
BL	/sbody length/s	0.0222222222222
BL	baseline sample	0.0222222222222
BL	body length	0.0444444444444
BL	basal cell layer	0.0222222222222
BL	aanterior basolateral amygdalar nucleus	0.0222222222222
BL	basolateral amygdala	0.0222222222222
BL	pbasolateral amygdala posterior part	0.0222222222222
BL	basolateral nucleus of the amygdala	0.0444444444444
BL	base level	0.0222222222222
BM	sbasement membranes	0.0384615384615
BM	basement membrane	0.0384615384615
BM	branchiomotor	0.0384615384615
BM	basal membrane	0.0384615384615
BM	basomedial amygdaloid nucleus	0.115384615385
BM	basomedial nucleus of the amygdala	0.0384615384615
BM	bone marrow	0.153846153846
BM	binding medium	0.0384615384615
BM	biological motion	0.0384615384615
BM	brachioradialis muscle	0.0769230769231
BM	basomedial amygdala	0.0384615384615
BM	baclofen+muscimol	0.0384615384615
BM	bimanual mirror	0.0384615384615
BM	basal medium	0.0384615384615
BM	basomedial (or accessory basal)	0.0384615384615
BM	baclofen/muscimol cocktail treatment	0.0384615384615
BM	basomedial	0.0384615384615
BM	basomedial nucleus	0.0384615384615
BM	basomedial nucleus of amygdala	0.0769230769231
TIV	total intracranial volume	1.0
TIP	39tuberoinfundibular peptide of 39 residues	1.0
BI	basolateral amygdaloid nucleus	0.1
BI	binocularity index	0.1
BI	brain injury	0.1
BI	bias index	0.2
BI	334/bi380background-corrected fura-2 emission intensity ratio	0.1
BI	blocking index	0.1
BI	burst interval	0.1
BI	bilaterality index	0.1
BI	2536	0.1
BJ	blackcurrant juice	1.0
BK	large conductance calcium-activated potassium	0.0227272727273
BK	large-conductance calcium-activated potassium channel	0.0227272727273
BK	big conductance calcium and voltage activated potassium	0.0227272727273
BK	big-conductance calcium-activated potassium channel	0.0227272727273
BK	bongkrekic acid	0.0227272727273
BK	channelslarge conductance ca2+-activated potassium channels	0.0227272727273
BK	large-conductance kca channel	0.0227272727273
BK	channellarge-conductance voltage- and calcium-activated potassium channel	0.0227272727273
BK	large (big) conductance ca2+-activated k+ channels	0.0227272727273
BK	calarge conductance ca2+-activated k+ channel	0.0227272727273
BK	big potassium channel	0.0227272727273
BK	large conductance ca2+-activated k+ channel	0.0227272727273
BK	large-conductance, calcium-activated potassium (channel)	0.0227272727273
BK	channel	0.0227272727273
BK	bradykinin	0.363636363636
BK	(ca2+)large conductance ca2+-sensitive k+ channels	0.0227272727273
BK	background	0.0227272727273
BK	large conductance calcium-activated potassium channel	0.0681818181818
BK	calcium- and voltage-sensitive large-conductance potassium channel	0.0227272727273
BK	“big conductance” or “maxi-k” type of ca2+-dependent k+ channel	0.0227272727273
BK	large-conductance ca2+-activated k+ channels	0.0227272727273
BK	big potassium (i.e. large-conductance calcium-activated k+ channels)	0.0227272727273
BK	large-conductance ca2+-activated k+ channel	0.0227272727273
BK	channellarge conductance ca2+-dependent k+ channel	0.0227272727273
BK	“maxi-k” k+ current	0.0227272727273
BK	large-conductance ca2+-dependent k+	0.0227272727273
BK	big conductance ca2+-dependent k+ channel	0.0227272727273
BT	biotinylated tyramide	0.111111111111
BT	xα-bungarotoxin	0.111111111111
BT	bicarbonate transporter	0.222222222222
BT	biotin–tyramine	0.111111111111
BT	2-sec-butyl dihydrothiazole	0.111111111111
BT	body temperature	0.111111111111
BT	biotinylated tyramine	0.222222222222
TIM	timolol maleate	0.333333333333
TIM	23translocase of the inner mitochondrial membrane 23	0.333333333333
TIM	tissue inhibitor of metalloproteinase	0.333333333333
BV	bee-venom	0.0714285714286
BV	bee venom	0.5
BV	2immortalized murine cell line	0.0714285714286
BV	brain ventricle	0.0714285714286
BV	bacterial vaginosis	0.0714285714286
BV	dblood vessel density	0.0714285714286
BV	biological variability	0.0714285714286
BV	brain volume	0.0714285714286
BW	20bandwidth measured at 20 db above threshold	0.0384615384615
BW	619c89	0.0769230769231
BW	watching birds	0.0384615384615
BW	bandwidth	0.192307692308
BW	busy waking	0.0384615384615
BW	body weight	0.576923076923
BW	bw284c51, 1,5-bis [4-allyldimethylammoniumphenyl]-pentan-3-one dibromide	0.0384615384615
TIH	time interval histogram	1.0
GSD	generalized seizure duration	1.0
BR	blocking reagent	0.1
BR	button release	0.1
BR	ibrachio radialis	0.2
BR	indexbaroreflex responsiveness index	0.1
BR	brush	0.1
BR	behavioral reinforcement	0.2
BR	bilirubin	0.1
BR	baroreceptor reflex	0.1
BS	phosphate-buffered saline	0.0294117647059
BS	binocular lid sutured	0.0294117647059
BS	before surgery	0.0294117647059
BS	forebrain–brainstem seizure	0.0294117647059
BS	fetal bovine serum	0.0294117647059
BS	bang-sensitive	0.0294117647059
BS	baseline	0.0588235294118
BS	3bis(sulfosuccinimidyl)suberate	0.0294117647059
BS	burst suppression	0.0294117647059
BS	buffered sucrose	0.0294117647059
BS	bulbospongiosus	0.176470588235
BS	bovine serum albumin	0.0294117647059
BS	breeding season	0.0294117647059
BS	blocking solution	0.0294117647059
BS	brainstem-spinal cord	0.0294117647059
BS	brain stem	0.0588235294118
BS	burst-spiking	0.0588235294118
BS	brain stems	0.0294117647059
BS	3bis (sulfosuccinimidyl) suberate	0.0294117647059
BS	brainstem	0.0588235294118
BS	burst-suppression	0.0294117647059
BS	1blood sample taken at the end of the experiment	0.0294117647059
BS	musclesbulbospongiosus muscles	0.0294117647059
BS	bulbospongiosus muscle	0.0588235294118
GSI	gonadosomatic index	0.333333333333
GSI	global severity index	0.333333333333
GSI	sγ-secretase inhibitors	0.333333333333
GSH	glutathione	0.588785046729
GSH	glutathione in its reduced form	0.00934579439252
GSH	glutathione, reduced form	0.00934579439252
GSH	ttotal glutathione	0.00934579439252
GSH	reduced glutathione	0.336448598131
GSH	reduced l-glutathione	0.00934579439252
GSH	glutathione reduced	0.00934579439252
GSH	glutathione (reduced)	0.00934579439252
GSH	oxidized glutathione	0.00934579439252
GSH	]glutathione levels	0.00934579439252
GSK	3βglycogen synthase kinase 3 β	0.0208333333333
GSK	3-βglycogen synthase kinase-3β	0.0208333333333
GSK	3βglycogen synthase kinase-3	0.0208333333333
GSK	3-β	0.0208333333333
GSK	3βglycogen synthase kinase 3-beta	0.0208333333333
GSK	3glycogen synthase kinase 3	0.208333333333
GSK	glycogen synthase kinase	0.125
GSK	3glycogen synthase kinase3	0.0208333333333
GSK	3βglycogen synthase kinase 3 beta	0.0416666666667
GSK	3βglycogen synthase kinase-3 beta	0.0416666666667
GSK	3glycogen synthase kinase	0.0208333333333
GSK	3βglycogen synthase kinase 3β	0.229166666667
GSK	3glycogen synthase kinase-3	0.104166666667
GSK	3	0.0208333333333
GSK	3ßglycogen synthase kinase 3-beta	0.0208333333333
GSK	3synthase kinase-3	0.0208333333333
GSK	glycogen synthesis kinase	0.0208333333333
GSK	3βglycogen synthase kinase 3beta	0.0208333333333
GSM	global system for mobile communication	1.0
TIA	transient ischemic attack	0.8
TIA	training-induced neuronal activity	0.2
BZ	2benzodiazepine 2	0.1
BZ	sbenzodiazepines	0.1
BZ	benzodiazepine	0.8
GSN	greater splanchnic nerve	1.0
NTSco	commissural nts	1.0
LPRM	nucleus lateralis posterior pars rostromedialis	1.0
NNH	3 terminus	1.0
SIADH	syndrome of inappropriate secretion of antidiuretic hormone	1.0
NNF	non-phosphorylated neurofilament protein	0.333333333333
NNF	no-net-flux microdialysis	0.333333333333
NNF	nonphosphorylated neurofilament	0.333333333333
NNE	non-neuronal enolase	1.0
6-OHDA	6-hydroxyxdopamine	0.00347222222222
6-OHDA	6-hydroxydopamine	0.951388888889
6-OHDA	6-hydrooxydopamine	0.00347222222222
6-OHDA	6-hydroxy dopamine	0.0104166666667
6-OHDA	6-hydroxydopmaine	0.00347222222222
6-OHDA	6-hydroxy-dopamine	0.00694444444444
6-OHDA	6-hydroxydopamine hydrobromide	0.00347222222222
6-OHDA	lesions	0.00347222222222
6-OHDA	6-hydrodopamine	0.00347222222222
6-OHDA	6-hydroxidopamine	0.00347222222222
6-OHDA	lesion	0.00347222222222
6-OHDA	model	0.00347222222222
TMX	tamoxifen	1.0
CCRCC	chemokine receptor	1.0
MPSS	methylprednisolone sodium succinate	1.0
sAHP	slow afterhyperpolarizing potential	0.125
sAHP	slow post-spike afterhyperpolarization potential	0.0625
sAHP	slow ahp	0.25
sAHP	slow afterhyperpolarization	0.5625
post-CGP	animalsrats treated postnatally with cgp 40116	1.0
NNT	number needed to treat	1.0
HKG	housekeeping gene	0.666666666667
HKG	house keeping gene	0.333333333333
DMSAmeso-2	3-dimercaptosuccinic acid	1.0
PLSD	protected least significant difference	0.659090909091
PLSD	post-hoc least significant difference	0.0227272727273
PLSD	protected least-significant difference	0.0227272727273
PLSD	post hoc protected least-significant differences	0.0227272727273
PLSD	fisher probability of least significant difference test	0.0227272727273
PLSD	protected least significant differences	0.0227272727273
PLSD	fisher's protected last significant difference	0.0227272727273
PLSD	pacemaker-like slow depolarization	0.0227272727273
PLSD	protected least significant difference test	0.0681818181818
PLSD	protected least squares difference	0.0454545454545
PLSD	post-hoc fisher’s protected least significant difference	0.0227272727273
PLSD	pacemaker-like slow depolarizing potential	0.0227272727273
PLSD	protected least squares design	0.0227272727273
2D-PAGE	two-dimensional polyacrylamide gel electrophoresis	1.0
CADO	2-chloroadenosine	1.0
CNQX6-cyano-7-nitroquinoxyline-2	3-dione	1.0
TBS-Tds	tris-buffered saline plus 3.0% normal donkey serum/0.2% triton x-100	1.0
PAGI-SYM	patient assessment of upper gi disorder severity symptom index	1.0
s-AHP	slow afterhyperpolarization	1.0
chBRS-	3.5chicken bombesin receptor subtype-3.5	1.0
DAS	donkey anti-sheep	1.0
SESS	ocioeconomic status	1.0
MEKK1	mek kinase 1	1.0
GDNFG	lial-derived neurotrophic factor	1.0
PGF	2αprostaglandin f2α	1.0
HK-	1hemokinin-1	0.75
HK-	1hemokinin 1	0.25
dhASC	sdifferentiated human adipose-derived stem cells	1.0
p-MCAO	permanent mcao	1.0
dDAVP	1-desamino-8-d-arginine vasopressin	0.5
dDAVP	1-deamino-8-d-arg-vasopressin	0.5
NIRS	near-infrared spectroscopy	0.5
NIRS	(functional) near-infrared spectroscopy	0.25
NIRS	near infrared spectroscopy	0.25
MGFP	mean global field power	1.0
EXE	exercised group	1.0
SQR	sulfide-quinone oxidoreductase	1.0
gVII	ngenu of the facial nerve	0.333333333333
gVII	facial ganglia	0.666666666667
TPQT	ri-dimensional personality questionnaire	1.0
p24B	orna disease virus phosphoprotein 24	1.0
B6	c57bl/6j	0.5
B6	c57bl/6	0.5
TVP	tetraspan vesicle membrane protein	0.5
TVP	tetraspan vesicle membrane proteins	0.5
NaHACU	na-dependent high-affinity choline uptake	1.0
α-KG	alpha ketoglutarate	1.0
GS-	propionaldehydeglutathionylpropionaldehyde	1.0
B9	b10 and b11, brodmann areas 9, 10 and 11	1.0
Acc	nucleus accumbens	0.5
Acc	accumbens nucleus	0.5
MAPKAPK-	2mapk-activated protein kinase 2	1.0
EET	s	0.2
EET	epoxyeicosatrienoic acid	0.6
EET	sepoxyeicosatrienoic acids	0.2
ROb	nucleus raphe obscurus	1.0
OVXDHT	ovariectomized female treated with dihydrotestosterone	1.0
U-	62066spiradoline mesylate salt	0.222222222222
U-	50488h(±)-trans-u-50488 methanesulfonate salt	0.111111111111
U-	50488	0.111111111111
U-	69593	0.333333333333
U-	92032	0.111111111111
U-	73122	0.111111111111
EEO	28early eyelid opening surgery at postnatal day 28	1.0
EEN	end-to-end neurorrhaphy	1.0
CNTFRalpha	alpha subunit of the ciliary neurotrophic factor receptor	1.0
EEG	electroencephalography	0.195970695971
EEG	electroencephalogram, electroencephalographic	0.0018315018315
EEG	electroencephalogram	0.631868131868
EEG	electroencephalography, electroencephalographic	0.0018315018315
EEG	electroencephalography/electroencephalographic	0.003663003663
EEG	electroencephalographic activity	0.003663003663
EEG	oscillations	0.0018315018315
EEG	selectroencephalograms	0.00915750915751
EEG	selectroencephalographs	0.0018315018315
EEG	theta activity	0.0018315018315
EEG	electro-encephalography	0.0018315018315
EEG	source localization	0.0018315018315
EEG	electroencephalogram/electroencephalographic	0.0128205128205
EEG	electroencephology	0.0018315018315
EEG	/erps	0.0018315018315
EEG	electro-encephalogram	0.0018315018315
EEG	electroencephalographic recordings	0.003663003663
EEG	electroencephalogram or -graphy or -graphic	0.0018315018315
EEG	electroencephalography/electroencephalogram	0.003663003663
EEG	electroencephalographic/electroencephalograph/electroencephalogram	0.0018315018315
EEG	electroencephalograms	0.0018315018315
EEG	electroencephalographic, electroencephalogram	0.003663003663
EEG	electroencephalographic	0.0750915750916
EEG	electroencephalograph	0.021978021978
EEG	electrical neuroimaging	0.0018315018315
EEG	electroencephalographic/electroencephalogram	0.00915750915751
EEA	1early endosome antigen-1	0.25
EEA	1early endosome antigen 1	0.75
TMJ	temporomandibular joint	1.0
Glrbspa	spastic allele of the murine gene encoding the glycine receptor β-subunit	1.0
ROI	sregions of interest	0.0697674418605
ROI	relative optical intensity	0.0077519379845
ROI	region-of-interest	0.046511627907
ROI	region of interests	0.00387596899225
ROI	sregion of interest	0.00387596899225
ROI	regions of interest	0.131782945736
ROI	area of interest	0.00387596899225
ROI	region of interest	0.717054263566
ROI	(brain) regions of interest	0.00387596899225
ROI	regions of interests	0.00387596899225
ROI	region of interest.	0.00387596899225
ROI	region of interest (in confocal analysis)	0.00387596899225
IPSCGABA	ergic inhibitory postsynaptic current	1.0
pI	isoelectric point	0.833333333333
pI	nsposterior insular cortex	0.166666666667
ROM	range of motion	1.0
RON	rat optic nerve	1.0
LLS	levator labii superioris	0.333333333333
LLS	levator labii superioris muscle	0.666666666667
LLR	long-latency reflex	1.0
ROC	receiver operating characteristic	0.818181818182
ROC	receiver-operating characteristic	0.181818181818
TEMCATEM	camera array	1.0
pMCA	opermanent middle cerebral artery occlusion	1.0
NALCNN	a+ leak channel	1.0
pO	2partial pressure of oxygen	0.4
pO	2oxygen partial pressure	0.2
pO	2partial pressure oxygen	0.2
pO	2tissue oxygen tension (mm hg)	0.2
4V	fourth ventricle	0.666666666667
4V	4th ventricle	0.333333333333
LLI	low-energy laser irradiation	1.0
LLH	long-lasting hyperpolarization	1.0
oPFC	orbital prefrontal cortex	0.666666666667
oPFC	orbital pfc	0.333333333333
PLC-β	phospholipase c-β	0.666666666667
PLC-β	3phospholipase c-beta 3	0.333333333333
PLC-γ	phospholipase c-γ	0.571428571429
PLC-γ	1	0.142857142857
PLC-γ	phospholipase cγ	0.142857142857
PLC-γ	phospholipase-c-γ	0.142857142857
ROP	retinopathy of prematurity	1.0
LLB	long lead burst	1.0
a-S	vg-30anti-sauvagine-30	1.0
ROS	sreactive oxygen species	0.00297619047619
ROS	radical oxygen species	0.00297619047619
ROS	rod outer segment	0.00297619047619
ROS	/rnsreactive oxygen and nitrogen species	0.00297619047619
ROS	reactive oxygen species	0.97619047619
ROS	reactive oxygen	0.00297619047619
ROS	reactive oxidative species	0.00297619047619
ROS	rod outer segments	0.00595238095238
ROT	rotenone	1.0
LLD	long-lasting depolarization	0.833333333333
LLD	dorsal nucleus of the lateral lemniscus	0.166666666667
UCH-L	1ubiquitin c-terminal hydrolase	1.0
MFG-E	8milk fat globule-egf-factor 8	1.0
BDA	biotinylated dextran amine (anterograde tracer)	0.00684931506849
BDA	biotinylated-dextran amine	0.013698630137
BDA	biotin dextran amine	0.0616438356164
BDA	biotinylated-dextranamine	0.00684931506849
BDA	biotinylated dextrane amine	0.00684931506849
BDA	biotinylated dextran amine	0.753424657534
BDA	biotin–dextran lysine	0.00684931506849
BDA	biotinylated dextran	0.00684931506849
BDA	biotinyl dextran amine	0.00684931506849
BDA	biotin–dextran amine	0.0205479452055
BDA	biotinylated dextranamine	0.0547945205479
BDA	biotinylated dextran-amine	0.0547945205479
TRKB	tyrosine kinase b	1.0
BDB	lock design	1.0
BDM	basal chemically-defined medium	1.0
fPSR	fast polysynaptic reflex	1.0
fPSP	field post-synaptic potential	0.285714285714
fPSP	field postsynaptic potential	0.571428571429
fPSP	synaptic field potential	0.142857142857
VEOG	vertical electrooculogram	0.666666666667
VEOG	vertical electrooculography	0.333333333333
4S	)-3-[(e)-but-2-enoyl]-4-benzyl-2-oxazolidinone	1.0
BDV	strain vlaboratory borna disease virus strain v	1.0
HbO2	oxyhaemoglobin	1.0
mTORC	2mtor complex 2	0.4
mTORC	1mammalian target of rapamycin complex 1	0.6
mTORM	ammalian target of rapamycin	1.0
ssRNA	single-stranded rna	1.0
TxB2	thromboxane b2	1.0
BDX	biotinylated dextran amine	1.0
WAVE	2wasp family verprolin-homologous protein 2	1.0
BDZ	benzodiazepines	0.333333333333
BDZ	benzodiazepine	0.666666666667
NDCBEN	a-driven cl-bicarbonate exchanger	0.333333333333
NDCBEN	a+-driven chloride bicarbonate exchanger	0.333333333333
NDCBEN	a-driven cl–hco3 exchanger	0.333333333333
S-INDF	stimulus-indifferent	1.0
UZ	unresponsive zone	1.0
UT	urea transporter	0.333333333333
UT	receptorurotensin ii receptor	0.166666666667
UT	unfused tetanus	0.166666666667
UT	urotensin ii receptor	0.166666666667
UT	utilisation time	0.166666666667
UW	gal-tguniversity of washington galanin transgenic mouse	1.0
UV	irradiation	0.0645161290323
UV	ultraviolet light	0.0645161290323
UV	ultraviolet	0.806451612903
UV	anucleus uvaeformis	0.0322580645161
UV	ultra violet	0.0322580645161
FLIPR	fluorometric imaging plate reader	1.0
MOMA-1	monocyte-derived macrophage marker-1	1.0
US	unconditional stimulus	0.036231884058
US	an unconditioned stimulus	0.00724637681159
US	unconditioned aversive stimulus	0.00724637681159
US	unconditioned stimuli	0.00724637681159
US	unstimulated controls	0.00724637681159
US	unconditioned stimulus	0.898550724638
US	uncoditioned stimulus	0.00724637681159
US	unconditioned stimulus.	0.00724637681159
US	unstressed	0.00724637681159
US	unconditioned stimulus (costimulation stimulus)	0.00724637681159
US	unsupported stance	0.00724637681159
UR	unconditioned response (response during costimulation)	0.111111111111
UR	unimanual right	0.111111111111
UR	unconditioned response	0.777777777778
UM	umbrella	1.0
UL	upper lip	0.1
UL	unilateral labyrinthectomy	0.7
UL	unilateral sympathectomy	0.1
UL	unimanual left	0.1
UN	uterine nerve	0.5
UN	unpaired group	0.5
UI	uninfected	1.0
FLIPF	as-associated protein with death domain-like interleukin-1β-converting enzyme-inhibitory protein	1.0
UD	undisturbed controls	1.0
UG	urethrogenital	1.0
TSSTT	rier social stress test	1.0
BISB	ehavioral inhibition system	0.333333333333
BISB	arratt impulsiveness scale	0.666666666667
UC	undercut model	0.166666666667
UC	unimplanted controls	0.166666666667
UC	unconditioned stimulus	0.166666666667
UC	omupper center of mass	0.166666666667
UC	untetanized controls	0.166666666667
UC	utensil condition	0.166666666667
UB	upper blade	1.0
GBSG	uillain-barre syndrome	0.25
GBSG	uillain–barré syndrome	0.25
GBSG	uillain-barré syndrome	0.5
PMv	ventral division of the premotor cortex	1.0
orb-V	2 regioninfraorbital nerve region	0.5
orb-V	2 regioninfraorbital nerve region of vp	0.5
LSPVZ	lower sub-paraventricular zone	1.0
EGTAo	o′-bis(2-aminoethyl)- ethyleneglycol-n,n,n′,n′-tetraacetic acid	1.0
orb-S	1infraorbital nerve area of s1	0.5
orb-S	2infraorbital nerve area of s2	0.5
IDV	integrated density value	0.666666666667
IDV	image digitization value	0.333333333333
5-MEOT	5-methoxytryptamine	1.0
IDR	delay rectifier potassium current	0.333333333333
IDR	reversal of intradimensional shift	0.333333333333
IDR	delayed rectifier current	0.333333333333
IDS	intradimensional set-shift	0.4
IDS	intradimensional shift	0.2
IDS	dendrotoxin-sensitive potassium current	0.2
IDS	dendrotoxin-sensitive current	0.2
VACT	vertical activity	1.0
PMd	dorsal premammillary nucleus	0.5
PMd	dorsal division of the premotor cortex	0.5
IDO	indoleamine-2,3-dioxygenase	1.0
Egr-1	early growth response factor-1	1.0
PPAR-αα-	peroxisome proliferator-activated nuclear receptors	1.0
VACC	svoltage-activated ca2+ channels	1.0
IDD	infrared diode detector	1.0
IDE	insulin-degrading enzyme	0.25
IDE	insulin degrading enzyme	0.75
CMSC	ommon mode sense	1.0
FURO	diuretic furosemide	0.0833333333333
FURO	furosemide	0.916666666667
IDA	(girk)dopamine d2 receptor-mediated girk current	0.5
IDA	idazoxan hydrochloride	0.5
PMT	spremotor reaction times	0.111111111111
PMT	pontomesencephalic tegmentum	0.333333333333
PMT	photomultiplier tube	0.333333333333
PMT	photomultiplier	0.111111111111
PMT	pedunculopontine mesencephalic tegmentum	0.111111111111
CGH	c-terminal gck homology	1.0
PMV	ventral premotor cortex	0.2
PMV	ventral premamillary nucleus	0.2
PMV	premammillary ventral nucleus	0.1
PMV	ventral premammillary body	0.1
PMV	ventral premammillary nucleus	0.4
PMP	22human protein myelin peripheral gene 22	0.166666666667
PMP	22peripheral myelin protein 22	0.666666666667
PMP	22	0.166666666667
CGL	corpus geniculatum laterale, lateral geniculate body	0.25
CGL	cholinergic gene locus	0.75
PMR	paramedian raphe nucleus	0.5
PMR	measured muscle resistance	0.5
PMS	post mitochondrial supernatant	0.166666666667
PMS	pectoral major superior	0.166666666667
PMS	premenstrual syndrome	0.5
PMS	ponto-medullary-spinal cord	0.166666666667
CGA	chromogranin a	0.5
CGA	central gray area	0.5
CGC	cerebellar granule cell	0.411764705882
CGC	cerebellar granule cells	0.294117647059
CGC	scerebellar granule cells	0.235294117647
CGC	cerebral giant cell	0.0588235294118
CGE	capillary gel electrophoresis	0.142857142857
CGE	caudal ganglionic eminence	0.571428571429
CGE	caudal ganglionic eminences	0.285714285714
PMY	peptide methionine–tyrosine	1.0
CGG	cpgpgp dna trinucleotide	1.0
PMD	dorsal premammillary nucleus	0.176470588235
PMD	post-mortem delay	0.0588235294118
PMD	postmortem dissection	0.0588235294118
PMD	dorsal premotor cortex	0.117647058824
PMD	postmortem delay	0.294117647059
PMD	periodic maternal deprivation	0.0588235294118
PMD	premammillary nucleus dorsal	0.0588235294118
PMD	premamillary nucleus, dorsal part	0.0588235294118
PMD	post mortem delay	0.0588235294118
PMD	premammillary dorsal nucleus	0.0588235294118
PME	palatable meal entrainment	1.0
PMF	peptide mass fingerprint	0.5
PMF	proton motive force	0.125
PMF	peptide mass fingerprinting	0.25
PMF	plethodontid modulating factor	0.125
PMA	4-β-phorbol 12-myristate 13-acetate	0.015873015873
PMA	premotor area	0.015873015873
PMA	phorbyl myristate	0.015873015873
PMA	phorbol-12 myristate-13-acetate	0.015873015873
PMA	para-methoxyamphetamine	0.031746031746
PMA	phorbol 12-myristrate 13-acetate	0.015873015873
PMA	phorbol-myristate acetate	0.015873015873
PMA	phorbol myristate acetate (pkc activator)	0.015873015873
PMA	phorbol myristate acetate	0.0634920634921
PMA	phorbol-12-myristate-13 acetate	0.015873015873
PMA	phorbol-12-myristate 13-acetate	0.047619047619
PMA	phorbol 12-myristate-13-acetate	0.0634920634921
PMA	phorbol-12-myristate-13-acetate	0.142857142857
PMA	phorbol 12-myristate 13-acetate	0.52380952381
PMB	plasma membrane-bound	1.0
PMC	pontine micturition center	0.172413793103
PMC	primary motor cortex	0.137931034483
PMC	premotor cortex	0.206896551724
PMC	oposteromedial cortical amygdala	0.0689655172414
PMC	oposteromedial cortical amygdaloid nucleus	0.206896551724
PMC	oxposteromedial cortical amygdala lesion group	0.0344827586207
PMC	pontine micturition centre	0.0344827586207
PMC	oposteromedial cortical nucleus	0.0344827586207
PMC	oposterior medial cortical amygdala	0.0344827586207
PMC	oposteromedial cortical amygdla	0.0344827586207
PMC	pontine micturition center (or m-region)	0.0344827586207
PML	promyelocytic leukemia protein	0.333333333333
PML	paramedian lobule	0.333333333333
PML	promyelocytic leukemia tumor suppressor protein	0.333333333333
CGP	cleaved grasp-1 antibody	0.04
CGP	56999ap-(3-aminopropyl)-p-diethoxymethyl-phosphinic acid	0.04
CGP	46381ciba geigy product 46381	0.04
CGP	37849(±)-2-amino-4-methyl-5-phosphono-3-pentenoic acid	0.08
CGP	56433a	0.04
CGP	55845agabab receptor antagonist	0.04
CGP	46381	0.04
CGP	39551(e)-(±)-2-amino-4-methyl-5-phospho no-3-pentenoic acid ethyl ester	0.04
CGP	12177	0.04
CGP	40116(e)-2-amino-4-methyl-5-phosphono-3-pentenoic acid	0.04
CGP	20712a(±)-2-hydroxy-5-(2-((2-hydroxy-3-(4-(1-methyl-4-(trifluoromethyl)-1h-imidazole-2-yl)-phenoxy)propyl)amino)ethoxy)-benzamide monomethane sulfonate	0.04
CGP	(3-aminopropyl)(diethoxymethyl)phosphinic acid hydrate	0.04
CGP	40116d-(e)-2-amino-4-methyl-5-phosphono-3-pentenoic acid	0.04
CGP	35348(3-aminopropyl)(diethoxymethyl)phosphinic acid	0.08
CGP	55845	0.04
CGP	35348p-(3-aminopropyl)-p-diethoxymethylphosphinic acid	0.04
CGP	56999a[3-[1-(r)-[(3-cyclohexylmethyl)hydroxyphosphinyl]-2-(s)-hydroxy-propyl]	0.04
CGP	35348p-α3-aminopropyl-p-diethoxymethyl-phosphinic acid	0.04
CGP	367423-aminopropyl-n-butyl-phosphinic acid	0.04
CGP	37849(e)-(±)-2-amino-4-methyl-5-phosphono-3-pentenoic acid	0.04
CGP	56433a[3-[1-(s)-[[3-(cyclohexylmethyl)-hydroxyphosphinoyl]-2-(s)-hydroxypropyl]	0.04
CGP	55845a	0.04
CGP	54626	0.04
PMN	polymorphonuclear	0.166666666667
PMN	spolymorphonuclear leukocytes	0.333333333333
PMN	polymorphonuclear leukocyte	0.333333333333
PMN	polymorphonuclear leukocytes	0.166666666667
pMCC	posterior portion of the medial cingulate cortex	0.5
pMCC	posterior mid-cingulate cortex	0.5
CGU	cerebral glucose utilization	1.0
PMI	postmortem intervals	0.03125
PMI	nucleus paramedianus internus	0.03125
PMI	post mortem interval	0.21875
PMI	postmortem interval	0.71875
FEF	right frontal eye field	0.0434782608696
FEF	sfrontal eye fields	0.0434782608696
FEF	frontal eye field	0.695652173913
FEF	frontal eye fields	0.173913043478
FEF	luoroemerald	0.0434782608696
pENK-	/-pro-enkephalin knockout	1.0
X-100	ph 7.3	0.333333333333
X-100	ph 7.6	0.333333333333
X-100	and 6% normal goat serum in phosphate-buffered saline	0.333333333333
CG-	1calcium green-1	1.0
nXr	nucleus motorius nervi vagi rostralis	1.0
FEN	fenfluramine-treated group of mice	0.333333333333
FEN	1‘flap’ structure specific endonuclease-1	0.333333333333
FEN	1flap endonuclease 1	0.333333333333
FEO	food entrainable oscillator	0.2
FEO	food-entrainable oscillators	0.4
FEO	food-entrainable oscillator	0.4
mGFAP-EGFP	mouse gfap promoter-controlled enhanced green fluorescent protein	1.0
FEM	finite element method	1.0
125I-OVTA	125i-ornithine vasotocin analog	1.0
mBB	rmonobromobimane	1.0
mBC	lmonochlorobimane	1.0
FEW	family-wise error	1.0
FET	field effect transistor	1.0
RN-DSC	rat neurons of dorsal spinal cord	1.0
FEP	flash evoked potential	0.333333333333
FEP	fluorinated ethylene propylene	0.666666666667
CG1	dorsal cingulate cortex	1.0
4EBP	1eif4e binding protein 1	1.0
hSTC-	1recombinant human stanniocalcin-1	1.0
DLCP	udorsolateral caudate putamen	1.0
α-AAA	α-aminoadipic acid	1.0
HAA-HDA	anterior hypothalamus	1.0
sfEPSP	slope of the field excitatory postsynaptic potential	1.0
hS	lohuman large conductance voltage and ca2+-activated k+ channel pore-forming α subunit	0.333333333333
hS	lohuman voltage-dependent and ca2+-activated k+ channel α subunit	0.333333333333
hS	ynhuman synapsin i promoter	0.333333333333
HMG-CoA	3-hydroxy-3-methylglutaryl-coa	0.5
HMG-CoA	3-hydroxy-3methylglutaryl-coenzyme a	0.5
hV	ariant 3third human accn2 transcript variant	1.0
A-β	amyloid-β	1.0
hT	au+/-whole human tau gene hemizygous transgenic mice	1.0
IBMX3-isobutyl-1-methyl-2	6(1h,3h)-purinedione	1.0
HEBN	head–eye related burst neuron	1.0
hB	uchehuman butyrylcholinesterase	1.0
hC	hr21human chromosome 21	1.0
qNCC	quail neural crest cells	1.0
hF	chuman fc domain of igg	1.0
dILP	sdrosophila insulin-like peptides	1.0
NAPPS	negative affective pain processing system	1.0
XE-99110	10-bis(4-pyridinylmethyl)-9(10h)-anthracenone dihydrochloride	1.0
XBP-	1x-box protein 1	1.0
RHIPP	right hippocampus	1.0
alpha4-GABA-	receptor	1.0
MSV	,	1.0
vRPO	ventral part of the oral pontine tegmentum	0.25
vRPO	ventral part of the oral pontine reticular nucleus	0.75
MSS	musculoskeletal symptoms	0.5
MSS	most sensitive spot of a receptive field	0.5
MSR	/2rate half that of msr	0.142857142857
MSR	monosynaptic reflex	0.285714285714
MSR	medium stress resilient	0.142857142857
MSR	medium stress-resilient	0.142857142857
MSR	magnetically shielded room	0.285714285714
pEPSP	spopulation excitatory post synaptic potentials	0.0769230769231
pEPSP	extracellular field potential	0.0769230769231
pEPSP	population excitatory postsynaptic potential	0.538461538462
pEPSP	population excitatory post-synaptic potential	0.153846153846
pEPSP	population excitatory postsynaptic potentials	0.153846153846
MSO	l-methionine-dl-sulfoximine	0.037037037037
MSO	methionine sulfoximine	0.0740740740741
MSO	l-methionine-s-sulfoximine	0.037037037037
MSO	medial superior olive	0.777777777778
MSO	mismatch sense oligonucleotide	0.037037037037
MSO	medial superior olivary nucleus	0.037037037037
MSN	main sensory nucleus [of the trigeminal nucleus]	0.0161290322581
MSN	sstriatal medium spiny neurons	0.0161290322581
MSN	medium spiny projection neurons	0.0161290322581
MSN	medium-sized spiny neurons	0.0161290322581
MSN	medium-sized spiny neuron	0.0322580645161
MSN	medium spiny neurons	0.0806451612903
MSN	medial septal nucleus	0.0645161290323
MSN	medium-sized spiny projection neurons	0.0161290322581
MSN	smedium spiny neurons	0.274193548387
MSN	smedium spiny output neurons	0.0161290322581
MSN	medium spiny neuron	0.354838709677
MSN	medium spiny neurones	0.0161290322581
MSN	smedium-spiny neurons	0.0161290322581
MSN	smedium-sized spiny neurons	0.0322580645161
MSN	medium-sized densely spiny neurons	0.0161290322581
MSN	medium spiny neurone	0.0161290322581
MSL	maximal spike latency	1.0
MSK	1mitogen- and stress-activated protein kinase 1	0.333333333333
MSK	mitogen- and stress-activated kinase	0.333333333333
MSK	mitogen- and stress-activated protein kinase	0.333333333333
MSI	multisensory integrative index	0.5
MSI	medium spiny i	0.5
MSH	melanocyte stimulating hormone	0.1
MSH	2muts homolog 2	0.1
MSH	melanocyte-stimulating hormone	0.6
MSH	(tyr6)-γ2-msh-6-12	0.1
MSH	muts homologue	0.1
MSG	monosodium glutamate	0.666666666667
MSG	monosodium l-glutamate	0.277777777778
MSG	l-monosodium glutamate	0.0555555555556
MSF	mixed lineage leukemia septin-like fusion protein	0.5
MSF	median superior frontal lobe	0.5
MSE	mean squared error	0.4
MSE	multiscale entropy	0.2
MSE	mean square error	0.4
MSD	mean squared deviation	0.2
MSD	motor system disease	0.2
MSD	mean square displacement	0.4
MSD	smusculoskeletal disorders	0.2
MSC	smesenchymal stem cells	0.368421052632
MSC	magnitude squared coherence	0.0526315789474
MSC	mesenchymal stem cell	0.368421052632
MSC	mesenchymal stem cells	0.210526315789
MSB	multiple synaptic bouton	0.2
MSB	multi-synaptic bouton	0.2
MSB	multiple synapse bouton	0.2
MSB	microtubule-stabilizing buffer	0.2
MSB	multisynaptic bouton	0.2
MSA	medial septal area	0.125
MSA	multiple system atrophy	0.75
MSA	muscle spindle afferent	0.125
pcdP	urkinje cell degeneration	1.0
AQP	9aquaporin 9	0.0153846153846
AQP	1aquaporin 1	0.0153846153846
AQP	aquaporin	0.230769230769
AQP	4aquaporin4	0.0615384615385
AQP	aquaporins	0.0153846153846
AQP	4+/+wild-type	0.0153846153846
AQP	1	0.0153846153846
AQP	saquaporins	0.0461538461538
AQP	4aquaporin 4	0.215384615385
AQP	4-/-aqp4 null	0.0153846153846
AQP	1aquaporin-1	0.0153846153846
AQP	4aquaporin-4	0.323076923077
AQP	4 s111amutated aquaporin 4 with ser111 substituted to alanine	0.0153846153846
S-cell	cell with simple rf	0.5
S-cell	neuron with receptive field of the simple type	0.5
DABdiaminobenzidine-2	3	1.0
MSt	medial striatum	1.0
JMUSC	joint muscle torque	1.0
Caspase	cysteine protease which cleaves at an aspartate residue	1.0
RTS	restraint stress	1.0
AQE	asynchronous quantal event	1.0
ORCH	orchidectomized	1.0
sVRP	slow ventral root potential	1.0
ADHDA	ttention-deficit hyperactivity disorder	0.5
ADHDA	ttention deficit hyperactivity disorder	0.25
ADHDA	ttention-deficit/hyperactivity disorder	0.25
c-SOM	cyclo-somatostatin	1.0
RTE	resistance to extinction	1.0
PDGFB	platelet-derived growth factor subunit b	1.0
FCCP	p-trifluoromethoxy-phenylhydrazone	0.0416666666667
FCCP	carbonylcyanide p-(trifluoromethoxy)phenylhydrazone	0.0416666666667
FCCP	carbonyl cyanide 4-trifluoro-methoxyphenylhydrazone	0.0416666666667
FCCP	carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone	0.125
FCCP	carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone	0.0833333333333
FCCP	carbonyl cyanide 4-trifluoromethoxyphenlhydrazone	0.0416666666667
FCCP	trifluorocarbonylcyanide phenylhydrazone	0.0416666666667
FCCP	carbonyl cyanide p-trifluoromethoxyphenyl-hydrazone	0.0416666666667
FCCP	carbonyl cyanide p-[trifluoromethoxy]-phenyl-hydrazone	0.0416666666667
FCCP	p-trifluoromethoxy carbonyl cyanide phenyl hydrazone	0.0416666666667
FCCP	carbonyl-cyanide-4-(trifluoromethoxy)-phenylhydrazone	0.0416666666667
FCCP	carbonylcyanide-p-trifluoromethoxyphenylhydrazone	0.0416666666667
FCCP	carbonyl cyanide-p-trifluoromethoxyphenyl-hydrazone	0.0416666666667
FCCP	carbonyl cyanide p-trifluoromethoxyphenylhydrazone	0.166666666667
FCCP	carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone	0.0833333333333
FCCP	carbonyl cyanide-p-trifluoromethoxyphenylhydrazone	0.0416666666667
FCCP	p-trifluoromethoxyphenylhydrazone	0.0416666666667
YLyoung	large litter size	1.0
NECAB	neuronal ca2+-binding protein	1.0
Gd-DTPA	gadolinium diethylenetriaminepenta-acetate	1.0
THFA	tetrahydrofuryl adenine	1.0
irSP	substance p immunoreactivity	1.0
STS-	90	1.0
cdKO	conditional double-knockout	1.0
GLIR	glutamate-like immunoreactivity	1.0
PDGFR	platelet-derived growth factor receptor	0.5
PDGFR	platelet-derived growth factor β-receptor	0.5
CYFIP	cytoplasmic fmrp interacting protein	0.5
CYFIP	2cytoplasmic fmr1-interacting protein 2	0.5
MOSP	myelin oligodendrocyte specific protein	1.0
DRF	dorsal reticular formation	1.0
SBSB-	205384	1.0
DWI	diffusion-weighed imaging	0.0714285714286
DWI	diffusion weighted imaging	0.214285714286
DWI	diffusion-weighted mri	0.142857142857
DWI	diffusion-weighted imaging	0.428571428571
DWI	diffusion weighted image	0.0714285714286
DWI	diffusion-weighted image	0.0714285714286
DABCYL	4-dimethylaminophenylazobenzoic acid	1.0
Iimmediate	family pictures i	1.0
DWM	dorsal white matter	0.5
DWM	developing white matter	0.5
CNP-	ase2′,3′-cyclic nucleotide-3′-phosphodiesterase	1.0
PEX	plasma exchange	0.5
PEX	13 brain mutant	0.5
Fura-2M	fura-2 acetoxymethyl ester	1.0
NPDP	non-proline directed sites phosphorylated	1.0
Sn-PP	tin protoporphyrin ix	1.0
MS-	222ethyl 3-aminobenzoate methanesulfonate	0.333333333333
MS-	ndbb complexmedial septum and the nucleus of the diagonal band of broca	0.333333333333
MS-	275	0.333333333333
SLDT	scrape-loading dye transfer	1.0
McN-A-343	4-[[[(3-chlorophenyl)amino]carbonyl]	0.333333333333
McN-A-343	(4-hydroxy-2-butynyl)-1-trimethylammonium-m-chloro-carbanilate chloride	0.333333333333
McN-A-343	(4-hydroxy-2-butynyl)-1-trimethylammonium-m-chlorocarbanilate chloride	0.333333333333
CSNA	cardiac sympathetic nerve activity	1.0
IECI	nternational electrotechnical commission	1.0
NUTSNovelty	unpredictability, threat to personality and sense of low control	1.0
HQL-	794-benzhydryloxy-(1) {3-(1h-tetrazol-5-yl)-propyl}piperidine	1.0
EPEA	eicosapentaenoyl ethanolamine	1.0
RORαR	etinoic acid-related orphan receptor alpha	1.0
DDPS	animals that received flash stimulation after dark rearing	1.0
CSNT	complete sciatic nerve transaction	1.0
ipsi-D	hemisphere ipsilateral to the dystonic arm	1.0
NO-Arg	nw-nitro-l-arginine	1.0
NSMase	neutral sphingomyelinase	1.0
TtBS	100mm tris–hcl ph 7.4, 0.9% nacl, 0.1% tween 20	1.0
Bailey	(1947)	1.0
CSNX	transection of the ipsilateral carotid sinus nerve	1.0
Vact	voltage of half activation	1.0
SCO-	spondin	1.0
ir-NPY	immunoreactive neuropeptide tyrosine	1.0
KYN	kynurenine	0.8
KYN	kynurenic acid	0.2
MWZM	orris water maze	1.0
AT1A	angiotensin receptor subtype 1a	1.0
Glra1spd-ot	oscillator allele of the glra1 gene	1.0
2PLUG	two-photon uncaging of glutamate	1.0
NFBDO	normal folic acid and vitamin b12 deficient and dha supplemented	1.0
PTNP	leiotrophin	1.0
M146L	mutation at codon 146 of presenilin-1 resulting in substitution of methionine by leucine	1.0
MEKKMEK	kinase	1.0
HADSH	ospital anxiety and depression scale	1.0
AMINO	aminoguanidine	1.0
TCGAP-R	esresistant form of tcgap	1.0
RIL	riluzole	1.0
DPEA	docosapentaenoyl ethanolamine	1.0
35S	]gtpγs autoradiography	0.105263157895
35S	]gtpγsguanosine-5′-o-(3-[35s]	0.0526315789474
35S	]gtpγsguanylyl 5′-[γ-35s]	0.0526315789474
35S	]gtpγsguanosine-5′-o-(3-thio) triphosphate	0.0526315789474
35S	]gtpγsguanosine 5′(γ-35s-thio) triphosphate	0.0526315789474
35S	]gtpγs binding	0.157894736842
35S	]gtpγs[35s]	0.210526315789
35S	]gtpγs stimulation	0.0526315789474
35S	]-tbps[35s]	0.0526315789474
35S	]-gtp gamma s[35s]	0.0526315789474
35S	]gtp	0.0526315789474
35S	]gtpγs [35s]	0.0526315789474
35S	]2′-deoxy 5′-o-(1-thio) atp binding	0.0526315789474
MCPG	(+)-α-methyl-4-carboxy-phenylglycine	0.0232558139535
MCPG	(r,s)-α-methyl-4-carboxyphenylglycine	0.139534883721
MCPG	(s)-methyl-4-carboxyphenylglycine	0.0232558139535
MCPG	(rs)-a-methyl-4-carboxyphenylglycine	0.0232558139535
MCPG	(rs)-methyl-4-carboxyphenyl-glycine	0.0232558139535
MCPG	(+)-α-methyl-4-carboxyphenylglycine	0.116279069767
MCPG	(rs)-α-methyl-4-carboxylphenylglycine	0.0232558139535
MCPG	(±)-α-methyl-4-carboxyphenylglycine	0.0232558139535
MCPG	(-)-α-methyl-4-carboxyphenylglycine	0.0232558139535
MCPG	(s)-α-methyl-4-carboxyphenylglycine	0.116279069767
MCPG	(rs)-alpha-methyl-4-carboxyphenylglycine	0.0232558139535
MCPG	(±)-α-methyl-(4-carboxyphenyl)glycine	0.046511627907
MCPG	(rs)-α-methyl-4-carboxyphenylglycine	0.279069767442
MCPG	(rs)-̃αmethyl-4-carboxyphenylglycine	0.0232558139535
MCPG	α-methyl-4 carboxyphenylglycine	0.0232558139535
MCPG	(+)α-methyl-4-carboxyphenilglycine	0.0232558139535
MCPG	α-methyl-4-carboxyphenylglycine	0.0232558139535
MCPG	methyl-4-carboxyphenylglycine	0.0232558139535
HSV-	1	0.333333333333
HSV-	1herpes simplex virus 1	0.166666666667
HSV-	1herpes simplex virus type-1	0.333333333333
HSV-	1herpes simplex virus type 1	0.166666666667
HPI-	201	1.0
HAND	human immunodeficiency virus–associated neurological decline	1.0
VEH-ICDMSO-	injected inactive control	1.0
oSO	outer stratum oriens	1.0
BCHE-K	butyrylcholinesterase k variant	1.0
GSMG	lobal system for mobile communication	1.0
PI-6	proteinase inhibitor 6	1.0
-ISM	potassium-sensitive microelectrode	1.0
HBV	hepatitis b virus	1.0
PI-3	4,5-p3phosphatidylinositol-3,4,5-trisphosphate	0.5
PI-3	phosphatidylinositol 3′-kinase	0.5
Hepes	ph 7.4, 25 units/ml of penicillin, and 25 μg/ml of streptomycin	1.0
LC-TT	light-chain tetanus toxin	1.0
TNFSF	tumor necrosis factor superfamily	1.0
HCCO	home cage control	1.0
IFN-gamma	interferon gamma	1.0
KN-62	1-[n,o-bis(5-isoquinolinesulfonyl)-n-methyl-l-tyrosyl]-4-phenylpiperazine	0.333333333333
KN-62	1-[n,o-bis(5-isoquinoline sulfonyl)-n-methyl-l-tyrosyl]-4-phenylpiperizine	0.333333333333
KN-62	1-[n,o-bis(1,5 isoquinolinesulfonyl-n-methyl-l-tyrosol]-4-phenylpiperazine	0.333333333333
pWAT	perirenal white adipose tissue	1.0
PRPP	phosphoribosyl-pyrophosphate	0.5
PRPP	5-phosphoribosyl-1-pyrophosphate	0.5
MWT-BMehrfachwahl-Wortschatz-Intelligenztest	part b	1.0
DKOα-	neurexin double-knockout	1.0
snoRNA	small nucleolar rna	1.0
CRTH	2receptor chemoattractant receptor–homologous molecule expressed on t-helper 2 cells	1.0
PIPESpiperazine-N	n′-bis[2-ethanesulfonic-acid]	0.2
PIPESpiperazine-N	n′-bis (2-ethanesulfonic acid)	0.4
PIPESpiperazine-N	n′-bis(2-ethanesulfonic acid)	0.2
PIPESpiperazine-N	n′-bis(2-ethanesulphonic acid)	0.2
eDG	external dentate gyrus	1.0
FMFR	sfrequency modulation following responses	1.0
CRTC	2regulated transcriptional coactivator 2	0.5
CRTC	screb-regulated transcriptional coregulators	0.5
SMTS-	methylisothiourea	0.5
SMTS-	methylisothiourea sulfate	0.5
5-HTTLPR	serotonin transporter-linked polymorphic region	0.2
5-HTTLPR	5-ht transporter gene	0.2
5-HTTLPR	5-ht transporter-linked polymorphic region	0.2
5-HTTLPR	5-htt-linked promoter region	0.2
5-HTTLPR	serotonin-transporter-linked promoter region	0.2
MAGUK	membrane associated guanylate kinase	0.0769230769231
MAGUK	membrane-associated guanylate kinase homolog	0.0769230769231
MAGUK	membrane-associated guanylate kinases	0.0769230769231
MAGUK	smembrane-associated guanylate kinases	0.0769230769231
MAGUK	membrane-associated guanylate kinase	0.692307692308
COHT	chronic ocular hypertension	1.0
MDEFT	modified driven-equilibrium fourier transform	1.0
PEV	periventricular nucleus of the hypothalamus	0.5
PEV	spup-exposed virgins	0.5
M-FR-3	modified fixed ratio-3 schedule	1.0
tBHP	tert-butyl hydroperoxide	1.0
Pul	pulvinar complex	0.5
Pul	pulvinar	0.5
A-state	active state	1.0
10N	dorsal motor nucleus of the vagus	0.6
10N	dorsal motor nucleus of vagus	0.4
l-αAA	l-α-aminoadipate	1.0
DEVD	caspase-3 substrate ac-devd-pna	1.0
BSI-B	4bandeiraea simplicifolia i-isolectin b4	1.0
U46619	9,1-dideoxy-11∝-epoxymethano-prostaglandin f2∝	1.0
10E	10% ethanol	1.0
IgG	immunoglobulin g	0.894736842105
IgG	immunoglobulin	0.0877192982456
IgG	immunoglobulin class g	0.0175438596491
CNPC	onsortium for neuropsychiatric phenomics	1.0
PaLM	lateral magnocellular pvn	1.0
10R	10 min ischemia and 10 min reperfusion	1.0
IgM	immunoglobulin m	1.0
SPBT	xspb with 0.1% triton x-100	1.0
SPBS	ørensen’s phosphate buffer	0.666666666667
SPBS	orenson's phosphate buffer	0.333333333333
CFRRC-	fiber-mediated reflex responses	1.0
PKCP	rotein kinase c	1.0
MIDIM	usical instrument digital interface	1.0
PKC-γ	protein kinase c gamma	1.0
PKC-α	protein kinase c-α	0.25
PKC-α	protein kinase chain alpha	0.25
PKC-α	protein kinase c-alpha	0.5
PAPA-NONOate1-propanamine	3-(2-hydroxy-2-nitroso-1-propylhydrazino) nonoate	1.0
iC-VC	ipsilateral caudal vestibulocerebellar group	1.0
PKCC	a2+/diacylglicerol protein kinase	0.5
PKCC	a2+/phospholipid-dependent protein kinase	0.5
SHAM-PR-ENT	sham-perirhinal–entorhinal cortex lesion	1.0
TβRII	transforming growth factor-β receptor ii	0.5
TβRII	transforming growth factor-β receptor type ii	0.5
RG20	rat α2d-adrenoceptor gene	1.0
CNTFR	∝ciliary neurotrophic factor ∝ receptor	1.0
PKCI	protein kinase c inhibitor	1.0
npCDP	snegative–positive cord dorsum potentials	1.0
3-OMD	3-o-methyl-dopa	0.5
3-OMD	3-o-methyl-dihydroxyphenylalanine	0.5
3-OMG	3-o-methylglucose	1.0
FLAIR	fluid attenuated inversion recovery	0.5
FLAIR	fluid-attenuated inversion recovery	0.5
GLUT-1	endothelial glucose transporter	1.0
PPID	40 kda peptidyl-prolyl cis–trans isomerase	1.0
HAM-DH	amilton rating scale for depression	0.666666666667
HAM-DH	amilton depression scale	0.333333333333
βARβ-	adrenergic receptors	1.0
fAHP	fast after-hyperpolarisation	0.0769230769231
fAHP	fast ahp	0.0769230769231
fAHP	fast afterhyperpolarization	0.846153846154
DORδ	opioid receptor	1.0
P-ODN	phosphorothioate-modified oligodeoxynucleotides	1.0
pAMPK	phosphoampk	1.0
NS-CHOL	non-stressed cholesterol animal group	1.0
mtPTP	mitochondrial permeability transition pore	1.0
PIPESpiperazine-1	4-bis-2-ethanesulfonic acid	1.0
C-E	control rat with enriched housing	1.0
cR-VC	contralateral rostral vestibulocerebellar group	1.0
MMPIM	innesota multiphasic personality inventory	1.0
VBD	vaginal balloon distension	1.0
postCG	postcentral gyrus	1.0
SBES	mad-binding element	1.0
NPR-B	natriuretic peptide receptor b	0.666666666667
NPR-B	natriuretic peptide receptor-b	0.333333333333
NPR-C	natriuretic peptide receptor c	1.0
VBM	voxel based morphometry	0.05
VBM	voxel-based morphometry	0.95
NPR-A	natriuretic peptide receptor a	0.75
NPR-A	/b/cnatriuretic peptide receptor a/b/c	0.25
VBS	virtual boundary of stability	0.333333333333
VBS	visible burrow system	0.666666666667
FBS-MEM	minimal essential medium supplemented with 10% fetal bovine serum	1.0
VBT	ventrobasal thalamus	1.0
TEA-Cl	tetraethylammonium chloride	1.0
TfR	transferrin receptor	1.0
TLS	translocated in liposarcoma	1.0
GSCG	lasgow coma scale	1.0
DPAL	dorsal pallidum	1.0
TASK	channeltwik-related acid sensitive k+ channel	0.25
TASK	tandem of p domains in a weak inwardly-rectifying k+ channel–related acid-sensitive k+ channel	0.25
TASK	a mammallian twk potassium channel subfamily	0.25
TASK	channelstwik-related acid sensitive k channels	0.25
TASM	tendon attachment of the anterior superficial portion of the masseter muscle	1.0
HEPESHCO	(30)-free n-2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.03125
HEPESHCO	(3-)-free n-2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.96875
IFN-γRαIFN-γ	receptor α	1.0
Fos-ir	fos-immunoreactive	1.0
KGDHCα-	ketoglutarate–dehydrogenase complex	0.5
KGDHCα-	ketoglutarate dehydrogenase complex	0.5
v-GLUT	1vesicular glutamate transporter 1	1.0
PSSG	protein-glutathione mixed disulfide	1.0
βIII-	tubulinβ-tubulin isotope iii	1.0
VLSCN	ventrolateral suprachiasmatic nucleus	1.0
GLT-	1glutamate transporter protein	0.0294117647059
GLT-	1glial glutamate transporter 1	0.0294117647059
GLT-	1glutamate transporter-1	0.264705882353
GLT-	1	0.147058823529
GLT-	1glu transporter-1	0.0882352941176
GLT-	1glial glutamate transporter-1	0.0588235294118
GLT-	1glutamate transporter 1	0.323529411765
GLT-	1glutamine transporter 1	0.0294117647059
GLT-	1glutamate transporter (eaat2)	0.0294117647059
CHO-KC	hinese hamster ovary	1.0
DOXO	doxorubicin	1.0
UCNII	urocortin ii	1.0
TASR	taste receptor	1.0
PSST	prosomatostatin	1.0
ADA-ir	ada immunoreactivity	1.0
fIR	functional infrared imaging	1.0
BINT	blast-induced neurotrauma	1.0
CMTC	harcot–marie–tooth	1.0
endoN	endoneuraminidase	0.666666666667
endoN	endoneuraminidase n	0.333333333333
7DHC	7-dehydrocholesterol	1.0
CHO-K1	chinese hamster ovary-k1	0.5
CHO-K1	chinese hamster ovary cells, wild-type	0.5
endoG	endonuclease g	1.0
APVD	l-2-amino-5-phosphonovaleric acid	1.0
FLRFamide	phe-leu-arg-phe-amide	1.0
NBPV	network burst peak value	1.0
Str	striatum	0.333333333333
Str	neostriatum	0.666666666667
THDTH	deficiency	1.0
RCS	royal college of surgeons	0.75
RCS	retrocalcarine sulcus	0.25
ETYA	eicosatetraynoic acid	1.0
JNK-1	c-jun n-terminal kinase-1	1.0
MMPI-	2minnesota multiphasic personality inventory 2	1.0
HIH	uman intruder (paradigm)	1.0
mSPF	pparvocellular subparafascicular thalamic nucleus	0.333333333333
mSPF	pmedial parvocellular subparafascicular thalamic nucleus	0.333333333333
mSPF	pmedial parvicellular part of the subparafascicular thalamic nucleus	0.333333333333
ALAα-	linolenic acid	1.0
hIL-2	human interleukin-2	1.0
FPIA	fluorescence polarization immunoassay	1.0
REINST	reinstatement	1.0
ICG	intrinsic cardiac ganglia	0.5
ICG	intracardiac ganglion (ganglia)	0.5
APVd	l-aminophosphonopentanoic acid	0.166666666667
APVd	l-2-amino-5-phosphonovalerate	0.166666666667
APVd	l-2-amino-5-phosphovaleric acid	0.166666666667
APVd	l-2-amino-5-phosphonopentanoic acid	0.166666666667
APVd	l-2-amino-5-phosphonovaleric acid	0.333333333333
GFRα-2	gdnf family receptor α-2	1.0
clCP	ucaudolateral caudate-putamen	1.0
ALZET	® osmotic pump	1.0
rhIGF-	1recombinant human insulin-like growth factor-1	1.0
PVSATP	aced visual serial-addition task	1.0
cVOR	canal vestibulo-ocular reflex	1.0
NeuN	neuronal specific nuclear protein	0.0909090909091
NeuN	neuronal nuclei	0.272727272727
NeuN	neuronal nuclear protein	0.181818181818
NeuN	neuronal nuclear marker	0.0454545454545
NeuN	neuron-specific nuclear protein	0.181818181818
NeuN	neuronal nuclear antigen	0.0454545454545
NeuN	neuronal nuclei marker	0.0454545454545
NeuN	neuron-specific nucleoprotein	0.0454545454545
NeuN	neuronal-specific antigen	0.0454545454545
NeuN	neuron nuclear	0.0454545454545
S3	cytosolic fraction	1.0
MAGUKmembrane-associated	guanylate kinase-like	1.0
aSPL	anterior part of the superior parietal lobule	1.0
IκB	inhibitory protein κb	0.0909090909091
IκB	inhibitor of nuclear factor κb	0.0909090909091
IκB	inhibitor protein of κb	0.0909090909091
IκB	nf-κb inhibitor	0.0909090909091
IκB	inhibitory κb	0.0909090909091
IκB	inhibitor of nf-κb	0.272727272727
IκB	inhibitory subunit of nuclear factor-κ b	0.0909090909091
IκB	inhibitor of κb	0.181818181818
68G	a-edta68ga-ethylenediaminetetraacetic acid	1.0
RCK	regulator of potassium conductance	0.5
RCK	regulator of conductance of potassium	0.5
MRXX-	linked nonsyndromic mental retardation	1.0
GLYT2	glycine transporter, subtype 2	1.0
CRTCCREB-	regulated transcription coactivator 1	1.0
aPI	agranular posterior insular cortex	1.0
VHCVHI	contralateral, ipsilateral ventral spinal horns	1.0
FPLC	fast protein liquid chromatography	1.0
aPC	anterior pc	0.142857142857
aPC	anterior piriform cortex	0.571428571429
aPC	ddorsal part of the anterior piriform cortex	0.142857142857
aPC	anterior part of piriform cortex	0.142857142857
no-LFT	no light finger touch during either vibration or post-vibration	1.0
Tr-J	trembler-j mouse	1.0
SEMs	slow eye movements	1.0
DN-GSK-	3βdead dominant negative glycogen synthase kinase-3β mutant	1.0
TISEANTI	me series analysis	1.0
MCTH	+-lactate	1.0
STY	styloglossus muscle	1.0
N40	negative auditory evoked potential with a latency to peak of approximately 40ms	1.0
APP670671	app with the swedish (sw) mutation (670/671km→nl)	1.0
FSLMI	intmutual information based on the first spike latency for test intensity	1.0
PTST	post-traumatic stress disorder	1.0
DCKY	5,7-dichlorokynurenic acid	1.0
pro-NGF	precursor of ngf	1.0
IKL	“leak” potassium current	1.0
GFAP	glial fibrillary associated protein	0.00197044334975
GFAP	glial-fibrillar acidic protein	0.000985221674877
GFAP	glial fibrillary acidic proteins	0.000985221674877
GFAP	glial fibrillar acidic protein	0.00886699507389
GFAP	glial-fibrillary acidic protein	0.00295566502463
GFAP	glial acidic fibrillary acidic protein	0.000985221674877
GFAP	+gfap-positive	0.000985221674877
GFAP	glial fibrillar acid protein	0.00197044334975
GFAP	anti-glial fibrillary acid protein	0.00197044334975
GFAP	glial fibrillary acidic protein	0.918226600985
GFAP	glial fibrillary astrocytic protein	0.000985221674877
GFAP	glial-fibrillary-acidic-protein	0.000985221674877
GFAP	flial fibrillary acidic protein	0.000985221674877
GFAP	glial fibrillary protein	0.00295566502463
GFAP	+glial fibrillary acidic protein–positive	0.000985221674877
GFAP	glial-fibrillary acid protein	0.000985221674877
GFAP	(glial fibrillary acidic protein)	0.000985221674877
GFAP	glial acidic fibrillary protein	0.00788177339901
GFAP	glial fibril acidic protein	0.00197044334975
GFAP	glial fibrillary acid protein	0.0374384236453
GFAP	glial fribrillary acidic protein	0.000985221674877
GFAP	glial fibrillary acidic protein (astrocyte specific marker)	0.000985221674877
GFAP	glial fibrilary acidic protein	0.000985221674877
GFAP	+glial fibrillary acidic protein immunoreactive	0.000985221674877
PTSD	)	0.0166666666667
PTSD	post-traumatic stress disorder	0.666666666667
PTSD	post traumatic stress disorder	0.05
PTSD	posttraumatic stress disorder	0.25
PTSD	post-traumatic-stress-disorder	0.0166666666667
MCT-	2monocarboxylate transporter-2	1.0
6-CF	6-carboxyfluorescein	1.0
pCREB	phosphorylated cyclic amp responsive element binding protein	0.0344827586207
pCREB	phosphorylated camp-response element binding protein	0.0172413793103
pCREB	phosphorylated camp response element-binding protein	0.051724137931
pCREB	phosphorylated-creb	0.0344827586207
pCREB	phosphorylated cyclic amp-responsive element binding protein	0.0172413793103
pCREB	phosphorylated camp response-element binding	0.0172413793103
pCREB	phospho-cyclic-amp response element binding protein	0.0172413793103
pCREB	phosphorylated 3′-5′-cyclic amp response element binding protein	0.0172413793103
pCREB	phosphorylated transcription factor creb	0.0172413793103
pCREB	phosphorylated creb on serine residue 133	0.0172413793103
pCREB	phosphorylated cyclic amp-response element-binding protein	0.0172413793103
pCREB	phosphorylated-3′,5′-cyclic amp response element-binding protein	0.0172413793103
pCREB	phosphorylated cyclic amp response element binding protein	0.120689655172
pCREB	phosphorylation of camp response element-binding protein	0.0172413793103
pCREB	phospho camp response element binding protein	0.0172413793103
pCREB	phosphorylated cyclic-amp response element binding protein	0.0344827586207
pCREB	phosphorylated camp response element binding protein	0.0862068965517
pCREB	phospho-cyclic amp response element binding protein	0.0172413793103
pCREB	phosphorylated creb	0.293103448276
pCREB	phosphorylated camp response-element binding protein	0.0172413793103
pCREB	phosphorylated cyclic amp response element binding	0.0172413793103
pCREB	phosphorylated cyclic amp response element-binding protein	0.051724137931
pCREB	phospho-creb	0.0172413793103
pCREB	cyclic amp response element binding protein phosphorylation	0.0172413793103
pCREB	phosphorylation of 3′–5′-cyclic amp response element-binding	0.0172413793103
NCS-3826	7,8,9-tetrahydro-5-[h]benzocyclohepte-5-ol-4-ylidene acetic acid	0.2
NCS-3826	7,8,9-tetrahydro-5-[h]benzocycloheptene-5 ol-4-ylidene acetic acid	0.2
NCS-3826	7,8,9-tetrahydro-5-hydroxy-5h-benzocyclohept-6-ylideneacetic acid	0.2
NCS-3826	7,8,9-tetrahydro-5-[h]-benzocycloheptene-5-ol-4-ylidene acetic acid	0.4
IDD-	type potassium current	1.0
MABC-	2movement assessment battery for children – 2nd edition	1.0
ANTH	/enthap180 n-terminal homology/epsin n-terminal homology	1.0
phospho-MAPK	phosphorylated mapk	1.0
GX	superior cervical ganglionectomy	1.0
ANTA	ttention network test	1.0
NP40	nonyl phenoxy polyethoxy ethanol	1.0
CJDC	reutzfeldt-jakob’s disease	0.166666666667
CJDC	reutzfeldt-jakob disease	0.333333333333
CJDC	reutzfeldt–jakob disease	0.166666666667
CJDC	reutzfeldt-jacobs disease	0.166666666667
CJDC	reutzfeldt-jacob disease	0.166666666667
Alk	activin receptor-like kinase	1.0
RPR	response peak ratio	1.0
TTZ	tetrodotoxin	1.0
LHON	leber’s hereditary optic neuropathy	1.0
BINA	biphenyl indadone-a	1.0
CCPA	2-chloro-n6-cyclopentyladenosine	0.75
CCPA	2-chloro-n6-cyclopentyl-adenosine	0.25
ZFOR	zebrafish opioid receptor	1.0
DAMGOD-A	la(2),n-me-phe(4),gly(5)-ol]-enkephalin	1.0
DCH2F	2′,7′-dichlorodihydrofluorescein	1.0
BINP	brain injury-derived neurotrophic peptide	1.0
S-1589	serine 1589	1.0
IN-1	antibody against ni-35 and ni-250	1.0
ATG	5autophagy-related gene 5	0.5
ATG	5autophagy-related 5	0.5
ABCHRP	avidin complexed with biotinylated horseradish peroxidase	1.0
ATPe	extracellular atp	1.0
VSOAC	volume-sensitive organic anion channel	1.0
PRh	perirhinal cortex	1.0
NS-16191	3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)-phenyl]-5-(trifluoromethyl)-2h-benzimidazol-2-one	1.0
SNpc	substantia nigra–pars compacta	0.0769230769231
SNpc	substantia nigra pars compacta	0.769230769231
SNpc	sn pars compacta	0.0769230769231
SNpc	pars compacta of the substantia nigra	0.0769230769231
DMPO5	5-dimethyl-pyrroline-oxide	1.0
DMS-NN	dimethylsphingosine	1.0
MOCB	medial olivocochlear bundle	1.0
TH-IR	tyrosine hydroxylase immunoreactivity/immunoreactive	0.166666666667
TH-IR	tyrosine hydroxylase immunoreactivity	0.166666666667
TH-IR	tyrosine hydroxylase immunoreactive	0.5
TH-IR	tyrosine hydroxylase-immunoreactivity	0.166666666667
PANSS	positive and negative symptom scale	1.0
VHL-ASVHL	antisense rna	1.0
ATC	acetylthiocholine iodide	1.0
PRE	the seven onsets before the pulse	0.0769230769231
PRE	pre-stimulus air exposure	0.0769230769231
PRE	presubiculum	0.0769230769231
PRE	initial reference value	0.307692307692
PRE	0842-(4-morpholinethyl)1-phenylcyclohexanecarboxylate	0.0769230769231
PRE	progesterone-responsive element	0.0769230769231
PRE	prolonged reduced excitability	0.0769230769231
PRE	average of initial values (before drug application) of ipscs or calcium currents	0.0769230769231
PRE	initial recording session	0.0769230769231
PRE	pre-solution	0.0769230769231
PRD	post-inhibitory rebound depression	0.5
PRD	proline-rich domain	0.5
JOR	jaw opening reflex	0.333333333333
JOR	jaw-opening reflex	0.666666666667
PRF	pontine reticular formation	0.789473684211
PRF	post-inhibitory rebound firing	0.0526315789474
PRF	prefrontal cortex	0.0526315789474
PRF	partial reinforcement	0.0526315789474
PRF	plethodontid receptivity factor	0.0526315789474
PRA	prazosin hydrochloride	1.0
PRC	perirhinal cortex	0.407407407407
PRC	polycomb repressive chromatin remodeling complex	0.037037037037
PRC	precomissural nucleus	0.037037037037
PRC	2polycomb repressive complex 2	0.148148148148
PRC	)	0.037037037037
PRC	polycomb repressive complex	0.037037037037
PRC	1protein regulator of cytokinesis 1	0.037037037037
PRC	phase-response curve	0.037037037037
PRC	perirhinal cortex (dorsal/ventral)	0.037037037037
PRC	phase response curve	0.148148148148
PRC	precuneus	0.037037037037
PRM	penis retractor muscle	1.0
PRL	prolactin	0.75
PRL	photoreceptor layer	0.166666666667
PRL	koprl null-mutant	0.0416666666667
PRL	prelimbic cortex	0.0416666666667
PRO	proestrus	0.5
PRO	procaine	0.5
REV-ERBα	/βreverse erithroblastosis virus α and β	1.0
PRI	peptidecell-permeable peptide containing the rbdi of pkr	0.5
PRI	perceptual reasoning index	0.5
PRH	perirhinal	1.0
l-NIO	l-n5-(1-iminoethyl)-ornithine	0.5
l-NIO	l-n(5)-(l-iminoethyl)ornithine	0.5
PRV	pseudorabies virus	0.970588235294
PRV	pseudorabies viru	0.0294117647059
PRP	pacap-related peptide	0.1
PRP	splasticity-related proteins	0.2
PRP	plasticity-related proteins	0.1
PRP	nucleus prepositus	0.1
PRP	spdgf-responsive progenitors	0.1
PRP	platelet-rich plasma	0.4
PRS	photoreceptor synapses	1.0
PRR	pattern recognition receptors	0.5
PRR	proline-rich region	0.5
LOTN	lateral olfactory tract nucleus	1.0
rMAO	rostral part of the medial accessory olive	1.0
GABARAPL	1	0.5
GABARAPL	1gaba(a) receptor-associated protein like 1	0.5
PBS-BT	phosphate-buffered saline containing 0.1% bovine serum albumin and 0.5% triton x-100	0.25
PBS-BT	phosphate-buffered saline+0.25% bovine serum albumin+0.1% triton x-100	0.25
PBS-BT	pbs with added bsa and triton x-100	0.25
PBS-BT	0.1% bovine serum albumin (bsa) and 0.3% triton x-100 in phosphate buffered saline	0.25
PRZ	prazosin	1.0
hAFC	shuman amniotic fluid-derived cells	1.0
ISP	isoproterenol	1.0
D3V	dorsal third ventricle	0.5
D3V	dorsal third ventrical	0.5
ZIPM	yr-ser-ile-tyr-arg-arg-gly-ala-arg-arg-trp-arg-lys-leu-oh	1.0
NEAA	non-essential amino acid	1.0
PR-	irpr-immunoreactivity	0.5
PR-	irprogesterone receptor-immunoreactive	0.5
HLA-DR	human leukocyte antigen dr	1.0
SSCx	primary somatosensory cortex	1.0
MAS	matsunami adhesive silane	0.25
MAS	oscillation strength	0.25
MAS	anterior superficial masseter muscle	0.5
HDRSH	amilton depression rating scale	1.0
TBSTTBS	containing tween 20	0.0769230769231
TBSTTBS	containing 0.5% triton x-100	0.0769230769231
TBSTTBS	containing 0.05% tween-20	0.0769230769231
TBSTTBS	containing 0.02% tween	0.0769230769231
TBSTTBS	containing 0.05% tween	0.0769230769231
TBSTTBS	plus 0.05% tween 20	0.0769230769231
TBSTTBS	supplemented with 0.05% tween 20	0.0769230769231
TBSTTBS	with 0.05% tween-20	0.0769230769231
TBSTTBS	containing 0.3% triton x-100	0.0769230769231
TBSTTBS	containing 1% triton x 100	0.0769230769231
TBSTTBS	containing 0.1% tween-20	0.153846153846
TBSTTBS	+tween	0.0769230769231
TALKTWIK-	related alkaline ph-activated k+ channel	1.0
L-NMMA	ng-monomethyl-l-arginine	1.0
FAC	ferric ammonium citrate	1.0
tTA	transactivating molecule	0.2
tTA	tetracycline-controlled transactivator	0.2
tTA	tetracycline transactivator	0.2
tTA	tetracycline dependent transactivator	0.2
tTA	tetracycline-repressive transcription factor	0.2
HFIP1	1,1,3,3,3-hexafluoro-2-propanol	1.0
tTG	tissue transglutaminase	1.0
VGAT	vesicular inhibitory transmitter transporter	0.0277777777778
VGAT	vesicular gaba transporter	0.972222222222
MAT	mechanical activation threshold	0.5
MAT	medial anterior thoracic	0.5
nmNSC	snon mesencephalic neural stem cells	1.0
ISK	small-conductance k+ current	1.0
SSCP	single strand conformation polymorphism	1.0
II-	zebrin ii-immunonegative	1.0
TBDMSC	ltert-butyldimethylsilyl chloride	1.0
uIPSC	unitary inhibitory postsynaptic current	0.5
uIPSC	sunitary inhibitory postsynaptic currents	0.5
1C	2expanded polyglutamine	1.0
Leu-ENK	leucine-enkephalin	1.0
OLIG	2oligodendrocyte transcription factor 2	1.0
SNN	spectrum of the neural noise	1.0
FNDF	os numerical density	1.0
CPAN6-cyclopentyladenosine	an a1 receptor agonist	1.0
SMOC	sspontaneous miniature outward currents	0.5
SMOC	spontaneous miniature outward current	0.5
FNDC	5fibronectin type iii domain containing 5	1.0
SNAP	s-nitroso-n-acetyl-d-penicillamine	0.0227272727273
SNAP	51141-[2-[tris(4-methoxyphenyl)methoxy]ethyl]	0.0227272727273
SNAP	synaptosome-associated protein	0.0454545454545
SNAP	25synaptosomal-associated protein-25	0.0227272727273
SNAP	compound sensory nerve action potentials	0.0227272727273
SNAP	25	0.0227272727273
SNAP	25 gene expression	0.0227272727273
SNAP	synaptosomal-associated protein	0.0454545454545
SNAP	stage-specific neurite-associated protein	0.0227272727273
SNAP	(s)-nitroso-n-acetylpenicillamine	0.0227272727273
SNAP	s-nitroso-n-penicillamine	0.0227272727273
SNAP	25synaptosome-associated protein 25	0.0227272727273
SNAP	synaptosomal-associated protein 25	0.0227272727273
SNAP	soluble n-ethylmaleimide-sensitive fusion protein attachment protein	0.0227272727273
SNAP	soluble nsf attachment proteins	0.0227272727273
SNAP	s-nitroso-n-acetyl-d,l-penicillamine	0.0454545454545
SNAP	25synaptosomal-associated protein of 25 kd	0.0227272727273
SNAP	s-nitroso-n-acetyl-dl-penicillamine	0.0454545454545
SNAP	soluble nsf sensitive attachment protein	0.0227272727273
SNAP	soluble nsf attachment protein	0.113636363636
SNAP	25synaptosomal-associated protein of 25 kda	0.0227272727273
SNAP	s-nitroso-acetyl-penicillamine	0.0227272727273
SNAP	s-nitroso-n-acetylpenicillamine	0.113636363636
SNAP	n-acetyl-s-nitroso-d-penicillamine	0.0227272727273
SNAP	25synaptosomal-associated protein 25	0.0681818181818
SNAP	sensory nerve action potential	0.0227272727273
SNAP	soluble nsf-attachment protein	0.0227272727273
SNAP	s-nitroso-n-acetyl-penicillamine	0.0227272727273
SNAP	s-nitroso-penicillamine	0.0227272727273
SNAP	sensory nerve action potentials	0.0227272727273
I-80	alternatively spliced embryonic gad67 mrna containing the 80 bp-long exon 7/a	1.0
SNAS	ambucus nigra agglutinin	1.0
SNAT	2sodium-coupled neutral amino-acid transporter member 2	0.166666666667
SNAT	2	0.166666666667
SNAT	sna+-coupled neutral amino acid transporters	0.166666666667
SNAT	1sodium-coupled neutral amino acid transporter 1	0.166666666667
SNAT	2sodium-coupled amino acid transporter 2	0.166666666667
SNAT	2sodium-dependent neutral amino-acid transporter	0.166666666667
SSCN	acl na-citrate	1.0
ISN	temperature insensitive neuron	0.5
ISN	inhibitory synaptic noise	0.5
1G	normogravity	1.0
MUTC	av1.2dhp-/- mice	1.0
GCHGTP	cyclohydrolase i	1.0
FUA	10μm 5-fluoro-2-desoxyuridine, 10μm uridine and 10μm cytosine-β-d-arabino-furanoside hydrochloride	1.0
SS-	14somatostatin-14	0.5
SS-	28somatostatin-28	0.5
ω-GVIA	ω-conotoxin gvia	1.0
RNAi	consists of approximately 21 nt rna strands, in duplex or single-stranded form	1.0
1H	magnetic resonance spectroscopy	0.2
1H	mrsproton magnetic resonance spectroscopy	0.4
1H	nmrhydrogen-1 nuclear magnetic resonance	0.2
1H	z-ltdlow frequency-induced long-term depression	0.2
dMSCS	chwann cell-like differentiated bone marrow-derived mesenchymal stem cell	1.0
NLm	magnocellular region of the nucleus lateralis	1.0
PDCL-trans-pyrrolydine-2	4-dicarboxylate	1.0
NLP	no light pulse	1.0
NLS	nuclear localization sequence	0.222222222222
NLS	nuclear localization signals	0.111111111111
NLS	nuclear localization signal motif	0.0555555555556
NLS	nuclear localization signal	0.611111111111
BSTpr	principal bed nucleus of the stria terminalis	1.0
NLV	lateral nucleus of the valvula	1.0
HMT	shistone lysine methyltransferases	0.25
HMT	histamine n-methyltransferase	0.25
HMT	shistone methyltransferases	0.25
HMT	shistone methyl transferases	0.25
NLX	naloxone hydrochloride	0.5
NLX	naloxone	0.5
HMW	high-molecular-weight	0.375
HMW	high molecular weight form	0.125
HMW	high molecular weight	0.5
SNT	sciatic nerve transection	0.5
SNT	spinal nerve transection	0.5
DL-	2-amino-5-phosphonovaleric acid	1.0
TRAAKTWIK-	1 related arachidonic acid-stimulated potassium channel	0.5
TRAAKTWIK-	related arachidonic acid-stimulated k+ channel	0.5
HMN	hypoglossal motoneuron	0.5
HMN	hypoglossal motor nucleus	0.5
MAP2ab	a and b isoforms of microtubule-associated protein 2	1.0
TKR	tyrosine kinase receptor	1.0
MERF	methionine enkephalin-arg-phe	1.0
NLF	non-linear forecasting	1.0
HMD	head mounted display	1.0
HME	hemimegalencephaly	1.0
HMG	high-mobility group	0.333333333333
HMG	high mobility group	0.5
HMG	high-mobility-group	0.166666666667
NLL	nucleus of the lateral lemniscus	0.75
NLL	nuclei of lateral lemniscus	0.25
MAD	median absolute deviation	1.0
DLC	2adynein light chain 2 a	0.5
DLC	desmosome-like contact	0.5
DLB	ppure form of dementia with lewy bodies	0.0714285714286
DLB	dementia with lewy bodies	0.785714285714
DLB	dementia with lb	0.0714285714286
DLB	dorsal lateral geniculate nucleus	0.0714285714286
DLA	nucleus dorsolateralis anterior	1.0
DLG	dorsal-lateral geniculate nucleus	0.05
DLG	dorsal lateral geniculate nuclei	0.05
DLG	dorsal lateral geniculate nucleus	0.6
DLG	discs large	0.05
DLG	dorsal geniculate	0.05
DLG	dorsolateral geniculate nucleus	0.05
DLG	dorsolateral geniculate	0.05
DLG	dorsal lateral geniculate	0.1
MAG	smyelin-associated glycoproteins	0.0384615384615
MAG	myelin associated glycoprotein	0.0769230769231
MAG	myelin-associated glycoprotein	0.769230769231
MAG	3-methyladenine dna glycosylase	0.0384615384615
MAG	monoacylglyceride	0.0384615384615
MAG	nucleus magnocellularis	0.0384615384615
DLE	dorsal lateral entorhinal field	1.0
DLD	dim light:dark	1.0
GIRKG	protein-regulated inwardly rectifying potassium channel	0.111111111111
GIRKG	protein coupled inward rectifying k+ channel or current	0.111111111111
GIRKG	protein-gated inwardly rectifying potassium channels	0.111111111111
GIRKG	protein-activated inwardly rectifying k+ channels	0.111111111111
GIRKG	protein-coupled inwardly rectifying k+ channel	0.111111111111
GIRKG	protein–coupled inwardly rectifying k+ channel	0.111111111111
GIRKG	protein–dependent inward rectifier k+	0.111111111111
GIRKG	protein-coupled inward rectifier potassium channel	0.111111111111
GIRKG	proteins that activate inwardly rectifying k+ channels	0.111111111111
DLH	dl-homocysteic acid	0.454545454545
DLH	d,l-homocysteic acid	0.454545454545
DLH	dorsal lateral hump	0.0909090909091
DLO	dorsolateral orbital cortex	0.857142857143
DLO	dorsolateral orbitofrontal cortex	0.142857142857
SSp	primary somatosensory	0.5
SSp	primary somatosensory area	0.5
DLM	medial portion of dorsolateral thalamus	0.1
DLM	dorsal longitudinal muscle	0.1
DLM	nucleus dorsolateralis anterior thalami, pars medialis	0.1
DLM	dorsolateral nucleus of the medial thalamus	0.1
DLM	dorsolateral thalamic nucleus	0.1
DLM	medial nucleus of the dorsolateral thalamus	0.1
DLM	dorsal lateral nucleus of the medial thalamus	0.1
DLM	dorsolateral mesencephalon	0.2
DLM	dorsolateral anterior thalamic nucleus	0.1
DLL	dorsal nucleus of lateral lemniscus	0.111111111111
DLL	dorsal nu lateral lemniscus	0.111111111111
DLL	4delta-like protein 4	0.111111111111
DLL	drosophila distal-less	0.111111111111
DLL	dorsal nucleus of the lateral lemniscus	0.555555555556
DLS	dorsolateral striatum	0.571428571429
DLS	tdorsolateral striatum	0.142857142857
DLS	vls, dorsal and ventral lateral suprasylvian areas	0.142857142857
DLS	dorsal lateral septum	0.142857142857
NSC-	34neuroblastoma-spinal cord subclones 34	1.0
RNA-	binding proteins	0.6
RNA-	binding protein	0.4
SP-R	short photoperiod-refractory (short photoperiod during 26 weeks)	1.0
IL-β	release	1.0
DLU	digital light units	1.0
DLT	dorsolateral tegmentum	1.0
FMEVF	riend mink cell focus forming/murine embryonic stem cell virus	1.0
DLX	2	1.0
IGF-	1rreceptor for igf-1	0.0204081632653
IGF-	1rigf-1 receptor	0.0204081632653
IGF-	1insulin like growth factor-1	0.0408163265306
IGF-	1rinsulin-like growth factor-1 receptor	0.0204081632653
IGF-	1insulin-like growth factor-i	0.0408163265306
IGF-	2insulin-like growth factor 2	0.0204081632653
IGF-	1	0.142857142857
IGF-	1insulin-like growth factor i (protein)	0.0204081632653
IGF-	1rinsulin-like growth factor 1 receptor	0.0204081632653
IGF-	1insulin-like growth factor 1	0.224489795918
IGF-	1insulin-like growth factor-1	0.367346938776
IGF-	1insulin-like-growth factor 1	0.0204081632653
IGF-	1insulin growth factor 1	0.0204081632653
IGF-	1-rαinsulin-like growth factor-1 receptor α	0.0204081632653
t-ADA	trans-azetidine-2,4-dicarboxylic acid	1.0
NGX	transection of the ipsilateral vagus nerve between the nodose ganglion and the brain	1.0
sGCα	1soluble guanylate cyclase α1	1.0
SSX	somatosensory cortex	1.0
SSZ	shear stress zone	0.333333333333
SSZ	sulfasalazine group	0.333333333333
SSZ	sulfasalazine	0.333333333333
SST	somatostatin	0.791666666667
SST	synacthen stimulation test	0.0416666666667
SST	stop signal task	0.0416666666667
SST	stop-signal task	0.0833333333333
SST	total sum of squares	0.0416666666667
SSV	small synaptic vesicles	0.166666666667
SSV	small synaptic vesicle	0.666666666667
SSV	ssmall synaptic vesicles	0.166666666667
SAAS	arpvkeprslsaasaplaetstplrl	1.0
SSP	sweet solution preference	0.4
SSP	spindle stimulation pattern	0.2
SSP	very short photoperiod ld6:18	0.2
SSP	stable substance p	0.2
SSS	sensory specific satiety	0.166666666667
SSS	sinus sagittalis superior	0.0833333333333
SSS	standard salt solution	0.0833333333333
SSS	superior sagittal sinus	0.5
SSS	sensation-seeking scale	0.0833333333333
SSS	salt-sensitive rat given high salt diet	0.0833333333333
SSR	simple sequence repeat	0.142857142857
SSR	180711	0.142857142857
SSR	subsynaptic reticulum	0.142857142857
SSR	5047342-chloro-n-[(s)-phenyl[(2s)-piperidin-2-yl] methyl]	0.142857142857
SSR	steady-state response	0.142857142857
SSR	succinic semialdehyde reductase	0.142857142857
SSR	separation stress+short reunion	0.142857142857
SSM	serum-supplemented medium	1.0
PVY	potato virus y	1.0
BSCB	blood–spinal cord barrier	1.0
SSN	superior salivary nucleus	0.25
SSN	salt-sensitive rat given normal salt diet	0.25
SSN	superior salivatory nucleus	0.25
SSN	short-shaft neurons	0.25
SSI	steady state inactivation	0.111111111111
SSI	sciatic static index	0.333333333333
SSI	small slow inward current	0.111111111111
SSI	surround selectivity index	0.111111111111
SSI	steady-state inactivation	0.111111111111
SSI	primary somatosensory cortex	0.111111111111
SSI	subfield size index	0.111111111111
Gi	gigantocellular reticular nucleus	0.333333333333
Gi	gigantocellular nucleus	0.666666666667
GLAST	glial glutamate-aspartate transporter	0.0222222222222
GLAST	glutamate-aspartate-transporter	0.0222222222222
GLAST	glutamate-aspartate transporter 1	0.0222222222222
GLAST	glial glutamate transporter	0.0222222222222
GLAST	l-glutamate/l-aspartate transporter	0.0666666666667
GLAST	glutamate-aspartate transporter	0.2
GLAST	rat glutamate/aspartate transporter	0.0222222222222
GLAST	glutamate aspartate transporter	0.222222222222
GLAST	glutamate/aspartate transporter	0.266666666667
GLAST	glial high affinity glutamate transporter (protein name)	0.0222222222222
GLAST	astrocyte-specific glutamate transporter	0.0222222222222
GLAST	glutamate–aspartate transporter	0.0666666666667
GLAST	l-glutamate-l-aspartate transporter	0.0222222222222
SSE	sum of squared errors	0.2
SSE	synaptically-induced suppression of excitation	0.2
SSE	steady state error	0.2
SSE	sum of squares error	0.2
SSE	sum of squared error	0.2
SSD	stop signal delay	0.3
SSD	stop-signal delay	0.2
SSD	specific signal density	0.3
SSD	subsynaptic density	0.1
SSD	single social defeat	0.1
SSG	suprasylvian gyrus	1.0
EBME	agle's basal medium	1.0
SSA	succinic semialdehyde	0.166666666667
SSA	steady state activation	0.166666666667
SSA	stimulus-specific adaptation	0.333333333333
SSA	steady-state activation	0.166666666667
SSA	sodium sulfosalicylate dihydrate	0.166666666667
SAAB	saline infusion in aab version	1.0
SSC	150mm sodium chloride–15mm sodium citrate	0.00197628458498
SSC	300mm sodium chloride/30mm sodium citrate	0.00197628458498
SSC	citrate buffer	0.00197628458498
SSC	saline-sodium citrate	0.0296442687747
SSC	sodium chloride–sodium citrate	0.0098814229249
SSC	secondary sexual characteristic	0.00197628458498
SSC	saline sodium citrate solution	0.00197628458498
SSC	side scattering	0.00197628458498
SSC	saline–sodium citrate buffer	0.00592885375494
SSC	saline plus sodium citrate	0.00197628458498
SSC	saline/sodium citrate buffer	0.00395256916996
SSC	xsomato-sensory cortex	0.00197628458498
SSC	side scatter	0.00395256916996
SSC	saline-sodium citrated	0.00197628458498
SSC	standard saline citrate (sodium chloride–sodium citrate)	0.00197628458498
SSC	sodium chloride–sodium citrate buffer	0.0138339920949
SSC	saline citrate buffer	0.00197628458498
SSC	sodium dodecyl sulfate	0.00197628458498
SSC	saline sodium citrate buffer (1×ssc contains 0.15 m nacl and 0.15 m sodium citrate)	0.00197628458498
SSC	sodium chloride/sodium citrate	0.0256916996047
SSC	standard saline citrate	0.5
SSC	standard saline/citrate	0.00197628458498
SSC	saline sodium citrate	0.185770750988
SSC	sodium saline citrate	0.0158102766798
SSC	standard saline citrate (ph 7.2)	0.00197628458498
SSC	saline-sodium citrate buffer	0.0158102766798
SSC	saline–sodium citrate	0.00790513833992
SSC	skin-derived stem/progenitor cell	0.00197628458498
SSC	superficial layer of the superior colliculus	0.00197628458498
SSC	superficial superior colliculus	0.00197628458498
SSC	subsurface cisterns	0.00197628458498
SSC	superficial sc	0.00197628458498
SSC	nacl, sodium citrate	0.00197628458498
SSC	sodium saline chloride	0.00197628458498
SSC	50% formamide saline–sodium citrate buffer	0.00197628458498
SSC	sodium chloride sodium citrate	0.00790513833992
SSC	standard sodium citrate	0.0375494071146
SSC	sodium citrate sodium chloride	0.00197628458498
SSC	standard saline citrate buffer	0.0237154150198
SSC	2× saline sodium citrate	0.00197628458498
SSC	sodium citrate chloride	0.00197628458498
SSC	saline/sodium citrate	0.00395256916996
SSC	somatosensory cortex	0.00790513833992
SSC	steady state current	0.00197628458498
SSC	saline-sodium phosphate	0.00197628458498
SSC	trisodium citrate dihydrate	0.00197628458498
SSC	salt sodium citrate	0.00395256916996
SSC	standard sodium chloride–sodium citrate	0.00197628458498
SSC	sodium chloride/sodium citrate buffer	0.00592885375494
SSC	sodium citrate buffer	0.00395256916996
SSC	salt and sodium citrate solution	0.00197628458498
SSC	sodium chloride and sodium citrate	0.00395256916996
SSC	saline citrate	0.00197628458498
SSC	saline sodium chloride	0.00197628458498
SSC	salt–sodium citrate buffer	0.00197628458498
SSC	standard sodium citrate buffer	0.00197628458498
SSC	sodium citrate/sodium chloride	0.00197628458498
SSC	saline sodium citrate buffer	0.0118577075099
SSB	ssingle-strand breaks	0.25
SSB	single strand break	0.125
SSB	scalp-skull-brain	0.25
SSB	ssingle-stranded breaks	0.125
SSB	single-synapse bouton	0.125
SSB	single-strand break	0.125
TNF-R	tumor necrosis factor-receptor	0.25
TNF-R	1tnf-receptor 1	0.25
TNF-R	1tumor necrosis factor-receptor 1	0.25
TNF-R	tumor necrosis factor receptors	0.25
TTX-RTTX-	resistant	1.0
BSRB	ayesian sequential risk-taking model	1.0
ECl	chloride equilibrium potential	1.0
MesV	mesencephalic trigeminal nucleus	1.0
iDMH	ipsilateral dorsomedial hypothalamus	0.5
iDMH	dorsomedial hypothalamus ipsilateral	0.5
ECu	external cuneate nucleus	1.0
CA-MEK	1constitutively active-mek1	1.0
RMg	raphe magnus nucleus	1.0
F3A-MT	mock-transfected cells	0.5
F3A-MT	mock-transfected (control) cells	0.5
LSb	nucleus accumbens shell near the lateral septum border	1.0
PBS-TXPBS	containing triton x-100 0.3%	0.333333333333
PBS-TXPBS	/0.3% triton x-100	0.333333333333
PBS-TXPBS	with 0.1% triton x-100	0.333333333333
ECG	electrocardiographic activity	0.027027027027
ECG	electrocardiography	0.027027027027
ECG	electrocardiographic	0.027027027027
ECG	etiocholan-3α-ol-17-one glucuronide	0.027027027027
ECG	electrocardiogram	0.891891891892
RMS	root mean squared	0.010752688172
RMS	root mean square value	0.010752688172
RMS	root mean square	0.344086021505
RMS	rostral-migratory stream	0.010752688172
RMS	root mean squares	0.010752688172
RMS	root-mean-square	0.0430107526882
RMS	rostro-migratory stream	0.010752688172
RMS	rostral migratory stream	0.559139784946
RMP	resting member potential	0.0128205128205
RMP	resting membrane potential (mv)	0.0128205128205
RMP	resting membrane potential	0.948717948718
RMP	resting membrane potentials	0.025641025641
ECD	ethylene dicysteinate	0.025641025641
ECD	excitotoxic cell death	0.025641025641
ECD	)	0.025641025641
ECD	high-performance liquid chromatography system with electrochemical detection	0.025641025641
ECD	equivalent current dipole	0.512820512821
ECD	sequivalent current dipoles	0.025641025641
ECD	electrochemical detection	0.307692307692
ECD	electrochemical detector	0.0512820512821
ECB	endocannabinoid	1.0
RMT	right middle temporal gyrus	0.0666666666667
RMT	grostromedial tegmental nucleus	0.466666666667
RMT	resting motor threshold	0.466666666667
ECN	eyes closed on normal	0.333333333333
ECN	external cuneate nucleus	0.666666666667
ECM	extra-cellular matrix	0.0128205128205
ECM	extracellular matrix protein	0.0128205128205
ECM	extracellular matrix	0.974358974359
ECL	excitation chemiluminescence	0.00990099009901
ECL	enhanced chemoluminescence	0.049504950495
ECL	enterochromaffin-like	0.00990099009901
ECL	enhanced chemiluminescence	0.663366336634
ECL	chemiluminescence	0.00990099009901
ECL	ec lesion	0.00990099009901
ECL	entorhinal cortex, caudal limiting subfield	0.00990099009901
ECL	enhanced chemiluminescent substrate	0.00990099009901
ECL	enhanced chemiluminescent	0.029702970297
ECL	enhanced chemiluminesence	0.00990099009901
ECL	enterochromaffin-like (cells)	0.00990099009901
ECL	enhanced chemo-luminescence	0.00990099009901
ECL	enhanced chemi luminescence	0.019801980198
ECL	lesion of the entorhinal cortex	0.00990099009901
ECL	electrochemical luminescence	0.00990099009901
ECL	enhanced chemiluminescence associated with horseradish peroxidase-catalyzed oxidation of luminol	0.00990099009901
ECL	entorhinal cortex lesion	0.0792079207921
ECL	electrochemiluminescence	0.039603960396
KORκ	opioid receptor	0.75
KORκ	opioid receptors	0.25
LNS	lesch nyhan syndrome	1.0
RMC	reticular nucleus	0.2
RMC	magnocellular part of the red nucleus	0.2
RMC	ramified microglial cells	0.2
RMC	red nucleus magnocellular	0.4
ECU	musculus extensor carpi ulnaris	1.0
ECT	electroconvulsive therapy	0.583333333333
ECT	electron cryotomography	0.0833333333333
ECT	ectorhinal cortex	0.0833333333333
ECT	electroconvulsive shock therapy	0.166666666667
ECT	electroconvulsive treatment	0.0833333333333
ECS	extracellular space	0.224489795918
ECS	extracellular solution	0.183673469388
ECS	electroconvulsive stimulation	0.0204081632653
ECS	electroshock	0.0204081632653
ECS	emotional contagion scale	0.0204081632653
ECS	endocannabinoid system	0.183673469388
ECS	minimal electroconvulsive shock	0.0204081632653
ECS	endocannabinoid system of the brain	0.0204081632653
ECS	electroconvulsive shock	0.244897959184
ECS	electroconvulsive seizures	0.0204081632653
ECS	electroconvulsive seizure	0.0408163265306
ECR	extensor carpi radialis longus	0.2
ECR	extensor carpi radialis	0.6
ECR	enhanced chemiluminescence reagent	0.2
RMD	reverse monocular deprivation	1.0
RME	reference memory errors	0.222222222222
RME	reference memory error	0.777777777778
BAFFB	cell-activating factor of the tumor necrosis factor family	1.0
RMN	rostral mesencephalic neurons	0.25
RMN	rolling mouse nagoya	0.5
RMN	raphe magnus nucleus	0.25
BLASTB	asic local alignment search tool	1.0
RMM	rostral medial medulla	1.0
TRIM	1-[2-(trifluoromethyl)phenyl] imidazole	0.2
TRIM	1-(2-trifluoromethylphenyl) imidazole	0.2
TRIM	1-(2-trifluoro-methylphenyl) imidazole	0.2
TRIM	1-(2-trifluoromethylphenyl)imidazole	0.4
BBN	broadband noise	0.5
BBN	broadband noises	0.125
BBN	broad band noise	0.375
imidazoline-I	2-receptors	1.0
BBG	brilliant blue g	1.0
IKKβ	/nf-κb	1.0
DAND	ivers alert network	1.0
VTApb	parabrachial ventral tegmental area	1.0
BBB	blood-brain barrier	0.0846774193548
BBB	blood–brain barrier	0.806451612903
BBB	asilen blue	0.00403225806452
BBB	brain–blood barrier	0.0120967741935
BBB	blood–brain-barrier	0.0241935483871
BBB	ilobalide	0.00403225806452
BBB	scale	0.00403225806452
BBB	blood brain barrier	0.0604838709677
GBLγ-	hydroxybutyrate lactone	0.5
GBLγ-	butyrolactone	0.5
CIBT	cold injury-induced brain trauma	1.0
BBS	bicarbonate-buffered saline	1.0
BBR	brain–behavior relationship	1.0
TRIS	tris(hydroxymethyl)aminomethane phosphate	0.5
TRIS	tris(hydroxymethyl)aminomethane	0.5
vCA	3ventral field 3 of ammon’s horn	1.0
GRGSH	reductase	1.0
shRNA	ishort hairpin rna interference	0.05
shRNA	or microrna from longer transcripts from micro genes	0.05
shRNA	small hairpin rna	0.25
shRNA	short-hairpin rna	0.1
shRNA	short hairpin rna	0.45
shRNA	short hairpin ribonucleic acid	0.1
preproN	/ofqprepronociceptin	1.0
PVM	nucleus periventricularis magnocellularis	1.0
HBMHEPES-	buffered medium	1.0
TCP-	1t-complex protein 1	1.0
NMDA-RNMDA	receptor	0.333333333333
NMDA-RNMDA	receptors	0.666666666667
NF-200	neurofilament protein	0.5
NF-200	neural filament of 200,000 mol. wt	0.5
H2O	10 ml hanks' balanced salt solution (ca2+ and mg2+-free) 10×, 1 ml hepes buffer, 1.0 m, ph 7.3, 1 ml antibiotic/antimycotic 100× liquid	1.0
NMDAR-EPSC	sexcitatory postsynaptic currents mediated by n-methyl-d-aspartate subclass of glutamate receptors	1.0
APSP	sartificial excitatory postsynaptic potentials	1.0
β-NADPHβ-	nicotinamide adenine dinucleotide phosphate diaphorase	1.0
DRLD	riven right leg	1.0
ZnT3	zinc transporter-3	1.0
NG-DAN	ewport green–diacetate	1.0
LTPL	ong term potentiation	0.666666666667
LTPL	ong-term potentiation	0.333333333333
BSRT	buschke’s selective reminding test	1.0
PePOA	periventricular preoptic area	1.0
LTPK	long-term potentiation induced by tea application	1.0
iso-OMPA	tetraisopropylpyro-phosphoramide	0.5
iso-OMPA	tetraisopropylpyrophosphoramide	0.5
POm	matrix region of the po	1.0
DH-β-E	dihydro-β-erythroidine	1.0
3nVK	analogue. it was created by replacing the central methylene group of analogue 2j with a carbonyl group	1.0
pVTA	posterior ventral tegmental area	0.5
pVTA	posterior vta	0.5
PDZPSD-	95/dlg/zo-1	0.5
PDZPSD-	95/discs large/zona occludens 1	0.5
dPAG	dorsal subdivision of periaqueductal gray matter	0.1
dPAG	dorsal half of the midbrain periaqueductal gray matter	0.1
dPAG	dorsolateral periaqueductal gray	0.1
dPAG	dorsal periaqueductal grey	0.1
dPAG	dorsal column of the periaqueductal gray matter	0.1
dPAG	dorsal periaqueductal gray matter	0.2
dPAG	dorsal periaqueductal gray	0.2
dPAG	dorsal pag	0.1
CRFOE	corticotropin-releasing factor overexpressing transgene	1.0
CYS	cysteine	1.0
p-SPS	partial sps	1.0
CYP	2d6cytochrome p450 2d6	0.0588235294118
CYP	[125i]	0.0588235294118
CYP	cytochrome p450 epoxygenases	0.0588235294118
CYP	2c11cytochrome p450 2c11	0.0588235294118
CYP	2e1cytochrome p450 2e1	0.0588235294118
CYP	cyclophosphamide	0.294117647059
CYP	7b1oxysterol 7α-hydroxylase	0.0588235294118
CYP	2c13/2c6	0.0588235294118
CYP	19cytochrome p450 19	0.0588235294118
CYP	cytochrome p450	0.235294117647
POZ	bric-a-brac tramtrack broad complex/pox virus and zinc finger	0.5
POZ	/btbpox virus and zinc finger/bric-a-brac tramtrack broad complex	0.5
FK-	506	1.0
CYT	cytisine	1.0
POW	partition coefficient between n-octanol and water	0.5
POW	postoperative week	0.5
NPAN	non-periodic activity neuron	1.0
POR	postrhinal cortex	0.857142857143
POR	peripheral opioid receptor	0.142857142857
POS	parieto-occipital sulcus	1.0
POP	pseudo-one-pulse	0.25
POP	prolyl oligopeptidase	0.75
PON	posterior octavomotor nucleus	0.333333333333
PON	periolivary nuclei	0.333333333333
PON	pons	0.333333333333
POL	γpolymerase γ	1.0
POM	medial preoptic nucleus	0.777777777778
POM	nucleus preopticus medialis	0.111111111111
POM	posteromedial nucleus of the thalamus	0.111111111111
CYF	control young females	1.0
POH	preopto-hypothalamic area	1.0
DARPP	32	0.2
DARPP	dopamine and camp-regulated phosphoprotein	0.2
DARPP	32dopamine- and camp-regulated neuronal phosphoprotein	0.2
DARPP	cyclic amp-regulated phosphoprotein	0.2
DARPP	dopamine- and cyclic amp-regulated phosphoprotein	0.2
POD	post-operative day	0.272727272727
POD	postoperation day	0.0909090909091
POD	horseradish peroxidase	0.0909090909091
POD	peroxidease	0.181818181818
POD	postoperative day	0.363636363636
IKI	inter-keystroke interval	1.0
POC	(also poc)commissural preoptic area (or commissural septo-preoptic area)	0.25
POC	parietal–occipital cortex	0.25
POC	primary olfactory cortex	0.25
POC	primary olfactory cortex/piriform cortex	0.25
CYM	control young males	1.0
POA	preoptic area	0.887096774194
POA	medial preoptic area	0.0161290322581
POA	preoptic area of the hypothalamus	0.0322580645161
POA	periodic oscillatory activity	0.0161290322581
POA	preoptic hypothalamic area	0.0161290322581
POA	preoptic area (rostral)	0.0161290322581
POA	/ahpreoptic/anterior hypothalamic area	0.0161290322581
CY3	cyanine-3	0.75
CY3	indocarbocyanine	0.25
SMEI	severe myoclonic epilepsy of infancy	1.0
DAT-KD	dopamine transporter knockdown	1.0
PO4	phosphate buffer	1.0
LiPC	lithium-pilocarpine	1.0
PO-	animals exposed to a neutral odour source	1.0
CART	cocaine- and amphetamine-related transcript	0.0238095238095
CART	cocaine and amphetamine regulated transcript	0.0952380952381
CART	cocaine-amphetamine related transcript	0.0238095238095
CART	cocaine amphetamine regulated transcript	0.0238095238095
CART	cocaine/amphetamine-regulated transcript	0.0238095238095
CART	cocaine- and amphetamine-regulated transcript peptide	0.047619047619
CART	cocaine- and amphetamine-regulated transcript	0.5
CART	cocaine and amphetamine-regulated transcript	0.047619047619
CART	ircart immunoreactive	0.0238095238095
CART	cocaine-and-amphetamine-regulated transcript	0.0238095238095
CART	cocaine amphetamine-regulated transcript	0.0238095238095
CART	cocaine–amphetamine-regulated transcript	0.0238095238095
CART	cocaine-amphetamine-regulated transcript	0.0238095238095
CART	cocaine and amphetamine-related transcript	0.0238095238095
CART	pcocaine- and amphetamine-regulated transcript peptide	0.047619047619
CART	pcocaine- and amphetamine-regulated-transcript peptide	0.0238095238095
PSA-NCAM	polysialated neuronal cell adhesion molecule	0.016393442623
PSA-NCAM	polysialylated form of the neural cell adhesion	0.016393442623
PSA-NCAM	polysialylted neural cell adhesion molecule	0.016393442623
PSA-NCAM	polysialylated form of the neuronal cell adhesion molecule	0.016393442623
PSA-NCAM	polysialylated isoform of ncam	0.016393442623
PSA-NCAM	polysialic acid–neural cell adhesion molecule	0.0491803278689
PSA-NCAM	polysialic-neural cell adhesion molecule	0.016393442623
PSA-NCAM	polysialylated form of the neural cell adhesion molecule	0.0819672131148
PSA-NCAM	polysialylated-ncam	0.016393442623
PSA-NCAM	polysialylated neural cell adhesion marker	0.016393442623
PSA-NCAM	polysialylated form of nerve cell adhesion molecule	0.016393442623
PSA-NCAM	polysialic acid-neural cell adhesion molecule	0.0491803278689
PSA-NCAM	polysialylated form of neural cell adhesion molecule	0.0655737704918
PSA-NCAM	polysialylated neural cell adhesion molecule	0.377049180328
PSA-NCAM	poly-sialylated neural cell adhesion molecule	0.016393442623
PSA-NCAM	polysialylated form of neural cell adhesion molecule 1	0.016393442623
PSA-NCAM	polysialic acid neural cell adhesion molecule	0.0983606557377
PSA-NCAM	polysialic-acid neural cell adhesion molecule	0.016393442623
PSA-NCAM	poly-sialated neuronal cell adhesion molecule	0.016393442623
PSA-NCAM	polysialated form of neural cell adhesion molecule	0.016393442623
PSA-NCAM	polysialylated-neural cell adhesion molecule	0.0491803278689
RANKL	receptor activator of nf-kb ligand	1.0
doR	dorsal raphe nucleus	1.0
TKOα	β, γ-triple knockout	1.0
LG-S	lateral gastrocnemius-soleus	1.0
U-CL	unidirectional neurons, responsive with rotations directed towards the side contralateral to recording, in the left vestibular nucleus	1.0
PBS-BSAc	pbs-acetylated bovine serum albumin	1.0
epigeneticsDNA	methylation	1.0
SHU-	9119ac-nle-c[asp-his-dnal(2′)-arg-trp-lys]-nh2	1.0
vlVMH	ventrolateral part of the ventromedial hypothalamic nucleus	0.5
vlVMH	ventromedial hypothalamus	0.5
EDS-R	eveds-reversal	1.0
TTI	tension–time index	1.0
CArG-BPA	carg binding protein a	0.5
CArG-BPA	carg-binding protein a	0.5
MDpc	mediodorsal nucleus, parvocellular division	1.0
VLA	very late antigen	1.0
MLCDP	mannosylated liposomal cdp-choline	1.0
NCAM-H	highly polysialylated neural cell adhesion molecule	1.0
LBA	lateral and basal nuclei of the amygdala	1.0
YKS-UHYKS	analog eliminating uh	1.0
CD-	8cluster of differentiation-8	0.5
CD-	1 mice	0.5
f-IPSC	fast ipsc	1.0
HVACC	shigh voltage-activated calcium channels	1.0
-1-Aminoindan-1	5-dicarboxylic acid	1.0
CHES	2-(cyclohexylamino)ethanesulfonic acid	1.0
INaW	window sodium current	1.0
H2DCF-DAchloromethyl-2	7-dichloro-dihydro-fluoresceindiacetate	1.0
NPBI	non-protein-bound-iron	1.0
S-SCAM	synaptic scaffolding molecule	1.0
FRT	flp-recombinase target	1.0
sIPSP	sspontaneous inhibitory postsynaptic potentials	0.25
sIPSP	spontaneous inhibitory postsynaptic potential	0.25
sIPSP	slow ipsp	0.25
sIPSP	spontaneously occurring ipsp	0.25
RCAS	replication-competent avian sarcoma-leukosis virus long-terminal repeat with a splice acceptor	1.0
BMPR-IA	bone morphogenetic protein receptor type ia	1.0
CHEF	clamped homogeneous electric field	1.0
GSC	glioma stem cell	1.0
CHEB	5-(2-cyclohexylidene-ethyl)-5-ethyl barbituric acid	1.0
MYPT	myosin-binding subunit of myosin phosphatase	1.0
AMPARAMPA	receptor	0.878787878788
AMPARAMPA	receptors	0.0909090909091
AMPARAMPA	type glutamate receptor	0.030303030303
LYVE-	1lymphatic vessel endothelial receptor 1	1.0
GPIAS	gap prepulse inhibition of the acoustic startle	0.5
GPIAS	gap prepulse-induced inhibition of the acoustic startle	0.5
COXIICOXIII	coxiv, subunits ii, iii, and iv, respectively, of the cytochrome c oxidase complex	1.0
sIPSC	sspontaneous inhibitory postsynaptic currents	0.234567901235
sIPSC	sspontaneous and miniature inhibitory postsynaptic currents	0.0123456790123
sIPSC	spontaneous inhibitory postsynaptic current	0.469135802469
sIPSC	sspontaneous inhibitory post synaptic currents	0.0123456790123
sIPSC	spontaneous inhibitory post-synaptic current	0.0617283950617
sIPSC	spontaneous inhibitory postsynaptic currents	0.037037037037
sIPSC	sspontaneous inhibitory synaptic currents	0.0123456790123
sIPSC	spontaneous ipsc	0.0740740740741
sIPSC	sspontaneous inhibitory currents	0.0123456790123
sIPSC	spontaneous inhibitory post synaptic current	0.0123456790123
sIPSC	evoked/delayed/miniature/spontaneous inhibitory postsynaptic current	0.0123456790123
sIPSC	sspontaneous ipscs	0.037037037037
sIPSC	spontaneous gabaa-mediated inhibitory postsynaptic current	0.0123456790123
IOβ	beta nucleus	1.0
NADPHβ-	nicotinamide adenine dinucleotide phosphate reduced tetra sodium salt	0.5
NADPHβ-	nicotinamide adenine dinucleotide 2′-phosphate	0.5
mtTFA	mitochondrial transcription factor a	1.0
ecto-ATP	ase	1.0
AVVL	anteroventral thalamic nucleus, ventrolateral part	1.0
AWC	average wavelet coefficient	1.0
LSS	lateral stripe of the striatum	0.666666666667
LSS	loud sound stress	0.333333333333
NIHSSN	ational institutes of health stroke scale	0.857142857143
NIHSSN	ational institutes of health stroke severity	0.142857142857
CCV	common cardinal vein	0.5
CCV	clathrin-coated vesicle	0.5
GLOM	glomerular cell layer	1.0
TNP-ATP	2′,3′-o-trinitrophenyl-atp	1.0
VORV	orozole	1.0
DAGsn-1	2-diacylglycerol	1.0
TTC	troponin-tropomyosin complex	0.0344827586207
TTC	2.3.5-triphenyltetrazolium chloride	0.0344827586207
TTC	time to contact	0.0344827586207
TTC	triphenyltetrazolium chloride	0.344827586207
TTC	2,3,5-triphenyltetrazolium chloride	0.103448275862
TTC	2,3,5-triphenyltetrazolium	0.0344827586207
TTC	time-to-contact	0.0344827586207
TTC	2,3,5-triphenyl tetrazolium chloride	0.0689655172414
TTC	staining	0.0344827586207
TTC	5-triphenyltetrazolium chloride	0.0344827586207
TTC	tetrazolium blue chloride	0.0344827586207
TTC	triphenyltetrazolium	0.0344827586207
TTC	triphenyl tetrazolium chloride	0.172413793103
PEDF	pigment epithelium-derived factor	1.0
FCAF	reund's complete adjuvant	0.333333333333
FCAF	reund’s complete adjuvant	0.666666666667
U-92032	[7-(bis-4-fluorophenyl) (methyl)-(1-piperazinyl)-2-(2-hydroxyethylamino)-4-1(1-methylethyl)-2,4,6,-cycloheptatrien-1-one]	1.0
VLP	1visinin like protein 1	1.0
SDB-L	styrene-divinylbenzene polymer	1.0
mEPSCs	miniature excitatory postsynaptic currents	0.666666666667
mEPSCs	ttx-resistant spontaneous excitatory postsynaptic currents	0.333333333333
MALDI-MS	matrix-assisted laser desorption ionization mass spectroscopy	0.5
MALDI-MS	matrix-assisted laser desorption ionization mass spectrometry	0.5
FEOF	oam eyes open condition	1.0
VLT	ventro-lateral thalamus	0.333333333333
VLT	nucleus ventrolateralis thalami	0.333333333333
VLT	ventrolateral thalamus	0.333333333333
CCN	central caudal nucleus	0.333333333333
CCN	cultured cortical neurons	0.333333333333
CCN	central cervical nucleus	0.333333333333
12-HETE	12-hydroxyeicosatetraenoic acid	1.0
HIF-	1α /2hypoxia inducible factor 1 α/ 2	0.0322580645161
HIF-	1αhypoxia-inducible transcription factor-1α	0.0322580645161
HIF-	1αhypoxia inducible factor 1 alpha	0.0322580645161
HIF-	1α	0.0645161290323
HIF-	1αhypoxia inducible factor-1 alpha	0.0645161290323
HIF-	1hypoxia inducible factor-1	0.0645161290323
HIF-	1αhypoxia inducible factor	0.0322580645161
HIF-	1αhypoxia-inducible factor 1α	0.129032258065
HIF-	1?hypoxia inducible factor 1-?	0.0322580645161
HIF-	1αhypoxia inducible factor-1α	0.0967741935484
HIF-	1αhypoxia-inducible	0.0322580645161
HIF-	1	0.0322580645161
HIF-	1hypoxia-inducible factor-1	0.129032258065
HIF-	1αhypoxia-inducible factor-1 α	0.0322580645161
HIF-	2αhypoxia-inducible factor 2α	0.0322580645161
HIF-	1αhypoxia-inducible factor-1α	0.0967741935484
HIF-	1αhypoxia induced factor	0.0322580645161
HIF-	1α)	0.0322580645161
SQSTM	1	1.0
cMRF	central mesencephalic reticular formation	1.0
PWTs	paw withdrawal thresholds	1.0
CaM-KIIN	ca2+/calmodulin-dependent protein kinase inhibitor	1.0
KDIlysine	aspartic acid, isoleucine (lys-asp-ile)	1.0
NMRSNMR	spectroscopy	1.0
EDSR	evextradimensional set-shift reversal	1.0
ZL	zonal layer	1.0
Ch3	cholinergic cells of the ventral horizontal limb of the diagonal band which have olfactory projections	1.0
MCIDM	icrocomputer imaging device	0.444444444444
MCIDM	icrocomputer imaging device system	0.111111111111
MCIDM	icro computer imaging device	0.333333333333
MCIDM	icrocomputer image device	0.111111111111
RSad	adapting regular spiking neurons	1.0
CT-FITC	cholera toxin subunit b	1.0
FRETF	örster (fluorescence) resonance energy transfer	0.333333333333
FRETF	örster resonance energy transfer	0.666666666667
rANOVA	repeated-measures anova	0.2
rANOVA	repeated measures analysis of variance	0.2
rANOVA	repeated-measures analysis of variance	0.4
rANOVA	repeated measures analyses of variance	0.2
BCECF-AM	2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester	1.0
BTFL	baseline tail-flick latency	1.0
FLIF	os like immunoreactivity	0.0833333333333
FLIF	os-like immunoreactivity	0.5
FLIF	os-like immunoreactive	0.333333333333
FLIF	os-like-immunoreactivity	0.0833333333333
CHOPCAAT	/enhancer binding protein homologous protein	1.0
ODNs	oligodeoxynucleotides	1.0
WAYWAY-100	635	1.0
CSNB-	2congenital stationary night blindness type 2	1.0
vLA	ventral lateral amygdala	1.0
EGR-	1	0.666666666667
EGR-	1early growth response factor-1	0.333333333333
CCB	cytochalasin b	1.0
PGX	transection of the ipsilateral glossopharyngeal nerve between the petrosal ganglion and the brain	1.0
MMEL	membrane metallo-endopeptidase-like protein	1.0
PIH	pharmacologically induced hypothermia	0.5
PIH	posterior inferior hypothalamus	0.5
GOESAG	oettingen sentence test	1.0
gPDC	general partial directed coherence	1.0
F3A-GDNF	glial cell line-derived neurotrophic factor secreting cells	0.5
F3A-GDNF	gdnf-secreting cells	0.5
II-C2A	anti-synaptotagmin i and ii c2a domain	1.0
preSMA	pre-supplementary motor area	1.0
p62AS	antisense deoxyoligonucleotide against p62	1.0
ACSVLA	cyl-coenzyme a synthetase very long	1.0
vMVN	ventral medial vestibular nucleus	0.5
vMVN	ventral part of the medial vestibular nucleus	0.5
LSIGRLL	eu-ser-ile-gly-arg-leu-nh2	1.0
MFDFA	multifractal detrended fluctuation analysis	1.0
FLSDF	ishers least significant difference test	1.0
MNIM	ontreal neurological institute	0.883720930233
MNIM	ontreal neurology institute	0.0232558139535
MNIM	ontréal neurological institute	0.0232558139535
MNIM	ontreal neurologic institute	0.0697674418605
NNMF	nonnegative matrix factorization	1.0
BHPAN-	biphenyl sulfonyl-phenylalanine hydroxamic acid	1.0
Cg1-2	cingulate cortex areas 1 and 2	1.0
VLPO	ventrolateral preoptic area of the hypothalamus	0.037037037037
VLPO	ventrolateral preoptic nucleus	0.444444444444
VLPO	ventrolateral preoptic area of hypothalamus	0.037037037037
VLPO	ventrolateral preoptic area	0.37037037037
VLPO	ventro-lateral preoptic	0.037037037037
VLPO	ccore vlpo	0.037037037037
VLPO	ventral lateral preoptic area	0.037037037037
DAB-Ni3	3′-diaminobenzidine and nickel sulfate	1.0
VLPF	ventrolateral prefrontal cortex	1.0
NF70	neurofilament 70 kda	1.0
PLOSL	polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy	1.0
pshRNA	plasmid dna containing short hairpin rna sequence	1.0
eIF-2α	α-subunit of the translation eukaryotic initiation factor 2	1.0
P-NALD	pseudo neonatal adrenoleukodystrophy	1.0
ABTS2	2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)	1.0
TTBS	triton x-100 in tris-buffered saline	0.0625
TTBS	0.1% tween 20 in tris-buffered saline	0.0625
TTBS	20 mm tris–hcl, 500 mm nacl, 0.1% tween 20, ph 7.6	0.0625
TTBS	tween tris-buffered saline	0.0625
TTBS	tween-20/tris-buffered saline	0.0625
TTBS	tbs and 0.1% (v/v) tween-20	0.0625
TTBS	tween-20–tris-buffered saline	0.0625
TTBS	tbs containing tween-20	0.0625
TTBS	tween-20-tris-buffered saline	0.0625
TTBS	tris-buffered saline containing tween-10	0.0625
TTBS	tbs and 0.1% tween-20	0.0625
TTBS	tbs with tween 20	0.0625
TTBS	tris–buffered saline containing 0.05% tween-20	0.0625
TTBS	tris-buffered saline with tween 20	0.1875
poly-ADP	ribose polymerase	1.0
rhHB-EGF	recombinant human hb-egf	1.0
LTMR	slow-threshold mechanoreceptors	1.0
OVAR	off-vertical axis rotation	1.0
WMPSRW	ilcoxon matched pair sign rank	1.0
EPSP-LTP	long-term potentiation of excitatory postsynaptic potential	1.0
BDP-	20	1.0
TP-IPL	inferior parietal lobule with the posterior temporal lobe	1.0
ECSs	electroconvulsive stimulations	1.0
INAP	persistant sodium current	1.0
OVAL	ovalbumin	1.0
QX314	n-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium bromide	0.25
QX314	lidocaine n-ethyl bromide	0.75
PIG	phosphate-independent glutaminase	0.5
PIG	sp53-induced genes	0.5
pMN	motor neuron progenitor domain	1.0
CUSchronic	unpredictable stress	1.0
vVNAB	ventral part of the ventral noradrenergic bundle	1.0
TMBS	tris–hydrochloride buffer containing sodium metabisulphite	1.0
IP3Rinositol-1	4,5-triphosphate receptor	0.333333333333
IP3Rinositol-1	4,5-trisphosphate receptor	0.666666666667
C-	polymodal nociceptors	0.025
C-	terminalcarboxy terminal	0.025
C-	thermal nociceptor	0.025
C-	fibres	0.05
C-	fibre	0.075
C-	group	0.025
C-	fibers	0.05
C-	terminalcarboxyl (cooh) terminal	0.025
C-	boutons	0.025
C-	ratscontrol rats	0.075
C-	type natriuretic peptides	0.025
C-	terminally truncated nr2a subunit	0.025
C-	fiber	0.15
C-	taucleaved tau	0.025
C-	type natriuretic peptide	0.025
C-	foscellular v-fos fbj murine osteosarcoma viral oncogene homolog	0.025
C-	taucleaved microtubule-associated protein tau	0.025
C-	type natriuretic peptide (cnp)	0.025
C-	taucleaved map-tau	0.025
C-	polymodal nociceptor afferents	0.025
C-	terminalcarboxyl-terminal	0.025
C-	sectioncesarean section	0.025
C-	typecore-type thalamocortical	0.025
C-	fos immunohistochemistry	0.025
C-	terminals	0.075
C-	terminalcarboxyl terminal	0.05
DETA	/nodeta/nonoate	0.25
DETA	nonoatediethylenetriamine nonoate	0.25
DETA	/no diethylenetriamine/no adduct	0.25
DETA	/nodiethylenetriamine-nitric oxide adduct	0.25
DETC	sodium diethyldithiocarbamate	0.333333333333
DETC	ferrous diethyldithiocarbamate	0.333333333333
DETC	diethyldithiocarbamic acid	0.333333333333
SWN	speech weighted noise	1.0
GPNMB	glycoprotein nonmetastatic melanoma protein b	1.0
TXFT	iao-xin-fang decoction	1.0
SWA	slow-wave activity (power density in the 0.75–4.5hz band)	0.0416666666667
SWA	slow-wave activity (eeg power in the 0.75–4.5hz range)	0.0416666666667
SWA	*, prevalence of slow-wave activity	0.0416666666667
SWA	slow-wave activity	0.5
SWA	slow wave activity	0.375
D-AP	5d-2-amino-5-phosponovaleric acid	0.0625
D-AP	52-amino-5-phosphonopentanoic acid	0.0625
D-AP	5d-(-)-2-amino-5-phosphonopentanoic acid	0.3125
D-AP	5d (-)-2-amino-5-phosphonopentanoic acid	0.0625
D-AP	52-amino-5-phosphonovalerianic acid	0.0625
D-AP	5	0.0625
D-AP	5d(-)-2-amino-5-phosphonopentanoic acid	0.125
D-AP	5d-2-amino-5-phosphonopentanoic acid	0.0625
D-AP	5d-2-amino-5-phosphonovaleric acid	0.125
D-AP	5d-(-)-2-amino-5-phosphomopentanoic acid	0.0625
RP-67	580(3ar,7ar)-7,7-diphenyl-2-(1-imino-2(2-methoxyphenyl)-ethyl) perhydroisoindol-4-1 hydrochloride	1.0
Int1	interneuron 1	1.0
EtOH	ethanol/alcohol	0.5
EtOH	ethanol	0.5
CPP-	3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate	0.5
CPP-	1cyclo (-7-aminoheptanoyl-phe-d-try-lys-o-benzyl-thr)acetate	0.5
C1	upper cervical cord transition	0.2
C1	botulinum neurotoxin c1	0.2
C1	c2first cervical and second cervical spinal cord segments	0.2
C1	adrenergic cell group in the ventrolateral medulla	0.2
C1	c1 adrenergic cells	0.2
BACHD	bacterial artificial chromosome transgenic mouse model	1.0
cPAG	caudal periaqueductal gray matter	0.333333333333
cPAG	caudal periaqueductal gray	0.666666666667
CCG-I	2-carboxycyclopropylglycine-i	1.0
CK	scytokines	0.0434782608696
CK	2protein kinase ck2	0.0434782608696
CK	1/2casein kinases 1/2	0.0434782608696
CK	creatine phosphokinase	0.0869565217391
CK	1αcasein kinase 1α	0.0869565217391
CK	20cytokeratin 20	0.0434782608696
CK	2casein kinase 2	0.130434782609
CK	casein kinase	0.130434782609
CK	cytokeratin	0.0434782608696
CK	2casein kinase ii	0.0434782608696
CK	8cytokeratin 8	0.0434782608696
CK	creatine kinase	0.260869565217
CI	coincidence index	0.0196078431373
CI	internal capsule	0.0196078431373
CI	scochlear implants	0.0196078431373
CI	cochlear implant	0.0392156862745
CI	cochlear implants	0.0196078431373
CI	contralateral loudspeaker led ipsilateral loudspeaker	0.0196078431373
CI	9595% confidence interval	0.0196078431373
CI	acentral varicosity of type ia synaptic glomerulus	0.0196078431373
CI	sconfidence intervals	0.0196078431373
CI	95% confidence interval	0.0588235294118
CI	inferior central nucleus	0.0196078431373
CI	atherosclerotic cerebral infarction	0.0196078431373
CI	calcium impermeable	0.0196078431373
CI	confidence interval.	0.0196078431373
CI	choice index	0.0196078431373
CI	caspase inhibitor	0.0196078431373
CI	95% confidence intervals	0.0196078431373
CI	calcium ionophore	0.0196078431373
CI	cardiac index	0.0196078431373
CI	conditioned inhibitor	0.0196078431373
CI	mitochondrial complex i	0.0196078431373
CI	confidence intervals	0.0392156862745
CI	chemosensitivity index	0.0196078431373
CI	cell index	0.0196078431373
CI	climbing index	0.0196078431373
CI	0coincidence index	0.0196078431373
CI	cerebral infarction	0.0196078431373
CI	confidence interval	0.372549019608
CI	chronic immobilization	0.0196078431373
CH	caudal hypothalamus	0.0714285714286
CH	centrifugal horizontal	0.0714285714286
CH	asechondroitinase	0.0714285714286
CH	chronic sustained hypoxia	0.0714285714286
CH	cluster headache	0.142857142857
CH	collagene homology domain	0.0714285714286
CH	chocolate entrainment group	0.0714285714286
CH	calponin homology	0.0714285714286
CH	emcerebellar cortex hemisphere	0.0714285714286
CH	heat- but not mechano-responsive c-unit	0.0714285714286
CH	5kmcontinuous hypobaric hypoxia at simulated 5 km altitude	0.0714285714286
CH	chronic hydrocephalus	0.0714285714286
CH	complete hippocampal lesion group	0.0714285714286
TMB3	3′,5,5′-tetramethyl benzidine	0.2
TMB3	3′-5′5′-tetramethylbenzidine	0.2
TMB3	3′,5,5′-tetramethylbenzidine	0.4
TMB3	3,5,5′-tetramethylbenzidine	0.2
CN	sodium cyanide	0.031746031746
CN	cochlear nuclear complex	0.015873015873
CN	neuronal cell line	0.015873015873
CN	98constitutively-activated calcineurin transgenic mouse line #98	0.015873015873
CN	cochlear nucleus	0.492063492063
CN	cuneate nucleus	0.15873015873
CN	cocaine no lever	0.015873015873
CN	deep cerebellar nuclei	0.031746031746
CN	commissural neuron	0.015873015873
CN	cranial nerve	0.015873015873
CN	cell capacitance	0.015873015873
CN	calcineurin	0.015873015873
CN	caudate nucleus	0.111111111111
CN	cerebellar nuclei	0.031746031746
CN	control group	0.015873015873
CM	childhood maltreatment	0.0135135135135
CM	vmmedium conditioned by nsvm	0.0135135135135
CM	c,rcentral medial nucleus of thalamus, caudal division, rostral division	0.0135135135135
CM	confusion matrix	0.0135135135135
CM	control medium	0.0135135135135
CM	confocal microscopy	0.0135135135135
CM	conditioned medium	0.135135135135
CM	centromedian thalamic nucleus	0.0135135135135
CM	midline thalamic central medial nucleus	0.0135135135135
CM	cross-modal	0.0135135135135
CM	centromedial nucleus	0.0135135135135
CM	/mintact vs. castrated male-soiled bedding two-choice test	0.0135135135135
CM	central medial thalamic nucleus	0.0540540540541
CM	center of mass	0.0405405405405
CM	conserved motif	0.0135135135135
CM	caudomedial belt area of the auditory cortex	0.0135135135135
CM	cortico-motoneuronal	0.0135135135135
CM	corticomedial group of the amygdala	0.0135135135135
CM	centromedian nucleus of thalamus	0.0135135135135
CM	conditioned media	0.0945945945946
CM	centrum medianum	0.0135135135135
CM	conditioned medium (media)	0.0135135135135
CM	central medial	0.027027027027
CM	cutaneus maximus	0.0135135135135
CM	centre median	0.0135135135135
CM	centromedian nucleus	0.0810810810811
CM	centromedial thalamic nucleus	0.027027027027
CM	center median nucleus	0.0135135135135
CM	central median nucleus	0.0135135135135
CM	central medial nucleus thalamus	0.0135135135135
CM	central mound	0.0135135135135
CM	cardiac muscle	0.0135135135135
CM	central medial nucleus	0.0135135135135
CM	component motion	0.0135135135135
CM	medial subdivision of the central nucleus	0.0135135135135
CM	cisterna magna	0.0405405405405
CM	sciatic nerve conditioned media	0.0135135135135
CM	centromedial thalamus	0.0135135135135
CM	caudomedial auditory cortical field	0.0135135135135
CM	rat sciatic nerve conditioned media	0.0135135135135
CM	centromedial nucleus of the thalamus	0.0135135135135
CM	continuous morphine	0.0135135135135
CM	nucleus centrum medianum	0.0135135135135
CM	correctly oriented mount	0.0135135135135
CM	central medial thalamic	0.0135135135135
CL	icaudal linear nucleus of the raphe	0.0181818181818
CL	current level (standard level unit used by cochlear's nucleus freedom systems)	0.0181818181818
CL	nucleus centralis lateralis	0.0181818181818
CL	claustrum	0.0363636363636
CL	centrolateral nucleus	0.0363636363636
CL	chronic fundus ligation	0.0181818181818
CL	contralateral	0.0363636363636
CL	central lateral nucleus	0.145454545455
CL	central lateral nucleus of thalamus	0.0181818181818
CL	central lateral nucleus thalamus	0.0181818181818
CL	cardiolipin	0.0181818181818
CL	cytoplasmic loop	0.0363636363636
CL	confidence limits	0.0545454545455
CL	95% confidence limit	0.0181818181818
CL	centrolateral	0.0181818181818
CL	centrolateral thalamic	0.0181818181818
CL	clomipramine	0.0181818181818
CL	contralateral side to lesion	0.0181818181818
CL	contralateral hemisphere	0.0181818181818
CL	cuneolemniscal neuron	0.0545454545455
CL	lateral subdivision of the central amygdaloid nucleus	0.0181818181818
CL	control rats for long-term kindled group	0.0181818181818
CL	confidence limit	0.0181818181818
CL	lateral subdivision of the central nucleus	0.0363636363636
CL	centrolateral thalmaic nucleus	0.0181818181818
CL	pposterior caudal lobe	0.0363636363636
CL	chemiluminescence	0.0181818181818
CL	centrolateral thalamic nucleus	0.109090909091
CL	confidence level	0.0181818181818
CL	pposterior part of cl	0.0181818181818
CL	cocaine lever available	0.0181818181818
CL	linear anisotropy	0.0181818181818
CL	icaudal linear raphe nucleus	0.0181818181818
CC	cage control group	0.00961538461538
CC	cingulate cortex	0.0288461538462
CC	hcarbamoylcholine	0.00961538461538
CC	hcarbachol	0.153846153846
CC	current-clamp	0.00961538461538
CC	1adenomatous polyposis coli	0.00961538461538
CC	circular corridor	0.00961538461538
CC	cage control	0.00961538461538
CC	hcarbamylcholine	0.00961538461538
CC	cerebral cortex/corpus callosum	0.00961538461538
CC	coiled-coil domain	0.0192307692308
CC	central canal	0.0673076923077
CC	50median convulsant current	0.00961538461538
CC	correlation coefficient	0.0384615384615
CC	contralateral commissural pathway	0.00961538461538
CC	cerebral commissure	0.00961538461538
CC	cocaine with cocaine challenge	0.00961538461538
CC	h-pscspscs induced by bath application of 100 μm carbachol	0.00961538461538
CC	3cleaved caspase 3	0.00961538461538
CC	cerebral cortex	0.0384615384615
CC	cat collar	0.0192307692308
CC	1first coiled-coil domain of p150glued	0.00961538461538
CC	callosal commissural	0.00961538461538
CC	coiled-coil	0.0288461538462
CC	cystic cavity	0.00961538461538
CC	chelerythrine chloride	0.0288461538462
CC	current clamp	0.00961538461538
CC	ocingulated cortex	0.00961538461538
CC	cross-correlogram	0.00961538461538
CC	motif) ligand 2	0.00961538461538
CC	cystatin c	0.00961538461538
CC	xcerebral cortex	0.00961538461538
CC	cingulate cortex area 2	0.00961538461538
CC	3cleaved cysteine-aspartic protease 3	0.00961538461538
CC	cage controls	0.00961538461538
CC	caged control	0.00961538461538
CC	control condition	0.00961538461538
CC	ontrol	0.0288461538462
CC	cross-correlation coefficient	0.00961538461538
CC	cerebellar cortex	0.0192307692308
CC	corpus callosum	0.230769230769
CC	region around the central canal	0.00961538461538
CC	cognitive control	0.00961538461538
CB	1cannabinoid receptor type i	0.00420168067227
CB	+calbindin-positive	0.00420168067227
CB	1 receptor	0.0420168067227
CB	1 knockout	0.00420168067227
CB	coupling buffer	0.00420168067227
CB	+calbindin immunopositive	0.00420168067227
CB	1 receptorcannabinoid receptor 1	0.00420168067227
CB	2rcannabinoid receptor 2	0.00420168067227
CB	cannabinoid	0.0210084033613
CB	cytoskeleton buffer	0.00420168067227
CB	1 cannabinoid receptor	0.0294117647059
CB	1cannabinoid receptor type 1	0.0210084033613
CB	2cannabinoid receptor 2	0.0126050420168
CB	2cannabinoid type 2 receptor	0.00420168067227
CB	1cannabinoid 1	0.0168067226891
CB	1type-1 cannabinoid receptor	0.00420168067227
CB	1/cb2 receptor agonist	0.00420168067227
CB	sodium cacodylate buffer containing 2 mm cacl2 at ph 7.4	0.00420168067227
CB	2cannabinoid receptor type 2	0.00420168067227
CB	1rcannabinoid cb1 receptor	0.00420168067227
CB	1rcannabinoid receptor type 1	0.00420168067227
CB	sncalbindin subnucleus/subnuclei	0.00420168067227
CB	1cannabinoid 1 receptor	0.0126050420168
CB	1-/-cb1 knockout mice	0.00420168067227
CB	1	0.0378151260504
CB	1rcannabinoid type 1 receptor	0.0126050420168
CB	couplet boundary	0.00420168067227
CB	1cannabinoid type 1	0.0210084033613
CB	1rscannabinoid 1 receptors	0.00420168067227
CB	sncalbindin d28k subnucleus	0.00420168067227
CB	2cannabinoid 2	0.00420168067227
CB	1rcannabinoid receptor cb1	0.00420168067227
CB	1rcannabinoid receptor 1	0.0168067226891
CB	calbindin	0.197478991597
CB	1rcannabinoid receptor subtype 1	0.00420168067227
CB	1cannabinoid-1	0.00420168067227
CB	calcium binding protein calbindin	0.00420168067227
CB	1ircannabinoid receptor type-1 immunoreactive	0.00420168067227
CB	1cannabinoid type 1 receptor	0.00840336134454
CB	1 receptors	0.0168067226891
CB	calbindin-d28kd	0.00420168067227
CB	cytochalasin b	0.00420168067227
CB	2xpmice overexpressing cb2 receptors	0.00420168067227
CB	1cannabinoid receptor 1	0.0336134453782
CB	cingulum bundle	0.00420168067227
CB	1 cannabinoid	0.00420168067227
CB	1 receptor binding	0.00420168067227
CB	2 receptor	0.00420168067227
CB	ircalbindin-d28k immunoreactive	0.00420168067227
CB	1rcannabinoid 1 receptor	0.0126050420168
CB	1rcb1 receptor	0.00840336134454
CB	1rtype 1 cannabinoid receptor	0.00420168067227
CB	1/cb2cannabinoid receptor type 1/2	0.00420168067227
CB	cholera toxin b subunit	0.00420168067227
CB	2	0.0126050420168
CB	2 receptorcannabinoid 2-type receptor	0.00420168067227
CB	1 receptorstype 1 cannabinoid receptors	0.00420168067227
CB	1cannabinoid receptors type 1	0.00420168067227
CB	chronic buspirone	0.00420168067227
CB	counting backwards	0.00420168067227
CB	cerebellum	0.0546218487395
CB	1rs(glu)cb1rs controlling glutamate transmission	0.00420168067227
CB	rcannabinoid receptors	0.00420168067227
CB	1type 1 cannabinoid receptor	0.0126050420168
CB	calbindin d28k	0.0252100840336
CB	carotid bodies	0.00840336134454
CB	1rstype i cannabinoid receptors	0.00420168067227
CB	1/2cannabinoid receptor type 1/2	0.00420168067227
CB	1rcannabinoid type 1 receptors	0.00420168067227
CB	1rcannabinoid-1 receptor	0.00420168067227
CB	2rcannabinoid receptor type 2	0.00420168067227
CB	calbindin-d28k	0.0672268907563
CB	+calbindin expressing	0.00420168067227
CB	cacodylate buffer	0.00840336134454
CB	calbindin d-28k	0.0378151260504
CB	cascade blue	0.00840336134454
CB	carotid body	0.00840336134454
CB	2cannabinoid type 2	0.00420168067227
CB	calbindin d28k (calcium binding protein)	0.00420168067227
CB	1 knockout mice	0.00420168067227
CB	6f1	0.00420168067227
CB	1rcb1 cannabinoid receptor	0.00840336134454
CA	1 region	0.015037593985
CA	1cornu ammonis subfield 1	0.00501253132832
CA	3cornu ammonis region 3 of the hippocampus proper	0.00250626566416
CA	3cornu ammonis region 3	0.015037593985
CA	/rcardiac arrest and resuscitation	0.00250626566416
CA	3hippocampal subregion ca3	0.00250626566416
CA	1 subregion	0.00250626566416
CA	central autonomic cells	0.00250626566416
CA	1cornu ammonis 1	0.0526315789474
CA	scatecholamines	0.00501253132832
CA	cornu ammonis (ammon's horn)	0.00501253132832
CA	1cornu ammonis area 1	0.0200501253133
CA	1cornu-ammonis area 1	0.00250626566416
CA	1 neurons	0.0100250626566
CA	1ammon's horn region 1	0.00250626566416
CA	3bcornu ammonis 3 – subregion b	0.00250626566416
CA	3 neurons	0.00250626566416
CA	2ca field of the hippocampus	0.00250626566416
CA	1field ca1 of the hippocampus	0.00501253132832
CA	1hippocampal area ca1	0.00250626566416
CA	calyculin a	0.00250626566416
CA	cornu ammonus	0.00250626566416
CA	central autonomic nucleus	0.00501253132832
CA	sca regions of ammon’s horn	0.00250626566416
CA	central nucleus of the amygdala	0.00250626566416
CA	1 neural network	0.00250626566416
CA	subfield of ammon's horn	0.00250626566416
CA	catecholamine	0.0225563909774
CA	1cornu ammon 1	0.00250626566416
CA	3 neuron	0.00250626566416
CA	1hippocampal ca1 region	0.00250626566416
CA	3 pyramidal neuron	0.00250626566416
CA	1cornus ammon 1	0.00250626566416
CA	fields of hippocampus	0.00250626566416
CA	cornu ammonis (of the hippocampus)	0.00250626566416
CA	1cornu ammonis i	0.00250626566416
CA	1dorsal hippocampal	0.00250626566416
CA	commissural associational	0.00250626566416
CA	ammon’s horn	0.00250626566416
CA	field of the hippocampus	0.00250626566416
CA	3raca3 stratum radiatum	0.00250626566416
CA	cell assemblies	0.00250626566416
CA	1–3hippocampal cornu ammoni’s regions	0.00250626566416
CA	1 heterotopia	0.00250626566416
CA	cornu ammonis	0.167919799499
CA	1cornu ammonis-1 (hippocampal area)	0.00250626566416
CA	caffeoylquinic acid	0.00250626566416
CA	1ca3 subregions of the hippocampal formation	0.00250626566416
CA	1 area	0.0100250626566
CA	3cornu ammonius 3	0.00250626566416
CA	1cornus ammonis subregion 1	0.00250626566416
CA	1ca1 region of hippocampus	0.00501253132832
CA	1ca1 subfield of hippocampus	0.00250626566416
CA	3	0.0375939849624
CA	1 pyramidal cell	0.00250626566416
CA	(μm2)tangential area of a cluster	0.00250626566416
CA	cornu ammonis subfield	0.00751879699248
CA	1/ca2/ca3field ca1/ca2/ca3 of hippocampus	0.00250626566416
CA	3ca3 area of the hippocampus	0.00250626566416
CA	anterior commissure	0.00250626566416
CA	4field ca4 of hippocampus	0.00250626566416
CA	1 pyramidal cells	0.00501253132832
CA	3medmedial portion of the ca3 field of the hippocampus	0.00250626566416
CA	1 and ca3	0.00250626566416
CA	1 areafield 1 of ammon's horn	0.00250626566416
CA	3field ca3 of hippocampus	0.00751879699248
CA	1ammon's horn ca1 hippocampus subfield	0.00250626566416
CA	cornu ammonis region of the hippocampus	0.00250626566416
CA	4hippocampal ca4 subregion	0.00250626566416
CA	ergiccatecholaminergic	0.00751879699248
CA	cornu amonis	0.00250626566416
CA	cocaine alternate environment	0.00250626566416
CA	1-3fields ca1-3 of ammon's horn	0.00250626566416
CA	1 region of the hippocampus	0.00501253132832
CA	3 pyramidal neurons	0.00501253132832
CA	catecholaminergic	0.0100250626566
CA	1hippocampus ca1	0.00501253132832
CA	1ca1 field of the hippocampus	0.00250626566416
CA	3cornu ammonis3	0.00250626566416
CA	1 pyramidal neurons	0.00501253132832
CA	ammon’s horn of the hippocampus	0.00250626566416
CA	1sector 1 cornu ammon	0.00250626566416
CA	3cornus ammonis field 3 of the hippocampus	0.00250626566416
CA	box(5′-ccacccct-3′) regulatory element in the β4 gene promoter	0.00250626566416
CA	1cornu ammonis region 1	0.0125313283208
CA	1cornus ammonis 1 of hippocampus	0.00250626566416
CA	1cornus ammonis 1	0.015037593985
CA	conceptional age	0.00250626566416
CA	1 hippocampal area	0.00250626566416
CA	cornus ammonis	0.0175438596491
CA	central amygdala	0.00250626566416
CA	1–4areas 1–4 of ammon's horn	0.00250626566416
CA	1-4fields of ammon’s horn 1–4	0.00250626566416
CA	1ca1 field of the ventral hippocampus	0.00250626566416
CA	3ca3 subfield of ammon's horn	0.00250626566416
CA	3cornus ammonis 3	0.00250626566416
CA	1cornu ammonis 1 region	0.00250626566416
CA	channel arrest	0.00250626566416
CA	1–ca4cornus ammonis subregions 1–4	0.00250626566416
CA	2/ca3a region	0.00250626566416
CA	1ammons horn of hippocampus	0.00250626566416
CA	1regio 1 cornus ammonis	0.00250626566416
CA	cardiac arrest	0.0100250626566
CA	cornu ammonis (ammon’s horn)	0.00501253132832
CA	3ammon's horn 3	0.00250626566416
CA	cerebellar ataxia	0.00250626566416
CA	3hippocampal field ca3	0.00250626566416
CA	4cellular area 4 of hippocampus	0.00250626566416
CA	3field three of ammon's horn	0.00250626566416
CA	constitutively active	0.00501253132832
CA	catecholamines	0.00250626566416
CA	cinnamaldehyde	0.00250626566416
CA	1-3fields 1–3 of ammon’s horn	0.00501253132832
CA	1hippocampal region ca1	0.00250626566416
CA	1hippocampal ca1	0.00250626566416
CA	1cornu ammonis 1 of hippocampus	0.00250626566416
CA	3fields of ca3 of ammon's horn in hippocampus	0.00250626566416
CA	3 area	0.00250626566416
CA	1cornu ammonis field 1 of hippocampus	0.00250626566416
CA	2cornu ammonis 2	0.00250626566416
CA	1cornu ammonis	0.0100250626566
CA	1 synaptic transmission	0.00250626566416
CA	3field ca3 of the hippocampus	0.00501253132832
CA	3ca3 field of the hippocampus proper	0.00250626566416
CA	3cornu ammonis 3	0.0325814536341
CA	3hippocampal subfield ca3	0.00250626566416
CA	3cornus ammoni 3	0.00250626566416
CA	1-3subregions of ammon's horn	0.00250626566416
CA	3field 3 of ammon's horn	0.00250626566416
CA	1–3fields ca1–3 of ammon's horn	0.00250626566416
CA	cerebral aneurysm	0.00250626566416
CA	3cornu ammonis area 3	0.00501253132832
CA	1	0.110275689223
CA	confocal aperture	0.00250626566416
CA	1cornu ammonis1	0.00250626566416
CA	1–3cornu ammonis 1–3	0.00250626566416
CA	3cornuammonis 3	0.00250626566416
CA	1ca1 region of dorsal hippocampus	0.00751879699248
CA	3cornu ammonis 3 (field of hippocampus)	0.00250626566416
CA	3subfield of the hippocampus	0.00250626566416
CA	iicarbonic anhydrase ii	0.00250626566416
CA	1-region	0.00250626566416
CA	hippocampal cornu ammonis	0.00250626566416
CA	central amygdaloid nucleus	0.00250626566416
CA	3regio inferior cornu ammonis	0.00250626566416
CA	1-3fields of the hippocampus	0.00250626566416
CA	1 or ca3cornu ammonae or ammon's horn regions 1 or 3	0.00250626566416
CA	1 subfield	0.00501253132832
CA	4ca4 field of the hippocampus	0.00250626566416
CA	3ca3 region of the hippocampus	0.00501253132832
CA	closed arms	0.00250626566416
CA	carbonic anhydrase	0.00751879699248
CA	3hippocampal region	0.00250626566416
CA	caudate nucleus	0.00501253132832
CA	1 hippocampus	0.00751879699248
CA	ammon's horn	0.00501253132832
CA	cornu ammonis (amon's horn of hippocampus)	0.00250626566416
CG	ciliary ganglion	0.0689655172414
CG	2area 2 of cingulate cortex	0.0344827586207
CG	cerebral ganglion	0.0344827586207
CG	cingulate cortex	0.172413793103
CG	1 and cg2cingulate cortex	0.0344827586207
CG	dldorsolateral part of the midbrain central gray	0.0344827586207
CG	central gray	0.103448275862
CG	cochlear ganglion	0.0689655172414
CG	central grey	0.0689655172414
CG	2anterior cingulate cortex	0.0344827586207
CG	cingulum	0.0689655172414
CG	coronal gyrus	0.0344827586207
CG	1-3cingulate areas 1-3	0.0344827586207
CG	cerebellar granule	0.0344827586207
CG	midbrain central gray	0.0344827586207
CG	control group	0.137931034483
CF	correction factor	0.0135135135135
CF	climbing fiber	0.22972972973
CF	commissural-associative fibre	0.0135135135135
CF	sclimbing fibers	0.027027027027
CF	the frequency to which a neuron was most sensitive	0.0135135135135
CF	center frequency	0.0135135135135
CF	rcingulate/frontal cortex	0.0135135135135
CF	central fixation point	0.0135135135135
CF	climbing fibers	0.0135135135135
CF	counting forwards	0.0135135135135
CF	climbing fibre	0.0675675675676
CF	characteristic frequency	0.527027027027
CF	os-ircfos-immunoreactivity	0.0135135135135
CF	cognitive flexibility	0.0135135135135
CF	cytosolic fraction	0.0135135135135
CE	constant error	0.02
CE	central amygdaloid nucleus	0.04
CE	coefficients of error	0.02
CE	control experiment	0.02
CE	central nucleus	0.04
CE	coefficient error	0.02
CE	clearance efficiency	0.02
CE	cinnamon extract	0.02
CE	mcentral medial	0.02
CE	/cmcauda equina/conus medullaris	0.02
CE	central nucleus of the amygdala	0.04
CE	+otcerebellum with optic tectum	0.02
CE	scoefficient of errors	0.02
CE	central nucleus;	0.02
CE	central nucleus of amygdala	0.02
CE	core enhancer region	0.02
CE	capillary electrophoresis	0.02
CE	coefficient of error	0.52
CE	caudal entorhinal field	0.02
CE	calexcitin	0.04
CE	contractile element	0.02
CD	cerebellar damage	0.0142857142857
CD	cholinergic denervation	0.0571428571429
CD	circular dichroism	0.0285714285714
CD	95-l	0.0142857142857
CD	133	0.0142857142857
CD	cortical dysplasia	0.0571428571429
CD	cluster of differentiation	0.1
CD	200cluster of differentiation 200	0.0142857142857
CD	cochlear duct	0.0285714285714
CD	cathepsin d	0.0142857142857
CD	contraction duration	0.0142857142857
CD	14cluster determinant 14	0.0142857142857
CD	24+/+cd24 wild-type	0.0142857142857
CD	cyclin-dependent	0.0142857142857
CD	connecting domain	0.0142857142857
CD	34+ cell	0.0142857142857
CD	8	0.0142857142857
CD	11bcluster of differentiation 11b	0.0142857142857
CD	sprague–dawley	0.0142857142857
CD	40lcd40 ligand	0.0142857142857
CD	11b	0.0285714285714
CD	24cd 24 antigen	0.0142857142857
CD	current densities	0.0142857142857
CD	39l1	0.0142857142857
CD	39l3	0.0142857142857
CD	xmethyl-β-cyclodextrin	0.0142857142857
CD	1 mice	0.0142857142857
CD	226	0.0142857142857
CD	finger-key contact duration	0.0142857142857
CD	95	0.0142857142857
CD	44cluster of differentiation 44	0.0285714285714
CD	68 (ed1)cluster of differentiation 68	0.0142857142857
CD	39	0.0142857142857
CD	14	0.0285714285714
CD	8 lymphocytes	0.0142857142857
CD	compound discrimination	0.1
CD	36	0.0142857142857
CD	68cluster of differentiation 68	0.0285714285714
CD	11bcluster of differentiation molecule 11b	0.0571428571429
CD	73	0.0142857142857
CD	1imposed semicircular finger trajectory pointing movement	0.0142857142857
CD	control diet	0.0285714285714
Aδ-	fiber	0.333333333333
Aδ-	fibers	0.666666666667
CZ	center zone	0.25
CZ	pcentral posterior zone	0.25
CZ	central zone	0.5
CPPG	(rs)-cyclopropyl-4-phosphonophenylglycine	0.117647058824
CPPG	(rs)-a-cyclopropyl-4-phosphonophenylglycine	0.0588235294118
CPPG	(rs)-α-cyclopropyl-4-phosphono-phenyl-glycine	0.0588235294118
CPPG	(r,s)-α-cyclopropyl-4-phosphonophenylglycine	0.0588235294118
CPPG	(rs)-α-cyclopropyl-4-phosphonophenyl glycine	0.0588235294118
CPPG	(rs)-α-cyclopropyl-4-phosphonophenylglycine	0.647058823529
CX	3cr1fractalkine receptor	0.0526315789474
CX	5161-(quinoxalin-6-ylcarbonyl)piperidine	0.0526315789474
CX	parietal cortex	0.0526315789474
CX	cortex lesion	0.0526315789474
CX	gonadectomized	0.0526315789474
CX	614	0.0526315789474
CX	43connexin 43	0.0526315789474
CX	3cl1	0.0526315789474
CX	546	0.105263157895
CX	cortex	0.0526315789474
CX	context	0.0526315789474
CX	castrates	0.0526315789474
CX	cerebral cortex	0.263157894737
CX	orf33chromosome x open reading frame 33	0.0526315789474
IntP	posterior interpositus nucleus	1.0
CPPC	ollaborative perinatal project	1.0
AcbS	shell region of the accumbens nucleus	1.0
CS	continuous stress	0.00363636363636
CS	cutting saline	0.00363636363636
CS	chronic saline	0.00363636363636
CS	chronic stress	0.0109090909091
CS	cocaine with saline challenge	0.00363636363636
CS	control rats for short-term kindled group	0.00363636363636
CS	conditional stimulus	0.0145454545455
CS	control mice treated with ssri during postnatal days 1–21	0.00363636363636
CS	chronic restraint stress	0.00363636363636
CS	chondroitin sulfate	0.04
CS	calamus scriptorius	0.0145454545455
CS	+, stimulus predictive of biologically significant event	0.00363636363636
CS	chronic-stress	0.00363636363636
CS	conditioning stimulus	0.0290909090909
CS	central sulcus	0.0145454545455
CS	in altered context during presentation of conditioned stimulus	0.00363636363636
CS	–usconditioned stimulus–unconditioned stimulus	0.00363636363636
CS	cold-stable	0.00363636363636
CS	+conditioned stimulus	0.00727272727273
CS	healthy controls	0.00363636363636
CS	oconditioned group not re-exposed	0.00363636363636
CS	chondroitin sulphate	0.00363636363636
CS	conditioned stimulus	0.632727272727
CS	/usconditioned/unconditioned stimulus	0.00363636363636
CS	+reinforced conditioned stimulus	0.00363636363636
CS	sustained chopper	0.00363636363636
CS	threshold conditioning stimulus	0.00363636363636
CS	conditioning stimulation	0.00727272727273
CS	corpus striatum	0.0145454545455
CS	complex spike	0.0327272727273
CS	corticospinal	0.00727272727273
CS	corticosterone	0.00727272727273
CS	centrum semiovale	0.00363636363636
CS	exploration of the control segment	0.00363636363636
CS	chondroitin sulfate proteoglycan	0.00363636363636
CS	/aspairing of conditioned stimulus and acoustic startle	0.00363636363636
CS	citrate synthase	0.0218181818182
CS	conditioned stimuli	0.0218181818182
CS	cold-sensitive	0.00363636363636
CS	2carbon disulfide	0.00363636363636
CS	+barats exposed to cigarette smoke and simultaneously administered with bacoside a	0.00363636363636
CS	+, conditioned stimulus	0.00363636363636
CS	central striatum	0.00363636363636
CS	calf serum	0.0109090909091
CS	0neutral stimulus never presented during training	0.00363636363636
CS	cytoskeleton stabilization buffer	0.00363636363636
CS	chronically stressed	0.00363636363636
CR	coincidence rate	0.00641025641026
CR	correct rate	0.0192307692308
CR	3type 3 complement receptor	0.00641025641026
CR	cue-guided response	0.00641025641026
CR	correct rejection	0.00641025641026
CR	corrected information ratio	0.00641025641026
CR	+calretinin-positive	0.025641025641
CR	calretinin (calcium binding protein)	0.00641025641026
CR	cochlear removal	0.00641025641026
CR	ccajal-retzius cell	0.00641025641026
CR	calretinin	0.474358974359
CR	ccajal–retzius cells	0.0128205128205
CR	3complement (c3bi) receptor	0.00641025641026
CR	cajal–retzius	0.0128205128205
CR	+, conditioned response (after costimulation), experimental region	0.00641025641026
CR	composition ratio	0.00641025641026
CR	+calretinin positive	0.00641025641026
CR	sconditional responses	0.00641025641026
CR	continuous reinforcement schedule	0.00641025641026
CR	3complement type 3 receptors	0.00641025641026
CR	cajal-retzius	0.00641025641026
CR	reversal of compound discrimination	0.00641025641026
CR	constant routine	0.00641025641026
CR	calorie restriction	0.0192307692308
CR	cognitive reserve	0.00641025641026
CR	control/baseline rapid eye movement sleep condition/group	0.00641025641026
CR	+calretinin immunopositive	0.00641025641026
CR	cellular recruitment	0.00641025641026
CR	conditioned response	0.185897435897
CR	–mi discrepancycentric relation–maximum intercuspation discrepancy	0.00641025641026
CR	3complement receptor 3	0.0128205128205
CR	conditioned responses	0.00641025641026
CR	caloric restriction	0.025641025641
CR	sconditioned responses	0.025641025641
CR	3complement receptor type 3	0.0128205128205
CR	cortex	0.00641025641026
CR	chronic restraint	0.00641025641026
CR	correct responses	0.00641025641026
CQ	clioquinol or 5-chloro-7-iodo-8-hydroxyquinoline	0.2
CQ	chloroquine	0.4
CQ	+vb12lead-exposed with clioquinol and vitamin b12 group	0.2
CQ	clioquinol	0.2
CP	critical period	0.00995024875622
CP	u(caudate-putamen) – striatum	0.00497512437811
CP	ucaudate putamen nucleus	0.00497512437811
CP	caudatoputamen	0.00497512437811
CP	cyclophosphamide	0.00995024875622
CP	capsule polysaccharide	0.00497512437811
CP	caudate-putamen	0.0398009950249
CP	zcontrol site	0.00497512437811
CP	cosmetic prosthesis	0.00497512437811
CP	ucaudate putamen	0.228855721393
CP	cervical paraspinals	0.00497512437811
CP	udorsal caudate-putamen	0.00497512437811
CP	cerebral palsy	0.0199004975124
CP	ucaudato-putamen	0.00497512437811
CP	ucaudate putamen (striatum)	0.00995024875622
CP	chronic pancreatitis	0.00497512437811
CP	1classification protocol 1	0.00497512437811
CP	ncortical plate neuron	0.00497512437811
CP	urrostral striatum	0.00497512437811
CP	central precuneus	0.00497512437811
CP	ucaudate/putamen	0.00995024875622
CP	acaudal paraventricular area	0.00497512437811
CP	icortex piriformis	0.00497512437811
CP	caudate putamen	0.0796019900498
CP	ucaudate putamen nuclei	0.00497512437811
CP	ucaudate–putamen	0.0248756218905
CP	cortical plate	0.124378109453
CP	posterior commissure	0.00497512437811
CP	urvcaudate-putamen rostral-ventral	0.00497512437811
CP	control rats receiving probiotic supplementation	0.00497512437811
CP	ceruloplasmin	0.0149253731343
CP	ucaudatoputamen	0.00497512437811
CP	central posterior nucleus	0.00497512437811
CP	cerebellar peduncle	0.00497512437811
CP	conductive polymer	0.00497512437811
CP	creatine phosphate	0.00995024875622
CP	dorsolateral caudate nucleus	0.00497512437811
CP	cerebral peduncle	0.00995024875622
CP	calcium permeable	0.00995024875622
CP	ucorpus striatum	0.00497512437811
CP	ipiriform cortex	0.00497512437811
CP	vehicle injection of 32% cyclodextrin	0.00497512437811
CP	changes in pixel	0.00497512437811
CP	ucaudate/putamen of the striatum	0.00497512437811
CP	caudate–putamen	0.0497512437811
CP	ucaudate-putamen	0.119402985075
CP	classification protocol	0.00497512437811
CP	conditioning potential	0.00497512437811
CP	upvparaventricular zone of the caudate putamen	0.00497512437811
CP	ucaudate-putamen (striatum)	0.00497512437811
CP	uvventral caudate	0.00497512437811
CP	1-3current protocols 1-3	0.00497512437811
CP	choroid plexus	0.0398009950249
CP	common peroneal	0.00995024875622
CW	critical word	0.0555555555556
CW	continuous wave (analog)	0.0555555555556
CW	clockwise	0.722222222222
CW	cerebral wall	0.0555555555556
CW	continuous wave	0.111111111111
CV	coefficient of period variation	0.0231213872832
CV	4caudal fourth ventricular	0.00578034682081
CV	coefficient of variation	0.543352601156
CV	the coefficient of variation	0.00578034682081
CV	cross-validation	0.0115606936416
CV	characteristic vector	0.0115606936416
CV	cranioventricular	0.00578034682081
CV	column volume	0.00578034682081
CV	conduction velocity	0.127167630058
CV	coefficient of variability	0.0115606936416
CV	coefficient of variation of response amplitude	0.0115606936416
CV	ercerebellar cortex vermis	0.00578034682081
CV	028upf0027 protein	0.00578034682081
CV	cervical vagus	0.00578034682081
CV	coefficient of variation of the interspike intervals distribution	0.00578034682081
CV	cyclic voltammogram	0.00578034682081
CV	injected cortical volume	0.00578034682081
CV	coefficient of variation of impulse activity	0.00578034682081
CV	2coefficient of variation	0.00578034682081
CV	coefficient of variation of the interspike intervals	0.00578034682081
CV	4caudal fourth ventricle	0.0115606936416
CV	cresyl violet	0.028901734104
CV	2coefficient of variability	0.0115606936416
CV	coefficient of variance	0.0346820809249
CV	circular variance	0.00578034682081
CV	coefficients of variation	0.0173410404624
CV	1first cervical vertebra	0.00578034682081
CV	scoefficients of variation	0.00578034682081
CV	ccaudal vc	0.00578034682081
CV	coefficient variance	0.00578034682081
CV	consonant–vowel	0.0115606936416
CV	coefficient of variation of the spike interval	0.0115606936416
CV	ipercent coefficient of variation of interburst interval	0.00578034682081
CV	relative variance	0.00578034682081
CV	observed variation	0.00578034682081
CV	coefficients of variance	0.00578034682081
CV	coefficient of variation of firing interval	0.00578034682081
MWMM	orris water-maze	0.012987012987
MWMM	orris water maze test	0.0519480519481
MWMM	orrris water maze	0.012987012987
MWMM	orris water maze	0.922077922078
CT	bb-subunit of cholera toxin	0.00966183574879
CT	bcholera-toxin b subunit	0.0048309178744
CT	bcholera toxin β-subunit	0.00966183574879
CT	conditioned tone	0.0048309178744
CT	cytoplasmic tail	0.0048309178744
CT	choice trial	0.0048309178744
CT	δ cycle threshold	0.0048309178744
CT	bcholera toxin-b	0.0048309178744
CT	cricothyroid	0.0048309178744
CT	b+, retrogradely-labelled cells	0.0048309178744
CT	cholera toxin subunit b	0.0048309178744
CT	xω-conotoxin gvia	0.00966183574879
CT	bcholera toxin b subunit	0.0579710144928
CT	scircadian times	0.0048309178744
CT	column of terni	0.0048309178744
CT	schromosome territories	0.0048309178744
CT	transient chopper	0.0048309178744
CT	concentration threshold	0.0048309178744
CT	circadian time	0.256038647343
CT	control rats	0.0048309178744
CT	carboxyl-terminus	0.0048309178744
CT	threshold cycle for real-time pcr	0.0048309178744
CT	clonic/tonic seizure	0.0048309178744
CT	bvctb-in vivo	0.0048309178744
CT	contralateral	0.0048309178744
CT	xmiiα-conotoxin mii	0.0048309178744
CT	computed tomography	0.0821256038647
CT	threshold cycles	0.0048309178744
CT	corticothalamic	0.0289855072464
CT	bcholera toxin-β subunit	0.0048309178744
CT	chorda tympani nerve	0.0048309178744
CT	control-transfected	0.0048309178744
CT	bcholera toxin subunit b	0.0531400966184
CT	difference in threshold cycle values	0.0048309178744
CT	bcholeratoxin subunit b	0.0048309178744
CT	untrained group (control)	0.0048309178744
CT	computerized tomography	0.0048309178744
CT	threshold cycle	0.135265700483
CT	bcholera toxin b-subunit	0.00966183574879
CT	b	0.0048309178744
CT	b-ircholera toxin-b immunoreactivity	0.0048309178744
CT	cycle threshold	0.0628019323671
CT	nervechorda tympani nerve	0.0048309178744
CT	cycle number at which the fluorescence passes the threshold level of detection	0.0048309178744
CT	computer tomography	0.0048309178744
CT	bcholera toxin subunit beta	0.0048309178744
CT	micro-computed tomography	0.0144927536232
CT	caudal temporal area	0.0048309178744
CT	bcholera toxin β subunit	0.0048309178744
CT	c-terminally directed	0.0048309178744
CT	bcholera toxin b	0.0048309178744
CT	chorda tympani	0.0338164251208
CT	cholera toxin	0.024154589372
CT	calcitonin	0.00966183574879
CT	carboxy terminal	0.0048309178744
CT	control group	0.00966183574879
HBBA	high basal brain activity	1.0
dLA	dorsal lateral amygdala	1.0
Ch	complex end-stopped	0.5
Ch	choline	0.5
BDMA	benzyldimethylamine	1.0
Cm	specific membrane capacitance	0.25
Cm	whole-cell capacitance	0.25
Cm	cell capacitance	0.25
Cm	membrane capacitance	0.25
Cl	claustrum	0.333333333333
Cl	centrolateral thalamus	0.333333333333
Cl	chloride	0.333333333333
20-HETE	20-hydroxyeicosatetraenoic acid	1.0
Ca	ca2+-dependent k+ current	0.333333333333
Ca	ca2+ integral of the i–v relation	0.333333333333
Ca	tris-buffered saline containing 1mm cacl2	0.333333333333
Cg	cingulate cortex	1.0
Ce	central amygdala	0.142857142857
Ce	central amygdaloid nucleus	0.571428571429
Ce	central nucleus of the amygdala	0.285714285714
Cd	caudate nucleus	0.666666666667
Cd	caudate	0.333333333333
dLS	dorsal subdivision of the lateral septal nucleus	0.333333333333
dLS	dorsal part of the lateral septum	0.333333333333
dLS	dorsal lateral septum	0.333333333333
Cy	carbocyanine	1.0
Cx	connexin	1.0
FdU	fluorodeoxyuridine	1.0
dLV	dorsal lateral vestibular nucleus	1.0
DGAVP	des-gly9-[arg8]-vasopressin	1.0
Cs	central nucleus, superior part	1.0
Cr	creatine	1.0
INAA	instrumental neutron activation analysis	1.0
ISHH	in-situ hybridization histochemistry	0.025641025641
ISHH	in situ hybridisation histochemistry	0.025641025641
ISHH	in situ hybridization histochemical	0.025641025641
ISHH	in situ hybridization	0.025641025641
ISHH	in situ hybridization histochemistry	0.897435897436
CO-II	cytochrome c oxidase subunit ii	1.0
hnRNA	heterogeneous nuclear ribonucleic acid	0.142857142857
hnRNA	high nuclear rna	0.142857142857
hnRNA	heteronuclear rna	0.571428571429
hnRNA	heterogeneous nuclear rna	0.142857142857
Nac	nucleus accumbens septi	1.0
TRDAT	exas red-conjugated dextran amine	0.25
TRDAT	exas red-conjugated dextran amines	0.25
TRDAT	exas red dextran amine	0.25
TRDAT	exas red conjugated dextran-amine	0.25
β-KIGSK	3β9a/9a knock-in	1.0
C-AS	carbachol induced active sleep	1.0
CAEP	scortical auditory evoked potentials	1.0
ADDAD	duration	1.0
SWS	2slow-wave sleep 2	0.0142857142857
SWS	slow–wave sleep	0.0142857142857
SWS	slow-wave sleep	0.5
SWS	slow wave sleep	0.442857142857
SWS	outh-west	0.0142857142857
SWS	wiss-webster	0.0142857142857
mid-DP	rostrocaudal middle level of dp	1.0
HHSS	hepes-buffered hank’s salt solution	1.0
SWR	ssharp wave–ripples	1.0
SR142948	selective non-peptide neurotensin receptor antagonists	1.0
CGSCGS	21680	1.0
norBNI	norbinaltorphimine	0.5
norBNI	nor-binaltorphimine	0.5
iS	2ipsilateral secondary somatosensory cortex	1.0
iR	item recognized	1.0
PGAD	persistent genital arausal disorder	1.0
PWAT	perirenal wat	1.0
NENP	non-enriched no-porsolt	1.0
V0	resting membrane potential	1.0
V1	visual area 1	0.0666666666667
V1	visual area 1 (primary visual cortex)	0.0666666666667
V1	v2, v3divisions of the trigeminal ganglion: ophthalmic (v1), maxillary (v2), mandibular (v3)	0.0666666666667
V1	primary visual cortex	0.333333333333
V1	striate or primary visual area	0.0666666666667
V1	5-6layers 5 and 6 of the primary visual cortex	0.0666666666667
V1	primary visual area (field 17)	0.0666666666667
V1	area 17 of the visual cortex	0.266666666667
V2	second visual area (field 18 in cats)	0.25
V2	visual area 2	0.25
V2	peristriate or secondary visual area	0.25
V2	secondary visual cortex	0.25
V3	third visual area (field 19 in cats)	1.0
V4	visual area 4	1.0
V5	visual area 5	1.0
V6	visual areas 1–6	1.0
iN	sinduced neurons	1.0
ILIGV	/areainverse logarithm of grain intensity per area	1.0
dmSTR	dorsomedial striatum	1.0
iE	item encoded	1.0
sFM	sinusoidally frequency modulated	1.0
iG	lurionotropic glutamate receptor	0.565217391304
iG	lu receptorsionotropic glutamate receptors	0.0434782608696
iG	luionotropic glutamate	0.0869565217391
iG	lursionotropic glutamate receptors	0.304347826087
MGmc	magnocellular medial geniculate nucleus	1.0
VA	ventro-anterior cell group	0.0277777777778
VA	mcventral anterior nucleus pars magnocellularis	0.0277777777778
VA	svolatile anesthetics	0.0277777777778
VA	voluntary activation	0.0277777777778
VA	vertical axis	0.0277777777778
VA	ventral auditory area	0.0277777777778
VA	ventroanterior thalamus	0.0277777777778
VA	ventral anterior thalamic nucleus	0.25
VA	ventral anterior thalamus nucleus	0.0277777777778
VA	/vlventral anterior/ventral lateral	0.0277777777778
VA	chtvesicular acetyl choline transporter	0.0277777777778
VA	vestibular area of the brainstem	0.0277777777778
VA	viable cell with abnormal nucleus	0.0277777777778
VA	ventral anterior	0.0277777777778
VA	chtvesicular acetylcholine transporter	0.0277777777778
VA	vitamin a	0.0277777777778
VA	ventral anterior nucleus	0.194444444444
VA	vl, vm, vpventroanterior, ventrolateral, ventromedial, and ventroposterior thalamic nuclei	0.0277777777778
VA	visual attention	0.0277777777778
VA	ventral anterior nuclei of the thalamus	0.0277777777778
VA	+matched condition	0.0277777777778
VA	vertical axis floccular purkinje cells	0.0277777777778
VB	veronal buffer	0.0769230769231
VB	ventral band	0.025641025641
VB	ventro-basal	0.025641025641
VB	ventrobasal	0.0769230769231
VB	ventrobasal nuclei	0.025641025641
VB	ventrobasal complex	0.384615384615
VB	12vitamin b12	0.025641025641
VB	ventrobasal nucleus of the thalamus	0.025641025641
VB	ventrobasal complex of the thalamus	0.0512820512821
VB	ventral basal	0.025641025641
VB	thalamusventrobasal thalamus	0.025641025641
VB	ventro-basalis	0.025641025641
VB	ventral basal nucleus of thalamus	0.025641025641
VB	ventrobasal nuclear complex of the thalamus	0.025641025641
VB	ventrobasal thalamus	0.0769230769231
VB	ventrobasal nucleus	0.0769230769231
VC	ventrocentral	0.05
VC	onventral cochlear nucleus	0.05
VC	cerebellar valvula	0.05
VC	visual cortex	0.15
VC	svoluntary muscular contractions	0.05
VC	variation coefficient	0.05
VC	vehicle-treated non-stressed control	0.05
VC	vertical cell	0.05
VC	vertical frame continuous vision	0.05
VC	vehicle control	0.15
VC	ventral cochlear nucleus	0.15
VC	vaginocervical	0.05
VC	voltage-clamp	0.1
VD	ventro-distal cell group	0.125
VD	vascular dementia	0.25
VD	ventricular dilator neuron	0.25
VD	visual discrimination	0.125
VD	ventricular dilator	0.25
VE	vehicle	0.0769230769231
VE	xvoluntary exercise	0.153846153846
VE	vascular endothelial	0.153846153846
VE	visceral e group neurons	0.0769230769231
VE	variable error	0.0769230769231
VE	voiding efficiency	0.153846153846
VE	nventral endopiriform nucleus	0.0769230769231
VE	vehicle (0.32% lactic acid for metoprine solution)	0.0769230769231
VE	ventricular epithelium	0.0769230769231
VE	vestibular-eye	0.0769230769231
VF	von frey	0.454545454545
VF	ventral funiculus	0.363636363636
VF	visual field	0.0909090909091
VF	voiding frequency	0.0909090909091
VG	vestibular ganglion	0.0512820512821
VG	ventral geniculate nucleus	0.025641025641
VG	lutvesicular glutamate transporter	0.179487179487
VG	lut1vesicular glutamate transporter 1	0.282051282051
VG	lut2vesicular glutamate transporter 2	0.179487179487
VG	lut2	0.025641025641
VG	lut2vesicular glutamate transporter type 2	0.0512820512821
VG	lut-1vesicular glutamate transporter-1	0.025641025641
VG	lut3vesicular glutamate transporter 3	0.0512820512821
VG	lut1-3neuron-specific vesicular glutamate transporters 1–3	0.025641025641
VG	lut	0.025641025641
VG	iventral gi	0.025641025641
VG	lut2vesicular glutamate transporter subtype 2	0.025641025641
VG	lut2vesicular glutamate transporter-2	0.025641025641
VH	ventral hippocampus	0.266666666667
VH	holding potential	0.333333333333
VH	ventral horn spinal cord	0.0166666666667
VH	ventral hippocampal lesion group	0.0166666666667
VH	ypventral hypothalamus	0.0166666666667
VH	ypventral hypothalamic nucleus	0.0166666666667
VH	holding membrane potential	0.0166666666667
VH	spinal cord ventral horn	0.0166666666667
VH	vehicle	0.0166666666667
VH	ventral hippocampal region	0.0333333333333
VH	pventral hippocampus proper	0.0166666666667
VH	holding membrane potential.	0.0166666666667
VH	ventral horn	0.183333333333
VH	ventral horn of the spinal cord	0.0333333333333
VI	variable interval	0.25
VI	variable-interval	0.166666666667
VI	variable interval (schedule of reinforcement)	0.0833333333333
VI	cortical layers i–vi	0.0833333333333
VI	abducens nucleus	0.0833333333333
VI	vigilance index	0.0833333333333
VI	vventral (caudal rectus) abducens subnucleus	0.0833333333333
VI	visual imagery	0.0833333333333
VI	abducens nerve	0.0833333333333
VK	3vitamin k3	1.0
VL	ventrolateral striatum	0.0135135135135
VL	ventro–lateral	0.0135135135135
VL	ventrolateral subnucleus of the lateral nucleus of the amygdala	0.0135135135135
VL	ventrolateral entorhinal area	0.0135135135135
VL	ventral lateral	0.0135135135135
VL	ventral lateral thalamus nucleus	0.0135135135135
VL	ventrolateral	0.175675675676
VL	ventrolateral nucleus	0.0810810810811
VL	thalamic ventrolateral nucleus	0.0135135135135
VL	vastus lateralis	0.0810810810811
VL	ventrolateral thalamus	0.0135135135135
VL	nucleus ventralis lateralis thalami	0.027027027027
VL	ventrolateral nucleus of thalamus	0.0135135135135
VL	lateral ventricle	0.0135135135135
VL	ventroanterior–ventrolateral thalamic complex	0.0135135135135
VL	ventral–lateral	0.0135135135135
VL	ventral lateral nucleus of the thalamus	0.0135135135135
VL	ventrolateral nucleus of the thalamus	0.027027027027
VL	aventral lateral anterior nucleus	0.027027027027
VL	ventrolateral thalamic nucleus	0.175675675676
VL	thalamic ventroanterior–ventrolateral complex	0.0135135135135
VL	ventrolateral subnucleus of the nts	0.0135135135135
VL	vestibular loss	0.027027027027
VL	ventrolateral thalamic	0.0135135135135
VL	ventrolateral (neostriatum)	0.0135135135135
VL	ventral lateral nucleus	0.0810810810811
VL	ventrolateral complex	0.0135135135135
VL	vertical lobe	0.0135135135135
VL	striatumvetrolateral striatum	0.0135135135135
VL	ventral lateral thalamic nucleus	0.027027027027
VM	ccaudal ventral medial thalamic nucleus	0.0113636363636
VM	vastus medialis	0.0227272727273
VM	ventral medial	0.0113636363636
VM	ventral mesencephalon	0.215909090909
VM	ventromedial nucleus of the thalamus	0.0113636363636
VM	ventro-medial cell group	0.0113636363636
VM	shellventromedial shell	0.0113636363636
VM	membrane voltage	0.0113636363636
VM	ventromedial striatum	0.0113636363636
VM	ventromesencephalic	0.0113636363636
VM	ventromedial subnucleus of the lateral nucleus of the amygdala	0.0113636363636
VM	ventromedial auditory field	0.0113636363636
VM	ventralmedial	0.0113636363636
VM	ventromedial	0.0909090909091
VM	resting membrane potential	0.0113636363636
VM	ventromedial thalamic nuclei	0.0113636363636
VM	poposterior part of the central medial nucleus	0.0113636363636
VM	vestibular migraine	0.0113636363636
VM	ventromedial nucleus	0.0454545454545
VM	visceral muscle	0.0113636363636
VM	ventral medial thalamic nucleus	0.0113636363636
VM	hventromedial nucleus of hypothalamus	0.0113636363636
VM	ventral mesencephalon/mesencephalic	0.0227272727273
VM	poposterior part of the ventral medial nucleus	0.0113636363636
VM	ventral medial nucleus	0.0454545454545
VM	ventral midbrain	0.0113636363636
VM	ventromedial thalamic	0.0113636363636
VM	ventromedial entorhinal area	0.0113636363636
VM	ventromedial thalamic nucleus	0.159090909091
VM	ventromedial nucleus of hypothalamus	0.0113636363636
VM	membrane potential	0.0113636363636
VM	ventro–medial	0.0113636363636
VM	visuomotor rotation	0.0113636363636
VM	ventral–medial	0.0113636363636
VM	ventral mesencephalic	0.0454545454545
VM	ventromedial subregion of the prefrontal cortex	0.0113636363636
VM	ventral medial nucleus thalamus	0.0113636363636
VM	ventromedian subdivision of the dorsal raphe nucleus	0.0113636363636
VM	visceromotor	0.0113636363636
VN	vestibular neuritis	0.0357142857143
VN	+video with consistent natural sound	0.0357142857143
VN	nvestibular nuclei neurons	0.0357142857143
VN	vomeronasal	0.0714285714286
VN	vehicle-treated noise-stressed	0.0357142857143
VN	viable cell with normal nucleus	0.0357142857143
VN	ventral nucleus of the octavolateral area	0.0714285714286
VN	vomeronasal nerve	0.0714285714286
VN	vestibular nucleus	0.142857142857
VN	vagus nerve	0.0357142857143
VN	vestibular nuclei	0.392857142857
VN	second-order vestibular neurons	0.0357142857143
VO	ventral orbitofrontal cortex	0.0333333333333
VO	vegetable oil	0.0333333333333
VO	vestibular-only	0.0333333333333
VO	2maximum oxygen consumption	0.0333333333333
VO	2oxygen consumption rate	0.0333333333333
VO	(opt)bis(1-n-oxide-pyridine-2-thiolato)oxovanadium(iv)	0.0333333333333
VO	2volume of oxygen consumption	0.0333333333333
VO	(opt)bis(1-oxy-2-pyridinethiolato)oxovanadium (iv)	0.0333333333333
VO	ventral orbital	0.0333333333333
VO	ventral orbital cortex	0.133333333333
VO	vestibular only	0.0333333333333
VO	2 maxmaximal oxygen uptake	0.0333333333333
VO	2maxmaximal oxygen uptake	0.0333333333333
VO	(opt)bis(1-oxy-2-pyridinethiolato)oxovanadium(iv)	0.0333333333333
VO	ventral orbital prefrontal cortex	0.1
VO	/loventral/lateral orbitofrontal cortex	0.0333333333333
VO	2rate of whole-body o2 consumption	0.166666666667
VO	2oxygen uptake	0.1
VO	vaginal opening	0.0333333333333
VP	1-nlsvp1 nuclear localization sequence of sv40 virus	0.00793650793651
VP	/siventral pallidum/substantia innominata	0.00793650793651
VP	vasopressin	0.261904761905
VP	ventral posterior nucleus of the thalamus	0.00793650793651
VP	ventroposterior auditory field	0.00793650793651
VP	substantia innominata/ventral pallidal region	0.00793650793651
VP	ventral posterior	0.00793650793651
VP	m/lventral posteromedial/lateral thalamic nucleus	0.00793650793651
VP	ventral pallium	0.00793650793651
VP	ventral posterior auditory cortical area	0.00793650793651
VP	ventroposterior thalamic nucleus	0.0238095238095
VP	ventral posterior thalamus	0.00793650793651
VP	ventral posterior complex thalamus	0.00793650793651
VP	ventral posterior nucleus	0.031746031746
VP	ventroposterior	0.00793650793651
VP	ventral palleostriatum	0.00793650793651
VP	thalamic ventroposterior nucleus	0.00793650793651
VP	ventral posterior the monkey and rat principal somatosensory nucleus	0.00793650793651
VP	ventroposterior nucleus	0.015873015873
VP	ventral paleostriatum or ventral pallidum	0.00793650793651
VP	mventral postero–medial thalamic nucleus	0.00793650793651
VP	voltage pulse-induced potentiation	0.00793650793651
VP	pcparvicellular part of the ventral posterior thalamic nucleus	0.015873015873
VP	chromaffin granule protein	0.00793650793651
VP	ventral posterior thalamic nuclei	0.00793650793651
VP	verb phrase	0.00793650793651
VP	arginine vasopressin	0.00793650793651
VP	ventral posterior thalamic nucleus	0.00793650793651
VP	ventral pallidum	0.468253968254
VQ	verbal quotient	1.0
VR	1vanilloid receptor subtype 1	0.0166666666667
VR	ventrorostral	0.0166666666667
VR	ventral root	0.183333333333
VR	ventral region of the spinal cord segments	0.0166666666667
VR	1vanilloid receptor	0.0166666666667
VR	efreference space of a given brain region	0.0166666666667
VR	variable ratio	0.0666666666667
VR	ventral roots	0.05
VR	1vanilloid receptor 1	0.116666666667
VR	virtual reality	0.0166666666667
VR	1	0.05
VR	sventral roots	0.0833333333333
VR	ventral rhizotomy	0.0333333333333
VR	1vallinoid receptor 1	0.0166666666667
VR	tventral reticular nucleus	0.0333333333333
VR	resting potential	0.0166666666667
VR	vanilloid receptor subtype	0.0166666666667
VR	1 receptor	0.0333333333333
VR	estresting membrane potential	0.0166666666667
VR	t* ventral reticular nucleus	0.0166666666667
VR	variance ratio	0.0166666666667
VR	1vanilloid receptor type 1	0.0166666666667
VR	1vanilloid receptor type i	0.0166666666667
VR	vascular resistance	0.0166666666667
VR	visually responsive	0.0166666666667
VR	varicosities	0.0166666666667
VR	1)	0.0166666666667
VR	vanilloid receptor	0.05
VS	vestibular schwannomas.	0.0322580645161
VS	trventral region of striatum	0.0322580645161
VS	voltage sensitive	0.0322580645161
VS	vector strength (this is a function whose values estimate the degree of phase-locking of the neural responses to the incoming stimuli)	0.0322580645161
VS	ventral striatum	0.161290322581
VS	+video with consistent speech	0.0322580645161
VS	vestibulospinal	0.129032258065
VS	vertical frame strobe vision	0.0322580645161
VS	ventral subiculum	0.161290322581
VS	vestibular schwannoma	0.0322580645161
VS	vector strength	0.129032258065
VS	visuo-spatial	0.0322580645161
VS	vanilla sugar	0.0645161290323
VS	vertical system	0.0645161290323
VS	vestibulo-spinal	0.0322580645161
VT	volume transmission	0.181818181818
VT	ventral thalamus	0.0909090909091
VT	vehicle treated	0.0454545454545
VT	/timean inspiratory flow	0.0909090909091
VT	ventral tier	0.0454545454545
VT	tidal volume	0.181818181818
VT	ventral tegmentum	0.0454545454545
VT	gventral tegmental nucleus	0.0909090909091
VT	gventral tegmentum nucleus	0.0454545454545
VT	vasotocin	0.0909090909091
VT	telencephalic ventricle	0.0454545454545
VT	vesicular transporter	0.0454545454545
NQONAD	(p)h:quinone oxidoreductase	1.0
VV	volume density of nerve fibers	0.2
VV	2valine/valine at codón 129 of prnp	0.2
VV	voided volume	0.2
VV	volume per unit volume	0.2
VV	visual vertical	0.2
VX	voluntary exercise	1.0
UNC-	5unc-5 homologues	1.0
VZ	ventricular zone	0.946428571429
VZ	ventral hypothalamic area	0.0178571428571
VZ	/svzventricular/subventricular zone	0.0178571428571
VZ	ventral zone of the hypothalamus	0.0178571428571
PeN	periventricular nucleus	1.0
Dk	nucleus of darkschewitsch	1.0
SEE	series elastic element	1.0
Vc	trigeminal nucleus caudalis	0.25
Vc	slope parameter	0.125
Vc	nucleus ventralis caudalis	0.125
Vc	contralateral vestibular horizontal canal	0.125
Vc	ventralis caudalis human principal somatosensory nucleus	0.125
Vc	trigeminal subnucleus caudalis	0.25
Vd	total volume of dextran spread	0.5
Vd	volume of distribution	0.5
FOXOF	orkhead protein	1.0
Cdc	central nucleus, densocellular part	1.0
Vh	potential of half-maximal activation	0.125
Vh	holding potential	0.75
Vh	holding membrane potential	0.125
Vi	trigeminal nucleus interpolaris	0.25
Vi	ipsilateral vestibular horizontal canal	0.125
Vi	inner volume	0.125
Vi	visceral sensory area	0.125
Vi	initial velocity for neurofilament transport	0.125
Vi	trigeminal subnucleus interpolaris	0.25
MAPK-ERK	1/2	1.0
MEKMAPK	/erk kinase	0.555555555556
MEKMAPK	kinase	0.444444444444
IAEI	nfluenza-associated encephalopathy	1.0
Vm	neuronal membrane potential	0.0666666666667
Vm	membrane potential	0.6
Vm	transmembrane potential	0.0666666666667
Vm	resting membrane potential	0.266666666667
Vo	extracellular d.c. potential shift	0.166666666667
Vo	trigeminal nucleus oralis	0.333333333333
Vo	void volume	0.166666666667
Vo	medial and ventral orbital cortices	0.166666666667
Vo	ophthalmic branch of trigeminal (v) nerve	0.166666666667
Vp	potential in pipette	0.166666666667
Vp	presynaptic potential	0.166666666667
Vp	trigeminal nucleus principalis	0.333333333333
Vp	ventral portion of medial vestibular nuclei	0.333333333333
Vr	resting membrane potential	1.0
Svehicle-treated	saline-challenged animals	1.0
MAP2B	microtubule-associated protein 2b	1.0
NIPP	1nuclear inhibitor of pp1	1.0
NFTs	neurofibrillary tangles	1.0
swLORETAstandardized	weighted low-resolution electromagnetic tomography	1.0
SSLSE	self sustaining limbic status epilepticus	0.5
SSLSE	self-sustained limbic status epilepticus	0.5
CRH-COE	conditional corticotropin releasing hormone–overexpressing	1.0
HPLC-ECD	high pressure liquid chromatography with electrochemical detection	0.0833333333333
HPLC-ECD	high-pressure liquid chromatography with electrochemical detection	0.0833333333333
HPLC-ECD	high performance liquid chromatography with electrochemical detection	0.166666666667
HPLC-ECD	high-pressure liquid chromatography-electrochemical detection	0.0833333333333
HPLC-ECD	high performance liquid chromatography coupled electrochemical detection	0.0833333333333
HPLC-ECD	high-performance liquid chromatography with electrochemical detection	0.416666666667
HPLC-ECD	high-performance liquid chromatography-electrochemical detection	0.0833333333333
α-MTPα-	methyl-dl-tryptophan	1.0
RSFC	resting-state functional connectivity	1.0
Cx-43	connexin-43	1.0
ALG	area in anterior part of lateral gyrus	1.0
rmTNF	recombinant murine tumor necrosis factor-α	1.0
NFOGQN	ew freezing of gait questionnaire	1.0
Ucn1	2, 3urocortin 1, 2, 3	1.0
RVF	right visual field	1.0
RVD	regulatory volume decrease	1.0
ALLO	allopregnanolone	0.75
ALLO	alopregnanolone	0.25
ALLN	acetyl-leu-leu-norleucinal	0.5
ALLN	n-acetyl-leu-leu-norleucinal	0.5
ANR1	antisense phosphodiester oligodeoxynucleotide specific for nmdar1	1.0
SPPB	short physical performance battery	1.0
RVM	rostral ventral medulla	0.0769230769231
RVM	rostral ventrolateral medulla	0.0153846153846
RVM	medial rostral ventral medulla	0.0153846153846
RVM	rostral ventromedial medulla	0.676923076923
RVM	rostroventromedial medulla	0.107692307692
RVM	rostroventral medulla	0.0923076923077
RVM	rostroventral medial medulla	0.0153846153846
RVL	rostral ventrolateral nucleus of the medulla	0.1
RVL	rostral ventrolateral medulla	0.4
RVL	rostral ventrolateral reticular formation	0.1
RVL	rostroventrolateral medulla	0.2
RVL	rostroventrolateral nucleus	0.1
RVL	rostral ventrolateral reticular nucleus	0.1
RVS	repeated variable stress	1.0
indo-1-AM	indo-1-acetoxymethyl ester	1.0
BLNG	‘basolateral’ nuclear group	0.333333333333
BLNG	basolateral nuclear group	0.666666666667
mTOR	mammalian target of rapamycin	0.863636363636
mTOR	the mammalian target of rapamycin	0.0227272727273
mTOR	mammalian targets of rapamycin	0.0227272727273
mTOR	mammalian tor	0.0227272727273
mTOR	mammalian target of rapamicin	0.0227272727273
mTOR	mammalian target for rapamycin	0.0227272727273
mTOR	mammalian target of rapamycin pathway	0.0227272727273
PFT-α	pifithrin-alpha	1.0
RVT	rotary vestibular test	1.0
βEND	β-endorphin	1.0
DL-SNr	dorsolateral part of the substantia nigra pars reticulata	1.0
PLLS	posterolateral lateral suprasylvian area	0.2
PLLS	posterolateral lateral suprasylvian	0.2
PLLS	posterolateral suprasylvian sulcus	0.4
PLLS	posterior lateral lateral suprasylvian area	0.2
N-SMaseneutral	mg2+-dependent sphingomyelinase	1.0
aBLA	anterior portion of basolateral nucleus of the amygdala	1.0
LESSPD	less affected idiopathic parkinson’s disease side	1.0
ST6N	α2,6(n)-sialyltransferase	1.0
r-nTS	solitary tract nucleus, rostral to area postrema	1.0
CaMPK	ca2+/calmodulin-dependent protein kinase	1.0
5OH-	indole5-hydroxyindole	1.0
αMTP	α-methyl-p-tyrosine	1.0
ArN	arcuate nucleus	1.0
OATP	organic anion-transporting polypeptide (oatp: rat ortholog)	0.333333333333
OATP	organic anion transporting polypeptide	0.333333333333
OATP	organic anion-transporting polypeptide	0.333333333333
SOCS3	suppressor of cytokines signaling 3	1.0
PLSD-test	protected least significant difference test	1.0
Arc	arcuate nucleus	0.714285714286
Arc	activity-regulated cytoskeleton-associated protein	0.285714285714
DZP7-chloro-1	3-dihydro-1methyl-5-phenyl-2h-1,4-benzodiazepine	1.0
NSLSN	ational synchrotron light source	1.0
SOCS-	2suppresor of cytokine signaling 2	0.5
SOCS-	3suppressor of cytokine signaling-3	0.5
ATZ3-amino-1	2,4-triazole	1.0
β-III	tubulin	1.0
DTCSN-	(dithiocarboxy)-sarcosine	1.0
HOMA	homeostasis model assessment index	0.5
HOMA	2homeostasis model assessment of insulin resistance 2	0.5
rRNA	ribosomal rna	1.0
rBAT	related b0,+ amino acid transporter	1.0
AMP-	activated protein kinasenutritionneurological disordersobesityvitamin b1	0.2
AMP-	response element-binding protein	0.2
AMP-	dependent protein kinase	0.6
NRMc	nucleus reticularis magnocellularis	1.0
3H-NMSN-	methyl-3h scopolamine	1.0
INBL	inner neuroblastic layer	1.0
FTDP-17	frontotemporal dementia with parkinsonism linked to chromosome 17	1.0
NCI-GCMS	negative ion chemical ionization gas chromatography–mass spectrometry	1.0
SURS	systematic uniform random sampling	1.0
ABSm	anterior biceps-semimembranosus	1.0
SRK	shaking rat kawasaki	1.0
CNQX7-nitro-2	3-dioxo-1,4-dihydroquinoxaline-6-carbonitrile	1.0
TRIFT	oll-interleukin 1 receptor domain-containing adaptor inducing interferon β	1.0
PTN	paratrigeminal nucleus	0.142857142857
PTN	posterior tubercle nucleus	0.142857142857
PTN	posterior tibial nerve	0.142857142857
PTN	pleiotrophin	0.571428571429
PTM	posttranslational modification	0.142857142857
PTM	post-translational modification	0.142857142857
PTM	photoperiodic time measurement	0.142857142857
PTM	sposttranslational modifications	0.285714285714
PTM	spost-translational modifications	0.285714285714
PTL	physiological target level	0.5
PTL	posterior parietal cortex	0.5
PTK	protein tyrosine kinase	0.692307692308
PTK	sprotein tyrosine kinases	0.0769230769231
PTK	protein-tyrosine kinase	0.153846153846
PTK	sprotein–tyrosine kinases	0.0769230769231
VPMpc	ventral posteromedial nucleus thalamus, parvicellular part	0.5
VPMpc	ventral posteromedial nucleus (parvicellular part)	0.5
PTH	parathyroid hormone	0.2
PTH	rpparathyroid hormone-related peptide	0.2
PTH	2rparathyroid hormone 2 receptor	0.4
PTH	post-tetanic hyperpolarization	0.2
PTG	posttraumatic growth	0.5
PTG	plasma triglyceride	0.5
PTE	post-traumatic epilepsy	0.333333333333
PTE	posttraumatic epilepsy	0.666666666667
PTD	pyrithiamine-induced thiamine deficiency	0.5
PTD	protein transduction domain	0.25
PTD	primary torsion dystonia	0.25
PTC	plasma total cholesterol	0.333333333333
PTC	posterior temporal cortex	0.333333333333
PTC	premature termination codon	0.333333333333
PTB	phosphotyrosine-binding domain	0.125
PTB	phosphotyrosine binding domain	0.125
PTB	pentobarbital	0.125
PTB	phosphotyrosine binding	0.25
PTB	phosphotyrosine-binding	0.25
PTB	polypyrimidine-tract-binding	0.125
PTA	pure-tone average	0.333333333333
PTA	post-term age: post-natal age corrected for gestational age at birth considering a term age of 40weeks	0.333333333333
PTA	phosphotungstic acid	0.333333333333
JMJ	endrassik maneuver	1.0
MBPM	yelin basic protein	1.0
PTZ	pentylenetetrazole	0.416666666667
PTZ	pentylenetetrazol (a.k.a. metrazol)	0.0208333333333
PTZ	prenatal pentylenetetrazol	0.0208333333333
PTZ	pentylenetetrazol	0.5
PTZ	pentylenetrazol	0.0416666666667
PTX	pertussi toxin	0.0119047619048
PTX	pertusis toxin	0.0119047619048
PTX	pertussis toxin	0.702380952381
PTX	picrotoxinin	0.0119047619048
PTX	picrotoxin	0.261904761905
HDAC	1histone deacetylase 1	0.0185185185185
HDAC	histone deactylase	0.0185185185185
HDAC	histone de-acetylase	0.0185185185185
HDAC	6histone deacetylase 6	0.0185185185185
HDAC	histone deacetylase	0.425925925926
HDAC	1/2histone deacetylase complexes 1 and 2	0.0185185185185
HDAC	ihistone deacetylase inhibitor	0.037037037037
HDAC	inhibitors	0.0185185185185
HDAC	histone deacetylase inhibitor	0.0185185185185
HDAC	shistone deacetylases	0.185185185185
HDAC	5histone deacetylase 5	0.0185185185185
HDAC	histone deacetylase inhibitors	0.0185185185185
HDAC	ihdac inhibitors	0.0185185185185
HDAC	histone deacetylases	0.111111111111
HDAC	histone deacetylase enzyme	0.0185185185185
HDAC	3histone deacetylase 3	0.0185185185185
HDAC	inhibitor	0.0185185185185
PTV	postero-temporal visual cortex	1.0
PTU	propylthiouracil	0.666666666667
PTU	6-n-propyl-2-thiouracil	0.333333333333
PTT	2β-propanoyl-3β-(4-tolyl)-tropane	0.5
PTT	pallidothalamic tractotomy	0.5
PTS	posttraumatic syringomyelia	0.111111111111
PTS	permanent threshold shift	0.888888888889
pMCAO	permanent mcao	0.0714285714286
pMCAO	permanent middle cerebral artery occlusion	0.857142857143
pMCAO	permanent distal middle cerebral artery occlusion	0.0714285714286
PTP	post-tetanus potentiation	0.0243902439024
PTP	protein tyrosine phosphates	0.0243902439024
PTP	post tetanic potentiation	0.0243902439024
PTP	postsynaptic protein tyrosine phosphatase	0.0243902439024
PTP	permeability transition pore	0.0975609756098
PTP	permeability transition pores	0.0243902439024
PTP	posttetanic potentiation	0.0731707317073
PTP	post-tetanic potentiation	0.439024390244
PTP	protein tyrosine phosphatase	0.268292682927
PT-	typepyramidal tract-type	1.0
DHD	orsal hippocampus	1.0
Sfi	nucleus septofimbrialis	1.0
DHC	dynein heavy chain	1.0
PT-L	large photothrombosis	1.0
T-CREB	total camp-response element binding protein	1.0
DHB	dihydroxybenzoic acid	1.0
PDSP	endred syndrome	1.0
PT-S	small photothrombosis	1.0
SUR-	1sulfonylurea receptor-1	1.0
VCFS	velo-cardio-facial syndrome	0.5
VCFS	velocardiofacial syndrome	0.5
ASV-	30antisauvagine-30	1.0
p75LNGFR	low affinity ngf receptor	0.5
p75LNGFR	low-affinity nerve growth factor receptor	0.5
SNCV	sensory nerve conduction velocity	1.0
AMPK	5′-amp-activated protein kinase	0.0909090909091
AMPK	5′-adenosine monophosphate-activated protein kinase	0.0909090909091
AMPK	5’-adenosine monophosphate-activated protein kinase	0.0909090909091
AMPK	adenosine 5′-monophosphate-activated protein kinase	0.272727272727
AMPK	adenosine monophosphate-activated protein kinase	0.454545454545
AMPH	amphetamine	0.783783783784
AMPH	d-amphetamine	0.162162162162
AMPH	d-amphetamine sulfate	0.0540540540541
BREK	brain-enriched kinase	1.0
SNCS	tanley neuropathology consortium	1.0
KO-NPC	snpcs derived from pgrn-deficient mice	1.0
DMPAG	or dmdorsomedial periaqueductal gray matter	0.142857142857
DMPAG	dorsomedial column of the periaqueductal gray	0.142857142857
DMPAG	dorsomedial periaqueductal gray	0.714285714286
AMPA	alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00501253132832
AMPA	rs-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazole	0.00501253132832
AMPA	dl-α-amino-3-hydroxy-5-methyl-4-isoxazole propionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-oxazole propionic acid	0.00250626566416
AMPA	d,l-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid	0.00501253132832
AMPA	receptors	0.0375939849624
AMPA	amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid	0.00250626566416
AMPA	/karsα-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptors	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid	0.00501253132832
AMPA	alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid	0.0125313283208
AMPA	amino-3-hydroxy-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	α-amino-5-hydroxy-3-methyl-4-isoxazole propionic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazide propionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxadepropionate	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-4 isoxazole propionic acid	0.00250626566416
AMPA	a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-4-isoazole propionic acid	0.00250626566416
AMPA	(s)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid	0.0325814536341
AMPA	2-amino-3-hydroxy-5-methyl-isoxozole	0.00250626566416
AMPA	/kainate receptor	0.00250626566416
AMPA	(rs)-α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate	0.00250626566416
AMPA	(±) α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-isoxalone-4-propionate	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-4 isoxazole proprionic acid	0.00250626566416
AMPA	(rs)-α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid	0.00250626566416
AMPA	(±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazole propionate	0.0551378446115
AMPA	(±)-α-amino-3-hydroxy-5-methylisoxazole-4-proprionate	0.00250626566416
AMPA	2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate	0.0100250626566
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid	0.00751879699248
AMPA	(s)-α-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	0.0325814536341
AMPA	denosine monophosphate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate	0.015037593985
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxaline propionic acid	0.00501253132832
AMPA	2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) propionate	0.00250626566416
AMPA	2-(aminomethyl) phenylacetic acid/kainite	0.00250626566416
AMPA	2-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid	0.00250626566416
AMPA	/kainate-epspα-amino-3-hydroxy-5-methyl-4-isoxazole propionate/kainate receptor-mediated excitatory postsynaptic potentials	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyloxole-4-propionate	0.00250626566416
AMPA	s-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4 isoxazolepropionate	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate	0.00250626566416
AMPA	(±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrate	0.00250626566416
AMPA	(s)-α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methylisoxazolone-4-propionic acid	0.00250626566416
AMPA	1-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	rampa-receptors	0.00250626566416
AMPA	amino α-3-hydroxy-5-methyl-4-isoaxazolepropionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.190476190476
AMPA	(±)-alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid hydrobromide	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid	0.00250626566416
AMPA	amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	0.0200501253133
AMPA	dl-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-propionic acid	0.00250626566416
AMPA	dl-α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid	0.00250626566416
AMPA	2-amino-3(3-hydroxy-5-methylisoxazol-4-yl)propionic acid	0.00250626566416
AMPA	receptor	0.0501253132832
AMPA	(s)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	0.00250626566416
AMPA	amino-3-hydroxy-5-methyl-4-isoazolepropionic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazole proprionate	0.00501253132832
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxaline proponic acid	0.00250626566416
AMPA	amino-methyl propionic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-isoxazole-4-propionate	0.0175438596491
AMPA	(±)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00501253132832
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate	0.015037593985
AMPA	d,l-alpha-amino-3-hydroxy-isoxazole proprionate	0.00250626566416
AMPA	(r,s)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	(r,s)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-isoxazolepropionate	0.00501253132832
AMPA	/kainate	0.00751879699248
AMPA	amino-3-hydroxy-5-methyl-isoxazolepropionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxalepropionic acid	0.00250626566416
AMPA	rα-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor	0.00751879699248
AMPA	alpha-amino-3-hydroxy-5-methyl-1,4 isoxazole proprionic acid	0.00250626566416
AMPA	(s)-ά-amino-3-bydroxy-5-methylisoxazole-4-propionic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid	0.00250626566416
AMPA	receptor internalization	0.00250626566416
AMPA	2-amino-3-hydroxy-5-methylisoxazole propionic acid	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid	0.0100250626566
AMPA	α-5-amino-3-hydroxy-5-methylisoxazole-4-propionate	0.00250626566416
AMPA	(rs)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	0.00501253132832
AMPA	amino-3-hydroxy-5-methyl-4-isoxazole propionate	0.00250626566416
AMPA	α-amino-3-methyl-5-hydroxyisoxazole-4-propionic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	0.0827067669173
AMPA	α-amino-3-hydroxy-5-methylisoxazole-4-proprionate	0.00751879699248
AMPA	aminomethyl phosphonic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoazole-proprionic acid	0.00250626566416
AMPA	/kainate receptors	0.00501253132832
AMPA	(±)-α-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid	0.00501253132832
AMPA	2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid	0.00501253132832
AMPA	(rs)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	(r,s)-α-amino-3-hydroxy-5-methylisoxazole-4-propionate	0.00250626566416
AMPA	channel	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-isoxazolpropionic acid	0.00250626566416
AMPA	(±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid	0.0175438596491
AMPA	(rs)-α-amino-3-hydroxy-5-methylisoxazole propionic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazole proprionate acid	0.00250626566416
AMPA	amino-3-hydroxy-5-methyl-4-isoxazole propionic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid	0.0375939849624
AMPA	receptor modulator	0.00250626566416
AMPA	α-amino-hydroxy-5-methylisoxazole-4-propionic acid	0.00250626566416
AMPA	alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid	0.00250626566416
AMPA	α-methyl-3-hydroxy-5-methylisoxazole-4-propionic acid	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methylisoxazole-4-propionate	0.0601503759398
AMPA	dl-α-amino-3-hydroxy-5-methyl-4 isoxazole propionic acid	0.00250626566416
AMPA	(s)-2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.00250626566416
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxalone propionic acid	0.00501253132832
AMPA	(±)-α-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid	0.00250626566416
AMPA	(±)-α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid	0.00250626566416
PCMT	1	1.0
SSAT	spermidine/spermine n1-acetyltransferase	1.0
UWU	niversity of washington	0.5
UWU	niversity of wisconsin	0.5
α-DG-N	globular amino-terminal domain of α-dg	1.0
DFMO	difluoromethylornithine	1.0
GABA-BGABA	receptor subtype b	1.0
RV-GFPGFP	comprising retroviral vector	1.0
MTTT	hiazolyl blue tetrazolium bromide	1.0
MATN	medial auditory thalamus nuclei	1.0
α-DG-C	globular carboxy-terminal domain of α-dg	1.0
17β-HSD	17β-hydroxysteroid dehydrogenase	0.5
17β-HSD	417β-hydroxysteroid dehydrogenase type 4	0.5
AMPT	α-methyl-para-tyrosine	0.285714285714
AMPT	alpha-methyl-p-tyrosine	0.142857142857
AMPT	α-methyl-p-tyrosine	0.142857142857
AMPT	alpha-methyl-para-tyrosine	0.285714285714
AMPT	α-methyl para-tyrosine	0.142857142857
SBTI	soybean trypsin inhibitor	1.0
SUG	superficial gray layers of the superior colliculus	1.0
NELF	negative elongation factor	1.0
SUD	substance use disorders	1.0
SUB	subordinates	0.166666666667
SUB	subiculum	0.666666666667
SUB	ventral subiculum	0.166666666667
Disorders	fourth edition	0.75
Disorders	4th edition	0.25
SACB	saline infusion in acb version	1.0
SUM	supramammillary area	0.235294117647
SUM	supramammillary nucleus	0.764705882353
NL-GABA	number of gaba synapses per unit length	1.0
p75I	nhp75 neurotrophin receptor inhibitor	1.0
SUI	static uncertainty index	1.0
5CSRTT	5-choice serial reaction time task	0.5
5CSRTT	5 choice serial reaction time task	0.5
BSA-	cacetylated bovine serum albumen	1.0
LAP-	1low alcohol preference-1	1.0
SUR	sulfonylurea receptors	0.333333333333
SUR	sulfonylurea receptor	0.333333333333
SUR	2sulfonylurea receptor 2	0.166666666667
SUR	sulphonylurea receptor	0.166666666667
CA074	n-(l-3-trans-propylcarbamoyloxirane-2-carbonyl)-l-isoleucyl-l-proline	1.0
UCP1	uncoupling protein 1	1.0
VPMV	entral posteromedial	1.0
SMCC	succinimidyl 4-(n-maleimidomethyl) cyclohexane-1-carboxylate	1.0
rhBDNF	recombinant human bdnf	1.0
ACAd	anterior cingulate area, dorsal	1.0
TEL	telencephalon	1.0
TEM	transmission electronic microscopy	0.027027027027
TEM	transmission em	0.027027027027
TEM	transmission electron microscope	0.108108108108
TEM	transmission electron microscopy	0.837837837838
subP	asubparaventricular hypothalamus	1.0
NBS	non–breeding season	1.0
TEA	tetra-ethylammonium	0.005
TEA	tetraethylammoniumchloride	0.005
TEA	+tetraethylammonium chloride	0.005
TEA	tetraethyammonium	0.005
TEA	tetraethylammonium cl	0.005
TEA	tetraethlyammonium	0.005
TEA	tetraethylammonium-chloride	0.005
TEA	tetraethyl-ammonium	0.01
TEA	+, tetraethylammonium	0.005
TEA	tetraethyl ammonium	0.03
TEA	tetramethylammonium	0.015
TEA	touch-evoked agitation	0.005
TEA	tetraethylammoniun	0.005
TEA	tetraetylammonium	0.005
TEA	temporal association area	0.005
TEA	triethylamine	0.005
TEA	triethanolamine	0.055
TEA	tetroethylammonium	0.005
TEA	tetraethylammonium	0.635
TEA	tetraethyl-ammonium chloride	0.005
TEA	tetrathylammonium	0.005
TEA	tetraethylammonium chloride	0.155
TEA	triethanolamine–hcl	0.005
TEA	+tetraethyl ammonium	0.005
TEA	tetraethyl ammonium chloride	0.01
NBP	dl-3-n-butylphthalide	1.0
αCSF	anti-granulocyte-monocyte colony stimulating factor	1.0
AVED	ataxia with vitamin e deficiency	1.0
NBT	/bcipnitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate	0.0416666666667
NBT	4-nitroblue tetrazolium chloride	0.0208333333333
NBT	nitro blue tetrazolium chloride	0.0208333333333
NBT	/bcipnitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate	0.0208333333333
NBT	/bcip,	0.0208333333333
NBT	nitroblue-tetrazolium-chloride	0.0208333333333
NBT	/bcipnitro-blue-tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate	0.0208333333333
NBT	4-nitro blue tetrazolium chloride	0.104166666667
NBT	/bcip4-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate	0.0208333333333
NBT	nitroblue tetazolium	0.0208333333333
NBT	nitroblue tetrazolium salt	0.0416666666667
NBT	nitro-blue tetrazolium	0.0208333333333
NBT	nitroblue tetrazoleum	0.0208333333333
NBT	nitro blue tetrazolium	0.1875
NBT	nitroblue tetrazolium	0.395833333333
NBT	nitrobenzyl-6-thio-inosine	0.0208333333333
ACAv	anterior cingulate area, ventral	1.0
ET-B	endothelin receptor b	1.0
GluR2	erendoplasmic reticulum	1.0
NTSge	gelatinous nts	1.0
NBN	narrow-band noise	0.333333333333
NBN	eurobasal medium	0.333333333333
NBN	narrowband noise	0.333333333333
NBM	nucleus basalis of meynert	0.173913043478
NBM	neural basal medium	0.0144927536232
NBM	basal nucleus of meynert	0.0579710144928
NBM	neurobasal medium	0.0724637681159
NBM	nucleus basalis magnocellularis	0.68115942029
NBL	neuroblastic layer	0.833333333333
NBL	neuroblast layer	0.166666666667
NBC	n1 (or 2)electroneutral na/bicarbonate cotransporter 1 (or 2)	0.166666666667
NBC	naïve bayesian classifier	0.166666666667
NBC	e1 (or 2)electrogenic na/bicarbonate cotransporter 1 (or 2)	0.166666666667
NBC	e1na/bicarbonate cotransporter	0.166666666667
NBC	sodium–bicarbonate co-transporter	0.166666666667
NBC	e1electrogenic sodium-bicarbonate cotransporter 1	0.166666666667
NBB	27psneurobasal/b27/penicillin/streptomycin	1.0
TER	transepithelial electrical resistance	0.5
TER	transcapillary exchange rate	0.5
TES	n-tris-(hydroxymethyl)methyl-2-aminoethanesulfonic acid	0.2
TES	transcranial electric stimulation	0.2
TES	tris (hydroxymethyl) methylaminoethanesulfonic acid	0.2
TES	n-tris[hydroxymethyl]methyl-2-aminoethanesulfonic acid	0.2
TES	n-tris[hydroxymethyl] methyl-2-amino-2-ethanesulfonic acid	0.2
TET	ten–eleven translocation	0.142857142857
TET	sallis entropy	0.142857142857
TET	tetanization	0.142857142857
TET	triethyltin	0.285714285714
TET	ris–edta	0.142857142857
TET	tetanus	0.142857142857
NBF	neutral-buffered formalin	0.5
NBF	neutral buffered formalin	0.5
NSAD	non-smoking alzheimer's disease patients	1.0
NBD	network burst duration	0.5
NBD	nucleotide-binding domain	0.5
DND	delayed neuronal death	1.0
ET-2	endothelin-2	1.0
ET-3	endothelin-3	1.0
DNA	repair	0.144927536232
DNA	deoxyribonucleic acid	0.0579710144928
DNA	sequence	0.0144927536232
DNA	binding	0.0289855072464
DNA	gel electrophoresis	0.0144927536232
DNA	polymerase from thermus aquaticus	0.0144927536232
DNA	memories	0.0144927536232
DNA	damage	0.144927536232
DNA	microarray	0.0144927536232
DNA	laddering	0.0144927536232
DNA	repair proteins	0.0289855072464
DNA	dsb	0.0144927536232
DNA	and protein synthesis	0.0144927536232
DNA	binding/differentiation	0.0144927536232
DNA	base excision repair	0.0144927536232
DNA	nick-end labelling	0.0144927536232
DNA	zyme	0.0289855072464
DNA	fragmentation	0.173913043478
DNA	sedeoxyribonuclease	0.0144927536232
DNA	methylation	0.130434782609
DNA	polymerase β	0.0289855072464
DNA	methyltransferase	0.0144927536232
DNA	binding protein	0.0144927536232
DNA	demethylation	0.0289855072464
DNB	dorsal noradrenergic bundle	0.833333333333
DNB	1,3-dinitrobenzene	0.166666666667
SCd	dorsomedial suprachiasmatic area	0.5
SCd	nucleus subcoeruleus dorsalis	0.5
DNO	diethylenetriamine-nitric oxide	1.0
CORO	2bcoronin-2b	1.0
DNI	distal nerve injury	1.0
DNJ	1-deoxynojirimycin	1.0
CORT	cortisol	0.0108695652174
CORT	plasma corticosterone	0.0108695652174
CORT	corticosterone	0.934782608696
CORT	chronic corticosterone administration	0.0108695652174
CORT	glucocorticoids	0.0108695652174
CORT	corticosterone treatment	0.0108695652174
CORT	corticosteroids	0.0108695652174
DNT	dysembryoplastic neuroepithelial tumor	1.0
CINC-	1cytokine-induced neutrophil chemoattractant-1	1.0
I-SC	imagery and spelling and counting complex task	1.0
DNP	dinitrophenol	0.5
DNP	dinitrophenyl	0.25
DNP	2,4-dinitrophenol	0.25
NS1619	1-(2′-hydroxy-5′-trifluoromethylphenyl)-5-trifluoromethyl-2-(3h)benzimidazolone	0.5
NS1619	1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-2h-benzimidazol-2-one	0.5
TE1	temporal cortex, area 1	1.0
d-βNal7	ile8]des-arg9-bradykinin	1.0
BSAc	chemically modified bovine serum albumin by acetylation	0.5
BSAc	bovine serum albumin (acetylated)	0.5
γ-GCL	gamma-glutamyl cysteine ligase	0.5
γ-GCL	gamma-glutamylcysteine ligase	0.5
EPAcis-5	8,11,14,17-eicosapentaenoic acid	1.0
d-NAMEN	w-nitro-d-arginine methyl ester	1.0
ENTC	excitatory nerve terminal current	1.0
β-ME	β-mercaptoethanol	1.0
TBPS	t-butylbyclophosphorothyonate	0.333333333333
TBPS	binding	0.333333333333
TBPS	t-butylbicyclophosphorothionate	0.333333333333
TBPT	ata binding protein	1.0
CTGF	connective tissue growth factor	1.0
GP1-ETVE	mutant grasp-1 mid-aspartates in the caspase cleavage site mutated into glumates	1.0
Z-DEVD-	fmkbenzyloxycarbonyl-asp(ome)-glu(ome)-val-asp(ome)-fluoromethylketone	1.0
BSAB	ovine serum albumin	1.0
TASK-1	twik-related acid-sensitive k+ channel	1.0
mE	scmethyl-scopolamine	0.5
mE	ntmedial entorhinal cortex	0.5
TRD	transcriptional repression domain	1.0
YM-2981986-amino-N-cyclohexyl-N	3-dimethylthiazolo[3,2-α]benzimidazole-2-carboxamide hydrochloride	1.0
N-TAF	1neuron-specific isoform of the taf1 gene	1.0
BAPB	ruton’s tyrosine kinase associated protein	1.0
EAc	central extended amygdala	1.0
NuRD	nucleosome remodeling and histone deacetylase	1.0
SIN-1	3-morpholino-sydnonimine hydrochloride	0.125
SIN-1	s-morpholinosydnonimine	0.125
SIN-1	3-morpholino-sydnonimine	0.25
SIN-1	3-morpholinosydnonimine	0.5
DISC	1disrupted-in-schizophrenia 1	0.0769230769231
DISC	death-inducing signaling complex	0.384615384615
DISC	1disrupted in schizophrenia-1	0.0769230769231
DISC	1disrupted in schizophrenia 1	0.307692307692
DISC	1	0.0769230769231
DISC	depolarization-induced slow current	0.0769230769231
DISD	isinhibition scale of the sss-v	1.0
QCF	sshort quasi constant frequency	1.0
GHAP	glial hyaluronate-binding protein	1.0
PIFT	peri-infarct flow transient	1.0
dInRdInR	drosophila insulin-like receptor	1.0
TCRT	cell receptor	1.0
α-KIGSK	3α21a/21a knock-in	1.0
rod-ON-BC	rod-dominant on type bc	1.0
NOMPC	no mechanoreceptor potential c	1.0
RKR	inger-krebs	1.0
EAN	experimental autoimmune neuritis	1.0
EAA	excitatory amino acids	0.093023255814
EAA	excitatory amino acid	0.837209302326
EAA	excitotoxic amino acid cocktail	0.0116279069767
EAA	sexcitatory amino acids	0.046511627907
EAA	(s)excitatory amino acid(s)	0.0116279069767
EAC	hequilibrium potential for diffusing acetylcholine	1.0
HO-	2heme oxygenase-2	0.0526315789474
HO-	1-/-heme oxygenase-1 knockout	0.0526315789474
HO-	1heme oxygenase 1	0.0526315789474
HO-	1	0.0526315789474
HO-	1heme-oxygenase-1	0.0526315789474
HO-	1hemeoxygenase-1	0.0526315789474
HO-	1heme oxygenase-1	0.684210526316
EAE	encephalomyelitis	0.030303030303
EAE	experimental allergic encephalitis	0.0151515151515
EAE	autoimmune encephalomyelitis	0.0151515151515
EAE	enclosed-arms entries	0.030303030303
EAE	experimental autoimmune encephalitis	0.0151515151515
EAE	receae rats recovered from clinical signs	0.0151515151515
EAE	experimental allergic encephalomyelitis	0.181818181818
EAE	experimental acute encephalitis	0.0151515151515
EAE	experimental autoimmune enchephalomyelitis	0.0151515151515
EAE	experimental autoimmune encephalomyelitis	0.666666666667
EAD	early alzheimer’s disease	1.0
EAG	ether-a-go-go	1.0
EAF	experimental aged females	1.0
LY341495	2s-2-amino-2-(1s,2s-2-carboxycyclopro-1-yl)-3-(xanth-9-yl)propanoic acid	1.0
cys-LT	scysteinyl leukotrienes	1.0
FTLD-U	sfrontotemporal lobar degeneration with ubiquitin-positive inclusions	1.0
calbindin-D	28k	1.0
EAP	ectopic action potential	1.0
GST-	πglutathione s-transferase-pi	0.5
GST-	piglutathione-s transferase-pi	0.5
RKI	iirho-kinase inhibitor ii	1.0
ALSA	myotrophic lateral sclerosis	1.0
sLTD	stress-enabled long-term depression	1.0
HOE	6943-(methylsulfonyl-4-piperidino-benzoyl)-guanidine methanesulfonate	1.0
MHPG3-methoxy	4-hydroxyphenylglycol	1.0
sLTM	strong long-term memory	1.0
vMMN	visual mismatch negativity	1.0
FapyG2	6-diamino-4-hydroxy-5-formamidopyrimidine	1.0
BNSTAL	anterolateral bnst	0.5
BNSTAL	anteriorlateral bed nucleus of the stria terminalis	0.5
GSTG	lutathione s-transferase	1.0
HOT	/cold	0.5
HOT	these groups were subjected to postischemic temperature regulation	0.5
GM2s-KOβ1	4-n-acetyl galactosamine-transferase knockout	1.0
GSTO	1glutathione s-transferase omega-1	1.0
ω-AgTx	ω-agatoxin iva	1.0
GSTM	5glutathione s-transferase mu 5	0.5
GSTM	1glutathione-s-transferase m1	0.5
CGS-21680	2-[p-(2-carboxyethyl)phenethylamino]adenosine-5′-n-ethyluronamide	1.0
NMGN-	methyl-d-glucamine	1.0
sgACC	)	0.333333333333
sgACC	subgenual anterior cingulate cortex	0.333333333333
sgACC	subgenual acc	0.333333333333
UHDRSU	nited huntington disease rating scale	1.0
4-α-PDD	4-α-phorbol 12,13-didecanoate	1.0
vAC	htvesicular acetylcholine transporter	1.0
NCBIN	ational center for biotechnology information	1.0
T-AVPNS	tracheobronchial-projecting avpns	1.0
D3	type 3 deiodinase	1.0
CT-B	cholera toxin b subunit	1.0
D1	d2 receptors	0.125
D1	major axis of the soma	0.125
D1	dopamine receptor type 1	0.125
D1	dopamine d1 receptor	0.125
D1	d2dopaminergic receptor types 1 and 2	0.125
D1	d2 and d3 receptors	0.125
D1	digit one	0.125
D1	dopamine receptor 1	0.125
4-HBA	4-hydroxybenzoic acid	1.0
PBTPBS	+0.1% tween-20	0.5
PBTPBS	with 0.05% triton x-100	0.5
NDSN	eurological deficit scores	1.0
mPSD	macular post-synaptic density	1.0
SK-N-SH	appwtsk-n-sh human neuroblastoma cells overexpressing wild type human app695	1.0
mPSB	medial pallial–subpallial boundary domain	1.0
mPSC	sminiature postsynaptic currents	0.125
mPSC	sminiature pscs	0.125
mPSC	miniature postsynaptic current	0.625
mPSC	sminiature postsynaptic potentials	0.125
rANOVAANOVA	for repeated measures	1.0
RIDN	srtn3-immunoreactive dystrophic neurites	1.0
IMZ	intermediate zone	1.0
z-DEVD-fmk	benzyloxycarbonyl-devd-fluoromethyl ketone	1.0
18α-GA	18α-glycyrrhetinic acid	1.0
LTRL	ysotracker red	1.0
AMD	actinomycin d	0.2
AMD	age-related macular degeneration	0.8
CNQX	6-nitro-7-cyanoquinoxaline-2,3-dione	0.00529100529101
CNQX	cyano-3,3-dihydro-7-nitroquinoxaline	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline 2,3 dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline-2,3-dione sodium	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline-2;3-dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline-2,3-(1h,4h)-dione	0.00529100529101
CNQX	6-eyano-7-nitroquinoxaline-2,3-dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline-(2,3)dione	0.00529100529101
CNQX	antagonist for ampa/kainate type receptors	0.00529100529101
CNQX	6-cyano-2,3-dihydroxy-7-nitroquinoxaline	0.021164021164
CNQX	6-cyano-7-nitroquinoxilane-2,3-dione	0.00529100529101
CNQX	6-cyano-7-nitroquioxiline-2,3-dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline-2,3-dione,	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline-2,3-dione disodium	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline-2,3-disodium	0.00529100529101
CNQX	6-cyano-5-nitroquinoxaline-2,3-dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxalone	0.015873015873
CNQX	6-cyano-7-nitroquinoxaline-2, 3-dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxoline-2,3-dione	0.00529100529101
CNQX	6 cyano-γ nitroquinoxaline dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline-2.3-dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxalone-2,3-dione	0.00529100529101
CNQX	6-cyano-7-nitro-quinoxalone	0.015873015873
CNQX	6-cyano-7-nitroquinoxaline-2,3-dione	0.719576719577
CNQX	6-cyano-7-nitro-quinoxaline-2,3-dione	0.031746031746
CNQX	6-cyano-7-nitroquinoxoline 2,3-dione	0.00529100529101
CNQX	6-cyano-7-nitroquinoxaline	0.0793650793651
CNQX	6-cyano-7-nitroquinoxaline-2,3-diome disodium	0.00529100529101
DIDSdiisothiocyanostilbene-2	2′-disulfonic acid	1.0
SSFB	scalp-skull-fluid-brain	0.5
SSFB	scalp–skull–fluid–brain	0.5
β-CCE	ethyl-β-carboline-3-carboxylate	1.0
Cl-IB-MECA	2-chloro-n6-(3-iodobenzyl)-adenosine-5′-n-methyluronamide	1.0
ICLR	interstrand cross-link repair	1.0
NDST	normal donkey serum triton	1.0
β-CCM	beta-carboline-3-carboxylate	1.0
SP-LISP-	like immunoreactivity	1.0
IFN-	8interferon-gamma	0.25
IFN-	gammainterferon-gamma	0.25
IFN-	gammainterferon-γ	0.25
IFN-	gammainterferon gamma	0.25
IS-SD	initial segment-somatodendritic spikes	0.2
IS-SD	initial-segment soma-dendrites	0.2
IS-SD	initial segment-somatodendritic	0.2
IS-SD	initial segment–soma dendritic	0.2
IS-SD	initial segment-somatodendritic delay	0.2
TAS-	20german 20-item version of the toronto alexithymia scale	1.0
αNGF	anti-nerve growth factor	1.0
TSG2	3,5,4′-tetrahydroxystilbene-2-o-β-d-glucoside	1.0
GST-RBD	glutathione s-transferase-tagged rhotekin rho-binding domain	1.0
O2-	superoxide anion	0.6
O2-	superoxide	0.2
O2-	superoxide anion radical	0.2
WN	white noise	1.0
RBMVEC	rat brain microvascular endothelial cells	1.0
RGM	a	0.5
RGM	arepulsive guidance molecule a	0.5
D31α	25-dihydroxyvitamin d3	1.0
FIR	first interval response	0.333333333333
FIR	finite impulse response	0.5
FIR	finite impulse response function	0.166666666667
LHF	left hemifield	1.0
FIV	feline immunodeficiency virus	1.0
LHB	lateral habenular nucleus	0.666666666667
LHB	lateral habenula	0.333333333333
LHA	lateral hypothalamus	0.0454545454545
LHA	lateral hypothalamic area	0.954545454545
OLWJO	uluwangji	1.0
ADTN	2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene	1.0
FIX	fixation period	1.0
Iout	total outward current	1.0
diA	sp	1.0
FIB	fibronectin	1.0
cSII	contralateral secondary somatosensory cortex	1.0
FIF	os immunoreactivity/immunoreactive	1.0
DLGD	iscs large	1.0
FID	free-induction decay	0.333333333333
FID	sfree induction decays	0.333333333333
FID	flame ionization detector	0.333333333333
PS-1	presenilin-1	1.0
CCLCC	chemokine ligand	1.0
FIH	factor inhibiting hif	1.0
PDDP	arkinson disease dementia	1.0
FIO	2inspiratory fraction of oxygen	1.0
FIL	first interspike interval long	1.0
FIM	fetally irradiated monkey	1.0
EVH-	1ena/vasp homology 1	1.0
GEAG	ene expression assay	1.0
PCTX	posterior cortex	1.0
LHb	lateral habenular nucleus	0.25
LHb	lateral habenula	0.75
TTBST	ris-tween buffered saline	0.0344827586207
TTBST	ween–tris buffer saline	0.0689655172414
TTBST	ris-buffered saline/0.1% tween 20	0.0344827586207
TTBST	ween 20-tbs	0.0689655172414
TTBST	ris-buffered saline tween 20	0.0344827586207
TTBST	ween 20 tris-buffered saline	0.0344827586207
TTBST	ween-20 tris-buffered saline solution	0.0344827586207
TTBST	ris-buffered saline	0.0344827586207
TTBST	ween tris-buffered saline	0.0344827586207
TTBST	ris-buffered saline containing 0.1% tween-20	0.0689655172414
TTBST	ris-buffered saline containing 0.01% tween 20	0.0344827586207
TTBST	ris-buffered saline with tween 20	0.0344827586207
TTBST	riton x-100 in tbs	0.0344827586207
TTBST	ris-buffered saline containing 0.25% tween-20	0.0344827586207
TTBST	ris-buffered saline containing 0.05% tween 20	0.0344827586207
TTBST	ween 20–tris-buffered saline	0.0689655172414
TTBST	ris–tween-buffered saline	0.0689655172414
TTBST	ween-tris buffered saline	0.0344827586207
TTBST	ris-buffered saline containing 0.1% tween 20	0.0344827586207
TTBST	ris with tween 20 buffered-saline	0.0344827586207
TTBST	ris-buffered saline with 0.5% tween 20	0.0344827586207
TTBST	ris-buffered saline with 0.05% tween 20	0.0689655172414
TTBST	ween–tris-buffered saline	0.0344827586207
DR-MV	mid ventral pole of dorsal raphe	1.0
FIV-C	refeline immunodeficiency virus-cre recombinase protein	1.0
TFII-IRD	1	1.0
OG-	5noregon green 488 bapta-5n-am	1.0
BARB	arrington's nucleus	0.333333333333
BARB	in/amphiphysin/rvs	0.333333333333
BARB	in/amphyphysin/rvs	0.333333333333
DEVD-AMC	caspase tetrapeptide substrate	0.5
DEVD-AMC	n-acetyl-asp-glu-val-asp-7-amino-4-methylcoumarin	0.5
DAout	da concentration in the output perfusate	1.0
DRB5	6-dichlororibofuranosyl benzimidazole	0.333333333333
DRB5	6-dichlorobenzimidazole 1-β-d-ribofuranoside	0.333333333333
DRB5	6-dichloro-1-b-d-ribofuranosylbenzimidazole	0.333333333333
NL-non-GABA	number of non-gaba synapses per unit length	1.0
LHy	nucleus lateralis hypothalami	1.0
WIPTIDEW	alsh inhibitor peptide	1.0
PDAPP	neuron-specific promoter	0.5
PDAPP	pdgf-b promoter driving a human app mini gene	0.5
CAPZA	2f-actin-capping protein subunit alpha-2	1.0
rrIL-	18recombinant rat il-18	1.0
CCFC	leveland clinic foundation	1.0
WP	whisker-pairing	0.5
WP	whisker pairing	0.5
PIP3PtdInsP3	phosphatidyl inositol 3,4,5-trisphosphate	1.0
DTTD	ithiothreitol	1.0
DTMR	dextran tetramethyl rhodamine	1.0
prHSP	27phosphorylated rhsp27	1.0
CNN	chronic neonatal nicotine treatment	0.5
CNN	chronic neonatal nicotine	0.5
sub-LT	sub-lactate threshold	1.0
RDL	rdl-encoded, gaba receptor subunit	1.0
RMFG	right middle frontal gyrus	1.0
Neu-N	neuronal-nuclei stain	1.0
MT-IIA	c-nle-c[asp-his-dphe-arg-trp-lys]-nh2	1.0
MT-IIM	elanotan-ii	1.0
Cntl	control	1.0
MT-III	metallothionein-iii	0.5
MT-III	metallothionein iii	0.5
FSLF	linders sensitive line	1.0
DEHSI	diffuse excessive high signal intensity	1.0
COApm	cortical nucleus amygdala, posterior part, medial zone	1.0
GrC	granule cell	1.0
sCT	[8–32]salmon calcitonin [8–32]	1.0
PSA-N-CAM	polysialylated isoform of n-cam	0.333333333333
PSA-N-CAM	polysialylated neural cell adhesion molecule	0.666666666667
VAMP-2	vesicle-associated membrane protein 2	1.0
HSP70	72 kda heat shock protein	0.5
HSP70	70,000 mol. wt heat shock protein	0.5
CPX8-cyclopentyl-1	3-dipropylxanthine	1.0
FLAV	flavopiridol	1.0
FSL-	1fibroblast-stimulating lipopeptide-1	1.0
FLAP	5-lipoxygenase activating protein	0.666666666667
FLAP	5-lipoxygenase-activating protein	0.333333333333
glycol-bis-2-aminoethylether-N	n,n′,n′-tetraacetic acid	1.0
MEM-H	minimal essential media with hepes	1.0
DST	caudate-putamen/dorsal striatum	0.25
DST	dexamethasone suppression test	0.75
MRIM	agnetic resonance imaging	1.0
DSR	distal stratum radium	1.0
DSS	dextran sodium sulfate	0.25
DSS	dejerine–sottas disease	0.25
DSS	dextrane sulfate sodium	0.25
DSS	dextran sulfate sodium	0.25
DSP	4n-(2-chloroethyl)-n-ethyl-2 bromobenzylamine	0.142857142857
DSP	4n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine hydrochloride	0.142857142857
DSP	4n-(2-chloroethyl)-n-ethyl-2-bromobenzyl amine	0.142857142857
DSP	4n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine	0.285714285714
DSP	4n-(2-chloro-ethyl)-n-ethyl-2-bromobenzylamine	0.142857142857
DSP	distal sensory polyneuropathy	0.142857142857
BMSB	asso mouse scale	0.833333333333
BMSB	asso mouse scale for locomotor recovery in mice	0.166666666667
BMSC	bone marrow stromal cell	0.416666666667
BMSC	sbone marrow derived stroma cells	0.0833333333333
BMSC	sbone marrow stromal cells	0.333333333333
BMSC	bone marrow–derived mesenchymal stromal cell	0.0833333333333
BMSC	bone marrow stem cells	0.0833333333333
SnPPIX	tin protoporphyrin ix	1.0
DSM	dutch chemical company	0.333333333333
DSM	diagnostic and statistical manual of mental disorders	0.333333333333
DSM	ivdiagnostic and statistical manual of mental disorders iv	0.333333333333
BrdUrd	5-bromo-2′-deoxyuridine	1.0
Bcl-XL	b cell lymphoma long isoform	1.0
DSI	depolarization-induced-suppression of inhibition	0.0555555555556
DSI	diffusion spectrum imaging	0.0555555555556
DSI	depolarization-induced suppression of inhibition	0.777777777778
DSI	direction selectivity index	0.0555555555556
DSI	depolarization-induced suppression	0.0555555555556
DSG	dorsal swallowing group	0.5
DSG	disuccimidyl glutarate	0.5
DSD	own syndrome	0.8125
DSD	own’s syndrome	0.125
DSD	decussatio supraoptica dorsalis	0.0625
DSE	depolarization-induced suppression of excitation	1.0
DSB	double strand break	0.3
DSB	double-strand break	0.2
DSB	double-strand dna break	0.1
DSB	sdouble-stranded breaks	0.1
DSB	sdouble-strand breaks	0.2
DSB	double-stranded breaks	0.1
DSC	dynamic susceptibility contrast	0.285714285714
DSC	dermis stem cell	0.142857142857
DSC	deep layer of the superior colliculus	0.142857142857
DSC	dorsal subiculum/ca1 of the hippocampus	0.142857142857
DSC	dorsal sensory cell	0.142857142857
DSC	deep superior colliculus	0.142857142857
GRGDNP	(np-rgd), glycine-arginine-glycine-aspartate-asparagine-proline peptide	1.0
PEBL	psychology experiment building language	1.0
DTT1	4-dithioerythritol	0.125
DTT1	4-dithiotreitol	0.25
DTT1	4-dithio-dl-threitol	0.375
DTT1	3-dithiothreitol	0.125
DTT1	4-dithiothreitol	0.125
ORE	osmotic responsive element	1.0
GRADSP	glycine–arginine–alanine–aspartate–serine–proline	0.5
GRADSP	gly-arg-ala-asp-ser-pro	0.5
4AP-	sensitive potassium channel	1.0
hESC	shuman embryonic stem cells	0.333333333333
hESC	human embryonic stem cell	0.666666666667
C-SMG	coeliac-superior mesenteric ganglia	1.0
DPP-IV	dipeptidyl peptidase iv	1.0
FILTER	filter-top cages	1.0
MRIs	magnetic resonance images	1.0
ratioS-	non-rewarded stimulus, to, time out	1.0
Technology	inc.	1.0
RLIMRING	finger lim-domain binding protein	1.0
tCREB	total creb	1.0
AV-SDF	1αa recombinant adenoviral vector containing a myc-tagged sdf1α cdna	1.0
ω-CTXω-	conotoxin gvia	1.0
1H-1	2,3-triazol-1-yl)methyl)-2-oxooxazolidin-3-yl)-2-fluorophenyl)piperazine-1-carboxylate	1.0
HSAH	omo sapiens autosome	1.0
DAF-	2dadiaminofluorescein-2 diacetate	0.5
DAF-	2diaminofluorescein-2	0.5
ECog	electrocorticogram	1.0
EWSE	wing sarcoma oncoprotein	1.0
AM1	2-bis-(2-aminophenoxy) ethane-n,n,n′,n′-tetraacetic acid tetrakis (acetoxymethyl) ester	0.333333333333
AM1	2-bis-(o-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid tetra(acetoxymethyl)ester	0.333333333333
AM1	2-bis(o-aminophenoxy)ethane-n,n,n′,n′-tetraacetic acid–1 acetoxymethyl ester	0.333333333333
ptrkB	phosphorylated trkb	1.0
EPAE	icosapentaenoicacid	1.0
EVA	enlarged vestibular aqueduct	0.5
EVA	extreme values analysis	0.5
T-MUS	1.5trained group that received 1.5 μg/g of muscimol	1.0
IEGs	immediate early genes	0.25
IEGs	immediate-early genes	0.75
HSAT	hebbian synapses with adaptive thresholds	1.0
wtMEFS	wild-type mouse embryonic fibroblasts	1.0
AβPs	synthetic β-amyloid peptides	1.0
ir-CGRP	outflow	1.0
V-ATPase	vacuolar h+-adenosine triphosphatase (vacuolar proton pump)	1.0
LTDGABA	long-term depression of gaba synapses	1.0
SPFpc	subparafascicular nucleus (parvicellular part)	1.0
CTB-AU	choleragenoid toxin subunit b conjugated to gold	1.0
RT-CES	real-time cell electronic sensing	1.0
UKU	nited kingdom	1.0
mAMY	medial amygdala	1.0
7-OH-PIPAT	(r)-trans-7-hydroxy-2-[n-propyl-n-(3′-iodo-2′-propenyl)-amino]tetralin	1.0
AUC	[da]area under the curve of da concentration	0.00757575757576
AUC	area(s) under the curve	0.00757575757576
AUC	area under curve	0.113636363636
AUC	cortarea under the curve for plasma corticosterone	0.00757575757576
AUC	0–∞area under the concentration-time curve from zero to infinity	0.00757575757576
AUC	areas under the curve	0.0151515151515
AUC	area-under-the-curve value	0.00757575757576
AUC	area under the time-dependent percentage edema curve	0.00757575757576
AUC	area under ca2+ peaks	0.00757575757576
AUC	areas under control	0.00757575757576
AUC	area under the number of flinches against time curve	0.00757575757576
AUC	area-under-the-curve	0.00757575757576
AUC	25area under the withdrawal curve calculated over a 25 h period	0.00757575757576
AUC	area under the concentration-time curve	0.00757575757576
AUC	area under the number of flinches against time curves	0.00757575757576
AUC	area under the curve	0.75
AUC	area created by the curve	0.00757575757576
AUC	area-under-curve	0.00757575757576
AUC	area under the roc curve	0.00757575757576
AUE	acute uremic encephalopathy	1.0
AUD	auditory cortex	0.2
AUD	pprimary auditory area	0.2
AUD	(d/p/v)auditory areas (dorsal/primary/ventral)	0.2
AUD	alcohol use disorder	0.4
SHAM-LX	sham-lesioned	1.0
RII	transforming growth factor-β receptors i and ii, respectively	1.0
S100	calcium-binding protein	1.0
pFRET	processed fret	1.0
HABP	hyaluronic acid-binding protein	0.666666666667
HABP	hyaluronic acid binding protein	0.333333333333
anti-P-C	amkiipolyclonal antibodies specific to the autophosphorylated state of ca2+/calmodulin-dependent protein kinase ii at thr-286 (α)/287 (β)	1.0
ASLEC	adolescent self-rating life events checklist	1.0
MHC-I	major histocompatibility complex class i	1.0
IR-HMC	infrared–hoffman modulation contrast	1.0
tBOOH	t-butyl hydroperoxide	1.0
PB-AHP	post-burst afterhyperpolarization	1.0
EGTA	ethyleneglycol-bis-(2-aminoethyl-ether)n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethylether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	glycol-bisaminoethyl-ether-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycolbis (aminoethylether)tetra-acetate	0.00395256916996
EGTA	ethyleneglycol-bis(β-aminoethylether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycolbis-(aminoethyl ether)tetra-acetate	0.00131752305665
EGTA	[ethylenebis (oxyethylene-nitrilo)]-tetraacetic acid	0.00131752305665
EGTA	ethylene-glycol-bis(oxyethylenenitrilo)-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol tetra-acetate	0.00263504611331
EGTA	ethylene glycol-bis(2-aminoethyl-ether)n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethyleneglyco-bis(2-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylenebis(oxyethylenenitrilo)tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol-bis-(β-aminoethyl ester)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol tetraacetic acid	0.239789196311
EGTA	ethylene glycol-bis(β-aminoethyl ether)-n,n,n’,n’-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol-bis(aminoethylether)n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethyl ether)-n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethylenediaminetetraaetic acid	0.00131752305665
EGTA	ethyleneglycolbis(aminoethyl ether)tetra-acetate	0.179183135705
EGTA	ethyleneglycol-bis-(β-aminoethyl ether) n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis (β-aminoethyl ether) tetraacetic acid	0.00263504611331
EGTA	ethyleneglycolbis(2-aminoethyl ether)tetra-acetate	0.00263504611331
EGTA	ethyleneglycolbis(β-aminoethylether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(amino-ethylether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol bis (β-aminoethyl ester)-n-n1-tetraacetic acid	0.00131752305665
EGTA	ethylene glycolbis(β-aminoethyl ether)-n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethyleneglycol-bis(aminoethyl ether)tetra-acetate	0.00131752305665
EGTA	ethyleneglycol bis (2-aminoethylester) tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(2-aminoethyl-ether-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis (2-amino ethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene-glycol-bis(2-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	(ethylene-bis[oxyethylenenitrilo])tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis-(β-aminoethyl ether)-n,n,n′,n′-tetraacetic acid	0.00395256916996
EGTA	ethylene glycol-bis(2-aminoethyl ether)-n,n,n′,n′-tetraacetic acid	0.00395256916996
EGTA	ethylene glycol bis(2-aminoethylether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol-bis-(β-aminoethylether)-n,n,n′,n′-tetraacetic acid	0.00263504611331
EGTA	ethylene glycol tetra-acetic acid	0.00395256916996
EGTA	ethyleneglycoltetra-acetate	0.0158102766798
EGTA	ethyleneglycolbis(aminoethyl-ether)tetra-acetate	0.00395256916996
EGTA	ethyleneglycol-bis-(β-aminoethylether)n,n′-tetra-acetate	0.00131752305665
EGTA	ethylene glycol tetracetic acid	0.00395256916996
EGTA	ethyleneglycolbis(aminoethyl ether)-n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis(2-aminoethyl-ether)-n,n,n′,n′-tetraacetate	0.00131752305665
EGTA	ethylene glycol-bis-(2-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00263504611331
EGTA	ethylene-bis(oxyethylenenitrilo) tetraacetic acid	0.00263504611331
EGTA	ethylenglycolbis(aminoethylether)tetra-acetate	0.00131752305665
EGTA	ethyleneglycol-bis(2-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00790513833992
EGTA	5-ethylenglycol-bis(β-aminoethyl ether)n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethyleneglycol-bis(β-aminoethyl ether)-n,n′-tetra-acetate	0.00131752305665
EGTA	ethyleneglycolbis(aminoethylether)tertracetate	0.00131752305665
EGTA	ethyleneglycol bis (aminoethylether) tetraacetic acid	0.00395256916996
EGTA	ethyleneglycolbis (aminoethyl-ether)tetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis(2-amino ethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00527009222661
EGTA	ethylene-glycol tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(2-amino-ethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylenglycol-tetraacetic acid	0.00131752305665
EGTA	[ethylene-bis(oxyethylenenitrilo)]-tetracetic acid	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00527009222661
EGTA	ethylene-bis(oxyethylenenitrilo)tetraacetic acid tetrasodium	0.00131752305665
EGTA	ethylglycoltetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis(2-amino ethyl)	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethyl-ether)-n,n,n′,n′-tetra acetic acid	0.00131752305665
EGTA	ethyleneglycolbis(β-aminoethyl ether)n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethyleneglycolbis (aminoethyl ether)tetra-acetate	0.00263504611331
EGTA	ethyleneglycol-bis(β-aminoethyl ether) n,n,n’,n’-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycolbis(amnioethylether)tetra-acetate	0.00263504611331
EGTA	ethyleneglycolbis(aminoethylether)tetra-acetate	0.218708827404
EGTA	ethyleneglycol bis(aminoethylether)tetraacetate	0.00131752305665
EGTA	ethyleneglycol-bis(amino-ethylether)-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycolbis(β-aminoethyl ether)tetra-acetate	0.00658761528327
EGTA	ethylene glycol-bis (β-aminoethyl ether)-n,n,n′,n′-tetraacetic acid	0.00263504611331
EGTA	ethyleneglycol-bis-(β-aminoethyl-ester) n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethyl ether)-n,n,n′-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol bis(2-aminoethylether)tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol-bis-(2-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00263504611331
EGTA	ethylene glycol-bis (2-aminoethyl-ether)-n,n,n′,n′-tetra-acetic acid	0.00131752305665
EGTA	ethylene glycol-bis(2-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.0527009222661
EGTA	ethylene glycoltetra acetate	0.00131752305665
EGTA	ethylenegycoltetra-acetate	0.00131752305665
EGTA	ethyleneglycol-tetra-acetate	0.00131752305665
EGTA	[ethylenebis(oxyethylenenitrilo)]-tetraacetic acid	0.00131752305665
EGTA	ethylenediamine tetraacetic acid	0.00263504611331
EGTA	ethyleneglycolbis(aminoethyl ether) tetra-acetate	0.00131752305665
EGTA	ethylene-glycolbis(aminoethylether)tetra-acetate	0.00131752305665
EGTA	ethylene glycolbis(aminoethylether)tetraacetate	0.00263504611331
EGTA	(-)-epigallocatechingallate	0.00131752305665
EGTA	ethylene glycol-bis-(aminoethyl ether)- n,n,n′, n′-tetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis(2-aminoethylether)-n,n,n′,n′-tetraacetic acid	0.00395256916996
EGTA	ethyleneglycolbis(aminoethyl ether)-tetra-acetate	0.00263504611331
EGTA	ethylene glycol-bis(β-aminoethyl ether)n,n,n′,n′-tetraacetic acid	0.00263504611331
EGTA	ethyleneglycolbis(amino-ethyl ether)tetra-acetate	0.00263504611331
EGTA	ethylene glycol-bis(β-aminoethyl ether)-n,n,n′,n′-tetraacetic acid	0.0184453227931
EGTA	ethyleneglycoltetraacetate	0.00131752305665
EGTA	ethyleneglycolbis(aminoethyl)tetra-acetate	0.00395256916996
EGTA	ethyleneglycol-bis(β-aminoethyl)-n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethylene-bis(oxyethylenenitrilo)tetraacetic acid	0.00131752305665
EGTA	ethylene-glycol tetra acetic acid	0.00131752305665
EGTA	ethylene glycol-bis(2-amino ethyl-ether)-n,n,n1n1-tetra acetic acid	0.00131752305665
EGTA	ethylenediaminetetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis aminoethyl ether tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol-bis(β-aminoethyl ether)-n,n,n′,n′ tetra-acetate	0.00131752305665
EGTA	ethylene-glycol-bis(2-aminoethyl-ether)n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethyleneglycolbis-(aminoethylether)tetra-acetate	0.00131752305665
EGTA	ethylene glycolbis(aminoethylether)tetra-acetate	0.00395256916996
EGTA	ethyleneglycol-bis(β-aminoethyl ether)tetra-acetate	0.00131752305665
EGTA	ethylene-glycol-bis(β-aminoethyl-ether)-n,n,n′,n′,-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol-bis(β-aminoethyl ether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycoltetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethyl ether)-tetraacetic acid	0.00263504611331
EGTA	ethylene glycol-bis (2-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00263504611331
EGTA	ethylene glycol-bis(β-aminoethyl ether)-n′, n′, n′, n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis (β-aminoethylether)-n,n,n′,n′,-tetra-acetic acid	0.00131752305665
EGTA	5-ethyleneglycolbis(β-aminoethylether)-n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	enthylenediaminotetraacetic acid	0.00131752305665
EGTA	ethyleneglycolbis(aminotheyl ether)tetra-acetate	0.00131752305665
EGTA	ethyleneglycolbis(β-aminoethyl ether)-n,n,n′,n′-tetra-acetate	0.0250329380764
EGTA	ethyleneglycol-bis(β-aminoethyl ether)-n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethyleneglycol-bis(β-aminoethyl)-n,n,n′,n′-tetraacetic acid	0.00263504611331
EGTA	ethylene glycol tetra-acetate	0.00263504611331
EGTA	ethyleneglycolbis-n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis(2-aminoethyl-ether)n,n,n′,n′-tetraacetic acid	0.00263504611331
EGTA	ethylene glycol-bis-(2-amino ethyl-ether)n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethyl)-n,n,n′,n′,-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycolbis(β-aminoethylether) n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis (β-aminoethyl ether) n,n,n′, n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethyl ether)-n,n′-tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis (β-aminoethyl ether)	0.00131752305665
EGTA	ethylene glycol-bis(2-aminoethylether)-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycolbis(β-amino-ethylether) n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis (β-aminoethylether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycolbis(aminoethylether) tetra-acetate	0.00131752305665
EGTA	ethylene glycol-bis (β-aminoethyl ether)-n, n, n′, n′-tetraaceticacid	0.00131752305665
EGTA	ethylene glycol bis (2-amino-ethyl-ester) tetraacetic acid	0.00131752305665
EGTA	ethylene glycol-bis(α-aminoethyl ether) n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	ethyleneglycol-tetraacetate	0.00131752305665
EGTA	ethylene glycol-bis(β-aminoethyl ether)-n,n,n′,n′-tetraacetate	0.00131752305665
EGTA	ethyleneglycolbis-(aminoethylether) tetra-acetate	0.00263504611331
EGTA	ethylene glycol-bis-(β-aminoethyl-ether)-n,n,n′,n′-tetraacetic acid	0.00131752305665
EGTA	o,o′-bis(2-aminoethyl)ethyleneglycol-n,n,n′,n′-tetra-acetate	0.00131752305665
EGTA	ethylene glycol tetraacetate	0.00131752305665
EGTA	ethylene glycoltetra-acetate	0.00131752305665
SCv	ventrolateral suprachiasmatic area	1.0
WSPW	ithdrawal seizure-prone	1.0
UBPα-	methyl-3-methyl-4-phosphonophenylglycine (ubp1112)	1.0
NMDGN-	methyl-d-glucamine chloride	0.0833333333333
NMDGN-	methyl-d-glutamate	0.0833333333333
NMDGN-	methyl-d-glucamine	0.833333333333
CI-AMPA	calcium-impermeable ampa receptor	1.0
NCBTN	a-coupled bicarbonate cotransporter	0.333333333333
NCBTN	a-coupled hco3– transporters	0.333333333333
NCBTN	a+-coupled hco3- transporter	0.333333333333
NAAGN-	acetyl-aspartyl-glutamate	0.25
NAAGN-	acetyl-aspartyl glutamate	0.125
NAAGN-	acetyl-l-aspartyl-l-glutamate	0.25
NAAGN-	acetyl-l-aspartyl-l-glutamic acid	0.125
NAAGN-	acetylaspartylglutamate	0.25
aNSC	sadult neural stem cells	1.0
HPLC-UV	high performance liquid chromatography combined with ultraviolet detection	0.5
HPLC-UV	high pressure liquid chromatography combined with ultraviolet detection	0.5
FBGRKO	forebrain glucocorticoid receptor knockout	0.5
FBGRKO	forebrain glucocorticoid receptor knockout mouse	0.5
LSEb	nerve lesion plus chronic stimulation with biphasic current	1.0
LSEm	nerve lesion plus chronic muscle stimulation	1.0
p53KO	p53 knockout	1.0
MMSEM	ini-mental state exam	0.130434782609
MMSEM	ini mental status exam	0.0434782608696
MMSEM	ini-mental state examination score	0.0434782608696
MMSEM	ini-mental status examination	0.0434782608696
MMSEM	ini mental-state evaluation	0.0434782608696
MMSEM	ini-mental state examination	0.347826086957
MMSEM	ini mental state exam	0.0434782608696
MMSEM	ini mental status examination	0.0434782608696
MMSEM	ini mental state examination	0.260869565217
TBET	ris–boric acid and 2 mm edta	0.333333333333
TBET	ukey's bisquare estimator	0.333333333333
TBET	ris borate ethylene-diamine-tetraacetic acid buffer	0.333333333333
AATYK	apoptosis-associated tyrosine kinase	1.0
WCPW	hole cell electrophysiology program	1.0
VPHA	2-propylpentane hydroxamic acid	1.0
RGC-	5retinal ganglion cells	1.0
ncRNA	snon-coding rnas	0.4
ncRNA	non-coding rna	0.2
ncRNA	snoncoding rnas	0.2
ncRNA	non-coding rnas	0.2
DHβE	dihydro-β-erythroidine hydrobromide	0.037037037037
DHβE	dihydro-β-erythroïdine	0.037037037037
DHβE	di-hydro-β-erythroidine	0.037037037037
DHβE	dihydro-β-erythrodine	0.037037037037
DHβE	dihydro-β-erythroidine	0.851851851852
DARTELD	iffeomorphic anatomical registration through exponentiated lie algebra	1.0
RISH	radioactive in situ hybridization	1.0
rev-T33	3′,5′-l-triiodothyronine	1.0
AβP	β-amyloid peptide	0.25
AβP	1–42	0.25
AβP	amyloid β-peptide	0.25
AβP	amyloid β-protein	0.25
sst2A	receptor	1.0
ODVO-	desmethylvenlafaxine	1.0
6xH	ishexahistidine tag	1.0
YFP	yellow fluorescent protein	0.85
YFP	enhanced yellow fluorescent protein	0.05
YFP	yellow-fluorescent protein	0.1
14C	]2-deoxyglucose	0.125
14C	]deoxyglucose	0.125
14C	]2-dg	0.125
14C	]gaba release	0.125
14C	]-2-dg[14c]	0.125
14C	)-2-fluoro-deoxyglucose	0.125
14C	]deoxyglucose method	0.125
14C	]inulin	0.125
cacna1atgT	ottering	1.0
mGAPDH	mouse glyceraldehyde-phosphate-dehydrogenase	1.0
AβA	myloid-β	0.5
AβA	myloid-beta	0.5
TFIID	transcription factor-iid	0.333333333333
TFIID	transcription factor iid	0.333333333333
TFIID	transcription factor iid complex	0.333333333333
DSAP	saporin toxin conjugated to an antibody against dopamine beta hydroxylase	1.0
PANSSP	ositive and negative syndrome scale	1.0
t-BOC7-amino-4-chloromethylcoumarin	t-boc-l-leucyl-l-methionine amide	1.0
RGCs	retinal ganglion cells	1.0
L-T	4l-thyroxine	1.0
ONH	optic nerve head	1.0
MRMT-	1mammary rat metastasis tumor	1.0
HAE	4-hydroxyalkenals	1.0
non-SCG	xnon-sympathectomized	1.0
IIV	intraindividual variability	1.0
L-A	rgl-arginine	0.25
L-A	mygnucleus amygdalae lateralis	0.25
L-A	gglow-aggression	0.5
NAl	nucleus ambiguus, loose formation	1.0
L-E	nkleucine-enkephalin	1.0
CPVM	ventromedial subregion of the caudate-putamen	1.0
CPVL	ventrolateral subregion of the caudate-putamen	1.0
MOC-1	human neural cell adhesion molecule antibody	1.0
IIS	interictal spike	0.666666666667
IIS	insulin/igf-1 signaling pathway	0.333333333333
dNB	1first dorsal narrow bandwidth region	1.0
fALS	familial als	0.25
fALS	familial amyotrophic lateral sclerosis	0.75
GR-55	5623-[3-(dimethylamino)propyl]-4-hydroxy-n-[4-(4-pyridinyl)phenyl]	1.0
ONC	optic nerve crush	1.0
RGCL	retinal ganglion cell layer	1.0
dASCS	chwann cell-like differentiated adipose-derived stem cell	1.0
sAHPslow	late component of afterhyperpolarization	1.0
NNDPDN	n dimethyl-p-phenylenediamine sulfate	1.0
Tris	150mm nacl, ph 7.5)	0.0588235294118
Tris	0.15 m nacl, ph 7.2) containing 0.05% tween-20	0.0588235294118
Tris	150 mm nacl, and 0.1% tween 20	0.0588235294118
Tris	2-amino-2-hydroxymethyl-propan-1,3-diol	0.0588235294118
Tris	150 mm nacl, 0.1% tween, ph 7.5	0.0588235294118
Tris	ph 7.6, 0.9% nacl, 0.01% tween 20	0.0588235294118
Tris	tris(hydroxymethyl)aminomethane	0.117647058824
Tris	150mm nacl, 0.1% tween-20, ph 8	0.0588235294118
Tris	nacl 1.5%, 0.05% tween 20, ph 7.5	0.0588235294118
Tris	trishydroxymethyl-amino methane	0.0588235294118
Tris	150 mm nacl, and 0.1% tween-20	0.0588235294118
Tris	500 mm nacl, 0.1% tween 20	0.0588235294118
Tris	0.9% nacl, 0.05% thimerosal in 10 mm phosphate buffer, ph 7.4	0.0588235294118
Tris	500mm nacl, ph 7.4 containing 0.1% triton x-100	0.0588235294118
Tris	ph 7.7, 137 mm nacl, 0.1% (vv-1) tween 20	0.0588235294118
Tris	0.05 m edta, in diethyl pyrocarbonate water, ph 8	0.0588235294118
α-MEMα-	modified eagle's minimal essential medium	1.0
FFX-	lesions	1.0
Ngb	neuroglobin	1.0
VFH	von frey hairs	0.111111111111
VFH	von frey hair	0.888888888889
VFF	von frey hair filaments	0.25
VFF	von frey filament	0.75
SD-S	social defeat-short	1.0
VFB	visual feedback	1.0
VPLm	medial part of the ventroposterolateral nucleus of the thalamus	1.0
NPγ	neuropeptide γ	1.0
G-MEMG	lasgow minimum essential medium	1.0
T-KT	ukey–kramer multiple-comparison test	1.0
piRNAP	iwi interacting rnas	1.0
BNA	basal nucleus of amygdala	1.0
USF-	1upstream stimulatory factor 1	1.0
WTR	wild-type rescue	1.0
α1-AR	α1a-adrenoceptor	1.0
WTW	ild type	0.5
WTW	ild-type	0.5
αDB-	koα-dystrobrevin knockout	1.0
rPAT	reverse sequence of pat	1.0
PDGF-AA	platelet-derived growth factor-aa	0.666666666667
PDGF-AA	platelet-derived growth factor	0.333333333333
WTA	wave-triggered average	1.0
IIF	intermediate-threshold fast-inactivating inward current	1.0
AIDα	1 interaction domain	1.0
BNE	blue native electrophoresis	1.0
FADD	adaptor	0.333333333333
FADD	fas-associated death domain	0.666666666667
IDECGI	nternational dietary energy consultancy group	1.0
WTN	wortmannin	1.0
UNAM	universidad nacional autónoma de méxico	1.0
eNOSE	ndothelial nitric oxide synthase	1.0
LSDF	isher’s least significant difference	0.666666666667
LSDF	isher’s least significant difference test	0.333333333333
8-ISO	8-isoprostane	1.0
IACh	current elicited by acetylcholine	1.0
ZD72884-ethylphenylamino-1	2-dimethyl-6-methylaminopyrimidinium chloride	0.5
ZD72884-ethylphenylamino-1	2-dimethyl-6-methylamino-pyrimidinium chloride	0.25
ZD72884-ethylphenylamino-1	2-dimethyl-6-methylaminopyrimidium chloride	0.25
Shc	src homology domain-containing protein	0.5
Shc	src homology 2 domain-containing transforming protein 1	0.5
CHOPC	/ebp-homologous protein 10	0.111111111111
CHOPC	/ebp homologous protein	0.444444444444
CHOPC	/ebp homology protein	0.111111111111
CHOPC	/ebp-homologous protein	0.333333333333
PGC-	1αproliferator-activated receptor γ coactivator 1α	0.0769230769231
PGC-	1peroxisome proliferator activated receptor gamma coactivator-1	0.0769230769231
PGC-	1αperoxisome proliferator-activated receptor gamma coactivator 1-alpha	0.153846153846
PGC-	1proliferator activated receptor coactivator-1	0.0769230769231
PGC-	1αperoxisome proliferator-activated receptor gamma coactivator-1α	0.0769230769231
PGC-	1αperoxisome proliferator-activated receptor γ coactivator 1α	0.0769230769231
PGC-	1αperoxisome-proliferator-activated receptor-c coactivator-1α	0.0769230769231
PGC-	1αperoxisome proliferator-activated receptor γ co-activator 1α	0.0769230769231
PGC-	1αperoxisome proliferator-activated receptor-gamma coactivator-1alpha	0.0769230769231
PGC-	1αperoxisome proliferator-activated receptor γ coactivator-1α	0.153846153846
PGC-	1α	0.0769230769231
dLOT	dorsal lateral olfactory tract	1.0
CTCFCCCTC	binding factor	1.0
hOE	human olfactory epithelial	1.0
hOC	human osteocalcin	1.0
PrCm	precentral medial cortex	1.0
t-PDCtrans-pyrrolidine-2	4-dicarboxylic acid	1.0
dCS	d-cycloserine	1.0
FPUT	fronto-parietal u-shaped tracts	1.0
HAC	shigh amplitude contractions	1.0
NIRF	near-infrared fluorescence	1.0
IIK	calcium calmodulin-dependent type ii protein kinase	1.0
devKYN	developmental kynurenine treatment	1.0
cyclic-AMP	response element binding protein	1.0
CGRP-	gold	1.0
cAMY	caudal amygdala	0.5
cAMY	cortical amygdala	0.5
DIND	delayed ischemic neurological deficits	1.0
LCα	nucleus locus coeruleus pars α	0.5
LCα	locus coeruleus α	0.5
cAMP	adenosine 3′,5′-cyclic monophosphorothioate	0.00523560209424
cAMP	]iintracellular 3′–5′-cyclic amp concentration	0.00523560209424
cAMP	cyclic adenosine 5′-monophosphate	0.0104712041885
cAMP	cyclic 3′,5′-adenosine monophosphate	0.00523560209424
cAMP	dibutyryl-cyclic-adenosine-monophosphate	0.00523560209424
cAMP	adenosine 3′,5′-cyclic monophosphate	0.0628272251309
cAMP	response element-binding protein (creb)	0.00523560209424
cAMP	responsive element binding protein	0.00523560209424
cAMP	)	0.00523560209424
cAMP	cyclic adenosine monophospate	0.00523560209424
cAMP	3′,5′-cyclic monophosphate	0.00523560209424
cAMP	/pkacyclic amp/protein kinase a	0.00523560209424
cAMP	cyclic-amp	0.0261780104712
cAMP	3′,5′-cyclic amp	0.0104712041885
cAMP	–pka signaling pathway	0.00523560209424
cAMP	3′-5′-cyclic adenosine monophosphate	0.0104712041885
cAMP	cyclic amp	0.492146596859
cAMP	cyclic 3′,5′ adenosine monophosphate	0.00523560209424
cAMP	cyclic adenosine 3′,5′-monophosphate	0.020942408377
cAMP	cyclic adenosine 5′- monophosphate	0.00523560209424
cAMP	cyclic adenosine monophosphate (camp)	0.00523560209424
cAMP	cyclic adenine monophosphate	0.00523560209424
cAMP	3′-5′-cyclic amp	0.0104712041885
cAMP	cyclic adenosine-3′, 5′-monophosphorothioate	0.00523560209424
cAMP	cyclic-3′,5′-amp	0.00523560209424
cAMP	cyclic-3′,5'-adenosine monophosphate	0.00523560209424
cAMP	adenosine-3′,5′-cyclic monophosphate	0.020942408377
cAMP	response element binding protein (creb)	0.00523560209424
cAMP	adenosine 3′ 5′-cyclic monophosphate	0.00523560209424
cAMP	cyclic adenosine monophosphate	0.225130890052
cAMP	3′–5′-cyclic amp	0.00523560209424
αβ-MeADPα	β-methylene adp sodium salt	1.0
aSTG	anterior superior temporal gyrus	1.0
APRIL	acidic protein rich in leucine	1.0
WHIMS	the women’s health initiative study	1.0
NoxNADPH	oxidase	1.0
aSTS	/mtganterior superior temporal sulcus/middle temporal gyrus	0.333333333333
aSTS	anterior part of the superior temporal sulcus	0.333333333333
aSTS	anterior superior temporal sulcus	0.333333333333
cAMG	central amygdala	1.0
CCL-	64 cellsmink lung epithelial cell	1.0
3HDA	[3h]d-aspartate	1.0
RTD	right touchdown	0.5
RTD	restoration of target denied	0.5
RTA	repressor of tamoxifen transcriptional activity	0.5
RTA	restoration of target allowed	0.5
FORM	formalin-treated group	1.0
d-NAP	d-napvsipq	1.0
MLPSLPS-	treated microglia-conditioned medium	1.0
RTL	retention transfer latency	1.0
RTO	rapidly turning over achr	1.0
RTN	reticular nucleus	0.0357142857143
RTN	1reticulon 1	0.0357142857143
RTN	retrotrapezoid nucleus	0.321428571429
RTN	/pfrgretrotrapezoid nucleus/parafacial respiratory group	0.0357142857143
RTN	thalamic reticular nucleus	0.0357142857143
RTN	3reticulon 3	0.0357142857143
RTN	reticular thalamic nucleus	0.464285714286
RTN	reticulotegmental nucleus	0.0357142857143
RTI	3β-(4-125i-iodophenyl)tropane-2β-carboxylic acid isopropyl ester	0.5
RTI	real-time iontophoretic	0.5
RTK	sreceptor tyrosine kinases	0.4
RTK	receptor protein tyrosine kinase	0.2
RTK	styrosine kinase receptors	0.2
RTK	receptor tyrosine kinase	0.2
2H6	monoclonal antibody to chondroitin sulfate	1.0
RTT	greticulotegmental nucleus of the pons	1.0
MCPC	magnocellular nucleus of the posterior commissure	0.5
MCPC	magnocellular nucleus posterior commissure	0.5
AGAT	l-arginine:glycine amidino transferase	0.333333333333
AGAT	arginine:glycine amidinotransferase	0.333333333333
AGAT	arginine: glycine amidinotransferase	0.333333333333
ChAT	choline acetyltransferase	0.946078431373
ChAT	cholineacetyltransferase	0.00490196078431
ChAT	choline acetyl transferase	0.0196078431373
ChAT	choline-acetyltransferase (ec 3.2.1.6)	0.00980392156863
ChAT	ec 3.2.1.6, choline-acetyltransferase	0.00490196078431
ChAT	choline acetyltransferase protein	0.00490196078431
ChAT	choline acetyl-transferase	0.00490196078431
ChAT	choline-acetyltransferase	0.00490196078431
RTR	everse transcription	0.5
RTR	eaction time	0.5
Rcad	r-cadherin	1.0
RTX	resiniferatoxin	1.0
MCPO	magnocellular preoptic area	0.217391304348
MCPO	/simagnocellular preoptic nucleus and substantia innominata	0.0434782608696
MCPO	magnocellular preoptic nucleus	0.608695652174
MCPO	horizontal part of diagonal band of broca/magnocellular preoptic nucleus	0.0434782608696
MCPO	magnocellular preoptic nucleus (medial central preoptic area)	0.0434782608696
MCPO	magnocellular preoptic nu	0.0434782608696
Vinact	voltage of half inactivation	1.0
RT-	pcrreverse transcription polymerase chain reaction	0.0909090909091
RT-	qpcrquantitative real-time reverse transcription polymerase chain reaction	0.0909090909091
RT-	qpcrreverse transcriptase–real time quantitative polymerase chain reaction	0.0909090909091
RT-	30”random time 30”	0.0909090909091
RT-	qpcrreverse-transcribed polymerase chain reaction	0.0909090909091
RT-	qpcrreverse transcription quantitative real-time polymerase chain reaction	0.0909090909091
RT-	97neurofilament marker	0.0909090909091
RT-	qpcrreal-time quantitative polymerase chain reaction	0.181818181818
RT-	qpcrreverse transcription quantitative pcr	0.181818181818
Lat-A	latrunculin a	1.0
ChEIs	cholinesterase inhibitors	1.0
MCP-	1monocyte chemotatic protein-1	0.037037037037
MCP-	1monocyte chemoattractant protein 1	0.0740740740741
MCP-	1monocyte-chemoattractant protein-1	0.037037037037
MCP-	1monocyte chemoattractant protein-1 (also called ccl2)	0.037037037037
MCP-	1	0.037037037037
MCP-	1monocyte chemoattractant protein-1	0.481481481481
MCP-	1macrophage chemoattractant protein-1	0.0740740740741
MCP-	1monocyte chemotactic protein-1	0.222222222222
PPARα	peroxisome proliferator-activated receptors type-α	0.333333333333
PPARα	peroxisome proliferator-activated receptor-α	0.666666666667
PPARγ	peroxisome proliferator-activated receptor gamma	0.75
PPARγ	peroxisome proliferator-activated receptor γ	0.125
PPARγ	peroxisome proliferator activator receptor gamma	0.125
T-RNARNA	from transduced cells	1.0
Apr	anteroprincipal thalamus nucleus	1.0
MAC-Q	memory assessment clinics questionnaire	1.0
SFADS	wedish familial alzheimer's disease	1.0
ppENK	preproenkephalin messenger rna	0.2
ppENK	preproenkephalin	0.8
SDSZ	ung self-rating depression scale	1.0
PBGD	porphobilinogen deaminase	1.0
β-PDEβ	subunit of the cgmp phosphodiesterase	1.0
Apo	apolipoprotein	1.0
NOS-α	nitric oxide synthase-α	1.0
mNTS	medial nucleus of the solitary tract	0.166666666667
mNTS	medial aspect of the nts	0.0555555555556
mNTS	medial subnucleus of the nucleus of the solitary tract	0.0555555555556
mNTS	medial subnucleus of the nts	0.0555555555556
mNTS	medial nts	0.0555555555556
mNTS	medial portion of the nucleus of the solitary tract	0.222222222222
mNTS	medial subnucleus of the solitray tract	0.0555555555556
mNTS	medial subnucleus of the nucleus tractus solitarius	0.0555555555556
mNTS	medial subnucleus of nucleus tractus solitarius	0.111111111111
mNTS	middle nucleus tractus solitarius	0.0555555555556
mNTS	medial nucleus tractus solitarius	0.0555555555556
mNTS	medial subnucleus of the solitary tract	0.0555555555556
SDSS	elf-rating depression scale	0.333333333333
SDSS	odium dodecyl sulfate	0.333333333333
SDSS	pecial diet services	0.166666666667
SDSS	equence detection system	0.166666666667
3PGDH	3-phosphoglycerate dehydrogenase	1.0
STRF	spectro-temporal receptive field	0.428571428571
STRF	spectrotemporal receptive field	0.428571428571
STRF	sspatiotemporal receptive fields	0.142857142857
1P	one pair of conditioning sessions	1.0
1S	3r)-1-amino-1,3-cyclopentanedicarboxylic acid	0.0487804878049
1S	2s)-2-(2-(n-[(3-benzimidazol-2-yl)propyl]-n-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]	0.0243902439024
1S	2s)-2-carboxycycloprop-1-yl]-3-(xan th-9-yl) propanoic acid	0.0243902439024
1S	3r-acpd, 1s,3r-aminocyclopentyl-dicarboxylate	0.0243902439024
1S	3r-acpd, 1-aminocyclopentane-1s,3r-dicarboxylate	0.0243902439024
1S	2s,5r,6s)-2-amino-bicyclo[3.1.0]-hexane-2,6-dicarboxylic acid	0.0243902439024
1S	2s)-3,4-dichloro-n-methyl-n-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamide	0.0243902439024
1S	2s,5r,6s)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid	0.0243902439024
1S	3r)-aminocyclopentane-1, 3-dicarboxylic acid	0.0243902439024
1S	3r)-acpd, (1s,3r)-amino-1,3-cyclopentanedicarboxylic acid	0.0243902439024
1S	3r)-acpd, (1s,3r)-1-aminocyclopentane-1,3-dicarboxylic acid	0.0487804878049
1S	2s)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid	0.121951219512
1S	3r-acpd, aminocyclopentane-1s,3r-dicarboxylic acid	0.0487804878049
1S	3r)-acpd(1s,3r)-1-aminocyclopentane-1,3-dicarboxylic acid	0.0243902439024
1S	3r-acpd, trans-(1s,3r)-1-amino-1,3-cyclopentanedicarboxylic acid	0.0243902439024
1S	3r-acpd, (1s,3r)-1-aminocyclopentane-1,3-dicarboxylic acid	0.0731707317073
1S	3r-acpd, 1s,3r-1-amino-1,3-cyclopentanedicarboxylic acid	0.0487804878049
1S	3s)-acpd, 1s,3s-1-aminocyclopentane-1,3-dicarboxylate	0.0243902439024
1S	3s-acpd, (1s,3s)-1-aminocyclopentane-1,3-dicarboxylic acid	0.0243902439024
1S	3r)-1-aminocyclopentane-trans-1,3,-dicarboxylic acid	0.0243902439024
1S	3r-acpd, 1s,3r-1-aminocyclopentane-1,3-dicarboxylic acid	0.0243902439024
1S	3r,4s)-1-aminocyclopentane-1,3,4-tricarboxylic acid	0.0243902439024
1S	2s)-2-carboxycyclopropyl]-9h-xanthine-9-propanoic acid	0.0243902439024
1S	3r-acpd, 1-amino-1,3-dicarboxylic acid	0.0243902439024
1S	3r-acpd1s,3r-1-amino-cyclopentan-1,3-dicarboxylic acid	0.0243902439024
1S	3s)-acpd, (1s,3s)-1-aminocyclopentane-1,3-dicarboxylic acid	0.0243902439024
1S	3r)-acpd, trans-(1s,3r)-1-amino-1,3-cyclopentanedicarboxylic acid	0.0243902439024
1S	3r)-aminocyclopentane-1,3-dicarboxylic acid	0.0243902439024
1S	2s)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl)propanoic acid	0.0243902439024
1S	3r)-1-aminocyclopentane-1,3-dicarboxylic acid	0.0487804878049
1R	4r,5s,6r)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid	0.25
1R	3s)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1h-2-benzopyran	0.25
1R	2r,3s,4r,5s)-4-[6-amino-2-(methylthio)-9h-purin-9-yl]-2,3-dihydroxybicyclo[3.1.0]	0.25
1R	3s)-1-aminomethyl-5,6-dihydroxy-3-phenylisochroman hcl	0.25
MAPKAP	kinase 2	0.5
MAPKAP	kinase 2mitogen activated protein kinase activated protein kinase 2	0.5
1W	one week	1.0
ISS	inter-spike intervals	0.25
ISS	steady-state current	0.5
ISS	interspike slope steepness	0.25
ISR	integrated stress response	1.0
RIMLF	rostral interstitial nucleus of the medial longitudinal fascicle	0.5
RIMLF	rostral interstitial nucleus of the medial longitudinal fasciculus	0.5
ISV	interstitial volume	1.0
ISU	upper inverse slope	1.0
IST	in situ tailing	1.0
1A	receptor	1.0
TNAP	tissue non-specific alkaline phosphatase	1.0
ISI	inter-stimuli intervals	0.00552486187845
ISI	interstimulus	0.00552486187845
ISI	inter-stimulus inter-spike interval	0.00552486187845
ISI	inter-spike intervals	0.00552486187845
ISI	inter-stimulus interval	0.160220994475
ISI	interspike interval	0.359116022099
ISI	cvinterspike interval coefficient of variation	0.00552486187845
ISI	inter-spike interval	0.127071823204
ISI	interstimulus interval	0.237569060773
ISI	inter-stimulus-interval	0.0110497237569
ISI	inter-stimulus intervals	0.0165745856354
ISI	interspike-interval	0.0110497237569
ISI	cvinter-spike-interval coefficient of variation	0.00552486187845
ISI	sinterstimulus intervals	0.00552486187845
ISI	inter-stimuli-interval	0.00552486187845
ISI	interstimulus intervals	0.0110497237569
ISI	inter-spike interval histogram	0.00552486187845
ISI	inter-spike-interval	0.0165745856354
ISH	in situ hybridisation	0.0380952380952
ISH	in situ hybridization	0.895238095238
ISH	in situ hybridization histochemistry	0.0666666666667
ISO	isoproterenol	0.454545454545
ISO	isoamyl acetate	0.0909090909091
ISO	l-isoproterenol hydrochloride	0.181818181818
ISO	isotonic saline	0.0909090909091
ISO	isoflurane	0.0909090909091
ISO	infra-slow oscillation	0.0909090909091
1D	electrophoresis1-dimensional electrophoresis	0.333333333333
1D	subunit	0.333333333333
1D	electrophoresisone-dimensional electrophoresis	0.333333333333
ISM	ion-selective microelectrode	0.666666666667
ISM	ion-sensitive microelectrode	0.333333333333
ISL	lower inverse slope	0.5
ISL	1islet1	0.5
ISC	intermediate layer of the superior colliculus	0.333333333333
ISC	ischemia–reperfusion only rats treated with vehicle	0.333333333333
ISC	ischemia	0.333333333333
CACNA	1dcalcium channel: voltage-dependent: l type: alpha 1d subunit	0.333333333333
CACNA	1acalcium channel gene encoding the ca(v)2.1 or p/q-type subunit	0.333333333333
CACNA	2d1	0.333333333333
FECT	food elicited cataplexy test	1.0
1IL-	1βinterleukin 1beta	1.0
1M	first magnetic component	0.2
1M	the first magnetic response	0.4
1M	–5m: the first (1m), second (2m), third (3m), fourth (4m) and fifth (5m) magnetic response recorded in the hemisphere contralateral to nerve stimulation	0.2
1M	major component of evoked magnetic fields	0.2
ISF	interstitial fluid	1.0
ISD	inactivating voltage-dependent potassium conductance	0.25
ISD	immediate shock deficit	0.25
ISD	depth of iso-suppression relative to ortho-suppression	0.25
ISD	intraindividual standard deviation	0.25
PVP	posterior part of the paraventricular thalamic nucleus	0.125
PVP	posterior paraventricular thalamus	0.125
PVP	position-vestibular-pause	0.125
PVP	paraventricular thalamic nucleus, posterior part	0.125
PVP	posterior paraventricular thalamic nucleus	0.125
PVP	periventricular preoptic area	0.125
PVP	polyvinylpyrrolidone	0.25
PVR	postvoid residual	0.5
PVR	pacap/vip receptor	0.5
PVT	hparaventricular nucleus of the thalamus	0.0322580645161
PVT	psychomotor vigilance task	0.0322580645161
PVT	paraventricular nucleus of thalamus	0.0322580645161
PVT	paraventricular nucleus thalamus	0.0322580645161
PVT	thalamic midline paraventricular nucleus	0.0322580645161
PVT	paraventricular nucleus	0.0645161290323
PVT	paraventricular thalamus	0.0645161290323
PVT	paraventricular thalamic nucleus	0.483870967742
PVT	paraventricular nucleus of the thalamus	0.193548387097
PVT	aanterior part of the paraventricular thalamic nucleus	0.0322580645161
MWT-BM	ehrfachwahl–wortschatz test (multiple choice vocabulary test)	1.0
PVZ	periventricular zone	1.0
FR-	fixed ratio	0.2
FR-	2fixed-ratio 2	0.2
FR-	1fixed ratio 1	0.2
FR-	1fixed ratio-1	0.4
PVA	anterior paraventricular nucleus of the thalamus	0.125
PVA	polyvinyl alcohol	0.25
PVA	periventricular areas	0.125
PVA	paraventricular thalamic nucleus, anterior part	0.125
PVA	parvalbumin	0.125
PVA	paraventricular thalamic nucleus	0.25
PVC	polyvinyl chloride	0.666666666667
PVC	primary visual cortex	0.333333333333
hNPFF	2rhuman neuropeptide ff2 receptor	1.0
EVS	efferent vestibular system	1.0
MRXSX-	linked syndromic mental retardation	1.0
PVG	piebald viral glaxo	0.25
PVG	proximal vagal ganglia	0.25
PVG	periventricular gray	0.5
PVH	pmposterior magnocellular part of the hypothalamic paraventricular nucleus	0.0285714285714
PVH	pparvocellular part of the paraventricular hypothalamic nucleus	0.0285714285714
PVH	paraventricular nucleus of the hypothalamus	0.257142857143
PVH	paraventricular hypothalamus	0.114285714286
PVH	paraventricular hypothalamic nucleus	0.285714285714
PVH	periventricular nucleus of the hypothalamus	0.0285714285714
PVH	paraventricular nucleus	0.114285714286
PVH	periventricular nucleus of hypothalamus	0.0285714285714
PVH	paraventricular nucleus of the thalamus	0.0285714285714
PVH	hypothalamic paraventricular nucleus	0.0285714285714
PVH	periventricular heterotopia	0.0285714285714
PVH	paraventricular nucleus hypothalamus	0.0285714285714
Post	postsubiculum	1.0
GSA-B	4griffonia simplicifolia agglutinin isolectin b4	1.0
RHSC	rat hippocampal slice culture	1.0
PVL	periventricular layer of olfactory bulb	0.0769230769231
PVL	periventricular leukomalacia	0.923076923077
PVO	periventricular hypothalamic organ	0.5
PVO	paraventricular organ	0.5
PVN	paraventricular	0.010101010101
PVN	paraventricular hypothalamic nucleus	0.0782828282828
PVN	paraventricular nucleus/nuclei	0.00252525252525
PVN	parvocellular region of the paraventricular nucleus of the hypothalamus	0.00252525252525
PVN	lmpvn lateral magnocellular part	0.00252525252525
PVN	* paraventricular hypothalamic nuclei	0.00252525252525
PVN	paraventricular nucleus (of the hypothalamus)	0.00252525252525
PVN	paraventricular nucleus of the hypothalamus	0.277777777778
PVN	paraventricular hypothalamic nuclei	0.00252525252525
PVN	paraventricular nuclei	0.00757575757576
PVN	pelvic nerves	0.00252525252525
PVN	paraventricular nucleus (hypothalamus)	0.00252525252525
PVN	pparvocellular part of the paraventricular nucleus	0.00252525252525
PVN	paraventricular hypothalamus nucleus	0.00252525252525
PVN	paraventricular nucleus thalamus	0.00252525252525
PVN	paraventricular hypothalamus	0.00505050505051
PVN	paraventricular nucleus	0.510101010101
PVN	hypothalamic paraventricular nucleus	0.0631313131313
PVN	paraventricular nucleus hypothalamus	0.00252525252525
PVN	paraventric hypoth nuc	0.00252525252525
PVN	pmposterior magnocellular pvn	0.00252525252525
PVN	paraventricular nuclei of the hypothalamus	0.00252525252525
PVN	paraventricular thalamic nucleus	0.00252525252525
PVN	paraventricular nucleus of hypothalamus	0.00505050505051
PVN	the paraventricular nucleus of the hypothalamus	0.00252525252525
FRB	fast rhythmic bursting	0.111111111111
FRB	fast-rhythmic-bursting (cortical neuron)	0.111111111111
FRB	fast rhythmic burst	0.111111111111
FRB	fast-rhythmic burst	0.111111111111
FRB	fast-rhythmic-bursting	0.444444444444
FRB	fast-rhythmic-bursting neuron	0.111111111111
FRA	frontal association cortex	0.04
FRA	flexor reflex afferents	0.04
FRA	frequency response area	0.36
FRA	sfos-related antigens	0.08
FRA	flexion reflex afferent	0.04
FRA	flexor reflex afferent	0.08
FRA	firing rate adaptation	0.04
FRA	fos-related antigen	0.32
PLi	posterior limitans	1.0
FRF	luoro ruby	0.0769230769231
FRF	ourier ratio	0.0769230769231
FRF	luro-ruby	0.0769230769231
FRF	luoro-ruby	0.153846153846
FRF	luorored	0.0769230769231
FRF	luororuby	0.307692307692
FRF	frequency response function	0.0769230769231
FRF	luororuby (tetramethylrhodamine dextran)	0.0769230769231
FRF	ura response	0.0769230769231
l-NAME	nω-nitro-l-arginine methyl ester	0.125
l-NAME	l-ng-nitroarginine methyl ester	0.0625
l-NAME	nitro-l-arginine methyl ester	0.03125
l-NAME	+l-argn(g) nitro-l-arginine methyl ester with the simultaneous i.t. application of the nitric oxide precursor l-arginine	0.03125
l-NAME	ng-nitro-l-arginine methyl ester hydrochloride	0.03125
l-NAME	ng-nitro-l-arginine methyl ester	0.25
l-NAME	ng-nitro-l-arginine methyl ester, hcl	0.03125
l-NAME	(nω-nitro-l-arginine methyl ester hydrochloride)	0.03125
l-NAME	nitroarginine-methylester	0.03125
l-NAME	l-nitro-arginine methyl ester	0.125
l-NAME	l-nitroarginine methyl ester	0.03125
l-NAME	n-nitro-l-arginine methyl ester hydrochloride	0.03125
l-NAME	l-ng-nitro-arginine methyl ester	0.03125
l-NAME	ng-nitro-l-arginine methyl ester dihydrochloride	0.03125
l-NAME	l-nitro arginine methyl ester	0.03125
l-NAME	n-nitro-l-arginine methylester	0.03125
l-NAME	n-nitro-l-arginine methyl ester	0.0625
FRI	fluorescence reflectance imaging	1.0
FRN	feedback-related negativity	0.666666666667
FRN	feedback related negativity	0.333333333333
FRM	formatio reticularis medialis mesencephali	1.0
FRL	formatio reticularis lateralis mesencephali	1.0
seizureKCC	2	1.0
FRR	fractional resting release	0.5
FRR	fractional release at rest	0.5
jTBI	juvenile traumatic brain injury	1.0
sAM	sinusoidally amplitude modulated	1.0
PV-	parvalbumin negative	0.25
PV-	ippv-ir identified by dab reaction product	0.25
PV-	/-parvalbumin-deficient	0.25
PV-	irparvalbumin-immunoreactive	0.25
EGFPE	nhanced green fluorescent protein	1.0
BPPV	benign paroxysmal positioning vertigo	1.0
DMTg	dorsomedial tegmental area	1.0
tPA	tissue type plasminogen activator	0.02
tPA	plasminogen activator	0.02
tPA	tissue-plasminogen activator	0.1
tPA	+/+wild-type c57/bl/6 mice	0.02
tPA	knockout mice	0.02
tPA	tissue-type plasminogen activator	0.12
tPA	tissue plasminogen activator	0.7
dST	dorsal striatum	1.0
ment-V	3 regionmental nerve region of vor	0.5
ment-V	3 regionmental nerve region	0.5
SNMP	sensory neuron membrane protein	1.0
NAcARCH	arch of the nucleus accumbens shell	1.0
ment-S	1mental nerve area of s1	0.5
ment-S	2mental nerve area of s2	0.5
preproTRH	mrna	1.0
cHH	crustacean hyperglycemic hormone	1.0
TPMPA	(1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid	0.333333333333
TPMPA	1,2,5,6-tetrahydro-(pyridin-4-yl) methylphosphinic acid	0.333333333333
TPMPA	(1,2,5,6-tetrahydropyridine)-methylphosphonic acid	0.333333333333
DCDHF-DA	2′-7′ dichlorodihydrofluorescein diacetate	1.0
IS-	2hanimals perfused 2 h after intraarticular injection of inflammatory soup	1.0
OX-R1	orexin-1 receptor protein	1.0
SNMG	seronegative myasthenia gravis	1.0
SGSC	spiral ganglion schwann cell	1.0
GLRA1	human gene of the glycine receptor α1-subunit	1.0
CNSC	entral nervous system	1.0
DN	dysmorphic neuron	0.037037037037
DN	ase ideoxyribonuclease i	0.037037037037
DN	asedesoxyribonuclease	0.037037037037
DN	dentate nucleus	0.0740740740741
DN	dorsal nucleus of the octavolateral area	0.111111111111
DN	dominant negative	0.037037037037
DN	drug-treated noise-stressed	0.037037037037
DN	diabetic neuropathy	0.037037037037
DN	asedeoxyribonuclease	0.222222222222
DN	sdark neurons	0.037037037037
DN	c-jundominant negative form of c-jun	0.037037037037
DN	sdystrophic neuritis	0.037037037037
DN	sdysmorphic neurons	0.037037037037
DN	dorsal neuron	0.037037037037
DN	dual	0.037037037037
DN	dystrophic neurite	0.037037037037
DN	asei hypersensitivity	0.037037037037
DN	dominant-negative	0.037037037037
DN	nucleus dentatus	0.037037037037
DO	dissolved oxygen	0.166666666667
DO	differential outcomes	0.166666666667
DO	docosahexaenoic acid	0.166666666667
DO	displaced object in object recognition task	0.166666666667
DO	displaced objects	0.166666666667
DO	detrusor overactivity	0.166666666667
DL	dextro/levo	0.025
DL	dorsoventral	0.025
DL	dark-light (reversed lighting cycle)	0.025
DL	double-labeled neuron	0.025
DL	deep lumbrical muscles	0.025
DL	dorsal–lateral	0.025
DL	delayed-reward-lever	0.025
DL	double-labeled	0.025
DL	dorso lateral	0.025
DL	dorsolateral (neostriatum)	0.025
DL	dorsolateral subregion of the prefrontal cortex	0.025
DL	double-lesioned animals with sequential bilateral infarcts	0.025
DL	dorsal lateral	0.025
DL	/ldorsolateral/lateral	0.025
DL	idorsal linear nucleus of raphe	0.025
DL	dorsolateral striatum	0.025
DL	dorsolateral	0.35
DL	dichotic listening	0.025
DL	dorsolateral pallium	0.025
DL	dorsolateral nucleus	0.075
DL	dioxin-like	0.025
DL	dorsolateral entorhinal area	0.025
DL	dorso–lateral	0.025
DL	two different locations exposure	0.025
DL	dorsolateral subnucleus of the lateral nucleus of the amygdala	0.025
DM	dorsomedian subdivision of the dorsal raphe nucleus	0.0138888888889
DM	defined medium	0.0277777777778
DM	shelldorsomedial shell	0.0138888888889
DM	diosmin	0.0138888888889
DM	dorsomedial hypothalamic	0.0138888888889
DM	diabetes mellitus	0.152777777778
DM	dendritic plasma membrane	0.0138888888889
DM	chemically defined medium	0.0138888888889
DM	dorso–medial	0.0138888888889
DM	dorsomedial nucleus of hypothalamus	0.0138888888889
DM	dorsomedial striatum	0.0138888888889
DM	dorsomedial	0.152777777778
DM	dorsomedial (neostriatum)	0.0138888888889
DM	defined media	0.0138888888889
DM	deltamethrin	0.0138888888889
DM	dichroic mirror	0.0138888888889
DM	dissociation media	0.0138888888889
DM	dorsomedial portion of the hippocampal formation	0.0138888888889
DM	dorsal medullary reticular area	0.0138888888889
DM	dorsomedial area	0.0138888888889
DM	dorsomedial nucleus	0.111111111111
DM	dystrophia myotonica/myotonic dystrophy	0.0138888888889
DM	deformation magnitude	0.0138888888889
DM	dorsomedial hypothalamic nucleus	0.0555555555556
DM	dorsal–medial	0.0138888888889
DM	hdorsomedial nucleus of hypothalamus	0.0138888888889
DM	dorsomedial hypothalamus	0.0138888888889
DM	dorsomedial pallium	0.0138888888889
DM	demyelination	0.0277777777778
DM	differentiation medium	0.0277777777778
DM	diabetic	0.0138888888889
DM	dextromethorphan	0.0138888888889
DM	dorsal medial nucleus of the midbrain	0.0138888888889
DM	dorsomedial telencephalic neuropile	0.0138888888889
DM	ndeep mesencephalic nucleus	0.0138888888889
DM	dorsal medulla	0.0138888888889
DM	deltoideus medius	0.0138888888889
DM	dorsal medial hypothalamic nucleus	0.0277777777778
SWM	spatial working memory	0.333333333333
SWM	spared white matter	0.666666666667
DK	nucleus of darkschewitsch	1.0
DH	spinal cord dorsal horn	0.0232558139535
DH	ypdorsal hypothalamic nucleus	0.0232558139535
DH	dorsal horn spinal cord	0.0232558139535
DH	dorsal hippocampal lesion group	0.0232558139535
DH	dorsal hippocampus	0.325581395349
DH	dorsal horn	0.511627906977
DH	dorsal horns	0.0232558139535
DH	dorsal horn of the spinal cord	0.0232558139535
DH	ypdorsal hypothalamus	0.0232558139535
DI	dysgranular division of the insular cortex	0.03125
DI	direction selectivity index	0.09375
DI	diestrus	0.0625
DI	density index	0.03125
DI	dose-inhibition	0.03125
DI	dysgranular insular cortex	0.3125
DI	day of insult	0.03125
DI	directionality index	0.0625
DI	discrimination index	0.0625
DI	dual	0.03125
DI	diazepam-insensitive	0.03125
DI	direction index	0.21875
DF	frequency of ponto-geniculo-occipital wave doublets (number/min)	0.0909090909091
DF	female diestrous rats	0.0909090909091
DF	digit span forward	0.0909090909091
DF	depth of focus	0.0909090909091
DF	dorsal funiculus	0.454545454545
DF	discharge frequency	0.0909090909091
DF	distribution function	0.0909090909091
DG	dentate gyrus, hippocampus region	0.00231481481481
DG	digoxigenin	0.00231481481481
DG	mbmedial blade of the dentate gyrus	0.00231481481481
DG	dentate gyrus of the hippocampal formation	0.00231481481481
DG	granular layer of the dentate gyrus	0.00231481481481
DG	gyrus dentatus	0.00231481481481
DG	ssuperior blade of the dentate gyrus	0.00231481481481
DG	dentate gyrus (of the hippocampus)	0.00231481481481
DG	hippocampus dg	0.00231481481481
DG	hippocampal dentate gyrus	0.00462962962963
DG	dentate gyrus of the hippocampus	0.0162037037037
DG	dentate gyrus of hippocampus	0.00462962962963
DG	diacylglycerol	0.00462962962963
DG	ininner molecular layer of the dentate gyrus	0.00231481481481
DG	dentate granule cell layer	0.00231481481481
DG	deoxyglucose	0.00231481481481
DG	ubupper blade of the dentate gyrus	0.00231481481481
DG	dystroglycan	0.00462962962963
DG	sdentate gyrus superior	0.00231481481481
DG	dentate gyrus	0.925925925926
DG	dark grey	0.00231481481481
DG	dentate granule	0.00231481481481
DG	hilus of the dentate gyrus of the hippocampus	0.00231481481481
DD	deep dorsal nucleus of the dorsal division of the medial geniculate body	0.0350877192982
DD	differential depth	0.0175438596491
DD	dark 24h	0.0175438596491
DD	constant dark	0.105263157895
DD	dopamine-deficient	0.0350877192982
DD	dark–dark or constant dark	0.0175438596491
DD	dark/dark	0.0526315789474
DD	deep dorsal nucleus	0.0175438596491
DD	distal dendrite	0.0175438596491
DD	constant darkness	0.631578947368
DD	death domain	0.0175438596491
DD	total darkness	0.0175438596491
DD	deceleration duration	0.0175438596491
DE	diestrous	0.0625
DE	dexamethasone plus exercise group	0.0625
DE	ndorsal endopiriform cortex	0.0625
DE	differential entropy	0.0625
DE	diencephalon	0.0625
DE	delayed excitation	0.1875
DE	discrete event	0.0625
DE	deep layer of entorhinal cortex	0.0625
DE	ndorsal endopiriform nucleus	0.25
DE	nendopiriform nucleus	0.125
DB	direction bias	0.0714285714286
DB	1tyrosine hydroxylase dilution buffer	0.0357142857143
DB	medial septum/diagonal band complex	0.0357142857143
DB	dilution buffer	0.0357142857143
DB	dehydro-exo-brevicomin	0.0357142857143
DB	medial septal nucleus–nucleus of the diagonal band	0.0357142857143
DB	diagonal band of broca	0.107142857143
DB	septum/diagonal band	0.0357142857143
DB	dorsal band	0.0357142857143
DB	nucleus of the diagonal band	0.0357142857143
DB	digit span backward	0.0357142857143
DB	diagonal band	0.178571428571
DB	vertical limb of the diagonal band of broca	0.0357142857143
DB	medial septum/diagonal band	0.0714285714286
DB	digoxigenin buffer	0.0357142857143
DB	diagonal band nucleus	0.0714285714286
DB	medial septum and diagonal band of broca	0.0357142857143
DB	dextran–biotin	0.0357142857143
DB	medial septum/diagonal band of broca	0.0357142857143
SWD	spike and wave discharge	0.133333333333
SWD	spike-wave discharge	0.133333333333
SWD	spike-wave discharges	0.0666666666667
SWD	spike–wave discharges	0.0666666666667
SWD	sspike wave discharges	0.0666666666667
SWD	sspike-wave discharges	0.133333333333
SWD	spike-and-wave discharge	0.333333333333
SWD	spike wave discharges	0.0666666666667
SAEM	stochastic approximation of the expectation maximization procedure	1.0
DA	dark-adapted	0.00117924528302
DA	dextran amine	0.00117924528302
DA	hypothalamic dorsal area	0.00117924528302
DA	ideltoïdus anterior	0.00117924528302
DA	dorsal area	0.00117924528302
DA	midbrain dopamine	0.00117924528302
DA	diacetate	0.00117924528302
DA	dopamine	0.858490566038
DA	denial of the antecedent	0.00117924528302
DA	day active	0.00117924528302
DA	domoic acid	0.00117924528302
DA	dopaminergic	0.0660377358491
DA	deafferentated area	0.00117924528302
DA	dorsal hypothalamic area	0.00589622641509
DA	utilization of dopamine	0.00117924528302
DA	drug abusers	0.00117924528302
DA	3-hydroxytyramine hydrochloride or dopamine	0.00117924528302
DA	dopamine and dopaminergic	0.00117924528302
DA	dark phase anesthesia	0.00117924528302
DA	extextracellular dopamine concentration	0.00117924528302
DA	dihydroxyphenylethylamine dopamine	0.00117924528302
DA	deltoid anterior	0.00117924528302
DA	1rdopamine one receptor	0.00117924528302
DA	2rda receptor 2	0.00117924528302
DA	ergicdopaminergic	0.0188679245283
DA	digital-to-analog	0.00117924528302
DA	dopamine, dopaminergic	0.00471698113208
DA	dark agouti	0.00117924528302
DA	axonal diffusivity	0.00117924528302
DA	partial least squares–discriminant analysis	0.00117924528302
DA	dopaminergic cells	0.00117924528302
DA	3-hydroxytyramine (dopamine)	0.00117924528302
DA	increment in extracellular da concentration	0.00117924528302
DA	dopamine (3-hydroxytyramine)	0.00235849056604
DA	ideltoidus anterior	0.00117924528302
DA	dopamine/dopaminergic	0.00353773584906
DA	dorsomedial thalamic complex	0.00117924528302
DA	d2dopamine d2 receptor	0.00117924528302
DA	transporterdat	0.00117924528302
DA	]maxmaximal concentration of dopamine	0.00117924528302
DA	day-active	0.00117924528302
FDIF	irst dorsal interosseous	1.0
S100B-s-s	disulphide-linked s100b	1.0
DZ	damaged zone	0.111111111111
DZ	diazepam	0.333333333333
DZ	dorsal zone	0.111111111111
DZ	dizygotic	0.333333333333
DZ	dead zone	0.111111111111
PPSH	peri-pgo spike histogram	1.0
DY	diamidino yellow	0.8
DY	asp-tyr	0.2
DV	dorsal–ventral	0.131578947368
DV	doros-ventral	0.0131578947368
DV	dorso-ventral stereotactic coordinate	0.0131578947368
DV	dorsoventral	0.552631578947
DV	dorsal-ventral	0.0526315789474
DV	dorso–ventral	0.0131578947368
DV	dependent variable	0.0131578947368
DV	ventral to dura	0.0131578947368
DV	ventral relative to bregma	0.0131578947368
DV	dorsal ventral	0.0263157894737
DV	dorso-ventral	0.131578947368
DV	dorsal to ventral	0.0131578947368
DV	dorsal/ventral	0.0131578947368
DW	distilled water	0.727272727273
DW	dry weight	0.272727272727
DT	dorsal thalamus	0.115384615385
DT	dantrolene	0.0384615384615
DT	gdual transgenic	0.0384615384615
DT	hdorsal thalamus	0.0769230769231
DT	gdorsal tegmental area	0.0384615384615
DT	double transgenic	0.0384615384615
DT	dual task	0.0384615384615
DT	gdorsal tegmental nucleus	0.153846153846
DT	dorsal tier	0.0384615384615
DT	xdendrotoxin	0.115384615385
DT	dipole tracing	0.115384615385
DT	double-transduced	0.0384615384615
DT	dwell time	0.0384615384615
DT	differential threshold	0.0384615384615
DT	sdegenerating terminals	0.0384615384615
DT	dorsal tegmental nucleus	0.0384615384615
TEVC	two-electrode voltage clamp	0.5
TEVC	two-electrode voltage-clamp	0.5
DR	deprived rearing	0.00735294117647
DR	delayed rectifier	0.00735294117647
DR	dorsal raphe	0.220588235294
DR	sdopamine receptors	0.00735294117647
DR	dark rearing	0.00735294117647
DR	delayed response test of visuospatial working memory	0.00735294117647
DR	dose-response	0.00735294117647
DR	hdorsal raphe nucleus	0.00735294117647
DR	diet restriction	0.00735294117647
DR	dark-reared rat	0.00735294117647
DR	dorsal root	0.139705882353
DR	dextran rhodamine	0.00735294117647
DR	dorsal raphe nuc	0.00735294117647
DR	discrimination ratio	0.0514705882353
DR	6death receptor-6	0.00735294117647
DR	null direction response	0.00735294117647
DR	diet-induced resistant	0.00735294117647
DR	dorsal spinal root	0.00735294117647
DR	dorsal rhizotomy	0.0147058823529
DR	radial diffusivity	0.00735294117647
DR	9	0.00735294117647
DR	dorsal nucleus of the raphe	0.00735294117647
DR	deep radial nerve	0.00735294117647
DR	dim red light	0.00735294117647
DR	dietary restriction	0.0147058823529
DR	dorsal raphe nucleus	0.286764705882
DR	dorsal raphe (nuclei)	0.00735294117647
DR	t* dorsal reticular nucleus	0.00735294117647
DR	serotonergic dorsal	0.00735294117647
DR	direct reversal	0.00735294117647
DR	delayed reward	0.00735294117647
DR	delayed response	0.0220588235294
DR	vventromedial subdivision of the dorsal raphé nucleus	0.00735294117647
DR	tdorsal reticular nucleus	0.0220588235294
DR	ventraldorsal raphé ventral	0.00735294117647
DR	dopamine receptor	0.0147058823529
DR	diet resistant	0.0147058823529
DS	donkey serum	0.0512820512821
DS	directional sensitivity	0.025641025641
DS	dentate field spike	0.025641025641
DS	discriminative stimulus	0.153846153846
DS	difference score	0.0512820512821
DS	dorsal striatum	0.205128205128
DS	diazepam-sensitive	0.025641025641
DS	22q11 deletion syndrome	0.025641025641
DS	directed song only	0.025641025641
DS	direction selective	0.025641025641
DS	dermorphin-saporin	0.025641025641
DS	hamdelayed sham	0.025641025641
DS	dorsal subiculum	0.0512820512821
DS	dynamic stabilization	0.025641025641
DS	trdorsal region of striatum	0.025641025641
DS	deep sleep	0.025641025641
DS	dorsolateral striatum	0.025641025641
DS	denervated-spinal	0.025641025641
DS	+tdifferent context shock+test	0.025641025641
DS	diagonal sequence	0.025641025641
DS	dorsal part of the striatum	0.025641025641
DS	tdorsal striatum	0.025641025641
DS	desynchronized sleep	0.025641025641
DS	dorsal subregion of the neostriatum	0.025641025641
DP	dorsal peduncular cortex	0.25
DP	dorsoposterior field	0.0416666666667
DP	diabetics rats recieving probiotic supplementation	0.0416666666667
DP	depotentiation	0.125
DP	dorsoposterior auditory field	0.0416666666667
DP	2 receptorprostaglandin d2 receptor 2	0.0416666666667
DP	dorsal pallium	0.0416666666667
DP	double-peaked	0.0416666666667
DP	deltoid posterior	0.0416666666667
DP	ideltoidus posterior	0.0416666666667
DP	deep peroneal	0.125
DP	dorsal peduncular	0.0416666666667
DP	dark phase	0.0416666666667
DP	delayed pairing	0.0416666666667
DP	ideltoïdus posterior	0.0416666666667
DQ	dye-quenched	0.5
DQ	dye quenched	0.25
DQ	dorsal quadrant	0.25
TGR	5g protein-coupled bile acid receptor 1 (gpbar1)	0.5
TGR	retinal transglutaminase	0.5
EYFEYWSLAAPQRF-NH	2	1.0
E10501	3,5(10)-estratrien-3,17 diol disulfate, disodium salt	1.0
CANTABC	ambridge neuropsychological test automated battery	1.0
TGT	tbs containing gelatin and triton x-100	1.0
PN-DRGs	peripheral nerves with their attached dorsal root ganglia	1.0
sIP	slow inhibitory potential	1.0
SOD1Cu	zn superoxide dismutase	0.25
SOD1Cu	zn-superoxide dismutase	0.75
t-ACPD	trans-1-aminocyclopentane-1,3-dicarboxylic acid	0.2
t-ACPD	(±)-1-amino-trans-1,3-cyclopentane-dicarboxylic acid	0.2
t-ACPD	(±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid	0.2
t-ACPD	(±)-1-aminocyclopentane-trans-1,3,dicarboxylic acid	0.2
t-ACPD	1s,3r-aminocyclopentane dicarboxylic acid	0.2
TGB	tiagabine	1.0
NMDA-NR	2anr2 subunit of the nmda receptor	1.0
TGA	transient global amnesia	0.5
TGA	tetraethylammonium	0.5
TGF	transfroming growth factor	0.0294117647059
TGF	transforming growth factor	0.970588235294
ACCx	anterior cingulate cortex	1.0
TGD	transganglionic degeneration	1.0
VCAM-	1	0.166666666667
VCAM-	1vascular cell adhesion molecule-1	0.5
VCAM-	1vascular cell adhesion molecule 1	0.166666666667
VCAM-	1vascular cell adhesion protein-1	0.166666666667
GTPCHGTP	cyclohydrolase i	1.0
TGI	gastrointestinal tract	1.0
TGN	trigeminal ganglion neuron	0.0588235294118
TGN	38trans golgi network 38	0.0588235294118
TGN	nerve-derived transglutaminase	0.0588235294118
TGN	trans-golgi network	0.764705882353
TGN	trans golgi network	0.0588235294118
AVCN	anteroventral cochlear nucleus	0.785714285714
AVCN	anterior ventral cochlear nucleus	0.178571428571
AVCN	anteroventral division of the cochlear nucleus	0.0357142857143
TUBA	tubulin alpha	1.0
DHK	dihydrokainate (glutamate uptake blocker)	0.0588235294118
DHK	dihydrokainic acid	0.529411764706
DHK	dihydrokainate	0.411764705882
IPACM	medial division of the interstitial nucleus of the posterior limb of the anterior commissure	1.0
DHG	sapo lesion+graft in the dorsal hippocampus	1.0
HDCH	istidine decarboxylase	1.0
DHE	dihydroethidium	0.928571428571
DHE	dihydro-β-erythroidine	0.0714285714286
COPI	coatomer protein complex i	1.0
TICA	tensorial-independent component analysis	1.0
INTH	interspike interval histogram	1.0
DHA	/seddha supplemental diet/sedentary	0.0333333333333
DHA	docosahexaenoic acid	0.766666666667
DHA	docosahexaenoic acid (22:6 n-3)	0.0333333333333
DHA	dorsal hypothalamic area	0.1
DHA	22:6n-3 docosahexaenoic acid	0.0333333333333
DHA	dehydroascorbate	0.0333333333333
T-PER	tissue protein extraction reagent	1.0
DHT	5α-dihydrotestosterone	0.258064516129
DHT	dihydrotestosterone	0.677419354839
DHT	5-α dihydrotestosterone	0.0322580645161
DHT	dihydrotestosterone propionate	0.0322580645161
DHR	123dihydrorhodamine 123	0.166666666667
DHR	dihydrorhodamine 123	0.666666666667
DHR	123dihydrorhodamine-123	0.166666666667
DHP	1,4-dihydropyridine class of calcium channel blockers	0.0434782608696
DHP	dorsal hippocampus	0.0434782608696
DHP	dihydroprogesterone	0.217391304348
DHP	asedihydropyrimidinase	0.0434782608696
DHP	5α-dihydroprogesterone	0.0434782608696
DHP	dihydropyridine	0.608695652174
dnTP	2′-deoxynucleotide 5′ triphosphate	1.0
D-	28k	0.214285714286
D-	amphetamine	0.0714285714286
D-	type potassium current	0.0714285714286
D-	ratsdeprived rats	0.214285714286
D-	aspartate	0.0714285714286
D-	hair receptor	0.0714285714286
D-	neuronsdark neurons	0.0714285714286
D-	600methoxy-verapamil	0.0714285714286
D-	serine	0.0714285714286
D-	2-hydroxyglutaric aciduria	0.0714285714286
MS-VDB	medial septum-vertical limb of the diagonal band complex	1.0
DL-STR	dorsolateral striatum	1.0
OBD	optical binding density	0.5
OBD	oesophageal balloon distension	0.5
SIPSS	tructured interview for prodromal syndromes	1.0
α-BT	xα-bungarotoxin.	0.333333333333
α-BT	xα-bungarotoxin	0.666666666667
lPAG	lateral periaqueductal gray	0.5
lPAG	lateral periaqueductal gray column	0.166666666667
lPAG	lateral column of the periaqueductal gray matter	0.166666666667
lPAG	lateral subdivision of periaqueductal gray matter	0.166666666667
6-nitro-NE	6-nitro-norepinephrine	1.0
D4	dopamine receptors	1.0
D5	digit five	1.0
CNQX6-cyano-7-nitroquinozaline-2	3-dione disodium	1.0
rFN	recombinant fibronectin	1.0
FP-CIT	2β-carbomethoxy-3β-(4-iodophenyl)-n-(3-fluoropropyl) nortropane	1.0
WG	weeks of gestation	1.0
WF	ponto-geniculo-occipital wave frequency	0.5
WF	232β-propanoyl-3β-(2-naphthyl)-tropane	0.5
WE	wernicke's encephalopathy	0.666666666667
WE	wavelet entropy	0.333333333333
WD	tryptophan–aspartic acid	0.1
WD	water deprivation	0.3
WD	–prwater deprivation–partial rehydration	0.1
WD	wallerian degeneration	0.1
WD	water-deprived rat	0.1
WD	45withdrawal day 45	0.1
WD	withdrawal	0.1
WD	water-deprivation	0.1
WC	widely compressed group	0.5
WC	wide-chopper	0.5
WB	western blots	0.111111111111
WB	washing buffer	0.111111111111
WB	whole brain	0.222222222222
WB	4101	0.222222222222
WB	chewhole-blood cholinesterase	0.111111111111
WB	western blot	0.222222222222
HPII	hyperprolinemia type ii	1.0
WM	working memory	0.418918918919
WM	_hgwhite matter under heschl’s gyrus	0.0135135135135
WM	water maze	0.0810810810811
WM	white matter	0.486486486486
WL	water level in the plexiglass column adjusted so that the pressure at level p1 in the column was 100 mm hg	0.333333333333
WL	wheel lock	0.333333333333
WL	from weaning throughout life	0.333333333333
UAS-GFP	upstream activation sequence–green fluorescent protein	1.0
SMIN	suprachiasmatic melanotrope-inhibiting neurons	1.0
WW	istar	0.2
WW	warm water	0.2
WW	wet weight	0.6
WT	wild-type	0.428169014085
WT	wild type	0.405633802817
WT	wild type(mice)	0.00281690140845
WT	wild-type littermates	0.00281690140845
WT	wortmannin	0.00281690140845
WT	wildtype neuregulin 1+/+	0.00281690140845
WT	wild type littermates	0.0056338028169
WT	wild-type mouse	0.00281690140845
WT	wiring transmission	0.0056338028169
WT	wild type mouse	0.00281690140845
WT	wildtype	0.0929577464789
WT	wild-type mice	0.0056338028169
WT	wild type c57bl/6	0.00281690140845
WT	wild type mice	0.00845070422535
WT	withdrawal thresholds	0.0056338028169
WT	weak training	0.00281690140845
WT	control mice for mice lacking the α2a-ar	0.00281690140845
WT	wide-type	0.00281690140845
WT	+/+wild type	0.00281690140845
WT	non-transgenic mice	0.00281690140845
WT	wild type-like	0.0056338028169
WT	wavelet transform	0.00281690140845
PAI	1plasminogen activator inhibitor type-1	0.5
PAI	plasminogen activator inhibitor	0.5
WR	wheel running	0.4
WR	weakly relearning	0.2
WR	sweber ratios	0.2
WR	wistar rat	0.2
PRTK	sprotein receptor tyrosine kinases	1.0
Test	part b	1.0
rAAV	recombinant adeno-associated viral vector	0.0833333333333
rAAV	srecombinant adeno-associated viruses	0.0833333333333
rAAV	2/1recombinant aav with serotype 2 backbone packaged with serotype 1 capsid	0.0833333333333
rAAV	recombinant adeno-associated virus	0.75
rLH	arostral lateral hypothalamic area	0.5
rLH	rostral lateral hypothalamus	0.5
III-V	third ventricle	1.0
HA-	1077	1.0
GWA	genome-wide association	1.0
HPIH	yperprolinemia type i	1.0
DAergic	dopaminergic	1.0
RIS	/rosretinal inner and outer segments	0.333333333333
RIS	relative intensity of staining	0.333333333333
RIS	rod inner segment	0.333333333333
RIP	rat insulin promoter	0.125
RIP	regulated intramembrane proteolysis	0.125
RIP	140receptor interacting protein 140	0.125
RIP	monoclonal antibody clone ns-1 that detects oligodendrocytes	0.125
RIP	receptor-interacting serine-threonine kinase	0.125
RIP	nucleus raphe interpositus	0.25
RIP	raphe interpositus nucleus	0.125
RIN	srna integrity numbers	0.5
RIN	input resistance	0.5
NAnoradrenaline	noradrenergic	1.0
RIM	1αrab3 interacting molecule 1α	0.333333333333
RIM	1	0.333333333333
RIM	1αrab3 interacting molecule 1 alpha	0.333333333333
STARTS	tar-related lipid-transfer	1.0
HSAS	hydrocephalus due to stenosis of the aqueduct of sylvius	1.0
RIF	rate-intensity function	1.0
RIG	ring interneuron g	1.0
RID	ratio of investigation duration	1.0
H2DFFDA	5-(and-6-)-carboxy-2′,7′-difluorodihydrofluorescein diacetate	1.0
RIC	3 protein	0.333333333333
RIC	radioimmunocytochemistry	0.666666666667
RIA	radioimmunoassay	0.955056179775
RIA	radioimmunoasssay	0.0112359550562
RIA	radio immunoassay	0.0112359550562
RIA	radio immuno assay	0.0224719101124
BNX	bilateral nephrectomy	1.0
HAL	haloperidol	0.833333333333
HAL	haloperidol 0.8 mg/kg	0.166666666667
HAM	hamstrings	1.0
HAN	handled-only control group	0.666666666667
HAN	handled only group	0.333333333333
hGAT-	1	1.0
HAA	hypothalamic attack area	1.0
HAB	shigh anxiety–related behavior rats	0.2
HAB	habenula nucleus	0.2
HAB	high anxiety-related behavior	0.4
HAB	habituation	0.2
BNP	brain natriuretic peptide	1.0
HAD	human immunodeficiency virus-1-associated dementia	0.5
HAD	high alcohol drinking	0.5
RISC	relative intensity of staining coefficient	1.0
dlPAG	dorsolateral periaqueductal gray column	0.0909090909091
dlPAG	dorsolateral periaqueductal grey	0.0909090909091
dlPAG	lateral/dorsolateral region of pag	0.0909090909091
dlPAG	dorsolateral periaqueductal gray	0.454545454545
dlPAG	lateral/dorsolateral region of periaqueductal gray	0.0909090909091
dlPAG	dorsolateral column of the periaqueductal gray matter	0.0909090909091
dlPAG	dorsolateral pag	0.0909090909091
BNI	nor-binaltorphimine	1.0
RI-	neuronrate increasing neuron	1.0
TRMD	treatment-resistant mood disorders	1.0
CICRC	a2+- induced ca2+ release	0.0909090909091
CICRC	a2+-induced calcium release	0.0909090909091
CICRC	a2+-induced ca2+-release	0.0909090909091
CICRC	a2+-induced ca2+ release	0.727272727273
HAP	hyperpolarizing afterpotential	0.125
HAP	hyperpolarizing after-potential	0.125
HAP	hyperpolarising after-potential	0.125
HAP	1huntingtin associated protein 1	0.125
HAP	human placental alkaline phosphatase	0.125
HAP	1huntingtin-associated protein 1	0.125
HAP	hypothalamus-pituitary-adrenal	0.125
HAP	1-irhap1-immunoreactive	0.125
BNB	arrington's nucleus	0.166666666667
BNB	blood-nerve barrier	0.166666666667
BNB	arrington’s nucleus	0.166666666667
BNB	blood–nerve barrier	0.333333333333
BNB	blood nerve barrier	0.166666666667
HAR	high acth response	1.0
HAS	hyaluronan synthase	0.75
HAS	human serum albumin	0.25
HAT	shistone acetyl transferases	0.0740740740741
HAT	histone acetyltransferase	0.296296296296
HAT	shistone lysine acetyltransferases	0.037037037037
HAT	hypoxanthine aminopterin thymidine	0.0740740740741
HAT	shistone acetyl-transferases	0.037037037037
HAT	histone acetyltransferases	0.037037037037
HAT	shistone acetyltransferases	0.259259259259
HAT	histone acetyl-transferase	0.037037037037
HAT	histone acetyltransferase enzymes	0.037037037037
HAT	histone acetyl transferase	0.111111111111
RISP	risperidone	1.0
Triton	tris buffered saline with 0.01% triton x-100	0.5
Triton	0.1m tris–hcl buffer (ph 7.6) containing 0.3% triton x-100	0.5
K-F	kölliker–fuse nucleus	1.0
K-C	l cotransport	1.0
K-A	cpotassium acetate	1.0
W-	13n-(4-aminobutyl)-1-naphthalenesulfonamide	0.166666666667
W-	7n-(6-aminohexil)-5-chloro-1-naphthalenesulfonamide hydrochloride	0.333333333333
W-	7n-(6-aminohexyl)-5-chloro-l-naphthalenesulyonamide	0.166666666667
W-	and y-channels	0.166666666667
W-	active neuronswaking-active neurons	0.166666666667
5HIAA	serotonin metabolite	0.333333333333
5HIAA	5-hydroxyindole acetic acid	0.666666666667
PAL	500500nmol/kg palmitic acid	0.333333333333
PAL	paired associate learning	0.333333333333
PAL	palmitic acid	0.333333333333
K-H	epes4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid potassium salt	1.0
PSTHP	ost-stimulus time histogram	1.0
K-S	kolmogorov–smirnov	0.25
K-S	testkolmogorov–smirnov test	0.25
K-S	testkolmogorov-smirnov test	0.5
W2	quiet wakefulness	1.0
W1	active wakefulness	1.0
pDH	posterior dorsal hippocampus	1.0
4-HDA	4-hydroxyalkenals	1.0
geN	orm	1.0
pDA	ergicputative dopaminergic	1.0
ARBDA	lcohol-related birth defects	1.0
HELP	hydrophobic echinoderm microtubule-associated protein-like protein	1.0
VGM	ventral gray matter	1.0
NMO-I	gg	1.0
GRO-α	growth regulatory protein-α	1.0
AβPPβ-	amyloid precursor protein	1.0
nRD	nucleus raphe dorsalis	1.0
DAMGOD-Ala2	me-phe4, gly-ol5-enkephalin	0.5
DAMGOD-Ala2	n-me-phe4,gly5-ol-enkephalin	0.5
VGAT-	irvesicular gaba transporter-immunoreactive	1.0
NBMN	eurobasal medium	1.0
TFLLRT	hr-phe-leu-leu-arg-nh2	1.0
nRT	the nucleus reticularis thalami	0.25
nRT	nucleus reticularis	0.25
nRT	thalamic reticular nucleus	0.25
nRT	reticular nucleus of the thalamus	0.25
vsWM	visuo-spatial working memory	1.0
FRLF	linders resistant line	0.666666666667
FRLF	frequency level receptive field	0.333333333333
IFN-γR	interferon-γ receptor	1.0
p75-NGFR	p75-nerve growth factor receptor	0.5
p75-NGFR	low-affinity nerve growth factor receptor	0.5
trans-PDCl-trans-pyrrolidone-2	4-dicarboxylic acid	1.0
3αDIOL	3α-androstanediol	1.0
m-PD	m-phenylenediamine dihydrochloride	0.5
m-PD	meta-phenylenediamine	0.5
FOV	field-of-view	0.121212121212
FOV	field of view	0.878787878788
MWTM	orris water task	1.0
FOR	frame of reference	0.333333333333
FOR	formic acid	0.333333333333
FOR	fastigial oculomotor region	0.333333333333
FOS	c-fos	0.5
FOS	+cells positive for fos staining	0.5
FOX	3homolouge 3 of feminizing locus on x protein 1	1.0
RyR3	ryanodine receptor 3	1.0
SMAX	maximal sensitivity vector	1.0
CPCP-55	940	1.0
NAALADaseN-acetylated	alpha-linked acidic dipeptidase	1.0
CPBBA	cholesterol-protein binding blot assay	1.0
FOE	focus of expansion	1.0
CPIP	chronic post-ischemic pain	1.0
FOG	freezing of gait	0.7
FOG	qfog questionnaire	0.1
FOG	fast-twitch oxidative glycolytic	0.2
ADVC	visual cortex of adult animal	1.0
FOB	functional observational battery	1.0
mVAChT	mouse vesicular acetylcholine transporter	1.0
pTRG	paratrigeminal respiratory group	1.0
CCACC	anadian council on animal care	1.0
pBSSK	pbluescript sk plasmid	1.0
sEH	soluble epoxide hydrolase	1.0
INCON-MIS	incongruent/gender-mismatch	1.0
BCCAL	bilateral common carotid artery ligation	1.0
3hMS	procedure of maternal separation for 3h	1.0
gACSF	high glucose artificial cerebrospinal fluid	1.0
X-G	al5-bromo-4-chloro-3-indolyl-β-galactoside	0.333333333333
X-G	al5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside	0.333333333333
X-G	al5-bromo-4-chloro-3-indolyl p3-d-galactoside	0.333333333333
γ-IFN	γ-interferon	1.0
half-BAPTA	n-(o-methoxyphenyl)-imino-diacetic acid	1.0
FGFR-1	high-affinity fgf receptor	1.0
antisense-ODN	antisense oligodeoxynucleotide	1.0
X-ALDX-	linked adrenoleukodystrophy	1.0
NBTIS-	(p-nitrobenzyl)-6-thioinosine	1.0
PDFs	probability density functions	1.0
L-NAMENG-	nitro-l-arginine methyl ester	1.0
mdDA	mesencephalic and diencephalic dopaminergic	1.0
DABP	diastolic arterial blood pressure	1.0
BP-Luc	bmp-4 promoter-driven luciferase reporter construct	1.0
CHIP	c-terminus of hsp70-interacting protein	1.0
8-Br-ATP	8-bromo-atp	1.0
SAF	scrapie-associated fibrils	1.0
fb-A	dk-tgadktm1-/-:tg(ubiadk):emx1-cre-tg3	1.0
rNTS	nucleus tractus solitarius (rostral)	0.25
rNTS	rostral nts	0.25
rNTS	rostral pole of nucleus tractus solitarius	0.25
rNTS	rostral nucleus tractus solitarius	0.25
LJP	liquid junction potential	1.0
N-Me-Phe3	d-pro4)-casomorphin(1-4)-nh2	1.0
LT-UL	lower thoracic-upper lumbar	1.0
4OH-GTS-	21	1.0
Aga-IVa	omega-agatoxin-iva	1.0
eIPSCs	evoked whole-cell gaba-mediated cl- currents (inhibitory postsynaptic currents)	1.0
CASA	chaperone-assisted selective autophagy	1.0
TAMRA6-carboxy-N	n,n′,n′-tetramethyl-rhodamine	1.0
CASC	ognitive assessment system	1.0
VMHL	lateral ventromedial hypothalamus	1.0
CASL	continuous arterial spin labeling	1.0
GABAA-RA-	type (ionotropic) gaba receptor	1.0
CAST	castrated	1.0
BICGABAA-	receptor antagonist bicuculline methiodide	1.0
PCVISISDA	average coefficient of variation of the interspike intervals across all cells with a stable delay-activated response	1.0
CASP	activated caspase 3	0.5
CASP	3caspase 3	0.5
mGABAA-PSC	miniature gabaa receptor-mediated postsynaptic current	1.0
ADVR	anterior dorsal ventricular ridge	1.0
α-BTX	[125i]-α bungarotoxin	0.2
α-BTX	α-bungarotoxin	0.6
α-BTX	alpha-bungarotoxin	0.2
vlNTS	ventrolateral subnucleus of the nucleus of the solitary tract	1.0
LC-PCR	light cycler polymerase chain reaction	1.0
CN-AIP	calcineurin autoinhibitory peptide	1.0
ApnA	diadenosine polyphosphate	1.0
NDRGN-	myc downregulated gene	1.0
VMH-	llateral ventromedial hypothalamus	1.0
CNQX6-cyano-7-nitroquinoxalinee-2	3-dione	1.0
COMP	cartilage oligomeric matrix protein	1.0
EMEME	agle’s minimum essential medium	0.4
EMEME	agle’s minimal essential medium	0.4
EMEME	agle's minimum essential medium	0.2
COMT	catecholamine-o-methyltransferase	0.025641025641
COMT	catecholamine-o-methyl-transferase	0.025641025641
COMT	catechol-o-methyl-transferase	0.025641025641
COMT	cathecol o-methyltransferase	0.025641025641
COMT	catechol-o-methyltransferase	0.717948717949
COMT	catechol-o-methyl transferase	0.102564102564
COMT	catechol-omethyltransferase	0.025641025641
COMT	catechol o-methyltransferase	0.0512820512821
SAS	startling auditory stimulus	0.181818181818
SAS	supervisory activating system	0.0909090909091
SAS	startling auditory stimuli	0.0909090909091
SAS	symmetric axospinous synapse	0.0909090909091
SAS	supervisory attentional system	0.0909090909091
SAS	salicylic acid sensitive	0.0909090909091
SAS	statistical analysis software	0.0909090909091
SAS	subarachnoid space	0.0909090909091
SAS	startling acoustic stimulus	0.0909090909091
SAS	self-rating anxiety scale	0.0909090909091
rtTA	reverse tetracycline trans activator	0.5
rtTA	tetracycline-activating transcription factor	0.5
COMM	commissural modulation	1.0
NIDDM	non-insulin-dependent diabetes mellitus	1.0
EMCCD	electron-multiplying charge-coupled device	1.0
kNN	k-nearest neighbor	1.0
Tn	ln, sn, nth thoracic, lumbar and sacral vertebrae, respectively, as well as roots entering the spinal canal at the superior limit of these vertebrae	1.0
A-T	ataxia-telangiectasia	0.5
A-T	ataxia–telangiectasia	0.5
caged-InsP3	p4(5)-1-(2-nitrophenyl)ethyl ester of myo-d-inositol-1,4,5-trisphosphate	1.0
PP-GC	perforant path–granule cell	1.0
SNAPS-N	itroso-n-acetyl-penisillamine	1.0
LFPO	ilocal field potential oscillation index	0.333333333333
LFPO	local field potential oscillation	0.666666666667
DL-APV	dl-2-amino-5-phosphonovaleric acid	1.0
2dG	2-deoxyguanosine	1.0
2-ANOVA	two-way analysis of variance	1.0
aPKC	atypical isoform of protein kinase c	0.142857142857
aPKC	atypical pkc	0.428571428571
aPKC	s	0.142857142857
aPKC	atypical protein kinase c	0.142857142857
aPKC	atypical-type protein kinase c	0.142857142857
SapoNBM	group of animals given both i.c.v. and nbm injections of immunotoxin	1.0
LFPS	low-frequency paired-pulse stimulation	1.0
MPEM	aximal possible effect	1.0
SPNO	spermine nonoate	1.0
SAT	spatial alternation task	0.2
SAT	spontaneous activity transient	0.2
SAT	2system a transporter 2	0.2
SAT	sustained attention task	0.2
SAT	speed-accuracy tradeoff	0.2
BN-PAGE	blue-native polyacrylamide gel electrophoresis	0.5
BN-PAGE	blue native-polyacrylamide gel electrophoresis	0.5
ODBl	optical density of nuclear or cytoplasmic non-specific staining in motor neurons	1.0
VDSC	voltage-dependent sodium channels	1.0
rhGDNF	recombinant human glial cell line-derived neurotrophic factor	1.0
Ti	ith postsynaptic interval	1.0
EPCR	endothelial protein c receptor	1.0
Precun7precuneus	ba 7	1.0
DL-APVDL-	2-amino-5-phosphonovalerate	1.0
JARID1ajumonji	at rich interactive domain 1a	1.0
NHS-N	anogold	1.0
SCIDS	tructured clinical interview for dsm-iv axis i disorders	0.5
SCIDS	tructured clinical interview for dsm-iv disorders	0.5
CKII	casein kinase ii	1.0
SEVC	single electrode voltage clamp	0.5
SEVC	single-electrode voltage-clamp	0.5
CNLT	contralateral	1.0
FDTFMRIB	's diffusion toolbox	0.5
FDTFMRIB	’s diffusion toolbox	0.5
RasGAP	ras guanyl activating protein	1.0
pR	bretinoblastoma protein	1.0
GRASPGABA-	receptor-associated long-lasting potentiation	1.0
LMMP	longitudinal muscle-myenteric plexus	0.2
LMMP	longitudinal muscle plus myenteric plexus	0.2
LMMP	longitudinal muscle–myenteric plexus	0.6
CRF-R1	corticotropin releasing factor type 1 receptor	0.5
CRF-R1	crf receptor type 1	0.5
flTRPV	1full-length trpv1	1.0
CMTNSCMT	neuropathy score	1.0
9-AA	9-aminoacridine	1.0
proBDNFBNDF	precursor	1.0
9-AC	anthracene-9 carboxylate	1.0
N-V	1the ophthalmic branch of the trigeminal nerve	1.0
JAR	jamming avoidance response	1.0
NOC-5	3-[2-hydroxy-1-(1-methylethyl)-2-nitrosohydrazine]-1-propanamine	1.0
pS	tat3phosphorylated stat3	0.0833333333333
pS	ubpostsubiculum	0.0833333333333
pS	mad3phospho-smad3	0.0833333333333
pS	6phosphorylated s6 ribosomal protein	0.0833333333333
pS	159-mar-abmonoclonal antibody against ser159-phospho-myristoylated alanine-rich c-kinase substrate	0.0833333333333
pS	picosiemens	0.0833333333333
pS	mad 2/3phosphorylated smad 2/3	0.0833333333333
pS	population spike	0.0833333333333
pS	mad2phospho-smad2	0.0833333333333
pS	214anti-phosphoser214	0.0833333333333
pS	9-gsk-3βphosphorylated gsk-3β at ser 9 epitope	0.0833333333333
pS	phosphorylation of serine	0.0833333333333
AIF-	1allograft inhibitory factor-1	0.5
AIF-	1allograft inflammatory factor-1	0.5
PDI-IVP	ersonality disorder interview	1.0
PEEK	polyaryletheretherketone	1.0
mPOAH	medial preoptico-anterior hypothalamus	1.0
L-CCG-I	(2s,3s,4s)-ccg/(2s,1′s,2′s)-2-(carboxycyclopropyl)glycine	0.2
L-CCG-I	l-2-carboxycyclopropylglycine	0.2
L-CCG-I	(2s,3s,4s)-ccg	0.2
L-CCG-I	(2s,1′s,2′s)-2-(carboxycyclopropyl) glycine	0.2
L-CCG-I	(2s,1′s,2′s)-2-(carboxycyclopropyl)glycine	0.2
N-B	rsucn-bromosuccinimide	1.0
N-C	ornuclear co-receptor	0.5
N-C	ornuclear receptor corepressor	0.5
N-A	rgng-nitro-l-arginine	1.0
cis-PnA	cis-parinaric acid	1.0
VLTg	ventrolateral tegmental nucleus	1.0
DAKO	fluorescence mounting medium	0.5
DAKO	drebrin a-specific knockout	0.5
MESF	molecules of equivalent soluble fluorochrome	1.0
MgCl2	100 mm nacl, 100 mm tris–hcl, ph 9.5	1.0
HIF-1	hypoxia-inducible factor-1	1.0
BREC	sbovine retinal endothelial cells	1.0
JAK-STATJ	anus kinase/signal transducers and activators of transcription	1.0
BNST	ovoval nucleus of the bed nucleus of the stria terminalis	0.0555555555556
BNST	bed nuclei stria terminalis	0.00694444444444
BNST	brain nucleus of stria terminalis	0.00694444444444
BNST	pmposteromedial bed nucleus of the stria terminalis	0.00694444444444
BNST	bed nucleus of the stria terminallis	0.00694444444444
BNST	pmposteromedial region of the bed nucleus of the stria terminalis	0.00694444444444
BNST	bed nucleus of stria terminalis	0.0902777777778
BNST	dbed nucleus of the stria terminalis dorsal	0.00694444444444
BNST	bed nucleus stria terminalis	0.0138888888889
BNST	pprincipal nucleus of the bed nucleus of the stria terminalis	0.0138888888889
BNST	bed nucleus of the stria terminalis	0.743055555556
BNST	the bed nucleus of the stria terminalis	0.0138888888889
BNST	basal nucleus of the stria terminalis	0.00694444444444
BNST	bed nuclei of the stria terminalis	0.00694444444444
BNST	(pm/pi), bed nucleus of the stria terminalis (posterior medial/posterior intermediate)	0.00694444444444
BNST	vbed nucleus stria terminalis ventral	0.00694444444444
CHS	continuous hippocampal stimulation	1.0
arVRG	anterior part of the rostral ventral respiratory group	1.0
cPOA	caudal preoptic area	1.0
CHT	1high-affinity choline transporter	0.181818181818
CHT	high-affinity choline transporter	0.181818181818
CHT	choline transporter	0.0909090909091
CHT	high affinity choline transporter	0.363636363636
CHT	1high affinity choline transporter	0.181818181818
TNF-αT	umor necrosis factor-α	1.0
TTFA	thenoyltrifluoroacetone	1.0
IFN-γ	interferon gamma	0.138888888889
IFN-γ	interferon γ	0.0555555555556
IFN-γ	interferon-γ	0.75
IFN-γ	interferon-gamma	0.0555555555556
NCB-	20 cells	1.0
IFN-α	interferon-α	1.0
LFS-SN	low-frequency stimulation of ipsilateral substantia nigra	1.0
TR	4testicular orphan nuclear receptor-4	0.0119047619048
TR	relaxation time	0.0119047619048
TR	transferrin receptor	0.0119047619048
TR	thyroid hormone receptors	0.0238095238095
TR	tennis racket	0.0119047619048
TR	taste reactivity	0.0119047619048
TR	/terepetition time/echo time	0.0119047619048
TR	7	0.0119047619048
TR	repitition time	0.0119047619048
TR	targeted replacement	0.0357142857143
TR	postpiriform transition area	0.0119047619048
TR	temporal resolution	0.0119047619048
TR	tractus retroflexus	0.0119047619048
TR	agala-pfluoro-phe-arg-cha-homoarg-tyr-nh2 (synthetic thrombin receptor agonist peptide)	0.0119047619048
TR	time repetition	0.0119047619048
TR	aav terminal repeat	0.0119047619048
TR	trained-only rats	0.0119047619048
TR	sthyroid hormone receptors	0.0119047619048
TR	thyroid receptor	0.0119047619048
TR	temporal restricted feeding	0.0119047619048
TR	texas red	0.0357142857143
TR	training period	0.0119047619048
TR	repetition-time	0.0238095238095
TR	nthalamic reticular nucleus	0.0119047619048
TR	time of repetition	0.0119047619048
TR	tonic regular-spiking cell	0.0119047619048
TR	trained group	0.0357142857143
TR	repeat time	0.0357142857143
TR	thyroid hormone receptor	0.0595238095238
TR	repetition time	0.488095238095
1G2	monoclonal antibody to c-terminal half of neurocan	1.0
RRGU	relative regional glucose utilization	1.0
KASE	kainic acid-induced status epilepticus	1.0
DOPAL3	4-dihydroxyphenylacetaldehyde	1.0
L-trans-pyrrolidine-2	4-dicarboxylic acid	1.0
NC-LV	negative control lentivirus	1.0
1400W	[n-(3-(aminomethyl)benzyl) acetamidine)]	1.0
AP-SPN	adrenally projecting spn	1.0
TN	true negative	0.0625
TN	terminal nerve	0.125
TN	tuberal nucleus	0.0625
TN	turnover number	0.0625
TN	tangential nucleus	0.0625
TN	temporal-to-nasal	0.0625
TN	tuberal (infundibular) nucleus	0.0625
TN	trigeminal neuralgia	0.125
TN	tenascin	0.0625
TN	tetanus toxin	0.0625
TN	trigeminal nucleus	0.1875
TN	temporal to nasal	0.0625
pJAK	2phospho-janus-activated kinase-2	1.0
2D-FFT	two-dimensional fast fourier transform	1.0
SODS	uperoxide dismutase	1.0
LGSL	ennox–gastaut syndrome	1.0
A0	non-inflected dorsal root ganglion a-neuron	1.0
CPT1	3-dimethyl-8-cyclopenthylxanthine	1.0
SPDP	n-succinimidyl 3-(2-pyridyldithio)propionate	1.0
sFTX	synthetic funnel-web spider toxin	1.0
dSTR	dorsal striatum	1.0
PMSF	phenylmethyl-sulfonyl fluoride	0.00819672131148
PMSF	phenylmethylsulphonyl fluoride	0.114754098361
PMSF	phenylethylsulfonylfluoride	0.00819672131148
PMSF	phenylmethanesulfonylfluoride	0.0245901639344
PMSF	phenyl methylsulfonyl fluoride	0.00819672131148
PMSF	phenylmethysulfonyl fluoride	0.00819672131148
PMSF	phenylmethylsulfonyl floride	0.016393442623
PMSF	phenylme-thylsulfonyl fluoride	0.00819672131148
PMSF	phenylmethanesulfonyl fluoride	0.0737704918033
PMSF	phenylmethanesulphonyl fluoride	0.00819672131148
PMSF	phenylmethylsulfonylfluoride	0.0409836065574
PMSF	phenyl methyl sulfonyl fluoride	0.00819672131148
PMSF	phenylmethyl sulforyl fluoride	0.00819672131148
PMSF	phenylmethylsulfonyl fluoride	0.606557377049
PMSF	phenylymethylsulfonyl fluoride	0.00819672131148
PMSF	phenylmethylsulfonyl-fluoride	0.00819672131148
PMSF	phenylmethanesulphonylfluoride	0.0327868852459
PMSF	phenylmethylsulfonyl	0.00819672131148
SPDH	sequential pulse-density histogram	0.5
SPDH	sequential pulse density histogram	0.5
A2	group v	0.5
A2	noradrenergic cell group in the nucleus of solitary tract	0.5
CPT-	camp8-(4-chlorophenylthio)cyclic amp	0.5
CPT-	camp8-(4-chlorophenylthio) adenosine 3′,5′-cyclic monophosphate sodium salt	0.5
MBIA	multiplexed bead immunoassay	1.0
SODN	sense oligodeoxynucleotide	1.0
dLGE	dorsal–lateral ganglionic eminence	1.0
HPLC	high performance liquid chromatography	0.248603351955
HPLC	high pressure liquid chromatography	0.0614525139665
HPLC	mshigh performance liquid chromatography coupled to electrospray mass spectrometry	0.00279329608939
HPLC	high performance liquid chromotography	0.00279329608939
HPLC	–mshigh-performance liquid chromatography–mass spectrometry	0.00558659217877
HPLC	high liquid performance chromatography	0.00279329608939
HPLC	/echigh performance liquid chromatography/electrochemical detection	0.00279329608939
HPLC	high-performance liquid chomatography	0.00279329608939
HPLC	high-performance liquid chromatography	0.558659217877
HPLC	high-performance-liquid-chromatography	0.00279329608939
HPLC	/echigh performance liquid chromatography with electrochemical detection	0.00558659217877
HPLC	high-pressure liquid chromatography	0.0865921787709
HPLC	high-performance liquid chromatograph	0.0111731843575
HPLC	–dad	0.00279329608939
HPLC	high-pressure liquid chromotography	0.00279329608939
HPLD	hand path linearity deviation	1.0
RPARNA	se a protection assay	1.0
rCMRglu	regional cerebral metabolic rate of glucose	1.0
m-CPP	meta-chlorophenylpiperazine	0.5
m-CPP	m-chlorophenylpiperazine	0.5
D-E5	7-dihydroxytryptamine injected rat with enriched housing	1.0
D-CPP	3-((r)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid	0.5
D-CPP	r-(-)-3-(2-carboxypiperazin-4-yl)propanephosphonic acid	0.5
SOD1	superoxide dismutase 1	0.2
SOD1	superoxide dismutase 1 enzyme	0.2
SOD1	cu/zn superoxide dismutase	0.2
SOD1	cu2+/zn2+ superoxide dismutase	0.2
SOD1	copper/zinc superoxide dismutase	0.2
IL-1α	interleukin-1α	1.0
A246E	mutation at codon 246 of presenilin-1 resulting in substitution of alanine by glutamic acid	1.0
DSCT	dorsal spinocerebellar tract	1.0
IL-1β	interleukin-1 beta	0.0555555555556
IL-1β	interleukin-1β	0.833333333333
IL-1β	interleukin 1β	0.0555555555556
IL-1β	(rat recombinant) interleukin-1β	0.0555555555556
HFS-LTP	high-frequency stimulation long-term potentiation	1.0
d-Ala2-N-Me-Phe4	gly-ol5]-enkephalin	1.0
α-BTXα-	bungarotoxin	1.0
acidseizuresP	rnpflanking genesknockout mice	1.0
SOD-	1superoxide dismutase	0.25
SOD-	1superoxide dismutase 1	0.25
SOD-	1superoxide dismutase-1	0.5
mLTD	muscarinic receptor dependent ltd	1.0
fdG	phenylalanine-(d) aspartate-(d) glycine	1.0
DLPFC	dorso-lateral pre-frontal cortex	0.0188679245283
DLPFC	the dorsolateral prefrontal cortex	0.0188679245283
DLPFC	dorsolateral prefrontal cortex	0.849056603774
DLPFC	dorso-lateral prefrontal cortex	0.0377358490566
DLPFC	dorsolateral regions of prefrontal cortex	0.0188679245283
DLPFC	dorsal lateral prefrontal cortex	0.0188679245283
DLPFC	dorsolateral pfc	0.0377358490566
NCBI	nrnational center for biotechnology information	1.0
CT-OA	cue–target onset asynchrony	1.0
Ste20	sterile 20	1.0
LAP-TGFβ	1latency associated protein-transforming growth factor β1 (precursor protein)	1.0
BDIB	ecky depression inventory	0.0833333333333
BDIB	eck depression inventory	0.833333333333
BDIB	eck's depression inventory	0.0833333333333
dHC	dorsal hippocampus	1.0
CD-IR	caldendrin-immunoreactivity	1.0
NACN-	acetyl-cysteine	0.148148148148
NACN-	acetyl-l-cysteine	0.259259259259
NACN-	acetylcysteine	0.555555555556
NACN-	acetyl cysteine	0.037037037037
PBS-Tx	pbs plus triton x-100	1.0
Ebr	ethidium bromide	1.0
LOAD	late-onset alzheimer's disease	1.0
dLGN	dorsal part of the lateral geniculate body	0.0285714285714
dLGN	dorso-lateral geniculate nucleus	0.0285714285714
dLGN	dorsal lateral geniculate nucleus	0.914285714286
dLGN	dorsolateral geniculate nucleus	0.0285714285714
NMRIN	aval medical research institute	1.0
ApoE-KO	(also, eko) apoe “knockout” mouse, targeted-mutation transgenic eliminating apoe expression	1.0
VDS	vocalizations during shock	0.4
VDS	visual danger stimulus	0.6
VDR	vitamin d3 receptor	0.333333333333
VDR	vitamin d receptors	0.166666666667
VDR	ontogeny	0.166666666667
VDR	vitamin d receptor	0.333333333333
IAA-	type k+ currents	0.111111111111
IAA-	type potassium current	0.333333333333
IAA-	type k current	0.0555555555556
IAA-	type k+ current	0.111111111111
IAA-	type current	0.0555555555556
IAA-	type transient k+ current	0.222222222222
IAA-	type voltage dependant potassium current	0.0555555555556
IAA-	type ik	0.0555555555556
ST-CHOL	stressed cholesterol animal group	1.0
TNT	buffer comprising tris, nacl and tween 20	0.2
TNT	tris-buffered saline with tween-20	0.2
TNT	ris–nacl	0.2
TNT	tris–nacl tween	0.2
TNT	tris–nacl–tween buffer	0.2
Viagra	revatio)	1.0
VDB	vertical limb of the diagonal band	0.142857142857
VDB	nu vertical limb diagonal band	0.0285714285714
VDB	nucleus of the vertical limb of the diagonal band	0.171428571429
VDB	vertical limb diagonal band	0.0285714285714
VDB	nucleus of ventral limb of the diagonal band	0.0285714285714
VDB	ventral diagonal band	0.0285714285714
VDB	vertical nucleus of the diagonal band of broca	0.0285714285714
VDB	vertical limb of diagonal band nucleus	0.0285714285714
VDB	the vertical limb of the diagonal band	0.0285714285714
VDB	vertical limb nuclei of the diagonal band of broca	0.0285714285714
VDB	vertical limb of the diagonal band of broca	0.228571428571
VDB	vertical diagonal band	0.0857142857143
VDB	vertical limb of diagonal band	0.0571428571429
VDB	vertical diagonal band nucleus	0.0285714285714
VDB	vertical diagonal band of broca	0.0571428571429
MeP	posterior subdivision of me	1.0
VDI	voltage-dependent inactivation	1.0
TFAM	mitochondrial transcription factor a	1.0
GABARAPGABAAR-	associated protein	1.0
hMYH	human muty homologue	1.0
VDN	vas deferens nerve	1.0
MPDC	l-anti-endo-3,4-methanopyrrolidinedicarboxylic acid	1.0
Nref	noise of cr+ref	1.0
ANOVAA	nalysis of variance	1.0
MPDM	ouse phenome database	1.0
SThN	subthalamic nucleus	1.0
ZId	dorsal zona incerta	1.0
dl-PBN	dorsal lateral subnucleus of pbn	1.0
PDGF-CC	platelet-derived growth factor-cc	1.0
AH	iamygdalo-hippocampal transition area	0.04
AH	neuronafter-hyperpolarizing neuron	0.02
AH	designation of neurons with a prominent and prolonged afterhyperpolarizing potential that follows the action potential	0.02
AH	designation of neurons with broad action potentials and long-lasting afterhyperpolarizations	0.02
AH	3(r)-α-methylhistamine	0.02
AH	ialanterolateral nucleus of the amygdala	0.02
AH	designation of neurons with broad action potentials and long-lasting after hyperpolarisations	0.02
AH	type of neuron in which the action potential is followed by an extended hyperpolarization	0.02
AH	iamygdalohippocampal area	0.06
AH	preoptic/anterior hypothalamus	0.02
AH	anterior hypothalamic area	0.08
AH	yanterior hypothalamus	0.02
AH	ianterior hypothalamic area	0.02
AH	anterior hypothalamus	0.32
AH	after-hyperpolarization	0.02
AH	anterior hypothalamic	0.02
AH	designation of neurons with long afterhyperpolarisation	0.02
AH	anterior nucleus of hypothalamus	0.02
AH	after hatching	0.04
AH	designation of neurons with action potentials having inflections on their falling phase, followed by prolonged ahps	0.02
AH	designation of neurons with broad action potentials and long-lasting after-hyperpolarizations	0.02
AH	designation of neurons having delayed and prolonged hyperpolarizations following soma action potentials	0.02
AH	neuronan enteric neuron with an afterhyperpolarizing potential following an action potential	0.02
AH	abductor hallucis	0.02
AH	designation applied to neurons having delayed and prolonged hyperpolarizations following soma action potentials	0.02
AH	designation of neurons with broad action potentials and long-lasting after-hyperpolarisations	0.02
AH	autoinhibitory helix	0.02
AH	designation of neurones with broad action potentials and long-lasting afterhyperpolarisations	0.02
BRL	544433-(1-methylpiperidine-4-yl)-1h-indol-5-ol maleate	1.0
LDL-CLDL	cholesterol	1.0
AK	audiogenic kindling	1.0
MDpl	mediodorsal nucleus, paralamellar division	1.0
f-AHP	fast-decaying afterhyperpolarization	0.333333333333
f-AHP	fast afterhyperpolarization	0.666666666667
GVA	general visceral afferent	1.0
CL316243	disodium-(r,r)-5-[2-[(2-3-chlorophenyl)-2-hydroxyethyl]-amino]	1.0
T2	second trial	1.0
APLP	app-like protein	0.125
APLP	amyloid precursor-like protein	0.75
APLP	2app-like protein 2	0.125
AL	ad libitum group	0.0588235294118
AL	santennal lobes	0.0294117647059
AL	pituitary anterior lobe	0.0294117647059
AL	anterior pituitary lobe	0.0294117647059
AL	ad libitum fed	0.117647058824
AL	anterior lateral	0.0294117647059
AL	alone condition of hi test	0.0294117647059
AL	ad libitum	0.147058823529
AL	ad libitum food access	0.0294117647059
AL	antennal lobe	0.0294117647059
AL	adductor longus	0.0294117647059
AL	ad libitum feeding	0.0588235294118
AL	ansa lenticularis	0.0882352941176
AL	anterior lobe	0.0294117647059
AL	food ad libitum	0.0294117647059
AL	lateral nucleus of the amygdala	0.0294117647059
AL	anterior lobe of the pituitary	0.0294117647059
AL	acute fundus ligation	0.0294117647059
AL	ad libitum control	0.0294117647059
AL	alloparenting	0.0294117647059
AL	alcohol treatment	0.0294117647059
AL	v/nvthe ratio of axon length density to neuron density	0.0294117647059
AL	adjacent left quadrant	0.0294117647059
GDRFGAT	down-regulating factor	1.0
Tris-HCl	137mm nacl, ph 7.4	1.0
T1	2,6,7-3h(n)-testosterone	0.25
T1	first trial	0.25
T1	superior temporal gyrus	0.25
T1	truncated isoform of trkb	0.25
des-IGF-1	des-n-(1-3)-insulin-like growth factor-1	1.0
VAdc	ventral anterior nucleus pars densicellularis	1.0
PMP22	peripheral myelin protein-22	1.0
CSAR	cardiac sympathetic afferent reflex	1.0
VD4	neuron visceral dorsal 4	1.0
NITT	nitrotyrosine	0.5
NITT	protein tyrosine nitration	0.5
TGOT	[thr4,gly7]oxytocin	1.0
hAC	he-tg//appswe micetransgenic mice overexpressing human synaptic acetylcholinesterase and carrying the swedish mutation of amyloid precursor protein	1.0
cdh2N-	cadherin	1.0
cytoC	cytochrome c	1.0
Me5	nucleus of the mesencephalic tract of the trigeminal nerve	0.333333333333
Me5	mesencephalic trigeminal nucleus	0.666666666667
mIPSC	miniature inhibitory postsynaptic current	0.446601941748
mIPSC	miniature ipsc	0.0873786407767
mIPSC	sminiature inhibitory postsynaptic currents	0.233009708738
mIPSC	sminiature ipscs	0.0485436893204
mIPSC	spontaneous miniature inhibitory post-synaptic current	0.00970873786408
mIPSC	minature inhibitory postsynaptic current	0.00970873786408
mIPSC	sminiature inhibitory post-synaptic currents	0.0194174757282
mIPSC	miniature inhibitory post-synaptic current	0.0679611650485
mIPSC	miniature spontaneous inhibitory post-synaptic current	0.00970873786408
mIPSC	miniature inhibitory postsynaptic currents	0.0485436893204
mIPSC	miniature gabaa-mediated inhibitory postsynaptic current	0.00970873786408
mIPSC	miniature (tetrodotoxin-resistant) inhibitory postsynaptic current	0.00970873786408
SPOMe	substance p-o-methylester	1.0
CAPZBF-	actin-capping protein subunit beta	1.0
αAPP	ssoluble α-secretase-derived fragment of app	1.0
AV3V	anteroventral third ventricle	0.714285714286
AV3V	anteroventral third ventricular (region)	0.142857142857
AV3V	antero-ventral region of the third cerebral ventricle	0.142857142857
5-HTNR	no response to 5-ht	1.0
ECur50	ejection current that produced approximately 50% of the maximum neuronal response	1.0
IAAT	insect amino acid transporter	1.0
mCPBG	m-chlorophenyl biguanide	0.4
mCPBG	m-chlorophenylbiguanide	0.4
mCPBG	1-(m-chlorophenyl)-biguanide	0.2
shHIF-	1αshrna plasmids for hif-1α	1.0
LAH	latero-anterior hypothalamus	1.0
NMDAN-M	ethyl-d-aspartate	0.571428571429
NMDAN-M	ethy-d-aspartate	0.142857142857
NMDAN-M	ethyl-d-aspartic acid	0.285714285714
LSND	lumbar sympathetic nerve activity	1.0
BECTS	benign childhood epilepsy with centro-temporal spikes	1.0
aSVZ	anterior subventricular zone	1.0
IUGR	intrauterine growth restriction	0.75
IUGR	intrauterine growth retardation	0.25
DPGi	dorsal paragigantocellular nucleus	1.0
CASK	calmodulin-dependent serine kinase	0.5
CASK	calcium/calmodulin-dependent serine protein kinase	0.5
coup-TF	chicken ovalbumin upstream promoter transcription factor	1.0
ArcL	lateral arcuate nucleus	1.0
LSNA	lumbar sympathetic nerve activity	1.0
SNARF-	5fsnarf-5f 5- (and -6) carboxylic acid	1.0
RRN	retrorubral nucleus	1.0
αβmeATP	α,β-methyleneadenosine 5′-triphosphate	1.0
FSRF	orce sensor resistance	1.0
RRG	respiratory rhythm generator	1.0
RRF	retrorubral field	0.888888888889
RRF	retro rubral field	0.111111111111
RRE	rapid response element	1.0
RRD	rapid repetitive discharge	0.5
RRD	respiratory-related discharge	0.5
LYLY	294002	1.0
RRA	rescaled range analysis	0.2
RRA	radioreceptor assay	0.2
RRA	retrorubral area	0.6
accVI	accessory abducens motor nucleus	1.0
RRZ	retinorecipient zone of the pulvinar	1.0
RRX	rhodamine red-x	1.0
RRS	righting reflex scale	0.5
RRS	rumination (or ruminative) responses scale	0.5
RRR	uthenium red	1.0
RRP	readily releasable pool of vesicles	0.0714285714286
RRP	rapidly releasable pool	0.0714285714286
RRP	readily releasable pool	0.857142857143
KRHK	rebs-ringer-henseleit	0.25
KRHK	rebs ringer buffer	0.25
KRHK	rebs-ringer-hepes buffer	0.25
KRHK	rebs–ringer-hepes	0.25
RR-	2random ratio-2	1.0
SCG10	sympathetic cervical ganglion clone 10	1.0
nAcc	nucleus accumbens	1.0
SEK1	sapk/erk kinase-1	0.5
SEK1	stress-activated protein/erk kinase 1	0.5
MAPKK	mitogen-activated protein kinase kinase	1.0
FPPGF	2α receptor	1.0
HNPP	hereditary neuropathy with liability to pressure palsies	0.5
HNPP	2-hydroxy-3-naphtoic acid-2′-phenylanilide phosphate	0.5
MAPKM	itogen-activated protein kinase	1.0
ethane-N	n,n,n-tetra-acetate	0.2
ethane-N	n,n′,n′-tetraacetic acid	0.2
ethane-N	n,n′,n′-tetra-acetic acid acetoxymethyl ester	0.6
oxLDL	oxidized low-density lipoproteins	1.0
ELFMF	sextremely low frequency magnetic fields	1.0
cnVIII	vestibulocochlear nerve	1.0
CLK	transcription factor clock	1.0
aMPT	alpha-methyl-p-tyrosine	1.0
ILSC	intermediate layers of superior colliculus	1.0
DP-	5-ctdipropyl-5-carboxamidotryptamine	1.0
EIPSP	reversal potential of ipsps	1.0
W-P	rpexternal work during propulsion	1.0
MUSCM	edical university of south carolina	1.0
SAN	sinoatrial node	1.0
PRV-IR	pseudorabies virus immunoreactivity	1.0
SRTT	serial reaction time task	1.0
TTPAα-	tocopherol transfer protein gene for the human version	1.0
M-MLVRTM	oloney murine leukemia virus reverse transcriptase	1.0
βCGRP	β calcitonin gene-related peptide	1.0
VEPs	visual evoked potentials	1.0
BCECF	2,7′-biscarboxyethyl-5,6-carboxyfluorescein	0.142857142857
BCECF	2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein	0.285714285714
BCECF	2′,7′-bis-(2-carboxyethyl)-5 (and -6) carboxyfluorescein	0.142857142857
BCECF	2′,7′-bis(2-carboxyethyl)-5,6-carboxyfluorescein	0.142857142857
BCECF	2′, 7′-bis-(2-carboxy-ethyl)-5, 6-carboxyfluorescein	0.142857142857
BCECF	2′,7′-bis(2-carboxyethyl)-5-(and-6-)-carboxyfluorescein	0.142857142857
W-A	bsexternal work during absorption	1.0
cyP	u5′,8-purine cyclodeoxynucleoside	1.0
cPAGl	vl, lateral and ventrolateral caudal periaqueductal gray	0.5
cPAGl	vl, caudal lateral and ventrolateral periaqueductal gray	0.25
cPAGl	vl, caudal periaqueductal gray, lateral and ventrolateral sectors	0.25
PVCT	post vogel conflict test	1.0
pERK	1/2phosphorylated extracellular-regulated kinase 1 and 2	0.0285714285714
pERK	1/2phosphorylated erk1/2	0.0571428571429
pERK	phosphorylated extracellular signal-regulated kinases 1/2	0.0285714285714
pERK	phosphorylated map kinase	0.0285714285714
pERK	phosphorylated extracellular signal-regulated kinases	0.0571428571429
pERK	phospho erk	0.0285714285714
pERK	phosphoerk	0.0285714285714
pERK	1/2phospho-extra-cellular regulated kinase	0.0285714285714
pERK	1/2phosphorylated extracellular signal-regulated kinase 1/2	0.0285714285714
pERK	phospho-erk	0.114285714286
pERK	phosphorylated extracellular signal-regulated kinase-1 and -2	0.0285714285714
pERK	phosphorylated extracellular cell-regulated protein kinase	0.0285714285714
pERK	1/2phosphorylated extracellular-signal-regulated kinase 1/2	0.0285714285714
pERK	phosphorylated erk	0.114285714286
pERK	phospho erk1/erk2	0.0285714285714
pERK	phosphorylated forms of extracellular signal-regulated kinase	0.0285714285714
pERK	1/2phosphorylated extracellular signal-regulated kinase-1 and -2	0.0285714285714
pERK	phospho-activated erk	0.0285714285714
pERK	phosphorylated extracellular signal-regulated kinase	0.142857142857
pERK	phosphorylated extracellular signal-regulated protein kinase	0.0285714285714
pERK	phosphor-extracellular signal-regulated protein kinase	0.0285714285714
pERK	1/2phosphorylated extracellular signal-regulated kinases	0.0285714285714
pERK	phosphorylated extracellular signal-related kinase	0.0285714285714
PCAF	p300/creb binding protein-associated factor	0.333333333333
PCAF	p300/cbp-associated factor	0.333333333333
PCAF	p300/cbp associated factor	0.333333333333
NEOUCOMN	ortheastern ohio universities college of medicine	1.0
IQR	interquartile range	0.583333333333
IQR	inter-quartile range	0.333333333333
IQR	interquartile ranges	0.0833333333333
USV	ultrasonic vocalization	0.416666666667
USV	sultrasonic vocalizations	0.333333333333
USV	sultrasonic vocalization	0.0833333333333
USV	sultrasound vocalizations	0.0833333333333
USV	ultrasonic vocalizations	0.0833333333333
USU	nited states	1.0
UST	uronyl 2-o-sulfotransferase	1.0
USS	unpredictable shock stress	1.0
Flk-1	fetal liver kinase-1	1.0
τON	on time constant	1.0
2-DGU	[14c]2-deoxyglucose uptake	1.0
PVCN	posterior ventral cochlear nucleus	0.210526315789
PVCN	posteroventral cochlear nucleus	0.736842105263
PVCN	postero-ventral cochlear nucleus	0.0526315789474
PCAP	avlovian conditional approach	1.0
VISL	lateral visual association cortex	1.0
VISp	primary visual area	1.0
HNPC	human neural progenitor cell	1.0
PXR	pregnane x receptor	1.0
A1R-IR	adenosine a1 receptor-like immunoreactivity	1.0
DBDDNA-	binding domain	1.0
FVBFVB	/nj	0.5
FVBFVB	/n	0.5
mSCA	medial superior cerebellar artery branch	1.0
Au	cortex—auditory area	1.0
A-lobe	arhabdomeral lobe	1.0
TI-VAMP	tetanus neurotoxin-insensitive vesicle-associated membrane protein	1.0
FPE	final position error	1.0
FPD	familial parkinson's disease	1.0
5-HT3R-AS	short form of the 5-ht3 receptor, a subunit	1.0
FPA	fixed potential amperometry	1.0
FPC	frontoparietal cortex	0.666666666667
FPC	frontopolar cortex	0.333333333333
StDL	dorsolateral striatum	1.0
FPL	fpl 64176	0.5
FPL	fasciculus prosencephali lateralis	0.5
FPI	fluid-percussion injury	0.235294117647
FPI	fluid-percussion brain injury	0.117647058824
FPI	fluid percussion injury	0.647058823529
DAP14	6-diamidino-2-phenylindole	1.0
FPT	inh iiifarnesyl protein transferase inhibitor iii	1.0
LPDS	lipoprotein-deficient serum	1.0
STFT	short-time fourier transform	0.5
STFT	short time fourier transform	0.5
T-tubules	transverse tubules	1.0
FPP	force production performance	0.2
FPP	fast prepotential	0.2
FPP	farnesyl pyrophosphate	0.2
FPP	farnesyl phosphopyruvate	0.2
FPP	fermented papaya preparation	0.2
FPS	fear-potentiated startle	0.9
FPS	fear-potentiated startle procedure	0.1
FPR	formyl peptide receptor	1.0
cA	mpamplitude of response to ctone	1.0
5-HT3R-AL	long form of the 5-ht3 receptor, a subunit	1.0
CMF-PBS	calcium–magnesium free phosphate-buffered saline	1.0
Gβ	1g protein beta polypeptide 1	1.0
sFTIR	synchrotron fourier transform infrared microspectroscopy	1.0
Gα	11	0.111111111111
Gα	0g0α-protein	0.111111111111
Gα	12g-protein alpha 12	0.111111111111
Gα	g protein α subunit	0.111111111111
Gα	sthe isoform of stimulatory g-protein α subunit	0.111111111111
Gα	i3	0.111111111111
Gα	zg protein alpha z polypeptide	0.111111111111
Gα	q/11g protein q/11 alpha subunit	0.111111111111
Gα	z	0.111111111111
sAPPα	soluble form α of the amyloid precursor protein	0.25
sAPPα	secreted form of β-amyloid precursor protein	0.25
sAPPα	soluble non-amyloidogenic peptide fragment	0.25
sAPPα	soluble appα	0.25
CAP-23	cortical cytoskeleton-associated protein-23	1.0
BRAC	basic rest-activity cycle	1.0
BRAA	brain-reactive auto-antibody	1.0
FSM	1hand primary motor cortex functional source	1.0
KCTDK	+ channel tetramerization domain-containing	1.0
IKir	inwardly rectifying k+ current	0.5
IKir	inwardly rectifying potassium current	0.5
WSRTW	ilcoxon signed rank test	1.0
SIS	short insular sulcus	0.333333333333
SIS	ocial interaction	0.333333333333
SIS	speech-induced suppression	0.333333333333
SIR	social isolation rearing	0.2
SIR	store/ignore/recall	0.2
SIR	second interval response	0.4
SIR	2silent information regulator 2	0.2
SIP	sensorimotor integration process	0.333333333333
SIP	stock solution of isoosmotic percoll	0.333333333333
SIP	stepping in place	0.333333333333
SIV	simian immunodeficiency virus	0.5
SIV	fourth somatic sensory area	0.5
SIT	shoulder inertial torque	0.25
SIT	social interaction test	0.25
SIT	superimposed twitch	0.25
SIT	sequential investment task	0.25
MGNF	medial giant nerve fiber	1.0
MEOH	methanol	1.0
ACEA	ng i-converting enzyme	0.333333333333
ACEA	arachidonyl-2′-chloroethylamide	0.333333333333
ACEA	arachidonyl-2-chloroethylamide	0.333333333333
SAGE	serial analysis of gene expression	1.0
ωCTxGVIA	ω-conotoxin gvia	1.0
POPS	1-palmitoyl-2-oleoyl -sn-glycero-3-phosphatidylserine	0.5
POPS	population spike	0.5
SIB	number of spikes in a burst	0.5
SIB	single igle-bouton	0.5
SIA	stress-induced antinociception	0.25
SIA	stress-induced analgesia	0.75
SIG	silver-intensified gold	0.714285714286
SIG	silver-intensified immunogold	0.285714285714
SIF	synthetic interstitial fluid	0.666666666667
SIF	cellssmall intensely fluorescent cells	0.0333333333333
SIF	single immunofluorescent	0.0333333333333
SIF	small, intensely fluorescent (cells)	0.0333333333333
SIF	singly-innervated muscle fiber	0.0333333333333
SIF	singly-innervated muscle fibre	0.0333333333333
SIF	small intensely fluorescent (cells)	0.0333333333333
SIF	small intensely fluorescent	0.133333333333
NICsham-operated	non-ischemic control	1.0
SIK	1salt-inducible kinase 1	1.0
SNRM	specific nuclear receptor modulator	1.0
SII	second somatic sensory area	0.0357142857143
SII	secondary somatosensory area	0.107142857143
SII	second somatosensory	0.0357142857143
SII	isecondary somatosensory cortex ipsilateral to stimulation	0.0357142857143
SII	second somatosensory area	0.0357142857143
SII	second somatosensory cortex	0.0357142857143
SII	secondary somatosensory cortex	0.714285714286
SIH	stress-induced hyperalgesia	0.571428571429
SIH	stress-induced hyperthermia	0.142857142857
SIH	stress-induced hypoalgesia	0.285714285714
1-OG	1-oleoyl glycerol	1.0
SIN	+ninstriatum in nigra+nigra in nigra	0.333333333333
SIN	sciatic inflammatory neuritis	0.333333333333
SIN	speech in noise (as in sin discrimination)	0.333333333333
SIM	selective ion monitoring	0.5
SIM	1single minded 1	0.5
SIL	sildenafil citrate	0.333333333333
SIL	silent cell	0.333333333333
SIL	silenced	0.333333333333
TAT	ris acetate	0.333333333333
TAT	protein	0.333333333333
TAT	ibialis anterior	0.333333333333
TAU	taurine	1.0
HQH	istory questionnaire	1.0
SIp	substantia innominata pars posterior	1.0
TAP	tobacco acid pysophosphatase	0.5
TAP	tandem affinity purification	0.5
-6-di-O-sulfo-α-d-glucopyranoside	disodium salt	1.0
TAR	dna binding protein 43 (tdp-43)	0.333333333333
TAR	total antioxidant reactivity	0.666666666667
VaD	vascular dementia	1.0
TAD	stopological-associated domains	1.0
TAE	0.04m tris-acetate, 0.001m edta buffer	0.5
TAE	tilt after-effect	0.5
VIAAT	vesicular transporter for inhibitory amino acids	0.166666666667
VIAAT	vesicular amino acid transporter	0.166666666667
VIAAT	vesicular inhibitory amino acid transporter	0.666666666667
TAG	triacylglycerols	0.333333333333
TAG	terminal abdominal ganglion	0.666666666667
TAA	thioacetamide	1.0
TAB	tris–acetate-buffer	1.0
TAC	1	0.25
TAC	transit amplifying cell	0.25
TAC	tacrolimus	0.25
TAC	total antioxidant capacity	0.25
AVAF	anterior ventral auditory field	1.0
TAN	s	0.166666666667
TAN	stonically active neurons	0.333333333333
TAN	tonically active neuron	0.333333333333
TAN	nucleus tangentialis vestibularis	0.166666666667
DJ-	1	1.0
CTACas-Block	0.3% triton x-100, 0.3% sodium azide	1.0
TAK	1	0.333333333333
TAK	1tgfβ-activated kinase 1	0.333333333333
TAK	1tgf β-activated kinase 1	0.333333333333
late-LTP	late-phase ltp	1.0
MTNR	1bgene encoding the mt2 receptor	1.0
M-L	lateral to the midline	0.2
M-L	medial–lateral	0.2
M-L	medio-lateral	0.4
M-L	mediolateral	0.2
I-RISAI	mpairments in response inhibition and salience attribution	1.0
ATP-	sensitive potassium channels	1.0
STNAS	toned a protein	1.0
TA-	easy taskan easy version of tactile discrimination with auditory clues	1.0
v-ATP	asevacuolar h+-atpase	1.0
ORL-	1opioid receptor-like 1	0.2
ORL-	1opioid-like receptor-1	0.2
ORL-	1 receptor	0.2
ORL-	1opioid-like receptor 1 (see nopr)	0.2
ORL-	1opioid receptor like-1	0.2
Mmesocortex	posterior division	1.0
IfK	isk and ik, fast, slow and non-inactivating potassium currents, respectively	1.0
L-NILL-N	6-(1-iminoethyl)-lysine	1.0
GRβ	glucocorticoid receptor β isoform	1.0
PHD-	2prolyl hydroxylase-2	1.0
POP-	spikepopulation spike	1.0
cD	chronic dark	1.0
C2-dihydroceramide	dihydro-n-acetyl-d-erythro-shingosine	1.0
DAGLα	diacylglycerol lipase α	0.5
DAGLα	diacylglycerol lipase alpha	0.5
rDM	rostral dorsomedial dorsal raphe nucleus	1.0
cPAGvl	caudal ventrolateral periaqueductal gray	0.5
cPAGvl	caudal periaqueductal gray, ventrolateral sector	0.5
90R	10 min ischemia and 90 min reperfusion	1.0
90S	90 degree scattered light	1.0
pFC	prefrontal cortex	1.0
MMP11	matrix metalloproteinase-11	1.0
SKSKH	1-e	1.0
XCIX-	chromosome inactivation	1.0
C2-ceramide	n-acetyl-d-sphingosine	1.0
NIII	nervus oculomotorius	0.5
NIII	oculomotor nerve	0.5
TACETNF-	alpha converting enzyme	1.0
Glut	glutamate	1.0
rACC	rostral anterior cingulate	0.142857142857
rACC	rostral anterior cingulate cortex	0.571428571429
rACC	rostral acc	0.142857142857
rACC	/mofcrostro-ventral anterior cingulate cortex/medial orbitofrontal cortex	0.142857142857
rACA	rostral anterior cingulate cortex	1.0
ω-Aga-VIA	ω-agatoxin-via	1.0
DL-TBOADL-	threo-β-benzyloxyaspartic acid	1.0
GABA-AGABA	a receptor	0.333333333333
GABA-AGABA	receptor type a	0.333333333333
GABA-AGABA	receptor subtype a	0.333333333333
KBK	luver barrera	1.0
NSE-	2neuron-specific enolase	0.5
NSE-	neuronsneurons that demonstrated activity related to non-specific elements of the operant task	0.5
HETEH	ydroxyeicosatetraenoic acid	1.0
cocaine-MI	cocaine-methiodide	1.0
NF-	kbnuclear factor-kappa b	0.0526315789474
NF-	kappab	0.0526315789474
NF-	200neurofilament 200 kda	0.0526315789474
NF-	68neurofilament-68	0.0526315789474
NF-	200neurofilament 200	0.157894736842
NF-	kappab inhibitor alpha	0.0526315789474
NF-	kbnuclear factor-kb	0.0526315789474
NF-	kβnuclear factor kappa-light-chain-enhancer of activated beta cells	0.0526315789474
NF-	200high-molecular weight neurofilaments	0.0526315789474
NF-	200neurofilament-200	0.157894736842
NF-	68neurofilament 68 kda	0.0526315789474
NF-	kbnuclear factor kappa b	0.0526315789474
NF-	kbnuclear factor-kappab	0.0526315789474
NF-	kbnuclear factor kappab	0.0526315789474
NF-	200neurofilament of 200 kda	0.0526315789474
SNRP	stress non-responsive period	1.0
DKOα	γ-double knockout	1.0
ANGII	angiotensin ii	1.0
OIL	sesame oil	1.0
KBP	kainate-binding protein	1.0
MALDI-TOF	msmatrix-assisted laser desorption/ionization time-of-flight mass spectrometer	0.0555555555556
MALDI-TOF	matrix-assisted laser desorption/ionization time-of-flight mass spectrometry	0.0555555555556
MALDI-TOF	matrix-assisted laser desorption/ionization time-of-flight	0.111111111111
MALDI-TOF	matrix-assisted laser desorption/ionization-time of flight	0.166666666667
MALDI-TOF	/tofmatrix-assisted laser desorption/ionization time-of-flight/time-of-flight	0.0555555555556
MALDI-TOF	msmatrix-assisted laser desorption/ionization time-of-flight mass spectrometry	0.111111111111
MALDI-TOF	matrix-assisted laser desorption ionization time of flight mass spectrometry	0.111111111111
MALDI-TOF	matrix-assisted laser desorption/ionization-time-of-flight	0.111111111111
MALDI-TOF	matrix assisted laser desorption/ionization time-of-flight	0.111111111111
MALDI-TOF	msmatrix-assisted laser desorption ionization–time of flight mass spectrometry	0.0555555555556
MALDI-TOF	msmatrix-assisted laser desorption/ionization time-of- flight mass spectrometry	0.0555555555556
HC-	3hemicholinium-3	0.75
HC-	3[3h]hemicholinium-3	0.125
HC-	3hemicholinium	0.125
HCR	high-running capacity	1.0
HCS	2helix command neuron-specific 2	0.5
HCS	hypotonia–cystinuria syndrome	0.5
HCP	hippocampal cell proliferation	1.0
BCRP	breast cancer resistance protein	1.0
HCV	hepatitis c virus	1.0
NFB	normal folic acid with vitamin b12	0.5
NFB	normal feedback	0.5
RIMR	ab3a-interacting molecule	0.5
RIMR	ab3a interacting molecule	0.5
gV	trigeminal ganglia	0.5
gV	trigeminal ganglion	0.5
IGLE	sintraganglionic laminar endings	0.2
IGLE	intraganglionic laminar ending	0.8
NFM	neurofilament middle molecular subunit	0.166666666667
NFM	neurofilaments of medium molecular weight	0.166666666667
NFM	neurofilament medium	0.166666666667
NFM	neurofilament	0.166666666667
NFM	medium neurofilament subunit	0.166666666667
NFM	neurofilament m	0.166666666667
NFL	frontolateral nidopallium	0.0833333333333
NFL	light subunit of neurofilament	0.0416666666667
NFL	human neurofilament antibody	0.0416666666667
NFL	light neurofilament subunit	0.0833333333333
NFL	neurofilaments of light molecular weight	0.0416666666667
NFL	neurofilament light chain protein	0.0416666666667
NFL	neurofilament l	0.0416666666667
NFL	low-molecular-weight neurofilament subunit	0.0416666666667
NFL	nerve fiber layer	0.541666666667
NFL	neurofilament light	0.0416666666667
BLQ	below level of quantitation	1.0
BLP	parvicellular basolateral nucleus of amygdala	0.142857142857
BLP	posterior division of the abl	0.142857142857
BLP	basolateral amygdaloid nucleus, posterior part	0.142857142857
BLP	band-limited power	0.142857142857
BLP	basolateral amygdaloid nucleus (posterior)	0.142857142857
BLP	basolateral nucleus of the amygdala (posterior)	0.142857142857
BLP	bombesin-like peptide	0.142857142857
NFI	nuclear fluorescence intensity	1.0
AFA	astrocyte-free area	0.333333333333
AFA	lexa fluor	0.166666666667
AFA	lexafluor	0.166666666667
AFA	lexa fluor 488	0.166666666667
AFA	across-field advantage	0.166666666667
CHEPS	contact heat-evoked potential stimulator	1.0
HCC	home cage control	0.5
HCC	home cage controls	0.5
HCA	hierarchical cluster analysis	0.4
HCA	homocysteic acid	0.6
HCF	hippocampal formation	1.0
NFR	nuclear fast red	0.333333333333
NFR	normal frog ringer	0.666666666667
HCD	2-hydroxypropyl-β-cyclodextrin	1.0
NFP	neurofilament protein 200	0.5
NFP	neurofilament protein	0.5
BLD	bright light:dark	1.0
HCH	ippocampus	0.5
HCH	artwell center for bioinformatics	0.5
AFC	7-amino-4-trifluoromethyl coumarin	0.333333333333
AFC	alternative forced choice	0.333333333333
AFC	auditory fear conditioning	0.333333333333
HCN	channels	0.0571428571429
HCN	hyperpolarisation-activated nucleotide-gated channel	0.0285714285714
HCN	hyperpolarization-activated cyclic-nucleotide-gated cation non-selective	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotide modulated channel	0.0285714285714
HCN	hyperpolarization and cyclic nucleotide-gated	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotide-modulated channel	0.0285714285714
HCN	hyperpolarization activated cyclic nucleotide gated	0.0285714285714
HCN	hyperpolarization-activated, cyclic nucleotide-gated cation channel	0.0285714285714
HCN	4hyperpolarization-activated cyclic nucleotide-gated potassium channel 4	0.0285714285714
HCN	channel	0.0285714285714
HCN	hyperpolarization activated and cyclic nucleotide gated cation channels	0.0285714285714
HCN	4hyperpolarization-activated and cyclic nucleotide-gated channel 4	0.0285714285714
HCN	hyperpolarization-activated nonselective cation	0.0285714285714
HCN	channelshyperpolarization-activated cyclic nucleotide-gated cation channels	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotide-gated cation	0.0285714285714
HCN	4hyperpolarization-activated cyclic nucleotide-gated cation channel 4	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotide-gate	0.0285714285714
HCN	4hyperpolarization-activated cyclic nucleotide-gated channel 4	0.0285714285714
HCN	hyperpolarization-activated cation channel	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotide-gated channel	0.0571428571429
HCN	1hyperpolarization-activated cyclic nucleotide-gated non-selective cation channel subunit 1	0.0285714285714
HCN	hyperpolarization-activated cation current	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotide-gated non-selective cation channel	0.0285714285714
HCN	hyperpolarization and cyclic nucleotide gated	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotide-gated	0.142857142857
HCN	hyperpolarization-activated cationic channel	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotide-gated channels	0.0285714285714
HCN	hyperpolarization-activated cyclic-nucleotide-gated channel	0.0285714285714
HCN	hyperpolarization-activated cyclic nucleotid-gated cation	0.0285714285714
pGFP	green fluorescence protein-expressing plasmid	1.0
BLC	basolateral nuclear complex of the amygdala	0.666666666667
BLC	basolateral nuclear complex	0.222222222222
BLC	basolateral amygdalar nuclear complex	0.111111111111
HCM	hemicholinium-3 mustard	1.0
Apaf-1	apoptotic protease-activating factor-1	0.5
Apaf-1	apoptotic protease activating factor-1	0.5
MIP-	3αmacrophage inflammatory protein-3α	0.111111111111
MIP-	4macrophage inflammatory protein-4	0.111111111111
MIP-	1α	0.111111111111
MIP-	1αmacrophage inflammatory protein-1α	0.111111111111
MIP-	2macrophage inflammatory protein-2	0.333333333333
MIP-	2	0.111111111111
MIP-	2macrophage-inflammatory protein-2	0.111111111111
BLp	posterior subdivision of the basolateral amygdalar nucleus	1.0
GalR3	galanin-3 receptor	1.0
GalR2	galanin-2 receptor	1.0
GalR1	galanin-1 receptor	1.0
LBVL	ewy body variant	1.0
dhDSCT	dorsal spinocerebellar tract neurons located in dorsal horn	1.0
iAUC	insulin area under the curve	1.0
BLa	basolateral amygdaloid nucleus	0.333333333333
BLa	anterior subdivision of the basolateral amygdalar nucleus	0.666666666667
HCl	ph 8.0, 150 mm nacl, 0.2% tween-20	0.0434782608696
HCl	ph 7.5, 150 mm nacl, 0.05% v/v tween-20	0.0434782608696
HCl	137 mm nacl, ph 7.4	0.0434782608696
HCl	ph 7.6 and 150mm nacl, 0.1% tween-20	0.0434782608696
HCl	ph 7.5, 150mm nacl, 0.05% tween 20	0.0434782608696
HCl	ph 7.5, 0.15 m nacl, 0.05% tween-20	0.0434782608696
HCl	150mm nacl, 0.05% tween 20	0.0434782608696
HCl	150 mm nacl, ph 7.5, 0.05% tween-20	0.0434782608696
HCl	ph 7.4, 1.5% nacl	0.0434782608696
HCl	edta and egta	0.0434782608696
HCl	ph 7.4, 140 mm nacl and 0.1% v/v tween 20	0.0434782608696
HCl	(-)-(r)-2-[4-[[(3,4-dihydro-2h-1-benzopyran-2-yl)methyl]amino]	0.0434782608696
HCl	ph 7.4, 140 mm nacl	0.0434782608696
HCl	ph 8.0, 150 mm nacl, 0.2% tween-20	0.0434782608696
HCl	137 mm nacl and 0.05% tween-20 (ph 7.6)	0.0434782608696
HCl	133 mm nacl, and 0.2% tween 20	0.0434782608696
HCl	150 mm nacl, and 0.1% tween 20 plus 5% non-fat milk powder	0.0434782608696
HCl	ph 7.4, 1.5% nacl, 0.3% triton x-100	0.0434782608696
HCl	ph 7.5, 150 mm nacl, and 0.1% tween 20	0.0434782608696
HCl	0.9% nacl and 0.1% tween 20	0.0434782608696
HCl	ph 7.5, 150 mm nacl, 0.1% tween-20	0.0434782608696
HCl	ph 7.6), containing 0.1% tween-20	0.0434782608696
HCl	137 mm nacl, ph 7.4.	0.0434782608696
CHRD	chordin	1.0
srEMG	smoothed rectified emg	1.0
nPO	nucleus pontis oralis	1.0
TSC-	22	1.0
RH-BTXR	hodaminated α-bungarotoxin	1.0
LTVP	long-term vasopressin potentiation	1.0
nPE	non-pre-exposed condition	1.0
nPG	iparagigantocellular nucleus	0.166666666667
nPG	inucleus paragigantocellularis	0.833333333333
RBCR	ohon-beard cell	1.0
L-PHAP	haseolus vulgaris leukoagglutinating lectin	1.0
nor-BNI	norbinaltorphimine	0.117647058824
nor-BNI	nor-binaltorphimine dihydrochloride	0.176470588235
nor-BNI	nor-binaltorphimine	0.588235294118
nor-BNI	nor-binaltor phimine dihydrochloride	0.0588235294118
nor-BNI	dihclnorbinaltorphimine dihydrochloride	0.0588235294118
HEK293	human embryonic kidney 293	1.0
anti-H	ebbian learning	1.0
mRGC	smelanopsin-containing retinal ganglion cells	1.0
nPR	nucleus paramedianus reticularis	1.0
chemLTP	chemical long-term potentiation	1.0
NSAID	snon-steroidal anti-inflammatory drugs	0.222222222222
NSAID	non-steroidal anti-inflammatory drug	0.407407407407
NSAID	snonsteroidal antiinflammatory drugs	0.037037037037
NSAID	nonsteroidal anti-inflammatory drug	0.222222222222
NSAID	snonsteroidal anti-inflammatory drugs	0.111111111111
ADP-	ribose) polymers (par)	0.25
ADP-	ribose)	0.25
ADP-	ribose	0.25
ADP-	ribosylate	0.25
Nphe1	arg14,lys15]n/ofq-nh2	0.5
Nphe1	arg14,lys15]nociceptin/orphanin fq-nh2	0.5
LR-CLR-	control	1.0
IDAMGO	damgo-activated inwardly rectifying k+ current	1.0
MELODICM	ultivariate exploratory linear decomposition into independent components	1.0
HDLD	high-density lipoprotein	1.0
FM-	thetafrontal-midline theta	1.0
ISEL	in situ end labelling	0.2
ISEL	in situ end-labelling	0.6
ISEL	in situ end labeling	0.2
AXB-D	acid-adjusted extraction buffer without detergent	1.0
LTS	low-threshold spike	0.184210526316
LTS	low-threshold somatic calcium spike	0.0263157894737
LTS	low threshold spike	0.210526315789
LTS	low-threshold ca2+ spike	0.0263157894737
LTS	low-threshold ca2+-spike	0.0263157894737
LTS	low-threshold calcium spike	0.210526315789
LTS	low-threshold ca spike	0.0263157894737
LTS	low-threshold spiking	0.0263157894737
LTS	low threshold calcium spike	0.0789473684211
LTS	low-threshold spikes	0.0526315789474
LTS	low threshold ca2+ spike	0.0263157894737
LTS	neurons	0.0263157894737
LTS	low threshold spikes	0.0789473684211
LTR	long-terminal repeat sequences	0.166666666667
LTR	lateral triangles	0.166666666667
LTR	long terminal repeat	0.666666666667
LTP	long-term-potentiation	0.00240963855422
LTP	long-term probe trial	0.00120481927711
LTP	long-term synaptic potentiation	0.00361445783133
LTP	/ltdlong-term potentiation/depression	0.00120481927711
LTP	long-term potential	0.00120481927711
LTP	long term potentiation	0.0843373493976
LTP	long-term potentiation	0.902409638554
LTP	reversal	0.00120481927711
LTP	long-term potentiated	0.00120481927711
LTP	slow ltp	0.00120481927711
FMZ	flumazenil	1.0
scNR	spatial context not retrieved	1.0
DCF-DA	2′,7′-dichlorofluorescein diacetate	1.0
ADPA	fterdepolarization potential	0.5
ADPA	denosine diphosphate	0.5
CLUTG	lucose transporter	1.0
FMS	fibromyalgia syndrome	1.0
LEPR	leptin receptor	1.0
FMN	flavin mononucleotide	0.222222222222
FMN	facial motor nucleus	0.555555555556
FMN	,	0.111111111111
FMN	sfacial motoneurons	0.111111111111
LTB	4leukotriene b4	0.8
LTB	low threshold burst	0.2
LTA	lipoteichoic acid	0.666666666667
LTA	glarge t antigen	0.333333333333
L-SOS	l-serine-o-sulfate	1.0
LTF	long term facilitation	0.0833333333333
LTF	long-term facilitation	0.666666666667
LTF	lateral tegmental field	0.25
LTE	4leukotriene e4	1.0
LTD	ilong-term depression of inhibitory transmission	0.00315457413249
LTD	long-term diet	0.00315457413249
LTD	long-term depression	0.876971608833
LTD	long-term synaptic depression	0.00315457413249
LTD	4leukotriene d4	0.00315457413249
LTD	long term depression	0.0946372239748
LTD	glateral tegmental nucleus	0.00315457413249
LTD	/plong-term depression/potentiation	0.00315457413249
LTD	long-term-depression	0.00315457413249
LTD	glaterodorsal tegmental nucleus	0.00315457413249
LTD	histhistamine-mediated long-term depression	0.00315457413249
FMF	ugl-meyer scale	1.0
ASYNC	asynchrony	1.0
sGC	cytosolic/soluble guanylyl cyclase	0.037037037037
sGC	guanylyl cyclase	0.037037037037
sGC	soluble guanylyl cyclase	0.555555555556
sGC	soluble guanylate cyclase	0.37037037037
LTH	long-term hyperexcitability	1.0
FMC	free moving control	0.333333333333
FMC	free-moving control	0.666666666667
LTM	low-threshold mechanoreceptive	0.0243902439024
LTM	low-threshold mechanoreceptor	0.0731707317073
LTM	long-term memory	0.878048780488
LTM	low-threshold mechanosensitive primary afferent fiber/terminal	0.0243902439024
FMA	formaldehyde in methyl alcohol	1.0
VSM	velocity storage mechanism	1.0
SV2B	synaptic vesicle glycoprotein 2 b	1.0
pGNC	particulate guanylyl cyclase	1.0
TSCI	traumatic spinal cord injury	1.0
TABPT	ype a behavior pattern	1.0
5HTTLPR	serotonin transporter long polymorphic region	0.333333333333
5HTTLPR	5-ht transporter promoter polymorphism	0.333333333333
5HTTLPR	serotonin transporter-linked polymorphic region	0.333333333333
GGF-	2glial growth factor-2	1.0
NESP55	neuroendocrine secretory protein 55	0.5
NESP55	neuroendocrine secretory protein of mr 55 000	0.5
IP-S	alineintra-peritoneal saline	1.0
L-NNAN	ω-nitro-l-arginine	1.0
SP-IR	spinophilin-immunoreactive	1.0
-APV	d(l)-2-amino-5-phosphonovalerate	1.0
aFGF	acidic fibroblast growth factor	0.8
aFGF	acidic fibroblast growth factor (fgf-1)	0.2
CREBCAMP-	response element binding protein	1.0
iPC	ischemic preconditioning	1.0
UNESCU	niversidade do extremo sul catarinense	1.0
HUVEC	human umbilical vein endothelial cells	0.333333333333
HUVEC	human umbilical vein endothelial cell	0.666666666667
iPD	incidental pd	0.5
iPD	incidental parkinson’s disease	0.5
tsSV	40temperature-sensitive simian virus 40	1.0
iPL	inferior parietal lobe	1.0
Ob-Rb	leptin receptor long form	1.0
trkA-IgG	synthetic fusion protein (part of trka receptor fused to part of an immnuoglobulin)	1.0
U-SAL	untrained saline-control group	1.0
βAP	β-amyloid peptide	1.0
muIL-	1βmurine interleukin-1β	1.0
EHS	ethanol-home cage-saline	1.0
calpeptinN-	benzyloxylcarbonyl-leu-nle-aldehyde	1.0
CHOC	hinese hamster ovary cell	0.0344827586207
CHOC	hinese hamster ovary	0.965517241379
GiV	ventral subdivision of nucleus gigantocellularis	1.0
HIHS	heat-inactivated horse serum	1.0
CHOI	rradiated chinese hamster ovary	1.0
GPRG-	protein coupled receptors	1.0
STLBA	single-trial lba	1.0
PSLD	post hoc least significant difference	1.0
PP2B	protein phosphatase 2b	1.0
Panterior	central, posterior	1.0
PP2A	protein phosphatase 2a α catalytic subunit	0.333333333333
PP2A	protein phosphatase 2a	0.666666666667
R-ACSF	regular artificial cerebrospinal fluid	1.0
GUI	graphic user interface	1.0
ARX	aristaless-related homeobox gene	1.0
paO	2arterial partial oxygen	1.0
P50	positive auditory evoked potential with a latency to peak of approximately 50ms	1.0
SpR	nucleus suprarotundus	1.0
Tyr	tyrosine	1.0
GCt	substantia grisea centralis	1.0
UPSU	biquitin proteasome system	1.0
p-LC	peri-lc	1.0
hsp70mRNA	for 70 kda inducible heat shock protein	1.0
MWMAM	orris water maze apparatus	1.0
BTB	/pozbric-a-brac tramtrac broad complex/pox virus and zinc finger	0.5
BTB	/poz	0.5
CHO-	h5-ht1achinese hamster ovary cells stably expressing human recombinant 5-ht1a receptors	0.5
CHO-	cellschinese hamster ovary cells	0.5
RGABAA	receptor and glycine receptor	1.0
ACONT	control brainstem site anterior to substantia nigra pars reticulata	1.0
THDOC	tetrahydrodeoxy-corticosterone	0.1
THDOC	3α,21-dihydroxy-5α-pregnan-20-one	0.1
THDOC	allotetrahydrodeoxycorticosterone	0.5
THDOC	tetrahydrodeoxycorticosterone	0.3
HGPRT	hypoxanthine guanine phosphoribosyltransferase	1.0
P5P	pyridoxal-5′-phosphate	1.0
vLVN	ventral lateral vestibular nucleus	1.0
2-FDG	(14c)-2-fluoro-deoxyglucose	1.0
α1G	280-kda subunit of the t-type vdcc	1.0
OPro	orbital proisocortex (dysgranular cortex)	1.0
non-REMS	non-rapid eye movement sleep	1.0
α1B	230-kda subunit of the n-type vdcc	1.0
α1C	190–220-kda subunit of the l-type vdcc	1.0
HASH-	1human achaete-scute homologue 1	1.0
Sn-P	tin-protoporphyrin	1.0
1S3R-ACPD	(1s,3r)-1-aminocyclopentane-1,3-dicarboxylic acid	1.0
AHY	anterior hypothalamic nucleus	1.0
IFDI	nduced fit docking	1.0
DMSO	dimethylsulfoxide	0.277669902913
DMSO	dimethylsulfate	0.00194174757282
DMSO	dymethylsulfoxide	0.00194174757282
DMSO	dimethyl sulfoxide	0.566990291262
DMSO	dimethy sulfoxide	0.00194174757282
DMSO	dimethysulfoxide	0.00388349514563
DMSO	dimethyl-sulfoxide	0.00776699029126
DMSO	dimethylsulphoxide	0.0970873786408
DMSO	dimethyl suphoxide	0.00194174757282
DMSO	dimethyl sulphoxide	0.0349514563107
DMSO	dimethyl sulfoscide	0.00194174757282
DMSO	dimethylsulfoxyde	0.00194174757282
SA-β-	galsenescence association β-galactosidase	1.0
NCr	wistar kyoto rat with congenital heart disease, normotensive and chronically hypoxic	1.0
2R4R-APDC	(2r,4r)-4-aminopyrrolidine-2,4-dicarboxylate	1.0
FOS-LI	fos-like immunoreactivity	1.0
R-VR	ice-vannucci	1.0
lyso-PLD	lysophospholipase d	1.0
RP-HPLC	reverse-phase high-performance liquid chromatography	0.333333333333
RP-HPLC	reverse phase high performance liquid chromatography	0.166666666667
RP-HPLC	reverse-phase high pressure liquid chromatography	0.166666666667
RP-HPLC	reverse phase-high performance liquid chromatography	0.166666666667
RP-HPLC	reversed phase-high performance liquid chromatography	0.166666666667
ANOVA	2two-way analysis of variance	0.000423190859077
ANOVA	analysis of varience	0.000423190859077
ANOVA	analysis-of-variance	0.000846381718155
ANOVA	factor analysis of variance	0.000423190859077
ANOVA	one-way analysis of variance	0.00592467202708
ANOVA	analysis of variances	0.00211595429539
ANOVA	sanalysis of variance	0.000423190859077
ANOVA	one way analysis of variance	0.00126957257723
ANOVA	variance analysis	0.000423190859077
ANOVA	sanalysis of variances	0.000423190859077
ANOVA	analysis of variation	0.000846381718155
ANOVA	sanalyses of variance	0.00126957257723
ANOVA	repeated measure of analysis of variance	0.000423190859077
ANOVA	one-way or two-way analysis of variance	0.000423190859077
ANOVA	two-ways analysis of variance	0.000423190859077
ANOVA	measures analysis of variance	0.000423190859077
ANOVA	analysis of variants	0.000423190859077
ANOVA	(s)analyse(s) of variance	0.000423190859077
ANOVA	analysis of variance test	0.00126957257723
ANOVA	sanalyses of variances	0.000423190859077
ANOVA	(multivariate) analysis of variance	0.000423190859077
ANOVA	analysis of variance	0.972069403301
ANOVA	analyses of variance	0.00846381718155
hGAT-1	human gaba transporter-1	1.0
PRX-	1peroxiredoxin 1	1.0
VTRZ	visual tegmental relay zone	1.0
SERCA	sarco/endoplasmic reticulum calcium atpase	0.0588235294118
SERCA	2bsarco/endoplasmic reticulum calcium atpase 2b	0.0588235294118
SERCA	sarco-endoplasmic reticulum ca2+-atpase	0.0588235294118
SERCA	sarcoplasmic-endoplasmic reticulum calcium atpase	0.0588235294118
SERCA	sarcoplasmic/endoplasmic reticulum ca2+-atpase	0.117647058824
SERCA	endoplasmic/sarcoplasmic reticulum atpase	0.0588235294118
SERCA	iianti-sarcoplasmic reticulum ca2+-atpase	0.0588235294118
SERCA	sarco(endo)plasmic reticulum ca2+-atpase	0.0588235294118
SERCA	sarcoendoplasmic reticulum ca2+-atpase	0.0588235294118
SERCA	2sarco/endoplasmic reticulum ca2+-atpase	0.0588235294118
SERCA	sarcoplasmatic reticulum/endoplasmic reticulum calcium atpase	0.0588235294118
SERCA	ssarco/endoplasmic reticulum ca2+ atpases	0.0588235294118
SERCA	sarco(endo)plasmic reticulum ca2+ atpase	0.0588235294118
SERCA	sarcoendoplasmic reticulum ca2+atpase	0.0588235294118
SERCA	sarcoplasmic/endoplasmic ca2+ pump	0.0588235294118
SERCA	atpaseendoplasmic reticulum ca2+ atpase	0.0588235294118
DAB3	3’-diaminobenzidine tetrahydrochloride	0.00675675675676
DAB3	3-diaminobenzidine-4hcl	0.00337837837838
DAB3	3′-diaminobenzidine tetra-hcl	0.00337837837838
DAB3	3'-diaminobenzidine hydrochloride	0.00337837837838
DAB3	3-diaminobenzidine tetrahydrochlorideβ	0.00337837837838
DAB3	3-diaminobenzidine	0.0675675675676
DAB3	3′-diamino-benzidine	0.00337837837838
DAB3	3′-diaminobenzidine-tetrahydrochloride	0.00675675675676
DAB3	3′ diaminobenzidine tetrahydrochloride	0.0101351351351
DAB3	3′-diaminobenzidine-4hcl	0.0135135135135
DAB3	3′-tetrachloride diaminobenzidine	0.00337837837838
DAB3	3' diaminobenzidine tetrahydrochloride	0.00337837837838
DAB3	3′- diaminobenzidine	0.00675675675676
DAB3	3′-diaminobenzidine 4hcl	0.00337837837838
DAB3	3’-diaminobenzidine	0.00337837837838
DAB3	3-diamino-benzidine-tetrahydrochloride	0.00337837837838
DAB3	3′-diaminobenzidine-4 hcl	0.00337837837838
DAB3	3′diaminobenzidine tetrahydrochloride	0.00675675675676
DAB3	3-diaminobenzidine-tetrahydrochloride	0.0101351351351
DAB3	3′-diaminobenzidine	0.486486486486
DAB3	3′ diaminobenzidine	0.0168918918919
DAB3	3′-diaminobenzidine-tetra hcl	0.00337837837838
DAB3	3′diaminobenzidine	0.0168918918919
DAB3	3′-diaminobenzidine hydrochloride	0.00675675675676
DAB3	3′,-diaminobenzidine tetrahydrochloride	0.00337837837838
DAB3	3-diaminobenzidin	0.00337837837838
DAB3	3,diaminobenzidine tetrahydrochloride	0.00337837837838
DAB3	3′-diaminobenzidine-tetrahydrochloride 4 hcl	0.00337837837838
DAB3	3′-diaminobenzidine-hydrochloride	0.00337837837838
DAB3	3 diaminobenzidine	0.00337837837838
DAB3	3-diaminibenzidine tetrahydrochloride	0.00337837837838
DAB3	3′-diaminobenzadine	0.00675675675676
DAB3	3-diaminobenzidine hydrochloride	0.00337837837838
DAB3	3 diaminobenzidine chromogen	0.00337837837838
DAB3	3'-diaminobenzidine	0.0168918918919
DAB3	3′-diaminobenzidine tetrahydrochloride	0.179054054054
DAB3	3′-diaminobenzidine tetrachloride	0.0101351351351
DAB3	3-diaminobenzidine tetrahydrochloride	0.0439189189189
DAB3	3′-diaminobenzidene	0.00675675675676
DAB3	3′-diaminobenzidine tetrahydrachloride	0.00337837837838
DAB3	3′-diaminobenzidine chromogen solution	0.00337837837838
DAB3	3-diaminobenzedine	0.00337837837838
DAB2	3,3′-diaminobenzidine tetrahydrochloride	0.333333333333
DAB2	4-diaminobutyric acid	0.333333333333
DAB2	2-diaminobenzidine	0.333333333333
DAB1	4-dideoxy-1,4-imino-d-arabinitol	0.5
DAB1	4-deoxy-1,4-imino-d-arabinitol	0.5
CSFB	choroid plexus–csf barrier	1.0
PABS	pattern a behavior scale	1.0
lICN	lateral intercalated nucleus	1.0
PABP	poly(a)-binding protein	0.5
PABP	poly-adenylated mrna binding protein	0.5
sAPPαα-	cleaved soluble β-amyloid precursor protein	1.0
CCK-IR	cholecystokinin-immunoreactive	1.0
Nmorphine-treated	naloxone-challenged animals	1.0
SMTCS-	methyl-l-thiocitrulline	1.0
AMAC-	1alternative macrophage activation-associated cc chemokine-1	1.0
EASTepilepsy	ataxia, sensorrineural deafness, and tubulopathy.	1.0
AFDX	11-[[2-[(diethylamino)methyl]-1-piperidinyl]	0.333333333333
AFDX	384n-[2-[2-[(dipropylamino)methyl]-1-piperidinyl]	0.333333333333
AFDX	384	0.333333333333
SEPT	4septin 4	1.0
SD-A	splice donor–acceptor	1.0
2P	two pairs of conditioning sessions	0.5
2P	domain k+ channel	0.5
2R	4r)-5-[2-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]	0.0833333333333
2R	4r)-4-aminopyrrolidine-2,4-dicarboxylic acid	0.0833333333333
2R	4r-apdc, 2r,4r-aminopyrrolidine-2,4-dicarboxylate	0.0833333333333
2R	4r)-apdc, (2r,4r)-4-aminopyrrolidine-2,4-dicarboxylate	0.166666666667
2R	4r-apdc, 2r,4r-4-aminopyrrolidine-2,4-dicarboxylate	0.0833333333333
2R	4r)-4-aminopyrrolidine-2,4-dicarboxylate, group ii agonist	0.0833333333333
2R	orexin- 1/2 receptors	0.0833333333333
2R	4r)-apdc(2r,4r)-4-amino-pyrrolidine-2,4-dicarboxylate	0.0833333333333
2R	4r)-4-aminopyrrolidine-2,4-dicarboxylate	0.25
2S	5r)-4-allyl-2,5-dimethylpiperazin-1-yl](3-methoxyphenyl)methyl]	0.0454545454545
2S	3s,4s)-α-(carboxycyclopropyl)-glycine	0.0454545454545
2S	5r)-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxy-benzyl]-n–n-diethylbenzamide	0.0454545454545
2S	5r)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-n,n-diethylbenzamide	0.0454545454545
2S	3s,4s)-ccg/(2s,1's,2's)-2-(carboxycyclopropyl)-glycine	0.0454545454545
2S	1′r,2′r,3′r)-2-(2,3-dicarboxycyclopropyl)-glycine	0.0454545454545
2S	2′r,3′r)-2-(2′,3′-dicarboxycyclopropyl)-glycine	0.0454545454545
2S	2′r,3′r)-2-(2′,3′-dicarboxycyclopropyl)glycine	0.363636363636
2S	3s,4s)-α-(carboxycyclopropyl)glycine)	0.0454545454545
2S	3s,4s)-ccg/(2s, 1′s,2′s)-2-(carboxycyclopropyl)glycine	0.0454545454545
2S	4r)-4-methylglutamic acid	0.0454545454545
2S	1′s,2′s)-2-(carboxycyclopropyl)glycine	0.0909090909091
2S	2′r,3′r)-2-(2′,3′-dicarboxycyclopropyl) glycine	0.0454545454545
2S	5r)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-n,n-diethylbenzamide	0.0454545454545
CPFchlorpyrifos	o,o-diethyl o-3,5,6-trichloro-2-pyridinyl phosphorothioate	1.0
2D	2 dimensions	0.0526315789474
2D	bi-dimensional	0.0526315789474
2D	two-dimensional	0.526315789474
2D	two dimensional	0.105263157895
2D	two-dimension	0.0526315789474
2D	digetwo dimensional difference in gel electrophoresis	0.0526315789474
2D	2-dimensional	0.0526315789474
2D	western blotting	0.0526315789474
2D	bidimensional	0.0526315789474
IHCI	mmunohistochemistry	1.0
2A	mouse neuroblastoma 2a cells	0.333333333333
2A	(sv2a)	0.333333333333
2A	receptors	0.333333333333
2B	calcineurin	1.0
CBTC	orsi block-tapping test	1.0
2M	e-satp2-methylthio-atp	0.25
2M	esadp2-methylthioadenosine 5′-diphosphate	0.25
2M	esatp2-methylthio atp	0.25
2M	esatp2-methylthioadenosine-5′-triphosphate	0.25
LacZ	adenovirus encoding β-galactosidase	0.5
LacZ	lactose operon gene encoding beta-galactosidase	0.5
PENA	pelvic efferent nerve activity	1.0
spOD	specific optical density	1.0
rhG-CSF	recombinant human granulocyte colony-stimulating factor	0.5
rhG-CSF	recombinant human g-csf	0.5
NTScom	commissural part of nts	1.0
LAI	large aspiny cholinergic interneuron	0.5
LAI	left anterior insula	0.5
OcNC1	olfactory cyclic nucleotide-gated channel	1.0
HAFD	high-amplitude and frequency discharge	0.75
HAFD	high-amplitude and -frequency discharge	0.25
MASH-	1mammalian achaete-scute homologue 1	1.0
PWS-ICPWS	imprinting center	1.0
PDMP	threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol	0.5
PDMP	d-threo-1-phenyl-2-decanoylamin-3-morpholinopropanol	0.5
TMR-DA	tetramethylrhodamine-conjugated dextran amine	0.333333333333
TMR-DA	tetramethyl rhodamine dextran	0.333333333333
TMR-DA	tetramethylrhodamine-dextran amine	0.333333333333
DABD	aminobenzidine	1.0
HMG-CR	3-hydroxy-3-methyl-glutaryl coa reductase	1.0
CSF-	ccerebrospinal fluid-contacting	1.0
SgII	secretogranin ii	1.0
d-NAME	nω-nitro-d-arginine methyl ester	0.5
d-NAME	d-ng-nitro-arginine methyl ester	0.5
UDSU	p–down state	1.0
MNCV	motor nerve conduction velocity	1.0
t-SNARE	target soluble n-ethyl maleimide-sensitive fusion protein attachment protein receptor	0.333333333333
t-SNARE	target-membrane snare	0.333333333333
t-SNARE	target-associated snare	0.333333333333
OSMRββ	subunit of oncostatin m receptor	1.0
18F-FMZ-PET	18f-flumazenil pet	1.0
SELDI	surface-enhanced laser desorption/ionization	1.0
DTXα-	dendrotoxin	1.0
LAA	l-α-aminoadipate	1.0
AChe	acetylcholinesterase	1.0
DMPX3	7-dimethyl-1-propargylxanthine	0.4
DMPX3	7-dimethyl-1-propargyl xanthine	0.2
DMPX3	7-dimethyl1-propargylxanthine	0.2
DMPX3	7-dimethyl-1-(2-propynyl) xanthine	0.2
HHBSS	hepes-buffered hanks' balanced salt sodium	0.333333333333
HHBSS	hepes hanks balanced saline solution	0.333333333333
HHBSS	hepes-buffered hank's balanced salt solution	0.333333333333
SPFS-	phase cell fraction	1.0
E-	box	0.142857142857
E-	decexpiratory-decrementing	0.142857142857
E-	faceextraplasmic fracture face	0.142857142857
E-	aloneestrogen-containing hormone therapy unopposed by progestin	0.142857142857
E-	faceextraplasmic leaflet	0.142857142857
E-	selectinendothelial leukocyte adhesion molecule 1	0.142857142857
E-	4031n-[4-[[1-[2-(6-methyl-2-pyridinyl)ethyl]-4-piperidinyl]	0.142857142857
RMLR	ocky mountain laboratories	1.0
LGUR	local glucose utilization rates	1.0
GATGABA	transporter	1.0
d-CPP	3-((r)-2-carboxypiperazin-4-yl)-propyl-phosphonic acid	1.0
LSAA	limbic system associated areas	1.0
LSAB	labeled streptavidin biotin	1.0
CS-BC	ockayne syndrome complementation group b cell line or patient	1.0
FFM	form-from-motion	1.0
PFGE	pulsed-field gel electrophoresis	1.0
1400WN-	(3-[aminomethyl]benzyl)acetamidine	0.5
1400WN-	[(3-(aminomethyl)-phenyl]methyl]	0.5
mEPSP	miniature excitatory postsynaptic potential	0.333333333333
mEPSP	miniature epsp	0.333333333333
mEPSP	sminiature excitatory postsynaptic potentials	0.333333333333
SPantagonist	[d-pro4,d-trp7,9]-substance p(4–11)	1.0
GATN	a+-gaba	1.0
E9	deletion of exon 9	0.5
E9	presenilin-1 exon 9 deletion	0.5
E8	embryonic day 8	1.0
nOBXN	eonatal bilateral ablation of the olfactory bulbs	1.0
PRESS	point resolved spectroscopy	1.0
E4	nse-apoe3 and nse-apoe4 homozygous mice	1.0
SPTg	subpeduncular tegmental nucleus	1.0
E1	embryonic day 1	0.5
E1	estrone	0.5
E2	17-β-estradiol	0.153846153846
E2	estradiol	0.230769230769
E2	17β-estradiol	0.615384615385
EM	bed 812epichlorohydrin epoxin resin for embedding	0.008
EM	electron microscopy	0.68
EM	eye-movement	0.008
EM	endomorphin	0.024
EM	electron micrograph	0.008
EM	electron microscope or microscopy	0.024
EM	2endomorphin 2	0.008
EM	episodic memory	0.008
EM	eye movement	0.016
EM	2-ipem2-immunopositive	0.008
EM	electron microscopy/electron microscope	0.016
EM	electron microscopic	0.08
EM	transmission electron microscopy	0.008
EM	electron-microscopy	0.008
EM	expectation–maximum	0.008
EM	electron microscope	0.072
EM	endogenous morphine	0.008
EM	ectopic mount	0.008
EL	latency to ejaculation	0.142857142857
EL	electrolytically lesioned	0.142857142857
EL	ejaculation latency	0.285714285714
EL	ependymal layer	0.142857142857
EL	endosomal-lysosomal	0.142857142857
EL	enriched lesioned group	0.142857142857
EO	entorhinal cortex, olfactory subfield	0.0666666666667
EO	eyes open	0.533333333333
EO	eye-only	0.0666666666667
EO	electric organ	0.0666666666667
EO	excitatory–no response	0.0666666666667
EO	/iexhibiting binaural suppressive interactions	0.0666666666667
EO	external abdominal oblique	0.0666666666667
EO	eyes open situation	0.0666666666667
EN	acepithelial sodium channel	0.333333333333
EN	acepithelial na+ channel	0.0666666666667
EN	entorhinal cortex	0.0666666666667
EN	acepithelia na+ channel	0.0666666666667
EN	endopiriform nucleus	0.333333333333
EN	entrance phase of hibernators	0.0666666666667
EN	ac/deg/asicepithelial na channel/degenerin/acid sensing ion channel	0.0666666666667
EI	expiratory–inspiratory phase spanning	0.111111111111
EI	emotional intelligence	0.111111111111
EI	entorhinal cortex, intermediate subfield	0.111111111111
EI	early weaning/social isolation	0.111111111111
EI	experimentally infected	0.111111111111
EI	efficacy index	0.111111111111
EI	excitatory–inhibitory binaural interaction	0.111111111111
EI	excitatory–inhibitory	0.111111111111
EI	extinction index	0.111111111111
EH	eye-head	0.125
EH	early handling	0.25
EH	epoxide hydrolase	0.125
EH	endolymphatic hydrops	0.125
EH	enucleated hamsters	0.125
EH	eye–head	0.125
EH	proton equilibrium potential	0.125
EK	equilibrium potential for k+ ions	0.2
EK	k+ reversal potential	0.2
EK	equilibrium potential for k+	0.2
EK	sendokinins	0.2
EK	equilibrium potential	0.2
OrbCx	orbitofrontal cortex	1.0
EE	energy expenditure	0.0333333333333
EE	excitatory–excitatory	0.0333333333333
EE	enriched environment	0.533333333333
EE	cellsectopic ependymal cells	0.0333333333333
EE	environmental enrichment	0.266666666667
EE	217α-ethynyl-estradiol	0.0333333333333
EE	erectile event	0.0333333333333
EE	enriched environments	0.0333333333333
ED	50effective dose that produce seizure protection in 50% of animals	0.02
ED	18.5embryonic day 18.5	0.02
ED	1ectodermal dysplasia 1	0.02
ED	electrochemical detection	0.02
ED	emergency department	0.02
ED	50median effective dose	0.08
ED	50effective dose 50%	0.02
ED	1+ed1-positive activated macrophages	0.02
ED	esophageal distension	0.04
ED	high-performance liquid chromatography with electrochemical detection	0.02
ED	1	0.06
ED	sembryonic days	0.02
ED	extra-dimensional shift	0.02
ED	echo duration	0.02
ED	embryonic day	0.26
ED	effective dose	0.02
ED	ethanol (6.5%, v:v) diet	0.02
ED	2extensor digitorum communis (2nd finger)	0.02
ED	escalating dose/s	0.02
ED	high-performance liquid chromatography–electrochemical detection	0.02
ED	intradimensional/extradimensional	0.02
ED	early diestrus	0.02
ED	extradimensional shift	0.02
ED	30effective dose 30	0.02
ED	extradimensional	0.04
ED	evoked discharge	0.02
ED	estimated displacement	0.02
ED	ear-down	0.04
ED	epileptiform discharge	0.02
ED	day of embryonic development	0.02
EG	bextract of ginkgo biloba	0.1
EG	aanterior eminentia granularis	0.1
EG	b 761	0.3
EG	eicosenoyl glycerol	0.1
EG	eminentia granularis	0.1
EG	bextract of gingko biloba	0.1
EG	externally guided	0.2
EF	ejaculation frequency	0.153846153846
EF	efferent fiber	0.0769230769231
EF	1aelongation factor 1-alpha	0.0769230769231
EF	earth fixed	0.0769230769231
EF	evoked firing	0.0769230769231
EF	/b–ef/bef/b continuing on ef/b after delivery	0.0769230769231
EF	hand	0.0769230769231
EF	epifascicular nucleus	0.0769230769231
EF	5	0.0769230769231
EF	executive functions	0.0769230769231
EF	1α promoter	0.0769230769231
EF	50effective force (g) to produce a 50% response frequency	0.0769230769231
EA	egg albumin	0.08
EA	experimenter-administered electrical stimulation	0.04
EA	entorhinal area	0.04
EA	ccentral extended amygdala	0.04
EA	electroacupuncture	0.24
EA	electro-acupuncture	0.04
EA	1episodic ataxia type 1	0.04
EA	evoked activity	0.08
EA	ethyl acetate	0.04
EA	2episodic ataxia type 2	0.12
EA	ethacrynic acid	0.08
EA	extended amygdala	0.04
EA	cis-11-eicosenoic acid	0.04
EA	epileptiform activity	0.04
EA	equivalent attenuation	0.04
GAT1	gaba transporter type 1	1.0
EC	endothelial cell	0.00448430493274
EC	50effective concentration for half-maximal response	0.00448430493274
EC	electrochemical detection	0.00448430493274
EC	50concentration of glycine producing half-maximal response	0.00448430493274
EC	50concentration producing 50% maximal depolarization	0.00448430493274
EC	ogelectrocorticography	0.00448430493274
EC	extracellular	0.00896860986547
EC	l-equilibrium potential for chloride	0.00448430493274
EC	eyes closed situation	0.00448430493274
EC	embryonal carcinoma	0.00896860986547
EC	50half-maximal response	0.00448430493274
EC	lchloride reversal potential	0.00448430493274
EC	energy charge	0.00896860986547
EC	high-pressure liquid chromatography with electrochemical detection	0.00448430493274
EC	exercise/control	0.00448430493274
EC	resting with eyes closed	0.00448430493274
EC	environmental complexity	0.00896860986547
EC	50concentration producing 50% maximal response	0.00448430493274
EC	50effective concentration producing half-maximal response	0.0134529147982
EC	extradural compression	0.00448430493274
EC	complex environment	0.00448430493274
EC	sefferent cells	0.00448430493274
EC	50agonist concentration inducing half-maximal response	0.0134529147982
EC	50intrinsic activity	0.00448430493274
EC	endothelial cells	0.0224215246637
EC	enriched housing condition	0.00448430493274
EC	elderly control	0.00448430493274
EC	sendothelial cells	0.0269058295964
EC	50effective concentration required for half-maximal activation	0.00448430493274
EC	external capsule	0.0358744394619
EC	cellsembryonic carcinoma cells	0.00448430493274
EC	electro detection	0.00448430493274
EC	50effective concentration for half-maximal effect	0.00448430493274
EC	5050% effective concentration	0.00896860986547
EC	dendothelial cell density	0.00448430493274
EC	50 valueconcentration of drug producing 50% of the maximum effect	0.00896860986547
EC	high-performance liquid chromatography/electrochemical detection	0.00448430493274
EC	50estimated dose for 50% cell survival	0.00448430493274
EC	eriochrome cyanine	0.00896860986547
EC	exercise control group	0.00448430493274
EC	ogelectrocorticogram	0.0627802690583
EC	uexternal cuneate nucleus	0.0269058295964
EC	50agonist concentration producing a half-maximal response	0.00896860986547
EC	entorhinal cortex, caudal subfield	0.00448430493274
EC	ogelectrocorticogram/electrocorticographic	0.00448430493274
EC	50half of the effective concentration	0.00448430493274
EC	50drug concentration causing 50% of maximal effect	0.00448430493274
EC	ogcortical electroencephalography	0.00448430493274
EC	50concentration of nmda that produced a half-maximal response	0.00448430493274
EC	50effective concentration to inhibit 50% of function	0.00448430493274
EC	50effective concentration of agonist to produce 50% of maximal response	0.00448430493274
EC	50concentration of pregnenolone sulfate that produced 50% potentiation	0.00448430493274
EC	enriched control group	0.00448430493274
EC	embryonic carcinoma	0.00448430493274
EC	50mean effective dose	0.00448430493274
EC	50effective concentration 50	0.00448430493274
EC	50half effective concentration	0.00448430493274
EC	enriched condition	0.00896860986547
EC	lreversal potentials for cl-	0.00448430493274
EC	ensheathing cell	0.00448430493274
EC	uexternal cuneate	0.00448430493274
EC	lcl- equilibrium potential	0.00896860986547
EC	50effective dose for 50% of the response	0.00448430493274
EC	50concentration eliciting 50% of the maximal response	0.00448430493274
EC	3.4.14.10	0.00448430493274
EC	enriched housing conditions	0.00448430493274
EC	50half-excitatory concentration	0.00448430493274
EC	50half maximal effect	0.00448430493274
EC	50effective concentration of drug for 50% of the increase	0.00448430493274
EC	lreversal potential of chloride	0.00448430493274
EC	neffective doses that evoked n% of maximal or control current generated by gaba for each individual cell	0.00448430493274
EC	electrochemical	0.00448430493274
EC	early component	0.00448430493274
EC	50effective concentration for 50% of response	0.00896860986547
EC	enterochromafiin	0.00448430493274
EC	ectodomain	0.00896860986547
EC	high-performance liquid chromatography with electrochemical detection	0.00896860986547
EC	lchloride equilibrium potential	0.00448430493274
EC	electrode control	0.00448430493274
EC	+feyes closed standing on a foam	0.00448430493274
EC	50half maximal effective concentration	0.0134529147982
EC	50effective concentration for half of the maximal effect	0.00448430493274
EC	5050% excitatory concentration	0.00448430493274
EC	50concentration of gaba that gives 50% of its maximal effect	0.00448430493274
EC	endocannabinoid	0.00448430493274
EC	adenylate energy charge	0.00448430493274
EC	5050% of the maximum response	0.00448430493274
EC	enterochromaffin	0.00448430493274
EC	50half-effective concentration	0.00448430493274
EC	50half-maximal effective concentration	0.00448430493274
EC	(-)-epicatechin	0.00448430493274
EC	entorhinal cortex	0.313901345291
EC	eyes closed	0.0313901345291
EC	areversal potential for ica	0.00448430493274
EC	estrous cycle	0.00448430493274
EB	embyoid body	0.0212765957447
EB	estradiol benzoate	0.489361702128
EB	17-β-estradiol 3-benzoate	0.0212765957447
EB	17β-estradiol 3-benzoate	0.0212765957447
EB	estradiol–benzoate	0.0212765957447
EB	gbackground excitation	0.0212765957447
EB	β-estradiol-3-benzoate	0.0212765957447
EB	early blind	0.0212765957447
EB	ethidium bromide	0.106382978723
EB	embryoid bodies	0.0425531914894
EB	essential blepharospasm	0.0212765957447
EB	17β-estradiol benzoate	0.0212765957447
EB	send-binding proteins	0.0212765957447
EB	end-binding protein	0.0212765957447
EB	sembryoid bodies	0.0425531914894
EB	ellipsoid body	0.0425531914894
EB	estradiol-treated ovariectomized	0.0212765957447
EB	embryonic body	0.0212765957447
GAT-	1vesicular gaba transporter 1	0.142857142857
GAT-	1glutamic acid transporter-1	0.142857142857
GAT-	1gaba transporter-1	0.285714285714
GAT-	2γ-amino butyric acid transporter 2	0.142857142857
GAT-	3plasma membrane gaba transporter 3	0.142857142857
GAT-	3glial gaba transporter	0.142857142857
Unc	uncoordinated	1.0
EX	exercise control	0.166666666667
EX	excitation filter	0.166666666667
EX	exercise group	0.333333333333
EX	exercise	0.333333333333
FFF	ano factor	1.0
EU	ear-up	0.5
EU	euthermic phase of hibernators	0.25
EU	endotoxin unit	0.25
ET	electroacupuncture therapy	0.027027027027
ET	rbendothelin receptor b	0.027027027027
ET	endothelin receptor	0.027027027027
ET	external tufted cell	0.027027027027
ET	estrogen therapy	0.0810810810811
ET	exercise/tpa-stop	0.027027027027
ET	sendothelins	0.027027027027
ET	endotoxin	0.0810810810811
ET	endothelin	0.405405405405
ET	etomidate	0.027027027027
ET	ethanol-treated	0.027027027027
ET	cellexternal tufted cell	0.027027027027
ET	epithalamus	0.027027027027
ET	essential tremor	0.027027027027
ET	external tufted	0.108108108108
ET	each time	0.027027027027
EW	ethanol withdrawal	0.166666666667
EW	pgedinger–westphal nucleus (preganglionic neurons)	0.166666666667
EW	cpcentral projecting edinger-westphal nucleus	0.166666666667
EW	edinger–westphal nucleus	0.5
EV	empty pcs2+ vector	0.5
EV	eye velocity	0.5
EQ	empathizing quotient	0.5
EQ	encephalization quotient	0.5
EP	ependymal layer	0.0113636363636
EP	endopiriform nucleus	0.0113636363636
EP	sevoked potentials	0.0340909090909
EP	lexternal plexiform layer of the ob	0.0113636363636
EP	3rep3 receptor	0.0113636363636
EP	receptor	0.0113636363636
EP	2prostaglandin e2 receptor	0.0113636363636
EP	endplate-enriched muscle region	0.0113636363636
EP	3 receptors	0.0113636363636
EP	e-subtype prostaglandin receptor	0.0113636363636
EP	prostaglandin e receptor subtype	0.0113636363636
EP	field potential	0.0113636363636
EP	2electrode position 2	0.0113636363636
EP	ethyl pyruvate	0.0340909090909
EP	estrogen and progesterone	0.0113636363636
EP	evoked field potential	0.0227272727273
EP	eeye position error	0.0113636363636
EP	pineal gland	0.0113636363636
EP	evoked potential	0.147727272727
EP	2e-prostanoid receptor 2	0.0113636363636
EP	lexternal plexiform layer	0.0113636363636
EP	endogenous pacemakers	0.0113636363636
EP	lexternal plexiform layer ob	0.0113636363636
EP	excitatory peak	0.0113636363636
EP	empty plasmid	0.0113636363636
EP	equatorial photoperiod	0.0113636363636
EP	lexternal plexiform layer of the olfactory bulb	0.0227272727273
EP	prostaglandin type e	0.0113636363636
EP	enriched porsolt	0.0113636363636
EP	endocochlear potential	0.0909090909091
EP	receptorprostaglandin e2 receptor	0.0113636363636
EP	explicitly paired training	0.0113636363636
EP	eye position	0.0227272727273
EP	elderly subjects with expressed presbycusis	0.0113636363636
EP	early progressive	0.0113636363636
EP	endolymphatic potential	0.0113636363636
EP	endoperoxide receptor	0.0113636363636
EP	24.15endopeptidase ec 24.15	0.0227272727273
EP	1prostaglandin e receptor 1	0.0113636363636
EP	entopeduncular nucleus	0.238636363636
EP	iaexternal plexiform layer of the accessory olfactory bulb	0.0113636363636
ES	escapable shock	0.047619047619
ES	cellsembryonic stem cells	0.031746031746
ES	equilibrium score	0.031746031746
ES	ynequilibrium potential for acetylcholine action	0.015873015873
ES	cellembryonic stem cell	0.015873015873
ES	electrospray	0.015873015873
ES	estrogen	0.015873015873
ES	extracellular space	0.015873015873
ES	epidermal stimulation	0.015873015873
ES	electric shock	0.015873015873
ES	extrasynaptic	0.015873015873
ES	experience seeking scale of the sss-v	0.015873015873
ES	embryonic stem	0.253968253968
ES	ierector spinae between l3 and l5	0.031746031746
ES	embryonic stem (cells)	0.015873015873
ES	horse serum	0.015873015873
ES	endurance sport	0.015873015873
ES	electrical stimulation	0.0793650793651
ES	extrastriolar zone	0.015873015873
ES	erector spinae	0.0634920634921
ES	embryonic stem cells	0.0793650793651
ES	escapable stress	0.047619047619
ES	escapable tail shock	0.015873015873
ES	effect size	0.031746031746
ES	extracellular solution	0.015873015873
ES	cells	0.015873015873
ES	early-life stress/limited nesting animal model	0.015873015873
ES	external standard	0.015873015873
ES	eye movement sensitivity	0.015873015873
ER	envelope responsive	0.00323624595469
ER	nuclear estrogen receptor	0.00323624595469
ER	se2 receptors	0.00323624595469
ER	evoked responses	0.00323624595469
ER	81ets transcription factor 81	0.00323624595469
ER	estrogen receptor	0.401294498382
ER	agonists	0.00323624595469
ER	endoreticulum	0.00323624595469
ER	error rates	0.00323624595469
ER	pendoplasmic reticulum protein	0.00323624595469
ER	endoplasmic reticulum	0.46925566343
ER	oestrogen receptor	0.00647249190939
ER	expected information ratio	0.00323624595469
ER	betaestrogen receptor beta	0.00647249190939
ER	sestradiol receptors	0.00323624595469
ER	estrogen receptors	0.0291262135922
ER	error rate	0.00323624595469
ER	stressendoplasmic reticulum stress	0.00323624595469
ER	stress	0.00323624595469
ER	sestrogen receptors	0.0194174757282
ER	reversal potential	0.00323624595469
ER	entorhinal cortex	0.00323624595469
ER	entorhinal cortex, rostral subfield	0.00323624595469
ER	(α or β)estrogen receptor (α or β)	0.00323624595469
ER	estradiol receptor	0.00323624595469
ER	enriched rearing	0.00323624595469
ER	endoplasmatic reticulum	0.00323624595469
Em	membrane potential	1.0
NASP	1-naphthylacetyl spermine	1.0
En	embryonic day n	0.333333333333
En	endopiriform nucleus	0.666666666667
NRTNN	eurturin	1.0
Eg	the potential at which gna is half of (gna)max	1.0
EBCC	eyeblink classical conditioning	1.0
N-D	non-differential	1.0
INFRA	infralimbic cortex	1.0
BCSFB	blood–cerebrospinal fluid-barrier	0.25
BCSFB	blood–cerebrospinal fluid barrier	0.75
SIRPα	signal regulatory protein α	1.0
LAR	leukocyte common antigen-related molecule	0.25
LAR	leucocyte common antigen-related protein receptor	0.25
LAR	linear autoregressive	0.25
LAR	low acth response	0.25
PBS-	tphosphate-buffered saline containing 0.2% triton x-100	0.25
PBS-	t0.2% triton x-100 in phosphate-buffered saline	0.25
PBS-	t10% normal goat serum and 0.2% triton x-100 in phosphate-buffered saline	0.25
PBS-	azide0.02% sodium azide in phosphate-buffered saline	0.25
Et	echinops telfairi	1.0
leu-E	nkleucine enkephalin	1.0
U-50	488h, trans-3,4-dichloro-n-methyl-n-[2,1-pyrrolidinyl)-cyclohexyl]-benzacetamide	0.5
U-50	488h[trans-(1s,2s(-3,4-dichloro-n-methyl-n-[2-(1-pyrrolidinyl) cyclohexyl]-benzenacetamide hydro-chloride]	0.5
IRM	immunoreactive material	1.0
p-PERK	phosphorylated form of perk	1.0
DHLA	dihydrolipoic acid	1.0
MCEC	multiple cauda equina constrictions	1.0
MAP-LC	3microtubule-associated protein 1 light chain 3	1.0
DOG	difference of integrated gaussians	0.5
DOG	difference of gaussians	0.5
DHPG3	4-dihydroxyphenylglycol	0.25
DHPG3	4-dihydroxyphenylethyleneglycol	0.0833333333333
DHPG3	5-dihydroxyphenylglycine	0.583333333333
DHPG3	5-dihydroxyphenylglycol	0.0833333333333
MESC	mouse embryonic stem cells	1.0
e-NOS	endothelial nitric oxide synthase	1.0
ETA-	1endothelin receptor a-1	1.0
DTN	dorsal terminal nucleus	0.333333333333
DTN	dorsal tegmental nucleus	0.333333333333
DTN	dorsal thalamic nucleus	0.333333333333
Traf2	tnf receptor associated factor 2	1.0
N-M	e-α-medan-methyl-α-methyldopamine	1.0
GPXG	lutathioneperoxidase	1.0
X-	gal5-bromo-4-chloro-3-indolyl-ß-d-galactopyranoside	0.1
X-	ray microanalysis	0.1
X-	inactivation	0.1
X-	gal5-bromo-4-chloro-3-indolyl-beta-d-galactoside	0.1
X-	gal5′-bromo-4-chloro-3-indoly-β-d-galactopyranoside	0.1
X-	linked mental retardation	0.2
X-	gal5-bromo-4-chloro-3-indolyl beta-galactoside	0.1
X-	linked inhibitor of apoptosis protein	0.1
X-	gal5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside	0.1
GP-NAE	sglycerophospho-containing n-acyl ethanolamines	1.0
BW1003C87	5-(2,3,5-trichlorophenyl)-2,4-diaminopyrimidine	1.0
MPFC	medial prefrontal cortex	0.888888888889
MPFC	medial aspects of prefrontal cortex	0.037037037037
MPFC	(right) medial prefrontal cortex	0.037037037037
MPFC	medial prefrontal cortices	0.037037037037
WPS	twhisker pad stimulation	1.0
SCAREDS	creen for child anxiety related emotional distress	1.0
SBMA	spinobulbar muscular atrophy	0.5
SBMA	spinal and bulbar muscular atrophy	0.5
ASIAA	merican spinal injury association	0.5
ASIAA	merican spinal cord injury association	0.5
PDZPSD-95	dlg, zo-1/dlg-homologous region	1.0
XK	ketamine and xylazine	1.0
18F	]fddnp2-(1-{6-[(2-[18f]	0.142857142857
18F	]flt	0.142857142857
18F	]fdg-pet18f-fluoro-2-deoxy-glucose positron emission tomography	0.142857142857
18F	]f-dopa6-[18f]	0.142857142857
18F	]femzient	0.142857142857
18F	]-fdg2-deoxy-2-(18f)fluoro-d-glucose	0.142857142857
18F	]mppf	0.142857142857
XO	xanthine oxidase	1.0
NMDAr	n-methyl-d-aspartate receptor	1.0
Slu	nucleus semilunaris	1.0
M-wave	compound muscle action potential	1.0
123I-IMP	123i-iodoamphetamine	1.0
FILMF	unctional magnetic resonance imaging of the brain’s improved linear model	1.0
FFTi	fast fourier transform image	1.0
CNTFR-α	alpha subunit of ciliary neurotrophic factor receptor	1.0
XP	xeroderma pigmentosum	1.0
CB-	calbindin-nonimmunoreactive	0.5
CB-	2cannabinoid-2 receptor	0.5
BHABP	biotinylated hyaluronic acid-binding protein	1.0
NOC-ANT	nociceptin antagonist [phe1psi(ch2-nh)gly2]nc(1-13)nh2	1.0
dCK5	7-dichlorokynurenic acid	1.0
EMAPII	endothelial monocyte-activating polypeptide ii	1.0
YC-1	3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole	0.5
YC-1	3-(5′-hydroxymethyl-2′-furyl)-1-benzyl-indazole	0.5
DHPGR	s-3,5-dihydroxyphenylglycol	1.0
bLR	bred low-responders	0.25
bLR	bred low responder	0.25
bLR	bred low responder rats	0.25
bLR	selectively bred low-responder rats	0.25
CB1	cb1 cannabinoid receptor	0.0714285714286
CB1	type 1 cannabinoid receptor	0.0714285714286
CB1	cb2cannabinoid receptors	0.0714285714286
CB1	cannabinoid receptor type 1	0.142857142857
CB1	cb2, cb3cannabinoid receptors 1, 2, 3	0.0714285714286
CB1	cannabinoid receptor subtype 1	0.0714285714286
CB1	brain cannabinoid receptor-1	0.142857142857
CB1	cannabinoid 1	0.0714285714286
CB1	cannabinoid 1 receptor	0.0714285714286
CB1	cannabinoid receptor	0.0714285714286
CB1	central cannabinoid receptor	0.0714285714286
CB1	cannabinoid-1	0.0714285714286
DNAD	eoxyribonucleic acid	1.0
FFTF	ast fourier transform	0.6
FFTF	ast fourier transformation	0.4
bLF	bovine lactoferrin	1.0
EACC	1excitatory amino acid carrier 1	1.0
BHLH	basic helix–loop–helix	1.0
NHS-ss-biotin	sulfosuccinimidyl-2(biotinamido)ethyl-1,3-dithiopropionate	1.0
VSCT	ventral spinocerebellar tract	1.0
PBSGTPBS	goat serum triton	1.0
R123	rhodamine 123	1.0
RAHF	research animal holding facility	1.0
mFPI	moderate fluid percussion injury	1.0
ZSZ	ellweger syndrome	1.0
RPa	nucleus raphe pallidus	1.0
AraC	cytosine-1-β-d arabinofuranoside	0.5
AraC	cytosine arabinoside	0.5
α-DTX	α-dendrotoxin	1.0
CCHS	congenital central hypoventilation syndrome	1.0
Aβ	1–42β-amyloid protein1–42	0.00478468899522
Aβ	25-35 induced amnesic mice	0.00478468899522
Aβ	amyloid β-peptide	0.0574162679426
Aβ	(1–42)amyloid β-peptide (1–42)	0.00478468899522
Aβ	beta-amyloid peptide	0.00478468899522
Aβ	amyloid beta	0.0861244019139
Aβ	42amyloid-β oligomers	0.00478468899522
Aβ	amyloid beta-protein	0.00956937799043
Aβ	amyloid β peptide	0.0430622009569
Aβ	42β-amyloid	0.00478468899522
Aβ	amyloid β-protein	0.0239234449761
Aβ	amyloid-beta protein	0.0191387559809
Aβ	fibers	0.00478468899522
Aβ	amyloid peptide	0.00478468899522
Aβ	amyloidβ	0.00478468899522
Aβ	4 000 mol. wt amyloid peptide	0.00478468899522
Aβ	amyloid-β	0.11004784689
Aβ	1-42 oligomers	0.00478468899522
Aβ	40beta-amyloid 1–40 peptide	0.00478468899522
Aβ	beta amyloid protein	0.00478468899522
Aβ	amyloid β-proteins	0.00478468899522
Aβ	42beta-amyloid1-42	0.00478468899522
Aβ	25–35(40), β-amyloid 25–35 or β-amyloid 25–40	0.00478468899522
Aβ	(1–40)amyloid β-peptide (1–40)	0.00478468899522
Aβ	42amyloid beta 42	0.00478468899522
Aβ	β-pleated amyloid peptide	0.00478468899522
Aβ	+tmamyloid-β protein25-35 in combination with tunicamycin	0.00478468899522
Aβ	beta amyloid peptide	0.00478468899522
Aβ	amyloid β protein	0.0191387559809
Aβ	β-amyloid peptide	0.0143540669856
Aβ	deposition	0.00478468899522
Aβ	levels	0.00478468899522
Aβ	beta amyloid	0.0287081339713
Aβ	25–35beta amyloid 25–35	0.00478468899522
Aβ	amyloid b protein	0.00478468899522
Aβ	beta-amyloid protein	0.00956937799043
Aβ	42amyloid-β 42	0.00478468899522
Aβ	amyloid beta peptide	0.0526315789474
Aβ	amyloid beta protein	0.00956937799043
Aβ	amyloid β	0.114832535885
Aβ	amyloid-beta peptides	0.00478468899522
Aβ	beta-amyloid	0.0622009569378
Aβ	β-amyloid peptides	0.00478468899522
Aβ	β-amyloid	0.0813397129187
Aβ	amyloid-β-peptide	0.00478468899522
Aβ	amyloid-β protein	0.00956937799043
Aβ	amyloid-β peptide	0.0526315789474
Aβ	amyloid-beta	0.0287081339713
Aβ	clearance	0.00478468899522
Aβ	4242-residue amyloid beta-protein	0.00478468899522
Aβ	amyloid-beta peptide	0.0191387559809
VSCC	voltage-sensitive calcium channel	0.384615384615
VSCC	voltage-sensitive ca2+ channels	0.115384615385
VSCC	volume-sensitive cl- channel	0.0384615384615
VSCC	voltage sensitive ca2+ channel	0.0384615384615
VSCC	voltage-sensitive calcium channels	0.115384615385
VSCC	voltage sensitive calcium channel	0.115384615385
VSCC	voltage sensitive calcium channels	0.0384615384615
VSCC	l-type voltage-sensitive calcium channel	0.0384615384615
VSCC	voltage-sensitive ca2+ channel	0.0769230769231
VSCC	svoltage-sensitive calcium channels	0.0384615384615
KRIT	1	1.0
RPP	relative peak power	1.0
RPS	16ribosomal protein s16	1.0
dmVMH	dorsomedial part of the ventromedial hypothalamic nucleus	1.0
Kir	potassium inward rectifier	0.5
Kir	inwardly rectifying potassium channel	0.5
ASYM	asymmetrical lesion group	1.0
GDPs	giant depolarizing potentials	1.0
DPAT	(+)-8-hydroxy-2-dipropylaminotetralin	0.2
DPAT	8-oh-dpat	0.2
DPAT	(+)8-hydroxy-2-(di-n-propylamino)tetralin	0.4
DPAT	8-hydroxy-2-(di-n-propylamino)-tetralin	0.2
RPA	rnase protection assay	0.142857142857
RPA	right parietal a	0.0714285714286
RPA	ribonuclease protection assay	0.785714285714
sEPSP	sspontaneous excitatory postsynaptic potentials	0.25
sEPSP	slow excitatory postsynaptic potential	0.25
sEPSP	spontaneous excitatory postsynaptic potential	0.5
RPC	resveratrol preconditioning	0.166666666667
RPC	sretinal progenitor cells	0.166666666667
RPC	parvicellular part of red nucleus	0.166666666667
RPC	red nucleus parvicellular	0.166666666667
RPC	nucleus reticularis pontis caudalis	0.166666666667
RPC	parvocellular red nucleus	0.166666666667
RPE	rating of perceived exertion	0.0952380952381
RPE	ratings of perceived exertion	0.047619047619
RPE	right paw entry	0.0952380952381
RPE	retinal pigment epithelium	0.619047619048
RPE	retina pigment epithelium	0.047619047619
RPE	pigment epithelium	0.047619047619
RPE	retinal pigmented epithelium	0.047619047619
RPD	rostral pars distalis	1.0
RPF	retroparafascicular nucleus	1.0
RPI	relative pruning index	1.0
front-S	2frontal nerve area of s2	0.5
front-S	1frontal nerve area of s1	0.5
SWRS	wiss webster	0.5
SWRS	wiss webster mice	0.5
DPAG	dorsal periaqueductal gray	0.666666666667
DPAG	periaqueductal grey, dorsal nuclei	0.166666666667
DPAG	dorsal periaqueductal gray matter	0.166666666667
RPL	retinal pigment epithelium layer	0.5
RPL	37ribosomal protein 37	0.5
RPO	preoptic area	0.111111111111
RPO	nucleus raphe pontis	0.111111111111
RPO	nucleus pontis oralis of the reticular formation	0.111111111111
RPO	oral pontine reticular nucleus	0.111111111111
RPO	nucleus reticularis pontis oralis	0.111111111111
RPO	rostral paraolivary nucleus	0.111111111111
RPO	reticularis pontis oralis nucleus	0.111111111111
RPO	rostral periolivary region	0.222222222222
front-V	1 regionfrontal nerve region of vp	0.5
front-V	1 regionfrontal nerve region	0.5
BCMB	ienenstock–cooper–murano	0.5
BCMB	ienenstock–cooper–munro	0.5
MAPII	microtubule-associated protein ii	1.0
NAALADase	n-acetylated α-linked acidic dipeptidase	0.5
NAALADase	n-acetylated-α-linked acidic dipeptidase	0.5
kD	a	0.181818181818
kD	akilodalton	0.272727272727
kD	a heat shock protein	0.0909090909091
kD	akilodaltons	0.181818181818
kD	akilo dalton	0.0909090909091
kD	kilodalton	0.181818181818
DOPE	dioleoylphosphatidylethanolamine	1.0
kH	zkilohertz	1.0
DATN	a+/cl- dependent dopamine transporter	1.0
WTGW	ildtype groningen rats	1.0
CLTCL-	thalamotomy	1.0
q-RT-PCR	quantitative reverse transcriptase polymerase chain reaction	0.5
q-RT-PCR	quantitative real-time polymerase chain reaction	0.5
PWL	paw withdrawal latency	0.760869565217
PWL	paw withdrawal latencies	0.0869565217391
PWL	paw-withdrawal latency	0.0869565217391
PWL	spaw withdrawal latencies	0.0434782608696
PWL	paw withdrawal thermal latency	0.0217391304348
DC-FG	cell type with dense cytoplasm and fine granules	1.0
6h-RF	six hours refed group	1.0
IMDMI	scove’s modified dulbecco’s medium	1.0
CNXQ6-cyano-7-nitroquinoxaline-2	3-dione	1.0
fMU	female mouse urine	1.0
fMR	functional magnetic resonance	1.0
MOP-R	smu opioid receptors	0.5
MOP-R	mu opioid peptide receptor	0.5
tBMF	temporal best modulation frequency	1.0
CPGs	central pattern generators	1.0
INa-p	persistent sodium current	1.0
l-APV	l-(+)-2-amino-5-phosphonopentanoic acid	1.0
C1-3	adrenergic cell groups	1.0
PWI	perfusion weighted imaging	1.0
1H-MRS	)	0.25
1H-MRS	proton magnetic resonance spectroscopy	0.75
HBM	hypertonic buffered medium	1.0
4E-BP	1eukaryotic initiation factor 4e-binding protein	0.333333333333
4E-BP	seif4e binding proteins	0.333333333333
4E-BP	eukaryotic initiation factor 4e binding protein	0.333333333333
cad6B	cadherin-6b	1.0
PCCB	/pccβpropionyl-coa carboxylase beta-subunit	0.5
PCCB	percentage change from control baseline	0.5
HIMBA	himbacine	1.0
mMFG	mean magnetic field gradient	1.0
ERAD	endoplasmic reticulum-associated degradation	0.5
ERAD	endoplasmic reticulum–associated degradation	0.5
BMPRI	bone morphogenetic protein receptor i	1.0
CGPCGP	52432	0.5
CGPCGP	55485	0.5
GABABR1a	gabab receptor r1 isoform a	1.0
HBI	head/body investigation	1.0
PCCP	earson's correlation coefficient	1.0
non-NMDA	glutamate receptor	0.142857142857
non-NMDA	receptor	0.285714285714
non-NMDA	non-n-methyl-d-aspartate	0.142857142857
non-NMDA	receptors	0.285714285714
non-NMDA	receptorsnon-n-methyl-d-aspartic acid receptors	0.142857142857
SHIP	src homology 2 domain-containing inositol polyphosphate 5-phosphatase	1.0
PCCT	phosphocholine cytidylyltransferase	1.0
PVAB	parvalbumin	1.0
IWB	isolated in vitro whole brain	1.0
DIDS4	4′-diisothiocyano-2,2′-stilbenedisulfonic acid	0.25
DIDS4	4′-diisothiocyanatostilbene-2,2′-disulfonic acid disodium salt hydrate	0.125
DIDS4	4′-diisothiocyanostilbene-2,2′-disulfonic acid	0.25
DIDS4	4′-diisothiocyanato-stilbene-2,2′-disulfonic acid	0.125
DIDS4	4′-diisothiocyanostilbene-2,2′-disulfonate or 5-isothiocyanato-2-[2-(4-isothiocyanato-2-sulfo-phenyl)ethenyl]benzenesulfonate	0.125
DIDS4	4′-diisothiocyanatostilbene-2,2′-disulfonic acid	0.125
NAE	sn-acyl ethanolamines	1.0
ERAN	early right anterior negativity	1.0
NAK	nerve injury-associated kinase	1.0
Rp-8-Br-cAMPS	rp-8-bromo-adenosine-3′,5′-cyclic monophosphorothioate	1.0
FVO	four-vessel occlusion	1.0
IRAK	interleukin-1 receptor associated kinases	0.5
IRAK	1interleukin-1 receptor activated kinase	0.5
HVEM	high-voltage electron microscope	0.5
HVEM	high voltage electron microscope	0.5
PT-cGMPS	8-(4-chlorophenylthio)-guanosine-3′, 5′-cyclic monophosphorothioate, rp-isomer	1.0
Ng-CAM	neuron-glia cell adhesion molecule	1.0
EEGE	lectroencephalogram	0.666666666667
EEGE	lectroencephalography	0.333333333333
RK-13	rabbit kidney cells 13	1.0
FVB	/n//c57b6 micec57b6 mice crossed with fvb/n mice	1.0
FVA	augmentation of the fiber volley	1.0
NSFN	ovelty-suppressed feeding	1.0
PZ-	peptide4-phenylazobenzyloxycarbonyl-pro-leu-gly-pro-d-arg	1.0
L-NOARG	l-nitroarginine	0.333333333333
L-NOARG	ng-nitro-l-arginine	0.666666666667
NAL	naloxone	0.5
NAL	10xhigh dosage of nal	0.5
IRAP	insulin-regulated aminopeptidase	1.0
HBB	horizontal band of broca	1.0
FVS	female vaginal secretions	1.0
STDP	spike timing dependent synaptic plasticity	0.0833333333333
STDP	spike timing–dependent plasticity	0.0833333333333
STDP	spike timing-dependent plasticity	0.333333333333
STDP	spike-timing dependent plasticity	0.25
STDP	spike-timing-dependent plasticity	0.166666666667
STDP	spike-time-dependent plasticity	0.0833333333333
7-CK	7-chlorokynurenic acid	1.0
Hist	histamine	1.0
XANESX-	ray absorption near edge structure	1.0
NPIM	neurosphere initiation medium	1.0
PNPP	p-nitrophenyl phosphate	1.0
15PI	15 paced intromissions	1.0
SNI-	spared nerve injury	1.0
ARJPD	autosomal recessive juvenile pd	1.0
CGS19755	cis-4-phosphonomethyl-2-piperidine carboxylic acid	1.0
PNPO	pyridoxine-5′-phosphate oxidase	1.0
TNF-R1	tumor necrosis factor receptor type 1	1.0
LLat	lateral motor column of spinal cord segments l4–l5	0.5
LLat	lateral motor columns of lumbar spinal cord segments l3 and l4	0.5
IR-Fos	immunoreactive fos	1.0
VMD	ventromedial diencephalon	1.0
mCPP	m-chlorophenylpiperazine	0.666666666667
mCPP	2-(2-methyl-4-clorophenoxy) propanoic acid	0.111111111111
mCPP	m-chlorophenyl piperazine	0.222222222222
MSDM	eso scale discovery	0.5
MSDM	esoscale discovery®	0.5
S-ROI	spatial regions of interest	1.0
DTMN	dorsal tuberomammillary nucleus	1.0
BTN	bitufted neuron	1.0
vBST	ventral bed nucleus of the stria terminalis	1.0
PHFD	post-hypoxic decline in respiratory frequency	1.0
GABA-BR	1gaba-b receptor subunit r1	1.0
NEO-PI-RNEO	personality inventory revised	1.0
IAMPAAMPA	current	1.0
MSDB	medial septal diagonal band	0.0833333333333
MSDB	medial septum–diagonal band complex	0.0833333333333
MSDB	medial septum diagonal band	0.0833333333333
MSDB	medial septum/diagonal band of broca complex	0.0833333333333
MSDB	medial septum and diagonal band of broca	0.0833333333333
MSDB	medial septum/diagonal band	0.166666666667
MSDB	medial septum–diagonal band	0.0833333333333
MSDB	medial septum/diagonal band of broca	0.333333333333
5-HTD	ep5-ht-evoked membrane depolarization	0.5
5-HTD	ep5-ht induced depolarization	0.5
SKF	82958 [(±)6-chloro-7;8-dihydroxy-3-allyl-1-phenyl-2;3;4;5-tetra-hydro-(1h)-3-benzazepine hydrobromide	0.0625
SKF	81297	0.125
SKF	83822	0.0625
SKF	38393	0.4375
SKF	82958	0.0625
SKF	r(+)-skf-38393	0.0625
SKF	963651-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl]	0.0625
SKF	963651-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl-1h-imidazole hydrochloride	0.0625
SKF	91488	0.0625
CTAP	cys2, tyr3, arg5, pen7 amide	0.142857142857
CTAP	d-phe-cys-trp-arg-thr-pen-thr-nh2	0.142857142857
CTAP	d-phe-cys-tyr-d-trp-arg-thr-pen-thr-nh2	0.714285714286
IGS	immunogold–silver	1.0
SKO	single knockout	1.0
Tris-OH	tris(hydroxymethyl)aminomethane	0.5
Tris-OH	tris(hydroxymethyl)-aminomethane	0.5
CS-GAG	chondroitin sulphated glycosaminoglycan	0.5
CS-GAG	chondroitin sulfate glycosaminoglycan	0.5
GER	greater epithelial ridge	1.0
MFB	mossy fibre boutons	0.0175438596491
MFB	medial forebrain bundle	0.947368421053
MFB	median forebrain bundle	0.0350877192982
MFC	medial frontal cortex	1.0
GEV	global explained variance	1.0
MFF	maximal firing frequency	1.0
MFG	the middle frontal gyrus	0.0769230769231
MFG	middle frontal gyrus	0.615384615385
MFG	medial frontal gyrus	0.153846153846
MFG	magnetic field gradient	0.153846153846
TCV	tonic-clonic episodes	1.0
MFI	mean fluorescence intensity	0.666666666667
MFI	mean fluorescent intensity	0.333333333333
TCT	total micturition contraction time	0.5
TCT	alairach coordinates	0.5
IGP	intragastric pressure	1.0
TCR	t-cell receptor	0.333333333333
TCR	t cell receptor	0.111111111111
TCR	transcription-coupled repair (subpathway of ner)	0.111111111111
TCR	transcription-coupled repair	0.444444444444
HNK-	1 antigens	0.2
HNK-	1human natural killer-1	0.2
HNK-	1human natural killer cell glycan	0.2
HNK-	1sthnk-1 sulfotransferase	0.2
HNK-	1,	0.2
TCP	n-[1-(2-thienyl)cyclohexyl]piperidine	0.25
TCP	tissue culture plastic	0.25
TCP	tenocylidine	0.25
TCP	t-complex polypeptide	0.25
MFO	medium frequency oscillation	1.0
GEC	1glandular epithelial cell 1	1.0
MFQ	mefloquine	1.0
GEA	rray hybridization	1.0
MFS	mossy fiber sprouting	0.714285714286
MFS	mossy fibre sprouting	0.285714285714
MFT	magnetic field tomography	0.75
MFT	mossy fiber terminations	0.25
GEF	guanidine exchange factor	0.0833333333333
GEF	guanine exchange factor	0.0833333333333
GEF	guanine-nucleotide-exchange factor	0.0833333333333
GEF	guanine nucleotide exchange factor	0.416666666667
GEF	sguanine exchange factors	0.166666666667
GEF	guanine nucleotide-exchange factor	0.0833333333333
GEF	guanyl nucleotide exchange factor	0.0833333333333
GEE	generalized estimating equation	1.0
TCI	transcallosal inhibition	1.0
TCF	transcription factor	0.5
TCF	7l2transcription factor 7-like 2	0.5
TCD	thalamocortical dysrhythmia	1.0
3-b-7-NI	3-bromo-7-nitro-indazole	1.0
TCC	trigeminocervical complex	0.333333333333
TCC	transitory cell compartment	0.333333333333
TCC	3transient cell compartment 3	0.333333333333
TCA	tricyclic antidepressant	0.027027027027
TCA	stricyclic antidepressants	0.027027027027
TCA	taurocholic acid	0.027027027027
TCA	trichloroacetic acid	0.554054054054
TCA	trichostatin a	0.0135135135135
TCA	tricarboxylic acid	0.162162162162
TCA	tricyclic antidepressants	0.0135135135135
TCA	sthalamocortical axons	0.027027027027
TCA	tyramide signal amplification	0.0135135135135
TCA	thalamocortical axon	0.0135135135135
TCA	triamcinolone acetonide	0.0135135135135
TCA	trichloro acetic acid	0.0135135135135
TCA	tricarboxylic acid cycle	0.0810810810811
TCA	thalamocortical axons	0.0135135135135
rCMR	glregional cerebral metabolic rate for glucose	0.5
rCMR	glcregional cerebral metabolic rates for glucose	0.5
125I-estrogen	17α-iodovinyl-11β-methoxyestradiol	1.0
DDS	dendrodendritic synaptosomes	1.0
U-CR	unidirectional neurons, responsive with rotations directed towards the side contralateral to recording, in the right vestibular nucleus	1.0
JGC	sjuxtaglomerular cells	0.5
JGC	juxtaglomerular cell	0.5
DDW	distilled deionized water	0.333333333333
DDW	double distilled water	0.333333333333
DDW	double-distilled water	0.333333333333
FNS	focal neurological scores	1.0
DDT	dithiothreitol	1.0
mitoKATP	mitochondrial atp-sensitive k+ channels	1.0
DDI	double deionized	1.0
DDH	deeper dorsal horn	0.333333333333
DDH	deep dorsal horn	0.666666666667
SQ-RT-PCR	semiquantitative reverse transcription-polymerase chain reaction	1.0
DDM	dodecyl-beta-d-maltoside	0.5
DDM	dodecyl-β-d-maltoside	0.5
DDL	animals exposed to ambient light after dark rearing	1.0
DDC	dopa decarboxylase	0.333333333333
DDC	diethyldithiocarbamate	0.166666666667
DDC	dorsal diencephalic conduction	0.166666666667
DDC	dopa-decarboxylase	0.166666666667
DDC	tdelta–delta ct	0.166666666667
INPP	4binositol polyphosphate 4-phosphatase	0.333333333333
INPP	1inositol polyphosphate 1-phosphatase	0.333333333333
INPP	5ainositol polyphosphate-5-phosphatase a	0.333333333333
DYN-	posdopamine d1 receptors	1.0
LNEP	late negative evoked potential	1.0
MSA-P	msa-parkinson subtype	1.0
SK1	sk2, sk3, small conductance calcium-activated potassium channels type 1, 2 or 3	1.0
IGF	insulin-like growth factor	0.75
IGF	insulin growth factor	0.075
IGF	binding protein network	0.025
IGF	insulin-like growth factor-1	0.025
IGF	1insulin like growth factor 1	0.025
IGF	1insulin-like growth factor 1	0.05
IGF	1rigf receptor	0.025
IGF	sinsulin-like growth factors (igfs)	0.025
HSVLatβ-gal	β-galactosidase encoding recombinant hsv-1	1.0
CNQXcyano-7-nitroquinoxaline-2	3-dione	1.0
IGE	idiopathic generalized epilepsy	1.0
cMEP	cortical mep	1.0
α-NEOα-	neoendorphin	1.0
RPDP	arkinson's disease patients with right initial motor signs	1.0
OPHN	1oligophernin-1	1.0
SK-	channelsmall-conductance ca2+-activated k+ channel	1.0
rBF	rostral basal forebrain	1.0
GIF	murine glial-derived neurotrophic factor-inducible transcription factor	1.0
E19	embryonic day 19	1.0
pEW	preganglionic edinger-westphal nucleus	1.0
IGF-II	insulin-like growth factor type ii	0.2
IGF-II	receptorinsulin-like growth factor-ii/mannose 6-phosphate receptor	0.2
IGF-II	insulin-like growth factor-ii	0.4
IGF-II	insulin-like growth factor ii	0.2
rHSV	recombinant hsv	1.0
DEHP	di(2-ethylhexyl) phthalate	1.0
TWIK-	1tandem of p domains in a weak inward rectifier k+ channel	0.5
TWIK-	1tandem of pore domains in a weak inward rectifying potassium channel	0.5
Bufm	bupivacaine pretreated 10 min before 5% formalin injection group of rats	1.0
vmPFC	ventral mpfc	0.047619047619
vmPFC	ventral medial prefrontal cortex	0.190476190476
vmPFC	ventromedial prefrontal cortex	0.666666666667
vmPFC	ventromedial pfc	0.0952380952381
GHKG	oldman-hodgkin-katz	1.0
3WKPD	6-ohda lesion group as 3 weeks post lesion	1.0
IGF-IR	insulin-like growth factor-i receptor	0.5
IGF-IR	insulin-like growth factor i receptor	0.5
IGM	intermediate gray matter	1.0
FK-506	tacrolimus	1.0
KDM	histone lysine demethylase	0.5
KDM	lysine de-methylase	0.5
pHi	intracellular ph	1.0
haFGF	human acidic fibroblast growth factor	1.0
pHo	extracellular ph	1.0
KDK	channel+dead trkb kinase	1.0
SCtx	somatosensory cortex	1.0
ERADER-	associated degradation	1.0
DNFB2	4-dinitrofluorobenzene	1.0
M-W-	3dmorphine (40 mg/kg) withdrawal for 3 days	1.0
IFNβ	interferon-β	1.0
SOL	slowly contracting extensor soleus	0.0769230769231
SOL	soleus	0.461538461538
SOL	musculus soleus	0.0769230769231
SOL	isoleus	0.153846153846
SOL	soleus muscle	0.153846153846
SOL	suppressor of lurcher	0.0769230769231
EGABA	equilibrium potential for gaba	1.0
KDR	delayed outwardly-rectifying k+ current	0.2
KDR	/flk-1kinase insert domain-containing receptor/fms-like tyrosine kinase 1	0.4
KDR	vascular endothelial growth factor receptor-2	0.2
KDR	delayed rectifier k+ channel	0.2
HET	heterozygous	0.769230769231
HET	heterozygous neuregulin 1+/-	0.0769230769231
HET	heterozygous mice	0.0769230769231
HET	heterozygote	0.0769230769231
Fos-LI	fos-like immunoreactivity	0.809523809524
Fos-LI	fos-like immunoreactive	0.190476190476
HZnon-ac	heterozygous non-activated mice	1.0
NDL	non dioxin-like	0.5
NDL	non-dioxin-like	0.5
NDO	non-differential outcomes	0.333333333333
NDO	non-displaced object in object recognition task	0.333333333333
NDO	non-displaced objects	0.333333333333
LCDP	liposomal cdp-choline	1.0
STMV	ventromedial division of the bed nucleus of the stria terminalis	1.0
ERNE	rror-related negativity	1.0
NDB	nucleus of diagonal band	0.111111111111
NDB	nucleus of the diagonal band	0.444444444444
NDB	nucleus of the diagonal band of broca	0.444444444444
NDD	sneurodegenerative diseases	1.0
HEF	1	1.0
TIBAT	interscapular brown adipose tissue temperature	1.0
GSEAG	ene set enrichment analysis	1.0
HEC	hippocampal–entorhinal cortical	0.5
HEC	hippocampal-entorhinal cortex	0.5
βTH	beta-thymosin homology domain	1.0
HEM	hemisphere	1.0
NDS	normal donkey serum	0.912621359223
NDS	neurological deficit scores	0.0194174757282
NDS	neurological deficit score	0.0388349514563
NDS	neurologic deficit score	0.0291262135922
HEH	ematoxylin and eosin	0.333333333333
HEH	aematoxylin-eosin	0.333333333333
HEH	ematoxylin-and-eosin	0.333333333333
GABAAγ-	aminobutyric acida	0.5
GABAAγ-	aminobutyric acid receptor subtype a	0.25
GABAAγ-	aminobutyric acid type-a	0.25
HEK	cellshuman embryonic kidney cells	0.0125
HEK	293human embryonic kidney 293 cells	0.05
HEK	293 cellshuman embryonic kidney cells	0.0125
HEK	293human embryonic kidney-293	0.0125
HEK	human embryonal kidney	0.0125
HEK	human embryonic kidney cells	0.05
HEK	human embryonic kidney line hek 293	0.0125
HEK	human embryonic kindney	0.0125
HEK	human embryonic kidney (cells)	0.0125
HEK	human embryonic kidney	0.625
HEK	293human embryonic kidney	0.0375
HEK	293human embryonic kidney cells	0.0125
HEK	293thuman embryonic kidney 293t	0.0125
HEK	293 cell	0.0125
HEK	293human embryonic kidney (cell line 293)	0.0125
HEK	293human embryonic kidney 293	0.0625
HEK	293 cellscell line originally derived from an embryonic human kidney	0.0125
HEK	293human embryo kidney 293 cells	0.0125
HEK	293 appswhuman embryonic kidney 293 cells bearing the swedish amyloid precursor protein mutation	0.0125
AβPPs	secreted amyloid β precursor protein	1.0
TRAF	6tumor necrosis factor receptor-associated factor 6	0.4
TRAF	4tnf receptor-associated factor 4	0.2
TRAF	tumor necrosis factor receptor-associated factor	0.2
TRAF	tumor necrosis factor receptor associated factor	0.2
GALR	galanin receptor	0.333333333333
GALR	2galanin receptor 2	0.333333333333
GALR	1galanin receptor 1	0.333333333333
aVIII	nanterior branches of the vestibular nerve	1.0
PREE	partial reinforcement extinction effect	1.0
PRED	methylprednisolone	1.0
PREG	/dheaboth preg(s) and dhea(s)	0.111111111111
PREG	pregnenolone	0.888888888889
STZ-NGSTZ-injected	normoglycemic	1.0
oFQ	orphanin fq	1.0
TRAP	transcripts with cell types	0.1
TRAP	tartrate resistant acid phosphatase	0.1
TRAP	thrombin receptor activator peptide	0.1
TRAP	tartrate-resistant acid phosphatase	0.1
TRAP	telomerase repeat amplification protocol	0.1
TRAP	1tumour necrosis factor receptor-associated protein 1	0.1
TRAP	total antioxidant potential	0.1
TRAP	thrombin receptor agonist peptides	0.1
TRAP	total radical-trapping antioxidant potential	0.1
TRAP	1transient receptor potential ankyrin repeat 1	0.1
iNOSKO	deficiency of inducible nitric oxide synthase mice	1.0
MDSFD	minimum discriminable spatial frequency difference	1.0
LY306155	(s) enantiomer of ly303870	1.0
PREP	prolyl endopeptidase	1.0
TAFTATA	binding protein-associated factor	1.0
PTIO2-phenyl-4	4,5,5-tetramethyl-imidazoline-1-oxyl 3-oxide	1.0
wtCHO	wild-type cho	1.0
CBN	carbenoxolone	1.0
nVL	vertical limb of the diagonal band nuclei	1.0
siRNA	rna interference	0.0196078431373
siRNA	(rnai)small interfering rna	0.0196078431373
siRNA	sshort interfering rnas	0.0196078431373
siRNA	small interfering rnas	0.0196078431373
siRNA	small interfering ribonucleic acid	0.0196078431373
siRNA	small interfering rna	0.647058823529
siRNA	small interference rna	0.0196078431373
siRNA	short interfering rna	0.0980392156863
siRNA	silencing rna	0.0196078431373
siRNA	short-interfering rna	0.0392156862745
siRNA	ssmall interfering rnas	0.0588235294118
siRNA	ssmall-interfering rnas	0.0196078431373
nVI	abducens nucleus	1.0
nVH	neonatal ventral hippocampus	0.5
nVH	neonatal ventral hippocampal	0.5
CBR	scannabinoid receptors	0.222222222222
CBR	central-type benzodiazepine receptor	0.333333333333
CBR	cannabinoid receptor	0.222222222222
CBR	cannabinoid receptors	0.111111111111
CBR	chromatin-bound rna	0.111111111111
UTPγS	uridine-5′-(γ-thio)-triphosphate trisodium salt	1.0
IPBN	lateral parabrachial nucleus	1.0
nVs	nucleus sensibilis nervi trigemini	1.0
FUDR	fluorodeoxyuridine	1.0
RMSD	shshoulder root mean squared difference	1.0
RMSE	root mean square error	0.333333333333
RMSE	proot mean squared error of the predicted residual sum	0.333333333333
RMSE	root mean squared error	0.333333333333
GTPCH	guanosine triphosphate cyclohydrolase i	1.0
L-703	606	1.0
Copl	posterolateral subdivision of the cortical amygdaloid nucleus	1.0
Copm	posteromedial subdivision of the cortical amygdaloid nucleus	1.0
RMSR	ostral migratory stream	0.333333333333
RMSR	oot mean square	0.666666666667
PPTP	ropylpyrazole-triol	1.0
ECFP	enhanced cyan fluorescent protein	1.0
SVAS	supravalvular aortic stenosis	1.0
ECFV	extracellular fluid volume	1.0
β-CIT	[-]-2-β-carbomethoxy-3-β-[4-iodophenyl]	0.5
β-CIT	[123i](-)-2-β-carboxymethoxy-3-β-(4-iodophenyl)tropane	0.5
PR-ENT	perirhinal–entorhinal cortex/perirhinal–entorhinal cortex lesion	1.0
nVm	nucleus motorius nervi trigemini	1.0
BCβ-	carboline	0.5
BCβ-	carbolines	0.5
τM	)membrane time constant	1.0
ADRP	autosomal dominant retinitis pigmentosa	1.0
LTPEPSCLTP	induced with subthreshold excitatory postsynaptic currents	1.0
CLOCKC	ircadian locomotor output cycles kaput	1.0
LVR	liver cells	1.0
FM-MAP1B	fast-migrating microtubule-associated protein 1b	1.0
HFIP	hexafluoroisopropanol	0.333333333333
HFIP	hexa-fluoroisopropanol	0.333333333333
HFIP	hexafluoro-2-propanol	0.333333333333
PDBP	rotein data bank	1.0
-BTX	[125i]	1.0
LVE	low-velocity-excitatory cells	1.0
CPMG	carr–purcell–meiboom–gill	1.0
popEPSPS	population epsp slope	1.0
LVF	left visual field	1.0
LVA	low-voltage activated	0.242424242424
LVA	slow voltage-activated calcium channels	0.030303030303
LVA	low threshold voltage-activated	0.030303030303
LVA	calcium channel	0.030303030303
LVA	low-voltage-activated	0.363636363636
LVA	low threshold voltage-activated calcium channel	0.030303030303
LVA	low voltage activated	0.151515151515
LVA	low voltage-activated calcium channel	0.030303030303
LVA	low voltage-activated	0.0909090909091
KE	kinetic edges	1.0
EAAT-	3excitatory amino acid transporter-3	1.0
GBRGBR	12909 30 mg/kg	1.0
MPPF4	2-(methoxyphenyl)-1-[2-(n-2-pyridinyl)-p-fluorobenzamido]	1.0
LVN	vventral part of the lateral vestibular nucleus	0.0434782608696
LVN	lateral ventricular nerve	0.0434782608696
LVN	lateral vestibular nucleus	0.913043478261
FEVG	erman version of the three-factor-eating questionnaire	1.0
T-ERK	stotal erks	1.0
GABAARα	1–3gabaa receptor subunit α1–3	1.0
XE	991xe991 dihydrochloride	1.0
IκB-α	inhibitory factor kappa b alpha	1.0
lDR	lateral dorsal raphe	1.0
hiPSC	shuman induced pluripotent stem cells	1.0
τD	eactdeactivation time constant	0.5
τD	decay time constant of postsynaptic currents	0.5
PDBu	phorbol dibutyrate	0.333333333333
PDBu	phorbol 12,13-dibutyrate	0.666666666667
DLMO	dim light melatonin onset	1.0
GAL-IR	galanin immunoreactivity	1.0
LVe	lateral vestibular nucleus	1.0
ATHA	anterior thalamus	1.0
DOPSl-3	4-dihydroxyphenylserine	1.0
HCbd	hemicerebellectomized	1.0
APTRA	2-aminophenol-n,n,o-triacetate	1.0
BLmc	magnocellular part of bl nucleus	1.0
THP5α	3α-tetrahydroprogesterone	1.0
JNK1	c-jun n-terminal kinase 1	1.0
HSV-GFP	herpes simplex virus-1 expressing green fluorescent protein	1.0
feG	phenylalanine-(d) glutamate-(d) glycine	1.0
TriMA	trimethylamine	1.0
BKCa	large-conductance ca2+-activated k+ channel	0.5
BKCa	large conductance ca2+-activated k+ channel	0.5
SSS-VS	ensation seeking scale-v	1.0
TPBST	ris-phosphate-buffered saline	0.25
TPBST	riton x-100 in pbs	0.25
TPBST	ris–phosphate-buffered saline	0.5
3-MATIDAα-	amino-5-carboxy-3-methyl-2-thiopheneacetic acid	1.0
MGMZ	marginal zone of the medial geniculate body	1.0
αMSH	melanocyte stimulating hormone	0.5
αMSH	alpha-melanocyte stimulating hormone	0.5
BDS-IIB	lood depressing substance ii	1.0
PDGFα-	recplatelet-derived growth factor-α receptor	0.5
PDGFα-	receptor	0.5
MLmediolateral	somatosensory area	1.0
BSA-AGE	bovine serum albumin–advanced glycation end-product	1.0
-1H-quinoline-2	4-dione (kr-22332)	1.0
IL-1rα	interleukin-1 receptor antagonist	1.0
c-A	blc-abelson	0.5
c-A	ktconstitutively active akt	0.5
SVS	single variable stress	1.0
sADP	slow afterdepolarization	1.0
cTBS	continuous tbs	0.25
cTBS	continuous theta-burst stimulation	0.25
cTBS	continuous theta burst stimulation	0.5
NP-NF	non-phosphorylated neurofilament	1.0
MYO	5bmyosin vb	1.0
PSNI	partial sciatic nerve injury	1.0
SIAN	stress-induced antinociception	1.0
snVII	facial afferent	1.0
PSNL	partial sciatic nerve ligation	0.8
PSNL	partial ligation of the sciatic nerve	0.1
PSNL	partial sciatic nerve transection	0.1
VAMCV	eteran’s affairs medical center	1.0
lADP	late after-depolarising potential	1.0
Dil	1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine	1.0
IURisotropic	uniform random	0.5
IURisotropic	uniform and random	0.5
CQA	caffeoylquinic acid	1.0
MOMP	mitochondrial outer membrane permeabilization	1.0
NANCnon-adrenergic	non-cholinergic	1.0
semA	semaphorin a	1.0
LSPV	lower sub-paraventricular zone	0.5
LSPV	lower subparaventricular zone	0.5
ms-dbB	medial septum-diagonal band of broca complex	1.0
rlCP	urostrolateral caudate-putamen	1.0
Diz	dizocilpine-treated	1.0
vLTF	ventilatory ltf	1.0
post-SE	7 days after status epilepticus	1.0
ABHD	12α/β-hydrolase domain 12	1.0
DiO	3,3′-dioctadecyloxacarbocyanine	1.0
nMEP	snormalized motor evoked potentials	1.0
DiI	1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate	0.0434782608696
DiI	1,1′-dioctadecyl-3,3,3′,3′-teramethylindocarbocyanine perchlorate	0.0434782608696
DiI	1,1′-diotadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	0.0434782608696
DiI	1,1′-didodecyl-3,3,3′,3′-tetramethyl indocarbocyanine perchlorate	0.0434782608696
DiI	1,1′didodecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	0.0434782608696
DiI	1,1′,dioctadecyl-3,3,3′,3-tetramethylindocarbocyanine perchlorate	0.0434782608696
DiI	1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine	0.260869565217
DiI	1,1′-dilinoleyl-3,3,3′,3′-tetramethylindocarbocyanine-4-chlorobenzenesulfonate	0.0434782608696
DiI	1,1’-didodecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate	0.0434782608696
DiI	1,1′-dioctodecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	0.0434782608696
DiI	1′,1-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine-perchlorate	0.0434782608696
DiI	1,1′-dioctadecyl-3,3,3′,3′-tetramethylindo-carbocyanine perchlorate	0.0869565217391
DiI	1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	0.173913043478
DiI	1,1′-didodecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	0.0434782608696
rtPA	recombinant tissue plasminogen activator	1.0
4-BPB	4-bromophenacryl bromide	1.0
AMPADL-	alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	1.0
NMDA-RN-	methyl-d-aspartate glutamate receptors	0.166666666667
NMDA-RN-	methyl-d aspartate receptor	0.166666666667
NMDA-RN-	methyl-d-aspartate receptor	0.666666666667
BZD	benzodiazepines	0.5
BZD	benzodiazepine	0.5
NRAGE	neurotrophin receptor-interacting melanoma antigen homolog	1.0
DiY	diamidino yellow	1.0
V-P-S	vestibular plus saccade	1.0
TDtypical	developmentally-age matched	1.0
DiV	days in vitro	1.0
NIMS	nanostructure-initiator mass spectrometry	1.0
JNKI	c-jun n-terminal kinase inhibitor	1.0
JNKK	c-jun nh2-terminal kinase kinase	1.0
JNKJ	anus kinase	0.125
JNKJ	un amino-terminal kinases	0.125
JNKJ	un kinase	0.25
JNKJ	un n-terminal kinase	0.5
VAGLAHSV	eterans affairs great los angeles health care system	1.0
gERMF	gustatory event-related magnetic fields	1.0
aCg	anterior cingulate cortex	1.0
ss-DBP	single-stranded d-box binding protein	1.0
CELN-	carboxyethyl-lysine	1.0
4F-APTRA	2-aminophenol-4-fluorophenol-n,n,o-triacetate	1.0
ZLI	zona limitans intrathalamica	1.0
RMS-OB	rostral migratory stream and its most anterior extension located in the deep part of the mob	1.0
moV	motor nucleus of trigeminal nerve	1.0
U-50488	trans-(±)-3,4-dichloro-n-methyl-n-[2-(1-pyrrolidinyl)-cyclohexyl]-benzeneacetamide methanesulfonate	1.0
BVP	bovine arginine vasopressin	1.0
BAPTAtetraacetoxymethyl-1	2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetate	1.0
sNAC1	the short isoform of nac1	1.0
aCSF	artificial cerebro spinal fluid	0.00289855072464
aCSF	artifical cerebrospinal fluid	0.00579710144928
aCSF	artificial cerebral-spinal fluid	0.00289855072464
aCSF	artificial cerebral spinal fluid	0.0405797101449
aCSF	martificial cerebrospinal fluid	0.00289855072464
aCSF	artificial cerebrospinal extracellular solution	0.00289855072464
aCSF	artificial csf	0.00579710144928
aCSF	artificial cerebro-spinal fluid	0.00869565217391
aCSF	artificial cerebrospinal-fluid	0.00289855072464
aCSF	artificial cerebrospinal fluid	0.924637681159
hOKR	horizontal optokinetic reflex	1.0
aCC	anterior cingulate cortex	1.0
SERT	+/+wild-type 5-ht transporter knockout	0.0169491525424
SERT	+/+wildtype littermate of heterozygous serotonin transporter knockout and homozygous serotonin transporter knockout rats	0.0169491525424
SERT	serotonin transporter	0.677966101695
SERT	(slc6a4)serotonin transporter	0.0169491525424
SERT	serotonin reuptake transporter	0.0677966101695
SERT	5-ht transporter	0.203389830508
tm2D	1tm2 domain containing 1	1.0
LMAN	lateral part of the magnocellular nucleus of the anterior nidopallium	0.1
LMAN	lateral portion of the magnocellular nucleus of the anterior nidopallium	0.1
LMAN	lateral magnocellular nucleus of the nidopallium	0.1
LMAN	lateral magnocellular nucleus of the anterior nidopallium	0.7
MCIM	ild cognitive impairment	1.0
Tβ	4thymosin β4	1.0
dSE	dorsal part of the se	1.0
D600	methoxyverapamil	1.0
MCID	microcomputer image device	0.25
MCID	micro computer imaging device	0.125
MCID	microcomputer imaging device	0.5
MCID	micromputer imaging device	0.125
SERF	ser fragment	1.0
siDJ	#2anti-mouse dj-1 sirna	1.0
U50488	3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide	1.0
ABCCATP-	binding cassette transporter subfamily c	1.0
SERM	sselective estrogen receptor modulators	0.181818181818
SERM	selective estrogen receptor modulator	0.818181818182
NAGN-	acetyl-β-d-glucosaminidase	1.0
CDDP	cis-diamine-dichloroplatinum ii	1.0
KIRK	+ inward rectifier current	1.0
GxA	amphiphilic globular che polymer made of x subunits	1.0
MCI-	1863-methyl-1-phenyl-2-pyrazolin-5-one	0.5
MCI-	186	0.5
SEJPs	spontaneous excitatory junction potentials	1.0
SMN	spinal motoneuron	0.166666666667
SMN	2survival of motor neuron 2	0.166666666667
SMN	survival motor neurons	0.166666666667
SMN	survival of motor neuron protein	0.166666666667
SMN	survival of motor neuron	0.166666666667
SMN	δ7 mouse	0.166666666667
ME-MRI	manganese-enhanced magnetic resonance imaging	1.0
FLAG-	μorflag-tagged μ opioid receptor	1.0
Pα	platelet-derived growth factor receptor alpha	1.0
GxS	secretory globular che polymer made of x subunits	1.0
GABAα	6gaba-a receptor subunit alpha 6	1.0
HLFHIF-	1 like factor	1.0
H-BMSC	shes1-down regulated bmscs	1.0
ADAS-cog	ad assessment scale-cognitive subscale	1.0
HADH	ospital anxiety and depression scale	1.0
Barr	barrington’s nucleus	1.0
ppTMS	paired-pulse tms	1.0
3MT	3-methoxytyramine	1.0
LPPC	lateral posterior parietal cortex	1.0
F-J	cfluoro-jade c	1.0
pAOB	posterior accessory olfactory bulb	0.666666666667
pAOB	posterior aob	0.333333333333
LVGCCL-	type voltage-gated calcium channels	1.0
3MG	threo-3-methyl glutamate	1.0
HMWMAP2	high molecular weight map2 isoforms	1.0
HADS	hospital anxiety and depression scale	0.5
HADS	hospital anxiety depression scales	0.5
3MA	3-methyladenin	0.333333333333
3MA	3-methyladenine	0.666666666667
cdLOP	cyclo1-8[dleu5]op	1.0
SYM22061	2-dihydro-1-methyl-2-propylcarbamoyl-6,7-methylenedioxyphthalazine	1.0
GVIA	ω-cgtx	0.1
GVIA	omega-conotoxin-gvia	0.1
GVIA	ω-conotoxin gvia	0.7
GVIA	omega conotoxin gvia	0.1
NFPSN	[3-(4-fluorophenil)-3-(4’-phenilphenoxy)]propylsarcosine	1.0
Endo-N	endoneuraminidase-n	1.0
rpL	32ribosomal protein l32	1.0
PFA-PBS	4% paraformaldehyde in phosphate-buffered saline	0.5
PFA-PBS	paraformaldehyde dissolved in pbs	0.5
KRBGK	rebs ringer bicarbonate glucose	1.0
cGKII	cgmp-dependent protein kinase ii	1.0
DHCDHI	contralateral, ipsilateral dorsal spinal horns	1.0
SST-	2skin surface thermoprobe	1.0
MeA	medial amygdala	0.625
MeA	medial amygdaloid nucleus	0.25
MeA	methylanthranilate	0.125
RJR-	2403(e)-n-methyl-4-(3-pyridinyl)-3-buten-1-amine	1.0
TANCOVA	topographic analysis of covariance	1.0
GlcA	glucuronic acid	1.0
ES-A	endurance sport athletes	1.0
fcMRI	functional connectivity magnetic resonance image	0.5
fcMRI	functional connectivity magnetic resonance imaging	0.5
LNAL	ocked-nucleic acid	1.0
LEU	leucine	1.0
mESC	smouse embryonic stem cells	0.2
mESC	miniature esc	0.2
mESC	miniature excitatory synaptic current	0.4
mESC	mouse embryonic stem cell	0.2
MBEC	smouse brain endothelial cells	0.333333333333
MBEC	mouse brain capillary endothelial cells	0.333333333333
MBEC	mouse brain endothelial cell	0.333333333333
LSCM	laser-scanning confocal microscopy	0.333333333333
LSCM	laser scanning confocal microscopy	0.333333333333
LSCM	laser scanning confocal microscope	0.333333333333
pLV-NT	3lentiviral plasmid encoding nt3	1.0
SAP102	synapse-associated protein of mol. wt 102,000	1.0
QP	coefficient of variation of qp	0.5
QP	quinpirole	0.5
LKB	1liver kinase b1	1.0
nIII	oculomotor nucleus	1.0
GABA-IRGABA	immunoreactivity	1.0
TMB-83	4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester	1.0
EDTAE	thylenediaminetetraacetic acid	1.0
CIRA	cirazoline hydrochloride	1.0
UHFV	ultra-high frequency vocalization	1.0
5NPI	5 non-paced intromissions	1.0
MOCS	medial olivocochlear system	1.0
SSTR	somatostatin receptor	0.8
SSTR	somatostatin receptors	0.2
RKIPR	af kinase inhibitor protein	0.5
RKIPR	af kinase inhibitory protein	0.5
AMOA	(r,s)-2-amino-3-[3-(carboxymethoxy)-5-methyl-isoxazol-4-y1]-propionic acid	1.0
PPEnk	preproenkephalin	1.0
IGABA	gaba-activated current	1.0
RANTES	regulated on activation, normal t expressed and secreted	0.25
RANTES	regulated upon activation normal t cell expressed and secreted factor	0.25
RANTES	regulated on activation of normal t cell expressed and secreted	0.25
RANTES	regulated on activation t-cells expressed and secreted	0.25
dDG	dorsal dentate gyrus	0.5
dDG	dentate gyrus, dorsal part	0.5
1H-NMR	1h nuclear magnetic resonance	1.0
SMH	secondary mechanical hypersensitivity	1.0
GDF-5	growth/differentiation factor-5	1.0
EAAC	1excitatory amino-acid carrier 1	0.0416666666667
EAAC	1excitatory amino acid (glutamate) transporter 1	0.0416666666667
EAAC	excitatory amino acid carrier	0.125
EAAC	1excitatory aminoacid transporter 1	0.0416666666667
EAAC	rabbit excitatory amino acid carrier	0.0416666666667
EAAC	1excitatory amino acid 1	0.0416666666667
EAAC	1excitatory amino acid transporter-1	0.0416666666667
EAAC	1excitatory amino acid carrier 1	0.416666666667
EAAC	1excitatory amino acid channel 1	0.0416666666667
EAAC	1excitatory amino acid carrier-1	0.0833333333333
EAAC	1-ireaac1-immunoreactive	0.0416666666667
EAAC	1excitatory amino acid carrier	0.0416666666667
TEOAE	transiently evoked otoacoustic emission	1.0
YMY-	maze	1.0
MNK	1map kinase-interacting protein kinase-1	1.0
HMWMAP	2high molecular-weight microtubule-associated protein-2	1.0
BNSTALG	anterolateral bed nucleus of the stria terminalis	0.5
BNSTALG	anterolateral cell group of the bed nucleus of the stria terminalis	0.5
VHS	visceral hypersensitivity	1.0
TBSTG	tbs containing triton x-100 and gelatin	1.0
TBSTX	tris-buffered saline with 0.05% triton x-100	0.5
TBSTX	tris-buffered saline with triton x-100	0.5
mCMV	mouse cytomegalovirus immediate early promoter	1.0
GSH-Px	glutathione peroxidase	1.0
VHG	very high glucose	0.5
VHG	sapo lesion+graft in the ventral hippocampus	0.5
VHF	very high frequency	1.0
TBSTT	ris-buffered saline and tween 20	0.0152671755725
TBSTT	ris-buffered saline+tween 20	0.00763358778626
TBSTT	ris-buffered saline containing tween-20	0.00763358778626
TBSTT	ris-buffered saline with 0.1% tween-20	0.0458015267176
TBSTT	ris-buffered saline plus triton x-100	0.00763358778626
TBSTT	ris-buffered saline–tween20	0.00763358778626
TBSTT	ween in tris-buffered saline	0.00763358778626
TBSTT	ween in tbs	0.00763358778626
TBSTT	ris-buffered saline plus 0.1% tween-20	0.00763358778626
TBSTT	ris-buffered saline containing 0.1% triton x-100	0.0381679389313
TBSTT	ris-buffered saline tween 20	0.0229007633588
TBSTT	ris-buffered saline containing tween 20	0.00763358778626
TBSTT	ris buffer containing tween 20	0.00763358778626
TBSTT	ris–buffered-saline-tween-20	0.00763358778626
TBSTT	ris-buffered saline containing 0.5% tween-20	0.00763358778626
TBSTT	ris-buffered saline–tween 20	0.00763358778626
TBSTT	ris-buffered saline containing triton x-100	0.00763358778626
TBSTT	ris buffer (ph 7.4) containing 0.8% nacl and 0.05% triton x-100	0.00763358778626
TBSTT	ris-buffered saline tween-20 solution	0.00763358778626
TBSTT	ris buffer saline plus 0.05% tween 20	0.00763358778626
TBSTT	ris-buffered saline and 0.05% tween-20	0.00763358778626
TBSTT	ris-buffered saline containing .01% tween-20	0.00763358778626
TBSTT	ris buffered saline+0.05% tween 20	0.00763358778626
TBSTT	ris-buffered saline containing 0.05% tween	0.0229007633588
TBSTT	ris buffered saline with tween-20	0.00763358778626
TBSTT	ris buffer with triton x-100	0.00763358778626
TBSTT	ris buffer with 0.1% tween 20	0.00763358778626
TBSTT	ris (0.05m)-buffered saline plus 0.3% of triton x-100	0.00763358778626
TBSTT	ris buffer saline with tween 20	0.00763358778626
TBSTT	ris-buffer saline containing 0.05% tween-20	0.00763358778626
TBSTT	ris-buffered saline with 0.05% tween-20	0.0229007633588
TBSTT	ris buffered saline containing 0.1% triton x-100	0.00763358778626
TBSTT	ris-buffered saline containing 0.1% tween-20	0.030534351145
TBSTT	ris-buffered saline ph 8.0 containing 0.5% triton x-100	0.00763358778626
TBSTT	ris–buffer saline with 0.05% tween-20	0.00763358778626
TBSTT	ris–hcl-buffered saline with triton x-100	0.00763358778626
TBSTT	ris–buffered saline containing 0.5% triton x-100	0.00763358778626
TBSTT	ris-buffered saline with tween 20	0.0610687022901
TBSTT	ritonx-100 in tbs	0.00763358778626
TBSTT	ris buffer plus 0.5% tween-20	0.00763358778626
TBSTT	ris-buffered saline+tween-20	0.00763358778626
TBSTT	ris buffered saline with 0.05% tween 20	0.00763358778626
TBSTT	ris buffered saline with tween 20	0.00763358778626
TBSTT	ris-buffered saline tween-20	0.0229007633588
TBSTT	ris-buffered saline (ph 7.6) containing 0.1% tween-20	0.00763358778626
TBSTT	ris buffer with 0.9% nacl and triton-x-100	0.00763358778626
TBSTT	ris-buffered saline	0.00763358778626
TBSTT	ris-buffered saline containing 0.05% tween 20	0.00763358778626
TBSTT	ris-buffered saline + tween 20	0.00763358778626
TBSTT	ris-buffer–saline–tween	0.00763358778626
TBSTT	ween 20–tris-buffered saline	0.00763358778626
TBSTT	ris-buffered saline with 0.2% tween-20	0.00763358778626
TBSTT	ris-buffered saline tween	0.0229007633588
TBSTT	ris-buffered saline containing 0.3% tween-20	0.0152671755725
TBSTT	ris-buffered saline-tween	0.00763358778626
TBSTT	ris-buffered saline containing 0.1% (v/v) tween 20	0.00763358778626
TBSTT	ris-buffered saline plus 0.1% triton x-100	0.00763358778626
TBSTT	ris-buffered saline and tween20	0.00763358778626
TBSTT	ris-buffered saline supplemented with tween-20	0.00763358778626
TBSTT	ris-buffered saline containing 0.1% tween 20	0.0381679389313
TBSTT	ris-buffered saline containing 0.5% tween 20	0.00763358778626
TBSTT	ris–hcl buffer containing 0.5 m and 0.05% tween 20	0.00763358778626
TBSTT	ris-buffered saline with triton x-100	0.0381679389313
TBSTT	ris-buffered saline containing tween	0.00763358778626
TBSTT	ris-buffered saline with 0.5% tween 20	0.00763358778626
TBSTT	ris-buffered saline containing 0.05% tween-20	0.0458015267176
TBSTT	ris-buffered saline containing 0.01% triton x-100	0.00763358778626
TBSTT	ris-buffered saline with tween	0.0381679389313
TBSTT	ris-buffered saline+0.1% tween-20	0.00763358778626
TBSTT	ris-buffered saline with tween-20	0.0152671755725
TBSTT	ris-buffered saline plus 0.05% tween 20	0.00763358778626
TBSTT	ris-buffered saline containing 0.2% tween-20	0.00763358778626
TBSTT	ris-buffered saline and tween-20	0.0152671755725
TBSTT	ris-buffered saline containing 0.01% (v/v) tween-20	0.00763358778626
TBSTT	ris-buffered saline with 0.1% tween 20	0.0534351145038
FLC	fibroblast-like cell	0.5
FLC	flowering locus c	0.5
VHC	ventral hippocampus	0.5
VHC	vestibular hair cells	0.5
l-NAMEN	(omega)-nitro-l-arginine methyl ester	0.333333333333
l-NAMEN	6-nitro-l-arginine methylester	0.333333333333
l-NAMEN	(g) nitro-l-arginine methyl ester	0.333333333333
DAMGO	[d-ala2,n-me-phe4,gly-ol]enkephalin	0.0227272727273
DAMGO	[d-ala2,n-me-phe4,gly5-ol]enkephalin	0.0681818181818
DAMGO	[d-ala2,n-me-phe4,gly-ol5]-enkephalin	0.0454545454545
DAMGO	[d-ala(2), n-mephe(4), gly-ol(5)]-enkephalin	0.0227272727273
DAMGO	????	0.0227272727273
DAMGO	[d-ala(2), n-me-phe(4), gly(5)-ol]-enkephalin	0.0227272727273
DAMGO	d-ala2,n-mephe4,gly5-ol-enkephalin	0.0227272727273
DAMGO	h-tyr-d-ala-gly-phe(n-me)-gly-ol	0.0227272727273
DAMGO	[d-ala2,mephe4,gly-ol5]enkephalin	0.0227272727273
DAMGO	[d-ala2,n-mephe4,gly-ol5]-enkephalin	0.0227272727273
DAMGO	[d-ala2me-phe4gly-ol5]enkephalin	0.0227272727273
DAMGO	d-ala2-mephe4-gly-ol5 enkephalin	0.0227272727273
DAMGO	[d-ala2,n-me-phe4,gly 5-ol]-enkephalin	0.0227272727273
DAMGO	[d-ala2-mephe4-gly(ol)5]enkephalin	0.0227272727273
DAMGO	[d-ala(2)-mephe(4)-gly(5)-ol]enkephalin	0.0227272727273
DAMGO	[d-ala2, n-me-phe4,gly5-ol]-enkephalin	0.0227272727273
DAMGO	[d-ala2, n-mephe4,gly-ol5]-enkephalin	0.0227272727273
DAMGO	[d-ala2,n-me-phe4,gly-ol5]enkephalin	0.0681818181818
DAMGO	[d-ala2 nme-phe4 gly-ol5]-enkephalin	0.0227272727273
DAMGO	[d-ala2, nmephe4, gly(ol)5]enkephalin	0.0454545454545
DAMGO	tyr-d-ala-gly-mephe-gly-ol	0.0227272727273
DAMGO	[d-ala2,mephe4,gly-ol5] enkephalin	0.0227272727273
DAMGO	d-ala2,nme-phe4,glyol5-enkephalin	0.0227272727273
DAMGO	[d-ala2,mephe4,gly-ol5]-enkephalin	0.0227272727273
DAMGO	[d-ala2,n-methyl-phe4,gly-ol5]-enkephalin	0.0227272727273
DAMGO	[d-ala2,n-mephe4,gly-ol5]enkephalin	0.0681818181818
DAMGO	tyr-d-ala-gly-n-methyl-phe-gly-ol	0.0227272727273
DAMGO	d-ala2,n-me-phe4,gly-ol5-enkephalin	0.0454545454545
DAMGO	[d-ala2,nhphe4,gly-ol]enkephalin	0.0227272727273
DAMGO	d-ala2-n-methyl-phe4-gly-ol5 enkephalin	0.0227272727273
DAMGO	[d-ala2,n-me-phe4,gly5-ol]-enkephalin	0.0681818181818
DAMGO	[d-ala2-n-methyl-phe4-gly5 ol] enkephalin	0.0454545454545
OBP	odorant binding protein	1.0
dNGA	dbda and dnta, internal standard rnas for ngf mrna, bdnf mrna and nt-3 mrna, respectively	1.0
glutathione-S-	transferase	1.0
cPC	central pc	0.333333333333
cPC	central piriform cortex	0.666666666667
L-DOPAl-3	4-dihydroxyphenylalanine	1.0
TXA	2thromboxane a2	1.0
DUMAS	drexel university image analysis system	1.0
DENO	denopamine	1.0
DNP2	4-dinitrophenylhydrazone	0.166666666667
DNP2	4-dinitrophenyl	0.166666666667
DNP2	4-dinitrophenyl hydrazone	0.333333333333
DNP2	4-dinitrophenylhydrazine	0.333333333333
EAAs	excitatory amino acids	1.0
EM-2	endomorphin-2	1.0
TXT	riton x 100	0.0588235294118
TXT	riton x-100	0.647058823529
TXT	riton x	0.0588235294118
TXT	riton-x	0.176470588235
TXT	riton-x 100	0.0588235294118
TXR	texas red-conjugated	0.5
TXR	texas red	0.5
TX-	100triton x-100	0.833333333333
TX-	100tritonx-100	0.0833333333333
TX-	100triton-x-100	0.0833333333333
sLFS	strong low-frequency stimulation	1.0
TMJD	temporomandibular joint disorder	1.0
5-HTP-B	l-5-hydroxytryptophan plus benserazide	1.0
dSPN	direct pathway spn	1.0
DNPH	dinitrophenylhydrazine	0.545454545455
DNPH	4-dinitrophenylhydrazine	0.181818181818
DNPH	2,4-dinitrophenylhydrazine	0.272727272727
DNPI	differentiation-associated na+-dependent inorganic phosphate co-transporter	1.0
DNPV	differential normal pulse voltammetry	1.0
CAMKII-α	alpha-type ii calcium/calmodulin-dependent protein kinase	1.0
DELT	ile5,6deltorphin b	0.5
DELT	d-ala2-deltorphin ii	0.5
DiIC18	1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	1.0
dSPZ	dorsal subparaventricular zone	1.0
ONOO-	peroxynitrite	0.857142857143
ONOO-	and pnperoxynitrite	0.0714285714286
ONOO-	peroxynitrate	0.0714285714286
gLMSG	eneral labeled magnitude scale	1.0
CYNCYN-	154806	1.0
RskII	ribosomal protein s6 serine kinase ii (pp90rsk, creb kinase)	1.0
NPC-17742	2r,4r,5s-2-amino-4,5-(1,2-cyclohexyl)-7-phosphoheptanoic acid	1.0
WCST-PEW	isconsin card sorting test-perseverative errors	1.0
DCKA5	7-dichlorokynurenic acid	1.0
I-B4	griffonia simplicifolia	1.0
PBTx	pb with 0.5% triton-x 100	1.0
QL	quadratus lumborum	0.5
QL	quantification limit	0.5
VH-	venspinal cord ventral horn	1.0
H2DCFDAcarboxyl-2	7-dichlorodihydrofluorescin diacetate	1.0
BROI	brain region of interest	1.0
tSNR	signal-to-noise ratios	1.0
PC-PLC	phosphatidylcholine-specific phospholipase c	0.333333333333
PC-PLC	phosphatidylcholine specific phospholipase c	0.333333333333
PC-PLC	phosphatidylcholine-phospholipase c	0.333333333333
devCTL	developmental control treatment	1.0
WINWIN55-212	2	1.0
Sp-cAMPS	sp-adenosine 3′5′-cyclic monophosphothioate triethylamine	1.0
DEVD-MCA	ac-asp-glu-val-asp-α-(4-methyl-coumaryl-7-amide)	1.0
AAPD	atypical antipsychotic drug	1.0
CWFG	cold water fish gelatin	1.0
PBAN	pheromone biosynthesis activating peptide	1.0
DSMO	dimethylsulfoxide	1.0
NTSm	medial nts	1.0
NTSl	lateral nts	1.0
NARP	neuronal activity regulated pentraxin	0.5
NARP	neuronal activity-regulated pentraxin	0.5
PART	partial	1.0
pFAS	partial fetal alcohol syndrome	1.0
cACT	contralateral henisphere of act	1.0
DOR1	cloned δ-opioid receptor	1.0
HNF-	6hepatocyte nuclear factor 6	0.5
HNF-	1βhepatocyte nuclear factor-1β	0.5
IRAK-	1/4 inhibitor	1.0
Sp-cAMPs	sp-adenosine 3′,5′-monophosphothioate triethylamine	1.0
ABS	manterior biceps-semimembranosus	1.0
GLAST-1	glutamate/aspartate transporter-1	1.0
BRK-1	bone morphogenic protein receptor kinase-1	1.0
NTSR	rostral portion of the nts	1.0
ALDO	aldolase	1.0
PAX	6paired box gene 6	1.0
cACA	caudal anterior cingulate cortex	1.0
ALp	posterior nucleus of the ansa lenticularis	1.0
cACC	caudal anterior cingulate cortex	0.666666666667
cACC	caudal acc	0.333333333333
ALDH	2aldehyde dehydrogenase 2	0.25
ALDH	aldehyde dehydrogenase	0.25
ALDH	1l1aldehyde dehydrogenase 1 family member l1	0.25
ALDH	1aldehyde dehydrogenase 1a1	0.25
DOR-	egfpdelta opioid receptor in fusion with the enhanced green fluorescent protein	1.0
NTSC	caudal portion of the nts	1.0
TBS-TSTBS	/0.1% triton x-100/3% donkey serum	1.0
DBAD	olichos biflorus lectin	0.5
DBAD	olichos biflorus agglutinin	0.5
FVII	afactor viia	1.0
WRC	wheel-running control	1.0
LIBRAL	ibrary for robust analysis	1.0
WRJ	wild running and jumping	1.0
NTS1	2, 3, neurotensin-receptor subtype 1, 2, 3	1.0
EM-ICC	electron microscopic immunocytochemistry	1.0
BVA	biological variance analysis	1.0
aMTG	anterior middle temporal gyrus	1.0
E64	trans-epoxy succinyl-l-leucylamido-(4-guanidino) butane	1.0
BSTFAN	o-bis(trimethylsilyl)trifluoroacetamide	1.0
8cG	and 8vgrespectively cochlear and vestibular ganglia	1.0
B6B10	balb, c3h and cast, five inbred strains of mice	1.0
NVIQ	nonverbal intelligence	1.0
vlM	ventrolateral medulla	1.0
PDCl-trans-2	4-pyrrolidine dicarboxylate	1.0
MEJPS	miniature excitatory junctional potentials	1.0
AS-ODN	antisense-oligonucleotide	0.2
AS-ODN	antisense oligonucleotides	0.2
AS-ODN	antisense oligodeoxynucleotide	0.6
L-NOARGNω-	nitro-l-arginine	1.0
WTET	weak tetanization	0.5
WTET	weak tetanus	0.5
LC-PUFA	long-chain polyunsaturated fatty acid	1.0
early-LTP	early-phase ltp	1.0
1S3R	4s)-1-aminocyclopentane-1,2,4-tricarboxylic acid	1.0
ASCI	acute spinal cord injury	1.0
NVII	facial nerve	0.5
NVII	facial nucleus	0.5
NTS	nucleus of the tractus solitaries	0.00328947368421
NTS	neurons	0.00328947368421
NTS	1neurotensin receptor 1	0.00328947368421
NTS	* nucleus tractus solitarius	0.00328947368421
NTS	nucleus of the tractus solitarii	0.00328947368421
NTS	tractus solitarius nuclei	0.00328947368421
NTS	solitary tract nucleus	0.0230263157895
NTS	rrostral part of the nucleus of the solitary tract	0.00328947368421
NTS	the nucleus of the tractus solitarius	0.00986842105263
NTS	nucleus tractus solitaris	0.00657894736842
NTS	nucleus tractus solitarius	0.315789473684
NTS	nucleus tractus solitaril	0.00328947368421
NTS	nucleus tractus solitarii	0.144736842105
NTS	solitary nucleus	0.00328947368421
NTS	nucleus tractus solitaries	0.00657894736842
NTS	(co/ge/l/m)nucleus of the solitary tract (commissural part/gelatinous part/lateral part/medial part)	0.00328947368421
NTS	nucleus of the solitary tract	0.371710526316
NTS	/apnucleus of the solitary tract adjacent to the area postrema	0.00328947368421
NTS	1high affinity neurotensin receptor	0.00328947368421
NTS	nucleus of tractus solitarius or nucleus tractus solitarii	0.00328947368421
NTS	nuclei tractus solitarius	0.00328947368421
NTS	nucleus of the solitary track	0.00328947368421
NTS	nucleus of solitary tract	0.0328947368421
NTS	nucleus of tractus solitarius	0.00657894736842
NTS	nucleus of the tractus solitarius	0.0296052631579
NTS	cnucleus tractus solitarius	0.00328947368421
PTCCP	eak to trough correlation coefficient	1.0
PS-NC	non-copulator of prenatally stressed group	1.0
CFAC	omplete freund’s adjuvent	0.0769230769231
CFAC	omplete freunds adjuvant	0.0769230769231
CFAC	omplete freund's adjuvant	0.230769230769
CFAC	omplete freund’s adjuvant	0.615384615385
CFAF	reund's complete adjuvant	1.0
3S	4ar, 6r, 8ar)-6-[2-(1(2) h-tetrazol-5-yl) ethyl]-decahydroisoquinoline-3-carboxylic acid}	0.333333333333
3S	4ar, 6s, 8ar)-6-((4-carboxyphenyl)methyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid]	0.333333333333
3S	4ar,6r,8ar)-6-[2-(1(2)h-tetrazol-5-yl)ethyl]-decahydroisoquinoline-3-carboxylic acid}	0.333333333333
3R	4r)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2h benzimidazol-2-one	1.0
semaIII	semaphorin iii/d	1.0
3P	three pairs of conditioning sessions	1.0
3W	three weeks	1.0
3V	3rd ventricle	0.178571428571
3V	third ventricule	0.0357142857143
3V	third ventricle	0.785714285714
tIPSP	tetanic stimulus-evoked inhibitory postsynaptic potential	1.0
UOC	uncrossed olivocochlear pathways	1.0
JHDMJ	mjc domain-containing histone demethylase	1.0
3H	]preg7-3h(n)-pregnenolone	0.0238095238095
3H	]sp[3h]	0.0238095238095
3H	]pk11195	0.0238095238095
3H	]ip[3h]	0.0238095238095
3H	]diprenorphine	0.0238095238095
3H	]insp[3h]	0.0238095238095
3H	]dopamine uptake	0.0238095238095
3H	]-glu[3h]	0.0238095238095
3H	]-prz[3h]	0.0238095238095
3H	] mk-801 binding	0.0238095238095
3H	]nα-methylhistamine binding	0.0238095238095
3H	]nisoxetine	0.0238095238095
3H	]-nmhan-α-[methyl-3h]	0.0238095238095
3H	]-dpat[3h]	0.0238095238095
3H	]preg[7-3h(n)]	0.0238095238095
3H	]damgo[3h]	0.0238095238095
3H	]aa[3h]	0.0238095238095
3H	]epibatidine	0.0238095238095
3H	]-8-oh-dpat[3h]	0.047619047619
3H	]qnb[3h]	0.0238095238095
3H	]-nbti[3h]	0.0238095238095
3H	]mus[3h]	0.0238095238095
3H	]-cytisine	0.0238095238095
3H	]s100	0.0238095238095
3H	]dpr[3h]	0.0238095238095
3H	]pk111951-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinoline carboxamide	0.0238095238095
3H	]eb[3h]	0.0238095238095
3H	]5α-dhp[3h]	0.0238095238095
3H	]-ach[3h]	0.0238095238095
3H	]d-aspartate	0.0238095238095
3H	]rauwolscine	0.0238095238095
3H	]prazosin	0.0238095238095
3H	]thymidine uptake	0.0238095238095
3H	]cgp 54626	0.0238095238095
3H	]az11637326	0.0238095238095
3H	]dopamine release	0.0238095238095
3H	]8-oh-dpat[3h]	0.0238095238095
3H	]-dpcpx[3h]	0.0238095238095
3H	] l-glutamate	0.0238095238095
3H	]zm241385[2-3h]	0.0238095238095
3H	]-ach release	0.0238095238095
3N	oculomotor nu	0.333333333333
3N	oculomotor nucleus	0.666666666667
3M	three months	1.0
PPT-A	preprotachykinin-a	0.2
PPT-A	preprotachykinin a	0.8
IPDd	inferior precentral dimple-dorsal	1.0
Fos-LIR	fos-like immunoreactivity	1.0
d-Pen2	5]-enkephalin hydrate	0.0833333333333
d-Pen2	d-pen5]enkephalin	0.166666666667
d-Pen2	5]-enkephalin	0.0833333333333
d-Pen2	d-pen5]enkephalin/[d-pen2,5]	0.0833333333333
d-Pen2	d-pen5]-enkephalin	0.5
d-Pen2	d-pen5)-enkephalin	0.0833333333333
GSA-IB	4griffonia simplicifolia isolectin b4	1.0
pENK	pro-enkephalin	1.0
SNKS	tudent–neuman–keul’s	0.0714285714286
SNKS	tudent–newman–keuls	0.214285714286
SNKS	tudent–newman–keuls test	0.0714285714286
SNKS	tudent-newman-keuls	0.357142857143
SNKS	tudent-neuman-keuls	0.142857142857
SNKS	tudent newman-keuls	0.0714285714286
SNKS	tudent–neuman–keuls	0.0714285714286
SCI-S	spinal cord–injured animal receiving saline	1.0
3D	3 dimensions	0.0222222222222
3D	3 days	0.0222222222222
3D	3-dimensional	0.0222222222222
3D	three-dimensional	0.6
3D	space	0.0222222222222
3D	pharmacophore model	0.0222222222222
3D	three dimensional	0.0888888888889
3D	reconstructions	0.0222222222222
3D	three dimensionally	0.0222222222222
3D	reconstruction	0.0666666666667
3D	three dimensions	0.0444444444444
3D	surface models	0.0222222222222
3D	3 dimensional	0.0222222222222
IUI	nternational unit	1.0
VPAC	1/vpac2pacap and vip mutual receptors	0.25
VPAC	vasoactive intestinal peptide receptor subtype	0.25
VPAC	1 and vpac2vasoactive intestinal peptide receptors	0.25
VPAC	1-r and vpac2-rpituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide mutual receptors	0.25
ASCF	artificial cerebrospinal fluid	1.0
rod-ON	bipolar cellrod-dominant on-type bipolar cell	1.0
VPAG	periaqueductal grey, ventral nuclei	1.0
NTH	1endonuclease iii homologue 1 glycosylase	0.5
NTH	1endonuclease iii homologue	0.5
MAPKKK	mitogen-activated protein kinase kinase kinase	0.75
MAPKKK	smitogen-activated protein kinase kinase kinase	0.25
hCRF	rat/human crf	1.0
IUE	in utero electroporation	1.0
JC-15	5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazole-carbocyanide iodine	0.111111111111
JC-15	5’,6,6’-tetrachloro-1,1’,3,3’ tetraethylbenzimidazolylcarbocyanine iodide	0.111111111111
JC-15	5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolyl-carbocyanine iodide	0.111111111111
JC-15	5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcabocyanine iodine, t-3168	0.111111111111
JC-15	5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolocarbocyanine iodide	0.111111111111
JC-15	5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide	0.444444444444
PN-1	protease nexin-1	1.0
California	los angeles	1.0
Orl	orconectes limosus	1.0
RT-PCRR	everse transcription-polymerase chain reaction	0.125
RT-PCRR	eal-time polymerase chain reaction	0.25
RT-PCRR	everse transcription polymerase chain reaction	0.25
RT-PCRR	everse transcription–polymerase chain reaction	0.125
RT-PCRR	everse transcription-pcr	0.125
RT-PCRR	everse transcriptase-polymerase chain reaction	0.125
Sp-cAMP	rp- and sp-adenosine-3′,5′-cyclic monophosphothioates	1.0
Ori	stratum oriens	1.0
SSANOVA	smoothing spline analysis of variance	1.0
IUR	isotropic uniform random	1.0
NTL	lateral tuberal nucleus	1.0
FOVF	ield-of-view	0.5
FOVF	ield of view	0.5
FTS	facteur thymique serique	1.0
FTR	first trial responses	1.0
RDLN	retrodorsal lateral motor nucleus (l5–l6)	0.333333333333
RDLN	retrodorsolateral nucleus	0.666666666667
FTT	food tolerance test	0.5
FTT	finger-tapping task	0.5
FJ-CF	luoro-jade c	1.0
FTX	funnel-web spider toxin	1.0
MPLN-	methylpyrrolidone	1.0
IMAC	immobilized metal affinity chromatography	0.5
IMAC	immobilized metal (fe+3 or al+3) affinity chromatography	0.5
NTA	nitrilotriacetate	1.0
FTC	frequency tuning curve	1.0
FTE	first trial effect	1.0
SCAMP	secretory carrier-associated membrane protein	0.5
SCAMP	5secretory carrier associated membrane protein 5	0.5
FTG	gigantocellular tegmental field	1.0
GRIA	2glutamate receptor ampa subunit alpha 2	1.0
FTI	farnesyl transferase inhibitor	1.0
PERG	pattern electroretinogram	1.0
WISDOM	women’s international study of long duration oestrogen after the menopause	1.0
FWEF	amily-wise error	1.0
ALT	alanine transaminase	0.666666666667
ALT	alternative lengthening of telomeres	0.333333333333
FTO	genefat-mass and obesity-associated gene	1.0
FTN	floccular target neuron	0.333333333333
FTN	sfloccular target neurons	0.333333333333
FTN	flocculus target neurons	0.333333333333
DORδ-	opioid receptor	1.0
NTB	non-transferrin bound	1.0
PMBSF	postero-medial barrel sub-field	0.111111111111
PMBSF	posterior medial barrel subfield	0.111111111111
PMBSF	postero-medial barrel subfield	0.111111111111
PMBSF	posteromedial barrel subfield	0.555555555556
PMBSF	posteromedial barrel subfield of somatosensory cortex	0.111111111111
eGFP	enhanced gfp	0.03125
eGFP	‘enhanced’ green fluorescent protein	0.03125
eGFP	enhanced green fluorescent protein	0.84375
eGFP	green fluorescent protein	0.0625
eGFP	endogenous green fluorescent protein	0.03125
NTD	naltrindole	1.0
FAS-L	fas ligand	1.0
PERK	protein kinase rna (pkr)-like er kinase	0.142857142857
PERK	double-stranded rna-activated protein kinase-like er kinase	0.142857142857
PERK	pancreatic endoplasmic reticulum kinase	0.142857142857
PERK	protein kinase rna-like er kinase	0.142857142857
PERK	double-stranded rna-dependent protein kinase-like endoplasmic reticulum kinase	0.142857142857
PERK	double-stranded rna-activated protein kinase-like endoplasmic reticulumkinase	0.142857142857
PERK	phospho-pkr-like endoreticulum (er)-localized elf2 kinase	0.142857142857
bNOS	brain nitric oxide synthase	1.0
mPD1	3-phenylenediamine	1.0
6R-BH4	6r-tetrahydrobiopterin	1.0
5-HTergic	serotonergic	1.0
PBSTPBS-	0.1% triton x-100	0.5
PBSTPBS-	containing triton x-100	0.5
DCD	eiter's cell	0.333333333333
DCD	diabetic cognitive dysfunction	0.333333333333
DCD	cut whisker	0.333333333333
MTLE	mesial temporal lobe epilepsy syndrome	0.0909090909091
MTLE	mesial temporal lobe epilepsy	0.909090909091
FP	frontal pole	0.0526315789474
FP	field potential	0.315789473684
FP	forward rotated initial posture	0.0263157894737
FP	front paw	0.0263157894737
FP	fluid-percussion	0.0263157894737
FP	free probe	0.0263157894737
FP	fungiform papillae	0.0263157894737
FP	field potentials	0.0263157894737
FP	receptorprostaglandin f2α receptor	0.0263157894737
FP	frontopolar	0.0263157894737
FP	fixation point	0.131578947368
FP	frontoparietal	0.0263157894737
FP	functional prosthesis	0.0263157894737
FP	follicular phase	0.0263157894737
FP	fluid percussion	0.105263157895
FP	forward primer	0.0263157894737
FP	–/–fp knockout	0.0263157894737
FP	4floor plate marker 4	0.0263157894737
FP	sfield potentials	0.0263157894737
FQ	receptor	0.333333333333
FQ	peptide	0.333333333333
FQ	nociceptin	0.333333333333
FR	fluororuby conjugated to dextran amine	0.0120481927711
FR	fixed-ratio-1	0.0120481927711
FR	food-restricted	0.0120481927711
FR	food-restriction	0.0120481927711
FR	firing rate	0.0240963855422
FR	food restriction	0.0481927710843
FR	5fixed ratio 5	0.0361445783133
FR	sfreezers	0.0120481927711
FR	fixed-ratio	0.0120481927711
FR	fractional release	0.0843373493976
FR	1fixed ratio 1	0.0240963855422
FR	cfood-restricted controls	0.0120481927711
FR	freezers	0.0120481927711
FR	(3)fixed ratio 3	0.0120481927711
FR	fasciculus retroflexus	0.0361445783133
FR	16fixed ratio 16	0.0120481927711
FR	1fixed-ratio 1	0.0361445783133
FR	4fixed ratio 4	0.0120481927711
FR	236924	0.0120481927711
FR	fluorored	0.0120481927711
FR	fully reduced	0.0120481927711
FR	free radical	0.0120481927711
FR	2fixed ratio 2	0.0120481927711
FR	rhodamine dextran amine (fluoro ruby)	0.0120481927711
FR	50maternal 50% food restriction	0.0120481927711
FR	fluororuby	0.0722891566265
FR	front-rear	0.0120481927711
FR	1fixed-ratio 1 schedule of reinforcement	0.0120481927711
FR	fixed ratio	0.397590361446
FS	filled square	0.0208333333333
FS	footpad stimuli	0.0208333333333
FS	fast-spiking	0.4375
FS	footshock	0.0625
FS	forced swim stress	0.0416666666667
FS	fast spiking cell	0.0208333333333
FS	foot shock	0.0208333333333
FS	fast-spiking, non-accommodating (cells)	0.0208333333333
FS	fluorescein	0.0416666666667
FS	free shaping	0.0208333333333
FS	fast-spiking (cortical neuron)	0.0208333333333
FS	functional source	0.0208333333333
FS	fast spiking	0.104166666667
FS	forced swim	0.0625
FS	fluorescein conjugated to dextran amine	0.0208333333333
FS	forced swimming	0.0416666666667
FS	fluorescein–dextran amine	0.0208333333333
FT	tuning to figure's shape	0.125
FT	full-term	0.125
FT	fatigue test	0.25
FT	fixed time	0.125
FT	forced trial	0.125
FT	asefarnesyl transferase	0.125
FT	tuning to figure shape	0.125
FU	fluorescence unit	1.0
FV	fiber volley	1.0
FW	leaning forward	1.0
FX	fornix	1.0
MDc	central md	1.0
SMU	single motor unit	1.0
SMT	submedial nucleus of thalamus	0.2
SMT	spinomesencephalic tract	0.2
SMT	submammillothalamic nucleus	0.2
SMT	s-methylisothiourea	0.2
SMT	superior and middle temporal gyri	0.2
SMS	sphingomyelin synthase	0.333333333333
SMS	space motion sickness	0.333333333333
SMS	sensorimotor synchronization	0.333333333333
SMR	spinal motor reflex	1.0
SMP	submitochondrial particles	1.0
SMO	smoothened receptor	1.0
pLHA	perifornical lateral hypothalamic area	1.0
FB	forebrain seizure	0.0384615384615
FB	foot boundary	0.0384615384615
FB	fast blue	0.576923076923
FB	mabfunction-blocking anti-integrin α2 monoclonal antibody	0.0384615384615
FB	1fumonisin b1	0.0384615384615
FB	false belief	0.0384615384615
FB	fan-shaped body	0.0384615384615
FB	forebrain	0.0384615384615
FB	background fluorescence	0.0384615384615
FB	fastblue	0.0384615384615
FB	first burst	0.0384615384615
FB	front brain	0.0384615384615
FC	mean frequency of correlated discharges	0.0238095238095
FC	fusiform cells	0.0238095238095
FC	sfusiform cells	0.0238095238095
FC	fear conditioning	0.047619047619
FC	control rats from strains selectively bred to be seizure-prone	0.0238095238095
FC	fear-conditioned group	0.0238095238095
FC	functional connectivity	0.0714285714286
FC	fold-change	0.0238095238095
FC	fluorocitrate	0.047619047619
FC	+lfsfear conditioning and hippocampal low-frequency stimulation	0.0238095238095
FC	fasciola cinerea	0.0238095238095
FC	xfrontal cortex	0.047619047619
FC	fold change in mrna levels	0.0238095238095
FC	frontal cortex	0.428571428571
FC	2frontal cortex area 2	0.0238095238095
FC	fusiform cell	0.0238095238095
FC	fold change	0.047619047619
FC	oouter layer of the frontal cortex	0.0238095238095
FC	monofluorescein-cadaverine	0.0238095238095
FD	fascia dentata	0.111111111111
FD	fiber diameter	0.111111111111
FD	fluorescein dextran	0.222222222222
FD	fluorescein-labeled dextran	0.111111111111
FD	prefrontal area	0.111111111111
FD	field dependency	0.111111111111
FD	field dependence	0.111111111111
FD	folate-deficient diet	0.111111111111
FE	frame effect	0.111111111111
FE	fear expression	0.111111111111
FE	fluoroemerald	0.333333333333
FE	finite element	0.111111111111
FE	freezing episodes	0.111111111111
FE	testfisher’s exact test	0.111111111111
FE	food entrainment group	0.111111111111
SMI	sensorimotor cortex	0.111111111111
SMI	smilagenin	0.222222222222
SMI	32non-phosphorylated neurofilament h	0.111111111111
SMI	32	0.111111111111
SMI	33nonphosphorylated nfs	0.111111111111
SMI	32nonphosphorylated neurofilament protein	0.111111111111
SMI	32neurofilament h non-phosphorylated	0.111111111111
SMI	32neurofilament h non-phosphorylated antibody	0.111111111111
FG	flurogold retrograde tracer	0.0113636363636
FG	fluoro-gold dye	0.0113636363636
FG	fusiform gyrus	0.0681818181818
FG	fluoro-gold	0.147727272727
FG	fasting plasma glucose	0.0113636363636
FG	oldfluorogold	0.0113636363636
FG	fluoro-gold (hydroxystilbamidine)	0.0113636363636
FG	7142	0.0113636363636
FG	fluorogold	0.681818181818
FG	fg 7142	0.0113636363636
FG	fast-twitch glycolytic	0.0227272727273
SMG	superior mesenteric ganglion	0.166666666667
SMG	supramarginal gyrus	0.666666666667
SMG	the supramarginal gyrus	0.166666666667
FI	intact female quail	0.0625
FI	fatigue index	0.125
FI	fixed interval	0.125
FI	fronto-insula cortex	0.0625
FI	fluorescence intensity (arbitrary units)	0.0625
FI	field independency	0.0625
FI	frontoinsular	0.0625
FI	field independence	0.0625
FI	fixed-interval	0.125
FI	food intake	0.0625
FI	feedback inhibition	0.0625
FI	fluorescence intensity	0.125
SME	saline-monitor-ethanol	0.333333333333
SME	stalk-median eminence	0.333333333333
SME	subsequent memory effect	0.333333333333
FK	bp5fk506 binding protein 5	0.0625
FK	506 derivatives	0.0625
FK	888n2-[(4r)-4-hydroxy-1-(1-methyl-1h-indol-3-yl) carbony-1-l-prolyl]-n-methyl-n-phenylmethyl-3-2-(2-naphtyl)-l-alaninamide	0.0625
FK	506tacrolimus	0.0625
FK	forskolin	0.3125
FK	506	0.375
FK	506)	0.0625
FL	cortical forelimb area	0.0526315789474
FL	smcforelimb sensorimotor cortex	0.0526315789474
FL	flicker cue	0.0526315789474
FL	.trkbfull-length trkb	0.0526315789474
FL	familiar location	0.0526315789474
FL	fusiform layer dorsal cochlear nu	0.0526315789474
FL	percentage distance from the heel in relation to foot length	0.0526315789474
FL	full length	0.0526315789474
FL	forelimb area	0.105263157895
FL	frontal lobe	0.0526315789474
FL	fundus ligated	0.0526315789474
FL	freeze lesion	0.0526315789474
FL	forelimb cortical area	0.0526315789474
FL	full-length	0.0526315789474
FL	flocculus	0.0526315789474
FL	forelimb	0.105263157895
FL	forelimb representation cortex	0.0526315789474
SMB	sodium metabisulphite	0.666666666667
SMB	sodium metabisulfite	0.333333333333
Veh	vehicle	1.0
FO	fornix	0.153846153846
FO	frontal operculum	0.0769230769231
FO	fully oxidized	0.0769230769231
FO	food odor	0.0769230769231
FO	fish oil	0.230769230769
FO	flexural organ	0.0769230769231
FO	first order	0.0769230769231
FO	foot off	0.0769230769231
FO	foramen ovale	0.0769230769231
FO	functional overload	0.0769230769231
GGT	asegeranylgeranyl transferase	1.0
Fr	frontal cortex	1.0
MDI	mean density index	0.25
MDI	motor deficit index	0.75
MDN	mediodorsal nucleus of the thalamus	0.333333333333
MDN	mesencephalic dopaminergic neuron	0.333333333333
MDN	midbrain dorsal raphe nuclei	0.333333333333
MDL	28170n-[n-[(phenylmethoxy)carbonyl]-l-valyl]	0.5
MDL	28170	0.5
GGR	global genome repair (subpathway of ner)	0.5
GGR	global genomic repair	0.5
MDB	mental deterioration battery	1.0
CTβG	cholera toxin β subunit gold conjugate	0.5
CTβG	cholera toxin β subunit conjugated to gold particles	0.5
MDA	malondialdehyde	0.946428571429
MDA	malonaldehyde	0.0535714285714
MDF	median frequency	1.0
MDD	major depressive disorder	0.944444444444
MDD	major depression	0.0277777777778
MDD	medial dorsal thalamus nucleus–dorsal part	0.0277777777778
MDZ	midazolam	1.0
PBEDPBS	containing 0.5% bsa and 2 mm edta	1.0
GGG	reenhouse–geisser	1.0
GGF	glial growth factor	0.5
GGF	2glial growth factor 2	0.5
LRRK2Lrrk2	leucine-rich repeat kinase 2	1.0
Fe	transferrin–iron complex	1.0
Ff	form factor	1.0
MDR	multiple drug resistance	0.166666666667
MDR	1multi drug resistance 1	0.166666666667
MDR	multidrug resistance protein	0.166666666667
MDR	1(pgp) multiple drug resistance protein	0.166666666667
MDR	1multidrug resistance polypeptide 1	0.166666666667
MDR	multidrug resistance	0.166666666667
MDS	mesocorticolimbic dopamine system	0.125
MDS	multidimensional scaling	0.5
MDS	myoclonus dystonia syndrome	0.125
MDS	mediodorsal striatum	0.125
MDS	middle dorsal striatum	0.125
MDP	muramyl dipeptide	1.0
Fl	fluorescein	0.5
Fl	flight	0.5
Fm	5% formalin injection alone group of rats	1.0
MDT	mediodorsal thalamus	0.4
MDT	mediodorsal nucleus of the thalamus	0.2
MDT	minimal deformation template	0.4
Fo	initial fluorescence	1.0
VOIQV	ividness of olfactory imagery questionnaire	1.0
K-ATPATP-	sensitive potassium channel	1.0
MD-	2myeloid differentiation factor 2	0.333333333333
MD-	2myeloid differentiation protein 2	0.333333333333
MD-	2myeloid differentiation factor-2	0.333333333333
DFT	discrete fourier transform	1.0
pMTG	posterior mtg	1.0
NDIINADH	dehydrogenase	1.0
Prnp	prion protein gene	1.0
DFP	diisopropylfluorophosphate	0.833333333333
DFP	diisopropylfluorphosphate	0.166666666667
NREM	or nrnon-rapid eye movement	0.0178571428571
NREM	non-rapid-eye-movement	0.0892857142857
NREM	none-rapid-eye-movement	0.0178571428571
NREM	non-rapid eye movement(sleep)	0.0178571428571
NREM	sleepnon-rapid eye movement sleep	0.0357142857143
NREM	non-rem	0.0357142857143
NREM	non-rapid eye movement sleep	0.107142857143
NREM	non-rapid eye movement	0.5
NREM	non–rapid eye movement	0.0357142857143
NREM	sleep	0.0178571428571
NREM	non-rapid eye movements	0.0178571428571
NREM	nonrapid eye movement	0.0178571428571
NREM	non rapid eye movement	0.0357142857143
NREM	non-rapid-eye-movement sleep	0.0178571428571
NREM	non-rapid-eye movement	0.0357142857143
CCMSC	ache county study of memory in aging	1.0
DFO	desferrioxamine	0.285714285714
DFO	deferrioxamine mesylate	0.142857142857
DFO	deferoxamine	0.571428571429
irNST	neuronostatin immunoreactivity	1.0
Rp-8-CTP-cAMPS	rp-8-p-chlorothiophenyladenosine 3″5″-cyclic monophosphothioate	1.0
BODIPY-cntkG	bodipy-conantokin-g	1.0
DFA	dorsal facial area	0.0833333333333
DFA	discriminant function analysis	0.166666666667
DFA	detrended fluctuation analysis	0.666666666667
DFA	discriminant factor analysis	0.0833333333333
oGCL	outer granule cell layer	1.0
F0	firing rate at straight-ahead gaze	1.0
L-750	667	1.0
FapyA4	6-diamino-5-formamidopyrimidine	1.0
PBSV	1× pbs containing 1 mm sodium orthovanadate	1.0
β-EP	β-endorphin	1.0
GPAS	acidic fixative (containing 2.5% glutaraldehyde, 0.01m sodium metaperiodate, 0.1m sodium chloride, 0.04m sodium phosphate and 1.0% acetic acid, ph 4.0)	1.0
INLL	intermediate nucleus of the lateral lemniscus	0.5
INLL	intermediate nucleus of lateral lemniscus	0.5
TOI	temporal overlap index	1.0
ACPT-1	(1s,3r,4s)-1-aminocyclopentane-1,2,4-tricarboxylic acid	1.0
NANAN-	acetylneuraminic acid	1.0
AMMSA	cademy of military medical sciences	1.0
I2-receptor	imidazoline-i2-receptor	1.0
F-	18] fdg micro pet	0.0833333333333
F-	actinfilamentous-actin	0.0833333333333
F-	spondinreelingene therapyamyloid-betaalzheimer’s disease	0.0833333333333
F-	actinactin filaments	0.0833333333333
F-	actin	0.0833333333333
F-	actinfibrous actin	0.166666666667
F-	neuronfast type neuron	0.0833333333333
F-	actinfilamentous actin	0.333333333333
MINTM	unc-18-interacting protein	1.0
5-HT-	1a	0.5
5-HT-	moduline	0.5
FPSP	field postsynaptic potential	1.0
YM	yoked-methamphetamine	1.0
YO	yohimbine hydrochloride	0.666666666667
YO	yohimbine	0.333333333333
3α-5α-THP	3α-hydroxy-5α-pregnan-20-one	1.0
revA	betareverse amyloid beta	1.0
ATP4-	tetra-anionic form of atp	1.0
YC	2.1yellow cameleon 2.1	0.333333333333
YC	young control group	0.333333333333
YC	young subjects with physiologic hearing/young controls	0.333333333333
YB	1y box-binding protein 1	1.0
rAOT	ricin conjugated to oxytocin	1.0
TAH	non-gated threshold adaptation, anti-hebbian and hebbian learning	1.0
YY	receptors	1.0
WLMW	ord list memory	1.0
MITM	assachusetts institute of technology	1.0
XLMR	protein related to neurite extension	1.0
GHIH	gonadotropin hormone	1.0
T-SOD	total superoxide dismutase	1.0
YS	yoked-saline	1.0
5-HT3	serotonin receptor 3	0.5
5-HT3	5-hydroxytryptamine3	0.5
BH4	(6r)-5,6,7,8-tetrahydro-l-biopterin	0.25
BH4	tetrahydrobiopterin	0.75
TIQ1	2,3,4-tetrahydroisoquinoline	1.0
GABAδGABA-A	receptor subunit delta	1.0
SHBG	steroid hormone-binding like domain	0.333333333333
SHBG	sex hormone binding globulin	0.666666666667
MFTC	multiple features targets cancellation task	1.0
DHPEG	dihydroxyphenylethylene glycol	1.0
iDG	intermediate dentate gyrus	0.5
iDG	internal dentate gyrus	0.5
PNKP	polynucleotide kinase 3′-phosphatase	1.0
TAI	traumatic axonal injury	1.0
ω-MVIIC	ω-conotoxin mviic	1.0
PCM-E	pcm supplemented with egf	1.0
Dil1	1′-dioctadecyl-3,3,3′,3′-tetramethyllindocarbocyanine perchlorate	0.333333333333
Dil1	1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	0.333333333333
Dil1	1′-dioctadecyl-3,3,3′,3′-tetramethylinodocarbocyanine perchlorate	0.333333333333
KFK	ölliker-fuse	0.266666666667
KFK	ölliker-fuse nucleus	0.533333333333
KFK	olliker-fuse nucleus	0.0666666666667
KFK	ölliker–fuse nucleus	0.0666666666667
KFK	ölliker-fuse subnucleus	0.0666666666667
MANCOVA	multivariate analysis of covariance	1.0
FREUD-	1five prime repressor element under dual repression	1.0
HIP	1huntingtin interacting protein 1	0.0555555555556
HIP	3hi performed at postnatal day 3	0.0555555555556
HIP	14htt-interacting protein 14	0.0555555555556
HIP	hippocampus	0.777777777778
HIP	1huntingtin-interacting protein 1	0.0555555555556
ABC	avidin–biotin immunoperoxidase	0.00675675675676
ABC	avidin–biotinylated horseradish-peroxidase complex	0.00337837837838
ABC	avidin–biotin–peroxidase complex kit	0.00337837837838
ABC	avidin biotinylated peroxidase complex	0.00337837837838
ABC	avidin–biotin–pe-roxidase reaction	0.00337837837838
ABC	avidin-biotin complex	0.0304054054054
ABC	avidin–biotinylated peroxidase complex	0.00337837837838
ABC	avidin–biotin–peroxidase complex	0.347972972973
ABC	avidine–biotin-complex	0.00337837837838
ABC	avidin-biotin-complex	0.00337837837838
ABC	avidin–biotin–horseradish peroxidase complex	0.0743243243243
ABC	avidin–biotin–hrp complex	0.00337837837838
ABC	avidin–biotin-complex-peroxidase	0.00337837837838
ABC	avidin–biotin-complex	0.0101351351351
ABC	avidin–biotin–peroxidase-complex	0.00337837837838
ABC	avidin–biotin-peroxidase complex	0.0337837837838
ABC	avidin-biotin-peroxidase complex	0.0135135135135
ABC	avidin-biotin horseradish peroxidase complex	0.00337837837838
ABC	avidin-biotin complexc	0.00337837837838
ABC	avidin biotin complex	0.0168918918919
ABC	avidin–biotinylated horseradish peroxidase complex	0.0168918918919
ABC	activities-specific balance confidence	0.00337837837838
ABC	avidin-biotin-elite complex solution	0.00337837837838
ABC	avidin–biotin–complex	0.00337837837838
ABC	avidin-biotinylated horseradish peroxidase complex	0.0101351351351
ABC	avidin–biotin–peroxidase system	0.00337837837838
ABC	adenosin triphosphate-binding cassette	0.00337837837838
ABC	methodavidin–biotin complex	0.00337837837838
ABC	avidin–biotin complex	0.236486486486
ABC	avidin-biotinylated enzyme complex	0.00337837837838
ABC	avidin-biotin peroxidase complex	0.0101351351351
ABC	avidin–biotin hrp complex	0.00337837837838
ABC	avidin–biotin-peroxidase serum	0.00337837837838
ABC	transporter	0.00337837837838
ABC	avidin–biotin-peroxidase	0.00675675675676
ABC	avidin-biotin–horseradish peroxidase complex	0.00337837837838
ABC	avidin–peroxidase complex	0.00337837837838
ABC	avidin-biotine-peroxydase complex	0.00337837837838
ABC	avidin–biotinylated–horseradish peroxidase complex	0.00337837837838
ABC	avidin–biotin–peroxidase	0.0202702702703
ABC	avidin–biotin conjugate	0.00675675675676
ABC	avidin–biotin horseradish peroxidase complex	0.00675675675676
ABC	avidin–biotin horseradish peroxidase complex method	0.00337837837838
ABC	avidin–biotin peroxidase technique	0.00337837837838
ABC	avidin–biotin–peroxidase complex staining system	0.00337837837838
ABC	avidin–biotin peroxidase complex	0.0506756756757
ABC	avidin–biotin–horseradish peroxidase	0.00337837837838
ABD	aortic barodenervation, aortic-barodenervated	0.5
ABD	actin-binding domain	0.5
ABE	arterial base excess	1.0
TRAFTNF	receptor-associated factor	1.0
EC-SOD	extracellular superoxide dismutase	1.0
ABH	mammalian alkb homologue	1.0
LPFC	lateral prefrontal cortex	1.0
HGR	high glucose response	1.0
OSGDoxygen	serum and glucose deprivation	1.0
ABN	arched-back nursing	1.0
ABP	albumin-binding protein	0.1
ABP	actin-binding protein	0.1
ABP	arterial blood pressure	0.8
hAP	human placental alkaline phosphatase	1.0
ABR	acoustic brainstem-evoked response	0.0322580645161
ABR	auditory brain stem response	0.0322580645161
ABR	evoked auditory brain stem response	0.0161290322581
ABR	sauditory brainstem responses	0.0483870967742
ABR	auditory brain response	0.0161290322581
ABR	auditory brain-stem response	0.0161290322581
ABR	auditory brainstem response testing	0.0161290322581
ABR	auditory brainstem response	0.629032258065
ABR	auditory brainstem responses	0.0967741935484
ABR	auditory-evoked brainstem response	0.0161290322581
ABR	auditory brainstem-evoked response	0.0161290322581
ABR	analysis of brain recurrence	0.0161290322581
ABR	auditory brain stem–evoked response	0.0161290322581
ABR	acoustic brainstem response	0.0161290322581
ABR	acoustic brain response	0.0161290322581
HIS	head in space	0.5
HIS	polyhistidine-tag	0.5
SMI35	medium-phosphorylated neurofilament 160–200,000 mol. wt	1.0
MKKMAPK	kinase	1.0
HGH	eschl’s gyrus	1.0
HGF	hepatocyte growth factor	0.777777777778
HGF	/sfhepatocyte growth factor/scatter factor	0.111111111111
HGF	hematopoietic growth factor	0.111111111111
sLLD	spontaneous long-lasting depolarization	1.0
FJBF	luoro-jade b	0.714285714286
FJBF	luoro jade b	0.0714285714286
FJBF	luorojade b	0.214285714286
15d-PGJ	2	0.5
15d-PGJ	215-deoxy-prostaglandin j2	0.5
HGA	high-glutaraldehyde	1.0
BHK	baby hamster kidney	0.75
BHK	baby hamster kidney-21	0.25
Y-	27632	0.1
Y-	containing nerves	0.1
Y-	maze	0.4
Y-	79 cells	0.1
Y-	receptor-knockout	0.1
Y-	chromosome	0.1
Y-	containing vasoconstrictor nerves	0.1
mISI	mean interspike interval	1.0
5-HTH	yp-dep5-ht induced hyperpolarization followed by depolarization	0.5
5-HTH	yp-dep5-ht-evoked membrane hyperpolarization followed by depolarization	0.5
BHB	cl-2 homology	0.333333333333
BHB	beta-hydroxybutyrate	0.666666666667
L-SOP	l-serine-o-phosphate	1.0
ICP-MS	inductively coupled plasma mass spectrometry	1.0
LBCCA	ligation of bilateral common carotid arteries	0.666666666667
LBCCA	bilateral common carotid artery ligation	0.333333333333
ω-Cm-MVIIC	ω-conotoxin-mviic	1.0
Y1	npy(y1) receptor	0.5
Y1	y2, y5, y6, neuropeptide y receptors 1, 2, 5 and 6	0.5
WEW	ernicke encephalitis	1.0
5-HTT	5-hydroxytryptamine transporter (serotonin transporter)	0.0454545454545
5-HTT	serotonin transporter	0.363636363636
5-HTT	5-hydroxytryptamine reuptake transporter	0.0454545454545
5-HTT	5-ht reuptake transporter	0.0454545454545
5-HTT	5-ht transporter gene	0.0454545454545
5-HTT	5-ht transporter	0.409090909091
5-HTT	selective serotonin transporter	0.0454545454545
5-HTS	erotonin	1.0
BHT	butylated hydrotoluene	0.333333333333
BHT	butylated hydroxytoluene	0.666666666667
5-HTP	l-5-hydroxytryptophan	0.166666666667
5-HTP	5-hydroxytryptophan	0.666666666667
5-HTP	5-hydroxy-l-tryptophan	0.166666666667
ARAS	ascending reticular activating system	0.8
ARAS	ascending reticular activation system	0.2
lE	ntolateral entorhinal cortex	1.0
Di-ASP	4-(4-didecylaminostyryl)-n-methylpyridinium iodide	1.0
lC	ereleft cerebellum	1.0
lN	lateral nidopallium	1.0
nTS	nucleus tractus solitarius	0.333333333333
nTS	solitary tract nucleus	0.166666666667
nTS	nucleus of the solitary tract	0.166666666667
nTS	nucleus tractus solitarii	0.333333333333
lM	lateral mesopallium	0.5
lM	1/s1left primary sensorimotor area	0.5
5HT5-hydroxytryptamine	serotonin	1.0
nTV	normalized tidal volume	1.0
nTH	non-tyrosine hydroxylase	1.0
lT	halleft thalamus	1.0
AFP-KOα-	fetoprotein knockout mice	1.0
lR	tlateral reticular nucleus	1.0
DCSD	esanctis-cacchione syndrome	1.0
lP	flateral parafascicular nucleus	1.0
eIPSC	sevoked inhibitory postsynaptic current	0.05
eIPSC	electrically evoked inhibitory postsynaptic current	0.05
eIPSC	evoked-ipsc	0.05
eIPSC	sevoked ipscs	0.05
eIPSC	sevoked inhibitory postsynaptic currents	0.2
eIPSC	evoked inhibitory postsynaptic current	0.55
eIPSC	evoked ipsc	0.05
mnTS	medial subnucleus of nts	1.0
AIDA1-aminoindan-1	5-dicarboxylic acid	1.0
NMP	negative mucosal potential	1.0
NBCS	newborn calf serum	1.0
SVCI	systemic vascular conductance index	1.0
RANB	second random oligodeoxynucleotide	1.0
IDPN	b,b′-iminodipropionitrile	0.5
IDPN	iminodipropionitrile	0.5
p75NTR	low-affinity neurotrophin receptor	0.104166666667
p75NTR	low-affinity neurotrophin receptor p75	0.0208333333333
p75NTR	75-kda low-affinity neurotrophin receptor	0.0416666666667
p75NTR	neurotrophin receptor p75ntr	0.0208333333333
p75NTR	p75 neurotrophin receptor	0.520833333333
p75NTR	low affinity p75 neurotrophin receptor	0.0208333333333
p75NTR	common low affinity neurotrophin receptor p75	0.0208333333333
p75NTR	anticy3-192 igg	0.0208333333333
p75NTR	common ngf neurotrophin receptor	0.0208333333333
p75NTR	neurotrophin receptor p75	0.0416666666667
p75NTR	p75 pan-neurotrophin receptor	0.0208333333333
p75NTR	pan-75 neurotrophin receptor	0.0208333333333
p75NTR	75 kda low-affinity neurotrophin receptor	0.0208333333333
p75NTR	low affinity neurotrophin receptor	0.0625
p75NTR	low-affinity nerve growth factor receptor	0.0208333333333
p75NTR	p75 low-affinity neurotrophin receptor	0.0208333333333
SPSS	statistical package for the social sciences	1.0
LP-	pulvinarlateral posterior nucleus–pulvinar complex	1.0
p-NF-κB	phosphorylated-nuclear factor-kappa b	1.0
ONOO	•peroxynitrite	0.5
ONOO	–peroxynitrite	0.5
NBCN	a+/hco3- cotransporter	0.25
NBCN	a+-hco3- cotransporter	0.25
NBCN	a/bicarbonate cotransporter	0.5
PEBP-	1phosphatidylethanolamine-binding protein 1	0.666666666667
PEBP-	2polyomavirus enhancer binding protein	0.333333333333
HIE	hypoxic–ischemic encephalopathy	0.5
HIE	hypoxia–ischemic encephalopathy	0.5
ω-C	gtx-gviaω-conotoxin gvia	0.272727272727
ω-C	gtxω-conotoxin gvia	0.363636363636
ω-C	onotoxin-gvia	0.0909090909091
ω-C	gtx gviaω-conotoxin gvia	0.181818181818
ω-C	gtx mviicω-conotoxin mviic	0.0909090909091
HIF	prolyl hydroxylase2 (phd2)	0.0833333333333
HIF	hippocampus	0.0833333333333
HIF	1αhypoxia-inducible factor 1α	0.0833333333333
HIF	shypoxia-inducible factors	0.0833333333333
HIF	hypoxic inducible factor	0.0833333333333
HIF	hypoxia-inducible factor	0.416666666667
HIF	hypoxia inducible factor	0.0833333333333
HIF	1-1αhypoxia-inducible factor 1α	0.0833333333333
ω-A	gatx ivaω-agatoxin iva	0.0714285714286
ω-A	gatoxin-iva	0.0714285714286
ω-A	gtxω-agatoxin iva	0.142857142857
ω-A	gatoxin iva	0.0714285714286
ω-A	ga ivaω-agatoxin iva	0.0714285714286
ω-A	ga-tkω-agatoxin tk	0.0714285714286
ω-A	ga-ivaω-agatoxin-iva	0.0714285714286
ω-A	ga-iva	0.0714285714286
ω-A	gtx-tkω-agatoxin tk	0.0714285714286
ω-A	gtx ivaω-agatoxin iva	0.142857142857
ω-A	ga-ivaω-agatoxin iva	0.142857142857
EYF	experimental young females	1.0
cited1CBP	/p300-interacting transactivators with glutamic acid/aspartic acid-rich carboxyl-terminal domain	1.0
6-OHD	6 hydroxy dopamine	1.0
LPS	low pain sensitivity	0.00380228136882
LPS	– lipopolysaccharide	0.00380228136882
LPS	lyposaccharide	0.00380228136882
LPS	e. coli lipopolysaccharide	0.00380228136882
LPS	)	0.00380228136882
LPS	lipopolysaccharide stress	0.00380228136882
LPS	lipopolysaccharde	0.00380228136882
LPS	lamina pallio-subpallialis	0.00380228136882
LPS	lipopolysacharride	0.00380228136882
LPS	late prenatal stress group	0.00380228136882
LPS	lipopolysaccharide	0.939163498099
LPS	lipopolysacharide	0.0114068441065
LPS	lipopolysaccharides	0.0114068441065
LPR	lever-pressing rate	0.5
LPR	low plaque regions	0.5
sEJP	spontaneous excitatory junction potential	1.0
LPP	late positive potential	0.333333333333
LPP	lateral perforant pathway	0.222222222222
LPP	lateral perforant path	0.444444444444
LPO	lipid peroxidation	0.288461538462
LPO	lipid hydroperoxide	0.0192307692308
LPO	lateral preotic area	0.0192307692308
LPO	lateral preoptic nuclei	0.0192307692308
LPO	lobus parolfactorius	0.153846153846
LPO	lateral preoptic area	0.461538461538
LPO	lipid peroxide	0.0192307692308
LPO	lateral preoptic nucleus	0.0192307692308
LPN	late posterior negativity	0.5
LPN	low-pass notched	0.166666666667
LPN	lateral pontine nucleus	0.166666666667
LPN	slateral posterior neurons	0.166666666667
LPM	liters per minute	0.5
LPM	liters per min	0.5
LPL	lipoprotein lipase	0.25
LPL	ipofectamine 2000	0.25
LPL	nucleus lateralis posterior pars lateralis	0.25
LPL	lateral protocerebral lobe	0.25
Lref	reference latency	1.0
LPG	ilateral paragigantocellular nucleus	0.857142857143
LPG	ilateral paragigantocellular reticular nucleus	0.0714285714286
LPG	lateral posterior gastric	0.0714285714286
LPE	lever press-excited	1.0
LPD	low protein diet	1.0
LPC	lysophosphatidylcholine	0.142857142857
LPC	large platform control	0.214285714286
LPC	late positive component	0.214285714286
LPC	lysophospatidylcholine	0.0714285714286
LPC	lyso-phosphatidylcholine	0.0714285714286
LPC	long photoperiod castrated	0.0714285714286
LPC	late positive complex	0.0714285714286
LPC	left posterior semicircular canal	0.0714285714286
LPC	lateral parietal cortex	0.0714285714286
LPB	lateral parabrachial area	0.0909090909091
LPB	lateral parabrachial nucleus	0.727272727273
LPB	lateral subnucleus of the parabrachial nucleus	0.0909090909091
LPB	lateral parabrachial nuclei	0.0909090909091
LPA	)	0.0769230769231
LPA	lysophasphatidic acid	0.0769230769231
LPA	lysophosphatidic acid	0.615384615385
LPA	1 receptor	0.0769230769231
LPA	lyso-phosphatidic acid	0.0769230769231
LPA	lysophophatidic acid	0.0769230769231
4-CPG	4-carboxyphenylglycine	0.25
4-CPG	(s)-4-carboxyphenylglycine	0.75
aSVG	anti-sauvagine	1.0
FIB-SEM	focused ion beam-sem	1.0
DIG-ISH	digoxigenin-labeled in situ hybridization	1.0
OIH	opioid-induced hyperalgesia	1.0
ROSA	26	1.0
SP-MF	suprapyramidal mossy fibres	0.5
SP-MF	supra-pyramidal mossy fiber terminal fields	0.5
ROSC	resumption of spontaneous circulation	0.142857142857
ROSC	restoration of spontaneous circulation	0.571428571429
ROSC	roscovitine	0.142857142857
ROSC	return of spontaneous circulation	0.142857142857
LAURA	local auto-regressive average	1.0
LPm	medial part of the lateral posterior nucleus	1.0
LPl	lpm), lateral posterior nucleus (lateral, medial)	0.333333333333
LPl	lateral part of the lp	0.333333333333
LPl	lateral part of the lateral posterior nucleus	0.333333333333
tMTF	temporal modulation transfer function	1.0
DYT-RP	dystonia manifestation-related pattern	1.0
mVM	mid-ventromedial dorsal raphe nucleus	1.0
ROSR	eactive oxygen species	1.0
DTNB5	5′-dithionitrobis 2-nitrobenzoic acid	0.0555555555556
DTNB5	5′-dithio-bis(2-nitrobenzoic acid)	0.111111111111
DTNB5	5′ dithio-bis-2-nitro benzoic acid	0.0555555555556
DTNB5	5-dithiobis (2-nitrobenzoic acid)	0.0555555555556
DTNB5	5′-dithiobis-2-nitrobenzoic acid	0.0555555555556
DTNB5	5-dithiobis-2-nitrobenzoic acid	0.0555555555556
DTNB5	5-dithiobis-(2-nitrobenzoic acid)	0.0555555555556
DTNB5	5-dithio-bis-(2-nitrobenzoic acid)	0.0555555555556
DTNB5	5′-dithiobis 2-nitrobenzoic acid	0.0555555555556
DTNB5	5′-dithio-bis-2-nitrobenzoic acid	0.111111111111
DTNB5	5′-dithiobis(2-nitrobenzoic acid)	0.111111111111
DTNB5	5′-dithiobis(2-nitrobenzoic acid)(3,3′-6)	0.0555555555556
DTNB5	5′-dithiobis-(2-nitrobenzoic acid)	0.166666666667
TBS-tg	tbs containing triton x-100 and gelatin	1.0
SR142948A	selective non-peptide neurotensin receptor antagonists	1.0
KATPATP-	sensitive k+ channels	0.0909090909091
KATPATP-	sensitive potassium channel	0.181818181818
KATPATP-	sensitive potassium channels	0.0909090909091
KATPATP-	sensitive potassium	0.272727272727
KATPATP-	sensitive k+	0.272727272727
KATPATP-	sensitive k channels	0.0909090909091
V-G	lutvesicular glutamate transporter	1.0
8-B	r-cgmp8-bromoguanosine-3′,5′-cyclic monophosphate	0.111111111111
8-B	r-camp8-bromoadenosine cyclic amp	0.111111111111
8-B	r-camp8-bromoadenosine 3′,5′-cyclic monophosphate	0.111111111111
8-B	r-camp8-bromo-adenosine 3′,5′-cyclic monophosphoate	0.111111111111
8-B	r-cgmp8-bromoguanosine-3′,5′-cyclomonophosphate sodium salt	0.111111111111
8-B	r-cgmp8-bromoguanosine-3′,5′-cyclic-monophosphate	0.111111111111
8-B	r-cadpr8-bromo-cyclic adp ribose	0.111111111111
8-B	r-camp8-bromo cyclic amp	0.111111111111
8-B	r-camp8-bromoadenosine 3′, 5′-cyclic monophosphate	0.111111111111
aECF	artificial extracellular fluid	1.0
PBil	internal lateral parabrachial subnucleus	1.0
NARF	neural activity-related ring finger protein	1.0
TTX-Rtetrodotoxin-resistent	ttx-s, tetrodotoxin-sensitive	1.0
V-S	p5oventral-sp5o	1.0
Peatyr1gene	mrna, or cdna of the periplaneta americana tyramine receptor 1	1.0
CS-	6-pgchondroitin-6-sulfate-containing proteoglycan	0.166666666667
CS-	non-conditioned stimulus	0.166666666667
CS-	unpaired stimulus	0.166666666667
CS-	6-pgchondroitin-6-sulfate-containing pg	0.166666666667
CS-	explicitly non-reinforced conditioned stimulus	0.166666666667
CS-	control stimulus	0.166666666667
FL-APP	full-length app	1.0
sAFM	single arched frequency modulated	1.0
KHBK	rebs henseleit buffer	0.5
KHBK	rebs–henseleit buffer	0.5
2-CFP	:wldscrossbred line of thy1.2-cfp and wlds mice	1.0
PreA4	alzheimer amyloid precursor protein a4 (695)	1.0
Icat	cationic current	1.0
DPARSFD	ata processing assistant for resting-state fmri	1.0
Cox-2	cyclooxygenase-2	0.5
Cox-2	cyclo-oxygenase-2	0.5
SOTA	self-organizing tree algorithm	1.0
cIAP-	2cellular inhibitor of apoptosis protein-2	1.0
4P-PDOT	4-phenyl-2-propionamidotetralin	1.0
SICI	short-interval cortical inhibition	0.2
SICI	short-interval intra-cortical inhibition	0.2
SICI	short-latency cortical inhibition	0.2
SICI	short-interval intracortical inhibition	0.4
sFRP	secreted frizzled-related protein	1.0
sRFM	stretched rippled frequency modulated	1.0
CS0	conditioned stimulus, control region	1.0
CAII	carbonic anhydrase ii	1.0
-N-	methyl-3-phenyl-[trifluoro-p-tolyloxy]	1.0
CSM	context signal memory	0.2
CSM	context-signal memory	0.8
sTNFR	soluble tumor necrosis factor receptor	1.0
CSN	cold sensitive neuron	0.1
CSN	scortical spinal neurons	0.1
CSN	carotid sinus nerve	0.6
CSN	cold-sensitive neuron	0.2
CSI	center selectivity index	0.5
CSI	curvature selectivity index	0.5
CSH	chronic sustaining hypoxia	1.0
Rhod-2xanthylium	9-[4-[bis[2-[(acetyloxy)methoxy]-2-oxoethyl]	1.0
CSE	cystathionine γ-lyase	0.333333333333
CSE	cystathionine gamma-lyase	0.111111111111
CSE	cystathionine-γ-lyase	0.222222222222
CSE	cystathionine γ lyase	0.111111111111
CSE	cochlear sensory epithelium	0.111111111111
CSE	cystashionine-γ-lyase	0.111111111111
CSD	cortical spreading depression	0.377777777778
CSD	current source density	0.466666666667
CSD	chronic social defeat	0.0222222222222
CSD	cysteine sulfinate decarboxylase	0.0222222222222
CSD	current–source–density	0.0222222222222
CSD	current-source density	0.0666666666667
CSD	current-source-density	0.0222222222222
CSG	cranial sensory ganglia	1.0
CSF	cerebrospinal fluid	0.913385826772
CSF	barrier	0.011811023622
CSF	granulocyte-macrophage–colony-stimulating factor	0.00393700787402
CSF	biomarkers	0.00393700787402
CSF	cerebral spinal fluid	0.0314960629921
CSF	artificial cerebrospinal fluid	0.0236220472441
CSF	granulocyte–macrophage colony stimulating factor	0.00393700787402
CSF	mock cerebrospinal fluid	0.00787401574803
CSA	cyclosporin a	0.0909090909091
CSA	cross-sectional area	0.454545454545
CSA	cysteine sulfinic acid	0.0909090909091
CSA	ischemia–reperfusion rats treated with csa	0.0909090909091
CSA	cross sectional area	0.0909090909091
CSA	complex spike activity	0.0909090909091
CSA	childhood or adolescence sexual abuse	0.0909090909091
CSC	8-(3-chlorostyryl) caffeine	0.0588235294118
CSC	8-(3-chlorostyryl)caffeine	0.0588235294118
CSC	anton-s	0.176470588235
CSC	cancer stem-like cell	0.0588235294118
CSC	commissure of the sc	0.0588235294118
CSC	chondroitin sulfate c	0.0588235294118
CSC	8-(3-chlorostyryl)-caffeine	0.117647058824
CSC	ockayne syndrome	0.411764705882
CSB	cytoskeleton-staining buffer	0.333333333333
CSB	chicago sky blue	0.333333333333
CSB	consummatory sexual behavior	0.333333333333
PEPA	4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide	1.0
PAGVLrost	periaqueductal gray, ventrolateral, rostral	1.0
dW	wrist velocity	1.0
JAM-	1junctional adhesion molecule-1	1.0
CSV	constitutive secretory vesicle	1.0
IL-1ra	interleukin-1 type 1 receptor antagonist (human recombinant)	0.111111111111
IL-1ra	interleukin-1 receptor antagonist	0.666666666667
IL-1ra	il-1 receptor antagonist	0.222222222222
CSP	cysteine string protein	0.25
CSP	corpus spongiosum of penis	0.25
CSP	cortical silent period	0.25
CSP	cysteine-string protein	0.25
CSS	chromosome substitution strains	0.25
CSS	corticospinal system	0.25
CSS	charcoal stripped calf serum	0.25
CSS	control salt solution	0.25
CSR	complete spatial randomness	0.333333333333
CSR	chronic sleep restriction	0.666666666667
mKGM	mouse keratinocyte growth medium	1.0
TGVS	trigeminovascular system	1.0
QRFP	pyroglutamylated rfamide peptide	1.0
MYSAM	ylein sheath attachment region	1.0
SDH-R	right-sided unilateral subdural haematoma	1.0
dR	p5′-deoxyribose phosphate	1.0
l-Dopal-4	5-dihydroxyphenylalanine	1.0
l-Dopal-3	4-dihydroxyphenylalanine	1.0
rPAP	rabbit peroxidase–antiperoxidase	1.0
TFMPP	n-(3-trifluoromethylphenyl)piperazine	1.0
mesDA	mesencephalic dopaminergic	1.0
NA	shnucleus accumbens shell	0.00193423597679
NA	noraradrenaline	0.00193423597679
NA	nucleus angularis	0.00386847195358
NA	noradrenergic bundle	0.00193423597679
NA	non-alternating	0.00193423597679
NA	ergic a7 neuronsnoradrenergic neurons of the a7 catecholamine cell group	0.00193423597679
NA	ccnucleus accumbens septi	0.00193423597679
NA	cshnac shell	0.00193423597679
NA	cc-shellshell of the nucleus accumbens	0.00193423597679
NA	csnucleus accumbens shell	0.00967117988395
NA	ccnucleus accumbens	0.121856866538
NA	ccnucleus accumbes	0.00193423597679
NA	noradrenaline hydrogen tartrate	0.00193423597679
NA	(-)-noradrenaline	0.00193423597679
NA	the nucleus ambiguus	0.00193423597679
NA	cshthe shell subregion of the nucleus accumbens	0.00193423597679
NA	dnoradrenaline	0.00193423597679
NA	noradrenaline (l-noradrenaline)	0.00193423597679
NA	cochlear nucleus angularis	0.00193423597679
NA	arcuate nucleus	0.00193423597679
NA	group of animals treated with nicotine/alcohol	0.00193423597679
NA	cbnucleus accumbens	0.00773694390716
NA	noise alone	0.00193423597679
NA	cvertvertex	0.00193423597679
NA	ergicnoradrenergic	0.00773694390716
NA	c-corenucleus accumbens core	0.00193423597679
NA	nucleus accumbens	0.0386847195358
NA	snucleus accumbens shell	0.00193423597679
NA	summed neural activity	0.00193423597679
NA	noradrenaline or noradrenergic	0.00193423597679
NA	cnucleus accumbens core	0.00193423597679
NA	night active	0.00193423597679
NA	norepinephrine	0.00193423597679
NA	numerical aperture	0.0309477756286
NA	noradrenergic	0.0174081237911
NA	cshnucleus accumbens shell	0.00773694390716
NA	cnucleus accumbens	0.334622823985
NA	number of averages	0.00386847195358
NA	nucleus ambiguous	0.00386847195358
NA	c-shellshell compartment of the nucleus accumbens	0.00193423597679
NA	noradrenalin	0.00580270793037
NA	noradrenaline	0.278529980658
NA	c shellnucleus accumbens shell	0.00386847195358
NA	c-shnucleus accumbens shell	0.00193423597679
NA	neuropil aggregate	0.00193423597679
NA	cbshthe shell of the nucleus accumbens	0.00193423597679
NA	snucleus accumbence shell	0.00193423597679
NA	shellnucleus accumbens shell	0.00193423597679
NA	nucleus ambiguus	0.0580270793037
NA	cvertvertex of the nucleus accumbens shell	0.00193423597679
SDH-L	left-sided unilateral subdural haematoma	1.0
VEα-	tocopherol	1.0
NIHL	noise-induced hearing loss	1.0
MeAV	medial amygdaloid nucleus, pars anteroventralis	1.0
ADI-RA	utism diagnostic interview	0.5
ADI-RA	utism diagnostic interview–revised	0.5
SARS-C	ovsevere acute respiratory syndrome coronavirus	1.0
MG2C2-GP4	guinea-pig anti-mglur2/3 antibody	1.0
DAN2	3- diaminonaphthalene	0.2
DAN2	3-diaminonaphthalene	0.8
MPOAd	dorsal part of the mpoa	1.0
AER	auditory evoked response	1.0
MeAD	medial amygdaloid nucleus, pars anterodorsalis	0.5
MeAD	medial amygdaloid nucleus, anterodorsal part	0.5
DiO3	3′-dioctadecyloxacarbocyanine perchlorate	1.0
I-HOHO	in intact animals	1.0
VSV-G	vesicular stomatitis virus	1.0
TBNC	trigeminal brainstem nuclear complex	1.0
sO	2oxygen saturation	1.0
Bmc	basal nucleus, magnocellular division	0.666666666667
Bmc	basal amygdala, magnocellular region	0.333333333333
Bmg	magnocellular basal amygdaloid nucleus	0.666666666667
Bmg	magnocellular basal nucleus	0.333333333333
HOMH	omozygous	1.0
GBA	gamma-band activity	1.0
PI-3K	phosphatidylinositol-3 kinase	0.25
PI-3K	phosphatidylinositol-3-kinase	0.25
PI-3K	phosphatidylinositol 3-kinase	0.25
PI-3K	phosphoinositol-3-kinase	0.25
D1D3	d5 and d7, the first, third, fifth and seventh, respectively, post-operational day	1.0
LORR	loss of righting reflex	1.0
DKIGSK	3α21a/21a/β9a/9a knock-in	1.0
aAP	antidromic action potential	1.0
DOI2	5-dimetoxy-4-iodoamphetamine hydrobromide	0.4
DOI2	5-dimethoxy-4-iodo-amphetamine	0.2
DOI2	5-dimethoxy-4-iodoamphetamine	0.4
MIRAGEM	ulti-institutional research on alzheimer genetic epidemiology	1.0
VPLPC	parvicellular part of the ventroposterior lateral thalamic nucleus	1.0
-CPP	3-[(r)-2-carboxypiperazin-4-yl]-propyl-1-phosphonate	0.5
-CPP	)(±)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	0.5
NAcSHELL	nucleus accumbens shell	1.0
VFFV	on frey filament	1.0
l-NOARG	l-ng-nitroarginine	0.166666666667
l-NOARG	l-ng-nitro-arginine	0.166666666667
l-NOARG	ng-nitro-l-arginine	0.5
l-NOARG	nω-nitro-l-arginine	0.166666666667
EB48	eb for 48h	1.0
FSTF	orced swim test	1.0
MPTP-	induced mouse model of parkinson’s disease	1.0
APPSWES	wedish mutant of amyloid precursor protein	1.0
Aβ-AGE	glycated aβ	1.0
PPAHV	phorbol 12-phenylacetate 13 acetate 20-homovanillate	1.0
PANAS-CP	ositive and negative affect schedule for children	1.0
DSM-IVIV	diagnostic and statistical manual of mental disorders	1.0
fLTP	fast ltp	1.0
aS	ynα-synuclein	1.0
BNIP	3bcl2/adenovirus e1b 19 kda protein-interacting protein 3 gene	0.333333333333
BNIP	3bcl2/adenovirus e1b 19kda protein-interacting protein 3	0.333333333333
BNIP	3δtmbcl-2/adenovirus e1b 19-kda-interacting protein 3 with deletion of transmembrane domain	0.333333333333
rAAV-POMC	recombinant adeno-associated virus-mediated pomc gene transfer	1.0
6-OHDA-	lesioned rats	1.0
EGLU	(s)-α-ethylglutamate	0.142857142857
EGLU	(2s)-α-ethylglutamic acid	0.714285714286
EGLU	(2s)-α-ethylglutamate	0.0714285714286
EGLU	(2s)-a-ethylglutamic acid	0.0714285714286
HEK-	293 cellshuman embryonic kidney cells	0.25
HEK-	293 cellshuman embryonic kidney-293 cells	0.25
HEK-	293human embryonic kidney 293	0.25
HEK-	293	0.25
ANES	recordings made under anesthesia	1.0
LPCM	nucleus lateralis posterior pars caudomedialis	1.0
S-DS	prague-dawley	1.0
GBS	glucose buffered saline	1.0
Par	parietal cortex	1.0
fADP	fast afterdepolarization	1.0
OMPFC	orbital and medial prefrontal cortex	0.5
OMPFC	orbitomedial prefrontal cortex	0.5
AEG	acidic epididymal glycoprotein	0.5
AEG	anterior ectosylvian gyrus	0.5
pSLM	splanarian seizure-like movements	1.0
PoDH	polymorphic dentate hilus	1.0
PoDG	polymorphic layer of dentate gyrus	1.0
2-PMPA	2-(phosphonomethyl)-pentanedioic acid	0.6
2-PMPA	2-(phosphonomethyl)pentanedioic acid	0.4
pSLA	planarian seizure-like activity	1.0
NAWM	normal appearing white matter	1.0
D-β-H	dopamine-β-hydroxylase	1.0
CRNDC	entre for research in neurodegenerative diseases	1.0
TIEGTGF-β	inducible early growth response	1.0
SSRT	stop signal response time	0.125
SSRT	stop-signal reaction time	0.75
SSRT	stop signal reaction time	0.125
miR	smicrornas	1.0
MEKIMEK	inhibitor u0126	1.0
Ang-II	angiotensin-ii	1.0
MLSS	maximal lactate steady state	0.333333333333
MLSS	maximal blood lactate steady state	0.666666666667
PaR	parasubiculum	1.0
CoSD	cortical spreading depression	1.0
PaV	ventral pvn	1.0
mXII	hypoglossal nucleus	1.0
iMVST	ipsilateral medial vestibulospinal trace	1.0
GBZ	gabazine	1.0
PSEUDO	pseudoconditioning random application of stimuli group	1.0
calbcalbindin-D	28k	1.0
GDP-β	sguanosine 5′-[β-thio]diphosphate trilithium salt	1.0
LDS-PAGE	lithium sulfate polyacrylamide gel electrophoresis	1.0
8-PT	8-phenyltheophyline	0.5
8-PT	8-phenyltheophylline	0.5
AEN	anterior ethmoidal nerve	1.0
Vhold	holding membrane potential	1.0
2-MeSATP	2-methylthioadenosine 5′-triphosphate	0.5
2-MeSATP	2-methylthio-atp	0.5
ADYLC	3adenylyl cyclase 3	1.0
MTSET	methanethiosulfonate-ethyltrimethylammonium	1.0
RPMIR	osswell park memorial institute	0.5
RPMIR	oswell park memorial institute medium	0.5
2-OH	saclofen2-hydroxy saclofen	1.0
TLFA	theta/low-frequency alpha activity (power density in the 5.25–9.0hz band)	1.0
WARW	istar audiogenic rat	1.0
CMFDA	chloromethylfluorescein diacetate	1.0
UMTS	3g mobile phone	1.0
DHSM	dihydrostreptomycin	1.0
MIR-	taskmirroring task	1.0
Cort-REC	corticosterone followed by recovery	1.0
HSP60	heat shock protein 60	1.0
4-DAMP1	1-dimethyl-4-diphenylacetoxypiperidinium iodide	1.0
NATN-	acetyl-l-tryptophan	0.5
NATN-	acetyltransferase	0.5
Q-RT-PCR	quantitative reverse transcription-polymerase chain reaction	1.0
S-100	s-100 protein	1.0
evEPSC	sevoked excitatory postsynaptic currents	0.5
evEPSC	sevoked excitatory postsynaptic glutamatergic currents	0.5
FLIRTFMRIB	linear image registration tool	0.5
FLIRTFMRIB	's linear image registration tool	0.5
5-HT3A-S	short form of the 5-ht3 receptor, a subunit	1.0
MARCKS-	related protein	1.0
m-nTS	solitary tract nucleus, subpostremal	1.0
dFA	deionized formamide	1.0
ISIHISI	histogram	1.0
VHL-WT	wild type vhl	1.0
BESN	n-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid	1.0
TPBS	triton x-100-containing phosphate-buffered saline	0.0434782608696
TPBS	(-x), tris phosphate-buffered saline with 0.3% triton x	0.0434782608696
TPBS	10mm phosphate buffered saline, ph7.4, containing 10mm tris and 0.05% thimerosal	0.0434782608696
TPBS	triton x-100 in phosphate-buffered saline	0.0434782608696
TPBS	0.3% triton x-100 in phosphate-buffered saline	0.0434782608696
TPBS	phosphate-buffered saline containing 0.05% tween-20	0.0434782608696
TPBS	phosphate-buffered saline containing 0.1% tween-20	0.0434782608696
TPBS	tris–phosphate-buffered saline	0.0434782608696
TPBS	tris merthiolate, sodium chloride, sodium phosphate buffer solution	0.0434782608696
TPBS	0.010 m phosphate-buffered saline (ph 7.4) and 0.10% tween-20	0.0434782608696
TPBS	phosphate-buffered saline containing 0.4% triton x-100	0.0434782608696
TPBS	10mm tris, 0.9% nacl, 0.05% thimerosal in 10mm sodium phosphate buffer (ph 7.4)	0.0434782608696
TPBS	pbs containing tris and thimerosal	0.0434782608696
TPBS	tris/phosphate-buffered saline	0.0869565217391
TPBS	phosphate-buffered saline containing 0.3% triton x-100	0.0434782608696
TPBS	phosphate-buffered saline containing 0.1% tween 20	0.0434782608696
TPBS	tris phosphate-buffered saline	0.0869565217391
TPBS	0.1m tris phosphate-buffered saline (ph 7.4) containing 0.05% merthiolate	0.0434782608696
TPBS	phosphate-buffered saline containing tween	0.0434782608696
TPBS	0.4% triton x-100 in pbs	0.0434782608696
TPBS	5% nonfat dry milk or 5% bsa in 0.01 m phosphate buffer saline (ph 7.4) and 0.05% tween-20	0.0434782608696
ERα-	irerα-immunoreactivity	1.0
DC-CK	1dendritic cell-chemokine 1	1.0
BSTM	bed nucleus of the stria terminalis medial nuclei	0.25
BSTM	bed stria terminalis nuclei	0.25
BSTM	medial part of the bed nucleus of the stria terminalis	0.25
BSTM	nucleus striae terminalis medialis	0.25
BSTL	nucleus striae terminalis lateralis (nucleus accumbens)	0.125
BSTL	lateral part of the bed nucleus of the stria terminalis	0.125
BSTL	lateral nucleus of the stria terminalis	0.125
BSTL	bed nucleus of the stria terminalis lateral part	0.125
BSTL	lateral bed nucleus of the stria terminalis	0.25
BSTL	bed nucleus of the stria terminalis, lateral division	0.25
FDAF	ood and drug administration	0.75
FDAF	ederal drug administration	0.25
IVIC	instituto venezolano de investigaciones científicas	1.0
DRAM	damage-regulated autophagy modulator	1.0
βIII-TUB	βiii-tubulin	1.0
LACU	low-affinity choline uptake	1.0
BSTS	bed nucleus of the stria terminalis, supracapsular part	0.5
BSTS	supracapsular part of the bed nucleus of the stria terminalis	0.5
pBDNF-E	plasmid encoding egfp-tagged bdnf	1.0
VGPC	svoltage-gated potassium channels	1.0
bHR	selectively bred high-responder rats	0.25
bHR	bred high-responders	0.25
bHR	bred high responder	0.25
bHR	bred high responder rats	0.25
dlCP	udorsolateral caudate-putamen	1.0
ALCARA	cetyl-l-carnitine	1.0
SERPIN	serine protease inhibitor	1.0
GS-PBS-T	- normalgoat serum in phosphate-buffered saline with triton x-100	1.0
hMSC	human marrow stromal cell	0.333333333333
hMSC	human mesenchymal stem cell	0.333333333333
hMSC	shuman mesenchymal stem cells	0.333333333333
VNC	ventral nerve cord	0.411764705882
VNC	ccaudal vestibular nuclear complex	0.0588235294118
VNC	vestibular nuclear complex	0.470588235294
VNC	vestibular nuclei complex	0.0588235294118
VNB	ventral noradrenergic bundle	1.0
VNA	ventral noradrenergic bundle	0.5
VNA	vagal nerve activity	0.5
VNO	xvomeronasal-organ removal	0.0416666666667
VNO	ireceived sham-operation of removal of the vomeronasal organ	0.0416666666667
VNO	vomeronasal organ	0.875
VNO	vomeronasal olfactory system	0.0416666666667
PD123	319 group	1.0
VNL	vomeronasal nerve layer	1.0
GAP-	43growth-associated protein 43	0.2
GAP-	43 (b-50), growth-associated protein-43	0.0222222222222
GAP-	43growth and plasticity-associated protein 43	0.0222222222222
GAP-	43growth-associated protein-43	0.266666666667
GAP-	43growth cone associated protein-43	0.0222222222222
GAP-	43growth-associated protein	0.0222222222222
GAP-	43: growth-associated protein43 kda	0.0222222222222
GAP-	43	0.244444444444
GAP-	43/b50	0.0222222222222
GAP-	43growth associated protein-43	0.0444444444444
GAP-	43growth associated protein 43	0.0666666666667
GAP-	43growth-associated protein of 43 kda	0.0222222222222
GAP-	43growth-associated proteins	0.0222222222222
FrPaM	frontoparietal motor	1.0
L-HCSA	l-homocysteinesulfinic acid	1.0
ActR-IB	activin receptor type ib	1.0
BSTv	ventral bst	1.0
cRF	scutaneous receptive fields	0.25
cRF	cutaneous receptive field	0.75
TZD	thiazolidinedione	0.75
TZD	sthiazolidinediones	0.25
Mol	molecular layer of dentate gyrus	1.0
SBE	single base extension	1.0
CCMD-	3chinese classification of mental disorders	1.0
CaMPK-II	calcium/calmodulin-dependent protein kinase ii	1.0
NTSCOM	commissural subnucleus of solitary tract nucleus	1.0
MPBN	medial parabrachial nucleus	1.0
PERKPKR-	like endoplasmic reticulum eif2 α kinase	0.2
PERKPKR-	like endoplasmic reticulum kinase	0.6
PERKPKR-	like endoplasmic reticulum stress kinase	0.2
GAPD	glyceraldehyde-3-phosphate dehydrogenase	0.5
GAPD	glyceraldehyde 3-phosphate dehydrogenase	0.5
fIPSP	fast inhibitory postsynaptic potential	1.0
GAPG	lyceraldehyde 3-phosphate dehydrogenase	1.0
VN-	video with inconsistent natural sound	1.0
RGEretinopathy	globe enlarged	1.0
nBNI	norbinaltorphimine	1.0
YVAD-CHO	n-acetyl-tyr-val-ala-asp-aldehyde	1.0
NFH-L	acz mice	1.0
NICALA	nicotinylalanine	1.0
SSTY	1spermiogenesis specific transcript on the y	1.0
5hmC	5-hydroxymethyl cytosine	0.333333333333
5hmC	5-hydroxymethylcytosine	0.666666666667
CALB	calbindin	0.25
CALB	calcium-binding protein calbindin 28k	0.25
CALB	calbindin 28k	0.25
CALB	1calbindin 1	0.25
IPGTT	intraperitoneal glucose tolerance test	1.0
iNOS	immunological nitric oxide synthase	0.00564971751412
iNOS	(nos-2), immunological nitric oxide synthase	0.00564971751412
iNOS	nos-ii, inducible nitric oxide synthase	0.00564971751412
iNOS	inducible (immunological) nitric oxide synthase	0.00564971751412
iNOS	inducible isoform of nitric oxide synthase (type ii)	0.00564971751412
iNOS	inducible nitric oxide synthase (type ii)	0.00564971751412
iNOS	inducible-nitric oxide synthase	0.00564971751412
iNOS	inducible form of nitric oxide synthase (nos ii)	0.00564971751412
iNOS	inducible nitric-oxide synthase	0.0225988700565
iNOS	inducible form of nitric oxide synthase	0.00564971751412
iNOS	inducible nitric oxide synthase	0.813559322034
iNOS	inducible no synthase	0.0395480225989
iNOS	nitric oxide synthase	0.00564971751412
iNOS	inducible nos	0.045197740113
iNOS	inducible nitric oxide synthetase	0.00564971751412
iNOS	inducible isoform of nitric oxide synthase	0.0169491525424
HBBSH	anks’ balanced salt solution	0.5
HBBSH	anks' balanced salt solution	0.5
bDFM	bent downward frequency modulated	1.0
DYNB	dynorphin b	1.0
nXII	tstracheosyringeal portion of the hypoglossal nucleus	0.25
nXII	tsnucleus xii tracheosyringelis	0.25
nXII	hypoglossal motor nucleus	0.25
nXII	hypoglossal nucleus	0.25
AV-C	ontrola recombinant adenoviral vector without sdf1α cdna	1.0
GAPs	gtpase-activating proteins	1.0
OFTO	pen field test	1.0
hGH	human growth hormone	1.0
APBO	acute partial bladder outlet obstruction	1.0
T-	maze learning	0.0294117647059
T-	type calcium channel	0.0882352941176
T-	cells	0.0588235294118
T-	typetransiently open-type	0.0294117647059
T-	type channels	0.0294117647059
T-	turnthe time needed for a mouse to turn completely head downward	0.0294117647059
T-	type ca2+ current	0.0882352941176
T-	type ca2+ channeltransient-type calcium channel	0.0294117647059
T-	currents	0.0294117647059
T-	reflextendinous reflex	0.0294117647059
T-	lymphocytes	0.0294117647059
T-	maze	0.323529411765
T-	typetransient	0.0294117647059
T-	type	0.0588235294118
T-	typeca2+ current	0.0294117647059
T-	type calcium channels	0.0882352941176
-ATPasesodium	potassium adenosine triphosphatase	1.0
PBOO	partial bladder outlet obstruction	1.0
apoD	apolipoprotein d	1.0
apoE	4-185apoe4[δ(186–299)]	0.0263157894737
apoE	apolipoprotein e	0.921052631579
apoE	apolipoprotein e gene/protein	0.0263157894737
apoE	tr micehuman apoe3- and apoe4-targeted replacement mice	0.0263157894737
DAdihydroxyphenylethylamine	3,4-[7-3h]	1.0
Z-DEVD-FMK	benzyloxycarbonyl-asp(ome)-glu(ome)-val-asp(ome)-fluoromethylketone	0.333333333333
Z-DEVD-FMK	caspase-3 inhibitor-ii	0.333333333333
Z-DEVD-FMK	n-benzyloxycarbonyl-asp(ome)-glu(ome)-val-asp(ome)-fluoromethyl ketone	0.333333333333
CCDC	22coiled-coil domain containing protein 22	1.0
apoM	apolipoprotein m	1.0
vlPAG	ventro-lateral periaquaeductal gray	0.0384615384615
vlPAG	ventrolateral periaqueductal gray matter	0.0384615384615
vlPAG	ventrolateral periaqueductal gray area	0.0384615384615
vlPAG	ventrolateral division of the periaqueductal gray	0.0384615384615
vlPAG	ventrolateral periaqueductal gray	0.692307692308
vlPAG	ventrolateral periaqueductal gray column	0.0384615384615
vlPAG	ventrolateral column of the periaqueductal gray matter	0.0384615384615
vlPAG	ventrolateral part of the periaqueductal gray matter	0.0384615384615
vlPAG	ventrolateral periaqueductal grey	0.0384615384615
LHSS	lateral hypothalamic self-stimulation	1.0
αβmeADP	α,β-methyleneadenosine 5′-diphosphate	1.0
Nle4	asp5, d-2-nal7, lys10]-cyclo-alpha-msh amide, fragments 4–10	1.0
COUP-TF	)-interacting protein 2	1.0
BIBP	3226	1.0
vGAT	vesicular gaba transporter	1.0
CD-GCAP	ca2+-dependent gc activating protein	1.0
GFRα-1	gdnf family receptor α1	0.5
GFRα-1	gdnf family receptor α-1	0.5
TAMP	amplitude of the n30 auditory potential evoked by the second (test) click	0.5
TAMP	test amplitude	0.5
nsMGV	mean gray value of the nonspecific staining	1.0
DPPIVDPPIV	dipeptidyl peptidase iv	1.0
KOPκ-	opioid	1.0
I-BAR	inverse-bin-amphiphysin-rvs	1.0
TAG-	1transient axonal glycoprotein	1.0
BSTMP	bed nucleus of the stria terminalis, medial division, posterior part	1.0
FGFRFGF	receptor	1.0
CMLN-	carboxymethyl-lysine	1.0
BICbicuculline	a gabaa receptor antagonist	1.0
HLSM	hindlimb sensorimotor	1.0
GM-CSF	granulocyte-macrophage colony-stimulating factor	0.3
GM-CSF	granulocyte-macrophage colony stimulating factor	0.1
GM-CSF	granulocyte macrophage colony-stimulating factor	0.1
GM-CSF	granulocyte-macrophage-colony stimulating factor	0.1
GM-CSF	granulocyte/macrophage colony-stimulating factor	0.1
GM-CSF	granulocyte–macrophage colony-stimulating factor	0.2
GM-CSF	granulocyte–macrophage colony stimulating factor	0.1
BCIP	5-bromo-chloro-3-indolyl-phosphate	0.030303030303
BCIP	/nbtbromo-chloro-indolyl phosphate/nitroblue tetrazolium	0.030303030303
BCIP	nitroblue tetrazolium/5-bromo-4-chloro-3-indolylphosphate	0.030303030303
BCIP	5-bromo-4-chloro-3-indolylphosphate	0.030303030303
BCIP	5-bromo-4-chloro-3-indolyl phosphate toluidine salt	0.030303030303
BCIP	5-bromo-4-chloro-3-indolyl phosphate-toluidine salt	0.030303030303
BCIP	5-bromo-4-chloro-3-indolyl-phosphate	0.121212121212
BCIP	/nbt5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium	0.0909090909091
BCIP	/nbt5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium	0.030303030303
BCIP	5-bromo-3-chloro-indolyl phosphate	0.030303030303
BCIP	bromo-chloro-indolyphosphate	0.030303030303
BCIP	5-bromo-4-chloro-3-indolyl phosphate	0.363636363636
BCIP	bromo-chloro-indolyl phosphate	0.030303030303
BCIP	5-bromo-4-chloro-3-indoyl-phosphate	0.0606060606061
BCIP	4-nitroblue-tetrazolium-chloride/5-bromine-4-chloride-3-indolyl-phosphate	0.030303030303
BCIP	5-bromo-4-chloro-3-indolyl-1-phosphate	0.030303030303
RAG	sregeneration-associated genes	0.5
RAG	regeneration-associated gene	0.5
ADMAδ-	mechanical unit	1.0
LY367385	(s)-(+)-α-amino-4-carboxy-2-methylbenzoacetic acid	0.2
LY367385	s-2-methyl-4-carboxy-phenylglycine	0.2
LY367385	(+)-2-methyl-4-carboxyphenylglycine	0.4
LY367385	(+)-2-methyl-4-carboxyphenyl-glycine	0.2
lPICA	lateral posterior inferior cerebellar artery branch	1.0
SUMA	surface mapper	1.0
WDR-L	wide dynamic range-like	1.0
FHR	fetal heart rate	1.0
MeApd	posterodorsal mea	1.0
TAGL	2transgelin	1.0
POMSP	rofile of mood states	1.0
l-SMTCS-	methyl-l-thiocitrulline	1.0
NTBI	non-transferrin bound iron	0.5
NTBI	non-transferrin-bound iron	0.5
sL	7-enphrlenti-sl7-enphr-eyfp-wpre	1.0
RGT	rodent gambling task	0.5
RGT	rat glutamate transporter	0.5
α-CtxMII	α-conotoxin mii	1.0
PSD-MAGUK	postsynaptic density-95-like subfamily of membrane-associated guanylate kinase protein	1.0
MELAS	mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes	1.0
HCNhyperpolarization-activated	cyclic nucleotide–regulated	0.25
HCNhyperpolarization-activated	cyclic nucleotide-gated, cation non-selective	0.25
HCNhyperpolarization-activated	cyclic nucleotide-gated cation channel	0.25
HCNhyperpolarization-activated	cyclic nucleotide-gated cation	0.25
XPSX-	ray photoelectron spectroscopy	1.0
ArcP	arcuate nucleus, pars posterior	1.0
ANXA	5annexin v	0.333333333333
ANXA	3annexin a3	0.333333333333
ANXA	4annexin a4	0.333333333333
GH-R	growth hormone receptor	1.0
MABT	maleic acid buffer with tween20	0.333333333333
MABT	maleic acid buffer with 1% tween-20	0.333333333333
MABT	maleic acid buffer	0.333333333333
STSS	pace transportation system	1.0
MABP	mean arterial blood pressure	0.903225806452
MABP	mean arterial blood pressue	0.0322580645161
MABP	arterial blood pressure	0.0322580645161
MABP	mean artery blood pressure	0.0322580645161
UMP	uridine-5′-monophosphate	1.0
NR2B	nmda receptor subunit 2b	1.0
NR2A	nmda receptor subunit 2a	1.0
nIF	neuronal intermediate filament	1.0
TCGAPTC	10β/cdc42 gtpase activating protein	1.0
mPFC	prelimbic area of the medial prefrontal cortex	0.00416666666667
mPFC	medial prefontal cortex	0.00416666666667
mPFC	vventral medial prefrontal cortex	0.00416666666667
mPFC	medial prefrontal cortex	0.975
mPFC	xmedial prefrontal cortical lesion	0.00416666666667
mPFC	medical prefrontal cortex	0.00416666666667
mPFC	medial pre-frontal cortex	0.00416666666667
MEMS-RA	minimal essential medium containing 20 μm retinoic acid	1.0
GLG	astrocnemius lateralis	1.0
CMRO	2cerebral metabolic rate of oxygen consumption	0.333333333333
CMRO	2cerebral metabolic rate of oxygen	0.666666666667
Y738A	n740a, p741a, and y743a all refer to appswey738a, appswe n740a, appswe p741a, and appswe y743a, respectively	1.0
UMA	sunconditioned response maximal amplitudes	0.5
UMA	unmyelinated axons	0.5
MABA	muscimol infusion in aba version	1.0
MABB	muscimol infusion in abb version	1.0
LDUL	aser-doppler units	1.0
7-C	l-kyn7-chlorokynurenic acid	1.0
CMRG	local cerebral metabolic rate of glucose	1.0
IP3inositol-1	4,5-triphosphate	0.222222222222
IP3inositol-1	4,5-trisphosphate	0.777777777778
GABABRγ-	aminobutyric acid b receptor	1.0
OLA	octavolateral area	1.0
K-ATP	atp-sensitive potassium	1.0
OMGO-	methyl-[3h]-glucose	1.0
EFBDO	excess folic acid and vitamin b12 deficient and dha supplemented	1.0
LOOCV	leave-one-out cross-validation	1.0
ICAM-	1intracellular adhesion molecule-1	0.0833333333333
ICAM-	1intercellular cell adhesion molecule-1	0.166666666667
ICAM-	5intracellular adhesion molecule 5	0.0833333333333
ICAM-	1intercellular adhesion molecule 1	0.25
ICAM-	5intercellular adhesion molecule-5	0.0833333333333
ICAM-	1intracellular adhesion molecule 1	0.0833333333333
ICAM-	5intercellular adhesion molecule 5	0.0833333333333
ICAM-	1intercellular adhesion molecule-1	0.166666666667
WHOW	orld health organization	1.0
OLL	outer limiting layer	1.0
OLM	outer limiting membrane	1.0
OLN	outer lip nerve	1.0
IKC	acalcium dependent potassium current	0.333333333333
IKC	a currentintermediate conductance ca2+-activated k+ current	0.333333333333
IKC	acalcium-dependent potassium current	0.333333333333
USO	untrained + sham-operated.	1.0
IKA	/iglu ratioratio of kainate- to glutamate-induced currents	0.5
IKA	kainic acid-induced current	0.5
OLV	optical luminosity value	1.0
IKD	delayed rectifying k+ current	1.0
P-FITP	arieto-frontal integration theory	1.0
46D	dorsal 46	1.0
OLZ	olanzapine	1.0
IKO	2o2-sensitive k+ current	1.0
5C-SRTT	5-choice serial reaction time task	1.0
LBD	lewy body dementia	0.142857142857
LBD	ligand-binding domain	0.428571428571
LBD	ligand binding domain	0.428571428571
ALFF	amplitude of low-frequency fluctuations	1.0
PDYN	prodynorphin	1.0
hCT-	1human recombinant ct-1	1.0
IGFBP	insulin-like growth factor binding protein	0.615384615385
IGFBP	igf binding protein	0.230769230769
IGFBP	sigf binding proteins	0.0769230769231
IGFBP	4insulin-like growth factor binding protein 4	0.0769230769231
FZP	flurazepam	1.0
IRES	2internal ribosomal entry sequence version 2	0.153846153846
IRES	internal ribosomal entry site	0.615384615385
IRES	internal ribosome entry site	0.230769230769
DPMA	n6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)- ethyl]adenosine	0.5
DPMA	n6-[2-(3,5-dimethyoxyphenyl)-2-(2-methylphenyl)-ethyl]adenosine	0.5
N-methyl-Arg	lys, pro, l-neo-trp, tert-leu, leu]	1.0
LTP-	reinforcement	1.0
2-PLSM	two-photon laser scanning microscope	1.0
FCCF	ood chemical codex	1.0
STSA	short-term saccade adaptation	1.0
IRED	infrared light emitting diode	0.181818181818
IRED	sinfrared-light-emitting diodes	0.0909090909091
IRED	infrared light-emitting diode	0.0909090909091
IRED	sinfrared emitting diodes	0.181818181818
IRED	infra-red emitting diode	0.0909090909091
IRED	infrared emitting diode	0.272727272727
IRED	infrared-emitting diode	0.0909090909091
SMTG	superior and middle temporal gyrus	1.0
ROS-GC	rod outer segment gc	1.0
IK-	channelintermediate-conductance ca2+-activated k+ channel	1.0
pre-I	pre-inspiratory	1.0
ZPAD	n-cbz-l-phenylalanyl-l-alanine-diazomethylketone	1.0
WGA-	apo-hrp-goldgold-labeled wheat germ agglutinin coupled to horseradish peroxidase	1.0
pre-B	ötcpre-bötzinger complex	0.333333333333
pre-B	ötzinger complex	0.666666666667
CNQX6-cyano-2	3-dihydroxy-7-nitro-quinoxaline disodium salt	0.111111111111
CNQX6-cyano-2	3-dihydroxy-7-nitroquinoxaline	0.111111111111
CNQX6-cyano-2	3-dihydroxy-7-nitro-quinoxaline	0.666666666667
CNQX6-cyano-2	3-dihydroxy-7-nitroquinoxaline-2,3-dione	0.111111111111
pCREBCREB	phosphorylated on serine 133	1.0
PD-LEFTPD	patients with predominant dopamine depletion in the left striatum	1.0
SANSS	cale for the assessment of negative symptoms	1.0
PAFAH	platelet-activating factor acetylhydrolase	0.5
PAFAH	1b1platelet-activating factor acetylhydrolase 1b subunit alpha	0.5
IQI	ntellectual quotient	0.5
IQI	ntelligence quotient	0.5
pre-S	h/tonepretraining sham lesion/auditory fear conditioning	1.0
pbFRET	photobleaching fluorescence resonance energy transfer	1.0
FOTr	fo plus treadmill trained	1.0
αR	βs)-α-(4-hydroxyphenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate	1.0
αS	ynα-synuclein	0.5
αS	alpha-synuclein	0.5
CVAF	cmcoefficient of variation of the average firing frequency of cell c to memorandum m	1.0
MMRRCM	utant mouse regional resource center	1.0
MCH-GFP	transgenic mouse	1.0
TBNT	tris-buffered nacl with triton	0.333333333333
TBNT	tris buffer containing 0.05m nacl and 0.1% triton x-100	0.666666666667
αB	gtα-bungarotoxin	1.0
αC	amkii autonomous activity	0.166666666667
αC	amkiica2+/calmodulin dependent protein kinase type ii subunit α	0.166666666667
αC	amkiiα-calmodulin-dependent kinase ii	0.166666666667
αC	amkiiacalmodulin kinase ii	0.166666666667
αC	amkiiα subunit of camkii	0.166666666667
αC	amkiiα-isoform of calcium-calmodulin-dependent protein kinase ii	0.166666666667
iGLUR	ionotropic glutamate receptor	1.0
DWFT	discrete windowed fourier transform	1.0
MGTM	odified gomori trichrome	1.0
αE	217α-estradiol	1.0
rdm-I	/ii-vcrostro-dorsomedial part of laminae i/ii of vc	1.0
DTAF	dichlorotriazinylaminofluorescin	0.1
DTAF	5-([4,6-dichlorotriazin-2-yl]amino) fluorescein	0.1
DTAF	dichlorotriaginyl amino fluorescein	0.1
DTAF	dichlorotriazinylamino-fluorescein	0.1
DTAF	dichlorotriazinylamino fluoroscein	0.1
DTAF	diaminotriazinyl-amino-fluorescein	0.1
DTAF	dichlorotriazinyl-amino-fluorescein	0.1
DTAF	dichlorotriazinyl amino fluorescein	0.1
DTAF	dichorotriazinylamino-fluorescein	0.2
MOT	medial olfactory tubercle	0.333333333333
MOT	medial olfactory tract	0.666666666667
PPADSpyridoxalphosphate-6-azophenyl-2	4-disulphonic acid	0.666666666667
PPADSpyridoxalphosphate-6-azophenyl-2	4-disulfonic acid	0.333333333333
MBM	ethylene blue	0.333333333333
MBM	illonigs’s buffer	0.333333333333
MBM	monobromobimane	0.333333333333
MBN	magnocellular nucleus basalis	0.75
MBN	bmushroom body neuroblast	0.25
NEFA	non-esterified fatty acids	0.25
NEFA	non-esterified fatty acid	0.75
SOD	superoxide-dismutase	0.00680272108844
SOD	mimetic	0.00680272108844
SOD	1g93asuperoxide dismutase-1 with glycine to alanine switch at codon 93	0.00680272108844
SOD	1copper/zinc superoxide dismutase	0.0136054421769
SOD	superoxyde dismutase	0.00680272108844
SOD	1superoxide dismutase 1	0.102040816327
SOD	1superoxide dismutase	0.0204081632653
SOD	1-g93ab6sjl-tg(sod1-g93a)1gur/j	0.00680272108844
SOD	1superoxide-dismutase 1	0.00680272108844
SOD	1type i copper–zinc superoxide dismutase	0.00680272108844
SOD	1	0.00680272108844
SOD	1wtwild-type superoxide dismutase 1	0.00680272108844
SOD	2	0.00680272108844
SOD	1copper-zinc superoxide dismutase 1	0.00680272108844
SOD	superoxide dismutase	0.646258503401
SOD	1copper zinc superoxide dismutase-1	0.00680272108844
SOD	simple odor discrimination	0.00680272108844
SOD	super oxide dismutase	0.00680272108844
SOD	1copper/zinc superoxide dismutase-1	0.0136054421769
SOD	1cu/zn superoxide dismutase	0.047619047619
SOD	1superoxide dismutase 1 gene	0.00680272108844
SOD	synthesis of superoxide dismutase	0.00680272108844
SOD	copper/zinc superoxide dismutase	0.00680272108844
SOD	superoxidedismutase	0.00680272108844
SOD	2superoxide dismutase	0.00680272108844
SOD	1superoxide dismutase-1	0.0136054421769
SOD	1cu/zn superoxide dismutase type 1	0.00680272108844
SOD	anti-superoxide dismutase	0.00680272108844
SOG	suboesophageal ganglion	0.5
SOG	subesophageal ganglion	0.5
SOF	study of osteoporotic fractures	1.0
MBD	methyl-cpg binding domain	0.142857142857
MBD	methyl-cpg-binding domain	0.142857142857
MBD	methyl cpg dna-binding domain	0.285714285714
MBD	methyl-binding proteins	0.142857142857
MBD	3methyl cytosine phosphate guanine binding domain-containing factor 3	0.142857142857
MBD	methyl-dna binding domain	0.142857142857
15-LOX	12/15-lipoxygenase inhibitor	1.0
GAT	1gaba transporter i	0.111111111111
GAT	1gaba transporter subtype 1	0.111111111111
GAT	1gaba transporter isoform 1	0.111111111111
GAT	1gaba membrane transporter-1	0.111111111111
GAT	1	0.111111111111
GAT	1gaba transporter 1	0.333333333333
GAT	sgaba transporters	0.111111111111
SOM	somatostatin	0.885714285714
SOM	somatosensory cortex	0.0285714285714
SOM	supraoculomotor area	0.0285714285714
SOM	somatostatin-14	0.0285714285714
SOM	omega-3-supplemented rats from strains selectively bred to be seizure-resistant	0.0285714285714
GAR	goat anti-rabbit	0.5
GAR	goat–anti-rabbit igg	0.5
SON	supraoptic nucleus of the hypothalamus	0.013986013986
SON	supraoptic nucleus of hypothalamus	0.00699300699301
SON	supraoptic nuclei of the hypothalamus	0.013986013986
SON	supra-optic nucleus	0.00699300699301
SON	hypothalamic supraoptic nucleus	0.00699300699301
SON	supraoptic nucleus	0.888111888112
SON	superior olivary nucleus	0.020979020979
SON	sense oligonucleotide	0.00699300699301
SON	supraoptic nucleus of the hypothlamus	0.00699300699301
SON	supraoptic nuclei	0.020979020979
SON	supraoptic	0.00699300699301
D-P	he-crh	0.333333333333
D-P	he crf(12–41)	0.333333333333
D-P	he-crf12-41	0.333333333333
GAN	ganaxolone	0.333333333333
GAN	ganaxalone	0.333333333333
GAN	giant aspiny neuron	0.333333333333
SOS	standard oocyte saline	0.25
SOS	l-serine-o-sulfate	0.25
SOS	l-serine o-sulfate	0.25
SOS	aline/odn	0.25
GAL	galantamine treatment	0.0526315789474
GAL	4/uas system	0.0526315789474
GAL	4galactosidase transcription activator protein 4	0.0526315789474
GAL	galanin	0.789473684211
GAL	-/-galanin knock-out mice	0.0526315789474
SOT	sensory organisation test	0.5
SOT	sensory organization test	0.5
D-V	dorsal–ventral	0.5
D-V	ventral from dura	0.5
COX-	1cytochrome-c oxidase i	0.0192307692308
COX-	2cyclo-oxygenase-2	0.0384615384615
COX-	2inducible form of cyclooxygenase	0.0192307692308
COX-	2cyclooxygenase-2	0.711538461538
COX-	2cycloxygenase-2	0.0576923076923
COX-	2cyclooxygenenase-2	0.0192307692308
COX-	2	0.0384615384615
COX-	2cyclooxegenase-2	0.0192307692308
COX-	2cyclooxygenase 2	0.0192307692308
COX-	4cytochrome c oxidase subunit iv	0.0192307692308
COX-	2cyclooxigenase-2	0.0384615384615
GAG	inkgolide a	0.0555555555556
GAG	olgi apparatus	0.0555555555556
GAG	glycosaminoglycan	0.722222222222
GAG	glucosaminoglycan	0.0555555555556
GAG	sglycosaminoglycans	0.111111111111
SOX	supraoptic decussation	0.333333333333
SOX	2sex determining region y-box 2	0.666666666667
GAD	65glutamate decarboxylase	0.00277008310249
GAD	glutamic acid decarboxylase-65	0.00277008310249
GAD	67glutamic acid decarboxlyase67	0.00277008310249
GAD	6767 kda molecular weight isoform of glutamic acid decarboxylase	0.00277008310249
GAD	+gad immunopositive	0.00277008310249
GAD	65glutamic acid decarboxylase 65	0.016620498615
GAD	67glutamic acid decarboxylase 67-kda isoform	0.00277008310249
GAD	67-gfpglutamic acid decarboxylase 67-green fluorescent protein	0.00277008310249
GAD	67glutamate decarboxylase (67 kd)	0.00277008310249
GAD	67glutamic acid decarboxylase isoform 67	0.00554016620499
GAD	65	0.00277008310249
GAD	67	0.00831024930748
GAD	67glutamate decarboxylase 67	0.0304709141274
GAD	67glutamic acid decarboxylase 67 kda isoform	0.00277008310249
GAD	1glutamic acid decarboxylase 1	0.00277008310249
GAD	65/67glutamic acid decarboxylase 65 and 67	0.00277008310249
GAD	nssmall non-gabaergic neuron	0.00277008310249
GAD	1glutamate decarboxylase 1	0.00277008310249
GAD	glutamate decarboxylase (glutamic acid decarboxylase)	0.00277008310249
GAD	glutamate decarboxylase of 65/67 kda	0.00277008310249
GAD	anti-gad65 and 67	0.00277008310249
GAD	2glutamic acid decarboxylase 2	0.00277008310249
GAD	65glutamate acid decarboxylase 65	0.00277008310249
GAD	67glutamic acid decarboxylase of 67 kd	0.00277008310249
GAD	67glutamic acid decarboxylase (67 kd)	0.00277008310249
GAD	67-gfp knock-in mice	0.00277008310249
GAD	65glutamic acid decarboxylase 65-kda	0.00277008310249
GAD	glutamine acid decarboxylase	0.00277008310249
GAD	gracile axonal dystrophy	0.00277008310249
GAD	67glutamic acid decarboxylase 67 kda	0.00277008310249
GAD	67+/+wild-type of 67-kda isoform glutamic acid decarboxylase deficiency	0.00277008310249
GAD	65glutamic acid decarboxylase 65kd	0.00277008310249
GAD	67glutamate decarboxylase 67 kda	0.00277008310249
GAD	67glutamic acid decarboxylase of 67 kilo dalton	0.00277008310249
GAD	65glutamate decarboxylase 65	0.0138504155125
GAD	67glutamate decarboxylase isoform of 67 kda	0.00277008310249
GAD	65glutamic acid decarboxylase 65kda promoter	0.00277008310249
GAD	glutamate decarboxylase	0.299168975069
GAD	67glutamic acid decarboxylase	0.00831024930748
GAD	glutamic acid decarboxylase	0.423822714681
GAD	67glutamate decarboxylase 1	0.00277008310249
GAD	65glutamic acid decarboxylase	0.00277008310249
GAD	67-irglutamic acid decarboxylase immunoreactivity	0.00277008310249
GAD	67isoform 67 of the glutamic acid decarboxylase	0.00277008310249
GAD	glutamate decarboxylase (ec 4.1.1.15)	0.00277008310249
GAD	67)	0.00277008310249
GAD	67glutamic acid decarboxylase-67	0.00831024930748
GAD	generalized anxiety disorder	0.016620498615
GAD	glutamate acid decarboxylase	0.00831024930748
GAD	65glutamic acid decarboxylase-65	0.00277008310249
GAD	glutamic acid decarboxylase 67	0.00277008310249
GAD	65/67glutamic acid decarboxylase 65/67	0.00554016620499
GAD	65-egfpglutamic acid decarboxylase 65-enhanced green fluorescent protein	0.00277008310249
GAD	65glutamic acid decarboxylase65	0.00277008310249
GAD	67glutamic acid decarboxylase 67	0.016620498615
GAD	67glutamate decarboxylase 67 kda isoform	0.00277008310249
GAD	67glutamic acid decarboxylase67	0.00277008310249
GAD	glutamate decarboxilase	0.00277008310249
GAD	67glutamic acid decarboxylase 67 kd isoform	0.00277008310249
GAD	67glutamic acid decarboxilase	0.00277008310249
GAD	65glutamic acid decarboxylase 65kda	0.00277008310249
GAD	glutamate decarboxylase 67	0.00554016620499
MBP	myelin binding protein	0.0181818181818
MBP	myelin basic protein	0.890909090909
MBP	maltose binding protein	0.0363636363636
MBP	mean blood pressure	0.0272727272727
MBP	maltose-binding protein	0.0181818181818
MBP	myelin basic proteins	0.00909090909091
ActR-IIB	activin receptor type iib	1.0
GAA	1glycosyl phosphatidyl-inositol anchor attachment protein 1	0.25
GAA	guanidinoacetate	0.5
GAA	guanidinoacetic acid	0.25
VILIP	visinin-like protein	1.0
SDS-PAGE	sodium dodecylsulfate polyacrylamide gel electrophoresis	0.0636363636364
SDS-PAGE	sodium docecyl sulphate-polyacrylamide gel electrophoresis	0.00909090909091
SDS-PAGE	sodium dodecylsulfate polyacrilamide gel electrophoresis	0.00909090909091
SDS-PAGE	sodium dodecyl-sulfate–polyacrylamide gel	0.00909090909091
SDS-PAGE	sds-polyacrylamide gel electrophoresis	0.00909090909091
SDS-PAGE	sodium-dodecyl sulfate–polyacrylamide	0.00909090909091
SDS-PAGE	sodium dodecyl sulfate–polyacrylamide gel electrophoresis	0.263636363636
SDS-PAGE	sodium dodecyl sulphate–polyacrylamide gel electrophoresis	0.0272727272727
SDS-PAGE	sodium dodecyl sulfate-polyacrylamide gel electrophoresis	0.172727272727
SDS-PAGE	sodium dodecylsulfate-polyacrylamide gel electrophoresis	0.0272727272727
SDS-PAGE	sodium dodecyl sulfate polyacrylamide gels	0.00909090909091
SDS-PAGE	sodium dodecyl-sulphate-polyacrylamide gel electrophoresis	0.00909090909091
SDS-PAGE	sodium dodecyl sulphate-polyacrylamide gel electrophoresis	0.0363636363636
SDS-PAGE	sodium dodecylsulfate polyacrylomide gel electrophoresis	0.00909090909091
SDS-PAGE	sodium dodecylsulphate–polyacrylamide gel	0.00909090909091
SDS-PAGE	sodium dodecyl sulphate polyacrylamide gel electrophoresis	0.00909090909091
SDS-PAGE	sodium dodecyl sulfate-polyacrylamide electrophoresis	0.00909090909091
SDS-PAGE	sodium dodecyl sulfate-polyacryl amide gel electrophoresis	0.00909090909091
SDS-PAGE	sodium dodecyl sulfate polyacrylamide gel electrophoresis	0.245454545455
SDS-PAGE	sodium dodecyl sulfate–polyacrylamide gel	0.00909090909091
SDS-PAGE	polyacrylamide gel electrophoresis in the presence of sds	0.00909090909091
SDS-PAGE	polyacrylamide gel electrophoresis	0.0181818181818
SDS-PAGE	sodium dodecylsulphate–polyacrylamide gel electrophoresis	0.00909090909091
SDS-PAGE	sodium dodecyl sulfate polyacrilamide gel electrophoresis	0.00909090909091
MPPTg	medial pedunculopontine tegmental nucleus	1.0
2-AP	52-amino-5-phosphonopentanoic acid	1.0
JCQ	job content questionnaire	1.0
BIBP3226	(n2- (diphenylacetyl)-n-[4-(hydroxyphenyl)methyl]d-arginamide)	0.5
BIBP3226	r-n2-(diphenylacetyl)-n-(4-hydroxyphenyl)-methyl argininamide	0.5
AUTA	lternate uses task	1.0
UDSUP	–down state	1.0
UCP-2	uncoupling protein-2	1.0
l-KYN	l-kynurenine	1.0
ALONE	males removed from the colony but remained alone in the testing cage and room for 30 min	1.0
OKAO	kadaic acid	1.0
2-AG	2-arachidonoyglycerol	0.0217391304348
2-AG	2-arachidonyl glycerol	0.0217391304348
2-AG	2-arachidonoylglycerol	0.54347826087
2-AG	2-arachidonoyl glycerol	0.130434782609
2-AG	2-arachidonoylgycerol	0.0217391304348
2-AG	2-arachidonylglycerol	0.130434782609
2-AG	2-ag	0.0217391304348
2-AG	arachidonoylglycerol	0.0217391304348
2-AG	2-arachidonoyl-glycerol	0.0652173913043
2-AG	2-arachidonoyl	0.0217391304348
L-anti-endo-MPDCL-anti-endo-3	4-methanopyrrolidine dicarboxylate	1.0
ELAM-	1endothelial cell-leukocyte adhesion molecule 1	1.0
extra-SCN	oscillators	1.0
GRGDSP	/rgd-peptideglycine–arginine–glycine–aspartate–serine–proline	0.5
GRGDSP	gly-arg-gly-asp-ser-pro	0.5
dbcGMP	n2,2′-o-dibutyrylguanosine-3′:5′-cyclic monophosphate sodium	0.333333333333
dbcGMP	n2,2′-o-dibutyrylguanosine 3′,5′-cyclic monophosphate	0.333333333333
dbcGMP	dibutyryl cyclic gmp	0.333333333333
aD	acute dark	1.0
ω-CgTx-GVIA	ω-conotoxin-gvia	1.0
PKC-θPKC-	theta	1.0
ADAS-C	ogalzheimer disease assessment scale-cognitive subscale	1.0
glycol-O	o′-bis-[2-amino-ethyl]-n,n,n′,n′,-tetraacetic acid	1.0
TBSθ	burst stimulation	1.0
RRMRNA-	recognition motif	1.0
PLRP	priming effect in lateralized readiness potential	1.0
NRGc	nucleus reticularis gigantocellularis	1.0
VOCC	voltage-operated ca2+ channel	0.375
VOCC	voltage-operated calcium channel	0.375
VOCC	voltage-operated calcium channels	0.25
vlBNST	ventral lateral subdivision of the bed nucleus of the stria terminalis	1.0
RSCTX	retrosplenial cortex	1.0
l-CCG-I	2s,1′s,2′s-2-(carboxycyclopropyl)glycine	0.25
l-CCG-I	(2s,1′s,2′s)-(carboxycyclopropyl)glycine	0.25
l-CCG-I	(2s,1′s,2′s)-(2-carboxycyclopropyl)glycine	0.25
l-CCG-I	(2s,1′s,2′s)-2-(carboxycyclopropyl)glycine	0.25
MAmonoarthritic	perfused 14 days after receiving intraarticular cfa injection	1.0
ENMG	electroneuromyogram	1.0
L-α-AA	l-α-aminoadipic acid	1.0
NP-CN	iemann-pick type c disease	1.0
TOF-MS	time-of-flight mass spectrometry	1.0
CDC	caudodorsal cell	1.0
SCAMPs	secretory carrier-associated membrane proteins	1.0
1-ANOVA	one-way analysis of variance	1.0
MEF-	2myocyte enhancer factor 2	1.0
EPTU	2-ethyl-2-thiopseudourea hydrobromide	1.0
UPDRSU	nited parkinson's disease rating scale	0.0454545454545
UPDRSU	nited parkinson’s disease rating scale	0.0454545454545
UPDRSU	nified parkinson’s disease rating scale	0.454545454545
UPDRSU	nified parkinson disease rating scale	0.0909090909091
UPDRSU	nified parkinson's disease rating scale	0.363636363636
Fmbu1	bupivacaine injected 10 min after 5% formalin injection group of rats	1.0
TNFα	tumor-necrosis factor α	0.0161290322581
TNFα	tumor necrosis factor-alpha	0.161290322581
TNFα	tumour necrosis factor-α	0.0161290322581
TNFα	)	0.0161290322581
TNFα	tumour necrosis factor alpha	0.0161290322581
TNFα	tissue necrosis factor α	0.0161290322581
TNFα	tumor necrosis factor alpha	0.225806451613
TNFα	tumor necrosis factor-α	0.258064516129
TNFα	tumor necrosis factor α	0.241935483871
TNFα	tumor necrosis factor	0.0161290322581
TNFα	tumour necrosis factor α	0.0161290322581
Fmbu2	bupivacaine injected 1 h after 5% formalin injection group of rats	1.0
3MSEM	odified mini-mental state examinations	1.0
NMSE	normalized mean square error	1.0
MPTPl-methyl-4-phenyl-1	2,3,6-tetrahydropyridine	1.0
EPTA	ethanolic phosphotungstic acid	1.0
NKCCN	a+-k+-2cl- cotransporter	0.2
NKCCN	a–k–cl cotranspotor	0.2
NKCCN	a+/k+/2cl- cotransporter	0.2
NKCCN	+/k+/cl- cotransporter	0.2
NKCCN	a+–k+-cl-	0.2
GRα	glucocorticoid receptor α isoform	1.0
TCDD	tetrachlorodibenzo-p-dioxin	1.0
KHT	krebs–henseleit–tris	1.0
BFNC	benign familial neonatal convulsions	0.333333333333
BFNC	benign familial neonatal convulsion	0.666666666667
KMO	kynurenine-3-monoxygenase	0.5
KMO	kynurenine 3-mono-oxygenase	0.5
KHK	homology	0.4
KHK	rebs-henseleit	0.6
deltaF	osb	1.0
KHB	krebs–hepes buffer	1.0
Ap3A	diadenosine triphosphate	1.0
hrt-PA	human recombinant tissue-plasminogen activator	1.0
aT	nanterior tuberal nucleus	1.0
DAin	da concentration perfused through the probe	1.0
TDP-	43tar dna binding protein 43	0.0909090909091
TDP-	43transitive response dna-binding protein 43	0.0909090909091
TDP-	4343-kda tar dna binding protein	0.0909090909091
TDP-	43tar dna-binding protein 43	0.0909090909091
TDP-	43tar dna-binding protein-43	0.0909090909091
TDP-	43	0.272727272727
TDP-	43tar-dna-binding protein-43	0.0909090909091
TDP-	43/tardbptransactive response dna binding protein	0.0909090909091
TDP-	43tar dna-binding protein	0.0909090909091
GABA-IR	gaba-immunoreactivity	0.5
GABA-IR	gaba-like immunoreactivity	0.5
pNPY	porcine npy	1.0
SDNN	standard deviation of normal r–r interval	1.0
pNPP	p-nitrophenyl-phosphate	0.333333333333
pNPP	p-nitrophenyl phosphate	0.666666666667
NOL	novel object location	1.0
NMDA-EPSC	nmda receptor-mediated excitatory postsynaptic current	1.0
tmTNF	transmembrane tumor necrosis factor-alpha	1.0
vMGN	ventral medial geniculate nucleus	1.0
MERGL	methionine enkephalin-arginine-glycine-leucine	0.5
MERGL	methionine-enkephalin-arg6-gly7-leu8	0.5
vMGC	ventral division of the medial geniculate complex	1.0
NXN	nucleoredoxin	1.0
SNAP-	25	0.258064516129
SNAP-	25a mrna	0.0322580645161
SNAP-	25synaptosomal-associated protein 25	0.129032258065
SNAP-	25synaptosomal associated protein of 25 kd	0.0322580645161
SNAP-	25synaptosomal-associated protein 25 kda	0.0322580645161
SNAP-	25synaptosomal associated protein of 25 kda	0.0322580645161
SNAP-	25synaptosome-associated protein with 25 kda	0.0322580645161
SNAP-	25synaptosome-associated protein of 25kda	0.0322580645161
SNAP-	25synaptosomal-associated protein of 25 kda	0.161290322581
SNAP-	25synaptosome-associated protein-25	0.0645161290323
SNAP-	25synaptosome-associated protein 25 kda	0.0322580645161
SNAP-	2525-kda synaptosome-associated protein	0.0322580645161
SNAP-	25synaptosomal-associated protein-25	0.0322580645161
SNAP-	isoform	0.0322580645161
SNAP-	25synaptosome-associated protein of 25 kda	0.0645161290323
NKCC1	2, na-k-2cl cotransporter 1, 2	1.0
CaCl2	0.1 mgcl2, 0.1 mncl2, and 1% triton x-100	0.333333333333
CaCl2	mgcl2 and mncl2	0.333333333333
CaCl2	0.1 mm mgcl2, 0.1 mm mncl2	0.333333333333
BVR	biliverdin reductase	1.0
TREK	tandem of p domains in a weak inwardly-rectifying k+ channel–related k+ channel	1.0
GDSG	eriatric depression scale	1.0
TREM	2triggering receptor expressed in myeloid cells 2	1.0
CNQX6-cyano-7-nitroquinoxline-2	3-dione	1.0
CING	anterior cingulate cortex	1.0
CIND	cognitive impairment no dementia	1.0
AMN082N	n′-dibenzhydrylethane-1,2-diamine dihydrochloride	0.333333333333
AMN082N	n'-bis(diphenylmethyl)-1,2-ethanediamine dihydrochloride	0.333333333333
AMN082N	n’-diphenylmethyl-1,2-ethanediamine dihydrochloride	0.333333333333
pAPA	pre-apa	1.0
CINC	cytokine induced neutrophil chemoattractant	1.0
PRAC	parallel rod activity chamber	1.0
ETA	endothelin type a receptor	0.25
ETA	(b), endothelin receptor type a (b)	0.25
ETA	endothelin a receptor	0.25
ETA	endothelin receptor-a	0.25
BVE	blood volume expansion	1.0
BVD	blood vessels and dura	1.0
hNSC	s	0.5
hNSC	human neural stem cell	0.5
PRAK	p38 regulated/activated protein kinase	1.0
VLCD	ventrolateral caudate	1.0
BVL	)	0.5
BVL	sbilateral vestibular-lesioned saline	0.5
PKR-	like endoplasmic reticulum kinase	1.0
IP31	4,5 triphosphate	0.2
IP31	4,5-inositol-trisphosphate	0.2
IP31	4,5-triphosphate inositol	0.2
IP31	4,5-inositol triphosphate	0.2
IP31	4,5-tris-phosphate	0.2
WPRE	woodchuck hepatitis virus post-transcriptional regulatory element	0.4
WPRE	woodchuck hepatitis virus posttranscriptional regulatory element	0.4
WPRE	woodchuck post-regulatory element	0.2
WFUW	ake forest university	1.0
WEBGESTALTWEB-	based gene set analysis toolkit	1.0
e-AP	ectopic action potential	1.0
mPer	mouse period	1.0
CASTC	omputer assisted stereological test	1.0
GBar	gabaa receptor subunit antibody	1.0
TBS-TTBS	/tween-20	0.125
TBS-TTBS	containing 0.05% tween-20	0.125
TBS-TTBS	containing 0.1% triton x-100	0.125
TBS-TTBS	with 0.5% triton x-100	0.125
TBS-TTBS	–tween 20	0.125
TBS-TTBS	+1% tween	0.125
TBS-TTBS	containing 2% milk and 1% tween	0.125
TBS-TTBS	containing 0.1% tween-20	0.125
APLPs	app-like proteins	1.0
GFRαGDNF	family receptor-α	0.333333333333
GFRαGDNF	family receptor α	0.666666666667
OSP	94osmotic stress protein 94	0.25
OSP	optimal scalp position	0.25
OSP	oligodendrocyte-specific protein	0.5
OSI	orientation-specificity index	0.166666666667
OSI	orientation selectivity index	0.666666666667
OSI	optical shift index	0.166666666667
BU224	2-(4,5-dihydroimidaz-2-yl)-quinoline	1.0
OSM	oncostatin-m	0.25
OSM	oncostatin m	0.75
OSN	olfactory sensory neurons	0.05
OSN	olfactory sensory neuron	0.6
OSN	solfactory sensory neurons	0.35
OSA	obstructive sleep apnea	1.0
Msj-1	mouse sperm dnaj 1	1.0
OSC	souter sulcus cells	0.5
OSC	orthogonal signal correction	0.5
BAG-	1b-cell cll/lymphoma2-associated protein-1	1.0
S-1755	serine 1755	1.0
SPMS	secondary progressive multiple sclerosis	0.142857142857
SPMS	secondary progressive form of ms	0.142857142857
SPMS	tatistical parametric mapping software	0.142857142857
SPMS	secondary-progressive course of ms	0.142857142857
SPMS	tatistical parametric mapping	0.428571428571
deO	lmos silver staining	1.0
AAV-α-	synuclein	1.0
NP-SLE	neuropsychiatric lupus manifestation	1.0
GalR	galanin receptor	1.0
NFH-GFP	mice	1.0
UPDRS	unified parkinson’s disease rating scale	0.25
UPDRS	united parkinson’s disease rating scale	0.0833333333333
UPDRS	iiiunified parkinson’s disease rating scale motor examination	0.0833333333333
UPDRS	unified parkinson's disease rating scale	0.583333333333
EWE	dinger-westphal nucleus	0.727272727273
EWE	dinger westphal nucleus	0.0909090909091
EWE	dinger–westphal nucleus	0.0909090909091
EWE	dinger-westphal	0.0909090909091
LRn	lateral reticular nucleus	1.0
npEW	non-preganglionic edinger-westphal nucleus	0.2
npEW	nonpreganglionic edinger-westphal nucleus	0.2
npEW	non-preganglionic edinger–westphal nucleus	0.6
NCKXN	a+/ca2+,k+ exchangers	1.0
CPAN	(6)-cyclopentyl-adenosine	0.111111111111
CPAN	(6)-cyclopentyladenosine	0.111111111111
CPAN	6-cyclopentyladenosine	0.777777777778
LRt	lateral reticular nucleus	0.833333333333
LRt	lateral reticular area	0.166666666667
GalC	galactocerebroside	1.0
6aR	10ar)-3-(1-methanesulfonylamino-4-hexyn-6-yl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6h-dibenzo[b,d]pyran	1.0
FSCV	fast-scan cyclic voltammetry	0.75
FSCV	fast scan cyclic voltammetry	0.125
FSCV	fast-scan cyclic voltammetry acid	0.125
3MST	3-mercaptopyruvate sulfotransferase	1.0
dCCK	desulfated cholecystokinin-8	1.0
IP3R	inositol 1,4,5-trisphosphate receptor	0.571428571429
IP3R	inositol-1,4,5-trisphosphate receptor	0.142857142857
IP3R	ip3 receptor	0.285714285714
pHFO	spathological high frequency oscillations	1.0
LRD	late recurrent discharge	1.0
LRG	lumber root ganglion	1.0
iSNA	integrated splanchnic nerve activity	1.0
NAMDAN-	acetyl-o-methyldopamine	1.0
LRN	lateral reticular nucleus	1.0
RALDH	2retinaldehyde-specific dehydrogenase type 2	1.0
BoTx	botulinum toxin a	1.0
LRS	low-retention score	0.5
LRS	likelihood ratio statistic	0.5
LRR	leucine-rich repeat	0.5
LRR	leucine-rich repeats	0.5
LRT	lateral reticular nucleus	1.0
mTL	medial temporal lobe	1.0
VDREs	vitamin d response elements	1.0
LDH-A	lactate dehydrogenase-a	1.0
cAMP-PK	cyclic amp-dependent protein kinase	1.0
Cdc2IPm	cdc2 immunoprecipitation from mitotic neuroblastoma cell	1.0
eMCAO	endothelin-induced transient occlusion of the middle cerebral artery	1.0
rMCP-1	recombinant monocyte chemoattractant protein-1	1.0
SAO	slowly-adapting stretch receptor organ	1.0
chAT	choline acetyltransferase	1.0
SKF-38393	2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine	0.333333333333
SKF-38393	r(+)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-henzazepine-7,8-diol hcl	0.333333333333
SKF-38393	definition?	0.333333333333
2AG	2-arachidonoylglycerol	0.333333333333
2AG	2-arachidonoylglicerol	0.333333333333
2AG	2-arachidonylglycerol	0.333333333333
CoCl2	cobalt chloride	1.0
STFP	social transmission of food preference	0.5
STFP	socially transmitted food preference	0.5
IκBα	inhibitor of kappa b alpha	0.166666666667
IκBα	inhibitor kappa b alpha	0.166666666667
IκBα	inhibitor of nuclear factor kappa b alpha	0.166666666667
IκBα	inhibitory factor κbα	0.5
v-SNARE	vesicle-membrane snare	0.25
v-SNARE	vesicular soluble n-ethyl maleimide-sensitive fusion protein attachment protein receptor	0.25
v-SNARE	vesicle-associated snare	0.25
v-SNARE	vesicular soluble n-ethylmalemide-sensitive factor attachment protein receptor	0.25
ABmc	accessory basal nucleus, magnocellular division	1.0
Tween	tris-buffered saline containing 0.1% tween 20	1.0
OGPβ-	d-glucopyranoside	1.0
aPCX	anterior piriform cortex	0.5
aPCX	anterior pcx	0.5
NaPB	sodium phosphate buffer solution	1.0
IFP	interstitial fluid pressure	1.0
SKIserine	lysine, isoleucine	1.0
KEGGK	yoto encyclopaedia of genes and genomes	0.125
KEGGK	yoto encyclopedia of genes and genomes	0.875
5-HTR	3a5-ht3a receptor	0.333333333333
5-HTR	serotonergic receptor	0.333333333333
5-HTR	2a5-hydroxytryptamine receptor 2a	0.333333333333
FDC-P	1	1.0
cIC	contralateral inferior colliculus	0.5
cIC	central nucleus of the inferior colliculus	0.5
cVN	cervical vagus nerve	1.0
5-HT	serotonergic	0.00182149362477
5-HT	25-hydroxytryptamine type ii	0.00182149362477
5-HT	2crserotonin 2c receptor	0.00546448087432
5-HT	3ar	0.00182149362477
5-HT	2crserotonergic 2c receptors	0.00182149362477
5-HT	3 receptors	0.00182149362477
5-HT	2cr5-ht2c receptor	0.00182149362477
5-HT	homeostasis	0.00182149362477
5-HT	5-hydroxytryptamine hydrochloride	0.00182149362477
5-HT	1a receptor5-hydroxytryptamine receptor type 1a	0.00182149362477
5-HT	1aserotonin receptor subtype 1a	0.00182149362477
5-HT	receptors	0.00728597449909
5-HT	5-hydoroxytryptamine	0.00182149362477
5-HT	4 receptor agonist	0.00182149362477
5-HT	5-hydroxytryptamine (serotonin)	0.0673952641166
5-HT	2ar5-ht 2a receptors	0.00182149362477
5-HT	2a receptors	0.00364298724954
5-HT	5-hydroxytriptamine (serotonin)	0.00182149362477
5-HT	1aserotonin 1 a receptor	0.00182149362477
5-HT	1a autoreceptor	0.00182149362477
5-HT	2	0.00182149362477
5-HT	1ar5-hydroxytryptamine receptor	0.00182149362477
5-HT	2cserotonin-2c receptor	0.00182149362477
5-HT	2ar5-hydroxytryptamine 2a receptor	0.00182149362477
5-HT	5-hydroxytraptamine	0.00182149362477
5-HT	1a5-hydroxytryptamine1a	0.00182149362477
5-HT	1a receptors	0.00182149362477
5-HT	1a5-ht 1a	0.00182149362477
5-HT	2a	0.00182149362477
5-HT	2 receptors	0.00182149362477
5-HT	2serotoninergic receptor type 2	0.00182149362477
5-HT	3serotonin 3 receptor	0.00182149362477
5-HT	2ar+5-ht type 2a receptor-positive	0.00182149362477
5-HT	serotonin/serotonergic	0.00182149362477
5-HT	serotonin or 5-hydroxytryptamine	0.00364298724954
5-HT	5-hydroxytryptamine, serotonin	0.0327868852459
5-HT	5-hydroxytryptamine hydrochloride or serotonin	0.00182149362477
5-HT	2cserotonin receptor 2c	0.00182149362477
5-HT	7	0.00182149362477
5-HT	7 receptor	0.00364298724954
5-HT	3a	0.00182149362477
5-HT	5-hydroxytrmptamine	0.00182149362477
5-HT	neurotoxicity	0.00182149362477
5-HT	1a5-hydroxytryptamine 1a receptor	0.00182149362477
5-HT	5-hyroxytryptamine	0.00182149362477
5-HT	1b5-ht receptor type 1b	0.00182149362477
5-HT	2c-rserotonin 5-ht2c receptor	0.00182149362477
5-HT	5-hydroxy-tryptamine (serotonin)	0.00182149362477
5-HT	3r5-hydroxytryptamine3 receptor	0.00182149362477
5-HT	2a5-ht type 2 a	0.00182149362477
5-HT	serotonin/5-hydroxytryptamine	0.00728597449909
5-HT	4 receptor	0.00182149362477
5-HT	receptor	0.00182149362477
5-HT	5-hydroxytrytamine or serotonin	0.00364298724954
5-HT	1a-r5-hydroxytryptamine1a receptor	0.00182149362477
5-HT	2serotonin 2 sub-type receptor	0.00182149362477
5-HT	2arserotonin 2a receptor	0.00182149362477
5-HT	system	0.00182149362477
5-HT	1a	0.0109289617486
5-HT	1b	0.00182149362477
5-HT	3r5-ht type 3 receptor	0.00182149362477
5-HT	2a5-hydroxytryptamine 2a receptor	0.00182149362477
5-HT	5-hydroxytryptamine;serotonin	0.00182149362477
5-HT	serotonin synthesizing	0.00182149362477
5-HT	1 receptor subtypes	0.00182149362477
5-HT	5-hydroxytryptamine or serotonin	0.0309653916211
5-HT	serotonin	0.307832422587
5-HT	5-hydroxytryptamine/serotonin	0.00546448087432
5-HT	2ar5-ht receptor subtype 2 a	0.00182149362477
5-HT	5-hydroxytryptamine	0.264116575592
5-HT	serotonin, 5-hydroxytryptamine	0.00364298724954
5-HT	(serotonin)5-hydroxytryptamine	0.00182149362477
5-HT	3 receptor	0.00182149362477
5-HT	1ar5-ht1a receptor	0.00182149362477
5-HT	6-receptor	0.00182149362477
5-HT	3a receptor	0.00364298724954
5-HT	3rserotonin 5-ht3 receptor	0.00182149362477
5-HT	]oextracellular concentration of 5-ht	0.00182149362477
5-HT	(5-hydroxytryptramine)/serotonin	0.00182149362477
5-HT	25-ht receptor subtype 2	0.00182149362477
5-HT	2ar(s)serotonin2a receptor(s)	0.00182149362477
5-HT	2aserotonin 2a	0.00182149362477
5-HT	2r5-ht2 receptor	0.00182149362477
5-HT	3aserotonin type 3a	0.00182149362477
5-HT	1a5-ht receptor 1a	0.00182149362477
5-HT	serotonin (5-hydroxytryptamine)	0.063752276867
5-HT	3 antagonist	0.00182149362477
5-HT	1f receptor	0.00182149362477
5-HT	3 r5-ht type 3 receptor	0.00182149362477
5-HT	2arpserotonin 2a receptor	0.00182149362477
5-HT	)	0.00364298724954
5-HT	2cr5-ht receptor 2c	0.00182149362477
5-HT	serotonin5-hydroxytryptamine	0.00182149362477
5-HT	3serotonin type 3 receptor	0.00182149362477
5-HT	1b receptors	0.00182149362477
5-HT	1a receptor	0.0109289617486
5-HT	serotonergic/serotonin	0.00182149362477
5-HT	transporter	0.0145719489982
5-HT	1a5-hydroxytryptamine 1a	0.00364298724954
IFR	instantaneous firing rates	0.5
IFR	instantaneous firing rate	0.5
MDAM	alondialdehyde	1.0
ASaged	small litter size	1.0
D2S	dopamine d2s receptor	1.0
D2R	dopamine 2 receptor	0.25
D2R	dopamine d2 receptor	0.25
D2R	d2 dopamine receptor	0.5
d3H2O	triply distilled water	1.0
AChR	acetylcholine receptor	1.0
TxR	toxin resistant	1.0
RCCA	right common carotid artery	1.0
B-HABP	1biotinylated hyaluronan-binding protein	1.0
SIEH	stimulus-induced enhancement of (endothelin) hyperalgesia	1.0
FASN	1fascin homolog 1	1.0
D2L	dopamine d2l receptor	1.0
PLCβ	phospholipase c beta	0.0769230769231
PLCβ	phospholipase-cβ	0.0769230769231
PLCβ	4phospholipase c beta 4	0.0769230769231
PLCβ	4phospopholipase cβ4	0.0769230769231
PLCβ	1/4phospholipase β1/4	0.0769230769231
PLCβ	1	0.0769230769231
PLCβ	phospholipase c-β	0.153846153846
PLCβ	2phospholipase c beta 2	0.0769230769231
PLCβ	phospholipase cβ	0.307692307692
PLCγ	phospholipase c	0.0714285714286
PLCγ	1phospholipase cγ1	0.0714285714286
PLCγ	phospholipase c gamma isoform	0.0714285714286
PLCγ	phospholipase c gamma	0.142857142857
PLCγ	phospholipase c-gamma	0.0714285714286
PLCγ	phospholipase cγ	0.357142857143
PLCγ	phospholipase c-γ	0.0714285714286
PLCγ	1phospholipase c-γ1	0.0714285714286
PLCγ	phospholipasecγ	0.0714285714286
AChE	acetyl cholinesterase	0.0210526315789
AChE	acetylcholinesterase (ec 3.1.1.7)	0.0210526315789
AChE	acetylcholineesterase	0.0105263157895
AChE	acetylcholine esterase	0.0105263157895
AChE	acetylcholinesterase	0.926315789474
AChE	acetycholinesterase	0.0105263157895
GRAC	gracile nucleus	1.0
FASF	etal alcohol syndrome	1.0
BFAB	refeldin a	1.0
FASD	fetal alcohol spectrum disorders	0.5
FASD	fetal alcohol spectrum disorder	0.5
fRPTPζ	full-length form of receptor-type protein tyrosine phosphatase ζ	1.0
Dex	diffusion coefficient in the synapse, between the sheath and extracellular space	1.0
FN-III	fibronectin type-iii	1.0
NEILN	ei-like homolog	1.0
CUS	chronic unpredictable stress	1.0
CUP	caudate putamen	1.0
aug-I	neuronaugmenting inspiratory neuron	1.0
hMOC	mouse anti-neural cell adhesion molecule	1.0
RTI-	55	1.0
eISPC	evoked inhibitory postsynaptic currents	1.0
TMST	ranscranial magnetic stimulation	1.0
Harlan	europe, uk	1.0
W-SP	group working during the sleep phase	1.0
SRTTS	erial reaction time task	1.0
CUN	cuneiform nucleus	0.666666666667
CUN	cuneate nucleus	0.333333333333
NOE	n-oleoylethanolamine	1.0
DMFN	n-dimethylformamide	0.5
DMFN	n-dimethylformide	0.5
BAPTA-1	hexapotassium salt cell impermeant	1.0
CSD-C	2	1.0
TJM	tremulous jaw movements	0.5
TJM	tremulous jaw movement	0.5
DR-O	object delayed response	1.0
NIAN	ational institute on aging	1.0
qt-PCR	quantitative real-time polymerase chain reaction	1.0
FCMF	low cytometry	1.0
TCFsshort	true constant frequency	1.0
RSDREM	sleep deprivation	1.0
P75LNGFR	low-affinity nerve growth factor receptor	1.0
FS-N	o injfootshock+no injection	1.0
TeTx	tetanus toxin	1.0
SRAF	suprarhinal auditory field	1.0
CGRP-IR	cgrp-like immunoreactivity	1.0
FS-F	ormfootshock+formalin	1.0
biotin-VAD-	fmkbiotin-val-ala-asp-fluoromethylketone	1.0
IACUC	institutional animal care and use committee	1.0
RMS-SD	root-mean square of beat-to-beat-difference	1.0
inTS	intermediate subnucleus of nts	1.0
NOG	noggin	1.0
AAV-V	1aadeno-associated viral vector containing v1a gene	1.0
rIL-	17arecombinant mouse-il-17a	1.0
3AP	3-acetylpyridine	1.0
SS-28	somatostatin-28	1.0
DHBP1	1′-diheptyl-4,4′-bipyridinium dibromide	1.0
OCR	oxygen consumption rate	0.5
OCR	ocular counter-rolling	0.333333333333
OCR	optocollic reflex	0.166666666667
HDRP	histone deacetylase-related protein	1.0
bis-I	bisindoylmaleimide 1	0.5
bis-I	bisindolylmaleimide-i	0.5
tgHD	transgenic rat model of hd	1.0
IFI	mmunofluorescence	0.5
IFI	inter-flash interval	0.5
PLSA	path length scaling algorithm	1.0
CLASPC	onstrained laplacian-based automated segmentation with proximities	1.0
SNX-	482	1.0
CAMs	cell adhesion molecules	1.0
GFPH	afanach-phenylalanine-methionine-arginine-phenylalanine-nh2–gated sodium channel from helix aspersa with an n-terminal green fluorescent protein fusion	1.0
GFPG	reen fluorescent protein	1.0
MVCM	aximal voluntary isometric contraction	1.0
RyR	ryanodine receptor	0.666666666667
RyR	ryanodine receptor protein	0.333333333333
PROG1	2,6,7-3h(n)-progesterone	1.0
Acb	nucleus accumbens	0.571428571429
Acb	accumbens nucleus	0.428571428571
25-OH	chol25-hydroxycholesterol	1.0
D-PBS	dulbecco's phosphate-buffered saline	1.0
pPVN	parvocellular paraventricular nucleus of the hypothalamus	0.142857142857
pPVN	parvocellular subset of paraventricular nucleus	0.142857142857
pPVN	parvocellular region of the paraventricular nucleus of the hypothalamus	0.142857142857
pPVN	posterior paraventricular nucleus	0.142857142857
pPVN	parvocellular part of the paraventricular hypothalamic nucleus	0.142857142857
pPVN	parvocellular paraventricular nucleus	0.285714285714
3αDIOL9	11-3h(n)-3α-androstanediol	1.0
DSM-IIIR	diagnostic and statistic manual, 3rd edn	1.0
Ach	acetylcholine	1.0
DAPC	dystrophin-associated glycoprotein complex	0.2
DAPC	dystrophin-associated-protein-complex	0.2
DAPC	dystrophin-associated protein complex	0.6
4N	trochlear nucleus	0.5
4N	trochlear nu	0.5
GFP-	irgfp immunoreactivity	0.5
GFP-	hsertgreen fluorescent protein-tagged human serotonin transporter	0.5
PSBP	ontamine sky blue	1.0
Act	activin receptor type	1.0
αSYNα-	synuclein	1.0
4D	i-10asp4-(4-dimethylaminostyryl)-n-methylpyridium-iodide	1.0
4E	eukaryotic initiation factor 4g and poly-adenylated mrna binding protein	1.0
dBBA	medial septal nucleus and diagonal band of broca area	1.0
LATERL	inear approach to threshold with ergodic rate	1.0
F-actin	filamentous actin	1.0
BIMC	blessed information memory and concentration test	1.0
VIGV	igilance	1.0
SNOG	nitrosoglutathione	1.0
SCPN	subcerebral projection neuron	1.0
NQSAC	hnon-quantal secretion of acetylcholine	1.0
GDNF	glial cell line-derived	0.0062893081761
GDNF	glial-cell line-derived neurotrophic factor	0.0062893081761
GDNF	glial cell-line-derived neurotrophic factor	0.0125786163522
GDNF	knockout	0.0062893081761
GDNF	glial cell-line derived neurotrophic factor	0.0188679245283
GDNF	glial-derived neurotrophic factor	0.125786163522
GDNF	glial cell line–derived neurotrophic factor	0.0377358490566
GDNF	glia-derived neurotrophic factor	0.0188679245283
GDNF	glial cell-line–derived neurotrophic factor	0.0062893081761
GDNF	glial cell-derived neurotrophic factor	0.0817610062893
GDNF	glial-cell-derived neurotrophic factor	0.0062893081761
GDNF	glial-cell-line-derived neurotrophic factor	0.0062893081761
GDNF	glial cell line-derived neurotrophic factor	0.566037735849
GDNF	glia cell line-derived neurotrophic factor	0.0125786163522
GDNF	neuroprotection	0.0062893081761
GDNF	glial cell line derived neurotrophic factor	0.0125786163522
GDNF	glial-derived neuronal factor	0.0062893081761
GDNF	glial cell derived neurotrophic factor	0.0188679245283
GDNF	glia-derived growth factor	0.0062893081761
GDNF	glial derived neurotrophic factor	0.0251572327044
GDNF	+ventral mesencephalon with glial cell line-derived neurotrophic factor hibernation and repeated exposure in culture	0.0062893081761
GDNF	glial cell-line neurotrophic factor	0.0062893081761
glutamateL-	glutamic acid sodium salt hydrate	1.0
Ihypoxic	hypoxic outward current	1.0
Acg	anterior cingulate cortex	1.0
RFEF	right frontal eye field	1.0
FXYD	7	1.0
LIFG	left inferior frontal gyrus	1.0
KHS	krebs'–henseleit solution	1.0
PHDA	periventricular hypothalamic dopaminergic neurons	1.0
7-NINA	monosodium salt of 7-nitroindazole	0.125
7-NINA	7-nitroindazole sodium	0.125
7-NINA	7-nitro-indazole-sodium salt	0.25
7-NINA	7-nitroindazole monosodium salt	0.5
SSPE	standard saline phosphate edta buffer	0.0625
SSPE	0.15m sodium chloride and 50mm sodium phosphate, ph 7.4	0.0625
SSPE	nacl–nah2po4–edta	0.0625
SSPE	saline sodium phosphate ethylenediaminetetra-acetate	0.0625
SSPE	sodium sodium phosphate–edta	0.0625
SSPE	sodium saline phosphate edta (ethylenediaminetetraacetic acid)	0.0625
SSPE	saline sodium phosphate ethylenediaminetetra-acetic acid buffer	0.0625
SSPE	sodium chloride/sodium phosphate/edta buffer	0.0625
SSPE	definition?	0.0625
SSPE	sustained slow postsynaptic excitation	0.1875
SSPE	saline sodium phosphate–edta	0.0625
SSPE	sodium chloride/sodium phosphate/edta	0.0625
SSPE	saline sodium phosphate edta	0.125
XBP	1x-box binding protein 1	1.0
MLAERP	middle latency auditory event-related potential	0.5
MLAERP	middle latency auditory event-related potentials	0.5
bgMGV	background mean gray value	1.0
LIFR	leukemia inhibitory factor receptor	0.5
LIFR	leukemia inhibitory factor receptor-β	0.5
ASP-GLU	l-aspartic-l-glutamic acid	1.0
6B4	anti-phosphacan monoclonal antibody	1.0
α-KTα-	keto-glutarate	1.0
MsODN	missense oligodeoxynucleotide	1.0
pSNL	partial sciatic nerve ligation	1.0
G4	tetrameric globular form of acetylcholinesterase	0.5
G4	tetrameric ache	0.5
G3	generation 3	1.0
G2	generation 2	0.5
G2	dimeric ache	0.5
G1	monomeric ache	0.5
G1	generation 1	0.5
L-NIO	l-n5-(1-iminoethyl)-ornithine	1.0
Crn	creatinine	1.0
AMPKAMP-	activated kinase	0.111111111111
AMPKAMP-	activated protein kinase	0.777777777778
AMPKAMP-	dependent protein kinase	0.111111111111
L-NIL	n-iminoethyl-l-lysine	1.0
C-C	collateral-collateral	1.0
MnTBAP	manganese(iii) tetrakis(4-benzoic acid)porphyrin	1.0
FTPD-	17frontotemporal dementia with parkinsonism associated to chromosome 17	1.0
CET	chronic ethanol treatment	1.0
VBMV	oxel based morphometry	0.5
VBMV	oxel-based morphometry	0.5
DNQXdinitroquinoxaline-2	3(1h, 4h)-dione	0.333333333333
DNQXdinitroquinoxaline-2	3-dione	0.666666666667
G-	proteinsguanine nucleotide-binding proteins	0.0408163265306
G-	minigöttingen minipig	0.0204081632653
G-	protein-coupled inwardly rectifying potassium current (girk)	0.0204081632653
G-	actinglobular actin	0.0408163265306
G-	proteingtp binding protein	0.0204081632653
G-	actinmonomeric actin	0.0204081632653
G-	protein-coupled receptor	0.0816326530612
G-	6-pdhglucose-6-phosphate dehydrogenase	0.0204081632653
G-	proteinguanine nucleotide-binding protein	0.0612244897959
G-	proteins	0.163265306122
G-	protein coupling	0.0204081632653
G-	protein activation	0.0204081632653
G-	protein-coupled receptors	0.122448979592
G-	protein coupled receptor	0.0408163265306
G-	protein–coupled receptor	0.0204081632653
G-	protein	0.244897959184
G-	saporin	0.0204081632653
G-	proteinguanine nucleotide binding protein	0.0204081632653
C-T	condition-test	0.5
C-T	intervalthe time between the two tectal stimulating pulses	0.5
C-S	control animal receiving saline	0.5
C-S	control rat with standard housing	0.5
TOGT	est of genuineness	1.0
PKG	cgmp-dependent protein kinase	0.142857142857
PKG	cgmp-dependent protein kinases	0.0357142857143
PKG	guanosine 3′,5′-cyclic monophosphate-dependent protein kinase	0.0357142857143
PKG	cyclic-gmp-dependent protein kinase	0.0357142857143
PKG	cyclic guanosine monophosphate–activated protein kinase	0.0357142857143
PKG	scgmp-dependent protein kinases	0.0357142857143
PKG	cgmp-dependent protein kinase g	0.0714285714286
PKG	cyclic gmp-dependent protein kinase	0.107142857143
PKG	protein kinase g	0.5
GW	gestational week	0.428571428571
GW	3965	0.142857142857
GW	gestational weeks	0.142857142857
GW	405833	0.142857142857
GW	96622-chloro-5-nitro-n-phenylbenzamide	0.142857142857
GV	gray value	1.0
GU	gustatory cortex	0.5
GU	glucose utilization	0.5
GT	sglutamate transporters	0.25
GT	1bneu5acα3-galβ3galnacβ4(neu5acα8neu5acα3)galβ4glccer	0.166666666667
GT	gliotransmission	0.0833333333333
GT	glutamate transporters	0.0833333333333
GT	gated threshold adaptation	0.0833333333333
GT	glutamate transporter	0.25
GT	sgoal-trackers	0.0833333333333
GS	grip strength	0.0208333333333
GS	glutamine synthase	0.125
GS	glial scar	0.0208333333333
GS	gonadal steroids	0.0416666666667
GS	glutathione synthetase	0.0208333333333
GS	glycogen synthase	0.0208333333333
GS	glutamine synthetase	0.666666666667
GS	goat serum	0.0416666666667
GS	generalized seizures	0.0208333333333
GS	stellate ganglia	0.0208333333333
GR	glutathione reductase	0.0645161290323
GR	pglucose-regulated protein	0.010752688172
GR	ovglucocorticoid receptor overexpression	0.00537634408602
GR	555623-[3-(dimethylamino)propyl]-4-hydroxy-n-[4-(4-pyridinyl)phenyl]	0.00537634408602
GR	nucleus gracilis	0.00537634408602
GR	gluthatione reductase	0.00537634408602
GR	sgranule cells	0.00537634408602
GR	73632δ-ala-phe-phe-pro-meleu-d-pro[spiro-γ-lactam]-leu-trp-nh2	0.00537634408602
GR	1138081-[2-[(methylsulfonyl)-amino]ethyl]	0.010752688172
GR	gritty texture stimulus	0.00537634408602
GR	psp6-gr-ha	0.00537634408602
GR	glucocorticoid	0.0161290322581
GR	glucocorticoid receptors	0.0591397849462
GR	gustatory receptor	0.00537634408602
GR	group reared	0.00537634408602
GR	glucorticoid receptor	0.00537634408602
GR	glucocorticoids receptor	0.010752688172
GR	sglucocorticoid receptors	0.0161290322581
GR	b1ginsenoside rb1	0.00537634408602
GR	glucocorticoid receptor	0.715053763441
GR	geometrical ratio	0.00537634408602
GR	sgustatory receptors	0.00537634408602
GR	glutathione disulfide reductase	0.00537634408602
GR	green	0.00537634408602
GR	glucocorticoid (type ii) receptor	0.00537634408602
GR	glucocorticoid type ii receptor	0.00537634408602
GQ	1b	0.5
GQ	1bneu5acα8neu5acα3galβ3-galnacβ4(neu5acα8neu5acα3)galβ4glccer	0.5
GP	globus pallidas	0.00602409638554
GP	eexternal globus pallidus	0.00602409638554
GP	x1glutathione peroxidase	0.00602409638554
GP	iinternal segment of globus pallidus	0.00602409638554
GP	xglutathione peroxidase activity	0.00602409638554
GP	globus pallidum	0.00602409638554
GP	xglutathione peroxidase	0.102409638554
GP	iinternal globus pallidus segment	0.00602409638554
GP	iglobus pallidus pars interna	0.00602409638554
GP	eexternal segment of globus pallidus	0.00602409638554
GP	external medullary lamina	0.00602409638554
GP	iinternal (medial) segment of the globus pallidus	0.00602409638554
GP	x-1glutathione peroxidase 1	0.00602409638554
GP	eexternal gp	0.00602409638554
GP	xglutathione-peroxidase	0.00602409638554
GP	globus pallidus	0.596385542169
GP	i/snrglobus pallidus interna/substantia nigra pars reticulata	0.00602409638554
GP	globus pallidus (paleostriatum primitivum)	0.00602409638554
GP	engrgdspca (‘gpen’), glycine-penicillamine-glycine-arginine-glycine-aspartate-serine-proline-cysteine-alanine [cyclical]	0.00602409638554
GP	xgluthatione peroxidase	0.00602409638554
GP	globus pallidus (external segment)	0.00602409638554
GP	x-1glutathione peroxidase-1	0.00602409638554
GP	iglobus pallidus interna	0.00602409638554
GP	eexternal part of globus pallidus	0.00602409638554
GP	globus palidus	0.00602409638554
GP	iinternal segments of the globus pallidus	0.00602409638554
GP	guinea-pig	0.00602409638554
GP	50glycoprotein of 50 kilodaltons	0.00602409638554
GP	sodium β-glycerophosphate	0.0120481927711
GP	iglobus pallidus internal	0.0120481927711
GP	iglobus pallidus internal segment	0.0180722891566
GP	iinternal segment of the globus pallidus	0.0421686746988
GP	mmedial globus pallidus	0.00602409638554
GP	xglutathione peroxidise	0.00602409638554
GP	eglobus pallidus external segment	0.00602409638554
GP	gold particle	0.00602409638554
GP	iinternal globus pallidus	0.0361445783133
GBG	enius buffer	0.5
GBG	inkgolide b	0.5
SNpr	pars reticularis of the substantia nigra	0.1
SNpr	substantia nigra–pars reticulata	0.1
SNpr	substantia nigra pars reticulata	0.7
SNpr	sn pars reticulata	0.1
VMT	ventromedial thalamus	0.333333333333
VMT	hventromedial thalamus	0.333333333333
VMT	ventrolateral/ventromedial thalamus	0.333333333333
NBT-BCIP	nitro-blue tetrazolium chloride and 5-bromo 4-chloro 3′indolyphosphate p-toluidine salt	1.0
GZ	granular zone	0.5
GZ	gabazine	0.5
dPFC	dorsal part of the prefrontal cortex	1.0
VIPPC	ventral inferior posterior parietal cortex	1.0
GG	gangliogliomas	0.0625
GG	genioglossus	0.3125
GG	genioglossus muscle	0.125
GG	olgi apparatus	0.0625
GG	ganglioglioma	0.3125
GG	geniculate ganglia	0.0625
GG	geniculate ganglion	0.0625
GF	giant fiber	0.1
GF	growth factors	0.1
GF	grip force	0.2
GF	growth factor	0.1
GF	109203x	0.1
GF	109203xbisindolylmaleimide i	0.1
GF	goodness of fit	0.1
GF	109203x2-[1-(3-dimethylaminopropyl)indol-3-yl]-3-(indol-3-yl)maleimide	0.1
GF	bisindolylmaleimide i	0.1
GE	gradient echo	0.0625
GE	ganglionic eminence	0.4375
GE	glucose-excited	0.0625
GE	gastric emptying	0.0625
GE	glucose-excitatory	0.0625
GE	general electric	0.0625
GE	ganglionic eminences	0.0625
GE	generalized epilepsies	0.0625
GE	glucose-excited neurons	0.0625
GE	glial envelope	0.0625
GD	2galnacβ4(neu5acα8-neu5acα3)galβ4glccer	0.030303030303
GD	gestational days	0.0606060606061
GD	gestational day	0.575757575758
GD	guanine derivatives	0.030303030303
GD	3neu5acα8neu5acα3galβ4glccer	0.030303030303
GD	11–13gestational days 11–13	0.030303030303
GD	3 synthase	0.030303030303
GD	gyrus dentatus	0.030303030303
GD	gestation day	0.0909090909091
GD	glucose deprivation	0.0606060606061
GD	day of gestation	0.030303030303
GC	granule cell layer	0.0196078431373
GC	/msgas chromatography/mass spectrometry	0.0196078431373
GC	sglucocorticoid drugs	0.00980392156863
GC	guanylate cyclase	0.0490196078431
GC	giant cell	0.00980392156863
GC	tsubstantia grisea centralis (mesencephalic central gray)	0.00980392156863
GC	galactocerebroside	0.00980392156863
GC	gustatory cortex	0.0392156862745
GC	sglucocorticoids	0.117647058824
GC	germinal center	0.00980392156863
GC	sglucocorticoid hormones	0.00980392156863
GC	granule cell	0.137254901961
GC	/onfganglion cell bodies and optic nerve fibers	0.00980392156863
GC	glucocorticoid	0.21568627451
GC	tmidbrain central gray	0.00980392156863
GC	sgiant cells	0.00980392156863
GC	granule cells	0.0294117647059
GC	gel chromatography	0.00980392156863
GC	cervical ganglia	0.00980392156863
GC	–msgas chromatography–mass spectrometry	0.0196078431373
GC	ganglion cell	0.0392156862745
GC	/msgas chromatography coupled with mass spectrometry	0.00980392156863
GC	glucocorticoids	0.0588235294118
GC	–msgas chromatography mass spectrometry	0.00980392156863
GC	sglial cells	0.00980392156863
GC	growth cone	0.00980392156863
GC	gas chromatography	0.0490196078431
GC	central gray	0.00980392156863
GC	sgranular cells	0.00980392156863
GC	guanylyl cyclase	0.0392156862745
GB	green beads	0.75
GB	granular blue	0.25
GA	gestational age	0.0588235294118
GA	guanidinoacetate	0.0588235294118
GA	glyzyrrhizic acid	0.0588235294118
GA	glutaraldehyde	0.529411764706
GA	gastrocnemius	0.0588235294118
GA	gyrate atrophy of the choroid and retina	0.0588235294118
GA	glatiramer acetate	0.0588235294118
GA	geldanamycin	0.117647058824
GO	golgi cell	0.0555555555556
GO	gene ontology	0.666666666667
GO	glucose oxidase	0.166666666667
GO	glycine oxydase	0.0555555555556
GO	gene ontogeny	0.0555555555556
GN	gracile nucleus	0.4
GN	input conductance	0.4
GN	gracile nuclei	0.2
GM	glial-conditioned medium	0.0196078431373
GM	geissoschizine methyl ether	0.0196078431373
GM	genetic manipulation	0.0196078431373
GM	gastric mill	0.0196078431373
GM	6001	0.0196078431373
GM	gluteus maximus	0.0392156862745
GM	good memory	0.0196078431373
GM	1 ganglioside	0.0196078431373
GM	6001n-[(2r)-2-(hydroxamidocarbonylmethyl)-4-methylpenthanoyl]-l-tryptophan methylamide	0.0196078431373
GM	medial geniculate nucleus	0.0196078431373
GM	gastrocnemius medialis	0.0196078431373
GM	6001n-[(2r)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-l tryptophanmethylamide	0.0196078431373
GM	grand mal seizures	0.0196078431373
GM	growth medium	0.0392156862745
GM	gray matter	0.411764705882
GM	gray matter (in p2-10 mice)	0.0196078431373
GM	nucleus geniculatus medialis	0.0196078431373
GM	gentamicin	0.0588235294118
GM	geometric mean	0.0196078431373
GM	1monosialoganglionside	0.0196078431373
GM	grey matter	0.0588235294118
GM	3neu5acα3galβ4glccer	0.0392156862745
GM	130golgi matrix protein 130	0.0392156862745
GL	granule cell layer	0.0961538461538
GL	glomerular layer of olfactory bulb	0.0192307692308
GL	good learner	0.0192307692308
GL	nerveglossopharyngeal nerve	0.0192307692308
GL	eakleak conductance	0.0192307692308
GL	glomerular layer	0.653846153846
GL	glomerular layer of the olfactory bulb	0.0192307692308
GL	granular layer	0.0384615384615
GL	dnucleus geniculatus lateralis dorsalis	0.0192307692308
GL	glomerular cell layer	0.0192307692308
GL	glossopharyngeal	0.0192307692308
GL	grey level	0.0192307692308
GL	/mclglomerular layer/mitral cell layer	0.0192307692308
GL	granule cell layer of cerebellum	0.0192307692308
GK	ratsgoto-kakizaki rats	0.333333333333
GK	ratsgoto–kakizaki rats	0.333333333333
GK	guanylate kinase like	0.333333333333
GJ	gap junction	1.0
GI	mglurgroup i metabotropic glutamate receptor	0.0285714285714
GI	glucose-inhibited	0.0285714285714
GI	glucose-inhibited neurons	0.0285714285714
GI	granular insular cortex	0.314285714286
GI	glomerular layer of the olfactory bulb	0.0285714285714
GI	gastrointestinal or gastrointestine	0.0285714285714
GI	granular division of the insular cortex	0.0285714285714
GI	gastro-intestinal	0.0285714285714
GI	gyrification index	0.0571428571429
GI	gastrointestinal	0.428571428571
GH	genetically hypertensive	0.05
GH	geniohyoideus muscle	0.05
GH	growth hormone	0.9
SIC	stretch-inactivated channel	0.2
SIC	slow inward current	0.6
SIC	stretch inhibitable channel	0.2
PKI	protein kinase inhibitor	0.166666666667
PKI	protein kinase a inhibitor fragment 14–22 myristoylated trifluoracetate salt	0.166666666667
PKI	myristoylated pka inhibitor amide 14–22	0.166666666667
PKI	protein kinase inhibitor peptide	0.166666666667
PKI	cyclic amp-dependent protein kinase inhibitor	0.166666666667
PKI	14-22myristoyl pka inhibitor peptide 14-22	0.166666666667
Gr	gracile nucleus	1.0
FASDF	etal alcohol spectrum disorders	1.0
Gx	ganglionectomy	0.5
Gx	ganglionectomy group	0.5
MDA3	4-methylenedioxyamphetamine	1.0
GYPGKFH-Gly-Tyr-Pro-Gly-Lys-Phe-OH	(mouse protease-activated receptor-4 activating peptide)	1.0
PSQIP	ittsburgh sleep quality index	0.666666666667
PSQIP	ittsburgh sleep quality questionnaire	0.333333333333
Go	guanine nucleotide-binding protein g(o), alpha subunit 1	1.0
SIRTS	ternberg item recognition test	1.0
AMCA	7-amino-4-methylcoumarin-3-acetic acid	0.263157894737
AMCA	aminomethylcalmarin	0.0526315789474
AMCA	7-amino-4-metylcoumarin-3-acetic acid	0.0526315789474
AMCA	7-amino-4-methylcoumarin-3 acetic acid	0.0526315789474
AMCA	aminomethylcoumarin	0.0526315789474
AMCA	cademic medical center	0.0526315789474
AMCA	7-amino 4-methyl coumarin 3-acetic acid	0.0526315789474
AMCA	9-amino-6-chloro-2-methoxyacridine	0.0526315789474
AMCA	c-devd-7-amino-4-methylcoumarin	0.0526315789474
AMCA	aminomethylcoumarin acetate	0.0526315789474
AMCA	7-amino-4-methylcoumarin-3 acetate	0.0526315789474
AMCA	aminomethylcoumarine	0.0526315789474
AMCA	7-amino-4-methyl coumarin-3-acetic acid	0.105263157895
AMCA	streptavidin-conjugated 7-amino-4-methyl-coumarin-3-acetic acid	0.0526315789474
CTC-	terminal	0.5
CTC-	terminal tail	0.5
PiTX	picrotoxin	1.0
APP-SL	mice carrying the human app gene with the swedish/london double mutation	1.0
lMAN	lateral part of the magnocellular nucleus of the anterior neostriatum	0.5
lMAN	lateral magnocellular nucleus of the anterior nidopallium	0.5
WGAapoHRP-Au	wheatgerm agglutinin apo horseradish peroxidase gold	1.0
LAAH	lateral area anterior hypothalamus	0.333333333333
LAAH	lateral area of the anterior hypothalamus	0.666666666667
VLa	anterior ventral lateral nucleus	0.333333333333
VLa	ventral lateral anterior nucleus	0.666666666667
mGlutR	metabotropic glutamate receptor	1.0
TTX-STTX-	sensitive	1.0
NH2dAD	5′-amino-5′-deoxyadenosine	1.0
β-APP	β-amyloid precursor protein	0.8
β-APP	beta amyloid precursor protein	0.2
VLp	ventral lateral posterior nucleus	0.75
VLp	posterior division of the ventral lateral nucleusof the thalamus	0.25
FFRT	free-floating roller-tube	1.0
SbM	submedius nucleus	1.0
VLH	ventral part of the lateral hypothalamic nucleus	0.111111111111
VLH	ventrolateral hypothalamus	0.555555555556
VLH	/vmhventrolateral/ventromedial hypothalamic nuclei	0.111111111111
VLH	ventral lateral hypothalamus	0.222222222222
TTY	tityustoxin-kα	1.0
TTX	tetrodotoxin.	0.0015600624025
TTX	stetrodotoxin sensitive	0.00312012480499
TTX	tedrodotoxin	0.0015600624025
TTX	tetrodotoxine	0.0015600624025
TTX	tetrodotoxin citrate	0.00780031201248
TTX	stetrodotoxin-sensitive	0.0015600624025
TTX	tetrodotoxin	0.979719188768
TTX	tetrodotoxin (voltage-dependent sodium channel antagonist)	0.0015600624025
TTX	tetradotoxin	0.0015600624025
VLM	lat* lateral portion of the caudal ventrolateral medulla	0.0185185185185
VLM	ventrolateral reticular nucleus of the medulla	0.0555555555556
VLM	ventral lateral medulla	0.0185185185185
VLM	ventrolateral medullary region	0.0185185185185
VLM	latlateralmost part of the caudal ventrolateral medulla	0.0185185185185
VLM	ventrolateral motor nucleus	0.0185185185185
VLM	ventrolateral medulla	0.814814814815
VLM	ventolateral medulla	0.0185185185185
VLM	caudal ventrolateral medulla	0.0185185185185
VLL	ventral nucleus of the lateral lemniscus	0.777777777778
VLL	ventral nu lateral lemniscus	0.111111111111
VLL	ventral lateral lemniscus	0.111111111111
VLO	ventral-lateral orbital	0.0666666666667
VLO	ventrolateral orbital cortex	0.866666666667
VLO	ventrolateral outgrowth	0.0666666666667
VLN	ventrolateral nucleus	0.666666666667
VLN	ventrolateral nucleus (of the inferior colliculus)	0.333333333333
TTS	tudent’s t-test	0.142857142857
TTS	temporary threshold shift	0.857142857143
TTR	transthyretin	1.0
VLC	ventrolateral column	1.0
TTP	times to peak	0.2
TTP	tristetraprolin	0.2
TTP	the time required to reach the peak of inward current	0.2
TTP	time to peak	0.4
CA-RP	carbonic anhydrase-related protein	1.0
VLG	ventrolateral geniculate	0.0833333333333
VLG	ventrolateral geniculate nucleu	0.0833333333333
VLG	ventral lateral geniculate	0.166666666667
VLG	ventrolateral geniculate nucleus	0.0833333333333
VLG	ventral lateral geniculate nucleus	0.583333333333
VLF	very low frequency	0.181818181818
VLF	ventrolateral funiculus	0.818181818182
cRSP	caudal retrosplenial cortex	1.0
TTH	tension-type headache	1.0
TTN	triakontatetraneuropeptide	0.5
TTN	triakontatetraneuropeptide dbi[17–50]	0.5
TTM	tetrathiomolybdate	1.0
TTL	transistor–transistor logic	0.333333333333
TTL	transistor-transistor logic	0.333333333333
TTL	transistor transistor logic	0.333333333333
VLQ	ventral–lateral quadrant	1.0
cNOS	constitutive nos	0.666666666667
cNOS	catalytic nitric oxide synthase	0.333333333333
VLS	ventrolateral striatum	0.307692307692
VLS	ventral lateral septum	0.153846153846
VLS	ventrolateral subregion of the neostriatum	0.0769230769231
VLS	ventrolateral septum	0.307692307692
VLS	ventrolateral part of the striatum	0.0769230769231
VLS	ventrolateral neostriatum	0.0769230769231
G-DNMS	delayed non-matching-to-sample task that requires discrimination of gaze direction	1.0
TTF	1transcription termination factor 1	1.0
TTE	therapeutic tongue exercises	1.0
TTD	trichothiodystrophy	0.666666666667
TTD	trichothiodystropy	0.333333333333
HPDP	biotin-hexyl pyridyldithiopropionamide	1.0
ZM	241385	1.0
ZO	zona occludens	0.333333333333
ZO	1tight junction-associated polypeptide (zonula occludens 1)	0.166666666667
ZO	zonula occludens	0.333333333333
ZO	zonula occuldens	0.166666666667
ZI	zona incer	0.0277777777778
ZI	zona incerta	0.916666666667
ZI	vventral sector of the zona incerta	0.0277777777778
ZI	vventral part of the zona incerta	0.0277777777778
ZD	7288	1.0
ZF	zona fasciculata	1.0
ZG	zona glomerulosa	1.0
β-EPβ-	endorphin	1.0
dCA1	ca1 field of dorsal hippocampus	1.0
dCA2	ca2 field of dorsal hippocampus	1.0
dCA3	ca3 field of dorsal hippocampus	1.0
BJLOTB	enton judgment of line orientation test	1.0
ZT	zeitgeber time	1.0
ZP	1zinpyr-1	1.0
SOLS	oleus	1.0
Zi	zona incerta	1.0
CpG	dna sequence in which a cytosine base precedes a guanosine base	1.0
APDC	2r,4r-4-aminopyrrolidine-2,4-dicarboxylate	1.0
EBDE	vans blue dye	1.0
LAOBP	lysine/arginine/ornithine-binding protein	1.0
MEMRI	manganese-enhanced mri	0.2
MEMRI	manganese-enhanced magnetic resonance imaging	0.8
tBuBHQ	2,5-diterbutyl-1,4-benzohydroquinone	1.0
CPMGC	arr–purcell–meibom–gill	1.0
Thin	food-restricted group	1.0
5-HD	5-hydroxydecanoic acid	1.0
GHRH	growth hormone-releasing hormone	0.416666666667
GHRH	growth hormone releasing hormone	0.416666666667
GHRH	growth hormone–releasing hormone	0.0833333333333
GHRH	rat growth hormone-releasing hormone	0.0833333333333
Msx2homeobox	msh-like 2	1.0
vPAG	ventral periaqueductal gray	0.285714285714
vPAG	ventral pag	0.142857142857
vPAG	ventrolateral periaqueductal gray	0.571428571429
ConA	concanavalina	1.0
FIHC	fluorescent ihc	1.0
PBST-NDSPBS	containing 0.3% triton x-100 and 0.05% nds	1.0
MIOD	mean integrated optical density	1.0
LBAL	inear ballistic accumulator	1.0
JNKN-	terminal jun-kinase	1.0
PBMC	peripheral blood mononuclear cells	0.333333333333
PBMC	peripheral blood mononuclear cell	0.333333333333
PBMC	speripheral blood mononuclear cells	0.333333333333
mDS	medial dorsal striatum	1.0
PRESSP	osition resolved spectroscopy	0.5
PRESSP	redicted residual estimated sum of squares	0.5
cAMPK	camp-dependent protein kinase	1.0
OSUO	hio state university	1.0
SNAMA	spontaneous non-ambulatory motor activity	1.0
RPARN	ase protection assay	1.0
TAF	1	0.5
TAF	transformed auditory feedback	0.5
SPARC	secreted protein acidic and rich in cysteine	1.0
DIDS	4,4′-diisothiocyanatostilbene-2, 2′disulphonic acid	0.1
DIDS	diisothiocyanatoostilbene-2,2′-disulfonic acid	0.1
DIDS	4,4′-di-isothyocyanatostilbene-2,2′-disulfonic acid	0.1
DIDS	4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid	0.2
DIDS	diisothiocyanostilbene-2,2′-disulfonate	0.1
DIDS	4,4′-diisothiocyanato-stilbene-2,2′-disulphonate	0.1
DIDS	4,4′-diisothiocyanatostilbene-2,2′-disulphonic acid	0.2
DIDS	4,4′-diisothiocyanostilbene-2,2′-disulfonic acid	0.1
VSEQ	visual sequence learning task	1.0
phospho-CREB	phosphorylated creb	0.666666666667
phospho-CREB	phosphorylated camp response element binding protein	0.333333333333
PSPNP	ersephin	1.0
UNOP	unoperated group	0.333333333333
UNOP	unoperated	0.666666666667
mG	lur5metabotropic glutamate receptor 5	0.0343347639485
mG	lur1metabotropic glutamate receptor of type-1	0.00429184549356
mG	lur1metabotropic glutamate receptor type 1	0.00429184549356
mG	lursg protein-coupled metabotropic receptors	0.00429184549356
mG	lur iimetabotropic glutamate receptor group ii	0.00429184549356
mG	lur1metabotropic glutamate receptor 1	0.0128755364807
mG	lur1type 1 metabotropic glutamate receptor	0.00429184549356
mG	lur,	0.00429184549356
mG	lur1α+metabotropic glutamate receptor 1α positive	0.00429184549356
mG	lur6	0.00429184549356
mG	lur5	0.00858369098712
mG	lur1metabotropic glutamate receptor subtype 1	0.00429184549356
mG	lur3	0.00429184549356
mG	lur2	0.00858369098712
mG	lur1	0.00429184549356
mG	lurmetabotropic glutamate receptor	0.429184549356
mG	lur1α+mglur1α-positive	0.00429184549356
mG	lumetabotropic glutamate	0.0386266094421
mG	nrhmammalian gonadotropin releasing hormone	0.00429184549356
mG	lur8	0.00429184549356
mG	lur	0.0429184549356
mG	lur6metabotropic glutamate receptors	0.00429184549356
mG	lursmetrabotropic glumate receptors	0.00429184549356
mG	lumetabotropic glutamate receptor	0.0128755364807
mG	lur2/3metabotropic glutamate receptors	0.00429184549356
mG	lurisgroup i metabotropic glutamate receptors	0.00429184549356
mG	lu1rmetabotropic glutamatergic receptor 1	0.00429184549356
mG	lur1α-metabotropic glutamate receptor 1α-negative	0.00429184549356
mG	lur5metabotropic glutamate receptor subtype 5	0.0128755364807
mG	lur3 mrna expression	0.00429184549356
mG	lur iii	0.00429184549356
mG	lurs-igroup i metabotropic glutamate receptors	0.00429184549356
mG	lur5metabotropic glutamate receptor	0.00429184549356
mG	lu-ltdmetabotropic glutamate receptor-dependent long-term depression	0.00429184549356
mG	lur1αmetabotropic glutamate receptor 1α	0.0128755364807
mG	lurmetabotropic glutamatereceptor	0.00429184549356
mG	lur1metabatropic glutamate receptor 1	0.00429184549356
mG	lumetabotropic l-glutamate receptor	0.00429184549356
mG	lur igroup i metabotropic glutamate receptor	0.00429184549356
mG	lu	0.00429184549356
mG	lur1 alphametabotropic glutamate receptor type 1 alpha	0.00429184549356
mG	lursmetabotropic glutamate receptors	0.111587982833
mG	lu2/3 receptor	0.00429184549356
mG	lurs	0.00429184549356
mG	lur1d	0.00429184549356
mG	lu receptorsmetabotropic glutamate receptors	0.00429184549356
mG	lur5metabotrobic glutamate receptor 5	0.00429184549356
mG	lur4+/+the metabotropic glutamate receptor 4 containing wild type control mice	0.00429184549356
mG	lur1group i metabotropic glutamate receptor	0.00429184549356
mG	lur5metabotropic glutamate receptors subtype 5	0.00429184549356
mG	lurgroup i metabotropic glutamate receptor	0.00429184549356
mG	fpmyristolated green fluorescent protein	0.00429184549356
mG	luriigroup ii metabotropic glutamate receptors	0.00429184549356
mG	lur2/3mglur2/mglur3	0.00429184549356
mG	lur1metabotropic glutamate receptors isoform 1	0.00429184549356
mG	lur6metabotropic glutamate receptor 6	0.0128755364807
mG	lu-1type-1 metabotropic glutamate	0.00429184549356
mG	lur5metabotropic glutamate receptor type 5	0.00429184549356
mG	lur1metabotropic glutamate receptor	0.00429184549356
mG	lur2group ii metabotropic glutamate receptor	0.00429184549356
mG	lurmetabotropic glutamate receptors	0.0429184549356
mG	lur2type 2 metabotropic glutamate receptor	0.00429184549356
mG	lurigroup i metabotropic glutamate receptors	0.00429184549356
mG	lurmetabotropic glutamate-dependent	0.00429184549356
mF	zdmouse frizzled (receptor)	1.0
mA	milliamps	0.0263157894737
mA	bmonoclonal ab	0.0526315789474
mA	bmonoclonal mouse antibody	0.0263157894737
mA	bmonoclonal antibody	0.763157894737
mA	chrmuscarinic acetylcholine receptor	0.0263157894737
mA	bsmonoclonal antibodies	0.0526315789474
mA	bmonoclonal amyloid β antibody	0.0263157894737
mA	b 5210mouse monoclonal anti-phosphacan	0.0263157894737
cAMP-	specific phosphodiesterase	0.2
cAMP-	responsive element binding protein	0.6
cAMP-	responsive element-binding protein (creb)	0.2
TAET	ris-acetate	1.0
mM	millimolar	0.1
mM	medial mesopallium	0.1
mM	nacl 1.5%, tween 20, 0.05%, ph 7.5	0.3
mM	nacl 150 mm, ph 7.5, containing 0.1% tween-20	0.1
mM	nacl 140 mm, ph 7.6), containing 0.1% tween 20	0.1
mM	ph 7.4) supplemented with nacl, tween-20, and non-fat milk powder	0.1
mM	tris–hcl, 137 mm nacl, ph 7.4	0.1
mM	ph 7.6) sodium chloride (140 mm) solution	0.1
mL	of 10%tween20	1.0
mN	medial nidopallium	1.0
mI	myo-inositol	0.5
mI	nsmyo-inositol	0.5
mH	bmedial habenula	0.5
mH	bmedial habenular nucleus	0.5
PLSDF	isher’s protected least significant difference test	0.5
PLSDF	isher's protected least significant difference test	0.5
K-ICSK	+-based intracellular solution	1.0
mT	au-/-/htau+/-whole human tau gene hemizygous transgenic mice on a mouse tau knockout background	1.0
mV	millivolt	0.5
mV	motor trigeminal nucleus	0.25
mV	trigeminal motor nucleus	0.25
mP	erivmedial peritrigeminal area	0.125
mP	er1	0.125
mP	fcmedial prefrontal cortex	0.25
mP	ermouseperiod	0.125
mP	er2mouse period2 gene	0.125
mP	er1mammalian period gene 1	0.125
mP	erperiod mrna	0.125
mS	lomouse or murine slo channel	0.2
mS	medial septal area	0.4
mS	medio-lateral septum	0.2
mS	medial septum	0.2
mR	median raphe nucleus	1.0
SChN	suprachiasmatic nucleus	1.0
AGRPA	gouti-related peptide	1.0
pSE	trials that followed a stop error	1.0
ATPA	denosine triphosphate	0.333333333333
ATPA	(rs)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid	0.333333333333
ATPA	(rs)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid	0.333333333333
BCGB	ergmann glial cells	1.0
GATE-	16golgi-associated atpase enhancer of 16 kda	1.0
dlSTR	dorsolateral striatum	1.0
PLSCR	3phospholipid scramblase 3	1.0
CE-LIF	capillary electrophoresis with laser-induced fluorescence	1.0
GAERSG	enetic absence epilepsy rat from strasbourg	0.5
GAERSG	enetic absence epilepsy rats from strasbourg	0.5
TPENN	n,n′,n′-tetrakis(2-pyridylmethyl)ethylenediamine	0.166666666667
TPENN	n,n',n'-tetrakis(2-pyridylmethyl)ehylenediamine	0.166666666667
TPENN	n,n′,n′-tetrakis(2-pyridylmethyl)-ethylenediamine	0.333333333333
TPENN	n,n′,n′-tetrakis(2-pyridylmethyl) ethylenediamine	0.166666666667
TPENN	n,n',n'-tetrakis-(2-pyridalmethyl)-ethylenediamine	0.166666666667
CVL	caudal ventrolateral nucleus of the medulla	0.5
CVL	caudal ventrolateral medulla	0.5
RMIR	ivermead mobility index	1.0
mG2Na-5	mouse anti-mglur2 antibody	1.0
Cx-36	connexin-36	1.0
ASDAA	merican sleep disorders association	1.0
BHT2	6-di-tert-butyl-p-hydroxytoluene	1.0
TR-FRET	time-resolved fluorescence resonance energy transfer	1.0
Meynert	cholinergic cell group 4, posterior sector	1.0
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazole-proprionate	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoaxolepropionic acid	0.00675675675676
AMPAα-	amino-3-hydroxyl-5-methylisoxazole-4-propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazolone-propionate	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	0.297297297297
AMPAα-	amino-5-hydroxy-3-methyl-4-isoxazole propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methylisoxazole-4-propionate	0.027027027027
AMPAα-	amino-3-hydroxyl-5-methyl-4-isoxazole propionate	0.00675675675676
AMPAα-	amino-3-hydroxyl-5-methyl-4-isoxazole-propionate	0.0405405405405
AMPAα-	amino-3-dihydro-5-methyl-4-isoxazole propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methylisoxazolepropionate	0.00675675675676
AMPAα-	amino-5-methyl-3-hydroxy-4-isoxazole propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor	0.0135135135135
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazole propionate	0.0540540540541
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazoleproprionate	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methy-4-isoxazole propionate	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazole proprionate	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoaxozole-propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid	0.0135135135135
AMPAα-	amino-3-hydroxi-5-methylisoxazole-4-propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxalone propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-isoxazole-4-propionate	0.00675675675676
AMPAα-	amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-ioxyzole-4-propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methylisoxazole-4-proprionic acid	0.0202702702703
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazolepropionate acid	0.00675675675676
AMPAα-	amino-methyl-4-isoxazole propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methylisoxazole-4-propionic acid	0.101351351351
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0.0608108108108
AMPAα-	3-hydroxy-5-methyl-4-isoxazole propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazole propanoic acid	0.0135135135135
AMPAα-	amino-3-hydroxy-5-methylisoxazoleproprionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazole propionic acid	0.0945945945946
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (ampa)	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-isoxazole propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isozazole propionate	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxazole-propionate	0.0135135135135
AMPAα-	amino-3-hydroxy-5methyl-4-isoxazole propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxyl-5-methyl-isoxazolepropionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methylisoxazole-4-proprionic acid type glutamate receptor	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-isoxazole-4-proprionate	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methylisoxadole-4-propionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxasole proprionic acid	0.00675675675676
AMPAα-	amino-3-hydro-methyl-4-isoxazolpropionic acid	0.00675675675676
AMPAα-	amino-3-hydroxy-methyl-4-isoaxoleproprionate	0.00675675675676
AMPAα-	amino-3-hydroxy-5-methyl-4-isoxalepropionic acid	0.00675675675676
eATP	extracellular adenosine 5′-triphosphate	1.0
FIRA	frequency-intensity response area	1.0
2-CADO	2-chloroadenosine	1.0
CRAMCRMP-	associated molecule	1.0
C-APP	c-terminal neo-epitope of app generated by caspase cleavage	1.0
NMDARNMDA-	receptor	1.0
LMWMAP	2low molecular-weight microtubule-associated protein-2	1.0
hCMEC	/d3human immortalized cerebral microvascular endothelial cells	1.0
CVG	cochleo-vestibular ganglion	1.0
IIo	lamina i/ii outer	0.5
IIo	outer part of lamina ii	0.5
IIi	inner part of lamina ii	0.5
IIi	outer/inner part of lamina ii	0.5
MuSK	muscle-specific receptor tyrosine kinase	1.0
ECoG	electrocorticogram	0.666666666667
ECoG	electrocorticography	0.0666666666667
ECoG	cortical electroencephalogram	0.0666666666667
ECoG	electrocorticogram/electrocorticographic	0.0666666666667
ECoG	cortical eeg	0.133333333333
PBSXPBS	with 0.05% triton x-100	1.0
IIP	intermediate-threshold non-inactivating inward current	1.0
ONL	olfactory nerve layer	0.214285714286
ONL	outer nuclear layer of the retina	0.0178571428571
ONL	outer nuclear layer	0.75
ONL	outer granular layer	0.0178571428571
IIR	inward rectifier current	0.5
IIR	inwardly rectifying potassium current	0.5
ONB	olfactory neuroblastoma	1.0
pSV	plasmid with simian virus 40 promoter	1.0
Sp5I	interpolar part of the spinal trigeminal nucleus	1.0
ONF	solfactory nerve fibroblasts	1.0
RQ	relative quantification	0.5
RQ	relative quantities	0.5
TMPP	tris(trimethoxyphenyl)phosphonium	1.0
IID	interaural intensity difference	0.25
IID	ischemia-induced depolarization	0.25
IID	sinterictal discharges	0.25
IID	independent and identically distributed	0.25
ONX	olfactory nerve transection	1.0
α2-AR	α2-adrenergic receptor	1.0
IIA	/iibdgluriia/dgluriib	0.5
IIA	slow-twitch oxidative glycolytic	0.5
IIB	slow-twitch glycolytic	1.0
ONS	optic nerve section	0.5
ONS	occipital nerve stimulation	0.5
III	inter-intromission interval	0.0625
III	llateral oculomotor subnucleus	0.0625
III	mglurs	0.0625
III	endothelial-type nitric oxide synthase	0.0625
III	–iv afferent	0.0625
III	β-tubulin	0.0625
III	toxin iii from the venom of the scorpion leiurus quinquestriatus hebraeus	0.0625
III	phosphodiesterase inhibitor	0.0625
III	oculomotor nucleus	0.25
III	vthird ventricle	0.0625
III	projection cells	0.0625
III	staining	0.0625
III	ncranial nerve iii	0.0625
IIH	insulin-induced hypoglycemia	0.666666666667
IIH	inter-spike interval histogram	0.333333333333
ONT	optic nerve transection	1.0
BLBP	brain lipid-binding protein	0.5
BLBP	brain lipid binding protein	0.333333333333
BLBP	brain-lipid-binding-protein	0.166666666667
IMER	immobilized enzyme reactor	1.0
sIAHP	slow afterhyperpolarization current	1.0
HCMV	human cytomegalovirus	1.0
ON-	cells	1.0
BAYKB	ay k 8644	1.0
hHSP27HSP27	purified from human lymphocytes	1.0
STNS	stomatogastric nervous system	1.0
FXS	fragile x syndrome	1.0
BLBB	urst lehman brothers	1.0
Sar9	met(o2)11]substance p	0.25
Sar9	met(o2)11]-substance p	0.25
Sar9	met (o2)11]-substance p to saporin	0.25
Sar9	met (o2)11]-substance p	0.25
OCBI	optical contralateral bias index	1.0
OVX-P	4animals injected with 2 mg of progesterone on day 14 post-ovariectomy	1.0
FM1-43	n-(3-triethyl ammoniumpropyl)-4-(p-dibutylaminostyryl) pyridinium, dibromide	0.333333333333
FM1-43	n-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl)pyridinium bromide	0.333333333333
FM1-43	[n-(3-(triethyl ammonium)propyl)-4-(4-dibutylaminostyryl pyridinium dibromide]	0.333333333333
EPSC2	epscs evoked by the first and second paired pulses, respectively	1.0
BHBβ-	hydroxybutyrate	1.0
SMART	simple modular architecture research tool	0.333333333333
SMART	switch mechanism at the 5′ end of rna template	0.333333333333
SMART	switching mechanism at 5′ end of rna transcript	0.333333333333
VGFVGF	nerve growth factor	1.0
ECASSE	uropean cooperative acute stroke study	1.0
hAPP	+, human app	0.25
hAPP	human app	0.25
hAPP	human β-amyloid precursor protein	0.25
hAPP	human amyloid precursor protein	0.25
UPDRS-IIIU	nified parkinson's disease rating scale part iii	1.0
Ras-GAP	ras-gtpase-activating protein	1.0
STNe	subthalamic nucleus explant	1.0
MGVd	mean grey value	1.0
VETSAV	ietnam era twin study of aging	1.0
Mn-SOD	manganese superoxide dismutase	0.333333333333
Mn-SOD	manganese-dependent superoxide dismutase	0.333333333333
Mn-SOD	mn-superoxide dismutase	0.333333333333
CMT1A	charcot–marie–tooth disease type 1a	1.0
GMSKG	aussian minimal-shift keying	1.0
2-dG	2-deoxyguanosine	1.0
LNGFR	low-affinity receptor for nerve growth factor	1.0
JOE	6-carboxy-4′,5′-dichloro-2′, 7′-dimetoxyfluorescein	1.0
NOArg	nω-nitro-l-arginine	1.0
cholecystokininB	receptors	1.0
rLV	recombinant lentiviral vector	1.0
β-AR	beta-adrenergic receptor	1.0
rLS	rostral lateral suprasylvian sulcus	1.0
NMDA-R	1n-methyl-d-aspartic acid receptor 1	0.5
NMDA-R	nmda receptor	0.5
NAGON-	acetyl glucosamine oligomer	0.5
NAGON-	acetylglucosamine oligomer	0.5
SAI	stratum album intermediale of superior colliculus	0.0909090909091
SAI	stroke-associated infection	0.0909090909091
SAI	slowly adapting type i mechanoreceptor	0.0909090909091
SAI	stratum album intermediale	0.636363636364
SAI	stratum album intermedium	0.0909090909091
SAH	subarachnoid hemorrhage	1.0
8-oxoG8-oxo-7	8-dihydroguanine	1.0
BCCAO	bilateral common carotid artery occlusion	0.666666666667
BCCAO	bilateral common carotid arteries occlusion	0.333333333333
SAM	sympathetic–adrenal–medullary	0.0416666666667
SAM	senescence-accelerated mouse	0.0416666666667
SAM	slowly adapting mechanoreceptor	0.0833333333333
SAM	substrate adhesion molecule	0.0416666666667
SAM	s-adenosyl-l-methionine	0.0416666666667
SAM	8senescence-accelerated mice	0.0416666666667
SAM	sinusoidal amplitude modulated	0.0416666666667
SAM	es-adenosyl-methionine	0.0416666666667
SAM	self-administering methamphetamine	0.0416666666667
SAM	senescence accelerated prone inbred strains of mice	0.0416666666667
SAM	sterile alpha motif	0.0416666666667
SAM	selective allosteric modulator	0.0416666666667
SAM	sinusoidally amplitude modulated	0.166666666667
SAM	significance analysis of microarrays	0.125
SAM	sinusoidal amplitude modulation	0.0416666666667
SAM	self-assembled monolayer	0.0416666666667
SAM	senescence-accelerated mice	0.0833333333333
SAL	saline	0.777777777778
SAL	saline-treated control group	0.0444444444444
SAL	1saline	0.0222222222222
SAL	control saline solution	0.0222222222222
SAL	prenatal saline exposure group	0.0222222222222
SAL	saline 2	0.0222222222222
SAL	saline group	0.0222222222222
SAL	saline-treated group of mice	0.0222222222222
SAL	crustacean saline solution	0.0222222222222
SAL	saline control	0.0222222222222
SAC	secondary auditory cortex	0.111111111111
SAC	stratum album centrale	0.444444444444
SAC	sstretch-activated channels	0.111111111111
SAC	starburst amacrine cell	0.111111111111
SAC	sensor activation curve	0.111111111111
SAC	stretch-activated channel	0.111111111111
SAB	spontaneous alternation behavior	0.333333333333
SAB	streptavidin–biotin	0.333333333333
SAB	streptavidin biotin	0.333333333333
ASt	amygdalostriatal transition area	1.0
SAG	1-stearoyl-2-arachidonoyl-glycerol	0.5
SAG	nucleus sagulum	0.5
S-ACSF	sucrose-based artificial cerebrospinal fluid	1.0
SAD	sinoaortic denervation	0.0833333333333
SAD	sspontaneous ads	0.0833333333333
SAD	sino-aortic denervation	0.0833333333333
SAD	symmetric axodendritic synapse	0.0833333333333
SAD	sinoaortic denervated	0.166666666667
SAD	smoking alzheimer's disease patients	0.0833333333333
SAD	seasonal affective disorder	0.416666666667
SAZ	lateral area of individual active zones	1.0
NP-40	nonidet p-40	1.0
BDI-IIB	eck depression inventory	1.0
Per12	period 1,2	1.0
cRNA	complementary ribonucleic acid	0.0526315789474
cRNA	complementary rna	0.842105263158
cRNA	capped rna	0.0526315789474
cRNA	complement rna	0.0526315789474
SAR	slowly adapting pulmonary stretch receptor	0.142857142857
SAR	specific absorption rate	0.428571428571
SAR	specific absorption ratio	0.142857142857
SAR	saralasin	0.142857142857
SAR	slowly adapting receptor	0.142857142857
SAQ	sylvian aqueduct	1.0
SAP	systolic arterial pressure	0.0232558139535
SAP	stretched-attend posture	0.0232558139535
SAP	sstretched-attend postures	0.046511627907
SAP	97synapse-associated protein 97 kda	0.046511627907
SAP	stretch attend postures	0.0232558139535
SAP	90synapse associated protein-90	0.0232558139535
SAP	synapsin	0.0232558139535
SAP	griseum album profundum	0.0232558139535
SAP	97synaptosome associated protein-97	0.0232558139535
SAP	90/psd-95	0.0232558139535
SAP	saporin	0.186046511628
SAP	102synapse-associated protein 102	0.0232558139535
SAP	synapse-associated protein	0.139534883721
SAP	serum amyloid p	0.0232558139535
SAP	stratum album profundum	0.093023255814
SAP	sympathoadrenal projection neurons	0.0232558139535
SAP	/jnk	0.0232558139535
SAP	102synapse associated protein 102	0.0232558139535
SAP	102	0.0232558139535
SAP	stratum album profundum of superior colliculus	0.0232558139535
SAP	systemic arterial pressure	0.116279069767
SAP	swimming adaption period	0.0232558139535
TDRP	torsion dystonia-related pattern	1.0
SAV	small agranular vesicles	1.0
ASB-	14amidosulfobetaine-14	1.0
CHA	[3h]-n6-cyclohexyladenosine	0.142857142857
CHA	cyclohexaladenosine	0.142857142857
CHA	cyclohexyladenosine	0.142857142857
CHA	n6-cyclohexyladenosine	0.571428571429
NAPLSN	orth american prodrome longitudinal study	1.0
CHC	clathrin heavy chain	1.0
CHD	5chromodomain helicase dna-binding protein 5	0.333333333333
CHD	chow diet	0.333333333333
CHD	control house chow diet	0.333333333333
NS-PRL	prolactin variant from non-sucked rats	1.0
PBS-TX	pbs with triton x-100	0.133333333333
PBS-TX	phosphate-buffered saline containing 0.3% triton x-100	0.133333333333
PBS-TX	phosphate-buffered saline plus 0.2% triton x-100	0.0666666666667
PBS-TX	0.01 m phosphate buffered saline at ph 7.4 containing 0.1% triton x-100	0.0666666666667
PBS-TX	phosphate-buffered saline containing 0.3% triton-x 100	0.0666666666667
PBS-TX	phosphate-buffered saline containing 0.2% triton x-100	0.133333333333
PBS-TX	pbs containing 0.05% triton x-100	0.0666666666667
PBS-TX	pbs supplemented with 0.1% triton x-100	0.0666666666667
PBS-TX	phosphate-buffered saline with triton x-100	0.2
PBS-TX	phosphate-buffered saline-triton x-100	0.0666666666667
CHI	closed head injury model	0.166666666667
CHI	closed head injury	0.666666666667
CHI	close head injury	0.166666666667
CRF-R2	corticotropin releasing factor type 2 receptor	0.5
CRF-R2	crf receptor type 2	0.5
CHL	conductive hearing loss	0.333333333333
CHL	1close homolog of l1	0.666666666667
CHO	chinese hamster ovary	0.733333333333
CHO	cellchinese hamster ovary cell	0.0666666666667
CHO	chinese hamster ovary (cell)	0.133333333333
CHO	cellschinese hamster ovary cells	0.0666666666667
CHP	calcium-binding protein p22-like	0.333333333333
CHP	cumene hydroperoxyde	0.333333333333
CHP	chronic cerebral hypoperfusion	0.333333333333
CHR	clinical high-risk	1.0
JAM	junctional adhesion molecule	1.0
40S	small ribosomal subunit	1.0
JAK	janus tyrosine kinase	0.111111111111
JAK	sjanus kinases	0.0555555555556
JAK	/statjanus kinase/signal transducer and activator of transcription	0.0555555555556
JAK	3janus kinase 3	0.0555555555556
JAK	2janus kinase2	0.111111111111
JAK	2/stat3	0.111111111111
JAK	janus kinase	0.222222222222
JAK	2janus kinase 2	0.222222222222
JAK	janus kinases	0.0555555555556
JAH	just after hatching	1.0
PBS-TG	phosphate buffer saline containing 0.5% triton x-100 and 5% normal goat serum	0.5
PBS-TG	phosphate-buffered saline containing 0.5% triton x-100 and 5% normal goat serum	0.5
CHX	2-cyclohexene-1-one	0.125
CHX	cyclohexamide	0.125
CHX	cycloheximide	0.75
rMOG	recombinant myelin oligodendrocyte glycoprotein	1.0
nVII	facial nerve	0.5
nVII	facial nucleus	0.5
DBI	diazepam-binding inhibitor	0.625
DBI	diffuse brain injury	0.125
DBI	diazepam binding inhibitor	0.25
DBH	dopamine β hydroxylase	0.0555555555556
DBH	dopamine-ß-hydroxylase	0.0138888888889
DBH	dopamine-beta-hydroxylase	0.0833333333333
DBH	dopamine beta-hydroxylase	0.0972222222222
DBH	dopamine beta hydroxylase	0.0416666666667
DBH	dopamin β-hydroxylase	0.0138888888889
DBH	dopamine-β-hydroxylase	0.291666666667
DBH	dopamine-beta hydroxylase	0.0138888888889
DBH	dopamine β-hydroxylase	0.375
DBH	dopamine beta-hydroxylase gene	0.0138888888889
m-CPU	medial caudate–putamen complex	1.0
DBA	/2 mice	0.125
DBA	dihydroxybenzylamine	0.125
DBA	dba/2jico	0.125
DBA	/2	0.5
DBA	mouse strain dba/2j	0.125
DBB	diagonal band of broca nucleus	0.0454545454545
DBB	diagonal band of broca	0.863636363636
DBB	nucleus of the diagonal band of broca	0.0454545454545
DBB	diagonal band of broca nuclei	0.0454545454545
DBE	dihydro-β-erythroidine	1.0
DBF	distance between feet	1.0
GPBS	5% goat serum in pbs	1.0
AnoM	anococcygeus muscle	1.0
Vtr	spinal trigeminal tract	1.0
THIK-	1 k+ channels	1.0
m-CPG	1-(m-chlorophenyl)-biguanide	1.0
DBP	diastolic arterial blood pressure	0.2
DBP	d-box binding protein	0.2
DBP	diastolic blood pressure	0.6
DBS	)	0.0526315789474
DBS	diencephalon-brainstem-spinal cord	0.0263157894737
DBS	deep brain stimulation	0.921052631579
DBR	deep brain recording	1.0
13-CRA	13-cis retinoic acid	1.0
NCBEN	a-driven cl-bicarbonate exchanger	1.0
ITT-	type calcium current	0.5
ITT-	type calcium voltage dependant current	0.5
rGMD	regional gray matter density	1.0
EUSE	external urethral sphincter electromyogram	1.0
pNR	1-ser896phosphorylated nr1 subunit of the nmda receptor at the ser896 site	0.5
pNR	1phosphorylation of the nr1	0.5
pNT	3-eplasmid encoding egfp-tagged nt3	1.0
VMAT-	2type-2 vesicular monoamine transporter	0.333333333333
VMAT-	2vesicular monoamine transporter 2	0.333333333333
VMAT-	2vesicular monoamine transporter type-2	0.333333333333
PDGF-β	platelet derived growth factor-β	1.0
pNA	para-nitroaniline	0.142857142857
pNA	chromophore p-nitroaniline	0.142857142857
pNA	p-nitroanaline	0.142857142857
pNA	p-nitroaniline	0.571428571429
4-HNE	4-hydroxynonenal histidine adduct	0.0454545454545
4-HNE	4-hydroxy-2-trans-nonenal	0.0454545454545
4-HNE	4-hydroxy-2-nonenal	0.136363636364
4-HNE	4-hydroxynonenal	0.772727272727
S-OFF	stimulus-off	1.0
TIM-	4t cell immunoglobulin mucin 4	1.0
AF-	2c-terminal ligand-dependent function	0.5
AF-	2activation function 2	0.5
ORL1	ofq/n receptor 1	0.125
ORL1	opioid receptor like1	0.125
ORL1	opioid receptor-like1	0.25
ORL1	opioid receptor-like 1	0.375
ORL1	opioid receptor like-1	0.125
PACE	paired basic amino acid cleaving enzyme	1.0
ILPFC	infralimbic prefrontal cortex	1.0
nREM	non rapid eye movement	1.0
TFB-TBOA	(3s)-3-[[3-[[4-(trifluoromethyl)ben zoyl]amino]	1.0
BADB	cl-2-associated death promoter	1.0
HPR	high plaque regions	0.5
HPR	horseradish peroxidase	0.5
SNARE	soluble n-ethylmaleimide-sensitive fusion protein, attachment protein receptor	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive factor attachment protein receptors	0.0188679245283
SNARE	soluble nsf attachment protein receptor	0.0754716981132
SNARE	soluble n-ethyl maleimide-sensitive fusion protein attachment protein receptor	0.0188679245283
SNARE	soluble n-ethylmaleimide sensitive-factor attachment protein receptor	0.0188679245283
SNARE	snap-receptor	0.0188679245283
SNARE	ssoluble nsf attachment protein receptors	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive fusion protein (nsf) attachment protein receptor	0.0188679245283
SNARE	snap receptors	0.0188679245283
SNARE	soluble n-ethylmaleimide receptor sensitive factor attachment	0.0188679245283
SNARE	snap receptor	0.0943396226415
SNARE	soluble n-ethylmaleimide-sensitive fusion protein attachment protein receptor	0.0188679245283
SNARE	soluble nsf-attachment receptor	0.0188679245283
SNARE	complex	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive factor attachment protein	0.0188679245283
SNARE	soluble n-ethylmaleimide sensitive factor attachment protein receptor	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive activating receptor	0.0188679245283
SNARE	soluble n-ethelmaleimide-sensitive factor-attachment protein receptor	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive-factor attachment protein receptor	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive factor-attached protein receptor	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive factor attachment protein-receptor	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive factor attachment protein receptor	0.22641509434
SNARE	ssoluble n-ethylmaleimide factor-attached protein receptors	0.0188679245283
SNARE	ssoluble n-ethylmaleimide sensitive factor attachment protein receptors	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive fusion attachment protein receptor	0.0188679245283
SNARE	soluble nsf attachment receptor	0.0566037735849
SNARE	soluble n-ethylmaleimide-sensitive fusion factor (nsf) attachment protein receptor	0.0188679245283
SNARE	vesicle-bound (target membrane) snap receptor	0.0188679245283
SNARE	proteins	0.0188679245283
SNARE	snap [soluble nsf (n-ethylmaleimide soluble factor) attachment protein] receptor	0.0188679245283
SNARE	s	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive factor activating protein receptor	0.0188679245283
SNARE	soluble n-ethylmaleimide-sensitive factor attachment receptor	0.0188679245283
QOL	quality of life	1.0
AFM	atomic force microscopy	1.0
GCC	glioma chloride currents	1.0
GCE	glutamate-induced calcium elevation	1.0
GCD	granule cell domain of the cochlear nucleus	0.333333333333
GCD	granule cell domain	0.666666666667
GCG	lucocorticoid	0.2
GCG	olgi complex	0.6
GCG	ranger causality	0.2
GCF	2gc-binding factor 2	1.0
GCI	glial cytoplasmic inclusion	0.5
GCI	global cerebral ischemia	0.25
GCI	glial cytoplasmic inclusions	0.25
GCH	gtp-cyclohydrolase	0.25
GCH	1gtp cyclohydrolase 1	0.5
GCH	gtp-cyclohydrolase i	0.25
GCK	germinal centre kinase	0.5
GCK	glucokinase	0.5
GCL	granule cell layer of the dentate gyrus	0.0106951871658
GCL	granule cell layer	0.497326203209
GCL	glutamate cysteine ligase	0.00534759358289
GCL	cerebellar granule cell layer	0.00534759358289
GCL	glutamate-cysteine ligase	0.00534759358289
GCL	granular cell layers	0.00534759358289
GCL	gcgranule cell in the granule cell layer	0.00534759358289
GCL	granular cell layer	0.0855614973262
GCL	granule cell layers	0.00534759358289
GCL	ganglion cells layer	0.00534759358289
GCL	ganglion cell layer	0.342245989305
GCL	internal granule cell layer	0.00534759358289
GCL	granular cell layer of olfactory bulb	0.00534759358289
GCL	ccatalytic glutamate-l-cysteine ligase	0.00534759358289
GCL	ganglion cell layer of the retina	0.00534759358289
GCL	granule cell layer of the olfactory bulb	0.00534759358289
BLR	binary logistic regression	1.0
GCN	2general control non-derepressible-2	0.5
GCN	2amino acids-regulated eif2α kinase	0.5
LPBN	lateral parabrachial nucleus	1.0
GCP	granule cell precursor	0.333333333333
GCP	iiglutamate carboxypeptidase ii	0.333333333333
GCP	sgranule cell precursors	0.333333333333
GCS	glucosylceramide synthase	0.25
GCS	sgeneralized clonic seizures	0.25
GCS	granule cell system	0.25
GCS	generalized convulsive seizure	0.25
VEGF-R	vascular-endothelial growth factor receptor	1.0
p150G	lued	1.0
GCV	ganciclovir	1.0
AFU	percentage of arbitrary fluorescence unit	1.0
KONG	2 knockout	1.0
AFP	alpha-fetoprotein	0.25
AFP	anterior forebrain pathway	0.75
AFR	animal facility reared	0.2
AFR	animal facility-reared	0.133333333333
AFR	animal facility-reared pups	0.0666666666667
AFR	animal facility rearing	0.466666666667
AFR	average firing rate	0.133333333333
LPBA	lateral parabrachial area	1.0
CTLA	4-igctla4 immunogloblin	0.5
CTLA	4-ig	0.5
TIMP	tissue inhibitors of matrix metalloproteinase	0.0769230769231
TIMP	stissue inhibitors of metalloproteinases	0.0769230769231
TIMP	tissue inhibitors of metalloproteinase	0.153846153846
TIMP	tissue inhibitor of metalloproteinase	0.153846153846
TIMP	stissue inhibitors of mmps	0.0769230769231
TIMP	tissue inhibitor of matrix metalloproteinase	0.230769230769
TIMP	1tissue inhibitor of metalloproteinase 1	0.0769230769231
TIMP	tissue inhibitors of the metalloproteinases	0.0769230769231
TIMP	tissue inhibitor of metalloproteinases	0.0769230769231
SCMI	intmutual information based on spike counts for test intensity	1.0
2-T	hioutp2-thiouridine 5′-triphosphate tetrasodium salt	1.0
BTS	back-to-sit	1.0
LCBF	local cerebral blood flow	1.0
HSV-TK	thymidine kinase gene of the herpes simplex virus	0.5
HSV-TK	thymidine kinase gene of herpes simplex virus	0.5
MEDH	medial edge of the dorsal horn	1.0
HSV-1	herpes simplex virus type 1	0.5
HSV-1	herpes simplex virus-1	0.25
HSV-1	herpes simplex virus type-1	0.25
BTX	bungarotoxin	0.428571428571
BTX	betaxolol	0.142857142857
BTX	α-bungarotoxin	0.285714285714
BTX	alpha-bungarotoxin	0.142857142857
Vim	nucleus ventralis intermedius	0.25
Vim	thalamic ventralis intermedius nucleus	0.25
Vim	ventralis intermedius	0.25
Vim	nucleus ventralis intermedius thalami	0.25
BTD	basal threonine-devoid	1.0
BTF	bitufted neurons	1.0
CIPA	congenital insensitivity to pain with anhidrosis	1.0
FIV-GFP	feline immunodeficiency virus-green fluorescent protein	1.0
ATCCA	merican type culture collection	0.75
ATCCA	merican-type culture collection	0.25
PROG	progesterone	1.0
CIPN	chemotherapy-induced peripheral neuropathy	1.0
IKleak	potassium leak conductance	1.0
L-703606	(cis-2-(diphenylmethyl)-n-[(2-iodophenyl)methyl]-1-azabicyclo-[2.2.2]	1.0
SCMS	chwann cell media	1.0
1RB	3an27immortalized rat mesencephalic dopaminergic cells	1.0
l-S	erl-serine	1.0
blEMG	baseline locomotor electromyography	1.0
LGNv	ventral lateral geniculate nucleus	1.0
Ve	extracellular field potential	1.0
ERSP	event-related spectral perturbations	0.333333333333
ERSP	sevent-related spectral perturbations	0.166666666667
ERSP	event-related spectral perturbation transform	0.166666666667
ERSP	event-related spectral perturbation	0.333333333333
LGNd	lgnv, lateral geniculate nucleus, dorsal and ventral divisions	0.142857142857
LGNd	dorsal lateral geniculate nucleus	0.714285714286
LGNd	dorsal lateral geniculate	0.142857142857
BCEC	sbrain capillary endothelial cells	0.5
BCEC	brain capillary endothelial cells	0.5
DOPδ-	opioid	1.0
VEGF-A	vascular endothelial growth factor-a	0.5
VEGF-A	vascular endothelial growth factor a	0.5
AP4A	p1,p4-di(adenosine-5′)tetraphosphate	0.5
AP4A	diadenosine tetraphosphate	0.5
trkB	high affinity tyrosine kinase receptor b	0.0588235294118
trkB	high-affinity receptor for bdnf	0.0588235294118
trkB	tyrosine kinase receptor b	0.117647058824
trkB	tropo-myosin-related kinase b	0.0588235294118
trkB	tyrosine receptor kinase b	0.117647058824
trkB	.fl mrnamrna encoding for brain-derived neurotrophic factor full-length catalytic receptor	0.0588235294118
trkB	.t1 mrna and trkb.t2 mrnamrna encoding for truncated forms of brain-derived neurotrophic factor tyrosine kinase receptors	0.0588235294118
trkB	tyrosine kinase b	0.294117647059
trkB	.t1 mrna and trkb.t2 mrnamrna truncated forms of trkb receptors	0.0588235294118
trkB	tyrosine kinase b receptor	0.0588235294118
trkB	tropomyosin receptor kinase b	0.0588235294118
trkA	tyrosine kinase a receptor	0.111111111111
trkA	high affinity nerve growth factor receptor	0.0555555555556
trkA	high-affinity ngf receptor	0.111111111111
trkA	tyrosine kinase receptor a	0.0555555555556
trkA	nerve growth factor high affinity receptor	0.0555555555556
trkA	high-affinity nerve growth factor receptor	0.0555555555556
trkA	tyrosine receptor kinase	0.0555555555556
trkA	tropomyosin-related kinase a	0.0555555555556
trkA	tyrosine receptor kinase a	0.0555555555556
trkA	p140 proto-oncogene tyrosine kinase receptor	0.0555555555556
trkA	tyrosine kinase a	0.222222222222
trkA	tropomysin receptor kinase a	0.0555555555556
trkA	tyrosine kinase receptor	0.0555555555556
-2PABH	exo-2-(2-pyridyl)-7-azabicyclo[2.2.1]heptane	1.0
PrPres	protease-resistant prion protein	1.0
TRADD	tumour necrosis factor receptor-associated death domain	1.0
TACE	tumor necrosis factor-α converting enzyme	0.833333333333
TACE	tumor necrosis factor-alpha convertase	0.166666666667
GBSSG	ey's balanced salt solution	1.0
stPVN	–rmgsimultaneous stimulation of pvn and rmg	1.0
trkT	rk receptor tyrosine kinases	1.0
ECLD	ulbecco’s modification of eagle’s medium	1.0
PACAP-R	pacap-r-hop1, pacap-r-hop2, pacap-r-hip, pacap-r-hip-hop1, the five splice variants with “hip” or “hop” cassettes of the pac1 receptor	1.0
IGF-I-R	insulin-like growth factor type i receptor	1.0
56433A	[3-[1-(s)-[[3-(cyclohexylmethyl)-hydroxyphosphinoyl]-2-(s)-hydroxypropyl]	1.0
l-M	npolateral lamina median preoptic nucleus	1.0
Ap5A	diadenosine pentaphosphate	1.0
DHDOC	5α-dihydro-deoxycorticosterone	1.0
Tyr-MIF-1	tyr-pro-leu-gly-nh2	1.0
Vg	potential across rg	1.0
rNK-3R	rat neurokinin-3 receptor	1.0
DERM-A	594dermorphin conjugated to alexa fluor 594	1.0
PBS-T	phosphate-buffered saline containing 0.3% triton x-100	0.114942528736
PBS-T	phosphate buffered saline with 0.05% tween 20	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.05% tween 20	0.0229885057471
PBS-T	ritonphosphate-buffered saline+0.2% triton x-100	0.0114942528736
PBS-T	ritonphosphate-buffered saline containing 0.2% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline with 2% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.05% tween	0.0114942528736
PBS-T	pbs containing 0.05% tween 20	0.0114942528736
PBS-T	pbs containing 0.1% triton x-100 and 0.1% (w/v) bovine serum albumin	0.0114942528736
PBS-T	pbs containing tween 20	0.0114942528736
PBS-T	pbs containing triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.1% tween 20	0.0344827586207
PBS-T	phosphate-buffered saline with triton x-100	0.0459770114943
PBS-T	phosphate-buffered saline with tween 20	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.5% triton x-100 solution	0.0114942528736
PBS-T	phosphate-buffered saline with 0.2% triton x-100	0.0114942528736
PBS-T	xphosphate-buffered saline containing 0.5% triton x-100	0.0114942528736
PBS-T	/ngs/saphosphate-buffered saline containing 0.3% triton x-100 and 0.05% normal goat serum and 0.1% sodium azide	0.0229885057471
PBS-T	phosphate buffer saline–tween	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.01% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.2% triton x-100	0.0344827586207
PBS-T	weenpbs containing 0.1% tween 20	0.0114942528736
PBS-T	phosphate-buffered saline plus 1% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline with 0.1% (v/v) triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.4% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.1% (vol/vol) tween-20	0.0114942528736
PBS-T	phosphate buffered saline–tween20	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.5% tween-20	0.0114942528736
PBS-T	phosphate-buffered saline (containing tween 20)	0.0114942528736
PBS-T	10 mm phosphate-buffered saline plus 0.05% tween-20	0.0114942528736
PBS-T	x-az0.1 m pbs with 0.1% triton x-100 and 0.1% sodium azide	0.0114942528736
PBS-T	phosphate buffered saline associated with 0.1% tween	0.0114942528736
PBS-T	ritonpbs containing 0.1% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline with 0.5% triton x-100	0.0114942528736
PBS-T	phosphate buffered saline containing 0.1% triton x-100	0.0114942528736
PBS-T	xpbs with 0.04% triton x-100	0.0114942528736
PBS-T	x0.1m pbs containing 0.3% triton x-100	0.0114942528736
PBS-T	phosphate buffer saline containing 0.3% triton x-100	0.0114942528736
PBS-T	phosphate buffer saline with 0.1% triton-x-100	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.05%tween 20	0.0114942528736
PBS-T	phosphate-buffered saline with 0.04% triton x-100	0.0114942528736
PBS-T	x0.01 m phosphate-buffered saline with 0.3% triton-x	0.0114942528736
PBS-T	phosphate-buffered saline containing 0.1% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline–tween	0.0114942528736
PBS-T	pbs with triton x-100	0.0229885057471
PBS-T	ritonphosphate-buffered saline/0.2% triton x-100	0.0114942528736
PBS-T	pbs containing 0.3% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline plus 0.1% tween 20	0.0114942528736
PBS-T	phosphate-buffered saline with 0.1% tween-20	0.0229885057471
PBS-T	ween-milkpbs with 0.1% tween-20 and 5% skimmed milk	0.0114942528736
PBS-T	phosphate buffered saline containing 0.2% triton-x-100	0.0114942528736
PBS-T	phosphate-buffered saline with 0.1% triton x-100	0.0229885057471
PBS-T	phosphate-buffered saline containing 0.2% tween-20	0.0114942528736
PBS-T	10% non-fat dried milk in pbs containing 0.05% tween 20	0.0114942528736
PBS-T	ritonphosphate-buffered saline containing 0.3% triton x-100	0.0114942528736
PBS-T	phosphate-buffered saline containing triton x-100	0.0574712643678
PBS-T	ritonphosphate-buffered saline with 0.3% triton x-100 and 0.001% thimerosal	0.0114942528736
PBS-T	phosphate-buffered saline–tween 0.2%	0.0114942528736
PBS-T	phosphate-buffered saline with 0.1% tween 20	0.0229885057471
PBS-T	ritonphosphate-buffered saline supplemented with 2% ngs and 0.1% triton x-100	0.0114942528736
PBS-T	pbs-tween-20	0.0114942528736
KORκ-	opioid receptor	1.0
l-A	spl-aspartate	0.5
l-A	rgl-arginine	0.5
EUS	external urethral sphincter	0.857142857143
EUS	extraurethral sphincter	0.142857142857
N-methyl-d-aspartate	excitatory amino acids	1.0
A-current	transient outward current	1.0
SWI	susceptibility weighted imaging	0.5
SWI	/snfswitch/sucrose nonfermentable	0.5
tBHQ	tert-butylhydroquinone	1.0
IBO-B	bilaterally ibotenic acid-lesioned	1.0
MEGYM	et-enkephalin-gly-tyr	0.5
MEGYM	et-enkephalin-glu-tyr	0.5
VEGF-M	utvascular endothelial growth factor promoter-luciferase plasmids carrying mutant hypoxia response element	1.0
IBO-L	unilaterally left ibotenic acid-lesioned	1.0
NCGGN	ational center for geriatrics and gerontology	1.0
CEAE	chronic experimental allergic encephalomyelitis	1.0
mRS	modified rankin scale	1.0
LLDA	local linear discriminant analysis	1.0
mRN	magnocellular red nucleus	1.0
DLSN	dorsolateral septal nucleus	1.0
IBO-R	unilaterally right ibotenic acid-lesioned	1.0
TRα	thyroid receptor alpha	1.0
TRβ	thyroid receptor beta	0.333333333333
TRβ	2thyroid hormone receptor β2	0.333333333333
TRβ	thyroid receptorβ	0.333333333333
l-G	lul-glutamate	1.0
DiMe-C7	([pglu5, mephe8, sar9]-substance p5–11	1.0
DLSC	deep layers of superior colliculus	1.0
αβ-mATP	α,β-methyleneadenosine 5′-triphosphate	1.0
ADPβS	adenosine 5′-o-2-thiodiphosphate	0.111111111111
ADPβS	adenosine 5′-o-(2-thio)-diphosphate	0.111111111111
ADPβS	adenosine 5′-o-(3-thiodiphosphate)	0.111111111111
ADPβS	adenosine 5′-o-(2-thiodiphosphate)	0.666666666667
V1R	vasopressin v1 receptor	1.0
MCMD	minor neurocognitive/motor disorder	1.0
VO43-	orthovanadate	1.0
LM-Sg	medial division of lateralis posterior/suprageniculate nucleus	1.0
UP-	spike	1.0
LVGCC	sl-type voltage-gated ca2+ channels	0.5
LVGCC	sl-type voltage gated ca2+ channels	0.5
Oc1B	binocular primary visual cortex	1.0
Oc1M	monocular striate cortex	1.0
CMC-	mechanoreceptors	0.333333333333
CMC-	mechanonociceptors	0.333333333333
CMC-	mechanoreceptor unit	0.333333333333
FDG	fluorescein di-β-d-galactopyranoside	0.0769230769231
FDG	18f-fluorodeoxyglucose	0.0769230769231
FDG	fluorodeoxyglucose	0.384615384615
FDG	flourodeoxyglucose	0.0769230769231
FDG	2-[18f]-fluoro-2-deoxy-d-glucose	0.0769230769231
FDG	[18f]-fluorodeoxyglucose	0.230769230769
FDG	fluordeoxyglucose	0.0769230769231
E-SD	excitatory-short duration response	1.0
NIN	nigra in nigra	1.0
TMB-8	[8-(n,n-diethylamino)-octyl-3,4,5-trimethoxybenzoate]	1.0
irFNDC	5fndc5 immunoreactivity	1.0
cKO	conditional knockout	1.0
CAMP	amplitude of the n30 auditory potential evoked by the first (conditioning) click	0.5
CAMP	conditioning amplitude	0.5
Syn	synaptophysin	1.0
CAMK	iicam-dependent protein kinase ii	1.0
OEFO	peration enduring freedom	1.0
CTRLS	controls	1.0
4C3HPG	(s)-4-carboxy-3-hydroxyphenylglycine	1.0
NF-Hneurofilament	heavy chain	1.0
CWT	continuous wavelet transform	0.5
CWT	continuous morlet wavelets transform	0.5
CBM	cerebellum	1.0
α-S	ynα-synuclein	0.4
α-S	ynuclein	0.2
α-S	ynalpha-synuclein	0.4
DOI1-2	5-dimethoxy-4-iodo-phenylaminopropane	1.0
VASV	isual analogue scale	1.0
CWD	chronic wasting disease	1.0
GLYT	glycine transporter	0.285714285714
GLYT	2glycine transporter 2	0.428571428571
GLYT	2	0.142857142857
GLYT	1glycine transporter type 1	0.142857142857
C5aR	c5a anaphylatoxin receptor	1.0
E-PHAP	haseolus vulgaris erythroagglutinating lectin	1.0
31742A	cis-3-(hexahydroazepin-1-yl)1-(3-chloro-4-cyclohexylphenyl)propene-1, hydrochloride	1.0
NICU	neonatal intensive care unit	1.0
SPWs	field irregular sharp spikes	1.0
ABRA	uditory brainstem evoked response	1.0
XRCCX-	ray repair cross-complementing	1.0
MOCM	anders overlap coefficient	1.0
SABS	pontaneous alternation behavior	1.0
YVAD-	pnaac-tyr-val-ala-asp-paranitroaniline	1.0
oxo-M	oxotremorine methiodide	0.5
oxo-M	oxotremorine-m	0.5
NICD	intracellular domain of the notch receptor	0.25
NICD	notch intracellular domain	0.25
NICD	notch1 intracellular cleaved domain	0.25
NICD	intracellular domain of notch-1 receptor	0.25
dBcAMP	dibutyryl cyclic-amp	0.333333333333
dBcAMP	dibutyryl camp	0.333333333333
dBcAMP	n6,2′-o-dibutyryladenosine 3′:5′-cyclic monophosphate	0.333333333333
ZFY	zinc finger y-chromosomal protein	1.0
MMLV-RTM	oloney murine-leukemia-virus reverse transcriptase	0.333333333333
MMLV-RTM	oloney murine leukemia virus reverse transcriptase	0.666666666667
TXGPBS	0.2% triton-x and 5.0% normal goat serum in 0.1 m pbs	1.0
HBBSS	hepes-buffered balanced salt solution	1.0
ENTH	epsin n-terminal homology domain	1.0
ZFP	36zinc-finger protein 36	1.0
-NT	ecto-5′-nucleotidase	1.0
CHRD-	like 2chordin-like 2	1.0
ENTO	entorhinal cortex	1.0
SNCBβ-	synuclein	1.0
BODIPY-glibenclamideglibenclamide-4	4-difluoro-4-bora-3a,4a-diaza-s-indacene	1.0
PBSTPBS	containing 0.1% tween 20	0.0740740740741
PBSTPBS	containing 0.2% triton x-100	0.037037037037
PBSTPBS	containing tween-20	0.037037037037
PBSTPBS	containing 0.5% triton x-100	0.037037037037
PBSTPBS	containing 0.1% triton x-100	0.0740740740741
PBSTPBS	+0.2% triton x-100	0.0740740740741
PBSTPBS	containing 0.05% tween 20	0.037037037037
PBSTPBS	with triton x-100	0.037037037037
PBSTPBS	and 0.3% triton x-100	0.037037037037
PBSTPBS	containing 0.3% of triton x-100	0.037037037037
PBSTPBS	+0.3% triton x-100	0.037037037037
PBSTPBS	0.3% triton x-100	0.037037037037
PBSTPBS	with 0.3% triton x-100	0.037037037037
PBSTPBS	containing 0.3% triton x-100	0.222222222222
PBSTPBS	with tween 20	0.0740740740741
PBSTPBS	containing triton x-100	0.037037037037
PBSTPBS	containing 1.0% tween-20	0.037037037037
PBSTPBS	containing 0.05% triton x-100	0.037037037037
BiP	immunoglobulin heavy chain binding protein	1.0
MVAR	multivariate auto-regressive	0.5
MVAR	multivariate autoregressive	0.25
MVAR	multivariate autoregressive model	0.25
E-A	loneunscented estrous females	1.0
GTPγS	guanosine-5′-o-(3-thiotriphosphate)	0.142857142857
GTPγS	guanosine5′-o-(3-thiotriphosphate	0.047619047619
GTPγS	guanosine-triphosphate-gamma-sulfate	0.047619047619
GTPγS	guanosine-5′-o-(3-thio) triphosphate	0.047619047619
GTPγS	guanosine-5′-o-(3-thio)triphosphate	0.190476190476
GTPγS	guanosine 5′-o-[gamma-thio]triphosphate acid	0.047619047619
GTPγS	guanylyl-5′-o-(γ-thio)-triphosphate	0.047619047619
GTPγS	binding	0.047619047619
GTPγS	guanosine 5′-o-(3-thiotriphosphate)	0.047619047619
GTPγS	guanosine 5′-o-(3-thiotriphosphate), tetralithium salt	0.047619047619
GTPγS	guanosine-5′-(γ-o-thio)triphosphate	0.047619047619
GTPγS	guanosine 5′-(γ-[35s]	0.047619047619
GTPγS	guanosine 5′-(γ-thio)triphosphate	0.047619047619
GTPγS	guanosine 5′-[γ-thio]triphosphate	0.047619047619
GTPγS	guanosine-5′-o(3-thiotriphosphate) tetralithium salt	0.047619047619
GTPγS	guanosine-5′-[γ-thio]-triphosphate	0.047619047619
Te	temporal cortex	1.0
Bic	bicuculline methiodide	1.0
PSD-	95post-synaptic protein-95	0.0142857142857
PSD-	95post-synaptic density protein 95 transcript	0.0142857142857
PSD-	95post-synaptic density 95	0.0285714285714
PSD-	95post-synaptic density-95	0.0142857142857
PSD-	95postsynaptic density protein of 95 kilodaltons	0.0142857142857
PSD-	95postsynaptic density protein of 95 kda	0.0285714285714
PSD-	95post-synaptic density protein 95	0.0571428571429
PSD-	95postsynaptic density 95	0.114285714286
PSD-	95post synaptic density protein-95	0.0285714285714
PSD-	95postsynaptic density-95	0.1
PSD-	95post-synaptic density molecule-95	0.0142857142857
PSD-	95/sap90	0.0142857142857
PSD-	95postsynaptic density protein of 95 kd	0.0142857142857
PSD-	95postsynaptic density protein-95	0.142857142857
PSD-	95postsynaptic density protein 95	0.157142857143
PSD-	93	0.0142857142857
PSD-	95	0.114285714286
PSD-	95post-synaptic density	0.0142857142857
PSD-	95post synaptic density 95	0.0142857142857
PSD-	95postsynaptic density-95 protein	0.0142857142857
PSD-	95postsynaptic density protein 95/sap90	0.0142857142857
PSD-	95post-synaptic density protein-95	0.0142857142857
PSD-	95postsynaptic-density protein of 95 kda	0.0142857142857
PSD-	95post-synaptic density protein of 95 kda	0.0142857142857
PSD-	95post-synaptic density protein of 95 kd	0.0142857142857
TDP-43TAR	dna-binding protein-43	1.0
T-MAG	0.1% triton x-100, 0.2% milk powder, 0.01% bovine serum albumin and 0.2% gelatin in pbs at ph7.4	1.0
E-S	excitatory postsynaptic potential to spike	0.5
E-S	excitatory postsynaptic potential-spike	0.5
CDNF	cerebral dopamine neurotrophic factor	0.5
CDNF	conserved dopamine neurotrophic factor	0.5
sPLA2	secreted form of 14,000 mol. wt pla2	0.5
sPLA2	secretory phospholipase a2	0.5
PSDC	postsynaptic dorsal column	1.0
GRCG	ranger causality	1.0
PSDA	postsynaptic dorsal column	1.0
HFT	shigh frequency trains	0.5
HFT	high frequency tetanization	0.5
SS-LISS-	like immunoreactivity	1.0
AHP50	duration of ahp at 75% and 50% of maximal amplitude	1.0
DNMTS	delayed non-matching-to-sample task	0.2
DNMTS	delayed-non-match-to-sample	0.4
DNMTS	delayed non-matching-to-sample	0.4
DNMTP	delayed non-match to position	0.5
DNMTP	delayed non-matching to position	0.5
WEM	whole encephalitic mass	1.0
WES	whole exome sequencing	1.0
MVIIC	ω-conotoxin mviic	0.857142857143
MVIIC	omega conotoxin mviic	0.142857142857
EGTAethyleneglycol-bis-β-aminoethylether-N	n,n′,n′-tetraacetic acid	1.0
5R	10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo [a,d] cyclohepten-5,10-imine hydrogen maleate	0.0526315789474
5R	10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10 imine-hydrogen-maleate	0.0526315789474
5R	10s)-(-)-5-methyl-10,11-dihydro-5h-dibenzo[a,d] cylcohepten-5,10-imine maleate	0.0526315789474
5R	10s)(-)-5-methyl 10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10imine hydrogen maleate	0.0526315789474
5R	10s)-(+)-5-methyl-10,11-dihydro-5h-debenzo[a,d]cyclohepten-5,10-imine hydrogen maleate (glutamate receptor antagonist)	0.0526315789474
5R	10s]-[+]	0.0526315789474
5R	10s)(+)-5-methyl 10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10 imine hydrogen maleate	0.0526315789474
5R	10s)-(+)-5-methyl-10, 11-dihydro-5h-dibenzo [a,d] cyclohepten-5,10-imine	0.0526315789474
5R	10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate	0.210526315789
5R	10s)-(-)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclo hepten-5,10-imine hydrogen maleate	0.0526315789474
5R	10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine	0.0526315789474
5R	10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo-[a,d]cyclo-hepten-5,10-iminemaleate	0.0526315789474
5R	10s)-(+)-5-methyl-10,11-dihydro-5h-dibenzo(a,d)cyclo-hepten-5,10-imine hydrogen maleate	0.0526315789474
5R	10s)-5-methyl-10,11-dihydro-5h-dibenzo-cyclohepten-5,10-imine	0.0526315789474
5R	10s)(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate	0.0526315789474
5R	10s)-(+)-5-methyl-10,11-dihydroxy-5h-dibenzo [a,d] cyclohepten-5,10-imine hydrogen maleate	0.0526315789474
PvPN	periventricular preoptic nucleus	1.0
TARGET	target stimulus	1.0
Ihhyperpolarization-activated	mixed na+/k+ inward current	0.333333333333
Ihhyperpolarization-activated	inwardly-rectifying cation current	0.333333333333
Ihhyperpolarization-activated	inward current	0.333333333333
tLHRH	salmon lhrh	1.0
TrkA	tyrosine kinase a nerve growth factor receptor	0.166666666667
TrkA	high-affinity nerve growth factor receptor	0.166666666667
TrkA	receptor tyrosine kinase (nerve growth factor receptor, ngfr)	0.166666666667
TrkA	tyrosine kinase receptor a	0.166666666667
TrkA	receptor tyrosine kinase a	0.166666666667
TrkA	high affinity ngf tyrosine kinase receptor	0.166666666667
GAD44	truncated forms of glutamate decarboxylase (25,000 and 44,000mol. wt, respectively) derived from embryonic-specific splice variants of gad67 mrnas	1.0
NIMHN	ational institute of mental health	1.0
OGTT	oral glucose tolerance test	1.0
SRC-	1steroid receptor coactivator 1	0.5
SRC-	2steroid receptor coactivator-2	0.5
γDGGγ-	d-glutamyl-glycine	1.0
FATP	4	1.0
vCA1	ca1 field of ventral hippocampus	1.0
MOPEG	3-methoxy-4-hydroxy-phenylglycol	0.5
MOPEG	3-methoxy-4-hydroxy phenylglycol	0.5
STA-HRP	streptavidin horseradish peroxidase	1.0
cyclic-AMP-	dependent protein kinase a	1.0
Str-REC	stress followed by recovery	1.0
HPNS	high pressure neurological syndrome	1.0
NSEN	euron-specific enolase	1.0
Aβ42	β-amyloid peptide 1–42	0.5
Aβ42	amyloid β1–42	0.5
dBA	audio decibel	0.5
dBA	decibels sound pressure level on the a-weighted scale	0.5
BOAA	β- n-oxalyl-amino- l-alanine	1.0
FRfood-restriction	food-restricted	1.0
JIPJNK-	interacting protein	1.0
SWC	spike-and-wave complex	0.333333333333
SWC	sleep–wake cycle	0.333333333333
SWC	sleep–wakefulness cycle	0.333333333333
DMPP1	1-dimethyl-4-phenylpiperazinium iodide	0.666666666667
DMPP1	1-dimethyl-4-phenyl-piperazinium iodide	0.333333333333
SSNA	splanchnic sympathetic nerve activity	1.0
ASICβ	acid-sensing ion channel β	1.0
NFC	neurosphere-forming cells	0.5
NFC	neonatal frontal-lesioned cats	0.5
dBS	delta burst stimulation	1.0
Hsp73	constitutively expressed 70-kda heat shock protein	1.0
KS	testkolmogorov-smirnov two-sample test	0.125
KS	short-term kindled group of rats	0.125
KS	testkolmogorov–smirnov test	0.375
KS	keratan sulphate	0.125
KS	keratan sulfate proteoglycan	0.125
KS	kolmogorov–smirnov test	0.125
DRSD	isability rating scale	1.0
HCT	=3030 min in acsf holding chamber	1.0
LIMKsLin-11	isl-1, and mec-3 kinases	1.0
NYSIBRN	ew york state institute for basic research institute in developmental disabilities	1.0
NEI-ir	nei immunoreactivity	1.0
2D-DIGE	two-dimensional difference gel electrophoresis	1.0
XDH	xanthine dehydrogenase	1.0
HIV-1	human immunodeficiency virus type-1	0.333333333333
HIV-1	human immunodeficiency virus-1	0.166666666667
HIV-1	human immunodeficiency virus type 1	0.5
KIF	1akinesin superfamily of motor protein 1a	0.333333333333
KIF	kinesin superfamily protein	0.333333333333
KIF	kinesin superfamily proteins	0.333333333333
CNP-IRCNP	ase-immunoreactive	1.0
BLT	fluorinated lysine derivative boc-lys-(tfa)-oh	1.0
3B5P	3β-hydroxy-5α-pregnan-20-one	1.0
mPBN	medial parabrachial nucleus	1.0
9-O-	acgd39-o-acetyl gd3	1.0
BLV	basolateral nucleus of the amygdala (ventral)	0.25
BLV	ventral division of the abl	0.25
BLV	basolateral amygdaloid nucleus (ventral)	0.25
BLV	basolateral ventral nucleus of amygdala	0.25
DPTA	nonoatedipropylenetriamine nonoate	1.0
Fctx	frontal cortex	1.0
CP55	940, (cis)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl](trans)-4-(3-hydroxypropyl)cyclohexanal	1.0
GMP-PNP	guanylyl-imidodiphosphate	0.5
GMP-PNP	guanylyl imidodiphosphate	0.5
HIPBS	hypoxia-inducible protein-binding sequence	1.0
CNS-OTCNS	oxygen toxicity	1.0
ABM	basomedial amygdala nucleus	1.0
NFH	high-molecular-weight neurofilament subunit	0.142857142857
NFH	neurofilaments of heavy molecular weight	0.142857142857
NFH	heavy neurofilament subunit	0.142857142857
NFH	neurofilament high molecular subunit	0.142857142857
NFH	high molecular weight neurofilament subunit	0.142857142857
NFH	neurofilament heavy chain	0.142857142857
NFH	neurofilament high	0.142857142857
3-APES	3-aminopropyltriethoxy-silane	1.0
BLM	magnocellular basolateral nucleus of amygdala	0.5
BLM	bilayer lipid membrane	0.5
NFV	narrow-field vertical	1.0
NASAN	ational aeronautics and space administration	1.0
Ldl	dorsolateral subdivision of the lateral nucleus	1.0
TCS	trichosanthin	0.333333333333
TCS	tissue collection solution	0.333333333333
TCS	tissue-collecting solution	0.333333333333
NFT	sneurofilament tangles	0.02
NFT	sneurofibrillary tangles	0.26
NFT	neurofibrillary tangles	0.26
NFT	sneurofibirillary tangles	0.02
NFT	neurofibrillary tangle	0.44
VHTD	very high trans fatty acid diet	1.0
Ldt	nucleus laterodorsalis tegmenti	1.0
CBCLC	hild behavior checklist	0.5
CBCLC	hild behavior checklist questionnaire	0.5
Ro-60	0175αs-6-chloro-5-fluoro-a-methyl-1h-indole-1-ethanamine fumarate	1.0
DEA-NO	diethylamine–nitric oxide complex, sodium salt	1.0
GEMS	gradient-echo multislice sequence	1.0
LVAC	low-voltage-activated calcium current	1.0
SHHS	onic hedgehog	1.0
TI-S	sslowly discharging tonic type i neurons discharging specifically in association with cortical activation during both waking and paradoxical sleep	1.0
UIM	ubiquitin interacting motif	0.5
UIM	subiquitin interacting motifs	0.5
483R	ik4833421e05rik	1.0
lPPL	left posterior parietal lobe	1.0
AGREA	utism genetic resource exchange	1.0
TBSNC	trigeminal brainstem sensory nuclear complex	1.0
IOP	rinferior olive (principal nucleus)	0.0714285714286
IOP	intraocular pressure	0.785714285714
IOP	principal olive	0.0714285714286
IOP	rprincipal nucleus of inferior olive	0.0714285714286
BSPT	2-(2′-benzothiazolyl)-5-styryl-3-(4′-phthalhydrazidyl) tetrazolium chloride	0.333333333333
BSPT	2-(2′-benzothiazolyl)-5-stryryl-3-(4′-phthalhydrazidyl)tetrazolium chloride	0.333333333333
BSPT	2-(2′-benzothiazolyl)-5-styryl-3-(4′-phthalhydrazidyl)-tetrazolium chloride	0.333333333333
BSPW	basal form of in vitro sharp wave	1.0
D-S5	7-dihydroxytryptamine injected rat with standard housing	1.0
VRP	ventral root potential	1.0
IEMG	integrated emg	1.0
TORC	transducers of regulated creb	0.333333333333
TORC	temporally orthogonal ripple combination	0.666666666667
BLA	basolateral portion of the amygdala	0.00836820083682
BLA	anterior part of the basolateral amygdala	0.00418410041841
BLA	basolateral amygdaloid complex	0.0209205020921
BLA	basolateral/lateral nuclei of the amygdala	0.00836820083682
BLA	basolateral nucleus amygdala	0.00418410041841
BLA	anterior part of basolateral amygdaloid nucleus	0.00418410041841
BLA	anterior part of the bl	0.00418410041841
BLA	basolateral complex	0.00418410041841
BLA	basolateral nucleus	0.00836820083682
BLA	baso-lateral amygdala	0.00418410041841
BLA	basal lateral amygdala	0.00418410041841
BLA	basolateral nucleus of amygdala	0.0334728033473
BLA	basolateral amygdala complex	0.0167364016736
BLA	basal nucleus of the amygdala	0.00418410041841
BLA	basolateral/lateral amygdala	0.00836820083682
BLA	/labasolateral/lateral nuclei of the amygdala	0.00418410041841
BLA	basolateral anterior nucleus of amygdala	0.00418410041841
BLA	basolateral amygdaloid nucleus	0.0627615062762
BLA	basolateral complex of the amygdala	0.0460251046025
BLA	lateral and basolateral amygdala	0.00418410041841
BLA	anterior division of the basolateral nucleus	0.00418410041841
BLA	basolateral amg	0.00418410041841
BLA	basolateral amygdal nuc	0.00418410041841
BLA	lateral/basolateral amygdala	0.00418410041841
BLA	basolateral amygdaloid nucleus (anterior)	0.00418410041841
BLA	basolateral amygdale	0.0251046025105
BLA	basolateral amygdala	0.539748953975
BLA	basolateral nucleus of the amygdala	0.150627615063
BLA	basolateral nucleus of the amygdale	0.00418410041841
EBSSE	arl’s balanced salt solution	0.0833333333333
EBSSE	arle's balanced salt solution	0.333333333333
EBSSE	arle’s balanced salt solution	0.5
EBSSE	arl's balanced salt solution	0.0833333333333
mER-X	membrane-bound estrogen receptor	1.0
TVR	tonic vibration reflex	1.0
VRC	ventral respiratory column	0.75
VRC	ventral root crushing	0.25
C-WD	prolonged withdrawal	1.0
VRA	ventral nerve root avulsion	0.2
VRA	ventral root avulsion	0.8
cVM	caudal ventromedial dorsal raphe nucleus	1.0
VRG	ventral respiratory group	1.0
TORP	torpor phase of hibernators	1.0
VRD	volume regulatory decrease	1.0
GAL-	irgalanin immunoreactive	1.0
BLB	asolateral	1.0
VRN	vomeronasal receptor neuron	1.0
PTSDP	ost-traumatic stress disorder	1.0
VRL	1vanilloid-receptor-like protein 1 (trpv2)	0.5
VRL	1vanilloid receptor-like protein 1	0.5
GALT	gut-associated lymphoid tissue	1.0
VR1	vanilloid receptor channel subtype 1	0.0714285714286
VR1	vanilloid receptor 1	0.428571428571
VR1	vanilloid receptor subtype 1	0.285714285714
VR1	vanilloid 1 rceptor	0.0714285714286
VR1	vanilloid receptor-1	0.0714285714286
VR1	vanilloid receptor	0.0714285714286
GALP	galanin-like peptide	1.0
MAGEM	elanoma antigen	1.0
S1P	sphingosine-1-phosphate	1.0
C-SRIF	cyclo-somatostatin	1.0
OVX-EB	+p4animals injected with 10 μg of estradiol benzoate on day 12 and 2 mg of progesterone on day 14 post-ovariectomy	1.0
HFO	high frequency oscillations	0.25
HFO	shigh-frequency oscillations	0.25
HFO	high-frequency oscillation	0.25
HFO	high frequency oscillation	0.25
COC-MET	cocaine-methiodide	1.0
SORA	ssingle orexin receptor antagonists	1.0
SORL	1sortilin-related receptor	1.0
cMAO	caudal medial accessory olive	1.0
NAN-	1901-(2-methoxyphenyl)4-[4-(phthalimido)butyl]-piperazine hydrobromide	0.25
NAN-	1901-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]-piperazine	0.25
NAN-	1901-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl] piperazine hydrobromide	0.25
NAN-	1901-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine hydrobromide	0.25
VR-	1vanilloid receptor 1	1.0
CrP	creatine phosphate	1.0
REM-M	rem sleep with moderate-voltage eeg	1.0
9-THCD	elta9 tetrahydrocannabinol	1.0
CrT	creatine transporter	1.0
WIPTIDE	walsh inhibitor peptide	0.666666666667
WIPTIDE	protein kinase a inhibitor	0.333333333333
MnPO	median preoptic nucleus	0.9
MnPO	median preoptic	0.1
GCAPs	gc-activating proteins	1.0
HFN	high-firing neuron	1.0
DOPEG3	4-dihydroxyphenylglycol	1.0
EBBSE	arle's buffered salt solution	1.0
REM-H	rem sleep with high-voltage eeg	1.0
EPC-K1	l-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6yl-hygrogen phosphate] potassium salt	1.0
GABABRGABAB	receptor	1.0
cPSP	scompound postsynaptic potentials	1.0
VDACV	oltage-dependent anion channel	1.0
HAM-F	10ham's f10 medium	1.0
TPT	tongue-protrusion task	1.0
LFEF	left frontal eye field	1.0
ADMHCAδ-	mechanoheat-cold unit	1.0
bis-C-β-aminoethylether-N	n,n′,n′-tetraacetic acid	1.0
v-GAT	vesicular gaba transporter	1.0
vPOA	ventral preoptic area	1.0
JORJ	aw-opening reflex	1.0
RAPI	row a-preference index	1.0
pDNA	plasmid dna	1.0
b-FGF	basic fibroblast growth factor	1.0
pSS	trials that followed a stop success	1.0
RAPA	rapamycin	1.0
ISI-CV	coefficient of variation of the inter-spike interval	1.0
DPLC	dorsolateral prefrontal cortex	1.0
RNAiRNA	interference	1.0
AVT-	irvasotocin-immunoreactive	1.0
lSTS	lower bank of anterior superior temporal sulcus	1.0
SALUB	salubrinal	1.0
RBPRIBEYE-	binding peptide	1.0
QSAR	quantitative structure–activity relationship	0.5
QSAR	quantitative structure-activity relationship	0.5
GEPR	genetically epilepsy-prone rat	0.5
GEPR	genetic epilepsy-prone rat	0.166666666667
GEPR	sgenetic epilepsy-prone rats	0.166666666667
GEPR	genetically epilepsy-prone rats	0.166666666667
BLi	intermediate division of the bl nucleus	1.0
CID-MS	/mscollision-induced dissociation mass spectrometry	1.0
8-OHG	8-hydroxyguanosine	1.0
DMEMHD	ulbecco’s modified eagle medium-high	1.0
ATGC	atypical ganglion cell	1.0
N-WASP	neural wiskott-aldrich syndrome protein	1.0
HPS	high pain sensitivity	1.0
nCDP	snegative cord dorsum potentials	1.0
HFC	high fat control	1.0
HPV	16human papillomavirus type 16	1.0
HPT	hot plate test	0.333333333333
HPT	hypothalamus	0.333333333333
HPT	hotplate test	0.333333333333
HPK	hematopoietic progenitor kinase	1.0
HPI	head position indicator	1.0
HPH	ypericum perforatum	1.0
HPL	hot-plate latency	1.0
HPC	hippocampus	0.652173913043
HPC	shematopoietic progenitor cells	0.0434782608696
HPC	hippocampal lesion	0.0434782608696
HPC	hypoxic preconditioning	0.130434782609
HPC	hippocampal formation	0.0434782608696
HPC	hypothermic preconditioning	0.0434782608696
HPC	heat/pinch/cold	0.0434782608696
TACA	(e)-4-amino-2-butenoic acid	0.5
TACA	trans-4-aminocrotonic acid	0.5
HPA	hypothalamic–pituitary–adrenocortical system	0.00534759358289
HPA	hypothalamic-pituitary-adrenal	0.112299465241
HPA	hypothalamic-pituitary adrenal	0.00267379679144
HPA	) axis	0.00267379679144
HPA	hypothalamic–pituitary–adrenal	0.401069518717
HPA	hypothamalo-pituitary–adrenal	0.00267379679144
HPA	hypothalamo-pituitary-adrenal axis	0.00802139037433
HPA	hypothalamic-pituitary-adrenal axis	0.0267379679144
HPA	hypothalamo–pituitary–adrenal axis	0.0106951871658
HPA	axishypothalamic-pituitary-adrenal axis	0.0133689839572
HPA	hypothalamus–pituitary–adrenal	0.0213903743316
HPA	hypothalamic–pituitary adrenal	0.00267379679144
HPA	hypothalamus-pituitary-adrenal	0.0133689839572
HPA	hypothalamus–pituitary–adrenal axis	0.0106951871658
HPA	hypothalamo–pituitary–adrenal	0.0427807486631
HPA	hypothalamic–pituitary axis	0.00267379679144
HPA	hypothalamus-pituitary axis	0.00267379679144
HPA	hypotha-lamic–pituitary–adrenal	0.00267379679144
HPA	axishypothalamic pituitary adrenal axis	0.00267379679144
HPA	hypothalamo-pituitary–adrenal	0.0160427807487
HPA	hypothalamo-pituitary-adrenal	0.0187165775401
HPA	hypothalamic pituitary adrenal axis	0.00534759358289
HPA	hypothalamus pituitary adrenal	0.00267379679144
HPA	hypothalamic-pituitary-adrenocortical	0.00802139037433
HPA	hypothalamo-pitutary-adrenal	0.00267379679144
HPA	axis	0.0320855614973
HPA	hypothalamo—pituitary—adrenal	0.00267379679144
HPA	hypothalmic-pituitary-adrenocortical	0.00267379679144
HPA	hypothalamus-pituitary-adrenal axis	0.00267379679144
HPA	hypothalamo-pituitary-adrenocortical	0.00534759358289
HPA	axishypothalamo-pituitary-adrenal axis	0.00267379679144
HPA	hypothalamic pituitary adrenal	0.0320855614973
HPA	hypothalamo–pituitary–adrenacortical	0.00267379679144
HPA	axishypothalamic–pituitary–adrenal axis	0.0187165775401
HPA	axishypothalamic-pituitary-adrenocortical axis	0.00267379679144
HPA	hypothalamic-pituitary adrenal axis	0.00267379679144
HPA	axisstress circuitrylipopolysaccharideimmune challengeneurodevelopmentpostnatal	0.00267379679144
HPA	human protein atlas	0.00267379679144
HPA	hypothalamo–pituitary–adrenocorticoid	0.00267379679144
HPA	axis hypothalamo–pituitary–adrenal axis	0.00267379679144
HPA	hypothalamic–pituitary–adrenal axis	0.0614973262032
HPA	hypothalamo–pituitary–adrenocortical	0.00802139037433
HPA	the hypothalamic-pituitary-adrenal	0.00534759358289
HPA	hypothalamic–pituitary–adrenal (axis)	0.00267379679144
HPA	hypothalamus pituitary adrenal axis	0.00267379679144
HPA	hypothalamo-pituitary adrenal axis	0.00267379679144
HPA	hypothalamo-pituitary-adenal	0.00267379679144
HPA	hypothalamo-pituitary–adrenal axis	0.00534759358289
HPA	hypothalamus–pituitary adrenal	0.00267379679144
HPA	hypothalamic–pituitary–adrenocortical	0.0294117647059
HPA	hypothalamus–pituitary–adrenals	0.00267379679144
HPA	hypothalamic–pituitary–adrenocortical axis	0.00534759358289
HPA	hypothalamic–adrenal	0.00267379679144
HPA	hypothalamic-pituitaryadrenal	0.00267379679144
HPA	hypothalamic–hypophyseal–adrenal	0.00267379679144
HPA	hypothalamo-hypophyso-adrenal	0.00267379679144
Ni-DAB3	3'-diaminobenzidine 4hcl intensified with ammonium nickel-sulfate	1.0
HPG	hypothalamo–pituitary–gonadal	0.125
HPG	the hypothalamic-pituitary-gonadal	0.0625
HPG	hippocampus and parahippocampus gyrus	0.0625
HPG	hypothalamic–pituitary–gonadal	0.5
HPG	hypothalamic-pituitary-gonadal	0.0625
HPG	hippocampus/parahippocampal gyrus	0.0625
HPG	hypothalamo-pituitary–gonadal	0.0625
HPG	axis	0.0625
HPF	high-power field	0.5
HPF	hydroxyphenyl fluorescein	0.125
HPF	high-power fields	0.125
HPF	high powered field	0.125
HPF	highly palatable food	0.125
HPE	holoprosencephaly	1.0
HPD	high protein diet	0.25
HPD	haloperidol	0.5
HPD	hearing protection devices	0.25
XDCT	crossed dorsal cochlear tract	1.0
MPNc	central portion of the medial preoptic nucleus	1.0
TKO	triple knock out	0.333333333333
TKO	synapsin triple knockout	0.333333333333
TKO	triple knockout	0.333333333333
SKF38393	(+)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol	0.5
SKF38393	(+)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine7,8,-diol	0.5
S-GABA	ergic neuronssmall gabaergic neurons	1.0
diAsp	n-4,4,4-didecylaminostyryl-n-methylpyridinium iodide	1.0
KWK	ruskal-wallis	1.0
sACSFsucrose-modified	artificial cerebrospinal fluid	1.0
MTBS	modified tris-buffered saline	1.0
5Z	11α,13e,15r)-11,15-dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranorprosta-5,13-dienoic acid methane sulfonamide	1.0
MAFP	methyl arachidonoyl fluorophosphonate	0.5
MAFP	methyl arachidonyl fluorophosphonate	0.5
5W	five weeks	1.0
DRST	delayed recognition span task	0.2
DRST	delayed recognition span test	0.6
DRST	delayed recognition memory span task	0.2
pEnkA	preproenkephalin a	1.0
5P	17-hydroxypregnenolone	1.0
5S	10r)-(+)-5-methyl-10, 11-dihydro-5h-dibenzo-[a, d]-cyclo-hepten-5, 10-imine hydrogen maleate	0.166666666667
5S	10r)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine maleate	0.166666666667
5S	10r)-(+)-5-methyl-10,11-dihydro-5h-ibenzo[a,d]cyclohepten-5,10-imine maleate	0.166666666667
5S	10r)-(+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]-cyclohepten-5,10-imine maleate	0.166666666667
5S	10r)-(+)-5-methyl-10,11-dihydro-5h dibenzo[a,d]cyclohepten -5,10-imine hydrogen maleate	0.166666666667
5S	10r)-(+)-5-methyl-10, 11-dihydro-5h-dibenzo [a,d]cyclohepten-5,10-imine	0.166666666667
SGOT	serum glutamate oxaloacetate transaminase	1.0
t-TBST	ris-buffered saline tween	1.0
5N	motor trigeminal nucleus	1.0
5I	5 intromissions	0.5
5I	five intromission female group	0.5
PDGFβ	platelet-derived growth factor β	1.0
PDGFα	platelet-derived growth factor-α	1.0
ADAMA	disintegrin and metalloproteinase	1.0
Hsp70	highly inducible 72 000 mol. wt heat shock protein	0.5
Hsp70	inducible 70,000mol.wt heat shock protein	0.5
5G	trigeminal ganglion	1.0
Hsp72	major inducible 70-kda heat shock protein	0.5
Hsp72	heat shock protein of 72kda	0.5
CUMS	chronic unpredictable mild stress	0.6
CUMS	chronic ultra-mild stress	0.2
CUMS	chronic ultra mild stress	0.2
Tcort	brain cortical temperature	0.666666666667
Tcort	cortical brain temperature	0.333333333333
NK-1	neurokinin-1	0.888888888889
NK-1	neurokinin-1 receptor	0.111111111111
DOPAC3	4 dihydroxyphenylacetic acid	0.0224719101124
DOPAC3	4-diydroxyphenylacetic acid	0.0112359550562
DOPAC3	4-dihydroxyphenylacetic acid	0.808988764045
DOPAC3	4-dihydroxyphenyl acetic acid	0.0561797752809
DOPAC3	4-hydroxyphenyl-acetic acid	0.0112359550562
DOPAC3	4-dihydoxyphenylacetic acid	0.0112359550562
DOPAC3	4-dihydroxy phenylacetic acid	0.0224719101124
DOPAC3	4-dehydroxyphenylacetic acid	0.0112359550562
DOPAC3	4-dihyroxyphenylacetic acid	0.0224719101124
DOPAC3	4-dihydroxy-phenylacetic acid	0.0224719101124
RBPC	rat brain pyramidal cell antigen	0.5
RBPC	rat brain pyramidal cells	0.5
RRPST	random-reward place-search task	1.0
PVIP	post-voiding intravesical pressure	1.0
UII	urotensin ii	1.0
CREBCRE	binding protein	1.0
IOS	intrinsic optic signal	0.1
IOS	intrinsic optical signals	0.2
IOS	inferior occipital sulcus	0.2
IOS	intrinsic optical signal	0.5
IOR	inhibition of return	1.0
PI-3-kinase	phosphatidylinositol-3-kinase	1.0
OHC	organotypic hippocampal slice cultures	0.0204081632653
OHC	outer hair cells	0.122448979592
OHC	souter hair cells	0.102040816327
OHC	organotypic hippocampal slice culture	0.0204081632653
OHC	outer hair cell(s)	0.0204081632653
OHC	outer hair cell	0.69387755102
OHC	souter hcs	0.0204081632653
MS-GABA	medial septal gabaergic neuron	1.0
ION	isthmo-optic nucleus	0.0833333333333
ION	infraorbital division of the trigeminal nerve	0.0833333333333
ION	intermediate octavomotor nucleus	0.0833333333333
ION	infraorbital nerve	0.25
ION	inferior olivary nucleus	0.416666666667
ION	nucleus isthmo-opticus	0.0833333333333
IOM	rostral lamella of the medial nucleus of inferior olivary nucleus	0.25
IOM	medial nucleus of inferior olive	0.25
IOM	inferior olive (medial nucleus)	0.25
IOM	inferior olive medial nucleus	0.25
IOK	cap of kooy of the medial nucleus of inferior olivary nucleus	1.0
IOI	intrinsic optical imaging	0.5
IOI	integrative optical imaging	0.5
IOF	input–output function	1.0
IOD	integrated optimal densities	0.030303030303
IOD	integrated optic density	0.030303030303
IOD	dorsal accessory nucleus of the inferior olivary nucleus	0.030303030303
IOD	dorsal accessory olive	0.030303030303
IOD	inferior olive dorsal accessory nucleus	0.030303030303
IOD	dorsal accessory nucleus of inferior olive	0.030303030303
IOD	integral optical density	0.030303030303
IOD	inferior olive (dorsal nucleus)	0.030303030303
IOD	integrated optical density	0.757575757576
IOC	inferior olivary complex	0.666666666667
IOC	subnucleus c of the medial nucleus of inferior olivary nucleus	0.166666666667
IOC	c subnucleus of the medial accessory olive	0.166666666667
IOB	subnucleus b of the medial nucleus of inferior olivary nucleus	1.0
IOA	iodoacetate	1.0
dSEVC	discontinuous single-electrode voltage-clamp	1.0
OH-	hydroxyl radical	1.0
DS-R	ed2red-fluorescence-tagged	1.0
STLD	dorsal lateral division of the bed nucleus of the stria terminalis	1.0
retigabineN-	(2-amino-4-(4-fluorobenzylamino)-phenyl)carbamic acid ethyl ester	1.0
NMB-R	neuromedin b peptide receptor	0.333333333333
NMB-R	exneuromedin b receptor–egfp transfected and expressing	0.333333333333
NMB-R	neuromedin b receptor	0.333333333333
M-MLVM	oloney murine leukemia virus	1.0
LTCCα	1dl-type ca2+ channel α1d subunit	1.0
NDAnaphthalene-2	3-dicarboxaldehyde	1.0
RXR	retinoid x receptor	0.65
RXR	retinoid x receptors	0.05
RXR	sretinoid x receptors	0.05
RXR	retinoic acid orphan (x) receptor	0.05
RXR	retinoic acid “x” receptor	0.05
RXR	retinoic acid receptor	0.05
RXR	retinoid-x receptors	0.05
RXR	retinoid “x” receptor	0.05
CC-B	odybody of the corpus callosum	1.0
HFF	high-frequency fatigue	0.666666666667
HFF	human foreskin fibroblasts	0.333333333333
SMPA	supramolecular physiological assembly	1.0
PLINK	phase linkage analysis tool	1.0
FPLSD	fisher's protected least significant difference	1.0
HMGA	high mobility group a	0.5
HMGA	high mobility group at-hook	0.5
HMGB	1high-mobility group box 1	0.363636363636
HMGB	1high-mobility group box1	0.272727272727
HMGB	1high mobility group box 1	0.181818181818
HMGB	high mobility group box	0.0909090909091
HMGB	1high-mobility group box 1 protein	0.0909090909091
HMGC	oar3-hydroxy-3-methylglutaryl coenzyme a reductase	1.0
OTAdesGly-NH2	d(ch2)5[d-tyr2,thr4]ovt	1.0
SMPS	submitochondrial particles	1.0
LECS	low intensity electroconvulsive shock	1.0
DRMDRL	dorsal or lateral part, respectively, of the dr	1.0
MM-ODN	mismatch oligodeoxynucleotide	1.0
HMGR	3-hydroxy-3-methylglutaryl-coenzyme a reductase	1.0
HZ	hydralazine	1.0
HY	hypoxia group	0.333333333333
HY	neurohypophysis	0.333333333333
HY	hypothalamus	0.333333333333
SCh	suprachiasmatic nucleus	1.0
H2DCFDA2	7-dichlorodihydrofluorescein diacetate	1.0
IZA	ginner zone-specific antigen	1.0
HR	high responder rats	0.0133333333333
HR	hyperpolarizing response	0.00666666666667
HR	high rapid eye movement sleep condition/group	0.00666666666667
HR	and lrhigh and low novelty-seeker rats	0.00666666666667
HR	hazard ratio	0.00666666666667
HR	high responders	0.02
HR	changes in heart rate	0.00666666666667
HR	heterozygous reeler	0.00666666666667
HR	high rearing	0.00666666666667
HR	heart rate change	0.00666666666667
HR	high responder	0.0266666666667
HR	high responders to novelty	0.0133333333333
HR	high-responder	0.00666666666667
HR	high reactive to novelty	0.00666666666667
HR	heart rate	0.793333333333
HR	hemodynamic response	0.00666666666667
HR	high responder to novelty	0.00666666666667
HR	high reward arm	0.00666666666667
HR	3histamine receptor 3	0.00666666666667
HR	homologous recombination	0.0333333333333
HR	maxmaximum heart rate	0.00666666666667
HS	high sociability	0.0192307692308
HS	control group	0.0192307692308
HS	+noisei.p. injection hydrogen-rich saline	0.0192307692308
HS	heterogenous strain	0.0192307692308
HS	hypertonic saline	0.0384615384615
HS	horizontal system	0.0192307692308
HS	heparan sulfate proteoglycan	0.0192307692308
HS	heparan sulfate	0.0384615384615
HS	heparan sulphate	0.0192307692308
HS	hyperthermia-induced seizure	0.0192307692308
HS	378	0.0192307692308
HS	hypertonic nacl	0.0192307692308
HS	aseheparitinase	0.0192307692308
HS	horse serum	0.423076923077
HS	uhigh-sucrose	0.0192307692308
HS	hindlimb suspension	0.0192307692308
HS	heat shocked	0.0192307692308
HS	hippocampal sclerosis	0.173076923077
HS	high suppressors	0.0192307692308
HS	hypothalamic stimulation	0.0192307692308
HS	high dose corticosterone, stressed	0.0192307692308
HP	high ethanol preference subgroup	0.027027027027
HP	hot plate	0.108108108108
HP	high pass	0.0540540540541
HP	1αheterocromatin protein 1α	0.027027027027
HP	1heterochromatin protein 1	0.027027027027
HP	holding potential	0.297297297297
HP	high predictability	0.027027027027
HP	high pressure	0.027027027027
HP	heart period	0.0540540540541
HP	hydroxylated proline	0.027027027027
HP	hotplate	0.027027027027
HP	hippocampus	0.162162162162
HP	homogeneous poisson process	0.027027027027
HP	healthy participant	0.027027027027
HP	horseradish peroxidase	0.027027027027
HP	hind paw representation area	0.027027027027
HP	high progesterone	0.027027027027
HV	high-voltage	1.0
HW	half width at half height	0.333333333333
HW	width at half-amplitude	0.333333333333
HW	half width	0.333333333333
HT	harmonic theme	0.0344827586207
HT	high threshold	0.0344827586207
HT	hemorrhagic transformation	0.172413793103
HT	22	0.0344827586207
HT	hormone therapy	0.0689655172414
HT	hhypothalamus	0.0344827586207
HT	heterozygote	0.0344827586207
HT	hypertonic	0.0344827586207
HT	3rht3 receptor	0.0344827586207
HT	heterozygous	0.0344827586207
HT	hypothalamus	0.172413793103
HT	high-threshold	0.103448275862
HT	hypertonic saline solution	0.0344827586207
HT	shemi-transections	0.0344827586207
HT	hormone treatment	0.0344827586207
HT	heavy touch	0.0344827586207
HT	hypothesis testing	0.0344827586207
HT	coolhigh threshold cool responsive neuron	0.0344827586207
HU	high dose corticosterone, unstressed	0.5
HU	210	0.5
vCA2	ca2 field of ventral hippocampus	1.0
HK	human kidney	0.25
HK	2hexokinase 2	0.25
HK	high kcl	0.25
HK	human primary keratinocytes	0.25
HH	bdeoxygenated hemoglobin	0.0666666666667
HH	hamburger–hamilton	0.133333333333
HH	hypodynamia-hypokinesia	0.0666666666667
HH	hypercapnic-hypoxia	0.0666666666667
HH	sthamburger/hamilton stage	0.0666666666667
HH	bdeoxygenated haemoglobin	0.0666666666667
HH	hamburger–hamilton stage	0.0666666666667
HH	bufferhepes-buffered recording solution	0.0666666666667
HH	modelhodgkin–huxley model	0.0666666666667
HH	hodgkin–huxley	0.133333333333
HH	hypobaric hypoxia	0.133333333333
HH	stage according to hamburger and hamilton (1951)	0.0666666666667
HI	hypoxia-ischemia	0.106382978723
HI	hypoxia ischemia	0.0212765957447
HI	hypoxia-ischemic	0.0212765957447
HI	hyperpallium intercalatum	0.0425531914894
HI	hypoxic ischemic	0.063829787234
HI	hypoxic–ischaemic	0.0212765957447
HI	homogeneity index	0.0212765957447
HI	high-intensity firing	0.0212765957447
HI	hearing impaired	0.0212765957447
HI	hyperalgesic index	0.0212765957447
HI	hypoxic-ischemic	0.063829787234
HI	hypoxic-ischemia	0.0425531914894
HI	hypoxia–ischaemia	0.0212765957447
HI	hypoxia-ischemia or hypoxic-ischemic	0.0212765957447
HI	high ethanol intake subgroup	0.0212765957447
HI	hypoxic/ischemic	0.0212765957447
HI	high-immobility	0.0212765957447
HI	hypoxic–ischaemia	0.0212765957447
HI	hypoxia–ischemic	0.0212765957447
HI	hypoxia–ischemia	0.36170212766
HI	hyperpallium intercalatum (hyperstriatum intercalatum supremum)	0.0212765957447
HN	humanin	0.142857142857
HN	habenular nucleus	0.142857142857
HN	highly negative	0.142857142857
HN	heart interneuron	0.142857142857
HN	hypoglossal nucleus	0.428571428571
HO	homozygous	0.0434782608696
HO	)	0.0434782608696
HO	1-/-ho1 knockout	0.0434782608696
HO	•hydroxyl radicals	0.0434782608696
HO	·hydroxyl radical	0.0434782608696
HO	normobaric hyperoxia	0.0434782608696
HO	haem oxygenase	0.0434782608696
HO	heme oxygenase	0.565217391304
HO	handled-only	0.0434782608696
HO	hyperoxia	0.0434782608696
HO	higher order	0.0434782608696
HL	hindlimb region of primary somatosensory cortex	0.0454545454545
HL	high-light open-field	0.0454545454545
HL	hindlimb cortical area	0.0454545454545
HL	heart and lung	0.0454545454545
HL	hearing level	0.0909090909091
HL	hindlimb cortex	0.0909090909091
HL	hindlimb	0.0454545454545
HL	hyperpallium laterale	0.0454545454545
HL	forelimb/hindlimb, a part of the cortex receiving sensory information from the limbs	0.0454545454545
HL	nucleus habenularis lateralis	0.0454545454545
HL	hemilabyrinthectomy, hemilabyrinthectomized	0.0454545454545
HL	hearing loss	0.136363636364
HL	hindlimb area	0.136363636364
HL	cortical hindlimb area	0.0454545454545
HL	hilus	0.0454545454545
HL	hindlimb representation cortex	0.0454545454545
HM	hypoglossal motor neuron	0.142857142857
HM	hypoglossal motoneurons	0.142857142857
HM	homogeneous motion	0.142857142857
HM	shypoglossal motoneurons	0.142857142857
HM	heavy membrane pellet	0.142857142857
HM	hypoglossal motoneuron	0.285714285714
AβPP	amyloid-β protein precursor	0.25
AβPP	amyloid β precursor protein	0.5
AβPP	amyloid precursor protein	0.25
HC	hair cells	0.0298507462687
HC	high-calorie condition	0.0149253731343
HC	shealthy controls	0.0149253731343
HC	bhemicerebellectomy	0.0149253731343
HC	home cage	0.0746268656716
HC	healthy control	0.0149253731343
HC	hypothermic control	0.0149253731343
HC	hair cell	0.164179104478
HC	home cage female group	0.0149253731343
HC	hippocampal system	0.0149253731343
HC	2s2immortalized neuronal progenitor cell line	0.0149253731343
HC	healthy controls	0.0298507462687
HC	histochemical	0.0149253731343
HC	lhydrochloric acid	0.044776119403
HC	home-cage	0.0149253731343
HC	home caged control	0.0149253731343
HC	high-chirping	0.0149253731343
HC	shair cells	0.044776119403
HC	hippocampus	0.194029850746
HC	horizontal cell	0.0597014925373
HC	healthy elderly control	0.0149253731343
HC	homecage	0.0298507462687
HC	lhydrochloride acid	0.0149253731343
HC	hippocampal/hippocampus	0.0149253731343
HC	lhydrochloride	0.0149253731343
HC	homecage control	0.0149253731343
HC	50carboxyterminal half of the heavy chain	0.0149253731343
HC	hydrogen clearance	0.0298507462687
HC	home cage controls	0.0149253731343
HC	lhydrogen chloride	0.0149253731343
HA	hyaluronan	0.015625
HA	hyperpallium apicale	0.0625
HA	hydroxylamine	0.03125
HA	nhigh anxiety	0.015625
HA	human influenza hemagglutinin tag	0.015625
HA	human astrocytes	0.015625
HA	high anxiety	0.015625
HA	hyperstriatum accessorium	0.03125
HA	handled	0.015625
HA	histamine/histaminergic	0.015625
HA	3hemagglutinin 3	0.015625
HA	2hemagglutinin 2 peptide	0.015625
HA	hearing aid	0.015625
HA	hemianopia	0.015625
HA	high-anxiety rats	0.015625
HA	hyaluronic acid	0.015625
HA	shealthy adults	0.015625
HA	high-anxious	0.015625
HA	asehyaluronidase	0.015625
HA	horizontal axis floccular purkinje cells	0.015625
HA	hemagglutinin a epitope	0.015625
HA	hemaglutinin	0.015625
HA	4hyaluronan tetrasaccharide	0.015625
HA	human agglutinin	0.015625
HA	hemagglutinin	0.265625
HA	high-anxiety	0.03125
HA	hyperpallium accessorium (hyperstriatum accessorium)	0.015625
HA	histamine dihydrochloride	0.015625
HA	histamine	0.203125
HA	hyaluronan or hyaluronic acid	0.015625
HF	high frequency of heart rate variability	0.0192307692308
HF	higher-fit	0.0192307692308
HF	heart failure	0.0384615384615
HF	high-frequency component power	0.0192307692308
HF	high-frequency	0.0961538461538
HF	hydroxyflutamide	0.0192307692308
HF	head-fixed	0.0384615384615
HF	heart rate	0.0192307692308
HF	high frequencies components in the power spectral analysis	0.0192307692308
HF	high frequency neurons	0.0192307692308
HF	hippocampal fissure	0.0192307692308
HF	high-fat diet	0.0192307692308
HF	high frequency	0.230769230769
HF	high fat	0.0384615384615
HF	hypocaloric feeding	0.0192307692308
HF	hippocampal formation	0.346153846154
HF	high frequency (stimulation)	0.0192307692308
HG	high glucose	0.428571428571
HG	high grooming rat	0.142857142857
HG	high grooming	0.142857142857
HG	hand grinding	0.142857142857
HG	bilateral handgrip	0.142857142857
HD	half-distance	0.0217391304348
HD	huntington’s disease	0.195652173913
HD	high-density	0.0217391304348
HD	huntington's disease	0.369565217391
HD	high dose	0.0217391304348
HD	high depression	0.0217391304348
HD	head direction (cells)	0.0217391304348
HD	head direction	0.0652173913043
HD	animal models	0.0217391304348
HD	high density	0.0217391304348
HD	1 and hd2helicase domains 1 and 2	0.0217391304348
HD	hyperpallium densocellulare (hyperstriatum dorsale)	0.0217391304348
HD	hopping and darting	0.0217391304348
HD	head dippings	0.0217391304348
HD	hyperpallium densocellulare	0.0652173913043
HD	head-direction	0.0217391304348
HD	high vesicular density	0.0217391304348
HD	densocellular part of the hyperpallium	0.0217391304348
HE	thydroethidine	0.0714285714286
HE	persistently high exploratory activity	0.0178571428571
HE	hematoxylin and eosin	0.321428571429
HE	haematoxylin–eosin	0.0892857142857
HE	healthy elderly	0.0178571428571
HE	2high dose 17β-estradiol-3-benzoate	0.0178571428571
HE	hematoxylin and eosin staining	0.0178571428571
HE	hemotoxylin-eosin	0.0178571428571
HE	1epididymal secretory glycoprotein 1	0.0178571428571
HE	high energy	0.0178571428571
HE	high estrogen	0.0178571428571
HE	hematoxylin-eosin	0.0892857142857
HE	hydroethidine	0.0178571428571
HE	hematoxylin–eosin	0.107142857143
HE	heat exhausted	0.0178571428571
HE	haematoxylin- eosin	0.0178571428571
HE	hepatic encephalopathy	0.125
SCM	sternocleidomastoid	0.777777777778
SCM	stretched-fibroblast-conditioned medium	0.111111111111
SCM	sternocleidomastoid muscle	0.111111111111
SCL	skin conductance level	0.666666666667
SCL	stem cell leukaemia	0.333333333333
SCO	subcommissural organ	0.5
SCO	scopolamine hydrobromide	0.25
SCO	scopolamine	0.25
SCN	7a	0.00431034482759
SCN	suprachiasmatic nucleus	0.788793103448
SCN	suprachiasmic nucleus	0.00431034482759
SCN	suprachiasmatic nuclei	0.137931034483
SCN	serotonin containing neurone	0.00431034482759
SCN	suprachiasmatic nuclei of the hypothalamus	0.0129310344828
SCN	1a	0.00431034482759
SCN	xsuprachiasmatic nucleus lesioned	0.00431034482759
SCN	supra chiasmatic nucleus	0.00431034482759
SCN	1bsodium channel β1 subunit	0.00431034482759
SCN	xsuprachiasmatic nucleus-lesioned	0.00431034482759
SCN	suprachiasmatic nucleus of the hypothalamus	0.0258620689655
SCI	stratum cellulare internum	0.00826446280992
SCI	spinal cord contusion injury/traumatic spinal cord injury	0.00826446280992
SCI	)	0.00826446280992
SCI	spike count index	0.00826446280992
SCI	spinal cord injury	0.933884297521
SCI	spinal cord injury/injured	0.00826446280992
SCI	spinal cord injury.	0.00826446280992
SCI	spinal cord injuries	0.0165289256198
SCH	23390schering compound 23390	0.0625
SCH	suprachiasmatic nucleus	0.0625
SCH	spinal cord homogenate	0.0625
SCH	23390	0.625
SCH	50911	0.0625
SCH	r(+)-sch-23390	0.0625
SCH	23390r(+)-sch-23390 hydrochloride	0.0625
YIGSR	tyrosine–isoleucine–glycine–serine–arginine	1.0
SCE	sister chromatid exchange	0.666666666667
SCE	stratum cellulare externum	0.333333333333
SCD	stearoyl-coa desaturase	1.0
SCG	10	0.0135135135135
SCG	10superior cervical ganglion 10	0.0135135135135
SCG	superior cervical ganglionectomy	0.0135135135135
SCG	superior cervical ganglion neurons	0.027027027027
SCG	satellite glial cells	0.0135135135135
SCG	supraoculomotor central gray	0.0135135135135
SCG	superior cervical ganglia	0.162162162162
SCG	superior cervical ganglion (ganglia)	0.0135135135135
SCG	sympathetic cervical ganglion	0.0135135135135
SCG	10superior cervical ganglion-10	0.0135135135135
SCG	superior cervical sympathetic ganglion	0.027027027027
SCG	superior cervical ganglion	0.648648648649
SCG	xsympathectomized	0.027027027027
SCF	stem cell factor	1.0
SCA	(number)spinocerebellar ataxias type (number)	0.0666666666667
SCA	superior cerebellar artery	0.0666666666667
SCA	8spinocerebellar ataxia type 8	0.0666666666667
SCA	3tgtransgenic mouse of spinocerebellar ataxia type 3	0.0666666666667
SCA	sspinocerebellar ataxias	0.0666666666667
SCA	3spinocerebellar ataxia type 3	0.0666666666667
SCA	sacrocaudal afferents	0.0666666666667
SCA	1spinocerebellar ataxia type 1	0.0666666666667
SCA	spinocerebellar ataxia	0.4
SCA	6spinocerebellar ataxia type 6	0.0666666666667
SCC	squamous cell carcinoma	0.1
SCC	ssolitary chemosensory cells	0.1
SCC	ssemicircular canals	0.1
SCC	small cell cap	0.2
SCC	sodium citrate/sodium chloride buffer	0.1
SCC	standard saline citrate	0.1
SCC	sodium citrate/sodium chloride	0.1
SCC	semicircular canal	0.2
SCB	sodium cacodylate buffer	1.0
MNH	medio-rostral neostriatum/hyperstriatum ventrale	0.25
MNH	medial neostriatum/hyperstriatum ventrale	0.25
MNH	mediorostral neostriatum/hyperstriatum ventrale	0.5
MNI	glutamate4-methoxy-7-nitroindolinyl-caged-l-glutamate	0.166666666667
MNI	4-methoxy-7-nitroindolinyl	0.333333333333
MNI	brainstandard montreal neurological institute brain	0.166666666667
MNI	montreal neurological institute	0.333333333333
DGGE	denaturing gradient gel electrophoresis	1.0
MNM	esencephalic neurons	0.333333333333
MNM	medio-rostral nidopallium/mesopallium	0.666666666667
MNN	magnocellular neurosecretory neurons	1.0
SCZ	schizophrenia	1.0
SCU	sub-cuneiform nucleus	1.0
SCT	sucrose consumption test	0.25
SCT	spinal cord transection	0.25
SCT	subcutaneous tissue	0.25
SCT	scopoletin	0.25
MNB	minibrain	1.0
SCV	sensory nerve conduction velocity	0.25
SCV	small clear vesicle	0.75
MND	motor neuron disease	0.5
MND	motor neurone disease	0.5
SCP	statistical cluster plot	0.0909090909091
SCP	superior cerebellar peduncle	0.818181818182
SCP	small cardioactive peptide	0.0909090909091
SCS	chaffer collateral	0.137931034483
SCS	chwann cell	0.206896551724
SCS	spinal cord stimulation	0.344827586207
SCS	yncam	0.0344827586207
SCS	plenium capitis	0.0344827586207
SCS	song control system	0.0344827586207
SCS	chwann cells	0.103448275862
SCS	stretch-cell-stress	0.0344827586207
SCS	haffer collateral	0.0344827586207
SCS	significantly changed site	0.0344827586207
SCR	skin conductance response	0.5
SCR	scrambled	0.125
SCR	sskin conductance responses	0.25
SCR	skin condunctance response	0.125
SC-	derived npcsspinal cord-derived neural progenitor cells	0.5
SC-	35	0.5
PBT	phosphate-buffered saline containing 0.3% triton x-100	0.0833333333333
PBT	pbs with 1% bovine serum albumin and 0.2% tween 20	0.0833333333333
PBT	phosphate-buffered saline with 0.1% tween-20	0.0833333333333
PBT	phosphate buffer with triton x-100 and bovine serum albumin	0.0833333333333
PBT	phosphate-buffered saline with 0.1% triton x-100	0.0833333333333
PBT	phosphate buffer+0.3% triton	0.0833333333333
PBT	1× phosphate-buffered saline, 2 mg/ml bovine serum albumin, 0.1% triton x-100	0.0833333333333
PBT	phosphate-buffered saline plus 0.3% triton x-100	0.0833333333333
PBT	phosphate-buffered saline containing 0.1% tween 20	0.0833333333333
PBT	phosphate buffer containing triton x-100	0.0833333333333
PBT	phosphate-buffered saline containing 0.5% triton x-100	0.0833333333333
PBT	pbs with 0.1% bsa and 0.1% triton x-100	0.0833333333333
NTRP	nucleus reticularis tegmenti pontis	1.0
PBQ	p-benzoquinone	1.0
PBP	penicillin-binding protein	0.125
PBP	parabrachial pigmented nucleus	0.25
PBP	post-burst potentiation	0.125
PBP	nucleus parabrachialis	0.125
PBP	parabrachial nucleus	0.125
PBP	parabrachial pigmental nucleus	0.125
PBP	hosphate buffer	0.125
PBS	+tphosphate-buffered saline with 0.2% triton x-100	0.000818107444778
PBS	phosphate buffer sodium	0.000272702481593
PBS	0.01m phosphate buffer/0.9% sodium chloride	0.000272702481593
PBS	phosphate-buffered saline	0.820561767112
PBS	pbs and 0.05% tween-20	0.000272702481593
PBS	+tpbs with 0.2% triton x-100	0.000272702481593
PBS	phosphate-based saline solution	0.000272702481593
PBS	phosphate-buffered saline ph 7.3	0.000272702481593
PBS	–tritonphosphate-buffered saline containing 0.3% triton x-100	0.000272702481593
PBS	phosphate-balanced solution	0.000272702481593
PBS	phosphate-buffered solution	0.007362967003
PBS	+0.1 m phosphate-buffered saline enriched with 0.2% triton-x and 0.1% bovine serum albumin	0.000272702481593
PBS	phosphate buffered solution	0.00136351240796
PBS	/tphosphate-buffered saline containing 0.5% triton x-100	0.000272702481593
PBS	phosphate saline buffer	0.00109080992637
PBS	phosphate-buffered saline (10mm)	0.000272702481593
PBS	phosphate buffer sulfate	0.000272702481593
PBS	10mm phosphate-buffered saline, ph 7.4	0.000272702481593
PBS	phosphate buffer	0.00599945459504
PBS	phosphate buffer and saline	0.000272702481593
PBS	phosphate-buffered saline containing 0.3m nacl	0.000272702481593
PBS	phopshate-buffered saline	0.000545404963185
PBS	/tritonphosphate-buffered saline with 0.5% triton x-100 and 0.01% thimerosal	0.000272702481593
PBS	sodium phosphate solution	0.000272702481593
PBS	+/+phosphate buffered saline with calcium and magnesium	0.000272702481593
PBS	30% sucrose in phosphate buffer containing 0.9% sodium chloride	0.000272702481593
PBS	phosphate-buffered saline, ph 7.4	0.000272702481593
PBS	+0.12 m phosphate-buffered saline+0.3% triton x-100	0.000272702481593
PBS	(–)ca-and mg-free phosphate-buffered saline	0.000272702481593
PBS	/txphosphate-buffered saline with 0.1% triton x-100	0.000272702481593
PBS	phosphate-buffered saline solution	0.00163621488956
PBS	,	0.000272702481593
PBS	phosphate-buffer saline	0.00245432233433
PBS	phosphate buffer containing 0.9% sodium chloride	0.000545404963185
PBS	phosphate buffer ssaline	0.000272702481593
PBS	phosphate buffer saline solution	0.000818107444778
PBS	+tphosphate-buffered saline solution with 0.2% triton x-100	0.000272702481593
PBS	phosphate buffer saline	0.0392691573493
PBS	sterile phosphate-buffered saline	0.000272702481593
PBS	phosphate-buffered salt solution	0.000272702481593
PBS	+ txpbs plus 0.1% triton x-100	0.000272702481593
PBS	phosphate-buffered normal saline	0.000545404963185
PBS	sodium phosphate buffer	0.00163621488956
PBS	(t), phosphate-buffered saline (tween 20)	0.000272702481593
PBS	0.05m phosphate-buffered saline	0.000818107444778
PBS	tposterior biceps-semitendinosus	0.000545404963185
PBS	phosphate-buffered saline.	0.000272702481593
PBS	phosphate-buffer solution	0.000272702481593
PBS	painful bladder syndrome	0.000545404963185
PBS	0.01 m phosphate-buffered saline	0.000545404963185
PBS	+tphosphate-buffered saline containing 0.3% triton x-100	0.000545404963185
PBS	phosphate buffer saline 0.1m	0.000272702481593
PBS	physiological buffer solution	0.000272702481593
PBS	phosphate-based saline	0.000272702481593
PBS	sodium phosphate buffer and saline	0.000545404963185
PBS	sodium phosphate-buffered saline	0.000818107444778
PBS	phosphate- buffered saline	0.000272702481593
PBS	x0.1 m phosphate-buffered saline with 0.1% triton x-100	0.000272702481593
PBS	sodium-phosphate buffered saline	0.000272702481593
PBS	phospate buffered saline	0.000545404963185
PBS	0.1 m phosphate buffer with 0.9% saline	0.000272702481593
PBS	–tphosphate-buffered saline with triton x-100	0.000272702481593
PBS	phosphate-buffered 0.9% saline	0.000545404963185
PBS	phosphate buffer solution	0.00899918189256
PBS	saline phosphate buffer	0.00109080992637
PBS	saline in phosphate buffer	0.000272702481593
PBS	/tritonphosphate-buffered saline/0.1% triton x-100	0.000272702481593
PBS	phoshate-buffered saline	0.000272702481593
PBS	phosphate-buffered saline ph 7.4	0.000545404963185
PBS	pb containing 0.9% nacl	0.000272702481593
PBS	/tritonpbs with 0.3% triton x-100 and 0.001% thimerosal	0.000545404963185
PBS	phosphate-buffered physiological saline	0.000545404963185
PBS	sodium phosphate buffered saline	0.000818107444778
PBS	phospate-buffered saline	0.000272702481593
PBS	buffered saline	0.000272702481593
PBS	(t), phosphate buffered saline (triton)	0.000272702481593
PBS	xphosphate-buffered saline with 0.1% triton x-100	0.000545404963185
PBS	phosphate buffered saline	0.0799018271066
PBS	phosphate buffered-saline	0.00245432233433
PBS	sterile 0.1 m phosphate-buffered saline	0.000272702481593
PBS	phosphate-buffered saline 0.1m	0.000272702481593
PBS	0.1m phosphate-buffered saline, ph 7.4	0.000272702481593
PBS	phosphobuffered saline	0.000272702481593
PBS	phosphate-buffered saline pro il-1β	0.000272702481593
PBS	phosphate-buffered saline with 0.3% triton x-100	0.000272702481593
PBR	peribrachial region of the brainstem	0.0666666666667
PBR	peripheral type benzodiazepine receptor	0.0666666666667
PBR	peripheral-type benzodiazepine receptor	0.266666666667
PBR	polybasic region	0.0666666666667
PBR	peripheral benzodiazepine receptor	0.4
PBR	parabrachial brainstem	0.0666666666667
PBR	peripheral benzodiazepin receptor	0.0666666666667
OX-R2	orexin-2 receptor protein	1.0
4thV	4th ventricle	1.0
CJD	creutzfeldt–jacob disease	0.333333333333
CJD	creutzfeldt–jakob disease	0.666666666667
pGSK	3βphosphorylated gsk3β	1.0
ASDH	acute subdural hemorrhage	1.0
PBD	post-burst depression	0.5
PBD	polo box domain	0.5
PBG	parabigeminal nucleus	0.5
PBG	1-phenilbiguanide	0.1
PBG	phenylbiguanide	0.1
PBG	1-phenylbiguanide	0.1
PBG	phosphate-buffered saline containing 10 mm glucose and bsa	0.1
PBG	phosphate buffered saline with gelatin	0.1
Amiloride3	5-diamino-n-(aminoiminomethyl)-6-chloropyrazinecarbox amide hydrochloride	1.0
PBA	phenylbutyric acid	0.333333333333
PBA	phosphate buffer	0.333333333333
PBA	parabrachial area	0.333333333333
TF-ROI	time-frequency regions of interest	1.0
PBC	speripheral blood cells	0.142857142857
PBC	pre-bötzinger complex	0.714285714286
PBC	pyramidal-shaped basket cell	0.142857142857
TrP	principal trigeminal nucleus	1.0
PBM	photobiomodulation	1.0
ASDA	utism spectrum disorder	0.5
ASDA	utism-spectrum-disorders	0.5
PBN	α-phenyl-tert-butyl nitrone	0.027027027027
PBN	parabrachial nuclei	0.027027027027
PBN	phenyl n-tert-butylnitrone	0.027027027027
PBN	parabrachial nucleus	0.783783783784
PBN	α-phenyl-n-tert-butyl nitrone	0.027027027027
PBN	α-phenyl-n-tert-butylnitron	0.027027027027
PBN	phenyl-n-tert-butylnitrone	0.027027027027
PBN	the parabrachial nucleus	0.027027027027
PBN	n-tert-butyl-α-phenylnitrone	0.027027027027
PBH	normal horse serum in 0.1m phosphate buffer	0.111111111111
PBH	phosphate-buffered horse serum	0.888888888889
ITPDC	inter-trial phase-difference coherence	1.0
CMHCC-	mechanoheat-cold unit	1.0
MTMEDIAL	temporal area	1.0
hCMV	human cytomegalovirus	1.0
2MeSATP	2-methylthio adenosine 5′-triphosphate	0.5
2MeSATP	2-methylthio-atp	0.5
LFCC	low-fat complex carbohydrate diet	1.0
MOXO	moxonidine	1.0
HRPCR	homologous-restraint pcr	1.0
H7	1-(5-isoquinolinylsulfonyl)-2-methylpiperazine	1.0
OTROT	receptor	1.0
TSKYR	thr-ser-lys-tyr-arg	1.0
H-	89n-[2-[[3-(4-bromophenyl)-2-propenyl]amino]	0.0588235294118
H-	89n-(2[p-bromocinnamylamino]-ethyl)-5-isoquinolinesulfonamide	0.0588235294118
H-	reflexhoffman reflex	0.0588235294118
H-	89n-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride	0.176470588235
H-	besthcl-best	0.0588235294118
H-	reflex	0.0588235294118
H-	89n-(2(methyl-amino)-ethyl)-5-isoquinoline sulfonamide dihydrochloride	0.0588235294118
H-	current	0.0588235294118
H-	89n-[2-(p-bromocinnamylamino)ethyl]-5-soquinolinesulfonamide	0.0588235294118
H-	71-(5-isoquinolinesulfonyl)-2-methylpiperazine	0.0588235294118
H-	7	0.0588235294118
H-	89n-[2-((p-bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide	0.117647058824
H-	89n-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide	0.0588235294118
H-	1152(s)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl) sulfonyl] homopiperazine	0.0588235294118
PBm	medial parabrachial nucleus	1.0
L-MAP4	α-methyl-(s)-2-amino-4-phosphonobutyrate	1.0
EJPs	excitatory junction potentials	1.0
PRE-TEST	pre-conditioning	1.0
apoEr2	apolipoprotein e receptor 2	1.0
LCL-	acsf	1.0
CBDBC	linical brain disorders branch	1.0
AT1R	angiotensin ii subtype 1 receptor	1.0
EPPs	endplate potentials	1.0
PRMT	protein arginine n-methyltransferase	1.0
vSE	ventral part of the se	1.0
LTRE	long-term rem enhancement	1.0
NalMb	naloxone methobromide	1.0
ISNEL	in situ nick end-labelling	1.0
vSN	ventral substantia nigra	1.0
HupA	huperzine a	1.0
APAF-	1apoptotic protease activating factor 1	1.0
SLOW	epileptogenic resistant	0.5
SLOW	selected mouse line insensitive to ethanol stimulation	0.5
TDTT	ucker-davis technologies	0.666666666667
TDTT	ucker davis technologies	0.222222222222
TDTT	ucker-davis-technologies	0.111111111111
PIPP	in	1.0
ppD	ynpreprodynorphin	1.0
TTA-P23	5-dichloro-n-[1-(2,2-dimethyltetrahudro-pyran-4-ylmethyl)-4-fluoro-piperidin-4-ylmethyl]-benzamide	1.0
ppN	/ofqpre-por-noniceptin/orphanin fq(the precursor peptide)	1.0
GDP-β-S	guanosine 5′-o-(2-thiodiphosphate)	0.352941176471
GDP-β-S	guanosine-5′-o-(2-thiodiphosphate)	0.176470588235
GDP-β-S	guanine 5′-[β-thio]diphosphate	0.0588235294118
GDP-β-S	5′-[β-thio]diphosphate	0.0588235294118
GDP-β-S	guanosine 5′-o-(2-thiobiphosphate)	0.0588235294118
GDP-β-S	guanosine-5′-o-2-thiodiphosphate	0.117647058824
GDP-β-S	guanosine-5-o-(2-thiodiphosphate)-s	0.0588235294118
GDP-β-S	guanosine 5′-[β-thio]diphosphate	0.0588235294118
GDP-β-S	guanosine 5′-diphosphate	0.0588235294118
ppT	preprotachykinin	1.0
DPSPs	depolarizing postsynaptic potentials	1.0
PAP-III	pancreatitis-associated protein-iii	1.0
aODN	antisense oligonucleotide	0.6
aODN	antisense oligodeoxynucleotide	0.4
PvTh	paraventricular thalamic nucleus	1.0
BAFB	oc-aspartyl(ome)-fluoromethylketone	0.5
BAFB	rahma-associated factors	0.5
ADT	androgen deprivation treatment	0.0526315789474
ADT	anterior dorsal tegmental region	0.0526315789474
ADT	anterodorsal thalamus	0.0526315789474
ADT	antidepressant therapy	0.0526315789474
ADT	anterodorsal thalamic nucleus	0.0526315789474
ADT	afterdischarge threshold	0.736842105263
ADU	arbitrary decision units	1.0
ADR	adriamycin	1.0
VGLUT	1vesicular glutamate transporter subtype 1	0.0114942528736
VGLUT	2type 2 vesicular glutamate transporter	0.0229885057471
VGLUT	1 and -2vesicular glutamate transporter 1 and 2	0.0114942528736
VGLUT	2vesicular glutamate transporter type 2	0.0229885057471
VGLUT	vesicular glutamate transporters	0.0114942528736
VGLUT	2vesicular glutamate transporter 2	0.149425287356
VGLUT	s	0.0114942528736
VGLUT	1-2vesicular glutamate transporters	0.0114942528736
VGLUT	vesicular transporter for glutamate	0.0114942528736
VGLUT	3vesicular glutamate transporter 3	0.0229885057471
VGLUT	1vesicular glutamate transporter type 1	0.0114942528736
VGLUT	1 and 2vesicular glutamate transporter 1 and 2	0.0229885057471
VGLUT	1vesicular glutamate transporter 1	0.114942528736
VGLUT	svesicular glutamate transporters	0.0114942528736
VGLUT	1vvesicular glutamate transporter 1 variant	0.0114942528736
VGLUT	1-irvesicular glutamate transporter subtype 1-immunoreactive	0.0114942528736
VGLUT	2type 2 vesicular glutamatergic transporter	0.0114942528736
VGLUT	vesicular glutamate transporter	0.471264367816
VGLUT	2vesicular glutamate transporter-2	0.0459770114943
ADP	after-depolarisation	0.03125
ADP	adenosine diphosphate	0.125
ADP	adenosine 5′-disphosphate	0.03125
ADP	afterdepolarizing potential (following an action potential)	0.03125
ADP	depolarizing afterpotential	0.03125
ADP	safter-depolarization potentials	0.03125
ADP	after depolarizing potential	0.03125
ADP	after depolarization potential	0.03125
ADP	/omoles of adp phosphorylated per moles of oxygen consumed	0.03125
ADP	after-depolarizing	0.03125
ADP	adenosine 5′-diphosphate	0.0625
ADP	after-depolarization	0.0625
ADP	afterdepolarization	0.1875
ADP	adenosine di-phosphate	0.03125
ADP	after-depolarizing potential	0.03125
ADP	anterodorsal preoptic nucleus	0.125
ADP	after-depolarization potential	0.09375
PIP2	phosphatidylinositol (4,5)biphosphate	0.5
PIP2	phosphatidylinositol 4,5-bisphosphate	0.5
GMC	sgiant migrating contractions	0.5
GMC	ganglion mother cell	0.5
GMA	gluteus maximus	1.0
vPFC	mventral medial prefrontal cortex	1.0
RCADS-PR	evised child anxiety and depression scales – parent form	1.0
GMF	glia maturation factor	1.0
ADX	adrenalectomy	0.333333333333
ADX	adrenalectomized/adrenalectomy	0.0740740740741
ADX	edadrenalectomized	0.037037037037
ADX	adrenalectomy/adrenalectomizing	0.037037037037
ADX	adrenalectomized	0.407407407407
ADX	adrenalectomy/adrenalectomized	0.0740740740741
ADX	adrenalectomy, adrenalectomized	0.037037037037
ADD	adductor muscles	0.0833333333333
ADD	associated afterdischarge duration	0.0833333333333
ADD	afterdischarge duration	0.75
ADD	2adducin 2	0.0833333333333
ROKRHO	kinase	1.0
ADB	antibody dilution buffer	0.333333333333
ADB	assay dilution buffer	0.333333333333
ADB	antiserum dilution buffer	0.333333333333
ADC	arginine decarboxylase	0.25
ADC	apparent diffusion coefficients	0.05
ADC	agmatine decarboxylase	0.05
ADC	apparent diffusion coefficient	0.65
ADA	fterdischarge	0.00229885057471
ADA	lzheimer’s dementia or disease	0.00229885057471
ADA	lzheimer disease	0.0551724137931
ADA	lzheimer’s diseases	0.00459770114943
ADA	lzheimer's diseases	0.00229885057471
ADA	sperger’s disorder	0.00229885057471
ADA	lzheimer dementia	0.00459770114943
ADA	trans-azetidine-2,4-dicarboxylic acid	0.00459770114943
ADA	lzheimer’s disease	0.406896551724
ADA	lzheimer's dementia	0.00459770114943
ADA	lzheimer's disease	0.475862068966
ADA	nterior deltoid	0.00229885057471
ADA	adenosine deaminase	0.032183908046
ADN	aortic depressor nerve	1.0
ADO	adenosine	1.0
ADL	apical dendritic length	1.0
GMP	guanosine 5′-monophosphate	0.142857142857
GMP	immunocytochemistry	0.142857142857
GMP	guanosine cyclic-3′,5′,monophosphate	0.142857142857
GMP	guanosine monophosphate	0.428571428571
GMP	guanosine-3′,5′-monophosphate	0.142857142857
ADK	adenosine kinase	1.0
ADH	adipic dihydrazide	0.2
ADH	alcohol dehydrogenase	0.2
ADH	antidiuretic hormone	0.6
ADI	attenuation differential index	0.5
ADI	attack/defeat index	0.5
LDTgV	laterodorsal tegmental nucleus, pars ventralis	1.0
DARPP-32cAMP-regulated-phosphoprotein-of-Mr32	000	1.0
Voa	nucleus ventrooralis anterior	1.0
M35	muscarinic ach receptor	1.0
vCA3	ca3 field of ventral hippocampus	1.0
α1A	250-kda subunit of the p/q-type vdcc	1.0
BRS	cardiac baroreflex sensitivity	0.25
BRS	baroreflex sensitivity	0.5
BRS	baroreceptor reflex sensitivity	0.25
BRR	baroreceptor reflex	1.0
BRP	bruchpilot	0.5
BRP	brain remaining percentage	0.5
dlPMC	dorsolateral premotor cortex	1.0
RPL-	19ribosomal protein l19	1.0
BChE	butyrylcholinesterase	1.0
FSCs	follicle sinus complexes	1.0
BRF	bulbar reticular formation	1.0
3-CSRT	three-choice serial reaction time task	1.0
uhASC	sundifferentiated human adipose-derived stem cells	1.0
pVNL	posterior vomeronasal nerve layer	1.0
BRB	blood–retinal barrier	1.0
nH	bnerve hemoglobin	1.0
EMGE	lectromyogram	1.0
GABAAR	type a gaba receptor	0.181818181818
GABAAR	sgabaa receptors	0.545454545455
GABAAR	type-a gaba receptor	0.0909090909091
GABAAR	gabaa receptor	0.0909090909091
GABAAR	gamma-aminobutyric acid a receptor	0.0909090909091
I5HT	current elicited by 5-hydroxytryptamine	1.0
nO	novel object	1.0
nA	chrnicotinic acetylcholine receptor	0.0909090909091
nA	mbnucleus ambiguus	0.0909090909091
nA	nucleus ambiguus	0.0909090909091
nA	cbnucleus accumbens	0.181818181818
nA	mbnucleus ambiguous	0.0909090909091
nA	ccnucleus accumbens	0.272727272727
nA	chrnicotinic receptor	0.0909090909091
nA	cnucleus accumbens	0.0909090909091
nC	renestin-cre	1.0
CL-A	calyculin a	1.0
DSP-	4n-(2-chloroethyl)-n-ethyl-2 bromobenzylamine	0.0666666666667
DSP-	4n-(2-chloroethyl)-n-ethyl 2-bromobenzylamine	0.0666666666667
DSP-	4n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine hydrochloride	0.2
DSP-	4n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine	0.4
DSP-	4n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine hydrocloride	0.0666666666667
DSP-	4	0.2
nG	igigantocellular reticular nucleus	1.0
nX	dorsal motor nucleus of the vagus	1.0
HB	hybridization buffer	0.0769230769231
HB	hirano body	0.0769230769231
HB	homogenization buffer	0.384615384615
HB	rhydrobromide	0.0769230769231
HB	heparin binding	0.0769230769231
HB	hybridoma	0.0769230769231
HB	high bigram string	0.0769230769231
HB	hemiballism	0.0769230769231
HB	henning berlin	0.0769230769231
mPT	mitochondrial permeability transition	1.0
NBD-SM	7-nitrobenz-z-oxa-1,3-diazol-4-yl-sphingomyelin	1.0
mPR	sprogesterone membrane receptors	0.333333333333
mPR	membrane progestin receptor	0.333333333333
mPR	)	0.333333333333
TTBSTBS	containing 0.1% tween-20	0.333333333333
TTBSTBS	with 0.05% tween	0.333333333333
TTBSTBS	with 0.5% tween 20	0.333333333333
GABAAA	subunit of the gamma-aminobutyric acid receptor	0.5
GABAAA	type gamma amino butyric acid receptor	0.5
nP	tplatinum nanoparticle	1.0
nR	tnucleus reticularis thalami	1.0
nT	yrnitrotyrosine	0.5
nT	no-touch	0.5
6MPH46-methyl-5	6, 7, 8-tetrahydropteriae dihydrochloride	1.0
NMAN-	methyl-dl-aspartate	0.5
NMAN-	methyl-d(l)-aspartic acid	0.5
GHRP-6	growth hormone-releasing peptide-6	1.0
VMHVL	ventromedial hypothalamic nucleus, ventrolateral part	0.5
VMHVL	ventromedial nucleus of the hypothalamus, ventrolateral part	0.5
z-VAD-	fmkn-benzyloxylcarbonyl-val-ala-asp(och3)-fluoromethyl ketone	0.5
z-VAD-	fmkz-val-ala-asp-fluoromethylketone	0.5
LICIL	ong-interval intracortical inhibition	1.0
UCPH-1012-amino-5	6,7,8-tetrahydro-4-(4-meroxyphenyl)-7-(naphtalen-1-yl)-5-oxo-4h-chromene-3-carbonitrile	1.0
CC-G	enugenu of the corpus callosum	1.0
CNGB	3b3 subunit of cyclic nucleotide–gated ion channels	1.0
l-DOPA3	4-dihydroxy-l-phenylalanine	1.0
bPHAL	biotinylated anti-phaseolus vulgaris leucoagglutinin	1.0
CYCLO	cyclodextrin	1.0
PLA2-170	phospholipase a2 of 170,000 mol. wt	1.0
LNTB	lateral nucleus of trapezoid body	0.25
LNTB	lateral nucleus of the trapezoid body	0.625
LNTB	lateral nucleus of the trapezoidal body	0.125
InsP3R	inositol 1,4,5-trisphosphate receptor protein	1.0
3h-RF	three hours refed group	1.0
FMT	fluorescence-mediated tomography	1.0
CS-PG	chondroitin sulphate proteoglycan	1.0
ESW	extracorporeal shock waves	1.0
MNX	1motor neuron and pancreas homeobox 1	0.5
MNX	methylnaloxonium	0.5
KLF	6krüppel-like factor 6	1.0
EST	sexpressed sequence tags	0.0416666666667
EST	estrous female sample	0.0416666666667
EST	electrical stimulation	0.0416666666667
EST	estrogen	0.0416666666667
EST	estrus	0.0416666666667
EST	expressed sequence tags	0.125
EST	loxastatin	0.0416666666667
EST	expressed sequence tag	0.583333333333
EST	electrographic seizure threshold	0.0416666666667
ESS	earle’s salt solution	0.5
ESS	earles' salt solution	0.5
ESR	electron spin resonance	0.333333333333
ESR	essential sensor for the response	0.166666666667
ESR	electron spin resonance spectroscopy	0.166666666667
ESR	ear-scratch response	0.166666666667
ESR	field excitatory postsynaptic potential slope ratio	0.166666666667
KLC	3kinesin light chain 3	0.5
KLC	kinesin light chain	0.5
MβCD	methyl-β-cyclodextrin	1.0
hNPY	human neuropeptide y	1.0
KLH	keyhole limpet hemagglutinin	0.0645161290323
KLH	keyhole limpet haematoxylin	0.0322580645161
KLH	keyhole limpet hemacyanin	0.0322580645161
KLH	keyhole limpet haemocyanin	0.0967741935484
KLH	keyhole limpet hemocyanin	0.709677419355
KLH	keyhole limpet hemocyanine	0.0322580645161
KLH	keyhole limpet cyanin	0.0322580645161
Hx	hemisection	1.0
KLK	kallikrein-related peptidase	0.5
KLK	rzanowski–lai	0.5
ESE	rectus spinae	0.5
ESE	electrographic status epilepticus	0.5
ESD	excitatory short-duration	1.0
ESC	embryonic stem cell	0.3
ESC	embryonic stem cells	0.2
ESC	excitatory synaptic current	0.2
ESC	sembryonic stem cells	0.3
AcCoA	acetyl coenzyme a	1.0
LDT-PPT	laterodorsal and pedunculopontine tegmental nuclei	1.0
ESM	ethosuximide	1.0
GAFP	glial fibrillary acid protein	1.0
ESI	electrospray ionization	0.181818181818
ESI	ms/mselectrospray ionization tandem mass spectrometry	0.0909090909091
ESI	electrospray ionization source	0.0909090909091
ESI	electrospray	0.0909090909091
ESI	electron spectroscopic imaging	0.454545454545
ESI	electrospray injection	0.0909090909091
NEBL	nebulette	1.0
iGluR	ionotropic glutamate receptor	1.0
LTC	4cys-leukotriene c4	0.333333333333
LTC	4leukotriene c4	0.333333333333
LTC	lateral temporal cortex	0.333333333333
NF-YA	nuclear transcription factor-y alpha	1.0
CECT	cardio–electroencephalographic covariance trace	1.0
A78645-androsten-3β	17β-diol disulfate, disodium salt	1.0
FMO	flavin monooxygenase	1.0
sqR	t-pcrsemiquantitative reverse transcriptase polymerase chain reaction	1.0
DSPH	dl-threo-dihydrosphingosine	1.0
CPEB	cytoplasmic polyadenylation element binding protein	1.0
GCβ	1guanylyl cyclase β1 subunit	1.0
MNP	mirror neuropathic pain	1.0
CRALBP	cellular retinaldehide binding protein	0.2
CRALBP	cellular retinaldehyde-binding protein	0.4
CRALBP	cellular retinaldehyde binding protein	0.4
8-pCPT-cGMP	8-(4-chlorophenylthio)-cyclic gmp	1.0
CLAMSC	omprehensive lab animal monitoring system	1.0
GABAA-	receptor	0.333333333333
GABAA-	receptor subunit assembly	0.333333333333
GABAA-	receptors	0.333333333333
FMK	fluoromethylketone	1.0
PBSTT	riton x-100/phosphate-buffered saline	0.25
PBSTT	riton x-100 in 0.1m phosphate-buffered saline	0.25
PBSTT	riton x-100 in pbs	0.25
PBSTT	riton-x-100 in pbs	0.25
MNS	mirror neuron system	0.6
MNS	mirror-neuron system	0.2
MNS	mean normalized sensitization	0.2
BNSTL	lateral portion of bed nucleus of stria terminalis	1.0
HBSSH	anks’ balanced salts solution	0.0344827586207
HBSSH	ank's buffered sterile saline	0.0114942528736
HBSSH	ank's buffered salt solution	0.0114942528736
HBSSH	anks' balanced salt solution	0.298850574713
HBSSH	anks buffered salt solution	0.0114942528736
HBSSH	anks balanced salt solution	0.0229885057471
HBSSH	anks’ buffered saline solution	0.0114942528736
HBSSH	ank's balanced saline solution	0.0114942528736
HBSSH	anks' buffered salt solution	0.0344827586207
HBSSH	epes-buffered salt solution	0.0114942528736
HBSSH	ank’s balanced salt solution	0.114942528736
HBSSH	ank’s buffered saline solution	0.0114942528736
HBSSH	ank’s-buffered salt solution	0.0114942528736
HBSSH	anks’ balanced salt solution	0.229885057471
HBSSH	anks' balanced salt solution for further dissection	0.0114942528736
HBSSH	ank's balanced salt solution	0.16091954023
PBS-TBPBS	/0.1% triton-x/0.1% bovine serum albumin	1.0
MNT	motor nerve terminal	0.2
MNT	smotor nerve terminals	0.2
MNT	mouse motor nerve terminal	0.2
MNT	masseteric nerve trunk	0.2
MNT	motor nerve terminals	0.2
chABC	chondroitinase abc	0.5
chABC	chondroitinaseabc	0.5
FMI	forceps minor, corpus callosum	1.0
iNP	inbred alcohol-nonpreferring	1.0
5-HPETE	s5-(s)-hydroxyeicosatetraenoic acids	1.0
iNR	item not recognized	1.0
24-OH	chol24s-hydroxycholesterol	1.0
LTK	fibroblasts of the l-m(tk-) cell line	1.0
TIN	temperature-insensitive neurons	1.0
l-DOPA	levodopa	0.35
l-DOPA	l-3,4-dihydroxyphenylalanine	0.35
l-DOPA	l-3-hydroxytyrosine	0.05
l-DOPA	l-3,4 dihydroxyphenylalanine	0.05
l-DOPA	l-dihydroxyphenylalanine	0.2
SFRP	secreted frizzled-related protein	1.0
NEO-FFINEO	five-factor inventory	1.0
iNE	item not encoded	1.0
HHBSSH	ank’s hepes-buffered saline solution	0.2
HHBSSH	anks’ hepes-buffered saline solution	0.2
HHBSSH	anks' hepes buffered saline solution	0.4
HHBSSH	ank's hepes buffered saline solution	0.2
modelBaranauskas	martina model of sodium channels	1.0
SHSY	5y neuroblastoma cells	1.0
NK-2R	neurokinin-2 receptor	1.0
CREBcAMP	response element binding protein	1.0
MUSM	uscimol	1.0
ACOX	1acyl-coa oxidase1	0.5
ACOX	acyl-coa oxidase	0.5
cMG	contralateral medial geniculate body	1.0
mNSSM	odified neurological severity score	1.0
CLSM	confocal laser scanning light microscope	0.0344827586207
CLSM	confocal laser scanning microscopy	0.172413793103
CLSM	confocal laser-scanning microscope	0.172413793103
CLSM	confocal laser scanning light microscopy	0.0689655172414
CLSM	confocal laser scanning microscope	0.551724137931
NPRA	nucleus para-retroambiguus	1.0
APVD-	(-)-2-amino-5-phosphonopentanoic acid	0.666666666667
APVD-	2-amino-5-phosphonopentanoic acid	0.333333333333
cNTS	central division of nucleus tractus solitarii	0.1
cNTS	the caudal nts	0.1
cNTS	caudal aspect of the nucleus of the solitary tract	0.1
cNTS	caudal nucleus tractus solitarius	0.1
cNTS	commissural nucleus of the solitary tract	0.2
cNTS	commissural nucleus tractus solitarius	0.1
cNTS	commissural subnucleus of the nucleus of the solitary tract	0.1
cNTS	caudal nucleus tractus solitarii	0.1
cNTS	nucleus tractus solitarius (commissural)	0.1
NALP	1 inflammasome	1.0
Met-ENK	[met]enkephalin	0.4
Met-ENK	methionine-enkephalin	0.2
Met-ENK	methionine enkephalin	0.2
Met-ENK	[met]5enkephalin	0.2
LTL	issauer's tract	1.0
SCX	subcortex	1.0
Cif	central nucleus, inferior part	1.0
GDP-βS	guanosine 5′-o-(2-thiodiphosphate)	0.5
GDP-βS	guanosine 5′-[β-thio]diphosphate trilithium salt	0.5
co-IP	co-immunoprecipitation	0.75
co-IP	sco-immunoprecipitations	0.25
Lew	lewis	1.0
NMDARN-	methyl-d-aspartic acid receptor	0.0687022900763
NMDARN-	methyl-d-aspartic acid receptors	0.00763358778626
NMDARN-	methyl-d-aspartate receptor	0.801526717557
NMDARN-	methyl d-aspartic acid receptor	0.00763358778626
NMDARN-	methyl d-aspartate glutamate receptor	0.00763358778626
NMDARN-	methyl-d-aspartate receptor(s)	0.00763358778626
NMDARN-	methyl-d-aspartate-sensitive glutamate	0.00763358778626
NMDARN-	methyl-d-aspartate-receptors	0.00763358778626
NMDARN-	methyl-d-aspartate	0.00763358778626
NMDARN-	methyl d-aspartate receptor	0.030534351145
NMDARN-	methyl-d-aspartate subtype of glutamate receptor	0.00763358778626
NMDARN-	methyl-d-aspartate receptors	0.030534351145
NMDARN-	methyl-d-aspartate glutamate receptors	0.00763358778626
Cin	membrane capacitance	1.0
Cim	central nucleus, intermediate part	1.0
Hb	haemoglobin	0.5
Hb	habenular complex	0.5
medOFC	medial orbitofrontal cortex	1.0
sulfo-LC-SMPT	4-sulfosuccinimidyl-[6-methyl-a-(2-pyridyldithio) toluamido] hexanoate	1.0
mEFP	mean extracellular field potential	1.0
VWRV	an waters rogers	1.0
MNA	medial nucleus of amygdala	1.0
SLC-1	generic name of the mch receptor	1.0
MAF	minor allele frequency	1.0
MNC	mononuclear cells	0.142857142857
MNC	smononuclear cells	0.142857142857
MNC	magnocellular neurosecretory cell	0.142857142857
MNC	mononuclear cell	0.285714285714
MNC	mononuclear blood cell	0.142857142857
MNC	smagnocellular neurosecretory cells	0.142857142857
sIahp	slow after-hyperpolarization current	1.0
αCaMKII	α-ca2+/calmodulin kinase ii	1.0
HOKR	horizontal optokinetic response	1.0
nsSNP	non-synonymous single nucleotide polymorphism	0.5
nsSNP	snonsynonymous single nucleotide polymorphisms	0.5
TII	type ii cells	1.0
CPCCOEt	7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate	0.5
CPCCOEt	cyclopropan[b]chromen-1a-carboxylic acid ethylester	0.5
HOKS	horizontal optokinetic stimulation	1.0
ECLIA	electrochemiluminescent immunoassay	1.0
NUCB	2nucleobindin 2	0.5
NUCB	2nucleobindin-2	0.5
4β-PMA	4β-phorbol 12-myristate 13-acetate	0.5
4β-PMA	4β-phorbol 12 myristate 13-acetate	0.5
MCFLIRT	motion correction using fmrib's linear image registration tool	1.0
PBTB	phosphate buffer containing triton x-100 and bovine serum albumin	1.0
NOCI-LI	nociceptin-like immunoreactivity	1.0
DiI1	1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (lipophilic dye)	0.0192307692308
DiI1	1′-didodecyl-3,3,3′,3′-tetramethyl-indocarbocyanine	0.0192307692308
DiI1	1′-dioleyl-3,3,3′,3′-tetramethylindocarbocyanine methanesulfonate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′-tetra-methylindocarbocyanine perchlorate	0.0192307692308
DiI1	10-dioctadecyl-3,3,30,30-tetramethylindocarbocyanine perchlorate	0.0192307692308
DiI1	1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine iodide	0.0192307692308
DiI1	1-dioctadecyl-3,3,3,3 tetramethylindocarbocyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbo-cyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate	0.0384615384615
DiI1	1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchloride	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′- tetramethylindocarbocyanine perchlorate	0.0192307692308
DiI1	1′dioctadecyl-3,3,3′,3-tetramethylindocarbocyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-6,6′-di(4-sulfophenyl)-3,3,3′,3′-tetramethylindocarbocyanine	0.0192307692308
DiI1	1′,di-octadecyl-3,3,3′3′-tetramethylindocarbocyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′-tertamethyllindocarbocyanine perchlorate	0.0384615384615
DiI1	1′-dioctodecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	0.0384615384615
DiI1	1′-dioctadecyl-3,3,3′,3′-tetramethyllindocarbocyanine	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′ tetramethylindocarbocyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorhydrate	0.0192307692308
DiI1	1′-didodecyl-3,3,3′,3′-tetramethyl indocarbocyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3, 3, 3′, 3′-tetramethylindocarbocyanine perchlorhydrate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′-tetra-methylindocarbocyamine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3,3′-tetramethylindocarbocyanineperchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′tetramethyl-indocarbocyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′ tetramethylindocarbocyanine methanesulfonate	0.0192307692308
DiI1	1'-dioctadecyl-3, 3, 3', 3'-tetramethylindocarbocyanine perchlorate	0.0192307692308
DiI1	1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate	0.403846153846
DiI1	1,1′-dioctadecyl-3,3,3,3′ tetramethlindocarbocyanine percholate	0.0192307692308
CNPase	2′,3′-cyclic nucleotide-3′-phosphodiesterase	0.166666666667
CNPase	2′,3′-cyclic nucleotide 3′-phosphodiesterase	0.333333333333
CNPase	2′,3′-cyclic nucleotide 3′-phosphohydrolase	0.333333333333
CNPase	cyclic nucleotide-phosphodiesterase	0.166666666667
N90	negative peak in the cortical response at 90 ms after stimulus	1.0
ORM	olton type radial maze	1.0
SRED	spontaneous recurrent epileptiform discharges	1.0
STC-	1stanniocalcin-1	1.0
AgTx	ω-agatoxin-iva	1.0
VbC	vestibulocerebellum	1.0
PBTT	riton x-100 in 0.1m phosphate buffered solution	1.0
GRP-BN-	likegastrin releasing peptide-bombesin-like	1.0
iHDAC	inhibitor of histone deacetylase	1.0
PBTX	0.1 m phosphate buffer with 0.9% saline containing 4% normal donkey serum	1.0
SRES	mad-response element	1.0
DN-BR	dominant negative bmp receptor	1.0
HARDI	high angular resolution diffusion imaging	0.666666666667
HARDI	high-angular resolution diffusion imaging	0.333333333333
COX2	cyclooxygenase 2	1.0
SWd	spike-and-wave discharge	1.0
-LI	-like immunoreactive	0.0625
-LI	-like immunoreactivity or immunoreactive	0.0625
-LI	-like immunoreactivity	0.75
-LI	like immunoreactivity	0.0625
-LI	-like immunopositive nuclei	0.0625
cGFP	green fluorescent protein from coral fish	1.0
BTX-A	botulinum toxin a	1.0
AMT2-amino-5	6-dihydro-6-methyl-4h-1,3-thiazine	1.0
mTPH	2rhesus monkey tph2	1.0
ReC	reuniens complex	1.0
TUJ-	1β-tubulin class iii	0.333333333333
TUJ-	1neuron-specific class iii β-tubulin	0.666666666667
PPAR-	gamma	1.0
PHA-LP	haseolus lectin	0.0357142857143
PHA-LP	haseolus vulgaris leukoagglutinin	0.0714285714286
PHA-LP	haseolus vulgaris-leucoagglutinin	0.25
PHA-LP	haseolus vulgaris leucoagglutinin	0.642857142857
WGE	whole ganglionic eminence	1.0
WGA	horseradish peroxidase–wheatgerm agglutinin	0.0263157894737
WGA	wheat germ agglutin	0.0263157894737
WGA	wheatgerm agglutinin	0.131578947368
WGA	wheat germ agglutinin	0.526315789474
WGA	–hrpwheat germ agglutinin conjugated to horseradish peroxidase	0.0263157894737
WGA	horseradish peroxidase conjugated wheat germ agglutinin	0.0263157894737
WGA	–hrp	0.0263157894737
WGA	wheat germ lectin agarose	0.0263157894737
WGA	–hrpwheat germ agglutinin–horseradish peroxidase conjugate	0.0263157894737
WGA	wheat-germ agglutinated	0.0263157894737
WGA	apohrp-aucolloidal gold-labelled wheat germ agglutinin conjugated to enzymatically inactive horseradish peroxidase	0.0263157894737
WGA	horseradish peroxidase–wheat germ agglutinin	0.0526315789474
WGA	wheat germ leucoagglutinin	0.0263157894737
WGA	horseradish peroxidase conjugated to wheat germ agglutinin	0.0263157894737
SATSAS	wedish adoption/twin study of aging	1.0
SIID	stroke-induced immunodepression	1.0
JAKJ	anus kinase	1.0
NGFβ	nerve growth factor beta	1.0
TWIN	time-window-of-integration	1.0
rAANP	ricin conjugated to atrial natriuretic peptide	1.0
WGS	waking ground squirrel	0.5
WGS	whole genome sequencing	0.5
TWIK	tandem of p domains in a weak inwardly rectifying k+ channel	0.4
TWIK	tandem of pore domains in a weak inward rectifying k+ channel	0.2
TWIK	tandem pore domain weak inwardly rectifying k	0.2
TWIK	tandem of p domains in a weak inwardly-rectifying k+ channel	0.2
PSFP	renatal stress+fluoxetine	1.0
PDGFR-α	platelet-derived growth factor receptor-α	1.0
aMCC	anterior portion of the medial cingulate cortex	1.0
PGFI	parsimony goodness of fit index	1.0
mPGES	microsomal prostaglandin e synthase	0.333333333333
mPGES	membrane bound prostaglandin e synthase	0.333333333333
mPGES	microsomal prostaglandin-e synthase	0.333333333333
KPBT	potassium phosphate buffer containing 0.3% triton x-100	1.0
KPBS	??	0.0140845070423
KPBS	potassium phosphate–buffered saline	0.056338028169
KPBS	potassium-phosphate-buffered saline	0.0281690140845
KPBS	potassium phosphate buffer saline	0.0281690140845
KPBS	potassium phosphate buffer containing sodium chloride	0.0140845070423
KPBS	0.02 м potassium pbs	0.0140845070423
KPBS	potassium-buffered saline	0.0422535211268
KPBS	potassium phosphate buffer	0.056338028169
KPBS	potassium phoshate-buffered saline	0.0140845070423
KPBS	potassium phosphate-buffered saline	0.577464788732
KPBS	potassium phosphate- buffered saline	0.0140845070423
KPBS	potassium phosphate buffer solution	0.0281690140845
KPBS	potassium phospate-buffered saline	0.0140845070423
KPBS	potassium containing phosphate-buffered saline solution	0.0140845070423
KPBS	potassium phosphate buffered saline	0.056338028169
KPBS	potassium phosphate-buffered physiological saline	0.0140845070423
KPBS	potassium-phosphate buffer saline	0.0140845070423
PPARs	peroxisomal proliferator-activated receptors	1.0
pacDNA	packaging/cleavage signal	1.0
GAD67	glutamate decarboxylase-67 (mol. wt 67,000)	0.166666666667
GAD67	67,000 mol. wt isoform of glutamate decarboxylase	0.166666666667
GAD67	glutamic acid decarboxylase of 67 kda	0.166666666667
GAD67	glutamate decarboxylase-67	0.166666666667
GAD67	glutamate decarboxylase 67	0.333333333333
GAD65	glutamic acid decarboxylase 65	0.2
GAD65	adult forms of glutamate decarboxylase (67,000 and 65,000mol. wt, respectively)	0.2
GAD65	glutamic acid decarboxylase	0.2
GAD65	65,000 mol. wt isoform of glutamate decarboxylase	0.4
PBT-	azide0.02% sodium azide in phosphate-buffered saline with 0.25% triton x-100	1.0
SUA	single-unit activities	1.0
DAF-2DA4	5-diaminofluorescein diacetate	0.666666666667
DAF-2DA4	5-diaminofluorescein-2-diacetate	0.333333333333
dmPFC	dorsal medial prefrontal cortex	0.2
dmPFC	dorsal portion of the mpfc	0.1
dmPFC	dorsomedial prefrontal cortex	0.7
TBSTTBS-	containing tween 20	0.5
TBSTTBS-	0.1% tween20	0.5
gPHAL	gold-conjugated phaseolus vulgaris-leucoagglutinin	1.0
EBIO	1-ethyl-2-benzimidazolinone	1.0
SUMX	supramammillary decussation	1.0
pHH	3phosphohistone-h3	1.0
preC	uprecuneus	1.0
preB	ötcprebötzinger complex	0.4
preB	ötpre-bötzinger complex	0.1
preB	ötcpre-bötzinger complex	0.4
preB	ötzinger complex	0.1
SUMO	small ubiquitin-like modifier protein	0.25
SUMO	1small ubiquitin-like modifier 1	0.25
SUMO	1small ubiquitin-like modifier	0.25
SUMO	small ubiquitin-like modifier	0.25
DDRT-PCR	differential display reverse transcription-polymerase chain reaction	0.666666666667
DDRT-PCR	differential display reverse transcription–polymerase chain reaction	0.333333333333
PBL	speripheral blood lymphocytes	0.2
PBL	parabrachial nucleus	0.2
PBL	lateral parabrachial nucleus	0.2
PBL	peripheral blood lymphocyte	0.2
PBL	plexus brachialis lesion	0.2
5HT-	irserotonin immunoreactivity	1.0
TIRAPT	oll/interleukin-1 receptor-associated protein	1.0
7TM	seven-transmembrane	0.5
7TM	seven transmembrane	0.5
TEAOH	tetraethylammonium hydroxide	1.0
IRBI	nstitutional review board	1.0
L-LTP	late phase of long-term potentiation	0.153846153846
L-LTP	late or long-lasting ltp	0.0769230769231
L-LTP	late-phase ltp	0.0769230769231
L-LTP	late phase long-term potentiation	0.0769230769231
L-LTP	late phase long term potentiation	0.0769230769231
L-LTP	late-long-term potentiation	0.230769230769
L-LTP	late long-term potentiation	0.230769230769
L-LTP	late-phase long-term potentiation	0.0769230769231
NALX	naloxone	1.0
PTX3	(human) pentraxin 3	1.0
HPTR	hypoxanthine phosphoribosyltransferase	1.0
PTPζ	receptor-type protein tyrosine phosphatase ζ	1.0
L-LTD	late long-term depression	0.5
L-LTD	late-phase long-term depression	0.5
Py	pyramidal 146,000 mol. wt glycoprotein	1.0
GHRP-	6	1.0
S-ESBA	(s)-4-(ethylsulfonyl)benzoylalanine	1.0
oxidase-A	inhibitor	1.0
CACA1	ca3 regions of ammon’s horn	1.0
PAHP	hen hydroxylase	1.0
PI3K	phosphatidylinositol 3-kinase	0.25
PI3K	phosphoinositide 3-kinase	0.5
PI3K	phosphatidylinositol-3-kinase	0.25
mutHRE	lucbnip3 promoter with a mutated hre site	1.0
MCAO	/rmiddle cerebral artery occlusion and reperfusion	0.00571428571429
MCAO	occluded right middle cerebral artery	0.00571428571429
MCAO	)	0.0114285714286
MCAO	permanent occlusion of the middle cerebral artery	0.00571428571429
MCAO	middle cerebral artery occlusion	0.942857142857
MCAO	medial cerebral artery occlusion	0.00571428571429
MCAO	middle cerebral arterial occlusion	0.0171428571429
MCAO	model	0.00571428571429
fas-L	fas ligand	1.0
AAALACA	ssociation for assessment and accreditation of laboratory animal care	0.5
AAALACA	ssociation for assessment and accreditation of laboratory animal care international	0.25
AAALACA	ssessment and accreditation of laboratory animal care international	0.25
gapdhmRNA	for glyceraldehyde-3-phosphate dehydrogenase	1.0
PTXN	picrotoxin	1.0
HCRT	2-saphypocretin2-saporin	0.0909090909091
HCRT	r1hcrt 1 receptor	0.0909090909091
HCRT	hypocretin	0.545454545455
HCRT	hypocretin also called orexin	0.272727272727
STEM	scanning transmission electron microscopy	1.0
LC-APCI-MS	liquid chromatography–atmospheric pressure chemical ionization–mass spectrometry	1.0
t-BHQ	tert-butylhydroquinone	1.0
5HTT	serotonin transporter	1.0
RB-2	reactive blue-2	0.5
RB-2	reactive blue 2	0.5
Ins13insula	ba 13	1.0
MCAo	middle cerebral artery occlusion	0.5
MCAo	mca occlusion	0.5
IFs	intermediate filaments	1.0
α2C-AR	α2c-adrenergic receptor	0.5
α2C-AR	α2c subclass of adrenergic receptor	0.5
BCAβ-	cyanoalanine	1.0
MOMM	ouse-on-mouse	1.0
I-FISH	interphase fluorescence in situ hybridization	1.0
VRL-1	vanilloid receptor 1-like	0.5
VRL-1	vanilloid receptor 1-like receptor	0.5
GPL	lateral globus pallidus	1.0
kDa	kilodaltons	1.0
FRAXS	fragile x syndrome	1.0
qPCR	quantitative real-time rt–pcr	0.0149253731343
qPCR	quantitative reverse transcription polymerase chain reaction	0.0149253731343
qPCR	quantitative polymerase chain reaction	0.313432835821
qPCR	quantitative realtime pcr	0.0149253731343
qPCR	quantitative real-time pcr	0.164179104478
qPCR	real-time quantitative reverse transcriptase polymerase chain reaction	0.0149253731343
qPCR	quantitative rt-pcr	0.0298507462687
qPCR	quantitative real time pcr	0.0597014925373
qPCR	quantitative pcr	0.134328358209
qPCR	quantitative real-time polymerase chain reaction	0.179104477612
qPCR	real-time quantitative pcr	0.0149253731343
qPCR	real-time quantitative polymerase chain reaction	0.0149253731343
qPCR	squantitative polymerase chain reactions	0.0149253731343
qPCR	real time quantitative polymerase chain reaction	0.0149253731343
DIG-UTP	digoxigenin-conjugated utp	1.0
Hsyn	synapse height	1.0
PCM-EI	pcm supplemented with egf and igf-i	1.0
IAUG	neuroninspiratory neuron with augmenting firing pattern	1.0
VPm	ventral posterior medial nucleus	0.25
VPm	medial part of the ventral pallidum	0.25
VPm	ventroposterior medial nucleus	0.5
IVSA	i.v. self-administration	0.5
IVSA	intravenous self-administration	0.5
mPSI	myristoylated pseudosubstrate inhibitor	1.0
VPi	ventral posterior inferior nucleus	1.0
GPI	glycosylphosphatidylinositol	0.6875
GPI	glycosyl phosphatidyl-inositol	0.0625
GPI	guinea-pig ileum	0.0625
GPI	glycosyl phosphatidyl inositol	0.0625
GPI	gylcosylphosphatidylinositol	0.0625
GPI	globus pallidus–internal segment	0.0625
SHNs	septohippocampal neurons	1.0
HCS2	helix command-specific 2 gene	1.0
VPP	vaginal photoplethysmograph	0.5
VPP	vertex positive potential	0.5
CLOX	executive clock drawing task	1.0
CRF-	binding protein	0.5
CRF-	ircorticotropin-releasing factor immunoreactive	0.5
5-CT	5-carboxamidotryptamine	0.916666666667
5-CT	5-carbamidotryptamine meleate	0.0833333333333
anti-GFAP	anti-glial fibrillary acidic protein	1.0
APHAB	abbreviated profile of hearing aid benefit	1.0
VCI	verbal comprehension index	1.0
VPA	valproic acid	0.775
VPA	valproic acid/valproate	0.025
VPA	sodium valproate	0.05
VPA	valproate	0.15
VPC	ventral posterior nuclear complex	1.0
GPE	globus pallidus–external segment	0.5
GPE	glycine-proline-glutamate	0.5
VPM	ventral posterior medial nucleus of thalamus	0.0175438596491
VPM	ventroposteriomedial thalamic nucleus	0.0350877192982
VPM	ventral posteromedial	0.0175438596491
VPM	medial ventroposterior thalamic nucleus	0.0175438596491
VPM	ventral posterior medial nucleus	0.0350877192982
VPM	ventral posterior medial thalamus	0.0175438596491
VPM	pcventroposteromedial parvicellular thalamic nucleus	0.0350877192982
VPM	ventral posteromedial nucleus thalamus	0.0175438596491
VPM	ventral posteromedial thalamic nuclei	0.0175438596491
VPM	ventroposteromedial nucleus	0.0175438596491
VPM	ventral posteromedial thalamus	0.0175438596491
VPM	ventroposterior medial thalamic nucleus	0.0175438596491
VPM	pcparvicellular part of ventroposteromedial thalamic nucleus	0.0175438596491
VPM	ventral posteromedial nucleus of the thalamus	0.0526315789474
VPM	ventral posteromedial thalamic	0.0175438596491
VPM	ventroposterior medial thalamus	0.0175438596491
VPM	ventral postero-medial	0.0175438596491
VPM	nucleus ventralis posteromedialis, pars magnocellularis/parvocellularis (mc/pc)	0.0175438596491
VPM	ventral posteromedial nucleus	0.0350877192982
VPM	ventral postero-medial nucleus of the thalamus	0.0175438596491
VPM	ventral posteriomedial thalamic nucleus	0.0175438596491
VPM	ventral posterior medial	0.0526315789474
VPM	ventroposterior medial nucleus of thalamus	0.0175438596491
VPM	pcparvicellular division of the ventroposteromedial nucleus of the thalamus	0.0175438596491
VPM	ventral postero-medial thalamic nucleus	0.0175438596491
VPM	pcventroposteromedial	0.0175438596491
VPM	ventroposterior medial nucleus	0.0526315789474
VPM	ventroposteromedial	0.0175438596491
VPM	ventral posterior medial thalamic nucleus	0.0175438596491
VPM	ventroposteromedial thalamus	0.0350877192982
VPM	thalamic ventroposteromedial nucleus	0.0175438596491
VPM	pcventroposterior medial thalamic nucleus	0.0175438596491
VPM	ventral posteromedial nucleus of thalamus	0.0175438596491
VPM	ventral posteromedial thalamic nucleus	0.228070175439
VPL	ventral postero-lateral thalamic nucleus	0.0161290322581
VPL	ventroposterolateral thalamus	0.0161290322581
VPL	ventral posterior lateral nucleus of the thalamus	0.0161290322581
VPL	ventroposterolateral nucleus of the thalamus	0.0645161290323
VPL	ventral posterolateral thalamic nucleus	0.161290322581
VPL	ventral postero-lateral	0.0322580645161
VPL	ventral posterior lateral nucleus	0.0645161290323
VPL	nucleus ventralis postero-lateralis	0.0161290322581
VPL	ventroposterior lateral thalamic nucleus	0.0322580645161
VPL	ventroposterior lateral nucleus	0.0322580645161
VPL	ventroposterolateral nucleus	0.0161290322581
VPL	ventral posterolateral thalamic nuclei	0.0161290322581
VPL	thalamic nucleus ventralis posterolateralis	0.0161290322581
VPL	ventral posterior lateral nucleus of thalamus	0.0161290322581
VPL	nventral posterolateral nucleus	0.0161290322581
VPL	pcventroposterolateral parvicellular thalamic nucleus	0.0322580645161
VPL	lateral ventroposterior thalamic nucleus	0.0161290322581
VPL	ventroposterolateral thalamic nucleus	0.0645161290323
VPL	ventral posterior lateral thalamus	0.0161290322581
VPL	ventroposterolateral	0.0322580645161
VPL	ventral posterior lateral thalamic nucleus	0.0161290322581
VPL	ventral posterolateral	0.0322580645161
VPL	/vpmventral posterolateral/posteromedial thalamic nucleus	0.0161290322581
VPL	lateral subnucleus of vp containing the representation of non-cranial structures	0.0161290322581
VPL	ventral posterolateral nucleus of the thalamus	0.0322580645161
VPL	ventral posterior lateral	0.0806451612903
VPL	ventral posterolateral nucleus	0.0645161290323
VPL	nucleus ventralis posterolateralis / pars magnocellularis/parvocellularis (mc/pc)	0.0161290322581
VPL	ventral posterolateral nucleus thalamus	0.0161290322581
VPL	ventral posterolateral thalamic	0.0161290322581
PPDR	paired pulse depression ratio	1.0
VPN	ventroposterior thalamic nucleus	1.0
VPI	????	0.25
VPI	ventral posterior inferior nucleus	0.5
VPI	ventroposterior inferior thalamic nucleus	0.25
CAUC	areful exploration	1.0
THT	tail hang test	0.333333333333
THT	yrosine hydroxylase	0.333333333333
THT	helper	0.333333333333
AMVAR	adaptive multivariate autoregressive	1.0
GLT1v	glutamate transporter 1 variant	1.0
rMTF	rate modulation transfer function	1.0
REST	repressor element-1 silencing transcription factor	0.166666666667
REST	relative expression software tool	0.333333333333
REST	repressor element 1 silencing transcription factor	0.166666666667
REST	repressor element-1 binding site-silencing transcription factor	0.166666666667
REST	/nrsfrepressor element 1-silencing transcription factor/neuron-restrictive silencer factor	0.166666666667
THR	action potential threshold	1.0
Ro61-80483	4-dimethoxy-n-[4-(3-nitrophenyl)thiazol-2-yl]-benzenesulfonamide	1.0
PPADS	pyridoxal-phosphate-6-azophenyl-2′,4′-disulphonic acid	0.128205128205
PPADS	pyridoxal-phosphate-6-azophenyl-2′,4′-sulfonic acid	0.025641025641
PPADS	pyridoxal-phosphate-6-azophenyl-2′,4′disulphonic acid	0.025641025641
PPADS	pyridoxal phosphate-6-azophenyl-2-4-disulfonic acid	0.025641025641
PPADS	phosphate-6-azophenyl-2′,4′-disulfonic acid	0.025641025641
PPADS	pyridoxal-6-azophenyl-2,4-disulphonic acid	0.025641025641
PPADS	pyridoxal-5′-phosphate-6-azophenyl-2′,4′-disulfonic acid	0.025641025641
PPADS	pyridoxalphosphate-6-azophenyl-2’,4’-disulfonic acid	0.025641025641
PPADS	pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid	0.102564102564
PPADS	pyridoxal-phosphate-6-azophenyl-2,4-disulfonic acid	0.025641025641
PPADS	pyridoxalphosphate-6-azophenyl-2'4’-disulphonic acid	0.025641025641
PPADS	pyridoxal-phosphate-6-azophenyl-2′,4′-disulphonic acid 4-sodium	0.025641025641
PPADS	pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonate	0.0769230769231
PPADS	pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid	0.205128205128
PPADS	pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonic acid	0.179487179487
PPADS	pyridoxal phosphate 6-azophenyl-2′,4′-disulfonic acid 4-sodium	0.025641025641
PPADS	4-[[4-formyl-5-hydroxy-6-methyl-3-[(phosphonooxy) methyl]-2-pyridinyl]	0.025641025641
KLFS	kindled+low frequency stimulation	0.5
KLFS	kindled+low-frequency stimulation	0.5
5-HT1B	serotonin receptor 1b	1.0
5-HT1A	5-ht2a, 5-ht2cserotonin 1a, 2a, 2c receptor subtypes	0.5
5-HT1A	5-ht2a receptor, 5-ht transporter, tryptophan hydroxylase-2 genes expression	0.5
GR53	glutamate receptor-related antigen of 53,000mol.wt	1.0
S-PBN	n-tert-butyl-(2-sulfophenyl)-nitrone	1.0
GPC	glycerophosphorylcholine	0.5
GPC	glycerophosphocholine	0.5
NEFSN	ew england family study	1.0
DD-PCR	differential display pcr	1.0
5-HT-IR5-HT	immunoreactivity	1.0
lacZβ-	galactosidase	1.0
PDD-NOS	pervasive developmental disorder-not otherwise specified	0.5
PDD-NOS	pervasive developmental disorder—not otherwise specified	0.5
GABAAGABA-	type a	1.0
hCVC	shuman chorial villi-derived cells	1.0
MPPH	megalencephaly-polymicrogyria-polydactyly-hydrocephalus	1.0
SH-EL	shoulder-elbow	1.0
USHU	sher syndrome	1.0
NMDAN-methyl-d-aspartate	nnos, neuronal nitric oxide synthase	1.0
ADMX	adrenomedullectomy	1.0
LOO	leaving-one-out	1.0
TPOA	taste-potentiated odor aversion	1.0
MICW	mechanically-induced intercellular calcium waves	1.0
-NF-κB	phosphorylated nf-κb	1.0
HSP-70	heat shock protein	1.0
U73122	1-[6-((17β-3-methoxyestra-1,3,5(10)-triene 17-yl)amino)hexyl]1h-pyrrole-2,5-dione	0.5
U73122	1-[6-[[17β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]	0.5
vPMC	ventral premotor cortex	0.5
vPMC	ventral part of the pmc	0.5
NMDA-EPSP	sn-methyl-d-aspartate receptor-mediated excitatory postsynaptic potentials	1.0
GAMS	d-glutamyl-amino-methanesulfonate	0.333333333333
GAMS	d-γ-glutamylaminomethane sulfonic acid	0.333333333333
GAMS	γ-glutamyl-aminomethanesulfonic acid	0.333333333333
PNSP	eripheral nervous system	1.0
IKKβIκB	kinase β	1.0
RARE	rapid-acquisition relaxation-enhancement	0.0666666666667
RARE	rapid acquisition relaxation-enhanced	0.0666666666667
RARE	relaxation enhancement	0.133333333333
RARE	rapid acquisition with relaxation enhancement	0.2
RARE	rapid acquisition with refocused echoes	0.0666666666667
RARE	retinoic acid response element	0.266666666667
RARE	rapid acquisition relaxation enhanced	0.2
U-73122	1-[6-9[(17β)-3-methoxyestra-1,3,5(10)-trien-17-yl]aminohexyl]	1.0
NOMOV	no movement	1.0
CREBαδ-	deficient micemice with a mutation in the alpha and delta isoforms of the camp response element binding protein gene	1.0
TP-	2-644-(2-benzhydryloxy-ethyl)-1-(4-nitro-benzyl)piperidine oxalate	1.0
4α-PDD4α-phorbol-12	13-didecanoate	1.0
THA	tuberal hypothalamic area	0.0909090909091
THA	dl-threo-β-hydroxy-aspartate	0.0909090909091
THA	d-(+)-threo-3-hydroxyaspartic acid	0.0909090909091
THA	dl-threo-β-hydroxyaspartic acid.	0.0909090909091
THA	d,l-threo-β-hydroxyaspartate	0.181818181818
THA	thalamus	0.272727272727
THA	tetrahydroaminoacridine	0.181818181818
XE-	991	1.0
LIMKLIM	kinase	1.0
IKLEAK	leak potassium current	1.0
RMANOVA	repeated-measures analyses of variance	0.2
RMANOVA	repeated measures analysis of variance	0.6
RMANOVA	analysis of variance for repeated measures	0.2
TPG	total product generated	1.0
TPF	testosterone propionate-treated female	1.0
IGSS	immunogold–silver staining	1.0
TPD	trained + pd	0.5
TPD	transverse patterning discriminations	0.5
RECA-	1rat endothelial cell antigen 1	0.5
RECA-	1rat endothelial cell antigen-1	0.5
TPA	12-o-tetradecanoylphorbol-13-acetate	0.25
TPA	12-o-tetradecanoyl-phorbol-13-acetate	0.166666666667
TPA	o-tetradecanoylphorbol 13-acetate	0.0833333333333
TPA	tripropylamine	0.0833333333333
TPA	12-o-tetradecanoylphorbol 13-acetate	0.25
TPA	12-o-tetradecanoylphorbol 13-acetate (phorbol 12-myristate 13-acetate)	0.0833333333333
TPA	phorbol 12-myristate 13-acetate	0.0833333333333
NIK	nck-interacting kinase	1.0
TPO	temporo-parieto-ocipitalis	0.166666666667
TPO	temporo-parieto-occipital area	0.333333333333
TPO	area temporo-parieto-occipitalis	0.333333333333
TPO	thrombopoietin	0.166666666667
HRT	hormone replacement therapy	0.75
HRT	female gonadal hormone replacement therapy	0.0833333333333
HRT	hormone replacement therapies	0.0833333333333
HRT	hormonal replacement therapy	0.0833333333333
TPM	tropomyosin	0.333333333333
TPM	topiramate	0.666666666667
HRV	heart rate variability	1.0
RAR-	betaretinoic acid receptor beta	1.0
HRP	cholera toxin b subunit conjugated to horseradish peroxidase	0.00269541778976
HRP	horseradish peroxide	0.00539083557951
HRP	wheatgerm agglutinin conjugated to horseradish peroxidase	0.00269541778976
HRP	houseradish peroxidase	0.00269541778976
HRP	colloidal gold apo-horseradish peroxidase complex	0.00269541778976
HRP	wheat germ agglutinin coupled with hrp	0.00269541778976
HRP	horseradish peroxidase conjugated to wheat germ agglutinin	0.00269541778976
HRP	wheat germ agglutinin conjugated to horseradish peroxidase	0.00808625336927
HRP	horseradish peroxidase-conjugated wheat germ agglutinin	0.00269541778976
HRP	wheat germ agglutinin–horseradish peroxidase	0.0215633423181
HRP	wheatgerm agglutinin-conjugated horseradish peroxidase	0.00269541778976
HRP	wheatgerm agglutinin–horseradish peroxidase	0.00539083557951
HRP	horse-radish peroxidase	0.00539083557951
HRP	α-rabbit igg–horseradish peroxidase	0.00269541778976
HRP	wheatgerm agglutinin (lectin)-conjugated horseradish peroxidase	0.00269541778976
HRP	horse radish peroxidase	0.0242587601078
HRP	horseradish peroxidise	0.00808625336927
HRP	wheatgerm agglutinin conjugated horseradish peroxidase	0.00269541778976
HRP	horseradish peroxidaseothalamic area	0.00269541778976
HRP	β-cholera toxin coupled to horseradish peroxidase	0.00269541778976
HRP	horseradish peroxidase–wheatgerm agglutinin conjugate	0.00539083557951
HRP	horseradish peroxidase	0.859838274933
HRP	horseradish-peroxidase	0.00539083557951
HRP	horseradish peroxides	0.00269541778976
HRP	horse radish peroxidise	0.00808625336927
HRP	choleragenoid–horseradish peroxidase	0.00269541778976
HRP	horse raddish peroxidise	0.00269541778976
TPI	triosephosphate isomerase	0.75
TPI	triose phosphate isomerase	0.25
TPH	tryptophan-5-hydroxylase	0.0178571428571
TPH	1tryptophan hydroxylase 1	0.0178571428571
TPH	tryptophan hydroxylase	0.589285714286
TPH	2tryptophan-hydroxylase 2	0.0178571428571
TPH	2human tryptophan hydroxylase 2 gene	0.0178571428571
TPH	2tryptophane hydroxylase type 2	0.0178571428571
TPH	2tryptophan hydroxylase2	0.0178571428571
TPH	2	0.0178571428571
TPH	2tryptophan hydroxylase-2	0.125
TPH	2tryptophan hydroxylase 2	0.142857142857
TPH	2tryptophan hydroxylase isoform 2	0.0178571428571
HRM	heterozygous reeler mice	1.0
TPV	time to peak velocity	1.0
AICA	5′-aminoimidazole-4-carboxamide	0.142857142857
AICA	kaike information criterion	0.142857142857
AICA	anterior inferior cerebellar artery	0.571428571429
AICA	kaike's information criterion	0.142857142857
IGSB	intraganglionic spiral bundle	1.0
TPS	theta-pulse stimulation	0.142857142857
TPS	thoracic propriospinal	0.142857142857
TPS	short thoracic propriospinal	0.142857142857
TPS	theta pulse stimulation	0.571428571429
TPR	tetratricopeptide repeat	0.4
TPR	total peripheral resistance	0.2
TPR	tetratricopepteide repeat	0.2
TPR	threo-β-benzyloxyaspartic acid potentiation ratio	0.2
PHGDH	3-phosphoglycerate dehydrogenase	0.5
PHGDH	phosphoglycerate dehydrogenase	0.5
TPP	thiamine pyrophosphate	1.0
HRE	hypoxia-response element	0.166666666667
HRE	hypoxia response element	0.166666666667
HRE	hypoxia-responsive element	0.5
HRE	hypoxic response element	0.166666666667
DTX-K	dendrotoxin-k	1.0
HRG	human heregulin-beta 1	1.0
HRF	hemodynamic response function	1.0
BCCA	both common carotid artery	1.0
STMPM	medial posteromedial division of the bed nucleus of the stria terminalis	1.0
L-IRR	learned irrelevance	1.0
RXRγ	retinoid x receptor gamma	1.0
PMSE	polyhydramnios-megalencephaly-symptomatic-epilepsy syndrome	1.0
IL-18	interleukin-18 (human recombinant)	1.0
P117L	mutation at codon 117 of presenilin-1 resulting in substitution of proline by leucine	1.0
MEAPM	et-enkephalin-arg6phe7	1.0
BCCL	bilateral common carotid ligation	1.0
dsRNA	double-strand rna	0.0909090909091
dsRNA	double stranded rna	0.0909090909091
dsRNA	double-stranded rna	0.727272727273
dsRNA	double-stranded ribonucleic acid	0.0909090909091
pHD	pressymptiomatic gene mutations carries huntington's disease	1.0
PeVN	periventricular nucleus	1.0
MT-II	melanotan-ii	1.0
TAAR	strace amine-associated receptors	1.0
GPe	globus pallidus external part	0.0714285714286
GPe	external subdivision of the gp	0.0714285714286
GPe	globus pallidus exterior	0.0714285714286
GPe	globus pallidus pars externalis	0.0714285714286
GPe	external part of the globus pallidus	0.0714285714286
GPe	globus pallidus, external segment	0.142857142857
GPe	globus pallidus externus	0.0714285714286
GPe	external part of the gp	0.0714285714286
GPe	external segment of the globus pallidus	0.357142857143
PKCα-YFPPKCα	tagged with yellow fluorescent protein	1.0
FERM	band four-point-one ezrin–radixin–moesin	1.0
NSNA	non-stationary noise analysis	1.0
6-CKU	6-chloro-4-hydroxyquinoline-2-carboxylic acid	1.0
CompB	1-[(3r,4r)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2h-benzimidazol-2-one	1.0
MTDC	bifunctional methylenetetrahydrofolate dehydogenase/cyclohydrolase	1.0
dPMC	dorsal part of the premotor cortex	0.5
dPMC	dorsal premotor cortex	0.5
nCL	non-cuneolemniscal neuron	0.666666666667
nCL	noncuneolemniscal neuron	0.333333333333
GRPRG	astrin-releasing peptide receptor	1.0
nCO	nuclear cytochrome oxidase subunit	1.0
MCSF-	1macrophage colony-stimulating factor-1	1.0
RFX-GCM	random effects granger causality mapping	1.0
MTDL	multi-target-directed ligand	1.0
EF1α	elongation factor 1α	1.0
P-CREB	phosphorylated cyclic amp response element-binding protein	0.25
P-CREB	phosphorylated creb	0.5
P-CREB	phosphorylated camp-response element binding protein	0.25
EGTA1	2,di-2-aminoethoxyethane-nnn′n′-tetraacetic acid	1.0
EJAC	males that mated to ejaculation within the 30-min test	1.0
ac-IPSC	amacrine cell-specific inhibitory postsynaptic current	1.0
SNSR	sensory neuron-specific receptor	0.5
SNSR	sensory neuron specific receptor	0.5
DCYTB	duodenal cytochrome b	1.0
RFS	referred sensation	0.166666666667
RFS	restricted feeding schedules	0.833333333333
RFR	ectus femoris	0.5
RFR	etrorubral field	0.5
RFP	red fluorescence protein	0.166666666667
RFP	red fluorescent protein	0.666666666667
RFP	monomeric red fluorescent protein	0.166666666667
END	2endomorphin-2	1.0
Y-BOCSY	ale–brown obsessive compulsive scale	1.0
RFU	relative fluorescence units	0.5
RFU	relative fluorescence unit	0.5
ENG	electroneurogram	0.5
ENG	electroneurographic	0.5
TIART	cell internal antigen-1 related protein	1.0
PIPES	piperazine n,n′-bis-[2-ethanesulphonic acid]	0.0263157894737
PIPES	piperazine-n-n′-bis[2-ethanesulfonic acid]	0.0789473684211
PIPES	piperazine-n-n′-bis-[z-ethanesulfonic acid]	0.0263157894737
PIPES	piperazine-n,n′-bis[2-ethanesulfonic acid]	0.0263157894737
PIPES	piperazine-n,n′-bis(ethanesulphonic acid)	0.0263157894737
PIPES	piperazine diethanesulfonic acid	0.0263157894737
PIPES	piperazine-n,n′-bis(ethanesulfonic acid)	0.0263157894737
PIPES	piperazine-n,n′-bis[2-ethanesulphonic acid]	0.0263157894737
PIPES	piperazine-n-n′ bis[2-ethanesulfonic acid]	0.0263157894737
PIPES	piperizine-n,n′-bis(2-ethanesulfonic acid)	0.0263157894737
PIPES	1,4-piperazinediethane-sulfonic acid	0.0263157894737
PIPES	piperazine-n,n′-(2-ethanesulfonic acid)	0.0263157894737
PIPES	piperazine-n-n′-bis[2-ethanesulphonic acid]	0.0789473684211
PIPES	piperazine-n,n1-bis[2-ethanesulfanic acid] disodium salt	0.0263157894737
PIPES	definition?	0.0263157894737
PIPES	piperzine-n,n′ bis(2-ethane-sulphonic acid),1,4-piperazine-diethane sulphonic acid	0.0263157894737
PIPES	piperazine-n,n′-bis(2-ethanesulphonic acid)	0.0789473684211
PIPES	piperazine-1,4-bis(2-ethanesulfonic acid)	0.0263157894737
PIPES	peperazine-n,n′-bis-(2-ethanesulfonic acid)	0.0263157894737
PIPES	piperazine-n,n'-bis[2-ethanesulphonic acid] disodium salt	0.0263157894737
PIPES	piperazine-n,n′-bis(2-ethanesulfonic acid)	0.105263157895
PIPES	piperazine-n-n′-bis-[2-ethanesulfonic acid]	0.0263157894737
PIPES	piperazine-n-n′-bis(ethanesulphonic acid)	0.0263157894737
PIPES	piperazine-n-n′-bis(2-ethanesulphonic acid)	0.0526315789474
PIPES	piperazine-n-n′-bis[2-ethane-sulphonic acid]	0.0263157894737
PIPES	piperazine-n,n′-bis(2-ethanesulfanic acid) disodium salt	0.0263157894737
PIPES	piperazine-n n′-bis [2-ethanesulfonic acid]	0.0263157894737
PIPES	piperazine-n,n′-bis-2-ethanesulfonic acid	0.0263157894737
ENK	enkephalinergic	0.0238095238095
ENK	proenkephalin	0.0238095238095
ENK	enkephalin	0.904761904762
ENK	enkephalins	0.047619047619
ENO	enolase	1.0
RFC	3replication factor c3	0.5
RFC	right forelimb contact	0.5
LUTS	lower urinary tract symptoms	1.0
RFA	rostral forelimb area	1.0
ENS	enteric nervous system	0.941176470588
ENS	enteric nervous systems	0.0588235294118
ENT	cxentorhinal cortex	0.125
ENT	entorhinal cortex	0.75
ENT	4	0.125
α-DGα-	dystroglycan	1.0
ENV	envelope protein	1.0
CT-β	cholera toxin β subunit	0.5
CT-β	cholera toxin-β	0.5
F12	dulbecco’s modified eagle’s medium/nutrient mixture-f12	0.142857142857
F12	dulbecco’s modified eagle’s medium/ham’s f12	0.142857142857
F12	dulbecco's modified eagle's medium plus ham's f-12 medium	0.142857142857
F12	dulbecco's modified eagle's medium and ham's f-12 nutrients mixture	0.142857142857
F12	dulbecco’s modified eagle’s medium and ham’s f12 nutrient mixture (1:1)	0.142857142857
F12	dulbecco’s modified eagle’s medium	0.142857142857
F12	supplemented with insulin, apotransferrin, putrescine, progesterone, sodium selenite	0.142857142857
RFI	relative fluorescence intensity	1.0
8-OH-DPAT	8-hydroxy-2-(di-n-propylamino)tetralin	0.323529411765
8-OH-DPAT	8-hydroxy-2-(di-n-propylamino)-tetralin	0.0441176470588
8-OH-DPAT	(±)-8-hydroxy-2-(di-n-propylamino)-tetralin hydrobromide	0.0147058823529
8-OH-DPAT	8-hydroxy-n,n-dipropyl-2-aminotetralin	0.0147058823529
8-OH-DPAT	8-hydroxy-2-(di-n-propylamino)-tetraline	0.0147058823529
8-OH-DPAT	8-hydroxy-2-(di-n-propylamine)tetralin	0.0294117647059
8-OH-DPAT	8-hydroxy-dipropyl-aminotetralin	0.0147058823529
8-OH-DPAT	8-hydroxy-2-(n-dipropylamino)tetralin hydrobromide	0.0147058823529
8-OH-DPAT	8-hydroxy-2(di-n-propylamino)tetralin	0.0147058823529
8-OH-DPAT	8-hydroxy-2-dipropylaminotetralin	0.0147058823529
8-OH-DPAT	(±)-8-hydroxy-2-(dipropylamino) tetralin hydrobromide	0.0147058823529
8-OH-DPAT	8-hydroxy-2(di-n-propyl)amino-tertraline	0.0147058823529
8-OH-DPAT	(±)-8-hydroxy-2-dipropylaminotetralin hydrobromide	0.0147058823529
8-OH-DPAT	(±)-8-hydroxy-dipropylaminotetralin hydrobromide	0.0294117647059
8-OH-DPAT	8-hydroxy-2-(di-n-propylamino) tetraline	0.0147058823529
8-OH-DPAT	8-hydroxy-2-(di-n-propylamino) tetralin	0.0294117647059
8-OH-DPAT	(±)-2-dipropylamino-8-hydroxyl-1,2,3,4-tetranaphthalene	0.0147058823529
8-OH-DPAT	8-hydroxy-2-dipropylaminotetralin hydrobromide	0.0147058823529
8-OH-DPAT	8-hydroxy-2-di-n-(propylamino)-tetralin	0.0147058823529
8-OH-DPAT	8-hydroxy-2(di-n-propylamino) tetralin	0.0147058823529
8-OH-DPAT	8-hydroxy-(dipropylamino)-tetraline	0.0147058823529
8-OH-DPAT	8-hydroxydipropylamino-tetralin	0.0147058823529
8-OH-DPAT	(7)-8-hydroxy-2-(di-n-propylamino)tetralin	0.0147058823529
8-OH-DPAT	(±)-2-dipropylamino-8-hydroxy-1,2,3,4-tetrahydronaphthaline hydrobromide	0.0441176470588
8-OH-DPAT	8-hydroxy-2-(dipropylamino)tetraline hydrobromide	0.0147058823529
8-OH-DPAT	8-hydroxy-(2-di-n-propylamino)tetralin	0.0294117647059
8-OH-DPAT	(r)-(+)-8-hydroxy-2-(dipropylamino)tetralin hydrobromide	0.0294117647059
8-OH-DPAT	8-hydroxy-2-(di-n-propylaminotetralin)	0.0147058823529
8-OH-DPAT	(±)-8-hydroxy-2-(di-n-propyl-amino)tetralin hydrobromide	0.0147058823529
8-OH-DPAT	(±)-8-hydroxy-2-(di-n-propyl-amino)tetralin	0.0147058823529
8-OH-DPAT	8-hydroxy-2-(di-n-propyl-amino)tetralin	0.0147058823529
8-OH-DPAT	8-hydroxy-dipropylaminotetraline	0.0147058823529
8-OH-DPAT	8-hydroxy-n,n-dipropyl-5-carboxamidotryptamine maleate	0.0147058823529
8-OH-DPAT	(±)-8-hydroxy-2-(dipropylamino)tetralin hydrobromide	0.0147058823529
8-OH-DPAT	(±)-8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide	0.0294117647059
8-OH-DPAT	(±)-8-hydroxy-2-(di-n-propylamino)tetralin	0.0147058823529
8-OH-DPAT	(+) 8-hydroxy-2-(di-n-propylamino)tetralin	0.0147058823529
RFN	rostral fastigial nucleus	1.0
UPPSUrgency	premeditation, perseverance and sensation seeking	1.0
RFL	radiofrequency lesion	0.5
RFL	ratio of bcecf fluorescence at 500/440nm	0.5
WTSyn	wild-type α-synuclein	1.0
RFr	rostral reticular formation	1.0
GABAAGABA	a type	0.0555555555556
GABAAGABA	receptor subtype a	0.0555555555556
GABAAGABA	receptor a subtype	0.0555555555556
GABAAGABA	(receptor) type a	0.0555555555556
GABAAGABA	receptor type a	0.111111111111
GABAAGABA	type a receptor	0.222222222222
GABAAGABA	receptor a	0.166666666667
GABAAGABA	type a	0.277777777778
UVILED	ultraviolet light emitting diode device	1.0
qRT-PCR	quantitative real-time reverse-transcription pcr	0.0151515151515
qRT-PCR	quantitative reverse transcription–polymerase chain reaction	0.0151515151515
qRT-PCR	real-time quantitative reverse transcription–polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative rt-pcr	0.0454545454545
qRT-PCR	semi-quantitative real time-polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative real-time reverse transcription pcr	0.0151515151515
qRT-PCR	quantitative reverse transcriptase pcr	0.0151515151515
qRT-PCR	quantitative reverse-transcription polymerase chain reaction	0.0454545454545
qRT-PCR	quantitative reverse transcription–pcr	0.0151515151515
qRT-PCR	quantitative reverse transcriptase-polymerase chain reaction	0.0454545454545
qRT-PCR	quantitative reverse transcription	0.0151515151515
qRT-PCR	quantitative reverse-transcriptase polymerase chain reaction	0.0151515151515
qRT-PCR	real-time quantitative reverse transcription polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative reverse transcription-polymerase chain reaction	0.0757575757576
qRT-PCR	quantitative real-time reverse transcription polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative real time polymerase chain reaction	0.0757575757576
qRT-PCR	quantitative real time-pcr	0.0151515151515
qRT-PCR	quantitative reverse transcriptase polymerase chain reaction	0.0454545454545
qRT-PCR	quantitative real time reverse transcriptase polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative reverse transcription pcr	0.0151515151515
qRT-PCR	quantitative real time pcr	0.0151515151515
qRT-PCR	real-time reverse-transcription polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative real-time pcr	0.0909090909091
qRT-PCR	quantitative real-time rt-pcr	0.0454545454545
qRT-PCR	real time quantitative pcr analysis	0.0151515151515
qRT-PCR	real-time quantitative reverse transcriptase-polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative reverse transcription–coupled pcr	0.0151515151515
qRT-PCR	quantitative real-time polymerase chain reaction	0.166666666667
qRT-PCR	quantitative real-time pcr polymerase chain reaction	0.0151515151515
qRT-PCR	quantitative reverse transcription polymerase chain reaction	0.0454545454545
NK3R	neurokinin-3 receptor	1.0
RSTR	esting	1.0
ATXω-	agatoxin iva	1.0
HMEG	hemimegalencephaly	1.0
TTX-R	ttx-resistant	0.0909090909091
TTX-R	tetrodotoxin resistant	0.272727272727
TTX-R	tetrodotoxin-resistant	0.636363636364
GABA-TGABA	transferase	0.25
GABA-TGABA	transaminase	0.75
RSTG	right superior temporal gyrus	1.0
CLiP	corticotropin-like intermediate lobe peptide	1.0
RINPUT	input resistance	1.0
T-H	4/h3total histone h4/h3	1.0
RFi	intermediate reticular formation	1.0
anti-DβH-SAP	anti-dopamine beta-hydroxylase-saporin	1.0
mCO	mitochondrial cytochrome oxidase subunit	1.0
OcNC	olfactory cyclic nucleotide-gated channel	1.0
rHP	rostral hippocampus	1.0
BDP-20	1-(1,3-benzodioxol-5-ylcarbonyl)piperidine-20	1.0
TNR	tenascin-r	1.0
CSSTC	onceptual set shifting task	1.0
γHNIC	low/high class of spontaneous nicotinic channel conductances	1.0
BMPRIABMPRIB	bone morphogenetic protein receptor i	1.0
rHN	rat hippocampal neurons	1.0
LFA-	1lymphocyte function-associated antigen-1	1.0
Cat-D	cathepsin-d	1.0
K2ATP	adenosine 5′-triphosphate dipotassium salt	1.0
SET	space exploring test	1.0
SES	socioeconomic status	0.571428571429
SES	outh-east	0.142857142857
SES	socio economic status	0.142857142857
SES	self-esteem scale	0.142857142857
SER	sarco/endoplasmic reticulum	0.0909090909091
SER	smooth endoplasmic reticulum	0.454545454545
SER	separation stress+extended reunion	0.0909090909091
SER	serotonin	0.0909090909091
SER	sspontaneously epileptic rats	0.0909090909091
SER	standard error comparing current predictions to future (hypothetical) empirically derived predictions	0.0909090909091
SER	serine	0.0909090909091
SEP	ssomatosensory-evoked-potentials	0.047619047619
SEP	superecliptic phluorin	0.047619047619
SEP	ssomatosensory evoked potentials	0.047619047619
SEP	sensory evoked potential	0.047619047619
SEP	somatosensory evoked potential	0.333333333333
SEP	ssomatosensory-evoked potentials	0.0952380952381
SEP	surface evoked potential	0.047619047619
SEP	somatosensory-evoked brain potentials	0.047619047619
SEP	somatosensory-evoked potential	0.190476190476
SEP	somatosensory evoked potentials	0.0952380952381
PODG	polymorph cells in the hilar area of the dentate gyrus	1.0
CXBK	mice	1.0
FDF	ukomys damarensis	1.0
β-CTFβ-C-	terminal fragment	1.0
SEZ	subependymal zone	1.0
EAAC-	1excitatory amino acid carrier-1	1.0
3H-T	hy[3h]thymidine	1.0
SOXSRY	box-(1 or 2)	1.0
SEF	standard error of model-free (empirically derived) estimates	0.0714285714286
SEF	somatosensory evoked magnetic field	0.142857142857
SEF	supplementary eye field	0.357142857143
SEF	supplementary eye fields	0.0714285714286
SEF	ssomatosensory evoked fields	0.0714285714286
SEF	somatosensory-evoked field	0.0714285714286
SEF	somatosensory-evoked magnetic fields	0.0714285714286
SEF	somatosensory evoked field	0.142857142857
EAAC1	excitatory amino acid carrier 1	0.666666666667
EAAC1	excitatory amino acid carrier	0.333333333333
SED	sedentary group – non-exercised rats with induction of pd	0.2
SED	sedentary group	0.2
SED	sedentary	0.4
SED	sedentary control	0.2
BnST	bed nucleus of the stria terminalis	1.0
VLDRPP	irradiationvery low dose rate prenatal protracted irradiation	1.0
SEA	staphylococcal enterotoxin a	1.0
SEM	standard error of measurement	0.00816326530612
SEM	structural equation modeling	0.0163265306122
SEM	semantic congruency	0.00408163265306
SEM	means±standard errors	0.00408163265306
SEM	standard error of estimate	0.00408163265306
SEM	the standard error of the mean	0.00816326530612
SEM	standard errors of the mean	0.0285714285714
SEM	standard error	0.0163265306122
SEM	standard error of mean	0.0857142857143
SEM	standard error of the means	0.00816326530612
SEM	standard error of the mean	0.714285714286
SEM	scanning electron microscopy	0.0612244897959
SEM	standard error of means	0.00408163265306
SEM	standard error mean	0.0163265306122
SEM	standard errors of mean	0.00816326530612
SEM	scanning em	0.00408163265306
SEM	standard error with which the mean y value is estimated by the current model	0.00408163265306
SEM	scanning electronic microscopy	0.00408163265306
SEL	subependymal layer	1.0
SEK	1	1.0
SEI	sleep efficiency index	1.0
IMA	sintramuscular arrays	0.2
IMA	intramuscular array	0.6
IMA	i.m. array	0.2
CLN	clonidine	0.25
CLN	colivelin	0.25
CLN	central lateral nucleus	0.25
CLN	caudal linear nucleus	0.25
CLO	clonidine hydrochloride	0.5
CLO	clonidine	0.166666666667
CLO	clozapine 15 mg/kg	0.166666666667
CLO	clomipramine	0.166666666667
CLH	contralateral hemisphere	1.0
PDZ	postsynaptic density 95/disc large/zonula occludens-1	0.0588235294118
PDZ	domain	0.0588235294118
PDZ	binding motif	0.0588235294118
PDZ	postsynaptic density-95/discs large/zona occludens-1	0.0588235294118
PDZ	postsynaptic density-95/discs large/zona occludins-1	0.0588235294118
PDZ	postsynaptic density protein-95/discs large/zona occludens-1	0.0588235294118
PDZ	postsynaptic density-95/discs large/zone occludens-1	0.0588235294118
PDZ	repeated sequences in post-synaptic density-95 (psd-95)	0.0588235294118
PDZ	post-synaptic density-95/dlg/zo-1	0.0588235294118
PDZ	postsynaptic density protein 95/dlg/zo-1	0.0588235294118
PDZ	domainpsd95/dgla/zo-1-like domains	0.0588235294118
PDZ	post-synaptic density-95/discs large/zonula occludens-1	0.0588235294118
PDZ	domainpostsynaptic protein psd95/drosophila junction protein disc-large/zonula occludens-1	0.0588235294118
PDZ	3the third pdz domain of zo-1	0.0588235294118
PDZ	psd-95/dlg-a/zo-1	0.0588235294118
PDZ	psd-95–disc large–zo-1	0.0588235294118
PDZ	post synaptic density-drosophila disc large tumor suppressor-zonula occludens-1	0.0588235294118
IMG	inferior mesenteric ganglion	0.4
IMG	intussusceptive microvascular growth	0.2
IMG	inferior mesenteric sympathetic ganglia	0.2
IMG	intramedullary gray	0.2
IMF	instantaneous mean frequency	1.0
IMI	intermeal interval	0.25
IMI	imipramine	0.75
WINWIN55	212-2 mesylate ((r)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]	0.2
WINWIN55	212-2	0.8
PDT	pain detection threshold	0.25
PDT	tremor predominant parkinson's disease	0.25
PDT	gposterodorsal tegmental nucleus	0.5
IMM	mesopallium intermediomediale	0.0909090909091
IMM	intermediate medial mesopallium	0.545454545455
IMM	intermediomedial gray matter	0.272727272727
IMM	inner mitochondrial membrane protein	0.0909090909091
IML	inner third of the dentate molecular layer	0.0121951219512
IML	inter-mediolateral cell column	0.0121951219512
IML	nucleus intermediolateralis pars principalis	0.0121951219512
IML	intermediolateral cell column of the thoraco-lumbar spinal cord	0.0121951219512
IML	intermediolateral cell column pars principalis	0.0121951219512
IML	bupper part of the inner molecular layer	0.0121951219512
IML	intermediolateral nucleus of the spinal cord	0.0121951219512
IML	intermediolateral cell column of the spinal cord	0.0365853658537
IML	inner molecular layer (of the dentate gyrus)	0.0121951219512
IML	inner molecular layer	0.182926829268
IML	intermediolateral cell coumn	0.0121951219512
IML	intermediolateral cell column	0.439024390244
IML	internal medullary lamina	0.0121951219512
IML	intermediate lateral	0.0121951219512
IML	inner molecular layer of the dentate gyrus	0.0243902439024
IML	intermediolateral column	0.0121951219512
IML	intermediolateral column of the spinal cord	0.0121951219512
IML	intermediolateral	0.0121951219512
IML	nucleus intermediolateralis, pars principalis	0.0609756097561
IML	intermediolateral nucleus	0.0853658536585
IMO	7seven times immobilization	0.1
IMO	mustard oil current	0.1
IMO	immobilisation	0.1
IMO	immobilization stress	0.2
IMO	immobility	0.1
IMO	immobilization	0.4
PDP	arkinsons disease	0.00286532951289
PDP	arkinson’s disease	0.45558739255
PDP	arkinson disease	0.0229226361032
PDP	presynaptic dense projection	0.00286532951289
PDP	proline-directed phosphorylation	0.00286532951289
PDP	arkinson's disease	0.498567335244
PDP	ostnatal days	0.00286532951289
PDP	proline directed sites phosphorylated	0.00286532951289
PDP	arkinson diseases	0.00286532951289
PDP	osterior deltoid	0.00286532951289
PDP	arkison's disease	0.00286532951289
IMP	inosine monophosphate	0.142857142857
IMP	intramembrane particle or intramembrane protein	0.047619047619
IMP	intramembrane particle/intramembrane protein	0.047619047619
IMP	intramembrane particle	0.285714285714
IMP	ase 1inositol monophosphatase 1	0.047619047619
IMP	aseinositol monophosphatase	0.047619047619
IMP	sintramembrane particles	0.0952380952381
IMP	intramembrane particles	0.0952380952381
IMP	inosine 5′-monophosphate	0.0952380952381
IMP	inosinate monophosphate	0.047619047619
IMP	impedance	0.047619047619
IMS	immortalized mouse schwann cells	0.25
IMS	imaging mass spectrometry	0.75
PDL	perfusion-deficient lesion	0.111111111111
PDL	periodontal ligament	0.111111111111
PDL	poly-d-lysine	0.666666666667
PDL	percentages of double-labeled neurons	0.111111111111
PDK	1phosphoinositide-dependent kinase-1	0.75
PDK	13-phosphoinositide-dependent protein kinase 1	0.25
PDI	protein disulfide isomerase	1.0
PDH	pyruvate dehydrogenase	0.5
PDH	pyruvate dehydrogenase (e.c. 1.2.4.1)	0.1
PDH	pulse density histogram	0.2
PDH	pyruvate dehydrogenase complex	0.1
PDH	pigment dispersing hormone	0.1
DTG1	3-di(2-tolyl)guanidine	0.333333333333
DTG1	3-di-o-tolylguanidine	0.333333333333
DTG1	3-di-(2-tolyl)guanidine)	0.333333333333
WHIW	omen’s health initiative	0.4
WHIW	omen's health initiative	0.6
PDE	3phosphodiesterase 3	0.0217391304348
PDE	camp phosphodiesterase	0.0217391304348
PDE	6cgmp phosphodiesterase-6	0.0217391304348
PDE	4btype iv phosphodiesterase	0.0217391304348
PDE	phosphodiesterase	0.5
PDE	4phosphodiesterase 4	0.0217391304348
PDE	2aphosphodiesterase 2a	0.0217391304348
PDE	4phosphodiesterase-4	0.0434782608696
PDE	phosphdiesterase	0.0217391304348
PDE	phosphodiesterases	0.0434782608696
PDE	3itype iii phosphodiesterase inhibitor	0.0217391304348
PDE	4bphosphodiasterase 4b	0.0217391304348
PDE	phosphodiesterase enzyme	0.0217391304348
PDE	5phosphodiesterase type 5	0.0217391304348
PDE	10a-irpde10a-like immunoreactivity	0.0217391304348
PDE	4phosphodiesterase type iv	0.0217391304348
PDE	5phosphodiesterase 5	0.0217391304348
PDE	5a phosphodiesterase type 5	0.0217391304348
PDE	iiitype iii phosphodiesterase	0.0217391304348
PDE	2a	0.0217391304348
PDE	10aphosphodiesterase 10a	0.0217391304348
PDE	cyclic nucleotide phosphodiesterase	0.0217391304348
MHC-II	major histocompatibility complex ii	0.5
MHC-II	major histocompatibility complex class ii	0.25
MHC-II	major histocompatibility complex class ii antigens	0.25
PDC	l-trans-pyrrolidine-2,4-dicarboxylate	0.4
PDC	l-trans-pyrrolidine-2,4-dicarboxylic acid	0.6
PDB	uphorbol dibutyrate	0.4
PDB	predorsal bundle	0.4
PDB	u,	0.2
CLR	calcitonin receptor-like receptor	1.0
EDTAethylenediamine-N	n,n′,n′-tetraacetic acid	0.888888888889
EDTAethylenediamine-N	n,n',n'-tetraacetic acid	0.111111111111
IMAX	maximal current	1.0
EXPE	xploration	1.0
CLi	central linear nucleus	1.0
BMDC	bone marrow–derived cells	0.333333333333
BMDC	bone marrow–derived cell	0.333333333333
BMDC	sbone marrow-derived cells	0.333333333333
FCTX	frontal cortex	1.0
U-IR	unidirectional neurons, responsive with rotations directed towards the side ipsilateral to recording, in the right vestibular nucleus	1.0
AWR	abdominal withdrawal reflex	1.0
REM-R	rapid eye movement sleep rebound	1.0
p-CAMKII	phosphorylated calcium/calmodulin protein kinase ii	1.0
L-DOPA	3,4-dihydroxyphenylalanine	0.1
L-DOPA	l-3,4-dihydroxyphenylalanine	0.6
L-DOPA	3,4-dihydroxyphenyl-l-alanine	0.1
L-DOPA	l-dihydroxyphenylalanine	0.2
NAcCONE	cone of the nucleus accumbens shell	1.0
HEBSSHEPES-	buffered earle's balanced salt solution	1.0
INFS	integrative nuclear fibroblast growth factor receptor signaling	1.0
TUNELTαT-	mediated x-dutp nick end labeling	1.0
BPA	bisphenol a	0.5
BPA	bisphenol-a	0.5
BPB	4-bromophenacyl bromide	1.0
BPE	bovine pituitary extract	1.0
BPD	borderline personality disorder	0.285714285714
BPD	bipolar disorder	0.714285714286
Vidm	dorsomedial nucleus of vi	1.0
BPH	benign prostatic hyperplasia	0.5
BPH	/2jschlager hypertensive mice	0.5
BPM	beats per minute	0.666666666667
BPM	beats/min	0.333333333333
WRITW	ide range intelligence test	1.0
BPN	basilar pontine nuclei	0.5
BPN	/3jschlager normotensive mice	0.5
BPP	binding potential the ratio at equilibrium of specifically bound tracer to that of total parent tracer in plasma	1.0
BPS	bathophenanthroline disulfonate	1.0
GMH	l-glutamyl γ-hydroxamate	1.0
BPV	blood pressure variability	1.0
NR2	nmda receptor subunits 1/2	0.5
NR2	nmda receptor subunit 2	0.5
NR1	nmda receptor 1 subunit	0.333333333333
NR1	subunit 1 of the nmda receptor	0.166666666667
NR1	nmda receptor subunit 1	0.5
RN1	rectal nerves group 1	1.0
poly-A	poly-adenylated	1.0
ADS	anterior dorsal striatum	1.0
DAF-2T-fluorescence4	5-diaminofluorescein-triazolium-fluorescence	1.0
SLMV	synaptic-like microvesicle	1.0
CaCRE	calcium- and camp-responsive element	1.0
SAP-	102synapse-associated protein 102	1.0
Mapping	version 8	1.0
ML-	103024-amino-5-chloro-2-methoxybenzoic acid 2-(1-piperidinyl)ethyl ester hydrochloride	1.0
PIVC	parieto-insular vestibular cortex	1.0
IHVA	high voltage–activated calcium currents	1.0
COC-HC	lcocaine	1.0
MCSM	ulti channel systems	1.0
oSVZ	outer subventricular zone	1.0
TCBB	subunit of cholera toxin	1.0
SB202190	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1h-imidazole	1.0
GEOG	ene expression omnibus	1.0
akA	phakia	1.0
MLB	medium lead burst	1.0
MLC	megalencephalic leukoencephalopathy with subcortical cysts	0.333333333333
MLC	morphine-like compound	0.333333333333
MLC	myosin light chain	0.333333333333
MLA	peripeduncular area/midbrain locomotor area	0.0243902439024
MLA	methyllycaconitine citrate	0.121951219512
MLA	methyl-lycaconitine	0.0487804878049
MLA	methyllycaconitine	0.780487804878
MLA	methyllicaconitine	0.0243902439024
GOI	gene of interest	1.0
FSAG	facial-stato-acoustic ganglia	1.0
MLK	3mixed lineage kinase 3	0.230769230769
MLK	2mixed lineage kinase 2	0.0769230769231
MLK	3mixed-lineage kinase 3	0.153846153846
MLK	mixed lineage kinase	0.153846153846
MLK	3mixed-lineage kinase-3	0.0769230769231
MLK	mixed-lineage kinase	0.307692307692
GOG	ene ontology	0.909090909091
GOG	olgi cell	0.0909090909091
MLI	interneuron in the molecular layer	0.4
MLI	molecular layer interneurons	0.2
MLI	mean lordosis intensity	0.2
MLI	molecular layer interneuron	0.2
MLN	64metastatic lymph node 64	0.5
MLN	median lip nerve	0.5
TV	tegmentum vasculosum	0.25
TV	thoracic vagus	0.25
TV	telencephalic ventricle	0.25
TV	tidal volume	0.25
MLL	mixed lineage leukemia	0.5
MLL	mixed-lineage leukemia	0.5
MLM	edial-lateral	0.333333333333
MLM	aximum likelihood	0.333333333333
MLM	edio–lateral	0.333333333333
MLR	midbrain locomotor region	0.0625
MLR	middle latency response	0.0625
MLR	multiple linear regression	0.0625
MLR	mixed lymphocyte reaction	0.0625
MLR	2second part of the medium-latency response	0.0625
MLR	middle latency responses	0.0625
MLR	mesencephalic locomotor region	0.625
MLS	maximum lateral shift	1.0
MLP	membrane lipid peroxidation	0.25
MLP	muscle lim protein	0.25
MLP	void mannosylated liposome	0.25
MLP	marcks-like protein	0.25
MLV	murine leukemia virus	1.0
GME	gluteus medius	0.5
GME	geissoschizine methyl ether	0.5
MLT	melatonin	1.0
MLU	mean light units	1.0
GOT	glutamate-oxaloacetate transaminase	0.666666666667
GOT	glutamate–oxaloacetate transaminase	0.333333333333
GOS	galactooligosacchrides	1.0
NRK	normal rat kidney fibroblasts	1.0
NRI	noradrenaline-reuptake inhibitor	1.0
NRH	nmda receptor hypofunction	1.0
NRO	nucleus raphe obscurus	0.8
NRO	nucleus raphe obscuris	0.2
E-PTA	ethanolic-phosphotungstic acid	1.0
NRM	magnus raphe nucleus	0.047619047619
NRM	nucleus raphe magnus	0.952380952381
RNSR	eactive nitrogen species	1.0
NRC	negative regulatory complex	1.0
RSP	regular step pattern	0.5
RSP	regulated secretory pathways	0.5
NRA	nerve root area	0.125
NRA	nucleus retroambiguous	0.125
NRA	nucleus retroambiguus	0.5
NRA	nucleus retroambigualis	0.25
CITS	cerebral infarction with transient signs	1.0
NRG	1neuregulin 1	0.208333333333
NRG	neuregulin	0.291666666667
NRG	1neuregulin-1	0.166666666667
NRG	1β-neuregulin-1	0.0833333333333
NRG	cnucleus reticularis gigantocellularis	0.125
NRG	sneuregulins	0.0416666666667
NRG	1neuregulin	0.0416666666667
NRG	neuregulin β1	0.0416666666667
NRF	nuclear respiratory factor	0.666666666667
NRF	1nuclear respiratory factor1	0.333333333333
IC-EVP	inferior colliculus evoked potential	1.0
NRD	cnardilysin (n-arginine dibasic convertase)	0.5
NRD	nucleus raphe dorsalis	0.5
ITPC	inter-trial phase coherence	1.0
CITI	nternational center of toxicology	1.0
lOFC	lateral orbitofrontal cortex	1.0
NRX	neurexin	1.0
SCID	structural clinical interview for dsm-iv	0.166666666667
SCID	structured clinical interview for diagnosis	0.166666666667
SCID	severe combined immunodeficient	0.333333333333
SCID	severe combined immunodeficiency	0.333333333333
3-NPA	3-nitroproprionic acid	0.142857142857
3-NPA	3-nitropropionic acid	0.857142857143
NRS	normal rabbit serum	0.857142857143
NRS	numerical rating scale	0.0571428571429
NRS	non-responsive subordinates	0.0285714285714
NRS	numeric rating scale	0.0285714285714
NRS	numerical rating scales	0.0285714285714
NRP	neuronal-restricted precursor	0.2
NRP	onucleus reticularis pontis oralis	0.4
NRP	nucleus raphe pallidus	0.4
Vmr	visceromotor reflex	1.0
NRT	thalamic reticular nucleus	0.166666666667
NRT	nucleus reticularis thalami	0.833333333333
EMEM	eagle's modified essential medium	0.142857142857
EMEM	earle’s minimum essential medium	0.142857142857
EMEM	eagle's minimum essential medium	0.428571428571
EMEM	eagle's mimimum essential medium	0.142857142857
EMEM	eagles's minimum essential medium	0.142857142857
GCLGC	layer	1.0
FZDF	rizzled family of wnt receptor	1.0
H-89	n-[2-((3-(bromophenyl)-2-propenyl)-amino)-ethyl]-5-isoquinolinesulfonamide dihydrochloride	0.333333333333
H-89	n-[2-((p-bromocinnamyl)amino)ethyl]5-isoquinolinesulfonamide	0.333333333333
H-89	n-(2-[p-bromocinnamylamino]ethyl)-5-isoquinolinesulfonamide hydrochloride	0.333333333333
TWIK-1	tandem of pore domains in a weak inwardly rectifying k+ channel	1.0
2-DIGE	2 dimensional fluorescence difference in gel electrophoresis	0.5
2-DIGE	two-dimensional in-gel electrophoresis	0.5
CREBcyclic-AMP	responsive element binding protein	1.0
GMS	global motion stimulus	1.0
HBOT	hyperbaric oxygen therapy	1.0
DGK-ζ	diacylglycerol kinase-ζ	1.0
4-VO	four-vessel occlusion	1.0
SULF	sulforaphane	1.0
CryabCrystallin	alpha b	1.0
SCPsegmented	completely partitioned (synapses)	1.0
ADM	astrocyte-defined medium	0.4
ADM	abductor digiti minimi	0.4
ADM	adrenomedullin	0.2
TMAM	eso3tetramethylammonium methanesulfonate	1.0
CNAP	compound nerve action potential	1.0
ARIC	atherosclerotic risk in communities	1.0
ARIA	acetylcholine receptor-inducing activity	1.0
E-NPP	ecto-nucleotide pyrophosphatases/phosphodiesterase	1.0
GMV	grey matter volume	0.5
GMV	gray matter volume	0.5
OX-42-IR	ox-42 immunoreactivity	1.0
dCP	udorsal caudate-putamen	0.5
dCP	udorsal caudate putamen	0.5
WIN-35428	(-)-2-β-carbomethoxy-3-β-(4-flurophenyl)tropane-1,5-naphthalene disulfonate	1.0
LTBE	. coli heat-labile toxin b subunit	1.0
ARIP	1activin receptor interacting protein 1	1.0
GMT	greenwich mean time	1.0
B-A	mygnucleus amygdalae basalis	1.0
Fura-2-AM	fura-2-acetoxymethyl ester	1.0
NINDSN	ational institute of neurologic disorders and stroke	0.5
NINDSN	ational institute of neurological disorders and stroke	0.5
MY-103	2-phthalimidoethanesulfonamide	1.0
cDMV	cadual dorsal motor nucleus of the vagus	1.0
BoNT	botulinum neurotoxin	1.0
cDMH	compact portion of dmh	0.5
cDMH	contralateral dorsomedial hypothalamus	0.5
OTRO	xytocin receptor	1.0
LXR	sliver x receptors	0.166666666667
LXR	snuclear hormone liver x receptors	0.166666666667
LXR	liver x receptor	0.666666666667
GPIG	lycosylphosphatidylinositol	1.0
p-STAT	3phosphorylated signal transducer and activator of transcription 3	1.0
CEMT	lymphoblastoid cell line	1.0
hcmfASW	high ca2+/mg2+-free artificial saltwater	1.0
SK-N-MC	neuroblastoma cells	1.0
hIL-	2human interleukin-2	1.0
LXA	4lipoxin a4	0.5
LXA	4me5 (s), 6 (r)-lipoxin a4 methyl ester	0.5
F-PLSDF	isher protected least significant difference	1.0
EOFAD	early-onset familial ad	1.0
RGP4	regulators of g-protein 4	1.0
ADDL	samyloid-beta derived diffusible ligands	0.5
ADDL	samyloid-derived diffusible ligands	0.5
MOFC	medial orbitofrontal cortex	1.0
MARRS	membrane-associated rapid response to steroid protein	1.0
S-4CPG	s-4-carboxyphenylglycine	1.0
MgSO4	magnesium sulphate	1.0
LY294002	[2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one]	0.333333333333
LY294002	[2-(4-marpholinyl)-8-phenyl]-4h-1-benzopyran-4-one	0.333333333333
LY294002	2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one	0.333333333333
PDCl-trans-pyrrolyidine-2	4-dicarboxylate	1.0
PeVH	periventricular hypothalamus	1.0
DNPDNA	nanoparticle	1.0
PEAN-	palmitoylethanolamide	1.0
Sapo50	sapo100 and sapo150, groups of animals given injections of 50, 100 and 150μg of immunotoxin, respectively	1.0
RIII-	reflex	0.5
RIII-	reflexnociceptive flexion reflex	0.5
Fmrp	mouse fragile x mental retardation 1 protein	1.0
i-LTP	inhibitory ltp	1.0
IVS	6-1intron/intervening sequence 6	1.0
lenti-AQP	1lentivirus-aqp1	1.0
cOP	cyclo1-8op	1.0
eNAD1	n6-etheno-nicotinamide adenine dinucleotide	1.0
8-brcGMP	8-bromo-guanosine-3′:5′-cyclic monophosphate sodium	1.0
RNm	red nucleus, magnocellular division	1.0
BRN	mixed brain cells	0.333333333333
BRN	basal retinal neuron	0.666666666667
MC-VR	cell type with moderately dense cytoplasm and varicose reticulum	1.0
L-AP6	l-2-amino-6-phosphonohexanoic acid	1.0
L-AP4	l-2-amino-4-phosphonobutanoic acid	0.0833333333333
L-AP4	l(+)-2-amino-4-phosphanobutyric acid	0.0833333333333
L-AP4	l-(+)-2-amino-4-phosphonobutyrate	0.0833333333333
L-AP4	(s)-2-amino-4-phosphonobutyrate	0.0833333333333
L-AP4	l-2-amino-4-phosphonobutyric acid	0.25
L-AP4	l-2-amino-4-phosphonobutyrate	0.25
L-AP4	l(+)-2-amino-4-phosphonobutanoic acid	0.0833333333333
L-AP4	l(+)-2-amino-4-phosphonobutyric acid	0.0833333333333
DD-RT-PCR	differential display-reverse transcription-polymerase chain reaction	1.0
DADLE	[d-ala2,d-leu5]enkephalin	0.333333333333
DADLE	d-ala-d-leu enkephalin	0.333333333333
DADLE	d-ala-d-leu-enkephalin	0.333333333333
L-AP-	4	1.0
PCβ	4phospholipase cβ4	1.0
Vop	nucleus ventrooralis posterior	1.0
αMEM	alpha-modified eagle's minimal essential medium	1.0
NPPB	5-nitro-2-(3-phenylpropyl-amino) benzoic acid	0.0909090909091
NPPB	5-nitro-2-(3 phenylpropylamino)benzoic acid	0.0909090909091
NPPB	5-nitro-2-(3-phenylpropylamino)benzoic acid	0.363636363636
NPPB	5-nitro-2-(3-phenylpropylamino)benzoate	0.0909090909091
NPPB	5-nitro-2-(3-phenylpropylamino) benzoic acid	0.363636363636
Bω	viscous component	1.0
N-ethoxycarbonyl-2-ethoxy-1	2-dihydroquinoline	0.5
N-ethoxycarbonyl-2-ethoxy-1	2-dihydroquinoline (eedq)	0.5
STAIR	stroke academic industry roundtable	1.0
STAIS	tate-trait-anxiety inventory	0.4
STAIS	pielberger state-trait anxiety inventory	0.2
STAIS	tate-trait anxiety inventory	0.2
STAIS	tate-trait anxiety-inventory	0.2
LY35470	(1s,2s,5r,6s)-2-aminobicyclo[3.1.0]hexane-2-6-dicarboxylate	1.0
ALACα-	lactoalbumin	1.0
BIS-I	bisindolylmaleide i hydrochloride	1.0
pJNK	polyclonal phospho-c-jun n-terminal kinase	1.0
YKS	yokukansan	1.0
TMUD	total number of motor unit discharges	1.0
IPLT	ipsilateral	1.0
Fmr1	mouse fragile x mental retardation 1 gene	1.0
FUNI	unimodal facilitation index	1.0
ICI-	acsf	1.0
TWEAK	tumor necrosis factor–like weak inducer of apoptosis	0.5
TWEAK	tumor necrosis factor-like weak inducer of apoptosis	0.5
-RACE	5′ and 3′-rapid amplification of cdna ends	1.0
UMU	niversity of michigan	1.0
SRIF-R	somatostatin receptor	1.0
hRL	hind-brain rhombic lip	1.0
paCO	2arterial partial carbon dioxide	1.0
ITSF	ninsulin/transferrin/selenium/fibronectin	1.0
CGP37849	dl-2-amino-4-methyl-5-phosphono-3-pentenoic acid	1.0
f-EPSP	field excitatory postsynaptic potential	1.0
125I-	estrogen17α-iodovinyl-11β-methoxyestradiol	1.0
FISH	florescence in situ hybridization	0.0714285714286
FISH	fluorescence in situ hybridization	0.642857142857
FISH	fluorescent in situ hybridization	0.285714285714
S-AdoMet	s-adenosyl-l-methionine	1.0
HBH	hypobaric hypoxia	1.0
JUNK	/junc-jun n-terminal kinase	1.0
NMSalN-methyl-salsolinol	1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline	1.0
gNa	the normalized na+ conductance	1.0
bUFM	bent upward frequency modulated	1.0
GABAAA-	type gamma-aminobutyric acid	1.0
PBRP	eripheral benzodiazepine receptor	1.0
HPLC-EC	high performance liquid chromatography coupled with electrochemical detection	0.0769230769231
HPLC-EC	high-pressure liquid chromatography with electrochemical detection	0.0769230769231
HPLC-EC	high-performance liquid chromatography using electrochemical detection	0.0769230769231
HPLC-EC	high performance liquid chromatography with electrochemical detection	0.461538461538
HPLC-EC	high-performance liquid chromatography with electrochemical detection	0.230769230769
HPLC-EC	high-performance liquid chromatography–electrochemical detection	0.0769230769231
HPLC-ED	high-performance liquid chromatography with electrochemical detector	0.0769230769231
HPLC-ED	high-pressure liquid chromatography with electrochemical detection	0.153846153846
HPLC-ED	high performance liquid chromatography with electrochemical detection	0.230769230769
HPLC-ED	high-performance liquid chromatography with electrochemical detection	0.538461538462
d-NAMENω-	nitro-d-arginine-methyl-ester	0.5
d-NAMENω-	nitro-d-arginine methyl ester	0.5
BESAB	rain electric source analysis software suite	1.0
Raclopride	s-(-)-raclopride l-tartrate	1.0
CGP-40116	d-2-amino-4-methyl-5-phosphono-3-pentenoic acid	1.0
Bup	bupivacaine injected alone group of rats	1.0
AICDβ-APP	intracellular domains	1.0
R-BR	ohon-beard	1.0
BSTSm	medial division of bsts	1.0
UCHL	1	1.0
ZBP	1zipcode binding protein 1	0.666666666667
ZBP	1zipcode-binding protein 1	0.333333333333
FAIR	flow-sensitive alternating inversion recovery	0.5
FAIR	flow alternating inversion recovery	0.5
CAAH	caudal area anterior hypothalamus	1.0
WAG	/rij rats	0.25
WAG	/rijwistar albino glaxo from rijswijk	0.25
WAG	/rijwistar albino glaxo/rijswijk	0.25
WAG	/rij ratswistar albino glaxo from rijswijk	0.25
vHPC	ventral hippocampus	1.0
DNDS4	4′-dinitrostilbene-2,2′-disulfonic acid	0.5
DNDS4	4′-dinitrostilbene-2,2′-disulfonate	0.5
nE	2neural e2	0.5
nE	nucleus electrosensorius	0.5
TTPα-	tocopherol transfer protein	1.0
WAY	100635n-[2-[4-2-[o-methoxyphenyl)-1-piperazinyl]ethyl]	0.333333333333
WAY	100635n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]	0.666666666667
WAT	white adipose tissue	1.0
WAS	water avoidance stress	1.0
WAR	swistar audiogenic rats	0.5
WAR	wall-assisted rears	0.5
pre-LC	pre-locus coeruleus	1.0
ir-GRP	immunoreactive grp	1.0
58KGP	58 kda golgi protein	1.0
NCS-	1	0.111111111111
NCS-	435γ-(p-methoxybenzil)-γ-hydroxybutyric acid	0.111111111111
NCS-	382	0.222222222222
NCS-	356γ-p-chlorophenyl-trans-hydroxycrotonate	0.222222222222
NCS-	1neuronal calcium sensor-1	0.333333333333
STAI-Y	2trait anxiety survey	1.0
DDYDDY	/hydrocephalus ii	1.0
6M	six months	1.0
6N	abducens nucleus	1.0
6-HD	6-hydroxydopamine	1.0
FARSF	riedreich ataxia rating scale	1.0
CLI	clomipramine	0.5
CLI	central linear nucleus raphe	0.5
WAYWAY-	100635	1.0
Gly-T2	glycine transporter 2	1.0
pSTS	/mtgposterior superior temporal sulcus/middle temporal gyrus	0.25
pSTS	posterior part of the superior temporal sulcus	0.25
pSTS	posterior superior temporal sulcus	0.5
ATXω	agatoxin iva	1.0
WAY100135	n-tert-butyl-3-4-(2-methoxyphenyl)piperazin-1-yl-2-phenylpropanamide dihydrochloride)	1.0
DSP4	n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine	1.0
8-methyl-9H-1	3-dioxolo[4,5-h][2,3]	0.5
8-methyl-9H-1	3-dioxolo[4,5h]{2,3}benzodiazepine-5-yl)-benzenamine hydrochloride	0.5
CMEP	scervicomedullary-evoked potentials	0.333333333333
CMEP	scervicomedullary motor-evoked potentials	0.333333333333
CMEP	cervicomedullary motor-evoked potential	0.333333333333
FPKM	fragments per kilobase of transcripts per million fragments mapped	1.0
ipRGC	intrinsically photosensitive retinal ganglion cell	0.5
ipRGC	sintrinsically photosensitive retinal ganglion cells	0.25
ipRGC	sintrinsically photoreceptive retinal ganglion cells	0.25
PCPA	irreversible inhibitor of tryptophane-5-hydroxylase, para-chlorophenylalanine	0.0555555555556
PCPA	parachorophenylalanine	0.0555555555556
PCPA	p-chlorophenylalanine	0.555555555556
PCPA	ρ-chlorophenylalanine methyl ester	0.0555555555556
PCPA	p-chlorophenylalanine-ethyl ester	0.0555555555556
PCPA	para-chlorophenylalanine	0.166666666667
PCPA	parachlorophenylalanine	0.0555555555556
GlyR	glycine receptor(s)	0.111111111111
GlyR	glycine receptor	0.777777777778
GlyR	inhibitory glycine receptor	0.111111111111
ePT	early preterm	1.0
sLN	vssmall ventral lateral neurons	1.0
COXI	cytochrome c oxidase	1.0
VS-	video with inconsistent speech	1.0
IACUCI	nstitutional animal care and use committees	0.142857142857
IACUCI	nstitutional animal care and use committee	0.857142857143
IRR-	learnersirradiated learners	1.0
Grb2	adapter protein that bridges shc to sos	1.0
I-	converting enzyme	0.142857142857
I-	mod neuroninspiratory-modulated neuron	0.142857142857
I-	1inhibitor-1	0.142857142857
I-	2inhibitor-2	0.142857142857
I-	thresholdthe current threshold for triggering a spike	0.142857142857
I-	mel2-iodomelatonin	0.142857142857
I-	ischemic non-enriched	0.142857142857
nV	mmotor trigeminal nucleus	0.333333333333
nV	no-vision	0.333333333333
nV	trigeminal nerve	0.333333333333
iEM	immuno-electron microscopy	1.0
CHAPSO	3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate	1.0
DPPH	diphenyl-picrylhydrazyl	0.5
DPPH	diphenyl-p-picrylhydrazyl	0.5
IX	glossopharyngeal motor nucleus	0.25
IX	cdfolium ixcd of the cerebellum	0.25
IX	mglossopharyngeal motor nucleus	0.25
IX	glossopharyngeal	0.25
IZ	intact zone	0.05
IZ	intermediate zone	0.95
GPCRG-	protein coupled-receptor	0.0217391304348
GPCRG-	protein-coupled heptahelical receptors	0.0217391304348
GPCRG-	protein-coupled receptor	0.586956521739
GPCRG-	protein coupled receptors	0.0434782608696
GPCRG-	protein-coupled receptors	0.0217391304348
GPCRG-	protein coupled receptor	0.304347826087
IQ	intellectual quotient	0.0909090909091
IQ	isoquinoline	0.0909090909091
IQ	q current	0.0909090909091
IQ	interquartile	0.0909090909091
IQ	intelligence quotient	0.636363636364
IP	ostcischemic postconditioning	0.00952380952381
IP	+, ischemic preconditioned enriched	0.00952380952381
IP	linternal plexiform layer of the olfactory bulb	0.00952380952381
IP	linternal plexiform layer of the ob	0.00952380952381
IP	3r1ip3 type 1 receptor	0.00952380952381
IP	initial phase	0.00952380952381
IP	inositol phosphate	0.00952380952381
IP	peak current	0.00952380952381
IP	3-r	0.00952380952381
IP	immunoprecipitation	0.161904761905
IP	4 receptor	0.00952380952381
IP	immunopositive	0.00952380952381
IP	nucleus interpeduncularis	0.00952380952381
IP	interpeduncular fossa	0.00952380952381
IP	interpeduncular nuclei	0.00952380952381
IP	3 receptors	0.0190476190476
IP	total non-inactivating inward current (carried by ba2+ or ca2+)	0.00952380952381
IP	interpeduncular nucleus	0.0952380952381
IP	intraparenchymal	0.00952380952381
IP	prostacyclin receptor	0.00952380952381
IP	intra-peritoneal	0.00952380952381
IP	intraperitoneal	0.12380952381
IP	prostaglandin i receptor	0.00952380952381
IP	3	0.047619047619
IP	immunodepletion	0.00952380952381
IP	3ionositol triphosphate	0.00952380952381
IP	inferior point	0.00952380952381
IP	3rip3 receptor	0.0190476190476
IP	bamplitude of ih in pb2+ solution	0.00952380952381
IP	simmunoprecipitations	0.00952380952381
IP	3rinositol trisphosphate	0.00952380952381
IP	3inositol triphosphate	0.0761904761905
IP	immunoprecipitate	0.00952380952381
IP	intraperitonial	0.00952380952381
IP	intraperitonal	0.00952380952381
IP	itintermediate lobe of the pituitary	0.00952380952381
IP	interception point	0.00952380952381
IP	3inositol trisphosphate	0.047619047619
IP	inosital phosphate	0.00952380952381
IP	i-subtype prostaglandin receptor	0.00952380952381
IP	3rsinositol triphosphate receptors	0.00952380952381
IP	linner plexiform layer ob	0.00952380952381
IP	3 receptor	0.00952380952381
IP	3rinositol-phosphate-3 receptor	0.00952380952381
IP	intermediate potential	0.00952380952381
IP	3r1	0.00952380952381
IP	interpositus nucleus	0.00952380952381
IP	3inositoltriphosphate	0.00952380952381
IP	intraperitoneally	0.0190476190476
IP	interferon inducible protein	0.00952380952381
IS	immediate shock	0.0222222222222
IS	/osinner and outer segments	0.0444444444444
IS	inverse slope	0.0222222222222
IS	internal standard	0.0222222222222
IS	inescapable shock	0.111111111111
IS	interictal eeg “spikes”	0.0222222222222
IS	intrastrial space	0.0222222222222
IS	immobilization stress	0.0222222222222
IS	injection saline	0.0222222222222
IS	immunostaining	0.0222222222222
IS	sustained current	0.0222222222222
IS	chronic isolation	0.0222222222222
IS	initial segment	0.0888888888889
IS	intermediate sag potential	0.0222222222222
IS	inflammatory soup	0.0666666666667
IS	intact-spinal	0.0222222222222
IS	inescapable tail shock	0.0222222222222
IS	inter-spike interval	0.0222222222222
IS	inescapable stress	0.0666666666667
IS	imperative stimulus	0.0444444444444
IS	inferior salivatory nucleus	0.0222222222222
IS	isthmus	0.0222222222222
IS	initiation site	0.0222222222222
IS	inner segment	0.0444444444444
IS	isolation	0.0222222222222
IS	slowly inactivating inward current	0.0222222222222
IS	interneuron selective	0.0444444444444
IS	animals perfused 4 min after intraarticular injection of inflammatory soup	0.0222222222222
IS	inner segments	0.0444444444444
IR	immunoreactivities	0.0032154340836
IR	immunoreactive, immunoreactivity	0.0337620578778
IR	ischemia reperfusion	0.0016077170418
IR	irregular cell	0.0016077170418
IR	insulin receptor	0.016077170418
IR	tintermediate reticular nucleus	0.008038585209
IR	-immunoreactivity	0.0016077170418
IR	infrared	0.0209003215434
IR	like immunoreactivity	0.008038585209
IR	ionizing radiation	0.0016077170418
IR	ionotropic receptor	0.0016077170418
IR	-like immunoreactivity	0.0016077170418
IR	immunoreactive	0.381028938907
IR	simmunoreactivities	0.0032154340836
IR	inferior rectus muscle	0.0032154340836
IR	immunostaining	0.0016077170418
IR	intercollicular region	0.0016077170418
IR	inner retina	0.0016077170418
IR	immediate reward	0.0016077170418
IR	immunoreactive/immunoreactivity	0.0369774919614
IR	isolation reared	0.0016077170418
IR	infra-red	0.0016077170418
IR	inward rectifying	0.0016077170418
IR	2inward rectifier 2	0.0016077170418
IR	tintermediate zone of the reticular formation	0.0016077170418
IR	immunoreactivity, immunoreactive	0.0209003215434
IR	inward rectifier	0.0016077170418
IR	immunoreactivity/immunopositive/immunoreactive	0.0016077170418
IR	immunoreaction	0.0032154340836
IR	ischemia and reperfusion	0.0016077170418
IR	immunoreactive or immunoreactivity	0.0144694533762
IR	immunoreactive-like	0.0016077170418
IR	inward rectifying potassium current	0.0016077170418
IR	immuno-reactive	0.0016077170418
IR	immunoreactive,	0.0016077170418
IR	indeximmunoreactivity index	0.0016077170418
IR	μ-opioid receptor immunoreactive/immunoreactivity	0.0016077170418
IR	incidence ratio	0.0016077170418
IR	inward rectification	0.0016077170418
IR	–dicinfra-red differential inference contrast	0.0016077170418
IR	insulin receptor kinase	0.0016077170418
IR	immunoreactivity	0.372990353698
IR	immunoreactivity/immunoreactive	0.0176848874598
IR	inward rectifier current	0.0016077170418
IR	ischemia-reperfusion	0.0016077170418
IR	/dicinfrared/differential interference contrast	0.0016077170418
IR	isthmic region	0.0016077170418
IR	input resistance	0.0032154340836
IR	–dicinfrared differential interference contrast	0.0016077170418
IU	international units	0.5
IU	institutional units	0.5
IT	rinferotemporal cortex rostral	0.0208333333333
IT	isotocin	0.0416666666667
IT	windowt-type ca2+ ‘window’ current	0.0208333333333
IT	intrathecally	0.0208333333333
IT	low-threshold, t-type ca2+ current	0.0208333333333
IT	low-threshold calcium conductance	0.0416666666667
IT	inferior temporal cortex	0.0416666666667
IT	fast transient current	0.0208333333333
IT	total k+ current	0.0208333333333
IT	bpdcinter-trial biphase difference coherence	0.0208333333333
IT	low threshold calcium current	0.0208333333333
IT	incompletely trained	0.0208333333333
IT	15interesting transcript 15	0.0208333333333
IT	intrathecal	0.166666666667
IT	low threshold-activation ca2+ current	0.0208333333333
IT	inflection theme	0.0208333333333
IT	initial training	0.0416666666667
IT	intratympanic	0.0208333333333
IT	low-threshold transient ca2+	0.0208333333333
IT	ischemic tolerance	0.0625
IT	intracellular tetanus	0.0208333333333
IT	imposed trajectory	0.0208333333333
IT	inferotemporal cortex	0.0625
IT	t-type calcium current	0.0416666666667
IT	low threshold ca current	0.0208333333333
IT	low-threshold transient ca2+ current	0.0208333333333
IT	low-threshold	0.0208333333333
IT	infero-temporal area	0.0208333333333
IT	inferior temporal	0.0833333333333
gKCa	calcium-activated potassium conductance	1.0
IV	fourth ventricle	0.111111111111
IV	injured group of animals treated with vehicle	0.0555555555556
IV	fourth revision of the diagnostic and statistical manual of mental disorders	0.0555555555556
IV	ca2+/calmodulin-dependent protein kinase ii/iv	0.0555555555556
IV	toxins iii and iv, respectively, from the venom of the scorpion buthus occitanus mardochei	0.0555555555556
IV	–vi of cerebral cortex	0.0555555555556
IV	collagen iv	0.0555555555556
IV	magnocellular zone of vc	0.111111111111
IV	–v	0.0555555555556
IV	trochlear nucleus	0.0555555555556
IV	einferior vestibular nucleus	0.0555555555556
IV	current–voltage	0.0555555555556
IV	intravenous	0.222222222222
II	receptor type 1	0.0232558139535
II	metabotropic glutamate receptors	0.0232558139535
II	glutamate carboxypeptidase ii	0.0697674418605
II	polymerase ii	0.0232558139535
II	collagen	0.0232558139535
II	synaptotagmin i or ii	0.0232558139535
II	chicken lhrh ii	0.0232558139535
II	increment index	0.0232558139535
II	ca+/calmodulin-dependent protein kinase type ii	0.0232558139535
II	metabotropic glutamate receptor	0.0232558139535
II	calcium/calmodulin-dependent protein kinase	0.046511627907
II	major histocompatibility complex class ii	0.0232558139535
II	olamina ii outer	0.0232558139535
II	)	0.0232558139535
II	ca2+/calmodulin-dependent protein kinase	0.0232558139535
II	angiotensin ii	0.0697674418605
II	superficial layers of vc	0.046511627907
II	oouter lamina ii	0.0232558139535
II	inducible-type nitric oxide synthase	0.0232558139535
II	vesicle-associated membrane protein ii	0.0232558139535
II	calmodulin-dependent protein kinase ii	0.0232558139535
II	cranial nerve 2 (optic)	0.0232558139535
II	calcium and calmodulin-dependent kinase ii	0.0232558139535
II	–iii linker	0.0232558139535
II	alpha subunit	0.0232558139535
II	igf receptor	0.0697674418605
II	oouter part of lamina ii	0.0232558139535
II	cadherins	0.0232558139535
II	α subunit	0.0232558139535
II	class ii major histocompatibility complex	0.0232558139535
II	type 2 receptors	0.0232558139535
II	calcium/calmodulin-dependent protein kinase ii	0.046511627907
II	lamina ii in the dorsal horn of the spinal cord	0.0232558139535
II	sarcosine1-angiotensin ii	0.0232558139535
RNS	nitrogen reactive species	0.0625
RNS	reactive nitrogen species	0.9375
IK	(erg)erg current	0.02
IK	offspring resulting from an illinois dam×kansas sire	0.02
IK	mm-current	0.02
IK	ir	0.04
IK	delayed rectifier k+ current	0.02
IK	non-inactivating potassium current	0.02
IK	intermediate conductance k+ current	0.02
IK	(l)low threshold k+ current	0.02
IK	voltage-dependent sustained currents	0.02
IK	potassium current	0.08
IK	(ca)calcium-activated potassium conductance	0.02
IK	delayed rectifier	0.04
IK	caca2+-activated k+ current	0.02
IK	ppressure-sensitive k+ current	0.02
IK	the dominant-sustained k-current	0.02
IK	intermediate conductance calcium-activated potassium channel	0.02
IK	(atp)atp-sensitive potassium channel current	0.02
IK	voltage-dependent dominant sustained current	0.04
IK	(ca)calcium-activated potassium current	0.02
IK	(ca), calcium-activated k+ current	0.02
IK	voltage-gated non-inactivating k+ current	0.02
IK	(dr)delayed rectifier k+ current	0.02
IK	voltage-dependent k+ currents	0.02
IK	(m), m-type k+ current	0.02
IK	outward delayed-rectifier potassium currents	0.02
IK	(v), voltage-activated k+ current	0.02
IK	slow-inactivating k+ current	0.02
IK	fibtx-sensitive k+ conductance	0.02
IK	(ca)ca2+-activated k+ current	0.04
IK	leakleak potassium current	0.02
IK	somatic k+ current	0.02
IK	voltage-dependent dominant sustained transient	0.02
IK	/caca2+-dependent k+ current	0.02
IK	irinwardly rectifying k+ current	0.02
IK	intermediate conductance calcium activated potassium channel	0.02
IK	(ca), calcium-dependent potassium current	0.02
IK	sustained k+ current	0.02
IK	delayed rectifier potassium current	0.04
IK	v, delayed, voltage-activated potassium current	0.02
IK	(ahp)calcium-activated potassium current	0.02
IK	mslow non-inactivating potassium current	0.02
IK	(ca), calcium-activated potassium current	0.02
IM	intercalated masses	0.0454545454545
IM	imagined movement	0.0454545454545
IM	intermediate region	0.0454545454545
IM	muscarine-sensitive potassium current	0.0454545454545
IM	gonad-intact male	0.0454545454545
IM	intracellular domain	0.0454545454545
IM	inflammatory mediators	0.0909090909091
IM	intermittent morphine	0.0454545454545
IM	inflammatory mediator	0.0454545454545
IM	intromission	0.0454545454545
IM	impedance magnitude	0.0454545454545
IM	intramuscular	0.0909090909091
IM	intermediate region (limbus+spiral lamina)	0.0454545454545
IM	isolation medium	0.0909090909091
IM	m current	0.0454545454545
IM	inner membrane	0.0454545454545
IM	intermediate	0.0454545454545
IM	immobilization	0.0909090909091
IL	1βinterleukin-1β	0.0036231884058
IL	rostral intralaminar thalamic nuclei	0.0036231884058
IL	1-rainterleukin-1ra	0.0036231884058
IL	l-type calcium current	0.0036231884058
IL	2interleukin-2	0.0036231884058
IL	ibotenic acid lesioned	0.0036231884058
IL	interleukin	0.565217391304
IL	pfcinfralimbic medial prefrontal cortex	0.0036231884058
IL	6ril6 receptor	0.0036231884058
IL	infralimbic cortex (area 25)	0.0036231884058
IL	inner layer	0.0036231884058
IL	intralaminar thalamus	0.0036231884058
IL	interleukine (6 or 8)	0.0036231884058
IL	interleukin-1	0.0036231884058
IL	infralimbic	0.0471014492754
IL	6	0.0036231884058
IL	infralimbic area	0.018115942029
IL	/plinfralimbic/prelimbic cortices	0.0036231884058
IL	infralimbic cortex	0.202898550725
IL	linear leak current	0.0036231884058
IL	1βinterleukin1β	0.0036231884058
IL	1-βinterleukin 1-β	0.00724637681159
IL	6interleukin 6	0.0108695652174
IL	tintralaminar nuclei of thalamus	0.0036231884058
IL	4interleukin-4	0.0036231884058
IL	leakage current	0.00724637681159
IL	10interleukin 10	0.0036231884058
IL	intermediate lobe	0.00724637681159
IL	infralimbic division of medial prefrontal cortex	0.0036231884058
IL	immediate-reward-lever	0.0036231884058
IL	infralimbic region of the prefrontal cortex	0.0036231884058
IL	intromission latency	0.00724637681159
IL	the infralimbic cortex	0.0036231884058
IL	intralaminar nuclei	0.00724637681159
IL	impaired leg placement	0.0036231884058
IL	ipsilateral side to lesion	0.0036231884058
IL	6interleukin-6	0.0036231884058
IL	interleukin-1 beta	0.0036231884058
IL	6-rαinterleukin-6 receptor alpha	0.0036231884058
IL	infralimbic prefrontal cortex	0.0108695652174
IL	pituitary intermediate lobe	0.0036231884058
IO	/iominferior olive/medial nucleus	0.0188679245283
IO	intrinsic optical	0.0188679245283
IO	the infraorbital nerve	0.0188679245283
IO	inferior olivary	0.0188679245283
IO	input-output	0.0188679245283
IO	inferior olivary nucleus	0.0943396226415
IO	input–output	0.0377358490566
IO	indirubin-3′-monoxime	0.0188679245283
IO	inferior oblique muscle	0.0377358490566
IO	inferior olivary complex	0.0566037735849
IO	iron overload	0.0188679245283
IO	inferior olive	0.603773584906
IO	infundibular organ	0.0188679245283
IO	principal nucleus of the inferior olive	0.0188679245283
IN	interneuron	0.027027027027
IN	/meinfundibular nucleus/median eminence	0.027027027027
IN	insular cortex	0.027027027027
IN	appersistent sodium current	0.108108108108
IN	cortical interneuron	0.027027027027
IN	avoltage-gated na+ current	0.027027027027
IN	interposed nuclei	0.027027027027
IN	appersistent na+ current	0.0810810810811
IN	appersistent sodium currents	0.027027027027
IN	asodium channel current	0.027027027027
IN	anti-caspase-12	0.027027027027
IN	afast activating na+ current	0.027027027027
IN	asodium current	0.0810810810811
IN	avoltage-gated sodium channel currents	0.0540540540541
IN	intranasal	0.027027027027
IN	intercalated nuclei	0.027027027027
IN	nucleus interpositus	0.027027027027
IN	sinterneurons	0.027027027027
IN	artetrodotoxin-resistant na+ current	0.027027027027
IN	apslow persistent sodium current	0.027027027027
IN	interpositus nucleus	0.0810810810811
IN	apvoltage-dependent persistent na+ current	0.027027027027
IN	attransient sodium current	0.108108108108
IN	immunonegative	0.027027027027
IA	transient potassium current	0.03125
IA	sslowly activating and slowly time-dependently inactivating potassium current	0.015625
IA	a-type potassium current	0.046875
IA	transient k+ current of the a type	0.015625
IA	voltage-dependent transient outward k+ currents	0.015625
IA	index of anti-nociception	0.015625
IA	transient outward current	0.015625
IA	transient a-type potassium current	0.015625
IA	intracranial aneurysm	0.015625
IA	a current	0.015625
IA	transient a-type k+ current	0.015625
IA	inactivating a type potassium current	0.015625
IA	integrated amplitude	0.03125
IA	ibotenic acid	0.03125
IA	step-down inhibitory avoidance	0.015625
IA	voltage-dependent transient currents	0.015625
IA	voltage-dependent fast inactivating transient k+ channel	0.015625
IA	voltage-dependent fast inactivating transient current	0.015625
IA	fast-inactivating k+ current	0.046875
IA	transient outward potassium current	0.03125
IA	interaural line	0.015625
IA	interaural point	0.015625
IA	voltage-dependent fast inactivating transient currents	0.015625
IA	interaural plane	0.015625
IA	sintracranial aneurysms	0.015625
IA	fast transient k+ current	0.015625
IA	transient outward k+ current	0.015625
IA	interaural	0.125
IA	intercalated nuclei amygdala	0.015625
IA	inhibitory avoidance	0.15625
IA	transient k+ current	0.015625
IA	transient potassium current or a-current	0.015625
IA	transiently activated outward k+ current	0.015625
IA	voltage-gated inactivating a-type k+ current	0.015625
IA	iodoacetamide	0.03125
IA	fast-inactivating transient a-current	0.015625
IA	insular auditory area	0.015625
IA	transient outward rectification	0.015625
IA	inactivating k current	0.015625
IC	50concentration of berberine required to inhibit control response to glutamate to 50% of maximum	0.00396825396825
IC	50half maximal inhibitory concentration	0.0119047619048
IC	50inhibitory concentration 50%	0.00396825396825
IC	50concentrations of half-maximal block	0.00396825396825
IC	insular cortex	0.0793650793651
IC	intercalated nucleus	0.00793650793651
IC	intracerebral	0.00396825396825
IC	xexternal cortex of the inferior colliculus	0.0119047619048
IC	large, voltage-dependent calcium-activated potassium current	0.00396825396825
IC	50antagonist concentration inducing half-maximal response	0.00793650793651
IC	inferior cardiac motorneuron	0.00396825396825
IC	50concentration resulting in an inhibition that is 50% of maximum	0.00396825396825
IC	nucleus intercalatus	0.00396825396825
IC	inner contour	0.00396825396825
IC	[ca2+]intracellular calcium	0.00396825396825
IC	incongruent	0.00396825396825
IC	50half-maximal inhibition concentration	0.00396825396825
IC	ipsilateral loudspeaker led contralateral loudspeaker	0.00396825396825
IC	lclateral cortex of the inferior colliculus	0.00396825396825
IC	inferior cardiac neuron	0.00396825396825
IC	50half-maximal inhibitory concentration	0.00793650793651
IC	sindependent components	0.00793650793651
IC	atlow-threshold voltage-activated transient calcium current	0.00396825396825
IC	onucleus intercollicularis	0.00396825396825
IC	jmmajor island of calleja	0.00396825396825
IC	isolated condition	0.00793650793651
IC	xexternal cortex of inferior colliculus	0.00396825396825
IC	oinsular cortex	0.00396825396825
IC	50antagonist concentration producing half-maximal inhibition	0.00396825396825
IC	50concentration of pregnenolone sulfate that produces 50% inhibition	0.00396825396825
IC	50concentration required for 50% inhibition	0.00396825396825
IC	50agonist concentration eliciting the half-maximal response	0.00396825396825
IC	50concentration of an inhibitor that produces 50% inhibition	0.00396825396825
IC	voltage-sensitive calcium-activated k+ current	0.00396825396825
IC	jmislands of calleja (major)	0.00396825396825
IC	immunohistochemistry	0.00396825396825
IC	50half-inhibitory concentration	0.00396825396825
IC	50effective concentration of drug for 50% of the inhibition	0.00793650793651
IC	intracisternal/intracisternally	0.00396825396825
IC	illusory contour	0.00396825396825
IC	omesencephalic nucleus intercollicularis	0.00396825396825
IC	50concentration to produce half-inhibition	0.00396825396825
IC	intercalated islands	0.00396825396825
IC	intrapericardial capsaicin	0.00396825396825
IC	ahigh voltage activated ca2+ current	0.00396825396825
IC	50concentration for 50% inhibition	0.00396825396825
IC	alow threshold calcium current	0.00396825396825
IC	a(hva), high voltage-activated ca2+ current	0.00396825396825
IC	jmmajor islands of calleja	0.00396825396825
IC	inferior cardiac	0.00793650793651
IC	inactive control	0.00396825396825
IC	50half maximal inhibition	0.00396825396825
IC	jislands of calleja	0.015873015873
IC	50the half-maximal inhibitory concentration	0.00396825396825
IC	avoltage-activated ca2+ channel currents	0.00396825396825
IC	50inhibitory concentration 50	0.0119047619048
IC	intracellular	0.00396825396825
IC	ointercollicular nucleus	0.00396825396825
IC	interstitial cystitis	0.015873015873
IC	ischiocavernosus	0.00396825396825
IC	infragranular callosal neurons	0.00396825396825
IC	50antagonist concentration inducing half-maximal inhibition	0.00396825396825
IC	inferior colliculus	0.43253968254
IC	50inhibitory concentration	0.00396825396825
IC	ictal	0.00396825396825
IC	50 valueconcentration of drug producing 50% of the maximum inhibition	0.00396825396825
IC	a2+ca2+ current	0.00396825396825
IC	aca2+current	0.00396825396825
IC	ischiocavernosus muscle	0.00793650793651
IC	ointercollicular complex	0.00396825396825
IC	50antagonist's concentration needed to reach fifty per cent response inhibition	0.00396825396825
IC	internal capsule	0.031746031746
IC	trlamplitude of ih in control solution	0.00396825396825
IC	immunocytochemistry	0.00396825396825
IC	isolated housing condition	0.00396825396825
IC	isolated housing conditions	0.00396825396825
IC	50effective doses that inhibited 50% of maximal or control current generated by gaba for each individual cell	0.00396825396825
IC	50half of maximum inhibitory concentration	0.00396825396825
IC	nucleus intercalate	0.00396825396825
IC	5050% inhibitory concentration	0.00396825396825
IC	intubated with isocaloric control	0.00396825396825
IC	acalcium current	0.0119047619048
IC	aca2+ current	0.0198412698413
IC	50concentration of morphine that produced a half-maximal decrease in gaba levels	0.00396825396825
IC	independent component	0.015873015873
IC	intermediate cell	0.00396825396825
IC	the inferior colliculus	0.00396825396825
IC	inferior pharyngeal constrictor muscle	0.00396825396825
IC	50concentration causing 50% inhibition	0.00396825396825
IB	4(+)isolectin b4-positive	0.00934579439252
IB	intrinsically busting	0.00934579439252
IB	4isolectin b4	0.514018691589
IB	4bandeiraea simplicifolia i-isolectin b4	0.00934579439252
IB	gbackground inhibition	0.00934579439252
IB	4isolectin b4 from griffonia simplicifolia	0.018691588785
IB	intrinsically burst-firing	0.018691588785
IB	4 (+)isolectin b4-positive	0.00934579439252
IB	4isolectin gs-ib4	0.00934579439252
IB	incubation buffer	0.00934579439252
IB	4isolection b4	0.00934579439252
IB	4isotectin-b4	0.00934579439252
IB	low-threshold spiking or intrinsic bursting	0.00934579439252
IB	4	0.00934579439252
IB	intrinsically bursting (cortical neuron)	0.00934579439252
IB	4-ib4 negative	0.00934579439252
IB	4griffonia simplicifolia isolectin b4	0.0467289719626
IB	4griffonia simplicifolia isolectin ib4	0.00934579439252
IB	4isolectin-b4	0.0280373831776
IB	4isolectin b4 of griffonia simplicifolia	0.00934579439252
IB	4bandeiraea simplicifolia isolectin b4	0.00934579439252
IB	4isolectin 4	0.00934579439252
IB	immunobuffer	0.00934579439252
IB	4griffonia (bandeiraea) simplicifolia isolectin b4	0.00934579439252
IB	abasal barium current	0.018691588785
IB	immunohistochemistry buffer	0.00934579439252
IB	aba2+ current	0.00934579439252
IB	4isolectin-4	0.00934579439252
IB	intraburst	0.00934579439252
IB	abarium current	0.0280373831776
IB	immunoblotting	0.018691588785
IB	intrinsically bursting	0.0280373831776
IB	intrinsically bursting neurons	0.00934579439252
IB	4-isolectin b4-negative	0.00934579439252
IB	intrinsic bursting	0.018691588785
IB	4griffonia (bandeiraea) simplicifolia lectin i	0.00934579439252
IB	impaired dynamic balance during gait	0.00934579439252
IB	aclofenbaclofen-induced current	0.00934579439252
IE	impoverished environment	0.117647058824
IE	piinter-episode interval	0.117647058824
IE	isolated environments	0.0588235294118
IE	immediate early	0.176470588235
IE	intrinsic excitability	0.0588235294118
IE	inhibition–excitation (response)	0.0588235294118
IE	interference efficiency	0.0588235294118
IE	intermediate entorhinal	0.0588235294118
IE	immediate-early	0.0588235294118
IE	inspiratory–expiratory phase-spanning	0.0588235294118
IE	information entropy	0.0588235294118
IE	62immediate-early gene protein 62	0.0588235294118
IE	intubated with ethanol	0.0588235294118
ID	voltage-dependent slow inactivating transient current	0.0625
ID	iron deficient	0.03125
ID	sinterindividual differences	0.03125
ID	“ischemic” depolarization	0.03125
ID	internal diameter	0.0625
ID	inner diameter	0.03125
ID	/edintradimensional/extradimensional task	0.03125
ID	integrated optical density	0.03125
ID	50dose that inhibits sucrose intake by 50%	0.03125
ID	/gpercentage injected dose per gram	0.03125
ID	injured group of animals treated with drug	0.03125
ID	discriminability index	0.03125
ID	intradimensional	0.0625
ID	intra-dimensional shift	0.03125
ID	index of difficulty	0.15625
ID	voltage-dependent dominant sustained currents	0.03125
ID	/edintra-dimensional/extra-dimensional attentional set shift task	0.03125
ID	/edintradimensional/extradimensional set-shifting	0.03125
ID	iron deficiency	0.0625
ID	integrated density	0.0625
ID	/edintradimensional/extradimensional set-shifting task	0.03125
ID	ischemic depolarization	0.0625
IG	intra gastric	0.0526315789474
IG	internally guided	0.105263157895
IG	inhibitory gating	0.105263157895
IG	lyglycine-induced current	0.105263157895
IG	intragastric	0.210526315789
IG	immunoglobulin	0.0526315789474
IG	indusium griseum	0.315789473684
IG	intragastric/intragastrically	0.0526315789474
IF	insoluble fraction	0.0243902439024
IF	intermittent fasting	0.0243902439024
IF	immunofluorescence histochemistry	0.0487804878049
IF	isolated ponto-geniculo-occipital wave frequency (mean number/min)	0.0243902439024
IF	instantaneous firing frequency	0.0243902439024
IF	isofrequency	0.0243902439024
IF	indirect immunofluorescence	0.0487804878049
IF	immunofluorescent/immunofluorescence	0.0243902439024
IF	total fast-inactivating inward current	0.0243902439024
IF	interfascicular nucleus	0.121951219512
IF	inhibitory fibre	0.0243902439024
IF	initial feed	0.0243902439024
IF	infralimbic	0.0243902439024
IF	–ihcimmunofluorescent–immunohistochemistry	0.0243902439024
IF	gonad-intact female	0.0243902439024
IF	infralimbic area	0.0243902439024
IF	intermediate filament	0.0975609756098
IF	intromission frequency	0.0243902439024
IF	immunofluorescence	0.341463414634
LCM	odellinear combination model	0.0714285714286
LCM	laser capture microdissection	0.714285714286
LCM	(r)-n-benzyl 2-acetomido-3-methoxypropionamide	0.0714285714286
LCM	laser capture microscopic	0.0714285714286
LCM	laser-captured microdissected	0.0714285714286
Iq	q-current	1.0
RSOM	somesthetic ratio	1.0
Is	epsc amplitude	1.0
Ir	immunoreactivity	1.0
It	low threshold calcium conductance	1.0
p38MAPK	p38 mitogen-activated protein kinase	1.0
Ih	hyperpolarization-activated, mixed na+/k+ inward current	0.0833333333333
Ih	anomalous inward rectification	0.0833333333333
Ih	h-current	0.0833333333333
Ih	half maximum stimulus intensity	0.0833333333333
Ih	hyperpolarization-activated cation conductance	0.166666666667
Ih	holding current	0.0833333333333
Ih	hyperpolarization-activated cationic current	0.0833333333333
Ih	hyperpolarization-activated cation current	0.166666666667
Ih	hyperpolarization-activated inward current	0.166666666667
Ik	kth presynaptic interval	0.5
Ik	outward potassium current	0.5
BBBBasso	beattie, bresnahan	0.222222222222
BBBBasso	beattie, and bresnahan open-field locomotor rating scale	0.0555555555556
BBBBasso	beattie, bresnahan motor recovery score	0.0555555555556
BBBBasso	beattie and bresnahan	0.333333333333
BBBBasso	beattie, and bresnahan	0.333333333333
In	intercalated nucleus of the medulla	1.0
URP	urotensin ii-related peptide	1.0
chromogranin-A	derivative	1.0
T3-IHC	t3-immunohistochemistry	1.0
aAOB	anterior aob	0.5
aAOB	anterior accessory olfactory bulb	0.5
Ig	immunoglobulin	1.0
If	f-current	1.0
SCint	superior colliculus intermediate layers	1.0
LLC-PK	1 epithelial cells	1.0
ωCTxMVIIC	ω-conotoxin mviic	1.0
CTRL	control	0.666666666667
CTRL	sham-operated control animals	0.111111111111
CTRL	control rats	0.111111111111
CTRL	control group	0.111111111111
DPPL	dipeptidyl-peptidase-like protein	1.0
CTOPD-P	he-cys-tyr-d-trp-orn-thr-pen-thr-nh2	0.666666666667
CTOPD-P	he-cys-tyr-d-trp-orn-thr-phe-thr-nh2	0.333333333333
IIT	intensive insulin therapy	1.0
PANA	pelvic afferent nerve activity	1.0
CES-DC	enter for epidemiological studies-depression scale	1.0
ABCG	transporters	1.0
GIRK	g-protein-activated inwardly rectifying potassium	0.0833333333333
GIRK	g protein-coupled inwardly-rectifying k+ channel	0.0833333333333
GIRK	sg-protein-linked inwardly rectifying potassium channels	0.0833333333333
GIRK	g-protein-coupled k+ channel	0.0833333333333
GIRK	g-protein-gated inwardly rectifying k channel	0.0833333333333
GIRK	2g-protein-gated inwardly rectifying potassium (k) channel subunit 2	0.0833333333333
GIRK	g-protein-coupled inwardly rectifying potassium channel	0.0833333333333
GIRK	g protein-gated inwardly rectifying potassium channel	0.0833333333333
GIRK	g-protein-gated inward rectifier potassium channel	0.0833333333333
GIRK	g-protein-coupled inward rectifier k+-channel	0.0833333333333
GIRK	2g protein-coupled inwardly rectifying potassium channel 2	0.0833333333333
GIRK	2g-protein activated inwardly rectifying potassium channel 2	0.0833333333333
OXO-M	oxotremorine-m	1.0
CRH-	ircrh-immunoreactive	1.0
SIDSS	udden infant death syndrome	1.0
PPFR	paired pulse facilitation ratio	1.0
SAHA	suberoylanilide hydroxamic acid	1.0
HRPH	orseradish peroxidase	1.0
DNMTDNA-	methyltransferase	1.0
2H	2oheavy water	1.0
APPβ-	amyloid precursor protein	1.0
6-NQ6-nitroquipazine	6-nitro-2-(1-piperazinyl)-quinoline	1.0
VNLL	columnar division of the ventral nucleus of the lateral lemniscus	0.125
VNLL	ventral nucleus of the lateral lemniscus	0.75
VNLL	mmultipolar division of ventral nucleus of lateral lemniscus	0.125
BAXBCL-	2-associated x protein	1.0
CNGA	4a4 subunit of cyclic nucleotide–gated ion channels	0.5
CNGA	5cyclic nucleotide-gated channel alpha subunit 5	0.5
CPP-BP	cpp-binding protein	1.0
C-SO	control group – soybean oil	1.0
HMG-C	oa3-hydroxy-3-methylglutaryl coa	0.125
HMG-C	oar3-hydroxy-3-methyl-coa reductase	0.125
HMG-C	oa3-hydroxy-3-methylglutaryl-coa	0.125
HMG-C	oa3-hydroxy-3-methyl glutaryl coenzyme a	0.125
HMG-C	oa3-hydroxy-3-methylglutaryl coenzyme a	0.375
HMG-C	oa reductasehydroxymethyl-glutaryl coa reductase	0.125
PPFM	“pli de passage fronto-parietal moyen”	1.0
VVA	volume occupied by all vesicles within terminal	1.0
p-JNK	phosphorylated jnk	0.333333333333
p-JNK	phosphorylated-c-jun n-terminal kinase	0.333333333333
p-JNK	phosphorylated c-jun n-terminal protein kinase	0.333333333333
GPVD	guinea-pig vas deferens	1.0
IPC	intermediate progenitor cell	0.157894736842
IPC	caudal interpeduncular nucleus	0.0526315789474
IPC	central subnucleus of the i.p.	0.0526315789474
IPC	interpeduncular nucleus central subnucleus	0.0526315789474
IPC	“inverted” pyramidal cell	0.0526315789474
IPC	interplexiform cell	0.0526315789474
IPC	sintermediate progenitor cells	0.0526315789474
IPC	inner pillar cell	0.0526315789474
IPC	nucleus isthmi parvocellularis	0.0526315789474
IPC	ischemic preconditioning	0.421052631579
dm-STR	dorsomedial striatum	1.0
NCAM-IC	intracellular cleaved neural cell adhesion molecule	1.0
LyNPY	lymnaea homologue of neuropeptide y	1.0
INaP	persistent na+ current	0.25
INaP	persistent sodium current	0.75
SC-TCAP-	1scrambled teneurin c-terminal-associated peptide	1.0
EXPCO	context exposure control	1.0
c-jun-GR	a glucocorticoid receptor-inducible construct of c-jun	1.0
NaCl	5% 2 m tris, ph 9.5, 5% 1 m mgcl2, 1% tween-20, diluted in mqh2o	0.0714285714286
NaCl	0.2% triton x-100	0.0714285714286
NaCl	0.01%tween-20	0.0714285714286
NaCl	20 mm tris–hcl, ph 7.6 with 0.1% tween	0.0714285714286
NaCl	sodium chloride	0.0714285714286
NaCl	50 mm tris base	0.0714285714286
NaCl	3mm kcl, 0.1% tween-20, 2mm levamisole and 25mm tris–hcl	0.0714285714286
NaCl	50 nmol/l tris, ph 7.6) with 0.1% (w/v) tween 20	0.0714285714286
NaCl	100 mm tris–hcl, ph7.5	0.0714285714286
NaCl	27 mm kcl, 81 mm na2hpo4-12h2o, 15 mm kh2po4, 1% tween-20	0.0714285714286
NaCl	20 mm tris–hcl, ph 7.5, 0.05% tween 20	0.0714285714286
NaCl	5 mm mgcl2	0.0714285714286
NaCl	ph 7.2	0.0714285714286
NaCl	0.05% tween 20	0.0714285714286
TRCT	issue resource centre	1.0
141716A	[n-piperidino-5-(4-chlorophenyl) 1-(2,4-dichloro-phenyl)-4-methyl pyrazole-3-carboxamide hydrochloride]	1.0
VVOR	vertical vor	0.5
VVOR	visually-enhanced vestibulo-ocular reflex	0.5
CRHR	1crh receptor 1	0.111111111111
CRHR	1corticotropin releasing hormone receptor subtype 1	0.111111111111
CRHR	1corticotropin-releasing hormone receptor type 1	0.111111111111
CRHR	1corticotrophin releasing hormone receptor type-1	0.111111111111
CRHR	1/2crh receptor type 1 and type 2	0.111111111111
CRHR	1	0.111111111111
CRHR	2corticotropin-releasing hormone receptor-2	0.111111111111
CRHR	1corticotropin-releasing hormone receptor 1	0.111111111111
CRHR	2corticotropin-releasing factor receptor type 2	0.111111111111
εH-FH	uyn–feldt epsilon	1.0
GABARAPGABAA	receptor associated protein	1.0
CLA	claustrum	1.0
COS	cv-1origin-minus, sv40	1.0
GSK-3β	glycogen synthase kinase-3β	0.5
GSK-3β	glycogen synthase kinase 3β	0.5
NAEN-	acylethanolamines	0.666666666667
NAEN-	acyl ethanolamine	0.333333333333
LFT-PV	light finger touch only during post-vibration	1.0
UK-114	542, 5-[2-ethoxy-5-(morpholinylacetyl)phenyl]-1,6-dihydro-1-methyl-3-propyl-7h-pyrazolo[4,3-d]	1.0
Pir	cortex—piriform cortex	0.166666666667
Pir	piriform cortex	0.833333333333
NPGi	nucleus paragigantocellularis	1.0
DCNDC	nuclei	1.0
IL-1R1	type 1 il-1 receptor	0.5
IL-1R1	type 1 interleukin-1 receptor	0.5
oVOR	otolith vestibulo-ocular reflex	1.0
rVA	rotation about the vertical axis	1.0
AAHC	atomize and agglomerate hierarchical clustering	1.0
MTH	maternal thyroid hormone	1.0
SDCN	sacral dorsal commissural nucleus	1.0
HBSSHEPES-	buffered saline solution	0.111111111111
HBSSHEPES-	buffered physiological salt solution	0.111111111111
HBSSHEPES-	buffered salt solution	0.666666666667
HBSSHEPES-	buffered hank’s salt	0.111111111111
NEST-IN	eurothera effectiveness and safety trial	1.0
α2C-KO	mice lacking the α2c-adrenergic receptor	1.0
CNQX6-cyano-7-nitro-quinoxaline-2	3-dione-disodium	0.2
CNQX6-cyano-7-nitro-quinoxaline-2	3-dione	0.8
VSOR	volume-sensitive outwardly rectifying	1.0
GYKI-	52466	1.0
MFGO	molecular function	1.0
ESP	erector spinae	0.5
ESP	1exocrine gland-secreting peptide 1	0.5
iNA	inhibitory nucleic acid	1.0
GABA-IRγ-	aminobutyric acid-immunoreactivity	1.0
ZnD	z score value for each normalized dot density value	1.0
MAPKKMEK	mitogen-activated protein kinase kinase	1.0
9CP-A	de9-(cyclopentyl)-adenine	1.0
FGFR	2fibroblast growth factor receptor subtype 2	0.0434782608696
FGFR	basic fibroblast growth factor receptor	0.0434782608696
FGFR	3fibroblast growth factor receptor 3	0.0434782608696
FGFR	sfgf receptors	0.0434782608696
FGFR	1fibroblast growth factor receptor 1	0.0434782608696
FGFR	fgf receptor	0.0434782608696
FGFR	1sfibroblast growth factor receptor 1 short	0.0434782608696
FGFR	fibroblast growth factor receptor	0.652173913043
FGFR	1fgf receptor type 1	0.0434782608696
sMEP	spinal mep	1.0
TRI	triple reuptake inhibitor	0.5
TRI	total rna isolation	0.5
TRH	tryptophan hydroxylase	0.0285714285714
TRH	thyrotrophin-releasing hormone	0.0571428571429
TRH	thyroid hormone releasing hormone	0.0285714285714
TRH	thyrotropin releasing hormone	0.142857142857
TRH	thyrotropin-releasing hormone	0.714285714286
TRH	2tryptophan hydroxylase 2	0.0285714285714
TRK	tyrosine kinase receptor	1.0
DHET	dihydroxyeicosatrienoic acid	1.0
TRL	threshold range length	1.0
A-O	atlanto-occipital	1.0
TRN	thalamic reticular nucleus	0.962962962963
TRN	nucleus reticularis thalami	0.037037037037
AIAQ	anger irritability and assault questionnaire	1.0
TRC	staste receptor cells	1.0
TRB	3tribbles homolog 3	1.0
TRE	12-o-tetradecanoylphorbol 13-acetate response element	0.307692307692
TRE	tetracycline-responsive element	0.0769230769231
TRE	sthyroid response elements	0.0769230769231
TRE	12-o-tetradecanoyl-phorbol-13-acetate response element	0.0769230769231
TRE	phorbol-12-myristate-13-acetate response element	0.0769230769231
TRE	thyroid response element	0.0769230769231
TRE	tetradecanoyl phorbol acetate response element	0.0769230769231
TRE	thyroid responsive element	0.0769230769231
TRE	tumour promoter response element	0.0769230769231
TRE	12-o-tetradecanoylphorbol-13-acetate-responsive element	0.0769230769231
A-D	/d-aanalog to digital/digital to analog	1.0
TRG	trigeminal root ganglion	0.384615384615
TRG	trigeminal ganglion	0.615384615385
TRF	timed restricted feeding	0.333333333333
TRF	tonal receptive field	0.333333333333
TRF	transferrin	0.333333333333
TRX	1 m pbs/0.3% triton x-100	1.0
5-AV	5-amino valeric acid	1.0
A-P	anterior–posterior	0.25
A-P	anterior to bregma	0.125
A-P	antero-posterior	0.375
A-P	antero–posterior centre of mass displacement	0.125
A-P	anteroposterior	0.125
TRS	transmitter release site	1.0
AVPR	1barginine vasopressin receptor subtype 1b	0.333333333333
AVPR	1bavp receptor type 1b	0.333333333333
AVPR	1avasopressin 1a receptor	0.333333333333
TRT	exas red	0.714285714286
TRT	trotting	0.142857142857
TRT	percent total recording time	0.142857142857
AVPV	anteroventral periventricular nuclei	0.0454545454545
AVPV	anteroventral periventricular nucleus of the hypothalamus	0.0909090909091
AVPV	anteroventral periventrical nucleus	0.0454545454545
AVPV	asopressin	0.0454545454545
AVPV	anteroventral periventricular nucleus of the preoptic area	0.0454545454545
AVPV	anteroventral preoptic area	0.0454545454545
AVPV	anteroventral periventricular nucleus	0.681818181818
BCAO	bilateral common carotid artery occlusion	0.5
BCAO	bilateral carotid artery occlusion	0.5
HTD	high trans fatty acid diet	1.0
FDG-PET	[18f]-fluoro-deoxyglucose positron emission tomography	0.5
FDG-PET	18f-fluorodeoxyglucose-positron emission tomography	0.5
HTO	high-threshold oscillation	0.5
HTO	high-threshold membrane oscillation	0.5
HTN	hypertension	1.0
HTM	high threshold mechanoreceptors	1.0
RVIS	visual ratio	1.0
α-SNAPα	–soluble n-ethylmaleimide-sensitive factor attachment protein	1.0
HTH	hypothalamus	1.0
COMT-scatechol-O-methyltransferase	soluble isoform	1.0
psNSNA	peak-scaled non-stationary noise analysis	1.0
HTS	high-threshold ca2+ spike	0.4
HTS	hypertonic saline	0.2
HTS	high-threshold ca2+-spike	0.2
HTS	high-threshold dendritic calcium spike	0.2
sSNA	splanchnic sympathetic nerve activity	1.0
N-6-Oxo-5	6-dihydrophenanthridin-2-yl)n,n-dimethylacetamide.hcl]	1.0
TRs	thyroid hormone receptors	1.0
HTZ	heterozygous	1.0
AVPv	anteroventral periventricular nucleus	1.0
NK12	3, neurokinin-1,2,3	1.0
oriS	origin of dna replication	1.0
dSC	superior colliculus, deep layers	1.0
ODp	optical density unit per pixel	1.0
MPTP1-methyl-4-phenyl-1	2,3,6-tetrahydropyridine hydrochloride	0.00877192982456
MPTP1-methyl-4-phenyl-1	2,3,6- tetrahydropyridine	0.00877192982456
MPTP1-methyl-4-phenyl-1	2,5,6-tetrahydropyridine	0.00877192982456
MPTP1-methyl-4-phenyl-1	2,3,6-tetrahydopyridine	0.00877192982456
MPTP1-methyl-4-phenyl-1	2, 3, 6-tetrahydropyridine (mptp)	0.00877192982456
MPTP1-methyl-4-phenyl-1	2,3,4-tetrahydropyridine	0.00877192982456
MPTP1-methyl-4-phenyl-1	2,3,6 tetrahydropyridine	0.00877192982456
MPTP1-methyl-4-phenyl-1	2, 3, 6-tetrahydropyridine	0.00877192982456
MPTP1-methyl-4-phenyl-1	2,3,6-tetrahydropyridine-hcl	0.00877192982456
MPTP1-methyl-4-phenyl-1	2,3,6-tetrahydropyridine	0.90350877193
MPTP1-methyl-4-phenyl-1	2,3,6-tetrahydropyrimidine	0.0175438596491
AβOAβ	oligomers	1.0
poly-H	ispolyhistidine-tagged	1.0
VCTV	ogel conflict test	1.0
CDR-SBCDR-	sum of boxes	1.0
nAC	hnon-cholinergic	0.00943396226415
nAC	hrneuronal nicotinic acetylcholine receptors	0.00943396226415
nAC	hrnicotinic acetylcholinergic receptor	0.00943396226415
nAC	hrnicotinic acetylcholine receptor	0.547169811321
nAC	hrsnicotinic acetylcholine receptors	0.122641509434
nAC	hnicotinic ach	0.00943396226415
nAC	hrnicotinic receptor for acetylcholine	0.00943396226415
nAC	hrnicotine acetylcholine receptor	0.0188679245283
nAC	hrnicotinic acetycholine receptor	0.00943396226415
nAC	hrs	0.00943396226415
nAC	hrnicotinic-acetylcholine receptor	0.0188679245283
nAC	hrnicotinic receptors	0.00943396226415
nAC	hrsacetylcholine receptors	0.00943396226415
nAC	hracetylcholine receptor	0.00943396226415
nAC	hr	0.00943396226415
nAC	hrnicotinic receptor	0.0283018867925
nAC	hrnicotinic cholinergic receptor	0.00943396226415
nAC	hrneuronal nicotinic acetylcholine receptor	0.00943396226415
nAC	hneuronal acetylcholine	0.00943396226415
nAC	hnicotinic acetylcholine	0.0471698113208
nAC	hrnicotinic acetylcholine receptors	0.0660377358491
nAC	hrsnicotinic receptor subunits	0.00943396226415
nAC	hrnicotinic ach receptor	0.00943396226415
CRISP	cysteine-rich secretory protein	1.0
PWSP	rader–willi syndrome	1.0
ODP	ocular dominance plasticity	1.0
ODQ	1h-[1,2,4]oxadiazolo[4,3-a]	0.545454545455
ODQ	1h-(1,2,4)-oxadiazolo-(4,3a)-quinoxalin-1-one	0.0909090909091
ODQ	1h-(1,2,4)oxadiazolo(4,3a)quinoxalin-1-one	0.0909090909091
ODQ	oxadiazolo-quinoxaline-one	0.0909090909091
ODQ	n(g)-nitro-1h-[1,2,4]oxodiazolo[4,3-a]	0.0909090909091
ODQ	1h-[1,2,4]oxadiazolo-[4,3-a]	0.0909090909091
ODR	optical density ratio	0.333333333333
ODR	oculomotor delayed response	0.333333333333
ODR	oculomotor delayed-response	0.333333333333
ODS	ratsosteogenic disorder shionogi rats	0.333333333333
ODS	octadecylsilyl	0.666666666667
ODT	odor detection threshold	1.0
ODV	optical density value	1.0
CONTRA	contralateral	0.6
CONTRA	the contralateral svz	0.2
CONTRA	contralateral movement	0.2
SGCZ	mutations	1.0
ODN	(s)phosphorothioate oligodeoxynucleotide(s)	0.0243902439024
ODN	oligodeoxynucleotides	0.0243902439024
ODN	sdesoxyribonucleic acids	0.0243902439024
ODN	oligonucleotides	0.0243902439024
ODN	octadecaneuropeptide	0.0975609756098
ODN	soligodeoxynucleotides	0.0243902439024
ODN	oligodeoxynucleoside	0.0243902439024
ODN	soligonucleotides	0.0243902439024
ODN	oligonucleotide	0.121951219512
ODN	oligodeoxynucleotide	0.585365853659
ODN	oligodeoxyribonucleotide	0.0243902439024
ODO	ptical density	1.0
RD-	neuronrate decreasing neuron	1.0
ODC	ornithine decarboxylase	0.888888888889
ODC	ocular dominance column	0.111111111111
ODD	oxygen degradation domain	1.0
ODE	originally deprived eye	0.333333333333
ODE	ordinary differential equation	0.666666666667
3-APAD	3-acetylpyridine-adenine-dinucleotide	1.0
NK1r	neurokinin 1 receptor	1.0
VSP	voltage step protocol	0.5
VSP	trigeminal spinal nucleus	0.5
ELH	egg-laying hormone	1.0
RDP	randomized double pulses	0.333333333333
RDP	random dot pattern	0.333333333333
RDP	randomized double pulse	0.333333333333
ELL	electrosensory lateral line lobe	0.6
ELL	electrosensory lobe	0.4
ELM	expiratory laryngeal motoneuron	0.5
ELM	episodic-like memory	0.5
cC-VC	contralateral caudal vestibulocerebellar group	1.0
ELF	extremely low frequency	1.0
ELG	extraorbital lacrimal gland	1.0
NTIS	non-thyroidal illness syndrome	1.0
ELE	early life experience	1.0
RDE	rotating disk electrode	1.0
RDD	rate dependent depression	1.0
GαG	protein α	1.0
RDA	dextran-amine conjugated to tetramethylrhodamine	0.25
RDA	rhodamine dextran amine	0.5
RDA	tetramethylrhodamine dextran amine	0.25
RDC	random dot cinematograms	0.5
RDC	/tmdresearch diagnostic criteria for temporomandibular disorders	0.5
ara-C	cytosine-d-arabinofuranoside	0.333333333333
ara-C	cytosine-a-d-arabinofuranoside	0.333333333333
ara-C	cytosine arabinoside	0.333333333333
ELS	early-life stress	0.5
ELS	early life stress	0.5
ELP	echinoderm microtubule-associated protein-like protein	0.333333333333
ELP	elastin-like polypeptide	0.333333333333
ELP	extra lever-presses	0.333333333333
RDI	response duration index	0.5
RDI	relative duration of investigation	0.5
aIPS	anterior intraparietal sulcus	0.5
aIPS	anterior segment of the intraparietal sulcus	0.5
RDK	random dot kinematograms	0.2
RDK	random dot kinematogram	0.8
Cdc2IPc	cdc2 immunoprecipitation from non-synchronous neuroblastoma cells	1.0
FBS	fetal borine serum	0.0042735042735
FBS	fetal bovine serum	0.965811965812
FBS	foetal bovine serum	0.0299145299145
LEA	linoleyl ethanolamine	0.166666666667
LEA	lateral entorhinal cortex	0.333333333333
LEA	lateral entorhinal cortex area	0.166666666667
LEA	lateral entorhinal area	0.333333333333
LEC	lateral entorhinal cortex	0.7
LEC	light-evoked current	0.1
LEC	xlateral entorhinal cortex	0.1
LEC	lateral ec	0.1
LED	slight emitting diodes	0.0416666666667
LED	light	0.0208333333333
LED	slight-emitting diodes	0.0625
LED	light-emitting diode	0.5
LED	light emitting diode	0.333333333333
LED	light emitting diodes	0.0208333333333
LED	light-emitting device	0.0208333333333
RSna	non-adapting regular spiking neurons	1.0
LEF	1lymphoid enhancer-binding factor 1	0.5
LEF	laser-evoked magnetic field	0.5
ELc	entorhinal cortex, lateral caudal subfield	1.0
LEL	ong–evans	0.2
LEL	lycopersicon esculentum lectin	0.2
LEL	ong-evans rats	0.2
LEL	ong evans	0.2
LEL	ong-evans	0.2
sVC	spinal trigeminal nucleus caudalis	1.0
cBSTM	caudal bed nucleus of the stria terminalis	1.0
LEO	light-entrainable oscillator	1.0
LEP	slaser-evoked brain potentials	0.0909090909091
LEP	slaser-evoked potentials	0.0909090909091
LEP	laser evoked potential	0.0909090909091
LEP	lateral fluid percussion	0.0909090909091
LEP	laser-evoked potential	0.454545454545
LEP	slaser evoked potentials	0.0909090909091
LEP	1early laser evoked potential	0.0909090909091
LER	lesser epithelial ridge	1.0
LES	lumbar erector spinae	0.25
LES	light-enhanced-startle	0.25
LES	light-enhanced startle	0.25
LES	low-intensity electroconvulsive shock	0.25
FBG	1	0.333333333333
FBG	fasting blood glucose	0.666666666667
FBF	ast blue	0.939393939394
FBF	ast-blue	0.030303030303
FBF	astblue	0.030303030303
LEV	levator labii superioris muscle	0.5
LEV	levetiracetam	0.5
LEW	lewis	1.0
RONS	reactive oxygen/nitrogen species	1.0
iGlu	ionotropic glutamate	0.5
iGlu	ionotropic glutamate receptor	0.5
FBI	full body illusion	1.0
orphanin-FQ	/nociceptin	1.0
FBN	fischer 344/brown–norway f1 hybrid rats	1.0
4-P-PDOT	4-phenyl-2-propionamidotetralin	1.0
NGR	nerve growth factor	1.0
2-Butyl-6	7dichloro-2-cyclopentyl-2,3-dihidro-1oxo-1h-inden-5-yl)oxy] butanoic acid	1.0
rPRL	rat prolactin	1.0
NCSP	neuronal calcium sensor protein	1.0
NPRAP	neural plakophilin-related arm protein	1.0
RSplG	retrosplenial granular cortex	1.0
BN-52021	ginkgolide b	1.0
C-SPW	scluster of spws	1.0
SGn	suprageniculate nucleus	1.0
CMiHi	mechano- and heat-insensitive c-unit	1.0
AHBs	antisense homology boxes	1.0
KCCK	+-cl- cotransporter	0.25
KCCK	+–cl-	0.25
KCCK	+/cl- cotransporter	0.5
SGZ	subgranular zone	0.913978494624
SGZ	subgranularzone	0.010752688172
SGZ	subgranular cell layer	0.0215053763441
SGZ	subgranular zone of the dentate gyrus	0.0322580645161
SGZ	sub granular zone	0.0215053763441
GLT-1	glutamate transporter 1	0.2
GLT-1	rat glutamate transporter	0.2
GLT-1	glutamate transporter-1	0.6
SGP	stratum griseum profundum	0.666666666667
SGP	stratum griseum periventriculare	0.111111111111
SGP	suprageniculate pretectal nucleus	0.111111111111
SGP	stratum griseum profundum of superior colliculus	0.111111111111
SGS	stratum griseum superficiale	0.875
SGS	stratum griseum superficial	0.0416666666667
SGS	stratum griseum superficiale (superficial grey layer of superior colliculus)	0.0416666666667
SGS	stratum griseum superficial of superior colliculus	0.0416666666667
SGR	subgranular regions	1.0
SGT	shoulder gravitational torque	1.0
SGV	ector ‘slate gray.’	1.0
SGI	stratum griseum intermediale	0.857142857143
SGI	silver–gold intensification	0.0714285714286
SGI	stratum griseum intermediale of superior colliculus	0.0714285714286
ACSL	4acyl-coa synthetase type 4 for long chain fatty acids	1.0
SGK	serum and glucocorticoid-inducible kinase	1.0
SGM	stratum griseum medium	1.0
SGL	subgranular layer	0.6
SGL	superficial gray layer	0.2
SGL	superficial grey layer	0.2
SGN	spiral ganglion neurones	0.0666666666667
SGN	supragenual nucleus	0.0666666666667
SGN	spiral ganglion neuron	0.333333333333
SGN	spiral ganglion neurons	0.133333333333
SGN	sspiral ganglion neurons	0.4
SGA	second generation antipsychotic	1.0
βAPP	β-amyloid precursor protein	1.0
SGC	stratum griseum superficiale	0.0434782608696
SGC	stratum griseum centrale	0.304347826087
SGC	spiral ganglion cell	0.0434782608696
SGC	sulfoglucuronyl carbohydrate	0.0434782608696
SGC	satellite glial cell	0.130434782609
SGC	satellite glial cells	0.0434782608696
SGC	superficial granule cells	0.0434782608696
SGC	ssatellite glia cells	0.0434782608696
SGC	sspiral ganglion cells	0.0869565217391
SGC	ssatellite glial cells	0.217391304348
ACSF	artificial cerebrospinal fluid solution	0.00135135135135
ACSF	artificial cerebro spinal fluid	0.00135135135135
ACSF	artificial cerebrospinal solution	0.0027027027027
ACSF	artifical cerebrospinal fluid	0.0027027027027
ACSF	artificial cerebral-spinal fluid	0.0027027027027
ACSF	artificial cerebral spinal fluid	0.0364864864865
ACSF	artificial cerebral–spinal fluid	0.00135135135135
ACSF	artificial cerebrospinal	0.00135135135135
ACSF	artificial cerebrospinal fluid/solution	0.00135135135135
ACSF	artificial csf	0.00405405405405
ACSF	artificial cerebro-spinal fluid	0.00540540540541
ACSF	artificial cerebrospinalfluid	0.00135135135135
ACSF	(modified) artificial cerebrospinal fluid	0.00135135135135
ACSF	artificial cerebrospinal fluid	0.936486486486
SGE	spinal generator for ejaculation	0.5
SGE	stearate-modified graphite paste electrode	0.5
SGD	serum and glucose deprivation	0.75
SGD	salivary gland duct	0.25
SGG	salt–glucose–glycine	1.0
SGF	stratum griseum et fibrosum superficiale	1.0
CNV	copy number variants	0.0714285714286
CNV	common copy number variants	0.0714285714286
CNV	copy number variant	0.214285714286
CNV	copy number variations	0.0714285714286
CNV	copy number variation	0.142857142857
CNV	contingent negative variation	0.357142857143
CNV	scopy number variations	0.0714285714286
Inter-B	mean interval separating two successive bursts	1.0
ICI	182	0.142857142857
ICI	intercontraction interval	0.142857142857
ICI	inter-contraction interval	0.142857142857
ICI	inter-click interval	0.285714285714
ICI	intra-cluster interval	0.285714285714
ICH	intracerebral hemorrhage	1.0
CNR	contrast-to-noise ratio	0.25
CNR	cadherin neural receptor	0.125
CNR	1cannabinoid receptor type 1 gene	0.125
CNR	1	0.25
CNR	4conserved non-coding region 4	0.125
CNR	4conserved noncoding region 4	0.125
CNS	development	0.00877192982456
CNS	motor programs	0.00438596491228
CNS	toxicity	0.00438596491228
CNS	diseases	0.00438596491228
CNS	plasticity	0.00438596491228
CNS	mapping	0.00438596491228
CNS	infections	0.00438596491228
CNS	regeneration	0.0131578947368
CNS	damage	0.00438596491228
CNS	and chondroitin sulphate proteoglycans	0.00438596491228
CNS	central nervous system	0.90350877193
CNS	acetylcholine release	0.0131578947368
CNS	drug discovery	0.00438596491228
CNS	injury	0.0175438596491
CNS	oxygen toxicity	0.00438596491228
CNP	central neuropathic pain	0.047619047619
CNP	ase2′,3′-cyclic nucleotide 3′ phosphodiesterase	0.0238095238095
CNP	ase2′, 3′-cyclic nucleotide 3′-phosphodiesterase	0.0238095238095
CNP	2′,3′-cyclic nucleotide 3'-phosphodiesterase	0.0238095238095
CNP	c-type natriuretic peptide	0.0238095238095
CNP	ase2′,3′-cyclic nucleotide 3′-phosphodiesterase(oligodendrocyte specific marker)	0.0238095238095
CNP	ase2”, 3”-cyclic nucleotide 3'-phosphodiesterase	0.0238095238095
CNP	2′,3′-cyclic nucleotide 3′-phosphodiesterase	0.0714285714286
CNP	ase2′,3′cyclic nucleotide 3′-phosphodiesterase	0.0238095238095
CNP	ase3′-5′cyclic nucleotide phosphodiesterase	0.0238095238095
CNP	2’,3’-cyclic nucleotide 3’-phosphodiesterase	0.047619047619
CNP	ase2′,3′-cyclic nucleotide-3′-phosphodiesterase	0.0714285714286
CNP	asecyclic nucleotide 3-phosphohydrolase	0.0238095238095
CNP	ase2′,3′-cyclic nucleotide 3′phosphodiesterase	0.0238095238095
CNP	ase2′,3′ cyclic nucleotide 3′-phosphodiesterase	0.0238095238095
CNP	ase2′,3′-cyclic nucleotide 3′-phosphodiesterase	0.309523809524
CNP	ase2′-3′-cyclic-nucleotide 3′-phosphodiesterase	0.047619047619
CNP	2′,3′-cyclic nucleotide-3′-phosphodiesterase	0.0238095238095
CNP	ase2′,3′ cyclic nucleotide 3′ phosphodiesterase	0.0238095238095
CNP	ase2′,3′-cyclic nucleotide 3′-phosphodiesteras	0.0238095238095
CNP	ase2-3-cyclic nucleotide 3-phosphodiesterase	0.0238095238095
CNP	2′-3′-cyclic nucleotide 3′phosphodiesterase	0.0238095238095
CNP	ase2″,3″-cyclic nucleotide 3′-phosphodiesterase	0.0238095238095
ICL	internal cell layer	1.0
ICC	interclass correlations	0.0142857142857
ICC	immunocytochemistry	0.714285714286
ICC	immunocytochemical	0.0142857142857
ICC	interstitial cells of cajal	0.0571428571429
ICC	sinterstitial cells of cajal	0.0142857142857
ICC	intraclass correlation coefficient	0.0285714285714
ICC	central nucleus of inferior colliculus	0.0285714285714
ICC	immunocytochemistry, immunocytochemical	0.0142857142857
ICC	immunocytochemistry/immunochemical staining	0.0142857142857
ICC	central nucleus of the inferior colliculus	0.0857142857143
ICC	intra-class correlation coefficient	0.0142857142857
ICB	intracerebellar	1.0
ICA	intercalated nucleus of the amygdala	0.0208333333333
ICA	internal carotid artery	0.604166666667
ICA	intensity correlation analysis	0.0416666666667
ICA	independent component analysis	0.291666666667
ICA	independent components analysis	0.0208333333333
ICA	induced chromosome aberration	0.0208333333333
cIAP	2cellular inhibitor of apoptosis protein 2	1.0
RTI-55	3β-(4-iodophenyl)tropan-2β-carboxylic acid methyl ester	1.0
ICF	intracortical facilitation	1.0
ICE	interleukin β-converting enzyme	0.0555555555556
ICE	interleukin-1β converting enzyme	0.5
ICE	the interleukin-1 beta converting enzyme	0.0555555555556
ICE	interleukin-1 converting enzyme	0.0555555555556
ICE	il-1β-converting enyme	0.0555555555556
ICE	interleukin-1β-converting enzyme	0.277777777778
ICD	intracellular depression	0.142857142857
ICD	initial cell density	0.142857142857
ICD	intracellular domain	0.285714285714
ICD	dorsal cortex of inferior colliculus	0.142857142857
ICD	dorsal cortex of the inferior colliculus	0.285714285714
CNF	cuneiform nucleus	0.8
CNF	scochlear nerve fibers	0.2
CNG	channelcyclic nucleotide-gated channel	0.0714285714286
CNG	cyclic nucleotide-gated cation channel	0.0714285714286
CNG	channelscyclic nucleotide-gated channels	0.0714285714286
CNG	scyclic nucleotide–gated ion channels	0.0714285714286
CNG	cyclic nucleotide gated	0.142857142857
CNG	cyclic nucleotide-gated	0.5
CNG	cyclic nucleotide gated channel	0.0714285714286
t-B	uoohtert-butyl hydroperoxide	1.0
ICX	external cortex of the inferior colliculus	1.0
CNB	cyclic nucleotide binding site	0.5
CNB	carboxy-nitrobenzyl	0.5
PPMS	primary progressive form of ms	0.5
PPMS	primary progressive multiple sclerosis	0.5
CNA	central amygdaloid nucleus	0.125
CNA	central nucleus of amygdala	0.125
CNA	central nucleus of the amygdala	0.75
ICS	intracellular solution	0.333333333333
ICS	intracranial electrical stimulation	0.166666666667
ICS	intracranial self-stimulation	0.166666666667
ICS	205-9303-tropanylindole-3-carboxylate hydrochloride	0.166666666667
ICS	intracranial stimulation	0.166666666667
ICR	mouseinstitute of cancer research mouse	0.5
ICR	simprint control regions	0.5
ICQ	intensity correlation quotient	1.0
ICP	intracranial pressure	0.72
ICP	intracavernous pressure	0.08
ICP	inferior cerebellar peduncle	0.04
ICP	0infected cell polypeptide 0	0.04
ICP	intracellular potentiation	0.04
ICP	meanmean intracavernosal pressure	0.04
ICP	infected-cell polypeptide	0.04
IBC	inner border cell	1.0
ICV	intra-cerebro-ventricular	0.0454545454545
ICV	intraventricular	0.0454545454545
ICV	intracranial volume	0.181818181818
ICV	intracerebral ventricular	0.0454545454545
ICV	intracerebroventricle	0.0454545454545
ICV	intracerbroventricular	0.0454545454545
ICV	intracerebroventricular	0.545454545455
ICV	intracerebralventricular	0.0454545454545
ICU	intensive care unit	1.0
BMG	beta-2 microglobulin	1.0
PFA	perifornical area	0.0139664804469
PFA	phosphate-buffered paraformaldehyde	0.00279329608939
PFA	paraformaldehyde 4%	0.00279329608939
PFA	4% paraformaldehyde solution in 0.1 m phosphate buffer	0.00279329608939
PFA	paraformaldeyde	0.00279329608939
PFA	–lhperifornical area and lateral hypothalamus	0.00279329608939
PFA	4% paraformaldehyde in 0.1m pbs	0.00279329608939
PFA	para-formaldehyde	0.00558659217877
PFA	contiguous perifornical area	0.00279329608939
PFA	paraformaldehyde in phosphate buffer	0.00279329608939
PFA	paraformaldehyde	0.958100558659
PEMS	posterior extramural migratory stream	1.0
PFC	prefrontal neocortex	0.0030303030303
PFC	the prefrontal cortex	0.0030303030303
PFC	/ba9prefrontal cortex/brodmann's area 9	0.0030303030303
PFC	)	0.0030303030303
PFC	medial prefrontal cortex	0.00909090909091
PFC	prefrontal cortex	0.933333333333
PFC	/ba9prefrontal cortex/brodmann’s area 9	0.00606060606061
PFC	pair-fed control	0.0030303030303
PFC	prefrontal frontal cortex	0.0030303030303
PFC	prefrontal cortical/cortex	0.0030303030303
PFC	pre frontal cortex	0.0030303030303
PFC	(medial) prefrontal cortex	0.0030303030303
PFC	prefrontal cortices	0.0030303030303
PFC	gprefrontal cingulate cortex	0.0030303030303
PFC	prelimbic region of prefrontal cortex	0.0030303030303
PFC	prefrontal cortex lesion	0.0030303030303
PFC	prefrontal/insular cortex	0.0030303030303
PFC	pre-frontal cortex	0.00909090909091
lSNA	lumbar sympathetic nerve	1.0
PFD	preferred firing direction	1.0
PFG	protein-free group	1.0
BoTx-A	botulinum toxin type a	1.0
ICc	central nucleus of the ic	1.0
PFH	perifornical lateral hypothalamus	0.5
PFH	perifornical hypothalamic area	0.5
ICa	calcium inward current	0.111111111111
ICa	calcium current	0.666666666667
ICa	ppersistent ca2+ current	0.111111111111
ICa	voltage-dependent ca2+-currents	0.111111111111
RMSEA	root mean square error of approximation	1.0
PFN	2profilin 2	0.333333333333
PFN	parafasicular nucleus	0.333333333333
PFN	phasic-firing neuron	0.333333333333
PFP	air-fed control group	0.666666666667
PFP	aeoniflorin	0.333333333333
DXM	bdexamethasone base	1.0
PFR	peak firing rate	0.25
PFR	prefrontal cortex	0.25
PFR	perifornical region	0.5
PFU	plaque-forming unit	0.375
PFU	plaque forming unit	0.25
PFU	plaque-forming units	0.125
PFU	plaque forming units	0.25
PFT	pifithrin-α	1.0
PFV	pre-synaptic fiber volley	1.0
2-IT	2-iminothiolane	1.0
NMAN-methyl-d	l-aspartic acid	1.0
Ileak	leak conductance	1.0
bWFA	biotinylated wisteria floribunda agglutinin	1.0
NP-	647l-pglu-(2-propyl)-l-his-l-pronh2	0.333333333333
NP-	1neuropilin-1	0.333333333333
NP-	40nonidet p-40	0.333333333333
2hR	2 h periods of rest during the sleep deprivation protocol	1.0
FPBI	fluid-percussion brain injury	1.0
ED50	doses that produce 50% of the maximum inhibition	0.25
ED50	50% of effective dose	0.25
ED50	half-maximal dose	0.25
ED50	effective dose in 50% of subjects	0.25
GWGABA	withdrawal	1.0
AH-	type neurons	1.0
vWM	ventral white matter	1.0
SCG-	10	1.0
RIC-	3resistance to inhibitors of cholinesterase-3	1.0
AβA-β	peptide	1.0
JIP-	1c-jun n-terminal kinase interacting protein 1	0.5
JIP-	1c-jun n-terminal kinase-interacting protein-1	0.5
AMPARAMPA-	type receptor	1.0
EPSPs	excitatory postsynaptic potentials	0.857142857143
EPSPs	excitatory post synaptic potentials	0.0714285714286
EPSPs	excitatory post-synaptic potentials	0.0714285714286
RS-79948-197	[8ar,12as,13as]-5,8,8a,9,10,11,12,12a,13,13a-decahydro-12-(ethylsulfonyl)-3-methoxy-6h-isoquino[2,1-g]	1.0
vWF	von willebrand factor	0.9
vWF	van willebrand factor	0.1
STAT-	1signal transducers and activator of transcription 1	1.0
hCBF	hippocampal blood flow	1.0
KATPATP	dependent potassium channel	0.5
KATPATP	sensitive potassium channels	0.5
SQRDL	sulfide-quinone reductase-like protein	1.0
PITP	avlovian-instrumental transfer	0.333333333333
PITP	phosphatidylinositol transfer protein	0.333333333333
PITP	avlovian-to-instrumental transfer	0.333333333333
7AAD	7-amino-actinomyocin d	1.0
DRPLA	dentatorubral-pallidoluysian atrophy	1.0
WGTA	wisconsin general test apparatus	1.0
IEG	immediate early genes	0.0357142857143
IEG	immediate-early gene	0.3
IEG	immediately early gene	0.00714285714286
IEG	immediate-early-gene	0.0142857142857
IEG	immediate-early gene(s)	0.00714285714286
IEG	immediate–early gene	0.00714285714286
IEG	immediate-early genes	0.0142857142857
IEG	simmediate-early genes	0.0214285714286
IEG	immediate early gene	0.521428571429
IEG	simmediate early genes	0.0714285714286
EDHF	endothelium-derived hyperpolarizing factor	1.0
PITC	phenylisothiocyanate	1.0
IEF	isoelectric focusing	0.818181818182
IEF	isoelectric focusing apparatus	0.0909090909091
IEF	isoelectric focusing system	0.0909090909091
GGTγ-	glutamyl transpeptidase	1.0
DADLD-Ala2	d-leu5-enkephalin	1.0
NPo	channel activity: product of number of channels (n) and open probability (po)	1.0
3-AP	3-acetylpyridine	1.0
TBS-C	atris-buffered saline supplemented with 1 mm cacl2	1.0
GIR	glucocorticoid-induced receptor	1.0
GIP	glucose-dependent insulinotropic polypeptide	0.5
GIP	gastric inhibitor polypeptide	0.25
GIP	sgpcr-interacting proteins	0.25
SSCT	standard saline citrate+01% tween 20	1.0
TK-HSV-1	thymidine kinase deficient hsv-1	1.0
8AG	8-azaguanine	1.0
3-AB	3-aminobenzamide	1.0
TBS-T	0.1% v/v triton x-100 in tbs	0.03125
TBS-T	20 mmol/l tris–hcl (ph 7.4), 150 mmol/l nacl and 0.1% tween 20	0.03125
TBS-T	tris-buffered saline/0.01% tween 20	0.03125
TBS-T	tris-buffered saline with tween 20 (10 mm tris ph 7.5, 100 mm nacl, 0.1% tween 20)	0.03125
TBS-T	20 mm tris–hcl (ph 7.4), 150 mm nacl and 0.1% tween 20	0.03125
TBS-T	weentbs+0.05% tween 20	0.03125
TBS-T	tris-buffered saline containing 0.1% tween-20	0.03125
TBS-T	tris buffered saline with 0.3% triton x-100	0.03125
TBS-T	tris-buffered saline	0.03125
TBS-T	tris buffered saline with 0.1% tween 20	0.03125
TBS-T	5% skimmed milk in 0.01% tween 20	0.03125
TBS-T	tris-buffered saline containing 0.2% tween-20	0.03125
TBS-T	tris-buffered saline with tween	0.03125
TBS-T	tbs containing 0.3% triton x-100	0.03125
TBS-T	tris-buffered saline containing triton x-100	0.03125
TBS-T	tris-buffered saline with 0.3% triton x-100	0.0625
TBS-T	tris-buffered saline with 0.1% tween 20	0.03125
TBS-T	tween 20	0.03125
TBS-T	xtris-buffered saline (ph 8.6) with 0.5% triton x-100	0.03125
TBS-T	tbs containing 0.5% triton x-100	0.03125
TBS-T	xtris-buffered saline and 0.5% triton x-100	0.03125
TBS-T	tris-buffered saline containing 0.1% tween20	0.03125
TBS-T	tbs containing triton x-100	0.03125
TBS-T	tris-buffered saline containing 0.1% tween	0.03125
TBS-T	tris–buffered saline with tween-20	0.03125
TBS-T	ritontriton x-100 in tbs	0.03125
TBS-T	tbs with triton x-100	0.03125
TBS-T	tris-buffered saline with triton x-100	0.03125
TBS-T	tris-buffered saline containing tween-20	0.03125
TBS-T	tris-buffered saline containing 0.5% triton x-100	0.03125
TBS-T	tris-buffered saline with tween 20	0.03125
GIA	gigantocellular reticular nucleus	1.0
rt-PA	recombinant tissue-type plasminogen activator	0.5
rt-PA	recombinant tissue plasminogen activator	0.5
EPSP2	epsps evoked by the first and second paired pulses, respectively	1.0
Vsp	spinal trigeminal nucleus	1.0
AHC	anterior hippocampal continuation	0.2
AHC	anterior hypothalamic area	0.2
AHC	anterior hypothalamic area (central)	0.2
AHC	anterior hypothalamus	0.2
AHC	anterior hypothalamus central	0.2
NPO	nucleus pontis oralis	0.8
NPO	nucleus reticularis pontis oralis	0.2
AHA	anterior hypothalamic area	0.565217391304
AHA	anterior hypotalamic area	0.0434782608696
AHA	danterior hypothalamic area dorsal	0.0434782608696
AHA	amygdalohippocampal area	0.347826086957
NPI	neuropsychiatric inventory	1.0
NPH	humulin neutral protamine hagedorn	0.142857142857
NPH	nucleus prepositus hypoglossi	0.428571428571
NPH	nucleus prepositus	0.142857142857
NPH	normal pressure hydrocephalus	0.142857142857
NPH	nitrophenylhydrazine	0.142857142857
NPK	neuropeptide k	1.0
AHE	acute hepatic encephalopathy	0.5
AHE	acute hyperammonemic encephalopathy	0.5
NPE	non-preexposed	0.133333333333
NPE	non-pre-exposed group	0.0666666666667
NPE	non-pre-exposed subgroup	0.0666666666667
NPE	non-pre-exposed	0.666666666667
NPE	nonpreexposed	0.0666666666667
NPD	normal pellet diet	0.333333333333
NPD	1neuroprotectin d1	0.666666666667
PBS-TPBS	with 0.1% tween-20	0.111111111111
PBS-TPBS	containing 0.2% triton x-100	0.111111111111
PBS-TPBS	/0.1% triton-x	0.111111111111
PBS-TPBS	that contained 0.3% triton x-100	0.111111111111
PBS-TPBS	+0.1% triton x-100	0.111111111111
PBS-TPBS	with triton	0.111111111111
PBS-TPBS	containing triton x-100	0.222222222222
PBS-TPBS	supplemented with 0.3% triton x-100	0.111111111111
NPA	nipecotic acid	1.0
NAALAD	asen-acetylated α-linked acidic dipeptidase	0.5
NAALAD	ase ln-acetylated-alpha-linked-acidic dipeptidase l	0.5
NPC	sneural progenitor cells	0.25
NPC	neuronal progenitor cells	0.0192307692308
NPC	1niemann-pick disease type c1	0.0192307692308
NPC	neural progenitor cell	0.192307692308
NPC	sneural precursor cells	0.115384615385
NPC	sneuroprogenitor cells	0.0192307692308
NPC	nuclear pore complex	0.0384615384615
NPC	niemann–pick type c disease	0.0192307692308
NPC	1niemann-pick type c1	0.0192307692308
NPC	niemann–pick c	0.0192307692308
NPC	nucleus reticularis pontis caudalis	0.0192307692308
NPC	neural progenitor cells	0.0576923076923
NPC	sneuronal progenitor cells	0.0192307692308
NPC	neural precursor/progenitor cell	0.0192307692308
NPC	nucleus of the posterior commissure	0.0192307692308
NPC	neural precursor cell	0.0769230769231
NPC	1niemann–pick type c1	0.0192307692308
NPC	nuclear core complex	0.0192307692308
NPC	neural precursor cells	0.0192307692308
NPC	sneural stem/progenitor cells	0.0192307692308
NPB	neuropeptide b	1.0
AHS	ammon’s horn sclerosis	0.5
AHS	ammon's horn sclerosis	0.5
AHP	afterhypolarizations	0.00571428571429
AHP	after-hyperpolarisation	0.0228571428571
AHP	spike after-hyperpolarization	0.00571428571429
AHP	afterhyperpolarising potential	0.0114285714286
AHP	safter-hyperpolarization	0.00571428571429
AHP	afterhyperpolarizing potential or afterhyperpolarization	0.00571428571429
AHP	postburst afterhyperpolarization	0.00571428571429
AHP	after-hyperpolarization potential	0.0171428571429
AHP	ffast component of afterhyperpolarization	0.00571428571429
AHP	afterhyperpolarizing potential	0.0514285714286
AHP	action potential's hyperpolarization	0.00571428571429
AHP	afterhyperpolarising potential (following an action potential)	0.00571428571429
AHP	after hyperpolarization potential	0.00571428571429
AHP	after hyperpolarising potential	0.00571428571429
AHP	anterior posterior hypothalamic nucleus	0.00571428571429
AHP	afterhyperpolarizing potential that follows the action potential	0.00571428571429
AHP	afterhyperpolarizing	0.00571428571429
AHP	after-hyperpolarization	0.0685714285714
AHP	afterhyperpolarisation	0.0228571428571
AHP	sslow afterhyperpolarization	0.00571428571429
AHP	after hyperpolarizing potential	0.00571428571429
AHP	spike afterhyperpolarizing potential	0.00571428571429
AHP	after-hyperpolarizing potential	0.0285714285714
AHP	hyperpolarizing afterpotential	0.00571428571429
AHP	afterhyperpolarization component	0.00571428571429
AHP	afterhyperpolarization	0.64
AHP	afterhyperpolarisation potential	0.00571428571429
AHP	afterhyperpolarization potential	0.0171428571429
AHP	amplitude of afterhyperpolarization	0.00571428571429
AHP	safterhyperpolarizations	0.00571428571429
NPY	neuropeptide-y	0.0284697508897
NPY	neuropeptide tyrosine (y)	0.0106761565836
NPY	neuropeptide y	0.914590747331
NPY	neuropeptide y (tyrosine)	0.00355871886121
NPY	neural peptide y	0.00355871886121
NPY	neuropeptide tyrosine	0.0249110320285
NPY	13-36preferential agonist for neuropeptide y2 receptor	0.00355871886121
NPY	y1 and y5 receptors	0.00355871886121
NPY	neuropeptide	0.00355871886121
NPY	neuropeptide y protein	0.00355871886121
GIa	group ia	1.0
ABC-	transporter	1.0
AHZ	acute herpes zoster	1.0
NPW	naloxone-precipitated withdrawal	0.5
NPW	neuropeptide w	0.5
NPV	negative predictive value	1.0
tADA	trans-azetidine-2,4-dicarboxylic acid	1.0
NPP	p-nitrophenyl phosphate	0.25
NPP	nucleus pretectalis principalis	0.25
NPP	neuropathic pain	0.5
NPS	neuropeptide s	1.0
NPR	nose-poke response	0.25
NPR	natriuretic peptide receptor	0.25
NPR	neuronal pentraxin receptor	0.5
DEVD-	pnan-acetyl-asp-glu-val-asp-p-nitroanilide	0.5
DEVD-	pnaac-asp-glu-val-asp-paranitroaniline	0.5
1TT	one-trial training	1.0
Na3GTP	guanosine 5′-triphosphate trisodium salt	1.0
CNQX6-cyano-7-nitroquinoxialine-2	3-dion	1.0
DHPR	dihydropyridine receptor	1.0
tBBB	transformed bbb scale	1.0
CDI	curvature discrimination index	0.25
CDI	calcium dependent inactivation	0.25
CDI	calcium-dependent inactivation	0.25
CDI	child depression inventory	0.25
dMAN	2-deoxymannojirimycin	1.0
CRHBPCRH-	binding protein	1.0
TFBS	transcription factor binding site	1.0
17-DMAG17-desmethoxy-17-N	n-dimethylaminoethylaminogeldanamycin	1.0
LRRTM	leucine-rich repeat transmembrane protein	1.0
CM-PF	centromedian-parafascicular	1.0
PBS-TX-NGS	10% normal goat serum in phosphate-buffered saline containing 0.3% triton x-100	1.0
SC-CA	1schaffer collateral-ca1	1.0
MHP36	maudsley hippocampal stem cell line, clone 36	1.0
CDT	sclock drawing tests	1.0
POSH	plenty of sh3s	0.5
POSH	plenty of sh3	0.5
SAHS-	adinosyl homocysteine	0.5
SAHS-	adenosylhomocysteine	0.5
MHDMAGE	homology domain	1.0
MSC-CMMSC	s conditioned medium	1.0
RIPP-	1ribosomal inhibitor of protein phosphatase 1	1.0
DNDS	4,4′-dinitrostilbene-2,2′-disulfonic acid	1.0
LTDL	ong term depression	1.0
nbM	nucleus basalis of meynert	0.75
nbM	basal nucleus of meynert	0.25
CIDIC	omposite international diagnostic interview	1.0
lSNc	lateral substantia nigra, pars compacta	1.0
PLC	phospholipase c	0.913461538462
PLC	oposterolateral cortical amygdaloid nucleus	0.0192307692308
PLC	prelimbic cortex	0.0192307692308
PLC	phospholipase	0.00961538461538
PLC	oposterolateral cortical amygdala	0.00961538461538
PLC	ß4phospholipase cß4	0.00961538461538
PLC	phospholipase c.	0.00961538461538
PLC	oposterolateral cortical nucleus	0.00961538461538
sGNC	soluble guanylyl cyclase	1.0
AROM	aromatase	1.0
gCTX	retrosplenial granulate cortex	1.0
SCNAS	omatic copy number aberrations	1.0
RTTR	ett syndrome	1.0
VEGFV	ascular endothelial growth factor	1.0
PLA	phospholipase a	0.0454545454545
PLA	the peri-lesion area of the striatum	0.0454545454545
PLA	2phospholipase a2	0.727272727273
PLA	2phospholipases a2	0.0909090909091
PLA	placebo	0.0454545454545
PLA	2phospholipase-a2	0.0454545454545
VEGFR	s	0.142857142857
VEGFR	2vegf receptor 2	0.142857142857
VEGFR	2vascular endothelial growth factor receptor 2	0.142857142857
VEGFR	vascular endothelial growth factor receptor	0.571428571429
TβR-I	type i transforming growth factor-beta receptor	1.0
CaBPs	calcium-binding proteins	1.0
IRCCTV	infrared closed-circuit television	1.0
KPB	potassium phosphate buffer	1.0
LHS	left hand side	0.5
LHS	left-hand side	0.5
2-OG	2-oxoglutarate	0.5
2-OG	2-oleoylglycerol	0.5
TKHSV-	1 thymidine kinase	1.0
KPI	kunitz protease inhibitor	0.666666666667
KPI	kunitz-type protease inhibitor	0.333333333333
KPK	ynurenine pathway	1.0
PCxApaleocortex	anterior part	1.0
P450C17	17α-hydroxylase	1.0
PulM	medial pulvinar nucleus	1.0
PulO	oral pulvinar nucleus	1.0
KOR-IR	kappa opioid receptor immunoreactivity	1.0
PLK	2	0.333333333333
PLK	pyridoxal kinase	0.666666666667
mtPS1	wild-type/mutant ps1 gene	1.0
cDKO	conditional double-knockout	1.0
BzATP	benzoyl–benzoyl-atp	1.0
BMDEC	bone marrow–derived endothelial cells	1.0
KPi	monobasic potassium phosphate	1.0
GJIC	gap junction intercellular communication	0.125
GJIC	gap junctional intercellular communication	0.875
MGv	ventral medial geniculate nucleus	1.0
Sal1-methyl-6	7-dihydroxy-1,2,3,4-tetrahydroisoquinoline	1.0
P-JNK	phosphorylated c-jun-n-terminal kinase	0.333333333333
P-JNK	anti-phospho thr183/tyr185 c-jun n-terminal kinase	0.333333333333
P-JNK	phospho-c-jun n-terminal kinases	0.333333333333
VPNA	vagal parasympathetic nerve activity	1.0
SHG	s-hexylglutathione	1.0
pCREBS	er133-phosphorylated form of cyclic amp-responsive element binding protein	1.0
hTH	human th	1.0
SHH	sonic hedgehog	1.0
ABTS	2,2′-azinobis-(3-ethyl-benzothiazoline-6-sulfonic acid)	0.5
ABTS	2,2′-azinobis(3-ethyl-benzthiazoline-6-sulfonic acid)	0.5
MPOM	medial preoptic nucleus	0.5
MPOM	yeloperoxidase	0.5
Ton	time from initiation of hypoxia/hypoglycaemia to the onset of da release	1.0
HR-D	efhr-defeated	1.0
EGFP-SC	sschwann cells expressing enhanced green fluorescent protein	1.0
VGCC	svoltage-gated ca2+ channels	0.0294117647059
VGCC	voltage-gated calcium channel	0.426470588235
VGCC	voltage-gated calcium channels	0.117647058824
VGCC	svoltage-gated calcium channels	0.117647058824
VGCC	voltage-gated ca2+ channel	0.161764705882
VGCC	svoltage dependent calcium currents	0.0147058823529
VGCC	voltage-gated ca2+ channels	0.0882352941176
VGCC	voltage gated calcium channels	0.0147058823529
VGCC	svoltage gated calcium channels	0.0294117647059
BSTLD	laterodorsal subnucleus of the bed nucleus of the stria terminalis	1.0
L-THA	lateral part of the tuberal hypothalamic area	1.0
6-FNE	6-fluronorepinephrine	1.0
MAP-K	mitogen activated protein kinase	0.333333333333
MAP-K	mitogen-activated protein kinase	0.666666666667
BSTLV	ventral part of lateral division of the bed nucleus of stria terminalis	1.0
cAC	caudal anterior cingulated	1.0
DCFH-DA	2′,7′-dichlorodihydro-fluorescein diacetate	0.0625
DCFH-DA	dihydrodichlorofluorescein diacetate	0.125
DCFH-DA	6-carboxy-2′,7′-dicholorfluorescin diacetate	0.0625
DCFH-DA	2′,7′-dichlorfluorescein-diacetate	0.125
DCFH-DA	2′,7′-dichlorofluorescin diacetate	0.1875
DCFH-DA	2′,7′-dichlorofluorescein-diacetate	0.0625
DCFH-DA	2′,7′-dichlorofluorescein diacetate	0.1875
DCFH-DA	2′,7′-dichlorofluorescin-diacetate	0.0625
DCFH-DA	2′, 7′-dihydrodichlorofluorescein diacetate	0.0625
DCFH-DA	dichloro-dihydro-fluorescein diacetate	0.0625
MAP-Z	microtubule associated protein-2	1.0
PP-LFS	paired-pulse low-frequency stimulation	1.0
99mT	c]-hmpao99mtc-hexamethylpropyleneamineoxime	0.5
99mT	co499mtc-pertechnetate	0.5
Fpeptide	n-glycosidase f	1.0
pVHL	von hippel-lindau protein	1.0
IBHIB	4 binding histochemistry	1.0
aNT-3	antiserum against nt-3	1.0
5Z-	7-oxozeaenol	1.0
BLAa	basolateral nucleus, amygdala, anterior part	1.0
MAP-2	microtubule-associated protein 2	0.323529411765
MAP-2	microtubule associated protein-2	0.0294117647059
MAP-2	microtubule-associated peptide-2	0.0294117647059
MAP-2	microtubule-associated protein-2	0.588235294118
MAP-2	microtubule-associated-protein-2	0.0294117647059
LNPY	lymnaea neuropeptide y	1.0
FSE	fast spin echo	1.0
fODF	fiber orientation distribution function	1.0
SPIN	speech perception in noise	0.5
SPIN	neuronspiny peri-intercalated nuclear neuron	0.5
ANCOVA	covariance analysis	0.0222222222222
ANCOVA	one-way analysis of covariance	0.0222222222222
ANCOVA	analyses of covariance	0.0444444444444
ANCOVA	analysis of co-variance	0.0222222222222
ANCOVA	analysis of covariance	0.888888888889
Eh	the half inactivation potential	1.0
5-αTHDOC	tetrahydroxycorticosterone	1.0
h-Bcl-2	human bcl-2	1.0
Int	interneuron	1.0
aEMGA	verage value of the rectified emg	1.0
MGD	dorsal division of the medial geniculate nucleus	0.181818181818
MGD	dorsal division of the medial geniculate body	0.727272727273
MGD	medial geniculate nucleus	0.0909090909091
CoBF	cortical blood flow	1.0
TAR-DNA-	binding protein-43	1.0
RFRPRF	amide-related peptide	1.0
PrPsc	disease-associated form of prion protein	1.0
SHy	septohypothalamic nucleus	1.0
IL1β	interleukin-1β	1.0
EBM	eagle's basal medium	1.0
CELSR	2cadherin egf lag seven-pass g-type receptor 2	1.0
GC-A	guanylyl cyclase-a	1.0
MAP5	microtubule-associated protein-5	1.0
EGFR	epidermal growth factor receptor	0.882352941176
EGFR	epithelial growth factor receptor	0.0588235294118
EGFR	epidermal growth-factor receptor (or erbb1)	0.0588235294118
GC-D	guanylyl cyclase d	0.5
GC-D	guanylyl cyclase-d	0.5
EGFP	enhanced green fluorescence protein	0.109756097561
EGFP	enhanced green fluorescent protein	0.853658536585
EGFP	enhancement green fluorescent protein	0.0121951219512
EGFP	exegfp transfected and expressing	0.0121951219512
EGFP	+enhanced green fluorescent protein positive cells	0.0121951219512
TBT	ris buffer	0.681818181818
TBT	ris-buffer	0.0454545454545
TBT	oluidine blue	0.0454545454545
TBT	total bed time	0.0454545454545
TBT	ris–hcl buffer	0.136363636364
TBT	total breathing time	0.0454545454545
MGPYM	ethyl green pyronine y	1.0
SRIH	somatostatin	0.5
SRIH	somatostatis	0.5
pRLC	population rlc	1.0
SRIF	growth hormone release-inhibiting hormone	0.0454545454545
SRIF	somatotrophin release inhibiting factor	0.0909090909091
SRIF	somatotropin release inhibitory factor	0.0454545454545
SRIF	somatotrophin release-inhibiting factor	0.0454545454545
SRIF	somatotropin release-inhibiting factor	0.0454545454545
SRIF	somatotrophin release-inhibiting factor somatostatin	0.0454545454545
SRIF	somatostatin	0.409090909091
SRIF	somatotropin release inhibiting factor (somatostatin)	0.0909090909091
SRIF	growth hormone-releasing hormone inhibitory factor somatostatin	0.0454545454545
SRIF	somatostatin releasing inhibitory factor	0.0454545454545
SRIF	somatotrophin-release-inhibiting factor or somatostatin	0.0454545454545
SRIF	somatrophin release inhibiting factor	0.0454545454545
AB-OROR	in ab-osns	1.0
DRN6	7-dorsal raphe nucleus	1.0
Bst	bed nucleus of stria terminalis	1.0
O14	orbital area 14	1.0
βERKOERβ	knock out	1.0
O-LM	oriens/lacunosum-moleculare	0.125
O-LM	cells terminating in conjunction with entorhinal afferents	0.125
O-LM	interneuron with soma and dendrites in stratum oriens and axon arborisation mainly in stratum lacunosum-moleculare	0.125
O-LM	celloriens lacunosum-moleculare cell	0.125
O-LM	strata oriens/lacunosum-moleculare	0.125
O-LM	oriens-lacunosum moleculare	0.25
O-LM	stratum oriens/lacunosum-moleculare-associated	0.125
iBAT	interscapular brown adipose tissue	0.75
iBAT	interscapular brown adipose tissues	0.25
nafadotrideN-	[(n-butyl-2-pyrrolidinyl)methyl]-1-methoxy-4-cyanonaphthalene-2-carboxamide tartrate	1.0
ASMase	acidic sphingomyelinase	1.0
GHSR-	1aghrelin receptor	1.0
l-NAMEN-ω-	nitro-l-arginine methyl ester	1.0
VDCC	voltage-dependent-calcium channel	0.0142857142857
VDCC	svoltage-dependent ca2+ channels	0.0285714285714
VDCC	voltage dependent calcium channel	0.0571428571429
VDCC	voltage-dependent calcium currents	0.0285714285714
VDCC	voltage-dependent calcium channel	0.471428571429
VDCC	voltage dependent ca2+ channel	0.0285714285714
VDCC	svoltage-dependent calcium channels	0.0142857142857
VDCC	voltage-dependent ca2+ channels	0.0714285714286
VDCC	voltage-dependent ca2+ channel	0.142857142857
VDCC	voltage dependent calcium channels	0.0142857142857
VDCC	voltage-dependent calcium channels	0.128571428571
IGFIRIGFI	receptor	1.0
CXCR4	cxc class chemokine receptor 4	1.0
vlpSCN	ventrolateral peri–suprachiasmatic nucleus	1.0
R-DA	rhodamine-conjugated dextran amines	1.0
MGV	ventral division of the medial geniculate body	0.615384615385
MGV	ventral medial geniculate nucleus	0.0769230769231
MGV	mean gray value	0.153846153846
MGV	ventral division of the medial geniculate nucleus	0.153846153846
GRIP	1	0.125
GRIP	glutamate receptor interacting protein	0.375
GRIP	1glutamate receptor interacting protein 1	0.125
GRIP	glutamate receptor-interacting protein	0.125
GRIP	glutamate receptor interacting protein 1	0.25
NF279	8,8′-(carbonylbis(imino-4,1-phenylenecarbonylimino-4,1-phenylenecarbonylimino))bis(1,3,5-naphthalenetrisulfonic) acid	1.0
oATP	periodate oxidized atp	1.0
MMSE	mini-mental status examination	0.1
MMSE	mini-mental state examination	0.5
MMSE	mini mental state examination	0.4
CGP56433A	3-[1-(s)-[[3-(cyclohexylmethyl)-hydroxyphosphinyl]-2(s)-hydroxypropyl]	1.0
PBSTPBS-T	ween 20	1.0
D-Phe12	nle21,38,cα-meleu37] crf 12-41	0.5
D-Phe12	nle21,38, cαme leu37] r/h crf(12–41)	0.5
ipsi-PTV	ipsilateral postero-temporal visual cortex	1.0
Akt	protein kinase b	0.5
Akt	the mammalian target of rapamycin (mtor)	0.5
MVePC	medial vestibular nucleus, parvicellular part	1.0
Gly	100μm glutamate and 10μm glycine	1.0
WCC	whole-cell current-clamp	1.0
PMNL	polymorphonuclear leukocyte (neutrophil)	1.0
CACA	cis-4-amino crotonic acid	0.2
CACA	cis-4-aminocrotonic acid	0.8
LEDGF	lens epithelium-derived growth factor	1.0
CACC	calcium-activated chloride channel	1.0
WCI	whole-cell inward current	1.0
DOCA	deoxycorticosterone acetate	0.8
DOCA	deoxycorticosterone	0.2
sAPP	soluble ectodomain of app	0.0833333333333
sAPP	soluble amyloid precursor protein.	0.0833333333333
sAPP	soluble amyloid precursor protein	0.25
sAPP	soluble (secreted) app	0.0833333333333
sAPP	secreted amyloid precursor protein	0.0833333333333
sAPP	secreted form of amyloid precursor protein	0.0833333333333
sAPP	secreted form of app	0.0833333333333
sAPP	soluble forms of app	0.0833333333333
sAPP	secreted forms of app	0.0833333333333
sAPP	secreted app	0.0833333333333
Glu	l-3,4-[3h]	0.2
Glu	1-glutamate	0.2
Glu	glutamate	0.6
GRIN	1glutamate receptor nmda subunit 1	1.0
RV-GFP	retroviral vector encoding green fluorescent protein	1.0
Nhl	nucleus of the horizontal limb of the diagonal band of broca	1.0
L-QUIS	l-quisqualic acid/quisqualate	1.0
14C-DA	radioactive dopamine	1.0
CHRNB	2beta2 subunit of the nicotinic acetylcholine receptor	0.5
CHRNB	4	0.5
ABAP2	2′-azo-bis(2-amidinopropane)	1.0
WRNW	erner helicase	1.0
CHRNA	7/chrna7gene (human/mouse) encoding the α7 nicotinic acetylcholine receptor	0.5
CHRNA	7alpha 7-nicotinic acetylcholine receptor subunit gene	0.25
CHRNA	7alpha7 subunit of the nicotinic acetylcholine receptor	0.25
HAP-	1high alcohol preference-1	1.0
NoFLT	no flight	1.0
piperazine-N	n′-(2-ethanesulfonic acid)	1.0
Er	reversal potential	1.0
IADLL	awton’s instrumental activities of daily living	1.0
IRimmunoreactive	immunoreactivity	1.0
IKKIκB-	kinase complex	1.0
HMGIY	/hmga1high-mobility group i-y protein	1.0
mNGF	mature beta-form of nerve growth factor	1.0
CPRKC	dk5/p35-regulated kinase	1.0
SOI	spatial overlap index	1.0
NREMS	non-rapid-eye-movement sleep	0.0833333333333
NREMS	non-rems	0.0833333333333
NREMS	non-rapid eye movement sleep	0.833333333333
mNET	mouse norepinephrine transporter	1.0
NREMP	non-rapid eye movement period	1.0
ClC-2	chloride channel-2	1.0
βGal	β-galactosidase	1.0
PCRt	parvocellular reticular nucleus	0.333333333333
PCRt	parvicellular reticular formation	0.333333333333
PCRt	parvocellular reticular formation	0.333333333333
eNOS	endothelial nitric oxide synthetase	0.0126582278481
eNOS	endotelial nitric oxide synthase	0.0126582278481
eNOS	endothelial form of nitric oxide synthase (nos iii)	0.0126582278481
eNOS	endothelial nitric oxide synthase;	0.0126582278481
eNOS	endothelial nos	0.0632911392405
eNOS	endothelial no synthase	0.0126582278481
eNOS	endothelial isoform of nos	0.0126582278481
eNOS	endothelial cell nitric oxide synthase	0.0126582278481
eNOS	endothelial nitric oxide synthase	0.772151898734
eNOS	endothelial nitric oxide synathase	0.0126582278481
eNOS	endothelial isoform of nitric oxide synthase	0.0126582278481
eNOS	nos-iii, endothelial nitric oxide synthase	0.0126582278481
eNOS	+/+, enos wild-type mice	0.0126582278481
eNOS	(nos-3), endothelial nitric oxide synthase	0.0126582278481
eNOS	endogenous nitric oxide synthase	0.0126582278481
NREMN	on-rapid eye movement	1.0
TMSBT	rizma-maleate sucrose buffer	1.0
cAMPN6	2′-o-dibutyryladenosine 3′,5′-cyclic monophosphate	0.5
cAMPN6	2′-o-dibutyryladenosine 3′,5′–cyclic monophosphate sodium salt	0.5
LINE	long interspersed nuclear element	0.333333333333
LINE	1long interspersed nucleotide element 1	0.333333333333
LINE	1 or l1long interspersed element-1	0.333333333333
LEN	lensspqaparrllpp	1.0
nGRE	negative glucocorticoid responsive element	0.5
nGRE	negative glucocorticoid response element	0.5
GABARGABA	receptor	1.0
NDkS	normal donkey serum	1.0
MAPKAPK-2	mapk-activated protein kinase-2	1.0
pSFO	dorsolateral peripheral part of the subfornical organ	1.0
U50	488h, trans-(±)-3,4-dicholoro-n-methyl-n-(2-[1-pyrrolidinyl]cyclohexyl)-benzene acetamide	0.142857142857
U50	488(±)-trans-u50,488 methanesulfonate salt	0.142857142857
U50	488h, trans-3,4-dichloro-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide	0.142857142857
U50	488h (u50)trans-(±)-3,4-dichloro-n-methyl-n-(2-[1-pyrrolidinyl]-cyclohexyl) benzeneacetamide methanesulfonate	0.142857142857
U50	488h, [trans-3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl) cyclohexyl)-benzeneacetamide] methane-sulfonate salt	0.142857142857
U50	488	0.142857142857
U50	488h, {trans-(±)-3,4-dichloro-n-methyl-n[2-(1-pyrrolidnyl)-cyclohexyl]benzeneacetamide methane sulphonate}	0.142857142857
GENSATG	ene expression nervous system atlas	1.0
PCRT	parvicellular reticular formation	1.0
PCRP	olymerase chain reaction	1.0
ADAMTS-	4/5a disintegrin and metalloproteinase with thrombospondin motifs 4 and 5	1.0
F-RNARNA	from cells growing as floating cultures	1.0
L-NAC	n-acetyl-l-cysteine	1.0
cSCS	cervical spinal cord stimulation	0.5
cSCS	or scscervical spinal cord stimulation	0.5
HPC-1	?	1.0
HCVR	hypercapnic ventilatory response	1.0
m-BDNF	mature brain-derived neurotrophic factor	1.0
PCR-	array	1.0
EETS	emotional empathic tendency scale	1.0
ACAN-	(p-amylcinnamoyl)anthranilic acid	1.0
ClC-n	chloride channel-n	1.0
2-BFI	[3h]	1.0
PALM	palmitic acid	1.0
TXTBST	ris-buffered saline with 0.02% triton x-100	0.333333333333
TXTBST	ris-buffered saline with 0.2% triton x-100	0.333333333333
TXTBST	riton x-100–tbs	0.333333333333
Oc1	primary visual cortex	0.25
Oc1	occipital area 1	0.25
Oc1	striate cortex	0.25
Oc1	occipital cortex, area 1	0.25
Oc2	occipital cortex, area 2	0.333333333333
Oc2	occipital cortex area 2	0.666666666667
DR-S	spatial delayed response	1.0
Erk	extracellular-regulated kinase	0.5
Erk	extracellular signal-regulated kinase	0.5
SEFs	somatosensory evoked magnetic fields	1.0
SSVEP	spatial sweep visually-evoked potential	1.0
vGLUT	2vesicular glutamate transporter 2	0.5
vGLUT	vesicular glutamate transporter	0.25
vGLUT	1vesicular glutamate transporter 1	0.25
FMeC11	7-bis(4′-hydroxy-3′-trifluoromethoxyphenyl)-4-methoxycarbonylethyl-1,6-heptadiene-3,5-dione	1.0
AERKO	knockout mice missing estrogen receptor alpha	1.0
IRPI	ntramural research program	1.0
7-TM	receptor	1.0
Fluo-3glycine	n-[4-[6-[(acetyloxy)methoxy]-2,7-dichloro-3-oxo-3h-xanthen-9-yl]	1.0
NAPEN-	acyl ethanolamine-hydrolyzing phospholipase d	0.5
NAPEN-	acyl phosphatidyl ethanolamine	0.5
rHSP	27recombinant hsp27	1.0
laEEG	low amplitude eeg	1.0
7-Clkyn	7-chlorokynurenic acid	1.0
BRL-	155724-(3-chlorophenyl)-α-(diphenylmethyl)-1-piperazineethanol hydrochloride	1.0
NPLANω-	propyl-l-arginine	1.0
DIAD	iaphragm	1.0
-IR-	immunoreactivity	0.5
-IR-	immunoreactive	0.5
WGA-Au	wheat germ agglutinin-conjugated gold	1.0
MSUS	unpredictable maternal separation combined with unpredictable maternal stress	1.0
HFhigh-fat	refined sugar diet	1.0
TSST-CT	rier social stress test for children	1.0
DBH-SAP	anti-dopamine-β-hydroxylase-saporin	1.0
ETOH	ethanol-exposed group	0.2
ETOH	ethanol	0.8
K-SFM	keratinocyte serum-free medium	1.0
l-NAMENG-	nitro-l-arginine methyl ester hcl	0.0666666666667
l-NAMENG-	nitro-l-arginine methyl ester hydrochloride	0.0666666666667
l-NAMENG-	nitro-l-arginine methyl ester	0.8
l-NAMENG-	nitro-l-arginine-methyl ester	0.0666666666667
DHBE	dihydro-β-erythroidine	1.0
DPDPET	yr-d-pen-gly-phe-d-pen	1.0
DHBA	dihydroxybenzoic acid	0.166666666667
DHBA	dihydrobenzylamine	0.166666666667
DHBA	dihydroxybenzylamine	0.333333333333
DHBA	dihydroxybenzylamide	0.166666666667
DHBA	3,4-dihydroxybenzylamine	0.166666666667
SYNGR	3synaptogyrin3	1.0
Bt2cAMPN6	o2′-dibutyryladenosine 3′:5′-cyclic monophosphate	1.0
PMC-	3881-piac-arg-[cys-met-ava-arg-val-tyr-ava-cys]-nh2	1.0
MS-ODN	mismatch scrambled oligodeoxynucleotide	0.5
MS-ODN	mismatch-oligonucleotide	0.5
SZS	chizophrenia	1.0
PPHG	posterior parahippocampal gyrus	1.0
TBPTATA	box-binding protein	0.5
TBPTATA	binding protein	0.5
IAHPC	a2+-activated k+ current	1.0
NOSENS	group of animals that did not express sensitization on challenge day in experiment 2	1.0
BMmc	magnocellular part of bm nucleus	1.0
β-ARβ-	adrenergic receptor	0.5
β-ARβ-	adrenergic receptors	0.5
GRPG	astrin-releasing peptide	1.0
lwDR	lateral wings of the dorsal raphe	1.0
Bio-WFA	biotinylated wisteria floribunda agglutinin	1.0
PMCI	progressive mild cognitive impairment	1.0
JSI-	124cucurbitacin-1	1.0
YTH	yeast two-hybrid	1.0
PMCA	plasma membrane calcium pump, plasmalemmal calcium pump	0.0769230769231
PMCA	plasma membrane calcium atpase	0.307692307692
PMCA	plasma membrane ca2+,h+-atpase	0.0769230769231
PMCA	plasma membrane calcium pump	0.0769230769231
PMCA	plasma membrane calcium-dependent atpase	0.0769230769231
PMCA	plasma membrane ca2+-atpase	0.230769230769
PMCA	plasma membrane ca2+ atpase	0.0769230769231
PMCA	2ca2+-atpase isoform 2	0.0769230769231
eSAT	easy version of the spatial alternation task	1.0
DHB2	3-dihydroxybenzoate	0.333333333333
DHB2	5-dihydroxybenzoic acid	0.666666666667
D-AMPH	d-amphetamine	1.0
HWHH	half-width of the tuning curve at half-height	0.333333333333
HWHH	half width at half height	0.333333333333
HWHH	half-width at half-height of the low-field resonance line of the lipid-specific spin label 5-doxylstearic acid in cortical synaptosomal membranes	0.333333333333
FXSF	ragile x syndrome	1.0
BBGB	rilliant blue g	1.0
A-IBO	subjects with amygdala-lesions created with ibotenic acid	1.0
6-BNZ-	camp-amacetoxymethyl ester of n6-benzoyl-camp	1.0
UMTSU	niversal mobile telecommunication system	1.0
mSNc	medial substantia nigra, pars compacta	1.0
SIVE	simian immunodeficiency virus induced encephalitis	1.0
CMTXC	harcot–marie–tooth disease	1.0
PMCo	posteromedial cortical amygdaloid nucleus	1.0
sPVZ	hypothalamic subparaventricular zone	1.0
TXRD	texas red	1.0
εA1	n6-ethenoadenine	1.0
APPA	dl-2-amino 4-methyl-5-phosphono-3-pentenoic acid	0.5
APPA	myloid precursor protein	0.5
PGOP	onto-geniculo-occipital	1.0
pYY	polypeptide yy	1.0
LATE-LTP	protein synthesis-dependent ltp (	1.0
PCX	piriform cortex	1.0
βE2	17β-estradiol	1.0
TMM	tuberomammillary nucleus	1.0
MTC	smuscle–tendon-complexes	0.5
MTC	morphine-treated cats	0.5
P-STAT3	phosphorylated stat3	1.0
WGBS	whole genome bisulfite sequencing	1.0
l-PDC	l-trans-pyrrolidine-2-4-dicarboxylate	1.0
αDBα-	dystrobrevin	1.0
CMI	cognitive-motor interference	1.0
HEPES	n-(2-hydroxyethyl)piperazine-n′-(2-ethanesulfanic acid)	0.00200601805416
HEPES	n-2-hydroxyethylpiperazine-n-2-ethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine- n′-2-ethanesulphonic acid	0.00100300902708
HEPES	n-(2-hydroxy ethyl)piperazine-n′-2(ethanesulfonic acid)	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-n′-(2-ethanesulphoric acid)	0.00100300902708
HEPES	–koh4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid–koh	0.00100300902708
HEPES	hydroxyethyl piperazinethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.210631895687
HEPES	n-(2-hydroxyethyl)piperazine-n′-(2-ethanesulphonic acid)	0.0300902708124
HEPES	n-2-hydroethylpiperazine-n′-2-ethanesulfonic acid	0.00200601805416
HEPES	2-[4-(2-hydroxyethyl)-1-piperazine]-ethanesulphonic acid	0.00100300902708
HEPES	n–2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethanesulphonic acid	0.245737211635
HEPES	hydroxyethyl peperazineethanesulfonic acid	0.00100300902708
HEPES	(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid	0.00100300902708
HEPES	n-(2-hydroethyl)-piperazine-n′-(2-ethanesulphonic acid)	0.00100300902708
HEPES	hydroxyethyl piperazine ethane sulfonic acid	0.00100300902708
HEPES	2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid	0.00802407221665
HEPES	n-(2-hydroxyethyl)-piperazine-n′-(2 ethanesulphonic acid)	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethane-sulfonic acid	0.00200601805416
HEPES	n-(2-hyroxyethyl) piperazine-n′-(2-ethanesulphonic acid)	0.00100300902708
HEPES	4-(2-hydroxyethyl) piperazineethane sulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-2-ethanesulfonic acid	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-n′-(2-ethanesulphanic acid)	0.00200601805416
HEPES	hydroxyethyl-piperazineethanesulfonic acid	0.00100300902708
HEPES	4-2-(hydroxyethyl)-1-piperazine-ethanesulfonic acid	0.00100300902708
HEPES	hydroxylethylpiperzine-n-2-ethanesulfonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)-1-piperazineethane sulfonic acid	0.00100300902708
HEPES	n-(2-hydroxyethylpiperazine)-n′-(2-ethanesulphonic acid)	0.00100300902708
HEPES	4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid	0.157472417252
HEPES	10 n-2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n’-2-ethanesulphonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-1-ethane sulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethanesulphate	0.00100300902708
HEPES	n-(2-hydroxyethylpiperazine)-n′-(2-ethane sulphonic acid)	0.00100300902708
HEPES	4-(2-hydroxyethyl)-piperazin-1-ethansulphonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid	0.00100300902708
HEPES	4-(2-hydroxy ethyl)-1-piperazineethanesulfonic acid	0.00100300902708
HEPES	(4-2-(hydroxyethyl)-1-piperazineethanesulfonic acid)	0.00100300902708
HEPES	2-[4-(2-hydroxyethyl)-1-piperazinyl] ethanesulfonic acid	0.00200601805416
HEPES	n-(2-hydroxyethyl)piperazine-n′(2-ethanesulfonic acid)	0.00200601805416
HEPES	4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)-1-piperazineethane-sulfonic acid	0.00100300902708
HEPES	n-2-hydoxyethylpiperazine-n′-2-ethanesulfonic acid	0.00100300902708
HEPES	n-[2-hydroxyethyl]piperazine-n-[2-ethanesulfonic acid]	0.00100300902708
HEPES	minimum essential medium–n-2-hydroxyethylpiperazine-n′-2-ethanesulphonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)-1-piperzineethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine- n′-2-ethanesulfonic acid	0.00100300902708
HEPES	n-2-(hydroxyethyl)piperazine-n′-2-(ethanesulfonic acid)	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethanesulphoric acid	0.00100300902708
HEPES	(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)	0.00300902708124
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethansulphonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid	0.00100300902708
HEPES	n-(2-hydroxyethyl) piperazine-n′-(2-ethanesulfonic acid)	0.00300902708124
HEPES	n-(2-hydroxyethyl)piperazine-n′-(2-ethanesulfonic acid)	0.0872617853561
HEPES	2-n-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpipetazine-n′-2-ethanesulphonic acid	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-n′-(2-ethane sulphonic acid)	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-ethanesulfonic acid	0.0150451354062
HEPES	n-(2-hydroxy ethyl)piperazine-n′-(2-ethanesulphonic acid)	0.00200601805416
HEPES	4-(2-hydroxyethyl) piperazineethanesulfonic acid	0.00100300902708
HEPES	(n-[2-hydroxyethyl]piperazine-n′-[2-ethanesulphonic acid]	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-n′-(2-ethanesulphonic acid	0.00200601805416
HEPES	n-2-hydoxyethylpiperazine-n′-2-ethanesulphonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid	0.0361083249749
HEPES	n-(2-hydroxy ethyl)piperazine-n′-(2-ethanesulfonic acid)	0.00300902708124
HEPES	n-(2-hydroxyethyl)piperazine-n’-(2-ethanesulfonic acid)	0.00100300902708
HEPES	n-(α-hydroxy ethyl)piperazine-n′-(α-ethanesulfonic acid)	0.00100300902708
HEPES	4-(2-hydroxyethyl)-1-piperazineethanesulfonic	0.00401203610832
HEPES	n-2-hydroxyethylpiperazine-n’-2-ethanesulphuric acid	0.00100300902708
HEPES	4-2-hydroxyethyl-1-piperazineethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n1-2-ethanesulphonic acid	0.00300902708124
HEPES	n-2-hydroxyethylpiperazine-2-ethanesulphonic acid	0.00200601805416
HEPES	n-2-hydroxyethylpiperazine- n′-2-ethane sulphonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethanosulphonic acid	0.00100300902708
HEPES	n-2-hydroxylethylpiperazine-n′-2-ethanesulfonic acid	0.00200601805416
HEPES	(n-[2-hydroxyethyl]piperazine-n′[ethanesulfonicacid]	0.00100300902708
HEPES	n-(2-hydroxyethyl)-1-piperazine-n′-(2-ethanesulfonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)piperazine-1-ethane sulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethane sulfonic acid	0.00100300902708
HEPES	2-[4-(2-hydroxyethyl)-1piperazil] ethanesulfonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-n′-[2-ethanesulfonic acid]	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine- n′-(2-ethanesulfonic acid)	0.00100300902708
HEPES	n-2-hydroxyethyl-piperazine-n′-2-ethanesulfonic acid	0.00200601805416
HEPES	n-(2-hydroxyethyl) piperazine-n′-(2-ethanesulfanoic acid)	0.00100300902708
HEPES	n-2-hydroxylethylpiperazine-n′-2-ethanesulphonic acid	0.00100300902708
HEPES	n-2-hydroxypiperazine-n′-2-ethanesulfonic acid	0.00100300902708
HEPES	n-(α-hydroxyethyl) piperazine-n′-(α-ethanesulphonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n∼-2-ethanesulfonic acid	0.00100300902708
HEPES	(n-[2-hydroxyethyl]piperazine-n′-[2-ethanesulfonic acid]	0.00601805416249
HEPES	n-(2-hydroxyethyl) piperazine-n′-(2-ethanesulphonic acid)	0.00401203610832
HEPES	4-(2-hydroxyethyl-1-piperazineethane sulfonic acid	0.00100300902708
HEPES	hydroxyethyl piperazineethanesulfonic acid	0.0310932798395
HEPES	2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid	0.0230692076229
HEPES	4-(2-hydroxyethyl)-1-piperazine ethane-sulfonic acid	0.00100300902708
HEPES	hydroxyethyl piperazine-ethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2′-ethanesulfonic acid	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-nˈ-(2-ethansulphonic acid)	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-n′-(4-ethanesulfonic acid)	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethansulfonic acid	0.00100300902708
HEPES	n-2-hydrozyethylpiperazine-n′-2-ethanesulphonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-ethanesulphonic acid	0.00501504513541
HEPES	n-(2-hydroxy ethyl) piperazine-n′-(2-ethane sulfanic acid)	0.00100300902708
HEPES	4-(2-hydroxythyl)-1-piperazineethanesulfonic acid	0.00100300902708
HEPES	n-(2-hydrozyethyl)piperazine-n1-(2-ethanesulfanic acid)	0.00100300902708
HEPES	n-(2-hydroxyethylpiperazine-n′-2-ethanesulphonic acid)	0.00100300902708
HEPES	n-2 hydroxyethylpiperazine-n′-2-ethansulphonic acid	0.00100300902708
HEPES	n-[2-hydroxyethyl]piperazine-n′-[2-ethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethlpiperazine-n′-2-ethanesulphonic acid	0.00100300902708
HEPES	10 n-hydroxyethylpiperazine-nv-2-ethanesulphonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n-2-ethanesulphonic acid	0.00100300902708
HEPES	4-(2-hydroxy-ethyl)piperazine-1-ethanesulfonic acid	0.00100300902708
HEPES	10 n-[2-hydroxyethyl] piperazine-n′-[2-ethane-sulfonic acid]	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n’-2-ethanesulfonic acid	0.00100300902708
HEPES	2-hydroxyethylpiperazine-n′-2-ethanesulfonic acid	0.00100300902708
HEPES	n-2-hydroxyethylpiperazine-n′-2-ethanasulphonic acid	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-n′-2(ethane-sulfonic acid)	0.00100300902708
HEPES	n-2-hydoxyethylpiperazine-n′-ethanesulphonic acid	0.00100300902708
HEPES	n-[2-hydroxyethyl]piperazine-n′-[2-ethanesulfonic acid]	0.00601805416249
HEPES	n-(2-hydroxyethyl) piperazine-n′(2-ethanesulfonic acid)	0.00100300902708
HEPES	n-(2-hydroxyethyl)piperazine-n′-(2-ethane-sulfonic acid)	0.00100300902708
HEPES	???	0.00100300902708
HEPES	(n-[hydroxyethyl]piperazin-n′-[2-ethanesulfonic acid]	0.00100300902708
HEPES	4-(2-hydroxylethyl)-1-piperazineetanesulphonic acid	0.00100300902708
HEPES	4-(2-hydroxyethyl)-piperazine-1-ethanesulphonic acid	0.00100300902708
proBDNF	brain-derived neurotrophic factor precursor	0.666666666667
proBDNF	precursor of bdnf	0.333333333333
PCR	polymerase-chain-reaction	0.0020618556701
PCR	reverse transcriptase–polymerase chain reaction	0.0123711340206
PCR	polimerase chain reaction	0.0020618556701
PCR	tparvocellular reticular formation	0.00618556701031
PCR	reverse transcription–polymerase chain reaction	0.0474226804124
PCR	reverse transcription–pcr	0.0020618556701
PCR	tparvicellular reticular nucleus	0.00618556701031
PCR	tparvocellular reticular nucleus	0.0020618556701
PCR	(qpcr)	0.0020618556701
PCR	quantitative reverse transcription pcrrip, receptor interacting protein	0.0020618556701
PCR	reverse transcription-polymerase chain reaction	0.0020618556701
PCR	polymerase chain reaction	0.903092783505
PCR	array	0.0020618556701
PCR	polymerase chain reactin	0.0020618556701
PCR	polymerase chain reactions	0.0020618556701
PCR	reverse transcription polymerase chain reaction	0.0020618556701
PCR	–rflppolymerase chain reaction–restriction fragment length polymorphism	0.0020618556701
SDAT	senile dementia of alzheimer's type	1.0
DAPI4	6-diamidio-2-phenylindole	0.0294117647059
DAPI4	6-dianidino-2-phenylindole	0.0294117647059
DAPI4	6 diamidino-2-phenylindole	0.0588235294118
DAPI4	6-diamidino-2-phinylindole	0.0294117647059
DAPI4	6′-diamidino-2-phenylindole	0.0294117647059
DAPI4	6-diamidino-2-phenylindole	0.558823529412
DAPI4	6-diamidino-2-phenyl-indole	0.0294117647059
DAPI4	6-diamino-2-phenyl indole	0.0294117647059
DAPI4	6-diamidine-2-phenylindole dihydrochloride	0.0294117647059
DAPI4	6-diamidino-2-phenylindole dihydrochloride	0.0294117647059
DAPI4	6-diamino-2-phenylindole	0.147058823529
SR-BI	scavenger receptor b-i	1.0
sMGB	vsuperior part of the ventral division of the medial geniculate body	1.0
QTL	quantitative trait locus	0.4
QTL	quantitative train locus	0.0666666666667
QTL	quantitative trait loci	0.533333333333
irIRN	irisin-immunoreactivity	1.0
PCP	4purkinje cell protein 4	0.0116279069767
PCP	earson correlation coefficient	0.0116279069767
PCP	phecyclohexyl piperidine	0.0116279069767
PCP	urkinje cells	0.0697674418605
PCP	phencyclidine	0.523255813953
PCP	urkinje cell	0.372093023256
VTA	ventral tegmental area	0.9633401222
VTA	rrostral vta	0.0020366598778
VTA	/snventral tegmental area and substantia nigra	0.0020366598778
VTA	ventral tegmental nucleus	0.0020366598778
VTA	ventral tegmental área	0.0020366598778
VTA	ventral tegmental area of midbrain	0.0020366598778
VTA	ventrotegmental area	0.0020366598778
VTA	rlrostral linear nucleus of the vta	0.0020366598778
VTA	ventral tegmentum area	0.0020366598778
VTA	/snventral mesencephalon (comprising the ventral tegmental area and substantia nigra)	0.0020366598778
VTA	/snventral tegmental area/substantia nigra	0.0020366598778
VTA	ventro-tegmental area	0.0020366598778
VTA	a10ventral tegmental area	0.0020366598778
VTA	ventral tagmental area	0.0040733197556
VTA	ventral–tegmental area	0.0020366598778
VTA	ventral tegmental area wakefulness	0.0020366598778
VTA	ventral tegmentum	0.0020366598778
VTA	/rventral tegmental area/rostral part	0.0020366598778
TLR	11	0.0169491525424
TLR	4 receptortoll-like receptor 4	0.0169491525424
TLR	toll like receptor	0.0338983050847
TLR	4toll like receptor 4	0.0338983050847
TLR	toll-like receptor	0.28813559322
TLR	7toll-like receptor 7	0.0169491525424
TLR	4toll-like receptor 4	0.372881355932
TLR	2	0.0169491525424
TLR	4	0.0508474576271
TLR	stoll-like receptors	0.118644067797
TLR	toll-like receptors	0.0169491525424
TLR	4toll-like receptor-4	0.0169491525424
p-ERK	dually phosphorylated thr183/tyr185	0.0588235294118
p-ERK	1/2extracellular-signal regulated kinase 1 and extracellular-signal regulated kinase 2 phosphorylated at serine/threonine residues	0.0588235294118
p-ERK	phosphorylated-erk	0.0588235294118
p-ERK	phosphorylated extracellular signalregulated kinase	0.0588235294118
p-ERK	1/2phospho-erk1/2	0.0588235294118
p-ERK	1/2phosphorylated erk1/2	0.0588235294118
p-ERK	phosphorylated extracellular signal-regulated kinase	0.294117647059
p-ERK	1/2phospho-extracellular signal-regulated kinase	0.0588235294118
p-ERK	1/2phosohorylated-erk1/2	0.0588235294118
p-ERK	phosphorylated-extracellular signal-regulated protein kinase	0.0588235294118
p-ERK	1/2phosphorylated extracellular signal-regulated kinases 1 and 2	0.0588235294118
p-ERK	phosphorylated erk	0.117647058824
GTC	green tea catechins	0.666666666667
GTC	sgeneralized tonic–clonic seizures	0.333333333333
VTE	vicarious trial-and-error behavior	0.5
VTE	vicarious trial-and-error	0.5
GTE	gesture trajectory extrema	1.0
GTF	general transcription factor	1.0
MPTP	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0.850746268657
MPTP	chronic parkinsonism model	0.0149253731343
MPTP	n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0.0298507462687
MPTP	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine pbs, phosphate-buffered saline	0.0149253731343
MPTP	1-methyl-4-phenyl-1,2,3,6-tetrahydropuridine	0.0149253731343
MPTP	4-methyl-1,2,5,6-tetrahydroxypyridine	0.0149253731343
MPTP	1-methyl-4-pheynyl-1,2,3,6-tetrahydropyridine	0.0149253731343
MPTP	pmptp/probenecid	0.0149253731343
MPTP	methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0.0149253731343
MPTP	mitochondrial permeability transition pore	0.0149253731343
GTH	gated threshold adaptation and gated hebbian learning	1.0
GTI	serotonin-o-carboxymethylglycyl-[125i]	0.5
GTI	serotonin-o-carboxymethyl-glycyl-[125i]	0.5
HVc	high vocal center	1.0
NADH-DH	nadh dehydrogenase	1.0
VTM	ventral tuberomammillary	0.333333333333
VTM	ventral tuberomammillary nucleus	0.666666666667
GTN	glyceryl trinitrate	1.0
GTO	golgi-tendon organ	1.0
GTP	asesguanosine triphosphatases	0.0178571428571
GTP	aseguanosine triphosphatase	0.0178571428571
GTP	aseguanosine triphosphate hydrolase	0.0178571428571
GTP	guanine triphosphate	0.0178571428571
GTP	cyclohydrolase	0.0178571428571
GTP	guanosine-5'-triphosphate	0.0357142857143
GTP	guanosine 5′ triphosphate	0.0357142857143
GTP	guanosine trisphosphate	0.0178571428571
GTP	ase	0.0357142857143
GTP	guanosine-5′-triphosphate	0.0714285714286
GTP	guanosine 5-triphosphate	0.0178571428571
GTP	guanosine 5′-triphosphate	0.107142857143
GTP	guanosine triphosphate	0.553571428571
GTP	binding protein	0.0178571428571
GTP	cyclohydrolase 1	0.0178571428571
Y2	npy(y2) receptor	1.0
GTS	generalized tonic seizure	1.0
GTT	glucose tolerance test	1.0
VTT	ventral tenia tecta	1.0
TLE	temporal-lobe epilepsy	0.0123456790123
TLE	transducin-like enhancer of split	0.0123456790123
TLE	temporal lobe epilepsy	0.962962962963
TLE	(mesial) temporal lobe epilepsy	0.0123456790123
F3A-NT3	neurotrophin-3-secreting cells	1.0
GfAP	glial fibrillary acidic protein	1.0
TLN	telencephalin	1.0
MYHM	uty dna glycosylase homologue	1.0
HVI	cerebellar hemispheral lobule vi according to larsell	0.333333333333
HVI	cerebellar cortical area hvi	0.333333333333
HVI	lobule simplex of the cerebellar cortex	0.333333333333
ITII	nter-trial-interval	1.0
m-CPBG	m-chlorophenyl biguanide	0.5
m-CPBG	1-(3-chlorophenyl)biguanide	0.5
ITIM	immunoreceptor tyrosine-based inhibition motif	0.5
ITIM	immunoreceptor tyrosine-based inhibitory motif	0.5
VTg	ventral tegmental nucleus of gudden	1.0
HVA	4-hydroxy-3-methoxyphenylacetic acid	0.0054347826087
HVA	high voltage–activated calcium channel	0.0054347826087
HVA	calcium channel	0.0054347826087
HVA	homavanillic acid	0.0054347826087
HVA	homovanillic acid/4-hydroxy-3-methoxyphenylacetic acid	0.0054347826087
HVA	homovanillic acid	0.673913043478
HVA	high voltage-activated, lva, low voltage-activated	0.0054347826087
HVA	shigh voltage-activated calcium channels	0.0054347826087
HVA	high threshold voltage-activated	0.0054347826087
HVA	high-voltage activated	0.0652173913043
HVA	4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid)	0.0054347826087
HVA	high-voltage-activated	0.135869565217
HVA	homovanilic acid	0.0108695652174
HVA	high-voltage-activated (ca2+ channels)	0.0054347826087
HVA	high voltage-activated calcium channel	0.0054347826087
HVA	high voltage-activated	0.0434782608696
HVA	homovallinic acid	0.0054347826087
HVA	high threshold voltage-activated calcium channel	0.0054347826087
VTh	ventral thalamus	1.0
HVC	used as the proper name	0.142857142857
HVC	higher vocal center	0.142857142857
HVC	(x)x-projecting hvc	0.142857142857
HVC	high vocal center	0.571428571429
DBDDNA	binding domain	1.0
HVE	high-velocity-excitatory cells	1.0
HVF	hydrogenated vegetable fat	0.5
HVF	hamster vaginal fluid	0.5
BZ-IS	benzodiazepine full agonist-insensitive receptor	1.0
TRHRTRH	receptor	1.0
MPTe	mesopontine tegmentum explant	1.0
PCI	phase coordination index	1.0
GREBd	glucocorticoid response element binding protein (dimer)	1.0
ZDI	normalized zinc density index	1.0
HVS	hamster vaginal secretions	0.25
HVS	high-voltage spindles	0.5
HVS	high-velocity-suppressive	0.25
contra-PrH	contralesional prepositus hypoglossal nucleus	1.0
M1-like	m1, m3 and m5 muscarinic acetylcholine receptors	1.0
GREBm	glucocorticoid response element binding protein (monomer)	1.0
PCO	2carbon dioxide partial pressure	0.285714285714
PCO	protein carbonyl	0.142857142857
PCO	2partial pressure of co2	0.142857142857
PCO	2partial pressure of carbon dioxide	0.428571428571
Q-PCR	quantitative real-time polymerase chain reaction	0.125
Q-PCR	quantitative polymerase chain reaction	0.125
Q-PCR	quantitative real-time pcr	0.25
Q-PCR	quantitative pcr	0.375
Q-PCR	quantitative-polymerase chain reaction	0.125
L-PSP	late depolarizing postsynaptic potential	1.0
IMM-	type k+ current	1.0
np-NF	non-phosphorylated neurofilament	1.0
tBS	theta burst stimulation	1.0
SDTS	ignal detection theory	1.0
ADOSA	utism diagnostic observation schedule	1.0
PPADSpyridoxal-phosphate-6-azophenyl-2	4-disulfonic acid	1.0
PCC	propionyl-coa carboxylase	0.0555555555556
PCC	posterior cingulum cortex	0.0555555555556
PCC	)	0.0555555555556
PCC	phasic contraction counts	0.0555555555556
PCC	pearson correlation coefficient	0.0555555555556
PCC	posterior cingulate cortex	0.666666666667
PCC	posterior cingulated cortex	0.0555555555556
TTX-S	tetrodotoxin sensitive	0.2
TTX-S	ttx-sensitive	0.2
TTX-S	tetrodotoxin-sensitive	0.6
FD2FD14	flight days 2 and 12 (respectively)	1.0
7G	facial ganglion	1.0
ENR	enriched environment	0.5
ENR	environmental enrichment	0.5
CMT	1a	0.2
CMT	c fibre mechanothermal afferent	0.2
CMT	centromedial nucleus of thalamus	0.2
CMT	1acmt disease type 1a	0.2
CMT	1acharcot–marie–tooth type 1a	0.2
UCS	unconditioned rf center stimulus	0.05
UCS	unconditioned stimuli	0.1
UCS	unconditioned effects group	0.05
UCS	unconditioned stimulus	0.8
7B	2	1.0
UCP	3uncoupling protein 3	0.0416666666667
UCP	2uncoupling 2 like proteins	0.0416666666667
UCP	2uncoupling protein-2	0.0833333333333
UCP	1uncoupling protein one	0.0416666666667
UCP	1uncoupling protein 1	0.125
UCP	uncoupling protein	0.375
UCP	upper cortical plate	0.0416666666667
UCP	mitochondria uncoupling protein	0.0416666666667
UCP	2uncoupling protein 2	0.208333333333
ARRN	anterior rhombencephalic reticular nuclei	0.2
ARRN	anterior rhombencephalic reticular nucleus	0.8
NBRP	network burst rising phase	1.0
pre-RP	pre-reperfusion	1.0
PCG	precentral gyrus	0.333333333333
PCG	posterior cingulate gyrus	0.333333333333
PCG	pontine central gray	0.333333333333
AECF	artificial extracellular fluid	1.0
ARC	arcuate nucleus of hypothalamus	0.0333333333333
ARC	activity-regulated cytoskeletal protein	0.0166666666667
ARC	activity-related cytoskeletal protein	0.0166666666667
ARC	arcuate nuclei	0.0166666666667
ARC	arcuate nucleus with median eminence	0.0166666666667
ARC	cytosine arabinoside	0.0166666666667
ARC	arcuate nucleus	0.733333333333
ARC	arcuate hypothalamic nucleus	0.0666666666667
ARC	hypothalamic arcuate nucleus	0.0166666666667
ARC	arcuate	0.0166666666667
ARC	arcuate nucleus of the hypothalamus	0.05
AMPA-R	amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors	1.0
UCB	unconjugated bilirubin	1.0
UCA	unilateral cochlear ablation	1.0
UCO	umbilical cord occlusion	1.0
UCN	urocortin	0.625
UCN	3urocortin 3	0.125
UCN	iiurocortin ii	0.125
UCN	1urocortin 1	0.125
PCE	prolonged calcium elevation	0.5
PCE	percentage of cells evoked	0.5
SMNs	somatic motor neurons	1.0
XA	rea x	1.0
ACSC	artificial cerebrospinal fluid	1.0
ARG	autoradiography	0.333333333333
ARG	arginine	0.333333333333
ARG	alcohol-responsive gene	0.333333333333
EZ	endocytic zone	1.0
RBP	retinol binding protein	0.5
RBP	jrecombination signal-binding protein for immunoglobulin kappa j region	0.25
RBP	srna-binding proteins	0.25
NBTIN-	nitrobenzylthioinosine	1.0
ARH	arcuate hypothalamus	0.1
ARH	arcuate nucleus of the hypothalamus	0.6
ARH	arcuate nucleus	0.1
ARH	arcuate hypothalamic nucleus	0.1
ARH	arcuate nucleus of hypothalamus	0.1
ARR3	arrestin3	1.0
ARR2	arrestin2	1.0
ARI	30aripiprazole 30 mg/kg	1.0
RBF	radial basis function	1.0
RBD	rna binding domain	0.333333333333
RBD	rapid eye movement sleep behavior disorder	0.333333333333
RBD	rapid eye movement sleep behavioral disorder	0.333333333333
EJP	excitatory junction potential	0.6
EJP	excitatory junctional potential	0.4
RBA	relative binding affinity	1.0
BSTenc	encapsulated portion of the bed nucleus of the stria terminalis	1.0
LGN	dorsal lateral geniculate nucleus	0.038961038961
LGN	vventral lateral geniculate nucleus	0.025974025974
LGN	ddorsal lateral geniculate nucleus	0.0649350649351
LGN	lateral geniculate nuclei	0.025974025974
LGN	lateral geniculate nucleus	0.831168831169
LGN	lateral geniculate nucleus (dorsal/ventral)	0.012987012987
α-SMA	alpha smooth muscle actin	1.0
LGL	ateral gastrocnemius	1.0
LGB	lateral geniculate body	1.0
LGC	light green cell	1.0
LGA	low-glutaraldehyde	1.0
RBs	rhodamine latex beads	1.0
somatostatin-NPY	interneurons	1.0
LGE	lateral ganglionic eminence	0.923076923077
LGE	lateral ganglionic eminences	0.0769230769231
neo-T	imm staining	1.0
p-MPPI	4-iodo-n-[2-[4-(methoxyphenyl)-1-pipiraziyl-benzamide hydrochloride	1.0
SMNF	small myelinated nerve fibers	1.0
6-G	uhen-hydroxysuccinimido 6-guanidohexanoic acid	1.0
LGR	7/8leucine-rich repeat-containing g-protein-coupled receptor-7/8 (also known as rxfp1/2)	0.333333333333
LGR	7/8leucine-rich repeat-containing g-protein-coupled receptor-7/8 (also classified as rxfp1/2)	0.333333333333
LGR	low glucose response	0.333333333333
LGS	lennox–gastaut syndrome	0.166666666667
LGS	lateral gastrocnemius and soleus muscles	0.166666666667
LGS	lateral gastrocnemius plus soleus	0.166666666667
LGS	lateral gastrocnemius–soleus	0.166666666667
LGS	lateral gastrocnemius-soleus	0.166666666667
LGS	lateral gastrocnemius and soleus	0.166666666667
LGP	lateral globus pallidus	1.0
SGYR	synaptogyrin	1.0
LGV	large granular vesicles	0.333333333333
LGV	large granular vesicle	0.333333333333
LGV	ventral lateral geniculate nucleus	0.333333333333
LGU	local glucose utilization	1.0
nMTF	rate normalized modulation transfer function	1.0
hOSM	human recombinant oncostatin m	1.0
WMEW	orking memory errors	1.0
PH-	2parenchymal hemorrhage type 2	1.0
BE	bestatin	0.333333333333
BE	binocular enucleated	0.333333333333
BE	ecfbase excess in extracellular fluid	0.333333333333
H-IBO	subjects with hippocampus-lesions created with ibotenic acid	1.0
BF	burst firing (pyramidal cell)	0.0116279069767
BF	rpulsatile blood flow of the renal artery	0.0116279069767
BF	ibiceps femoris	0.0232558139535
BF	burst frequency	0.0116279069767
BF	burst firing cells	0.0116279069767
BF	basal forebrain	0.476744186047
BF	blood flow	0.0116279069767
BF	base frequency	0.0348837209302
BF	ponto-geniculo-occipital wave burst frequency (mean number/min)	0.0116279069767
BF	biceps femoris	0.0697674418605
BF	best frequency	0.313953488372
BF	barrel field	0.0116279069767
rPPL	right posterior parietal lobe	1.0
DZN	ep3-deazaneplanocin a	0.5
DZN	diazinon	0.5
DZP	diazepam	1.0
JN	juxtanodin	1.0
NPF	neuropeptide f	1.0
TβRTGF-β	receptor	1.0
ASSET	array spatial sensitivity encoding technique	1.0
JG	juxtaglomerular	0.833333333333
JG	juxtaglomerular cell	0.166666666667
SubCDsubcoeruleus	dorsal part	1.0
GST	gluthatione-s-transferase	0.0106382978723
GST	glutathione	0.0106382978723
GST	sglutathione-s-transferases	0.0106382978723
GST	glutathione transferase	0.0106382978723
GST	glutathion-s-transferase	0.0106382978723
GST	grip strength task	0.0106382978723
GST	πglutathione-s-transferase pi	0.0106382978723
GST	πglutathione s-transferase pi	0.0106382978723
GST	glutathione sulfotransferase	0.0106382978723
GST	generalized seizure threshold	0.0531914893617
GST	grip strength test	0.0106382978723
GST	glutathione s transferase	0.0106382978723
GST	galactocereboside sulfotransferase	0.0106382978723
GST	galactosylceramide sulfotransferase	0.0106382978723
GST	genistein	0.0106382978723
GST	glutathione-s-transferase	0.340425531915
GST	glutathione s-transferase	0.457446808511
IA-	2islet-associated protein 2	0.5
IA-	2 and ia-2βinsulinoma associated proteins	0.5
PVN-	spinal neurones	1.0
GSW	gill and siphon withdrawal	1.0
AHDC	adult-hemidecorticated cats	1.0
GABAB-RB-	type of receptor of gaba	1.0
post-I	neuronpostinspiratory neuron	1.0
Cxconnexin	designated according to molecular weight in kilodaltons	1.0
MPRN	median/paramedian raphe	1.0
GWSGABA	withdrawal syndrome	1.0
NAcLAT	lateral zone of the nucleus accumbens shell	1.0
post-S	h/tonepost-training sham lesion/auditory fear conditioning	1.0
hPLP	1human myelin proteolipid protein 1	1.0
D-JNKI	1d-retro-inverso form of c-jun n-terminal kinase-inhibitor	1.0
post-V	eh animalsrats treated postnatally with vehicle	1.0
GSX	total glutathione	1.0
RHAMM	receptor for hyaluronic acid-mediated motility	1.0
BN	–sds/page	0.0909090909091
BN	bulimia nervosa	0.181818181818
BN	burst number	0.0909090909091
BN	bombesin	0.272727272727
BN	/f344brown norway×fischer 344 hybrid rat	0.0909090909091
BN	sburst neurons	0.0909090909091
BN	fischer 344/brown norway hybrids	0.0909090909091
BN	[multi-talker] babble noise	0.0909090909091
PCo	posterior cortical nucleus	1.0
IAM	interanteromedial thalamic nucleus	0.5
IAM	interanteromedial nucleus of thalamus	0.5
FRAF	requency response area	0.5
FRAF	os-related antigen	0.5
OFA	occipital face area	1.0
OFF	off levodopa medication	0.333333333333
OFF	cells	0.333333333333
OFF	bcoff cone bipolar cell	0.333333333333
BH	4tetrahydrobiopterin	0.416666666667
BH	black hooded	0.0833333333333
BH	3bcl-2 homology 3	0.0833333333333
BH	3bcl-2 homology domain	0.0833333333333
BH	3bcl-2 homology domain 3	0.166666666667
BH	brief handling	0.0833333333333
BH	black-hooded	0.0833333333333
IAF	individual alpha peak	0.142857142857
IAF	individual alpha frequency	0.428571428571
IAF	individual alpha frequency peak	0.142857142857
IAF	integrate-and-fire	0.142857142857
IAF	insular auditory field	0.142857142857
IAA	inhibitory amino acid	0.375
IAA	currents activated by arachidonic acid	0.125
IAA	iodoacetamide	0.125
IAA	iodoacetic acid	0.25
IAA	indispensable amino acid	0.125
OFO	pen field task	1.0
OFL	optic fiber layer	0.666666666667
OFL	optic fibre layer	0.333333333333
TIQ	1,2,3,4-tetrahydroisoquinoline	1.0
OFR	ocular following response	1.0
NEDA	neuroendocrine dopaminergic	1.0
OFQ	nociceptin/orphanin fq	0.133333333333
OFQ	/norphanin fq/nociceptin	0.133333333333
OFQ	orphanin fq	0.666666666667
OFQ	orphanin fq/nociceptin	0.0666666666667
TIR	tonic irregular-spiking cell	0.5
TIR	third interval response	0.5
OFT	open-field test	0.0909090909091
OFT	the open field test	0.0909090909091
OFT	open field test	0.818181818182
FRAP	fluoride-resistant acid phosphatase	0.428571428571
FRAP	fluorescent recovery after photobleaching	0.0714285714286
FRAP	fluorescence recovery after photobleaching	0.357142857143
FRAP	fluorescence recovery after photo-bleaching	0.0714285714286
FRAP	ferric reducing antioxidant power	0.0714285714286
IAV	influenza a/wsn/33 h1n1 virus	1.0
DARPP-	32dopamine- and cyclic amp-regulated phosphoprotein of 32 kd	0.0212765957447
DARPP-	32dopamine- and camp-regulated phosphoprotein of 32 kda	0.063829787234
DARPP-	32dopamine and cyclic amp regulated phosphoprotein-23 kda	0.0212765957447
DARPP-	32dopamine and cylcic amp-regulated phosphoprotein-32	0.0212765957447
DARPP-	32the dopamine and camp-regulated phosphoprotein of 32 kda	0.0425531914894
DARPP-	32dopamine- and camp- regulated phosphoprotein-32	0.0212765957447
DARPP-	32dopamine and camp-regulated phosphoprotein of 32 kda	0.0212765957447
DARPP-	32dopamine and camp-regulated phosphoprotein of 32 kilodaltons	0.0212765957447
DARPP-	32dopamine and camp regulated phosphoprotein of 32 kda	0.0212765957447
DARPP-	32dopamine-regulated and cyclic-amp-regulated phosphoprotein	0.0212765957447
DARPP-	32dopamine- and camp-regulated phosphoprotein of 32kda	0.0212765957447
DARPP-	32dopamine and cyclic amp-regulated phosphoroprotein 32 kda	0.0212765957447
DARPP-	32dopamine- and camp-regulated phosphoprotein-32	0.0212765957447
DARPP-	32dopamine and camp responsive phosphoprotein 32 kda	0.0212765957447
DARPP-	32dopamine- and cyclic amp-regulated phosphoprotein-32	0.0212765957447
DARPP-	32dopamine and camp-regulated phosphoprotein of mr 32 kda	0.0212765957447
DARPP-	32dopamine and camp-regulated phosphoprotein-32	0.0212765957447
DARPP-	32dopamine- and camp-regulated phosphoprotein	0.0425531914894
DARPP-	32dopamine-receptor related phosphoprotein (32 kda)	0.0212765957447
DARPP-	32dopamine- and camp-regulated neuronal phosphoprotein of molecular mass of 32kda	0.0212765957447
DARPP-	32dopamine- and cyclic amp-regulated phosphoprotein with molecular weight 32 kda	0.0212765957447
DARPP-	32dopamine- and cyclic amp-regulated phosphoprotein of about 32 kd	0.0212765957447
DARPP-	32dopamine and camp regulated phosphoprotein-32 kda	0.0212765957447
DARPP-	32dopamine and cyclic amp-regulated phosphoprotein with molecular weight 32 kda	0.0212765957447
DARPP-	32dopamine- and cyclic amp-regulated phosphoprotein	0.0212765957447
DARPP-	32dopamine- and 3′–5′-cyclic amp–regulated phosphoprotein with molecular weight 32 kda	0.0212765957447
DARPP-	32dopamine adenosine 3′:5′-monophosphate regulated phospho-protein	0.0212765957447
DARPP-	32dopamine and camp regulated phosphoprotein-mw 32	0.0212765957447
DARPP-	32dopamine- and camp-regulated phosphoprotein of mr 32 kda	0.0212765957447
DARPP-	32	0.234042553191
DARPP-	32dopamine- and cyclic amp-regulated phosphoprotein of 32 kda	0.0212765957447
DARPP-	32dopamine and cyclic-amp regulated phosphoprotein-32	0.0212765957447
DARPP-	32dopamine and the cyclic amp-regulated phosphoprotein	0.0212765957447
IAP	inhibitor of apoptosis	0.157894736842
IAP	inhibitor of apoptosis proteins	0.105263157895
IAP	sinhibitor of apoptosis proteins	0.0526315789474
IAP	inhibitor of apoptosis protein	0.210526315789
IAP	inhibitor-of-apoptosis protein	0.105263157895
IAP	islet activating protein	0.0526315789474
IAP	islet-activating protein (pertussis toxin)	0.0526315789474
IAP	iodoantipyrine	0.0526315789474
IAP	sinhibitor-of-apoptosis proteins	0.0526315789474
IAP	inhibitory apoptosis protein	0.0526315789474
IAP	inhibitors of apoptosis	0.0526315789474
IAP	integrin-associated protein	0.0526315789474
IAS	intense auditory stimulation	1.0
IAR	intermediate acth response	0.25
IAR	immunoautoradiography	0.25
IAR	anomalous rectifying current	0.25
IAR	instantaneous axis of rotation	0.25
GSA	1-isolectin b4griffonia (bandeirea) simplicifolia lectin 1	0.25
GSA	griffonia simplicifolia lectin b4	0.25
GSA	igriffonia simplicifolia i	0.25
GSA	goat serum albumin	0.25
PHI	prolyl-4-hydroxylase inhibitor	0.5
PHI	peptide histidine isoleucine	0.5
PHN	posterior hypothalamic nucleus	0.25
PHN	postherpetic neuralgia	0.25
PHN	prepositus hypoglossi nucleus	0.25
PHN	nucleus periventricularis hypothalami	0.25
RHAR	oman high-avoidance	0.5
RHAR	oman high avoidance	0.25
RHAR	oman high-avoidance (rat line)	0.25
SG-II	secretogranin ii	1.0
PHA	posterior hypothalamic area	0.666666666667
PHA	phytohemagglutinin	0.333333333333
THIP	gaboxadol	0.285714285714
THIP	4,5,6,7-tetrahydroisoxazolo-[5,4-c]-pyridin-3-ol	0.142857142857
THIP	4,5,6,7-tetrahydroisoxazolo-(5,4-c)pyridin-3-ol	0.142857142857
THIP	4,5,6,7-tetrahydroisoxazol [5,4-c] pyridin-3-ol	0.142857142857
THIP	4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol	0.285714285714
PHG	parahippocampal gyrus	0.5
PHG	(right) parahippocampal gyrus	0.5
MRRN	middle rhombencephalic reticular nuclei	0.2
MRRN	middle rhombencephalic reticular nucleus	0.6
MRRN	medial rhombencephalic reticular nucleus	0.2
PHE	phenylephrine	0.666666666667
PHE	phenylalanine	0.333333333333
PHD	prolyl hydroxylase enzymes	0.166666666667
PHD	prolyl-hydroxylase	0.166666666667
PHD	prolyl hydroxylase	0.333333333333
PHD	post-hatch day	0.166666666667
PHD	prolyl-hydroxylases 2	0.166666666667
THIK	tandem pore domain halothane-inhibited k+ channel	1.0
ADDLAβ-	derived diffusible ligand	1.0
PHY	physical	1.0
RCA120	ricinus communis agglutinin	1.0
FRAs	fos-related antigens	1.0
SPlv	lateral-ventral septal nucleus	1.0
PHS	post-spike hyperpolarization	0.5
PHS	patterned high-frequency stimulation	0.5
BP	mean arterial blood pressure	0.0121951219512
BP	bimanual parallel	0.0121951219512
BP	band-pass	0.0243902439024
BP	arterial blood pressure	0.0243902439024
BP	blood pressure	0.634146341463
BP	bite plate	0.0121951219512
BP	bromopropane	0.0121951219512
BP	bipolar disorder	0.0121951219512
BP	button press	0.0121951219512
BP	binding potential	0.0853658536585
BP	backward rotated initial posture	0.0121951219512
BP	basal plate	0.0121951219512
BP	break point	0.0121951219512
BP	breakpoint	0.0121951219512
BP	growth hormone receptor/binding protein	0.0121951219512
BP	band pass	0.0487804878049
BP	blocking peptide	0.0121951219512
BP	breaking point	0.0121951219512
BP	binding protein	0.0243902439024
l-AP	4l-(+)-2-amino-4-phosphonobutyric acid	0.52380952381
l-AP	4l-2-amino-4-phosphonobutanoate	0.047619047619
l-AP	4l(+)-2-amino-4-phosphonobutyric acid	0.047619047619
l-AP	4l(+)-2.amino-4-phosphonobutyric acid	0.047619047619
l-AP	4l(+)-2-amino-4-phosphonbutyric acid	0.047619047619
l-AP	4	0.0952380952381
l-AP	4l-2-amino-4-phosphonobutyrate	0.142857142857
l-AP	4l-2-amino-4-phosphonobutyric acid	0.047619047619
PHP	passive hyperpolarizing potential	0.5
PHP	post hoc power	0.5
5-OH-U	5-hydroxyuracil	1.0
GRKG-	protein coupled receptor kinase	0.3
GRKG-	protein receptor kinases	0.1
GRKG-	protein-coupled receptor kinase	0.5
GRKG-	protein receptor kinase	0.1
IODMC	dorsomedial cell column of the inferior olivary nucleus	1.0
A-SM	aseacidic sphingomyelinase	1.0
α-SNAP	α-soluble n-ethylmaleimide-sensitive factor attachment protein	0.666666666667
α-SNAP	alpha-soluble n-ethyl maleimide attachment protein	0.333333333333
MNPO	median preoptic nucleus	1.0
DAPTA	d-ala-peptide t-amide	1.0
A-SC	actual mirror-reading and spelling and counting complex task	1.0
ω-CTx	ω-conotoxin gvia	1.0
GSHE	reduced glutathione monoethyl ester	1.0
DFMOα-	difluoromethylornithine	1.0
GPCPD	glycerophosphocholine phosphodiesterase	1.0
NaK-ATPase	sodium potassium atp	1.0
LM-R	strata lacunosum moleculare/radiatum border	1.0
MC-R	melanocortin receptor	1.0
15K	2α15-keto-prostaglandin f2α	0.5
15K	15-keto-prostaglandin f2α	0.5
Ni-DAB	nickel-enhanced diaminobenzidine	1.0
APLP2	amyloid precursor-like protein-2	1.0
ERαERβ	estrogen receptors, α and β	1.0
hFZD	human frizzled	1.0
hRFM	humped rippled frequency modulated	1.0
NCIN	ational cancer institute	1.0
ipc-IPSC	interplexiform cell-specific inhibitory postsynaptic current	1.0
mRNP	messenger ribonucleotide particles	0.5
mRNP	mrna–protein	0.5
mGluR1α	type 1α metabotropic glutamate receptor	1.0
Hsp	heat shock protein	1.0
TIB	time in bed.	0.5
TIB	time in bed	0.5
MECmecamylamine	n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride	1.0
TIC	total-ion current	1.0
IENF	intraepidermal nerve fiber	0.5
IENF	intraepidermal nerve fibers	0.2
IENF	intra-epidermal nerve fiber	0.3
MHO	mid-hindbrain organizer	1.0
DL-AP	52-amino-5-phosphonopentanoic acid	0.5
DL-AP	7dl-2-amino-7-phosphonoheptanoic acid	0.5
MHD	μ2 homology domain	1.0
MHB	mid-/hindbrain boundary	0.2
MHB	midbrain-hindbrain boundary	0.2
MHB	midbrain–hindbrain boundary	0.6
MHC	iiclass ii major histocompatibility complex	0.0204081632653
MHC	myosin heavy chain	0.0612244897959
MHC	major histocompatibility complex	0.836734693878
MHC	major histocompability complex	0.0204081632653
MHC	1major histocompatibility complex class 1	0.0204081632653
MHC	major histocompatibility complex/class	0.0204081632653
MHC	iimajor histocompatibility complex class ii	0.0204081632653
GKI	glucose–potassium–insulin	1.0
PARP-	1poly-(adp-ribose)-polymerase-1	0.181818181818
PARP-	1poly(adp-ribose)polymerase 1	0.0909090909091
PARP-	1	0.0909090909091
PARP-	1poly(adp-ribose) polymerase 1	0.0909090909091
PARP-	1poly(adp-ribose) polymerase enzyme 1	0.0909090909091
PARP-	1poly(adp-ribose) polymerase-1	0.363636363636
PARP-	1poly (adp-ribose) polymerase-1	0.0909090909091
SIRT	1mammalian silent information regulator 2	0.2
SIRT	1silent information regulator type 1	0.1
SIRT	1silent information regulator 1	0.2
SIRT	1	0.2
SIRT	mammalian sir2-related protein	0.1
SIRT	1sirtuin 1	0.2
aCAF	artificial cerebro spinal fluid	1.0
MHV	mouse herpes virus	1.0
8-SPT	8-sulphophenyltheophylline	0.5
8-SPT	8-sulfophenyltheophylline	0.5
GKG	oto-kakizaki	1.0
NVU	)	0.142857142857
NVU	neurovascular unit	0.857142857143
ANG	angiopoietin	0.0555555555556
ANG	angiotensin ii	0.0555555555556
ANG	angiotensin	0.0555555555556
ANG	iiangiotensin ii	0.833333333333
ANA	anandamide	0.5
ANA	bantinuclear antibody	0.25
ANA	integrated aortic nerve activity	0.25
NVP	neuronal visinin-like protein	0.333333333333
NVP	neural visinin-like protein	0.666666666667
WAT-SNA	white adipose tissue sympathetic nerve activity	1.0
ANN	attractor neural netwoks	0.25
ANN	artificial neural networks	0.25
ANN	artificial neural network	0.5
MHb	medial habenula	1.0
ANI	anisole	0.142857142857
ANI	anisomycin	0.857142857143
ANT	)	0.142857142857
ANT	adenine nucleotide translocase	0.285714285714
ANT	anterior nuclei	0.142857142857
ANT	antagonist	0.142857142857
ANT	attention network task	0.285714285714
NVE	sexually-naïve	1.0
VLCFA	very long chain fatty acids	0.5
VLCFA	svery long chain of fatty acids	0.5
ANP	atrial natriuretic peptide	0.933333333333
ANP	atriopeptin/atrial natriuretic peptide	0.0666666666667
ANR	anterior neural ridge	1.0
ANS	autonomic nervous system	1.0
NVN	non-viable cell with normal nucleus	1.0
bHABP	biotinylated hyaluronan-binding protein	1.0
NVI	abducens nerve	1.0
NVH	neonatal ventral hippocampus	1.0
pan-NF	pan-neurofilament	1.0
EMAP	echinoderm microtubule-associated protein	1.0
pP	38phospho p38	0.5
pP	average of pj	0.5
NADH	reduced form of nicotine amide adenine dinucleotide	0.03125
NADH	reduced form of nicotinamide adenine dinucleotide	0.09375
NADH	nicotinamide adenine dinucleotide	0.3125
NADH	fluorescence	0.03125
NADH	nicotinamide adenine dinucleotide-reduced	0.03125
NADH	nicotinamide adenine dinucleotide hydrogenase	0.03125
NADH	nicotinamide adenine dinucleotide reduced	0.03125
NADH	nicotinamide adenine diuncleotide hydrogen	0.03125
NADH	reduced nicotinamide-adenosine dinucleotide	0.03125
NADH	nicotinamide adenine dinucleotide diaphorase	0.03125
NADH	reduced nicotinamide adenine dinucleotide	0.25
NADH	beta-nicotinamide adenine dinucleotide reduced dipotassium salt	0.03125
NADH	nicotinamide adenine dinucleotide dehydrogenase	0.03125
NADH	nicotinamide adenine dinucleotide (reduced)	0.03125
pV	principal sensory trigeminal nucleus	1.0
nBM	nucleus basalis of meynert	0.428571428571
nBM	basal nucleus of meynert	0.285714285714
nBM	nucleus basalis magnocellularis	0.285714285714
pT	yrphosphotyrosine	0.111111111111
pT	phospho tau	0.111111111111
pT	rkb	0.111111111111
pT	auphosphorylated tau	0.111111111111
pT	212anti-phosphothr212	0.111111111111
pT	phosphorylation of threonine	0.111111111111
pT	231phosphorylated tau at thr 231 epitope	0.111111111111
pT	rkbphosphorylated trkb	0.222222222222
DPCPXcyclopentyl-1	3-dypropylxanthine,8-[dipropy-2,3-3h(n)]	0.5
DPCPXcyclopentyl-1	3-dypropylxanthine,8-[dip ropy-2,3-3h(n)]	0.5
APOapomorphine	r-(-) apomorphine hydrochloride hemihydrate	1.0
NADA	sn-acyldopamines	1.0
pY	490a peptide antibody directed against a synthetic ptyr 490 peptide	0.333333333333
pY	phosphorylation of tyrosine	0.333333333333
pY	1472-nr2bphospho-tyr1472 of nr2b subunits	0.333333333333
RHL	right hindlimb	1.0
Bi	basal amygdala, intermediate region	0.5
Bi	basal nucleus, intermediate division	0.5
pC	amkiiphosphorylated calcium/calmodulin dependent protein kinase ii	0.0909090909091
pC	amk-iiαphosphor-ca2+/calmodulin dependent protein kinase ii alpha	0.0909090909091
pC	hatcholine acetyltransferase of a peripheral type	0.0909090909091
pC	amk-ii	0.0909090909091
pC	hatperipheral type of choline acetyltransferase	0.0909090909091
pC	amkii(phosphothr286)calcium/calmodulin-dependent protein kinase ii	0.0909090909091
pC	amkiiphosphorylated calcium/calmodulin-dependent protein kinase ii	0.0909090909091
pC	amk-iiαphosphorylated calcium/calmodulin-dependent protein kinase-iiα	0.0909090909091
pC	amkiiαphosphorylated calcium/calmodulin-dependent protein kinase ii	0.0909090909091
pC	gposterior cingulate cortex	0.0909090909091
pC	amkiiββ subunit of pcamkii	0.0909090909091
ILH	ipsilateral hemisphere	1.0
pA	bpolyclonal antibodies	0.111111111111
pA	bpolyclonal ab	0.0555555555556
pA	bprimary antibody	0.0555555555556
pA	ktphosphorylated protein kinase b	0.0555555555556
pA	ktphosphorylated akt	0.222222222222
pA	bpolyclonal antibody	0.333333333333
pA	polyadenylation sequence	0.0555555555556
pA	ktphosphorylated forms of akt	0.0555555555556
pA	bspolyclonal antibodies	0.0555555555556
pF	cell capacitance	0.333333333333
pF	paraformaldehyde	0.666666666667
pG	trials that followed a go success	0.333333333333
pG	zperiodic acceleration	0.333333333333
pG	lur1	0.333333333333
pD	ynprodynorphin	1.0
pE	lk-1phosphorylated elk-1	1.0
pK	ir2.1pigeon's inwardly rectifying potassium channel	0.5
pK	irpigeon k inward rectifier	0.5
pH	aarterial ph	0.0416666666667
pH	i	0.0416666666667
pH	regulation	0.125
pH	ish3phosphorylated histone h3	0.0416666666667
pH	shifts	0.0416666666667
pH	iintracellular ph	0.25
pH	50ph value for half maximal activation	0.0833333333333
pH	3phospho-histone h3	0.0416666666667
pH	50half-maximum activation ph value	0.0416666666667
pH	oextracellular ph	0.125
pH	2a.xphospho-histone h2a.x (ser 139)	0.0416666666667
pH	changes	0.0416666666667
pH	membtransmembrane ph gradient	0.0416666666667
pH	50ph value for half-maximal activation	0.0416666666667
NADP	(h)nicotinamide adenine dinucleotide phosphate-oxidase	0.0909090909091
NADP	(h)nicotinamide adenine dinucleotide phosphate hydrogenase	0.0909090909091
NADP	oxidized form of nicotinamide adenine dinucleotide phosphate	0.0909090909091
NADP	(h)reduced nicotinamide adenine dinucleotide phosphate	0.0909090909091
NADP	nicotinamide adenine dinucleotide phosphate	0.636363636364
pN	estin-gfpthat expressed enhanced green fluorescent protein under the control of the nestin gene regulatory region	1.0
IGF-I	insulin-like growth factor type i	0.0357142857143
IGF-I	ii, insulin-like growth factor-1, 2	0.0357142857143
IGF-I	insulin-like growth factor-i	0.571428571429
IGF-I	insulin-like growth factor i	0.321428571429
IGF-I	and igf-iiinsulin-like growth factor i and ii	0.0357142857143
MDFi	medial dorsal thalamus nucleus–pars fibrosa	1.0
PSFR	persistent spontaneous flinching reflex	1.0
MApd	posterodorsal ma	1.0
MDFa	medial dorsal thalamus nucleus–pars fasiculosa	1.0
OVXT	ovariectomized female treated with testosterone	1.0
PVNm	hypothalamic paraventricular nucleus, magnocellular	1.0
GHRG-	1growth hormone response gene-1	1.0
MApv	posteroventral ma	1.0
eIF	2αeukaryotic initiation factor 2α	0.0909090909091
eIF	2α(p)eukaryotic initiation factor 2 phospho-form	0.0454545454545
eIF	2α-pphosphorylated form of eukaryotic initiation factor-2α	0.0454545454545
eIF	5eukaryotic translation initiation factor 5	0.0454545454545
eIF	4a3	0.0454545454545
eIF	2αα subunit of the translation initiation factor-2	0.0454545454545
eIF	2αeukaryotic initiation factor 2 α	0.0454545454545
eIF	2αalpha subunit of eukaryotic initiation factor 2	0.0909090909091
eIF	2αα subunit of the eukaryotic initiation factor 2	0.0454545454545
eIF	2αeukaryotic initiation factor-2α	0.0909090909091
eIF	4aeukaryotic translation initiation factor 4 a	0.0454545454545
eIF	2αeukaryotic initiation factor 2 alpha	0.0454545454545
eIF	eukaryotic translation initiation factor	0.0454545454545
eIF	eukaryotic initiation factor	0.0909090909091
eIF	eucaryotic initiation factor	0.0454545454545
eIF	4g(p)phosphorylated eukaryotic initiation factor	0.0454545454545
eIF	4eeukaryotic initiation factor 4e	0.0909090909091
OVXE	ovariectomized female treated with estrogen	1.0
MPMM	ultiple platform method	1.0
HADHIV-	1-associated dementia	1.0
BMMCGFP	+bone marrow mononuclear cells expressing green fluorescent protein	1.0
KRP	krebs’–ringer’s phosphate	0.25
KRP	krebs–ringer phosphate buffer	0.25
KRP	potassium ringer phosphate	0.25
KRP	kreb's ringer phosphate buffer	0.25
BALB	/c	1.0
LOCL	ocomotion	1.0
avANT	avian adenine nucleotide translocator	1.0
c-FOS-IR	c-fos immunoreactivity	1.0
LOCS	lateral olivocochlear system	1.0
OVX-	30+ebovariectomized rats+estradiol injection	1.0
KRB	kreb’s ringer buffer	0.1
KRB	krebs'–ringer bicarbonate buffer	0.1
KRB	krebs–ringer buffer	0.3
KRB	kreb's–ringer–bicarbonate	0.1
KRB	krebs–ringer bicarbonate buffer	0.3
KRB	krebbs–ringer buffer	0.1
Aδ	fibres	1.0
D-MEMD	ulbecco’s modified eagle medium	0.5
D-MEMD	ulbecco’s modified eagle’s medium	0.5
HLBE	hemianopic line bisection error	1.0
IGF-1	insulin-line growth factor-1	0.0769230769231
IGF-1	insulin-like growth factor-1	0.846153846154
IGF-1	insulin like growth factor-1	0.0769230769231
RAHR	oyal adelaide hospital	1.0
129129S	6/svevtac	1.0
NNP	nucleated neuronal profile	1.0
DHEA-S	dehydroepiandrosterone-sulfate	0.5
DHEA-S	dehydroepiandosterone-sulphate	0.5
cIGL	contralateral intergeniculate leaflet	1.0
BCITB	ox control of incompletely trained	1.0
IPSCs	inhibitory postsynaptic currents	1.0
BDL	basal dendritic length	0.5
BDL	bile duct ligation	0.5
cCr	cyclocreatine	1.0
ECOG	electrocorticogram	1.0
C1-C2	cervical spinal cord segments 1-2	1.0
EHNA	erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride	0.4
EHNA	erythro-9(2-hydroxy-3-nonyl) adenine	0.2
EHNA	erythro-9-[3-(2-hydroxynonyl)] adenine	0.2
EHNA	erythro-9-(2-hydroxy-3nonyl) adenine	0.2
ω-CTx-MVIIC	ω-conotoxin mviic	0.333333333333
ω-CTx-MVIIC	ω-conotoxin-mviic	0.666666666667
rPMA	right premotor area	1.0
MPOA-AH	medial preoptic anterior hypothalamic continuum	1.0
NGF-IR	ngf-immunoreactivity	1.0
7-AAD	7-amino-actinomycin d	0.25
7-AAD	7-aminoactinomycin d	0.75
pBNST	ccaudal posterior bed nucleus of the stria terminalis	1.0
BPSDB	ehavioral and psychological symptoms of dementia	1.0
0G	microgravity	1.0
INM	interkinetic nuclear migration	1.0
IPSCP	sinhibitory post-synaptic potentials	1.0
hEOG	horizontal electrooculogram	1.0
cCP	vmcaudal caudate putamen ventromedial subdivision	1.0
MOCneurons	medial olivocochlear neurons	1.0
RX821002	1,4-[6,7(n)-3h]	0.5
RX821002	(1,4-benzodioxan-2-methoxy-2-yl)2-imidazoline hydrochloride	0.5
ICP4	infected-cell protein 4	1.0
iCOH	sigavaveraged jackknife significance of icoh	1.0
ICP6	infected cell polypeptide 6	1.0
sGCβ	1soluble guanylate cyclase β1	1.0
rNST	rostral subdivision of the nucleus of the solitary tract	0.166666666667
rNST	rostral nucleus of the solitary tract	0.833333333333
IDDM	insulin-dependent diabetes mellitus	1.0
ICPI	intracortical potential image	1.0
YOH	yohimbine	1.0
SA-PMP	streptavidin paramagnetic particles	1.0
PC-	12pheochromocytoma	0.5
PC-	12	0.5
HDVEHH	untington's disease mice treated with vehicle	1.0
HBO-PC	hyperbaric oxygen preconditioning	1.0
SNPc	substantia nigra pars compacta	1.0
DNAB	dorsal noradrenergic bundle	1.0
NADPH-d	reduced nicotinamide adenine dinucleotide phosphate-diaphorase	0.0526315789474
NADPH-d	nicotinamide adenine dinucleotide phosphate diaphorase	0.105263157895
NADPH-d	nicotinamide adenine dinucleotide phosphate-diaphorase	0.526315789474
NADPH-d	reduced nicotinamide-adenine dinucleotide diaphorase	0.0526315789474
NADPH-d	reduced nicotinamide adenine dinucleotide phosphate diaphorase	0.0526315789474
NADPH-d	nadph-diaphorase	0.210526315789
SPON	superior paraolivary nucleus	0.833333333333
SPON	spontaneous	0.166666666667
PpT	pedunculopontine tegmental nucleus	1.0
FFG	fusiform gyrus	1.0
Raf1	serine/threonine kinase (mitogen activated protein kinase kinase kinase, map kinase kinase kinase, mapkkk, mek kinase, mekk)	1.0
IPPI	mage-pro plus	1.0
Con	control	1.0
CoP	posterior cortical nucleus	1.0
ILS	intermediate lateral septum	1.0
dLFP	derivative of the lfp	1.0
PPAR-γ	peroxisome proliferators activated receptors-γ	0.25
PPAR-γ	peroxisome proliferator-activated receptor gamma	0.25
PPAR-γ	peroxisome proliferator-activated receptor-gamma	0.25
PPAR-γ	proliferator-activated receptor gamma	0.25
PPAR-α	peroxisome proliferator-activated receptor alpha	1.0
5PI	5 paced intromissions	1.0
D-S	p5odorsal-sp5o;	1.0
CoA	anterior cortical nucleus	1.0
LTPGABA	long-term potentiation of gaba synapses	1.0
NADPH-D	reduced nicotinamide adenine dinucleotide phosphate-diaphorase	1.0
CCAs	common carotid arteries	1.0
DARPP32	dopamine- and camp-regulated phosphoprotein of 32 kda	1.0
SPECT	single photon emission computerized tomography	0.2
SPECT	single photon emission computed tomography	0.7
SPECT	single-photon emission computed tomography	0.1
INC	interstitial nucleus of cajal	1.0
PTSD-SS	post-traumatic stress disorder self-rating scale	1.0
LLP	very long photoperiod ld18:6	1.0
ORXDHT	orchidectomized male treated with dihydrotestosterone	1.0
MC2R	melanocortin 2 receptor	1.0
iBRB	inner blood–retinal barrier	1.0
GDNFRα	glial cell line–derived neurotrophic factor receptor-α	1.0
UDCA	ursodeoxycholic acid	1.0
SIFTS	orting intolerant from tolerant	1.0
CPCCOE	t7-(hydroxyl-imino)cyclopropa[b]chromen-1a-carboxylate ethyl ester	0.0526315789474
CPCCOE	t7-(hydroxyimino)-cyclopropa-[b]-chromen-1a-carboxylate ethyl ester	0.0526315789474
CPCCOE	t7-hydroxyiminocyclopropan[b]chromen-1α-carboxylic acid ethyl ester	0.157894736842
CPCCOE	t7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester	0.210526315789
CPCCOE	t7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester	0.263157894737
CPCCOE	t7(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester	0.0526315789474
CPCCOE	t7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate	0.0526315789474
CPCCOE	t7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxylate ethyl ester	0.0526315789474
CPCCOE	t7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxylate ethyl ester	0.0526315789474
CPCCOE	t7-(hydroxyimino)cyclopropa[β]chromen-1a-carboxylate ethyl ester	0.0526315789474
TFRGAPH-T	hr-phe-arg-gly-ala-pro-oh (human par-3 activating peptide)	1.0
HPTS8-hydroxypyrene-1	3,6-trisulphonic acid	1.0
OAMB	octopamine receptor in mushroom body	1.0
IOBe	β subnucleus of the medial nucleus of inferior olivary nucleus	1.0
GLO	1lactoylglutathione lyase	1.0
FICO	2inspiratory fraction of carbon dioxide	1.0
l-DOPSl-threo-3	4-dihydroxyphenylserine	1.0
OXPHOS	oxidative phosphorylation	0.75
OXPHOS	oxidative phosphorylation system	0.25
GLA	glia limitans accessoria	0.5
GLA	gamma linolenic acid	0.5
GLB	glibenclamide treatment group	1.0
VDAC	2voltage-dependent anion-selective channel protein 2	0.111111111111
VDAC	voltage-dependent anion channel	0.777777777778
VDAC	1voltage-dependent anion channel 1	0.111111111111
GLC	glucose treatment group	1.0
FM2-10	(n-(3-ethylammoniumpropyl)-4-(4(diethylamino)styryl)pyridinium dibromide)	1.0
WMS	wechsler memory scale	1.0
hPMAT	human plasma membrane monoamine transporter	1.0
WMV	white matter volume	1.0
WMI	white matter injury	1.0
WMH	white matter hyperintensity	1.0
WMM	orris water maze test	1.0
WML	white matter lesions	1.0
GRKG	protein receptor kinase	0.25
GRKG	protein-coupled receptor kinase	0.75
SIOC	semi-quantitative indicator of co-localization	1.0
SARAS	cale for the assessment and rating of ataxia	1.0
CKBB	creatine kinase bb	1.0
FAME	fatty acid methyl esters	1.0
WME	incorrectworking memory errors incorrect	0.1
WME	working memory error	0.7
WME	working memory errors	0.2
WMD	weighted mean difference	0.5
WMD	white matter damage	0.5
IK-C	aca2+-activated k+ current	1.0
PTMA	phenyltrimethylammonium chloride	1.0
aVOR	angular vestibulo-ocular reflex	1.0
deltorphin-II	[d-ala2]-deltorphin ii	1.0
proNGF	pro-nerve growth factor	1.0
RPM	reward-processing module	0.333333333333
RPM	revolutions per minute	0.666666666667
el-PBN	external lateral subnucleus of pbn	1.0
non-REM	non–rapid eye movement	0.333333333333
non-REM	sleepnon-rapid eye movement sleep	0.333333333333
non-REM	non-rapid eye movement or slow wave sleep	0.333333333333
CTB-HRP	choleratoxin b subunit–horseradish peroxidase conjugate	0.5
CTB-HRP	cholera toxin b conjugated to horseradish peroxidase	0.5
MMV	maximum movement velocity value	1.0
CBDAC	ascade blue-conjugated dextran amines	1.0
EEGelectroencephalogram	sensu latu, including intracranial and semimicroelectrode recordings	0.5
EEGelectroencephalogram	electroencephalographic	0.5
DAR-	4mdiaminorhodamine-4m	1.0
B-	oligomer	0.2
B-	50	0.2
B-	cell lymphoma-2	0.2
B-	zipbasic region leucine zipper	0.2
B-	cell-cll/lymphoma 2	0.2
mGFP	membrane gfp	0.5
mGFP	membrane-anchored version of green fluorescent protein	0.5
NAcc	nucleus accumbens	0.941176470588
NAcc	nucleus accumbens core	0.0588235294118
TAT-PTD	transactivator of transcription protein transduction domain	1.0
EBSS	earle’s balanced salt solution	1.0
EBST	elevated body swing test	1.0
BHSB	ehavioural hypoactivity score	1.0
NAcs	nucleus accumbens shell	1.0
pCO2	partial pressure of carbon dioxide	1.0
DMOTC	defined-medium organotypic culture	1.0
Ntab	non-coding transcript abundantly expressed in brain	1.0
FR-1	fr-5 and fr-10, fixed ratio-1, -5 and -10 schedules	1.0
AMYG	amygdala	1.0
EDI	echo-planar-imaging	1.0
VRL-	1	1.0
B4	isolectin b4 from griffonia simplicifolia i	1.0
pre-OL	pre-oligodendrocyte	0.5
pre-OL	spre-oligodendrocytes	0.5
LDDL	hermitte-duclos disease	1.0
low-M	g2+	1.0
rmoB	ucherecombinant mouse buche	1.0
BIMBIM	23056	1.0
CMAH	cytidine monophosphate-n-acetylneuraminic acid hydroxylase	1.0
35S-UTP	35s-uridine triphosphate	1.0
CRF-R	2type 2 crf receptor	0.142857142857
CRF-R	2α-trtype 2 corticotropin releasing factor receptor (truncated isoform)	0.142857142857
CRF-R	2type 2 corticotropin releasing factor receptor	0.142857142857
CRF-R	1corticotropin-releasing factor receptor-1	0.142857142857
CRF-R	crf receptor	0.142857142857
CRF-R	2corticotropin-releasing factor receptor 2	0.142857142857
CRF-R	1corticotropin-releasing factor receptor subtype 1	0.142857142857
dsDNA	double-stranded dna	1.0
CMAP	scompound muscle action potentials	0.166666666667
CMAP	compound motor action potential	0.166666666667
CMAP	compound muscle action potential	0.666666666667
KTK	channel+trkb kinase	1.0
PVTN	paraventricular thalamic nucleus	1.0
STINS	tereotyped internodal region	1.0
T-TBSTBS	containing 0.5% tween-20	1.0
SSFS	patial span forward	1.0
Atm	the gene mutated in ataxia–telangiectasia	1.0
aMO	anterior part of the medulla oblongata	1.0
G185R	glycine-to-arginine substitution at amino acid 185	1.0
TpOH	tryptophan hydroxylase	1.0
125I	]iodopindolol	0.0625
125I	]rti-553 beta-(4-iodophenyl)tropan-2 beta-carboxylic acid methyl ester	0.0625
125I	]-rti-55[125i]	0.0625
125I	]-(±)-doi	0.0625
125I	]α-btx[125i]	0.0625
125I	]-α-bungarotoxin	0.0625
125I	]rti-553β-(4′-125iodophenyl)tropan-2β-carboxylic acid methyl ester	0.0625
125I	]-epi[125i]	0.0625
125I	]-apt[125i]	0.0625
125I	]iodoproxyfan	0.0625
125I	]iodoaminopotentidine	0.0625
125I	]-ncq 298(s)-3-iodo-n-[(1-ethyl-2pyrrolidinyl)methyl]	0.0625
125I	]bhe[125i]	0.0625
125I	]-αbgt[125i]	0.0625
125I	]rti-55	0.0625
125I	]-btx[125i]	0.0625
Epo	erythropoietin	1.0
SSPSar9	met(o2)11-substance p	1.0
aMT	active motor threshold	1.0
tNAA	total n-acetylaspartate	1.0
HPLC-ECDHPLC	analysis with electrochemical detection	1.0
DFK	difluoroketone	1.0
ICAN	calcium-activated non-selective cationic current	1.0
Rob	raphe obscurus	1.0
vomAMY	vomeronasal amygdala	1.0
DPDPED-Pen2	d-pen5-enkephalin	1.0
PTVP	iccolo/bassoon transport vesicles	1.0
P-GPP-	glycoprotein	1.0
HBSS-TH	anks' balanced salt solution containing 0.1% tween-20	1.0
NVPNVP-AAM	077	1.0
l-NMMAN-	nitro-l-arginine methyl ester	1.0
MGCm	medial subdivision of the geniculate complex	1.0
GAD-	6767 kda form of glutamic acid decarboxylase	0.111111111111
GAD-	67glutamic acid decarboxylase	0.111111111111
GAD-	ipgad-ir identified by dab reaction product	0.111111111111
GAD-	67l-glutamic acid decarboxylase-67	0.222222222222
GAD-	67	0.222222222222
GAD-	67glutamic acid decarboxylase-67	0.111111111111
GAD-	glutamic acid decarboxylase negative	0.111111111111
ASN	antisense oligodeoxynucleotide to ngfi-a	1.0
METHY	methysergide	1.0
BATF	basic leucine zipper transcription factor	1.0
TH-IHC	tyrosine hydroxylase-immunohistochemistry	1.0
SPRIA	scintillation proximity radioimmunoassay	1.0
A2M	α2-macroglobulin	0.5
A2M	alpha-2-macroglobulin	0.5
CISS	constructive interference in steady state-3d-fourier transformation	1.0
sEHKO	seh knockout	1.0
3β-D	iol3β-androstanediol	1.0
VPO	ventral periolivary nucleus	1.0
L-364	718, 3s(-)-n-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl)-1h-indole-2-carboxamide (devazepide)	0.5
L-364	718	0.5
MIDAS	metal ion dependent adhesion site	1.0
INTERACTI	ntensive blood pressure reduction in acute cerebral hemorrhage	1.0
1-PP	1-(2-pyrimidinyl-piperazine)	1.0
DPSPX1	3dipropyl-8-p-sulfophenylxanthine	1.0
NHuS	normal human serum	1.0
DOPR	delta opioid receptor	1.0
RNA-S	eq	1.0
STREX	stress axis hormone-regulated exon	1.0
HRLF	high repetition low force	1.0
GNG-D	go/nogo differential	1.0
SALS	sporadic amyotrophic lateral sclerosis	0.571428571429
SALS	sporadic als	0.428571428571
HRLM	high resolution light microscope	1.0
CRLR	calcitonin-receptor-like receptor	0.2
CRLR	calcitonin receptor-like receptor	0.8
PmV	ventral premammillary nucleus	1.0
PFWS	periodically firing with skipping	1.0
Glra1	murine gene of the glycine receptor α1-subunit	1.0
PSTHs	peristimulus time histograms	1.0
EEP	semf-evoked potentials	0.5
EEP	selectrical evoked potentials	0.5
ir-CRF	immunoreactive crf	1.0
BSE	bovine spongiform encephalopathy	1.0
DCFHDA	2′,7′-dichlorofluorescein-diacetate	1.0
NCAM-EC	extracellular cleaved neural cell adhesion molecule	1.0
BBAB	eta-boswellic acid	1.0
BSG	buffered saline–glucose	1.0
DGL-α	diacylglycerol lipase α	0.5
DGL-α	diacylglycerol lipase-α	0.5
GADD	153growth arrest and dna-damage inducible protein	0.2
GADD	153growth arrest and dna damage-inducible gene	0.2
GADD	growth arrest and dna damage inducible	0.2
GADD	growth arrest and dna damage	0.4
HB-GAM	heparin-binding growth-associated molecule or pleiotrophin	0.25
HB-GAM	heparin-binding growth-associated molecule	0.75
OTO	lfactory tubercle	0.5
OTO	otolith organ	0.5
HINGS	heat-inactivated normal goat serum	1.0
LLL	large/luck-linked	1.0
PMAT	plasma membrane monoamine transporter	1.0
VAChT	vesicular acetylcholine transporter	1.0
DBPD-	box binding protein	1.0
LTN	lateral terminal nucleus	1.0
MICARSI	nternational cooperative ataxia rating scale	1.0
REIN	reinnervation alone or in combination with hyperthyroidism	1.0
zFA-fmk	n-benzyloxycarbonyl-phe-ala-fluoromethylketone	1.0
ALLNA	c-llnl-cho	1.0
PA-GFP	photoactivatable green fluorescent protein	1.0
PBsl	superior lateral parabrachial subnucleus	1.0
mGFAP	monoclonal gfap	1.0
NK-	1 receptors	0.037037037037
NK-	3neurokinin-3	0.037037037037
NK-	1rneurokinin-1 receptor	0.0740740740741
NK-	1r-irnk-1r-immunoreactive	0.037037037037
NK-	1,	0.037037037037
NK-	1 and nk-3 receptors	0.037037037037
NK-	1rneurokinin-1 receptor (substance p receptor)	0.0740740740741
NK-	1rsubstance p (neurokinin 1) receptor	0.037037037037
NK-	1 receptor	0.0740740740741
NK-	1neurokinin-1 receptor	0.185185185185
NK-	1neurokinin-1	0.37037037037
RVMM	(io)rostral ventromedial medulla at the level of the rostral inferior olivary nucleus	0.25
RVMM	rostral ventromedial medulla	0.75
NK1	nk2, nk3, neurokinin receptor subtypes	0.047619047619
NK1	neurokinin1	0.047619047619
NK1	neurokinin 1	0.333333333333
NK1	neurokinin receptor-1	0.047619047619
NK1	neurokinin-1	0.428571428571
NK1	nk2, and nk3 binding sites	0.047619047619
NK1	2,3neurokinin-1,2,3	0.047619047619
NK2	neurokinin 2	1.0
NK3	neurokinin-3 (receptor)	0.5
NK3	neurokinin 3	0.5
PEE	parallel elastic element	1.0
DSCAM	down syndrome cell adhesion molecule	1.0
Neurog1	neurog2, ascl1	1.0
α2C-OE	mice overexpressing the α2c-adrenergic receptor	1.0
PIMT	protein l-isoaspartyl methyltransferase	1.0
R-PIAR-	phenylisopropyladenosine	1.0
pLV-EGFP	lentiviral plasmid encoding egfp	1.0
MPV-	2426	1.0
OSMR	oncostatin m receptor	1.0
HVLF	high-voltage low-frequency	1.0
NMRI	mice	1.0
MIER	smagnetically evoked interenlargement responses	1.0
SynEGFP	α-synuclein–enhanced green fluorescent protein	1.0
5-MT	5-methoxytryptamine	1.0
VESPA	visual-evoked spread spectrum analysis	1.0
GVI	gray value index	1.0
TNS	tris-buffered non-saline	0.5
TNS	tris non-saline buffer	0.5
A1R	a1 adenosine receptor	0.333333333333
A1R	adenosine a1 receptor	0.666666666667
ICD-10	tenth revision of the international criteria for diseases	1.0
ERGICER-	golgi compartments	1.0
tetR	tetracycline repressor	1.0
GVF	gradient vector flow	1.0
GVG	(±)-γ-vinyl gaba	1.0
GVE	general visceral efferent	1.0
TND	transneuronal degeneration	1.0
ATOH	1	1.0
TNF	tumor necrosis factor-alpha	0.025
TNF	tumour necrosis factor (α or β)	0.00833333333333
TNF	abtnf-α antibody	0.00833333333333
TNF	tumour necrosis factor	0.166666666667
TNF	tumor necrotic factor	0.00833333333333
TNF	tumor necrosis factor α	0.00833333333333
TNF	tumor necrosis factor-α	0.0333333333333
TNF	alpha	0.00833333333333
TNF	tumor necrosis factor	0.733333333333
TNA	total nucleic acid	1.0
TNC	tenascin c	0.2
TNC	trigeminal nucleus caudalis	0.6
TNC	tenascin-c	0.2
TNB	5-thio-2-nitro-benzoic acid	0.166666666667
TNB	buffer comprising tris, nacl and blocking reagent	0.166666666667
TNB	2-nitro-5-thiobenzoic acid	0.166666666667
TNB	tris-buffered saline with casein	0.166666666667
TNB	tris–nacl blocking buffer	0.333333333333
GVS	galvanic vestibular stimulation	1.0
VZV	varicella zoster virus	1.0
NKA	neurokinin a	1.0
NKB	neurokinin b	1.0
MHCII	major histocompatibility complex class i/class ii	1.0
HHT	hyperoncotic/hypertonic solution treatment	1.0
SLIGRLH-S	er-leu-ile-gly-arg-leu-oh (rat par-2 activating peptide)	1.0
dUTP	nick end labelling	0.0769230769231
dUTP	digoxigenin–deoxyuridine triphosphate	0.0769230769231
dUTP	2′-deoxyuridine 5′-triphosphate	0.0769230769231
dUTP	deoxyuridinetriphosphate	0.0769230769231
dUTP	nick end labeling	0.230769230769
dUTP	2′-deoxyuridine-5′-triphosphate	0.0769230769231
dUTP	deoxyuridine-triphosphate	0.0769230769231
dUTP	deoxyuridine triphosphate	0.307692307692
DBSD	eep-brain stimulation	1.0
LDL-R	low-density lipoprotein receptor	0.5
LDL-R	low density lipoprotein receptor	0.5
sISPC	spontaneous inhibitory postsynaptic currents	1.0
ipsi-MVe	ipsilesional medial vestibular nucleus	1.0
uPA	urokinase plasminogen activator	0.142857142857
uPA	urokinase type plasminogen activator	0.142857142857
uPA	urokinase-type plasminogen activator	0.714285714286
HHC	l	1.0
UDP-G	lcuridine diphosphate glucose	1.0
NKR	neurokinin k receptor	0.333333333333
NKR	neurokinin b receptor	0.333333333333
NKR	neuromedin k receptor	0.333333333333
MCAP	megalencephaly-capillary malformation	1.0
HHG	1mm hepes buffer, 2% horse serum, 10% goat serum in hbss	1.0
NPAR-	propylnorapomorphine	1.0
BVRT	benton visual retention test	1.0
HNPE	human non-pigmented ciliary epithelial cells	1.0
NKX	2-1	1.0
HHH	amburger and hamilton stages	0.2
HHH	amburger–hamilton stage	0.4
HHH	odgkin–huxley	0.2
HHH	amburger and hamilton	0.2
NNC-711	1-(2-{[(diphenylmethylene)amino]oxy}ethyl)-1,2,5,6-tetrahydro-3-pyridine-carboxylic acid hydrochloride	1.0
DYNLT	1dynein light chain tctex-type 1	1.0
PDHS	plasma-derived horse serum	1.0
Ad-hCuZnSOD	recombinant adenovirus encoding the human cu/zn sod	1.0
mEC	medial entorhinal cortex	0.5
mEC	medial ec	0.5
ROD	relative optic density	0.0384615384615
ROD	relative optical densities	0.0192307692308
ROD	relative optical density	0.923076923077
ROD	relative od within the region to be measured	0.0192307692308
mEH	microsomal epoxide hydrolase	1.0
TSNC	trigeminal sensory nuclear complex	0.75
TSNC	trigeminal sensory nuclei complex	0.25
LLV	left lateral ventricle	0.5
LLV	ventral nucleus of the lateral lemniscus	0.5
APO-SUS	apomorphine-susceptible	1.0
APVα-	amino-5-phosphonopentanoic acid	1.0
AR-IR	sandrogen receptor immunoreactive neurons	1.0
mES	minimal electroshock seizure	0.333333333333
mES	mouse embryonic stem cells	0.333333333333
mES	cellsmouse embryonic stem cells	0.333333333333
mER	membrane form of estrogen receptor	0.25
mER	smembrane estrogen receptors	0.25
mER	membrane estrogen receptor	0.5
NAcbC	core of the nucleus accumbens	1.0
3α5α-THDOC	3α,5α-tetrahydrodeoxycorticosterone	1.0
LLT	lateral longitudinal tract	1.0
ELPSP	electrotonic postsynaptic potential	1.0
PLGA-	blended microparticles	1.0
scNE	spatial context not encoded	1.0
SCH-	23390	1.0
dHIPP	dorsal hippocampus	1.0
UAP	universal amplification primer	1.0
UAS	upstream activating sequences	0.2
UAS	upstream activation sequence	0.2
UAS	upstream activating sequence	0.6
OTT	one-trial tolerance	1.0
UAW	upper airway	1.0
UAV	upper adjacent value	1.0
vDMH	ventral portion of dmh	1.0
pKA	protein kinase a	1.0
HEEG	hippocampal eeg	1.0
MANF	mesencephalic astrocyte-derived neurotrophic factor	1.0
vDMN	ventral part of the dorsomedial hypothalamic nucleus	1.0
FGLFG	loop (peptide)	1.0
MK-80	dizocilpine maleate	1.0
AC-DEVD-CHO	acetyl-devd-cho	1.0
FOS-IRFOS-	immunoreactivity	1.0
2m5-HT	2-methyl-5-hydroxytryptamine	1.0
ACPT	testicular acid phosphatase	1.0
IC50	concentration giving half the maximum normalized response determined from dose–inhibition curve	1.0
YC-	1	0.333333333333
YC-	13-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole	0.333333333333
YC-	13-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole	0.333333333333
EHP	extrinsic hyperpolarizing potential	1.0
SBS	short burst stimulation	0.5
SBS	pinal border	0.5
NF-kB	nuclear factor-kappab transcription factor	1.0
Bcl-X	anti-apoptotic proteins	1.0
EHC	ethyl homocholine	1.0
DOTAP	1,2-bis(oleoyloxy)-3-(trimethylammonio)propane	1.0
ROR	retinoic acid orphan receptor	1.0
LAL	levator auris longus muscle	0.428571428571
LAL	levator auris longus	0.428571428571
LAL	limulus amebocyte lysate	0.142857142857
NFκB-I	nuclear factor kappa b inhibitor	1.0
PDMS	polydimethylsiloxane	0.5
PDMS	periventricular dorsomedial striatum	0.5
PANASP	ositive and negative affect schedule	1.0
FOXO	1forkhead box o1	1.0
FFX	fimbria–fornix	0.5
FFX	fimbria fornix lesions	0.5
LAD	low alcohol drinking	0.25
LAD	slamina-associated domains	0.25
LAD	lamina arcopallialis dorsalis	0.25
LAD	left anterior descending coronary artery	0.25
LAE	locomotor aftereffect	1.0
FFT	fundamental fourier component	0.0188679245283
FFT	fast-fourier transforms	0.0188679245283
FFT	fast fourier transforms	0.0377358490566
FFT	fast fourier transform	0.735849056604
FFT	fimbria–fornix transection	0.0377358490566
FFT	fast fourier transformation	0.11320754717
FFT	fast fourier transformations	0.0188679245283
FFT	1fundamental fourier component	0.0188679245283
01M	ph 7.4)	1.0
LAB	low anxiety-related behavior	0.666666666667
LAB	slow anxiety–related behavior rats	0.333333333333
LAC	l-acetylcarnitine	1.0
MMU	male mouse urine	1.0
IRimmunoreactivity	immunoreactive	1.0
FFL	fornix–fimbria lesion	1.0
MATRICSM	easurement and treatment research to improve cognition in schizophrenia	1.0
LAT	lateral nucleus	0.166666666667
LAT	lateral	0.166666666667
LAT	lateral nucleus of the amygdala	0.166666666667
LAT	lateral nucleus of the basolateral complex	0.166666666667
LAT	latency associated transcripts	0.166666666667
LAT	support surface tilted in the medial–lateral direction 10° to the right	0.166666666667
FOXP	1	0.5
FOXP	2	0.5
LAV	lower adjacent value	1.0
LAP	latency-associated peptide	0.25
LAP	lysosomal acid phosphatase	0.5
LAP	latency-associated protein	0.25
FFA	facial-facial anastomisis	0.0526315789474
FFA	fusiform face area	0.421052631579
FFA	flufenamic acid	0.210526315789
FFA	facial-facial anastomosis	0.0526315789474
FFA	free fatty acid	0.105263157895
FFA	free fatty acids	0.157894736842
LAS	left anterior superior region	1.0
rPVH	rostral portion of the pvh	1.0
DTI	diffusion tensor imaging	0.972972972973
DTI	diffusion tensor mri	0.027027027027
DTH	delayed-type hypersensitivity	0.8
DTH	delayed type hypersensitivity	0.2
MRP-	1multi drug resistant protein-1	1.0
TRIS2-amino-2-hydroxymethyl-propane-1	3-diol	1.0
DTM	dorsal tuberomammillary nucleus	0.5
DTM	dorsal tuberomamillary nucleus	0.5
NaAc	sodium acetate buffer	1.0
DTB	dorsal tegmental bundle	0.5
DTB	diencephalon-telencephalon boundary	0.5
DTA	diptheria toxin a	1.0
PRFPRL	release-stimulating factor(s)	1.0
DTF	directed transfer function	1.0
DTE	dual-task effect	1.0
SN-PR	substantia nigra pars reticulata	1.0
CB2	cannabinoid receptor type 2	1.0
MOP-	rmu opioid receptor	0.6
MOP-	rmu-opioid receptor	0.2
MOP-	rmu opioid receptors	0.2
FKBPFK-	binding protein	1.0
DTX	dendrotoxin	0.75
DTX	dextran tetramethyl-rhodamine	0.125
DTX	discontinuous transmission mode	0.125
L655708	11,12,13,13a-tetrahydro-7-methoxy-9-oxo-9h-imidazo[1,5-a]pyrrolo[2,1-c]	1.0
TBCA	tetrabromocinnamic acid	0.5
TBCA	tubulin-specific chaperone protein a	0.5
z-DEVD-	fmkn-benzyloxycarbonyl-asp(ome)-glu(ome)-val- asp(ome)-fluoromethyl ketone	0.5
z-DEVD-	fmkn-benzyloxylcarbonyl-asp(och3)-glu(och3)-val-asp(och3)-fluoromethyl ketone	0.5
ZD7288	4-(n-ethyl-n-phenylamino)-1,2-dimethyl-6- (methylamino)-pyrimidinium chloride	0.333333333333
ZD7288	4-(n-ethyl-n-phenylamino)-1,2-dimethyl-6-(methylamino)pyridinium chloride	0.333333333333
ZD7288	n-ethyl-1,6-dihydro-1,2-dimethyl-6-(methylimino)-n-phenyl-4-pyridinamine	0.333333333333
DTR	dorsal tegmental region	0.5
DTR	dextran amine conjugated with texas red	0.5
DTT	dithiothréitol	0.00564971751412
DTT	dl-dithiotheitol	0.00564971751412
DTT	1,4-dithiothreitol	0.0225988700565
DTT	diffusion tensor tractography	0.0112994350282
DTT	[dl]-dithiothreitol	0.00564971751412
DTT	dl-dithiothreitol	0.00564971751412
DTT	dithiothreitol	0.90395480226
DTT	d,l-dithiothreitol	0.00564971751412
DTT	dithiothreiotol	0.00564971751412
DTT	dorsal tenia tecta	0.0112994350282
DTT	dithioerythritol	0.00564971751412
DTT	detecting-time threshold	0.00564971751412
DTT	dithiotreitol	0.00564971751412
autDSE	autaptic depolarization-induced suppression of excitation	1.0
OX1	orexin type 1	1.0
SBC	sspherical bushy cells	0.166666666667
SBC	spherical bushy cell	0.833333333333
TBOADL-	threo-beta-benzyloxyaspartate	0.333333333333
TBOADL-	threo-β-benzyloxyaspartic acid	0.666666666667
α2-KO	α2-adrenergic receptor knockout	1.0
autDSI	autaptic depolarization-induced suppression of inhibition	1.0
4-CIN	α-cyano-4-hydroxycinnamic acid	1.0
cMUA	continuous multiunit activity	1.0
SBA	soybean agglutinin	1.0
Vcpor	ventralis caudalis portae subnuclei of vc	1.0
TsTX	tityustoxin	1.0
SBF	skin blood flow	1.0
PDGF-B	platelet-derived growth factor b	1.0
MLDA	mesolimbic dopamine	1.0
PDGF-A	platelet-derived growth factor	1.0
ppMCH	prepro-hormone mch	1.0
MSOPPE	(rs)-α-methylserine-o-phosphate monophenyl ester	0.5
MSOPPE	(rs)-α-methylserine o-phosphate monophenylester	0.25
MSOPPE	(r,s)-α-methylserine-o-phosphate monophenyl ester	0.25
IGT	impaired glucose tolerance	1.0
SHANKSH	3 and multiple ankyrin repeat domains protein	1.0
IGR	intermediate glucose response	1.0
nVsv	nucleus sensibilis nervi trigemini (pars ventralis)	1.0
NBTI	s-(4-nitrobenzylnitrobenzyl)-6-thioinosine	0.2
NBTI	s-(4-nitrobenzyl)-6-thioinosine	0.4
NBTI	6-[(4-nitrobenzyl)thio]-9-β-d-ribofuranosylpurine	0.2
NBTI	s-(p-nitrobenzyl)n6-thioinosine	0.2
l-AP4	(s)-2-amino-4-phosphonobutanoate	0.333333333333
l-AP4	s-2-amino-4-phosphonobutanoate	0.166666666667
l-AP4	l(+)-2-amino-4-phosphonobutyrate	0.166666666667
l-AP4	l-(+)-2-amino-4-phosphonobutyric acid	0.166666666667
l-AP4	l(+)-2-amino-4-phosphonobutyric acid	0.166666666667
l-AP3	l(+)-2-amino-3-phosphonopropionic acid	1.0
IGZ	inner granule zone	1.0
NBTN	itro-blue tetrazolium	0.5
NBTN	itroblue tetrazolium	0.5
aRNB	asymmetric reversible neurotransmission blocking	1.0
aRNA	amplified rna	0.25
aRNA	anti-sense rna	0.25
aRNA	antisense amplified rna	0.25
aRNA	antisense rna	0.25
pSTAT	3phospho-signal transducer and activator of transcription 3	0.2
pSTAT	3phosphorylated signal transducer and activator of transcription 3	0.2
pSTAT	5-irpstat5 immunoreactivity	0.2
pSTAT	3phosphorylated stat3	0.2
pSTAT	3phosphorylated-stat3	0.2
SPP	sphingosine-1-phosphate	1.0
nVsd	nucleus sensibilis nervi trigemini (pars dorsalis)	1.0
SARS	salicylic acid–resistant with sustained acid-evoked current	1.0
SQSQ-	22536	1.0
MRPs	symbol abcc)	1.0
IGL	intermediate gray layer of the superior colliculus	0.0166666666667
IGL	isolated glomerular layer	0.0166666666667
IGL	intermediate gray layer	0.0166666666667
IGL	intergeniculate leaflet	0.516666666667
IGL	intergeniculate leaflets of the thalamus	0.0166666666667
IGL	intergeniculate leaflet of the thalamus	0.0333333333333
IGL	intergeniculate leaflets	0.0166666666667
IGL	internal granular cell layer	0.0166666666667
IGL	internal granule cell layer	0.15
IGL	internal granule layer	0.0333333333333
IGL	inner granular layer	0.0166666666667
IGL	internal granular layer	0.116666666667
IGL	internal granule layer of the cerebellum	0.0166666666667
IGL	intergeniculate leaf	0.0166666666667
MMG	mechanomyogram/mechanomyographic (torque)	0.333333333333
MMG	mechanomyogram/mechanomyographic	0.666666666667
SHRSP	/izmstroke-prone spontaneously hypertensive rats	0.2
SHRSP	stroke-prone spontaneously hypertensive rats	0.4
SHRSP	spontaneously hypertensive stroke-prone	0.2
SHRSP	stroke-prone spontaneously hypertensive rat	0.2
CBB	coomassie brilliant blue	1.0
CBC	cone bipolar cell	0.333333333333
CBC	cerebrobuccal connectives	0.333333333333
CBC	ajal body	0.333333333333
SSBS	patial span backward	1.0
CBA	chicken beta actin	0.166666666667
CBA	cytometric bead array	0.333333333333
CBA	hybrid cytomegalovirus enhancer/chicken beta-actin promoter	0.166666666667
CBA	chicken β-actin	0.166666666667
CBA	constant bearing angle	0.166666666667
CBF	1c-promoter binding factor 1	0.01
CBF	cerebrovascular blood flow	0.01
CBF	cerebral blood flow	0.87
CBF	local cerebral blood flow	0.01
CBF	1	0.01
CBF	cochlear blood flow	0.03
CBF	cholinergic basal forebrain	0.04
CBF	cortical blood flow	0.01
CBF	ciliary beat frequency	0.01
CBG	corticosterone binding globulin	0.428571428571
CBG	corticosteroid-binding globulin	0.428571428571
CBG	corticosteroid binding globulin	0.142857142857
CBD	cannabidiol	0.666666666667
CBD	corticobasal degeneration	0.333333333333
DEPC-PBS	4% paraformaldehyde in 0.1 m phosphate buffer saline	1.0
SBN	saccade-related burst neuron	1.0
CBI	coastline bursting index	0.2
CBI	contralateral bias index	0.8
GPX-	1glutathione peroxidase-1	1.0
MOPR	mu opioid receptor	0.8
MOPR	μ-opioid receptors	0.2
MOPS	3-(n-morpholino)propanesulfonic acid	0.3
MOPS	3-[n-morpholino]propanesulfonic acid	0.1
MOPS	4-morpholinepropane sulfonic acid	0.05
MOPS	3-n-morpholino-propanesulfonic acid	0.05
MOPS	3-(n-morpholino) propanesulfonic acid	0.15
MOPS	3-[n-morpholino]propane-sulfonic acid	0.05
MOPS	3-(n-morpholino)-propanesulfonic acid	0.1
MOPS	3-n-morpholino propane sulphonic acid	0.05
MOPS	3-(n-morpholino)propanesulphonic acid	0.05
MOPS	morpholinopropane sulfonic acid	0.05
MOPS	morpholinepropanesulfonic acid	0.05
NRSE	neuronally restrictive silencer element	0.25
NRSE	neuron-restrictive silencer element	0.75
CBS	cystathionine-β-synthase	0.166666666667
CBS	cystashionine-β-synthase	0.0833333333333
CBS	central bright structure	0.0833333333333
CBS	cystathionine beta-synthase	0.166666666667
CBS	+/+ micewild-type mice	0.0833333333333
CBS	cystathionine β synthase	0.0833333333333
CBS	cystathionine β-synthase	0.333333333333
CBP	/p-300	0.05
CBP	calcium-binding protein	0.2
CBP	cyclic amp-responsive element-binding binding protein	0.05
CBP	calcium binding protein	0.2
CBP	cyclic-amp response element binding protein	0.05
CBP	camp response element binding protein-binding protein	0.05
CBP	creb-binding protein	0.1
CBP	cyclic amp response element binding protein	0.05
CBP	camp response element binding protein	0.05
CBP	calmodulin-binding peptide	0.05
CBP	cyclic amp response element binding protein-binding protein	0.05
CBP	camp-response element binding protein	0.05
CBP	calcium binding proteins	0.05
NRSF	neuron-restrictive silencer factor	0.8
NRSF	neuron-restrictive silencing factor	0.2
CBV	cerebal blood flow	0.111111111111
CBV	cerebral blood volume	0.888888888889
SART	salicylic acid–resistant with transient acid-evoked current	1.0
CBT	cognitive behavioral therapy	0.25
CBT	core body temperature	0.5
CBT	cognitive-behavior therapy	0.25
CBZ	carbamazepine	1.0
2-MI	2-methoxyidazoxan	1.0
CBX	carbenoxolone (3β-hydroxy-11-oxoolean-12-en-30-oic acid 3-hemisuccinate)	0.166666666667
CBX	carbenoxolone	0.833333333333
ABPAMPA	receptor-binding protein	0.5
ABPAMPA	receptor binding protein	0.5
BDP	breakdown products	0.5
BDP	breakdown product	0.5
PMAphorbol-12-myristate	13-acetate	1.0
DCP-LA	8-[2-(2-pentyl-cyclopropylmethl)-cyclopropyl]-octanoic acid	1.0
BZR	benzodiazepine receptor	1.0
TICV	total intracranial volume	0.5
TICV	total-intracranial volume	0.5
BZP	benzodiazepine	1.0
NT1	type 1 neurotensin receptor	0.5
NT1	high-affinity neurotensin receptor	0.5
NT3	neurotrophin-3	0.2
NT3	type 3 neurotensin receptor	0.2
NT3	neurotrophic factor 3	0.2
NT3	neurotrophin 3	0.4
NT2	low-affinity neurotensin receptor	0.333333333333
NT2	type 2 neurotensin receptor	0.333333333333
NT2	nt-era2/cl.d1	0.333333333333
SCCM	schwann cell conditioned medium	1.0
GSNA	greater splanchnic nerve activity	1.0
SOD1copper	zinc superoxide dismutase	1.0
SCCP	superior colliculus chondroitin sulfate proteoglycan	1.0
NT-	3neurotrophic factor 3	0.0151515151515
NT-	4/5neurotrophin-4/5	0.0909090909091
NT-	irneurotensin-immunoreactive	0.0151515151515
NT-	4neurotrophin-4	0.136363636364
NT-	4neurotrophin 4	0.030303030303
NT-	3	0.0757575757576
NT-	3third neurotrophic factor	0.0151515151515
NT-	4	0.0151515151515
NT-	3neurotrophin 3	0.0606060606061
NT-	4/5neurotrophin 4/5	0.0151515151515
NT-	3neurotrophin-3	0.530303030303
RFTR	od and frame test	1.0
M-ACSF	modified artificial cerebrospinal fluid	1.0
T33	5,3′-triiodothyronine	0.25
T33	3′,5 triiodo-l-thyronine	0.125
T33	5,3′-l-triiodothyronine	0.125
T33	5,3′-triiodothyronie	0.125
T33	3′,5-triiodo-l-thyronine	0.125
T33	3′,5-triiodothyronine	0.125
T33	3',5 triiodo-l-thyronine	0.125
GSNO	s-nitrosoglutathione	1.0
FSSLT	food search spatial learning task	1.0
tEBC	trace eyeblink conditioning	1.0
BSNP	burst-spiking non-pyramidal	1.0
Ap6A	diadenosine hexaphosphate	1.0
DMTUN	n′-dimethylthiourea	1.0
redM	35 m reduced	1.0
MVP	maximal voiding pressure	1.0
CVOs	circumventricular organs	1.0
MVR	maximal voluntary rate	1.0
MVT	maximal voluntary torque	1.0
gap-FRAP	fluorescent recovery after photobleaching	1.0
NAcRP	rostral pole of the nucleus accumbens	1.0
trK-B	tyrosine receptor kinase-b	1.0
M-TIN	moderate-slope temperature-insensitive neuron	1.0
ALa	lateral amygdala nucleus	0.5
ALa	anterior nucleus of the ansa lenticularis	0.5
MVA	motor vehicle accident	0.5
MVA	mid-threshold voltage-activated	0.5
MVB	multivesicular body/endosomes	0.333333333333
MVB	multivesicular body	0.666666666667
MVC	maximal voluntary contractions	0.05
MVC	measurement of maximal voluntary contraction	0.05
MVC	smaximal voluntary contractions	0.05
MVC	maximal voluntary contraction	0.4
MVC	maximum voluntary contraction	0.35
MVC	maximal voluntary isometric contraction	0.05
MVC	maximum voluntary isometric contraction	0.05
MVD	mouse vas deferens	1.0
MVF	manual von frey	1.0
CRIBC	dc42/rac interactive binding	1.0
SERT-	/-homozygous serotonin transporter knockout rat	0.5
SERT-	/-homozygous 5-ht transporter knockout rat	0.5
SITS	4-acetamido-4′-isothiocyanostilbene-2,2′-disulfonic acid	0.666666666667
SITS	4-acetamido-4′-isothiocyanostilbene-2,2′-disulfonate	0.333333333333
MVL	mesopallium ventrolaterale	1.0
MVN	nmedial vestibular nucleus neurons	0.025
MVN	/nmvn neurons with axons that could not be traced	0.025
MVN	pcmedial vestibular nucleus parvicellular part	0.025
MVN	ccaudal mvn	0.025
MVN	medial vestibular nucleus	0.8
MVN	medial vestibular nuclei	0.075
MVN	vventral part of the medial vestibular nucleus	0.025
Ac-DEVD-AMC	ac-asp-glu-val-asp-amc	0.333333333333
Ac-DEVD-AMC	acetyl-asp-glu-val-asp-aminomethyl-coumarin	0.333333333333
Ac-DEVD-AMC	acetyl-asp-glu-val-asp-amino-4-methylcoumarin	0.333333333333
NTX	naltrexone	1.0
ALL	anterior lateral line nerve	1.0
hDBB	horizontal limb of the dbb	0.25
hDBB	horizontal limb of the diagonal band of broca	0.75
ALK	4activin-like kinase receptor-4	0.25
ALK	anaplastic lymphoma kinase	0.25
ALK	5activin-like kinase 5	0.25
ALK	1activin receptor-like kinase i	0.25
ALH	after larval hatching	1.0
ALF	ad libitum feeding	1.0
NTP	nucleotide triophosphate	1.0
ALD	aldosterone	1.0
ALE	activation likelihood estimation	1.0
ALB	albumin	0.5
ALB	anxiety-like behavior	0.5
ALC	acetyl-l-carnitine	0.545454545455
ALC	ethanol liquid diet group	0.0909090909091
ALC	alcohol	0.272727272727
ALC	alcohol-treated group of mice	0.0909090909091
ALA	alpha lipoic acid	0.25
ALA	alpha linolenic acid	0.25
ALA	alanine	0.25
ALA	500500nmol/kg α-linolenic acid	0.25
NTI	naltrindole hydrochloride	0.2
NTI	nerve terminal impulse	0.2
NTI	naltrindole	0.6
Iso-OMPA	tetraisopropyl pyrophosphoramide	1.0
LPPTg	lateral pedunculopontine tegmental nucleus	1.0
GABA-A	gamma-aminobutyric acid type a receptor	0.0909090909091
GABA-A	gamma amino butyric acid a receptor	0.0909090909091
GABA-A	receptor	0.545454545455
GABA-A	gamma aminobutyric acid-type a	0.0909090909091
GABA-A	receptors	0.181818181818
MVe	medial vestibular nucleus	1.0
ALX	1393	0.333333333333
ALX	lipoxin a4 receptor	0.333333333333
ALX	5407(r)-n[3-(4-fluorophenyl)-3-(4-phenyl-phenoxy)propyl]-sarcosine	0.333333333333
NTN	eurotrace	0.1
NTN	neurturin	0.9
ALV	alveus	1.0
NTC	no template control	0.333333333333
NTC	no-template negative control	0.333333333333
NTC	non-template control	0.333333333333
U01261	4-diamino-2, 3-dicyano-1, 4-bis (2-aminophenylthio) butadiene	0.1
U01261	4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene	0.3
U01261	4-diamino-2,3-dicyano-1,4-bis-[2-aminophenylthio]-butadiene	0.1
U01261	4-diamino2,3dicyano-1,4-bis[2-aminophenyltio]butadiene	0.1
U01261	4-diamino-2, 3-dicyano-1, 4-bis (2-aminophenylthio)	0.1
U01261	4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthiol]-butadiene	0.1
U01261	4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene	0.1
U01261	4-diamino-2,3-dicyano-1,4-bis-[2-aminophenylthio]butadiene	0.1
ALS	amyotropic lateral sclerosis	0.0243902439024
ALS	amyotrophic lateral sclerosis	0.959349593496
ALS	autophagy-lysosome system	0.00813008130081
ALS	acid labile subunit	0.00813008130081
ALP	autophagy–lysosome pathway	0.5
ALP	alkaline phosphatase	0.5
NTF	neurotrophic factor	0.4
NTF	n-terminal fragment	0.4
NTF	neurofibrillary tangle	0.2
FITC-SBA	fluorescein isothiocyanate conjugate soybean agglutinin	1.0
-ethane-N	n,n,n-tetraacetic acid	1.0
ERC	event-related causal interactions	0.333333333333
ERC	entorhinal cortex	0.333333333333
ERC	xentorhinal cortex	0.333333333333
ADBL	average dendritic branch length	1.0
TMEVT	heiler’s murine encephalomyelitis virus	1.0
bRG	basal radial glia	1.0
LINE-1	type of transposable dna element	1.0
CaNcalcineurin	protein phosphatase 2b	1.0
KOP	kappa opioid peptide	0.4
KOP	rkappa opioid receptor	0.2
KOP	kappa opioid	0.2
KOP	kappa-opioid receptors	0.2
MEMα	minimum essential medium alpha	1.0
AlzArc1	alzarc2 and alzarc3three drosophila lines expressing the arctic mutant (glu22gly) of aβ1–42 peptide	1.0
SDLE	spreading depression-like event	1.0
ERO	event-related oscillation	1.0
serotonin1A	receptor	1.0
mAchR	muscarinic acetylcholine receptor	1.0
GlyRN	neonatal glycine receptor isoform	0.5
GlyRN	glycine receptor, neonatal isoform	0.5
GlyRA	glycine receptor, adult isoform	1.0
WCRSW	riter's cramp rating scale	1.0
CNQX6-cyano-7-nitroquinoaxaline-2	3-dione	1.0
17β-E	217β-estradiol	1.0
ISST	sst-sensitive current	1.0
eGL	external granular layer	1.0
CLat	lateral motor column of spinal cord segments c3–c5	1.0
IBMX3	7-dihydro-1-methyl-3-(2-methylpropyl)-1h-purine-2,6-dione	1.0
EWMNE	shkol-wachmann movement notation	1.0
tACPD	(1s,3r)-1-aminocycloheptane-trans-1,3-dicarboxylic acid	0.5
tACPD	(±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid	0.5
Mi-CK	mitochondrial ck	1.0
OTSO	ne touch stockings	1.0
rhActivinA	recombinant human activina	1.0
p-T	hr34-darpp-32phospho-thr34-dopamine and camp regulated phosphoprotein-mr 32 kda	0.333333333333
p-T	rkbphosphorylated tropomyosin receptor kinase b	0.333333333333
p-T	autau hyper-phosphorylation	0.333333333333
HRDC	helicase rnase d conserved domain	1.0
UF	uncinate fasciculus	0.75
UF	ultrasound field	0.25
LSMEAN	least square means	1.0
EMBLE	uropean molecular biology laboratory	1.0
p-S	erserine phosphorylation	0.2
p-S	er194 fadd	0.2
p-S	6rphospho-s6r	0.2
p-S	tat3phosphorylated stat3	0.2
p-S	133creb	0.2
UA	uranyl acetate	0.25
UA	uric acid	0.5
UA	unruptured aneurysm	0.25
OAL	ipsilateral occipital artery	1.0
MDMA-	metabolites	1.0
MDMA3	4-methylenedioxy-n-methylamphetamine	0.0625
MDMA3	4-methylenedioxy-n-methylamphetamin	0.03125
MDMA3	4-methylenedioxymethamphetamine (“ecstasy”)	0.0625
MDMA3	4-methy-lenedioxymethamphetamine	0.03125
MDMA3	4-methylenedioxymethamphetamine or “ecstasy”	0.03125
MDMA3	4-methylenedioxymethamphetamine (ecstasy)	0.03125
MDMA3	4-methylenedioxymethamphetamine	0.71875
MDMA3	4-methyl-enedioxymethamphetamine	0.03125
3α-ADIOL5α-androstane-3α	17β-diol	1.0
IMCT	immunotoxin-mediated cell targeting	1.0
ZIc	caudal zona incerta	1.0
p-A	ktphosphorylation of akt	0.0909090909091
p-A	ddphosphoadducin	0.0909090909091
p-A	ktphospho-akt	0.454545454545
p-A	ktphosphorylated form of akt	0.0909090909091
p-A	kt	0.0909090909091
p-A	ktphosphorylated akt	0.181818181818
p-C	amkiiphospho-camkii	0.333333333333
p-C	amkiiphosphorylated calcium/calmodulin-dependent protein kinase ii	0.333333333333
p-C	amkiiphosphorylated camkii	0.333333333333
RNAse	ribonuclease	1.0
DSHB	developmental studies hybridoma bank	1.0
U0126	(1,4-diamino-2,3-dicyano-1,4 bis [2-aminophenylthio] butadiene)	1.0
p-H	3phosphohistone h3	1.0
DSSD	ang-gui-shao-yao decoction	1.0
LCPUFA	long-chain polyunsaturated fatty acid	1.0
PESCE	protein-enriched spinal cord extract	1.0
APUD	amine precursor uptake decarboxylation	1.0
CMHC-	mechanoheat	0.428571428571
CMHC-	fiber mechano-heat	0.142857142857
CMHC-	mechanoheat nociceptors	0.142857142857
CMHC-	mechanoheat unit	0.142857142857
CMHC-	fiber mechano- and heat-sensitive	0.142857142857
IAHP	afterhyperpolarization current	0.272727272727
IAHP	voltage-insensitive calcium-activated k+ current	0.0909090909091
IAHP	calcium dependant potassium current	0.0909090909091
IAHP	voltage-insensitive calcium-activated potassium current	0.0909090909091
IAHP	slow ca2+-activated k+ current	0.0909090909091
IAHP	ca2+-dependent k+ current	0.0909090909091
IAHP	inhibitory after-hyperpolarization	0.0909090909091
IAHP	afterhypolarizing current	0.0909090909091
IAHP	membrane current mediating ahp	0.0909090909091
NCAM-	180neural cell adhesion molecule-180	1.0
UPRU	nfolded protein response	1.0
HPC-θ	hippocampal theta wave	1.0
LTα	lymphotoxin-alpha	1.0
st-FITC	streptavidin-conjugated fluorescein isothiocyanate	1.0
β-NAD	+β-nicotinamide adenine dinucleotide	1.0
VPD	valpromide	1.0
Pr5	principal nucleus of the trigeminal nerve	1.0
UIBU	niversity of the balearic islands	1.0
BuChE	butyrylcholinesterase	0.5
BuChE	butyryl cholinesterase	0.5
AMPArAMPA	receptor	1.0
DDR	2discoidin domain receptor 2	1.0
cRET	ret proto-oncogene	1.0
mtER	sestradiol receptors localized in the mitochondria	1.0
MLBM	g2+ lysis/wash buffer	1.0
CRSC	hronic restraint stress treatment	1.0
RMCP	rat mast cell protease	1.0
ICRI	nstitute for cancer research	0.4
ICRI	mprinting control region	0.2
ICRI	nstitute of cancer research	0.4
SubCAsubcoeruleus	alpha part	1.0
PrC	precommissural nucleus	1.0
PrL	prelimbic cortex	1.0
VAmc	magnocellular ventral anterior nucleus	0.333333333333
VAmc	ventral anterior nucleus pars magnocellularis	0.666666666667
PrH	nucleus prepositus hypoglossi	0.333333333333
PrH	prepositus hypoglossi nucleus	0.166666666667
PrH	praepositus hypoglossal	0.166666666667
PrH	prepositus hypoglossal nucleus	0.333333333333
CTFβC-	terminal fragment	1.0
fMLFN-	formylmethionine-leucine-phenylalanine	0.5
fMLFN-	formyl-methionyl-leucyl-phenylalanine	0.5
PrV	principal nucleus of the trigeminal nerve	0.5
PrV	nucleus principalis trigemini	0.5
PrP	prion protein	1.0
PrS	presubiculum	1.0
mENK	methionine enkephalin-like immunoreactivity	1.0
7-OH-DPAT7-hydroxy-N	n-di-n-propylaminotetralin hydrobromide	0.333333333333
7-OH-DPAT7-hydroxy-N	n-di-n-propyl-2-aminotetralin	0.666666666667
13C	nmr	1.0
hASIC	3human acid-sensing ion channel 3	1.0
Prb	probst’s nucleus	1.0
CaS	calcarine sulcus	1.0
YFLLRNPα-	thrombin (protease-activated receptor-1) antagonist peptide	1.0
13N	]ammonia[13n]	1.0
N-ACM	normal astrocyte-conditioned medium	1.0
IM-SC	intact-muscle:short-cutaneous	1.0
CaN	calcineurin	1.0
CaM	calcium/calmodulin-dependent protein	0.222222222222
CaM	calmodulin	0.555555555556
CaM	calmodulin gene	0.111111111111
CaM	calcium/calmodulin	0.111111111111
CaB	calbindin-d28k	1.0
4OA	c5gc4-o-acetyl-n-glycolylneuraminic acid	1.0
FVe	f cell group of the vestibular nuclei	1.0
AsODN	antisense oligodeoxynucleotide	1.0
3α-HSOR	3α-hydroxysteroid oxidoreductase	1.0
ToMCsToM	cartoons	1.0
VLDLR	very-low-density-lipoprotein receptor	0.125
VLDLR	very low-density lipoprotein receptor	0.5
VLDLR	very low density lipoprotein receptor	0.125
VLDLR	very-low-density lipoprotein receptor	0.125
VLDLR	the very low density lipoprotein receptor	0.125
TBPTATA-	binding protein	1.0
vcM	eponventro-caudal division of the median preoptic nucleus	1.0
mNSS	modified neurological severity score	0.789473684211
mNSS	modified neurologic stroke severity	0.0526315789474
mNSS	modified neurological severity scores	0.0526315789474
mNSS	modified neurologic severity score	0.0526315789474
mNSS	modified neurologic severity scores	0.0526315789474
CaMKII	calcium/calmodulin-dependent kinase type ii	0.0714285714286
CaMKII	calmodulin-dependent protein kinase ii	0.0714285714286
CaMKII	calcium/calmodulin kinase ii	0.0714285714286
CaMKII	ca2+/calmodulin-dependent protein kinase ii	0.214285714286
CaMKII	calcium-calmodulin-dependent protein kinase ii	0.0714285714286
CaMKII	calcium/calmodulin-dependent protein kinase ii	0.285714285714
CaMKII	calmodulin-stimulated protein kinase ii	0.0714285714286
CaMKII	ca2+-calmodulin-dependent protein kinase ii	0.0714285714286
CaMKII	calcium calmodulin-dependent protein kinase type ii	0.0714285714286
DAPs	dystrophin-associated proteins	1.0
TPBS-X	0.1m tris phosphate-buffered saline (ph 7.4) containing 0.05% merthiolate and 0.3% triton x	1.0
STN-DBS	deep brain stimulation of the stn	1.0
HATA	hippocampal–amygdaloid transition area	1.0
SNAP-25	synaptosomal-associated protein	0.0588235294118
SNAP-25	synaptosome-associated protein of 25,000 mol. wt	0.117647058824
SNAP-25	synaptosomal-associated protein of 25,000 mol. wt	0.294117647059
SNAP-25	synaptosomal protein, mol. wt 25 000	0.0588235294118
SNAP-25	synaptosomal-associated protein of mol. wt 25,000	0.0588235294118
SNAP-25	synaptosomal-associated protein of mol. wt 25 000	0.0588235294118
SNAP-25	synaptosomal-associated protein-25	0.117647058824
SNAP-25	synaptosomal-associated protein 25	0.117647058824
SNAP-25	?	0.0588235294118
SNAP-25	synaptosome associated protein	0.0588235294118
WRATW	ide range achievement test	1.0
LMWMAP2	low molecular weight map2 isoforms	1.0
PMn	paramedian nucleus	1.0
vlnTS	ventrolateral subnucleus of nts	1.0
INF-γ	interferon-γ	1.0
X-Gal	5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside	0.666666666667
X-Gal	5-bromo-4-chloro-3-indolyl-β- d-galactoside	0.333333333333
TDIthreshold	discrimination, identification	1.0
RAGE	advanced glycation endproducts receptor	0.0588235294118
RAGE	receptor of advanced glycation products	0.0588235294118
RAGE	advanced glycation end products receptor	0.0588235294118
RAGE	receptor for advanced end glycation products	0.0588235294118
RAGE	receptors for advanced glycation end product	0.0588235294118
RAGE	receptor for advanced glycation end products	0.470588235294
RAGE	receptor for advanced glycation end-products	0.0588235294118
RAGE	receptor for ages	0.0588235294118
RAGE	receptor for advanced glycation endproducts	0.117647058824
DAPI	4'-6-diamidino-2-phenylindole	0.0126582278481
DAPI	4′6-diamidino-2-phenylindole	0.0126582278481
DAPI	4′-diamidino-2-phenylindole	0.0042194092827
DAPI	4′,6′-diamidino-2-phenylindole dihydrochloride hydrate	0.0042194092827
DAPI	4′, 6′-diamidino-2-phenylindole	0.0042194092827
DAPI	4',6-diamidino-2-phenyl-indole	0.0042194092827
DAPI	4′-6-diamino-2-phenylindole	0.0042194092827
DAPI	6-diamidino-2-phenyl-indole	0.0042194092827
DAPI	4,6-diamino-2-phenylindole	0.0210970464135
DAPI	4′,6-diamidino-2-phenylindole dihydrochloride	0.0675105485232
DAPI	4′,6-diamidino-2-phenylindoledihydrochloride	0.0042194092827
DAPI	4',6-diamidino-2-phenylindole	0.0506329113924
DAPI	4′,6-diamidino-2-phenylindol	0.0084388185654
DAPI	4.6-diamidino-2-phenylindole	0.0042194092827
DAPI	4’, 6-diamidino-2-phenylindole	0.0084388185654
DAPI	a nuclear staining with 4′,6-diamidine-2′-phenylindole dihydrochloride	0.0042194092827
DAPI	4',6-diamidino-2-phenylindoledihydrochloride	0.0042194092827
DAPI	4′, 6-diamidino-2-phenylindole	0.0337552742616
DAPI	4′,6-diamidoino-2-phenylindole	0.0084388185654
DAPI	4′,6′-diamidino-2-phenylindole	0.0295358649789
DAPI	6-diamidino-2-phenylindoledihydrochloride	0.0042194092827
DAPI	4′,6-diaminodino-2-phenylindole	0.0042194092827
DAPI	4′,6′-diamidino-2-phenylindole dihydrochloride	0.0042194092827
DAPI	4′,6-diamindino-2-phenylindole dihydrochloride	0.0042194092827
DAPI	4′,6′-diamidino-2-phenylindole hydrochloride	0.0042194092827
DAPI	4′,6-diamidino-2-phenylindole	0.392405063291
DAPI	4′,6-diamidine-2-phenyl-indole dihydrochloride	0.0042194092827
DAPI	4′,6-diamidino-2-phenyl-indole	0.0084388185654
DAPI	4′6-diamidino-2-phenylindole-dihydrochloride	0.0042194092827
DAPI	4′,6-diamidine-2-phenylindole	0.0042194092827
DAPI	4′6′ diamidino 2 phenylindole	0.0042194092827
DAPI	staina nuclear staining with 4′,6-diamidin-2′-phenylindol-dihydrochloride	0.0042194092827
DAPI	4′ 6′-diamidino-2-phenylindole hydrochloride	0.0042194092827
DAPI	4’,6’-diamino-2-phenylindole	0.0042194092827
DAPI	4’,6-diamidino-2-phenylindole	0.0337552742616
DAPI	6-diamino-2-phenylindole	0.0042194092827
DAPI	4',6-diamidino-2-phenylindole dihydrochloride	0.0042194092827
DAPI	4′,6′-diamidino-2-phenylindol	0.0042194092827
DAPI	4′,6-diamidino-2-phenylindol dihydrochloride	0.0042194092827
DAPI	4′,6′-diamino-2′-phenylindole	0.0042194092827
DAPI	4′6-diamidino-2-phenylindole-2hci	0.0042194092827
DAPI	4′-6-diamidino-2-phenylindole	0.0886075949367
DAPI	phenylindole dihydrochloride	0.0042194092827
DAPI	4′,6-diaminidino-2-phenylindole dihydrochloride	0.0042194092827
DAPI	4′,6-diamedino-2-phenylindole	0.0042194092827
DAPI	4,6-diamidino-2-phenylindole	0.0253164556962
DAPI	4′, 6-diamidino-2-phenyl-indole	0.0042194092827
DAPI	4′,6-diamino-2-phenylindole	0.0126582278481
DAPI	4,6-diamidino-2-phenylindole dihydrochloride	0.0042194092827
DAPI	4′-6-diamidino-2-phenylindole dihydrochloride	0.0126582278481
DAPI	4′,6-diamidine-2′-phenylindol dihydrochloride	0.0042194092827
DAPI	4′,6-diamidin-2′-phenylindol-dihydrochlorid	0.0042194092827
DAPI	4′-6-diamidino-2-phenylindole(a nuclear stain)	0.0042194092827
DAPI	4′6-diamindino-2-phenylindole	0.0042194092827
DAPI	4′,6-diamino-2-phenylindol	0.0042194092827
DAPI	4′,6-diamidine-2′-phenylindole dihydrochloride	0.0042194092827
DAPI	diamidino-2-phenylindole	0.0042194092827
DAPI	4′,6-diamidino-2-phenylindole-dihydrochloride	0.0042194092827
BIMM	bisindolylmaleimide	0.5
BIMM	bisindolylmaleimide 1 hcl	0.5
DAPK	death-associated protein kinase	0.5
DAPK	death associated protein kinase	0.5
IDIBAPSI	nstitute for biomedical investigation august pi i sunyer	1.0
IDC	interdental cell	1.0
RAGP	right atrial ganglionated plexus	1.0
PDRS	parkinson's disease rating scales	1.0
SRMZ	the surrounding region of the multisensory zone	1.0
VLDBB	medial septal–vertical limb of diagonal band of broca	1.0
IBTX	iberiotoxin	1.0
192I	ggmonoclonal antibody against p75ntr neutrophin receptors	1.0
WOX	1ww domain-containing oxidoreductase	1.0
ILMI	isolated leg movement index	1.0
C-FOSFOS	proto-oncogene protein	1.0
DAP-	kinasedeath-associated protein kinase	1.0
DAB-N	idab intensified with nickel sulfate	0.333333333333
DAB-N	inickel-enhanced diaminobenzidine	0.666666666667
Sema	semaphorins	1.0
TPH-	2tryptophan hydroxylase-2	0.5
TPH-	irtryptophan hydroxylase immunoreactivity	0.5
BRCA	1breast cancer type 1 susceptibility protein	1.0
DAP3	4 diaminopyridine	1.0
GDW	gating difference wave	1.0
cES	conditioning electrical stimulation	1.0
GEPR-9	genetically epilepsy-prone rat	1.0
nVIII	vestibulocochlear nerve root	0.5
nVIII	vestibular nerve	0.5
RNase	ribonuclease a	0.5
RNase	ribonuclease	0.5
RBMEC	srat brain microvascular endothelial cells	1.0
WOG	wogonin	1.0
PD-RIGHTPD	patients with predominant dopamine depletion in the right striatum	1.0
PKMζ	protein kinase m zeta	0.25
PKMζ	protein kinase ζ	0.25
PKMζ	protein kinase mζ	0.5
EGTAO	o′-bis(2-aminoethyl)ethyleneglycol-n,n,n′,n′-tetraacetic acid	1.0
N13	negative peak in the cortical response at 13 ms after stimulus	1.0
Rp-8-p-CPT-cGMPS	rp-8-[(4-chlorophenyl)thio]-cgmps triethylamine	1.0
8B	rcgmp8 bromo cyclicgmp	1.0
CGN	cerebellar granule cell	0.0625
CGN	scerebellar granule neurons	0.125
CGN	cerebellar granule cells	0.0625
CGN	cerebellar granule neuron	0.4375
CGN	cerebellar granule neurons	0.3125
ICC-IM	i.m. interstitial cells of cajal in the musculature	1.0
TUBB	3βiii-tubulin protein	0.5
TUBB	tubulin beta	0.5
RSNOS-	nitrosothiols	1.0
IR-α	insulin receptor α subunit	1.0
CRFR	1corticotropin-releasing factor receptor type 1	0.125
CRFR	2corticotropin-releasing factor 2 receptor	0.125
CRFR	2αcorticotropin-releasing factor receptor 2α	0.125
CRFR	1crf receptor 1	0.125
CRFR	2crf receptor type 2	0.125
CRFR	2-/-corticotropin-releasing factor receptor 2-deficient	0.125
CRFR	corticotropin-releasing factor receptor	0.125
CRFR	2corticotropin-releasing factor receptor 2	0.125
8-OHdG	8-hydroxy-2-deoxyguanosine	1.0
methoctramineN	n′-bis [6-[[(2-methoxyphenyl)methyl]amino]	1.0
PAGVL	periaqueductal gray, ventrolateral	1.0
GANG	ganglioside	1.0
TβRITGF-β	type i receptor	1.0
CURT	curve randomization test	1.0
Ctb	cholera toxin b subunit	1.0
MpT	α-methyl-p-tyrosine	1.0
α-BuTx	α-bungarotoxin	1.0
K-	complex	0.25
K-	252a	0.5
K-	252b	0.25
ASOT	gtransgenic mice overexpressing human α-synuclein	1.0
IGCL	internal granule cell layer	1.0
NANCnonadrenergic	noncholinergic	1.0
ADCA	autosomal dominant cerebellar ataxia	1.0
WCSTW	isconsin card sorting task	0.3
WCSTW	isconsin card sorting test	0.4
WCSTW	isconsin card sort task	0.1
WCSTW	isconsin card sort test	0.2
d-NMMANG-	monomethyl-d-arginine	1.0
EEDQN-ehtoxycarbonyl-2-ethoxy-1	2-dihydroquinoline	1.0
SKP	skin-derived neural precursor cell	0.5
SKP	sskin-derived precursor cells	0.5
qRT-PCRQ	uantitative real time-pcr	0.333333333333
qRT-PCRQ	uantitative real-time polymerase chain reaction	0.333333333333
qRT-PCRQ	uantitative real-time reverse transcription polymerase chain reaction	0.333333333333
α-MPT	α-methyl-p-tyrosine	0.8
α-MPT	dl-α-methyl-p-tyrosine methyl ester	0.2
MASC	muscle-associated specificity component	1.0
TNFR	tnf receptor	0.0666666666667
TNFR	1tumor necrosis factor receptor 1	0.2
TNFR	tumor necrosis factor receptors	0.0666666666667
TNFR	2tumor necrosis factor receptor 2	0.0666666666667
TNFR	1+2kotnfr1 and 2 knockout	0.0666666666667
TNFR	tumor necrosis factor receptor	0.333333333333
TNFR	2tumor necrosis factor alpha receptor 2	0.0666666666667
TNFR	2tumor necrosis factor receptor type 2	0.0666666666667
TNFR	1tnf receptor 1	0.0666666666667
DFPI	delayed fluid-percussion injury	1.0
dTC	d-tubocurarine	1.0
CaM-BP	calmodulin-binding protein	1.0
PORN	poly-l-ornithine	1.0
MASK	masking stimulus	1.0
SSDD	succinic semialdehyde dehydrogenase deficiency	1.0
MASH	1mammalian homolog of achaete-scute complex-like 1	0.5
MASH	1mammalian achaete-schute homolog 1	0.5
rBDNF	recombinant bdnf	1.0
MAST	205microtubule-associated serine/threonine kinase-205 kda	1.0
GR-IR	glucocorticoid receptor immunoreactivity	1.0
YPL	animals yoked to poor learners	1.0
HRAP	homologous-restraint accumulation primer	1.0
-DHPG	(s)-3,5-dihydroxyphenylglycine	1.0
UCMS	unpredictable chronic mild stress	1.0
PANDAS	pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection	1.0
GP1-DTVD	mid-type grasp-1	1.0
d-NAMENω-N	itro-d-arginine methyl ester hydrochloride	1.0
T-cells	cytoplasmic, calcineurin-dependent 4	1.0
His6-synaphin	histidine-tagged synaphin	1.0
OB-R	leptin receptor	1.0
FMRFamide	phe-met-arg-phe-nh2	1.0
Kd	receptor affinity	0.142857142857
Kd	coefficient of distribution	0.142857142857
Kd	equilibrium dissociation constant	0.142857142857
Kd	dissociation constant	0.571428571429
CSTC	ell signaling technology	1.0
Ki	equilibrium dissociation constant of inhibitor	1.0
CSTA	cystatin a	1.0
Km	michaelis constant	1.0
iPNAPNA	“integration”	1.0
LRSC	lissamine rhodamine sulphonylchloride	0.0833333333333
LRSC	lissamine–rhodamine b sulfonyl chloride	0.0833333333333
LRSC	lissamine rhodamine b sulfonyl chloride	0.0833333333333
LRSC	lissamine-rhodamine sulfonyl chloride	0.0833333333333
LRSC	lissamine rhodamine sulfonyl chloride	0.0833333333333
LRSC	lissamine rhodamine sulphonyl chloride	0.0833333333333
LRSC	lissamine-rhodamine succinyl chloride	0.0833333333333
LRSC	lissamine-rhodamine sulphonyl chloride	0.0833333333333
LRSC	lissamine rhodamine	0.333333333333
Kv	voltage-gated k-channels	1.0
PMM	premammillary nucleus	1.0
AMT2-amion-5	6-dihydro-6-methyl-4h-1,3-thiazine	1.0
PLGF	placental growth factor	1.0
PLGA	poly(lactic-co-glycolic) acid	1.0
CGS	21680	0.307692307692
CGS	cyclic gaussian stimulation	0.0769230769231
CGS	216802-[p-(carboxyethyl)-phenylethylamino]-5′-n-ethylcarboxyamidoadenosine	0.0769230769231
CGS	216804-[2-[[6-amino-9-(n-ethyl-b-d-ribofuranuronamidosyl)-9h-purin-2-yl]amino]	0.0769230769231
CGS	216802-[4-(2-p-carboxyethyl)phenylamino]-5′-n-ethylcarboxamidoadenosine	0.0769230769231
CGS	216802-p-(2-carboxyethyl)phenethylamino-5′-n-ethylcarboxamidoadenosine	0.0769230769231
CGS	216804-[2-[[6-amino-9-(n-ethyl-β-d-ribofuranuronamidosyl)-9h-purin-2-yl]amino]	0.0769230769231
CGS	216802-[p-(2-carboxyethyl)-phenethylamino]-5′-n-ethylcarbox-amidoadenosine	0.0769230769231
CGS	216802-[4-(2-carboxyethyl)phenethylamino]-5′-n-ethylcarboxamidoadenosine	0.0769230769231
CGS	2160	0.0769230769231
KC	hip1–4potassium channel interacting protein 1–4	0.0322580645161
KC	hipvoltage-gated potassium channel-interacting protein	0.0322580645161
KC	hipskv-channel interacting proteins	0.0322580645161
KC	sk-complexes	0.0322580645161
KC	aca2+-activated k+	0.0645161290323
KC	k-complex	0.0322580645161
KC	acalcium-activated potassium channels	0.0322580645161
KC	aca2+-activated k+ channel	0.0322580645161
KC	acalcium-dependent potassium	0.0322580645161
KC	l	0.0645161290323
KC	aca2+-activated potassium channel	0.0322580645161
KC	keratinocyte chemoattractant	0.0322580645161
KC	hipkv channel interacting proteins	0.0322580645161
KC	aca2+-activated k channels	0.0322580645161
KC	lpotassium chloride	0.290322580645
KC	hipkv channel interacting protein	0.0322580645161
KC	alarge-conductance ca2+-activated k+ channels	0.0322580645161
KC	kidney cortex	0.0322580645161
KC	aca2+-activated k+ channels	0.0322580645161
KC	hippotassium channel interacting protein	0.0322580645161
KC	a channelcalcium-activated potassium channel	0.0322580645161
KB	bufferkrebs-bicarbonate buffer	1.0
KA	kainite	0.0132450331126
KA	fast activating and inactivating outwardly-rectifying k+ current	0.00662251655629
KA	transient (a-type) potassium currents	0.00662251655629
KA	kainic acid/kainate	0.0132450331126
KA	kynurenic acid	0.0331125827815
KA	kainate	0.23178807947
KA	kainic acid (a.k.a. kainate)	0.00662251655629
KA	kainic acid	0.649006622517
KA	transient outward a-type k+	0.00662251655629
KA	sppotassium aspartate	0.00662251655629
KA	)	0.00662251655629
KA	kainite glutamatergic receptors	0.00662251655629
KA	kainate receptors	0.00662251655629
KA	kainate receptor	0.00662251655629
Te3	secondary auditory cortex	1.0
WINWIN-	55212-2	1.0
KF	/a7 areakölliker-fuse nucleus/a7 area	0.25
KF	koelle–friedenwald	0.25
KF	kölliker–fuse nucleus	0.5
PGm-vmc	ventromedial cell group of the medial subdivision of the preglomerular nucleus	1.0
KD	equilibrium disssociation constant	0.111111111111
KD	knockdown	0.222222222222
KD	kinase-dead	0.222222222222
KD	dissociation constant	0.333333333333
KD	1straight knee pointing movement	0.111111111111
KK	v subfamily member 1.3 alone	1.0
PMH	preoptic area-midbrain-hypothalamus	0.5
PMH	premammillary hypothalamus	0.5
KI	knock-in	0.666666666667
KI	knock in	0.111111111111
KI	offspring resulting from kansas dam×illinois sire	0.111111111111
KI	knockin	0.111111111111
KH	krebs'–henseleit buffer	0.333333333333
KH	high-affinity binding state	0.333333333333
KH	k homology	0.333333333333
KO	sst2 receptor knock-out	0.00555555555556
KO	knock out	0.0666666666667
KO	dopamine transporter knockout	0.00555555555556
KO	knee only	0.00555555555556
KO	alpha2c-adrenoceptor knockout	0.00555555555556
KO	aquaporin-4 null (knockout)	0.00555555555556
KO	knock-out mice	0.00555555555556
KO	knockout	0.738888888889
KO	hmkiloohm	0.00555555555556
KO	y2 receptor knock-out	0.00555555555556
KO	knock-out	0.105555555556
KO	knocked out	0.00555555555556
KO	knockout mice	0.00555555555556
KO	‘knock-out’ gene-targeted deletion	0.00555555555556
KO	knock-out group of mice	0.00555555555556
KO	knockout mouse	0.0111111111111
KO	opioid receptor triple knock-out	0.00555555555556
KO	(gene) knockout	0.00555555555556
KN	93n-[2-(n-chlorocynnamyl-n-methylaminomethylphenyl]-n-[2-hydroxyethyl]	0.5
KN	ana+-activated k+ channel	0.5
KM	kanamycin	0.333333333333
KM	kidney medulla	0.333333333333
KM	eso4potassium methylsulfate	0.333333333333
KL	low-affinity binding state	0.5
KL	long-term kindled group of rats	0.5
cVCN	caudal ventral cochlear nucleus	1.0
KR	bkrebs ringer-bicarbonate	0.333333333333
KR	knowledge of result	0.333333333333
KR	hepes-buffered krebs-ringer saline	0.333333333333
KP	kynurenine pathway	0.5
KP	korsakoff's psychosis	0.5
KW	kruskal–wallis statistics	0.333333333333
KW	kruskall–wallis test	0.333333333333
KW	kruskal–wallis statistic	0.333333333333
KV	voltage-gated k+ channels	0.5
KV	3.1	0.25
KV	voltage-gated potassium channel	0.25
KT	5823protein kinase g inhibitor	0.5
KT	ketamine hydrochloride	0.5
HDACI	histone deacetylase inhibitor	0.666666666667
HDACI	shistone deacetylase inhibitors	0.333333333333
optEPSP	optically-recorded excitatory postsynaptic potential	1.0
KX	ketamine-xylazine	1.0
PTPN	5	1.0
Dig	digoxygenin	0.333333333333
Dig	digoxigenin	0.666666666667
SKC	a2+-activated k+ current sk type	0.333333333333
SKC	asmall conductance ca2+-activated k+ channel	0.333333333333
SKC	a“small” ca2+-dependent k+-conductance	0.333333333333
RSCEM	rabbit small clot embolic stroke model	1.0
cGK	cyclic guanosine-3′,5′-monophosphate-dependent protein kinase	0.5
cGK	cgmp-dependent protein kinase	0.5
d-NAMEN-	nitro-d-arginine methyl ester	1.0
JC-1	5,5′,6,6′-tetrachloro-1,1,3,3-tetraethylbenzimidazolcarbocyanine iodide	1.0
Interleukin-1ra	interleukin-1 receptor antagonist	1.0
SAPO-SPT	group of rats with a 192 igg-saporin lesion	1.0
NNBsshort	narrowband noise burst	1.0
Gmax	maximal conductance	1.0
OVA-NC	ovalbumin coupled to nitrocellulose beads	1.0
AMNs	autonomic motor neurons	1.0
HDL-CHDL	cholesterol	1.0
CYTB	cytochrome b	1.0
MSQM	otion sickness questionnaire	1.0
PORT	place object recognition task	1.0
FDSF	lexor digitorum superficialis	1.0
MBL	/maspmannose-binding lectin/mannose-binding lectin-associated serine protease	1.0
DLCD	dorsolateral caudate	1.0
eGFP-C	hat	1.0
BHRP	cholera toxin subunit b–horseradish peroxidase	0.5
BHRP	horseradish peroxidase conjugated to cholera toxin	0.5
mBF	magnocellular basal forebrain	0.5
mBF	magnocellular bf	0.5
GES	gastric electrical stimulation	1.0
BSF-	2bbottenstein's culture medium	1.0
eADPR1	n6-etheno-adp-ribose	1.0
cVA	11-cis-vaccenyl acetate	1.0
RED2	dsrna-specific editase 1 and 2	1.0
PoT	triangular posterior nucleus	1.0
CtC	terminus	1.0
dmM	dorsomedial medulla	1.0
3-MT	3-methoxytyramine	0.9375
3-MT	3-o-methoxy-4-hydroxy-phenylethylamine	0.0625
anti-PMN	anti-polymorphonuclear antiserum	1.0
ShamNBM	group of animals given bilateral injections of pbs into the nbm	1.0
Y33	rabbit anti-mglur3 antibody	1.0
TSKY	thr-ser-lys-tyr	1.0
CRND	8 transgenic mice	1.0
125I-RTI-	55[125i]rti-55 ((-)-2beta-carbomethoxy-3 beta-(4-iodophenyl) tropane)	1.0
2-PG	2-palmitoyl glycerol	1.0
NDAEN	a+-dependent anion (cl--hco3-) exchanger	0.5
NDAEN	a-driven anion exchanger	0.5
2-PM	2-photon microscopy	1.0
GET	1/2the average time to empty half of the gastric contents	1.0
USPU	niversidade de são paulo	1.0
CaMIII	calmodulin gene iii	1.0
ppCCK	preprocholecystokinin	1.0
PBS-GT	xphosphate-buffered saline with 0.1% pig gelatine and 0.3% tritonx-100	1.0
ESI-QTOF-MS	/mselectrospray ionization quadrupole time of flight tandem ms	1.0
CTAPH-	d-phe-cys-tyr-d-trp-arg-thr-pen-thr-nh2	1.0
CGRP	calcitonin gene–related peptide	0.00337837837838
CGRP	calcitonine gene-related peptide	0.00337837837838
CGRP	2calcitonin gene-related peptide receptor (type 2)	0.00337837837838
CGRP	calcitonin gene-related protein	0.00675675675676
CGRP	calcitonin gene-related peptide	0.888513513514
CGRP	calcitonin-gene-related-peptide	0.00337837837838
CGRP	calcitonin gene related protein	0.00337837837838
CGRP	calcitonin-gene-related peptide	0.0202702702703
CGRP	α-calcitonin gene-related peptide	0.00337837837838
CGRP	calcitonin gene related peptide	0.0236486486486
CGRP	calcitonin-gene related peptide	0.0236486486486
CGRP	+calcitonin gene-related peptide positive	0.00337837837838
CGRP	calcitonin-related gene peptide	0.00337837837838
CGRP	calcitonin-gene–related peptide	0.00337837837838
CGRP	calcitonin gene-related peptide α	0.00337837837838
CGRP	8–378–37 cgrp fragment	0.00337837837838
BM-MSC	sbone marrow-derived mscs	0.333333333333
BM-MSC	derived from bone marrow	0.333333333333
BM-MSC	sbone marrow-derived mesenchymal stem cells	0.333333333333
GSSG	glutathione oxidized	0.0243902439024
GSSG	reduced glutathione	0.0243902439024
GSSG	megssg methyl ester	0.0243902439024
GSSG	glutathione-disulfide	0.0243902439024
GSSG	glutathione oxidised	0.0243902439024
GSSG	oxidized glutathione	0.609756097561
GSSG	erstmann-straüssler-scheinker	0.0243902439024
GSSG	oxidized glutathione or gsh disulphide	0.0243902439024
GSSG	glutathione disulfide	0.219512195122
BGA	beta–gamma activity	1.0
eIPSP	evoked inhibitory postsynaptic potential	0.333333333333
eIPSP	single stimulus shock-evoked inhibitory postsynaptic potential	0.333333333333
eIPSP	sevoked inhibitory postsynaptic potentials	0.333333333333
BGC	biased gene conversion	1.0
NbM	magnocellular nuclei of the basal forebrain	1.0
WLRW	ord list recall	1.0
HISH	achinski ischemic score	1.0
PBS-G-T-A	sodium phosphate-buffered saline containing 0.25% triton x-100, 0.2% gelatin and 0.001% azide	1.0
β-FNAβ-	funaltrexamine	0.5
β-FNAβ-	funaltrexamine hydrochloride	0.5
RNAPIIRNA	polymerase ii	1.0
dmX	dorsal motor nucleus of the vagus	1.0
BGS	basal ganglia slice	1.0
BGT	1betaine/gaba transporter 1	0.5
BGT	1betaine/gaba transporter	0.5
GSSP	gold-substituted silver peroxidase	1.0
PBSTN	phosphate-buffered saline–triton azide	0.5
PBSTN	pbs containing triton x-100 and nan3	0.5
CL218	872	1.0
CDD-0097	5-propargyloxycarbonyl-1,4,5,6-tetrahydropyrimidine hydrochloride	1.0
TCN	temporally coherent networks	1.0
PBSTw	phosphate-buffered saline with tween 20	1.0
5-HTP5-hydroxytryptophan	5-hydroxy-l-tryptophan	1.0
DAMPS	danger-associated molecular patterns	1.0
MPP1	3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1h-pyrazole dihydrochloride (methyl-piperidino-pyrazole)	1.0
SMRTS	ilencing mediator of retinoic acid and thyroid hormone receptor	1.0
MFR	mean firing rate	1.0
Ntyr	nitrotyrosine	1.0
iRG-	like cellinduced retinal ganglion-like cell	1.0
TH-	irtyrosine hydroxylase-immunoreactivity	0.04
TH-	irimmunoreactive for tyrosine hydroxylase	0.04
TH-	irtyrosine hydroxylase–immunoreactive	0.04
TH-	irth immunoreactive	0.08
TH-	irtyrosine hydroxylase-immunoreactive	0.16
TH-	irtyrosine hydroxylase immunoreactive	0.24
TH-	irth-immunoreactivity	0.04
TH-	irth-immunoreactive	0.12
TH-	irtyrosine hydroxylase immunoreactivity	0.2
TH-	irth immunoreactivity	0.04
TCM	trichlormethiazide	1.0
b-AP	back-propagating action potential	1.0
PICK	1protein interacting with c kinase	0.111111111111
PICK	1protein interacting with c-kinase-1	0.222222222222
PICK	1protein interacting with c-kinase 1	0.222222222222
PICK	1protein interacting with c kinase 1	0.444444444444
GEG	eneral electric	1.0
SBBB	superblock blocking buffer	1.0
VLpv	dorsal and ventral divisions of the vlp	1.0
PICA	probabilistic independent component analysis	0.333333333333
PICA	posterior inferior cerebellar artery	0.666666666667
SDMT	symbol digit modalities test	1.0
eIF-	3η	0.5
eIF-	4eeukaryotic initiation factor 4e	0.5
PCVAFDA	average coefficient of variation of the average firing frequency of all cells with a delay-activated response	1.0
GPM	medial globus pallidus	1.0
GPN	glossopharyngeal nerve	1.0
GPO	glutathione peroxidase	1.0
3-MA	3-methyladenine	1.0
mini-IPSC	s	1.0
3-APADP	3-acetylpyridine-adenine-dinucleotide phosphate	1.0
HSVLatEnk1	preproenkephalin a-encoding recombinant hsv-1	1.0
TMPT	etramethylpyrazine	1.0
MPPP	1-methyl-4-phenyl-4-propionpiperidine	1.0
GPA	gomori-positive astrocytes	0.333333333333
GPA	3-guanidinopropionic acid	0.333333333333
GPA	guanidinopropionic acid	0.333333333333
THP	tetrahydropalmatine	0.1
THP	tetrahydroprogesterone	0.6
THP	tetrahydropapaveroline	0.2
THP	3α-oh-5[α]β-pregnan-20-one or [allo]	0.1
UV-V	isultraviolet-visible	1.0
THL	anteroventricular thalamic nucleus	0.5
THL	thalamus	0.5
GPX	anti-glutathione peroxidase	0.166666666667
GPX	glutathione peroxidase	0.833333333333
THI	tinnitus handicap inventory	1.0
GPT	glutamate–pyruvate transaminase	0.2
GPT	grooved pegboard task	0.2
GPT	glutamate pyruvate transaminase	0.2
GPT	glutamate-pyruvate transaminase	0.2
GPT	gabapentin	0.2
THF	tetrahydrofolic acid	0.333333333333
THF	tetrahydrofuran	0.666666666667
THE	tonic hindlimb extension	1.0
THC	delta-9-tetrahydrocanabinol	0.030303030303
THC	δ-9-tetrahydrocannabinol	0.030303030303
THC	δ(9)-tetrahydrocannabinol	0.030303030303
THC	delta 9-tetrahydrocannabinol	0.030303030303
THC	delta-9-tetrahydrocannabinol	0.121212121212
THC	δ9(-)-tetrahydrocannabinol	0.030303030303
THC	(-)δ9-tetrahydrocannabinol	0.030303030303
THC	δ9-tetrahydrocannabinol	0.454545454545
THC	δ9 tetrahydrocannabinol	0.030303030303
THC	9-tetrahydrocannabinol	0.0606060606061
THC	δ9- tetrahydrocannabinol	0.030303030303
THC	tetrahydrocannabinol	0.0909090909091
THC	delta9-tetrahydrocannabinol	0.030303030303
THB	tissue homogenization buffer	1.0
GPR	10g-protein coupled receptor	0.047619047619
GPR	147	0.047619047619
GPR	30g-protein-coupled receptor 30	0.142857142857
GPR	30g-protein coupled receptor 30	0.047619047619
GPR	7	0.047619047619
GPR	30	0.047619047619
GPR	30g protein-coupled receptor	0.047619047619
GPR	30g protein–coupled receptor 30	0.0952380952381
GPR	17g-protein-coupled receptor 17	0.047619047619
GPR	17g protein-coupled receptor 17	0.047619047619
GPR	40	0.047619047619
GPR	88g protein-coupled receptor 88	0.047619047619
GPR	30g-protein-coupled estrogen receptor 30	0.047619047619
GPR	54g protein-coupled receptor 54	0.0952380952381
GPR	g-protein coupled receptor	0.047619047619
GPR	39g protein-linked receptor 39	0.047619047619
GPR	55g protein-coupled receptor 55	0.047619047619
GPS	group-based prediction system	0.5
GPS	global positioning system	0.5
GPl	lateral globus pallidus	1.0
GPm	medial globus pallidus	1.0
NIH	national institute of health	0.333333333333
NIH	novelty-induced hypophagia	0.166666666667
NIH	national institutes of health	0.333333333333
NIH	image	0.166666666667
NII	sneuronal intranuclear inclusions	0.5
NII	neuronal intranuclear inclusion	0.5
DW-MRI	diffusion-weighted magnetic resonance imaging	1.0
GPi	globus pallidus internus	0.0666666666667
GPi	globus pallidus, internal segment	0.133333333333
GPi	globus pallidus internal segment	0.0666666666667
GPi	globus pallidus pars interna	0.0666666666667
GPi	globus pallidus internal part	0.0666666666667
GPi	internal subdivision of the gp	0.0666666666667
GPi	internal part of the globus pallidus	0.0666666666667
GPi	internal segment of the globus pallidus	0.4
GPi	globus pallidus interior	0.0666666666667
NIL	neuro-intermediate lobe	0.2
NIL	neuroimmunophilin ligand	0.2
NIL	nidopallium intermedium laterale	0.2
NIL	/plneurointermediate lobe/posterior lobe of the pituitary	0.2
NIL	unimpaired leg placement	0.2
NIM	nimodipine	1.0
NIB	non-inactivating bursting	0.5
NIB	unimpaired dynamic balance during gait	0.5
NIC	+etohnicotine and ethanol-exposed group	0.125
NIC	nicotine	0.25
NIC	group of animals treated with nicotine alone	0.125
NIC	nonischemic control	0.5
CaN-B	b subunit of calcineurin	1.0
NIA	nucleus interpositus anterior	1.0
NIF	nifedipine	0.5
NIF	neural information flow	0.5
GLAHSG	reater los angeles healthcare system	1.0
HAART	highly active antiretroviral therapy	0.666666666667
HAART	highly active anti-retroviral therapeutic drugs	0.333333333333
GDE	1glycerophosphodiesterase	1.0
NIR	near-infrared	1.0
NIS	nigra in striatum	0.5
NIS	neuronal information storage	0.5
NIP	nipecotic acid	0.333333333333
NIP	nucleus interpositus posterior	0.666666666667
LCSM	laser confocal scanning microscopy	1.0
NORN	ovel object recognition	1.0
RBP-JK	recombination signal-binding protein 1 for j-kappa	1.0
FDA	fluorescein-conjugated dextran amines	0.0833333333333
FDA	food and drug administration	0.166666666667
FDA	fluorescein diacetate	0.5
FDA	dextran-amine conjugated to fluorescein	0.0833333333333
FDA	fluorescein-conjugated dextran amine	0.0833333333333
FDA	fluorescein-coupled dextranamine	0.0833333333333
FDB	flexor digitorum brevis	1.0
FDE	frequency-dependent excitation	1.0
V-ATP	asevacuolar-type h+-atpase	1.0
DLBD	diffuse lewy body disease	1.0
LC1	lipocortin-1	0.333333333333
LC1	lipocortin1	0.333333333333
LC1	lipocortin 1	0.333333333333
FDI	first dorsal interosseous muscle	0.0434782608696
FDI	frequency-dependent inhibition	0.0869565217391
FDI	frequency difference image	0.0434782608696
FDI	first dorsal interosseous	0.521739130435
FDI	field dependence–independence	0.0434782608696
FDI	first dorsal interosseus	0.260869565217
FDM	form-deprivation myopia	1.0
FDL	flexorum digitorum longus	0.333333333333
FDL	flexor digitorum and hallucis longus	0.666666666667
PSPB	pallial–subpallial boundary	1.0
TxA2	thromboxane a2	1.0
FDS	flexor digitorum superficialis	1.0
FDR	false-discovery rate	0.0789473684211
FDR	false discovery rate	0.921052631579
FDU	5-fluoro-2′-deoxyuridine	1.0
RN2	rectal nerves group 2	1.0
SYNT	1syntaxin 1	1.0
GALKO	galanin knockout	1.0
GAL-DA	galactosylated form of dopamine	1.0
mCP	umedial caudate-putamen	1.0
ASPergic	glutamatergic/aspartatergic	1.0
LY367366	(±)-α-thioxanthylmethyl-4-carboxyphenylglycine	1.0
PIP2phosphatidylinositol-4	5-bisphosphate	1.0
mPTP	mitochondria permeability transition pore	0.333333333333
mPTP	mitochondrial permeability transition pore	0.666666666667
Rh	rheobase	0.166666666667
Rh	rhomboid	0.166666666667
Rh	rhinal group	0.166666666667
Rh	membrane input resistance after hyperpolarizing current injections	0.166666666667
Rh	rhomboid thalamic nucleus	0.333333333333
EF5	2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide	1.0
QX-	314n-ethyllidocaine	0.125
QX-	314n-ethyl-lidocaine cl	0.125
QX-	314lidocaine n-ethyl bromide	0.75
DREADD	designer receptors exclusively activated by designer drugs	1.0
CFQC	halder fatigue questionnaire	1.0
EF-	1αelongation factor 1-alpha	0.2
EF-	hand	0.8
MO-M	mounts-only group exposed	1.0
MO-L	mounts-only group exposed to males anaesthetized with lidocaine	1.0
ACSFA	rtificial cerebrospinal fluid	1.0
ROCK	rho-activated coiled-coil kinase	1.0
H-PGDS	haematopoietic prostaglandin d synthase	0.333333333333
H-PGDS	hematopoietic prostaglandin d synthase	0.666666666667
TWSG	1twisted gastrulation	1.0
DIPdefensive-like	immobile posture	1.0
HLA-DRD-	related human leukocyte antigen	1.0
M-sema	mouse semaphorin	1.0
EFP	epileptiform field potentials	0.2
EFP	epileptiform field potential	0.6
EFP	evoked field potential	0.2
EFR	envelope following response	1.0
EFS	electrical field stimulation	1.0
EFT	earth-fixed target	1.0
ICC-DMP	interstitial cells of cajal in the deep muscular plexus layer of the small intestine	1.0
EFI	extended focus image	1.0
SuMMsupramammillary	medial nucleus	1.0
EFA	essential fatty acids	1.0
EFB	excess folic acid with vitamin b12	1.0
EFD	energy flux density	1.0
Ro-32-0432	2-{8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]	1.0
RNH	reverse northern hybridization	1.0
LCR	+, latency of the cr+	0.333333333333
LCR	low-running capacity	0.333333333333
LCR	lissencephaly critical region	0.333333333333
microRNA	cooperativity	0.5
microRNA	(mirna)	0.5
LCP	lateral collateral pathway	0.25
LCP	lateral collateral projection	0.5
LCP	lower cortical plate	0.25
STRS	troop	1.0
RNB	reversible neurotransmission blocking	1.0
RNA	splicing	0.0192307692308
RNA	se a protection assay	0.0192307692308
RNA	mainly occurs due to viral infection and therefore produces an anti-viral response, generally cleaved into short interfering rna by dicer	0.0192307692308
RNA	polymerase ii	0.0384615384615
RNA	irna-interference	0.0192307692308
RNA	iribonucleic acid interference	0.0384615384615
RNA	cargo	0.0192307692308
RNA	amplification	0.0384615384615
RNA	targeting	0.0192307692308
RNA	interference	0.0769230769231
RNA	ishrna interference	0.0192307692308
RNA	s (lncrnas)	0.0192307692308
RNA	ribonucleic acid	0.0384615384615
RNA	irna interference	0.326923076923
RNA	i-lvscn7a sirna lentivirus	0.0192307692308
RNA	brain-specific cytoplasmic rna 1	0.0192307692308
RNA	editing	0.0192307692308
RNA	probes	0.0192307692308
RNA	c/d box 2	0.0192307692308
RNA	seribonuclease	0.0384615384615
RNA	iinterference rna	0.0384615384615
RNA	i	0.0961538461538
RNA	toxicity	0.0192307692308
sLP	slow long-lasting potentiation	1.0
OLN-	93an oligodendrocytic cell line from rat	0.333333333333
OLN-	93	0.333333333333
OLN-	93an oligodendrocytic cell line (from rat)	0.333333333333
RND	subset of r cells with no delay in spike onset	0.5
RND	2rho family gtpase2	0.5
LCD	l-cis-diltiazem	0.25
LCD	local combination detectors	0.25
LCD	liquid-crystal display	0.25
LCD	left cerebellar damage	0.25
FD2	fd14, flight day 2 and 12 (respectively)	1.0
LCA	leukocyte common antigen	0.5
LCA	leukocyte common antigens	0.5
LCN	local circuit neuron	0.2
LCN	local circuit neurons	0.3
LCN	2lipocalin 2	0.1
LCN	lateral cerebellar nuclei	0.2
LCN	lateral cervical nucleus	0.2
LCL	und concept	0.25
LCL	ocus coeruleus	0.5
LCL	lymphoblastoid cell line	0.25
RNP	ribonucleoprotein	0.833333333333
RNP	motifs	0.166666666667
BZ-S	benzodiazepine full agonist-sensitive receptor	1.0
LBL	ewy body	0.428571428571
LBL	ewy bodies	0.428571428571
LBL	uria-bertani	0.142857142857
-EP	non-endplate muscle region	1.0
GDPβS	guanosine 5′-o-(2-thiodiphosphate)	0.5
GDPβS	guanosine-5′-0-(2-thiodiphosphate)	0.25
GDPβS	guanosine 5′-o-(2-thiodiphosphate), trilithium salt	0.25
DVL	dorso- plus ventrolateral subregion of the prefrontal cortex	1.0
DVN	deep vibrissal nerve	0.0625
DVN	dynamic visual noise	0.0625
DVN	dorsal ventricular nerve	0.0625
DVN	dorsal vagal neurons	0.125
DVN	descending vestibular nucleus	0.5
DVN	dorsal vagal motor nucleus	0.125
DVN	dorsal motor nucleus of the vagus nerve	0.0625
ABCA	1atp-binding cassette transporter a1	0.166666666667
ABCA	vidin biotin complex	0.166666666667
ABCA	vidin–biotin complex	0.166666666667
ABCA	ctivities specific balance scale	0.166666666667
ABCA	ctivities-specific balance confidence	0.166666666667
ABCA	1atp-binding cassette transporter a-1	0.166666666667
ABCC	subfamily c of atp-binding cassette transporters	1.0
DVD	orssal-ventral	0.333333333333
DVD	developmental vitamin d	0.666666666667
MOR1	cloned μ-opioid receptor	0.5
MOR1	μ-opioid receptor	0.5
DVA	interneuron with cell body in dorsal rectal ganglion and process extending to nerve ring	1.0
DVC	dorsovagal complex	0.0909090909091
DVC	visual cortex of x-day-old animal	0.0454545454545
DVC	dorsal vagal complex	0.863636363636
RY	ryanodine	1.0
met-E	nkmethionin-enkephalin	1.0
DMDD	uchenne muscle dystrophy	0.0909090909091
DMDD	uchenne muscular dystrophy	0.909090909091
COXIV	cytochrome c oxidase subunit iv	0.5
COXIV	cytochrome oxidase subunit iv	0.5
MOR-	1	0.25
MOR-	1mu opioid receptor	0.5
MOR-	1cdna clone encoding a μ opioid receptor	0.25
S-LM	stratum lacunosum moleculare	1.0
Pctx	parietal cortex	1.0
DVS	desvenlafaxine succinate	1.0
DVR	distribution volume ratio	0.5
DVR	dorsal ventricular ridge	0.5
GDPβs	guanosine 5′-o-(2-thiodiphosphate) trilithium salt	1.0
STAT3	signal transducer and activator of transcription 3	0.666666666667
STAT3	signal transducers and activators of transcription 3	0.333333333333
hSOD	1human sod1	0.333333333333
hSOD	1g93amutated human superoxide dismutase 1	0.333333333333
hSOD	1human superoxide dismutase 1	0.333333333333
lRF	lateral reticular formation	1.0
shNMUR	2small hairpin nmur2 knockdown rna	1.0
dopamine-D	2	1.0
MBA	mediobasal amygdala	0.5
MBA	mean background activity	0.5
pKD-	log kd (receptor affinity)	1.0
GPHN	gephyrin gene	1.0
h-CuZnSOD	human cuznsod	1.0
hSOS	human sos (“son of sevenless”)	1.0
OBO	lfactory bulb	1.0
MST	middle superior temporal area	0.0769230769231
MST	medial superior temporal area	0.384615384615
MST	minimal spanning tree	0.0769230769231
MST	magnetic seizure therapy	0.0769230769231
MST	medial superior temporal	0.384615384615
STATS	ignal transducers and activators of transcription	1.0
IEP	ihp, or initial gaze position, igp)	1.0
IES	inescapable electric shock	0.25
IES	intraoperative electrical stimulation	0.25
IES	inescapable shock	0.25
IES	inescapable stress	0.25
IER	3immediate early response 3	1.0
OBC	olfactory bulb cistern	0.5
OBC	object-based colocalization	0.5
lRL	lower rhombic lip	1.0
IEI	inter-exposure interval	0.117647058824
IEI	le-enkephalin	0.0588235294118
IEI	inter-event interval	0.470588235294
IEI	inter event interval	0.0588235294118
IEI	interevent interval	0.294117647059
THIKTWIK-	related halothane-inhibitable k+ channel	1.0
a-apoE-AB	anti-apoe antibody	1.0
IEM	immunogold electron microscopy	0.5
IEM	imposed eye movement	0.5
IEL	internal elastic lamina	1.0
OBX	unilateral olfactory bulbectomy	0.0666666666667
OBX	rat	0.0666666666667
OBX	olfactory bulbectomy	0.733333333333
OBX	olfactory bulbectomized	0.0666666666667
OBX	bulbectomy	0.0666666666667
OBV	olfactory bulb ventricle	1.0
NIH-NICHDN	ational institutes of health–national institute of child health and human development	1.0
MSP	1major sperm protein-1	0.333333333333
MSP	monosynaptic peak	0.333333333333
MSP	methylation-specific pcr	0.333333333333
TEER	transepithelial electrical resistance	0.142857142857
TEER	transendothelial electrical resistance	0.571428571429
TEER	trans-endothelial electrical resistance	0.142857142857
TEER	transmembrane electrical epithelial resistance	0.142857142857
IED	interelectrode distance	0.5
IED	ipsilateral ear down	0.5
FTDP-	17frontotemporal dementia with parkinsonism linked to chromosome 17	0.25
FTDP-	17frontotemporal dementia linked to chromosome 17	0.25
FTDP-	17frontotemporal dementia and parkinsonism linked to chromosome 17	0.5
FRET	fluorescence resonance energy transfer	1.0
PLW	point-light walker	1.0
CDE	cell death elisa	1.0
CDF	calcium-dependent facilitation	0.5
CDF	cumulative distribution function	0.5
PLT	progressive lowering of temperature	0.5
PLT	place-learning task	0.5
PLS	pontomedullary locomotor strip	0.333333333333
PLS	partial least squares	0.166666666667
PLS	partial least square	0.166666666667
PLS	phase-locking statistics	0.166666666667
PLS	paradoxical latency shift	0.166666666667
CDA	contralateral delay activity	1.0
PLP	1 geneproteolipid protein 1 gene	0.025641025641
PLP	paraformaldehyde, lysine, sodium m-periodate	0.025641025641
PLP	pyridoxal-5′-phosphate	0.0512820512821
PLP	1proteolipid protein gene 1	0.025641025641
PLP	1proteolipid protein gene	0.025641025641
PLP	paraformaldehyde-lysine-sodium periodate	0.025641025641
PLP	_egfpproteolipid protein enhanced green protein	0.025641025641
PLP	paraformaldehyde–lysine–sodium periodate	0.025641025641
PLP	proteolipid protein	0.307692307692
PLP	periodate lysine paraformaldehyde	0.0512820512821
PLP	myelin proteolipid protein	0.025641025641
PLP	phantom limb pain	0.025641025641
PLP	paraformaldehyde-lysine-periodate fixative	0.0512820512821
PLP	peak lifetime period	0.025641025641
PLP	proteolipid	0.025641025641
PLP	paraformaldehyde–lysine–periodate	0.0769230769231
PLP	paraformaldehyde/d,l-lysine/sodium periodate	0.025641025641
PLP	urkinje cell layer	0.0512820512821
PLP	paraformaldehyde–lysine–periodate fixative	0.0512820512821
PLP	pyridoxal 5′-phosphate	0.0512820512821
CDL	dorsolateral corticoid area	0.5
CDL	area corticoidea lateralis	0.25
CDL	dorsolateral corticoid area/area corticoidea dorsolateralis	0.25
CDM	chemically defined medium	1.0
CDN	car-dependent navigation	1.0
CDH	23cadherin-23	1.0
PLZ	phenelzine	1.0
CDK	6cyclin dependent kinase 6	0.0434782608696
CDK	scyclin-dependent kinases	0.0434782608696
CDK	5cyclin-dependent kinase 5	0.347826086957
CDK	cyclin dependent kinase	0.130434782609
CDK	5cycline-dependent kinase 5	0.0434782608696
CDK	5	0.0434782608696
CDK	cyclin-dependent protein kinase	0.0869565217391
CDK	10cell division protein kinase 10	0.0434782608696
CDK	2cyclin-dependent kinase 2	0.0434782608696
CDK	cyclin-dependent kinase	0.173913043478
S-EPSP	slope of the field epsp	0.4
S-EPSP	slope of the epsp	0.2
S-EPSP	slope of the excitatory postsynaptic potential	0.2
S-EPSP	small excitatory postsynaptic potential	0.2
iPSC	sinduced pluripotent stem cells	0.5
iPSC	induced pluripotent cell	0.25
iPSC	induced pluripotent stem cell	0.25
PB-TX	0.1 m phosphate buffer (ph 7.2) with 0.3% triton-x	1.0
PLD	post-lesional day	0.125
PLD	phospholipase d	0.875
CDP	sspontaneous cord dorsum potentials	0.166666666667
CDP	cord dorsum potential	0.166666666667
CDP	choline	0.166666666667
CDP	chlordiazepoxide	0.333333333333
CDP	scord dorsum potentials	0.166666666667
MBC	methyl-β-cyclodextrin	1.0
CDR	current density reconstruction	0.166666666667
CDR	clinical dementia rating	0.833333333333
CDS	coding sequences	0.5
CDS	coding sequence	0.5
PLO	poly-l-ornithine	1.0
PLN	posterior lip nerve	1.0
MRNM	re11/rad50/nbs1	1.0
PLL	poly(l-lysine)	0.0416666666667
PLL	posterior lateral line nerve	0.0416666666667
PLL	poly-l-lysine hydrobromide	0.0416666666667
PLL	poly-l-lysine	0.833333333333
PLL	poly-d-lysine	0.0416666666667
CDX	hydroxypropyl-β-cyclodextrin	1.0
PLI	phase lag index	0.75
PLI	phase-locking index	0.25
PLH	peduncular part of lateral hypothalamus	0.5
PLH	posterior lateral hypothalamus	0.5
PKA-r	regulatory subunit of pka	1.0
CdP	caudate–putamen	1.0
BSI	brain boundary shift integral	0.5
BSI	bandaireae simplicifolia i	0.5
ENEP	early negative evoked potential	1.0
SCAN	1spinocerebellar ataxia with axonal neuropathy	0.5
SCAN	1oculomotor apraxia type 1	0.5
PMLDP	elizaeus–merzbacher-like disease	1.0
MNTB	medial nucleus of trapzoid body	0.025641025641
MNTB	medial nucleus of the trapezoidal body	0.025641025641
MNTB	lntb, vntb, medial, lateral and ventral nuclei of the trapezoid body	0.025641025641
MNTB	medial nucleus of the trapezoid body	0.820512820513
MNTB	medial nucleus of trapezoid body	0.102564102564
PSAPP	mousedouble transgenic mouse expressing mutant amyloid precursor protein (app k670n/m671l) and presenilin-1 (ps1 m146l)	1.0
PKA-c	catalytic subunit of pka	1.0
p75NGFR	p75 nerve growth factor receptor	0.5
p75NGFR	low-affinity nerve growth factor receptor	0.5
EOADE	arly-onset alzheimer’s disease	1.0
DINE	damage-induced neuronal endopeptidase	1.0
A-WD	acute withdrawal	1.0
frqN	eurospora frequency gene	1.0
mAHP	medium afterhyperpolarization	0.4
mAHP	medium afterhyperpolarizing potentials	0.1
mAHP	medium-duration afterhyperpolarization	0.3
mAHP	medium-duration after-hyperpolarisation	0.1
mAHP	medium ahp	0.1
AR-	irandrogen immunoreactivity	1.0
3PG	3-phosphoglycerate	1.0
MTP	mitochondria permeability transition pore	0.333333333333
MTP	metatarsophalangeal	0.333333333333
MTP	matching-to-place	0.333333333333
NET-	1ne transporter type 1	1.0
LPS-RS	lipopolysaccharide from rhodobacter sphaeroides	1.0
cfhmASWC	a2+-free/high-mg2+ artificial seawater	1.0
MT3	muscarinic toxin-3	1.0
TNFRI	tumor necrosis factor receptor i	1.0
MT1	muscarinic toxin-1	1.0
Te2C	temporal area 2, caudal part	1.0
JAXAJ	apan aerospace exploration agency	1.0
SPFPC	parvicellular part of the subparafascicular thalamic nucleus	1.0
TTOT	total respiratory time	1.0
MT-	7muscarinic toxin 7	1.0
X-SOL	cross-reinnervated soleus muscle	1.0
BrdU	bromodeoxyuridine	0.530612244898
BrdU	2-bromodeoxyuridine	0.0204081632653
BrdU	bromo-deoxyuridine	0.0408163265306
BrdU	5′-bromodeoxyuridine	0.0612244897959
BrdU	5-bromodeoxyuridine	0.0408163265306
BrdU	5-bromo-2′-deoxyuridine	0.30612244898
MNTs	motor nerve terminals	1.0
VM-VF	white matter ventral funiculus	1.0
MTX	methotrexate	0.5
MTX	methoxamine hydrochloride	0.5
LIFRβ	leukemia inhibitory factor receptor β	0.666666666667
LIFRβ	leukemia inhibitory factor receptor beta	0.333333333333
1-IR	cellular retinoic acid-binding protein type 1-immunoreactivity	1.0
MTR	magnetization transfer ratio	1.0
MTS	mitochondrial-targeting sequence	0.2
MTS	mitochondrial targeting sequence	0.4
MTS	mesial temporal sclerosis	0.2
MTS	/pmsmodified tetrazolium/formazan	0.2
PE2I	[125i]-(e)-n-(3-iodoprop-2-enyl)-2β-carboxymethyl-3β-(4′-methylphenyl)-nortropane	0.5
PE2I	(e)-n-(3-iodoprop-2-enyl)-2β-carboxymethyl-3β-(4′-methylphenyl)-nortropane	0.5
FSIQ	full-scale iq	0.333333333333
FSIQ	full-scale intelligence quotient	0.666666666667
MTV	micturition threshold volume	1.0
MCN-A-343	4-hydroxy-2-butyl-1-trimethylammonium-m-chlorocarbanilate chloride	1.0
MTT	mean transient time	0.0222222222222
MTT	1-(4,5-dimethylthiozol-2-yl)-2,5-diphenyltetrazolium bromide	0.0222222222222
MTT	3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide	0.0888888888889
MTT	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide	0.0888888888889
MTT	[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl]tetrazolium bromide	0.0222222222222
MTT	3-(4,5-di-methylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide	0.0222222222222
MTT	thiazolyl blue	0.0222222222222
MTT	methylthiazol-tetrazolium test	0.0222222222222
MTT	methyl thiazole tetrazolium	0.0222222222222
MTT	definition?	0.0222222222222
MTT	methyl thiazol tetrazolium	0.0444444444444
MTT	methylthiazol tetrazolium	0.0222222222222
MTT	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)	0.0222222222222
MTT	cell proliferation kit i (boehringer-mannheim) using the tetrazolium salt mtt	0.0222222222222
MTT	3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2h-tetrazolium bromide	0.0222222222222
MTT	dimethyl thiazolyl diphenyl tetrazolium	0.0222222222222
MTT	3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide	0.0222222222222
MTT	3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide	0.0444444444444
MTT	methylthiazolyldiphenyl-tetrazolium bromide	0.0444444444444
MTT	3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide	0.0222222222222
MTT	mammillothalamic tract	0.0222222222222
MTT	methyl thiazolyl tetrazorium	0.0222222222222
MTT	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide	0.244444444444
MTT	methylthiazoldiphenyl tetrazolium	0.0222222222222
MTT	multiple trace theory	0.0222222222222
MTT	3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium	0.0222222222222
TPJ	temporal-parietal junction	0.1
TPJ	temporal–parietal junction	0.1
TPJ	temporo-parietal junction	0.5
TPJ	temporoparietal junction	0.2
TPJ	(right) temporo-parietal junction	0.1
eEF-2	eukaryotic elongation factor 2	1.0
TNFR1	tumor necrosis factor receptor 1 (a.k.a. p55, cd120a)	1.0
MTI	mild thermal injury	1.0
MTN	medial terminal nucleus	0.25
MTN	monotufted neuron	0.25
MTN	medial terminal nucleus of the accessory optic tract	0.25
MTN	monotufted neurons	0.25
HRS	high-retention score	1.0
MTL	mitral/tufted cell layer	0.166666666667
MTL	medial temporal lobe	0.666666666667
MTL	mitral cell layer	0.166666666667
MTM	mid-term memory	0.5
MTM	medium-term memory	0.5
GRPR	gastrin-releasing peptide receptor	1.0
HRR	homologous recombination repair	1.0
MTF	modulation transfer function	0.75
MTF	metal regulatory element transcription factor	0.25
MTG	medial temporal gyrus	0.3
MTG	middle temporal gyrus	0.7
MTD	maximum tolerated dose	1.0
rSPF	rostral subparafascicular nucleus	0.5
rSPF	rostral part of the subparafascicular area	0.5
ARP	acetic ribosomal protein	0.333333333333
ARP	associative reward-penalty	0.333333333333
ARP	aripiprazole	0.333333333333
ARS	agranular retrosplenial cortex	0.5
ARS	audiogenic response score	0.5
ART	artemin	0.5
ART	acoustic reflex threshold	0.25
ART	adhesive-removal test	0.25
CRF-OE	corticotropin-releasing factor overexpressing mice	1.0
BRLBRL	15572	0.5
BRLBRL	44408	0.5
Ch1	cholinergic cells in the medial septal nucleus	1.0
GluR5	6,7glutamate receptor 5,6,7	1.0
MTs	metallothioneins	0.5
MTs	microtubules	0.5
GluR7	kainate receptor subunit glur7	1.0
GluR6	kainate receptor subunit glur6	1.0
GluR1	glutamate receptor subunit 1	0.2
GluR1	glutamate receptor r1	0.2
GluR1	ampa-class glutamate receptor subunit 1	0.2
GluR1	2, 3, glutamate receptor subunits 1, 2, 3	0.2
GluR1	glutamate receptor, type 1 subunit	0.2
GluR3	α-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid type glutamate receptor subunit types 1, 2 or 3	1.0
sEPSCs	spontaneous excitatory postsynaptic currents	1.0
MTh	medial thalamus	1.0
TIA-	1t cell internal antigen 1	0.142857142857
TIA-	1t cell internal antigen	0.571428571429
TIA-	1t-cell intracellular antigen 1	0.142857142857
TIA-	1t-cell internal antigen	0.142857142857
DA3-amino	4-aminomethyl-2′,7′-difluorescein, diacetate	1.0
ARE	adenine and uridine rich element	0.133333333333
ARE	androgen response element	0.0666666666667
ARE	antioxidant responsive element	0.0666666666667
ARE	hormone/androgen response elements	0.0666666666667
ARE	antioxidant response element	0.333333333333
ARE	adenylate/uridylate-rich element	0.0666666666667
ARE	arecoline	0.0666666666667
ARE	antioxidant-responsive element	0.133333333333
ARE	alcohol response element	0.0666666666667
ARF	acute renal failure	0.333333333333
ARF	1-gaparf1 gtpase-activating protein	0.333333333333
ARF	aggregate receptive field	0.333333333333
LETOL	ong-evans tokushima otsuka	0.666666666667
LETOL	ong evans tokushima otsuka	0.333333333333
SCA1	spinocerebellar ataxia type 1	1.0
HRI	heme-regulated eif2α kinase	1.0
T-L	ugaro celltriangular lugaro cell	1.0
MTg	mesopontine tegmentum	1.0
ARO	aromatase	1.0
RSE	relative standard error of the mean	1.0
vHC	ventral hippocampus	1.0
AXPC	axial protocadherin	1.0
CPSI	calculated preferred shape index	1.0
nLOT	2layer 2 of the nucleus of the lateral olfactory tract	1.0
nPKC	novel pkc	0.428571428571
nPKC	“novel” protein kinase c	0.142857142857
nPKC	novel protein kinase c	0.428571428571
AICD	amyloid precursor protein intracellular domain	1.0
ADLA	ctivities of daily living scale	1.0
CPSC	contralateral primary somatosensory cortex	1.0
NCIC	non-cajal interstitial cell	1.0
AC-YVAD-CHO	acetyl-yvad-cho	1.0
HRD	hypoxic respiratory depression	1.0
M500542	2′-methylenebis (1,3-cyclohexanedione)	1.0
BDNF	metmethionine in codon 66 of the bdnf protein	0.00131061598952
BDNF	brain-derived neurotrophin factor	0.00393184796855
BDNF	brain-derived neurotropic factor	0.00524246395806
BDNF	brain-derived neurotrophic factor	0.909567496723
BDNF	anti-brain-derived neurotrophic factor	0.00131061598952
BDNF	brain derived neurophic factor	0.00131061598952
BDNF	brain-derived nerve growth factor	0.00262123197903
BDNF	brain derived-neurotrophic factor	0.00131061598952
BDNF	hetbdnf heterozygous	0.00131061598952
BDNF	brain-derived-neurotrophic-factor	0.00131061598952
BDNF	mrna	0.00131061598952
BDNF	brain-derived nerve factor	0.00131061598952
BDNF	brain-derived growth factor	0.00917431192661
BDNF	brain derived neural factor	0.00131061598952
BDNF	+/-bdnf heterozygous mice	0.00131061598952
BDNF	brain derived neurotrophic factor	0.0563564875491
CPSP	central post-stroke pain	1.0
dbcAMP	dibutyryl cyclic amp	0.357142857143
dbcAMP	dibutyryladenosine 3′, 5′-cyclic-monophosphate	0.0714285714286
dbcAMP	dibutyrylcamp	0.0714285714286
dbcAMP	dibutyryl camp	0.285714285714
dbcAMP	dibutyryl cyclic adenosine monophosphate	0.0714285714286
dbcAMP	n6,2′-o-dibutyryl-adenosine-3′:5′-cyclic monophosphate sodium	0.0714285714286
dbcAMP	dibutyl camp	0.0714285714286
LDHL	actate dehydrogenase	1.0
VAChT-LI	vacht-like immunoreactive	1.0
hmWDR	thermal and mechano-receptive wide dynamic range	1.0
VLJ	liquid junction potential	1.0
-4-CPG	(s)-4-carboxyphenylglycine	1.0
Fas	fasciculin	1.0
Fat	ad libitum-fed group	1.0
l-NION	5-(1-iminoethyl)-l-ornithine	1.0
ALADINalacrima	achalasia, adrenal insufficiency neurologic disorder	1.0
bFGF	basic-fibroblast growth factor	0.00970873786408
bFGF	basic fibroblast grown factor	0.00970873786408
bFGF	basic fibroblast growth factor (or fibroblast growth factor type ii)	0.00970873786408
bFGF	basal fibroblast growth factor	0.00970873786408
bFGF	fibroblast growth factor beta	0.00970873786408
bFGF	fibroblast growth factor basic	0.00970873786408
bFGF	basic fibroblast growth factor (fgf-2)	0.00970873786408
bFGF	or fgf-2basic fibroblast growth factor	0.00970873786408
bFGF	basic fibroblast growth factor	0.922330097087
OX7-sap	ox7-saporin	1.0
eEF	2eukaryotic elongation factor 2	1.0
E-NTPD	aseecto-nucleoside triphosphate diphosphohydrolase	0.5
E-NTPD	asesecto-nucleoside triphosphate diphosphohydrolases	0.5
pLIMK	phosphorylated-lim kinase	1.0
d-TC	tubocurarine chloride	0.333333333333
d-TC	d-tubocurarine	0.666666666667
nASW	normal artificial seawater	0.333333333333
nASW	normal artificial salt water	0.666666666667
17β-Eβ-	estradiol	1.0
CLEAR	coordinated lysosomal expression and regulation	1.0
SLEA	ccentral sublenticular extended amygdala	0.333333333333
SLEA	sublenticular extended amygdala	0.333333333333
SLEA	extended amygdala	0.333333333333
pro-IL-	1βinactive precursor of interleukin-1β	1.0
LMTG	left middle temporal gyrus	1.0
BAHC	benzylaminehydrochloride	1.0
WIN55	212–2r(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]	0.166666666667
WIN55	212-2 autoradiography	0.166666666667
WIN55	212-2(r)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]	0.166666666667
WIN55	212-2r(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]	0.166666666667
WIN55	212-2(r)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone	0.166666666667
WIN55	212-2	0.166666666667
bNCSC	boundary cap neural crest stem cells	1.0
FTLD	fronto–temporal lobar degeneration	0.25
FTLD	frontotemporal lobar degeneration	0.75
RLAR	oman low-avoidance (rat line)	0.25
RLAR	oman low avoidance	0.25
RLAR	oman low-avoidance	0.5
PKARIIβ	protein kinase a regulatory subunit iiβ	1.0
PETN	pentaerythrittetranitrate	1.0
EP3R	ep3 receptor	1.0
PKCδI	protein kinase	1.0
ARCARC	239	1.0
TNF-RIITNF-	receptor ii	1.0
NXII	hypoglossal nucleus	1.0
NSFN-	ethylmaleimide-sensitive factor	0.4
NSFN-	ethylmaleimide sensitive factor	0.3
NSFN-	ethylmaleimide-sensitive fusion protein	0.2
NSFN-	ethyl-maleimide-sensitive fusion protein	0.1
AH-POA	anterior hypothalamic-preoptic area	1.0
HL-OF	high-light open-field	1.0
GABABR2	gabab receptor subunit r2	0.5
GABABR2	gababreceptor subunit-2	0.5
NASPM	1-naphthylacetyl spermine trihydrochloride	0.5
NASPM	1-naphthyl acetyl spermine	0.5
VRSV	irchow-robin spaces	1.0
SCdp	superior colliculus deep layers	1.0
CHIMESCHI	nese medicine neuroaid efficacy on stroke recovery	1.0
CSRP	1cysteine and glycine-rich protein 1	1.0
PANTHERISP	reventive antibacterial therapy in stroke	1.0
Suc	succinate	1.0
Sub	subiculum	0.5
Sub	submedius thalamic nucleus	0.5
GLUT	11	0.0555555555556
GLUT	l-glutamate	0.0555555555556
GLUT	sglucose transporters	0.0555555555556
GLUT	facilitated glucose transporter	0.0555555555556
GLUT	glucose transporter	0.166666666667
GLUT	3	0.0555555555556
GLUT	4glucose transporter-4	0.0555555555556
GLUT	1glucose transporter 1	0.111111111111
GLUT	vesicular glutamate transporter	0.0555555555556
GLUT	4glucose transporter 4	0.0555555555556
GLUT	glucose transporters	0.166666666667
GLUT	1glucose transporter-1	0.0555555555556
GLUT	glutamate	0.0555555555556
SUBIC	subiculum	1.0
GLUR	glutamate receptor	1.0
BAEEN-	benzoyl-l-arginine ethyl ester	1.0
irAMY	amylin-immunoreactive	1.0
LVPO	lateroventral periolivary nucleus	1.0
AOL	anterior olfactory nucleus (lateral)	1.0
11C-	flumazenil	1.0
pEYFP-GolgipEYFP-Gal-T	enhanced yellow fluorescent protein/human β1,4-galactosyltransferase	1.0
bGH	bovine growth hormone	1.0
SuM	supramamillary nucleus	0.4
SuM	supramammillary nucleus	0.6
3DCS	3d curvature-selective	1.0
APPCTF	sapp c-terminal fragments	1.0
NR-ISH	non-radioactive in situ hybridization	1.0
SuP	superprotein	1.0
2APB	2-aminoethoxydiphenylborate	0.666666666667
2APB	2aminoethoxydiphenyl borate	0.333333333333
control-NC	non-copulator of control group	1.0
TDBTN	total dendritic branch tip number	1.0
VTO	variable time-out	1.0
PNMI	periodic neck movement index	1.0
NMDAR-	1n-methyl d-aspartate receptor 1	0.5
NMDAR-	1n-methyl-d-aspartate receptor 1	0.5
RMER	eference memory errors	1.0
matBDNF	mature bdnf	1.0
CNIC	central nucleus of the inferior colliculus	1.0
Li	nucleus limitans	1.0
Cch	carbachol	0.5
Cch	carbamyl choline (carbachol)	0.5
PK-C	protein kinase-c	1.0
A-APA	antigen affinity-purified antisera	1.0
NMDAR2	n-methyl-d-aspartate receptor 2	1.0
α-NAAG	n-acetylaspartylglutamate	1.0
NMDAR1	nmda receptor subunit 1	0.1
NMDAR1	n-methyl-d-aspartate receptor 1	0.1
NMDAR1	subunit 1 of the nmda receptor	0.1
NMDAR1	r1 subunit of the nmda receptor	0.1
NMDAR1	nmda receptor 1	0.1
NMDAR1	nmda receptor	0.1
NMDAR1	nmda glutamate receptor subunit 1	0.1
NMDAR1	n-methyl-d-aspartate r1 subunit	0.1
NMDAR1	n-methyl-d-aspartate receptor subunit 1	0.2
IPTG	isopropyl-β-thiogalactopyranoside	0.166666666667
IPTG	isopropyl β-d-thioglucopyranoside	0.166666666667
IPTG	isopropyl-β-d-thiogalactopyranoside	0.166666666667
IPTG	isopropyl-ß-d-thiogalactoside	0.166666666667
IPTG	isopropyl-1-thio-β-d-galactopyranoside	0.166666666667
IPTG	isopropyl βd-thiogalactopyranoside	0.166666666667
DPDPE	[d-pen2,d-pen5]enkephalin	0.166666666667
DPDPE	[d-pen2d-pen5]enkephalin	0.0555555555556
DPDPE	d-penicillamine2-d-penicillamine5enkephalin	0.0555555555556
DPDPE	d-pen2,5-enkephalin	0.0555555555556
DPDPE	[d-pen2,5]-enkephalin	0.166666666667
DPDPE	[d-pen]-enkephalin	0.0555555555556
DPDPE	[d-phen2,5]enkephalin	0.0555555555556
DPDPE	d-pen2, d-pen5-enkephalin	0.0555555555556
DPDPE	[d-pen2,5]enkephalin	0.0555555555556
DPDPE	d-pen2-d-pen5-enkephalin	0.0555555555556
DPDPE	[d-phe2, d-phe5] enkephalin	0.0555555555556
DPDPE	[d-pen2	0.0555555555556
DPDPE	d-pen2,d-pen5-enkephalin	0.0555555555556
DPDPE	[d-pen(2), d-pen(5)]enkephalin	0.0555555555556
wTPS	weak θ-patterned stimulation	1.0
ndV	trigeminal descending tract nucleus	1.0
VACCs	voltage-activated ca2+ channels	1.0
CMRglu	cerebral metabolic rate of glucose	1.0
PCS	portacaval shunts	0.5
PCS	pain-catastrophizing scale	0.5
BIBN4096BS	1-piperidinecarboxamide, n-[2-[[5-amino-1-[[4-(4-pyridinyl)-1-piperazinyl]carbonyl]	1.0
11C	]dasb[11c]	0.333333333333
11C	]pk11195	0.333333333333
11C	]sch23390	0.333333333333
LDH-	2lactate dehydrogenase 2	1.0
MGPM	atrix gla protein	1.0
MPTP1-Methyl-4-phenyl-1	2,3,6-tetrahydropyridine	1.0
l-DOPAL-3	4-dihydroxyphenylalanine	1.0
SPCA	secretory pathway ca2+/mn2+-atpases	1.0
PaMP	medial parvocellular pvn	1.0
cPLA	2cytosolic phospholipase a2	0.545454545455
cPLA	2calcium-dependent phospholipase a2	0.0909090909091
cPLA	2cytosolic-phospholipase a2	0.0909090909091
cPLA	2calcium-dependent cytosolic phospholipase a2	0.0909090909091
cPLA	2cytosolic ca2+-dependent phospholipase a2	0.0909090909091
cPLA	2ivacytosolic calcium-dependent phospholipase a2 group iva	0.0909090909091
DNMT	1dna methyltransferase 1	0.2
DNMT	3a	0.4
DNMT	smethyltransferases	0.2
DNMT	sdna methyltransferases	0.2
DN-jun	a dominant negative mutant of c-jun	1.0
DNMP	delayed non-match to position	0.5
DNMP	delayed non-matching to position	0.5
DNMS	delayed nonmatching to sample	0.153846153846
DNMS	delayed non-match to sample	0.153846153846
DNMS	delayed nonmatching-to-sample	0.0769230769231
DNMS	nonmatching-to-sample recognition memory task	0.0769230769231
DNMS	delayed (non)-matching to sample	0.0769230769231
DNMS	delayed non-matching to sample	0.153846153846
DNMS	delayed non-matching-to-sample	0.307692307692
LY-278	5841-methyl-n-[8-methyl-8-azabicyclo (3.2.1)-oct-3-yl]-1h-indazole-3-carboxamide	1.0
M2-like	m2 and m4 muscarinic acetylcholine receptors	1.0
W-AP	group working during their active phase	1.0
TAT-	permeable peptide	1.0
Isl-2	islet-2	1.0
lincRNA	slong intergenic non-coding rnas	1.0
Isl-1	islet-1	1.0
FSLFMRIB	’s software library	0.25
FSLFMRIB	software libraries	0.125
FSLFMRIB	software library	0.625
TLESR	transient lower esophageal sphincter relaxation	1.0
PGD2	prostaglandin d2	1.0
TTCT	riphenyl tetrazolium chloride	1.0
CUHKC	hinese university of hong kong	1.0
CDRA	common disease/rare variant	1.0
VMCPT	ventromedial part of the caudal pontine tegmentum	1.0
HPLC-MS	high-pressure liquid chromatographic separation coupled with mass-spectrometric detection	1.0
l-NOARGNG-	nitro-l-arginine	1.0
p-STAT-	3phospho-stat-3	1.0
EC-CVE	riochrome cyanine-cresyl violet	1.0
Amb	nucleus ambiguus	0.5
Amb	ambiguus nucleus, compact formation	0.5
rDNA	ribosomal dna	1.0
LLCPK	1lewis lung carcinoma porcine kidney cells	1.0
mitoBKC	a channelmitochondrial large conductance calcium activated potassium channel	0.5
mitoBKC	amitochondrial large conductance ca2+-activated potassium channel	0.5
MSPPOHN-	methylsulfonyl-6-(2-propargyloxyphenyl) hexanamide	1.0
cIEG	cellular immediate early gene	1.0
attB	/attp transgenic system	1.0
MBR	mean bursting rate	0.666666666667
MBR	smitochondrial benzodiazepine receptors	0.333333333333
Te1	temporal area 1	0.333333333333
Te1	3temporal cortex	0.333333333333
Te1	primary auditory cortex	0.333333333333
phMRI	pharmacological magnetic resonance imaging	0.571428571429
phMRI	pharmacologic magnetic resonance imaging	0.142857142857
phMRI	pharmacological mri	0.142857142857
phMRI	pharmacological challenge magnetic resonance imaging	0.142857142857
VSTM	visual short-term memory	1.0
Peri	perifornical organ	1.0
DAMP1	1-dimethyl-4-diphenylacetoxypiridinium iodide	1.0
SMRIS	tanley medical research institute	1.0
NEMN-	ethylmaleimide	1.0
TAG-1	transient axonal glycoprotein	1.0
WTwild-type	+/+	1.0
OXorexin	hypocretin	1.0
cGC	caudal gustatory cortex	0.5
cGC	caudal part of gustatory cortex	0.5
SODM	n-superoxide dismutase	1.0
Sp-8-Br-cAMPS	8-bromo-adenosine 3′,5′-cyclic monophosphorothioate, sp-isomer	1.0
IFNγ	interferon gamma	0.0714285714286
IFNγ	interferon-gamma	0.357142857143
IFNγ	interferon-γ	0.428571428571
IFNγ	gamma-interferon	0.0714285714286
IFNγ	interferonγ	0.0714285714286
AITC	allyl isothiocyanate	0.818181818182
AITC	allyl-isothiocyanate	0.0909090909091
AITC	allylisothiocyanate	0.0909090909091
VTR	ventral tegmental area	1.0
PSPs	postsynaptic potentials	1.0
FESEM	field emission scanning electron microscopy	1.0
F380	ratio between the fura-2 fluorescence intensities excited at 340nm and 380nm	0.5
F380	fluorescence emission elicited by an excitation wavelength of 380 nm	0.5
PSPN	persephin	1.0
P-ERK	phosphorylated extracellular signal-regulated kinase	0.333333333333
P-ERK	sphosphorylated erks	0.333333333333
P-ERK	phosphorylated form of erk	0.333333333333
AVPARG	8-vasopressin	1.0
FAAH	fatty acid amide hydrolase	0.848484848485
FAAH	fatty-acid amide hydrolase	0.0909090909091
FAAH	fatty acid amide hydrolases	0.030303030303
FAAH	fatty acid amid hydrolase	0.030303030303
dUMP	deoxyuridine monophosphate	1.0
WIN	55212-2	0.25
WIN	55;212–2	0.5
WIN	55212-2 (r)-(+)-[2,3-dihydro-5-methyl-3-[(4-morpholino)methyl]pyrrolo-[1,2,3-de]	0.25
COV-IS	coefficient of variation of the inter-spike-interval	1.0
CCKAR	cholecystokinin a receptor	1.0
WIW	istar	1.0
WIV	weeks in vitro	1.0
PGDS	prostaglandin d synthase	1.0
PBdl	dorsal lateral parabrachial subnucleus	1.0
TUBAL	3tubulin alpha chain-like 3	1.0
vEEG	video-electroencephalography	1.0
PSPP	rogressive supranuclear palsy	1.0
ATRA	all-trans-retinoic acid	0.333333333333
ATRA	all-trans retinoic acid	0.444444444444
ATRA	all-trans-ra	0.111111111111
ATRA	ng type receptor	0.111111111111
HRP-WGA	horseradish peroxidase conjugated to wheat germ agglutinin	0.666666666667
HRP-WGA	horseradish peroxidase to wheat germ agglutinin	0.333333333333
pro-DYN	pro-dynorphin	1.0
MTSS	1metastasis suppressor 1	1.0
BB-CK	brain-specific cytosolic isoform of creatine kinase	1.0
carboxy-PTIO	2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-l-oxyl-3-oxide potassium	0.333333333333
carboxy-PTIO	2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide	0.333333333333
carboxy-PTIO	2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide	0.333333333333
VCAM	vascular cell adhesion molecule-1	0.25
VCAM	vascular cell adhesion molecule	0.75
DPX1	3-dipropyl-8-phenylxanthine, a selective adenosine a1 receptor antagonist	0.5
DPX1	3-dipropyl-8-phenylxanthine	0.5
GDNF-	irglial cell line-derived neurotrophic factor immunoactivity	1.0
MTSB	microtubule-stabilizing buffer	1.0
5-HT1B5-HT5A	5-ht1a, serotonin receptors	1.0
SHR-SP	spontaneously hypertensive stroke-prone	1.0
AIW	axon imaging workbench	1.0
DPXdistrene	plasticiser, xylene	1.0
Flt-1	vascular endothelial growth factor receptor-1	1.0
SSBR	single-strand break repair	1.0
APTEX	3-aminopropyltrietoxysilane	1.0
HER	1	0.333333333333
HER	human epidermal growth factor receptor	0.333333333333
HER	prenatal heroin exposure group	0.333333333333
PLA2	phospholipase a2	1.0
MT-MMP	1membrane-type matrix metalloproteinase-1	1.0
TGase	transglutaminase	1.0
mGluR5	metabotropic glutamate receptor 5	0.5
mGluR5	metabotropic glutamate receptor type 5	0.5
mGluR1	subtype 1 metabotropic glutamate receptor	0.5
mGluR1	metabotropic glutamate receptor 1	0.5
GDX-pl	gonadectomized, placebo implanted	1.0
l-NNA	n-nitro-l-arginine	0.25
l-NNA	nitro-l-arginine	0.25
l-NNA	nω-nitro- l-arginine	0.25
l-NNA	ng-nitro-l-arginine	0.25
ZVADZ-V	al-ala-asp-fluoromethylketone	1.0
ling-V	3 regionlingual nerve region of vor	0.5
ling-V	3 regionlingual nerve region	0.5
siREMS	single rapid eye movement sleep	1.0
NDC	nidopallium dorso-caudale	1.0
ling-S	1lingual nerve area of s1	0.5
ling-S	2lingual nerve area of s2	0.5
nNOS-IR	neuronal nitric oxide synthase-immunoreactive	1.0
P-SH	protein thiol	1.0
1DM	e)y8fad.tyr-leu-[n-me]phe-gln-pro-gln-arg-phe-nh	1.0
APN-KOAPN-	deficient mice	1.0
PLAP	phospholipase a2 activating protein	1.0
CGP55845A	3-n[1-(s)-(3,4-dichlorophenyl)ethyl]amino-2-(s)-hydroxypropyl-p-benzylphosphinic acid	0.5
CGP55845A	(2s)-3-[[(1s)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl]	0.5
m-PFTG	medial pontine gigantocellular tegmental field	1.0
CDRC	linical dementia rating score	0.111111111111
CDRC	linical dementia rating	0.666666666667
CDRC	linical dementia rating scale	0.222222222222
129S	1/svimj mice	0.5
129S	v129s2/sv	0.5
CNQX6-cyano-7-nitroquinoxalene-2	3-dione	1.0
CDRG	cervical dorsal root ganglion	1.0
GHS-R	1a	0.166666666667
GHS-R	growth hormone secretagogues receptor sub-type 1a	0.166666666667
GHS-R	growth hormone secretagogue receptor	0.333333333333
GHS-R	1agrowth hormone secretagogue receptor 1a	0.333333333333
MEPPs	miniature end plate potentials	1.0
POP-spike	population spike	1.0
MRS25781	4-di[3-(3-isothiocyanatophenyl)thioureido]butane	1.0
UMDU	niversity of maryland	1.0
Emax	maximal predicted effect	0.333333333333
Emax	the maximal response	0.333333333333
Emax	maximal response	0.333333333333
NRNMDA	glutamatergic receptor subunit	0.2
NRNMDA	receptor	0.8
DCHF	fluorescent dichlorofluorescein	1.0
IKKI	кb kinase	0.5
IKKI	kb kinase	0.5
aROC	area under the receiver-operating characteristic curve	1.0
PEG-SOD	polyethylene glycol–conjugated superoxide dismutase	1.0
VMNvl	ventrolateral vmn	1.0
ERKOERα	knock out	1.0
mGluRs	metabotropic glutamate receptors	1.0
HDAAH	untington's disease mice treated with ascorbate	1.0
ALS-	stshort-term survival	1.0
mAChRs	muscarinic acetylcholine receptors	1.0
UGTUDP-	glucuronosyl-transferase enzymes	1.0
RSGC	retrosplenial granular cortex	1.0
